PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Galal, WC; Pan, M; Kelman, Z; Hurwitz, J				Galal, Wiebke Chemnitz; Pan, Miao; Kelman, Zvi; Hurwitz, Jerard			Characterization of DNA Primase Complex Isolated from the Archaeon, Thermococcus kodakaraensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFOLOBUS-SOLFATARICUS; BIOCHEMICAL-CHARACTERIZATION; HETERODIMERIC PRIMASE; REPLICATION FORK; RNA; POLYMERASES; IDENTIFICATION; DOMAIN	In most organisms, DNA replication is initiated by DNA primases, which synthesize primers that are elongated by DNA polymerases. In this study, we describe the isolation and biochemical characterization of the DNA primase complex and its subunits from the archaeon Thermococcus kodakaraensis. The T. kodakaraensis DNA primase complex is a heterodimer containing stoichiometric levels of the p41 and p46 subunits. The catalytic activity of the complex resides within the p41 subunit. We show that the complex supports both DNA and RNA synthesis, whereas the p41 subunit alone marginally produces RNA and synthesizes DNA chains that are longer than those formed by the complex. We report that the T. kodakaraensis primase complex preferentially interacts with dNTP rather than ribonucleoside triphosphates and initiates RNA as well as DNA chains de novo. The latter findings indicate that the archaeal primase complex, in contrast to the eukaryote homolog, can initiate DNA chain synthesis in the absence of ribonucleoside triphosphates. DNA primers formed by the archaeal complex can be elongated extensively by the T. kodakaraensis DNA polymerase (Pol) B, whereas DNA primers formed by the p41 catalytic subunit alone were not. Supplementation of reactions containing the p41 subunit with the p46 subunit leads to PolB-catalyzed DNA synthesis. We also established a rolling circle reaction using a primed 200-nucleotide circle as the substrate. In the presence of the T. kodakaraensis minichromosome maintenance (MCM) 3'-> 35' DNA helicase, PolB, replication factor C, and proliferating cell nuclear antigen, long leading strands (>10 kb) are produced. Supplementation of such reactions with the DNA primase complex supported lagging strand formation as well.	[Galal, Wiebke Chemnitz; Hurwitz, Jerard] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Pan, Miao; Kelman, Zvi] Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Kelman, Zvi] Natl Inst Stand & Technol, Rockville, MD 20850 USA	Memorial Sloan Kettering Cancer Center; National Institute of Standards & Technology (NIST) - USA	Hurwitz, J (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	j-hurwitz@ski.mskcc.org	Pan, Miao/E-7346-2012		National Institutes of Health [GH034559]; National Science Foundation [MCB-0815646]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work was supported, in whole or in part, by National Institutes of Health Grant GH034559 (to J. H.). This work was also supported by National Science Foundation Grant MCB-0815646 (to Z. K.).	Beck K, 2007, NUCLEIC ACIDS RES, V35, P5635, DOI 10.1093/nar/gkm625; Bocquier AA, 2001, CURR BIOL, V11, P452, DOI 10.1016/S0960-9822(01)00119-1; CONAWAY RC, 1982, P NATL ACAD SCI-BIOL, V79, P2523, DOI 10.1073/pnas.79.8.2523; De Falco M, 2004, NUCLEIC ACIDS RES, V32, P5223, DOI 10.1093/nar/gkh865; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Galal WC, 2012, J BIOL CHEM, V287, P16220, DOI 10.1074/jbc.M111.338160; JOSSE J, 1961, J BIOL CHEM, V236, P864; Kasiviswanathan R, 2004, J BIOL CHEM, V279, P28358, DOI 10.1074/jbc.M403202200; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Ladner JE, 2011, P NATL ACAD SCI USA, V108, P2711, DOI 10.1073/pnas.1019179108; Lao-Sirieix SH, 2005, TRENDS GENET, V21, P568, DOI 10.1016/j.tig.2005.07.010; Lao-Sirieix SH, 2004, J MOL BIOL, V344, P1251, DOI 10.1016/j.jmb.2004.10.018; Le Breton M, 2007, J MOL BIOL, V374, P1172, DOI 10.1016/j.jmb.2007.10.015; Li Z, 2010, MBIO, V1, DOI 10.1128/mBio.00221-10; Liu LD, 2001, J BIOL CHEM, V276, P45484, DOI 10.1074/jbc.M106391200; MAITRA U, 1965, P NATL ACAD SCI USA, V54, P815, DOI 10.1073/pnas.54.3.815; Matsunaga F, 2003, EMBO REP, V4, P154, DOI 10.1038/sj.embor.embor732; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Norais C, 2007, PLOS GENET, V3, P729, DOI 10.1371/journal.pgen.0030077; Pan M, 2011, NUCLEIC ACIDS RES, V39, P9671, DOI 10.1093/nar/gkr624; Robinson NP, 2004, CELL, V116, P25, DOI 10.1016/S0092-8674(03)01034-1; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Walter P, 2006, MOL MICROBIOL, V62, P1076, DOI 10.1111/j.1365-2958.2006.05393.x; WANG TSF, 1991, ANNU REV BIOCHEM, V60, P513, DOI 10.1146/annurev.biochem.60.1.513; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200	28	25	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16209	16219		10.1074/jbc.M111.338145	http://dx.doi.org/10.1074/jbc.M111.338145			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22351771	Green Published, hybrid			2022-12-27	WOS:000304030900013
J	Anjem, A; Imlay, JA				Anjem, Adil; Imlay, James A.			Mononuclear Iron Enzymes Are Primary Targets of Hydrogen Peroxide Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-THREONINE DEHYDROGENASE; PROTEIN-TYROSINE PHOSPHATASES; ESCHERICHIA-COLI; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; TRANSCRIPTION FACTOR; CATALYTIC MECHANISM; CYTOSINE DEAMINASE; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; OXIDATIVE STRESS	This study tested whether nonredox metalloenzymes are commonly charged with iron in vivo and are primary targets of oxidative stress because of it. Indeed, three sample mononuclear enzymes, peptide deformylase, threonine dehydrogenase, and cytosine deaminase, were rapidly damaged by micromolar hydrogen peroxide in vitro and in live Escherichia coli. The first two enzymes use a cysteine residue to coordinate the catalytic metal atom; it was quantitatively oxidized by the radical generated by the Fenton reaction. Because oxidized cysteine can be repaired by cellular reductants, the effect was to avoid irreversible damage to other active-site residues. Nevertheless, protracted H2O2 exposure gradually inactivated these enzymes, consistent with the overoxidation of the cysteine residue to sulfinic or sulfonic forms. During H2O2 stress, E. coli defended all three proteins by inducing MntH, a manganese importer, and Dps, an iron-sequestration protein. These proteins appeared to collaborate in replacing the iron atom with nonoxidizable manganese. The implication is that mononuclear metalloproteins are common targets of H2O2 and that both structural and metabolic arrangements exist to protect them.	[Anjem, Adil; Imlay, James A.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Imlay, JA (corresponding author), Univ Illinois, Dept Microbiol, 601 S Goodwin Ave, Urbana, IL 61801 USA.	jimlay@illinois.edu			National Institutes of Health [GM049640]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049640, R01GM049640, R01GM071041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM049640.	ALTUVIA S, 1994, MOL MICROBIOL, V13, P265, DOI 10.1111/j.1365-2958.1994.tb00421.x; Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; ARCHIBALD F, 1986, CRC CR REV MICROBIOL, V13, P63, DOI 10.3109/10408418609108735; ARCHIBALD FS, 1981, J BACTERIOL, V145, P442, DOI 10.1128/JB.145.1.442-451.1981; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Becker A, 1998, NAT STRUCT BIOL, V5, P1053, DOI 10.1038/4162; BERTHIER F, 1993, LETT APPL MICROBIOL, V16, P150, DOI 10.1111/j.1472-765X.1993.tb01381.x; BOYLAN SA, 1981, J BIOL CHEM, V256, P1809; Chan MK, 1997, BIOCHEMISTRY-US, V36, P13904, DOI 10.1021/bi9711543; CHANG EC, 1989, J BIOL CHEM, V264, P12172; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Cotruvo JA, 2011, BIOCHEMISTRY-US, V50, P1672, DOI 10.1021/bi101881d; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; DUGGLEBY RG, 1974, J BIOL CHEM, V249, P167; EPPERLY BR, 1991, J BIOL CHEM, V266, P6086; Forman HJ, 2004, AM J PHYSIOL-CELL PH, V287, pC246, DOI 10.1152/ajpcell.00516.2003; GIACHETTI E, 1984, EXPERIENTIA, V40, P227, DOI 10.1007/BF01963614; Gort AS, 1998, J BACTERIOL, V180, P1402, DOI 10.1128/JB.180.6.1402-1410.1998; Grass G, 2005, J BACTERIOL, V187, P1604, DOI 10.1128/JB.187.5.1604-1611.2005; Hall RS, 2011, BIOCHEMISTRY-US, V50, P5077, DOI 10.1021/bi200483k; Helmann JD, 2003, J BACTERIOL, V185, P243, DOI 10.1128/JB.185.1.243-253.2003; Higashi N, 2008, J BIOCHEM, V144, P77, DOI 10.1093/jb/mvn041; Inaoka T, 1999, J BACTERIOL, V181, P1939, DOI 10.1128/JB.181.6.1939-1943.1999; Ireton GC, 2002, J MOL BIOL, V315, P687, DOI 10.1006/jmbi.2001.5277; Ishikawa K, 2007, J MOL BIOL, V366, P857, DOI 10.1016/j.jmb.2006.11.060; Jain RK, 2005, J AM CHEM SOC, V127, P4558, DOI 10.1021/ja0503074; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Jang SJ, 2007, J BIOL CHEM, V282, P929, DOI 10.1074/jbc.M607646200; Johnson AR, 1998, ARCH BIOCHEM BIOPHYS, V358, P211, DOI 10.1006/abbi.1998.0845; Kehres DG, 2002, J BACTERIOL, V184, P3151, DOI 10.1128/JB.184.12.3151-3158.2002; Lazennec C, 1997, ANAL BIOCHEM, V244, P180, DOI 10.1006/abio.1996.9910; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Martin JE, 2011, MOL MICROBIOL, V80, P319, DOI 10.1111/j.1365-2958.2011.07593.x; Miller J. H., 1972, EXPT MOL GENETICS, P431; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; PORTER DJT, 1993, J BIOL CHEM, V268, P24005; Porter DJT, 2000, BBA-PROTEIN STRUCT M, V1476, P239, DOI 10.1016/S0167-4838(99)00246-0; Rajagopalan PTR, 1998, J BIOL CHEM, V273, P22305, DOI 10.1074/jbc.273.35.22305; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Rowe JL, 2005, J BACTERIOL, V187, P6317, DOI 10.1128/JB.187.18.6317-6323.2005; Sanchez RJ, 2005, J BIOL INORG CHEM, V10, P913, DOI 10.1007/s00775-005-0044-y; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Smith KJ, 2003, PROTEIN SCI, V12, P349, DOI 10.1110/ps.0229303; Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108; Takanishi CL, 2007, BIOCHEMISTRY-US, V46, P14725, DOI 10.1021/bi701625s; Tanner JJ, 2011, ANTIOXID REDOX SIGN, V15, P77, DOI 10.1089/ars.2010.3611; Tseng HJ, 2002, INFECT IMMUN, V70, P1635, DOI 10.1128/IAI.70.3.1635-1639.2002; Tseng HJ, 2001, MOL MICROBIOL, V40, P1175, DOI 10.1046/j.1365-2958.2001.02460.x; Winterbourn CC, 1999, FREE RADICAL BIO MED, V27, P322, DOI 10.1016/S0891-5849(99)00051-9; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Woodmansee AN, 2002, METHOD ENZYMOL, V349, P3, DOI 10.1016/S0076-6879(02)49316-0; Zaffagnini M, 2007, FEBS J, V274, P212, DOI 10.1111/j.1742-4658.2006.05577.x; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	61	151	153	1	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15544	15556		10.1074/jbc.M111.330365	http://dx.doi.org/10.1074/jbc.M111.330365			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22411989	Green Published, hybrid			2022-12-27	WOS:000304006300035
J	Bansal, S; Srinivasan, S; Anandasadagopan, S; Chowdhury, AR; Selvaraj, V; Kalyanaraman, B; Joseph, J; Avadhani, NG				Bansal, Seema; Srinivasan, Satish; Anandasadagopan, Sureshkumar; Chowdhury, Anindya Roy; Selvaraj, Venkatesh; Kalyanaraman, Balaraman; Joseph, Joy; Avadhani, Narayan G.			Additive Effects of Mitochondrion-targeted Cytochrome CYP2E1 and Alcohol Toxicity on Cytochrome c Oxidase Function and Stability of Respirosome Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC ETHANOL-CONSUMPTION; INDUCED LIVER-INJURY; OXIDATIVE STRESS; FATTY LIVER; HUMAN-CELLS; ENERGY-METABOLISM; REACTIVE OXYGEN; NITRIC-OXIDE; SUBUNIT-VB; DYSFUNCTION	Alcohol treatment induces oxidative stress by a combination of increased production of partially reduced oxygen species and decreased cellular antioxidant pool, including GSH. Recently, we showed that mitochondrion-targeted CYP2E1 augments alcohol-mediated toxicity, causing an increase in reactive oxygen species production and oxidative stress. Here, we show that cytochrome c oxidase (CcO), the terminal oxidase of the mitochondrial respiratory chain, is a critical target of CYP2E1-mediated alcohol toxicity. COS-7 and Hep G2 cell lines expressing predominantly mitochondrion-targeted (Mt(++)) CYP2E1 and livers from alcohol-treated rats showed loss of CcO activity and increased protein carbonylation, which was accompanied by a decline in the steady state levels of subunits I, IVI1, and Vb of the CcO complex. This was also accompanied by reduced mitochondrial DNA content and reduced mitochondrial mRNA. These changes were more prominent in Mt(++) cells in comparison with wild type (WT) CYP2E1-expressing or ER+ (mostly microsome-targeted) cells. In addition, mitochondrion-specific antioxidants, ubiquinol conjugated to triphenyl phosphonium, triphenylphosphonium conjugated carboxyl proxyl, and the CYP2E1 inhibitor diallyl sulfide prevented the loss of CcO activity and the CcO subunits, most likely through reduced oxidative damage to the enzyme complex. Our results suggest that damage to CcO and dissociation of respirosome complexes are critical factors in alcohol-induced toxicity, which is augmented by mitochondrion-targeted CYP2E1. We propose that CcO is one of the direct and immediate targets of alcohol-induced toxicity causing respiratory dysfunction.	[Bansal, Seema; Srinivasan, Satish; Anandasadagopan, Sureshkumar; Chowdhury, Anindya Roy; Selvaraj, Venkatesh; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Bansal, Seema; Srinivasan, Satish; Anandasadagopan, Sureshkumar; Chowdhury, Anindya Roy; Selvaraj, Venkatesh; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [Kalyanaraman, Balaraman; Joseph, Joy] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Kalyanaraman, Balaraman; Joseph, Joy] Med Coll Wisconsin, Free Rad Res Ctr, Milwaukee, WI 53226 USA	University of Pennsylvania; University of Pennsylvania; Medical College of Wisconsin; Medical College of Wisconsin	Avadhani, NG (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	Narayan@vet.upenn.edu		Ananda Sadagopan, Suresh Kumar/0000-0001-5178-005X	National Institutes of Health [AA-017749]; ARRA [GM-34883]; Harriet Ellison Woodward Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017749] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harriet Ellison Woodward Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA-017749 and ARRA supplement to GM-34883. This work was also supported by an endowment from the Harriet Ellison Woodward Foundation.	Abdelmegeed MA, 2010, BIOCHEM PHARMACOL, V79, P57, DOI 10.1016/j.bcp.2009.07.016; ARAI M, 1984, BIOCHIM BIOPHYS ACTA, V797, P320, DOI 10.1016/0304-4165(84)90252-6; Aubert J, 2011, CLIN RES HEPATOL GAS, V35, P630, DOI 10.1016/j.clinre.2011.04.015; Bailey SM, 2003, FREE RADICAL RES, V37, P585, DOI 10.1080/1071576031000091711; Bansal S, 2010, J BIOL CHEM, V285, P24609, DOI 10.1074/jbc.M110.121822; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Bender E, 2000, FEBS LETT, V466, P130, DOI 10.1016/S0014-5793(99)01773-1; Betts J, 2004, NEUROCHEM RES, V29, P505, DOI 10.1023/B:NERE.0000014821.07269.8d; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Bondoc FY, 1999, BIOCHEM PHARMACOL, V58, P461, DOI 10.1016/S0006-2952(99)00111-2; BONDY SC, 1994, EUR J PHARM-ENVIRON, V270, P349, DOI 10.1016/0926-6917(94)90011-6; BOTTENUS RE, 1982, BIOCHEM BIOPH RES CO, V105, P1368, DOI 10.1016/0006-291X(82)90938-X; Butura A, 2009, J HEPATOL, V50, P572, DOI 10.1016/j.jhep.2008.10.020; Cahill A, 1999, HEPATOLOGY, V30, P881, DOI 10.1002/hep.510300434; Cahill A, 1997, BIOCHEM BIOPH RES CO, V235, P286, DOI 10.1006/bbrc.1997.6774; CEDERBAUM AI, 1974, ARCH BIOCHEM BIOPHYS, V165, P560, DOI 10.1016/0003-9861(74)90283-5; Chandran K, 2009, BIOPHYS J, V96, P1388, DOI 10.1016/j.bpj.2008.10.042; Cifelli PM, 2002, J INHERIT METAB DIS, V25, P411, DOI 10.1023/A:1020112119716; COLEMAN WB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P142, DOI 10.1016/0005-2728(90)90136-R; Conard C. C., 2001, PROTEOMICS, V22, P2046; Corbucci GG, 2006, MINERVA ANESTESIOL, V72, P337; CUNNINGHAM CC, 1990, ALCOHOL ALCOHOLISM, V25, P127, DOI 10.1093/oxfordjournals.alcalc.a044987; Dhanasekaran A, 2005, FREE RADICAL BIO MED, V39, P567, DOI 10.1016/j.freeradbiomed.2005.04.016; DIMAURO S, 1986, ANN NY ACAD SCI, V488, P19; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Fang JK, 2007, FEBS LETT, V581, P1302, DOI 10.1016/j.febslet.2007.02.042; FIAMINGO FG, 1990, BIOCHEMISTRY-US, V29, P4627, DOI 10.1021/bi00471a018; Fromenty B, 2004, DIABETES METAB, V30, P121, DOI 10.1016/S1262-3636(07)70098-8; Galati D, 2009, BIOCHEM J, V420, P439, DOI 10.1042/BJ20090214; Gonzalez FJ, 2005, MUTAT RES-FUND MOL M, V569, P101, DOI 10.1016/j.mrfmmm.2004.04.021; Guengerich F Peter, 2003, Mol Interv, V3, P194, DOI 10.1124/mi.3.4.194; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168, DOI 10.1021/tx00020a008; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Harman D, 1973, Triangle, V12, P153; HOEK JB, 1994, CURR TOP BIOENERG, V17, P197; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; Kadenbach B, 2004, BBA-BIOENERGETICS, V1655, P400, DOI 10.1016/j.bbabio.2003.06.005; Kadenbach B, 2009, TRENDS MOL MED, V15, P139, DOI 10.1016/j.molmed.2009.02.004; Kennedy JM, 1998, CARDIOVASC RES, V37, P141, DOI 10.1016/S0008-6363(97)00198-3; Knockaert L, 2011, TOXICOL IN VITRO, V25, P475, DOI 10.1016/j.tiv.2010.11.019; Kono H, 1999, AM J PHYSIOL-GASTR L, V277, pG1259, DOI 10.1152/ajpgi.1999.277.6.G1259; KOOP DR, 1986, ALCOHOL CLIN EXP RES, V10, pS44, DOI 10.1111/j.1530-0277.1986.tb05179.x; KOOP DR, 1992, FASEB J, V6, P724, DOI 10.1096/fasebj.6.2.1537462; Korourian S, 1999, TOXICOL SCI, V47, P110, DOI 10.1093/toxsci/47.1.110; KRAHENBUHL S, 1989, BIOCHEM PHARMACOL, V38, P1583, DOI 10.1016/0006-2952(89)90305-5; Krieg RC, 2004, PROTEOMICS, V4, P2789, DOI 10.1002/pmic.200300796; Kuo WW, 2005, J BIOMED SCI, V12, P601, DOI 10.1007/s11373-005-7373-2; Lands WEM, 1998, ALCOHOL, V15, P147, DOI 10.1016/S0741-8329(97)00110-9; Lieber Charles S, 2005, Clin Liver Dis, V9, P1, DOI 10.1016/j.cld.2004.10.005; LIEBER CS, 1973, RES COMMUN CHEM PATH, V6, P983; Lieber CS, 2004, ALCOHOL, V34, P9, DOI 10.1016/j.alcohol.2004.07.008; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu YK, 2010, FREE RADICAL BIO MED, V49, P1406, DOI 10.1016/j.freeradbiomed.2010.07.026; Lu YX, 2008, INT J DIGIT EARTH, V1, P1, DOI 10.1080/17538940801918857; Mantena SK, 2008, FREE RADICAL BIO MED, V44, P1259, DOI 10.1016/j.freeradbiomed.2007.12.029; Mari R, 2000, J BIOL CHEM, V275, P15563; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; Morgan K, 2002, HEPATOLOGY, V36, P122, DOI 10.1053/jhep.2002.33720; MORIMOTO M, 1995, J NUTR, V125, P2953; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; NIRANJAN BG, 1984, J BIOL CHEM, V259, P2495; NOZU F, 1992, HEPATOLOGY, V15, P1099, DOI 10.1002/hep.1840150621; Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200; Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016; Robinson BH, 2000, PEDIATR RES, V48, P581, DOI 10.1203/00006450-200011000-00004; Ronis MJJ, 1996, CYTOCHROMES P450 MET, P211; Sanz A, 2006, ANTIOXID REDOX SIGN, V8, P582, DOI 10.1089/ars.2006.8.582; Sayen MR, 2003, AM J PHYSIOL-CELL PH, V284, pC562, DOI 10.1152/ajpcell.00336.2002; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Sharov VG, 2005, HEART FAIL REV, V10, P305, DOI 10.1007/s10741-005-7545-1; Shiva S, 2003, IUBMB LIFE, V55, P585, DOI 10.1080/15216540310001640489; Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277; Sohn OS, 2001, CANCER RES, V61, P8435; Steenaart NAE, 1997, FEBS LETT, V415, P294, DOI 10.1016/S0014-5793(97)01145-9; Sumner SCJ, 1999, CHEM RES TOXICOL, V12, P1110, DOI 10.1021/tx990040k; Tanji K, 2000, BRAIN PATHOL, V10, P422; Venkatraman A, 2004, J BIOL CHEM, V279, P22092, DOI 10.1074/jbc.M402245200; Venkatraman A, 2003, HEPATOLOGY, V38, P141, DOI 10.1053/jhep.2003.50293; Wang Y, 2009, HEPATOLOGY, V50, P453, DOI 10.1002/hep.22978; Wu DF, 2009, SEMIN LIVER DIS, V29, P141, DOI 10.1055/s-0029-1214370; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Yang S, 2004, CELL MOL LIFE SCI, V61, P220, DOI 10.1007/s00018-003-3357-4; Yu HL, 2003, PROTEOMICS, V3, P2240, DOI 10.1002/pmic.200300475; Yu Q, 2008, AM J PHYSIOL-HEART C, V294, pH2637, DOI 10.1152/ajpheart.91476.2007; Zaher H, 1998, TOXICOL APPL PHARM, V152, P193, DOI 10.1006/taap.1998.8501; Zeng T, 2008, TOXICOLOGY, V252, P86, DOI 10.1016/j.tox.2008.07.062	87	24	25	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15284	15297		10.1074/jbc.M111.314062	http://dx.doi.org/10.1074/jbc.M111.314062			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22396533	Green Published, hybrid			2022-12-27	WOS:000304006300012
J	Cho, SJ; Jung, YS; Zhang, J; Chen, XB				Cho, Seong-Jun; Jung, Yong-Sam; Zhang, Jin; Chen, Xinbin			The RNA-binding Protein RNPC1 Stabilizes the mRNA Encoding the RNA-binding Protein HuR and Cooperates with HuR to Suppress Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE-MEDIATED CLEAVAGE; BREAST-CANCER; EXPRESSION; P53; PHOSPHORYLATION; TRANSLATION; CARCINOMA; ELEMENT; TARGET; CONTRIBUTES	The RNA-binding protein HuR, a member of the embryonic lethal abnormal vision/Hu protein family, plays a critical role in many cellular processes, including cell proliferation, angiogenesis, and inflammatory response. Despite significant progresses in understanding how HuR functions, the mechanism by which HuR expression is controlled is still poorly understood. Here, we showed that RNA-binding protein RNPC1 post-transcriptionally regulates HuR expression via mRNA stability. Specifically, we showed that overexpression of RNPC1 increases, whereas knockdown or knock-out of RNPC1 decreases, the level of HuR transcript and protein. Moreover, we showed that RNPC1, but not mutant RNPC1 deficient in RNA binding, stabilizes HuR transcript via binding to its 3'-untranslated region. Furthermore, to determine the biological significance of RNPC1-enhanced HuR expression, we showed that HuR, by repressing c-Myc expression, facilitates RNPC1-mediated growth suppression. Together, we have uncovered a novel mechanism by which HuR is regulated by RNPC1 via mRNA stability and HuR is a mediator of RNPC1-induced growth suppression.	[Cho, Seong-Jun; Jung, Yong-Sam; Zhang, Jin; Chen, Xinbin] Univ Calif Davis, Ctr Comparat Oncol, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Ctr Comparat Oncol, Davis, CA 95616 USA.	xbchen@ucdavis.edu	Cho, Seong-Jun/P-2491-2019		National Institutes of Health [R01 CA076069, R01 CA102188]; NATIONAL CANCER INSTITUTE [R01CA076069, R01CA081237, R01CA102188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA076069 and R01 CA102188.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Abdelmohsen K, 2010, CELL CYCLE, V9, P1354, DOI 10.4161/cc.9.7.11164; Abdelmohsen K, 2008, P NATL ACAD SCI USA, V105, P20297, DOI 10.1073/pnas.0809376106; Adams DJ, 2003, J BIOL CHEM, V278, P44894, DOI 10.1074/jbc.M307782200; Cho SJ, 2010, NUCLEIC ACIDS RES, V38, P2256, DOI 10.1093/nar/gkp1229; Dai WJ, 2012, NUCLEIC ACIDS RES, V40, P787, DOI 10.1093/nar/gkr783; Datta K, 2005, ONCOGENE, V24, P7850, DOI 10.1038/sj.onc.1208912; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Doller A, 2011, CARCINOGENESIS, V32, P676, DOI 10.1093/carcin/bgr024; Guo X, 2006, CANCER RES, V66, P7948, DOI 10.1158/0008-5472.CAN-05-4362; Guo X, 2009, RNA BIOL, V6, P575, DOI 10.4161/rna.6.5.10079; Harms KL, 2007, CANCER RES, V67, P3145, DOI 10.1158/0008-5472.CAN-06-4397; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Leveille N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1519; Liu L, 2009, MOL BIOL CELL, V20, P4885, DOI 10.1091/mbc.E09-07-0550; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Miyamoto S, 2009, GENES CELLS, V14, P1241, DOI 10.1111/j.1365-2443.2009.01347.x; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Shu LM, 2006, GENE DEV, V20, P2961, DOI 10.1101/gad.1463306; Sully G, 2004, BIOCHEM J, V377, P629, DOI 10.1042/BJ20031484; Talwar S, 2011, J BIOL CHEM, V286, P32333, DOI 10.1074/jbc.M111.255927; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Xu F, 2010, J CELL BIOCHEM, V111, P727, DOI 10.1002/jcb.22762; Yang XL, 2004, J BIOL CHEM, V279, P49298, DOI 10.1074/jbc.M407535200; Zhang J, 2011, GENE DEV, V25, P1528, DOI 10.1101/gad.2069311; Zou TT, 2010, MOL CELL BIOL, V30, P5021, DOI 10.1128/MCB.00807-10	36	30	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14535	14544		10.1074/jbc.M111.326827	http://dx.doi.org/10.1074/jbc.M111.326827			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22371495	Green Published, hybrid			2022-12-27	WOS:000304003200020
J	Jacques, C; Holzenberger, M; Mladenovic, Z; Salvat, C; Pecchi, E; Berenbaum, F; Gosset, M				Jacques, Claire; Holzenberger, Martin; Mladenovic, Zvezdana; Salvat, Colette; Pecchi, Emilie; Berenbaum, Francis; Gosset, Marjolaine			Proinflammatory Actions of Visfatin/Nicotinamide Phosphoribosyltransferase (Nampt) Involve Regulation of Insulin Signaling Pathway and Nampt Enzymatic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-ENHANCING FACTOR; PROSTAGLANDIN-E SYNTHASE-1; GROWTH-FACTOR-I; ARTICULAR CHONDROCYTES; RHEUMATOID-ARTHRITIS; 3T3-L1 ADIPOCYTES; GENE-EXPRESSION; PRIMARY CULTURE; BETA-CELLS; IGF-I	Visfatin (also termed pre-B-cell colony-enhancing factor (PBEF) or nicotinamide phosphoribosyltransferase (Nampt)) is a pleiotropic mediator acting on many inflammatory processes including osteoarthritis. Visfatin exhibits both an intracellular enzymatic activity (nicotinamide phosphoribosyltransferase, Nampt) leading to NAD synthesis and a cytokine function via the binding to its hypothetical receptor. We recently reported the role of visfatin in prostaglandin E-2 (PGE(2)) synthesis in chondrocytes. Here, our aim was to characterize the signaling pathways involved in this response in exploring both the insulin receptor (IR) signaling pathway and Nampt activity. IR was expressed in human and murine chondrocytes, and visfatin triggered Akt phosphorylation in murine chondrocytes. Blocking IR expression with siRNA or activity using the hydroxy-2-naphthalenyl methyl phosphonic acid tris acetoxymethyl ester (HNMPA-(AM)(3)) inhibitor diminished visfatin-induced PGE(2) release in chondrocytes. Moreover, visfatin-induced IGF-1R(-/-) chondrocytes released higher concentration of PGE(2) than IGF-1R (+/+) cells, a finding confirmed with an antibody that blocked IGF-1R. Using RT-PCR, we found that visfatin did not regulate IR expression and that an increased insulin release was also unlikely to be involved because insulin was unable to increase PGE(2) release. Inhibition of Nampt activity using the APO866 inhibitor gradually decreased PGE(2) release, whereas the addition of exogenous nicotinamide increased it. We conclude that the proinflammatory actions of visfatin in chondrocytes involve regulation of IR signaling pathways, possibly through the control of Nampt enzymatic activity.	[Berenbaum, Francis] Univ Paris 06, UR 4, Aging Stress & Inflammat Lab, F-75252 Paris 5, France; [Holzenberger, Martin] Pierre & Marie Curie Fac Med, INSERM, U938, F-75571 Paris, France; [Berenbaum, Francis] Hop St Antoine, Dept Rheumatol, AP HP, F-75571 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Berenbaum, F (corresponding author), Univ Paris 06, UR 4, Aging Stress & Inflammat Lab, 7 Quai St Bernard, F-75252 Paris 5, France.	francis.berenbaum@sat.aphp.fr	Holzenberger, Martin/N-9732-2018; Berenbaum, Francis/AAO-5690-2020; Gosset, Marjolaine/ACE-0183-2022	Berenbaum, Francis/0000-0001-8252-7815; Gosset, Marjolaine/0000-0002-4875-7892; JACQUES, Claire/0000-0002-2741-5340; Holzenberger, Martin/0000-0003-4869-725X	Fondation Arthritis; French Society of Rheumatology	Fondation Arthritis; French Society of Rheumatology	This work was supported by the Fondation Arthritis and the French Society of Rheumatology.	Adya R, 2008, CARDIOVASC RES, V78, P356, DOI 10.1093/cvr/cvm111; Aigner T, 2006, ADV DRUG DELIVER REV, V58, P128, DOI 10.1016/j.addr.2006.01.020; Albrecht C, 2009, INT J MOL MED, V23, P347, DOI 10.3892/ijmm_00000138; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; BALTENSPERGER K, 1992, P NATL ACAD SCI USA, V89, P7885, DOI 10.1073/pnas.89.17.7885; Bao JP, 2009, J INT MED RES, V37, P1655, DOI 10.1177/147323000903700601; Bi TQ, 2010, CANCER BIOL THER, V10, P119, DOI 10.4161/cbt.10.2.12581; Blaise R, 2009, ARTHRITIS RHEUM-US, V60, P428, DOI 10.1002/art.24250; Boini KM, 2010, BBA-MOL CELL BIOL L, V1801, P1294, DOI 10.1016/j.bbalip.2010.09.001; Brentano F, 2007, ARTHRITIS RHEUM, V56, P2829, DOI 10.1002/art.22833; Brown JEP, 2010, J MOL ENDOCRINOL, V44, P171, DOI 10.1677/JME-09-0071; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; Chabane N, 2008, OSTEOARTHR CARTILAGE, V16, P1267, DOI 10.1016/j.joca.2008.03.009; Chan SJ, 1997, P NATL ACAD SCI USA, V94, P12446, DOI 10.1073/pnas.94.23.12446; Claassen H, 2011, ANN ANAT, V193, P23, DOI 10.1016/j.aanat.2010.09.005; Dahl TB, 2007, CIRCULATION, V115, P972, DOI 10.1161/CIRCULATIONAHA.106.665893; Dominici FP, 2005, GROWTH HORM IGF RES, V15, P324, DOI 10.1016/j.ghir.2005.07.001; DORE S, 1995, ARTHRITIS RHEUM, V38, P413, DOI 10.1002/art.1780380319; Ekenstedt KJ, 2006, ARTHRITIS RHEUM-US, V54, P3850, DOI 10.1002/art.22254; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Fukuhara A, 2007, SCIENCE, V318, P565, DOI 10.1126/science.318.5850.565b; Gonzalez-Rodriguez A, 2010, DIABETES, V59, P588, DOI 10.2337/db09-0796; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Gosset M, 2008, ARTHRITIS RHEUM-US, V58, P1399, DOI 10.1002/art.23431; Jacques C, 1997, J CLIN INVEST, V99, P1864, DOI 10.1172/JCI119353; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Kim JJ, 2002, GROWTH HORM IGF RES, V12, P84, DOI 10.1054/ghir.2002.0265; Kim MK, 2006, J MOL BIOL, V362, P66, DOI 10.1016/j.jmb.2006.06.082; Kralisch S, 2005, J ENDOCRINOL, V185, pR1, DOI 10.1677/joe.1.06211; Kralisch S, 2005, AM J PHYSIOL-ENDOC M, V289, pE586, DOI 10.1152/ajpendo.00090.2005; Li XF, 2005, J RHEUMATOL, V32, P887; Liu P, 2009, CELL BIOL INT, V33, P19, DOI 10.1016/j.cellbi.2008.10.015; Luk T, 2008, J LEUKOCYTE BIOL, V83, P804, DOI 10.1189/jlb.0807581; Masuko-Hongo K, 2004, ARTHRITIS RHEUM-US, V50, P2829, DOI 10.1002/art.20437; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Remacle-Bonnet M, 2005, AM J PATHOL, V167, P761, DOI 10.1016/S0002-9440(10)62049-4; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Romacho T, 2009, DIABETOLOGIA, V52, P2455, DOI 10.1007/s00125-009-1509-2; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; Rosa SC, 2011, OSTEOARTHR CARTILAGE, V19, P719, DOI 10.1016/j.joca.2011.02.004; Salvat C, 2005, OSTEOARTHR CARTILAGE, V13, P243, DOI 10.1016/j.joca.2004.11.008; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Schmidt MB, 2006, OSTEOARTHR CARTILAGE, V14, P403, DOI 10.1016/j.joca.2005.10.011; Sun Q, 2009, ANN MED, V41, P311, DOI 10.1080/07853890902729760; Xie H, 2007, CALCIFIED TISSUE INT, V80, P201, DOI 10.1007/s00223-006-0155-7; Yammani RR, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3705; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC; Yin WH, 2009, J BIOL CHEM, V284, P31972, DOI 10.1074/jbc.M109.056838; Zhang J, 2007, J BIOL CHEM, V282, P34356, DOI 10.1074/jbc.M706644200; Zhang R, 2010, J BIOL CHEM, V285, P7097, DOI 10.1074/jbc.M109.038604	51	54	60	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15100	15108		10.1074/jbc.M112.350215	http://dx.doi.org/10.1074/jbc.M112.350215			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22399297	Green Published, hybrid			2022-12-27	WOS:000304003200071
J	Roman-Vendrell, C; Yu, YJ; Yudowski, GA				Roman-Vendrell, Cristina; Yu, Y. Joy; Yudowski, Guillermo Ariel			Fast Modulation of mu-Opioid Receptor (MOR) Recycling Is Mediated by Receptor Agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; MYOSIN VB; POSTSYNAPTIC PLASTICITY; FLUORESCENCE MICROSCOPY; MORPHINE-TOLERANCE; PLASMA-MEMBRANE; AMPA RECEPTORS; ENDOCYTOSIS; TRAFFICKING; DESENSITIZATION	The mu-opioid receptor (MOR) is a member of the G protein-coupled receptor family and the main target of endogenous opioid neuropeptides and morphine. Upon activation by ligands, MORs are rapidly internalized via clathrin-coated pits in heterologous cells and dissociated striatal neurons. After initial endocytosis, resensitized receptors recycle back to the cell surface by vesicular delivery for subsequent cycles of activation. MOR trafficking has been linked to opioid tolerance after acute exposure to agonist, but it is also involved in the resensitization process. Several studies describe the regulation and mechanism of MOR endocytosis, but little is known about the recycling of resensitized receptors to the cell surface. To study this process, we induced internalization of MOR with [D-Ala(2), N-Me-Phe(4), Gly(5)-ol]-enkephalin (DAMGO) and morphine and imaged in real time single vesicles recycling receptors to the cell surface. We determined single vesicle recycling kinetics and the number of receptors contained in them. Then we demonstrated that rapid vesicular delivery of recycling MORs to the cell surface was mediated by the actin-microtubule cytoskeleton. Recycling was also dependent on Rab4, Rab11, and the Ca2+-sensitive motor protein myosin Vb. Finally, we showed that recycling is acutely modulated by the presence of agonists and the levels of cAMP. Our work identifies a novel trafficking mechanism that increases the number of cell surface MORs during acute agonist exposure, effectively reducing the development of opioid tolerance.	[Roman-Vendrell, Cristina; Yudowski, Guillermo Ariel] Univ Puerto Rico, Inst Neurobiol, San Juan, PR 00901 USA; [Roman-Vendrell, Cristina; Yudowski, Guillermo Ariel] Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00901 USA; [Yu, Y. Joy] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94158 USA	University of Puerto Rico; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of California System; University of California San Francisco	Yudowski, GA (corresponding author), Univ Puerto Rico, Inst Neurobiol, 201 Calle Norzagaray, San Juan, PR 00901 USA.	Guillermo.yudowski@upr.edu		Yudowski, Guillermo/0000-0001-5989-4131	National Institutes of Health (NIH) [K99/R00]; NIH, National Institute on Drug Abuse [DA023444]; NIH, American Recovery and Reinvestment Act [1P30NS069258]; Puerto Rico Science, Technology, and Research Trust; Kirschstein Predoctoral National Research Service; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA023444, K99DA023444] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH, American Recovery and Reinvestment Act(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Puerto Rico Science, Technology, and Research Trust; Kirschstein Predoctoral National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant K99/R00; NIH, National Institute on Drug Abuse, Grant DA023444; and NIH, American Recovery and Reinvestment Act, Grant 1P30NS069258. This work was also supported by the Puerto Rico Science, Technology, and Research Trust Fund.; Supported by a Kirschstein Predoctoral National Research Service Award.	Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Archer-Lahlou E, 2009, J CELL MOL MED, V13, P147, DOI 10.1111/j.1582-4934.2008.00308.x; Debic HH, 2005, J NEUROSCI, V25, P7847, DOI 10.1523/JNEUROSCI.5045-04.2005; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Enquist J, 2011, J PHARMACOL EXP THER, V338, P633, DOI 10.1124/jpet.111.179754; Evans LL, 1998, J CELL SCI, V111, P2055; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Groc L, 2008, MOL MEMBR BIOL, V25, P344, DOI 10.1080/09687680801958364; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; JIN MJ, 1993, J BIOL CHEM, V268, P18390; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kennedy MJ, 2011, NEURON, V69, P856, DOI 10.1016/j.neuron.2011.02.032; Koch T, 2005, MOL PHARMACOL, V67, P280, DOI 10.1124/mol.104.004994; Koch T, 1998, J BIOL CHEM, V273, P13652, DOI 10.1074/jbc.273.22.13652; Koch T, 2008, PHARMACOL THERAPEUT, V117, P199, DOI 10.1016/j.pharmthera.2007.10.003; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Martini L, 2007, CURR OPIN NEUROBIOL, V17, P556, DOI 10.1016/j.conb.2007.10.004; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Onoprishvili I, 2003, MOL PHARMACOL, V64, P1092, DOI 10.1124/mol.64.5.1092; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Qiu Y, 2003, J BIOL CHEM, V278, P36733, DOI 10.1074/jbc.M305857200; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Schmoranzer J, 2000, J CELL BIOL, V149, P23, DOI 10.1083/jcb.149.1.23; Schonteich E, 2008, J CELL SCI, V121, P3824, DOI 10.1242/jcs.032441; Sheff DR, 2002, MOL BIOL CELL, V13, P262, DOI 10.1091/mbc.01-07-0320; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stepanenko OV, 2004, BIOCHEMISTRY-US, V43, P14913, DOI 10.1021/bi048725t; Volpicelli LA, 2002, J NEUROSCI, V22, P9776, DOI 10.1523/jneurosci.22-22-09776.2002; Wang FF, 2008, MOL ENDOCRINOL, V22, P1881, DOI 10.1210/me.2007-0496; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Yu YJ, 2010, J NEUROSCI, V30, P11703, DOI 10.1523/JNEUROSCI.6282-09.2010; Yudowski GA, 2006, NAT NEUROSCI, V9, P622, DOI 10.1038/nn1679; Yudowski GA, 2007, J NEUROSCI, V27, P11112, DOI 10.1523/JNEUROSCI.2465-07.2007; Yudowski GA, 2011, METHODS MOL BIOL, V756, P325, DOI 10.1007/978-1-61779-160-4_19; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892	45	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14782	14791		10.1074/jbc.M111.319616	http://dx.doi.org/10.1074/jbc.M111.319616			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22378794	Green Published, hybrid			2022-12-27	WOS:000304003200043
J	Sarkar, J; Poruri, K; Boniecki, MT; McTavish, KK; Martinis, SA				Sarkar, Jaya; Poruri, Kiranmai; Boniecki, Michal T.; McTavish, Katherine K.; Martinis, Susan A.			Yeast Mitochondrial Leucyl-tRNA Synthetase CP1 Domain Has Functionally Diverged to Accommodate RNA Splicing at Expense of Hydrolytic Editing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-I INTRONS; MATURASE DEFICIENCY; CRYSTAL-STRUCTURE; PROTEIN; ACID; NAM2; CEREVISIAE; TRNA(LEU); SEQUENCES; REQUIRES	The yeast mitochondrial leucyl-tRNA synthetase (ymLeuRS) performs dual essential roles in group I intron splicing and protein synthesis. A specific LeuRS domain called CP1 is responsible for clearing noncognate amino acids that are misactivated during aminoacylation. The ymLeuRS CP1 domain also plays a critical role in splicing. Herein, the ymLeuRS CP1 domain was isolated from the full-length enzyme and was active in RNA splicing in vitro. Unlike its Escherichia coli LeuRS CP1 domain counterpart, it failed to significantly hydrolyze misaminoacylated tRNA(Leu). In addition and in stark contrast to the yeast domain, the editing-active E. coli LeuRS CP1 domain failed to recapitulate the splicing activity of the full-length E. coli enzyme. Although LeuRS-dependent splicing activity is rooted in an ancient adaptation for its aminoacylation activity, these results suggest that the ymLeuRS has functionally diverged to confer a robust splicing activity. This adaptation could have come at some expense to the protein's housekeeping role in aminoacylation and editing.	[Sarkar, Jaya; Poruri, Kiranmai; Boniecki, Michal T.; McTavish, Katherine K.; Martinis, Susan A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Martinis, SA (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61820 USA.	martinis@life.illinois.edu		poruri, kiran/0000-0002-3127-0244; Martinis, Susan/0000-0001-5730-8346	National Institutes of Health [GM063789, GM63107]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063789, R01GM063107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM063789 and GM63107.	AKINS RA, 1987, CELL, V50, P331, DOI 10.1016/0092-8674(87)90488-0; Betha AK, 2007, BIOCHEMISTRY-US, V46, P6258, DOI 10.1021/bi061965j; Boniecki MT, 2009, J BIOL CHEM, V284, P26243, DOI 10.1074/jbc.M109.031179; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; CHERNIACK AD, 1990, CELL, V62, P745, DOI 10.1016/0092-8674(90)90119-Y; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; DELASALLE H, 1982, CELL, V28, P721, DOI 10.1016/0092-8674(82)90051-4; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; GRODBERG J, 1988, J BACTERIOL, V170, P1245, DOI 10.1128/jb.170.3.1245-1253.1988; HERBERT CJ, 1988, EMBO J, V7, P473, DOI 10.1002/j.1460-2075.1988.tb02835.x; HOU YM, 1991, P NATL ACAD SCI USA, V88, P976, DOI 10.1073/pnas.88.3.976; Houman F, 2000, P NATL ACAD SCI USA, V97, P13743, DOI 10.1073/pnas.240465597; Hsu JL, 2006, J BIOL CHEM, V281, P23075, DOI 10.1074/jbc.M601606200; Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Karkhanis VA, 2006, J BIOL CHEM, V281, P33217, DOI 10.1074/jbc.M607406200; LABOUESSE M, 1984, EUR J BIOCHEM, V144, P85, DOI 10.1111/j.1432-1033.1984.tb08434.x; LABOUESSE M, 1987, EMBO J, V6, P713, DOI 10.1002/j.1460-2075.1987.tb04812.x; LABOUESSE M, 1985, CELL, V41, P133, DOI 10.1016/0092-8674(85)90068-6; LABOUESSE M, 1990, MOL GEN GENET, V224, P209, DOI 10.1007/BF00271554; LAMBOWITZ AM, 1990, TRENDS BIOCHEM SCI, V15, P440, DOI 10.1016/0968-0004(90)90283-H; Li GY, 1996, MOL GEN GENET, V252, P667, DOI 10.1007/BF02173972; Li T, 1999, BIOCHEMISTRY-US, V38, P13063, DOI 10.1021/bi990384+; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; Martinis Susan A., 1999, EMBO (European Molecular Biology Organization) Journal, V18, P4591, DOI 10.1093/emboj/18.17.4591; Mascarenhas AP, 2008, BIOCHEMISTRY-US, V47, P4808, DOI 10.1021/bi702494q; Nawaz M. H., 2008, WILEY ENCY CHEM BIOL, P1; Nawaz MH, 2007, J MOL BIOL, V367, P384, DOI 10.1016/j.jmb.2006.12.051; Paukstelis PJ, 2008, P NATL ACAD SCI USA, V105, P6010, DOI 10.1073/pnas.0801722105; Paukstelis PJ, 2008, NATURE, V451, P94, DOI 10.1038/nature06413; Rho SB, 2002, EMBO J, V21, P6874, DOI 10.1093/emboj/cdf671; Rho SB, 2000, RNA, V6, P1882, DOI 10.1017/S1355838200001254; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; SCHREIER AA, 1972, BIOCHEMISTRY-US, V11, P1582, DOI 10.1021/bi00759a006; SERAPHIN B, 1987, P NATL ACAD SCI USA, V84, P6810, DOI 10.1073/pnas.84.19.6810; STARZYK RM, 1987, SCIENCE, V237, P1614, DOI 10.1126/science.3306924; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Williams AM, 2006, P NATL ACAD SCI USA, V103, P3586, DOI 10.1073/pnas.0507362103	38	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14772	14781		10.1074/jbc.M111.322412	http://dx.doi.org/10.1074/jbc.M111.322412			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22383526	hybrid, Green Published			2022-12-27	WOS:000304003200042
J	Yoboue, ED; Augier, E; Galinier, A; Blancard, C; Pinson, B; Casteilla, L; Rigoulet, M; Devin, A				Yoboue, Edgar D.; Augier, Eric; Galinier, Anne; Blancard, Corinne; Pinson, Benoit; Casteilla, Louis; Rigoulet, Michel; Devin, Anne			cAMP-induced Mitochondrial Compartment Biogenesis ROLE OF GLUTATHIONE REDOX STATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; GENE-EXPRESSION; GROWTH-YIELD; ACTIVATION; CELLS; SITE; CONSEQUENCES; METABOLISM; MECHANISMS	Cell fate and proliferation are tightly linked to the regulation of the mitochondrial energy metabolism. Hence, mitochondrial biogenesis regulation, a complex process that requires a tight coordination in the expression of the nuclear and mitochondrial genomes, has a major impact on cell fate and is of high importance. Here, we studied the molecular mechanisms involved in the regulation of mitochondrial biogenesis through a nutrient-sensing pathway, the Ras-cAMP pathway. Activation of this pathway induces a decrease in the cellular phosphate potential that alleviates the redox pressure on the mitochondrial respiratory chain. One of the cellular consequences of this modulation of cellular phosphate potential is an increase in the cellular glutathione redox state. The redox state of the glutathione disulfide-glutathione couple is a well known important indicator of the cellular redox environment, which is itself tightly linked to mitochondrial activity, mitochondria being the main cellular producer of reactive oxygen species. The master regulator of mitochondrial biogenesis in yeast (i.e. the transcriptional co-activator Hap4p) is positively regulated by the cellular glutathione redox state. Using a strain that is unable to modulate its glutathione redox state (Delta glr1), we pinpoint a positive feedback loop between this redox state and the control of mitochondrial biogenesis. This is the first time that control of mitochondrial biogenesis through glutathione redox state has been shown.	[Yoboue, Edgar D.; Augier, Eric; Blancard, Corinne; Pinson, Benoit; Rigoulet, Michel; Devin, Anne] CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, F-33000 Bordeaux, France; [Yoboue, Edgar D.; Augier, Eric; Blancard, Corinne; Pinson, Benoit; Rigoulet, Michel; Devin, Anne] Univ Bordeaux, Inst Biochim & Genet Cellulaires, UMR 5095, F-33000 Bordeaux, France; [Galinier, Anne; Casteilla, Louis] UMR UPS CNRS 5273, EFS, INSERM U1031, STROMALab,IFR 150, F-31432 Toulouse 4, France; [Galinier, Anne; Casteilla, Louis] Ctr Hosp Univ Rangueil, Biochim Lab, F-31059 Toulouse 9, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse	Devin, A (corresponding author), CNRS, IBGC, Bioenerget & Cell Metab Lab, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	anne.devin@ibgc.u-bordeaux2.fr	YOBOUE, Edgar D./AAA-7706-2019	Casteilla, Louis/0000-0001-9647-3248; Galinier, Anne/0000-0003-2454-5681; Pinson, Benoit/0000-0003-2936-9058	Agence Nationale de la Recherche [NT05-2_42268]; Conseil Regional d'Aquitaine; Association contre les Maladies Mitochondriales	Agence Nationale de la Recherche(French National Research Agency (ANR)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Association contre les Maladies Mitochondriales	This work was supported in part by Agence Nationale de la Recherche Grant NT05-2_42268 and the Conseil Regional d'Aquitaine.; Supported in part by the Association contre les Maladies Mitochondriales.	ATZORI L, 1990, J CELL PHYSIOL, V143, P165, DOI 10.1002/jcp.1041430123; Ayer A, 2010, FREE RADICAL BIO MED, V49, P1956, DOI 10.1016/j.freeradbiomed.2010.09.023; BEAUVOIT B, 1993, EUR J BIOCHEM, V214, P163, DOI 10.1111/j.1432-1033.1993.tb17909.x; Bogacka I, 2005, J CLIN ENDOCR METAB, V90, P6650, DOI 10.1210/jc.2005-1024; Buschlen S, 2003, COMP FUNCT GENOM, V4, P37, DOI 10.1002/cfg.254; CAIN K, 1977, BIOCHEM J, V162, P575, DOI 10.1042/bj1620575; Chevtzoff C, 2005, BBA-BIOENERGETICS, V1706, P117, DOI 10.1016/j.bbabio.2004.10.001; Chevtzoff C, 2010, J BIOL CHEM, V285, P1733, DOI 10.1074/jbc.M109.019570; DANG VD, 1994, YEAST, V10, P1273, DOI 10.1002/yea.320101004; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; Dejean L, 2000, BBA-BIOENERGETICS, V1457, P45, DOI 10.1016/S0005-2728(00)00053-0; Dejean L, 2002, BBA-BIOENERGETICS, V1554, P159, DOI 10.1016/S0005-2728(02)00240-2; Dejean L, 2002, BIOCHEM BIOPH RES CO, V293, P1383, DOI 10.1016/S0006-291X(02)00391-1; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Denis V, 1998, MOL MICROBIOL, V30, P557, DOI 10.1046/j.1365-2958.1998.01087.x; Devin A, 2004, TOXICOL MECH METHOD, V14, P271, DOI 10.1080/15376520490479620; Devin A, 2007, AM J PHYSIOL-CELL PH, V292, pC52, DOI 10.1152/ajpcell.00208.2006; Devin A, 2006, J BIOL CHEM, V281, P26779, DOI 10.1074/jbc.M604800200; Fondrat C, 1996, COMPUT APPL BIOSCI, V12, P363; FORSBURG SL, 1989, ANNU REV CELL BIOL, V5, P153, DOI 10.1146/annurev.cb.05.110189.001101; FORSBURG SL, 1988, MOL CELL BIOL, V8, P647, DOI 10.1128/MCB.8.2.647; Grant CM, 1996, MOL MICROBIOL, V21, P171, DOI 10.1046/j.1365-2958.1996.6351340.x; GUARENTE L, 1981, P NATL ACAD SCI-BIOL, V78, P2199, DOI 10.1073/pnas.78.4.2199; HAHN S, 1988, MOL CELL BIOL, V8, P655, DOI 10.1128/MCB.8.2.655; Hutter DE, 1997, EXP CELL RES, V232, P435, DOI 10.1006/excr.1997.3527; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; KIPPERT F, 1995, FEMS MICROBIOL LETT, V128, P201, DOI 10.1016/0378-1097(95)00113-J; Kirlin WG, 1999, FREE RADICAL BIO MED, V27, P1208, DOI 10.1016/S0891-5849(99)00145-8; Kumar A, 2006, BIOCHEM J, V396, P61, DOI 10.1042/BJ20051411; Lascaris R, 2003, GENOME BIOL, V4; Leverve X, 1998, MOL CELL BIOCHEM, V184, P53, DOI 10.1023/A:1006810209531; Loret MO, 2007, YEAST, V24, P47, DOI 10.1002/yea.1435; MCNABB DS, 1995, GENE DEV, V9, P47, DOI 10.1101/gad.9.1.47; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9; Noubhani A, 2009, J BIOL CHEM, V284, P27229, DOI 10.1074/jbc.M109.029454; OLESEN J, 1987, CELL, V51, P953, DOI 10.1016/0092-8674(87)90582-4; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Perrone GG, 2008, BBA-MOL CELL RES, V1783, P1354, DOI 10.1016/j.bbamcr.2008.01.023; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Pinson B, 2004, J BIOL CHEM, V279, P35273, DOI 10.1074/jbc.M405398200; Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Sumner JB, 1944, SCIENCE, V100, P413, DOI 10.1126/science.100.2601.413; THEVELEIN JM, 1987, J GEN MICROBIOL, V133, P2197; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; WILSON RB, 1993, FEBS LETT, V325, P191, DOI 10.1016/0014-5793(93)81071-7	47	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14569	14578		10.1074/jbc.M111.302786	http://dx.doi.org/10.1074/jbc.M111.302786			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22396541	Green Published, hybrid			2022-12-27	WOS:000304003200023
J	Linley, AJ; Mathieu, MG; Miles, AK; Rees, RC; McArdle, SEB; Regad, T				Linley, Adam J.; Mathieu, Morgan G.; Miles, Amanda K.; Rees, Robert C.; McArdle, Stephanie E. B.; Regad, Tarik			The Helicase HAGE Expressed by Malignant Melanoma-Initiating Cells Is Required for Tumor Cell Proliferation in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER/TESTIS ANTIGEN CAGE; RNA HELICASES; MULTIFUNCTIONAL PROTEINS; SIGNALING PATHWAYS; ONCOGENIC RAS; BOX PROTEINS; CANCER; FAMILY; P68; ERK	Malignant melanoma-initiating cells (MMIC) are a subpopulation of cells responsible for melanoma tumor growth and progression. They are defined by the expression of the ATP-binding cassette (ABC) subfamily B member 5 (ABCB5). Here, we identified a critical role for the DEAD-box helicase antigen (HAGE) in ABCB5+ MMIC-dependent tumorigenesis and show that HAGE-specific inactivation inhibits melanoma tumor growth mediated by this tumor-initiating population. Knockdown of HAGE led to a significant decrease in RAS protein expression with a concomitant decrease in activation of the AKT and ERK signaling pathways implicated to play an important role in melanoma progression. To confirm that the reduction in NRAS (Neuroblastoma RAS) expression was dependent on the HAGE helicase activity, we showed that NRAS, effectively silenced by siRNA, could be rescued by reintroduction of HAGE in cells lacking HAGE. Furthermore, we provide a mechanism by which HAGE promotes NRAS unwinding in vitro. We also observed using tumor transplantation in Non-obese diabetic/severe combined immunodeficiency mice that the HAGE knockdown in a ABCB5+ melanoma cell line displayed a significant decrease in tumor growth and compared with the control. Our results suggest that the helicase HAGE is required for ABCB5+ MMIC-dependent tumor growth through promoting RAS protein expression and that cancer therapies targeting HAGE helicase may have broad applications for treating malignant melanoma and potentially other cancer types.	[Linley, Adam J.; Mathieu, Morgan G.; Miles, Amanda K.; Rees, Robert C.; McArdle, Stephanie E. B.; Regad, Tarik] Nottingham Trent Univ, Sch Sci & Technol, John van Geest Canc Res Ctr, Nottingham NG11 8NS, England	Nottingham Trent University	Regad, T (corresponding author), Nottingham Trent Univ, Sch Sci & Technol, John van Geest Canc Res Ctr, Clifton Lane, Nottingham NG11 8NS, England.	tarik.regad@ntu.ac.uk	McArdle, Stephanie EB/I-4712-2015; Regad, Tarik/A-6095-2012	McArdle, Stephanie EB/0000-0001-6929-9782; Regad, Tarik/0000-0003-4028-6368; Miles, Amanda/0000-0002-5388-938X; Linley, Adam/0000-0002-8176-5560	John and Lucille van Geest Foundation	John and Lucille van Geest Foundation	This work was supported by the John and Lucille van Geest Foundation.	AKAO Y, 1995, CANCER RES, V55, P3444; Amler LC, 1996, GENE CHROMOSOME CANC, V15, P134, DOI 10.1002/(SICI)1098-2264(199602)15:2<134::AID-GCC9>3.0.CO;2-4; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; BOS JL, 1989, CANCER RES, V49, P4682; Camats M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002926; Campbell PM, 2004, SEMIN CANCER BIOL, V14, P105, DOI 10.1016/j.semcancer.2003.09.015; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Castellano E, 2010, CURR TOP MICROBIOL, V346, P143, DOI 10.1007/82_2010_56; Causevic M, 2001, ONCOGENE, V20, P7734, DOI 10.1038/sj.onc.1204976; Christensen C, 2005, ONCOGENE, V24, P6292, DOI 10.1038/sj.onc.1208758; Clark EL, 2008, CANCER RES, V68, P7938, DOI 10.1158/0008-5472.CAN-08-0932; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Eberle J, 2002, BRIT J CANCER, V86, P1957, DOI 10.1038/sj.bjc.6600351; Frank NY, 2011, CANCER RES, V71, P1474, DOI 10.1158/0008-5472.CAN-10-1660; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Fuller-Pace FV, 2011, FUTURE ONCOL, V7, P239, DOI 10.2217/FON.11.1; Giehl K, 2005, BIOL CHEM, V386, P193, DOI 10.1515/BC.2005.025; Godbout R, 1998, J BIOL CHEM, V273, P21161, DOI 10.1074/jbc.273.33.21161; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Janknecht R, 2010, AM J TRANSL RES, V2, P223; Jankowsky A, 2011, NUCLEIC ACIDS RES, V39, pD338, DOI 10.1093/nar/gkq1002; Kim Y, 2008, J MICROBIOL BIOTECHN, V18, P600; Kim Y, 2010, J BIOL CHEM, V285, P25957, DOI 10.1074/jbc.M109.095950; Liggins Amanda P, 2010, Cancer Immun, V10, P8; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Manoukian AS, 2002, ADV CANCER RES, V84, P203, DOI 10.1016/S0065-230X(02)84007-6; Martelange V, 2000, CANCER RES, V60, P3848; Mathieu Morgan G, 2010, Cancer Immun, V10, P2; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Na YR, 2009, CANCER SCI, V100, P1429, DOI 10.1111/j.1349-7006.2009.01218.x; Por E, 2010, J BIOL CHEM, V285, P14475, DOI 10.1074/jbc.M109.084400; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Shim H, 2006, MOL CELLS, V21, P367; Silverman E, 2003, GENE, V312, P1, DOI 10.1016/S0378-1119(03)00626-7; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wilson BJ, 2011, CANCER RES, V71, P5307, DOI 10.1158/0008-5472.CAN-11-0221	42	28	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13633	13643		10.1074/jbc.M111.308973	http://dx.doi.org/10.1074/jbc.M111.308973			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22393060	Green Published, hybrid			2022-12-27	WOS:000303996300019
J	Shao, QM; Yang, B; Xu, QY; Li, XQ; Lu, ZQ; Wang, CS; Huang, YP; Soderhall, K; Ling, EJ				Shao, Qimiao; Yang, Bing; Xu, Qiuyun; Li, Xuquan; Lu, Zhiqiang; Wang, Chengshu; Huang, Yongping; Soderhall, Kenneth; Ling, Erjun			Hindgut Innate Immunity and Regulation of Fecal Microbiota through Melanization in Insects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SILKWORM BOMBYX-MORI; MANDUCA-SEXTA; DROSOPHILA-MELANOGASTER; IN-VITRO; PHENOLOXIDASE; INFECTION; IDENTIFICATION; BACTERIA; DEFENSE; OXIDASE	Many insects eat the green leaves of plants but excrete black feces in an as yet unknown mechanism. Insects cannot avoid ingesting pathogens with food that will be specifically detected by the midgut immune system. However, just as in mammals, many pathogens can still escape the insect midgut immune system and arrive in the hindgut, where they are excreted out with the feces. Here we show that the melanization of hindgut content induced by prophenoloxidase, a key enzyme that induces the production of melanin around invaders and at wound sites, is the last line of immune defense to clear bacteria before feces excretion. We used the silkworm Bombyx mori as a model and found that prophenoloxidase produced by hindgut cells is secreted into the hindgut contents. Several experiments were done to clearly demonstrate that the blackening of the insect feces was due to activated phenoloxidase, which served to regulate the number of bacteria in the hindgut. Our analysis of the silkworm hindgut prophenoloxidase discloses the natural secret of why the phytophagous insect feces is black and provides insight into hindgut innate immunity, which is still rather unclear in mammals.	[Soderhall, Kenneth] Uppsala Univ, Dept Comparat Physiol, S-75218 Uppsala, Sweden; [Shao, Qimiao; Yang, Bing; Xu, Qiuyun; Li, Xuquan; Wang, Chengshu; Huang, Yongping; Ling, Erjun] Chinese Acad Sci, Key Lab Insect Dev & Evolutionary Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai 200032, Peoples R China; [Lu, Zhiqiang] NW A&F Univ, Coll Plant Protect, Yangling 712100, Shanxi, Peoples R China	Uppsala University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Northwest A&F University - China	Soderhall, K (corresponding author), Uppsala Univ, Dept Comparat Physiol, Norbyvagen 18 A, S-75218 Uppsala, Sweden.	kenneth.soderhall@ebc.uu.se; erjunling@sippe.ac.cn	Wang, Chengshu/A-1656-2011	Wang, Chengshu/0000-0003-1477-1466	National Natural Science Foundation of China [30970408]; National Basic Research Program of China [2012CB114605]; Chinese Academy of Sciences [KSCX2-EW-J-12, 2009OHTP05]; Swedish Science Research Council [319-2010-6250]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Swedish Science Research Council	This work was supported by the National Natural Science Foundation of China (30970408), National Basic Research Program of China (2012CB114605), Chinese Academy of Sciences (KSCX2-EW-J-12 and 2009OHTP05), and the Swedish Science Research Council (319-2010-6250).	Apidianakis Y, 2011, DIS MODEL MECH, V4, P21, DOI 10.1242/dmm.003970; Asano T, 2009, INSECT MOL BIOL, V18, P223, DOI 10.1111/j.1365-2583.2008.00858.x; ASHIDA M, 1971, ARCH BIOCHEM BIOPHYS, V144, P749, DOI 10.1016/0003-9861(71)90383-3; Ashida M., 1998, RECENT ADV RES INSEC; Carvalho FA, 2012, ANNU REV PHYSIOL, V74, P177, DOI 10.1146/annurev-physiol-020911-153330; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Chen JM, 2010, P NATL ACAD SCI USA, V107, P20774, DOI 10.1073/pnas.1009223107; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dittmer NT, 2010, INSECT BIOCHEM MOLEC, V40, P179, DOI 10.1016/j.ibmb.2010.02.006; Dittmer NT, 2009, INSECT BIOCHEM MOLEC, V39, P596, DOI 10.1016/j.ibmb.2009.06.006; Field KG, 2007, WATER RES, V41, P3517, DOI 10.1016/j.watres.2007.06.056; Fouda MMA, 2010, J INSECT PHYSIOL, V56, P1728, DOI 10.1016/j.jinsphys.2010.07.003; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Hakim RS, 2010, ANNU REV ENTOMOL, V55, P593, DOI 10.1146/annurev-ento-112408-085450; Hiruma K, 2009, INSECT BIOCHEM MOLEC, V39, P245, DOI 10.1016/j.ibmb.2009.01.008; Jiang HB, 1997, INSECT BIOCHEM MOLEC, V27, P835, DOI 10.1016/S0965-1748(97)00066-0; Kanost M. R., 2008, PHENOLOXIDASES INSEC; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Lehane M. J., 1996, BIOL INSECT MIDGUT; Li XQ, 2012, DEV COMP IMMUNOL, V36, P648, DOI 10.1016/j.dci.2011.11.005; Ling E, 2006, DEV COMP IMMUNOL, V30, P531, DOI 10.1016/j.dci.2005.08.003; Ling EJ, 2008, MOL IMMUNOL, V45, P2598, DOI 10.1016/j.molimm.2007.12.021; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Nosanchuk JD, 2007, FUNGAL GENET BIOL, V44, P517, DOI 10.1016/j.fgb.2006.09.006; Ryazanova AD, 2012, J ENZYM INHIB MED CH, V27, P78, DOI 10.3109/14756366.2011.576010; Schoonhoven L. M., 2005, Insect-plant biology; Seisenbacher G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002168; Strand Michael R., 2008, Insect Science, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Tan Anjiang, 2003, Journal of Insect Biotechnology and Sericology, V72, P41; Walter J, 2011, ANNU REV MICROBIOL, V65, P411, DOI 10.1146/annurev-micro-090110-102830; Wang ZX, 2011, EXP PARASITOL, V127, P135, DOI 10.1016/j.exppara.2010.07.005; Wittkopp PJ, 2009, SEMIN CELL DEV BIOL, V20, P65, DOI 10.1016/j.semcdb.2008.10.002; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Zhao PC, 2007, INSECT BIOCHEM MOLEC, V37, P952, DOI 10.1016/j.ibmb.2007.05.001	34	86	91	1	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14270	14279		10.1074/jbc.M112.354548	http://dx.doi.org/10.1074/jbc.M112.354548			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22375003	Green Published, hybrid			2022-12-27	WOS:000303996300078
J	Tome, CML; Palma, E; Ferluga, S; Lowther, WT; Hantgan, R; Wykosky, J; Debinski, W				Tome, Carla M. Lema; Palma, Enzo; Ferluga, Sara; Lowther, W. Todd; Hantgan, Roy; Wykosky, Jill; Debinski, Waldemar			Structural and Functional Characterization of Monomeric EphrinA1 Binding Site to EphA2 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; GLIOBLASTOMA-MULTIFORME; LIGAND-BINDING; TUMOR-CELLS; IN-VITRO; CANCER; EXPRESSION; ACTIVATION; OVEREXPRESSION; PATHWAY	The EphA2 receptor is overexpressed in glioblastoma multiforme and has been to shown to contribute to cell transformation, tumor initiation, progression, and maintenance. EphrinA1 (eA1) is a preferred ligand for the receptor. Treatment with monomeric eA1, the form of eA1 found in the extracellular environment, causes receptor phosphorylation, internalization, and down-regulation with subsequent anti-tumor effects. Here, we investigated the structure-function relationship of a monomeric eA1 focusing on its G-H loop ((108)FQRFTPFTLGKEFKE(123)G), a highly conserved region among eAs that mediates binding to their receptors. Alanine substitution mutants of the G-H loop amino acids were transfected into U-251 MG glioblastoma multiforme cells, and functional activity of each mutant in conditioned media was assessed by EphA2 down-regulation, ERK and AKT activation and cellular response assays. Alanine substitutions at positions Pro-113 Thr-115, Gly-117, Glu-122, and also Gln-109 enhanced the EphA2 receptor down-regulation and decreased p-ERK and p-AKT. Substitution mutants of eA1 at positions Phe-108, Arg-110, Phe-111, Thr-112, Phe-114, Leu-116, Lys-118, Glu-119, and Phe-120 had a deleterious effect on EphA2 down-regulation when compared with eA1-WT. Mutants at positions Phe-108, Lys-18, Lys-121, Gly-123 retained similar properties to eA1-WT. Recombinant eA1-R110A, -T115A, -G117A, and -F120A have been found to exhibit the same characteristics as the ligands contained in the conditioned media mainly due to the differences in their binding to the receptor. Thus, we have identified variants of eA1 that possess either superagonistic or antagonistic properties. These new findings will be important in the understanding of the receptor/ligand interactions and in further design of anti-cancer therapies targeting the eA/EphA system.	[Tome, Carla M. Lema; Palma, Enzo; Ferluga, Sara; Wykosky, Jill; Debinski, Waldemar] Wake Forest Sch Med, Dept Neurosurg, Brain Tumor Ctr Excellence, Winston Salem, NC 27157 USA; [Lowther, W. Todd] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Hantgan, Roy] Wake Forest Sch Med, Dept Biochem & Mol Med, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest University; Wake Forest University	Debinski, W (corresponding author), Wake Forest Sch Med, Dept Neurosurg, Brain Tumor Ctr Excellence, Med Ctr Blvd, Winston Salem, NC 27157 USA.	debinski@wakehealth.edu		Ferluga, Sara/0000-0002-6151-5492	National Institutes of Health [CA 74145]; Brain Tumor Center of Excellence; North Carolina Biotechnology Center [2006-IDG-1004]; NATIONAL CANCER INSTITUTE [R01CA074145, T32CA113267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Tumor Center of Excellence; North Carolina Biotechnology Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA 74145 (NCI; to W. D.). This work was supported by the Brain Tumor Center of Excellence (to W. D.) and Institutional Development Grant 2006-IDG-1004 from the North Carolina Biotechnology Center (to R. H.).	Beauchamp A, 2012, SEMIN CELL DEV BIOL, V23, P109, DOI 10.1016/j.semcdb.2011.10.019; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Duxbury MS, 2004, BIOCHEM BIOPH RES CO, V320, P1096, DOI 10.1016/j.bbrc.2004.06.054; Fritsche-Guenther R, 2010, HISTOPATHOLOGY, V57, P836, DOI 10.1111/j.1365-2559.2010.03713.x; Guo H, 2006, CANCER RES, V66, P7050, DOI 10.1158/0008-5472.CAN-06-0004; Hantgan RR, 2010, BIOCHEMISTRY-US, V49, P9217, DOI 10.1021/bi1009858; Hantgan RR, 2009, BIOCHEMISTRY-US, V48, P8355, DOI 10.1021/bi900475k; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Himanen JP, 2009, EMBO REP, V10, P722, DOI 10.1038/embor.2009.91; Ireton RC, 2005, CURR CANCER DRUG TAR, V5, P149, DOI 10.2174/1568009053765780; Kataoka H, 2004, CANCER SCI, V95, P136, DOI 10.1111/j.1349-7006.2004.tb03194.x; Kinch MS, 2003, CLIN EXP METASTAS, V20, P59, DOI 10.1023/A:1022546620495; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Lai KO, 2009, CURR OPIN NEUROBIOL, V19, P275, DOI 10.1016/j.conb.2009.04.009; Li X, 2007, TUMOR BIOL, V28, P165, DOI 10.1159/000103010; Liu FH, 2006, CANCER RES, V66, P10815, DOI 10.1158/0008-5472.CAN-06-1408; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Merlos-Suarez A, 2008, CURR OPIN CELL BIOL, V20, P194, DOI 10.1016/j.ceb.2008.01.011; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Mudali SV, 2006, CLIN EXP METASTAS, V23, P357, DOI 10.1007/s10585-006-9045-7; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; Nakamura R, 2005, CANCER SCI, V96, P42, DOI 10.1111/j.1349-7006.2005.00007.x; Parri M, 2009, CANCER RES, V69, P2072, DOI 10.1158/0008-5472.CAN-08-1845; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pratt RL, 2002, ONCOGENE, V21, P7690, DOI 10.1038/sj.onc.1205758; Qin HN, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-2; Qin HN, 2010, J BIOL CHEM, V285, P644, DOI 10.1074/jbc.M109.064824; SHAO HN, 1995, J BIOL CHEM, V270, P5636, DOI 10.1074/jbc.270.10.5636; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; Walker-Daniels J, 2003, AM J PATHOL, V162, P1037, DOI 10.1016/S0002-9440(10)63899-0; Walker-Daniels J, 2002, MOL CANCER RES, V1, P79; Wang LF, 2008, ONCOL REP, V19, P151; Wimmer-Kleikamp SH, 2005, IUBMB LIFE, V57, P421, DOI 10.1080/15216540500138337; Wu QH, 2004, PATHOL ONCOL RES, V10, P26, DOI 10.1007/BF02893405; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Wykosky J, 2008, ONCOGENE, V27, P7260, DOI 10.1038/onc.2008.328; Wykosky J, 2007, MOL CANCER THER, V6, P3208, DOI 10.1158/1535-7163.MCT-07-0200; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Yang NY, 2011, CELL SIGNAL, V23, P201, DOI 10.1016/j.cellsig.2010.09.004; Zelinski DP, 2001, CANCER RES, V61, P2301; Zeng GY, 2003, AM J PATHOL, V163, P2271, DOI 10.1016/S0002-9440(10)63584-5	48	19	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14012	14022		10.1074/jbc.M111.311670	http://dx.doi.org/10.1074/jbc.M111.311670			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22362770	hybrid, Green Published			2022-12-27	WOS:000303996300056
J	Dunlop, MH; Dray, E; Zhao, WX; Filippo, JS; Tsai, MS; Leung, SG; Schild, D; Wiese, C; Sung, P				Dunlop, Myun Hwa; Dray, Eloise; Zhao, Weixing; Filippo, Joseph San; Tsai, Miaw-Sheue; Leung, Stanley G.; Schild, David; Wiese, Claudia; Sung, Patrick			Mechanistic Insights into RAD51-associated Protein 1 (RAD51AP1) Action in Homologous DNA Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; RECOMBINASE; ENHANCEMENT; INTERACTS; DMC1	Homologous recombination catalyzed by the RAD51 recombinase is essential for maintaining genome integrity upon the induction of DNA double strand breaks and other DNA lesions. By enhancing the recombinase activity of RAD51, RAD51AP1 (RAD51-associated protein 1) serves a key role in homologous recombination-mediated chromosome damage repair. We show here that RAD51AP1 harbors two distinct DNA binding domains that are both needed for maximal protein activity under physiological conditions. We have finely mapped the two DNA binding domains in RAD51AP1 and generated mutant variants that are impaired in either or both of the DNA binding domains. Examination of these mutants reveals that both domains are indispensable for RAD51AP1 function in cells. These and other results illuminate the mechanistic basis of RAD51AP1 action in homologous DNA repair.	[Tsai, Miaw-Sheue; Leung, Stanley G.; Schild, David; Wiese, Claudia] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Dunlop, Myun Hwa; Dray, Eloise; Zhao, Weixing; Filippo, Joseph San; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Yale University	Wiese, C (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	CWiese@lbl.gov; Patrick.Sung@yale.edu	zhao, weixing/H-3154-2013; Classen, Scott/AAY-8176-2020; Dray, Eloise/E-3938-2012; Dray, Eloise/AAD-5147-2021	Dray, Eloise/0000-0001-6793-9838; zhao, weixing/0000-0001-5746-3696	National Institutes of Health [RO1ES015252, RO1ES015632, RO1ES07061, PO1CA129186, R01CA120315, P01CA092584]; NATIONAL CANCER INSTITUTE [P01CA129186, R01CA120315, P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061, R01ES015252, R01ES015632, R01ES021454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1ES015252, RO1ES015632, RO1ES07061, PO1CA129186 (to P. S.), R01CA120315 (to D. S.), and P01CA092584 (to D. S. and P. S.).	Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Dray E, 2010, NAT STRUCT MOL BIOL, V17, P1255, DOI 10.1038/nsmb.1916; Dray E, 2011, P NATL ACAD SCI USA, V108, P3560, DOI 10.1073/pnas.1016454108; Dunlop MH, 2011, J BIOL CHEM, V286, P37328, DOI 10.1074/jbc.M111.290015; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Kovalenko OV, 2006, NUCLEIC ACIDS RES, V34, P5081, DOI 10.1093/nar/gkl665; Kovalenko OV, 1997, NUCLEIC ACIDS RES, V25, P4946, DOI 10.1093/nar/25.24.4946; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Mizuta R, 1997, P NATL ACAD SCI USA, V94, P6927, DOI 10.1073/pnas.94.13.6927; Modesti M, 2007, MOL CELL, V28, P468, DOI 10.1016/j.molcel.2007.08.025; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Wiese C, 2007, MOL CELL, V28, P482, DOI 10.1016/j.molcel.2007.08.027	14	29	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12343	12347		10.1074/jbc.C112.352161	http://dx.doi.org/10.1074/jbc.C112.352161			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22375013	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000302782200073
J	Seldin, MM; Peterson, JM; Byerly, MS; Wei, ZK; Wong, GW				Seldin, Marcus M.; Peterson, Jonathan M.; Byerly, Mardi S.; Wei, Zhikui; Wong, G. William			Myonectin (CTRP15), a Novel Myokine That Links Skeletal Muscle to Systemic Lipid Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; INSULIN-RESISTANCE; ENDOCRINE ORGAN; ADIPOSE-TISSUE; PROTEIN; FAMILY; IDENTIFICATION; EXPRESSION; GLUCOSE; GENE	Skeletal muscle plays important roles in whole-body glucose and fatty acid metabolism. However, muscle also secretes cytokines and growth factors (collectively termed myokines) that can potentially act in an autocrine, a paracrine, and/or an endocrine manner to modulate metabolic, inflammatory, and other processes. Here, we report the identification and characterization of myonectin, a novel myokine belonging to the C1q/TNF-related protein (CTRP) family. Myonectin transcript was highly induced in differentiated myotubes and predominantly expressed by skeletal muscle. Circulating levels of myonectin were tightly regulated by the metabolic state; fasting suppressed, but refeeding dramatically increased, its mRNA and serum levels. Although mRNA and circulating levels of myonectin were reduced in a diet-induced obese state, voluntary exercise increased its expression and circulating levels. Accordingly, myonectin transcript was up-regulated by compounds (forskolin, epinephrine, ionomycin) that raise cellular cAMP or calcium levels. In vitro, secreted myonectin forms disulfide-linked oligomers, and when co-expressed, forms heteromeric complexes with other members of the C1q/TNF-related protein family. In mice, recombinant myonectin administration reduced circulating levels of free fatty acids without altering adipose tissue lipolysis. Consistent with this, myonectin promoted fatty acid uptake in cultured adipocytes and hepatocytes, in part by up-regulating the expression of genes (CD36, FATP1, Fabp1, and Fabp4) that promote lipid uptake. Collectively, these results suggest that myonectin links skeletal muscle to lipid homeostasis in liver and adipose tissue in response to alterations in energy state, revealing a novel myonectin-mediated metabolic circuit.	[Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 855 N Wolfe St, Baltimore, MD 21205 USA.	gwwong@jhmi.edu	Peterson, Jonathan M./H-3122-2019	Peterson, Jonathan M./0000-0002-9873-3880; Wong, G. William/0000-0002-5286-6506; Wei, Zhikui/0000-0002-2311-9800	National Institutes of Health [DK084171, T32DK007751]; American Heart Association [SDG2260721, PRE3790034]; National Institutes of Health National Research Service [F32DK084607]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084171, F32DK084607, T32DK007751, P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	* This work was supported, in whole or in part, by National Institutes of Health Grant DK084171 (to G. W. W.). This work was also supported in part by American Heart Association Grant SDG2260721 (to G. W. W.).; <SUP>1</SUP> Supported by National Institutes of Health National Research Service Award F32DK084607. Present address: Dept. of Health Sciences, School of Public Health, East Tennessee State University, Johnson City, TN 37614.; <SUP>2</SUP> Supported by National Institutes of Health Training Grant T32DK007751.; <SUP>3</SUP> Supported by American Heart Association Fellowship PRE3790034.	Briggs DB, 2009, BIOCHEMISTRY-US, V48, P12345, DOI 10.1021/bi9015555; Broholm C, 2011, J APPL PHYSIOL, V111, P251, DOI 10.1152/japplphysiol.01399.2010; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Deans MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012765; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Haugen F, 2010, AM J PHYSIOL-CELL PH, V298, pC807, DOI 10.1152/ajpcell.00094.2009; Hayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289; Henningsen J, 2010, MOL CELL PROTEOMICS, V9, P2482, DOI 10.1074/mcp.M110.002113; Hojman P, 2009, DIABETES, V58, P2797, DOI 10.2337/db09-0713; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Lim S, 2012, J CLIN ENDOCR METAB, V97, pE88, DOI 10.1210/jc.2011-1743; Lok S, 2000, BIOL REPROD, V62, P1593, DOI 10.1095/biolreprod62.6.1593; Mashimo J, 1997, CANCER LETT, V113, P213, DOI 10.1016/S0304-3835(97)04700-9; Nickerson JG, 2009, J BIOL CHEM, V284, P16522, DOI 10.1074/jbc.M109.004788; Nishizawa H, 2004, J BIOL CHEM, V279, P19391, DOI 10.1074/jbc.C400066200; Norheim F, 2011, AM J PHYSIOL-ENDOC M, V301, pE1013, DOI 10.1152/ajpendo.00326.2011; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Park SY, 2009, J BIOL CHEM, V284, P27780, DOI 10.1074/jbc.M109.005611; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen BK, 2009, J APPL PHYSIOL, V107, P1006, DOI 10.1152/japplphysiol.00734.2009; Petersen KF, 2002, AM J CARDIOL, V90, p11G; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Peterson JM, 2009, BIOCHEM BIOPH RES CO, V388, P360, DOI 10.1016/j.bbrc.2009.08.014; Quinn LS, 2009, AM J PHYSIOL-ENDOC M, V296, pE191, DOI 10.1152/ajpendo.90506.2008; Rasbach KA, 2010, P NATL ACAD SCI USA, V107, P21866, DOI 10.1073/pnas.1016089107; Rasmussen BB, 1999, ANNU REV NUTR, V19, P463, DOI 10.1146/annurev.nutr.19.1.463; Ring A, 2006, BBA-MOL CELL BIOL L, V1761, P416, DOI 10.1016/j.bbalip.2006.03.016; Steensberg A, 2001, AM J PHYSIOL-CELL PH, V281, pC1001; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Wang H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207779; Wasserman DH, 2005, CLIN EXP PHARMACOL P, V32, P319, DOI 10.1111/j.1440-1681.2005.04191.x; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Yan AX, 2005, J BIOL CHEM, V280, P3121, DOI 10.1074/jbc.R400036200; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zeng L, 2010, J BIOL CHEM, V285, P36060, DOI 10.1074/jbc.M110.160879	46	248	273	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11968	11980		10.1074/jbc.M111.336834	http://dx.doi.org/10.1074/jbc.M111.336834			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351773	Green Published, hybrid			2022-12-27	WOS:000302782200035
J	Fazly, A; Li, Q; Hu, Q; Mer, G; Horazdovsky, B; Zhang, ZG				Fazly, Ahmed; Li, Qing; Hu, Qi; Mer, Georges; Horazdovsky, Bruce; Zhang, Zhiguo			Histone Chaperone Rtt106 Promotes Nucleosome Formation Using (H3-H4)(2) Tetramers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN ASSEMBLY FACTOR-1; DNA-REPLICATION INVITRO; STRUCTURAL BASIS; H3; ACETYLATION; LYSINE-56; ASF1; PURIFICATION; SUBUNIT; REPAIR	The yeast histone chaperone Rtt106 is involved in de novo assembly of newly synthesized histones into nucleosomes during DNA replication and plays a role in regulating heterochromatin silencing and maintaining genomic integrity. The interaction of Rtt106 with H3-H4 is modulated by acetylation of H3 lysine 56 catalyzed by the lysine acetyltransferase Rtt109. Using affinity purification strategies, we demonstrate that Rtt106 interacts with (H3-H4)(2) heterotetramers in vivo. In addition, we show that Rtt106 undergoes homo-oligomerization in vivo and in vitro, and mutations in the N-terminal homodimeric domain of Rtt106 that affect formation of Rtt106 oligomers compromise the function of Rtt106 in transcriptional silencing and response to genotoxic stress and the ability of Rtt106 to bind (H3-H4)(2). These results indicate that Rtt106 deposits H3-H4 heterotetramers onto DNA and provide the first description of a H3-H4 chaperone binding to (H3-H4)(2) heterotetramers in vivo.	[Fazly, Ahmed; Li, Qing; Hu, Qi; Mer, Georges; Horazdovsky, Bruce; Zhang, Zhiguo] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic	Zhang, ZG (corresponding author), 200 1st St SW, Rochester, MN 55905 USA.	zhang.zhiguo@mayo.edu	hu, qi/K-1462-2014; Mer, Georges/AAT-4946-2021	Mer, Georges/0000-0002-1900-1578; /0000-0003-3279-0425	National Institutes of Health [GM72719, GM81838]; NATIONAL CANCER INSTITUTE [R01CA132878, P50CA108961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081838, R01GM072719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported, in whole or in part, by National Institutes of Health Grants GM72719 and GM81838.	Allis CD, 2007, EPIGENETICS; Bowman A, 2011, MOL CELL, V41, P398, DOI 10.1016/j.molcel.2011.01.025; Chodaparambil JV, 2006, E SCHERING RES FDN W, V57, P29; Das C, 2010, TRENDS BIOCHEM SCI, V35, P476, DOI 10.1016/j.tibs.2010.04.001; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; English CM, 2005, BIOCHEMISTRY-US, V44, P13673, DOI 10.1021/bi051333h; Gerard A, 2006, EMBO REP, V7, P817, DOI 10.1038/sj.embor.7400750; Han JH, 2007, J BIOL CHEM, V282, P14158, DOI 10.1074/jbc.M700611200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Huang SB, 2005, P NATL ACAD SCI USA, V102, P13410, DOI 10.1073/pnas.0506176102; Huang SB, 2007, EMBO J, V26, P2274, DOI 10.1038/sj.emboj.7601670; Ito T, 1996, MOL CELL BIOL, V16, P3112; JACKSON V, 1981, CELL, V23, P121, DOI 10.1016/0092-8674(81)90277-4; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; LEFFAK IM, 1977, CELL, V12, P837, DOI 10.1016/0092-8674(77)90282-3; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Quivy JP, 2001, EMBO J, V20, P2015, DOI 10.1093/emboj/20.8.2015; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; RUSSEV G, 1981, NUCLEIC ACIDS RES, V9, P4129, DOI 10.1093/nar/9.16.4129; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; STILLMAN B, 1986, CELL, V45, P555, DOI 10.1016/0092-8674(86)90287-4; Su D, 2012, NATURE, V483, P104, DOI 10.1038/nature10861; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; van Holde KE., 1989, SPRINGER SERIES MOL; Zhou H, 2006, BIOCHEMISTRY-US, V45, P2852, DOI 10.1021/bi0521083	29	33	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10753	10760		10.1074/jbc.M112.347450	http://dx.doi.org/10.1074/jbc.M112.347450			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22337870	Green Published, hybrid			2022-12-27	WOS:000302780100004
J	Ueki, T; Leang, C; Inoue, K; Lovley, DR				Ueki, Toshiyuki; Leang, Ching; Inoue, Kengo; Lovley, Derek R.			Identification of Multicomponent Histidine-Aspartate Phosphorelay System Controlling Flagellar and Motility Gene Expression in Geobacter Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SUBSURFACE ENVIRONMENTS; PSEUDOMONAS-AERUGINOSA; SP-NOV; SULFURREDUCENS; GENOME; REDUCTION; IRON; MICROORGANISM; CHEMOTAXIS	Geobacter species play an important role in the natural bio-geochemical cycles of aquatic sediments and subsurface environments as well as in subsurface bioremediation by oxidizing organic compounds with the reduction of insoluble Fe(III) oxides. Flagellum-based motility is considered to be critical for Geobacter species to locate fresh sources of Fe(III) oxides. Functional and comparative genomic approaches, coupled with genetic and biochemical methods, identified key regulators for flagellar gene expression in Geobacter species. A master transcriptional regulator, designated FgrM, is a member of the enhancer-binding protein family. The fgrM gene in the most studied strain of Geobacter species, Geobacter sulfurreducens strain DL-1, is truncated by a transposase gene, preventing flagellar biosynthesis. Integrating a functional FgrM homolog restored flagellar biosynthesis and motility in G. sulfurreducens DL-1 and enhanced the ability to reduce insoluble Fe(III) oxide. Interrupting the fgrM gene in G. sulfurreducens strain KN400, which is motile, removed the capacity for flagellar production and inhibited Fe(III) oxide reduction. FgrM, which is also a response regulator of the two-component His-Asp phosphorelay system, was phosphorylated by histidine kinase GHK4, which was essential for flagellar production and motility. GHK4, which is a hybrid kinase with a receiver domain at the N terminus, was phosphorylated by another histidine kinase, GHK3. Therefore, the multicomponent His-Asp phosphorelay system appears to control flagellar gene expression in Geobacter species.	[Ueki, Toshiyuki] Univ Massachusetts, Dept Microbiol, Morrill Sci Ctr 4 N, Amherst, MA 01003 USA; [Inoue, Kengo] Miyazaki Univ, Interdisciplinary Res Org, Miyazaki 8891692, Japan	University of Massachusetts System; University of Massachusetts Amherst; University of Miyazaki	Ueki, T (corresponding author), Univ Massachusetts, Dept Microbiol, Morrill Sci Ctr 4 N, 639 N Pleasant St, Amherst, MA 01003 USA.	tueki@microbio.umass.edu		Inoue, Kengo/0000-0002-9680-8359	Office of Science (Biological and Environmental Research), United States Department of Energy [DE-FC02-02ER63446, DE-SC0004080]	Office of Science (Biological and Environmental Research), United States Department of Energy(United States Department of Energy (DOE))	This work was supported by Grants DE-FC02-02ER63446 and DE-SC0004080 from the Office of Science (Biological and Environmental Research), United States Department of Energy.	Aklujkar M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-490; Aklujkar M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-109; Anantharaman V, 2001, J MOL BIOL, V307, P1271, DOI 10.1006/jmbi.2001.4508; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Arora SK, 1997, J BACTERIOL, V179, P5574, DOI 10.1128/jb.179.17.5574-5581.1997; CACCAVO F, 1994, APPL ENVIRON MICROB, V60, P3752, DOI 10.1128/AEM.60.10.3752-3759.1994; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Childers SE, 2002, NATURE, V416, P767, DOI 10.1038/416767a; Coppi MV, 2001, APPL ENVIRON MICROB, V67, P3180, DOI 10.1128/AEM.67.7.3180-3187.2001; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Esteve-Nunez A, 2008, ENVIRON MICROBIOL, V10, P497, DOI 10.1111/j.1462-2920.2007.01470.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hoch JA, 1995, 2 COMPONENT SIGNAL T; Holmes DE, 2004, INT J SYST EVOL MICR, V54, P1591, DOI 10.1099/ijs.0.02958-0; Leang C, 2010, APPL ENVIRON MICROB, V76, P4080, DOI 10.1128/AEM.00023-10; Leang C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-331; Lonergan DJ, 1996, J BACTERIOL, V178, P2402, DOI 10.1128/jb.178.8.2402-2408.1996; Lovley DR, 2008, GEOBIOLOGY, V6, P225, DOI 10.1111/j.1472-4669.2008.00148.x; Lovley DR, 2011, ADV MICROB PHYSIOL, V59, P1, DOI 10.1016/B978-0-12-387661-4.00004-5; LOVLEY DR, 1986, APPL ENVIRON MICROB, V51, P683, DOI 10.1128/AEM.51.4.683-689.1986; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; Mahadevan R, 2011, NAT REV MICROBIOL, V9, P39, DOI 10.1038/nrmicro2456; Malvankar NS, 2011, NAT NANOTECHNOL, V6, P573, DOI [10.1038/nnano.2011.119, 10.1038/NNANO.2011.119]; McCarter LL, 2006, CURR OPIN MICROBIOL, V9, P180, DOI 10.1016/j.mib.2006.02.001; Methe BA, 2003, SCIENCE, V302, P1967, DOI 10.1126/science.1088727; Miller J.H., 1972, EXPT MOL GENETICS; Nagarajan H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010922; Prouty MG, 2001, MOL MICROBIOL, V39, P1595, DOI 10.1046/j.1365-2958.2001.02348.x; Reguera G, 2006, APPL ENVIRON MICROB, V72, P7345, DOI 10.1128/AEM.01444-06; SANDLER SJ, 1994, J BACTERIOL, V176, P3661, DOI 10.1128/JB.176.12.3661-3672.1994; Smith TG, 2009, ADV APPL MICROBIOL, V67, P257, DOI 10.1016/S0065-2164(08)01008-3; Soutourina OA, 2003, FEMS MICROBIOL REV, V27, P505, DOI 10.1016/S0168-6445(03)00064-0; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Taylor BL, 2007, MOL MICROBIOL, V65, P1415, DOI 10.1111/j.1365-2958.2007.05889.x; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Tran HT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-471; Ueki T, 2002, J BIOL CHEM, V277, P6170, DOI 10.1074/jbc.M110155200; Ueki T, 2010, NUCLEIC ACIDS RES, V38, P7485, DOI 10.1093/nar/gkq652; Ueki T, 2010, NUCLEIC ACIDS RES, V38, P810, DOI 10.1093/nar/gkp1085; Wigneshweraraj S, 2008, MOL MICROBIOL, V68, P538, DOI 10.1111/j.1365-2958.2008.06181.x; Yi HN, 2009, BIOSENS BIOELECTRON, V24, P3498, DOI 10.1016/j.bios.2009.05.004	41	18	18	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10958	10966		10.1074/jbc.M112.345041	http://dx.doi.org/10.1074/jbc.M112.345041			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22362768	Green Published, hybrid			2022-12-27	WOS:000302780100024
J	Hamdan, AM; Koyanagi, S; Wada, E; Kusunose, N; Murakami, Y; Matsunaga, N; Ohdo, S				Hamdan, Ahmed M.; Koyanagi, Satoru; Wada, Erika; Kusunose, Naoki; Murakami, Yuichi; Matsunaga, Naoya; Ohdo, Shigehiro			Intestinal Expression of Mouse Abcg2/Breast Cancer Resistance Protein (BCRP) Gene Is under Control of Circadian Clock-activating Transcription Factor-4 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL LINES; ABCG2; IDENTIFICATION; BCRP/ABCG2; PROMOTERS; ATF4; DBP	ABCG2, encoding breast cancer resistance protein (BCRP), is a member of the ATP-binding cassette transporter family and is often associated with cancer chemotherapeutic resistance. BCRP is also expressed in a variety of normal cells and acts as a xenobiotic efflux transporter. Because intestinal BCRP limits systemic exposure to xenobiotics, alterations in the function and expression of this transporter could account for part of the variation in oral drug absorption. In this study, we show that ATF4, a molecular component of the circadian clock, induces circadian expression of the Abcg2 gene in mouse small intestine. Three types of leader exons (termed exons 1A, 1B, and 1C) are identified in the 5'-untranslated region of mouse Abcg2 transcripts. The exon 1B-containing Abcg2 transcript was the only isoform detected in mouse small intestine, and its mRNA levels oscillated in a circadian time-dependent manner. ATF4 bound time-dependently to the cAMP response element within the exon 1B promoter region of the Abcg2 gene, thereby causing the oscillation of BCRP protein abundance and its efflux pump function. The circadian clock-ATF4 pathway appears to enhance the function of BCRP during a specific time window and to modulate intestinal drug absorption. Our findings suggest a mechanism underlying circadian change in xenobiotic detoxification.	[Hamdan, Ahmed M.; Koyanagi, Satoru; Wada, Erika; Kusunose, Naoki; Murakami, Yuichi; Matsunaga, Naoya; Ohdo, Shigehiro] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Ohdo, S (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ohdo@phar.kyushu-u.ac.jp	Koyanagi, Satoru/AAE-6843-2020; Hamdan, Ahmed M/H-3794-2018	Hamdan, Ahmed M/0000-0003-4930-792X; matsunaga2, naoya2/0000-0001-6226-8473; Koyanagi, Satoru/0000-0003-4849-2377	Japan Society for the Promotion of Science [21390047, 24390149]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-aid for Scientific Research (B) 21390047 (to S. O.) and 24390149 (to S. K.) from the Japan Society for the Promotion of Science.	Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Baraldo M, 2008, EXPERT OPIN DRUG MET, V4, P175, DOI 10.1517/17425255.4.2.175; Beal S., 1992, CRIT REV BIOMED ENG, V8, P195; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Ifergan I, 2004, J BIOL CHEM, V279, P25527, DOI 10.1074/jbc.M401725200; Igarashi T, 2007, ONCOGENE, V26, P4749, DOI 10.1038/sj.onc.1210289; Iwamoto T, 2011, BIOSCI BIOTECH BIOCH, V75, P925, DOI 10.1271/bbb.100887; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Koyanagi S, 2011, J BIOL CHEM, V286, P32416, DOI 10.1074/jbc.M111.258970; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Litman T, 2000, J CELL SCI, V113, P2011; Murakami Y, 2008, GASTROENTEROLOGY, V135, P1636, DOI 10.1053/j.gastro.2008.07.073; Ohdo S, 2010, BIOL PHARM BULL, V33, P159, DOI 10.1248/bpb.33.159; Ripperger JA, 2000, GENE DEV, V14, P679; Stearns AT, 2008, J PHARMACOL SCI, V108, P144, DOI 10.1254/jphs.08100SC; Suzuki M, 2003, J BIOL CHEM, V278, P22644, DOI 10.1074/jbc.M212399200; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Zaher H, 2006, MOL PHARMACEUT, V3, P55, DOI 10.1021/mp050113v; Zong Y, 2006, J BIOL CHEM, V281, P29625, DOI 10.1074/jbc.M606314200	24	34	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17224	17231		10.1074/jbc.M111.333377	http://dx.doi.org/10.1074/jbc.M111.333377			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22396548	hybrid, Green Published			2022-12-27	WOS:000306373000022
J	Kang, YX; Wu, ZW; Lau, TCK; Lu, XF; Liu, L; Cheung, AKL; Tan, ZW; Ng, J; Liang, JG; Wang, HB; Li, SK; Zheng, BJ; Li, B; Chen, L; Chen, ZW				Kang, Yuanxi; Wu, Zhiwei; Lau, Terrence C. K.; Lu, Xiaofan; Liu, Li; Cheung, Allen K. L.; Tan, Zhiwu; Ng, Jenny; Liang, Jianguo; Wang, Haibo; Li, Saikam; Zheng, Bojian; Li, Ben; Chen, Li; Chen, Zhiwei			CCR5 Antagonist TD-0680 Uses a Novel Mechanism for Enhanced Potency against HIV-1 Entry, Cell-mediated Infection, and a Resistant Variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; REVERSE-TRANSCRIPTASE INHIBITOR; SMALL-MOLECULE INHIBITOR; HIGHLY POTENT; CROSS-RESISTANCE; TYPE-1 ENTRY; CORECEPTOR; MARAVIROC; CHEMOKINE; BINDING	Regardless of the route of transmission, R5-tropic HIV-1 predominates early in infection, rendering C-C chemokine receptor type 5 (CCR5) antagonists as attractive agents not only for antiretroviral therapy but also for prevention. Here, we report the specificity, potency, and underlying mechanism of action of a novel small molecule CCR5 antagonist, TD-0680. TD-0680 displayed the greatest potency against a diverse group of R5-tropic HIV-1 and SIV strains when compared with its prodrug, TD-0232, the Food and Drug Administration-approved CCR5 antagonist Maraviroc, and TAK-779, with EC50 values in the subnanomolar range (0.09-2.29 nM). Importantly, TD-0680 was equally potent at blocking envelope-mediated cell-cell fusion and cell-mediated viral transmission as well as the replication of a TAK-779/Maraviroc-resistant HIV-1 variant. Interestingly, TD-0232 and TD-0680 functioned differently despite binding to a similar transmembrane pocket of CCR5. Site-directed mutagenesis, drug combination, and antibody blocking assays identified a novel mechanism of action of TD-0680. In addition to binding to the transmembrane pocket, the unique exo configuration of this molecule protrudes and sterically blocks access to the extracellular loop 2 (ECL2) region of CCR5, thereby interrupting the interaction between virus and its co-receptor more effectively. This mechanism of action was supported by the observations of similar TD-0680 potency against CD4-dependent and -independent SIV strains and by molecular docking analysis using a CCR5 model. TD-0680, therefore, merits development as an anti-HIV-1 agent for therapeutic purposes and/or as a topical microbicide for the prevention of sexual transmission of R5-tropic HIV-1.	[Kang, Yuanxi; Lu, Xiaofan; Liu, Li; Cheung, Allen K. L.; Tan, Zhiwu; Ng, Jenny; Liang, Jianguo; Wang, Haibo; Zheng, Bojian; Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, AIDS Inst, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China; [Kang, Yuanxi; Lu, Xiaofan; Liu, Li; Cheung, Allen K. L.; Tan, Zhiwu; Ng, Jenny; Liang, Jianguo; Wang, Haibo; Zheng, Bojian; Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Infect & Immun, Pokfulam, Hong Kong, Peoples R China; [Wu, Zhiwei] Nanjing Univ, Sch Med, Ctr Publ Hlth Res, Nanjing 210093, Jiangsu, Peoples R China; [Lau, Terrence C. K.; Li, Saikam] City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China; [Li, Ben; Chen, Li] Shanghai Targetdrug Co Ltd, Shanghai 20023, Peoples R China; [Chen, Zhiwei] Shenzhen Third Peoples Hosp, Shenzhen Hong Kong Inst Infect Dis, HKU AIDS Inst Shenzhen Res Lab, Shenzhen 518020, Peoples R China	University of Hong Kong; University of Hong Kong; Nanjing University; City University of Hong Kong	Chen, ZW (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, AIDS Inst, Dept Microbiol, L5-45,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	zchenai@hku.hk	Cheung, Allen/Q-9558-2016; Tang, Xian/C-5535-2015; Liu, Li/ABA-8315-2020; Chen, Zhiwei/B-7793-2019; Lau, Terrence/ABB-7900-2021; Chen, Zhiwen/S-7256-2016	Liu, Li/0000-0003-2566-7357; Chen, Zhiwei/0000-0002-4511-2888; Lau, Terrence/0000-0002-7505-7306; Chen, Zhiwen/0000-0001-9625-8556; Cheung, Allen/0000-0001-8989-0537	HKU-UDF; HKU-LKSFM [2008ZX10001-015/2012ZX10001007-009, 2012ZX10001-009]; NSFC [30870124]	HKU-UDF; HKU-LKSFM; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by HKU-UDF and HKU-LKSFM matching funds to the AIDS Institute, China's 12th Five-year National Science and Technology Mega Projects on the Prevention and Treatment of AIDS 2008ZX10001-015/2012ZX10001007-009, 2012ZX10001-009, and NSFC Grant 30870124.	Achour L, 2009, BLOOD, V113, P1938, DOI 10.1182/blood-2008-02-141275; Armand-Ugon M, 2010, J ANTIMICROB CHEMOTH, V65, P417, DOI 10.1093/jac/dkp482; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Ben L, 2010, BIOORG MED CHEM LETT, V20, P4012, DOI 10.1016/j.bmcl.2010.05.102; Berro R, 2011, J VIROL, V85, P8227, DOI 10.1128/JVI.00767-11; Billick E, 2004, J VIROL, V78, P4134, DOI 10.1128/JVI.78.8.4134-4144.2004; Chen ZW, 1998, J EXP MED, V188, P2057, DOI 10.1084/jem.188.11.2057; Chen ZW, 1997, J VIROL, V71, P2705, DOI 10.1128/JVI.71.4.2705-2714.1997; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; DE CLERCQ E, 1994, ANTIMICROB AGENTS CH, V38, P668, DOI 10.1128/AAC.38.4.668; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; Garcia-Perez J, 2011, J BIOL CHEM, V286, P33409, DOI 10.1074/jbc.M111.279596; Garg H, 2007, J BIOL CHEM, V282, P16899, DOI 10.1074/jbc.M701701200; Geeraert L, 2008, ANNU REV MED, V59, P487, DOI 10.1146/annurev.med.59.062806.123001; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kondru R, 2008, MOL PHARMACOL, V73, P789, DOI 10.1124/mol.107.042101; Lee B, 1999, J BIOL CHEM, V274, P9617, DOI 10.1074/jbc.274.14.9617; Li B, 2010, BIOORG MED CHEM LETT, V20, P5334, DOI 10.1016/j.bmcl.2010.05.046; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Lu XF, 2012, ANTIMICROB AGENTS CH, V56, P341, DOI 10.1128/AAC.05537-11; Ma DW, 2007, CHEMMEDCHEM, V2, P187, DOI 10.1002/cmdc.200600182; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Morner A, 1999, J VIROL, V73, P2343; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Neff CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020209; Nozza S, 2010, AIDS, V24, P924, DOI 10.1097/QAD.0b013e3283372d76; Parra J, 2011, CLIN DRUG INVEST, V31, P527, DOI 10.2165/11590700-000000000-00000; PRICHARD MN, 1990, ANTIVIR RES, V14, P181, DOI 10.1016/0166-3542(90)90001-N; Schanzer J, 2011, ANTIMICROB AGENTS CH, V55, P2369, DOI 10.1128/AAC.00215-10; Shang H, 2011, J BIOL CHEM, V286, P14531, DOI 10.1074/jbc.M111.224527; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Tilton JC, 2010, J VIROL, V84, P10863, DOI 10.1128/JVI.01109-10; Tsamis F, 2003, J VIROL, V77, P5201, DOI 10.1128/JVI.77.9.5201-5208.2003; Veazey RS, 2003, J EXP MED, V198, P1551, DOI 10.1084/jem.20031266; Wang HB, 2010, JAIDS-J ACQ IMM DEF, V53, P285, DOI 10.1097/QAI.0b013e3181cc4f4a; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wilkin TJ, 2010, JAIDS-J ACQ IMM DEF, V54, P470, DOI 10.1097/QAI.0b013e3181e2cba0; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xiao XD, 1999, P NATL ACAD SCI USA, V96, P7496, DOI 10.1073/pnas.96.13.7496; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	49	18	19	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16499	16509		10.1074/jbc.M112.354084	http://dx.doi.org/10.1074/jbc.M112.354084			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22447925	Green Published, hybrid			2022-12-27	WOS:000304030900040
J	Zhou, Y; Cho, KJ; Plowman, SJ; Hancock, JF				Zhou, Yong; Cho, Kwang-Jin; Plowman, Sarah J.; Hancock, John F.			Nonsteroidal Anti-inflammatory Drugs Alter the Spatiotemporal Organization of Ras Proteins on the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-RAS; LIPID RAFTS; K-RAS; NANOCLUSTER FORMATION; FOREIGN MOLECULES; DOMAIN FORMATION; DYNAMICS; ASSOCIATION; ORIENTATION; ANESTHETICS	Ras proteins on the inner leaflet of the plasma membrane signal from transient nanoscale proteolipid assemblies called nanoclusters. Interactions between the Ras lipid anchors and plasma membrane phospholipids, cholesterol, and actin cytoskeleton contribute to the formation, stability, and dynamics of Ras nanoclusters. Many small biological molecules are amphiphilic and capable of intercalating into membranes and altering lipid immiscibility. In this study we systematically examined whether amphiphiles such as indomethacin influence Ras protein nanoclustering in intact plasma membrane. We found that indomethacin, a nonsteroidal anti-inflammatory drug, induced profound and complex effects on Ras spatial organization, all likely related to liquid-ordered domain stabilization. Indomethacin enhanced the clustering of H-Ras. GDP and N-Ras.GTP in cholesterol-dependent nanoclusters. Indomethacin also abrogated efficient GTP-dependent lateral segregation of H- and N-Ras between cholesterol-dependent and cholesterol-independent clusters, resulting in mixed heterotypic clusters of Ras proteins that normally are separated spatially. These heterotypic Ras nanoclusters showed impaired Raf recruitment and kinase activation resulting in significantly compromised MAPK signaling. All of the amphiphilic anti-inflammatory agents we tested had similar effects on Ras nanoclustering and signaling. The potency of these effects correlated with the membrane partition coefficients of the individual agents and was independent of COX inhibition. This study shows that biological amphiphiles have wide-ranging effects on plasma membrane heterogeneity and protein nanoclustering, revealing a novel mechanism of drug action that has important consequences for cell signaling.	[Zhou, Yong; Cho, Kwang-Jin; Plowman, Sarah J.; Hancock, John F.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Hancock, JF (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Med Sch Bldg Ste 4-098,6431 Fannin St, Houston, TX 77030 USA.	John.F.Hancock@uth.tmc.edu	Cho, Kwang-jin/AAI-4923-2020	Zhou, Yong/0000-0002-0214-8151; Hancock, John/0000-0003-0542-4710	National Institutes of Health [GM066717]; Cancer Prevention Research Institute of Texas [RP100483]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM066717. This work was also supported by Grant RP100483 from the Cancer Prevention Research Institute of Texas.	Abankwa D, 2007, SEMIN CELL DEV BIOL, V18, P599, DOI 10.1016/j.semcdb.2007.08.003; Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Ahearn IM, 2011, MOL CELL, V41, P173, DOI 10.1016/j.molcel.2011.01.001; Baker TL, 2003, J BIOL CHEM, V278, P19292, DOI 10.1074/jbc.M206956200; Bakht O, 2007, BIOPHYS J, V93, P4307, DOI 10.1529/biophysj.107.114967; Belanis L, 2008, MOL BIOL CELL, V19, P1404, DOI 10.1091/mbc.E07-10-1053; BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9; BESAG J, 1977, J ROYAL STAT SOC B, V39, P193, DOI DOI 10.1016/J.FORECO.2009.04.009; Bhagatji P, 2010, BIOPHYS J, V99, P3327, DOI 10.1016/j.bpj.2010.10.001; Chang CW, 2007, METHOD CELL BIOL, V81, P495, DOI 10.1016/S0091-679X(06)81024-1; Diggle PJ, 2000, ADV APPL PROBAB, V32, P331, DOI 10.1017/S0001867800009952; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Glaser M, 1996, J BIOL CHEM, V271, P26187, DOI 10.1074/jbc.271.42.26187; Gorfe AA, 2007, ANGEW CHEM INT EDIT, V46, P8234, DOI 10.1002/anie.200702379; Gorfe AA, 2007, J AM CHEM SOC, V129, P12280, DOI 10.1021/ja073949v; Gorfe AA, 2007, J MED CHEM, V50, P674, DOI 10.1021/jm061053f; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Heerklotz H, 2003, J MOL BIOL, V329, P793, DOI 10.1016/S0022-2836(03)00504-7; Inder K, 2008, MOL BIOL CELL, V19, P4776, DOI 10.1091/mbc.E08-04-0407; JORGENSEN K, 1991, ANN NY ACAD SCI, V625, P747, DOI 10.1111/j.1749-6632.1991.tb33908.x; JORGENSEN K, 1991, BIOCHIM BIOPHYS ACTA, V1067, P241, DOI 10.1016/0005-2736(91)90050-I; Jutila A, 2001, CHEM PHYS LIPIDS, V112, P151, DOI 10.1016/S0009-3084(01)00175-X; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; KIM JY, 1994, J BIOL CHEM, V269, P28214; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Plowman SJ, 2008, MOL CELL BIOL, V28, P4377, DOI 10.1128/MCB.00050-08; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; Sawdy RJ, 2003, EUR J OBSTET GYN R B, V109, P33, DOI 10.1016/S0301-2115(02)00481-5; SEDGHI S, 1993, GUT, V34, P1191, DOI 10.1136/gut.34.9.1191; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Tian TH, 2010, BIOPHYS J, V99, P534, DOI 10.1016/j.bpj.2010.04.055; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wesolowska O, 2011, MOL MEMBR BIOL, V28, P103, DOI 10.3109/09687688.2010.533706; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zhou Y, 2010, J BIOL CHEM, V285, P35188, DOI 10.1074/jbc.M110.141200; Zhou Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008811	51	42	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16586	16595		10.1074/jbc.M112.348490	http://dx.doi.org/10.1074/jbc.M112.348490			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22433858	Green Published, hybrid			2022-12-27	WOS:000304030900048
J	Pucci, M; Pasquariello, N; Battista, N; Di Tommaso, M; Rapino, C; Fezza, F; Zuccolo, M; Jourdain, R; Agro, AF; Breton, L; Maccarrone, M				Pucci, Mariangela; Pasquariello, Nicoletta; Battista, Natalia; Di Tommaso, Monia; Rapino, Cinzia; Fezza, Filomena; Zuccolo, Michela; Jourdain, Roland; Agro, Alessandro Finazzi; Breton, Lionel; Maccarrone, Mauro			Endocannabinoids Stimulate Human Melanogenesis via Type-1 Cannabinoid Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID AMIDE HYDROLASE; PROTEIN-KINASE; IN-VIVO; EPIDERMAL DIFFERENTIATION; CONTACT-DERMATITIS; HUMAN MELANOCYTES; MELANOMA-CELLS; CYCLIC-AMP; ANANDAMIDE; TRANSCRIPTION	We show that a fully functional endocannabinoid system is present in primary human melanocytes (normal human epidermal melanocyte cells), including anandamide (AEA), 2-arachidonoylglycerol, the respective target receptors (CB1, CB2, and TRPV1), and their metabolic enzymes. We also show that at higher concentrations AEA induces normal human epidermal melanocyte apoptosis (similar to 3-fold over controls at 5 mu M) through a TRPV1-mediated pathway that increases DNA fragmentation and p53 expression. However, at lower concentrations, AEA and other CB1-binding endocannabinoids dose-dependently stimulate melanin synthesis and enhance tyrosinase gene expression and activity (similar to 3-and similar to 2-fold over controls at 1 mu M). This CB1-dependent activity was fully abolished by the selective CB1 antagonist SR141716 or by RNA interference of the receptor. CB1 signaling engaged p38 and p42/44 mitogen-activated protein kinases, which in turn activated the cyclic AMP response element-binding protein and the microphthalmia-associated transcription factor. Silencing of tyrosinase or microphthalmia-associated transcription factor further demonstrated the involvement of these proteins in AEA-induced melanogenesis. In addition, CB1 activation did not engage the key regulator of skin pigmentation, cyclic AMP, showing a major difference compared with the regulation of melanogenesis by alpha-melanocyte-stimulating hormone through melanocortin 1 receptor.	[Pucci, Mariangela; Pasquariello, Nicoletta; Battista, Natalia; Di Tommaso, Monia; Rapino, Cinzia; Maccarrone, Mauro] Univ Teramo, Dept Biomed Sci, I-64100 Teramo, Italy; [Zuccolo, Michela; Jourdain, Roland; Breton, Lionel] LOreal Res & Innovat, F-92110 Clichy, France; [Fezza, Filomena; Agro, Alessandro Finazzi] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy; [Agro, Alessandro Finazzi] Univ Campus Biomed Roma, CIR, I-00128 Rome, Italy; [Battista, Natalia; Fezza, Filomena; Maccarrone, Mauro] Santa Lucia Fdn, European Ctr Brain Res CERC, I-00143 Rome, Italy	University of Teramo; L'Oreal Group; University of Rome Tor Vergata; University Campus Bio-Medico - Rome Italy; IRCCS Santa Lucia	Maccarrone, M (corresponding author), Univ Teramo, Dept Biomed Sci, Piazza A Moro 45, I-64100 Teramo, Italy.	mmaccarrone@unite.it	Maccarrone, Mauro/K-5398-2012; Battista, Natalia/AAC-2529-2019; Pucci, Mariangela/K-6379-2016	Maccarrone, Mauro/0000-0002-3990-2963; Battista, Natalia/0000-0002-1936-6710; Pucci, Mariangela/0000-0003-4657-6075	L'Oreal Research and Innovation, Paris; Fondazione Cassa di Risparmio di Teramo	L'Oreal Research and Innovation, Paris; Fondazione Cassa di Risparmio di Teramo	This work was supported by L'Oreal Research and Innovation, Paris and by Fondazione Cassa di Risparmio di Teramo Grant 2009-2012 (to M.M.).	Abdel-Malek ZA, 2010, PIGM CELL MELANOMA R, V23, P171, DOI 10.1111/j.1755-148X.2010.00679.x; American Cancer Society, 2009, CANC FACTS FIG 2009; Bari M, 2005, J BIOL CHEM, V280, P12212, DOI 10.1074/jbc.M411642200; Berdyshev EV, 2001, FASEB J, V15, P2171, DOI 10.1096/fj.01-0181com; Bifulco M, 2002, NAT MED, V8, P547, DOI 10.1038/nm0602-547; Biro T, 2009, TRENDS PHARMACOL SCI, V30, P411, DOI 10.1016/j.tips.2009.05.004; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Blazquez C, 2006, FASEB J, V20, P2633, DOI 10.1096/fj.06-6638fje; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; BRONNERFRASER M, 1988, NATURE, V335, P161, DOI 10.1038/335161a0; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Casanova ML, 2003, J CLIN INVEST, V111, P43, DOI 10.1172/JCI200316116; Casu MA, 2005, BRAIN RES, V1048, P41, DOI 10.1016/j.brainres.2005.04.053; Cheli Y, 2010, PIGM CELL MELANOMA R, V23, P27, DOI 10.1111/j.1755-148X.2009.00653.x; Cheli Y, 2009, J BIOL CHEM, V284, P18699, DOI 10.1074/jbc.M109.005819; Choi TY, 2009, J DERMATOL SCI, V56, P128, DOI 10.1016/j.jdermsci.2009.07.002; Colombo G, 2009, J MOL NEUROSCI, V37, P111, DOI 10.1007/s12031-008-9114-2; Corre S, 2006, J INVEST DERMATOL, V126, P916, DOI 10.1038/sj.jid.5700190; Di Marzo V, 2008, REV PHYSIOL BIOCH P, V160, P1, DOI 10.1007/112_0505; Di Marzo V, 2010, CURR MED CHEM, V17, P1430; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Dobrosi N, 2008, FASEB J, V22, P3685, DOI 10.1096/fj.07-104877; FELDER CC, 1993, P NATL ACAD SCI USA, V90, P7656, DOI 10.1073/pnas.90.16.7656; Fezza F, 2005, ANAL BIOCHEM, V339, P113, DOI 10.1016/j.ab.2004.12.005; Francavilla F, 2009, ENDOCRINOLOGY, V150, P4692, DOI 10.1210/en.2009-0057; Gattinoni S, 2010, BIOORG MED CHEM LETT, V20, P4406, DOI 10.1016/j.bmcl.2010.06.050; Guzman M, 2003, NAT REV CANCER, V3, P745, DOI 10.1038/nrc1188; Hanus LO, 2010, CURR MED CHEM, V17, P1341, DOI 10.2174/092986710790980096; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Howlett AC, 2010, CURR MED CHEM, V17, P1382, DOI 10.2174/092986710790980023; Ibrahim MM, 2005, P NATL ACAD SCI USA, V102, P3093, DOI 10.1073/pnas.0409888102; Johnson SL, 2011, DEV BIOL, V350, P405, DOI 10.1016/j.ydbio.2010.12.004; Karsak M, 2007, SCIENCE, V316, P1494, DOI 10.1126/science.1142265; Khasabova IA, 2008, J NEUROSCI, V28, P11141, DOI 10.1523/JNEUROSCI.2847-08.2008; Kumagai A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026148; Kupczyk P, 2009, EXP DERMATOL, V18, P669, DOI 10.1111/j.1600-0625.2009.00923.x; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Ligresti A, 2009, CURR OPIN CHEM BIOL, V13, P321, DOI 10.1016/j.cbpa.2009.04.615; Liu J, 2003, J BIOL CHEM, V278, P45034, DOI 10.1074/jbc.M306062200; Liu J, 2000, BIOCHEM J, V346, P835, DOI 10.1042/0264-6021:3460835; Liu JJ, 2010, PIGM CELL MELANOMA R, V23, P741, DOI 10.1111/j.1755-148X.2010.00775.x; Maccarrone M, 2003, J BIOL CHEM, V278, P33896, DOI 10.1074/jbc.M303994200; Maccarrone M, 2006, ENDOCANNABINOIDS: THE BRAIN AND BODY'S MARIJUANA AND BEYOND, P451; Maccarrone M, 2010, TRENDS BIOCHEM SCI, V35, P601, DOI 10.1016/j.tibs.2010.05.008; Magina S, 2011, ARCH DERMATOL RES, V303, P201, DOI 10.1007/s00403-011-1126-z; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Oka S, 2006, J IMMUNOL, V177, P8796, DOI 10.4049/jimmunol.177.12.8796; Okamoto Y, 2009, VITAM HORM, V81, P1, DOI 10.1016/S0083-6729(09)81001-7; Park SY, 2010, BMB REP, V43, P824, DOI 10.5483/BMBRep.2010.43.12.824; Pasquariello N, 2009, J BIOL CHEM, V284, P29413, DOI 10.1074/jbc.M109.044412; Pasquariello N, 2009, VITAM HORM, V81, P441, DOI 10.1016/S0083-6729(09)81017-0; Paus R, 2006, J CLIN INVEST, V116, P1174, DOI 10.1172/JCI28553; Pertwee RG, 2010, CURR MED CHEM, V17, P1360, DOI 10.2174/092986710790980050; Petrosino S, 2009, CURR OPIN CHEM BIOL, V13, P309, DOI 10.1016/j.cbpa.2009.04.616; Pistis M, 2010, CURR MED CHEM, V17, P1450, DOI 10.2174/092986710790980014; Price ER, 1998, J BIOL CHEM, V273, P17983, DOI 10.1074/jbc.273.29.17983; Pucci M, 2011, EUR J DERMATOL, V21, P29, DOI 10.1684/ejd.2011.1266; Ross RA, 2009, TRENDS PHARMACOL SCI, V30, P156, DOI 10.1016/j.tips.2008.12.004; Scuderi MR, 2011, CANCER LETT, V310, P240, DOI 10.1016/j.canlet.2011.07.008; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Siegmund SV, 2006, J BIOL CHEM, V281, P10431, DOI 10.1074/jbc.M509706200; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Simon JD, 2009, PIGM CELL MELANOMA R, V22, P563, DOI 10.1111/j.1755-148X.2009.00610.x; Smit N, 2009, INT J MOL SCI, V10, P5326, DOI 10.3390/ijms10125326; Sugawara K., 2012, J ALLERGY CLIN IMMUN, V129, P726; Tada A, 2002, J INVEST DERMATOL, V118, P316, DOI 10.1046/j.0022-202x.2001.01694.x; Telek A, 2007, FASEB J, V21, P3534, DOI 10.1096/fj.06-7689com; Wan P, 2011, MOL CELL BIOCHEM, V354, P241, DOI 10.1007/s11010-011-0823-4; Werz O, 2001, BLOOD, V97, P2487, DOI 10.1182/blood.V97.8.2487; Xiao L, 2007, ARCH DERMATOL RES, V299, P245, DOI 10.1007/s00403-007-0740-2; Xu WD, 2000, EXP CELL RES, V255, P135, DOI 10.1006/excr.2000.4803; Zorina Y, 2010, J BIOL CHEM, V285, P1358, DOI 10.1074/jbc.M109.049841	75	47	48	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15466	15478		10.1074/jbc.M111.314880	http://dx.doi.org/10.1074/jbc.M111.314880			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22431736	hybrid, Green Published			2022-12-27	WOS:000304006300028
J	Qi, JP; Zhang, K; Zhang, Q; Sun, Y; Fu, T; Li, GH; Chen, JF				Qi, JunPeng; Zhang, Kun; Zhang, Qiao; Sun, Yi; Fu, Ting; Li, GuoHui; Chen, JianFeng			Identification, Characterization, and Epitope Mapping of Human Monoclonal Antibody J19 That Specifically Recognizes Activated Integrin alpha(4)beta(7)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-I DOMAIN; AVIDITY REGULATION; OVERLAP EXTENSION; STRUCTURAL BASIS; FIRM ADHESION; OUTSIDE-IN; AFFINITY; BINDING; CONFORMATION; ECTODOMAIN	Integrin alpha(4)beta(7) is a lymphocyte homing receptor that mediates both rolling and firm adhesion of lymphocytes on vascular endothelium, two of the critical steps in lymphocyte migration and tissue-specific homing. The rolling and firm adhesions of lymphocytes rely on the dynamic shift between the inactive and active states of integrin alpha(4)beta(7), which is associated with the conformational rearrangement of integrin molecules. Activation-specific antibodies, which specifically recognize the activated integrins, have been used as powerful tools in integrin studies, whereas there is no well characterized activation-specific antibody to integrin alpha(4)beta(7). Here, we report the identification, characterization, and epitope mapping of an activation-specific human mAb J19 against integrin alpha(4)beta(7). J19 was discovered by screening a human single-chain variable fragment phage library using an activated alpha(4)beta(7) mutant as target. J19 IgG specifically bound to the high affinity alpha(4)beta(7) induced by Mn2+, DTT, ADP, or CXCL12, but not to the low affinity integrin. Moreover, J19 IgG did not interfere with alpha(4)beta(7)-MAdCAM-1 interaction. The epitope of J19 IgG was mapped to Ser-331, Ala-332, and Ala-333 of beta(7) I domain and a seven-residue segment from 184 to 190 of alpha(4)beta-propeller domain, which are buried in low affinity integrin with bent conformation and only exposed in the high affinity extended conformation. Taken together, J19 is a potentially powerful tool for both studies on alpha(4)beta(7) activation mechanism and development of novel therapeutics targeting the activated lymphocyte expressing high affinity alpha(4)beta(7).	[Qi, JunPeng; Zhang, Kun; Zhang, Qiao; Sun, Yi; Chen, JianFeng] Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Fu, Ting; Li, GuoHui] Chinese Acad Sci, Lab Mol Modeling & Design, State Key Lab Mol React Dynam, Dalian Inst Chem Phys, Dalian 116023, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS	Chen, JF (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai Inst Biol Sci, 320 YueYang Rd, Shanghai 200031, Peoples R China.	jfchen@sibs.ac.cn	Qi, Junpeng/AAH-5525-2020; Qi, Junpeng/G-6949-2019		National Basic Research Program of China [2010CB529703]; National Natural Science Foundation of China [31190061, 30970604, 30700119]; Science and Technology Commission of Shanghai Municipality [11JC1414200]; Novo Nordisk-CAS Research Foundation [NN-CAS 2008-1]; Shanghai Pujiang Program [08PJ14106]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Novo Nordisk-CAS Research Foundation(Novo Nordisk Foundation); Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was supported by National Basic Research Program of China Grant 2010CB529703; National Natural Science Foundation of China Grants 31190061, 30970604, and 30700119; Science and Technology Commission of Shanghai Municipality Grant 11JC1414200; Novo Nordisk-CAS Research Foundation Grant NN-CAS 2008-1; and Shanghai Pujiang Program Grant 08PJ14106.	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; BRISKIN MJ, 1993, NATURE, V363, P461, DOI 10.1038/363461a0; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Chen JF, 2004, J BIOL CHEM, V279, P55556, DOI 10.1074/jbc.M407773200; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Chen J, 2006, P NATL ACAD SCI USA, V103, P13062, DOI 10.1073/pnas.0605666103; DAVIS GE, 1993, J IMMUNOL, V151, P7138; de Chateau M, 2001, BIOCHEMISTRY-US, V40, P13972, DOI 10.1021/bi011582f; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; EDWARDS BS, 1995, BLOOD, V86, P2288, DOI 10.1182/blood.V86.6.2288.bloodjournal8662288; Gorfu G, 2009, CURR MOL MED, V9, P836, DOI 10.2174/156652409789105525; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; LAZAROVITS AI, 1984, J IMMUNOL, V133, P1857; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; Morin NA, 2008, J EXP MED, V205, P195, DOI 10.1084/jem.20071543; MURGO AJ, 1992, J PHARMACOL EXP THER, V261, P580; Ni HY, 1998, J BIOL CHEM, V273, P7981, DOI 10.1074/jbc.273.14.7981; Pan YP, 2010, P NATL ACAD SCI USA, V107, P21388, DOI 10.1073/pnas.1015487107; Park EJ, 2007, J CLIN INVEST, V117, P2526, DOI 10.1172/JCI31570; Rutgeerts P, 2009, GASTROENTEROLOGY, V136, P1182, DOI 10.1053/j.gastro.2009.02.001; SCHWEIGHOFFER T, 1993, J IMMUNOL, V151, P717; Shimaoka M, 2006, P NATL ACAD SCI USA, V103, P13991, DOI 10.1073/pnas.0605716103; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Stefanelli T, 2008, AUTOIMMUN REV, V7, P364, DOI 10.1016/j.autrev.2008.01.002; Sun DS, 2005, J BIOMED SCI, V12, P937, DOI 10.1007/s11373-005-9016-z; Sun H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208900; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; TEIXIDO J, 1992, J BIOL CHEM, V267, P1786; Tidswell M, 1997, J IMMUNOL, V159, P1497; Weitz-Schmidt G, 2011, J BIOL CHEM, V286, P42115, DOI 10.1074/jbc.M111.282830; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xie C, 2004, P NATL ACAD SCI USA, V101, P15422, DOI 10.1073/pnas.0406680101; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Yamamoto M, 1998, J IMMUNOL, V160, P2188; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	47	7	9	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15749	15759		10.1074/jbc.M112.341263	http://dx.doi.org/10.1074/jbc.M112.341263			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22418441	Green Published, hybrid			2022-12-27	WOS:000304006300053
J	Leonardi, R; Subramanian, C; Jackowski, S; Rock, CO				Leonardi, Roberta; Subramanian, Chitra; Jackowski, Suzanne; Rock, Charles O.			Cancer-associated Isocitrate Dehydrogenase Mutations Inactivate NADPH-dependent Reductive Carboxylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; ALPHA-KETOGLUTARATE; ONCOMETABOLITE 2-HYDROXYGLUTARATE; GLUTAMINE-METABOLISM; IDH2 MUTATIONS; GLIOMA; R132H; LIPOGENESIS; INHIBITION; MECHANISMS	Isocitrate dehydrogenase (IDH) is a reversible enzyme that catalyzes the NADP(+)-dependent oxidative decarboxylation of isocitrate (ICT) to alpha-ketoglutarate (alpha KG) and the NADPH/CO2-dependent reductive carboxylation of alpha KG to ICT. Reductive carboxylation by IDH1 was potently inhibited by NADP(+) and, to a lesser extent, by ICT. IDH1 and IDH2 with cancer-associated mutations at the active site arginines were unable to carry out the reductive carboxylation of alpha KG. These mutants were also defective in ICT decarboxylation and converted alpha KG to 2-hydroxyglutarate using NADPH. These mutant proteins were thus defective in both of the normal reactions of IDH. Biochemical analysis of heterodimers between wild-type and mutant IDH1 subunits showed that the mutant subunit did not inactivate reductive carboxylation by the wild-type subunit. Cells expressing the mutant IDH are thus deficient in their capacity for reductive carboxylation and may be compromised in their ability to produce acetyl-CoA under hypoxia or when mitochondrial function is otherwise impaired.	[Leonardi, Roberta; Subramanian, Chitra; Jackowski, Suzanne; Rock, Charles O.] St Jude Childrens Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Rock, CO (corresponding author), St Jude Childrens Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	charles.rock@stjude.org	Jackowski, Suzanne/N-8168-2018; Chitra, S/GPX-8113-2022; Subramanian, Chitra/N-9210-2018	Jackowski, Suzanne/0000-0002-6855-1429; Subramanian, Chitra/0000-0003-1101-5307	National Institutes of Health [GM062896, GM034496]; Cancer Center (CORE) [CA21765]; American Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034496, R37GM034496, R01GM062896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center (CORE); American Syrian Associated Charities; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM062896 (to S. J.) and GM034496 (to C. O. R.) and Cancer Center (CORE) Support Grant CA21765. This work was also supported by the American Syrian Associated Charities.	ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; Andersson AK, 2011, LEUKEMIA, V25, P1570, DOI 10.1038/leu.2011.133; Bralten LBC, 2011, ANN NEUROL, V69, P455, DOI 10.1002/ana.22390; Ceccarelli C, 2002, J BIOL CHEM, V277, P43454, DOI 10.1074/jbc.M207306200; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; DADAMO AF, 1965, J BIOL CHEM, V240, P613; DALZIEL K, 1968, BIOCHEM J, V110, P223, DOI 10.1042/bj1100223; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Jin GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016812; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; NORTHROP DB, 1974, J BIOL CHEM, V249, P2928; OCHOA S, 1948, J BIOL CHEM, V174, P133; Pietrak B, 2011, BIOCHEMISTRY-US, V50, P4804, DOI 10.1021/bi200499m; RAMACHANDRAN N, 1980, J BIOL CHEM, V255, P8859; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; UHR ML, 1974, J BIOL CHEM, V249, P2920; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Williamson J R, 1979, Methods Enzymol, V55, P200; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang B, 2010, CELL RES, V20, P1188, DOI 10.1038/cr.2010.145; Yoo H, 2004, J LIPID RES, V45, P1324, DOI 10.1194/jlr.M400031-JLR200; Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	30	124	125	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14615	14620		10.1074/jbc.C112.353946	http://dx.doi.org/10.1074/jbc.C112.353946			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22442146	hybrid, Green Published			2022-12-27	WOS:000304003200028
J	Singha, UK; Hamilton, V; Duncan, MR; Weems, E; Tripathi, MK; Chaudhuri, M				Singha, Ujjal K.; Hamilton, VaNae; Duncan, Melanie R.; Weems, Ebony; Tripathi, Manish K.; Chaudhuri, Minu			Protein Translocase of Mitochondrial Inner Membrane in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA IMPORT; PREPROTEIN TRANSLOCASE; OUTER-MEMBRANE; INDUCIBLE EXPRESSION; ALTERNATIVE OXIDASE; DOWN-REGULATION; INSERTION; COMPLEX; IDENTIFICATION; BIOGENESIS	Translocases of mitochondrial inner membrane (TIMs) are multiprotein complexes. The only Tim component so far characterized in kinetoplastid parasites such as Trypanosoma brucei is Tim17 (TbTim17), which is essential for cell survival and mitochondrial protein import. Here, we report that TbTim17 is present in a protein complex of about 1,100 kDa, which is much larger than the TIM complexes found in fungi and mammals. Depletion of TbTim17 in T. brucei impairs the mitochondrial import of cytochrome oxidase subunit IV, an N-terminal signal-containing protein. Pretreatment of isolated mitoplasts with the anti-TbTim17 antibody inhibited import of cytochrome oxidase subunit IV, indicating a direct involvement of the TbTim17 in the import process. Purification of the TbTim17-containing protein complex from the mitochondrial membrane of T. brucei by tandem affinity chromatography revealed that TbTim17 associates with seven unique as well as a few known T. brucei mitochondrial proteins. Depletion of three of these novel proteins, i.e. TbTim47, TbTim54, and TbTim62, significantly decreased mitochondrial protein import in vitro. In vivo targeting of a newly synthesized mitochondrial matrix protein, MRP2, was also inhibited due to depletion of TbTim17, TbTim54, and TbTim62. Co-precipitation analysis confirmed the interaction of TbTim54 and TbTim62 with TbTim17 in vivo. Overall, our data reveal that TbTim17, the single homolog of Tim17/22/23 family proteins, is present in a unique TIM complex consisting of novel proteins in T. brucei and is critical for mitochondrial protein import.	[Singha, Ujjal K.; Hamilton, VaNae; Duncan, Melanie R.; Weems, Ebony; Chaudhuri, Minu] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Tripathi, Manish K.] Vanderbilt Univ, Dept Surg Oncol, Nashville, TN 37232 USA	Meharry Medical College; Vanderbilt University	Chaudhuri, M (corresponding author), Meharry Med Coll, Dept Microbiol & Immunol, W Basic Sci Bldg,Rm 4105, Nashville, TN 37208 USA.	mchaudhuri@mmc.edu			National Center for Research Resources [U54RR026140]; National Institute for Minority Health and Health Disparities [U54MD07593]; National Institutes of Health [G12RR003032, 2SC1GM081146]; National Institute for Heart, Lung, and Blood [T32HL007737]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140, G12RR003032] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM081146] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007593] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute for Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Heart, Lung, and Blood; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Core facilities are supported by Grants U54RR026140 from National Center for Research Resources, U54MD07593 from National Institute for Minority Health and Health Disparities, and G12RR003032 from National Institutes of Health. V. H., E. W., and M. R. D. are supported by training Grant T32HL007737 from National Institute for Heart, Lung, and Blood. M. C. is supported by Grant 2SC1GM081146 from the National Institutes of Health.	Acestor N, 2009, PROTEOMICS, V9, P5497, DOI 10.1002/pmic.200900354; Al-Khodor S, 2010, TRENDS MICROBIOL, V18, P132, DOI 10.1016/j.tim.2009.11.004; Bagos PG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-189; Bains G, 1999, BIOESSAYS, V21, P1; Bauer MF, 1999, J MOL BIOL, V289, P69, DOI 10.1006/jmbi.1999.2751; Becker T, 2008, BBA-BIOENERGETICS, V1777, P557, DOI 10.1016/j.bbabio.2008.03.017; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Chaudhuri M, 1998, MOL BIOCHEM PARASIT, V95, P53, DOI 10.1016/S0166-6851(98)00091-7; Chaudhuri M, 1996, MOL BIOCHEM PARASIT, V83, P125, DOI 10.1016/S0166-6851(96)02754-5; Chaudhuri M, 2001, GENE, V266, P1, DOI 10.1016/S0378-1119(01)00367-5; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Gentle IE, 2007, MOL BIOL EVOL, V24, P1149, DOI 10.1093/molbev/msm031; Gunzl Arthur, 2009, Curr Protoc Protein Sci, VChapter 19, DOI 10.1002/0471140864.ps1919s55; Hashimi H, 2008, RNA, V14, P970, DOI 10.1261/rna.888808; Hausler T, 1997, EUR J CELL BIOL, V73, P240; Hewitt V, 2011, BBA-BIOMEMBRANES, V1808, P947, DOI 10.1016/j.bbamem.2010.07.019; Kerscher O, 1997, J CELL BIOL, V139, P1663, DOI 10.1083/jcb.139.7.1663; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lister R, 2005, MOL MEMBR BIOL, V22, P87, DOI 10.1080/09687860500041247; Lithgow T, 2010, PHILOS T R SOC B, V365, P799, DOI 10.1098/rstb.2009.0167; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Panigrahi AK, 2003, RNA, V9, P484, DOI 10.1261/rna.2194603; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Panigrahi AK, 2007, METHOD ENZYMOL, V424, P3, DOI 10.1016/S0076-6879(07)24001-7; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Paris Z, 2011, MOL BIOCHEM PARASIT, V176, P116, DOI 10.1016/j.molbiopara.2010.12.010; Pusnik M, 2011, CURR BIOL, V21, P1738, DOI 10.1016/j.cub.2011.08.060; Rapaport D, 2005, J CELL BIOL, V171, P419, DOI 10.1083/jcb.200507147; Rassow J, 1999, J MOL BIOL, V286, P105, DOI 10.1006/jmbi.1998.2455; Rehling P, 2003, J MOL BIOL, V326, P639, DOI 10.1016/S0022-2836(02)01440-7; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Schneider A, 2001, INT J PARASITOL, V31, P1403, DOI 10.1016/S0020-7519(01)00296-X; Schneider A, 2008, TRENDS CELL BIOL, V18, P12, DOI 10.1016/j.tcb.2007.09.009; Schneider A, 2011, ANNU REV BIOCHEM, V80, P1033, DOI 10.1146/annurev-biochem-060109-092838; Sharma S, 2010, MOL BIOCHEM PARASIT, V174, P89, DOI 10.1016/j.molbiopara.2010.07.003; Singha UK, 2008, MOL BIOCHEM PARASIT, V159, P30, DOI 10.1016/j.molbiopara.2008.01.003; Singha UK, 2009, EUKARYOT CELL, V8, P1418, DOI 10.1128/EC.00132-09; Sternberg JM, 2010, PARASITOLOGY, V137, P2007, DOI 10.1017/S0031182010000946; Tewari R, 2010, TRENDS CELL BIOL, V20, P470, DOI 10.1016/j.tcb.2010.05.003; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; Tschopp F, 2011, EMBO REP, V12, P825, DOI 10.1038/embor.2011.111; van der Laan M, 2010, BBA-MOL CELL RES, V1803, P732, DOI 10.1016/j.bbamcr.2010.01.013; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Williams S, 2008, EXP PARASITOL, V118, P420, DOI 10.1016/j.exppara.2007.10.008; Wittig I, 2008, PROTEOMICS, V8, P3974, DOI 10.1002/pmic.200800017; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; WOODS A, 1989, J CELL SCI, V93, P491; World Health Organization, 2006, REP INF DIS; Zhang XB, 2010, NUCLEIC ACIDS RES, V38, P7378, DOI 10.1093/nar/gkq618; Zikova A, 2006, MOL BIOCHEM PARASIT, V149, P65, DOI 10.1016/j.molbiopara.2006.04.007; Zikova A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000436	61	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14480	14493		10.1074/jbc.M111.322925	http://dx.doi.org/10.1074/jbc.M111.322925			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22408251	Green Published, hybrid			2022-12-27	WOS:000304003200015
J	Ermak, G; Sojitra, S; Yin, F; Cadenas, E; Cuervo, AM; Davies, KJA				Ermak, Gennady; Sojitra, Sonal; Yin, Fei; Cadenas, Enrique; Cuervo, Ana Maria; Davies, Kelvin J. A.			Chronic Expression of RCAN1-1L Protein Induces Mitochondrial Autophagy and Metabolic Shift from Oxidative Phosphorylation to Glycolysis in Neuronal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; SYNDROME CRITICAL REGION-1; ALZHEIMERS-DISEASE; DOWN-SYNDROME; DSCR1 ADAPT78; CALCINEURIN REGULATORS; MONITORING AUTOPHAGY; INHIBITS CALCINEURIN; RAT HEPATOCYTES; STRESS	Expression of the RCAN1 gene can be induced by multiple stresses. RCAN1 proteins (RCAN1s) have both protective and harmful effects and are implicated in common human pathologies. The mechanisms by which RCAN1s function, however, remain poorly understood. We identify RCAN1s as regulators of mitochondrial autophagy (mitophagy) and demonstrate that induction of RCAN1-1L can cause dramatic degradation of mitochondria. The mechanisms of such degradation involve the adenine nucleotide translocator and mitochondrial permeability transition pore opening. We also demonstrate that RCAN1-1L induction can shift cellular bioenergetics from aerobic respiration to glycolysis, yet RCAN1-1L has very little effect on cell division, whereas it has a cumulative negative effect on cell survival. These results shed the light on mechanisms by which RCAN1s can protect or harm cells and by which they may operate in human pathologies. They also suggest that RCAN1s are important players in autophagy and such elusive phenomena as the mitochondrial permeability transition pore.	[Ermak, Gennady; Sojitra, Sonal; Davies, Kelvin J. A.] Univ So Calif, Davis Sch Gerontol, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA; [Ermak, Gennady; Sojitra, Sonal; Davies, Kelvin J. A.] Univ So Calif, Dornsife Coll Letters Arts & Sci, Dept Biol Sci, Div Mol & Computat Biol, Los Angeles, CA 90089 USA; [Yin, Fei; Cadenas, Enrique] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	University of Southern California; University of Southern California; University of Southern California; Yeshiva University; Albert Einstein College of Medicine	Davies, KJA (corresponding author), Univ So Calif, Davis Sch Gerontol, Ethel Percy Andrus Gerontol Ctr, 3715 McClintock Ave, Los Angeles, CA 90089 USA.	kelvin@usc.edu		Yin, Fei/0000-0002-5996-2410; Davies, Kelvin/0000-0001-7790-3003; Cuervo, Ana Maria/0000-0002-0771-700X	National Institutes of Health [RO1-ES003598, 3RO1-ES 003598-22S2, R01AG016718]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016718] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-ES003598 (and American Recovery and Reinvestment Act supplement 3RO1-ES 003598-22S2) (to K. J. A. D.) and R01AG016718 (to E. C.).	Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Cao X, 2002, BIOCHEM J, V367, P459, DOI 10.1042/BJ20011797; Chang KT, 2005, NAT NEUROSCI, V8, P1577, DOI 10.1038/nn1564; Cook CN, 2005, J ALZHEIMERS DIS, V8, P63; Crawford DR, 1997, ARCH BIOCHEM BIOPHYS, V342, P6, DOI 10.1006/abbi.1997.0109; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; Ermak G, 2002, FASEB J, V16, DOI 10.1096/fj.01-0846com; Ermak G, 2004, FASEB J, V18, P62, DOI 10.1096/fj.03-0451com; Ermak G, 2006, FEBS J, V273, P2100, DOI 10.1111/j.1742-4658.2006.05217.x; Ermak G, 2003, IUBMB LIFE, V55, P29, DOI 10.1080/1521654031000066820; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; Ermak G, 2011, FASEB J, V25, P3306, DOI 10.1096/fj.11-185728; Ermak G, 2009, J BIOL CHEM, V284, P11845, DOI 10.1074/jbc.M900639200; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Gorlach J, 2000, EMBO J, V19, P3618, DOI 10.1093/emboj/19.14.3618; Harris CD, 2007, FEBS J, V274, P1715, DOI 10.1111/j.1742-4658.2007.05717.x; Harris CD, 2005, CELL MOL LIFE SCI, V62, P2477, DOI 10.1007/s00018-005-5085-4; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; Javadov S, 2007, CELL PHYSIOL BIOCHEM, V20, P1, DOI 10.1159/000103747; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Leahy KP, 2000, ARCH BIOCHEM BIOPHYS, V379, P221, DOI 10.1006/abbi.2000.1897; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Mijaljica D, 2007, AUTOPHAGY, V3, P4, DOI 10.4161/auto.3011; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Porta S, 2007, EUR J NEUROSCI, V26, P1213, DOI 10.1111/j.1460-9568.2007.05749.x; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rodriguez-Enriquez S, 2004, INT J BIOCHEM CELL B, V36, P2463, DOI 10.1016/j.biocel.2004.04.009; Rodriguez-Enriquez S, 2009, AUTOPHAGY, V5, P1099, DOI 10.4161/auto.5.8.9825; Romanello V, 2010, CURR HYPERTENS REP, V12, P433, DOI 10.1007/s11906-010-0157-8; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Sun XL, 2011, J BIOL CHEM, V286, P9049, DOI 10.1074/jbc.M110.177519; Wang YL, 2002, AM J PHYSIOL-HEART C, V283, pH533, DOI 10.1152/ajpheart.00002.2002; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Zorov DB, 2009, CARDIOVASC RES, V83, P213, DOI 10.1093/cvr/cvp151	44	56	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14088	14098		10.1074/jbc.M111.305342	http://dx.doi.org/10.1074/jbc.M111.305342			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22389495	Green Published, hybrid			2022-12-27	WOS:000303996300062
J	Jung, S; Sonnichsen, FD; Hung, CW; Tholey, A; Boidin-Wichlacz, C; Haeusgen, W; Gelhaus, C; Desel, C; Podschun, R; Waetzig, V; Tasiemski, A; Leippe, M; Grotzinger, J				Jung, Sascha; Soennichsen, Frank D.; Hung, Chien-Wen; Tholey, Andreas; Boidin-Wichlacz, Celine; Haeusgen, Wiebke; Gelhaus, Christoph; Desel, Christine; Podschun, Rainer; Waetzig, Vicki; Tasiemski, Aurelie; Leippe, Matthias; Groetzinger, Joachim			Macin Family of Antimicrobial Proteins Combines Antimicrobial and Nerve Repair Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDES; SYSTEM; LEECH; ANTIBACTERIAL; CHALLENGE; RESISTANT; DEFENSIN	The tertiary structures of theromacin and neuromacin confirmed the macin protein family as a self-contained family of antimicrobial proteins within the superfamily of scorpion toxinlike proteins. The macins, which also comprise hydramacin-1, are antimicrobially active against Gram-positive and Gram-negative bacteria. Despite high sequence identity, the three proteins showed distinct differences with respect to their biological activity. Neuromacin exhibited a significantly stronger capacity to permeabilize the cytoplasmic membrane of Bacillus megaterium than theromacin and hydramacin-1. Accordingly, it is the only macin that displays pore-forming activity and that was potently active against Staphylococcus aureus. Moreover, neuromacin and hydramacin-1 led to an aggregation of bacterial cells that was not observed with theromacin. Analysis of the molecular surface properties of macins allowed confirmation of the barnacle model as the mechanistic model for the aggregation effect. Besides being antimicrobially active, neuromacin and theromacin, in contrast to hydramacin-1, were able to enhance the repair of leech nerves ex vivo. Notably, all three macins enhanced the viability of murine neuroblastoma cells, extending their functional characteristics. As neuromacin appears to be both a functional and structural chimera of hydramacin-1 and theromacin, the putative structural correlate responsible for the nerve repair capacity in leech was located to a cluster of six amino acid residues using the sequence similarity of surface-exposed regions.	[Jung, Sascha; Desel, Christine; Groetzinger, Joachim] Univ Kiel, Inst Biochem, D-24098 Kiel, Germany; [Soennichsen, Frank D.] Univ Kiel, Otto Diels Inst Organ Chem, D-24098 Kiel, Germany; [Gelhaus, Christoph; Leippe, Matthias] Univ Kiel, Inst Zool, D-24098 Kiel, Germany; [Hung, Chien-Wen; Tholey, Andreas] Univ Kiel, Inst Expt Med, Div Systemat Proteome Res, D-24105 Kiel, Germany; [Boidin-Wichlacz, Celine; Tasiemski, Aurelie] Univ Lille 1, CNRS FRE2933, Lab Neuroimmunol & Neurochim Evolut, F-59655 Villeneuve Dascq, France; [Haeusgen, Wiebke; Waetzig, Vicki] Univ Hosp Schleswig Holstein, Inst Expt & Clin Pharmacol, D-24105 Kiel, Germany; [Podschun, Rainer] Univ Hosp Schleswig Holstein, Inst Infect Med, D-24105 Kiel, Germany	University of Kiel; University of Kiel; University of Kiel; University of Kiel; Universite de Lille - ISITE; Universite de Lille; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Grotzinger, J (corresponding author), Univ Kiel, Inst Biochem, Olshausenstr 40, D-24098 Kiel, Germany.	jgroetzinger@biochem.uni-kiel.de	Sönnichsen, Frank D/D-8408-2011; Tholey, Andreas/B-3407-2010; Leippe, Matthias/AAP-1677-2020; Gelhaus, Christoph/D-8050-2011; Tasiemski, Aurelie/S-2537-2016	Sönnichsen, Frank D/0000-0002-4539-3755; Tholey, Andreas/0000-0002-8687-6817; Wichlacz, Celine/0000-0002-0242-868X; Jung, Sascha/0000-0003-4970-6904; Tasiemski, Aurelie/0000-0003-3559-5115	excellence cluster "Inflammation at Interfaces"; Ministere de l'Enseignement de la Recherche et des Technologies; CNRS	excellence cluster "Inflammation at Interfaces"; Ministere de l'Enseignement de la Recherche et des Technologies; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the excellence cluster "Inflammation at Interfaces," the Ministere de l'Enseignement de la Recherche et des Technologies, and the CNRS.	Blanc E, 1998, BIOCHEMISTRY-US, V37, P12412, DOI 10.1021/bi9809371; Boidin-Wichlacz C., 2012, CELL MOL LI IN PRESS; Bosch TCG, 2007, DEV BIOL, V303, P421, DOI 10.1016/j.ydbio.2006.12.012; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cook WJ, 2002, PROTEIN SCI, V11, P479, DOI 10.1110/ps.39202; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dingley Andrew J., 2008, V451, P441, DOI 10.1007/978-1-59745-102-4_30; Duan YL, 2005, CELL MOL NEUROBIOL, V25, P441, DOI 10.1007/s10571-005-3152-x; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Herbst R, 2002, J BIOL CHEM, V277, P22353, DOI 10.1074/jbc.M201475200; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Otero-Gonzalez AJ, 2010, FASEB J, V24, P1320, DOI 10.1096/fj.09-143388; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jung S, 2011, ANTIMICROB AGENTS CH, V55, P954, DOI 10.1128/AAC.00872-10; Jung S, 2009, J BIOL CHEM, V284, P1896, DOI 10.1074/jbc.M804713200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lamberty M, 2001, BIOCHEMISTRY-US, V40, P11995, DOI 10.1021/bi0103563; Lay FT, 2003, J MOL BIOL, V325, P175, DOI 10.1016/S0022-2836(02)01103-8; LEIPPE M, 1991, P NATL ACAD SCI USA, V88, P7659, DOI 10.1073/pnas.88.17.7659; Neonakis IK, 2011, INT J ANTIMICROB AG, V37, P102, DOI 10.1016/j.ijantimicag.2010.10.014; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; PICK U, 1981, ARCH BIOCHEM BIOPHYS, V212, P186, DOI 10.1016/0003-9861(81)90358-1; Sahly H, 2003, ANTIMICROB AGENTS CH, V47, P1739, DOI 10.1128/AAC.47.5.1739-1741.2003; Schaller HC, 1996, INT J DEV BIOL, V40, P339; Schikorski D, 2008, J IMMUNOL, V181, P1083, DOI 10.4049/jimmunol.181.2.1083; Schwab U, 1999, ANTIMICROB AGENTS CH, V43, P1435, DOI 10.1128/AAC.43.6.1435; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Tasiemski A, 2004, J BIOL CHEM, V279, P30973, DOI 10.1074/jbc.M312156200; Tasiemski A, 2010, ADV EXP MED BIOL, V708, P80; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wilmes M, 2011, NAT PROD REP, V28, P1350, DOI 10.1039/c1np00022e; Yang YS, 2000, BIOCHEMISTRY-US, V39, P14436, DOI 10.1021/bi0011835; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zucca M, 2011, MINI-REV MED CHEM, V11, P888, DOI 10.2174/138955711796575498	37	28	29	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14246	14258		10.1074/jbc.M111.336495	http://dx.doi.org/10.1074/jbc.M111.336495			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22396551	Green Published, hybrid			2022-12-27	WOS:000303996300076
J	Gamper, AM; Choi, S; Matsumoto, Y; Banerjee, D; Tomkinson, AE; Bakkenist, CJ				Gamper, Armin M.; Choi, Serah; Matsumoto, Yoshihiro; Banerjee, Dibyendu; Tomkinson, Alan E.; Bakkenist, Christopher J.			ATM Protein Physically and Functionally Interacts with Proliferating Cell Nuclear Antigen to Regulate DNA Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATAXIA-TELANGIECTASIA; REPLICATION FORK; HUMAN PCNA; KINASE; REPAIR; POLYMERASE; DAMAGE; PHOSPHORYLATION; INHIBITION; ACTIVATION	Ataxia telangiectasia (A-T) is a pleiotropic disease, with a characteristic hypersensitivity to ionizing radiation that is caused by biallelic mutations in A-T mutated (ATM), a gene encoding a protein kinase critical for the induction of cellular responses to DNA damage, particularly to DNA double strand breaks. Along known characteristic of A-T cells is their ability to synthesize DNA even in the presence of ionizing radiation-induced DNA damage, a phenomenon termed radioresistant DNA synthesis. We previously reported that ATM kinase inhibition, but not ATM protein disruption, blocks sister chromatid exchange following DNA damage. We now show that ATM kinase inhibition, but not ATM protein disruption, also inhibits DNA synthesis. Investigating a potential physical interaction of ATM with the DNA replication machinery, we found that ATM co-precipitates with proliferating cell nuclear antigen (PCNA) from cellular extracts. Using bacterially purified ATM truncation mutants and in vitro translated PCNA, we showed that the interaction is direct and mediated by the C terminus of ATM. Indeed, a 20-amino acid region close to the kinase domain is sufficient for strong binding to PCNA. This binding is specific to ATM, because the homologous regions of other PIKK members, including the closely related kinase A-T and Rad3-related (ATR), did not bind PCNA. ATM was found to bind two regions in PCNA. To examine the functional significance of the interaction between ATM and PCNA, we tested the ability of ATM to stimulate DNA synthesis by DNA polymerase delta, which is implicated in both DNA replication and DNA repair processes. ATM was observed to stimulate DNA polymerase activity in a PCNA-dependent manner.	[Gamper, Armin M.; Choi, Serah; Bakkenist, Christopher J.] Univ Pittsburgh, Dept Radiat Oncol, Pittsburgh, PA 15213 USA; [Bakkenist, Christopher J.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Matsumoto, Yoshihiro; Banerjee, Dibyendu; Tomkinson, Alan E.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Matsumoto, Yoshihiro; Banerjee, Dibyendu; Tomkinson, Alan E.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of New Mexico; University of New Mexico	Bakkenist, CJ (corresponding author), Univ Pittsburgh, Sch Med, Hillman Canc Ctr, Dept Radiat Oncol, Res Pavilion,Suite 2-6,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	bakkenistcj@upmc.edu	Banerjee, Dibyendu/Y-4652-2019	Matsumoto, Yoshihiro/0000-0001-6580-7188; Banerjee, Dibyendu/0000-0003-4244-9714; Gamper, Armin/0000-0002-6003-0768	National Institutes of Health [CA148644, GM57479, P30CA047904]; Frieda G. and Saul F. Shapira Breast Cancer Research Program; NATIONAL CANCER INSTITUTE [R01CA148644, P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057479] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frieda G. and Saul F. Shapira Breast Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA148644 (to C. J. B.), GM57479 (to A. E. T.), and P30CA047904. This work was also supported by the Frieda G. and Saul F. Shapira Breast Cancer Research Program.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Choi S, 2010, CELL CYCLE, V9, P4052, DOI 10.4161/cc.9.20.13471; COHEN MM, 1980, CYTOGENET CELL GENET, V28, P24, DOI 10.1159/000131508; CORNFORTH MN, 1985, SCIENCE, V227, P1589, DOI 10.1126/science.3975628; Fazlieva R, 2009, NUCLEIC ACIDS RES, V37, P2854, DOI 10.1093/nar/gkp155; Fox JT, 2011, FEBS LETT, V585, P2780, DOI 10.1016/j.febslet.2011.05.053; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hishiki A, 2009, J BIOL CHEM, V284, P10552, DOI 10.1074/jbc.M809745200; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Li X, 2009, MOL CELL, V36, P704, DOI 10.1016/j.molcel.2009.09.036; de Saro FJL, 2009, CURR GENOMICS, V10, P206, DOI 10.2174/138920209788185234; Lydeard JR, 2010, GENE DEV, V24, P1133, DOI 10.1101/gad.1922610; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; MURNANE JP, 1982, P NATL ACAD SCI-BIOL, V79, P1960, DOI 10.1073/pnas.79.6.1960; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Stolimenov I, 2009, BIOCHEM SOC T, V37, P605, DOI 10.1042/BST0370605; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; White JS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000758	35	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12445	12454		10.1074/jbc.M112.352310	http://dx.doi.org/10.1074/jbc.M112.352310			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22362778	hybrid, Green Published			2022-12-27	WOS:000302782200084
J	Sawant, A; Chanda, D; Isayeva, T; Tsuladze, G; Garvey, WT; Ponnazhagan, S				Sawant, Anandi; Chanda, Diptiman; Isayeva, Tatyana; Tsuladze, George; Garvey, W. T.; Ponnazhagan, Selvarangan			Noggin Is Novel Inducer of Mesenchymal Stem Cell Adipogenesis IMPLICATIONS FOR BONE HEALTH AND OBESITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOCYTE DIFFERENTIATION; MORPHOGENETIC PROTEINS; SIGNALING PATHWAY; RETINOIC ACID; CYCLIC-AMP; TGF-BETA; MARROW; GROWTH; EXPRESSION; RECEPTOR	Noggin is a glycosylated-secreted protein known so far for its inhibitory effects on bone morphogenetic protein (BMP) signaling by sequestering the BMP ligand. We report here for the first time a novel mechanism by which noggin directly induces adipogenesis of mesenchymal stem cells independently of major human adipogenic signals through C/EBP delta, C/EBP alpha and peroxisome proliferator-activated receptor-gamma. Evaluation of a possible mechanism for noggin-induced adipogenesis of mesenchymal stem cells identified the role of Pax-1 in mediating such differentiation. The relevance of elevated noggin levels in obesity was confirmed in a preclinical, immunocompetent mouse model of spontaneous obesity and in human patients with higher body mass index. These data clearly provide a novel role for noggin in inducing adipogenesis and possibly obesity and further indicates the potential of noggin as a therapeutic target to control obesity.	[Ponnazhagan, Selvarangan] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Garvey, W. T.] Univ Alabama, Dept Nutr Sci, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Ponnazhagan, S (corresponding author), Univ Alabama, Dept Pathol, 701 19th St S,LHRB 505, Birmingham, AL 35294 USA.	pons@uab.edu			National Institutes of Health [AR050251, AR060948, DK083562, DK038765]; University of Alabama at Birmingham Diabetes Research and Training Center [P60 DK079626]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060948, R01AR050251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038765, R01DK038765, R01DK083562, P60DK079626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham Diabetes Research and Training Center; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AR050251, AR060948 (to S. P.), DK083562 (to W. T. G.), and DK038765 (to W. T. G.). This work was also supported by the University of Alabama at Birmingham Diabetes Research and Training Center Grant P60 DK079626 (to W. T. G.).	Barness LA, 2007, AM J MED GENET A, V143A, P3016, DOI 10.1002/ajmg.a.32035; Beraldo FH, 2005, J CELL BIOL, V170, P551, DOI 10.1083/jcb.200505117; Bredella MA, 2011, OBESITY, V19, P49, DOI 10.1038/oby.2010.106; CHALEPAKIS G, 1991, CELL, V66, P873, DOI 10.1016/0092-8674(91)90434-Z; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; Choi KS, 2011, ARCH PHARM RES, V34, P599, DOI 10.1007/s12272-011-0410-y; Choy L, 2003, J BIOL CHEM, V278, P9609, DOI 10.1074/jbc.M212259200; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; DiPaola CP, 2005, J ORTHOP RES, V23, P1112, DOI 10.1016/j.orthres.2005.03.008; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hata K, 2003, MOL BIOL CELL, V14, P545, DOI 10.1091/mbc.E02-06-0356; Holecki M, 2010, POL ARCH MED WEWN, V120, P361, DOI 10.20452/pamw.969; Kajkenova O, 1997, J BONE MINER RES, V12, P1772, DOI 10.1359/jbmr.1997.12.11.1772; Kim JS, 2010, ARTHRITIS RHEUM-US, V62, P3706, DOI 10.1002/art.27733; Lee JS, 2011, BIOCHEM BIOPH RES CO, V409, P550, DOI 10.1016/j.bbrc.2011.05.042; Magni P, 2010, CURR MOL MED, V10, P522; Marchildon F, 2010, J BIOL CHEM, V285, P13274, DOI 10.1074/jbc.M109.054536; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; MonsoroBurq AH, 1996, DEVELOPMENT, V122, P3607; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Rodriguez JP, 2008, CURR STEM CELL RES T, V3, P208, DOI 10.2174/157488808785740325; Ryden M, 2003, BIOCHEM BIOPH RES CO, V311, P391, DOI 10.1016/j.bbrc.2003.10.010; Takada I, 2009, EXPERT OPIN THER TAR, V13, P593, DOI [10.1517/14728220902915310 , 10.1517/14728220902915310]; Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030; VALENZUELA DM, 1995, J NEUROSCI, V15, P6077; van Harmelen V, 2002, DIABETES, V51, P2029, DOI 10.2337/diabetes.51.7.2029; WALTHER C, 1991, GENOMICS, V11, P424, DOI 10.1016/0888-7543(91)90151-4; Wang LA, 2010, CELL PHYSIOL BIOCHEM, V26, P1093, DOI 10.1159/000323987; Warden CH, 2004, MAMM GENOME, V15, P460, DOI 10.1007/s00335-004-2353-9; Wu XB, 2003, J CLIN INVEST, V112, P924, DOI 10.1172/JCI200315543; Yan Q, 2007, J BIOL CHEM, V282, P13954, DOI 10.1074/jbc.M611476200; Yang DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001540; Yu WH, 2008, MOL CELL BIOCHEM, V310, P11, DOI 10.1007/s11010-007-9661-9	38	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12241	12249		10.1074/jbc.M111.293613	http://dx.doi.org/10.1074/jbc.M111.293613			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351751	Green Published, hybrid			2022-12-27	WOS:000302782200065
J	Zhang, WJ; Mendoza, MC; Pei, XL; Ilter, D; Mahoney, SJ; Zhang, YM; Ma, DL; Blenis, J; Wang, Y				Zhang, Wenjuan; Mendoza, Michelle C.; Pei, Xiaolei; Ilter, Didem; Mahoney, Sarah J.; Zhang, Yingmei; Ma, Dalong; Blenis, John; Wang, Ying			Down-regulation of CMTM8 Induces Epithelial-to-Mesenchymal Transition-like Changes via c-MET/Extracellular Signal-regulated Kinase (ERK) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; HUMAN HEPATOCELLULAR-CARCINOMA; EARLY GENE-PRODUCTS; COLORECTAL-CANCER; POOR-PROGNOSIS; PATHWAY; EXPRESSION; TRANSFORMATION; PROGRESSION; ACTIVATION	The acquisition of an invasive phenotype is a critical turning point for malignant tumor cells. CMTM8, a potential tumor suppressor, is frequently down-regulated in solid tumors, and its overexpression induces tumor cell apoptosis. Here, we identify a new role for CMTM8 in regulating tumor cell migration. Reducing CMTM8 expression in HepG2 hepatocellular carcinoma cells results in the acquisition of epithelial-to-mesenchymal transition (EMT) features, including a morphological change from organized epithelial sheets to scattered fibroblast-like shapes, reduction of the epithelial marker E-cadherin, and an increased invasive and migratory ability. These phenotypic changes are mediated in large part by the ERK-MAPK pathway, as the MEK inhibitor U0126 and shRNA-mediated knockdown of ERK2 significantly reversed these phenotypes. Hepatocyte growth factor binding to the c-MET receptor is known to induce EMT in HepG2 cells. We found that CMTM8 knockdown in HepG2 cells induced c-MET signaling and ERK activation. Inhibition of c-MET signaling with the small molecule inhibitor SU11274 or c-MET RNAi blocked the EMT-like changes following CMTM8 knockdown. CMTM8 overexpression in HepG2 cells inhibited hepatocyte growth factor-induced EMT-like morphological changes and cell motility. Down-regulation of CMTM8 also promoted an EMT-like change in MCF-10A cells, indicating a broader role for CMTM8 in regulating cellular transformation.	[Mendoza, Michelle C.; Ilter, Didem; Mahoney, Sarah J.; Blenis, John] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Zhang, Wenjuan; Pei, Xiaolei; Zhang, Yingmei; Ma, Dalong; Wang, Ying] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Key Lab Med Immunol,Minist Hlth,Dept Immunol, Beijing 100191, Peoples R China; [Zhang, Wenjuan] Capital Med Univ, Peking Univ, Hosp 9, Beijing Shijitan Hosp,Canc Res Lab, Beijing 100038, Peoples R China	Harvard University; Harvard Medical School; Peking University; Capital Medical University; Peking University	Blenis, J (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Longwood Ave, Boston, MA 02115 USA.	jblenis@hms.harvard.edu; yw@bjmu.edu.cn		Ilter, Didem/0000-0001-7506-8198	National Institutes of Health from NCI [R37CA46595]; National Natural Science Foundation of China [81071749, 30872292, 90813025]; National Basic Research Program of China [2012CB518000]; National Key New Drug Creation Program of China [2009ZX09503-004]; China Scholarship Council; Susan G. Komen for the Cure; NATIONAL CANCER INSTITUTE [R37CA046595, K01CA168850] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Key New Drug Creation Program of China; China Scholarship Council(China Scholarship Council); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R37CA46595 from NCI (to J. B.). This work was also supported by National Natural Science Foundation of China Grants 81071749, 30872292, and 90813025; National Basic Research Program of China Grant 2012CB518000; National Key New Drug Creation Program of China Grant 2009ZX09503-004; the China Scholarship Council; and Susan G. Komen for the Cure (to M. C. M.).	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Hwang YH, 2004, HEPATOL RES, V29, P113, DOI 10.1016/j.hepres.2004.02.009; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Jin CN, 2007, J CELL PHYSIOL, V211, P112, DOI 10.1002/jcp.20914; Jin CN, 2005, FEBS LETT, V579, P6375, DOI 10.1016/j.febslet.2005.10.021; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Kondo A, 2008, J BIOL CHEM, V283, P1428, DOI 10.1074/jbc.M704999200; Lahsnig C, 2009, ONCOGENE, V28, P638, DOI 10.1038/onc.2008.418; Lee SA, 2010, HEPATOLOGY, V52, P506, DOI 10.1002/hep.23681; Li D, 2007, INT J BIOCHEM CELL B, V39, P2107, DOI 10.1016/j.biocel.2007.06.002; Li Ning, 2008, V457, P305, DOI 10.1007/978-1-59745-261-8_23; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Mendoza MC, 2011, MOL CELL, V41, P661, DOI 10.1016/j.molcel.2011.02.031; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nagai T, 2011, MOL CANCER THER, V10, P169, DOI 10.1158/1535-7163.MCT-10-0544; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Pramanik R, 2003, J BIOL CHEM, V278, P4831, DOI 10.1074/jbc.M207732200; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Salvi A, 2007, INT J ONCOL, V31, P451; Sattler Martin, 2007, Curr Oncol Rep, V9, P102, DOI 10.1007/s11912-007-0005-4; Sattler Martin, 2009, Update Cancer Ther, V3, P109, DOI 10.1016/j.uct.2009.01.001; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Schmitz KJ, 2008, J HEPATOL, V48, P83, DOI 10.1016/j.jhep.2007.08.018; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Tavian D, 2000, INT J CANCER, V87, P644, DOI 10.1002/1097-0215(20000901)87:5<644::AID-IJC4>3.3.CO;2-N; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Togawa A, 2010, BIOCHEM BIOPH RES CO, V400, P271, DOI 10.1016/j.bbrc.2010.08.060; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Tsukada Y, 2001, J BIOL CHEM, V276, P40968, DOI 10.1074/jbc.M010890200; Ueki T, 1997, HEPATOLOGY, V25, P862, DOI 10.1002/hep.510250413; Vincan E, 2008, CLIN EXP METASTAS, V25, P657, DOI 10.1007/s10585-008-9156-4; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Yeh JJ, 2009, MOL CANCER THER, V8, P834, DOI 10.1158/1535-7163.MCT-08-0972; Yoshida T, 2006, ONCOGENE, V25, P6056, DOI 10.1038/sj.onc.1209635; ZARNEGAR R, 1989, BIOCHEM BIOPH RES CO, V163, P1370, DOI 10.1016/0006-291X(89)91130-3	45	45	51	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11850	11858		10.1074/jbc.M111.258236	http://dx.doi.org/10.1074/jbc.M111.258236			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337876	hybrid, Green Published			2022-12-27	WOS:000302782200024
J	Galal, WC; Pan, M; Giulian, G; Yuan, W; Li, SW; Edwards, JL; Marino, JP; Kelman, Z; Hurwitz, J				Galal, Wiebke Chemnitz; Pan, Miao; Giulian, Gary; Yuan, Wei; Li, Shuwei; Edwards, James L.; Marino, John P.; Kelman, Zvi; Hurwitz, Jerard			Formation of dAMP-glycerol and dAMP-Tris Derivatives by Thermococcus kodakaraensis DNA Primase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETERODIMERIC PRIMASE; EUKARYOTIC PRIMASE; PRIMER SYNTHESIS; P58 SUBUNIT; INITIATION; DOMAIN; TRANSFERASE; POLYMERASE; MECHANISM; COMPLEX	In the presence of dATP, glycerol, and Tris buffer, the DNA primase isolated from Thermococcus kodakaraensis catalyzed the formation of dAMP and two products that were identified as dAMP-glycerol and dAMP-Tris. These products were formed by the T. kodakaraensis p41 catalytic subunit alone and the T. kodakaraensis p41-p46 complex in the absence of a DNA template. They were not formed with preparations containing the catalytically inactive p41 subunit. Similar glycerol and Tris derivatives as well as dNMPs were also formed with dGTP, dCTP, or dTTP. The mechanism contributing to the formation of these products and its implications in the initiation reaction catalyzed by the T. kodakaraensis primase are discussed.	[Galal, Wiebke Chemnitz; Hurwitz, Jerard] 5 Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY USA; [Pan, Miao; Giulian, Gary; Yuan, Wei; Li, Shuwei; Edwards, James L.; Marino, John P.; Kelman, Zvi] Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Marino, John P.; Kelman, Zvi] Natl Inst Stand & Technol, Rockville, MD 20850 USA	National Institute of Standards & Technology (NIST) - USA	Hurwitz, J (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	j-hurwitz@ski.mskcc.org	Pan, Miao/E-7346-2012; Yuan, Wei/C-4938-2012		National Institutes of Health [GM034559]; National Science Foundation [MCB-0815646]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM034559 (to J. H.). This work was also supported by National Science Foundation Grant MCB-0815646 (to Z. K.).	Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Galal WC, 2012, J BIOL CHEM, V287, P16209, DOI 10.1074/jbc.M111.338145; GLYNN IM, 1964, BIOCHEM J, V90, P147, DOI 10.1042/bj0900147; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Ito N, 2003, GENES CELLS, V8, P913, DOI 10.1111/j.1365-2443.2003.00693.x; Iyer LM, 2005, NUCLEIC ACIDS RES, V33, P3875, DOI 10.1093/nar/gki702; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Kornberg A., 1992, DNA REPLICATION, P415; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Lao-Sirieix SH, 2004, J MOL BIOL, V344, P1251, DOI 10.1016/j.jmb.2004.10.018; Le Breton M, 2007, J MOL BIOL, V374, P1172, DOI 10.1016/j.jmb.2007.10.015; Liu LD, 2001, J BIOL CHEM, V276, P45484, DOI 10.1074/jbc.M106391200; Matsunaga F, 2003, EMBO REP, V4, P154, DOI 10.1038/sj.embor.embor732; Ramadan K, 2004, J MOL BIOL, V339, P395, DOI 10.1016/j.jmb.2004.03.056; SHEAFF RJ, 1993, BIOCHEMISTRY-US, V32, P3027, DOI 10.1021/bi00063a014; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Yuan W, 2011, J CHROMATOGR A, V1218, P2561, DOI 10.1016/j.chroma.2011.02.063; Zerbe LK, 2002, BIOCHEMISTRY-US, V41, P4891, DOI 10.1021/bi016030b	18	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16220	16229		10.1074/jbc.M111.338160	http://dx.doi.org/10.1074/jbc.M111.338160			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22427647	Green Published, hybrid			2022-12-27	WOS:000304030900014
J	Mitra, A; Ross, JA; Rodriguez, G; Nagy, ZS; Wilson, HL; Kirken, RA				Mitra, Abhisek; Ross, Jeremy A.; Rodriguez, Georgialina; Nagy, Zsuzsanna S.; Wilson, Harry L.; Kirken, Robert A.			Signal Transducer and Activator of Transcription 5b (Stat5b) Serine 193 Is a Novel Cytokine-induced Phospho-regulatory Site That Is Constitutively Activated in Primary Hematopoietic Malignancies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; DNA-BINDING ACTIVITY; JANUS KINASE; MYELOMONOCYTIC LEUKEMIA; PROTEIN-KINASE; PHOSPHORYLATION; SURVIVAL; CELLS; REVEALS; GROWTH	Signal transducer and activator of transcription 5b (Stat5b) is a critical node in the signaling network downstream of external (cytokines or growth factors) or internal (oncogenic tyrosine kinases) stimuli. Maximum transcriptional activation of Stat5b requires both tyrosine and serine phosphorylation. Although the mechanisms governing tyrosine phosphorylation and activation of Stat5b have been extensively studied, the role of serine phosphorylation remains to be fully elucidated. Using mass spectrometry and phospho-specific antibodies, we identified Ser-193 as a novel site of cytokine-induced phosphorylation within human Stat5b. Stat5b Ser(P)-193 was detected in activated primary human peripheral blood mononuclear cells or lymphoid cell lines in response to several gamma common (gamma c) cytokines, including interleukin (IL)-2, IL-7, IL-9, and IL-15. Kinetic and spatial analysis indicated that Stat5b Ser-193 phosphorylation was rapid and transient and occurred in the cytoplasmic compartment of the cell prior to Stat5b translocation to the nucleus. Moreover, inducible Stat5b Ser-193 phosphorylation was sensitive to inhibitors of mammalian target of rapamycin (mTOR), whereas inhibition of protein phosphatase 2A (PP2A) induced phosphorylation of Ser-193. Reconstitution assays in HEK293 cells in conjunction with site-directed mutagenesis, EMSA, and reporter assays indicated that Ser(P)-193 is required for maximal Stat5b transcriptional activity. Indeed, Stat5b Ser193 was found constitutively phosphorylated in several lymphoid tumor cell lines as well as primary leukemia and lymphoma patient tumor cells. Taken together, IL-2 family cytokines tightly control Stat5b Ser-193 phosphorylation through a rapamycin-sensitive mechanism. Furthermore, constitutive Ser-193 phosphorylation is associated with Stat5b proto-oncogenic activity and therefore may serve as a novel therapeutic target for treating hematopoietic malignancies.	[Mitra, Abhisek; Ross, Jeremy A.; Rodriguez, Georgialina; Nagy, Zsuzsanna S.; Kirken, Robert A.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Mitra, Abhisek; Ross, Jeremy A.; Rodriguez, Georgialina; Nagy, Zsuzsanna S.; Kirken, Robert A.] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA; [Wilson, Harry L.] Providence Mem Hosp, Dept Pathol, El Paso, TX 79902 USA	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso	Kirken, RA (corresponding author), Univ Texas El Paso, Dept Biol Sci, 500 W Univ Ave, El Paso, TX 79968 USA.	rkirken@utep.edu			Lizanell and Colbert Coldwell Foundation; Edward N. and Margaret G. Marsh Foundation; University Research Institute at the University of Texas at El Paso; National Institutes on Minority Health and Health Disparities (NIMHD), a component of the National Institutes of Health (NIH) [G12MD007592]; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	Lizanell and Colbert Coldwell Foundation; Edward N. and Margaret G. Marsh Foundation; University Research Institute at the University of Texas at El Paso; National Institutes on Minority Health and Health Disparities (NIMHD), a component of the National Institutes of Health (NIH); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by grants from the Lizanell and Colbert Coldwell Foundation (to R. A. K.), the Edward N. and Margaret G. Marsh Foundation (to R. A. K. and J. A. R.), and the University Research Institute at the University of Texas at El Paso (to J. A. R.), and was made possible by Grant G12MD007592 from the National Institutes on Minority Health and Health Disparities (NIMHD), a component of the National Institutes of Health (NIH).	Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bunting KD, 2007, FRONT BIOSCI-LANDMRK, V12, P2807, DOI 10.2741/2274; Carron C, 2000, BLOOD, V95, P3891; Chai SK, 1997, J IMMUNOL, V159, P4720; Cheng H, 2008, MOL CELL BIOL, V28, P2271, DOI 10.1128/MCB.01789-07; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; DAVID M, 1995, SCIENCE, V269, P1721, DOI 10.1126/science.7569900; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Friedbichler K., 2012, FRONT BIOSCI, V17, P3043; Friedbichler K, 2010, BLOOD, V116, P1548, DOI 10.1182/blood-2009-12-258913; Funakoshi-Tago M, 2010, J BIOL CHEM, V285, P5296, DOI 10.1074/jbc.M109.040733; Gaipa G, 2009, LEUKEMIA, V23, P791, DOI 10.1038/leu.2008.265; Harir N, 2008, BLOOD, V112, P2463, DOI 10.1182/blood-2007-09-115477; Harir N, 2007, BLOOD, V109, P1678, DOI 10.1182/blood-2006-01-029918; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Ho JMY, 1999, BLOOD, V93, P4354, DOI 10.1182/blood.V93.12.4354.412k30_4354_4364; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; Ilaria RL, 1996, J BIOL CHEM, V271, P31704, DOI 10.1074/jbc.271.49.31704; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Jain N, 1999, J BIOL CHEM, V274, P24392, DOI 10.1074/jbc.274.34.24392; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; Kato Y, 2005, J EXP MED, V202, P169, DOI 10.1084/jem.20042541; KIRKEN RA, 1995, CYTOKINE, V7, P689, DOI 10.1006/cyto.1995.0081; Kirken RA, 1997, J BIOL CHEM, V272, P15459, DOI 10.1074/jbc.272.24.15459; Kirken RA, 2000, J IMMUNOL, V165, P5097, DOI 10.4049/jimmunol.165.9.5097; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; Leonard WJ, 2001, INT J HEMATOL, V73, P271, DOI 10.1007/BF02981951; Levine RL, 2005, BLOOD, V106, P3377, DOI 10.1182/blood-2005-05-1898; Lin JX, 1996, J BIOL CHEM, V271, P10738, DOI 10.1074/jbc.271.18.10738; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Nagy ZS, 2002, J LEUKOCYTE BIOL, V72, P819; Nagy ZS, 2006, J IMMUNOL, V177, P5032, DOI 10.4049/jimmunol.177.8.5032; Nagy ZS, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-67; Nakajima H, 2001, EMBO J, V20, P6836, DOI 10.1093/emboj/20.23.6836; Nguyen VAT, 2000, BIOCHEM J, V349, P427, DOI 10.1042/0264-6021:3490427; Nieborowska-Skorska M, 1999, J EXP MED, V189, P1229, DOI 10.1084/jem.189.8.1229; Nyga R, 2005, BIOCHEM J, V390, P359, DOI 10.1042/BJ20041523; Pircher TJ, 1999, MOL ENDOCRINOL, V13, P555, DOI 10.1210/mend.13.4.0263; Ross JA, 2008, J BIOL CHEM, V283, P4699, DOI 10.1074/jbc.M708232200; Ross JA, 2010, J BIOL CHEM, V285, P3582, DOI 10.1074/jbc.M109.053843; Schuringa JJ, 2000, BLOOD, V95, P3765, DOI 10.1182/blood.V95.12.3765; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Shuai K, 1996, ONCOGENE, V13, P247; Smithgall TE, 2000, ONCOGENE, V19, P2612, DOI 10.1038/sj.onc.1203477; Snow JW, 2002, BLOOD, V99, P95, DOI 10.1182/blood.V99.1.95; Spiekermann K, 2002, EXP HEMATOL, V30, P262, DOI 10.1016/S0301-472X(01)00787-1; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Van Etten RA, 2007, ONCOGENE, V26, P6738, DOI 10.1038/sj.onc.1210758; Wang YL, 2004, J BIOL CHEM, V279, P25196, DOI 10.1074/jbc.M313668200; Winston LA, 1996, CURR BIOL, V6, P668, DOI 10.1016/S0960-9822(09)00445-X; Woetmann A, 2003, J BIOL CHEM, V278, P2787, DOI 10.1074/jbc.M210196200; Woetmann A, 1999, P NATL ACAD SCI USA, V96, P10620, DOI 10.1073/pnas.96.19.10620; Yamashita H, 1998, J BIOL CHEM, V273, P30218, DOI 10.1074/jbc.273.46.30218; Yamashita H, 2001, MOL CELL ENDOCRINOL, V183, P151, DOI 10.1016/S0303-7207(01)00546-9; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7	64	26	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16596	16608		10.1074/jbc.M111.319756	http://dx.doi.org/10.1074/jbc.M111.319756			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22442148	hybrid, Green Published			2022-12-27	WOS:000304030900049
J	Young, SG; Jung, HJ; Coffinier, C; Fong, LG				Young, Stephen G.; Jung, Hea-Jin; Coffinier, Catherine; Fong, Loren G.			Understanding the Roles of Nuclear A- and B-type Lamins in Brain Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GILFORD PROGERIA SYNDROME; AUTOSOMAL-DOMINANT LEUKODYSTROPHY; DREIFUSS MUSCULAR-DYSTROPHY; EMBRYONIC STEM-CELLS; PRELAMIN-A; STRUCTURAL ORGANIZATION; NEURONAL MIGRATION; DISEASE PHENOTYPES; SYNDROME MUTATION; GENE-EXPRESSION	The nuclear lamina is composed mainly of lamins A and C (A-type lamins) and lamins B1 and B2 (B-type lamins). Dogma has held that lamins B1 and B2 play unique and essential roles in the nucleus of every eukaryotic cell. Recent studies have raised doubts about that view but have uncovered crucial roles for lamins B1 and B2 in neuronal migration during the development of the brain. The relevance of lamins A and C in the brain remains unclear, but it is intriguing that prelamin A expression in the brain is low and is regulated by miR-9, a brain-specific microRNA.	[Young, Stephen G.; Coffinier, Catherine; Fong, Loren G.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Young, Stephen G.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Jung, Hea-Jin] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Young, SG (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA.	sgyoung@mednet.ucla.edu; lfong@mednet.ucla.edu		Young, Stephen/0000-0001-7270-3176	National Institutes of Health [HL76839, CA099506-07, HL086683, HL089781]; American Heart Association, National Office; NATIONAL CANCER INSTITUTE [R01CA099506] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086683, R01HL089781, R01HL076839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG035626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association, National Office(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL76839, CA099506-07, HL086683, and HL089781. This work was also supported by a Scientist Development Award from the American Heart Association, National Office.	BECK LA, 1990, J CELL BIOL, V110, P1489, DOI 10.1083/jcb.110.5.1489; BELMONT AS, 1993, J CELL BIOL, V123, P1671, DOI 10.1083/jcb.123.6.1671; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; BIAMONTI G, 1992, MOL CELL BIOL, V12, P3499, DOI 10.1128/MCB.12.8.3499; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Brussino A, 2009, J NEUROL NEUROSUR PS, V80, P237, DOI 10.1136/jnnp.2008.147330; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Coffinier C, 2011, MOL BIOL CELL, V22, P4683, DOI 10.1091/mbc.E11-06-0504; Coffinier C, 2010, NUCLEUS-AUSTIN, V1, P407, DOI 10.4161/nucl.1.5.12830; Coffinier C, 2010, J BIOL CHEM, V285, P20818, DOI 10.1074/jbc.M110.128835; Coffinier C, 2010, P NATL ACAD SCI USA, V107, P5076, DOI 10.1073/pnas.0908790107; Corrigan DP, 2005, BIOCHEM J, V387, P129, DOI 10.1042/BJ20041359; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Davies BSJ, 2010, HUM MOL GENET, V19, P2682, DOI 10.1093/hmg/ddq158; Davies BSJ, 2009, ANNU REV GENOM HUM G, V10, P153, DOI 10.1146/annurev-genom-082908-150150; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fong LG, 2006, J CLIN INVEST, V116, P743, DOI 10.1172/JCI27125; Gambello MJ, 1999, NEUROGENETICS, V2, P77, DOI 10.1007/s100480050056; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Harborth J, 2001, J CELL SCI, V114, P4557; HENNEKES H, 1994, J CELL SCI, V107, P1019; Hernandez L, 2010, DEV CELL, V19, P413, DOI 10.1016/j.devcel.2010.08.013; Ji JY, 2007, J BIOL CHEM, V282, P20015, DOI 10.1074/jbc.M611094200; Jung HJ, 2012, P NATL ACAD SCI USA, V109, pE423, DOI 10.1073/pnas.1111780109; Kim Y, 2011, SCIENCE, V334, P1706, DOI 10.1126/science.1211222; Lee R, 2010, HUM MOL GENET, V19, P1603, DOI 10.1093/hmg/ddq036; LIN F, 1995, GENOMICS, V27, P230, DOI 10.1006/geno.1995.1036; LIN F, 1993, J BIOL CHEM, V268, P16321; LUTZ RJ, 1992, P NATL ACAD SCI USA, V89, P3000, DOI 10.1073/pnas.89.7.3000; Malhas A, 2007, J CELL BIOL, V176, P593, DOI 10.1083/jcb.200607054; Malhas A, 2010, CELL CYCLE, V9, P531, DOI 10.4161/cc.9.3.10511; Malhas AN, 2009, J CELL BIOL, V184, P45, DOI 10.1083/jcb.200804155; Martin C, 2009, J CELL SCI, V122, P1551, DOI 10.1242/jcs.046284; Meijer IA, 2008, ARCH NEUROL-CHICAGO, V65, P1496, DOI 10.1001/archneur.65.11.1496; Mewborn SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014342; MOIR RD, 1994, J CELL BIOL, V125, P1201, DOI 10.1083/jcb.125.6.1201; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Muchir A, 2012, CARDIOVASC RES, V93, P311, DOI 10.1093/cvr/cvr301; Padiath QS, 2006, NAT GENET, V38, P1114, DOI 10.1038/ng1872; Patterson K, 2004, MOL BIOL CELL, V15, P600, DOI 10.1091/mbc.E03-06-0374; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Puckelwartz MJ, 2011, NUCLEUS-PHILA, V2, P162, DOI [10.4161/nucl.2.3.16003, 10.1083/jcb.201101046]; ROBER RA, 1989, DEVELOPMENT, V105, P365; Rosengardten Y, 2011, AGING CELL, V10, P1011, DOI 10.1111/j.1474-9726.2011.00743.x; Schuster J, 2011, NEUROGENETICS, V12, P65, DOI 10.1007/s10048-010-0269-y; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; SINENSKY M, 1994, J CELL SCI, V107, P61; Solecki DJ, 2006, GENE DEV, V20, P2639, DOI 10.1101/gad.1462506; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Tang CW, 2008, J CELL SCI, V121, P1014, DOI 10.1242/jcs.020982; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771; Tsukahara T, 2002, MUSCLE NERVE, V25, P898, DOI 10.1002/mus.10085; Vallee RB, 2006, GENE DEV, V20, P1384, DOI 10.1101/gad.1417206; Vergnes L, 2004, P NATL ACAD SCI USA, V101, P10428, DOI 10.1073/pnas.0401424101; WEBER K, 1989, FEBS LETT, V257, P411, DOI 10.1016/0014-5793(89)81584-4; Wilson KL, 2001, CELL, V104, P647, DOI 10.1016/S0092-8674(02)01452-6; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679; Wynshaw-Boris A, 2007, CLIN GENET, V72, P296, DOI 10.1111/j.1399-0004.2007.00888.x; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Yang SH, 2008, J CLIN INVEST, V118, P3291, DOI 10.1172/JCI35876; Yang SH, 2008, BBA-MOL CELL BIOL L, V1781, P36, DOI 10.1016/j.bbalip.2007.11.003; Yang SH, 2011, NUCLEUS-PHILA, V2, P562, DOI 10.4161/nucl.2.6.18085; Yang SH, 2011, HUM MOL GENET, V20, P3537, DOI 10.1093/hmg/ddr266; Yang SH, 2011, HUM MOL GENET, V20, P436, DOI 10.1093/hmg/ddq490; Yang SH, 2006, J CLIN INVEST, V116, P2115, DOI 10.1172/JCI28968; Young SG, 2006, J BIOL CHEM, V281, P39741, DOI 10.1074/jbc.R600033200; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018	72	42	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16103	16110		10.1074/jbc.R112.354407	http://dx.doi.org/10.1074/jbc.R112.354407			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22416132	Green Published, hybrid			2022-12-27	WOS:000304030900003
J	Cheng, AC; Wu, HL; Shi, GY; Tsai, IH				Cheng, An-Chun; Wu, Hua-Lin; Shi, Guey-Yueh; Tsai, Inn-Ho			A Novel Heparin-dependent Inhibitor of Activated Protein C That Potentiates Consumptive Coagulopathy in Russell's Viper Envenomation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-X ACTIVATOR; ANTITHROMBIN-III; MAST-CELLS; FACTOR-VA; IN-VIVO; VENOM; COAGULATION; MECHANISM; THROMBIN; SNAKE	The activation of coagulation factors V and X by Russell's viper venom (RVV) has been implicated in the development of consumptive coagulopathies in severely envenomed patients. However, factor Va is prone to inactivation by activated protein C (APC), an important serine protease that negatively regulates blood coagulation. It is therefore hypothesized that APC may be down-regulated by some of the venom components. In this study, we managed to isolate a potent Kunitz-type APC inhibitor, named DrKIn-I. Using chromogenic substrate, DrKIn-I dose-dependently inhibited the activity of APC. Heparin potentiated the inhibition and reduced the IC50 of DrKIn-I by 25-fold. DrKIn-I, together with heparin, also protected factor Va from APC-mediated inactivation. Using surface plasmon resonance, DrKIn-I exhibited fast binding kinetics with APC (association rate constant = 1.7 x 10(7) M-1 s(-1)). Direct binding assays and kinetic studies revealed that this inhibition (K-i = 53 pM) is due to the tight binding interactions of DrKIn-I with both heparin and APC. DrKIn-I also effectively reversed the anticoagulant activity of APC and completely restored the thrombin generation in APC-containing plasma. Furthermore, although the injection of either DrKIn-I or RVV-X (the venom factor X-activator) into ICR mice did not significantly deplete the plasma fibrinogen concentration, co-administration of DrKIn-I with RVV-X resulted in complete fibrinogen consumption and the deposition of fibrin thrombi in the glomerular capillaries. Our results provide new insights into the pathogenesis of RVV-induced coagulopathies and indicate that DrKIn-I is a novel APC inhibitor that is associated with potentially fatal thrombotic complications in Russell's viper envenomation.	[Cheng, An-Chun; Tsai, Inn-Ho] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Wu, Hua-Lin; Shi, Guey-Yueh] Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Coll Med, Tainan 70101, Taiwan; [Wu, Hua-Lin; Shi, Guey-Yueh] Natl Cheng Kung Univ, Ctr Biosci & Biotechnol, Tainan 70101, Taiwan; [Tsai, Inn-Ho] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan	Academia Sinica - Taiwan; National Cheng Kung University; National Cheng Kung University; National Taiwan University	Tsai, IH (corresponding author), Acad Sinica, Inst Biol Chem, 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	bc201@gate.sinica.edu.tw			Academia Sinica; National Science Council [NSC 99-2311-B-001-016-MY3]	Academia Sinica(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Academia Sinica and from the National Science Council (NSC 99-2311-B-001-016-MY3).	Alirol E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000603; BAUER KA, 1991, SEMIN HEMATOL, V28, P10; Bombeli T, 1997, THROMB HAEMOSTASIS, V77, P408; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; CAVARI S, 1992, THROMB RES, V67, P157, DOI 10.1016/0049-3848(92)90135-W; Chen HS, 2008, FEBS J, V275, P3944, DOI 10.1111/j.1742-4658.2008.06540.x; Cheng YC, 2005, BBA-PROTEINS PROTEOM, V1747, P213, DOI 10.1016/j.bbapap.2004.11.006; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Dahlback B, 2005, J INTERN MED, V257, P209, DOI 10.1111/j.1365-2796.2004.01444.x; Engelberg H, 2001, ATHEROSCLEROSIS, V159, P253, DOI 10.1016/S0021-9150(01)00650-5; Esmon CT, 2001, CRIT CARE, V5, pS7, DOI 10.1186/cc1333; ESPANA F, 1989, THROMB RES, V55, P369, DOI 10.1016/0049-3848(89)90069-8; Friedrich U, 2001, J BIOL CHEM, V276, P24122, DOI 10.1074/jbc.M011567200; Fromm JR, 1997, ARCH BIOCHEM BIOPHYS, V343, P92, DOI 10.1006/abbi.1997.0147; Griffin JH, 2007, J THROMB HAEMOST, V5, P73, DOI 10.1111/j.1538-7836.2007.02491.x; GRIFFITH MJ, 1982, J BIOL CHEM, V257, P7360; Gupta A, 2007, AM J PHYSIOL-RENAL, V293, pF245, DOI 10.1152/ajprenal.00477.2006; HEEB MJ, 1988, J BIOL CHEM, V263, P11613; HIGGINBOTHAM RD, 1965, J IMMUNOL, V95, P867; Hirsh J, 2001, ARTERIOSCL THROM VAS, V21, P1094, DOI 10.1161/hq0701.093686; Hung DZ, 2002, PHARMACOL TOXICOL, V91, P106, DOI 10.1034/j.1600-0773.2002.910303.x; IHRCKE NS, 1993, IMMUNOL TODAY, V14, P500, DOI 10.1016/0167-5699(93)90265-M; Kang HM, 2005, THROMB RES, V115, P327, DOI 10.1016/j.thromres.2004.09.015; Knoebl Paul N, 2008, Biologics, V2, P285; LIU LB, 1995, THROMB HAEMOSTASIS, V73, P405; Mann KG, 2003, J THROMB HAEMOST, V1, P1504, DOI 10.1046/j.1538-7836.2003.00298.x; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; NESHEIM ME, 1982, J BIOL CHEM, V257, P1443; Nielsen VG, 2001, J CRIT CARE, V16, P64, DOI 10.1053/jcrc.2001.26292; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; Petaja J, 1997, J CLIN INVEST, V99, P2655, DOI 10.1172/JCI119454; Rapaport SI, 1997, ARTERIOSCL THROM VAS, V17, P409, DOI 10.1161/01.ATV.17.2.409; RATCLIFFE PJ, 1989, AM J TROP MED HYG, V40, P312, DOI 10.4269/ajtmh.1989.40.312; Segers K, 2007, J BIOL CHEM, V282, P33915, DOI 10.1074/jbc.M701123200; Shoichet BK, 2006, J MED CHEM, V49, P7274, DOI 10.1021/jm061103g; Smith OP, 1999, BRIT J HAEMATOL, V104, P202, DOI 10.1046/j.1365-2141.1999.01186.x; Sugimoto M, 1997, THROMB HAEMOSTASIS, V77, P1223; Suntravat M, 2011, TOXICON, V58, P230, DOI 10.1016/j.toxicon.2011.05.007; SUZUKI K, 1984, J BIOCHEM, V95, P187, DOI 10.1093/oxfordjournals.jbchem.a134583; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; THANTHAN, 1989, ACTA TROP, V46, P23, DOI 10.1016/0001-706X(89)90013-2; THANTHAN, 1988, BRIT J HAEMATOL, V69, P513, DOI 10.1111/j.1365-2141.1988.tb02408.x; TINNUSWE, 1993, T ROY SOC TROP MED H, V87, P678, DOI 10.1016/0035-9203(93)90290-7; van Holde KE, 2002, BIOPHYS CHEM, V101, P249, DOI 10.1016/S0301-4622(02)00176-X; WARRELL DA, 1989, T ROY SOC TROP MED H, V83, P732, DOI 10.1016/0035-9203(89)90311-8; Win-Aung, 1998, T ROY SOC TROP MED H, V92, P322, DOI 10.1016/S0035-9203(98)91031-8; Yegneswaran S, 2009, THROMB HAEMOSTASIS, V101, P55, DOI 10.1160/TH08-07-0491; YOSHIKAWA T, 1981, RES EXP MED, V179, P223, DOI 10.1007/BF01851619; Zupunski V, 2003, FEBS LETT, V547, P131, DOI 10.1016/S0014-5793(03)00693-8	49	14	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15739	15748		10.1074/jbc.M111.323063	http://dx.doi.org/10.1074/jbc.M111.323063			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22416129	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000304006300052
J	Slotman, JA; Almeida, ACD; Hassink, GC; van de Ven, RHA; van Kerkhof, P; Kuiken, HJ; Strous, GJ				Slotman, Johan A.; Almeida, Ana C. da Silva; Hassink, Gerco C.; van de Ven, Robert H. A.; van Kerkhof, Peter; Kuiken, Hendrik J.; Strous, Ger J.			Ubc13 and COOH Terminus of Hsp70-interacting Protein (CHIP) Are Required for Growth Hormone Receptor Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE CHIP; REPEAT-CONTAINING PROTEIN; QUALITY-CONTROL; CONJUGATING ENZYMES; DEPENDENT ENDOCYTOSIS; CHAPERONE FUNCTIONS; CARBOXYL-TERMINUS; C-CBL; DEGRADATION; BINDING	Growth hormone receptor (GHR) endocytosis is a highly regulated process that depends on the binding and activity of the multimeric ubiquitin ligase, SCF beta TrCP (Skp Cullin F-box). Despite a specific interaction between beta-transducin repeat-containing protein (beta TrCP) and the GHR, and a strict requirement for ubiquitination activity, the receptor is not an obligatory target for SCF beta TrCP-directed Lys(48) polyubiquitination. We now show that also Lys(63)-linked ubiquitin chain formation is required for GHR endocytosis. We identified both the ubiquitin-conjugating enzyme Ubc13 and the ubiquitin ligase COOH terminus of Hsp70 interacting protein ( CHIP) as being connected to this process. Ubc13 activity and its interaction with CHIP precede endocytosis of GHR. In addition to beta TrCP, CHIP interacts specifically with the cytosolic tails of the dimeric GHR, identifying both Ubc13 and CHIP as novel factors in the regulation of cell surface availability of GHR.	[Slotman, Johan A.; Almeida, Ana C. da Silva; Hassink, Gerco C.; van de Ven, Robert H. A.; van Kerkhof, Peter; Strous, Ger J.] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; [Slotman, Johan A.; Almeida, Ana C. da Silva; Hassink, Gerco C.; van de Ven, Robert H. A.; van Kerkhof, Peter; Strous, Ger J.] Inst Biomembranes, NL-3584 CX Utrecht, Netherlands; [Kuiken, Hendrik J.] Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Netherlands Cancer Institute	Strous, GJ (corresponding author), Univ Med Ctr Utrecht, Dept Cell Biol, Heidelberglaan 100,AZU H02-313, NL-3584 CX Utrecht, Netherlands.	gstrous@umcutrecht.nl		van Kerkhof, Peter/0000-0002-8954-2230; Slotman, Johan A./0000-0001-9705-9620	Netherlands Proteomics Centre [NPC3.1]; European Network of Excellence [LSHG-CT-2005-018683]; Marie Curie Network [MRTN-CT-2006-034555]	Netherlands Proteomics Centre; European Network of Excellence(European Commission); Marie Curie Network(European Commission)	This work was supported by the Netherlands Proteomics Centre NPC3.1, European Network of Excellence Grant LSHG-CT-2005-018683, and Marie Curie Network Grant MRTN-CT-2006-034555.	Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; BAXTER RC, 1985, ENDOCRINOLOGY, V117, P650, DOI 10.1210/endo-117-2-650; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Brun J, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-24; Cliff MJ, 2005, J MOL BIOL, V346, P717, DOI 10.1016/j.jmb.2004.12.017; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Faresse N, 2010, AM J PHYSIOL-RENAL, V299, pF1462, DOI 10.1152/ajprenal.00285.2010; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Gent J, 2002, P NATL ACAD SCI USA, V99, P9858, DOI 10.1073/pnas.152294299; Govers R, 1999, EMBO J, V18, P28, DOI 10.1093/emboj/18.1.28; Graf C, 2010, BIOCHEMISTRY-US, V49, P2121, DOI 10.1021/bi901829f; Grove DE, 2009, MOL BIOL CELL, V20, P4059, DOI 10.1091/mbc.E08-09-0929; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Hurley JH, 2011, ANNU REV BIOPHYS, V40, P119, DOI 10.1146/annurev-biophys-042910-155404; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Kazazic M, 2009, TRAFFIC, V10, P235, DOI 10.1111/j.1600-0854.2008.00858.x; Kramer LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014291; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Le Bras S, 2011, TRAFFIC, V12, P149, DOI 10.1111/j.1600-0854.2010.01126.x; Maldonado-Baez L, 2006, TRENDS CELL BIOL, V16, P505, DOI 10.1016/j.tcb.2006.08.001; McDonough H, 2009, J BIOL CHEM, V284, P20649, DOI 10.1074/jbc.M109.011767; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; MURPHY LJ, 1984, ENDOCRINOLOGY, V115, P1625, DOI 10.1210/endo-115-4-1625; Nelson RF, 2006, J BIOL CHEM, V281, P20242, DOI 10.1074/jbc.M602423200; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; Nie L, 2008, J BIOL CHEM, V283, P684, DOI 10.1074/jbc.M704981200; Paiva S, 2009, J BIOL CHEM, V284, P19228, DOI 10.1074/jbc.M109.008318; Parsons JL, 2008, MOL CELL, V29, P477, DOI 10.1016/j.molcel.2007.12.027; Pashkova N, 2010, MOL CELL, V40, P433, DOI 10.1016/j.molcel.2010.10.018; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Putters J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014676; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; ROUPAS P, 1988, MOL CELL ENDOCRINOL, V57, P93, DOI 10.1016/0303-7207(88)90037-8; Schantl JA, 2003, BIOCHEM J, V373, P855, DOI 10.1042/BJ20021591; Sehat B, 2008, CANCER RES, V68, P5669, DOI 10.1158/0008-5472.CAN-07-6364; Soss SE, 2011, J BIOL CHEM, V286, P21277, DOI 10.1074/jbc.M111.224006; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Strous GJ, 1996, EMBO J, V15, P3806, DOI 10.1002/j.1460-2075.1996.tb00754.x; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Timsit YE, 2005, BIOCHEM BIOPH RES CO, V328, P550, DOI 10.1016/j.bbrc.2005.01.022; van Dam EM, 2002, J BIOL CHEM, V277, P48876, DOI 10.1074/jbc.M206271200; van den Eijnden MJM, 2006, J CELL SCI, V119, P3078, DOI 10.1242/jcs.03036; van Kerkhof P, 2002, ENDOCRINOLOGY, V143, P1243, DOI 10.1210/en.143.4.1243; van Kerkhof P, 2001, MOL BIOL CELL, V12, P2556, DOI 10.1091/mbc.12.8.2556; van Kerkhof P, 2007, J BIOL CHEM, V282, P20475, DOI 10.1074/jbc.M702610200; van Kerkhof P, 2011, EXP CELL RES, V317, P1071, DOI 10.1016/j.yexcr.2010.12.020; vanDelft S, 1997, J BIOL CHEM, V272, P14013, DOI 10.1074/jbc.272.22.14013; Varghese B, 2008, MOL CELL BIOL, V28, P5275, DOI 10.1128/MCB.00350-08; Vina-Vilaseca A, 2010, J BIOL CHEM, V285, P7645, DOI 10.1074/jbc.M109.058990; Wang L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201814; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Windheim M, 2008, BIOCHEM J, V409, P723, DOI 10.1042/BJ20071338; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhu T, 2001, CELL SIGNAL, V13, P599, DOI 10.1016/S0898-6568(01)00186-3	59	26	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15533	15543		10.1074/jbc.M111.302521	http://dx.doi.org/10.1074/jbc.M111.302521			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22433856	Green Published, hybrid			2022-12-27	WOS:000304006300034
J	Ding, BX; Sun, Y; Huang, JT				Ding, Boxiao; Sun, Yin; Huang, Jiaoti			Overexpression of SKI Oncoprotein Leads to p53 Degradation through Regulation of MDM2 Protein Sumoylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORMING-GROWTH-FACTOR; TRANSCRIPTIONAL REPRESSION; SKELETAL-MUSCLE; LIGASE ACTIVITY; CO-REPRESSOR; TUMOR-GROWTH; RAR-ALPHA; IN-VIVO; UBIQUITINATION; PATHWAY	Protooncogene Ski was identified based on its ability to transform avian fibroblasts in vitro. In support of its oncogenic activity, SKI was found to be overexpressed in a variety of human cancers, although the exact molecular mechanism(s) responsible for its oncogenic activity is not fully understood. We found that SKI can negatively regulate p53 by decreasing its level through up-regulation of MDM2 activity, which is mediated by the ability of SKI to enhance sumoylation of MDM2. This stimulation of MDM2 sumoylation is accomplished through a direct interaction of SKI with SUMO-conjugating enzyme E2, Ubc9, resulting in enhanced thioester bond formation and mono-sumoylation of Ubc9. A mutant SKI defective in transformation fails to increase p53 ubiquitination and is unable to increase MDM2 levels and to increase mono-sumoylation of Ubc9, suggesting that the ability of SKI to enhance Ubc9 activity is essential for its transforming function. These results established a detailed molecular mechanism that underlies the ability of SKI to cause cellular transformation while unraveling a novel connection between sumoylation and tumorigenesis, providing potential new therapeutic targets for cancer.	[Ding, Boxiao; Sun, Yin; Huang, Jiaoti] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Huang, Jiaoti] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Huang, Jiaoti] Univ Calif Los Angeles, David Geffen Sch Med, Broad Ctr Regenerat Med & Stem Cell Res, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sun, Y (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	yinsun@mednet.ucla.edu; jiaotihuang@mednet.ucla.edu	Ding, Boxiao/C-1017-2011	Huang, Jiaoti/0000-0003-1195-1998	National Institutes of Health [RO1 CA093848, 1R01CA158627]; Department of Defense [PC1001008]; UCLA SPORE in Prostate Cancer; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA158627, R01CA093848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); UCLA SPORE in Prostate Cancer; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA093848 (to Y. S.).; Supported by Department of Defense Prostate Cancer Research Program Grant PC1001008, UCLA SPORE in Prostate Cancer (to R. Reiter), a challenge award from the Prostate Cancer Foundation (to O. Witte), a creativity award from Prostate Cancer Foundation (to M. Rettig), and National Institutes of Health Grant 1R01CA158627 (to L. Marks). To whom correspondence may be addressed. E-mail: jiaotihuang@mednet.ucla.edu.	Akagi T, 2004, TRENDS MOL MED, V10, P542, DOI 10.1016/j.molmed.2004.09.001; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Barkas A., 1986, THESIS NEW YORK U; Berk M, 1997, GENE DEV, V11, P2029, DOI 10.1101/gad.11.16.2029; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Buess M, 2004, NEOPLASIA, V6, P207, DOI 10.1593/neo.03442; Buschmann T, 2001, J BIOL CHEM, V276, P40389, DOI 10.1074/jbc.M103786200; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Carter S, 2008, CELL CYCLE, V7, P2519, DOI 10.4161/cc.7.16.6422; Chen DH, 2009, PIGM CELL MELANOMA R, V22, P761, DOI 10.1111/j.1755-148X.2009.00603.x; Chu Y, 2011, ONCOGENE, V30, P1108, DOI 10.1038/onc.2010.462; Colmenares C, 2002, NAT GENET, V30, P106, DOI 10.1038/ng770; COLMENARES C, 1989, CELL, V59, P293, DOI 10.1016/0092-8674(89)90291-2; COLMENARES C, 1991, MOL CELL BIOL, V11, P1167, DOI 10.1128/MCB.11.2.1167; Dahl R, 1998, ONCOGENE, V16, P1579, DOI 10.1038/sj.onc.1201687; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Ferrand N, 2010, CANCER RES, V70, P8457, DOI 10.1158/0008-5472.CAN-09-4088; Fukuchi M, 2004, INT J CANCER, V108, P818, DOI 10.1002/ijc.11651; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Heider TR, 2007, ANN SURG, V246, P61, DOI 10.1097/SLA.0b013e318070cafa; Hock A, 2010, INT J BIOCHEM CELL B, V42, P1618, DOI 10.1016/j.biocel.2010.06.011; Hollstein M, 2010, J PATHOL, V220, P164, DOI 10.1002/path.2637; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Inoue Y, 2011, J BIOL CHEM, V286, P6311, DOI 10.1074/jbc.M110.177683; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lee MH, 2006, NAT CELL BIOL, V8, P1424, DOI 10.1038/ncb1512; LI Y, 1986, J VIROL, V57, P1065, DOI 10.1128/JVI.57.3.1065-1072.1986; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Long JY, 2004, P NATL ACAD SCI USA, V101, P99, DOI 10.1073/pnas.0307598100; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Medrano EE, 2003, ONCOGENE, V22, P3123, DOI 10.1038/sj.onc.1206452; Miyauchi Y, 2002, J BIOL CHEM, V277, P50131, DOI 10.1074/jbc.M208319200; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Pelisch F, 2010, P NATL ACAD SCI USA, V107, P16119, DOI 10.1073/pnas.1004653107; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Ritter M, 2006, LEUKEMIA, V20, P437, DOI 10.1038/sj.leu.2404093; Shinagawa T, 2001, ONCOGENE, V20, P8100, DOI 10.1038/sj.onc.1204987; Subramaniam S, 2010, J BIOL CHEM, V285, P20428, DOI 10.1074/jbc.C110.127191; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; Sun Y, 2011, J BIOL CHEM, V286, P18623, DOI 10.1074/jbc.M110.176693; SUTRAVE P, 1990, GENE DEV, V4, P1462, DOI 10.1101/gad.4.9.1462; Takahata M, 2009, J BIOL CHEM, V284, P3334, DOI 10.1074/jbc.M808989200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tokitou F, 1999, J BIOL CHEM, V274, P4485, DOI 10.1074/jbc.274.8.4485; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Wu CW, 2004, NATURE, V432, P640, DOI 10.1038/nature03173; Xu WD, 2000, P NATL ACAD SCI USA, V97, P5924, DOI 10.1073/pnas.090097797; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	54	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14621	14630		10.1074/jbc.M111.301523	http://dx.doi.org/10.1074/jbc.M111.301523			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22411991	Green Published, hybrid			2022-12-27	WOS:000304003200029
J	Sen, D; Nandakumar, D; Tang, GQ; Patel, SS				Sen, Doyel; Nandakumar, Divya; Tang, Guo-Qing; Patel, Smita S.			Human Mitochondrial DNA Helicase TWINKLE Is Both an Unwinding and Annealing Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; SINGLE-STRANDED-DNA; STRUCTURE-FUNCTION DEFECTS; NUCLEOTIDE HYDROLYSIS; CENTRAL CHANNEL; GENE-4 PROTEIN; REPLICATION; BINDING; BACTERIOPHAGE-T7; PRIMASE	TWINKLE is a nucleus-encoded human mitochondrial (mt) DNA helicase. Point mutations in TWINKLE are associated with heritable neuromuscular diseases characterized by deletions in the mtDNA. To understand the biochemical basis of these diseases, it is important to define the roles of TWINKLE in mtDNA metabolism by studying its enzymatic activities. To this end, we purified native TWINKLE from Escherichia coli. The recombinant TWINKLE assembles into hexamers and higher oligomers, and addition of MgUTP stabilizes hexamers over higher oligomers. Probing into the DNA unwinding activity, we discovered that the efficiency of unwinding is greatly enhanced in the presence of a heterologous single strand-binding protein or a single-stranded (ss) DNA that is complementary to the unwound strand. We show that TWINKLE, although a helicase, has an antagonistic activity of annealing two complementary ssDNAs that interferes with unwinding in the absence of gp2.5 or ssDNA trap. Furthermore, only ssDNA and not double-stranded (ds)DNA competitively inhibits the annealing activity, although both DNAs bind with high affinities. This implies that dsDNA binds to a site that is distinct from the ssDNA-binding site that promotes annealing. Fluorescence anisotropy competition binding experiments suggest that TWINKLE has more than one ssDNA-binding sites, and we speculate that a surface-exposed ssDNA-specific site is involved in catalyzing DNA annealing. We propose that the strand annealing activity of TWINKLE may play a role in recombination-mediated replication initiation found in the mitochondria of mammalian brain and heart or in replication fork regression during repair of damaged DNA replication forks.	[Sen, Doyel; Nandakumar, Divya; Tang, Guo-Qing; Patel, Smita S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Patel, SS (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA.	patelss@umdnj.edu	Nandakumar, Divya/K-6250-2014	Nandakumar, Divya/0000-0001-7672-0213	National Institutes of Health [GM55310]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM55310.	Ahnert P, 2000, EMBO J, V19, P3418, DOI 10.1093/emboj/19.13.3418; Cheok CF, 2005, NUCLEIC ACIDS RES, V33, P3932, DOI 10.1093/nar/gki712; Costa A, 2006, J STRUCT BIOL, V156, P210, DOI 10.1016/j.jsb.2006.04.001; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; Delagoutte E, 2011, BIOCHEMISTRY-US, V50, P932, DOI 10.1021/bi101583e; Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025; Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116; Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301; Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359; HALLER I, 1974, P NATL ACAD SCI USA, V71, P2018, DOI 10.1073/pnas.71.5.2018; HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028; Holmlund T, 2009, BBA-MOL BASIS DIS, V1792, P132, DOI 10.1016/j.bbadis.2008.11.009; Jemt E, 2011, NUCLEIC ACIDS RES, V39, P9238, DOI 10.1093/nar/gkr653; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Korhonen JA, 2008, J MOL BIOL, V377, P691, DOI 10.1016/j.jmb.2008.01.035; Longley MJ, 2010, J BIOL CHEM, V285, P29690, DOI 10.1074/jbc.M110.151795; Machwe A, 2005, J BIOL CHEM, V280, P23397, DOI 10.1074/jbc.M414130200; Mao Chih-Chieh, 2009, Chang Gung Med J, V32, P354; MATSON SW, 1985, J BIOL CHEM, V260, P2281; MATSON SW, 1983, J BIOL CHEM, V258, P4017; Matsushima Y, 2008, J BIOL CHEM, V283, P23964, DOI 10.1074/jbc.M803674200; Oliveira MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015379; PATEL SS, 1992, J BIOL CHEM, V267, P15013; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Picha KM, 2000, BIOCHEMISTRY-US, V39, P6401, DOI 10.1021/bi992857i; Picha KM, 1998, J BIOL CHEM, V273, P27315, DOI 10.1074/jbc.273.42.27315; Pohjoismaki JLO, 2009, J BIOL CHEM, V284, P21446, DOI 10.1074/jbc.M109.016600; Rasnik I, 2008, EMBO J, V27, P1727, DOI 10.1038/emboj.2008.106; Remus D, 2009, CURR OPIN CELL BIOL, V21, P771, DOI 10.1016/j.ceb.2009.08.002; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Tang GQ, 2006, BIOCHEMISTRY-US, V45, P4936, DOI 10.1021/bi0522910; Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215; Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015; Xu XH, 2009, EMBO J, V28, P568, DOI 10.1038/emboj.2009.13; Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454; Ziebarth TD, 2007, J MOL BIOL, V367, P1382, DOI 10.1016/j.jmb.2007.01.079; Ziebarth TD, 2010, J BIOL CHEM, V285, P14639, DOI 10.1074/jbc.M109.099663	38	44	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14545	14556		10.1074/jbc.M111.309468	http://dx.doi.org/10.1074/jbc.M111.309468			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22383523	hybrid, Green Published			2022-12-27	WOS:000304003200021
J	Woo, JS; Cho, CH; Lee, KJ; Kim, DH; Ma, JJ; Lee, EH				Woo, Jin Seok; Cho, Chung-Hyun; Lee, Keon Jin; Kim, Do Han; Ma, Jianjie; Lee, Eun Hui			Hypertrophy in Skeletal Myotubes Induced by Junctophilin-2 Mutant, Y141H, Involves an Increase in Store-operated Ca2+ Entry via Orai1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM; CARDIAC-HYPERTROPHY; TRIADIC PROTEINS; PLASMA-MEMBRANE; CALCIUM INFLUX; HEART-FAILURE; MUSCLE FIBERS; STIM1; CARDIOMYOPATHY; CONTRACTION	Junctophilins (JPs) play an important role in the formation of junctional membrane complexes (JMC) in striated muscle by physically linking the transverse-tubule and sarcoplasmic reticulum (SR) membranes. Researchers have found five JP2 mutants in humans with hypertrophic cardiomyopathy. Among these, Y141H and S165F are associated with severely altered Ca2+ signaling in cardiomyocytes. We previously reported that S165F also induced both hypertrophy and altered intracellular Ca2+ signaling in mouse skeletal myotubes. In the present study, we attempted to identify the dominant-negative role(s) of Y141H in primary mouse skeletal myotubes. Consistent with S165F, Y141H led to hypertrophy and altered Ca2+ signaling (a decrease in the gain of excitation-contraction coupling and an increase in the resting level of myoplasmic Ca2+). However, unlike S165F, neither ryanodine receptor 1-mediated Ca2+ release from the SR nor the phosphorylation of the mutated JP2 by protein kinase C was related to the altered Ca2+ signaling by Y141H. Instead, abnormal JMC and increased SOCE via Orai1 were found, suggesting that the hypertrophy caused by Y141H progressed differently from S165F. Therefore JP2 can be linked to skeletal muscle hypertrophy via various Ca2+ signaling pathways, and SOCE could be one of the causes of altered Ca2+ signaling observed in muscle hypertrophy.	[Woo, Jin Seok; Lee, Keon Jin; Lee, Eun Hui] Catholic Univ Korea, Coll Med, Dept Physiol, Seoul 137701, South Korea; [Cho, Chung-Hyun] Seoul Natl Univ, Coll Med, Dept Pharmacol, Seoul 110799, South Korea; [Cho, Chung-Hyun] Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Seoul 110799, South Korea; [Kim, Do Han] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; [Ma, Jianjie] UMDNJ Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA	Catholic University of Korea; Seoul National University (SNU); Seoul National University (SNU); Gwangju Institute of Science & Technology (GIST); Rutgers State University New Brunswick; Rutgers State University Medical Center	Lee, EH (corresponding author), Catholic Univ Korea, Coll Med, Dept Physiol, Seoul 137701, South Korea.	EHUI@catholic.ac.kr	Cho, Chung-Hyun/H-7286-2012	Lee, Eun Hui/0000-0003-4555-1730	Ministry of Health & Welfare, Republic of Korea [A090047]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0022731, 2010-0028236]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A090047) (to E. H. L.), and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by Ministry of Education, Science and Technology Grants 2010-0022731 (to E. H. L.) and 2010-0028236 (to C. H. C.).	Chopra N, 2009, P NATL ACAD SCI USA, V106, P7636, DOI 10.1073/pnas.0902919106; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Garbino A, 2009, PHYSIOL GENOMICS, V37, P175, DOI 10.1152/physiolgenomics.00017.2009; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hirata Y, 2006, BIOPHYS J, V90, P4418, DOI 10.1529/biophysj.105.076570; Ito K, 2001, J CELL BIOL, V154, P1059, DOI 10.1083/jcb.200105040; Kawasaki T, 2010, J BIOL CHEM, V285, P25720, DOI 10.1074/jbc.M109.022996; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; Landstrom AP, 2007, J MOL CELL CARDIOL, V42, P1026, DOI 10.1016/j.yjmcc.2007.04.006; Landstrom AP, 2011, CIRC-HEART FAIL, V4, P214, DOI 10.1161/CIRCHEARTFAILURE.110.958694; Launikonis BS, 2007, J PHYSIOL-LONDON, V583, P81, DOI 10.1113/jphysiol.2007.135046; Lee EH, 2006, J BIOL CHEM, V281, P10042, DOI 10.1074/jbc.M600981200; Lee EH, 2006, MOL CELLS, V21, P315; Lee EH, 2010, PROG BIOPHYS MOL BIO, V103, P35, DOI 10.1016/j.pbiomolbio.2010.05.003; Li HL, 2010, J BIOL CHEM, V285, P39171, DOI 10.1074/jbc.M110.149690; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Louis M, 2008, J CELL SCI, V121, P3951, DOI 10.1242/jcs.037218; Lyfenko AD, 2008, J PHYSIOL-LONDON, V586, P4815, DOI 10.1113/jphysiol.2008.160481; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Matsushita Y, 2007, J HUM GENET, V52, P543, DOI 10.1007/s10038-007-0149-y; Minamisawa S, 2004, BIOCHEM BIOPH RES CO, V325, P852, DOI 10.1016/j.bbrc.2004.10.107; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Naito Y, 2004, NUCLEIC ACIDS RES, V32, pW124, DOI 10.1093/nar/gkh442; Nishi M, 2000, BIOCHEM BIOPH RES CO, V273, P920, DOI 10.1006/bbrc.2000.3011; Nishi M, 2003, MOL BRAIN RES, V118, P102, DOI 10.1016/S0169-328X(03)00341-3; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Rando TA, 1997, METHOD CELL BIOL, V52, P261, DOI 10.1016/S0091-679X(08)60382-9; Rochlin K, 2010, DEV BIOL, V341, P66, DOI 10.1016/j.ydbio.2009.10.024; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; van Oort RJ, 2011, CIRCULATION, V123, P979, DOI 10.1161/CIRCULATIONAHA.110.006437; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Voelkers M, 2010, J MOL CELL CARDIOL, V48, P1329, DOI 10.1016/j.yjmcc.2010.01.020; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324; Wilburn B, 2011, NEURON, V70, P427, DOI 10.1016/j.neuron.2011.03.021; Woo JS, 2008, BIOCHEM J, V411, P399, DOI [10.1042/BJ20071504, 10.1042/bj20071504]; Woo JS, 2010, BIOCHEM J, V427, P125, DOI 10.1042/BJ20091225; Woo JS, 2009, MOL CELL BIOCHEM, V328, P25, DOI 10.1007/s11010-009-0070-0; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu M, 2007, PLOS BIOL, V5, P203, DOI 10.1371/journal.pbio.0050021; Yamazaki D, 2009, PHARMACOL THERAPEUT, V121, P265, DOI 10.1016/j.pharmthera.2008.11.004; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zucchi R, 1997, PHARMACOL REV, V49, P1	46	30	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14336	14348		10.1074/jbc.M111.304808	http://dx.doi.org/10.1074/jbc.M111.304808			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22389502	hybrid, Green Published			2022-12-27	WOS:000304003200003
J	Yu, X; Luo, Y; Dinkel, P; Zheng, J; Wei, GH; Margittai, M; Nussinov, R; Ma, BY				Yu, Xiang; Luo, Yin; Dinkel, Paul; Zheng, Jie; Wei, Guanghong; Margittai, Martin; Nussinov, Ruth; Ma, Buyong			Cross-seeding and Conformational Selection between Three- and Four-repeat Human Tau Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; BETA-SHEET; AGGREGATION; BINDING; TRANSMISSION; ISOFORMS; FIBRILS; BRAIN; CORE	In Alzheimer's disease and frontotemporal dementias, the microtubule-associated protein Tau forms intracellular paired helical filaments. The filaments can form not only by the full-length human Tau protein, but also by the three repeated (K19) or four repeated (K18) Tau segments. However, of interest, experimentally, K19 can seed K18, but not vice versa. To obtain insight into the cross-seeding between K18 and K19 aggregates, here, K18 and K19 octamers with repeat 3 (R3) in U-shaped, L-shaped, and long straight line-shaped (SL-shape) conformations are assembled into different structures. The simulation results show that K18-8/K19-8 (K18 and K19 assemblies number 8) with R3 in an L shape and K18-9/K19-9 with R3 in an SL shape are highly populated and present the highest structural similarity among all simulated K18 and K19 octamers, suggesting that similar folding of K18/K19 may serve as structural core for the K18-K19 co-assembled heterogeneous filament. We demonstrate that formation of stable R2 and R3 conformations is the critical step for K18 aggregation, and R3 is critical for K19 fibrillization. The different core units in K18 and K19 may create a cross-seeding barrier for the K18 seed to trigger K19 fibril growth because R2 is not available for K19. Our study provides insights into cross-seeding involving heterogeneous structures. The polymorphic nature of protein aggregation could be magnified in the cross-seeding process. If the seeding conformations lead to too much divergence in the energy landscape, it could impede fibril formation. Such an effect could also contribute to the asymmetric barrier between K18 and K19.	[Yu, Xiang; Luo, Yin; Zheng, Jie] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA; [Luo, Yin; Wei, Guanghong] Fudan Univ, State Key Lab Surface Phys, Key Lab Computat Phys Sci, Minist Educ, Shanghai 200433, Peoples R China; [Luo, Yin; Wei, Guanghong] Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China; [Dinkel, Paul; Margittai, Martin] Univ Denver, Dept Chem & Biochem, Denver, CO 80208 USA; [Nussinov, Ruth; Ma, Buyong] NCI, Basic Res Program, SAIC Frederick Inc, Ctr Canc Res Nanobiol Program, Frederick, MD 21702 USA; [Nussinov, Ruth] Tel Aviv Univ, Dept Human Genet & Mol Med, Sackler Inst Mol Med, Sackler Sch Med, IL-69978 Tel Aviv, Israel	University System of Ohio; University of Akron; Fudan University; Fudan University; University of Denver; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Tel Aviv University; Sackler Faculty of Medicine	Zheng, J (corresponding author), Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.	zhengj@uakron.edu; ghwei@fudan.edu.cn; ruthnu@helix.nih.gov	Zheng, Jie/B-5057-2013; Ma, Buyong/F-9491-2011; Margittai, Martin/D-5039-2014; Yu, Xiang/A-9765-2012	Zheng, Jie/0000-0003-1547-3612; Ma, Buyong/0000-0002-7383-719X; Margittai, Martin/0000-0003-1903-5927; Nussinov, Ruth/0000-0002-8115-6415; Yu, Xiang/0000-0002-0486-1110; Wei, Guanghong/0000-0001-5814-3328	National Institutes of Health [R01NS076619]; National Cancer Institute [HHSN261200800001E]; National Cancer Institute Center for Cancer Research, National Science Foundation [CBET-0952624]; National Natural Science Foundation of China [11074047]; Research Fund for the Doctoral Program of Higher Education of China [RFDP-20100071110006]; NATIONAL CANCER INSTITUTE [ZIABC010441, ZIABC010440] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [0952624] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute Center for Cancer Research, National Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS076619 (to M. M.). This work was also supported by National Cancer Institute Contract HHSN261200800001E, the intramural research program of the National Cancer Institute Center for Cancer Research, National Science Foundation CAREER Award CBET-0952624 (to J. Z.), a 3M nontenured faculty award (to J. Z.), National Natural Science Foundation of China Grant 11074047 (to G. W.), and Research Fund for the Doctoral Program of Higher Education of China Grant RFDP-20100071110006 (to G. W.).	Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Dinkel PD, 2011, BIOCHEMISTRY-US, V50, P4330, DOI 10.1021/bi2004685; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Lee MS, 2002, J CHEM PHYS, V116, P10606, DOI 10.1063/1.1480013; Li L, 2002, J BIOL CHEM, V277, P41390, DOI 10.1074/jbc.M206334200; Ma B., 2012, J MOL BIOL IN PRESS; Ma BY, 2011, J BIOL CHEM, V286, P34244, DOI 10.1074/jbc.M111.241141; Ma BY, 2010, J BIOL CHEM, V285, P37102, DOI 10.1074/jbc.M110.133488; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Ma BY, 2002, P NATL ACAD SCI USA, V99, P14126, DOI 10.1073/pnas.212206899; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Matsumura S, 2011, J BIOL CHEM, V286, P11555, DOI 10.1074/jbc.M110.181313; Miller Y, 2011, BIOCHEMISTRY-US, V50, P5172, DOI 10.1021/bi200400u; Miller Y, 2010, CHEM REV, V110, P4820, DOI 10.1021/cr900377t; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Sibille N, 2006, BIOCHEMISTRY-US, V45, P12560, DOI 10.1021/bi060964o; Siddiqua A, 2010, J BIOL CHEM, V285, P37920, DOI 10.1074/jbc.M110.185728; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; Wegmann S, 2010, J BIOL CHEM, V285, P27302, DOI 10.1074/jbc.M110.145318; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Xu SH, 2010, ALZHEIMERS DEMENT, V6, P110, DOI 10.1016/j.jalz.2009.06.002; Zheng J, 2008, FRONT BIOSCI-LANDMRK, V13, P3919, DOI 10.2741/2980; Zheng J, 2006, PHYS BIOL, V3, pP1, DOI 10.1088/1478-3975/3/3/P01	42	55	56	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14950	14959		10.1074/jbc.M112.340794	http://dx.doi.org/10.1074/jbc.M112.340794			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22393063	Green Published, hybrid			2022-12-27	WOS:000304003200057
J	Calix, JJ; Saad, JS; Brady, AM; Nahm, MH				Calix, Juan J.; Saad, Jamil S.; Brady, Allison M.; Nahm, Moon H.			Structural Characterization of Streptococcus pneumoniae Serotype 9A Capsule Polysaccharide Reveals Role of Glycosyl 6-O-Acetyltransferase wcjE in Serotype 9V Capsule Biosynthesis and Immunogenicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLATION; PNEUMOCOCCAL SEROTYPE; CONJUGATE VACCINE; IDENTIFICATION; VALIDATION; RESPONSES; CARRIAGE; MODEL; ASSAY; LOCI	The putative capsule O-acetyltransferase gene wcjE is highly conserved across various Streptococcus pneumoniae serotypes, but the role of the gene in capsule biosynthesis and bacterial fitness remains largely unclear. Isolates expressing pneumococcal serotype 9A arise from precursors expressing wcjE-associated serotype 9V through loss-of-function mutation to wcjE. To define the biosynthetic role of 9V wcjE, we characterized the structure and serological properties of serotype 9V and 9A capsule polysaccharide (PS). NMR data revealed that both 9V and 9A PS are composed of an identical pentasaccharide repeat unit, as reported previously. However, in sharp contrast to previous studies on 9A PS being devoid of any O-acetylation, we identified O-acetylation of alpha-glucuronic acid and alpha-glucose in 9A PS. In addition, 9V PS also contained -CH2 O-acetylation of beta-N-acetylmannosamine, a modification that disappeared following in vitro recombinatorial deletion of wcjE. We also show that serotyping sera and monoclonal antibodies specific for 9V and 9A bound capsule PS in an O-acetate-dependent manner. Furthermore, IgG and to a lesser extent IgM from human donors immunized with serotype 9V PS displayed stronger binding to 9V compared with 9A PS. We conclude that serotype 9V wcjE mediates 6-O-acetylation of beta-N-acetylmannosamine. This PS modification can be selectively targeted by antibodies in immunized individuals, identifying a potential selective advantage for wcjE inactivation and serotype 9A emergence.	[Calix, Juan J.; Saad, Jamil S.; Brady, Allison M.; Nahm, Moon H.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Nahm, Moon H.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Nahm, MH (corresponding author), BBRB 614,1530 3rd Ave S, Birmingham, AL 35294 USA.	nahm@uab.edu		Saad, Jamil/0000-0001-9503-6484; Brady, Allison/0000-0003-0606-1384; Nahm, Moon/0000-0002-6922-1042	National Institutes of Health [AI-93103, AI-31473]; Department of Microbiology at the University of Alabama at Birmingham; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051, F31AI093103, R56AI031473, R01AI031473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Microbiology at the University of Alabama at Birmingham; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-93103 (to J. J. C.) and AI-31473 (to M. H. N.). This work was also supported by the Department of Microbiology at the University of Alabama at Birmingham (to J. S. S.). The University of Alabama at Birmingham has intellectual property rights for some of the reagents used in this study, and all authors are University of Alabama at Birmingham. MHN serves as a consultant to Merck Inc. for S. pneumoniae diagnosis assays.	Aanensen DM, 2007, J BACTERIOL, V189, P7856, DOI 10.1128/JB.00837-07; Abeygunawardana C, 2000, ANAL BIOCHEM, V279, P226, DOI 10.1006/abio.1999.4470; Aubry C, 2011, J INFECT DIS, V204, P731, DOI 10.1093/infdis/jir396; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Berry DS, 2002, INFECT IMMUN, V70, P3707, DOI 10.1128/IAI.70.7.3707-3713.2002; Beynon LM, 1997, EUR J BIOCHEM, V250, P163, DOI 10.1111/j.1432-1033.1997.00163.x; Bratcher PE, 2010, MICROBIOL-SGM, V156, P555, DOI 10.1099/mic.0.034116-0; Calix JJ, 2012, CLIN INFECT DIS, V54, P794, DOI 10.1093/cid/cir953; Calix JJ, 2011, J INFECT DIS, V204, P1585, DOI 10.1093/infdis/jir593; Calix JJ, 2011, J BACTERIOL, V193, P5271, DOI 10.1128/JB.05034-11; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fattom AI, 1998, INFECT IMMUN, V66, P4588, DOI 10.1128/IAI.66.10.4588-4592.1998; Fox KL, 2005, MOL MICROBIOL, V58, P207, DOI 10.1111/j.1365-2958.2005.04814.x; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kamerling JP., 2000, STREPTOCOCCUS PNEUMO, P81; Lemercinier X, 2006, CARBOHYD RES, V341, P68, DOI 10.1016/j.carres.2005.10.014; Lin JS, 2006, J CLIN MICROBIOL, V44, P383, DOI 10.1128/JCM.44.2.383-388.2006; Mavroidi A, 2007, J BACTERIOL, V189, P7841, DOI 10.1128/JB.00836-07; McNeely TB, 1998, INFECT IMMUN, V66, P3705, DOI 10.1128/IAI.66.8.3705-3710.1998; Park IH, 2007, INFECT IMMUN, V75, P4482, DOI 10.1128/IAI.00510-07; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; PERRY MB, 1982, MOL IMMUNOL, V19, P235, DOI 10.1016/0161-5890(82)90336-4; ROBBINS JB, 1983, J INFECT DIS, V148, P1136, DOI 10.1093/infdis/148.6.1136; RUTHERFORD TJ, 1991, CARBOHYD RES, V218, P175, DOI 10.1016/0008-6215(91)84096-W; Skinner JM, 2011, VACCINE, V29, P8870, DOI 10.1016/j.vaccine.2011.09.078; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Sun Y, 1999, INFECT IMMUN, V67, P1172, DOI 10.1128/IAI.67.3.1172-1179.1999; Theilacker C, 2003, INFECT IMMUN, V71, P3875, DOI 10.1128/IAI.71.7.3875-3884.2003; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; VERMA NK, 1991, MOL MICROBIOL, V5, P71, DOI 10.1111/j.1365-2958.1991.tb01827.x; Zartler ER, 2009, J BIOL CHEM, V284, P7318, DOI 10.1074/jbc.M807952200	32	26	28	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13996	14003		10.1074/jbc.M112.346924	http://dx.doi.org/10.1074/jbc.M112.346924			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22367197	Green Published, hybrid			2022-12-27	WOS:000303996300054
J	Hehemann, JH; Smyth, L; Yadav, A; Vocadlo, DJ; Boraston, AB				Hehemann, Jan-Hendrik; Smyth, Leo; Yadav, Anuj; Vocadlo, David J.; Boraston, Alisdair B.			Analysis of Keystone Enzyme in Agar Hydrolysis Provides Insight into the Degradation of a Polysaccharide from Red Seaweeds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZOBELLIA-GALACTANIVORANS; REVEALS; PURIFICATION; MECHANISMS; PREDICTION; PORPHYRAN; HYDROLASE; PROTEINS; FAMILY; NOV	Agars are abundant polysaccharides from marine red algae, and their chemical structure consists of alternating D-galactose and 3,6-anhydro-L-galactose residues, the latter of which are presumed to make the polymer recalcitrant to degradation by most terrestrial bacteria. Here we study a family 117 glycoside hydrolase (BpGH117) encoded within a recently discovered locus from the human gut bacterium Bacteroides plebeius. Consistent with this locus being involved in agarocolloid degradation, we show that BpGH117 is an exo-acting 3,6-anhydro-alpha(1,3)-L-galactosidase that removes the 3,6-anhydrogalactose from the non-reducing end of neoagaro-oligosaccharides. A Michaelis complex of BpGH117 with neoagarobiose reveals the distortion of the constrained 3,6-anhydro-L-galactose into a conformation that favors catalysis. Furthermore, this complex, supported by analysis of site-directed mutants, provides evidence for an organization of the active site and positioning of the catalytic residues that are consistent with an inverting mechanism of catalysis and suggests that a histidine residue acts as the general acid. This latter feature differs from the vast majority of glycoside hydrolases, which use a carboxylic acid, highlighting the alternative strategies that enzymes may utilize in catalizing the cleavage of glycosidic bonds.	[Hehemann, Jan-Hendrik; Smyth, Leo; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Yadav, Anuj; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	University of Victoria; Simon Fraser University	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	boraston@uvic.ca	Vocadlo, David J/E-5508-2014	Vocadlo, David J/0000-0001-6897-5558; Hehemann, Jan-Hendrik/0000-0002-8700-2564; Smyth, Leo/0000-0002-4329-4331; Boraston, Alisdair/0000-0001-6417-0592	Natural Sciences and Engineering Research Council of Canada; European Molecular Biology Organization	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported in part by a Natural Sciences and Engineering Research Council of Canada discovery grant.; Supported by a European Molecular Biology Organization long term fellowship.	Alberto F, 2004, J BIOL CHEM, V279, P18903, DOI 10.1074/jbc.M313911200; Allouch J, 2004, STRUCTURE, V12, P623, DOI 10.1016/j.str.2004.02.020; Allouch J, 2003, J BIOL CHEM, V278, P47171, DOI 10.1074/jbc.M308313200; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbeyron T, 2001, INT J SYST EVOL MICR, V51, P985, DOI 10.1099/00207713-51-3-985; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Correc G, 2011, CARBOHYD POLYM, V83, P277, DOI 10.1016/j.carbpol.2010.07.060; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DUCKWORTH M, 1970, J CHROMATOGR, V49, P482, DOI 10.1016/S0021-9673(00)93663-X; Ekborg NA, 2006, APPL ENVIRON MICROB, V72, P3396, DOI 10.1128/AEM.72.5.3396-3405.2006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Flament D, 2007, APPL ENVIRON MICROB, V73, P4691, DOI 10.1128/AEM.00496-07; Ha SC, 2011, BIOCHEM BIOPH RES CO, V412, P238, DOI 10.1016/j.bbrc.2011.07.073; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Henshaw J, 2006, J BIOL CHEM, V281, P17099, DOI 10.1074/jbc.M600702200; Hitchens AP, 1939, J BACTERIOL, V37, P485, DOI 10.1128/JB.37.5.485-493.1939; Jam M, 2005, BIOCHEM J, V385, P703, DOI 10.1042/BJ20041044; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lee S, 2009, ACTA CRYSTALLOGR F, V65, P1299, DOI 10.1107/S174430910904603X; Litzinger S, 2010, J BIOL CHEM, V285, P35675, DOI 10.1074/jbc.M110.131037; Martone PT, 2009, CURR BIOL, V19, P169, DOI 10.1016/j.cub.2008.12.031; Michel G, 2006, APPL MICROBIOL BIOT, V71, P23, DOI 10.1007/s00253-006-0377-7; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Navarro DA, 2005, CARBOHYD RES, V340, P2030, DOI 10.1016/j.carres.2005.05.022; Nurizzo D, 2002, NAT STRUCT BIOL, V9, P665, DOI 10.1038/nsb835; POTIN P, 1993, EUR J BIOCHEM, V214, P599, DOI 10.1111/j.1432-1033.1993.tb17959.x; Rebuffet E, 2011, ENVIRON MICROBIOL, V13, P1253, DOI 10.1111/j.1462-2920.2011.02426.x; REES DA, 1961, BIOCHEM J, V81, P347, DOI 10.1042/bj0810347; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; SMITH SV, 1981, SCIENCE, V211, P838, DOI 10.1126/science.211.4484.838; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sulzenbacher G, 1996, BIOCHEMISTRY-US, V35, P15280, DOI 10.1021/bi961946h; Suzuki H, 2002, J BIOSCI BIOENG, V93, P456, DOI 10.1263/jbb.93.456; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	50	64	66	1	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13985	13995		10.1074/jbc.M112.345645	http://dx.doi.org/10.1074/jbc.M112.345645			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22393053	hybrid, Green Published			2022-12-27	WOS:000303996300053
J	Philpott, CC				Philpott, Caroline C.			Coming into View: Eukaryotic Iron Chaperones and Intracellular Iron Delivery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HYPOXIA-INDUCIBLE FACTOR; SACCHAROMYCES-CEREVISIAE; SULFUR CLUSTER; MONOTHIOL GLUTAREDOXIN; PROTEIN; HIF; FRATAXIN; HYDROXYLASE; LOCALIZATION; FAMILY	Eukaryotic cells contain hundreds of metalloproteins, and ensuring that each protein receives the correct metal ion is a critical task for cells. Recent work in budding yeast and mammalian cells has uncovered a system of iron delivery operating in the cytosolic compartment that involves monothiol glutaredoxins, which bind iron in the form of iron-sulfur clusters, and poly(rC)-binding proteins, which bind Fe(II) directly. In yeast cells, cytosolic monothiol glutaredoxins are required for the formation of heme and iron-sulfur clusters and the metallation of some non-heme iron enzymes. Poly(rC)-binding proteins can act as iron chaperones, delivering iron to target non-heme enzymes through direct protein-protein interactions. Although the molecular details have yet to be explored, these proteins, acting independently or together, may represent the basic cellular machinery for intracellular iron delivery.	NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Philpott, CC (corresponding author), NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA.	carolinep@intra.niddk.nih.gov			National Institutes of Health of NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054510] Funding Source: NIH RePORTER	National Institutes of Health of NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of NIDDK. This is the second article in the Thematic Minireview Series on Metals in Biology 2012.	Amr S, 2007, AM J HUM GENET, V81, P673, DOI 10.1086/520961; Andreini C, 2009, ACCOUNTS CHEM RES, V42, P1471, DOI 10.1021/ar900015x; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Conlan AR, 2009, J MOL BIOL, V392, P143, DOI 10.1016/j.jmb.2009.06.079; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; Denisenko O, 2002, MOL CELL BIOL, V22, P286, DOI 10.1128/MCB.22.1.286-297.2002; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Haunhorst P, 2010, BIOCHEM BIOPH RES CO, V394, P372, DOI 10.1016/j.bbrc.2010.03.016; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hintze KJ, 2006, CELL MOL LIFE SCI, V63, P591, DOI 10.1007/s00018-005-5285-y; Irie K, 2002, EMBO J, V21, P1158, DOI 10.1093/emboj/21.5.1158; Jbel M, 2011, EUKARYOT CELL, V10, P629, DOI 10.1128/EC.00015-11; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kasai T, 2004, PROTEIN SCI, V13, P545, DOI 10.1110/ps.03401004; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Mangus DA, 1998, MOL CELL BIOL, V18, P7383, DOI 10.1128/MCB.18.12.7383; Mercier A, 2009, J BIOL CHEM, V284, P20249, DOI 10.1074/jbc.M109.009563; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Nandal A, 2011, CELL METAB, V14, P647, DOI 10.1016/j.cmet.2011.08.015; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Ostareck-Lederer A, 2004, BIOL CELL, V96, P407, DOI 10.1016/j.biolcel.2004.03.010; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Pohl Thomas, 2007, BMC Biochemistry, V8, DOI 10.1186/1471-2091-8-13; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Rosenzweig AC, 2002, CHEM BIOL, V9, P673, DOI 10.1016/S1074-5521(02)00156-4; Rouhier N, 2010, TRENDS BIOCHEM SCI, V35, P43, DOI 10.1016/j.tibs.2009.08.005; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; Tsai CL, 2011, BIOCHEMISTRY-US, V50, P6478, DOI 10.1021/bi200666h; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Yoon H, 2012, BIOCHEM J, V441, P473, DOI 10.1042/BJ20111637; Zuris JA, 2011, P NATL ACAD SCI USA, V108, P13047, DOI 10.1073/pnas.1109986108	47	79	84	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13518	13523		10.1074/jbc.R111.326876	http://dx.doi.org/10.1074/jbc.R111.326876			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22389494	Green Published, hybrid			2022-12-27	WOS:000303996300003
J	Bonala, S; Lokireddy, S; Arigela, H; Teng, S; Wahli, W; Sharma, M; McFarlane, C; Kambadur, R				Bonala, Sabeera; Lokireddy, Sudarsanareddy; Arigela, Harikumar; Teng, Serena; Wahli, Walter; Sharma, Mridula; McFarlane, Craig; Kambadur, Ravi			Peroxisome Proliferator-activated Receptor beta/delta Induces Myogenesis by Modulating Myostatin Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAUSES INSULIN-RESISTANCE; RETINOID-X-RECEPTOR; SKELETAL-MUSCLE; LIPID-METABOLISM; PPAR-ALPHA; PHARMACOLOGICAL ACTIVATION; SARCOMERIC PROTEINS; SELF-RENEWAL; IN-VIVO; DIFFERENTIATION	Classically, peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) function was thought to be restricted to enhancing adipocyte differentiation and development of adipose-like cells from other lineages. However, recent studies have revealed a critical role for PPAR beta/delta during skeletal muscle growth and regeneration. Although PPAR beta/delta has been implicated in regulating myogenesis, little is presently known about the role and, for that matter, the mechanism(s) of action of PPAR beta/delta in regulating postnatal myogenesis. Here we report for the first time, using a PPAR beta/delta-specific ligand (L165041) and the PPAR beta/delta null mouse model, that PPAR beta/delta enhances postnatal myogenesis through increasing both myoblast proliferation and differentiation. In addition, we have identified Gasp-1 (growth and differentiation factor-associated serum protein-1) as a novel downstream target of PPAR beta/delta in skeletal muscle. In agreement, reduced Gasp-1 expression was detected in PPAR beta/delta-null mice muscle tissue. We further report that a functional PPAR-responsive element within the 1.5-kb proximal Gasp-1 promoter region is critical for PPAR beta/delta regulation of Gasp-1. Gasp-1 has been reported to bind to and inhibit the activity of myostatin; consistent with this, we found that enhanced secretion of Gasp-1, increased Gasp-1 myostatin interaction and significantly reduced myostatin activity upon L165041-mediated activation of PPAR beta/delta. Moreover, we analyzed the ability of hGASP-1 to regulate myogenesis independently of PPAR beta/delta activation. The results revealed that hGASP-1 protein treatment enhances myoblast proliferation and differentiation, whereas silencing of hGASP-1 results in defective myogenesis. Taken together these data revealed that PPAR beta/delta is a positive regulator of skeletal muscle myogenesis, which functions through negatively modulating myostatin activity via a mechanism involving Gasp-1.	[Bonala, Sabeera; Lokireddy, Sudarsanareddy; Arigela, Harikumar; Teng, Serena; Kambadur, Ravi] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [McFarlane, Craig; Kambadur, Ravi] ASTAR, Singapore Inst Clin Sci, Singapore 117609, Singapore; [Wahli, Walter] Univ Lausanne, NCCR Frontiers Genet, Ctr Integrat Gen, CH-1015 Le Genopode, Switzerland; [Sharma, Mridula] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); University of Lausanne; National University of Singapore	Kambadur, R (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	KRavi@ntu.eud.sg	Wahli, Walter/B-1398-2009; Wahli, Walter/I-3194-2019; harikumar, arigela/J-9872-2019	Wahli, Walter/0000-0002-5966-9089; harikumar, arigela/0000-0003-3293-7618	National Research Foundation, Singapore	National Research Foundation, Singapore(National Research Foundation, Singapore)	This work was supported by the National Research Foundation, Singapore.	Akiyama Taro E, 2005, Curr Diab Rep, V5, P45, DOI 10.1007/s11892-005-0067-3; ALLEN DM, 1995, CLIN ORTHOP RELAT R, P122; Angione AR, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-33; Bernardo BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011307; Bigot A, 2008, BIOL CELL, V100, P189, DOI 10.1042/BC20070085; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; Castillero E, 2011, AM J PHYSIOL-ENDOC M, V300, pE790, DOI 10.1152/ajpendo.00590.2010; DEDUVE C, 1969, ANN NY ACAD SCI, V168, P369; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Gaudel C, 2008, AM J PHYSIOL-ENDOC M, V295, pE297, DOI 10.1152/ajpendo.00581.2007; Ge XJ, 2011, CELL RES, V21, P1591, DOI 10.1038/cr.2011.72; GEARING KL, 1993, P NATL ACAD SCI USA, V90, P1440, DOI 10.1073/pnas.90.4.1440; Giordano C, 2009, PFLUG ARCH EUR J PHY, V458, P901, DOI 10.1007/s00424-009-0676-9; Han J. K., 2011, EUR HEART J IN PRESS; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Heinaniemi M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r147; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Hill JJ, 2003, MOL ENDOCRINOL, V17, P1144, DOI 10.1210/me.2002-0366; Hondares E, 2007, BIOCHEM BIOPH RES CO, V354, P1021, DOI 10.1016/j.bbrc.2007.01.092; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jacquemin V, 2004, EXP CELL RES, V299, P148, DOI 10.1016/j.yexcr.2004.05.023; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Kondas K, 2008, J BIOL CHEM, V283, P23677, DOI 10.1074/jbc.M803025200; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Leibowitz MD, 2000, FEBS LETT, V473, P333, DOI 10.1016/S0014-5793(00)01554-4; Li P, 2006, AM J PHYSIOL-CELL PH, V290, pC1461, DOI 10.1152/ajpcell.00532.2005; Lokireddy S, 2011, AM J PHYSIOL-CELL PH, V301, pC1316, DOI 10.1152/ajpcell.00114.2011; Lokireddy S, 2011, MOL ENDOCRINOL, V25, P1936, DOI 10.1210/me.2011-1124; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McFarlane C, 2008, CURR OPIN CLIN NUTR, V11, P422, DOI 10.1097/MCO.0b013e32830007e2; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; McFarlane C, 2008, EXP CELL RES, V314, P317, DOI 10.1016/j.yexcr.2007.09.012; McFarlane C, 2011, AM J PHYSIOL-CELL PH, V301, pC195, DOI 10.1152/ajpcell.00012.2011; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Miura P, 2009, HUM MOL GENET, V18, P4640, DOI 10.1093/hmg/ddp431; PALMER CNA, 1995, J BIOL CHEM, V270, P16114, DOI 10.1074/jbc.270.27.16114; Phillips SA, 2005, OBES RES, V13, P1321, DOI 10.1038/oby.2005.160; Rieck M, 2008, MOL PHARMACOL, V74, P1269, DOI 10.1124/mol.108.050625; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Roy RR, 1999, J APPL PHYSIOL, V87, P634, DOI 10.1152/jappl.1999.87.2.634; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; WAHLI W, 1995, CHEM BIOL, V2, P261, DOI 10.1016/1074-5521(95)90045-4; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang C, 2011, DIABETOLOGIA, V54, P1491, DOI 10.1007/s00125-011-2079-7; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	54	27	28	3	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12935	12951		10.1074/jbc.M111.319145	http://dx.doi.org/10.1074/jbc.M111.319145			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22362769	hybrid, Green Published			2022-12-27	WOS:000302903700033
J	Maxwell, BA; Xu, CL; Suo, ZC				Maxwell, Brian A.; Xu, Cuiling; Suo, Zucai			DNA Lesion Alters Global Conformational Dynamics of Y-family DNA Polymerase during Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFOLOBUS-SOLFATARICUS P2; CRYSTAL-STRUCTURES; STRUCTURAL BASIS; FIDELITY; REPLICATION; DPO4; BYPASS; BETA; TRANSITIONS; MECHANISM	A major product of oxidative damage to DNA, 8-oxo-7,8-dihydro-2'-deoxyguanine (8-oxoG), can lead to genomic mutations if it is bypassed unfaithfully by DNA polymerases in vivo. However, our pre-steady-state kinetic studies show that DNA polymerase IV (Dpo4), a prototype Y-family enzyme from Sulfolobus solfataricus, can bypass 8-oxoG both efficiently and faithfully. For the first time, our stopped-flow FRET studies revealed that a DNA polymerase altered its synchronized global conformational dynamics in response to a DNA lesion. Relative to nucleotide incorporation into undamaged DNA, three of the four domains of Dpo4 undertook different conformational transitions during 8-oxoG bypass and the subsequent extension step. Moreover, the rapid translocation of Dpo4 along DNA induced by nucleotide binding was significantly hindered by the interactions between the embedded 8-oxoG and Dpo4 during the extension step. These results unprecedentedly demonstrate that a Y-family DNA polymerase employs different global conformational dynamics when replicating undamaged and damaged DNA.	[Maxwell, Brian A.; Xu, Cuiling; Suo, Zucai] Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; [Maxwell, Brian A.; Suo, Zucai] Ohio State Univ, Biophys Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Suo, ZC (corresponding author), Ohio State Univ, Dept Biochem, 484 W 12th Ave, Columbus, OH 43210 USA.	suo.3@osu.edu		Maxwell, Brian/0000-0002-0177-3991	National Science Foundation [MCB-0447899, MCB-0960961]; Div Of Molecular and Cellular Bioscience [0960961] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Career Award MCB-0447899 and Grant MCB-0960961 (to Z. S.).	Boudsocq F, 2004, J BIOL CHEM, V279, P32932, DOI 10.1074/jbc.M405249200; Cadet J, 2003, MUTAT RES-FUND MOL M, V531, P5, DOI 10.1016/j.mrfmmm.2003.09.001; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2106, DOI 10.1021/bi0357457; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Irimia A, 2010, ACTA CRYSTALLOGR F, V66, P1013, DOI 10.1107/S1744309110029374; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Joyce CM, 2008, BIOCHEMISTRY-US, V47, P6103, DOI 10.1021/bi7021848; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5; Krahn JM, 2003, STRUCTURE, V11, P121, DOI 10.1016/S0969-2126(02)00930-9; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; Rechkoblit O, 2009, STRUCTURE, V17, P725, DOI 10.1016/j.str.2009.03.011; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Silverstein TD, 2010, STRUCTURE, V18, P1463, DOI 10.1016/j.str.2010.08.019; Wang YL, 2006, PROTEIN SCI, V15, P135, DOI 10.1110/ps.051726906; Wong JH, 2008, J MOL BIOL, V379, P317, DOI 10.1016/j.jmb.2008.03.038; Xu CL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000225; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zhang LK, 2009, BIOCHEMISTRY-US, V48, P7492, DOI 10.1021/bi900532w	25	20	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13040	13047		10.1074/jbc.M112.345835	http://dx.doi.org/10.1074/jbc.M112.345835			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22362779	hybrid, Green Published			2022-12-27	WOS:000302903700042
J	Murai, J; Huang, SYN; Das, BB; Dexheimer, TS; Takeda, S; Pommier, Y				Murai, Junko; Huang, Shar-yin N.; Das, Benu Brata; Dexheimer, Thomas S.; Takeda, Shunichi; Pommier, Yves			Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Repairs DNA Damage Induced by Topoisomerases I and II and Base Alkylation in Vertebrate Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; CLEAVAGE COMPLEXES; SPINOCEREBELLAR ATAXIA; COVALENT COMPLEXES; REPLICATION FORKS; AXONAL NEUROPATHY; ANTITUMOR DRUGS; TRANSCRIPTION; ENZYME; PHOSPHORYLATION	Tyrosyl-DNA phosphodiesterase 1 (Tdp1) repairs topoisomerase I cleavage complexes (Top1cc) by hydrolyzing their 3'-phosphotyrosyl DNA bonds and repairs bleomycin-induced DNA damage by hydrolyzing 3'-phosphoglycolates. Yeast Tdp1 has also been implicated in the repair of topoisomerase II-DNA cleavage complexes (Top2cc). To determine whether vertebrate Tdp1 is involved in the repair of various DNA end-blocking lesions, we generated Tdp1 knock-out cells in chicken DT40 cells (Tdp1(-/-)) and Tdp1-complemented DT40 cells with human TDP1. We found that Tdp1(-/-) cells were not only hypersensitive to camptothecin and bleomycin but also to etoposide, methyl methanesulfonate (MMS), H2O2, and ionizing radiation. We also show they were deficient in mitochondrial Tdp1 activity. In biochemical assays, recombinant human TDP1 was found to process 5'-phosphotyrosyl DNA ends when they mimic the 5'-overhangs of Top2cc. Tdp1 also processes 3'-deoxyribose phosphates generated from hydrolysis of abasic sites, which is consistent with the hypersensitivity of Tdp1(-/-) cells to MMS and H2O2. Because recent studies established that CtIP together with BRCA1 also repairs topoisomerase-mediated DNA damage, we generated dual Tdp1-CtIP-deficient DT40 cells. Our results show that Tdp1 and CtIP act in parallel pathways for the repair of Top1cc and MMS-induced lesions but are epistatic for Top2cc. Together, our findings reveal a broad involvement of Tdp1 in DNA repair and clarify the role of human TDP1 in the repair of Top2-induced DNA damage.	[Huang, Shar-yin N.; Das, Benu Brata; Dexheimer, Thomas S.; Pommier, Yves] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Murai, Junko; Takeda, Shunichi] Kyoto Univ, Dept Radiat Genet, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Kyoto University	Pommier, Y (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	pommier@nih.gov	Das, Benu Brata/AAC-3452-2022; DAS, BENU BRATA BRATA/AAX-4347-2021; Murai, Junko/AAU-9516-2021	DAS, BENU BRATA BRATA/0000-0003-2519-7105; Takeda, Shunichi/0000-0002-7924-7991	National Institutes of Health through NCI Center for Cancer Research; Japan Society for the Promotion of Science; NATIONAL CANCER INSTITUTE [ZIABC006150] Funding Source: NIH RePORTER	National Institutes of Health through NCI Center for Cancer Research; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health through the Intramural Program of the NCI Center for Cancer Research.; Recipient of a fellowship from the Japan Society for the Promotion of Science.	Antony S, 2007, CANCER RES, V67, P10397, DOI 10.1158/0008-5472.CAN-07-0938; Barthelmes HU, 2004, J BIOL CHEM, V279, P55618, DOI 10.1074/jbc.M405042200; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Daroui P, 2004, J BIOL CHEM, V279, P14587, DOI 10.1074/jbc.M311370200; Das BB, 2010, P NATL ACAD SCI USA, V107, P19790, DOI 10.1073/pnas.1009814107; Das BB, 2009, EMBO J, V28, P3667, DOI 10.1038/emboj.2009.302; Datta K, 2011, RADIAT RES, V175, P97, DOI 10.1667/RR2332.1; Debethune L, 2002, NUCLEIC ACIDS RES, V30, P1198, DOI 10.1093/nar/30.5.1198; Deng CC, 2005, GENETICS, V170, P591, DOI 10.1534/genetics.104.028795; Dexheimer TS, 2008, ANTI-CANCER AGENT ME, V8, P381, DOI 10.2174/187152008784220357; Dexheimer TS, 2010, NUCLEIC ACIDS RES, V38, P2444, DOI 10.1093/nar/gkp1206; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; El-Khamisy SF, 2009, DNA REPAIR, V8, P760, DOI 10.1016/j.dnarep.2009.02.002; ENG WK, 1988, MOL PHARMACOL, V34, P755; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Hamilton NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015387; Hartsuiker E, 2009, MOL CELL, V33, P117, DOI 10.1016/j.molcel.2008.11.021; Hawkins AJ, 2009, DNA REPAIR, V8, P654, DOI 10.1016/j.dnarep.2008.12.012; HENNER WD, 1983, J BIOL CHEM, V258, P711; Hirano R, 2007, EMBO J, V26, P4732, DOI 10.1038/sj.emboj.7601885; Iiizumi S, 2006, BIOTECHNIQUES, V41, P311, DOI 10.2144/000112233; Inamdar KV, 2002, J BIOL CHEM, V277, P27162, DOI 10.1074/jbc.M204688200; Interthal H, 2005, J BIOL CHEM, V280, P36518, DOI 10.1074/jbc.M508898200; Interthal H, 2005, EMBO J, V24, P2224, DOI 10.1038/sj.emboj.7600694; Interthal H, 2011, BIOCHEM J, V436, P559, DOI 10.1042/BJ20101841; Katyal S, 2007, EMBO J, V26, P4720, DOI 10.1038/sj.emboj.7601869; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; Lebedeva NA, 2011, FEBS LETT, V585, P683, DOI 10.1016/j.febslet.2011.01.032; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Marchand C, 2009, MOL CANCER THER, V8, P240, DOI 10.1158/1535-7163.MCT-08-0878; Miao ZH, 2006, DNA REPAIR, V5, P1489, DOI 10.1016/j.dnarep.2006.07.004; Nakamura K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000828; NITISS J, 1988, P NATL ACAD SCI USA, V85, P7501, DOI 10.1073/pnas.85.20.7501; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nitiss KC, 2006, P NATL ACAD SCI USA, V103, P8953, DOI 10.1073/pnas.0603455103; PEGG AE, 1984, CANCER INVEST, V2, P223, DOI 10.3109/07357908409104376; Plo I, 2003, DNA REPAIR, V2, P1087, DOI 10.1016/S1568-7864(03)00116-2; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2012, NAT REV DRUG DISCOV, V11, P25, DOI 10.1038/nrd3404; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Pommier Y, 2009, MOL CANCER THER, V8, P1008, DOI 10.1158/1535-7163.MCT-08-0706; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Pouliot JJ, 2001, GENES CELLS, V6, P677, DOI 10.1046/j.1365-2443.2001.00452.x; Pourquier P, 1997, J BIOL CHEM, V272, P26441, DOI 10.1074/jbc.272.42.26441; Pourquier P, 1997, J BIOL CHEM, V272, P7792, DOI 10.1074/jbc.272.12.7792; Pourquier P, 2001, ADV CANCER RES, V80, P189, DOI 10.1016/S0065-230X(01)80016-6; Povirk LF, 2007, J BIOL CHEM, V282, P3547, DOI 10.1074/jbc.M607745200; Regairaz M, 2011, J CELL BIOL, V195, P739, DOI 10.1083/jcb.201104003; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Sordet O, 2008, J MOL BIOL, V381, P540, DOI 10.1016/j.jmb.2008.06.028; Sordet O, 2010, CELL CYCLE, V9, P274, DOI 10.4161/cc.9.2.10506; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Strumberg D, 2000, MOL CELL BIOL, V20, P3977, DOI 10.1128/MCB.20.11.3977-3987.2000; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; TSAO YP, 1993, CANCER RES, V53, P5908; Tuduri S, 2009, NAT CELL BIOL, V11, P1315, DOI 10.1038/ncb1984; Vance JR, 2002, P NATL ACAD SCI USA, V99, P13669, DOI 10.1073/pnas.202242599; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Yamazoe M, 2004, DNA REPAIR, V3, P1175, DOI 10.1016/j.dnarep.2004.03.039; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534; Zeng ZH, 2011, J BIOL CHEM, V286, P403, DOI 10.1074/jbc.M110.181016; Zhou T, 2005, NUCLEIC ACIDS RES, V33, P289, DOI 10.1093/nar/gki170; Zhou T, 2009, DNA REPAIR, V8, P901, DOI 10.1016/j.dnarep.2009.05.003	67	130	137	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12848	12857		10.1074/jbc.M111.333963	http://dx.doi.org/10.1074/jbc.M111.333963			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22375014	Green Published, hybrid			2022-12-27	WOS:000302903700024
J	Nicoll, G; Davidson, S; Shanley, L; Hing, B; Lear, M; McGuffin, P; Ross, R; MacKenzie, A				Nicoll, Gemma; Davidson, Scott; Shanley, Lynne; Hing, Ben; Lear, Marissa; McGuffin, Peter; Ross, Ruth; MacKenzie, Alasdair			Allele-specific Differences in Activity of a Novel Cannabinoid Receptor 1 (CNR1) Gene Intronic Enhancer in Hypothalamus, Dorsal Root Ganglia, and Hippocampus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC PLASTICITY; SIGNAL-TRANSDUCTION; SENSORY NEURONS; ANGIOTENSIN-II; TAC1 LOCUS; EXPRESSION; PSYCHOSIS; PHARMACOLOGY; ASSOCIATION; OBESITY	Polymorphisms within intron 2 of the CNR1 gene, which encodes cannabinoid receptor 1 (CB1), have been associated with addiction, obesity, and brain volume deficits. We used comparative genomics to identify a polymorphic (rs9444584-C/T) sequence (ECR1) in intron 2 of the CNR1 gene that had been conserved for 310 million years. The C-allele of ECR1 (ECR1(C)) acted as an enhancer in hypothalamic and dorsal root ganglia cells and responded to MAPK activation through the MEKK pathway but not in hippocampal cells. However, ECR1(T) was significantly more active in hypothalamic and dorsal root ganglia cells but, significantly, and in contrast to ECR1(C), was highly active in hippocampal cells where it also responded strongly to activation of MAPK. Intriguingly, rs9444584 is in strong linkage disequilibrium with two other SNPs (rs9450898 (r(2) = 0.841) and rs2023239 (r(2) = 0.920)) that have been associated with addiction, obesity (rs2023239), and reduced fronto-temporal white matter volumes in schizophrenia patients as a result of cannabis misuse (rs9450898). Considering their high linkage disequilibrium and the increased response of ECR1(T) to MAPK signaling when compared with ECR1(C), it is possible that the functional effects of the different alleles of rs9444584 may play a role in the conditions associated with rs9450898 and rs2023239. Further analysis of the different alleles of ECR1 may lead to a greater understanding of the role of CNR1 gene misregulation in these conditions as well as chronic inflammatory pain.	[Nicoll, Gemma; Davidson, Scott; Shanley, Lynne; Hing, Ben; Lear, Marissa; Ross, Ruth; MacKenzie, Alasdair] Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen AB25 2ZD, Scotland; [McGuffin, Peter] Kings Coll London, Inst Psychiat, Med Res Council Social Genet & Dev Psychiat Ctr C, London SE5 8AF3, England	University of Aberdeen	Ross, R (corresponding author), Univ Aberdeen, Inst Med Sci, Sch Med Sci, Foresterhill, Aberdeen AB25 2ZD, Scotland.	r.ross@abdn.ac.uk; alasdair.mackenzie@abdn.ac.uk	Ross, R./AAG-7468-2019; McGuffin, Peter/A-1565-2012	McGuffin, Peter/0000-0002-9888-2907; Hing, Benjamin/0000-0002-9437-6118	Tenovus Trust; Wellcome Trust [080980/Z/06/Z]; Medical Research Council [G0701003]; Nuffield Foundation; Biotechnology and Biological Sciences Research Council [BBS/S/2005/12001]; Biotechnology and Biological Sciences Research Council [BB/D524932/1, BB/D004659/1] Funding Source: researchfish; Medical Research Council [G9817803B] Funding Source: researchfish; BBSRC [BB/D524932/1] Funding Source: UKRI; MRC [G0701003] Funding Source: UKRI	Tenovus Trust; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Nuffield Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Tenovus Trust, the Wellcome Trust (080980/Z/06/Z), and the Medical Research Council (G0701003).; Supported by a Nuffield Foundation Oliver Bird studentship.; Supported by a Biotechnology and Biological Sciences Research Council strategic studentship (BBS/S/2005/12001).	Akbas F, 2009, OBES REV, V10, P58, DOI 10.1111/j.1467-789X.2008.00520.x; Ashtari M, 2011, J PSYCHIATR RES, V45, P1055, DOI 10.1016/j.jpsychires.2011.01.004; Benzinou M, 2008, HUM MOL GENET, V17, P1916, DOI 10.1093/hmg/ddn089; Breivogel CS, 1997, J PHARMACOL EXP THER, V282, P1632; Carr TP, 2008, NUTR RES, V28, P641, DOI 10.1016/j.nutres.2008.08.003; Chen XN, 2008, ARCH GEN PSYCHIAT, V65, P816, DOI 10.1001/archpsyc.65.7.816; Davidson S, 2006, MOL PSYCHIATR, V11, P410, DOI 10.1038/sj.mp.4001787; Davidson S, 2011, NEUROPSYCHOPHARMACOL, V36, P2211, DOI 10.1038/npp.2011.93; Davidson S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-614; Dinu I R, 2009, Rom J Intern Med, V47, P9; Ehlers CL, 2007, TWIN RES HUM GENET, V10, P805, DOI 10.1375/twin.10.6.805; Filbey FM, 2010, NEUROPSYCHOPHARMACOL, V35, P967, DOI 10.1038/npp.2009.200; Graham ES, 2006, J BIOL CHEM, V281, P29085, DOI 10.1074/jbc.M602516200; Haughey HM, 2008, ADDICTION, V103, P1678, DOI 10.1111/j.1360-0443.2008.02292.x; Henquet C, 2008, SCHIZOPHRENIA BULL, V34, P1111, DOI 10.1093/schbul/sbn108; Hipskind Robert A., 1998, Frontiers in Bioscience, V3, pD804; Ho BC, 2011, SCHIZOPHR RES, V128, P66, DOI 10.1016/j.schres.2011.02.021; Hutchison KE, 2008, ARCH GEN PSYCHIAT, V65, P841, DOI 10.1001/archpsyc.65.7.841; Idelevich Evgeny, 2009, Ther Adv Cardiovasc Dis, V3, P75, DOI 10.1177/1753944708098226; Iversen L, 2003, BRAIN, V126, P1252, DOI 10.1093/brain/awg143; Jo YH, 2005, NEURON, V48, P1055, DOI 10.1016/j.neuron.2005.10.021; Karanian DA, 2005, EUR J PHARMACOL, V508, P47, DOI 10.1016/j.ejphar.2004.12.009; Kawasaki Y, 2006, J PHARMACOL EXP THER, V316, P601, DOI 10.1124/jpet.105.093583; Kristensen F W, 1994, Ugeskr Laeger, V156, P2875; Kristensen F. W., 1994, UGESKRIFT LAEGER, V156, P2881; Lopez-Moreno JA, 2008, ADDICT BIOL, V13, P160, DOI 10.1111/j.1369-1600.2008.00105.x; MacKenzie A, 2000, MOL CELL NEUROSCI, V16, P620, DOI 10.1006/mcne.2000.0902; MacKenzie A, 1997, MECH DEVELOP, V62, P29, DOI 10.1016/S0925-4773(96)00646-6; MacKenzie A, 2004, BIOESSAYS, V26, P1217, DOI 10.1002/bies.20117; MacKenzie A., 2010, PROJECTS; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Miller KA, 2008, DEV BIOL, V317, P686, DOI 10.1016/j.ydbio.2008.02.016; Miller KA, 2007, DEV BIOL, V311, P665, DOI 10.1016/j.ydbio.2007.07.022; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Pertwee RG, 1999, FORSCH KOMPLEMENTMED, V6, P12, DOI 10.1159/000057150; PORT RL, 1995, BIOL PSYCHIAT, V37, P318, DOI 10.1016/0006-3223(94)00128-P; Reeves SJ, 2001, BRIT J PSYCHIAT, V179, P172, DOI 10.1192/bjp.179.2.172; Riedel G, 2005, HANDB EXP PHARMACOL, V168, P445; Roth TL, 2008, NAT NEUROSCI, V11, P993, DOI 10.1038/nn0908-993; Rubino T, 2005, J NEUROCHEM, V93, P984, DOI 10.1111/j.1471-4159.2005.03101.x; Schmitz U, 1997, TRENDS ENDOCRIN MET, V8, P261, DOI 10.1016/S1043-2760(97)00101-X; Shanley L, 2010, NEUROSIGNALS, V18, P173, DOI 10.1159/000322010; Shanley L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-10; Takahashi E, 1998, ACTA PHYSIOL SCAND, V164, P611, DOI 10.1111/j.1365-201X.1998.tb10705.x; Talwar R, 2011, CNS NEUROL DISORD-DR, V10, P536, DOI 10.2174/187152711796235005; TOUW M, 1981, J PSYCHOACTIVE DRUGS, V13, P23, DOI 10.1080/02791072.1981.10471447; Turu G, 2010, J MOL ENDOCRINOL, V44, P75, DOI 10.1677/JME-08-0190; Vanheusden K, 2008, PSYCHOL MED, V38, P1095, DOI 10.1017/S0033291707002401; Veling W, 2007, INT J EPIDEMIOL, V36, P761, DOI 10.1093/ije/dym085; Waltereit R, 2003, MOL NEUROBIOL, V27, P99, DOI 10.1385/MN:27:1:99; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Wolf G, 1997, SEMIN NEPHROL, V17, P448; Zolkowska K, 2001, PSYCHOL MED, V31, P669, DOI 10.1017/S0033291701003786	54	8	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12828	12834		10.1074/jbc.M111.336750	http://dx.doi.org/10.1074/jbc.M111.336750			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22362764	Green Published, hybrid			2022-12-27	WOS:000302903700022
J	Schaper, W; Bentrop, J; Ustinova, J; Blume, L; Kats, E; Tiralongo, J; Weinhold, B; Bastmeyer, M; Munster-Kuhnel, AK				Schaper, Wiebke; Bentrop, Joachim; Ustinova, Jana; Blume, Linda; Kats, Elina; Tiralongo, Joe; Weinhold, Birgit; Bastmeyer, Martin; Muenster-Kuehnel, Anja-K.			Identification and Biochemical Characterization of Two Functional CMP-Sialic Acid Synthetases in Danio rerio	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNAL; GENOME DUPLICATION; MOLECULAR-CLONING; POLYSIALIC ACID; EXPRESSION; EVOLUTION; PROTEIN; GENES; SIALYLATION; UTILIZES	Sialic acids (Sia) form the nonreducing end of the bulk of cell surface-expressed glycoconjugates. They are, therefore, major elements in intercellular communication processes. The addition of Sia to glycoconjugates requires metabolic activation to CMP-Sia, catalyzed by CMP-Sia synthetase (CMAS). This highly conserved enzyme is located in the cell nucleus in all vertebrates investigated to date, but its nuclear function remains elusive. Here, we describe the identification and characterization of two Cmas enzymes in Danio rerio (dreCmas), one of which is exclusively localized in the cytosol. We show that the two cmas genes most likely originated from the third whole genome duplication, which occurred at the base of teleost radiation. cmas paralogues were maintained in fishes of the Otocephala clade, whereas one copy got subsequently lost in Euteleostei (e.g. rainbow trout). In zebrafish, the two genes exhibited a distinct spatial expression pattern. The products of these genes (dreCmas1 and dreCmas2) diverged not only with respect to subcellular localization but also in substrate specificity. Nuclear dreCmas1 favored N-acetylneuraminic acid, whereas the cytosolic dreCmas2 showed highest affinity for 5-deaminoneuraminic acid. The subcellular localization was confirmed for the endogenous enzymes in fractionated zebrafish lysates. Nuclear entry of dreCmas1 was mediated by a bipartite nuclear localization signal, which seemed irrelevant for other enzymatic functions. With the current demonstration that in zebrafish two subfunctionalized cmas paralogues co-exist, we introduce a novel and unique model to detail the roles that CMAS has in the nucleus and in the sialylation pathways of animal cells.	[Schaper, Wiebke; Blume, Linda; Kats, Elina; Weinhold, Birgit; Muenster-Kuehnel, Anja-K.] Hannover Med Sch MHH, Inst Cellular Chem, D-30625 Hannover, Germany; [Bentrop, Joachim; Ustinova, Jana; Bastmeyer, Martin] KIT, Inst Zool 1, D-76131 Karlsruhe, Germany; [Tiralongo, Joe] Griffith Univ, Inst Glyc, Southport, Qld 4222, Australia	Hannover Medical School; Helmholtz Association; Karlsruhe Institute of Technology; Griffith University	Munster-Kuhnel, AK (corresponding author), Hannover Med Sch MHH, Inst Cellular Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	muenster.anja@mh-hannover.de	Bastmeyer, Martin/H-9342-2013	Bastmeyer, Martin/0000-0003-3471-8400; Tiralongo, Joe/0000-0002-3529-6310	German Research Foundation (DFG) [MU1849/1, BA 1034/15-19]; DFG for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy)	German Research Foundation (DFG)(German Research Foundation (DFG)); DFG for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) Grant MU1849/1 (to A. K. M. K.) and BA 1034/15-19 (to M. B. and J.B.) and by funding from the DFG for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy).	Bentrop J, 2008, DEV DYNAM, V237, P808, DOI 10.1002/dvdy.21451; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Chang LY, 2009, GLYCOCONJUGATE J, V26, P263, DOI 10.1007/s10719-008-9165-1; Chang LY, 2009, GLYCOCONJUGATE J, V26, P247, DOI 10.1007/s10719-008-9161-5; Christophe D, 2000, CELL SIGNAL, V12, P337, DOI 10.1016/S0898-6568(00)00077-2; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; Guerardel Y, 2006, GLYCOBIOLOGY, V16, P244, DOI 10.1093/glycob/cwj062; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Heppell J, 1998, FISH SHELLFISH IMMUN, V8, P271, DOI 10.1006/fsim.1997.0133; Inoue S, 2006, GLYCOCONJUGATE J, V23, P277, DOI 10.1007/s10719-006-6484-y; Kassahn KS, 2009, GENOME RES, V19, P1404, DOI 10.1101/gr.086827.108; KEAN E L, 1991, Glycobiology, V1, P441, DOI 10.1093/glycob/1.5.441; KEAN EL, 1969, EXP EYE RES, V8, P44, DOI 10.1016/S0014-4835(69)80079-5; Kean EL, 2004, BBA-GEN SUBJECTS, V1673, P56, DOI 10.1016/j.bbagen.2004.04.006; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Krapp S, 2003, J MOL BIOL, V334, P625, DOI 10.1016/j.jmb.2003.09.080; Langhauser M, 2012, GLYCOBIOLOGY, V22, P196, DOI 10.1093/glycob/cwr129; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawrence SM, 2001, GLYCOCONJUGATE J, V18, P205, DOI 10.1023/A:1012452705349; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Marx M, 2001, DEVELOPMENT, V128, P4949; Marx M, 2007, DEV BIOL, V306, P560, DOI 10.1016/j.ydbio.2007.03.032; Mosimann SC, 2001, J BIOL CHEM, V276, P8190, DOI 10.1074/jbc.M007235200; Munster AK, 2002, J BIOL CHEM, V277, P19688, DOI 10.1074/jbc.M201093200; Munster AK, 1998, P NATL ACAD SCI USA, V95, P9140, DOI 10.1073/pnas.95.16.9140; Munster-Kuhnel AK, 2004, GLYCOBIOLOGY, V14, p43R, DOI 10.1093/glycob/cwh113; Nakata D, 2001, GLYCOBIOLOGY, V11, P685, DOI 10.1093/glycob/11.8.685; Oschlies M, 2009, J MOL BIOL, V393, P83, DOI 10.1016/j.jmb.2009.08.003; Potvin B, 1995, J BIOL CHEM, V270, P30415, DOI 10.1074/jbc.270.51.30415; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Sohn H, 2006, FASEB J, V20, P1248, DOI 10.1096/fj.05-4911fje; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Thisse B., 2001, ZFIN ON LINE PUBLICA; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tiralongo J, 2007, GLYCOBIOLOGY, V17, P945, DOI 10.1093/glycob/cwm064	42	14	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13239	13248		10.1074/jbc.M111.327544	http://dx.doi.org/10.1074/jbc.M111.327544			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22351762	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000302903700061
J	Xiao, SH; Tang, YS; Khan, RA; Zhang, YH; Kusumanchi, P; Stabler, SP; Jayaram, HN; Antony, AC				Xiao, Suhong; Tang, Ying-Sheng; Khan, Rehana A.; Zhang, Yonghua; Kusumanchi, Praveen; Stabler, Sally P.; Jayaram, Hiremagalur N.; Antony, Asok C.			Influence of Physiologic Folate Deficiency on Human Papillomavirus Type 16 (HPV16)-harboring Human Keratinocytes in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMMON FRAGILE SITES; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS; MESSENGER-RNA; 3'-UNTRANSLATED REGION; CERVICAL DYSPLASIA; URACIL MISINCORPORATION; UNTRANSLATED REGION; NATURAL-HISTORY; DOMAIN PROTEINS; BINDING-PROTEIN	Although HPV16 transforms infected epithelial tissues to cancer in the presence of several co-factors, there is insufficient molecular evidence that poor nutrition has any such role. Because physiological folate deficiency led to the intracellular homocysteinylation of heterogeneous nuclear ribonucleoprotein E1 (hnRNP-E1) and activated a nutrition-sensitive (homocysteine-responsive) posttranscriptional RNA operon that included interaction with HPV16 L2 mRNA, we investigated the functional consequences of folate deficiency on HPV16 in immortalized HPV16-harboring human (BC-1-Ep/SL) keratinocytes and HPV16-organotypic rafts. Although homocysteinylated hnRNP-E1 interacted with HPV16 L2 mRNA cis-element, it also specifically bound another HPV16 57-nucleotide poly(U)-rich cis-element in the early polyadenylation element (upstream of L2 boolean AND L1 genes) with greater affinity. Together, these interactions led to a profound reduction of both L1 and L2 mRNA and proteins without effects on HPV16 E6 and E7 in vitro, and in cultured keratinocyte monolayers and HPV16-low folate-organotypic rafts developed in physiological low folate medium. In addition, HPV16-low folate-organotypic rafts contained fewer HPV16 viral particles, a similar HPV16 DNA viral load, and a much greater extent of integration of HPV16 DNA into genomic DNA when compared with HPV16-high folate-organotypic rafts. Subcutaneous implantation of 18-day old HPV16-low folate-organotypic rafts into folate-replete immunodeficient mice transformed this benign keratinocyte-derived raft tissue into an aggressive HPV16-induced cancer within 12 weeks. Collectively, these studies establish a likely molecular linkage between poor folate nutrition and HPV16 and predict that nutritional folate and/or vitamin-B12 deficiency, which are both common worldwide, will alter the natural history of HPV16 infections and also warrant serious consideration as reversible co-factors in oncogenic transformation of HPV16-infected tissues to cancer.	[Xiao, Suhong; Tang, Ying-Sheng; Khan, Rehana A.; Zhang, Yonghua; Kusumanchi, Praveen; Antony, Asok C.] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Jayaram, Hiremagalur N.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Stabler, Sally P.] Univ Colorado, Sch Med, Dept Med, Aurora, CO 80045 USA; [Kusumanchi, Praveen; Jayaram, Hiremagalur N.; Antony, Asok C.] Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Antony, AC (corresponding author), 980 W Walnut St,Walther Hall R3 C321B, Indianapolis, IN 46202 USA.	aantony@iupui.edu			National Institutes of Health [R01CA120843, R01HD39295, AG09834]; Veterans Affairs Merit Review Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039295] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA120843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review Award(US Department of Veterans Affairs); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA120843 and R01HD39295 (to A. C. A.) and AG09834 (to S. P. S.). This work was also supported by a Veterans Affairs Merit Review Award (to A. C. A. and H. N. J.). One of the authors (S. P. S.) and the University of Colorado hold patents on the use of assays for total homocysteine and other metabolites to diagnose vitamin-B<INF>12</INF> (cobalamin) and folate deficiencies, and a company has been formed at the University of Colorado to perform such assays.	Ames BN, 2002, NAT REV CANCER, V2, P694, DOI 10.1038/nrc886; Antony A. C., 2009, HEMATOLOGY BASIC PRI, P491; Antony AC, 2004, J CLIN INVEST, V113, P285, DOI 10.1172/JCI200411548; Antony AC, 2003, AM J CLIN NUTR, V78, P3, DOI 10.1093/ajcn/78.1.3; Antony AC, 2001, AM J CLIN NUTR, V74, P157; BARBI G, 1984, HUM GENET, V68, P290, DOI 10.1007/BF00292586; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Blyn LB, 1997, J VIROL, V71, P6243, DOI 10.1128/JVI.71.8.6243-6246.1997; Bonnez W, 2005, METH MOLEC MED, V119, P203; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; BRANDSMA JL, 1995, J VIROL, V69, P2716, DOI 10.1128/JVI.69.4.2716-2721.1995; Budy B, 2006, ARCH BIOCHEM BIOPHYS, V446, P119, DOI 10.1016/j.abb.2005.12.014; BUTTERWORTH CE, 1992, JAMA-J AM MED ASSOC, V267, P528, DOI 10.1001/jama.267.4.528; BUTTERWORTH CE, 1982, AM J CLIN NUTR, V35, P73, DOI 10.1093/ajcn/35.1.73; BUTTERWORTH CE, 1993, J AM COLL NUTR, V12, P438, DOI 10.1080/07315724.1993.10718334; Campos SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004463; Carcopino X, 2006, J MED VIROL, V78, P1131, DOI 10.1002/jmv.20673; Chakravarty I, 2002, NUTR REV, V60, pS53, DOI 10.1301/00296640260130740; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chitambar C. R., 2006, MODERN NUTR HLTH DIS, P1436; CHOI YD, 1986, SCIENCE, V231, P1534, DOI 10.1126/science.3952495; Ciappio E, 2010, FOLATE HLTH DIS, P235; Collier B, 1998, J BIOL CHEM, V273, P22648, DOI 10.1074/jbc.273.35.22648; Czyzyk-Krzeska MF, 1999, BLOOD, V93, P2111, DOI 10.1182/blood.V93.6.2111.406k24_2111_2120; DAS KC, 1989, AM J HEMATOL, V31, P11, DOI 10.1002/ajh.2830310103; DIANOV GL, 1991, MOL GEN GENET, V225, P448, DOI 10.1007/BF00261686; Duthie SJ, 1998, FASEB J, V12, P1491, DOI 10.1096/fasebj.12.14.1491; Feldman JP, 2009, J APPL QUANT METHODS, V4, P455, DOI DOI 10.1111/J.2042-3306.2010.TB05629.X; Flores ER, 1999, VIROLOGY, V262, P344, DOI 10.1006/viro.1999.9868; Flores ER, 2000, J VIROL, V74, P6622, DOI 10.1128/JVI.74.14.6622-6631.2000; Gamarnik AV, 1997, RNA, V3, P882; Giles KM, 2003, J BIOL CHEM, V278, P2937, DOI 10.1074/jbc.M208439200; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; GOULIAN M, 1980, J BIOL CHEM, V255, P630; GOULIAN M, 1980, P NATL ACAD SCI-BIOL, V77, P1956, DOI 10.1073/pnas.77.4.1956; JEON S, 1995, P NATL ACAD SCI USA, V92, P1654, DOI 10.1073/pnas.92.5.1654; JEON S, 1995, J VIROL, V69, P2989, DOI 10.1128/JVI.69.5.2989-2997.1995; Jiang Y, 2006, MOL CELL BIOL, V26, P2419, DOI 10.1128/MCB.26.6.2419-2429.2006; Johnston C, 2000, LANCET, V355, P2179, DOI 10.1016/S0140-6736(00)02395-3; Kalantari M, 1998, INT J GYNECOL PATHOL, V17, P146, DOI 10.1097/00004347-199804000-00009; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kim YI, 1997, AM J CLIN NUTR, V65, P46, DOI 10.1093/ajcn/65.1.46; Kwanbunjan K, 2005, NUTR RES, V25, P641, DOI 10.1016/j.nutres.2005.05.004; LAIMINS LA, 1993, INFECT AGENT DIS, V2, P74; Lindahl T, 2000, MUTAT RES-REV MUTAT, V462, P129, DOI 10.1016/S1383-5742(00)00024-7; Longworth MS, 2004, MICROBIOL MOL BIOL R, V68, P362, DOI 10.1128/MMBR.68.2.362-372.2004; Mashiyama ST, 2004, ANAL BIOCHEM, V330, P58, DOI 10.1016/j.ab.2004.03.065; Motulsky H., 2004, FITTING MODELS BIOL, P296; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; Paulding WR, 1999, J BIOL CHEM, V274, P2532, DOI 10.1074/jbc.274.4.2532; Peitsaro P, 2002, J CLIN MICROBIOL, V40, P886, DOI 10.1128/JCM.40.3.886-891.2002; Piyathilake CJ, 2010, INT J WOMENS HEALTH, V2, P7; Piyathilake CJ, 2004, CANCER RES, V64, P8788, DOI 10.1158/0008-5472.CAN-04-2402; REIDY JA, 1988, MUTAT RES, V200, P215, DOI 10.1016/0027-5107(88)90085-1; Savelyeva L, 2006, CANCER LETT, V232, P58, DOI 10.1016/j.canlet.2005.08.033; Schwartz M, 2006, CANCER LETT, V232, P13, DOI 10.1016/j.canlet.2005.07.039; Schwartz S, 2000, UPSALA J MED SCI, V105, P171; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Stabler SP, 2004, ANNU REV NUTR, V24, P299, DOI 10.1146/annurev.nutr.24.012003.132440; Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201; Sun XL, 1996, J BIOL CHEM, V271, P25539; SUTHERLAND GR, 1995, CURR OPIN GENET DEV, V5, P323, DOI 10.1016/0959-437X(95)80046-8; Tang YS, 2011, J BIOL CHEM, V286, P39100, DOI 10.1074/jbc.M111.230938; Thomson SW, 2000, NUTR CANCER, V37, P128, DOI 10.1207/S15327914NC372_2; Thorland EC, 2003, ONCOGENE, V22, P1225, DOI 10.1038/sj.onc.1206170; Thorland EC, 2000, CANCER RES, V60, P5916; Thyagarajan A, 2004, J BIOL CHEM, V279, P49680, DOI 10.1074/jbc.M408915200; WANG XM, 1995, MOL CELL BIOL, V15, P1769; Weinstein SJ, 2001, CANCER CAUSE CONTROL, V12, P317, DOI 10.1023/A:1011290103779; White WI, 1998, J VIROL, V72, P959, DOI 10.1128/JVI.72.2.959-964.1998; WICKRAMASINGHE SN, 1994, BLOOD, V83, P1656; Wilke CM, 1996, HUM MOL GENET, V5, P187, DOI 10.1093/hmg/5.2.187; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Woolaway K, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-28; Xiao SH, 2005, BIRTH DEFECTS RES A, V73, P6, DOI 10.1002/bdra.20105; Xiao XL, 2001, J BIOL CHEM, V276, P41510, DOI 10.1074/jbc.M106824200; Yeap BB, 2002, J BIOL CHEM, V277, P27183, DOI 10.1074/jbc.M202883200; YUNIS JJ, 1984, SCIENCE, V226, P1199, DOI 10.1126/science.6239375; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207; Zhao XM, 2005, J VIROL, V79, P4270, DOI 10.1128/JVI.79.7.4270-4288.2005	81	16	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12559	12577		10.1074/jbc.M111.317040	http://dx.doi.org/10.1074/jbc.M111.317040			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351779	hybrid, Green Published			2022-12-27	WOS:000302782200095
J	Yaguchi, H; Okumura, F; Takahashi, H; Kano, T; Kameda, H; Uchigashima, M; Tanaka, S; Watanabe, M; Sasaki, H; Hatakeyama, S				Yaguchi, Hiroaki; Okumura, Fumihiko; Takahashi, Hidehisa; Kano, Takahiro; Kameda, Hiroyuki; Uchigashima, Motokazu; Tanaka, Shinya; Watanabe, Masahiko; Sasaki, Hidenao; Hatakeyama, Shigetsugu			TRIM67 Protein Negatively Regulates Ras Activity through Degradation of 80K-H and Induces Neuritogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYSTIC LIVER-DISEASE; E3 UBIQUITIN LIGASES; RING FINGER; U-BOX; SIGNAL-TRANSDUCTION; CELLS; IDENTIFICATION; GROWTH; SYSTEM; FAMILY	Tripartite motif (TRIM)-containing proteins, which are defined by the presence of a common domain structure composed of a RING finger, one or two B-box motifs and a coiled-coil motif, are involved in many biological processes including innate immunity, viral infection, carcinogenesis, and development. Here we show that TRIM67, which has a TRIM motif, an FN3 domain and a SPRY domain, is highly expressed in the cerebellum and that TRIM67 interacts with PRG-1 and 80K-H, which is involved in the Ras-mediated signaling pathway. Ectopic expression of TRIM67 results in degradation of endogenous 80K-H and attenuation of cell proliferation and enhances neuritogenesis in the neuroblastoma cell line N1E-115. Furthermore, morphological and biological changes caused by knockdown of 80K-H are similar to those observed by overexpression of TRIM67. These findings suggest that TRIM67 regulates Ras signaling via degradation of 80K-H, leading to neural differentiation including neuritogenesis.	[Hatakeyama, Shigetsugu] Hokkaido Univ, Grad Sch Med, Dept Biochem, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Yaguchi, Hiroaki; Kano, Takahiro; Sasaki, Hidenao] Hokkaido Univ, Grad Sch Med, Dept Neurol, Sapporo, Hokkaido 0608638, Japan; [Uchigashima, Motokazu; Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; [Tanaka, Shinya] Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido 0608638, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Hatakeyama, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Biochem, Kita Ku, Kita15,Nishi7, Sapporo, Hokkaido 0608638, Japan.	hatas@med.hokudai.ac.jp	Hatakeyama, Shigetsugu/C-8333-2012; Hidehisa, Takahashi/E-2175-2012; Kano, Takahiro/G-1721-2012; Tanaka, Shinya/D-3586-2011; Uchigashima, Motokazu/C-5715-2012; WATANABE, Masahiko/A-4055-2012	Hatakeyama, Shigetsugu/0000-0002-2150-9979; WATANABE, Masahiko/0000-0001-5037-7138	Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [23659144] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology.	Ajioka I, 2007, CELL, V131, P378, DOI 10.1016/j.cell.2007.09.036; Alexander M, 2010, DEV CELL, V18, P961, DOI 10.1016/j.devcel.2010.05.016; Aravind L, 2000, CURR BIOL, V10, pR132, DOI 10.1016/S0960-9822(00)00398-5; Brauer AU, 2008, BBA-MOL CELL BIOL L, V1781, P595, DOI 10.1016/j.bbalip.2008.04.004; Brauer AU, 2003, NAT NEUROSCI, V6, P572, DOI 10.1038/nn1052; Caldon CE, 2010, CELL CYCLE, V9, P1918, DOI 10.4161/cc.9.10.11474; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Drenth JPH, 2003, NAT GENET, V33, P345, DOI 10.1038/ng1104; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Goh KC, 1996, J BIOL CHEM, V271, P5832, DOI 10.1074/jbc.271.10.5832; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hao JC, 2010, DEV CELL, V18, P950, DOI 10.1016/j.devcel.2010.02.019; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Hisatsune C, 2006, J NEUROSCI, V26, P10916, DOI 10.1523/JNEUROSCI.3269-06.2006; Hodgkinson CP, 2005, BIOCHEM J, V388, P785, DOI 10.1042/BJ20041845; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kanai M, 1997, J BIOL CHEM, V272, P6621, DOI 10.1074/jbc.272.10.6621; Kawaai K, 2009, J BIOL CHEM, V284, P372, DOI 10.1074/jbc.M805828200; Kitamura T, 1998, INT J HEMATOL, V67, P351; KLINT P, 1995, J BIOL CHEM, V270, P23337, DOI 10.1074/jbc.270.40.23337; KRUMAN II, 1993, BIOCHEM BIOPH RES CO, V191, P1309, DOI 10.1006/bbrc.1993.1360; Li AR, 2003, AM J HUM GENET, V72, P691, DOI 10.1086/368295; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Mohammadi M, 1996, MOL CELL BIOL, V16, P977; Moore SW, 2008, DEVELOPMENT, V135, P2855, DOI 10.1242/dev.024133; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Peters JM, 1998, CURR OPIN CELL BIOL, V10, P759, DOI 10.1016/S0955-0674(98)80119-1; Rajsbaum R, 2008, EUR J IMMUNOL, V38, P619, DOI 10.1002/eji.200737916; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Song S, 2011, J GENET GENOMICS, V38, P1, DOI 10.1016/j.jcg.2010.12.004; Tanji K, 2010, NEUROBIOL DIS, V38, P210, DOI 10.1016/j.nbd.2010.01.007; Tokumitsu H, 2010, BIOCHEM J, V431, P81, DOI 10.1042/BJ20100637; Trimbuch T, 2009, CELL, V138, P1222, DOI 10.1016/j.cell.2009.06.050; Trombetta ES, 1996, J BIOL CHEM, V271, P27509, DOI 10.1074/jbc.271.44.27509; Yamada M, 2008, J NEUROCHEM, V106, P2375, DOI 10.1111/j.1471-4159.2008.05579.x	42	33	34	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12050	12059		10.1074/jbc.M111.307678	http://dx.doi.org/10.1074/jbc.M111.307678			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337885	Green Published, hybrid			2022-12-27	WOS:000302782200042
J	Lortat-Jacob, H; Burhan, I; Scarpellini, A; Thomas, A; Imberty, A; Vives, RR; Johnson, T; Gutierrez, A; Verderio, EAM				Lortat-Jacob, Hugues; Burhan, Izhar; Scarpellini, Alessandra; Thomas, Aline; Imberty, Anne; Vives, Romain R.; Johnson, Timothy; Gutierrez, Aldo; Verderio, Elisabetta A. M.			Transglutaminase-2 Interaction with Heparin IDENTIFICATION OF A HEPARIN BINDING SITE THAT REGULATES CELL ADHESION TO FIBRONECTIN-TRANSGLUTAMINASE-2 MATRIX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS 3T3 FIBROBLASTS; TISSUE TRANSGLUTAMINASE; SULFATE PROTEOGLYCANS; PROTEIN; ACTIVATION; GTP; TRANSAMIDATION; CONFORMATION; EXPRESSION; MIGRATION	Heparan sulfate proteoglycans are critical binding partners for extracellular tranglutaminase-2 (TG2), a multifunctional protein involved in tissue remodeling events related to organ fibrosis and cancer progression. We previously showed that TG2 has a strong affinity for heparan sulfate (HS)/heparin and reported that the heparan sulfate proteoglycan syndecan-4 acts as a receptor for TG2 via its HS chains in two ways: by increasing TG2-cell surface trafficking/externalization and by mediating RGD-independent cell adhesion to fibronectin-TG2 matrix during wound healing. Here we have investigated the molecular basis of this interaction. Site-directed mutagenesis revealed that either mutation of basic RRWK (262-265) or KQKRK (598-602) clusters, forming accessible heparin binding sequences on the TG2 three-dimensional structure, led to an almost complete reduction of heparin binding, indicating that both clusters contribute to form a single binding surface. Mutation of residues Arg(19) and Arg(28) also led to a significant reduction in heparin binding, suggesting their involvement. Our findings indicate that the heparin binding sites on TG2 mainly comprise two clusters of basic amino acids, which are distant in the linear sequence but brought into spatial proximity in the folded "closed" protein, forming a high affinity heparin binding site. Molecular modeling showed that the identified site can make contact with a single heparin-derived pentasaccharide. The TG2-heparin binding mutants supported only weak RGD-independent cell adhesion compared with wild type TG2 or mutants with retained heparin binding, and both heparin binding clusters were critical for TG2-mediated cell adhesion. These findings significantly advance our knowledge of how HS/heparin influences the adhesive function of TG2.	[Verderio, Elisabetta A. M.] Nottingham Trent Univ, Biomed Life & Hlth Sci Res Ctr, Sch Sci & Technol, Nottingham NG11 8NS, England; [Lortat-Jacob, Hugues; Vives, Romain R.] Univ Grenoble 1, CNRS Commissariat Energie Atom, Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble 01, France; [Thomas, Aline; Imberty, Anne] CNRS, Ctr Rech Macromol Vegetales, F-38041 Grenoble 9, France; [Johnson, Timothy] Univ Sheffield, Acad Nephrol Unit, Sheffield S10 2RZ, S Yorkshire, England	Nottingham Trent University; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Sheffield	Verderio, EAM (corresponding author), Nottingham Trent Univ, Biomed Life & Hlth Sci Res Ctr, Sch Sci & Technol, Nottingham NG11 8NS, England.	hugues.lortat-jacob@ibs.fr; elisabetta.verderio-edwards@ntu.ac.uk	Vives, Romain/I-9372-2012; Verderio, Elisabetta/H-2789-2016; Imberty, Anne/P-6451-2018	Verderio, Elisabetta/0000-0001-9153-8997; Imberty, Anne/0000-0001-6825-9527	Wellcome Trust [087163]; Nottingham Trent University-RAE QR [U12]	Wellcome Trust(Wellcome TrustEuropean Commission); Nottingham Trent University-RAE QR	This work was supported in part by Wellcome Trust Project 087163 (to E. A. M. V. and T. J.) and by Nottingham Trent University-RAE QR (U12) fund (to E. A. M. V. and A. G.).	Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Antonyak MA, 2009, J BIOL CHEM, V284, P17914, DOI 10.1074/jbc.M109.013037; Balklava Z, 2002, J BIOL CHEM, V277, P16567, DOI 10.1074/jbc.M109836200; Begg GE, 2006, J BIOL CHEM, V281, P12603, DOI 10.1074/jbc.M600146200; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; Belkin AM, 2011, FEBS J, V278, P4704, DOI 10.1111/j.1742-4658.2011.08346.x; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; CARDIN AD, 1989, ANN NY ACAD SCI, V556, P186; Cros S, 1997, BIOORGAN MED CHEM, V5, P1301, DOI 10.1016/S0968-0896(97)00087-4; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GENTILE V, 1991, J BIOL CHEM, V266, P478; Hadjivassiliou M, 2010, LANCET NEUROL, V9, P318, DOI 10.1016/S1474-4422(09)70290-X; Han BG, 2010, INT J BIOL MACROMOL, V47, P190, DOI 10.1016/j.ijbiomac.2010.04.023; Hwang JY, 2008, CANCER RES, V68, P5849, DOI 10.1158/0008-5472.CAN-07-6130; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Jang GY, 2010, ONCOGENE, V29, P356, DOI 10.1038/onc.2009.342; Jeitner TM, 2009, J NEUROCHEM, V109, P160, DOI 10.1111/j.1471-4159.2009.05843.x; Jin X, 2011, J BIOL CHEM, V286, P37866, DOI 10.1074/jbc.M111.287490; Johnson TS, 2003, J AM SOC NEPHROL, V14, P2052, DOI 10.1097/01.ASN.0000079614.63463.DD; Jones RA, 1997, J CELL SCI, V110, P2461; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Khan S, 2010, J MOL BIOL, V395, P504, DOI 10.1016/j.jmb.2009.10.064; Kiraly R, 2011, FEBS J, V278, P4717, DOI 10.1111/j.1742-4658.2011.08345.x; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Piper JL, 2002, BIOCHEMISTRY-US, V41, P386, DOI 10.1021/bi011715x; Radisky DC, 2009, NAT REV MOL CELL BIO, V10, P228, DOI 10.1038/nrm2633; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Rossi V, 2010, J IMMUNOL, V184, P4982, DOI 10.4049/jimmunol.0902016; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Satpathy M, 2009, J BIOL CHEM, V284, P15390, DOI 10.1074/jbc.M808331200; Scarpellini A, 2009, J BIOL CHEM, V284, P18411, DOI 10.1074/jbc.M109.012948; Shin DM, 2008, FASEB J, V22, P2498, DOI 10.1096/fj.07-095455; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; Telci D, 2008, J BIOL CHEM, V283, P20937, DOI 10.1074/jbc.M801763200; Telci D, 2009, J BIOL CHEM, V284, P29547, DOI 10.1074/jbc.M109.041806; Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874; Verderio EAM, 2009, AMINO ACIDS, V36, P671, DOI 10.1007/s00726-008-0134-6; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Verderio EAM, 2003, J BIOL CHEM, V278, P42604, DOI 10.1074/jbc.M303303200; Verderio E, 2010, THESCIENTIFICWORLDJO, V10, P1073, DOI 10.1100/tsw.2010.102; Vives RR, 2004, J BIOL CHEM, V279, P54327, DOI 10.1074/jbc.M409760200; Yu YH, 2005, J BIOL CHEM, V280, P32200, DOI 10.1074/jbc.M505738200; Zehe C, 2006, P NATL ACAD SCI USA, V103, P15479, DOI 10.1073/pnas.0605997103; Zemskov EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019414	50	38	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18005	18017		10.1074/jbc.M111.337089	http://dx.doi.org/10.1074/jbc.M111.337089			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22442151	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000306411600010
J	Ceholski, DK; Trieber, CA; Young, HS				Ceholski, Delaine K.; Trieber, Catharine A.; Young, Howard S.			Hydrophobic Imbalance in the Cytoplasmic Domain of Phospholamban Is a Determinant for Lethal Dilated Cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC SARCOPLASMIC-RETICULUM; DEPENDENT PROTEIN-KINASE; HEART-FAILURE; CALCIUM-PUMP; HYPERTROPHIC CARDIOMYOPATHY; INHIBITORY FUNCTION; GENE-THERAPY; CO-CRYSTALS; CA2+ PUMP; PHOSPHORYLATION	The sarco(endo)plasmic reticulum calcium ATPase (SERCA) and its regulatory partner phospholamban (PLN) are essential for myocardial contractility. Arg(9) -> Cys (R9C) and Arg(14) deletion (R14del) mutations in PLN are associated with lethal dilated cardiomyopathy in humans. To better understand these mutations, we made a series of amino acid substitutions in the cytoplasmic domain of PLN and tested their ability to inhibit SERCA. R9C is a complete loss-of-function mutant of PLN, whereas R14del is a mild loss-of-function mutant. When combined with wild-type PLN to simulate heterozygous conditions, the mutants had a dominant negative effect on SERCA function. A series of targeted mutations in this region of the PLN cytoplasmic domain ((8)TRSAIRR(14)) demonstrated the importance of hydrophobic balance in proper PLN regulation of SERCA. We found that Arg(9) -> Leu and Thr(8) -> Cys substitutions mimicked the behavior of the R9C mutant, and an Arg(14) -> Ala substitution mimicked the behavior of the R14del mutant. The results reveal that the change in hydrophobicity resulting from the R9C and R14del mutations is sufficient to explain the loss of function and persistent interaction with SERCA. Hydrophobic imbalance in the cytoplasmic domain of PLN appears to be a predictor for the development and progression of dilated cardiomyopathy.	[Ceholski, Delaine K.; Trieber, Catharine A.; Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Trieber, Catharine A.; Young, Howard S.] Univ Alberta, Natl Inst Nanotechnol, Edmonton, AB T6G 2M9, Canada	University of Alberta; National Research Council Canada; University of Alberta	Young, HS (corresponding author), Univ Alberta, Dept Biochem, 327 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	hyoung@ualberta.ca		Trieber, Catharine/0000-0002-1336-1126; Young, Howard/0000-0002-5990-8422	Heart and Stroke Foundation; Canadian Institutes of Health Research (CIHR) [MOP53306]; Alberta Innovates-Technology Futures (AI-TF)	Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Technology Futures (AI-TF)	This work was supported by grants from the Heart and Stroke Foundation and Canadian Institutes of Health Research (CIHR) Grant MOP53306.; Supported by Canada Graduate Scholarships from CIHR and Alberta Innovates-Technology Futures (AI-TF).	Akin BL, 2012, J BIOL CHEM, V287, P7582, DOI 10.1074/jbc.M111.334987; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; Brittsan AG, 2000, J BIOL CHEM, V275, P12129, DOI 10.1074/jbc.275.16.12129; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; Chen ZH, 2005, J BIOL CHEM, V280, P10530, DOI 10.1074/jbc.M414007200; Chen Z, 2007, J BIOL CHEM, V282, P20968, DOI 10.1074/jbc.M703516200; Chen ZH, 2010, J BIOL CHEM, V285, P3253, DOI 10.1074/jbc.M109.080820; COLYER J, 1991, J BIOL CHEM, V266, P17486; Dellefave L, 2010, CURR OPIN CARDIOL, V25, P198, DOI 10.1097/HCO.0b013e328337ba52; DeWitt MM, 2006, J AM COLL CARDIOL, V48, P1396, DOI 10.1016/j.jacc.2006.07.016; Douglas JL, 2005, PROTEIN EXPRES PURIF, V40, P118, DOI 10.1016/j.pep.2004.11.015; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5; Ferrington DA, 2002, BIOCHEMISTRY-US, V41, P13289, DOI 10.1021/bi026407t; FOWLER C, 1989, BIOCHIM BIOPHYS ACTA, V980, P348, DOI 10.1016/0005-2736(89)90323-4; Glaves JP, 2011, J MOL BIOL, V405, P707, DOI 10.1016/j.jmb.2010.11.014; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; Gustavsson M, 2011, BIOCHEMISTRY-US, V50, P10367, DOI 10.1021/bi200759y; Ha KN, 2011, P NATL ACAD SCI USA, V108, P2735, DOI 10.1073/pnas.1013987108; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Haghighi K, 2008, HUM MUTAT, V29, P640, DOI 10.1002/humu.20692; HASENFUSS G, 1994, CIRC RES, V75, P434, DOI 10.1161/01.RES.75.3.434; Hou ZJ, 2010, J MOL BIOL, V402, P210, DOI 10.1016/j.jmb.2010.07.023; INESI G, 1988, METHOD ENZYMOL, V157, P154; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; Karim CB, 2006, J MOL BIOL, V358, P1032, DOI 10.1016/j.jmb.2006.02.051; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kirchberber M A, 1975, Recent Adv Stud Cardiac Struct Metab, V5, P103; Landstrom AP, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.08.001; Lockamy EL, 2011, BIOCHEM BIOPH RES CO, V408, P388, DOI 10.1016/j.bbrc.2011.04.023; LOUIS CF, 1987, NEUROCHEM RES, V12, P937, DOI 10.1007/BF00966316; Lu LP, 1998, BIOPOLYMERS, V47, P41, DOI 10.1002/(SICI)1097-0282(1998)47:1<41::AID-BIP6>3.0.CO;2-X; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Medeiros A, 2011, AM HEART J, V162, P1088, DOI 10.1016/j.ahj.2011.07.028; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; Minamisawa S, 2003, BIOCHEM BIOPH RES CO, V304, P1, DOI 10.1016/S0006-291X(03)00526-6; Mishra S, 2002, J HEART LUNG TRANSPL, V21, P366, DOI 10.1016/S1053-2498(01)00390-4; Negash S, 2000, BIOCHEM J, V351, P195, DOI 10.1042/0264-6021:3510195; Negash S, 1996, BIOCHEMISTRY-US, V35, P11247, DOI 10.1021/bi960864q; Posch MG, 2009, HEART RHYTHM, V6, P480, DOI 10.1016/j.hrthm.2009.01.016; Rapti K, 2011, CAN J CARDIOL, V27, P265, DOI 10.1016/j.cjca.2011.02.005; REDDY LG, 1995, J BIOL CHEM, V270, P9390, DOI 10.1074/jbc.270.16.9390; Reddy LG, 1996, J BIOL CHEM, V271, P14964, DOI 10.1074/jbc.271.25.14964; Reddy LG, 1999, J BIOL CHEM, V274, P7649, DOI 10.1074/jbc.274.12.7649; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; Stokes DL, 2006, BIOPHYS J, V90, P4213, DOI 10.1529/biophysj.105.079640; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; TOYOFUKU T, 1994, J BIOL CHEM, V269, P3088; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Traaseth NJ, 2006, J MOL BIOL, V358, P1041, DOI 10.1016/j.jmb.2006.02.047; Trieber CA, 2005, BIOCHEMISTRY-US, V44, P3289, DOI 10.1021/bi047878d; Trieber CA, 2009, BIOCHEMISTRY-US, V48, P9287, DOI 10.1021/bi900852m; WARREN GB, 1974, P NATL ACAD SCI USA, V71, P622, DOI 10.1073/pnas.71.3.622; Young HS, 2001, BIOPHYS J, V81, P884, DOI 10.1016/S0006-3495(01)75748-7	55	35	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16521	16529		10.1074/jbc.M112.360859	http://dx.doi.org/10.1074/jbc.M112.360859			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22427649	Green Published, hybrid			2022-12-27	WOS:000304030900042
J	Dai, YM; Chen, H; Mo, C; Cui, LX; He, W				Dai, Yumei; Chen, Hui; Mo, Chen; Cui, Lianxian; He, Wei			Ectopically Expressed Human Tumor Biomarker MutS Homologue 2 Is a Novel Endogenous Ligand That Is Recognized by Human gamma delta T Cells to Induce Innate Anti-tumor/Virus Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-MISMATCH REPAIR; B-CELLS; RECEPTOR; NKG2D; LYMPHOCYTES; PROTEIN; ACTIVATION; SURFACE; IDENTIFICATION; CYTOTOXICITY	Human (h) MutS homologue 2, a nuclear protein, is a critical element of the DNA mismatch repair system. Our previous studies suggest that hMSH2 might be a protein ligand for TCR gamma delta. Here, we show that hMSH2 is ectopically expressed on a large panel of epithelial tumor cells. We found that hMSH2 interacts with both TCR gamma delta and NKG2D and contributes to V delta 2 T cell-mediated cytolysis of tumor cells. Moreover, recombinant human MSH2 protein stimulates the proliferation and IFN-gamma secretion of V delta 2 T cells in vitro. Finally, hMSH2 expression is induced on the cell surface of Epstein-Barr virus-transformed lymphoblastoid cell lines, and the induction increases the sensitivity of these lymphoblastoid cell lines to gamma delta T cell-mediated cytolysis. Our data suggest that hMSH2 functions as a tumor-associated or virus infection-related antigen recognized by both V delta 2 TCR and NKG2D, and it plays a role in eliciting the immune responses of gamma delta T cells against tumor-and virus-infected cells. The recognition of ectopic surface-expressing endogenous antigen by TCR gamma delta and NKG2D may be an important mechanism of innate immune response to carcinogenesis and viral infection.	[Dai, Yumei; Chen, Hui; Mo, Chen; Cui, Lianxian; He, Wei] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China; [Dai, Yumei; Mo, Chen; Cui, Lianxian; He, Wei] Sch Peking Union Med Coll, Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	He, W (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	hewei@moh.gov.cn			National Natural Science Foundation [30930083]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by Grant 30930083 from the National Natural Science Foundation.	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Botzler C, 1998, CELL STRESS CHAPERON, V3, P6, DOI 10.1379/1466-1268(1998)003<0006:DOELEO>2.3.CO;2; Chen H, 2008, J BIOL CHEM, V283, P12528, DOI 10.1074/jbc.M708067200; CHEUNG RK, 1993, VIROLOGY, V193, P700, DOI 10.1006/viro.1993.1178; CHUNG DC, 1995, GASTROENTEROLOGY, V109, P1685, DOI 10.1016/0016-5085(95)90660-6; DEPAOLI P, 1990, J INFECT DIS, V161, P1013, DOI 10.1093/infdis/161.5.1013; Eccleston J, 2011, J IMMUNOL, V186, P2336, DOI 10.4049/jimmunol.1003104; Gomes AQ, 2010, CANCER RES, V70, P10024, DOI 10.1158/0008-5472.CAN-10-3236; Gomes AQ, 2010, HAEMATOL-HEMATOL J, V95, P1397, DOI 10.3324/haematol.2009.020602; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; Halary F, 2005, J EXP MED, V201, P1567, DOI 10.1084/jem.20041851; Hirsh MI, 2008, AM J RESP CELL MOL, V39, P509, DOI 10.1165/rcmb.2008-0090TR; Jenkins MR, 2009, IMMUNITY, V31, P621, DOI 10.1016/j.immuni.2009.08.024; Knudsen NO, 2009, DNA REPAIR, V8, P682, DOI 10.1016/j.dnarep.2009.03.005; Kong Y, 2009, BLOOD, V114, P310, DOI 10.1182/blood-2008-12-196287; Kotsiopriftis M, 2005, J VIROL, V79, P7255, DOI 10.1128/JVI.79.11.7255-7261.2005; Kreslavsky T, 2010, SEMIN IMMUNOL, V22, P214, DOI 10.1016/j.smim.2010.04.001; Lanca T, 2010, BLOOD, V115, P2407, DOI 10.1182/blood-2009-08-237123; Meng Xialong, 2004, P R Health Sci J, V23, P103; Mookerjee-Basu J, 2010, J IMMUNOL, V184, P6920, DOI 10.4049/jimmunol.0904024; MULTHOFF G, 1995, INT J CANCER, V61, P272, DOI 10.1002/ijc.2910610222; Nedellec S, 2010, J IMMUNOL, V185, P55, DOI 10.4049/jimmunol.1000373; Peters AC, 2003, DNA REPAIR, V2, P427, DOI 10.1016/S1568-7864(03)00003-X; Poggi A, 2004, CANCER RES, V64, P9172, DOI 10.1158/0008-5472.CAN-04-2417; Rincon-Orozco B, 2005, J IMMUNOL, V175, P2144, DOI 10.4049/jimmunol.175.4.2144; Rolle A, 2003, J IMMUNOL, V171, P902, DOI 10.4049/jimmunol.171.2.902; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Seifert M, 2008, J INVEST DERMATOL, V128, P203, DOI 10.1038/sj.jid.5700941; Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937; STURM E, 1990, J IMMUNOL, V145, P3202; Thedrez A, 2007, IMMUNOL REV, V215, P123, DOI 10.1111/j.1600-065X.2006.00468.x; Vetter CS, 2002, J INVEST DERMATOL, V118, P600, DOI 10.1046/j.1523-1747.2002.01700.x; Viey E, 2005, J IMMUNOL, V174, P1338, DOI 10.4049/jimmunol.174.3.1338; Wilson IA, 2001, NAT IMMUNOL, V2, P579, DOI 10.1038/89718; Xi XY, 2009, J BIOL CHEM, V284, P27449, DOI 10.1074/jbc.M109.011684	41	44	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16812	16819		10.1074/jbc.M111.327650	http://dx.doi.org/10.1074/jbc.M111.327650			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22433851	Green Published, hybrid			2022-12-27	WOS:000304030900068
J	Ertekin, A; Aramini, JM; Rossi, P; Leonard, PG; Janjua, H; Xiao, R; Maglaqui, M; Lee, HW; Prestegard, JH; Montelione, GT				Ertekin, Asli; Aramini, James M.; Rossi, Paolo; Leonard, Paul G.; Janjua, Haleema; Xiao, Rong; Maglaqui, Melissa; Lee, Hsiau-Wei; Prestegard, James H.; Montelione, Gaetano T.			Human Cyclin-dependent Kinase 2-associated Protein 1 (CDK2AP1) Is Dimeric in Its Disulfide-reduced State, with Natively Disordered N-terminal Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; NMR STRUCTURE; INTRINSIC DISORDER; TUMOR-SUPPRESSOR; KAPPA-B; GROWTH SUPPRESSOR; SOFTWARE SUITE; EXPRESSION; P12(DOC-1); MUTATION	CDK2AP1 (cyclin-dependent kinase 2-associated protein 1), corresponding to the gene doc-1 (deleted in oral cancer 1), is a tumor suppressor protein. The doc-1 gene is absent or down-regulated in hamster oral cancer cells and in many other cancer cell types. The ubiquitously expressed CDK2AP1 protein is the only known specific inhibitor of CDK2, making it an important component of cell cycle regulation during G(1)-to-S phase transition. Here, we report the solution structure of CDK2AP1 by combined methods of solution state NMR and amide hydrogen/deuterium exchange measurements with mass spectrometry. The homodimeric structure of CDK2AP1 includes an intrinsically disordered 60-residue N-terminal region and a four-helix bundle dimeric structure with reduced Cys-105 in the C-terminal region. The Cys-105 residues are, however, poised for disulfide bond formation. CDK2AP1 is phosphorylated at a conserved Ser-46 site in the N-terminal "intrinsically disordered" region by I kappa B kinase epsilon.	[Ertekin, Asli; Aramini, James M.; Rossi, Paolo; Leonard, Paul G.; Janjua, Haleema; Xiao, Rong; Maglaqui, Melissa; Montelione, Gaetano T.] Rutgers State Univ, CABM, Piscataway, NJ 08854 USA; [Ertekin, Asli; Aramini, James M.; Rossi, Paolo; Leonard, Paul G.; Janjua, Haleema; Xiao, Rong; Maglaqui, Melissa; Montelione, Gaetano T.] Rutgers State Univ, NE Struct Genom Consortium, Piscataway, NJ 08854 USA; [Ertekin, Asli] Rutgers State Univ, BioMaPS Inst Quantitat Biol, Piscataway, NJ 08854 USA; [Leonard, Paul G.; Montelione, Gaetano T.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Leonard, Paul G.] Howard Hughes Med Inst, Athens, GA 30602 USA; [Lee, Hsiau-Wei; Prestegard, James H.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Lee, Hsiau-Wei; Prestegard, James H.] Univ Georgia, NE Struct Genom Consortium, Athens, GA 30602 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Howard Hughes Medical Institute; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Montelione, GT (corresponding author), Rutgers State Univ, CABM, 679 Hoes Lane, Piscataway, NJ 08854 USA.	guy@cabm.rutgers.edu	LEE, HSIAU-WEI/A-1415-2012	Montelione, Gaetano/0000-0002-9440-3059; Lee, Hsiau-Wei/0000-0002-6060-6341	National Institutes of Health from NIGMS [U54-GM-094597]; Jerome and Lorraine Aresty Cancer Biology Fellowship; National Institutes of Health [5 R90 DK071502]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094597] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Jerome and Lorraine Aresty Cancer Biology Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Protein Structure Initiative Grant U54-GM-094597 from NIGMS.; Supported by a Jerome and Lorraine Aresty Cancer Biology Fellowship and a National Institutes of Health Interdisciplinary Research Workforce Fellowship 5 R90 DK071502.	Acton TB, 2011, METHOD ENZYMOL, V493, P21, DOI 10.1016/B978-0-12-381274-2.00002-9; Adli M, 2006, J BIOL CHEM, V281, P26976, DOI 10.1074/jbc.M603133200; Aramini JM, 2007, PROTEINS, V68, P789, DOI 10.1002/prot.21450; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buajeeb W, 2004, BIOCHEM BIOPH RES CO, V315, P998, DOI 10.1016/j.bbrc.2004.02.003; Choi MG, 2009, EUR SURG RES, V42, P223, DOI 10.1159/000208521; Cwikla SJ, 2000, J ORAL MAXIL SURG, V58, P406, DOI 10.1016/S0278-2391(00)90924-8; Daigo Y, 1997, GENE CHROMOSOME CANC, V20, P204, DOI 10.1002/(SICI)1098-2264(199710)20:2<204::AID-GCC12>3.0.CO;2-Q; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Eddy SF, 2005, CANCER RES, V65, P11375, DOI 10.1158/0008-5472.CAN-05-1602; Englander SW, 1996, CURR OPIN STRUC BIOL, V6, P18, DOI 10.1016/S0959-440X(96)80090-X; Ezeokonkwo C, 2011, RNA, V17, P652, DOI 10.1261/rna.2273111; Figueiredo ML, 2005, CLIN CANCER RES, V11, P3939, DOI 10.1158/1078-0432.CCR-04-2085; Fong JH, 2010, MOL BIOSYST, V6, P1821, DOI 10.1039/c005144f; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gokhale RS, 2000, CURR OPIN CHEM BIOL, V4, P22, DOI 10.1016/S1367-5931(99)00046-0; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hiscott J, 2007, CYTOKINE GROWTH F R, V18, P483, DOI 10.1016/j.cytogfr.2007.06.002; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; Huang YPJ, 2008, MOL CELL PROTEOMICS, V7, P2048, DOI 10.1074/mcp.M700550-MCP200; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Kim Y, 2005, J BIOL CHEM, V280, P23273, DOI 10.1074/jbc.M412929200; Kim Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004518; Kornhaber GJ, 2006, J BIOMOL NMR, V34, P259, DOI 10.1007/s10858-006-0027-5; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laue TM, 1992, ROYAL SOC CHEM, P90; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Matsuo K, 2000, FASEB J, V14, P1318, DOI 10.1096/fj.14.10.1318; Moseley HNB, 2004, J BIOMOL NMR, V28, P341, DOI 10.1023/B:JNMR.0000015420.44364.06; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pantazatos D, 2004, P NATL ACAD SCI USA, V101, P751, DOI 10.1073/pnas.0307204101; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sharma S, 2009, PROTEINS, V76, P882, DOI 10.1002/prot.22394; Shintani S, 2000, MOL CELL BIOL, V20, P6300, DOI 10.1128/MCB.20.17.6300-6307.2000; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Spraggon G, 2004, PROTEIN SCI, V13, P3187, DOI 10.1110/ps.04939904; Spruijt CG, 2010, MOL BIOSYST, V6, P1700, DOI 10.1039/c004108d; Stuart AC, 1999, J AM CHEM SOC, V121, P5346, DOI 10.1021/ja984172w; Terret ME, 2003, DEVELOPMENT, V130, P5169, DOI 10.1242/dev.00731; TODD R, 1995, FASEB J, V9, P1362, DOI 10.1096/fasebj.9.13.7557027; Tsuji T, 1998, J BIOL CHEM, V273, P6704, DOI 10.1074/jbc.273.12.6704; Valafar H, 2004, J MAGN RESON, V167, P228, DOI 10.1016/j.jmr.2003.12.012; Wang T. S, 1996, DNA REPLICATION EUKA; Wang YF, 2011, NAT CHEM BIOL, V7, P214, DOI 10.1038/NCHEMBIO.536; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; Yuan ZQ, 2003, ONCOGENE, V22, P6304, DOI 10.1038/sj.onc.1206609; Zhou HX, 2001, BIOCHEMISTRY-US, V40, P15069, DOI 10.1021/bi015795g; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	63	9	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16541	16549		10.1074/jbc.M112.343863	http://dx.doi.org/10.1074/jbc.M112.343863			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22427660	hybrid, Green Published			2022-12-27	WOS:000304030900044
J	Gavin, JM; Chen, JJ; Liao, H; Rollins, N; Yang, XF; Xu, Q; Ma, JY; Loke, HK; Lingaraj, T; Brownell, JE; Mallender, WD; Gould, AE; Amidon, BS; Dick, LR				Gavin, James M.; Chen, Jesse J.; Liao, Hua; Rollins, Neil; Yang, Xiaofeng; Xu, Qing; Ma, Jingya; Loke, Huay-Keng; Lingaraj, Trupti; Brownell, James E.; Mallender, William D.; Gould, Alexandra E.; Amidon, Benjamin S.; Dick, Lawrence R.			Mechanistic Studies on Activation of Ubiquitin and Di-ubiquitin-like Protein, FAT10, by Ubiquitin-like Modifier Activating Enzyme 6, Uba6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-ASSISTED INHIBITION; CRYSTAL-STRUCTURE; NATURAL-HISTORY; SUMO E1; NEDD8; INSIGHTS; PATHWAY; DEGRADATION; CONJUGATION; AFFINITY	Uba6 is a homolog of the ubiquitin-activating enzyme, Uba1, and activates two ubiquitin-like proteins (UBLs), ubiquitin and FAT10. In this study, biochemical and biophysical experiments were performed to understand the mechanisms of how Uba6 recognizes two distinct UBLs and catalyzes their activation and transfer. Uba6 is shown to undergo a three-step activation process and form a ternary complex with both UBLs, similar to what has been observed for Uba1. The catalytic mechanism of Uba6 is further supported by inhibition studies using a mechanism-based E1 inhibitor, Compound 1, which forms covalent adducts with both ubiquitin and FAT10. In addition, pre-steady state kinetic analysis revealed that the rates of UBL-adenylate (step 1) and thioester (step 2) formation are similar between ubiquitin and FAT10. However, distinct kinetic behaviors were also observed for ubiquitin and FAT10. FAT10 binds Uba6 with much higher affinity than ubiquitin while demonstrating lower catalytic activity in both ATP-PPi exchange and E1-E2 transthiolation assays. Also, Compound 1 is less potent with FAT10 as the UBL compared with ubiquitin in ATP-PPi exchange assays, and both a slow rate of covalent adduct formation and weak adduct binding to Uba6 contribute to the diminished potency observed for FAT10. Together with expression level analysis in IM-9 cells, this study sheds light on the potential role of cytokine-induced FAT10 expression in regulating Uba6 pathways.	[Gavin, James M.; Chen, Jesse J.; Liao, Hua; Rollins, Neil; Yang, Xiaofeng; Xu, Qing; Ma, Jingya; Loke, Huay-Keng; Lingaraj, Trupti; Brownell, James E.; Mallender, William D.; Gould, Alexandra E.; Amidon, Benjamin S.; Dick, Lawrence R.] Millennium Pharmaceut Inc, Discovery, Cambridge, MA 02139 USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Gavin, JM (corresponding author), 40 Landsdowne St, Cambridge, MA 02139 USA.	james.gavin@mpi.com	Dick, Lawrence/ABA-8831-2021	Dick, Larry/0000-0002-6880-0405				Aichem A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1012; Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Bruzzese FJ, 2009, ANAL BIOCHEM, V394, P24, DOI 10.1016/j.ab.2009.07.011; Burroughs AM, 2009, PROTEINS, V75, P895, DOI 10.1002/prot.22298; Burroughs AM, 2012, FRONT BIOSCI-LANDMRK, V17, P1433, DOI 10.2741/3996; Chen JJ, 2011, J BIOL CHEM, V286, P40867, DOI 10.1074/jbc.M111.279984; Chiu YH, 2007, MOL CELL, V27, P1014, DOI 10.1016/j.molcel.2007.08.020; Fan WF, 1996, IMMUNOGENETICS, V44, P97, DOI 10.1007/s002510050095; Gong PF, 2010, J AM SOC NEPHROL, V21, P316, DOI 10.1681/ASN.2009050479; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1982, J BIOL CHEM, V257, P329; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hipp MS, 2004, J BIOL CHEM, V279, P16503, DOI 10.1074/jbc.M310114200; Hjerpe R, 2012, BIOCHEM J, V441, P927, DOI 10.1042/BJ20111671; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Lee PCW, 2011, MOL CELL, V43, P392, DOI 10.1016/j.molcel.2011.05.034; Li TW, 2011, ARCH BIOCHEM BIOPHYS, V509, P164, DOI 10.1016/j.abb.2011.02.017; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Nagashima Y, 2011, J BIOL CHEM, V286, P29594, DOI 10.1074/jbc.M111.261032; Narasimhan J, 2005, J BIOL CHEM, V280, P27356, DOI 10.1074/jbc.M502814200; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Pelzer C, 2007, J BIOL CHEM, V282, P23010, DOI 10.1074/jbc.C700111200; PICKART CM, 1994, J BIOL CHEM, V269, P7115; Raasi S, 1999, EUR J IMMUNOL, V29, P4030, DOI 10.1002/(SICI)1521-4141(199912)29:12<4030::AID-IMMU4030>3.0.CO;2-Y; Schlieker CD, 2008, P NATL ACAD SCI USA, V105, P18255, DOI 10.1073/pnas.0808756105; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Streich FC, 2010, SUBCELL BIOCHEM, V54, P1, DOI 10.1007/978-1-4419-6676-6_1; Tokgoz Z, 2012, J BIOL CHEM, V287, P311, DOI 10.1074/jbc.M111.294975; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Whitby FG, 1998, J BIOL CHEM, V273, P34983, DOI 10.1074/jbc.273.52.34983	37	32	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15512	15522		10.1074/jbc.M111.336198	http://dx.doi.org/10.1074/jbc.M111.336198			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427669	Green Published, hybrid			2022-12-27	WOS:000304006300032
J	Stryer, L				Stryer, Lubert			Exploring Light and Life Undergraduate, Medical School, and Postdoctoral Years	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-GMP; ENERGY-TRANSFER; RETINAL RODS; PHOSPHODIESTERASE; FLUORESCENCE; RHODOPSIN; KINETICS; VISION; ACTIVATION; MOLECULES		Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Stryer, L (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	stryer@stanford.edu						Aitken CE, 2010, NAT STRUCT MOL BIOL, V17, P793, DOI 10.1038/nsmb.1828; Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BAYLOR DA, 1987, J PHYSIOL-LONDON, V390, P145, DOI 10.1113/jphysiol.1987.sp016691; BLOUT ER, 1959, P NATL ACAD SCI USA, V45, P1591, DOI 10.1073/pnas.45.11.1591; BROWN PK, 1964, SCIENCE, V144, P45, DOI 10.1126/science.144.3614.45; Cario G, 1923, Z PHYS, V17, P202, DOI 10.1007/BF01328679; Choi UB, 2010, NAT STRUCT MOL BIOL, V17, P318, DOI 10.1038/nsmb.1763; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; FUNG BKK, 1980, P NATL ACAD SCI-BIOL, V77, P2500, DOI 10.1073/pnas.77.5.2500; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; GLAZER AN, 1989, J BIOL CHEM, V264, P1; GLAZER AN, 1983, BIOPHYS J, V43, P383, DOI 10.1016/S0006-3495(83)84361-6; GLAZER AN, 1984, TRENDS BIOCHEM SCI, V9, P423, DOI 10.1016/0968-0004(84)90146-4; GRIFFITHS M, 1955, NATURE, V176, P1211, DOI 10.1038/1761211a0; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; HAUGLAND RP, 1969, P NATL ACAD SCI USA, V63, P23, DOI 10.1073/pnas.63.1.23; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; HUBBARD R, 1958, P NATL ACAD SCI USA, V44, P130, DOI 10.1073/pnas.44.2.130; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; Jacobs GH, 2009, SCI AM, V300, P56, DOI 10.1038/scientificamerican0409-56; KARPEN JW, 1988, COLD SPRING HARB SYM, V53, P325, DOI 10.1101/SQB.1988.053.01.039; KARPEN JW, 1988, P NATL ACAD SCI USA, V85, P1287, DOI 10.1073/pnas.85.4.1287; Komatsuzaki T., 2011, ADV CHEM PHYS, V146, P23; KUHN H, 1980, NATURE, V283, P587, DOI 10.1038/283587a0; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; MACNICHOL EF, 1964, SCI AM, V211, P48, DOI 10.1038/scientificamerican1264-48; MATHIES R, 1976, P NATL ACAD SCI USA, V73, P2169, DOI 10.1073/pnas.73.7.2169; MATHIES R, 1976, P NATL ACAD SCI USA, V73, P1, DOI 10.1073/pnas.73.1.1; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Miyawaki A, 2011, ANNU REV BIOCHEM, V80, P357, DOI 10.1146/annurev-biochem-072909-094736; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NICOL GD, 1978, P NATL ACAD SCI USA, V75, P5217, DOI 10.1073/pnas.75.10.5217; OI VT, 1982, J CELL BIOL, V93, P981, DOI 10.1083/jcb.93.3.981; Pober J S, 1979, Adv Cyclic Nucleotide Res, V11, P265; Regan BC, 2001, PHILOS T R SOC B, V356, P229, DOI 10.1098/rstb.2000.0773; STRYER L, 1987, CHEM SCRIPTA, V27B, P161; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; STRYER L, 1959, BIOCHIM BIOPHYS ACTA, V35, P242, DOI 10.1016/0006-3002(59)90355-5; STRYER L, 1964, J MOL BIOL, V8, P96, DOI 10.1016/S0022-2836(64)80152-2; Stryer L., 1995, BIOCHEMISTRY-US, V4th ed.; STRYER LUBERT, 1960, RADIATION RES SUPPL, V2, P432, DOI 10.2307/3583609; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; TOMITA T, 1970, Quarterly Reviews of Biophysics, V3, P179; Tsien RY, 2009, ANGEW CHEM INT EDIT, V48, P5612, DOI 10.1002/anie.200901916; WEBER G, 1954, BIOCHEM J, V56, pR31; WHEELER GL, 1977, P NATL ACAD SCI USA, V74, P4238, DOI 10.1073/pnas.74.10.4238; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; WU C, 1972, P NATL ACAD SCI USA, V69, P1104, DOI 10.1073/pnas.69.5.1104; YEE R, 1978, J BIOL CHEM, V253, P8902; Young T., 1802, PHILOS T ROY SOC LON, V92, P12, DOI DOI 10.1098/RSTL.1802.0004; ZIMMERMAN AL, 1985, P NATL ACAD SCI USA, V82, P8813, DOI 10.1073/pnas.82.24.8813; Zimmermann B, 2006, BBA-BIOENERGETICS, V1757, P311, DOI 10.1016/j.bbabio.2006.03.020	56	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15164	15173		10.1074/jbc.X112.361436	http://dx.doi.org/10.1074/jbc.X112.361436			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22411992	Green Published, hybrid			2022-12-27	WOS:000304006300002
J	Wang, K; Gu, SM; Yin, XY; Weintraub, ST; Hua, ZC; Jiang, JX				Wang, Ke; Gu, Sumin; Yin, Xinye; Weintraub, Susan T.; Hua, Zichun; Jiang, Jean X.			Developmental Truncations of Connexin 50 by Caspases Adaptively Regulate Gap Junctions/Hemichannels and Protect Lens Cells against Ultraviolet Radiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; FUNCTIONAL-CHARACTERIZATION; JUNCTIONS; DEGRADATION; MECHANISM; MICROPHTHALMIA; HEMICHANNEL; PROPAGATION; CLEAVAGE; DOMAIN	The gap junction-forming connexin (Cx) 50 is truncated gradually during lens development. Premature cleavage of lens connexins is thought to be associated with cataract formation. We have shown previously that Cx50 is likely to be cleaved by caspase-3 like protease during chick lens development. Here, using HPLC-electrospray tandem mass spectrometry, we mapped two cleavage sites at the C terminus of Cx50 after Glu-368 and Asp-379 and identified caspase-3 and caspase-1 as the responsible proteases, respectively. The activity of caspase-1, like caspase-3, was detected in the outer cortex increased during lens development, which coincided with the accumulation of the truncated fragments of Cx50 in the core region of the lens. The truncated Cx50 fragments present in older lenses were reproduced in the younger lens after treatment with UV radiation; this cleavage could be partially blocked by caspase-1/3-specific inhibitors. Interestingly, as compared with full-length Cx50, caspase-truncated Cx50 showed a dramatic decrease in gap junction coupling and a loss of hemichannel function. Furthermore, expression of caspase-truncated Cx50 fragments increased cell viability against UV radiation as compared with full-length Cx50. Together, these results suggest that both caspase-1 and -3 are responsible for the cleavage at the C terminus of Cx50 during lens development. The reduction of gap junction coupling and closure of hemichannels formed by truncated Cx50 are likely to adaptively protect cells against elevated oxidative stress associated with lens aging.	[Wang, Ke; Gu, Sumin; Yin, Xinye; Weintraub, Susan T.; Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Wang, Ke; Hua, Zichun] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Coll Life Sci, Nanjing 210093, Jiangsu, Peoples R China	University of Texas System; University of Texas Health San Antonio; Nanjing University	Jiang, JX (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	jiangj@uthscsa.edu		Jiang, Jean/0000-0002-2185-5716	National Institutes of Health [EY012085]; Welch Foundation [AQ-1507]; State Key Laboratory of Pharmaceutical Biotechnology [KFGW-200802]; NATIONAL EYE INSTITUTE [R29EY012085, R01EY012085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); State Key Laboratory of Pharmaceutical Biotechnology; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY012085. This work was also supported by Welch Foundation Grant AQ-1507 (to J. X. J) and the Open Fund from the State Key Laboratory of Pharmaceutical Biotechnology (KFGW-200802) (to Z. H.).	Ayala MN, 2000, EXP EYE RES, V70, P451, DOI 10.1006/exer.1999.0801; Bassnett S, 1997, J CELL BIOL, V137, P37, DOI 10.1083/jcb.137.1.37; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Beebe DC, 2010, OPHTHALMIC RES, V44, P155, DOI 10.1159/000316481; Bergamini CM, 2004, CURR PHARM DESIGN, V10, P1611, DOI 10.2174/1381612043384664; Berthoud VM, 2009, ANTIOXID REDOX SIGN, V11, P339, DOI 10.1089/ars.2008.2119; Chai ZF, 2011, MOL BIOL CELL, V22, P4503, DOI 10.1091/mbc.E11-05-0438; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Cooper K., 1991, BIOPHYSICS GAP JUNCT, P57; Cusato K, 2003, J NEUROSCI, V23, P6413; DeRosa AM, 2006, INVEST OPHTH VIS SCI, V47, P4474, DOI 10.1167/iovs.05-1582; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Fang X, 2011, ANTIOXID REDOX SIGN, V14, P2427, DOI 10.1089/ars.2010.3150; Gong X, 2007, J MEMBRANE BIOL, V218, P9, DOI 10.1007/s00232-007-9033-0; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Gu SM, 2003, INVEST OPHTH VIS SCI, V44, P2103, DOI 10.1167/iovs.02-1045; Jiang JX, 2010, CURR MOL MED, V10, P851; Jiang J. X., 2000, CONNEXIN METHODS PRO, P159; JIANG JX, 1994, MOL BIOL CELL, V5, P363, DOI 10.1091/mbc.5.3.363; KISTLER J, 1987, INVEST OPHTH VIS SCI, V28, P1687; Kjenseth A, 2010, CELL SIGNAL, V22, P1267, DOI 10.1016/j.cellsig.2010.03.005; Krysko DV, 2005, APOPTOSIS, V10, P459, DOI 10.1007/s10495-005-1875-2; Laing JG, 1997, EXP CELL RES, V236, P482, DOI 10.1006/excr.1997.3747; Lin DB, 2006, J EXP BIOL, V209, P4371, DOI 10.1242/jeb.02524; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; Lin JS, 1997, EUR J CELL BIOL, V73, P141; Mese G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/sj.jid.5700770; Munoz B, 1999, ANN EPIDEMIOL, V9, P53, DOI 10.1016/S1047-2797(98)00026-X; Musil LS, 2000, J BIOL CHEM, V275, P25207, DOI 10.1074/jbc.275.33.25207; Ramachandran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000712; Rong P, 2002, DEVELOPMENT, V129, P167; Sellitto C, 2004, INVEST OPHTH VIS SCI, V45, P3196, DOI 10.1167/iovs.04-0194; Stergiopoulos K, 1999, CIRC RES, V84, P1144, DOI 10.1161/01.RES.84.10.1144; Wang Z, 2009, EXP EYE RES, V89, P898, DOI 10.1016/j.exer.2009.07.015; White TW, 1998, J CELL BIOL, V143, P815, DOI 10.1083/jcb.143.3.815; Xu X, 2002, J MEMBRANE BIOL, V186, P101, DOI 10.1007/s00232-001-0139-5; Yin XY, 2001, J BIOL CHEM, V276, P34567, DOI 10.1074/jbc.M106073200; Zandy AJ, 2005, J BIOL CHEM, V280, P30263, DOI 10.1074/jbc.M504007200; ZIGMAN S, 1979, INVEST OPHTH VIS SCI, V18, P462	39	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15786	15797		10.1074/jbc.M111.313171	http://dx.doi.org/10.1074/jbc.M111.313171			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22418432	Green Published, hybrid			2022-12-27	WOS:000304006300056
J	Duprez, L; Bertrand, MJM; Vanden Berghe, T; Dondelinger, Y; Festjens, N; Vandenabeele, P				Duprez, Linde; Bertrand, Mathieu J. M.; Vanden Berghe, Tom; Dondelinger, Yves; Festjens, Nele; Vandenabeele, Peter			Intermediate Domain of Receptor-interacting Protein Kinase 1 (RIPK1) Determines Switch between Necroptosis and RIPK1 Kinase-dependent Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NONAPOPTOTIC CELL-DEATH; L929 CELLS; NECROSIS; ACTIVATION; COMPLEX; CIAP1; UBIQUITINATION; MECHANISMS; REQUIRES	Receptor-interacting protein kinase 1 (RIPK1) is an important component of the tumor necrosis factor receptor 1 (TNFR1) signaling pathway. Depending on the cell type and conditions, RIPK1 mediates MAPK and NF-kappa B activation as well as cell death. Using a mutant form of RIPK1 (RIPK1 Delta ID) lacking the intermediate domain (ID), we confirm the requirement of this domain for activation of these signaling events. Moreover, expression of RIPK1 Delta ID resulted in enhanced recruitment of caspase-8 to the TNFR1 complex II component Fas-associated death domain (FADD), which allowed a shift from TNF-induced necroptosis to apoptosis in L929 cells. Addition of the RIPK1 kinase inhibitor necrostatin-1 strongly reduced recruitment of RIPK1 and caspase-8 to FADD and subsequent apoptosis, indicating a role for RIPK1 kinase activity in apoptotic complex formation. Our study shows that RIPK1 has an anti-apoptotic function residing in its ID and demonstrates a cellular system as an elegant genetic model for RIPK1 kinase-dependent apoptosis that, in contrast to the Smac mimetic model, does not rely on depletion of cellular inhibitor of apoptosis protein 1 and 2 (cIAP1/2).	[Duprez, Linde; Bertrand, Mathieu J. M.; Vanden Berghe, Tom; Dondelinger, Yves; Festjens, Nele; Vandenabeele, Peter] Univ Ghent VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium; [Duprez, Linde; Bertrand, Mathieu J. M.; Vanden Berghe, Tom; Dondelinger, Yves; Festjens, Nele; Vandenabeele, Peter] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Vandenabeele, P (corresponding author), Univ Ghent VIB, Dept Mol Biomed Res, Technol Pk 927, B-9052 Ghent, Belgium.	Peter.Vandenabeele@dmbr.vib-UGent.be	Festjens, Nele/C-2093-2009; Vandenabeele, Peter/C-8597-2009; Bertrand, Mathieu JM/AAD-2653-2019; Bertrand, Mathieu J/P-6465-2016; Berghe, Tom Vanden/N-2902-2019; Vandenabeele, Peter/AAD-5793-2022; Vanden Berghe, Tom/C-4916-2009	Festjens, Nele/0000-0002-3429-5463; Bertrand, Mathieu JM/0000-0001-9000-0626; Bertrand, Mathieu J/0000-0001-9000-0626; Berghe, Tom Vanden/0000-0002-1633-0974; Vandenabeele, Peter/0000-0002-6669-8822; Vanden Berghe, Tom/0000-0002-1633-0974; Dondelinger, Yves/0000-0002-5242-6834	European grants (FP6 ApopTrain) [MRTN-CT-035624]; European Commission for Research and Technological Development [FP7-200767]; Euregional PACT II; Belgian grants [IAP 6/18]; Flemish grants (Research Foundation Flanders) [FWO G.0875.11, FWO G.0973.11]; Ghent University (GROUP-ID consortium); Flanders Institute for Biotechnology (VIB); Agency for Innovation by Science and Technology; Flemish Government [BOF09/01M00709]	European grants (FP6 ApopTrain); European Commission for Research and Technological Development; Euregional PACT II; Belgian grants; Flemish grants (Research Foundation Flanders)(FWO); Ghent University (GROUP-ID consortium); Flanders Institute for Biotechnology (VIB); Agency for Innovation by Science and Technology; Flemish Government(European Commission)	This work was supported by European grants (FP6 ApopTrain, MRTN-CT-035624; FP7 European Commission for Research and Technological Development Integrated Project, Apo-Sys, FP7-200767; Euregional PACT II), Belgian grants (Interuniversity Attraction Poles, IAP 6/18), Flemish grants (Research Foundation Flanders, FWO G.0875.11 and FWO G.0973.11), Ghent University grants (Multidisciplinary Research Partnerships, GROUP-ID consortium), and grants from Flanders Institute for Biotechnology (VIB).; Recipient of a PhD grant from the Agency for Innovation by Science and Technology.; Recipient of Methusalem Grant BOF09/01M00709 from the Flemish Government.	Bell BD, 2008, P NATL ACAD SCI USA, V105, P16677, DOI 10.1073/pnas.0808597105; Bertrand MJM, 2010, CELL DEATH DIFFER, V17, P379, DOI 10.1038/cdd.2009.213; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Choi YE, 2009, J BIOL CHEM, V284, P12772, DOI 10.1074/jbc.M807550200; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Ermolaeva MA, 2008, NAT IMMUNOL, V9, P1037, DOI 10.1038/ni.1638; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Grimm S, 1996, P NATL ACAD SCI USA, V93, P10923, DOI 10.1073/pnas.93.20.10923; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holcik M, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-5; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Ikner A, 2011, J BIOL CHEM, V286, P21546, DOI 10.1074/jbc.M110.203745; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Knox PG, 2011, J CELL BIOL, V192, P391, DOI 10.1083/jcb.201003087; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Legarda-Addison D, 2009, CELL DEATH DIFFER, V16, P1279, DOI 10.1038/cdd.2009.41; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Lim SY, 2007, CARDIOVASC DRUG THER, V21, P467, DOI 10.1007/s10557-007-6067-6; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; O'Donnell MA, 2007, CURR BIOL, V17, P418, DOI 10.1016/j.cub.2007.01.027; O'Donnell MA, 2011, FEBS J, V278, P877, DOI 10.1111/j.1742-4658.2011.08016.x; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Pobezinskaya YL, 2008, NAT IMMUNOL, V9, P1047, DOI 10.1038/ni.1639; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vince JE, 2009, J BIOL CHEM, V284, P35906, DOI 10.1074/jbc.M109.072256; Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Wong WWL, 2010, CELL DEATH DIFFER, V17, P482, DOI 10.1038/cdd.2009.178; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878	56	32	38	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14863	14872		10.1074/jbc.M111.288670	http://dx.doi.org/10.1074/jbc.M111.288670			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22362767	hybrid, Green Published			2022-12-27	WOS:000304003200050
J	Komoriya, Y; Ariga, T; Iino, R; Imamura, H; Okuno, D; Noji, H				Komoriya, Yoshihito; Ariga, Takayuki; Iino, Ryota; Imamura, Hiromi; Okuno, Daichi; Noji, Hiroyuki			Principal Role of the Arginine Finger in Rotary Catalysis of F-1-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI ATP SYNTHASE; YEAST F-1 ATPASE; ESCHERICHIA-COLI; SINGLE-MOLECULE; ALPHA-SUBUNIT; CRYSTAL-STRUCTURE; ROTATION; MECHANISM; SITE; F1-ATPASE	F-1-ATPase (F-1) is an ATP-driven rotary motor wherein the gamma subunit rotates against the surrounding alpha(3)beta(3) stator ring. The 3 catalytic sites of F-1 reside on the interface of the alpha and beta subunits of the alpha(3)beta(3) ring. While the catalytic residues predominantly reside on the beta subunit, the alpha subunit has 1 catalytically critical arginine, termed the arginine finger, with stereogeometric similarities with the arginine finger of G-protein-activating proteins. However, the principal role of the arginine finger of F1 remains controversial. We studied the role of the arginine finger by analyzing the rotation of a mutant F-1 with a lysine substitution of the arginine finger. The mutant showed a 350-fold longer catalytic pause than the wild-type; this pause was further lengthened by the slowly hydrolyzed ATP analog ATP gamma S. On the other hand, the mutant F1 showed highly unidirectional rotation with a coupling ratio of 3 ATPs/turn, the same as wild-type, suggesting that cooperative torque generation by the 3 beta subunits was not impaired. The hybrid F-1 carrying a single copy of the alpha mutant revealed that the reaction step slowed by the mutation occurs at + 200 degrees from the binding angle of the mutant subunit. Thus, the principal role of the arginine finger is not to mediate cooperativity among the catalytic sites, but to enhance the rate of the ATP cleavage by stabilizing the transition state of ATP hydrolysis. Lysine substitution also caused frequent pauses because of severe ADP inhibition, and a slight decrease in ATP binding rate.	[Iino, Ryota; Noji, Hiroyuki] Univ Tokyo, Dept Appl Chem, Sch Engn, Tokyo 1138656, Japan; [Komoriya, Yoshihito; Imamura, Hiromi; Okuno, Daichi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Ariga, Takayuki] Univ Tokyo, Dept Appl Phys, Sch Engn, Tokyo 1138656, Japan	University of Tokyo; Osaka University; University of Tokyo	Noji, H (corresponding author), Univ Tokyo, Dept Appl Chem, Sch Engn, Tokyo 1138656, Japan.	hnoji@appchem.t.u-tokyo.ac.jp	Ariga, Takayuki/ACM-3092-2022; Imamura, Hiromi/AAD-5109-2019; Iino, Ryota/B-7746-2011	Imamura, Hiromi/0000-0002-1896-0443; Iino, Ryota/0000-0003-0110-5704; Ariga, Takayuki/0000-0002-2045-5761	MEXT [18074005]; Ministry of Education, Culture, Sports, Science, and Technology, Japan	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research from MEXT (Project ID 18074005) (to H. N.), and by special education and research expenses grant (to H. N.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Ahmad Z, 2005, J BIOENERG BIOMEMBR, V37, P437, DOI 10.1007/s10863-005-9486-8; Ariga T, 2007, NAT STRUCT MOL BIOL, V14, P841, DOI 10.1038/nsmb1296; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; Digel JG, 1996, J BIOL CHEM, V271, P19976, DOI 10.1074/jbc.271.33.19976; Dittrich M, 2003, BIOPHYS J, V85, P2253, DOI 10.1016/S0006-3495(03)74650-5; Duser MG, 2009, EMBO J, V28, P2689, DOI 10.1038/emboj.2009.213; Enoki S, 2009, J BIOL CHEM, V284, P23169, DOI 10.1074/jbc.M109.026401; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Iko Y, 2009, FEBS LETT, V583, P3187, DOI 10.1016/j.febslet.2009.08.042; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Kabaleeswaran V, 2009, J BIOL CHEM, V284, P10546, DOI 10.1074/jbc.M900544200; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; Kinosita K Jr, 2000, Essays Biochem, V35, P3; Le NP, 2000, BIOCHEMISTRY-US, V39, P2778, DOI 10.1021/bi992530h; Mao HZ, 2007, P NATL ACAD SCI USA, V104, P18478, DOI 10.1073/pnas.0709322104; Masaike T, 2008, NAT STRUCT MOL BIOL, V15, P1326, DOI 10.1038/nsmb.1510; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Nadanaciva S, 1999, BIOCHEMISTRY-US, V38, P15493, DOI 10.1021/bi9917683; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Noji H, 2001, J BIOL CHEM, V276, P25480, DOI 10.1074/jbc.M102200200; Okuno D, 2008, P NATL ACAD SCI USA, V105, P20722, DOI 10.1073/pnas.0805828106; Omote H, 1999, P NATL ACAD SCI USA, V96, P7780, DOI 10.1073/pnas.96.14.7780; Oster G, 2000, BBA-BIOENERGETICS, V1458, P482, DOI 10.1016/S0005-2728(00)00096-7; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Shimo-Kon R, 2010, BIOPHYS J, V98, P1227, DOI 10.1016/j.bpj.2009.11.050; Sielaff H, 2008, BIOPHYS J, V95, P4979, DOI 10.1529/biophysj.108.139782; SOGA S, 1989, ARCH BIOCHEM BIOPHYS, V268, P643, DOI 10.1016/0003-9861(89)90332-9; Spetzler D, 2006, BIOCHEMISTRY-US, V45, P3117, DOI 10.1021/bi052363n; TURINA P, 1993, J BIOL CHEM, V268, P6978; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; Watanabe R, 2012, NAT CHEM BIOL, V8, P86, DOI 10.1038/nchembio.715; Watanabe R, 2010, NAT CHEM BIOL, V6, P814, DOI 10.1038/NCHEMBIO.443; Weber J, 2010, NAT CHEM BIOL, V6, P794, DOI 10.1038/nchembio.458; Yang W, 2003, P NATL ACAD SCI USA, V100, P874, DOI 10.1073/pnas.0337432100; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	44	28	28	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15134	15142		10.1074/jbc.M111.328153	http://dx.doi.org/10.1074/jbc.M111.328153			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22403407	Green Published, hybrid			2022-12-27	WOS:000304003200074
J	Mencarelli, C; Bode, GH; Losen, M; Kulharia, M; Molenaar, PC; Veerhuis, R; Steinbusch, HWM; De Baets, MH; Nicolaes, GAF; Martinez-Martinez, P				Mencarelli, Chiara; Bode, Gerard H.; Losen, Mario; Kulharia, Mahesh; Molenaar, Peter C.; Veerhuis, Robert; Steinbusch, Harry W. M.; De Baets, Marc H.; Nicolaes, Gerry A. F.; Martinez-Martinez, Pilar			Goodpasture Antigen-binding Protein/Ceramide Transporter Binds to Human Serum Amyloid P-Component and Is Present in Brain Amyloid Plaques	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; GLOMERULAR-BASEMENT-MEMBRANE; MICROSCALE THERMOPHORESIS; NONVESICULAR TRAFFICKING; ALZHEIMERS-DISEASE; HEPARAN-SULFATE; IV COLLAGEN; AGGREGATION; CERAMIDE; PHOSPHORYLATES	Serum amyloid P component (SAP) is a non-fibrillar glycoprotein belonging to the pentraxin family of the innate immune system. SAP is present in plasma, basement membranes, and amyloid deposits. This study demonstrates, for the first time, that the Goodpasture antigen-binding protein (GPBP) binds to human SAP. GPBP is a nonconventional Ser/Thr kinase for basement membrane type IV collagen. Also GPBP is found in plasma and in the extracellular matrix. In the present study, we demonstrate that GPBP specifically binds SAP in its physiological conformations, pentamers and decamers. The START domain in GPBP is important for this interaction. SAP and GPBP form complexes in blood and partly colocalize in amyloid plaques from Alzheimer disease patients. These data suggest the existence of complexes of SAP and GPBP under physiological and pathological conditions. These complexes are important for understanding basement membrane, blood physiology, and plaque formation in Alzheimer disease.	[Mencarelli, Chiara; Bode, Gerard H.; Losen, Mario; Molenaar, Peter C.; Steinbusch, Harry W. M.; De Baets, Marc H.; Martinez-Martinez, Pilar] Maastricht Univ, Dept Neurosci, Sch Mental Hlth & Neurosci, NL-6200 MD Maastricht, Netherlands; [Kulharia, Mahesh; Nicolaes, Gerry A. F.] Maastricht Univ, Dept Biochem, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands; [Veerhuis, Robert] Vrije Univ Amsterdam, Dept Clin Chem, Univ Med Ctr, NL-1007 MB Amsterdam, Netherlands; [Veerhuis, Robert] Vrije Univ Amsterdam, Dept Psychiat, Univ Med Ctr, NL-1007 MB Amsterdam, Netherlands; [Veerhuis, Robert] Vrije Univ Amsterdam, Alzheimer Ctr, Univ Med Ctr, NL-1007 MB Amsterdam, Netherlands; [De Baets, Marc H.] Hasselt Univ, Neuroimmunol Grp, Biomed Res Inst BIOMED, Diepenbeek, Belgium	Maastricht University; Maastricht University; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Hasselt University	Martinez-Martinez, P (corresponding author), Maastricht Univ, Dept Neurosci, Sch Mental Hlth & Neurosci, POB 616, NL-6200 MD Maastricht, Netherlands.	p.martinez@maastrichtuniversity.nl	Nicolaes, Gerry A.F./A-8421-2016; Steinbusch, Heinrich/L-6950-2017	Nicolaes, Gerry A.F./0000-0002-2482-0412; Martinez Martinez, Pilar/0000-0002-5990-3373; Losen, Mario/0000-0002-9761-0002	Netherlands Organization for Scientific Research [91107006]; Transnationale Universiteit Limburg; Netherlands Organization for Scientific Research; Brain Foundation of the Netherlands	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Transnationale Universiteit Limburg; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Brain Foundation of the Netherlands	This work was supported by Netherlands Organization for Scientific Research Grant 91107006 (to G. A. F. N.) and a grant from the .Transnationale Universiteit Limburg (to G. A. F. N.).; Supported by a Veni fellowship of the Netherlands Organization for Scientific Research and a fellowship of the Brain Foundation of the Netherlands	ALMUTLAQ H, 1993, HISTOCHEM J, V25, P219, DOI 10.1007/BF00163818; Ashton AW, 1997, J MOL BIOL, V272, P408, DOI 10.1006/jmbi.1997.1271; Baaske P, 2010, ANGEW CHEM INT EDIT, V49, P2238, DOI 10.1002/anie.200903998; BALTZ ML, 1982, BIOCHIM BIOPHYS ACTA, V701, P229, DOI 10.1016/0167-4838(82)90118-2; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRISTOW CL, 1986, MOL IMMUNOL, V23, P1045, DOI 10.1016/0161-5890(86)90003-9; Burgess RR, 2000, METHOD ENZYMOL, V328, P141, DOI 10.1016/S0076-6879(00)28396-1; CATHCART ES, 1965, NEW ENGL J MED, V273, P143, DOI 10.1056/NEJM196507152730306; Chan CS, 2008, ADV BIOCHEM ENG BIOT, V110, P195, DOI 10.1007/10_2007_090; DE FRUTOS PG, 1995, J BIOL CHEM, V270, P26950, DOI 10.1074/jbc.270.45.26950; DEBEER FC, 1981, J EXP MED, V154, P1134, DOI 10.1084/jem.154.4.1134; DYCK RF, 1980, LANCET, V2, P607; DYCK RF, 1980, J EXP MED, V152, P1162, DOI 10.1084/jem.152.5.1162; Familian A, 2001, J IMMUNOL, V167, P647, DOI 10.4049/jimmunol.167.2.647; Familian A, 2007, NEUROSCI LETT, V416, P87, DOI 10.1016/j.neulet.2007.01.052; HAMAZAKI H, 1995, J BIOL CHEM, V270, P10392, DOI 10.1074/jbc.270.18.10392; HAMAZAKI H, 1987, J BIOL CHEM, V262, P1456; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5; Ho JGS, 2005, J BIOL CHEM, V280, P31999, DOI 10.1074/jbc.M504403200; Hohenester E, 1997, J MOL BIOL, V269, P570, DOI 10.1006/jmbi.1997.1075; HUTCHCRAFT CL, 1981, J IMMUNOL, V126, P1217; Jankowsky JL, 2007, J BIOL CHEM, V282, P22707, DOI 10.1074/jbc.M611050200; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Kudo N, 2010, J MOL BIOL, V396, P245, DOI 10.1016/j.jmb.2009.12.029; MELVIN T, 1986, AM J PATHOL, V125, P460; Mencarelli C, 2010, J NEUROCHEM, V113, P1369, DOI 10.1111/j.1471-4159.2010.06673.x; Mencarelli C, 2009, J CHEM NEUROANAT, V38, P97, DOI 10.1016/j.jchemneu.2009.06.005; NIELSEN EH, 1994, APMIS, V102, P420, DOI 10.1111/j.1699-0463.1994.tb04893.x; PAINTER RH, 1982, ANN NY ACAD SCI, V389, P199, DOI 10.1111/j.1749-6632.1982.tb22138.x; PEPYS MB, 1978, CLIN EXP IMMUNOL, V32, P119; POTEMPA LA, 1985, J BIOL CHEM, V260, P2142; Raya A, 1999, J BIOL CHEM, V274, P12642, DOI 10.1074/jbc.274.18.12642; Raya A, 2000, J BIOL CHEM, V275, P40392, DOI 10.1074/jbc.M002769200; Revert F, 2008, J BIOL CHEM, V283, P30246, DOI 10.1074/jbc.M805026200; Saus J. V., 2011, U.S. Patent, Patent No. [US7935492, 7935492]; Schwab C, 2008, J ALZHEIMERS DIS, V13, P359; STANTON M. C., 1958, AUSTRALASEAN ANN MED, V7, P132; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; Thompson D, 2002, J MOL BIOL, V320, P1081, DOI 10.1016/S0022-2836(02)00514-4; TSENG J, 1986, IMMUNOL INVEST, V15, P749, DOI 10.3109/08820138609036360; Veerhuis R, 2003, ACTA NEUROPATHOL, V105, P135, DOI 10.1007/s00401-002-0624-7; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; YING SC, 1993, J IMMUNOL, V150, P169; YOUNG L, 1994, PROTEIN SCI, V3, P717; Zahedi K, 1996, J BIOL CHEM, V271, P14897, DOI 10.1074/jbc.271.25.14897; Zahedi K, 1997, J BIOL CHEM, V272, P2143; ZHAN SS, 1995, NEURODEGENERATION, V4, P291, DOI 10.1016/1055-8330(95)90018-7	52	29	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14897	14911		10.1074/jbc.M111.299545	http://dx.doi.org/10.1074/jbc.M111.299545			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22396542	hybrid, Green Published			2022-12-27	WOS:000304003200053
J	Minashima, T; Small, W; Moss, SE; Kirsch, T				Minashima, Takeshi; Small, William; Moss, Stephen E.; Kirsch, Thorsten			Intracellular Modulation of Signaling Pathways by Annexin A6 Regulates Terminal Differentiation of Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; GROWTH-PLATE CARTILAGE; HYPERTROPHIC CHONDROCYTES; X COLLAGEN; ALKALINE-PHOSPHATASE; SKELETAL DEVELOPMENT; MATRIX VESICLES; MINERALIZATION; EXPRESSION; APOPTOSIS	Annexin A6 (AnxA6) is highly expressed in hypertrophic and terminally differentiated growth plate chondrocytes. Rib chondrocytes isolated from newborn AnxA6-/- mice showed delayed terminal differentiation as indicated by reduced terminal differentiation markers, including alkaline phosphatase, matrix metalloproteases-13, osteocalcin, and runx2, and reduced mineralization. Lack of AnxA6 in chondrocytes led to a decreased intracellular Ca2+ concentration and protein kinase C alpha (PKC alpha) activity, ultimately resulting in reduced extracellular signal-regulated kinase (ERK) and p38 mitogen-activated protein kinase (MAPK) activities. The 45 C-terminal amino acids of AnxA6 (AnxA6(1-627)) were responsible for the direct binding of AnxA6 to PKC alpha. Consequently, transfection of AnxA6-/- chondrocytes with full-length AnxA6 rescued the reduced expression of terminal differentiation markers, whereas transfection of AnxA6-/- chondrocytes with AnxA6(1-627) did not or only partially rescued the decreased mRNA levels of terminal differentiation markers. In addition, lack of AnxA6 in matrix vesicles, which initiate the mineralization process in growth plate cartilage, resulted in reduced alkaline phosphatase activity and Ca2+ and inorganic phosphate (Pi) content and the inability to form hydroxyapatite-like crystals in vitro. Histological analysis of femoral, tibial, and rib growth plates from newborn mice revealed that the hypertrophic zone of growth plates from newborn AnxA6-/- mice was reduced in size. In addition, reduced mineralization was evident in the hypertrophic zone of AnxA6-/- growth plate cartilage, although apoptosis was not altered compared with wild type growth plates. In conclusion, AnxA6 via its stimulatory actions on PKC alpha and its role in mediating Ca2+ flux across membranes regulates terminal differentiation and mineralization events of chondrocytes.	[Minashima, Takeshi; Small, William; Kirsch, Thorsten] NYU, Hosp Joint Dis, Dept Orthopaed Surg, Musculoskeletal Res Ctr, New York, NY 10003 USA; [Moss, Stephen E.] UCL, UCL Inst Ophthalmol, Div Cell Biol, London EC1V 9EL, England	New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; University of London; University College London	Kirsch, T (corresponding author), NYU, Hosp Joint Dis, Dept Orthopaed Surg, Musculoskeletal Res Ctr, Suite 1500,301 E 17th St, New York, NY 10003 USA.	thorsten.kirsch@nyumc.org	Kirsch, Thorsten/GQP-1157-2022		National Institutes of Health from the NIAMS [R01AR046245, R01AR049074]; United Kingdom Medical Research Council; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046245, R01AR049074] Funding Source: NIH RePORTER	National Institutes of Health from the NIAMS; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AR046245 and R01AR049074 from the NIAMS (to T. K.). This work was also supported by the United Kingdom Medical Research Council (to S. E. M.).	Anderson H Clarke, 2003, Curr Rheumatol Rep, V5, P222, DOI 10.1007/s11926-003-0071-z; Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; Belluoccio D, 2010, J BONE MINER RES, V25, P141, DOI 10.1359/jbmr.090710; Bist P, 2011, ONCOGENE, V30, P3174, DOI 10.1038/onc.2011.28; Boyan BD, 2004, STEROIDS, V69, P591, DOI 10.1016/j.steroids.2004.05.008; Brachvogel B, 2003, MOL CELL BIOL, V23, P2907, DOI 10.1128/MCB.23.8.2907-2913.2003; Cardo-Vila M, 2003, MOL CELL, V11, P1151, DOI 10.1016/S1097-2765(03)00138-2; Caunt CJ, 2012, BIOCHEM SOC T, V40, P224, DOI 10.1042/BST20110662; Dubois T, 1996, BBA-MOL CELL RES, V1313, P290, DOI 10.1016/0167-4889(96)00102-4; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Ge CX, 2012, J BONE MINER RES, V27, P538, DOI 10.1002/jbmr.561; Geisow MJ, 1988, MOL MECH SECRETION, P598; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Grewal T, 2005, ONCOGENE, V24, P5809, DOI 10.1038/sj.onc.1208743; Hawkins TE, 1999, MOL CELL BIOL, V19, P8028; Hsieh YH, 2007, CANCER RES, V67, P4320, DOI 10.1158/0008-5472.CAN-06-2486; Iwata T, 2000, HUM MOL GENET, V9, P1603, DOI 10.1093/hmg/9.11.1603; KIRSCH T, 1992, DIFFERENTIATION, V52, P89, DOI 10.1111/j.1432-0436.1992.tb00503.x; KIRSCH T, 1994, J BIOL CHEM, V269, P11462; Kirsch T, 2000, OSTEOARTHR CARTILAGE, V8, P294, DOI 10.1053/joca.1999.0304; Kirsch T, 2000, J BIOL CHEM, V275, P35577, DOI 10.1074/jbc.M005648200; Kirsch T, 1997, J CELL BIOL, V137, P1149, DOI 10.1083/jcb.137.5.1149; LEBOY PS, 1989, J BIOL CHEM, V264, P17281; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Miedlich SU, 2010, J BIOL CHEM, V285, P18270, DOI 10.1074/jbc.M109.098616; Nakashima S, 2002, J BIOCHEM, V132, P669, DOI 10.1093/oxfordjournals.jbchem.a003272; Namdari S, 2008, ARTHRITIS RHEUM, V58, P3520, DOI 10.1002/art.23999; Pfander D, 2001, AM J PATHOL, V159, P1777, DOI 10.1016/S0002-9440(10)63024-6; Rentero C, 2006, CELL SIGNAL, V18, P1006, DOI 10.1016/j.cellsig.2005.08.008; SCHLAEPFER DD, 1992, BIOCHEMISTRY-US, V31, P1886, DOI 10.1021/bi00121a043; Schmitz-Peiffer C, 1998, BIOCHEM J, V330, P675, DOI 10.1042/bj3300675; Shimo T, 2005, J BONE MINER RES, V20, P867, DOI 10.1359/JBMR.041235; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Wang W, 2003, J BIOL CHEM, V278, P3762, DOI 10.1074/jbc.M208868200; Wang W, 2002, J CELL BIOL, V157, P1061, DOI 10.1083/jcb.200203014; Wang W, 2006, J BIOL CHEM, V281, P30848, DOI 10.1074/jbc.M605937200; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Young SW, 1996, FEBS LETT, V384, P181, DOI 10.1016/0014-5793(96)00287-6; Zhen XC, 2001, J BIOL CHEM, V276, P4879, DOI 10.1074/jbc.M004990200	42	25	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14803	14815		10.1074/jbc.M111.297861	http://dx.doi.org/10.1074/jbc.M111.297861			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22399299	hybrid, Green Published			2022-12-27	WOS:000304003200045
J	Takahashi, K; Mitoma, J; Hosono, M; Shiozaki, K; Sato, C; Yamaguchi, K; Kitajima, K; Higashi, H; Nitta, K; Shima, H; Miyagi, T				Takahashi, Kohta; Mitoma, Junya; Hosono, Masahiro; Shiozaki, Kazuhiro; Sato, Chihiro; Yamaguchi, Kazunori; Kitajima, Ken; Higashi, Hideyoshi; Nitta, Kazuo; Shima, Hiroshi; Miyagi, Taeko			Sialidase NEU4 Hydrolyzes Polysialic Acids of Neural Cell Adhesion Molecules and Negatively Regulates Neurite Formation by Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE-BRAIN DEVELOPMENT; CENTRAL-NERVOUS-SYSTEM; COLON-CANCER CELLS; GANGLIOSIDE SIALIDASE; EXPRESSION; DIFFERENTIATION; NCAM; PLASTICITY; GROWTH; MICE	Modulation of levels of polysialic acid (polySia), a sialic acid polymer, predominantly associated with the neural cell adhesion molecule (NCAM), influences neural functions, including synaptic plasticity, neurite growth, and cell migration. Biosynthesis of polySia depends on two polysialyltransferases ST8SiaII and ST8SiaIV in vertebrate. However, the enzyme involved in degradation of polySia in its physiological turnover remains uncertain. In the present study, we identified and characterized a murine sialidase NEU4 that catalytically degrades polySia. Murine NEU4, dominantly expressed in the brain, was found to efficiently hydrolyze oligoSia and polySia chains as substrates in sialidase in vitro assays, and also NCAM-Fc chimera as well as endogenous NCAM in tissue homogenates of postnatal mouse brain as assessed by immunoblotting with anti-polySia antibodies. Degradation of polySia by NEU4 was also evident in neuroblastoma Neuro2a cells that were co-transfected with Neu4 and ST8SiaIV genes. Furthermore, in mouse embryonic hippocampal primary neurons, the endogenously expressed NEU4 was found to decrease during the neuronal differentiation. Interestingly, GFP- or FLAG-tagged NEU4 was partially co-localized with polySia in neurites and significantly suppressed their outgrowth, whereas silencing of NEU4 showed the acceleration together with an increase in polySia expression. These results suggest that NEU4 is involved in regulation of neuronal function by polySia degradation in mammals.	[Miyagi, Taeko] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Canc Glycosylat Res, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Mitoma, Junya; Higashi, Hideyoshi] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Glycosignal Res, Sendai, Miyagi 9818558, Japan; [Hosono, Masahiro; Nitta, Kazuo] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Cell Recognit Study, Sendai, Miyagi 9818558, Japan; [Shiozaki, Kazuhiro] Kagoshima Univ, Marine Biochem Lab, Kagoshima 8900056, Japan; [Sato, Chihiro; Kitajima, Ken] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan; [Yamaguchi, Kazunori; Shima, Hiroshi] Miyagi Canc Ctr, Res Inst, Natori, Miyagi 9811293, Japan; [Takahashi, Kohta; Shima, Hiroshi] Tohoku Univ, Grad Sch Med, Div Canc Mol Biol, Sendai, Miyagi 9808575, Japan	Tohoku Medical & Pharmaceutical University; Tohoku Medical & Pharmaceutical University; Tohoku Medical & Pharmaceutical University; Kagoshima University; Nagoya University; Miyagi Cancer Center; Tohoku University	Miyagi, T (corresponding author), Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Canc Glycosylat Res, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	tmiyagi@tohoku-pharm.ac.jp	Naganawa, Shinji/I-1572-2012; SATO, Chihiro/B-7396-2014	Naganawa, Shinji/0000-0002-0214-613X; Shiozaki, Kazuhiro/0000-0002-0523-838X				Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Angata K, 2007, MOL CELL BIOL, V27, P6659, DOI 10.1128/MCB.00205-07; Brocco M, 2003, J NEUROSCI RES, V74, P744, DOI 10.1002/jnr.10781; Brocco MA, 2006, FEBS LETT, V580, P4723, DOI 10.1016/j.febslet.2006.07.058; Burgess A, 2008, DEV NEUROBIOL, V68, P1580, DOI 10.1002/dneu.20681; Comelli EM, 2003, GENE, V321, P155, DOI 10.1016/j.gene.2003.08.005; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Fanzani A, 2004, FEBS LETT, V566, P178, DOI 10.1016/j.febslet.2004.03.115; Franceschini I, 2001, GLYCOBIOLOGY, V11, P231, DOI 10.1093/glycob/11.3.231; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Hasegawa T, 2000, J BIOL CHEM, V275, P8007, DOI 10.1074/jbc.275.11.8007; Hinek A, 2008, AM J PATHOL, V173, P1042, DOI 10.2353/ajpath.2008.071081; Inoko E, 2010, GLYCOBIOLOGY, V20, P916, DOI 10.1093/glycob/cwq049; Isomura R, 2011, J BIOL CHEM, V286, P21535, DOI 10.1074/jbc.M111.221143; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Kanato Y, 2008, GLYCOBIOLOGY, V18, P1044, DOI 10.1093/glycob/cwn084; Kato T, 2001, INT J CANCER, V92, P797, DOI 10.1002/ijc.1268; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kochlamazashvili G, 2010, J NEUROSCI, V30, P4171, DOI 10.1523/JNEUROSCI.5806-09.2010; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; Kurosawa N, 1997, J NEUROCHEM, V69, P494; Mitoma J, 1998, NEUROSCI RES, V30, P195, DOI 10.1016/S0168-0102(97)00113-2; Miyagi T., 2007, COMPREHENSIVE GLYCOS, P297; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Muhlenhoff M, 1998, CURR OPIN STRUC BIOL, V8, P558, DOI 10.1016/S0959-440X(98)80144-9; Nakata D, 2005, J BIOL CHEM, V280, P38305, DOI 10.1074/jbc.M508762200; Oltmann-Norden I, 2008, J BIOL CHEM, V283, P1463, DOI 10.1074/jbc.M708463200; Proshin S, 2002, NEUROCHEM RES, V27, P841, DOI 10.1023/A:1020269326825; Rodriguez JA, 2001, J NEUROSCI, V21, P8387, DOI 10.1523/JNEUROSCI.21-21-08387.2001; RUTISHAUSER U, 1985, J CELL BIOL, V101, P1842, DOI 10.1083/jcb.101.5.1842; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; SATO C, 1995, J BIOL CHEM, V270, P18923, DOI 10.1074/jbc.270.32.18923; Sato C, 2000, J BIOL CHEM, V275, P15422, DOI 10.1074/jbc.275.20.15422; Schonherr C, 2010, ONCOGENE, V29, P2817, DOI 10.1038/onc.2010.27; SEKI T, 1993, NEUROSCI RES, V17, P265, DOI 10.1016/0168-0102(93)90111-3; Seyrantepe V, 2008, HUM MOL GENET, V17, P1556, DOI 10.1093/hmg/ddn043; Seyrantepe V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001118; Shiozaki K, 2011, J BIOL CHEM, V286, P21052, DOI 10.1074/jbc.M111.231191; Shiozaki K, 2009, J BIOL CHEM, V284, P21157, DOI 10.1074/jbc.M109.012708; Shiozaki K, 2009, CANCER SCI, V100, P588, DOI 10.1111/j.1349-7006.2008.01080.x; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; Uemura T, 2009, ONCOGENE, V28, P1218, DOI 10.1038/onc.2008.471; Wang Y, 2010, J NEUROSCI, V30, P3482, DOI 10.1523/JNEUROSCI.3940-09.2010; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yamaguchi K, 2005, BIOCHEM J, V390, P85, DOI 10.1042/BJ20050017	48	34	34	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14816	14826		10.1074/jbc.M111.324186	http://dx.doi.org/10.1074/jbc.M111.324186			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22393058	hybrid, Green Published			2022-12-27	WOS:000304003200046
J	Deutsch, C; El Yacoubi, B; de Crecy-Lagard, V; Iwata-Reuyl, D				Deutsch, Christopher; El Yacoubi, Basma; de Crecy-Lagard, Valerie; Iwata-Reuyl, Dirk			Biosynthesis of Threonylcarbamoyl Adenosine (t(6)A), a Universal tRNA Nucleoside	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER RIBONUCLEIC-ACID; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ENZYMATIC-SYNTHESIS; MASS-SPECTROMETRY; UNKNOWN FUNCTION; L-THREONINE; IN-VITRO; PROTEIN; N-(PURIN-6-YLCARBAMOYL)THREONINE	The anticodon stem-loop (ASL) of transfer RNAs (tRNAs) drives decoding by interacting directly with the mRNA through codon/anticodon pairing. Chemically complex nucleoside modifications found in the ASL at positions 34 or 37 are known to be required for accurate decoding. Although over 100 distinct modifications have been structurally characterized in tRNAs, only a few are universally conserved, among them threonylcarbamoyl adenosine (t(6)A), found at position 37 in the anticodon loop of a subset of tRNA. Structural studies predict an important role for t(6)A in translational fidelity, and in vivo work supports this prediction. Although pioneering work in the 1970s identified the fundamental substrates for t(6)A biosynthesis, the enzymes responsible for its biosynthesis have remained an enigma. We report here the discovery that in bacteria four proteins (YgjD, YrdC, YjeE, and YeaZ) are both necessary and sufficient for t(6)A biosynthesis in vitro. Notably, YrdC and YgjD are members of universally conserved families that were ranked among the top 10 proteins of unknown function in need of functional characterization, while YeaZ and YjeE are specific to bacteria. This latter observation, coupled with the essentiality of all four proteins in bacteria, establishes this pathway as a compelling new target for antimicrobial development.	[El Yacoubi, Basma; de Crecy-Lagard, Valerie] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Deutsch, Christopher; Iwata-Reuyl, Dirk] Portland State Univ, Dept Chem, Portland, OR 97207 USA	State University System of Florida; University of Florida; Portland State University	de Crecy-Lagard, V (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, POB 110700, Gainesville, FL 32611 USA.	vcrecy@ufl.edu; iwatareuyld@pdx.edu	de Crecy-Lagard, Valerie/AAN-8995-2020		National Institutes of Health [GM070641-01A3]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant GM070641-01A3 from the National Institutes of Health (to V. de C.-L. and D. I.-R.).	Agari Y, 2008, PROTEINS, V70, P1108, DOI 10.1002/prot.21794; Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Allali-Hassani A, 2004, BIOCHEM J, V384, P577, DOI 10.1042/BJ20041082; Bergmiller T, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-118; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campbell TL, 2007, J BACTERIOL, V189, P3318, DOI 10.1128/JB.00131-06; CHHEDA GB, 1972, BIOCHEM J, V127, P515, DOI 10.1042/bj1270515; CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y; Daugeron MC, 2011, NUCLEIC ACIDS RES, V39, P6148, DOI 10.1093/nar/gkr178; de Crecky-Lagard V, 2007, METHOD ENZYMOL, V425, P153; Downey M, 2006, CELL, V124, P1155, DOI 10.1016/j.cell.2005.12.044; El Yacoubi B, 2011, EMBO J, V30, P882, DOI 10.1038/emboj.2010.363; El Yacoubi B, 2009, NUCLEIC ACIDS RES, V37, P2894, DOI 10.1093/nar/gkp152; ELKINS BN, 1974, BIOCHEMISTRY-US, V13, P4622, DOI 10.1021/bi00719a024; Galperin MY, 2010, TRENDS BIOTECHNOL, V28, P398, DOI 10.1016/j.tibtech.2010.05.006; GARCIA GA, 1998, MODIFICATION EDITING, P135; Grosjean H., 2009, DNA RNA MODIFICATION, P1; Handford JI, 2009, J BACTERIOL, V191, P4732, DOI 10.1128/JB.00136-09; Harris KA, 2011, RNA, V17, P1678, DOI 10.1261/rna.2592411; Hashimoto C, 2011, J BACTERIOL, V193, P6075, DOI 10.1128/JB.05733-11; Hecker A, 2007, NUCLEIC ACIDS RES, V35, P6042, DOI 10.1093/nar/gkm554; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Katz C, 2010, MBIO, V1, DOI 10.1128/mBio.00195-10; Kisseleva-Romanova E, 2006, EMBO J, V25, P3576, DOI 10.1038/sj.emboj.7601235; KORNER A, 1974, FEBS LETT, V39, P301, DOI 10.1016/0014-5793(74)80135-3; Kuratani M, 2011, PROTEINS, V79, P2065, DOI 10.1002/prot.23026; Lei T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020163; Lescrinier E, 2006, NUCLEIC ACIDS RES, V34, P2878, DOI 10.1093/nar/gkl081; Lin CA, 2010, MOL CELL BIOL, V30, P354, DOI 10.1128/MCB.00754-09; Morin A, 1998, RNA, V4, P24; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P1186, DOI 10.1038/nsmb861; Nichols CE, 2006, PROTEINS, V64, P111, DOI 10.1002/prot.20982; Petkun S, 2011, STRUCTURE, V19, P1773, DOI 10.1016/j.str.2011.09.023; POMERANTZ SC, 1990, METHOD ENZYMOL, V193, P796, DOI 10.1016/0076-6879(90)93452-Q; POWERS DM, 1972, BIOCHEM BIOPH RES CO, V46, P831, DOI 10.1016/S0006-291X(72)80216-X; POWERS DM, 1972, J BIOL CHEM, V247, P6394; Qian QA, 1998, J BACTERIOL, V180, P1808, DOI 10.1128/JB.180.7.1808-1813.1998; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; SCHWEIZE.MP, 1969, BIOCHEMISTRY-US, V8, P3283, DOI 10.1021/bi00836a023; Sherlin LD, 2001, RNA, V7, P1671; Soultanas P, 2000, EMBO J, V19, P3799, DOI 10.1093/emboj/19.14.3799; Srinivasan M, 2011, EMBO J, V30, P873, DOI 10.1038/emboj.2010.343; Stuart JW, 2000, BIOCHEMISTRY-US, V39, P13396, DOI 10.1021/bi0013039; WEISSENBACH J, 1981, EUR J BIOCHEM, V116, P207, DOI 10.1111/j.1432-1033.1981.tb05320.x	46	86	92	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13666	13673		10.1074/jbc.M112.344028	http://dx.doi.org/10.1074/jbc.M112.344028			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22378793	Green Published, hybrid			2022-12-27	WOS:000303996300022
J	Noh, KT; Son, KH; Jung, ID; Kang, HK; Hwang, SA; Lee, WS; You, JC; Park, YM				Noh, Kyung Tae; Son, Kwang Hee; Jung, In Duk; Kang, Hyun Kyu; Hwang, Sun Ae; Lee, Won Suk; You, Ji Chang; Park, Yeong-Min			Protein Kinase C delta (PKC delta)-Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Signaling Cascade Regulates Glycogen Synthase Kinase-3 (GSK-3) Inhibition-mediated Interleukin-10 (IL-10) Expression in Lipopolysaccharide (LPS)-induced Endotoxemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; UNITED-STATES; SEVERE SEPSIS; NITRIC-OXIDE; INNATE; EPIDEMIOLOGY; DYSFUNCTION; MICE	Glycogen synthase kinase-3 (GSK-3) modulates a wide array of cellular processes, including embryonic development, cell differentiation, survival, and apoptosis. Recently, it was reported that a GSK-3 inhibitor attenuates lipopolysaccharide (LPS)-induced septic shock and regulates the mortality of endotoxemic mice. However, the detailed mechanism of reduced mortality via GSK-3 inhibition is not well defined. Herein, we showed that GSK-3 inhibition induces extracellular signal-regulated kinase 1/2 (ERK1/2) activation under LPS-stressed conditions via protein kinase C delta (PKC delta) activation. Furthermore, PKC delta-induced ERK1/2 activation by the inhibition of GSK-3 provoked the production of interleukin (IL)-10, playing a crucial role in regulating endotoxemia. Using a mitogen-activated protein kinase kinase-1 (MEK-1) and PKC delta inhibitor, we confirmed that GSK-3 inhibition induces PKC delta and subsequent ERK1/2 activation, resulting in increased IL-10 expression under LPS-treated conditions. We verified that septic shock caused by LPS is attenuated by GSK-3 inhibition using a GSK-3 inhibitor. This relieved endotoxemia induced by GSK-3 inhibition was restored in an ERK1/2-dependent manner. Taken together, IL-10 expression produced by GSK-3 inhibition-induced ERK1/2 activation via PKC delta relieved LPS-mediated endotoxemia. This finding suggests that IL-10 hyperexpression resulting from GSK-3 inhibition-induced ERK activation could be a new therapeutic pathway for endotoxemia.	[Noh, Kyung Tae; Son, Kwang Hee; Jung, In Duk; Kang, Hyun Kyu; Park, Yeong-Min] Pusan Natl Univ, Sch Med, Dept Microbiol & Immunol, Yangsan 626870, Gyeongsangnam D, South Korea; [Hwang, Sun Ae; Lee, Won Suk] Pusan Natl Univ, Sch Med, Dept Pharmacol, Yangsan 626870, Gyeongsangnam D, South Korea; [Park, Yeong-Min] Pusan Natl Univ, Res Inst Convergence Biomed Sci & Technol, Yangsan 626770, Gyeongsangnam D, South Korea; [You, Ji Chang] Catholic Univ Korea, Sch Med, Dept Pathol, Natl Res Lab Mol Virol, Seoul 137701, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Catholic University of Korea	Park, YM (corresponding author), Pusan Natl Univ, Sch Med, Dept Microbiol & Immunol, Yangsan 626870, Gyeongsangnam D, South Korea.	immunpym@pusan.ac.kr			Ministry for Health Welfare and Family Affairs, Republic of Korea [A100462]	Ministry for Health Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Korea Healthcare Technology R&D Project, Ministry for Health Welfare and Family Affairs, Republic of Korea, Grant A100462.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bauer Philippe R., 2002, Pathophysiology, V8, P141, DOI 10.1016/S0928-4680(02)00007-X; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Castellheim A, 2009, SCAND J IMMUNOL, V69, P479, DOI 10.1111/j.1365-3083.2009.02255.x; Cavaillon JM, 2003, SCAND J INFECT DIS, V35, P535, DOI 10.1080/00365540310015935; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dinarello CA, 1997, CHEST, V112, p321S, DOI 10.1378/chest.112.6_Supplement.321S; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Doughty L, 1998, CHEST, V113, P1625, DOI 10.1378/chest.113.6.1625; GERARD C, 1993, J EXP MED, V177, P547, DOI 10.1084/jem.177.2.547; Ginnan R, 2006, AM J PHYSIOL-CELL PH, V290, pC1583, DOI 10.1152/ajpcell.00390.2005; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kim JW, 2003, J BIOL CHEM, V278, P13995, DOI 10.1074/jbc.M300253200; LAM C, 1994, J CLIN INVEST, V94, P2077, DOI 10.1172/JCI117562; Latifi SQ, 2002, INFECT IMMUN, V70, P4441, DOI 10.1128/IAI.70.8.4441-4446.2002; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Minden A, 1997, BBA-REV CANCER, V1333, pF85, DOI 10.1016/S0304-419X(97)00018-8; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Noh KT, 2011, EXP CELL RES, V317, P1663, DOI 10.1016/j.yexcr.2011.03.022; Peters K, 2003, CARDIOVASC RES, V60, P49, DOI 10.1016/S0008-6363(03)00397-3; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schwartz D, 1997, J CLIN INVEST, V100, P439, DOI 10.1172/JCI119551; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Song GY, 1999, SURGERY, V126, P378, DOI 10.1016/S0039-6060(99)70180-7; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; Steinhauser ME, 1999, J IMMUNOL, V162, P392; Tschoeke SK, 2008, SCAND J IMMUNOL, V68, P565, DOI 10.1111/j.1365-3083.2008.02176.x; VANDERPOLL T, 1995, J IMMUNOL, V155, P5397; Wang HZ, 2011, J IMMUNOL, V186, P675, DOI 10.4049/jimmunol.1001473; Wang Q, 2006, ONCOGENE, V25, P43, DOI 10.1038/sj.onc.1209004; Woodgett J R, 2001, Sci STKE, V2001, pre12, DOI 10.1126/stke.2001.100.re12; WRIGHT CE, 1992, CARDIOVASC RES, V26, P48, DOI 10.1093/cvr/26.1.48; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	38	35	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14226	14233		10.1074/jbc.M111.308841	http://dx.doi.org/10.1074/jbc.M111.308841			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22393041	Green Published, hybrid			2022-12-27	WOS:000303996300074
J	Ramos, SBV				Ramos, Silvia B. V.			Characterization of Delta N-Zfp36l2 Mutant Associated with Arrest of Early Embryonic Development and Female Infertility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; EARLY RESPONSE GENE; C-ELEGANS EMBRYOS; AU-RICH ELEMENTS; MESSENGER-RNA; TRISTETRAPROLIN FAMILY; TNF-ALPHA; GERMLINE SPECIFICATION; PIE-1 PROTEIN; TIS11 FAMILY	The zinc finger protein 36-like 2, Zfp36l2, has been implicated in female mouse infertility, because an amino-terminal truncation mutation (Delta N-Zfp36l2) leads to two-cell stage arrest of embryos derived from the homozygous mutant female gamete. Zfp36l2 is a member of the tristetraprolin (TTP) family of CCCH tandem zinc finger proteins that can bind to transcripts containing AU-rich elements ( ARE), resulting in deadenylation and destabilization of these transcripts. I show here that the mouse Zfp36l2 is composed of two exons and a single intron, encoding a polypeptide of 484 amino acids. I observed that Delta N-Zfp36l2 protein is similar to both wild-type Zfp36l2 and TTP (Zfp36) in that it shuttles between the cytoplasm and nucleus, binds to RNAs containing AREs, and promotes deadenylation of a model ARE transcript in a cell-based co-transfection assay. Surprisingly, in contrast to TTP, Zfp36l2 mRNA and protein were rapidly down-regulated upon LPS exposure in bone marrow-derived macrophages. The Delta N-Zfp36l2 protein was substantially more resistant to stimulus-induced down-regulation than the WT. I postulate that the embryonic arrest linked to the Delta N-Zfp36l2 truncation might be related to its resistance to stimulus-induced down-regulation.	Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Ramos, SBV (corresponding author), Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, 333 S Columbia St,255 MacNider Hall,CB 7570, Chapel Hill, NC 27599 USA.	sramos@med.unc.edu			National Institutes of Health from NIEHS; Nova Carta Foundation at University of North Carolina; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD069597] Funding Source: NIH RePORTER	National Institutes of Health from NIEHS; Nova Carta Foundation at University of North Carolina; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by National Institutes of Health grant from Intramural Research Program, NIEHS (to the Blackshear laboratory). This work was also supported at University of North Carolina by the Nova Carta Foundation.	BACHVAROVA R, 1980, DEV BIOL, V74, P1, DOI 10.1016/0012-1606(80)90048-2; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Blackshear PJ, 2005, BIOL REPROD, V73, P297, DOI 10.1095/biolreprod.105.040527; BUSTIN SA, 1994, DNA CELL BIOL, V13, P449, DOI 10.1089/dna.1994.13.449; Cao H, 2008, J NUTR, V138, P833, DOI 10.1093/jn/138.5.833; Cao HP, 2006, BIOCHEM J, V394, P285, DOI 10.1042/BJ20051316; Cao HP, 2004, J BIOL CHEM, V279, P21489, DOI 10.1074/jbc.M400900200; Carballo E, 1997, J CLIN INVEST, V100, P986, DOI 10.1172/JCI119649; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carrick DM, 2007, ARCH BIOCHEM BIOPHYS, V462, P278, DOI 10.1016/j.abb.2007.04.011; CLEGG KB, 1983, DEV BIOL, V95, P331, DOI 10.1016/0012-1606(83)90034-9; Clement SL, 2011, MOL CELL BIOL, V31, P256, DOI 10.1128/MCB.00717-10; DeRenzo C, 2004, TRENDS CELL BIOL, V14, P420, DOI 10.1016/j.tcb.2004.07.005; DeRenzo C, 2003, NATURE, V424, P685, DOI 10.1038/nature01887; Frederick ED, 2008, J BIOL CHEM, V283, P14792, DOI 10.1074/jbc.M801234200; GOMPERTS M, 1990, ONCOGENE, V5, P1081; Guedes S, 1997, DEVELOPMENT, V124, P731; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Ino T, 1995, ONCOGENE, V11, P2705; Johnson BA, 2002, J BIOL CHEM, V277, P18029, DOI 10.1074/jbc.M110465200; Johnson BA, 2002, ONCOGENE, V21, P4237, DOI 10.1038/sj.onc.1205526; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Maclean KN, 1998, BRIT J BIOMED SCI, V55, P184; MACLEAN KN, 1995, GENOMICS, V30, P89, DOI 10.1006/geno.1995.0014; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; Minami N, 2003, BIOL REPROD, V69, P1736, DOI 10.1095/biolreprod.103.018051; MURPHY JJ, 1990, BIOCHIM BIOPHYS ACTA, V1049, P261; NIE XF, 1995, GENE, V152, P285, DOI 10.1016/0378-1119(94)00696-P; Nishi Y, 2005, DEV BIOL, V288, P139, DOI 10.1016/j.ydbio.2005.09.053; Pagano JM, 2007, J BIOL CHEM, V282, P8883, DOI 10.1074/jbc.M700079200; Phillips RS, 2002, J BIOL CHEM, V277, P11606, DOI 10.1074/jbc.M111457200; Ramos SBV, 2004, DEVELOPMENT, V131, P4883, DOI 10.1242/dev.01336; Reese KJ, 2000, MOL CELL, V6, P445, DOI 10.1016/S1097-2765(00)00043-5; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Stumpo DJ, 2009, BLOOD, V114, P2401, DOI 10.1182/blood-2009-04-214619; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; Tabara H, 1999, DEVELOPMENT, V126, P1; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tong ZB, 2004, ENDOCRINOLOGY, V145, P1427, DOI 10.1210/en.2003-1160; VARNUM BC, 1991, MOL CELL BIOL, V11, P1754, DOI 10.1128/MCB.11.3.1754; Wu XM, 2003, BIOL REPROD, V69, P861, DOI 10.1095/biolreprod.103.016022	47	15	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13116	13127		10.1074/jbc.M111.330837	http://dx.doi.org/10.1074/jbc.M111.330837			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367205	Green Published, hybrid			2022-12-27	WOS:000302903700051
J	Wu-Zhang, AX; Schramm, CL; Nabavi, S; Malinow, R; Newton, AC				Wu-Zhang, Alyssa X.; Schramm, Cicely L.; Nabavi, Sadegh; Malinow, Roberto; Newton, Alexandra C.			Cellular Pharmacology of Protein Kinase M zeta (PKM zeta) Contrasts with Its in Vitro Profile IMPLICATIONS FOR PKM zeta AS A MEDIATOR OF MEMORY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPA RECEPTOR TRAFFICKING; LONG-TERM-MEMORY; C ISOZYMES; CHELERYTHRINE; INHIBITION; MECHANISM; PHOSPHORYLATION; MAINTENANCE; SPECIFICITY; APOPTOSIS	A number of recent studies have used pharmacological inhibitors to establish a role for protein kinase M zeta (PKM zeta) in synaptic plasticity and memory. These studies use zeta inhibitory peptide (ZIP) and chelerythrine as inhibitors of PKM zeta to block long term potentiation and memory; staurosporine is used as a negative control to show that a nonspecific kinase inhibitor does not block long term potentiation and memory. Here, we show that neither ZIP nor chelerythrine inhibits PKM zeta in cultured cells or brain slices. In contrast, staurosporine does block PKM zeta activity in cells and brain slices by inhibiting its upstream phosphoinositide-dependent kinase-1. These studies demonstrate that the effectiveness of drugs against purified PKM zeta may not be indicative of their specificity in the more complex environment of the cell and suggest that PKM zeta is unlikely to be the mediator of synaptic plasticity or memory.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Wu-Zhang, Alyssa X.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Nabavi, Sadegh; Malinow, Roberto] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Nabavi, Sadegh; Malinow, Roberto] Univ Calif San Diego, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Malinow, R (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	rmalinow@ucsd.edu; anewton@ucsd.edu		Nabavi, Sadegh/0000-0002-3940-1210	National Institutes of Health [GM-43154, MH-049159]; Cure Alzheimer's Foundation; University of California San Diego (UCSD) through NIGMS, National Institutes of Health [T32 GM007752]; National Science Foundation (NSF) [0742551]; National Institutes of Health/NIDDK [5T32-DK007233]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043154, T32GM007752, R37GM043154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH049159, R01MH091119, R37MH049159, R01MH049159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Foundation; University of California San Diego (UCSD) through NIGMS, National Institutes of Health; National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-43154 (to A. C. N.) and MH-049159 (to R. M.). This work was also supported by Cure Alzheimer's Foundation (to R. M.).; Supported in part by the University of California San Diego (UCSD) Graduate Training Program in Cellular and Molecular Pharmacology through Institutional Training Grant T32 GM007752 from the NIGMS, National Institutes of Health, and in part by a National Science Foundation (NSF) GK-12 STEM fellowship in education at UCSD, PI Maarten Chrispeels, NSF 0742551.; Supported by the National Institutes of Health/NIDDK Hemoglobin and Blood Protein Chemistry Training Grant 5T32-DK007233.	Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Gould CM, 2011, J BIOL CHEM, V286, P28922, DOI 10.1074/jbc.M111.272526; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Hernandez AI, 2003, J BIOL CHEM, V278, P40305, DOI 10.1074/jbc.M307065200; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Komander D, 2003, BIOCHEM J, V375, P255, DOI 10.1042/BJ20031119; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; ORR JW, 1992, J BIOL CHEM, V267, P15263; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; SEYNAEVE CM, 1994, MOL PHARMACOL, V45, P1207; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Shema R, 2011, SCIENCE, V331, P1207, DOI 10.1126/science.1200215; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Squire L., 2008, MEMORY MIND MOL; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Thompson LJ, 1996, J BIOL CHEM, V271, P15045, DOI 10.1074/jbc.271.25.15045; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Yamamoto S, 2001, J MOL CELL CARDIOL, V33, P1829, DOI 10.1006/jmcc.2001.1446; Yu R, 2000, J BIOL CHEM, V275, P9612, DOI 10.1074/jbc.275.13.9612	28	45	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12879	12885		10.1074/jbc.M112.357244	http://dx.doi.org/10.1074/jbc.M112.357244			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22378786	Green Published, hybrid			2022-12-27	WOS:000302903700027
J	De Bock, M; Wang, N; Bol, M; Decrock, E; Ponsaerts, R; Bultynck, G; Dupont, G; Leybaert, L				De Bock, Marijke; Wang, Nan; Bol, Melissa; Decrock, Elke; Ponsaerts, Raf; Bultynck, Geert; Dupont, Genevieve; Leybaert, Luc			Connexin 43 Hemichannels Contribute to Cytoplasmic Ca2+ Oscillations by Providing a Bimodal Ca2+-dependent Ca2+ Entry Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CAPACITATIVE CALCIUM-ENTRY; ATP RELEASE; 2-AMINOETHOXYDIPHENYL BORATE; EXTRACELLULAR CALCIUM; CYTOSOLIC CALCIUM; TEMPORAL ASPECTS; CYTOCHROME-C; CELL-DEATH; BRADYKININ	Many cellular functions are driven by changes in the intracellular Ca2+ concentration ([Ca2+](i)) that are highly organized in time and space. Ca2+ oscillations are particularly important in this respect and are based on positive and negative [Ca2+](i) feedback on inositol 1,4,5-trisphosphate receptors (InsP(3)Rs). Connexin hemichannels are Ca2+-permeable plasma membrane channels that are also controlled by [Ca2+](i). We aimed to investigate how hemichannels may contribute to Ca2+ oscillations. Madin-Darby canine kidney cells expressing connexin-32 (Cx32) and Cx43 were exposed to bradykinin (BK) or ATP to induce Ca2+ oscillations. BK-induced oscillations were rapidly (minutes) and reversibly inhibited by the connexin-mimetic peptides (32)Gap27/(43)Gap26, whereas ATP-induced oscillations were unaffected. Furthermore, these peptides inhibited the BK-triggered release of calcein, a hemichannel-permeable dye. BK-induced oscillations, but not those induced by ATP, were dependent on extracellular Ca2+. Alleviating the negative feedback of [Ca2+](i) on InsP(3)Rs using cytochrome c inhibited BK- and ATP-induced oscillations. Cx32 and Cx43 hemichannels are activated by < 500 nM [Ca2+](i) but inhibited by higher concentrations and CT9 peptide (last 9 amino acids of the Cx43 C terminus) removes this high [Ca2+](i) inhibition. Unlike interfering with the bell-shaped dependence of InsP3Rs to [Ca2+](i), CT9 peptide prevented BK-induced oscillations but not those triggered by ATP. Collectively, these data indicate that connexin hemichannels contribute to BK-induced oscillations by allowing Ca2+ entry during the rising phase of the Ca2+ spikes and by providing an OFF mechanism during the falling phase of the spikes. Hemichannels were not sufficient to ignite oscillations by themselves; however, their contribution was crucial as hemichannel inhibition stopped the oscillations.	[Leybaert, Luc] Univ Ghent, Dept Basic Med Sci, Physiol Grp, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Ponsaerts, Raf; Bultynck, Geert] KULeuven, Dept Mol Cell Biol, Lab Mol & Cellular Signaling, B-3000 Louvain, Belgium; [Dupont, Genevieve] Univ Libre Bruxelles, Theoret Chronobiol Unit, B-1050 Brussels, Belgium	Ghent University; KU Leuven; Universite Libre de Bruxelles	Leybaert, L (corresponding author), Univ Ghent, Dept Basic Med Sci, Physiol Grp, Fac Med & Hlth Sci, De Pintelaan 185,Bldg B,Rm 310, B-9000 Ghent, Belgium.	Luc.Leybaert@UGent.be	Leybaert, Luc/F-4079-2015; De Bock, Marijke/J-3253-2016	Leybaert, Luc/0000-0001-6452-6982; Bultynck, Geert/0000-0002-5968-4828; De Bock, Marijke/0000-0002-5590-2760; De Bock, Marijke/0000-0001-8823-0000	Institute for the Promotion of Innovation of Science and Technology in Flanders (IWT Vlaanderen) [63352]; Fund for Scientific Research Flanders (FWO) [G.0140.08, 3G.0134.09, G.0298.11]; Interuniversity Attraction Poles Program (Belgian Science Policy) [P6/31, P6/28]	Institute for the Promotion of Innovation of Science and Technology in Flanders (IWT Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fund for Scientific Research Flanders (FWO)(FWO); Interuniversity Attraction Poles Program (Belgian Science Policy)(Belgian Federal Science Policy Office)	This work was supported by the Institute for the Promotion of Innovation of Science and Technology in Flanders (IWT Vlaanderen) Grant 63352 (to M. D. B.), the Fund for Scientific Research Flanders (FWO) grants G.0140.08 and 3G.0134.09 (to L. L.) and G.0298.11 (L. L. and G. B.), and the Interuniversity Attraction Poles Program (Belgian Science Policy) P6/31 (to L. L.) and P6/28 (to G. B.).	Alexander DB, 2003, CURR MED CHEM, V10, P2045, DOI 10.2174/0929867033456927; Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Bergner A, 2002, AM J PHYSIOL-LUNG C, V283, pL1271, DOI 10.1152/ajplung.00139.2002; BERRIDGE MJ, 1988, PHILOS T ROY SOC B, V320, P325, DOI 10.1098/rstb.1988.0080; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; Bindschadler M, 2001, CHAOS, V11, P237, DOI 10.1063/1.1342161; BIRD GSJ, 1993, J BIOL CHEM, V268, P8425; BOARDER MR, 1992, BRIT J PHARMACOL, V107, P1140, DOI 10.1111/j.1476-5381.1992.tb13420.x; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Boehning D, 2005, P NATL ACAD SCI USA, V102, P1466, DOI 10.1073/pnas.0409650102; Boehning D, 2004, CELL CYCLE, V3, P252; Braet K, 2003, J CELL PHYSIOL, V197, P205, DOI 10.1002/jcp.10365; Braet K, 2003, CELL CALCIUM, V33, P37, DOI 10.1016/S0143-4160(02)00180-X; CARTER TD, 1991, BIOCHEM J, V278, P697, DOI 10.1042/bj2780697; Case RM, 2007, CELL CALCIUM, V42, P345, DOI 10.1016/j.ceca.2007.05.001; Clarke TC, 2009, EUR J PHARMACOL, V605, P9, DOI 10.1016/j.ejphar.2008.12.005; Colosetti P, 2003, J CELL SCI, V116, P2791, DOI 10.1242/jcs.00482; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; Davis RJ, 1999, BIOCHEM J, V341, P813, DOI 10.1042/0264-6021:3410813; Dawson AP, 1997, CURR BIOL, V7, pR544, DOI 10.1016/S0960-9822(06)00277-6; De Blasio BF, 2004, EUR BIOPHYS J BIOPHY, V33, P657, DOI 10.1007/s00249-004-0409-0; De Blasio BF, 2004, ACTA PHYSIOL SCAND, V180, P335, DOI 10.1111/j.1365-201X.2004.01261.x; De Bock M, 2011, J CEREBR BLOOD F MET, V31, P1942, DOI 10.1038/jcbfm.2011.86; De Vuyst E, 2006, EMBO J, V25, P34, DOI 10.1038/sj.emboj.7600908; De Vuyst E, 2008, BIOPHYS J, V94, P469, DOI 10.1529/biophysj.107.109470; De Vuyst E, 2009, CELL CALCIUM, V46, P176, DOI 10.1016/j.ceca.2009.07.002; Decrock E, 2009, CELL DEATH DIFFER, V16, P151, DOI 10.1038/cdd.2008.138; Dupont G, 2011, COLD SPRING HARB PER, V3; Dupont G, 2007, INT REV CYTOL, V261, P193, DOI 10.1016/S0074-7696(07)61005-5; Easton AS, 2002, BRAIN RES, V953, P157, DOI 10.1016/S0006-8993(02)03281-X; Estrada M, 2005, J ENDOCRINOL, V184, P371, DOI 10.1677/joe.1.05921; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Fioretti B, 2005, BIOPHYS CHEM, V113, P17, DOI 10.1016/j.bpc.2004.07.037; Fukami K, 2010, PROG LIPID RES, V49, P429, DOI 10.1016/j.plipres.2010.06.001; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; GOLDBETER A, 1990, P NATL ACAD SCI USA, V87, P1461, DOI 10.1073/pnas.87.4.1461; Gomez-Hernandez JM, 2003, P NATL ACAD SCI USA, V100, P16030, DOI 10.1073/pnas.2530348100; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hajnoczky G, 1997, EMBO J, V16, P3533, DOI 10.1093/emboj/16.12.3533; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Iyer S, 2007, COMPUT METH PROG BIO, V85, P203, DOI 10.1016/j.cmpb.2006.11.004; Jones BF, 2008, HEPATOLOGY, V48, P1273, DOI 10.1002/hep.22461; Kawano S, 2006, CELL CALCIUM, V39, P313, DOI 10.1016/j.ceca.2005.11.008; KEIZER J, 1992, BIOPHYS J, V61, P649, DOI 10.1016/S0006-3495(92)81870-2; Kennedy C, 1997, CAN J PHYSIOL PHARM, V75, P563, DOI 10.1139/cjpp-75-6-563; Koizumi S, 2010, FEBS J, V277, P286, DOI 10.1111/j.1742-4658.2009.07438.x; Leybaert L, 2003, CELL COMMUN ADHES, V10, P251, DOI 10.1080/15419060390262985; LOEWENSTEIN WR, 1981, PHYSIOL REV, V61, P829, DOI 10.1152/physrev.1981.61.4.829; MARTIN SC, 1994, FEBS LETT, V352, P32, DOI 10.1016/0014-5793(94)00913-9; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; MEYER T, 1988, P NATL ACAD SCI USA, V85, P5051, DOI 10.1073/pnas.85.14.5051; Monaco G, 2012, CELL DEATH DIFFER, V19, P295, DOI 10.1038/cdd.2011.97; Nash MS, 2002, J BIOL CHEM, V277, P35947, DOI 10.1074/jbc.M205622200; Nash MS, 2001, NATURE, V413, P381, DOI 10.1038/35096643; O'Quinn MP, 2011, CIRC RES, V108, P704, DOI 10.1161/CIRCRESAHA.110.235747; Pacher P, 2001, EMBO J, V20, P4107, DOI 10.1093/emboj/20.15.4107; PARKER I, 1990, P NATL ACAD SCI USA, V87, P260, DOI 10.1073/pnas.87.1.260; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pizzo P, 2001, J NEUROCHEM, V79, P98, DOI 10.1046/j.1471-4159.2001.00539.x; Politi A, 2006, BIOPHYS J, V90, P3120, DOI 10.1529/biophysj.105.072249; Ponsaerts R, 2010, FASEB J, V24, P4378, DOI 10.1096/fj.09-153007; Putney JW, 2008, J PHYSIOL-LONDON, V586, P3055, DOI 10.1113/jphysiol.2008.153221; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Reetz G, 1996, CELL CALCIUM, V19, P143, DOI 10.1016/S0143-4160(96)90083-4; Retamal MA, 2007, J NEUROSCI, V27, P13781, DOI 10.1523/JNEUROSCI.2042-07.2007; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; Rottingen JA, 1997, CELL CALCIUM, V21, P195, DOI 10.1016/S0143-4160(97)90044-0; Sacks RS, 2008, AM J PHYSIOL-LUNG C, V295, pL1048, DOI 10.1152/ajplung.90259.2008; SAGE SO, 1989, J BIOL CHEM, V264, P6; Sanchez HA, 2009, AM J PHYSIOL-CELL PH, V297, pC665, DOI 10.1152/ajpcell.00200.2009; Schalper KA, 2010, AM J PHYSIOL-CELL PH, V299, pC1504, DOI 10.1152/ajpcell.00015.2010; Shintani-Ishida K, 2007, AM J PHYSIOL-HEART C, V293, pH1714, DOI 10.1152/ajpheart.00022.2007; Shuttleworth TJ, 2003, BIOCHEM SOC T, V31, P916; Shuttleworth TJ, 1999, CELL CALCIUM, V25, P237, DOI 10.1054/ceca.1999.0022; Shuttleworth TJ, 1996, BIOCHEM J, V313, P815, DOI 10.1042/bj3130815; Sneyd J, 2006, P NATL ACAD SCI USA, V103, P1675, DOI 10.1073/pnas.0506135103; SNEYD J, 1995, FASEB J, V9, P1463, DOI 10.1096/fasebj.9.14.7589988; Stridh MH, 2008, J BIOL CHEM, V283, P10347, DOI 10.1074/jbc.M704153200; Swann K, 2008, INT J DEV BIOL, V52, P585, DOI 10.1387/ijdb.072530ks; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Tai CJ, 2001, J CLIN ENDOCR METAB, V86, P773, DOI 10.1210/jc.86.2.773; Tao L, 2007, MOL PHARMACOL, V71, P570, DOI 10.1124/mol.106.027508; Thimm J, 2005, J BIOL CHEM, V280, P10646, DOI 10.1074/jbc.M412749200; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; Thore S, 2004, J BIOL CHEM, V279, P19396, DOI 10.1074/jbc.C400088200; Tu HP, 2005, BIOPHYS J, V88, P1056, DOI 10.1529/biophysj.104.049601; Uhlen P, 2010, BIOCHEM BIOPH RES CO, V396, P28, DOI 10.1016/j.bbrc.2010.02.117; Van Moorhem M, 2010, CELL CALCIUM, V47, P287, DOI 10.1016/j.ceca.2010.01.001; Verma V, 2009, EUR J CELL BIOL, V88, P79, DOI 10.1016/j.ejcb.2008.08.005; Vinken M, 2010, CELL MOL LIFE SCI, V67, P907, DOI 10.1007/s00018-009-0220-2; Willars GB, 1999, AM J PHYSIOL-CELL PH, V277, pC859, DOI 10.1152/ajpcell.1999.277.5.C859; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Young KW, 2003, J BIOL CHEM, V278, P20753, DOI 10.1074/jbc.M211555200; Zhang SW, 2007, TOXICOL IN VITRO, V21, P1476, DOI 10.1016/j.tiv.2007.06.013	97	87	87	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12250	12266		10.1074/jbc.M111.299610	http://dx.doi.org/10.1074/jbc.M111.299610			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351781	Green Published, hybrid			2022-12-27	WOS:000302782200066
J	Shahnawaz, M; Soto, C				Shahnawaz, Mohammad; Soto, Claudio			Microcin Amyloid Fibrils A Are Reservoir of Toxic Oligomeric Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; FUNCTIONAL AMYLOIDS; PROTEIN; DISEASE; E492; STABILITY; PROTOFIBRILS; BACTERIOCIN; PROTOFILAMENTS	Microcin E492 (Mcc), a low molecular weight bacteriocin produced by Klebsiella pneumoniae RYC492, has been shown to exist in two forms: soluble forms that are believed to be toxic to the bacterial cell by forming pores and non-toxic fibrillar forms that share similar biochemical and biophysical properties with amyloids associated with several human diseases. Here we report that fibrils polymerized in vitro from soluble forms sequester toxic species that can be released upon changing environmental conditions such as pH, ionic strength, and upon dilution. Our results indicate that basic pH (>= 8.5), low NaCl concentrations (<= 50 mM), and dilution (>10-fold) destabilize Mcc fibrils into more soluble species that are found to be toxic to the target cells. Additionally, we also found a similar conversion of non-toxic fibrils into highly toxic oligomers using Mcc aggregates produced in vivo. Moreover, the soluble protein released from fibrils is able to rapidly polymerize into amyloid fibrils under fibril-forming conditions and to efficiently seed aggregation of monomeric Mcc. Our findings indicate that fibrillar forms of Mcc constitute a reservoir of toxic oligomeric species that is released into the medium upon changing the environmental conditions. These findings may have substantial implications to understand the dynamic process of interconversion between toxic and non-toxic aggregated species implicated in protein misfolding diseases.	[Shahnawaz, Mohammad; Soto, Claudio] Univ Texas Houston, Sch Med, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Dept Neurol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Soto, C (corresponding author), Univ Texas Houston, Sch Med, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Dept Neurol, 6431 Fannin St, Houston, TX 77030 USA.	Claudio.Soto@uth.tmc.edu						Badtke MP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.280pe43; BAQUERO F, 1984, FEMS MICROBIOL LETT, V23, P117; Bieler S, 2005, J BIOL CHEM, V280, P26880, DOI 10.1074/jbc.M502031200; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 2001, PROTEIN SCI, V10, P2541, DOI 10.1110/ps.ps.10201; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Corsini G, 2002, BIOCHIMIE, V84, P539, DOI 10.1016/S0300-9084(02)01415-3; DELORENZO V, 1985, J ANTIBIOT, V38, P340, DOI 10.7164/antibiotics.38.340; DELORENZO V, 1984, J GEN MICROBIOL, V130, P391; DELORENZO V, 1985, ANTIMICROB AGENTS CH, V27, P666, DOI 10.1128/AAC.27.4.666; DELORENZO V, 1984, ARCH MICROBIOL, V139, P72, DOI 10.1007/BF00692715; Destoumieux-Garzon D, 2003, MOL MICROBIOL, V49, P1031, DOI 10.1046/j.1365-2958.2003.03610.x; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Hetz C, 2002, P NATL ACAD SCI USA, V99, P2696, DOI 10.1073/pnas.052709699; Hotze EM, 2002, J BIOL CHEM, V277, P11597, DOI 10.1074/jbc.M111039200; LAGOS R, 1993, FEBS LETT, V321, P145, DOI 10.1016/0014-5793(93)80096-D; Lashuel H. A., 2005, SCI AGING KNOWLEDGE, V2005, pe28; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Nichols MR, 2005, J BIOL CHEM, V280, P2471, DOI 10.1074/jbc.M410553200; Orellana C, 1996, FEMS MICROBIOL LETT, V136, P297; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Riley MA, 1998, ANNU REV GENET, V32, P255, DOI 10.1146/annurev.genet.32.1.255; Riley MA, 2002, BIOCHIMIE, V84, P357, DOI 10.1016/S0300-9084(02)01421-9; Riley MA, 2003, J EVOLUTION BIOL, V16, P690, DOI 10.1046/j.1420-9101.2003.00575.x; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Shammas SL, 2011, BIOPHYS J, V100, P2783, DOI 10.1016/j.bpj.2011.04.039; Sikkink LA, 2008, BIOPHYS CHEM, V135, P25, DOI 10.1016/j.bpc.2008.02.019; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Soto C, 2001, FEBS LETT, V498, P204, DOI 10.1016/S0014-5793(01)02486-3; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; Zurdo J, 2001, J MOL BIOL, V311, P325, DOI 10.1006/jmbi.2001.4858	38	54	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11665	11676		10.1074/jbc.M111.282533	http://dx.doi.org/10.1074/jbc.M111.282533			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337880	Green Published, hybrid			2022-12-27	WOS:000302782200007
J	Girotto, S; Sturlese, M; Bellanda, M; Tessari, I; Cappellini, R; Bisaglia, M; Bubacco, L; Mammi, S				Girotto, Stefania; Sturlese, Mattia; Bellanda, Massimo; Tessari, Isabella; Cappellini, Rekha; Bisaglia, Marco; Bubacco, Luigi; Mammi, Stefano			Dopamine-derived Quinones Affect the Structure of the Redox Sensor DJ-1 through Modifications at Cys-106 and Cys-53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PARKINSONS-DISEASE; CYSTEINE-SULFINIC ACID; REGULATING KINASE 1; PROTEIN DJ-1; MITOCHONDRIAL LOCALIZATION; MOLECULAR SIMULATION; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; ALPHA-SYNUCLEIN; CELL-DEATH	The physiological role of DJ-1, a protein involved in familial Parkinson disease is still controversial. One of the hypotheses proposed indicates a sensor role for oxidative stress, through oxidation of a conserved cysteine residue (Cys-106). The association of DJ-1 mutations with Parkinson disease suggests a loss of function, specific to dopaminergic neurons. Under oxidative conditions, highly reactive dopamine quinones (DAQs) can be produced, which can modify cysteine residues. In cellular models, DJ-1 was found covalently modified by dopamine. We analyzed the structural modifications induced on human DJ-1 by DAQs in vitro. We described the structural perturbations induced by DAQ adduct formation on each of the three cysteine residues of DJ-1 using specific mutants. Cys-53 is the most reactive residue and forms a covalent dimer also in SH-SY5Y DJ-1-transfected cells, but modification of Cys-106 induces the most severe structural perturbations; Cys-46 is not reactive. The relevance of these covalent modifications to the several functions ascribed to DJ-1 is discussed in the context of the cell response to a dopamine-derived oxidative insult.	[Tessari, Isabella; Cappellini, Rekha; Bisaglia, Marco; Bubacco, Luigi] Univ Padua, Dept Biol, I-35121 Padua, Italy; [Girotto, Stefania; Sturlese, Mattia; Bellanda, Massimo; Mammi, Stefano] Univ Padua, Dept Chem Sci, I-35131 Padua, Italy	University of Padua; University of Padua	Bubacco, L (corresponding author), Univ Padua, Dept Biol, Via Ugo Bassi 58B, I-35121 Padua, Italy.	luigi.bubacco@unipd.it; stefano.mammi@unipd.it	Tessari, Isabella/K-7847-2016; Bubacco, Luigi/B-5602-2012; Sturlese, Mattia/P-9473-2019	Tessari, Isabella/0000-0002-5823-645X; Bubacco, Luigi/0000-0001-7927-9208; Sturlese, Mattia/0000-0003-3944-0313	University of Padova Progetto di Ricerca di Ateneo [CPDA 087059]; Progetto di Ricerca di Ateneo [CPDA 103503]; Ministero Istruzione Universita Ricerca, Progetti di Ricerca di Interesse Nazionale [2008 5SYP79]	University of Padova Progetto di Ricerca di Ateneo; Progetto di Ricerca di Ateneo; Ministero Istruzione Universita Ricerca, Progetti di Ricerca di Interesse Nazionale(Ministry of Education, Universities and Research (MIUR))	This work was supported by University of Padova Progetto di Ricerca di Ateneo 2008 Grant CPDA 087059 and Progetto di Ricerca di Ateneo 2010 Grant CPDA 103503 and by Ministero Istruzione Universita Ricerca, Progetti di Ricerca di Interesse Nazionale, 2008 Grant 2008 5SYP79.	Akagawa M, 2006, BIOCHEMISTRY-US, V45, P15120, DOI 10.1021/bi0614434; Anderson PC, 2008, BIOCHEMISTRY-US, V47, P9380, DOI 10.1021/bi800677k; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bisaglia M, 2007, J BIOL CHEM, V282, P15597, DOI 10.1074/jbc.M610893200; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Cha SS, 2008, J BIOL CHEM, V283, P34069, DOI 10.1074/jbc.M804243200; Chen J, 2010, HUM MOL GENET, V19, P2395, DOI 10.1093/hmg/ddq113; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; da Costa CA, 2007, CURR MOL MED, V7, P650, DOI 10.2174/156652407782564426; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dodson MW, 2007, CURR OPIN NEUROBIOL, V17, P331, DOI 10.1016/j.conb.2007.04.010; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; HASTINGS TG, 1994, J NEUROCHEM, V63, P1126; Hastings TG, 1996, P NATL ACAD SCI USA, V93, P1956, DOI 10.1073/pnas.93.5.1956; Herrera FE, 2007, J BIOL CHEM, V282, P24905, DOI 10.1074/jbc.M701013200; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Jin JH, 2005, MOL BRAIN RES, V134, P119, DOI 10.1016/j.molbrainres.2004.10.003; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Logan T, 2010, BIOCHEMISTRY-US, V49, P5624, DOI 10.1021/bi902164h; Malgieri G, 2008, PROTEIN SCI, V17, P855, DOI 10.1110/ps.073411608; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Mo JS, 2010, J CELL BIOCHEM, V110, P229, DOI 10.1002/jcb.22530; Moore DJ, 2005, HUM MOL GENET, V14, P71, DOI 10.1093/hmg/ddi007; Neumann M, 2004, ACTA NEUROPATHOL, V107, P489, DOI 10.1007/s00401-004-0834-2; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; PAZ MA, 1991, J BIOL CHEM, V266, P689; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Shen XM, 1996, CHEM RES TOXICOL, V9, P1117, DOI 10.1021/tx960052v; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Van Laar VS, 2009, NEUROBIOL DIS, V34, P487, DOI 10.1016/j.nbd.2009.03.004; Waak J, 2009, J BIOL CHEM, V284, P14245, DOI 10.1074/jbc.M806902200; Waragai M, 2006, BIOCHEM BIOPH RES CO, V345, P967, DOI 10.1016/j.bbrc.2006.05.011; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Witt AC, 2008, BIOCHEMISTRY-US, V47, P7430, DOI 10.1021/bi800282d; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030	49	46	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18738	18749		10.1074/jbc.M111.311589	http://dx.doi.org/10.1074/jbc.M111.311589			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22431735	hybrid, Green Published			2022-12-27	WOS:000306411600082
J	Bonner, SM; Pietropaolo, SL; Fan, Y; Chang, YG; Sethupathy, P; Morran, MP; Beems, M; Giannoukakis, N; Trucco, G; Palumbo, MO; Solimena, M; Pugliese, A; Polychronakos, C; Trucco, M; Pietropaolo, M				Bonner, Samantha M.; Pietropaolo, Susan L.; Fan, Yong; Chang, Yigang; Sethupathy, Praveen; Morran, Michael P.; Beems, Megan; Giannoukakis, Nick; Trucco, Giuliana; Palumbo, Michael O.; Solimena, Michele; Pugliese, Alberto; Polychronakos, Constantin; Trucco, Massimo; Pietropaolo, Massimo			Sequence Variation in Promoter of Ica1 Gene, Which Encodes Protein Implicated in Type 1 Diabetes, Causes Transcription Factor Autoimmune Regulator (AIRE) to Increase Its Binding and Down-regulate Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISLET-CELL AUTOANTIGEN; B-LYMPHOCYTE DEPLETION; CLASS-III ALLELES; T-CELL; SELF-TOLERANCE; HUMAN THYMUS; CAENORHABDITIS-ELEGANS; INSULIN EXPRESSION; NOD MICE; ANTIGEN	ICA69 (islet cell autoantigen 69 kDa) is a protein implicated in type 1 diabetes mellitus in both the non-obese diabetic (NOD) mouse model and humans. ICA69 is encoded by the Ica1 gene on mouse chromosome 6 A1-A2. We previously reported reduced ICA69 expression in the thymus of NOD mice compared with thymus of several non-diabetic mouse strains. We propose that reduced thymic ICA69 expression could result from variations in transcriptional regulation of the gene and that polymorphisms within the Ica1 core promoter may partially determine this transcriptional variability. We characterized the functional promoter of Ica1 in NOD mice and compared it with the corresponding portions of Ica1 in non-diabetic C57BL/6 mice. Luciferase reporter constructs demonstrated that the NOD Ica1 promoter region exhibited markedly reduced luciferase expression in transiently transfected medullary thymus epithelial (mTEC(+)) and B-cell (M12)-derived cell lines. However, in a non-diabetic strain, C57BL/6, the Ica1 promoter region was transcriptionally active when transiently transfected into the same cell lines. We concomitantly identified five single nucleotide polymorphisms within the NOD Ica1 promoter. One of these single nucleotide polymorphisms increases the binding affinity for the transcription factor AIRE (autoimmune regulator), which is highly expressed in thymic epithelial cells, where it is known to play a key role regulating self-antigen expression. We conclude that polymorphisms within the NOD Ica1 core promoter may determine AIRE-mediated down-regulation of ICA69 expression in medullary thymic epithelial cells, thus providing a novel mechanistic explanation for the loss of immunologic tolerance to this self-antigen in autoimmunity.	[Bonner, Samantha M.; Pietropaolo, Susan L.; Chang, Yigang; Morran, Michael P.; Beems, Megan; Pietropaolo, Massimo] Univ Michigan, Sch Med, Brehm Ctr Diabet Res, Immunogenet Lab,Dept Internal Med, Ann Arbor, MI 48105 USA; [Fan, Yong; Giannoukakis, Nick; Trucco, Massimo] Univ Pittsburgh, Sch Med, Rangos Res Ctr, Dept Pediat,Div Immunogenet, Pittsburgh, PA 15224 USA; [Sethupathy, Praveen] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Giannoukakis, Nick; Trucco, Giuliana] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA; [Palumbo, Michael O.; Polychronakos, Constantin] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Res Inst,Endocrine Genet Lab, Montreal, PQ H3H 1P3, Canada; [Solimena, Michele] Tech Univ Dresden, Carl Gustav Carus Sch Med, Paul Langerhans Inst Dresden, Dept Mol Diabetol, D-01307 Dresden, Germany; [Pugliese, Alberto] Univ Miami, Miller Sch Med, Diabet Res Inst,Div Endocrinol Diabet & Metab, Immunogenet Program,Dept Med, Miami, FL 33136 USA	University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; McGill University; Technische Universitat Dresden; University of Miami	Pietropaolo, M (corresponding author), Univ Michigan, Sch Med, Brehm Ctr Diabet Res, Immunogenet Lab,Dept Internal Med, 1000 Wall St, Ann Arbor, MI 48105 USA.	maxtp@umich.edu	Solimena, Michele/GVS-5990-2022; Solimena, Michele/E-1275-2011	Polychronakos, Constantin/0000-0002-7624-6635; Beems, Megan/0000-0002-2767-5994	National Institutes of Health (NIH) [R01 DK53456, R01 DK56200, R01 DK24021, R01 AI-44456, DK-53015, 54913]; NIH, NIDDK [PA-04-081]; Juvenile Diabetes Research Foundation [4-1999-945]; an American Diabetes Association Career Development Award; Juvenile Diabetes Research Foundation Career Development Award [296117]; German Center for Diabetes Research, the German Federal Ministry for Education and Research; Alexander Von Humboldt Foundation; Tissue Banks through National Institutes of Health, NICHD [NO1-HD-8-3284]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD083284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053456, R01DK024021, R01DK056200, P01DK053015, R01DK054913, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); an American Diabetes Association Career Development Award; Juvenile Diabetes Research Foundation Career Development Award(Juvenile Diabetes Research Foundation); German Center for Diabetes Research, the German Federal Ministry for Education and Research; Alexander Von Humboldt Foundation(Alexander von Humboldt Foundation); Tissue Banks through National Institutes of Health, NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants R01 DK53456 and R01 DK56200; NIH, NIDDK, Grant PA-04-081 (to M. P.); NIH Grant R01 DK24021 (to M. T.); NIH Grant R01 AI-44456 (to A. P.); and NIH Grants DK-53015 and 54913 (to M. S.). This work was also supported by Juvenile Diabetes Research Foundation Grant 4-1999-945 (to M. T.), an American Diabetes Association Career Development Award (to M. P.), and Juvenile Diabetes Research Foundation Career Development Award 296117 (to A. P.). This work was also partially supported by grants from the German Center for Diabetes Research, the German Federal Ministry for Education and Research, and the Alexander Von Humboldt Foundation (to M. S.).; We thank Dr. W. Dunnick for providing the M12 cells and Drs. R. Menon and T. Smith for helpful discussions. We also thank D. Stenger for critical reading of the manuscript. Tissues were provided by Drs. C. K. Petito and I. Logvisnki (Diabetes Research Institute Cell Transplant Center Team, University of Miami Brain and Fetal Tissue Bank; a joint effort with the University of Maryland Brain and Tissue Banks through National Institutes of Health, NICHD, Contract NO1-HD-8-3284).	Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; Anderson MS, 2011, CURR OPIN IMMUNOL, V23, P198, DOI 10.1016/j.coi.2010.11.007; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; BRUGGINK F, 2004, NAT METHODS, V1, P177; Budarf ML, 2011, GENES IMMUN, V12, P51, DOI 10.1038/gene.2010.47; Buffa L, 2008, EUR J CELL BIOL, V87, P197, DOI 10.1016/j.ejcb.2007.11.003; Chen W, 2001, J IMMUNOL, V167, P4926, DOI 10.4049/jimmunol.167.9.4926; DeVoss JJ, 2007, CURR OPIN GENET DEV, V17, P193, DOI 10.1016/j.gde.2007.04.001; Dogra RS, 2006, DIABETOLOGIA, V49, P953, DOI 10.1007/s00125-006-0185-8; Dosch HM, 1999, J IMMUNOL, V163, P6933; Durinovic-Bello I, 2005, DIABETES, V54, pS18, DOI 10.2337/diabetes.54.suppl_2.S18; Fan Y, 2009, EMBO J, V28, P2812, DOI 10.1038/emboj.2009.212; Fletcher AL, 2011, CRIT REV IMMUNOL, V31, P171, DOI 10.1615/CritRevImmunol.v31.i3.10; Friday RP, 2003, J BIOL CHEM, V278, P853, DOI 10.1074/jbc.M210175200; GAEDIGK R, 1994, CYTOGENET CELL GENET, V66, P274, DOI 10.1159/000133711; Gaedigk R, 1996, GENOMICS, V38, P382, DOI 10.1006/geno.1996.0641; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; GLIMCHER LH, 1982, NATURE, V298, P283, DOI 10.1038/298283a0; Hanahan D, 1998, CURR OPIN IMMUNOL, V10, P656, DOI 10.1016/S0952-7915(98)80085-X; Hannenhalli S, 2003, MAMM GENOME, V14, P611, DOI 10.1007/s00335-002-2260-x; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hubert FX, 2008, J IMMUNOL, V180, P3824, DOI 10.4049/jimmunol.180.6.3824; Igoillo-Esteve M, 2011, ENDOCRINOLOGY, V152, P447, DOI 10.1210/en.2010-0790; JOLICOEUR C, 1994, P NATL ACAD SCI USA, V91, P6707, DOI 10.1073/pnas.91.14.6707; Karges W, 1997, DIABETES, V46, P1548, DOI 10.2337/diabetes.46.10.1548; Karges W, 1996, DIABETES, V45, P513, DOI 10.2337/diabetes.45.4.513; Kumar PG, 2001, J BIOL CHEM, V276, P41357, DOI 10.1074/jbc.M104898200; Kyewski B, 2010, CELL, V140, P24, DOI 10.1016/j.cell.2009.12.036; MARTIN S, 1995, DIABETOLOGIA, V38, P351, DOI 10.1007/s001250050292; Mathews CE, 2003, ANN NY ACAD SCI, V1005, P412, DOI 10.1196/annals.1288.070; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Nitta T, 2008, ADV IMMUNOL, V99, P59, DOI 10.1016/S0065-2776(08)00603-2; O'Neill SK, 2009, CURR OPIN ENDOCRINOL, V16, P293, DOI 10.1097/MED.0b013e32832e06a7; Palumbo MO, 2006, DIABETES, V55, P2595, DOI 10.2337/db05-1651; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; PIETROPAOLO M, 1993, J CLIN INVEST, V92, P359, DOI 10.1172/JCI116574; Pilon M, 2000, MOL BIOL CELL, V11, P3277, DOI 10.1091/mbc.11.10.3277; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Pugliese A, 2001, J CLIN INVEST, V107, P555, DOI 10.1172/JCI10860; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Reifsnyder PC, 1999, MAMM GENOME, V10, P161, DOI 10.1007/s003359900962; Roep BO, 1996, EUR J IMMUNOL, V26, P1285, DOI 10.1002/eji.1830260616; Sabater L, 2005, J AUTOIMMUN, V25, P312, DOI 10.1016/j.jaut.2005.08.006; SCHMID I, 1991, CYTOMETRY, V12, P279, DOI 10.1002/cyto.990120312; Song AH, 2003, EUR J IMMUNOL, V33, P546, DOI 10.1002/immu.200310031; Spitzenberger F, 2003, J BIOL CHEM, V278, P26166, DOI 10.1074/jbc.M213222200; Sumakovic M, 2009, J CELL BIOL, V186, P897, DOI 10.1083/jcb.200902096; Vafiadis P, 1998, J CLIN ENDOCR METAB, V83, P2933, DOI 10.1210/jc.83.8.2933; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Vafiadis P, 2001, J CLIN ENDOCR METAB, V86, P3705, DOI 10.1210/jc.86.8.3705; Winer S, 2000, J IMMUNOL, V165, P4086, DOI 10.4049/jimmunol.165.7.4086; Xiu Y, 2008, J IMMUNOL, V180, P2863, DOI 10.4049/jimmunol.180.5.2863	55	10	10	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17882	17893		10.1074/jbc.M111.319020	http://dx.doi.org/10.1074/jbc.M111.319020			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22447927	hybrid, Green Published			2022-12-27	WOS:000306373000085
J	Alonso-del-Rivero, M; Trejo, SA; Reytor, ML; Rodriguez-de-la-Vega, M; Delfin, J; Diaz, J; Gonzalez-Gonzalez, Y; Canals, F; Chavez, MA; Aviles, FX				Alonso-del-Rivero, Maday; Trejo, Sebastian A.; Reytor, Mey L.; Rodriguez-de-la-Vega, Monica; Delfin, Julieta; Diaz, Joaquin; Gonzalez-Gonzalez, Yamile; Canals, Francesc; Angeles Chavez, Maria; Aviles, Francesc X.			Tri-domain Bifunctional Inhibitor of Metallocarboxypeptidases A and Serine Proteases Isolated from Marine Annelid Sabellastarte magnifica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC TRYPSIN-INHIBITOR; ENDOGENOUS PROTEIN INHIBITOR; AMINO-ACID-SEQUENCE; CARBOXYPEPTIDASE INHIBITOR; SEA-ANEMONE; 3-DIMENSIONAL STRUCTURE; ELASTASE INHIBITORS; CRYSTAL-STRUCTURE; ACTINIA-EQUINA; CDNA CLONING	This study describes a novel bifunctional metallocarboxypeptidase and serine protease inhibitor (SmCI) isolated from the tentacle crown of the annelid Sabellastarte magnifica. SmCI is a 165-residue glycoprotein with a molecular mass of 19.69 kDa (mass spectrometry) and 18 cysteine residues forming nine disulfide bonds. Its cDNA was cloned and sequenced by RT-PCR and nested PCR using degenerated oligonucleotides. Employing this information along with data derived from automatic Edman degradation of peptide fragments, the SmCI sequence was fully characterized, indicating the presence of three bovine pancreatic trypsin inhibitor/Kunitz domains and its high homology with other Kunitz serine protease inhibitors. Enzyme kinetics and structural analyses revealed SmCI to be an inhibitor of human and bovine pancreatic metallocarboxypeptidases of the A-type (but not B-type), with nanomolar K-i values. SmCI is also capable of inhibiting bovine pancreatic trypsin, chymotrypsin, and porcine pancreatic elastase in varying measures. When the inhibitor and its nonglycosylated form (SmCI N23A mutant) were overproduced recombinantly in a Pichia pastoris system, they displayed the dual inhibitory properties of the natural form. Similarly, two bi-domain forms of the inhibitor (recombinant rSmCI D1-D2 and rSmCI D2-D3) as well as its C-terminal domain (rSmCI-D3) were also overproduced. Of these fragments, only the rSmCI D1-D2 bi-domain retained inhibition of metallocarboxypeptidase A but only partially, indicating that the whole tri-domain structure is required for such capability in full. SmCI is the first proteinaceous inhibitor of metallocarboxypeptidases able to act as well on another mechanistic class of proteases (serine-type) and is the first of this kind identified in nature.	[Alonso-del-Rivero, Maday; Reytor, Mey L.; Delfin, Julieta; Diaz, Joaquin; Gonzalez-Gonzalez, Yamile; Angeles Chavez, Maria] Univ La Habana, Fac Biol, Ctr Estudio Prot, Havana 10400, Cuba; [Canals, Francesc] Hosp Valle De Hebron, Inst Recerca, E-08193 Barcelona, Spain; [Trejo, Sebastian A.; Rodriguez-de-la-Vega, Monica; Aviles, Francesc X.] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; [Trejo, Sebastian A.; Rodriguez-de-la-Vega, Monica; Aviles, Francesc X.] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain	Universidad de la Habana; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Autonomous University of Barcelona	Chavez, MA (corresponding author), Univ La Habana, Fac Biol, Ctr Estudio Prot, Havana 10400, Cuba.	mchavez@infomed.sld.cu; FrancescXavier.Aviles@uab.es	Rodriguez de la Vega Otazo, Monica Margarita/H-7008-2015; Avilés, Francesc Xavier/A-2664-2015; Aviles, Francesc Xavier/F-3482-2019	Rodriguez de la Vega Otazo, Monica Margarita/0000-0002-1061-3471; Avilés, Francesc Xavier/0000-0002-1399-6789; Aviles, Francesc Xavier/0000-0002-1399-6789; Alonso del Rivero Antigua, Maday/0000-0003-1988-6852; Reytor Gonzalez, Mey Ling/0000-0002-0903-8772; Trejo, Sebastian/0000-0003-2866-5613	International Science Foundation, Sweden [F3342-1, F3342-2, F3276-1]; Ministerio de Ciencia e Innovacion, Spain [BIO2010-22321]; Xarxa de Referencia de Biotecnologia (Generalitat de Catalunya); Ministerio de Educacion y Ciencia of Spain; Agency for the Management of Grants from University and Research of Catalonia (Generalitat de Catalunya)	International Science Foundation, Sweden; Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xarxa de Referencia de Biotecnologia (Generalitat de Catalunya); Ministerio de Educacion y Ciencia of Spain(Spanish Government); Agency for the Management of Grants from University and Research of Catalonia (Generalitat de Catalunya)	This work was supported in part by Grants F3342-1, F3342-2, and F3276-1 from the International Science Foundation, Sweden, Grant BIO2010-22321 from Ministerio de Ciencia e Innovacion, Spain, and by Xarxa de Referencia de Biotecnologia (Generalitat de Catalunya).; Recipient of a visiting fellowship from Ministerio de Educacion y Ciencia of Spain.; Recipient of a visitor grant from Agency for the Management of Grants from University and Research of Catalonia (Generalitat de Catalunya). To whom correspondence may be addressed. Tel.: 53-7832-4830; E-mail: mchavez@infomed.sld.cu.	Alonso del Rivero M., 2003, REV BIOL, V17, P80; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arolas JL, 2005, J MOL BIOL, V350, P489, DOI 10.1016/j.jmb.2005.05.015; Arolas JL, 2005, J BIOL CHEM, V280, P3441, DOI 10.1074/jbc.M411086200; Arolas JL, 2004, BIOCHEMISTRY-US, V43, P7973, DOI 10.1021/bi049596j; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Azzolini SS, 2003, ARCH BIOCHEM BIOPHYS, V417, P176, DOI 10.1016/S0003-9861(03)00344-8; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P561; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; BERGER A, 1970, PHILOS T R SOC B, V257, P249, DOI 10.1098/rstb.1970.0024; Bergmeyer H. U., 1974, METHOD ENZYMAT AN, V1, P436; BIETH JG, 1995, METHOD ENZYMOL, V248, P59; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Chand HS, 2004, J BIOL CHEM, V279, P17500, DOI 10.1074/jbc.M400802200; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Chavez M., 1998, Toxicon, V36, P1275; Czapinska H, 2000, J MOL BIOL, V295, P1237, DOI 10.1006/jmbi.1999.3445; Delfin J, 1994, Arch Med Res, V25, P199; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; Franco OL, 2002, PROTEINS, V49, P335, DOI 10.1002/prot.10228; FRITZ H, 1983, ARZNEIMITTELFORSCH, V33-1, P479; FRITZ H, 1972, H-S Z PHYSIOL CHEM, V353, P19, DOI 10.1515/bchm2.1972.353.1.19; Gong HY, 2007, J INSECT PHYSIOL, V53, P1079, DOI 10.1016/j.jinsphys.2007.06.008; Gonzalez Y, 2004, TOXICON, V43, P219, DOI 10.1016/j.toxicon.2003.11.016; Gonzalez Y, 2007, BIOL CHEM, V388, P1183, DOI 10.1515/BC.2007.129; Gonzalez Y, 2007, COMP BIOCHEM PHYS A, V146, P506, DOI 10.1016/j.cbpa.2006.01.022; Grzesiak A, 2000, J MOL BIOL, V301, P205, DOI 10.1006/jmbi.2000.3935; GUASCH A, 1992, J MOL BIOL, V224, P141, DOI 10.1016/0022-2836(92)90581-4; HASS GM, 1981, BIOCHEMISTRY-US, V20, P2256, DOI 10.1021/bi00511a029; Hiraga K, 2000, J BIOL CHEM, V275, P25173, DOI 10.1074/jbc.M002623200; HOCHSTRASSER K, 1983, H-S Z PHYSIOL CHEM, V364, P1689, DOI 10.1515/bchm2.1983.364.2.1689; HOMANDBERG GA, 1989, ARCH BIOCHEM BIOPHYS, V270, P153, DOI 10.1016/0003-9861(89)90017-9; Huerta V., 1988, BIOTECNOLOGIA APLICA, V15, P108; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Kajan L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-304; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; KOLKENBROCK H, 1987, BIOL CHEM H-S, V368, P93, DOI 10.1515/bchm3.1987.368.1.93; Krowarsch D, 1999, J MOL BIOL, V289, P175, DOI 10.1006/jmbi.1999.2757; Kurioka A, 1999, EUR J BIOCHEM, V259, P120, DOI 10.1046/j.1432-1327.1999.00030.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laskowski Jr. M., 2000, PROTEIN PROTEIN RECO, P228; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Lenarcic B, 1997, J BIOL CHEM, V272, P13899; Liu Q, 2000, MOL BIOL REP, V27, P241, DOI 10.1023/A:1010971219806; Marlor CW, 1997, J BIOL CHEM, V272, P12202, DOI 10.1074/jbc.272.18.12202; MARTIN P, 1980, BIOCHIM BIOPHYS ACTA, V612, P410, DOI 10.1016/0005-2744(80)90124-2; Mateo C, 2007, BIOCHEM SOC T, V35, P1593, DOI 10.1042/BST0351593; McBride JD, 1999, EUR J BIOCHEM, V266, P403, DOI 10.1046/j.1432-1327.1999.00867.x; MEBS D, 1980, TOXICON, V18, P97, DOI 10.1016/0041-0101(80)90035-5; Milstone AM, 2000, J BIOL CHEM, V275, P29391, DOI 10.1074/jbc.M002715200; Minagawa S, 1997, COMP BIOCHEM PHYS B, V118, P381, DOI 10.1016/S0305-0491(97)00174-0; Mitteilung Z, 1976, J Clin Chem Clin Biochem, V14, P245; Mock WL, 1996, ANAL BIOCHEM, V239, P218, DOI 10.1006/abio.1996.0318; Mock WL, 1999, BIOORG MED CHEM LETT, V9, P187, DOI 10.1016/S0960-894X(98)00715-X; Nagle GT, 2001, EUR J BIOCHEM, V268, P1213, DOI 10.1046/j.1432-1327.2001.01972.x; NAKAJIMA K, 1979, J BIOL CHEM, V254, P4027; Normant E, 1995, P NATL ACAD SCI USA, V92, P12225, DOI 10.1073/pnas.92.26.12225; Otlewski J, 1999, ACTA BIOCHIM POL, V46, P531, DOI 10.18388/abp.1999_4128; Pallares I, 2005, P NATL ACAD SCI USA, V102, P3978, DOI 10.1073/pnas.0500678102; Pascual I, 2004, INT J BIOCHEM CELL B, V36, P138, DOI 10.1016/S1357-2725(03)00175-4; REES DC, 1980, P NATL ACAD SCI-BIOL, V77, P4633, DOI 10.1073/pnas.77.8.4633; Reverter D, 1998, J BIOL CHEM, V273, P32927, DOI 10.1074/jbc.273.49.32927; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sanglas L, 2009, P NATL ACAD SCI USA, V106, P1743, DOI 10.1073/pnas.0812623106; Shia S, 2005, J MOL BIOL, V346, P1335, DOI 10.1016/j.jmb.2004.12.048; Strukelj B, 2000, BIOCHEM BIOPH RES CO, V269, P732, DOI 10.1006/bbrc.2000.2356; Tanaka AS, 1999, IMMUNOPHARMACOLOGY, V45, P171, DOI 10.1016/S0162-3109(99)00074-0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TSCHESCHE H, 1987, BIOL CHEM H-S, V368, P1297, DOI 10.1515/bchm3.1987.368.2.1297; Vallee F, 1998, STRUCTURE, V6, P649, DOI 10.1016/S0969-2126(98)00066-5; Vendrell J., 2006, HDB METALLOPROTEINS, V3, P176; Ventura S, 1999, J BIOL CHEM, V274, P19925, DOI 10.1074/jbc.274.28.19925; Villanueva J, 1998, FEBS LETT, V440, P175, DOI 10.1016/S0014-5793(98)01447-1; Williams J W, 1979, Methods Enzymol, V63, P437; Xu YB, 1998, J MOL BIOL, V276, P955, DOI 10.1006/jmbi.1997.1582; ZEMKE KJ, 1991, FEBS LETT, V279, P240, DOI 10.1016/0014-5793(91)80158-Y; ZYKOVA TA, 1985, BIOORG KHIM+, V11, P293; Zykova TA, 1998, BIOORG KHIM+, V24, P509	79	20	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15427	15438		10.1074/jbc.M111.337261	http://dx.doi.org/10.1074/jbc.M111.337261			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22411994	Green Published, hybrid			2022-12-27	WOS:000304006300024
J	Coic, YM; Baleux, F; Poyraz, O; Thibeaux, R; Labruyere, E; Chretien, F; Sobhani, I; Lazure, T; Wyplosz, B; Schneider, G; Mulard, L; Sansonetti, PJ; Marteyn, BS				Coic, Yves-Marie; Baleux, Francoise; Poyraz, Oemer; Thibeaux, Roman; Labruyere, Elisabeth; Chretien, Fabrice; Sobhani, Iradj; Lazure, Thierry; Wyplosz, Benjamin; Schneider, Gunter; Mulard, Laurence; Sansonetti, Philippe J.; Marteyn, Benoit S.			Design of a Specific Colonic Mucus Marker Using a Human Commensal Bacterium Cell Surface Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; GASTROINTESTINAL-TRACT; INTESTINAL MUCUS; IN-VIVO; EXPRESSION; MUCIN; MUC5AC; CARCINOMAS; THICKNESS; VIRULENCE	Imaging living cells and organs requires innovative, specific, efficient, and well tolerated fluorescent markers targeting cellular components. Such tools will allow proceeding to the dynamic analysis of cells and the adaptation of tissues to environmental cues. In this study, we have identified and synthesized a novel non-toxic fluorescent marker allowing a specific fluorescent staining of the human colonic mucus. Our strategy to identify a molecule able to specifically bind to the human colonic mucus was on the basis of the mucus adhesion properties of commensal bacteria. We identified and characterized the mucus-binding property of a 70-amino acid domain (MUB70) expressed on the surface of Lactobacillus strains. The chemical synthesis of MUB70 was achieved using the human commensal bacterium Lactobacillus reuteri AF120104 protein as a template. The synthesized Cy5-conjugated MUB70 marker specifically stained the colonic mucus on fixed human, rabbit, and guinea pig tissues. Interestingly, murine tissue was not stained, suggesting significant differences in the composition of the murine colonic mucus. In addition, this marker stained the mucus of living cultured human colonic cells (HT29-MTX) and human colonic tissue explants. Using a biotinylated derivative of MUB70, we demonstrated that this peptide binds specifically to Muc2, the most abundant secreted mucin, through its glycosylated moieties. Hence, Cy5-MUB70 is a novel and specific fluorescent marker for mammalian colonic mucus. It may be used for live imaging analysis but also, as demonstrated in this study, as a marker for the diagnosis and the prognosis of colonic mucinous carcinomas.	[Marteyn, Benoit S.] Inst Pasteur, Unite Pathogenie Microbienne Mol, INSERM, U786, F-75724 Paris 15, France; [Coic, Yves-Marie; Baleux, Francoise; Mulard, Laurence] Inst Pasteur, Unite Chim Biomol, INSERM, F-75724 Paris 15, France; [Thibeaux, Roman; Labruyere, Elisabeth] Inst Pasteur, Unite Biol Cellulaire Parasitisme, INSERM, F-75724 Paris 15, France; [Chretien, Fabrice] Inst Pasteur, Unite Histol Humaine & Modeles Anim, INSERM, F-75724 Paris 15, France; [Coic, Yves-Marie; Mulard, Laurence] Inst Pasteur, Dept Biotechnol, CNRS, URA 2128, F-75724 Paris 15, France; [Poyraz, Oemer; Schneider, Gunter] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Sobhani, Iradj] Hop Henri Mondor, AP HP, Serv Hepathol & Gastroenterol, F-94000 Creteil, France; [Thibeaux, Roman; Chretien, Fabrice; Lazure, Thierry; Wyplosz, Benjamin] Hop Bicetre, AP HP, F-94275 Le Kremlin Bicetre, France; [Sansonetti, Philippe J.] Coll France, F-75231 Paris 05, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Karolinska Institutet; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; College de France	Marteyn, BS (corresponding author), Inst Pasteur, Unite Pathogenie Microbienne Mol, INSERM, U786, 28 Rue Dr Roux, F-75724 Paris 15, France.	marteyn@pasteur.fr	SOBHANI, Iradj/A-3973-2013; Chretien, fabrice B/D-4035-2018; Marteyn, Benoit S/M-3763-2017; Thibeaux, Roman/AAW-7667-2020	Chretien, fabrice B/0000-0002-2794-1383; Thibeaux, Roman/0000-0002-4872-0088; Schneider, Gunter/0000-0003-0622-5713; Marteyn, Benoit/0000-0001-5638-702X; Wyplosz, Benjamin/0000-0002-9779-9044	European Research Council [232798, 222720]; Ministere de l'Enseignement Superieur et de la Recherche	European Research Council(European Research Council (ERC)European Commission); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	This work was supported by FP7 European Research Council "HOMEOEPITH" Grant 232798 and FP7 Tornado Grant 222720 (to B. M.). This work was also supported by a PhD fellowship from the Ministere de l'Enseignement Superieur et de la Recherche (to R. T.).	Allen A, 1998, INT J BIOCHEM CELL B, V30, P797, DOI 10.1016/S1357-2725(98)00028-4; Bansal D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000551; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Boekhorst J, 2006, MICROBIOL-SGM, V152, P273, DOI 10.1099/mic.0.28415-0; Cardona V, 2008, INT J PEPT RES THER, V14, P285, DOI 10.1007/s10989-008-9154-z; Chan WC, 2000, FMOC SOLID PHASE PEP; Faure M, 2004, DIGEST DIS SCI, V49, P339, DOI 10.1023/B:DDAS.0000017462.75257.70; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johnson T, 1995, J Pept Sci, V1, P11, DOI 10.1002/psc.310010104; Karlsson NG, 1996, GLYCOCONJUGATE J, V13, P823, DOI 10.1007/BF00702346; Khattab AZM, 2011, MED ONCOL, V28, pS207, DOI 10.1007/s12032-010-9699-5; Lau SK, 2004, AM J CLIN PATHOL, V122, P61, DOI 10.1309/9R6673QEC06D86Y4; Lauer Janelle L., 1995, Letters in Peptide Science, V1, P197, DOI 10.1007/BF00117955; LESUFFLEUR T, 1994, CRIT REV ONCOL HEMAT, V17, P153, DOI 10.1016/1040-8428(94)90053-1; LESUFFLEUR T, 1990, CANCER RES, V50, P6334; MacKenzie DA, 2009, J BIOL CHEM, V284, P32444, DOI 10.1074/jbc.M109.040907; Marteyn B, 2011, CELL MICROBIOL, V13, P171, DOI 10.1111/j.1462-5822.2010.01549.x; Marteyn B, 2010, NATURE, V465, P355, DOI 10.1038/nature08970; Mergler M, 2003, J PEPT SCI, V9, P36, DOI 10.1002/psc.430; Mesquita P, 2004, AM J SURG PATHOL, V28, P1254, DOI 10.1097/01.pas.0000135517.50095.7f; Mukhopadhyay P, 2011, BBA-REV CANCER, V1815, P224, DOI 10.1016/j.bbcan.2011.01.001; MUTTER M, 1995, PEPTIDE RES, V8, P145; Ouwehand AC, 2001, INT J FOOD MICROBIOL, V64, P119, DOI 10.1016/S0168-1605(00)00440-2; PACKMAN LC, 1994, PEPTIDE RES, V7, P125; Park SY, 2009, ONCOL REP, V22, P649, DOI 10.3892/or_00000485; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; Robbe C, 2003, J BIOL CHEM, V278, P46337, DOI 10.1074/jbc.M302529200; Roos S, 2002, MICROBIOL-SGM, V148, P433, DOI 10.1099/00221287-148-2-433; RUBINSTEIN A, 1994, PHARM RES-DORDR, V11, P794, DOI 10.1023/A:1018961204325; Schultsz C, 1999, GASTROENTEROLOGY, V117, P1089, DOI 10.1016/S0016-5085(99)70393-8; Shaoul R, 2004, J PEDIATR GASTR NUTR, V38, P488, DOI 10.1097/00005176-200405000-00006; Strugala V, 2008, INT J CLIN PRACT, V62, P762, DOI 10.1111/j.1742-1241.2007.01665.x; Travo A, 2010, HISTOPATHOLOGY, V56, P921, DOI 10.1111/j.1365-2559.2010.03563.x; TYTGAT KMAJ, 1994, GASTROENTEROLOGY, V107, P1352, DOI 10.1016/0016-5085(94)90537-1; Van Klinken BJW, 1999, AM J PHYSIOL-GASTR L, V276, pG115, DOI 10.1152/ajpgi.1999.276.1.G115; Wong WM, 1999, GUT, V44, P890, DOI 10.1136/gut.44.6.890; Zhang SL, 1998, CLIN CANCER RES, V4, P295	37	16	19	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15916	15922		10.1074/jbc.M111.310003	http://dx.doi.org/10.1074/jbc.M111.310003			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427651	Green Published, hybrid			2022-12-27	WOS:000304006300070
J	Ma, LS; Narberhaus, F; Lai, EM				Ma, Lay-Sun; Narberhaus, Franz; Lai, Erh-Min			IcmF Family Protein TssM Exhibits ATPase Activity and Energizes Type VI Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROAGGREGATIVE ESCHERICHIA-COLI; GRAM-NEGATIVE BACTERIA; II SECRETION; AGROBACTERIUM-TUMEFACIENS; AEROMONAS-HYDROPHILA; PSEUDOMONAS-AERUGINOSA; CONFORMATIONAL-CHANGES; MEMBRANE-PROTEIN; EXEAB COMPLEX; IV SECRETION	The type VI secretion system (T6SS) with diversified functions is widely distributed in pathogenic Proteobacteria. The IcmF (intracellular multiplication protein F) family protein TssM is a conserved T6SS inner membrane protein. Despite the conservation of its Walker A nucleotide-binding motif, the NTPase activity of TssM and its role in T6SS remain obscure. In this study, we characterized TssM in the plant pathogen Agrobacterium tumefaciens and provided the first biochemical evidence for TssM exhibiting ATPase activity to power the secretion of the T6SS hallmark protein, hemolysin-coregulated protein (Hcp). Amino acid substitutions in the Walker A motif of TssM caused reduced ATP binding and hydrolysis activity. Importantly, we discovered the Walker B motif of TssM and demonstrated that it is critical for ATP hydrolysis activity. Protein-protein interaction studies and protease susceptibility assays indicated that TssM undergoes an ATP binding-induced conformational change and that subsequent ATP hydrolysis is crucial for recruiting Hcp to interact with the periplasmic domain of the TssM-interacting protein TssL (an IcmH/DotU family protein) into a ternary complex and mediating Hcp secretion. Our findings strongly argue that TssM functions as a T6SS energizer to recruit Hcp into the TssM-TssL inner membrane complex prior to Hcp secretion across the outer membrane.	[Ma, Lay-Sun; Lai, Erh-Min] Acad Sinica, Inst Plant & Microbial Biol, Taipei 11529, Taiwan; [Ma, Lay-Sun; Lai, Erh-Min] Acad Sinica, Mol & Biol Agr Sci Program, Taiwan Int Grad Program, Taipei 11529, Taiwan; [Ma, Lay-Sun; Lai, Erh-Min] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 402, Taiwan; [Narberhaus, Franz] Ruhr Univ Bochum, Lehrstuhl Biol Mikroorganismen, D-44780 Bochum, Germany	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Chung Hsing University; Ruhr University Bochum	Lai, EM (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, 128,Sec 2,Acad Rd, Taipei 11529, Taiwan.	emlai@gate.sinica.edu.tw	Ma, Lay-Sun/ABH-3013-2020; Lai, Erh-Min/ABG-9558-2020	Ma, Lay-Sun/0000-0003-4349-228X; Lai, Erh-Min/0000-0003-3630-8683; Narberhaus, Franz/0000-0002-8552-5310	National Science Council [NSC 98-2311-B-001-002-MY3]; German Academic Exchange Service (DAAD); Taiwan National Science Council (PPP) [0970029248P]	National Science Council(Ministry of Science and Technology, Taiwan); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Taiwan National Science Council (PPP)	This work was supported by National Science Council Grant NSC 98-2311-B-001-002-MY3 and a joint grant from the German Academic Exchange Service (DAAD) and the Taiwan National Science Council (PPP Grant 0970029248P) (to F. N. and E.-M. L.).	Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Aksyuk AA, 2009, EMBO J, V28, P821, DOI 10.1038/emboj.2009.36; Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x; Ast VM, 2002, MOL MICROBIOL, V44, P217, DOI 10.1046/j.1365-2958.2002.02870.x; Atmakuri K, 2004, MOL MICROBIOL, V54, P1199, DOI 10.1111/j.1365-2958.2004.04345.x; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Bernard CS, 2010, J BACTERIOL, V192, P3850, DOI 10.1128/JB.00370-10; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Brown ED, 2005, BIOCHEM CELL BIOL, V83, P738, DOI 10.1139/O05-162; Bruser T, 2007, APPL MICROBIOL BIOT, V76, P35, DOI 10.1007/s00253-007-0991-z; Camberg JL, 2005, J BACTERIOL, V187, P249, DOI 10.1128/JB.187.1.249-256.2005; Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; CHANG BY, 1994, J BACTERIOL, V176, P3102, DOI 10.1128/jb.176.11.3102-3110.1994; Cho YK, 2001, J BIOL CHEM, V276, P12573, DOI 10.1074/jbc.M011478200; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; de Bruin OM, 2011, MICROBIOL-SGM, V157, P3483, DOI 10.1099/mic.0.052308-0; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; HENKEL RD, 1988, ANAL BIOCHEM, V169, P312, DOI 10.1016/0003-2697(88)90290-4; Heyduk T, 2002, CURR OPIN BIOTECH, V13, P292, DOI 10.1016/S0958-1669(02)00332-4; Hormaeche I, 2002, J BIOL CHEM, V277, P46456, DOI 10.1074/jbc.M207250200; Howard SP, 2006, MOL MICROBIOL, V59, P1062, DOI 10.1111/j.1365-2958.2005.05003.x; Howard SP, 1996, MOL MICROBIOL, V22, P595, DOI 10.1046/j.1365-2958.1996.d01-1713.x; Jani AJ, 2010, CELL HOST MICROBE, V8, P2, DOI 10.1016/j.chom.2010.06.012; Jobichen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012910; Juhas M, 2008, CELL MICROBIOL, V10, P2377, DOI 10.1111/j.1462-5822.2008.01187.x; KORONAKIS E, 1995, MOL MICROBIOL, V16, P87, DOI 10.1111/j.1365-2958.1995.tb02394.x; Krehenbrink M, 2011, MOL MICROBIOL, V82, P164, DOI 10.1111/j.1365-2958.2011.07803.x; Lai EM, 1998, J BACTERIOL, V180, P2711, DOI 10.1128/JB.180.10.2711-2717.1998; Larsen RA, 1999, MOL MICROBIOL, V31, P1809, DOI 10.1046/j.1365-2958.1999.01317.x; Leiman PG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-355; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Leung KY, 2011, CURR OPIN MICROBIOL, V14, P9, DOI 10.1016/j.mib.2010.09.017; Li G, 2011, J BACTERIOL, V193, P197, DOI 10.1128/JB.00882-10; Liu AC, 2008, J APPL MICROBIOL, V105, P1372, DOI 10.1111/j.1365-2672.2008.03874.x; Lossi NS, 2011, MICROBIOL-SGM, V157, P3292, DOI 10.1099/mic.0.051987-0; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; Miyata ST, 2011, INFECT IMMUN, V79, P2941, DOI 10.1128/IAI.01266-10; Motojima F, 2003, J BIOL CHEM, V278, P26648, DOI 10.1074/jbc.M300806200; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Pietrosiuk A, 2011, J BIOL CHEM, V286, P30010, DOI 10.1074/jbc.M111.253377; Possot OM, 1997, MOL MICROBIOL, V24, P457, DOI 10.1046/j.1365-2958.1997.3451726.x; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Ratelade J, 2009, APPL ENVIRON MICROB, V75, P3803, DOI 10.1128/AEM.00255-09; Records AR, 2011, MOL PLANT MICROBE IN, V24, P751, DOI 10.1094/MPMI-11-10-0262; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P5563, DOI 10.1128/JB.181.18.5563-5571.1999; SCHNEIDER E, 1994, J BIOL CHEM, V269, P20456; Schoenhofen IC, 2005, J BACTERIOL, V187, P6370, DOI 10.1128/JB.187.18.6370-6378.2005; Schoenhofen IC, 1998, MOL MICROBIOL, V29, P1237, DOI 10.1046/j.1365-2958.1998.01011.x; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; SHINKAI A, 1991, J BIOL CHEM, V266, P5827; Shiue SJ, 2006, EMBO J, V25, P1426, DOI 10.1038/sj.emboj.7601036; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; van der Wolk JPW, 1997, EMBO J, V16, P7297, DOI 10.1093/emboj/16.24.7297; Vergunst AC, 2000, SCIENCE, V290, P979, DOI 10.1126/science.290.5493.979; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wu HY, 2008, J BACTERIOL, V190, P2841, DOI 10.1128/JB.01775-07; Yao HB, 2006, ARCH BIOCHEM BIOPHYS, V451, P175, DOI 10.1016/j.abb.2006.04.011; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x	76	58	58	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15610	15621		10.1074/jbc.M111.301630	http://dx.doi.org/10.1074/jbc.M111.301630			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22393043	Green Published, hybrid			2022-12-27	WOS:000304006300041
J	Martinez, FP; Tang, QY				Martinez, Francisco Puerta; Tang, Qiyi			Leucine Zipper Domain Is Required for Kaposi Sarcoma-associated Herpesvirus (KSHV) K-bZIP Protein to Interact with Histone Deacetylase and Is Important for KSHV Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; PRIMARY EFFUSION LYMPHOMA; MULTICENTRIC CASTLEMANS-DISEASE; CREB-BINDING PROTEIN; CELL-CYCLE ARREST; GENE-EXPRESSION; HUMAN CYTOMEGALOVIRUS; DNA-REPLICATION; LYTIC REPLICATION; SPINDLE CELLS	The Kaposi sarcoma-associated herpesvirus (KSHV; or human herpesvirus-8)-encoded protein called K-bZIP (also named K8) was found to be multifunctional. In this study, we discovered that K-bZIP interacts with histone deacetylase (HDAC) 1/2 in 12-O-tetradecanoylphorbol-13-acetate-stimulated BCBL-1 lymphocyte cells. K-bZIP appears to repress HDAC activity through this interaction, which we determined to be independent of K-bZIP SUMOylation. We dissected the domains of K-bZIP and found that the leucine zipper (LZ) domain is essential for the interaction of K-bZIP and HDAC. In addition, we constructed a KSHV bacterial artificial chromosome (BAC) with LZ domain-deleted K-bZIP (KSHVdLZ) and transfected this mutated KSHV BAC DNA into HEK 293T cells. As a result, it was consistently found that K-bZIP without its LZ domain failed to interact with HDAC2. We also showed that the interaction between K-bZIP and HDAC is necessary for the inhibition of the lytic gene promoters (ORF50 and OriLyt) of KSHV by K-bZIP. Furthermore, we found that the LZ domain is also important for the interaction of K-bZIP with the promoters of ORF50 and OriLyt. Most interestingly, although it was found to have suppressive effects on the promoters of ORF50 and OriLyt, KSHVdLZ replicates at a significantly lower level than its BAC-derived revertant (KSHVdLZRev) or KSHVWT (BAC36) in HEK 293T cells. The defectiveness of KSHVdLZ replication can be partially rescued by siRNA against HDAC2. Our results suggest that the function of K-bZIP interaction with HDAC is two-layered. 1) K-bZIP inhibits HDAC activity generally so that KSHVdLZ replicates at a lower level than does KSHVWT. 2) K-bZIP can recruit HDAC to the promoters of OriLyt and ORF50 through interaction with HDAC for K-bZIP to have a temporary repressive effect on the two promoters.	[Martinez, Francisco Puerta; Tang, Qiyi] Ponce Sch Med, Res Ctr Minor Inst RCMI Program, Ponce, PR 00716 USA		Tang, QY (corresponding author), Ponce Sch Med, Res Ctr Minor Inst RCMI Program, Ponce, PR 00716 USA.	qtang@psm.edu			National Institutes of Health [U54RR022762]; National Center for Research Resources; RCMI Program Pilot [2G12RR003050-24]; American Cancer Society [RSG-090289-01-MPC]; American Cancer Society Institutional Research [IRG-92-032-13, Subaward 60-14599-01-01-S6]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003050, U54RR022762] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); RCMI Program Pilot; American Cancer Society(American Cancer Society); American Cancer Society Institutional Research(American Cancer Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grant U54RR022762 from the National Center for Research Resources (to Q. T.). This work was also supported by RCMI Program Pilot Grant 2G12RR003050-24 (to Q. T.), American Cancer Society Grant RSG-090289-01-MPC (to Q. T), and American Cancer Society Institutional Research Grant IRG-92-032-13, Subaward 60-14599-01-01-S6 (to Q. T.).	Al Mehairi S, 2005, J VIROL, V79, P7905, DOI 10.1128/JVI.79.12.7905-7910.2005; AMBROZIAK JA, 1995, SCIENCE, V268, P582, DOI 10.1126/science.7725108; Biberfeld P, 1998, CURR OPIN INFECT DIS, V11, P97, DOI 10.1097/00001432-199804000-00002; Blasig C, 1997, J VIROL, V71, P7963, DOI 10.1128/JVI.71.10.7963-7968.1997; BOSHOFF C, 1995, NAT MED, V1, P1274, DOI 10.1038/nm1295-1274; Boshoff C, 2001, ANNU REV MED, V52, P453, DOI 10.1146/annurev.med.52.1.453; Byun H, 2002, MOL CELLS, V14, P185; Carroll KD, 2006, J VIROL, V80, P9697, DOI 10.1128/JVI.00746-06; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Chang PC, 2010, J BIOL CHEM, V285, P5266, DOI 10.1074/jbc.M109.088088; Chang PJ, 2011, VIROLOGY, V413, P194, DOI 10.1016/j.virol.2011.02.013; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Diamond C, 1998, J VIROL, V72, P6223, DOI 10.1128/JVI.72.7.6223-6227.1998; Dupin N, 1999, P NATL ACAD SCI USA, V96, P4546, DOI 10.1073/pnas.96.8.4546; Ellison TJ, 2009, VIROLOGY, V387, P76, DOI 10.1016/j.virol.2009.02.016; Ferenczy MW, 2009, J VIROL, V83, P8514, DOI 10.1128/JVI.00785-09; Gradoville L, 2000, J VIROL, V74, P6207, DOI 10.1128/JVI.74.13.6207-6212.2000; Gruffat H, 1999, J GEN VIROL, V80, P557, DOI 10.1099/0022-1317-80-3-557; Huang LM, 2001, J BIOL CHEM, V276, P13427, DOI 10.1074/jbc.M011314200; Hwang S, 2003, J GEN VIROL, V84, P665, DOI 10.1099/vir.0.18699-0; Hwang S, 2001, J VIROL, V75, P9509, DOI 10.1128/JVI.75.19.9509-9516.2001; Izumiya Y, 2005, J VIROL, V79, P9912, DOI 10.1128/JVI.79.15.9912-9925.2005; Izumiya Y, 2003, J VIROL, V77, P9652, DOI 10.1128/JVI.77.17.9652-9661.2003; Izumiya Y, 2003, J VIROL, V77, P1441, DOI 10.1128/JVI.77.2.1441-1451.2003; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kalejta RF, 2008, CURR TOP MICROBIOL, V325, P101; Katano H, 2001, VIROLOGY, V286, P446, DOI 10.1006/viro.2001.1005; Kato-Noah T, 2007, J VIROL, V81, P13519, DOI 10.1128/JVI.00832-07; Lefort S, 2007, J VIROL, V81, P10950, DOI 10.1128/JVI.00183-07; Lefort S, 2009, J VIROL, V83, P5869, DOI 10.1128/JVI.01821-08; Liao W, 2003, J VIROL, V77, P3809, DOI 10.1128/JVI.77.6.3809-3815.2003; Lin Cui Li, 2003, Journal of Virology, V77, P5578, DOI 10.1128/JVI.77.10.5578-5588.2003; Lin SF, 1999, J VIROL, V73, P1909, DOI 10.1128/JVI.73.3.1909-1917.1999; Lindsay CR, 2008, FRONT BIOSCI-LANDMRK, V13, P7132, DOI 10.2741/3216; Lu F, 2006, J VIROL, V80, P5273, DOI 10.1128/JVI.02541-05; Maul GG, 2008, CURR TOP MICROBIOL, V325, P117; Michaelis M, 2005, INVEST OPHTH VIS SCI, V46, P3451, DOI 10.1167/iovs.05-0369; Miller G, 1997, J VIROL, V71, P314, DOI 10.1128/JVI.71.1.314-324.1997; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Nevels M, 2004, P NATL ACAD SCI USA, V101, P17234, DOI 10.1073/pnas.0407933101; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Park J, 2000, J VIROL, V74, P11977, DOI 10.1128/JVI.74.24.11977-11982.2000; Park JJ, 2007, J GEN VIROL, V88, P3214, DOI 10.1099/vir.0.83171-0; Portes-Sentis S, 2001, J GEN VIROL, V82, P507, DOI 10.1099/0022-1317-82-3-507; Reinke AW, 2010, BIOCHEMISTRY-US, V49, P1985, DOI 10.1021/bi902065k; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Seaman WT, 1999, VIROLOGY, V263, P436, DOI 10.1006/viro.1999.9963; Seaman WT, 2003, VIROLOGY, V310, P72, DOI 10.1016/S0042-6822(03)00095-3; Sinclair AJ, 2003, J GEN VIROL, V84, P1941, DOI 10.1099/vir.0.19112-0; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Staskus KA, 1997, J VIROL, V71, P715, DOI 10.1128/JVI.71.1.715-719.1997; Sturzl M, 1997, INT J CANCER, V72, P68, DOI 10.1002/(SICI)1097-0215(19970703)72:1&lt;68::AID-IJC10&gt;3.0.CO;2-6; Tang QY, 2006, J VIROL, V80, P7510, DOI 10.1128/JVI.00684-06; Tang QY, 2000, J VIROL, V74, P9694, DOI 10.1128/JVI.74.20.9694-9700.2000; Tang QY, 2003, J VIROL, V77, P1357, DOI 10.1128/JVI.77.2.1357-1367.2003; Tang S, 2002, J BIOL CHEM, V277, P14547, DOI 10.1074/jbc.M111308200; Tomita M, 2004, ONCOGENE, V23, P8272, DOI 10.1038/sj.onc.1208059; Viejo-Borbolla Abel, 2003, AIDS Rev, V5, P222; Wang SZE, 2004, J VIROL, V78, P4248, DOI 10.1128/JVI.78.8.4248-4267.2004; Wang Y, 2004, VIROLOGY, V325, P149, DOI 10.1016/j.virol.2004.04.030; Wang Y, 2008, J VIROL, V82, P2867, DOI 10.1128/JVI.01319-07; Wang Y, 2011, J VIROL, V85, P1943, DOI 10.1128/JVI.02060-10; Warden C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/124595; Wu FY, 2003, J VIROL, V77, P8893, DOI 10.1128/JVI.77.16.8893-8914.2003; Wu FY, 2002, P NATL ACAD SCI USA, V99, P10683, DOI 10.1073/pnas.162352299; Wu FY, 2001, J VIROL, V75, P1487, DOI 10.1128/JVI.75.3.1487-1506.2001; Yamanegi K, 2005, J VIROL, V79, P14207, DOI 10.1128/JVI.79.22.14207-14221.2005; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Ye JJ, 2007, J VIROL, V81, P9279, DOI 10.1128/JVI.00982-07; Zhou FC, 2002, J VIROL, V76, P6185, DOI 10.1128/JVI.76.12.6185-6196.2002	70	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15622	15634		10.1074/jbc.M111.315861	http://dx.doi.org/10.1074/jbc.M111.315861			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22416134	Green Published, hybrid			2022-12-27	WOS:000304006300042
J	Osborne, SE; Tuinema, BR; Mok, MCY; Lau, PS; Bui, NK; Tomljenovic-Berube, AM; Vollmer, W; Zhang, K; Junop, M; Coombes, BK				Osborne, Suzanne E.; Tuinema, Brian R.; Mok, Mac C. Y.; Lau, Pui Sai; Bui, Nhat Khai; Tomljenovic-Berube, Ana M.; Vollmer, Waldemar; Zhang, Kun; Junop, Murray; Coombes, Brian K.			Characterization of DalS, an ATP-binding Cassette Transporter for D-Alanine, and Its Role in Pathogenesis in Salmonella enterica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGENICITY ISLAND-2; PEPTIDOGLYCAN STRUCTURE; SECRETION SYSTEM; VIRULENCE GENES; EXPRESSION; PROTEIN; IDENTIFICATION; TYPHIMURIUM; SURVIVAL	Expansion into new host niches requires bacterial pathogens to adapt to changes in nutrient availability and to evade an arsenal of host defenses. Horizontal acquisition of Salmonella Pathogenicity Island (SPI)-2 permitted the expansion of Salmonella enterica serovar Typhimurium into the intracellular environment of host cells by allowing it to deliver bacterial effector proteins across the phagosome membrane. This is facilitated by the SsrA-SsrB two-component regulatory system and a type III secretion system encoded within SPI-2. SPI-2 acquisition was followed by evolution of existing regulatory DNA, creating an expanded SsrB regulon involved in intracellular fitness and host infection. Here, we identified an SsrB-regulated operon comprising an ABC transporter in Salmonella. Biochemical and structural studies determined that the periplasmic solute-binding component, STM1633/DalS, transports D-alanine and that DalS is required for intracellular survival of the bacteria and for fitness in an animal host. This work exemplifies the role of nutrient exchange at the host-pathogen interface as a critical determinant of disease outcome.	[Osborne, Suzanne E.; Tuinema, Brian R.; Tomljenovic-Berube, Ana M.; Junop, Murray; Coombes, Brian K.] Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada; [Osborne, Suzanne E.; Tuinema, Brian R.; Mok, Mac C. Y.; Lau, Pui Sai; Tomljenovic-Berube, Ana M.; Zhang, Kun; Junop, Murray; Coombes, Brian K.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Bui, Nhat Khai; Vollmer, Waldemar] Newcastle Univ, Inst Cell & Mol Biosci, Ctr Bacterial Cell Biol, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England	McMaster University; McMaster University; Newcastle University - UK	Coombes, BK (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.	coombes@mcmaster.ca	Junop, Murray S/E-4160-2015	Junop, Murray S/0000-0001-6676-5717; Tomljenovic-Berube, Ana/0000-0003-4733-7164; Coombes, Brian/0000-0001-9883-1010	Canadian Institutes of Health [MOP-82704]; Canada Research Chairs Program; Infrastructure Investment from the Canada Foundation for Innovation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Infrastructure Investment from the Canada Foundation for Innovation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by Canadian Institutes of Health Research Grant MOP-82704 (to B. K. C.), the Canada Research Chairs Program (to B. K. C.), and Infrastructure Investment from the Canada Foundation for Innovation (to B. K. C.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Bijlsma JJE, 2005, MOL MICROBIOL, V57, P85, DOI 10.1111/j.1365-2958.2005.04668.x; Coombes BK, 2005, P NATL ACAD SCI USA, V102, P17460, DOI 10.1073/pnas.0505401102; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng XH, 2004, MOL MICROBIOL, V54, P823, DOI 10.1111/j.1365-2958.2004.04317.x; Folkesson A, 2005, CELL MICROBIOL, V7, P147, DOI 10.1111/j.1462-5822.2004.00443.x; Giuliani SE, 2008, BIOCHEMISTRY-US, V47, P13974, DOI 10.1021/bi801648r; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; GOODELL EW, 1987, J BACTERIOL, V169, P3861, DOI 10.1128/jb.169.8.3861-3865.1987; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Linehan SA, 2005, INFECT IMMUN, V73, P4354, DOI 10.1128/IAI.73.7.4354-4362.2005; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; OH BH, 1993, J BIOL CHEM, V268, P11348; Osborne SE, 2009, P NATL ACAD SCI USA, V106, P3982, DOI 10.1073/pnas.0811669106; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Quintela JC, 1997, MOL MICROBIOL, V23, P693, DOI 10.1046/j.1365-2958.1997.2561621.x; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Silphaduang U, 2007, J BACTERIOL, V189, P3669, DOI 10.1128/JB.00002-07; Tomljenovic-Berube AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000875; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Votsch W, 2000, J BIOL CHEM, V275, P39032, DOI 10.1074/jbc.M004797200; Walthers D, 2007, MOL MICROBIOL, V65, P477, DOI 10.1111/j.1365-2958.2007.05800.x; YAO NH, 1994, BIOCHEMISTRY-US, V33, P4769, DOI 10.1021/bi00182a004; Yoon HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000306	28	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15242	15250		10.1074/jbc.M112.348227	http://dx.doi.org/10.1074/jbc.M112.348227			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22418438	Green Published, hybrid			2022-12-27	WOS:000304006300008
J	Perez-Gil, J; Calisto, BM; Behrendt, C; Kurz, T; Fita, I; Rodriguez-Concepcion, M				Perez-Gil, Jordi; Calisto, Barbara M.; Behrendt, Christoph; Kurz, Thomas; Fita, Ignacio; Rodriguez-Concepcion, Manuel			Crystal Structure of Brucella abortus Deoxyxylulose-5-phosphate Reductoisomerase-like (DRL) Enzyme Involved in Isoprenoid Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE; ISOPENTENYL DIPHOSPHATE ISOMERASE; MEP PATHWAY; MEVALONATE PATHWAY; ANTIMALARIAL-DRUGS; BACILLUS-SUBTILIS; FOSMIDOMYCIN; COMPLEX; BINDING; TARGET	Most bacteria use the 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway for the synthesis of their essential isoprenoid precursors. The absence of the MEP pathway in humans makes it a promising new target for the development of much needed new and safe antimicrobial drugs. However, bacteria show a remarkable metabolic plasticity for isoprenoid production. For example, the NADPH-dependent production of MEP from 1-deoxy-D-xylulose 5-phosphate in the first committed step of the MEP pathway is catalyzed by 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) in most bacteria, whereas an unrelated DXR-like (DRL) protein was recently found to catalyze the same reaction in some organisms, including the emerging human and animal pathogens Bartonella and Brucella. Here, we report the x-ray crystal structures of the Brucella abortus DRL enzyme in its apo form and in complex with the broad-spectrum antibiotic fosmidomycin solved to 1.5 and 1.8 angstrom resolution, respectively. DRL is a dimer, with each polypeptide folding into three distinct domains starting with the NADPH-binding domain, in resemblance to the structure of bacterial DXR enzymes. Other than that, DRL and DXR show a low structural relationship, with a different disposition of the domains and a topologically unrelated C-terminal domain. In particular, the active site of DRL presents a unique arrangement, suggesting that the design of drugs that would selectively inhibit DRL-harboring pathogens without affecting beneficial or innocuous bacteria harboring DXR should be feasible. As a proof of concept, we identified two strong DXR inhibitors that have virtually no effect on DRL activity.	[Perez-Gil, Jordi; Rodriguez-Concepcion, Manuel] Univ Barcelona, Dept Mol Genet, CRAG, CSIC,IRTA,UAB, Barcelona 08193, Spain; [Calisto, Barbara M.; Fita, Ignacio] CSIC, IBMB, E-08028 Barcelona, Spain; [Calisto, Barbara M.; Fita, Ignacio] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain; [Behrendt, Christoph; Kurz, Thomas] Univ Dusseldorf, Inst Pharmazeust & Med Chem, D-40225 Dusseldorf, Germany	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Heinrich Heine University Dusseldorf	Rodriguez-Concepcion, M (corresponding author), Univ Barcelona, Dept Mol Genet, CRAG, CSIC,IRTA,UAB, Campus UAB, Barcelona 08193, Spain.	manuel.rodriguez@cragenomica.es	Perez-Gil, Jordi/I-1853-2013; Rodriguez-Concepcion, Manuel/I-7229-2015; Fita, Ignasi/R-4515-2019	Perez-Gil, Jordi/0000-0002-5632-9556; Rodriguez-Concepcion, Manuel/0000-0002-1280-2305; Fita, Ignasi/0000-0002-7521-2679; Calisto, Barbara/0000-0003-1732-571X	FPI [BFU2009-09268, BIO2008-00432]; Spanish Ministerio de Ciencia e Innovacion [CSD2007-00036]; XRB from the Generalitat de Catalunya;  [2009SGR-26]	FPI(Spanish Government); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); XRB from the Generalitat de Catalunya(Generalitat de Catalunya); 	This work was supported by a FPI fellowship (to J. P. G.), Research Grants BFU2009-09268 (to I. F.) and BIO2008-00432 (to M. R.-C.), and Consolider Program Grant CSD2007-00036 from the Spanish Ministerio de Ciencia e Innovacion and by Grants 2009SGR-26 and XRB from the Generalitat de Catalunya.	Behrendt CT, 2011, J MED CHEM, V54, P6796, DOI 10.1021/jm200694q; Behrendt CT, 2010, CHEMMEDCHEM, V5, P1673, DOI 10.1002/cmdc.201000276; Boucher Y, 2000, MOL MICROBIOL, V37, P703, DOI 10.1046/j.1365-2958.2000.02004.x; Bouvier F, 2005, PROG LIPID RES, V44, P357, DOI 10.1016/j.plipres.2005.09.003; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Davey MS, 2011, ANTIMICROB AGENTS CH, V55, P3635, DOI 10.1128/AAC.00382-11; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Henriksson LM, 2007, J BIOL CHEM, V282, P19905, DOI 10.1074/jbc.M701935200; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kaneda K, 2001, P NATL ACAD SCI USA, V98, P932, DOI 10.1073/pnas.020472198; Kuzuyama T, 2000, J BIOL CHEM, V275, P19928, DOI 10.1074/jbc.M001820200; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Laupitz R, 2004, EUR J BIOCHEM, V271, P2658, DOI 10.1111/j.1432-1033.2004.04194.x; Mac Sweeney A, 2005, J MOL BIOL, V345, P115, DOI 10.1016/j.jmb.2004.10.030; Maurin M, 1997, EUR J CLIN MICROBIOL, V16, P487, DOI 10.1007/BF01708232; Morris JG, 2010, J INFECT DIS, V202, P1, DOI 10.1086/653085; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pappas G, 2006, CELL MOL LIFE SCI, V63, P2229, DOI 10.1007/s00018-006-6311-4; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Phillips MA, 2008, TRENDS PLANT SCI, V13, P619, DOI 10.1016/j.tplants.2008.09.003; Proteau PJ, 2004, BIOORG CHEM, V32, P483, DOI 10.1016/j.bioorg.2004.08.004; Reuter K, 2002, J BIOL CHEM, V277, P5378, DOI 10.1074/jbc.M109500200; Ricagno S, 2004, BBA-PROTEINS PROTEOM, V1698, P37, DOI 10.1016/j.bbapap.2003.10.006; Rodriguez-Concepion M, 2004, CURR PHARM DESIGN, V10, P2391, DOI 10.2174/1381612043384006; Rohdich F, 2005, BIOCHEM SOC T, V33, P785, DOI 10.1042/BST0330785; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Sangari FJ, 2010, P NATL ACAD SCI USA, V107, P14081, DOI 10.1073/pnas.1001962107; Sauret-Gueto S, 2006, FEBS LETT, V580, P736, DOI 10.1016/j.febslet.2005.12.092; Singh N, 2007, CURR PHARM DESIGN, V13, P1161, DOI 10.2174/138161207780618939; Steinbacher S, 2003, J MOL BIOL, V329, P973, DOI 10.1016/S0022-2836(03)00527-8; Steinbacher S, 2003, J BIOL CHEM, V278, P18401, DOI 10.1074/jbc.M300993200; Takenoya M, 2010, J STRUCT BIOL, V170, P532, DOI 10.1016/j.jsb.2010.03.015; Umeda T, 2010, ACTA CRYSTALLOGR F, V66, P330, DOI 10.1107/S1744309110001739; Yajima S, 2002, J BIOCHEM, V131, P313, DOI 10.1093/oxfordjournals.jbchem.a003105; Yajima S, 2007, ACTA CRYSTALLOGR F, V63, P466, DOI 10.1107/S1744309107024475; Yang DSC, 1998, BIOPHYS J, V74, P2142, DOI 10.1016/S0006-3495(98)77923-8; Zingle C, 2010, J ORG CHEM, V75, P3203, DOI 10.1021/jo9024732	42	6	6	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15803	15809		10.1074/jbc.M112.354811	http://dx.doi.org/10.1074/jbc.M112.354811			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22442144	Green Published, hybrid			2022-12-27	WOS:000304006300060
J	Ren, KQ; Lu, J; Porollo, A; Du, CY				Ren, Keqin; Lu, Jing; Porollo, Aleksey; Du, Chunying			Tumor-suppressing Function of Caspase-2 Requires Catalytic Site Cys-320 and Site Ser-139 in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; DNA-DAMAGE; MITOTIC CATASTROPHE; GENE-EXPRESSION; CYTOCHROME-C; HEPATOCELLULAR-CARCINOMA; B-CELLS; KAPPA-B; APOPTOSIS; CANCER	The multifunctional caspase-2 protein is involved in apoptosis, NF-kappa B regulation, and tumor suppression in mice. However, the mechanisms of caspase-2 responsible for tumor suppression remain unclear. Here we identified two sites of caspase-2, the catalytic Cys-320 site and the Ser-139 site, to be important for suppression of cellular transformation and tumorigenesis. Using SV40- and K-Ras-transformed caspase-2 KO mouse embryonic fibroblast cells reconstituted with expression of wild-type, catalytic dead (C320A), or Ser-139 (S139A) mutant caspase-2, we demonstrated that similar to caspase-2 deficiency, when Cys-320 and Ser-139 were mutated, caspase-2 lost its ability to inhibit cellular transformation and tumorigenesis. These mutant cells exhibited enhanced cell proliferation, elevated clonogenic activity, accelerated anchorage-independent growth, and transformation and were highly tumorigenic, rapidly producing large tumors in athymic nude mice. Investigation into the underlying mechanism showed that these two residues are needed for caspase-2 to suppress NF-kappa B activity, promote apoptosis, and sustain the G(2)/M checkpoint following DNA damage induction. In addition, tumors in nude mice derived from the two mutant cell lines had higher constitutive NF-kappa B activity and elevated expression of NF-kappa B targets of antiapoptotic proteins Bcl-xL, XIAP, and cIAP2. A reduction in caspase-2 mRNA was associated with multiple types of cancers in patients. Together, these observations suggest the combined functions of caspase-2 in suppressing NF-kappa B activation, promoting apoptosis, and sustaining G(2)/M checkpoint contribute to caspase-2 tumor-suppressing function and that caspase-2 may also impact tumor suppression in humans. These findings provide insight into tumor suppression at the cross-roads of apoptosis, cell cycle checkpoint, and NF-kappa B pathways.	[Du, Chunying] Univ Cincinnati, Med Ctr, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45267 USA; [Porollo, Aleksey] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Du, CY (corresponding author), Univ Cincinnati, Med Ctr, Coll Med, Dept Canc & Cell Biol, 3125 Eden Ave, Cincinnati, OH 45267 USA.	ducg@ucmail.uc.edu		Porollo, Alexey/0000-0002-3202-5099	Department of Cancer and Cell Biology, University of Cincinnati College of Medicine	Department of Cancer and Cell Biology, University of Cincinnati College of Medicine	This work was supported by the startup fund of the Department of Cancer and Cell Biology, University of Cincinnati College of Medicine.	Akyurek N, 2006, CANCER-AM CANCER SOC, V107, P1844, DOI 10.1002/cncr.22219; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Andersen JL, 2009, EMBO J, V28, P3216, DOI 10.1038/emboj.2009.253; Baptiste-Okoh N, 2008, P NATL ACAD SCI USA, V105, P1937, DOI 10.1073/pnas.0711800105; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bouchier-Hayes L, 2012, CELL DEATH DIFFER, V19, P51, DOI 10.1038/cdd.2011.157; Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fushimi K, 2008, P NATL ACAD SCI USA, V105, P15708, DOI 10.1073/pnas.0805569105; Gao ZH, 2005, J BIOL CHEM, V280, P38271, DOI 10.1074/jbc.M506488200; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guha M, 2010, ONCOGENE, V29, P1280, DOI 10.1038/onc.2009.428; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Ho LH, 2009, P NATL ACAD SCI USA, V106, P5336, DOI 10.1073/pnas.0811928106; Hu SM, 2006, J CLIN INVEST, V116, P174, DOI 10.1172/JCI25641; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kashkar H, 2003, J EXP MED, V198, P341, DOI 10.1084/jem.20021279; Kashkar H, 2006, BLOOD, V108, P3434, DOI 10.1182/blood-2006-05-021675; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015074; Kitevska T, 2009, APOPTOSIS, V14, P829, DOI 10.1007/s10495-009-0365-3; Krumschnabel G, 2009, ONCOGENE, V28, P3093, DOI 10.1038/onc.2009.173; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; KUMAR S, 1995, HUM GENET, V95, P641; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; Lamkanfi M, 2005, J BIOL CHEM, V280, P6923, DOI 10.1074/jbc.M411180200; Lavrik IN, 2006, BLOOD, V108, P559, DOI 10.1182/blood-2005-07-007096; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110; Mendelsohn AR, 2002, P NATL ACAD SCI USA, V99, P6871, DOI 10.1073/pnas.072290599; Narine KAD, 2010, DNA REPAIR, V9, P161, DOI 10.1016/j.dnarep.2009.11.010; Nutt LK, 2009, DEV CELL, V16, P856, DOI 10.1016/j.devcel.2009.04.005; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Oliver TG, 2011, MOL CELL, V43, P57, DOI 10.1016/j.molcel.2011.06.012; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Runnebaum IB, 2005, CLIN CANCER RES, V11, P6325, DOI 10.1158/1078-0432.CCR-05-0182; Shin S, 2005, EMBO J, V24, P3532, DOI 10.1038/sj.emboj.7600827; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Tang J, 2005, CANCER BIOL THER, V4, P645, DOI 10.4161/cbt.4.6.1729; Tinel A, 2011, CELL DEATH DIFFER, V18, P506, DOI 10.1038/cdd.2010.124; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tyagi A, 2006, CARCINOGENESIS, V27, P2269, DOI 10.1093/carcin/bgl098; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Vakifahmetoglu H, 2006, ONCOGENE, V25, P5683, DOI 10.1038/sj.onc.1209569; Vega MI, 2005, J IMMUNOL, V175, P2174, DOI 10.4049/jimmunol.175.4.2174; Wagner KW, 2004, J BIOL CHEM, V279, P35047, DOI 10.1074/jbc.M400708200; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Zhivotovsky B, 2005, BIOCHEM BIOPH RES CO, V331, P859, DOI 10.1016/j.bbrc.2005.03.191	59	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14792	14802		10.1074/jbc.M112.347625	http://dx.doi.org/10.1074/jbc.M112.347625			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22396545	Green Published, hybrid			2022-12-27	WOS:000304003200044
J	Wickner, RB				Wickner, Reed B.			Discovering Protein-based Inheritance through Yeast Genetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; BETA-SHEET STRUCTURE; RIBOSOMAL-SUBUNIT BIOGENESIS; TERMINATION FACTOR ERF3; PRION-INDUCING DOMAIN; L-A VIRUS; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; IN-VITRO; ESCHERICHIA-COLI		NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wickner, RB (corresponding author), NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA.	wickner@helix.nih.gov			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024950] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AIGLE M, 1975, MOL GEN GENET, V136, P327, DOI 10.1007/BF00341717; Al Safadi R, 2011, FEMS YEAST RES, V11, P151, DOI 10.1111/j.1567-1364.2010.00700.x; ALPER T, 1967, NATURE, V214, P764, DOI 10.1038/214764a0; Antzutkin ON, 2000, P NATL ACAD SCI USA, V97, P13045, DOI 10.1073/pnas.230315097; Bateman DA, 2012, GENETICS, V190, P569, DOI 10.1534/genetics.111.136655; Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; Baxa U, 2007, BIOCHEMISTRY-US, V46, P13149, DOI 10.1021/bi700826b; Belew AT, 2011, NUCLEIC ACIDS RES, V39, P2799, DOI 10.1093/nar/gkq1220; Benard L, 1998, MOL CELL BIOL, V18, P2688, DOI 10.1128/MCB.18.5.2688; Benzinger TLS, 1998, P NATL ACAD SCI USA, V95, P13407, DOI 10.1073/pnas.95.23.13407; BEVAN EA, 1973, NATURE, V245, P81, DOI 10.1038/245081b0; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Caston JR, 1997, J CELL BIOL, V138, P975, DOI 10.1083/jcb.138.5.975; Chen B, 2009, P NATL ACAD SCI USA, V106, P14339, DOI 10.1073/pnas.0907821106; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Dalstra HJP, 2003, P NATL ACAD SCI USA, V100, P6616, DOI 10.1073/pnas.1030058100; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Diaz-Avalos R, 2005, P NATL ACAD SCI USA, V102, P10165, DOI 10.1073/pnas.0504599102; Dinman J. D., 2006, TRANSLATIONAL CONTRO, P625; DINMAN JD, 1995, GENETICS, V141, P95; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; DINMAN JD, 1994, GENETICS, V136, P75; DOEL SM, 1994, GENETICS, V137, P659; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Edskes HK, 2011, GENETICS, V188, P81, DOI 10.1534/genetics.111.127217; Edskes HK, 2009, GENETICS, V181, P1159, DOI 10.1534/genetics.108.099929; Edskes HK, 1999, P NATL ACAD SCI USA, V96, P1498, DOI 10.1073/pnas.96.4.1498; Edskes HK, 1998, J BIOL CHEM, V273, P28912, DOI 10.1074/jbc.273.44.28912; Engel A, 2011, BIOCHEMISTRY-US, V50, P5971, DOI 10.1021/bi200142x; ESTEBAN R, 1986, MOL CELL BIOL, V6, P1552, DOI 10.1128/MCB.6.5.1552; FINK GR, 1972, P NATL ACAD SCI USA, V69, P2846, DOI 10.1073/pnas.69.10.2846; FUJIMURA T, 1988, CELL, V55, P663, DOI 10.1016/0092-8674(88)90225-5; FUJIMURA T, 1989, J BIOL CHEM, V264, P10872; Funakoshi Y, 2007, GENE DEV, V21, P3135, DOI 10.1101/gad.1597707; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Hawthorne D C, 1974, Curr Top Microbiol Immunol, V64, P1; HERRING AJ, 1974, J GEN VIROL, V22, P387, DOI 10.1099/0022-1317-22-3-387; Hoshino S, 1999, J BIOL CHEM, V274, P16677, DOI 10.1074/jbc.274.24.16677; Hosoda N, 2003, J BIOL CHEM, V278, P38287, DOI 10.1074/jbc.C300300200; Hunter N, 1997, TRENDS MICROBIOL, V5, P331, DOI 10.1016/S0966-842X(97)01081-0; ICHO T, 1989, J BIOL CHEM, V264, P6716; INGE-VECHTOMOV S G, 1970, Genetika, V6, P103; JONES EW, 1991, J BIOL CHEM, V266, P7963; JULIUS D, 1984, CELL, V37, P1075, DOI 10.1016/0092-8674(84)90442-2; Jung G, 2000, GENETICS, V156, P559; KELEHER CA, 1992, CELL, V68, P709, DOI 10.1016/0092-8674(92)90146-4; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; Kirkland PA, 2011, GENETICS, V188, P565, DOI 10.1534/genetics.111.129460; Kirschner DA, 2000, J STRUCT BIOL, V130, P87, DOI 10.1006/jsbi.2000.4293; Kochneva-Pervukhova NV, 1998, EMBO J, V17, P5805, DOI 10.1093/emboj/17.19.5805; LACROUTE F, 1971, J BACTERIOL, V106, P519, DOI 10.1128/JB.106.2.519-522.1971; LEIBOWITZ MJ, 1976, P NATL ACAD SCI USA, V73, P2061, DOI 10.1073/pnas.73.6.2061; LUND PM, 1981, GENET RES, V37, P173, DOI 10.1017/S0016672300020140; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Bevan E. A., 1963, Genetics today. Proceedings of the XI International Congress of Genetics, The Hague, The Netherlands, September 1963., V1, P202; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Masison DC, 1997, P NATL ACAD SCI USA, V94, P12503, DOI 10.1073/pnas.94.23.12503; MASISON DC, 1995, MOL CELL BIOL, V15, P2763; MATSUMOTO Y, 1990, P NATL ACAD SCI USA, V87, P7628, DOI 10.1073/pnas.87.19.7628; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Moreno-Gonzalez I, 2011, SEMIN CELL DEV BIOL, V22, P482, DOI 10.1016/j.semcdb.2011.04.002; Naitow H, 2002, NAT STRUCT BIOL, V9, P725, DOI 10.1038/nsb844; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; OHTAKE Y, 1995, MOL CELL BIOL, V15, P2772; ONO BI, 1979, J MOL BIOL, V128, P81, DOI 10.1016/0022-2836(79)90309-7; Parry H.B., 1983, SCRAPIE DIS SHEEP HI; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; PRIOLA SA, 1994, J VIROL, V68, P4873, DOI 10.1128/JVI.68.8.4873-4878.1994; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; RIDLEY SP, 1984, MOL CELL BIOL, V4, P761, DOI 10.1128/MCB.4.4.761; Roberts BT, 2003, GENE DEV, V17, P2083, DOI 10.1101/gad.1115803; RODRIGUEZCOUSINO N, 1991, J BIOL CHEM, V266, P12772; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2005, NAT CELL BIOL, V7, P1039, DOI 10.1038/ncb1105-1039; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; SCHALLER H, 1972, J MOL BIOL, V63, P183, DOI 10.1016/0022-2836(72)90369-5; Schwimmer C, 2002, MOL CELL BIOL, V22, P3590, DOI 10.1128/MCB.22.11.3590-3598.2002; Searfoss AW, 2000, P NATL ACAD SCI USA, V97, P9133, DOI 10.1073/pnas.97.16.9133; Shewmaker F, 2008, BIOCHEMISTRY-US, V47, P4000, DOI 10.1021/bi7024589; Shewmaker F, 2007, GENETICS, V176, P1557, DOI 10.1534/genetics.107.074153; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Shewmaker F, 2009, BIOCHEMISTRY-US, V48, P5074, DOI 10.1021/bi900345q; SINGH A, 1979, P NATL ACAD SCI USA, V76, P1952, DOI 10.1073/pnas.76.4.1952; SOMERS JM, 1969, GENET RES, V13, P71, DOI 10.1017/S0016672300002743; SOMMER SS, 1987, VIROLOGY, V157, P252, DOI 10.1016/0042-6822(87)90338-2; SOMMER SS, 1982, CELL, V31, P429, DOI 10.1016/0092-8674(82)90136-2; STEINER DF, 1992, J BIOL CHEM, V267, P23435; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; TERAVANESYAN MD, 1994, GENETICS, V137, P671; TERCERO JC, 1992, J BIOL CHEM, V267, P20277; TOHE A, 1978, J BACTERIOL, V136, P1002, DOI 10.1128/JB.136.3.1002-1007.1978; Toombs J. A., 2012, P NATL ACAD IN PRESS; Toombs JA, 2010, MOL CELL BIOL, V30, P319, DOI 10.1128/MCB.01140-09; Tortorici MA, 2003, J BIOL CHEM, V278, P32673, DOI 10.1074/jbc.M305358200; TUITE MF, 1981, GENETICS, V98, P691; VODKIN M, 1974, J BACTERIOL, V117, P681, DOI 10.1128/JB.117.2.681-686.1974; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; WESOLOWSKI M, 1984, MOL CELL BIOL, V4, P181, DOI 10.1128/MCB.4.1.181; WESTAWAY D, 1994, CELL, V76, P117, DOI 10.1016/0092-8674(94)90177-5; Westermark GT, 2010, TRENDS MOL MED, V16, P501, DOI 10.1016/j.molmed.2010.08.004; WICKNER RB, 1972, J BIOL CHEM, V247, P498; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; WICKNER RB, 1969, J BIOL CHEM, V244, P6550; WICKNER RB, 1974, J BACTERIOL, V117, P252, DOI 10.1128/JB.117.1.252-260.1974; Wickner RB, 2005, SCIENCE, V309, P874; WICKNER RB, 1972, P NATL ACAD SCI USA, V69, P3233, DOI 10.1073/pnas.69.11.3233; WICKNER RB, 1983, MOL CELL BIOL, V3, P654, DOI 10.1128/MCB.3.4.654; WICKNER RB, 1970, J BIOL CHEM, V245, P2132; WICKNER RB, 1980, CELL, V21, P217, DOI 10.1016/0092-8674(80)90129-4; Wickner RB, 1997, P NATL ACAD SCI USA, V94, P10012, DOI 10.1073/pnas.94.19.10012; Wickner RB, 2008, BIOESSAYS, V30, P955, DOI 10.1002/bies.20821; Wickner RB, 2008, P NATL ACAD SCI USA, V105, P2403, DOI 10.1073/pnas.0712032105; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Wickner RB, 2011, SEMIN CELL DEV BIOL, V22, P469, DOI 10.1016/j.semcdb.2011.02.021; Wickner RB, 2010, FEMS YEAST RES, V10, P980, DOI 10.1111/j.1567-1364.2010.00666.x; WIDNER WR, 1993, MOL CELL BIOL, V13, P4331, DOI 10.1128/MCB.13.7.4331; WILLIAMS FE, 1991, MOL CELL BIOL, V11, P3307, DOI 10.1128/MCB.11.6.3307; ZUBENKO GS, 1982, GENETICS, V102, P679	128	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14432	14442		10.1074/jbc.X112.355636	http://dx.doi.org/10.1074/jbc.X112.355636			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22396539	hybrid, Green Published			2022-12-27	WOS:000304003200011
J	Phuan, PW; Ratelade, J; Rossi, A; Tradtrantip, L; Verkman, AS				Phuan, Puay-Wah; Ratelade, Julien; Rossi, Andrea; Tradtrantip, Lukmanee; Verkman, A. S.			Complement-dependent Cytotoxicity in Neuromyelitis Optica Requires Aquaporin-4 Protein Assembly in Orthogonal Arrays	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; WATER CHANNEL; MULTIPLE-SCLEROSIS; 1ST COMPONENT; RAT-BRAIN; BINDING; IGG; ANTIBODIES; CELLS; ACTIVATION	Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system in which binding of pathogenic autoantibodies (NMO-IgG) to astrocyte aquaporin-4 (AQP4) causes complement-dependent cytotoxicity (CDC) and inflammation. We previously reported a wide range of binding affinities of NMO-IgGs to AQP4 in separate tetramers versus intramembrane aggregates (orthogonal arrays of particles, OAPs). We report here a second, independent mechanism by which CDC is affected by AQP4 assembly. Utilizing lactate dehydrogenase release and live/dead cell cytotoxicity assays, we found in different cell lines, and with different monoclonal and patient-derived NMO-IgGs, that CDC was greatly (>100-fold) reduced in cells expressing M1-versus M23-AQP4. Studies using a M23-AQP4 mutant containing an OAP-disrupting mutation, and in cells expressing AQP4 in different M1/M23 ratios, indicated that NMO-IgG-dependent CDC requires AQP4OAP assembly. In contrast, antibody-dependent cell-mediated cytotoxicity produced by natural killer cells did not depend on AQP4 OAP assembly. Measurements of C1q binding and complement attack complex (C9neo) supported the conclusion that the greatly enhanced CDC by OAPs is due to efficient, multivalent binding of C1q to clustered NMO-IgG on OAPs. We conclude that AQP4 assembly in OAPs is required for CDC in NMO, establishing a new mechanism of OAP-dependent NMO pathogenesis. Disruption of AQP4 OAPs may greatly reduce NMO-IgG dependent CDC and NMO pathology.	[Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Med, 1246 Hlth Sci E Tower, San Francisco, CA 94143 USA.	Alan.Verkman@ucsf.edu		Ratelade, Julien/0000-0001-7968-5409; Rossi, Andrea/0000-0001-5863-6448	National Institutes of Health [EY13574, EB00415, DK35124, HL73856, DK86125, DK72517]; Guthy-Jackson Charitable Foundation; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035124, RC1DK086125, R37DK035124, P30DK072517] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guthy-Jackson Charitable Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EY13574, EB00415, DK35124, HL73856, DK86125, and DK72517 (to A. S. V.) This work was also supported by a grant from the Guthy-Jackson Charitable Foundation.	Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Crane JM, 2008, MOL BIOL CELL, V19, P3369, DOI 10.1091/mbc.E08-03-0322; Crane JM, 2011, J NEUROIMMUNOL, V236, P93, DOI 10.1016/j.jneuroim.2011.05.001; Crane JM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227298; Crane JM, 2009, J BIOL CHEM, V284, P35850, DOI 10.1074/jbc.M109.071670; Crane JM, 2009, J CELL SCI, V122, P813, DOI 10.1242/jcs.042341; Cree BAC, 2005, NEUROLOGY, V64, P1270, DOI 10.1212/01.WNL.0000159399.81861.D5; Daha NA, 2011, MOL IMMUNOL, V48, P1656, DOI 10.1016/j.molimm.2011.04.024; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; Eggleton P, 1998, TRENDS CELL BIOL, V8, P428, DOI 10.1016/S0962-8924(98)01373-7; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; Gomez AM, 2010, AUTOIMMUNITY, V43, P353, DOI 10.3109/08916930903555943; HASEGAWA H, 1994, J BIOL CHEM, V269, P5497; Hinson SR, 2007, NEUROLOGY, V69, P2221, DOI 10.1212/01.WNL.0000289761.64862.ce; Hinson SR, 2012, P NATL ACAD SCI USA, V109, P1245, DOI 10.1073/pnas.1109980108; Hinson SR, 2009, ARCH NEUROL-CHICAGO, V66, P1164, DOI 10.1001/archneurol.2009.188; HUGHESJONES NC, 1977, IMMUNOLOGY, V32, P191; Jarius S, 2008, NAT CLIN PRACT NEURO, V4, P202, DOI 10.1038/ncpneuro0764; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; Jin BJ, 2011, BIOPHYS J, V100, P2936, DOI 10.1016/j.bpj.2011.05.012; Kalluri SR, 2010, ARCH NEUROL-CHICAGO, V67, P1201, DOI 10.1001/archneurol.2010.269; Kinoshita M, 2009, BIOCHEM BIOPH RES CO, V386, P623, DOI 10.1016/j.bbrc.2009.06.085; LANDIS DMD, 1974, J CELL BIOL, V60, P316, DOI 10.1083/jcb.60.1.316; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Loirat C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-60; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Miyamoto K, 2009, THER APHER DIAL, V13, P505, DOI 10.1111/j.1744-9987.2009.00780.x; Nielsen S, 1997, J NEUROSCI, V17, P171; Parker C, 2005, BLOOD, V106, P3699, DOI 10.1182/blood-2005-04-1717; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Ratelade J, 2011, J BIOL CHEM, V286, P45156, DOI 10.1074/jbc.M111.297275; REID KBM, 1983, BIOCHEM SOC T, V11, P1; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Rossi A, 2012, TRAFFIC, V13, P43, DOI 10.1111/j.1600-0854.2011.01299.x; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Sabater L, 2009, J NEUROIMMUNOL, V215, P31, DOI 10.1016/j.jneuroim.2009.07.014; SCHUMAKER VN, 1976, BIOCHEMISTRY-US, V15, P5175, DOI 10.1021/bi00668a035; SCHUMAKER VN, 1986, MOL IMMUNOL, V23, P557, DOI 10.1016/0161-5890(86)90119-7; SELLAR GC, 1991, BIOCHEM J, V274, P481, DOI 10.1042/bj2740481; Skerka C, 2010, SEMIN THROMB HEMOST, V36, P625, DOI 10.1055/s-0030-1262884; SLEDGE CR, 1973, J BIOL CHEM, V248, P2818; Tajima M, 2010, J BIOL CHEM, V285, P8163, DOI 10.1074/jbc.M109.093948; Tradtrantip L, 2012, ANN NEUROL, V71, P314, DOI 10.1002/ana.22657; Verbavatz JM, 1997, J CELL SCI, V110, P2855; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006; Wilde B, 2011, KIDNEY INT, V79, P599, DOI 10.1038/ki.2010.472; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; WOLBURG H, 1995, J BRAIN RES, V36, P239; Yang BX, 1996, J BIOL CHEM, V271, P4577	53	101	115	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13829	13839		10.1074/jbc.M112.344325	http://dx.doi.org/10.1074/jbc.M112.344325			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22393049	Green Published, hybrid			2022-12-27	WOS:000303996300038
J	Gonzalez-Salgado, A; Steinmann, ME; Greganova, E; Rauch, M; Maser, P; Sigel, E; Butikofer, P				Gonzalez-Salgado, Amaia; Steinmann, Michael E.; Greganova, Eva; Rauch, Monika; Maeser, Pascal; Sigel, Erwin; Buetikofer, Peter			myo-Inositol Uptake Is Essential for Bulk Inositol Phospholipid but Not Glycosylphosphatidylinositol Synthesis in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-STREAM-FORM; DEVELOPMENTAL VARIATION; FUNCTIONAL EXPRESSION; SUBSTRATE-SPECIFICITY; METABOLITE INOSITOL; TRANSPORT FUNCTION; CANDIDA-ALBICANS; MEMBRANE ANCHORS; LIPID-METABOLISM; POLAR LIPIDS	myo-Inositol is an essential precursor for the production of inositol phosphates and inositol phospholipids in all eukaryotes. Intracellular myo-inositol is generated by de novo synthesis from glucose 6-phosphate or is provided from the environment via myo-inositol symporters. We show that in Trypanosoma brucei, the causative pathogen of human African sleeping sickness and nagana in domestic animals, myo-inositol is taken up via a specific proton-coupled electrogenic symport and that this transport is essential for parasite survival in culture. Down-regulation of the myo-inositol transporter using RNA interference inhibited uptake of myo-inositol and blocked the synthesis of the myo-inositol-containing phospholipids, phosphatidylinositol and inositol phosphorylceramide; in contrast, it had no effect on glycosylphosphatidylinositol production. This together with the unexpected localization of the myo-inositol transporter in both the plasma membrane and the Golgi demonstrate that metabolism of endogenous and exogenous myo-inositol in T. brucei is strictly segregated.	[Gonzalez-Salgado, Amaia; Steinmann, Michael E.; Rauch, Monika; Sigel, Erwin; Buetikofer, Peter] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Greganova, Eva; Maeser, Pascal] Swiss Trop & Publ Hlth Inst, CH-4051 Basel, Switzerland	University of Bern; University of Basel; Swiss Tropical & Public Health Institute	Butikofer, P (corresponding author), Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland.	peter.buetikofer@ibmm.unibe.ch	Sigel, Erwin/F-7736-2015	Maser, Pascal/0000-0003-3122-1941	Sinergia [CRSII3-127300]; Swiss National Science Foundation [31003A-130815]	Sinergia; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Sinergia Grant CRSII3-127300 and in part by Grant 31003A-130815 from the Swiss National Science Foundation.	Baur R, 2007, J NEUROCHEM, V103, P2556, DOI 10.1111/j.1471-4159.2007.04982.x; Berry GT, 2003, J BIOL CHEM, V278, P18297, DOI 10.1074/jbc.M213176200; Bersudsky Y, 2008, BIPOLAR DISORD, V10, P453, DOI 10.1111/j.1399-5618.2007.00546.x; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; BRUN R, 1979, ACTA TROP, V36, P289; Butikofer P, 1997, BIOCHEM J, V326, P415; BUTIKOFER P, 1989, BLOOD, V73, P1699; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Chau JFL, 2005, FASEB J, V19, P1887, DOI 10.1096/fj.05-4192fje; Chen YL, 2008, INFECT IMMUN, V76, P2793, DOI 10.1128/IAI.01514-07; Coady MJ, 2002, J BIOL CHEM, V277, P35219, DOI 10.1074/jbc.M204321200; Di Daniel E, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-54; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; DREW ME, 1995, MOL CELL BIOL, V15, P5508; Einicker-Lamas M, 2000, EUR J BIOCHEM, V267, P2533, DOI 10.1046/j.1432-1327.2000.01302.x; Einicker-Lamas M, 2007, EXP PARASITOL, V117, P171, DOI 10.1016/j.exppara.2007.04.011; FIELD MC, 1991, J BIOL CHEM, V266, P8392; FIELD MC, 1992, J BIOL CHEM, V267, P5324; FISCHL AS, 1986, J BIOL CHEM, V261, P3178; Gibellini F, 2009, MOL MICROBIOL, V73, P826, DOI 10.1111/j.1365-2958.2009.06764.x; Guan XL, 2008, FRONT BIOSCI-LANDMRK, V13, P3239; Guther MLS, 2006, MOL BIOL CELL, V17, P5265, DOI 10.1091/mbc.E06-08-0702; HAGER K, 1995, J MEMBRANE BIOL, V143, P103; He CY, 2004, J CELL BIOL, V165, P313, DOI 10.1083/jcb.200311076; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jin JHQ, 2003, MICROBIOL-SGM, V149, P3371, DOI 10.1099/mic.0.26644-0; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Koga Y, 2007, MICROBIOL MOL BIOL R, V71, P97, DOI 10.1128/MMBR.00033-06; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Loewus Frank A., 2006, V39, P21; Majumder AL, 2003, FEBS LETT, V553, P3, DOI 10.1016/S0014-5793(03)00974-8; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Martin KL, 2006, MOL MICROBIOL, V61, P89, DOI 10.1111/j.1365-2958.2006.05216.x; Martin KL, 2006, BIOCHEM J, V396, P287, DOI 10.1042/BJ20051825; Martin KL, 2005, BIOCHEM SOC T, V33, P983, DOI 10.1042/BST20050983; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Mongan TP, 2004, MOL BIOCHEM PARASIT, V135, P133, DOI 10.1016/j.molbiopara.2004.01.015; Morita YS, 2011, BBA-GEN SUBJECTS, V1810, P630, DOI 10.1016/j.bbagen.2011.03.017; Niederberger C, 1998, CURR GENET, V33, P255, DOI 10.1007/s002940050334; NIKAWA J, 1991, J BIOL CHEM, V266, P11184; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Pittet M, 2007, BBA-MOL CELL BIOL L, V1771, P405, DOI 10.1016/j.bbalip.2006.05.015; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Reynolds TB, 2009, MICROBIOL-SGM, V155, P1386, DOI 10.1099/mic.0.025718-0; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Schneider S, 2008, PLANT CELL, V20, P1073, DOI 10.1105/tpc.107.055632; Schneider S, 2006, PLANT PHYSIOL, V141, P565, DOI 10.1104/pp.106.077123; Serricchio M, 2011, FEBS J, V278, P1035, DOI 10.1111/j.1742-4658.2011.08012.x; Sevova ES, 2010, J BIOL CHEM, V285, P20580, DOI 10.1074/jbc.M110.127662; Seyfang A, 2000, J BIOL CHEM, V275, P5687, DOI 10.1074/jbc.275.8.5687; Seyfang A, 1997, J BIOL CHEM, V272, P24210, DOI 10.1074/jbc.272.39.24210; Sigel E, 2005, MOL NUTR FOOD RES, V49, P228, DOI 10.1002/mnfr.200400104; SIGEL E, 1987, J PHYSIOL-LONDON, V386, P73, DOI 10.1113/jphysiol.1987.sp016523; Signorell A, 2008, J BIOL CHEM, V283, P23636, DOI 10.1074/jbc.M803600200; Signorell A, 2009, MOL MICROBIOL, V72, P1068, DOI 10.1111/j.1365-2958.2009.06713.x; Smith TK, 2010, MOL BIOCHEM PARASIT, V172, P66, DOI 10.1016/j.molbiopara.2010.04.001; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sutterwala SS, 2008, MOL MICROBIOL, V70, P281, DOI 10.1111/j.1365-2958.2008.06393.x; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730	65	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13313	13323		10.1074/jbc.M112.344812	http://dx.doi.org/10.1074/jbc.M112.344812			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22351763	Green Published, hybrid			2022-12-27	WOS:000302903700067
J	Ohnishi, H; Oka, K; Mizuno, S; Nakamura, T				Ohnishi, Hiroyuki; Oka, Kiyomasa; Mizuno, Shinya; Nakamura, Toshikazu			Identification of Mannose Receptor as Receptor for Hepatocyte Growth Factor beta-Chain NOVEL LIGAND-RECEPTOR PATHWAY FOR ENHANCING MACROPHAGE PHAGOCYTOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE BIOLOGICAL RESPONSES; C-MET PROTOONCOGENE; APOPTOTIC CELLS; NEUTROPHIL ELASTASE; LIVER-REGENERATION; ENDOTHELIAL-CELLS; SERINE-PROTEASE; INVASIVE GROWTH; SCATTER FACTOR; BINDING	Hepatocyte growth factor (HGF), a heterodimer composed of the alpha-chain and beta-chain, exerts multifunctional actions for tissue repair and homeostasis via its receptor, MET. HGF is cleaved by proteases secreted from inflammatory cells, and NK4 and beta-chain remnant (HGF-beta) are generated. Here, we provide evidence that HGF-beta binds to a new receptor other than MET for promoting a host cell clearance system. By an affinity cross-linking, radiolabeled HGF-beta was bound to liver non-parenchymal cells, particularly to Kupffer cells and sinusoidal endothelial cells, but not to parenchymal hepatocytes. The cross-linked complex was immunoprecipitated by anti-HGF antibody, but not anti-MET antibody, implying that HGF-beta binds to non-parenchymal cells at a site distinct from MET. Mass spectrometric detection of the ligand receptor complex revealed that the binding site of HGF-beta was the mannose receptor (MR). Actually, an ectopic expression of MR in COS-7 cells, which express no endogenous MR or MET, enabled HGF-beta to bind these cells at a K-D of 89 nM, demonstrating that MR is the new receptor for HGF-beta. Interaction of HGF-beta and MR was diminished by EGTA, and by an enzymatic digestion of HGF-beta sugar chains, suggesting that MR may recognize the glycosylation site(s) of HGF-beta in a Ca2+-dependent fashion. Notably, HGF-beta, but not other MR ligands, enhanced the ingestion of latex beads, or of apoptotic neutrophils, by Kupffer cells, possibly via an F-actin-dependent pathway. Thus, the HGF-beta center dot MRcomplex may provide a new pathway for the enhancement of cell clearance systems, which is associated with resolution of inflammation.	[Ohnishi, Hiroyuki; Oka, Kiyomasa; Nakamura, Toshikazu] Osaka Univ, Grad Sch Med, Kringle Pharma Joint Res Div Regenerat Drug Disco, Ctr Adv Sci & Innovat, Suita, Osaka 5650871, Japan; [Mizuno, Shinya] Osaka Univ, Grad Sch Med, Div Virol, Dept Microbiol & Immunol, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Nakamura, T (corresponding author), Osaka Univ, Grad Sch Med, Kringle Pharma Joint Res Div Regenerat Drug Disco, Ctr Adv Sci & Innovat, Yamadaoka 2-1, Suita, Osaka 5650871, Japan.	nakamura@casi.osaka-u.ac.jp			Ministry of Education, Science, Technology, Sports and Culture of Japan [21390079, 23590458]; COE	Ministry of Education, Science, Technology, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); COE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work was supported by Ministry of Education, Science, Technology, Sports and Culture of Japan Grants 21390079 (to T. N.) and 23590458 (to S. M.) and the 21st Century global COE program (to T. N.).	Allavena P, 2004, CRIT REV IMMUNOL, V24, P179, DOI 10.1615/CritRevImmunol.v24.i3.20; Amanzada A, 2011, HISTOCHEM CELL BIOL, V135, P305, DOI 10.1007/s00418-011-0787-1; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Buchstein N, 2009, AM J PATHOL, V174, P2116, DOI 10.2353/ajpath.2009.080597; Campo GM, 2008, BRIT J PHARMACOL, V155, P945, DOI 10.1038/bjp.2008.338; Date K, 1997, FEBS LETT, V420, P1, DOI 10.1016/S0014-5793(97)01475-0; DeFife KM, 1999, FASEB J, V13, P823, DOI 10.1096/fasebj.13.8.823; DINI L, 1992, FEBS LETT, V296, P174, DOI 10.1016/0014-5793(92)80373-O; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; Fukuta K, 2005, BIOCHEM J, V388, P555, DOI 10.1042/BJ20041698; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105; HARA H, 1993, J BIOCHEM-TOKYO, V114, P76, DOI 10.1093/oxfordjournals.jbchem.a124143; Hart SP, 2008, METHODS, V44, P280, DOI 10.1016/j.ymeth.2007.11.009; HARTMANN G, 1992, P NATL ACAD SCI USA, V89, P11574, DOI 10.1073/pnas.89.23.11574; HIGUCHI O, 1992, FEBS LETT, V301, P282, DOI 10.1016/0014-5793(92)80257-H; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Ichinose M, 1996, PEPTIDES, V17, P1405, DOI 10.1016/S0196-9781(96)00198-2; ISHIKI Y, 1992, HEPATOLOGY, V16, P1227, DOI 10.1016/0270-9139(92)90019-6; Kawao N, 2011, THROMB HAEMOSTASIS, V105, P892, DOI 10.1160/TH10-08-0516; KINOSHITA T, 1989, BIOCHEM BIOPH RES CO, V165, P1229, DOI 10.1016/0006-291X(89)92733-2; Kirchhofer D, 2004, J BIOL CHEM, V279, P39915, DOI 10.1074/jbc.M404795200; Kosai K, 1998, BIOCHEM BIOPH RES CO, V244, P683, DOI 10.1006/bbrc.1998.8293; Kuba K, 2000, CANCER RES, V60, P6737; Kumar S, 2010, CYTOM PART A, V77A, P467, DOI 10.1002/cyto.a.20852; Kurtagic E, 2009, AM J PHYSIOL-LUNG C, V296, pL534, DOI 10.1152/ajplung.90505.2008; Kyo E, 2001, J NUTR, V131, p1075S, DOI 10.1093/jn/131.3.1075S; Leclerc L, 2010, INHAL TOXICOL, V22, P1091, DOI 10.3109/08958378.2010.522781; Linehan SA, 2001, EUR J IMMUNOL, V31, P1857, DOI 10.1002/1521-4141(200106)31:6<1857::AID-IMMU1857>3.0.CO;2-D; Lungarella G, 2008, INT J BIOCHEM CELL B, V40, P1287, DOI 10.1016/j.biocel.2007.12.008; Maderna P, 2003, BBA-MOL BASIS DIS, V1639, P141, DOI 10.1016/j.bbadis.2003.09.004; Matsumoto K, 1998, J BIOL CHEM, V273, P22913, DOI 10.1074/jbc.273.36.22913; MIZUNO K, 1994, J BIOL CHEM, V269, P1131; MIZUNO K, 1992, BIOCHEM BIOPH RES CO, V189, P1631, DOI 10.1016/0006-291X(92)90264-L; Morimoto K, 2001, AM J RESP CELL MOL, V24, P608, DOI 10.1165/ajrcmb.24.5.4292; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Nakamura T, 1997, CANCER RES, V57, P3305; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; Nakamura T, 2010, ANTI-CANCER AGENT ME, V10, P36, DOI 10.2174/1871520611009010036; Nakamura T, 2010, P JPN ACAD B-PHYS, V86, P588, DOI 10.2183/pjab.86.588; NALDINI L, 1991, EMBO J, V10, P2867, DOI 10.1002/j.1460-2075.1991.tb07836.x; Oka K, 2011, CURR SIGNAL TRANSD T, V6, P200, DOI 10.2174/157436211795659973; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; PANDIELLA A, 1991, P NATL ACAD SCI USA, V88, P1726, DOI 10.1073/pnas.88.5.1726; Raymond WW, 2006, J BIOL CHEM, V281, P1489, DOI 10.1074/jbc.M511154200; Roseman DS, 2000, P NATL ACAD SCI USA, V97, P9949, DOI 10.1073/pnas.170184597; Roszer T, 2011, J IMMUNOL, V186, P621, DOI 10.4049/jimmunol.1002230; Sakai K, 2009, J BIOL CHEM, V284, P22491, DOI 10.1074/jbc.M109.025148; SCHAFER S, 1987, HEPATOLOGY, V7, P680, DOI 10.1002/hep.1840070411; Sender V, 2011, J IMMUNOL, V186, P2397, DOI 10.4049/jimmunol.1002446; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; TAYLOR ME, 1993, J BIOL CHEM, V268, P399; Tokairin T, 2002, J HEPATOL, V36, P725, DOI 10.1016/S0168-8278(02)00048-X; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Tse SML, 2003, J BIOL CHEM, V278, P3331, DOI 10.1074/jbc.M207966200; Valenzuela-Fernandez A, 2002, J BIOL CHEM, V277, P15677, DOI 10.1074/jbc.M111388200	57	13	13	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13371	13381		10.1074/jbc.M111.318568	http://dx.doi.org/10.1074/jbc.M111.318568			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22354962	Green Published, hybrid			2022-12-27	WOS:000302903700072
J	Carbonaro, M; Escuin, D; O'Brate, A; Thadani-Mulero, M; Giannakakou, P				Carbonaro, Marisa; Escuin, Daniel; O'Brate, Aurora; Thadani-Mulero, Maria; Giannakakou, Paraskevi			Microtubules Regulate Hypoxia-inducible Factor-1 alpha Protein Trafficking and Activity IMPLICATIONS FOR TAXANE THERAPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL-CELL CARCINOMA; TUBULIN-BINDING AGENTS; NUCLEAR ACCUMULATION; CYTOPLASMIC DYNEIN; DYNACTIN COMPLEX; PROSTATE-CANCER; GENE-EXPRESSION; TRANSPORT; BETA; RESISTANCE	Disruption of the microtubule cytoskeleton impairs tumor angiogenesis by inhibiting the hypoxia-inducible factor (HIF1 alpha) pathway. However, the signaling cascade linking microtubule disruption to HIF-1 alpha inactivation has not been elucidated. Here, we show that microtubule-targeting drug (MTD) treatment impaired HIF-1 alpha protein nuclear translocation, which significantly down-regulated HIF transcriptional activity. We provide strong evidence that HIF-1 alpha protein associates with polymerized microtubules and traffics to the nucleus, with the aid of the dynein motor protein. Together, these data suggest that microtubules are critically involved in the nuclear trafficking and transcriptional activity of HIF-1 alpha. We also show that the connection between the microtubule cytoskeleton and HIF-1 alpha regulation is lost in renal cell carcinoma (RCC), where HIF-1 alpha is overexpressed because of mutations in the von Hippel Lindau (VHL) tumor suppressor protein. Specifically, we show that MTD treatment of RCC cells did not impair HIF-1 alpha nuclear accumulation or transcriptional activity, and had no effect on the polysome association profile of HIF-1 alpha. Interestingly, we found that HIF-1 alpha protein did not bind microtubules in RCC. Moreover, restoration of VHL function failed to restore the ability of MTDs to inhibit HIF-1 alpha, suggesting that VHL does not contribute to this phenotype. Together, these results suggest that HIF-1 alpha regulation is microtubule-independent, and likely contributes to the chemoresistant nature of RCCs. Further understanding of the microtubule-dependent HIF-1 alpha regulation, and lack thereof in RCC, is essential given the impor-tance of HIF-1 alpha in tumor biology, and the widespread use of MTDs in clinical oncology.	[Carbonaro, Marisa; Escuin, Daniel; O'Brate, Aurora; Thadani-Mulero, Maria; Giannakakou, Paraskevi] Cornell Univ, Weill Med Coll, Div Hematol & Med Oncol, Dept Med, New York, NY 10065 USA	Cornell University	Giannakakou, P (corresponding author), Cornell Univ, Weill Med Coll, Div Hematol & Med Oncol, Dept Med, 1300 York Ave,C610C, New York, NY 10065 USA.	pag2015@med.cornell.edu		Escuin, Daniel/0000-0003-3538-0579	National Institutes of Health [R01 CA114335, R01 CA100202, R01 CA137020]; NCI [U54 CA143876, R01 CA86335]; Entremed, Inc. [659342]; Weill Cornell Medical College (WCMC) Clinical and Translational Science Center [TL1RR024998]; NATIONAL CANCER INSTITUTE [U54CA143876, R01CA114335, R01CA086335, R01CA137020, R01CA100202] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Entremed, Inc.; Weill Cornell Medical College (WCMC) Clinical and Translational Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA114335, R01 CA100202, R01 CA137020, NCI U54 CA143876, NCI Supplement to R01 CA86335; Entremed, Inc. Grant 659342 (to P. G.), and Grant TL1RR024998 of the Weill Cornell Medical College (WCMC) Clinical and Translational Science Center (to M. C.).	AMBRON RT, 1992, J NEUROSCI, V12, P2813; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Carbonaro M, 2011, J CELL BIOL, V192, P83, DOI 10.1083/jcb.201004145; Darshan MS, 2011, CANCER RES, V71, P6019, DOI 10.1158/0008-5472.CAN-11-1417; Depping R, 2008, BBA-MOL CELL RES, V1783, P394, DOI 10.1016/j.bbamcr.2007.12.006; Derry WB, 1997, BIOCHEMISTRY-US, V36, P3554, DOI 10.1021/bi962724m; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Eckley DM, 1999, J CELL BIOL, V147, P307, DOI 10.1083/jcb.147.2.307; Escuin D, 2004, CANCER BIOL THER, V3, P608, DOI 10.4161/cbt.3.7.954; Escuin D, 2005, CANCER RES, V65, P9021, DOI 10.1158/0008-5472.CAN-04-4095; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Ferguson RE, 2005, CLIN CANCER RES, V11, P3439, DOI 10.1158/1078-0432.CCR-04-2049; Ferguson RE, 2005, INT J CANCER, V115, P155, DOI 10.1002/ijc.20816; Galigniana MD, 2004, J BIOL CHEM, V279, P22483, DOI 10.1074/jbc.M402223200; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; Giannakakou P, 2002, P NATL ACAD SCI USA, V99, P10855, DOI 10.1073/pnas.132275599; Goodson HV, 2003, CELL MOTIL CYTOSKEL, V55, P156, DOI 10.1002/cm.10114; Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899; Jordan MA, 2007, CURR CANCER DRUG TAR, V7, P730, DOI 10.2174/156800907783220417; Kaelin WG, 1998, TRENDS GENET, V14, P423, DOI 10.1016/S0168-9525(98)01558-3; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Lam MHC, 2002, MOL ENDOCRINOL, V16, P390, DOI 10.1210/me.16.2.390; Leopold PL, 2006, TRAFFIC, V7, P516, DOI 10.1111/j.1600-0854.2006.00408.x; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Mabjeesh NJ, 2002, CANCER RES, V62, P2478; Motzer RJ, 2000, J UROLOGY, V163, P408, DOI 10.1016/S0022-5347(05)67889-5; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Post DE, 2001, GENE THER, V8, P1801, DOI 10.1038/sj.gt.3301605; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Raspaglio G, 2008, GENE, V409, P100, DOI 10.1016/j.gene.2007.11.015; Schermer B, 2006, J CELL BIOL, V175, P547, DOI 10.1083/jcb.200605092; SCHNAPP BJ, 1989, P NATL ACAD SCI USA, V86, P1548, DOI 10.1073/pnas.86.5.1548; SCHROER TA, 1989, CELL, V56, P937, DOI 10.1016/0092-8674(89)90627-2; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Smith HMS, 1999, PLANT PHYSIOL, V119, P1157, DOI 10.1104/pp.119.4.1157; Thoma CR, 2007, NAT CELL BIOL, V9, P588, DOI 10.1038/ncb1579; Thoma CR, 2010, J CELL BIOL, V190, P991, DOI 10.1083/jcb.201006059; Thoma CR, 2009, NAT CELL BIOL, V11, P994, DOI 10.1038/ncb1912; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; Zhang XY, 2005, INVEST OPHTH VIS SCI, V46, P4607, DOI 10.1167/iovs.05-0571; Zhou Jun, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P65, DOI 10.2174/1568011053352569; Zhuang SH, 2005, CANCER-AM CANCER SOC, V103, P1932, DOI 10.1002/cncr.20977	44	52	53	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11859	11869		10.1074/jbc.M112.345587	http://dx.doi.org/10.1074/jbc.M112.345587			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22367210	Green Published, hybrid			2022-12-27	WOS:000302782200025
J	Wang, J; Wang, YM; Lu, L				Wang, Jie; Wang, Yumei; Lu, Luo			De-SUMOylation of CCCTC Binding Factor (CTCF) in Hypoxic Stress-induced Human Corneal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULATOR PROTEIN; C-MYC; INDUCED APOPTOSIS; GROWTH-FACTOR; SUMO PATHWAY; CHROMATIN; TRANSCRIPTION; COHESIN; GENOME; SITES	Epigenetic factor CCCTC binding factor (CTCF) plays important roles in the genetic control of cell fate. Previous studies found that CTCF is positively and negatively regulated at the transcriptional level by epidermal growth factor (EGF) and ultraviolet (UV) stimulation, respectively. However, it is unknown whether other stresses modify the CTCF protein. Here, we report that regulation of CTCF by de-SUMOylation is dependent upon hypoxic and oxidative stresses. We found that stimulation of human corneal epithelial cells with hypoxic stress suppressed a high molecular mass form of CTCF (150 kDa), but not a lower molecular weight form of CTCF (130 kDa). Further investigation revealed that the hypoxic stress-suppressed 150kDa CTCF was a small ubiquitin-related modifier (SUMO)ylated form of the protein. Hypoxic stress-induced de-SUMOylation of human CTCF was associated with lysine 74 and 689 residues, but not to the phosphorylation of CTCF. Overexpression of SENP1 induced de-SUMOylation of CTCF. However, knockdown of SENP1 could not rescue hypoxic stress-induced CTCF de-SUMOylation. Overexpression of SUMO1 and SUMO2 increased SUMOylation of CTCF and partially blocked hypoxic stress-induced CTCF de-SUMOylation, suggesting that free cellular SUMO proteins play roles in regulating hypoxia-induced CTCF de-SUMOylation. In addition, hypoxic stress significantly inhibited PAX6 mRNA and protein expressions by suppression of PAX6-P0 promoter activity. The result was further supported by data showing that knockdown of CTCF significantly enhanced expression of PAX6 and abolished hypoxia-induced suppression of PAX6. Thus, we conclude that hypoxic stress induces de-SUMOylation of CTCF to functionally regulate CTCF activity.	[Wang, Jie; Wang, Yumei; Lu, Luo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Torrance, CA 90502 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lu, L (corresponding author), 1124 W Carson St,H-H Bldg, Torrance, CA 90502 USA.	lluou@ucla.edu			National Institutes of Health [R01-EY015282]; NATIONAL EYE INSTITUTE [R01EY022364, R01EY015281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-EY015282 (to L. L.).	Agbor TA, 2008, BIOCHEM SOC T, V36, P445, DOI 10.1042/BST0360445; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Docquier F, 2009, CLIN CANCER RES, V15, P5762, DOI 10.1158/1078-0432.CCR-09-0329; El-Kady A, 2005, FEBS LETT, V579, P1424, DOI 10.1016/j.febslet.2005.01.044; Farrar D, 2010, MOL CELL BIOL, V30, P1199, DOI 10.1128/MCB.00827-09; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fink T, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-98; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Gomes NP, 2010, GENE DEV, V24, P1022, DOI 10.1101/gad.1881010; Kamitani T, 1998, J BIOL CHEM, V273, P3117, DOI 10.1074/jbc.273.6.3117; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kimura K, 2010, EXP EYE RES, V90, P337, DOI 10.1016/j.exer.2009.11.012; Kitchen NS, 2010, J CELL BIOCHEM, V111, P665, DOI 10.1002/jcb.22751; Klenova EM, 2001, MOL CELL BIOL, V21, P2221, DOI 10.1128/MCB.21.6.2221-2234.2001; Li T, 2005, J BIOL CHEM, V280, P12988, DOI 10.1074/jbc.M412458200; Li T, 2004, J BIOL CHEM, V279, P27575, DOI 10.1074/jbc.M313942200; Li T, 2007, EXP CELL RES, V313, P3057, DOI 10.1016/j.yexcr.2007.05.018; Li T, 2006, INVEST OPHTH VIS SCI, V47, P5218, DOI 10.1167/iovs.06-0254; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; Lu L, 2010, J BIOL CHEM, V285, P9373, DOI 10.1074/jbc.M109.094425; MacPherson MJ, 2009, MOL CELL BIOL, V29, P714, DOI 10.1128/MCB.00825-08; Meinecke I, 2007, P NATL ACAD SCI USA, V104, P5073, DOI 10.1073/pnas.0608773104; Morris JR, 2010, BIOCHEM SOC T, V38, P92, DOI 10.1042/BST0380092; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Tempe D, 2008, BIOCHEM SOC T, V36, P874, DOI 10.1042/BST0360874; Teranishi S, 2008, INVEST OPHTH VIS SCI, V49, P2432, DOI 10.1167/iovs.07-1464; Ulrich Helle D., 2009, V497, P3, DOI 10.1007/978-1-59745-566-4_1; Wang L, 2008, J BIOL CHEM, V283, P25928, DOI 10.1074/jbc.M801326200; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wendt KS, 2009, CHROMOSOME RES, V17, P201, DOI 10.1007/s10577-008-9017-7; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Wu D, 2006, INVEST OPHTH VIS SCI, V47, P2422, DOI 10.1167/iovs.05-0536; Yan S, 2010, EMBO J, V29, P3773, DOI 10.1038/emboj.2010.245; Yanai R, 2008, EXP EYE RES, V86, P412, DOI 10.1016/j.exer.2007.11.014; Yang W, 2008, J CEREBR BLOOD F MET, V28, P269, DOI 10.1038/sj.jcbfm.9600523; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Yun CW, 2008, J CELL BIOL, V183, P589, DOI 10.1083/jcb.200807185; Zlatanova J, 2009, J CELL SCI, V122, P1275, DOI 10.1242/jcs.039990	48	23	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12469	12479		10.1074/jbc.M111.286641	http://dx.doi.org/10.1074/jbc.M111.286641			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22354964	hybrid, Green Published			2022-12-27	WOS:000302782200086
J	Sun, LL; Chen, YX; Rajendran, C; Mueller, U; Panjikar, S; Wang, MT; Mindnich, R; Rosenthal, C; Penning, TM; Stoockigt, J				Sun, Lianli; Chen, Yixin; Rajendran, Chitra; Mueller, Uwe; Panjikar, Santosh; Wang, Meitian; Mindnich, Rebekka; Rosenthal, Cindy; Penning, Trevor M.; Stoeckigt, Joachim			Crystal Structure of Perakine Reductase, Founding Member of a Novel Aldo-Keto Reductase (AKR) Subfamily That Undergoes Unique Conformational Changes during NADPH Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-ANALYSIS; STRICTOSIDINE SYNTHASE; FUNCTIONAL EXPRESSION; DIFFRACTION DATA; ACTIVE-SITE; DEHYDROGENASE; ENZYME; BIOSYNTHESIS; CLONING; IDENTIFICATION	Background: Perakine reductase (PR) is an AKR involved in the Rauvolfia alkaloid biosynthetic network. Results: Three-dimensional structures of PR and the A213W mutant complex with NADPH were solved. Conclusion: PR folds as an unusual alpha(8)/beta(6) barrel and undergoes unexpected conformational changes upon NADPH binding. Significance: PR represents the founding member of the new AKR13D subfamily and provides a structural and cofactor binding template for the AKR13 family.	[Sun, Lianli; Chen, Yixin; Stoeckigt, Joachim] Zhejiang Univ, Coll Pharmaceut Sci, Inst Mat Med, Hangzhou 310058, Zhejiang, Peoples R China; [Rajendran, Chitra; Wang, Meitian] Paul Scherrer Inst, Swiss Light Source PX 3, CH-5232 Villigen, Switzerland; [Mueller, Uwe] Elektronenspeicherring BESSY II, BESSY MX, Soft Matter & Funct Mat, Macromol Crystallog, D-12489 Berlin, Germany; [Panjikar, Santosh] Australian Synchrotron, Clayton, Vic 3168, Australia; [Mindnich, Rebekka; Penning, Trevor M.] Univ Penn, Sch Med, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA; [Mindnich, Rebekka; Penning, Trevor M.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Rosenthal, Cindy] Johannes Gutenberg Univ Mainz, Dept Pharmaceut Biol, Inst Pharm, D-55128 Mainz, Germany	Zhejiang University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); University of Pennsylvania; University of Pennsylvania; Johannes Gutenberg University of Mainz	Stoockigt, J (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Inst Mat Med, Yuhangtang Rd 388, Hangzhou 310058, Zhejiang, Peoples R China.	joesto2000@yahoo.com	Panjikar, Santosh/D-2709-2012; Wang, Meitian/D-3208-2013; Mueller, Uwe/B-6293-2013	Panjikar, Santosh/0000-0001-7429-3879; Penning, Trevor/0000-0002-3937-1066; Wang, Meitian/0000-0002-5340-3036	Fonds der Chemischen Industrie (Frankfurt/Main, Germany); Deutsche Forschungsgemeinschaft (Bad Godesberg, Germany); Zhejiang University K.P. Chao's Hi-Tech Foundation (Hangzhou, China); China Postdoctoral Science Foundation [20100471745]	Fonds der Chemischen Industrie (Frankfurt/Main, Germany)(Fonds der Chemischen Industrie); Deutsche Forschungsgemeinschaft (Bad Godesberg, Germany)(German Research Foundation (DFG)); Zhejiang University K.P. Chao's Hi-Tech Foundation (Hangzhou, China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by funds from Fonds der Chemischen Industrie (Frankfurt/Main, Germany), Deutsche Forschungsgemeinschaft (Bad Godesberg, Germany), Zhejiang University K.P. Chao's Hi-Tech Foundation (Hangzhou, China; to J. S.), and China Postdoctoral Science Foundation Grant 20100471745 (to L. S.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bennett MJ, 1996, BIOCHEMISTRY-US, V35, P10702, DOI 10.1021/bi9604688; Cordell G.A., 1981, INTRO ALKALOIDS BIOG; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Di Costanzo L, 2008, J BIOL CHEM, V283, P16830, DOI 10.1074/jbc.M801778200; Edwankar RV, 2011, ORG LETT, V13, P5216, DOI 10.1021/ol202101p; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faucher F, 2006, J MOL BIOL, V364, P747, DOI 10.1016/j.jmb.2006.09.030; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hicks MA, 2011, PROTEINS, V79, P3082, DOI 10.1002/prot.23135; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Jin Y, 2007, ANNU REV PHARMACOL, V47, P263, DOI 10.1146/annurev.pharmtox.47.120505.105337; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kiesecker C, 2004, N-S ARCH PHARMACOL, V370, P423, DOI 10.1007/s00210-004-0976-8; Lee HY, 2009, CHEM BIOL, V16, P1225, DOI 10.1016/j.chembiol.2009.11.016; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Loris EA, 2007, CHEM BIOL, V14, P979, DOI 10.1016/j.chembiol.2007.08.009; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olsen JG, 2008, PROTEINS, V71, P1572, DOI 10.1002/prot.21996; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; PERSSON B, 1991, EUR J BIOCHEM, V200, P537, DOI 10.1111/j.1432-1033.1991.tb16215.x; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Richter N, 2010, J MOL BIOL, V404, P353, DOI 10.1016/j.jmb.2010.09.049; Rosenthal C, 2006, ACTA CRYSTALLOGR F, V62, P1286, DOI 10.1107/S174430910605041X; Runguphan W, 2010, NATURE, V468, P461, DOI 10.1038/nature09524; Ruppert M, 2005, CURR ORG CHEM, V9, P1431, DOI 10.2174/138527205774370540; RYPNIEWSKI WR, 1993, BIOCHEMISTRY-US, V32, P9851, DOI 10.1021/bi00088a041; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanli G, 2001, J MOL BIOL, V309, P1209, DOI 10.1006/jmbi.2001.4739; Sauter NK, 2010, J APPL CRYSTALLOGR, V43, P611, DOI 10.1107/S0021889810010782; Schlegel BP, 1998, BIOCHEMISTRY-US, V37, P3538, DOI 10.1021/bi9723055; Scoble J, 2010, J MOL BIOL, V398, P26, DOI 10.1016/j.jmb.2010.02.021; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Simpson PJ, 2009, J MOL BIOL, V392, P465, DOI 10.1016/j.jmb.2009.07.023; Stockigt J, 2008, PLANT PHYSIOL BIOCH, V46, P340, DOI 10.1016/j.plaphy.2007.12.011; Sun LL, 2008, PLANT MOL BIOL, V67, P455, DOI 10.1007/s11103-008-9331-7; Sundaram K, 2011, BIOORG MED CHEM LETT, V21, P801, DOI 10.1016/j.bmcl.2010.11.086; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Unterlinner B, 1999, PLANT J, V18, P465, DOI 10.1046/j.1365-313X.1999.00470.x; Yang LQ, 2009, ANGEW CHEM INT EDIT, V48, P5211, DOI 10.1002/anie.200900150; Zou HB, 2010, CHEM-ASIAN J, V5, P2400, DOI 10.1002/asia.201000520; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	46	10	12	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11213	11221		10.1074/jbc.M111.335521	http://dx.doi.org/10.1074/jbc.M111.335521			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334702	Green Published, hybrid			2022-12-27	WOS:000302780100049
J	Zhao, YJ; Wang, YS; Hu, J; Zhang, X; Zhang, YW				Zhao, Yingjun; Wang, Yunshu; Hu, Jin; Zhang, Xian; Zhang, Yun-wu			CutA Divalent Cation Tolerance Homolog (Escherichia coli) (CUTA) Regulates beta-Cleavage of beta-Amyloid Precursor Protein (APP) through Interacting with beta-Site APP Cleaving Protein 1 (BACE1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; ALZHEIMERS-DISEASE; SECRETASE ACTIVITY; MEMORY DEFICITS; CELL-SURFACE; HELA-CELLS; PHOSPHORYLATION; PRESENILIN-1; EXPRESSION; GENERATION	Background: The function of the CutA divalent cation tolerance homolog (Escherichia coli) (CUTA) is largely unknown. Results: CUTA has several isoforms, and the longest interacts with BACE1, regulates intracellular trafficking of BACE1, and affects A beta generation. Conclusion: CUTA is a novel BACE1-interacting protein and regulates the beta-cleavage of APP. Significance: CUTA may play a role in Alzheimer disease.	[Zhao, Yingjun; Wang, Yunshu; Hu, Jin; Zhang, Xian; Zhang, Yun-wu] Xiamen Univ, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen 361005, Fujian, Peoples R China	Xiamen University	Zhang, YW (corresponding author), Xiamen Univ, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen 361005, Fujian, Peoples R China.	yunzhang@xmu.edu.cn	Zhao, Yingjun/G-9173-2016; Zhang, Xian/AAV-7491-2021; Zhang, YW/G-3999-2010	Zhao, Yingjun/0000-0003-2832-6590; Zhang, Yun-wu/0000-0002-7152-7630	Alzheimer Association; National Natural Science Foundation of China [30973150, 81161120496]; 973 Prophase Project [2010CB535004]; Natural Science Foundation of Fujian Province of China [2009J06022, 2010J01235]; Program for New Century Excellent Talents in Universities; Fundamental Research Funds for the Central Universities; Fok Ying Tung Education Foundation; NATIONAL INSTITUTE ON AGING [R21AG038968] Funding Source: NIH RePORTER	Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Prophase Project(National Basic Research Program of China); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); Program for New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Alzheimer Association (to Y.- W. Z.), National Natural Science Foundation of China (Grants 30973150 and 81161120496), 973 Prophase Project (Grant 2010CB535004), and Natural Science Foundation of Fujian Province of China Grants 2009J06022 (to Y.- W. Z.) and 2010J01235 (to X. Z.).; Supported by the Program for New Century Excellent Talents in Universities, the Fundamental Research Funds for the Central Universities, and the Fok Ying Tung Education Foundation. To whom correspondence should be addressed. Tel.: 86-592-2188528; Fax: 86-592-2188528; E-mail: yunzhang@xmu.edu.cn.	Arnesano F, 2003, J BIOL CHEM, V278, P45999, DOI 10.1074/jbc.M304398200; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; FONG ST, 1995, MOL MICROBIOL, V15, P1127, DOI 10.1111/j.1365-2958.1995.tb02286.x; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Huse JT, 2002, J BIOL CHEM, V277, P16278, DOI 10.1074/jbc.M111141200; Johnston JA, 2005, BIOCHEM SOC T, V33, P1096, DOI 10.1042/BST0331096; Kwak YD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-17; Lau KF, 2000, MOL CELL NEUROSCI, V16, P557, DOI 10.1006/mcne.2000.0898; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Liang D, 2009, J BIOL CHEM, V284, P5195, DOI 10.1074/jbc.M806260200; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Murayama KS, 2006, EUR J NEUROSCI, V24, P1237, DOI 10.1111/j.1460-9568.2006.05005.x; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; Okada H, 2010, FASEB J, V24, P2783, DOI 10.1096/fj.09-146357; Perrier AL, 2000, J BIOL CHEM, V275, P34260, DOI 10.1074/jbc.M004289200; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; Savchenko A, 2004, PROTEINS, V54, P162, DOI 10.1002/prot.10585; Shi Q, 2009, J NEUROSCI, V29, P9163, DOI 10.1523/JNEUROSCI.5741-08.2009; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Tanaka Y, 2004, FEBS LETT, V556, P167, DOI 10.1016/S0014-5793(03)01402-9; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tisdale EJ, 2001, J BIOL CHEM, V276, P2480, DOI 10.1074/jbc.M007567200; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Yang JC, 2008, ACTA BIOCHIM POL, V55, P411, DOI 10.18388/abp.2008_3089; Yang JC, 2009, MOL BIOL REP, V36, P63, DOI 10.1007/s11033-007-9152-9; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3; Zhang YW, 2009, NEURON, V64, P328, DOI 10.1016/j.neuron.2009.08.036	40	18	20	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11141	11150		10.1074/jbc.M111.330209	http://dx.doi.org/10.1074/jbc.M111.330209			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22351782	Green Published, hybrid			2022-12-27	WOS:000302780100042
J	Muer, A; Overkamp, T; Gillissen, B; Richter, A; Pretzsch, T; Milojkovic, A; Dorken, B; Daniel, PT; Hemmati, P				Mueer, Annika; Overkamp, Tim; Gillissen, Bernd; Richter, Antje; Pretzsch, Thomas; Milojkovic, Ana; Doerken, Bernd; Daniel, Peter T.; Hemmati, Philipp			p14(ARF)-induced Apoptosis in p53 Protein-deficient Cells Is Mediated by BH3-only Protein-independent Derepression of Bak Protein through Down-regulation of Mcl-1 and Bcl-x(L) Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; BCL-2 FAMILY; MITOCHONDRIAL APOPTOSIS; P53-INDEPENDENT APOPTOSIS; P53-DEPENDENT APOPTOSIS; CYCLE ARREST; ARF; DEATH; ACTIVATION; INDUCTION	The p14(ARF) tumor suppressor plays a central role in regulating cell cycle arrest and apoptosis. We reported previously that p14(ARF) is capable of triggering apoptosis in a p53-independent manner. However, the mechanism remained unclear. Here we demonstrate that the p53-independent activation of the mitochondrial apoptosis pathway by p14(ARF) is primarily mediated by the pro-apoptotic Bax-homolog Bak. Expression of p14(ARF) exclusively triggers a N-terminal conformational switch of Bak, but not Bax, which allows for mitochondrial permeability shift, release of cytochrome c, activation of caspases, and subsequent fragmentation of genomic DNA. Although forced expression of Bak markedly sensitizes toward p14(ARF)-induced apoptosis, re-expression of Bax has no effect. Vice versa, knockdown of Bak by RNA interference attenuates p14(ARF)-induced apoptosis, whereas down-regulation of Bax has no effect. Bak activation coincides with a prominent, caspase-independent deprivation of the endogenous Bak inhibitors Mcl-1 and Bcl-x(L). In turn, mitochondrial apoptosis is fully blocked by overexpression of either Mcl-1 or Bcl-x(L). Taken together, these data indicate that in the absence of functional p53 and Bax, p14(ARF) triggers mitochondrial apoptosis signaling by activating Bak, which is facilitated by down-regulating anti-apoptotic Mcl-1 and Bcl-x(L). Moreover, our data suggest that the simultaneous inhibition of two central endogenous Bak inhibitors, i.e. Mcl-1 and Bcl-x(L), may be sufficient to activate mitochondrial apoptosis in the absence of BH3-only protein regulation.	[Daniel, Peter T.] Charite, ECRC, Max Delbruck Ctr Mol Med Clin & Mol Oncol, D-13125 Berlin, Germany; [Mueer, Annika; Overkamp, Tim; Gillissen, Bernd; Richter, Antje; Milojkovic, Ana; Doerken, Bernd; Daniel, Peter T.; Hemmati, Philipp] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Pretzsch, Thomas; Doerken, Bernd; Daniel, Peter T.; Hemmati, Philipp] Charite, Dept Hematol Oncol & Tumor Immunol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Daniel, PT (corresponding author), Charite, ECRC, Max Delbruck Ctr Mol Med Clin & Mol Oncol, Campus Berlin Buch,Lindenberger Weg 80, D-13125 Berlin, Germany.	pdaniel@mdc-berlin.de		Milojkovic, Ana/0000-0001-7505-9996; Gillissen, Bernhard/0000-0002-1815-2091				Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Bornkamm GW, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni137; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Cartron PF, 2003, MOL CELL BIOL, V23, P4701, DOI 10.1128/MCB.23.13.4701-4712.2003; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Czabotar PE, 2009, CELL DEATH DIFFER, V16, P1187, DOI 10.1038/cdd.2009.83; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; DURO D, 1995, ONCOGENE, V11, P21; Eymin B, 2001, ONCOGENE, V20, P1033, DOI 10.1038/sj.onc.1204220; Eymin B, 2003, ONCOGENE, V22, P1822, DOI 10.1038/sj.onc.1206303; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Gelinas W, 2005, GENE DEV, V19, P1263, DOI 10.1101/gad.1326205; Giam M, 2008, ONCOGENE, V27, pS128, DOI 10.1038/onc.2009.50; Gillissen B, 2003, EMBO J, V22, P3580, DOI 10.1093/emboj/cdg343; Gillissen B, 2007, J CELL BIOL, V179, P701, DOI 10.1083/jcb.200703040; Gillissen B, 2010, J CELL BIOL, V188, P851, DOI 10.1083/jcb.200912070; Hasenjager A, 2004, ONCOGENE, V23, P4523, DOI 10.1038/sj.onc.1207594; Hemmati PG, 2006, ONCOGENE, V25, P6582, DOI 10.1038/sj.onc.1209668; Hemmati PG, 2005, ONCOGENE, V24, P4114, DOI 10.1038/sj.onc.1208579; Hemmati PG, 2002, ONCOGENE, V21, P3149, DOI 10.1038/sj.onc.1205458; Hemmati PG, 2010, J MOL MED, V88, P609, DOI 10.1007/s00109-010-0606-5; Hikita H, 2009, HEPATOLOGY, V50, P1217, DOI 10.1002/hep.23126; Inoue R, 1999, ANTICANCER RES, V19, P2939; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Lindenboim L, 2005, CELL DEATH DIFFER, V12, P713, DOI 10.1038/sj.cdd.4401638; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; MAO L, 1995, CANCER RES, V55, P2995; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Normand G, 2005, J BIOL CHEM, V280, P7118, DOI 10.1074/jbc.M412330200; Ozenne P, 2010, INT J CANCER, V127, P2239, DOI 10.1002/ijc.25511; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Pardo J, 2006, J CELL BIOL, V174, P509, DOI 10.1083/jcb.200604044; Pimkina J, 2009, J BIOL CHEM, V284, P2803, DOI 10.1074/jbc.M804705200; QUELLE DE, 1995, CELL, V83, P993; Radfar A, 1998, P NATL ACAD SCI USA, V95, P13194, DOI 10.1073/pnas.95.22.13194; Reef S, 2006, MOL CELL, V22, P463, DOI 10.1016/j.molcel.2006.04.014; Rocha S, 2005, EMBO J, V24, P1157, DOI 10.1038/sj.emboj.7600608; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; STONE S, 1995, CANCER RES, V55, P2988; Sturm I, 2006, CELL DEATH DIFFER, V13, P619, DOI 10.1038/sj.cdd.4401782; Suzuki H, 2003, BIOCHEM BIOPH RES CO, V312, P1273, DOI 10.1016/j.bbrc.2003.11.071; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Theodorakis P, 2002, CANCER RES, V62, P3373; Tsuji K, 2002, BIOCHEM BIOPH RES CO, V295, P621, DOI 10.1016/S0006-291X(02)00723-4; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; von Haefen C, 2004, ONCOGENE, V23, P8320, DOI 10.1038/sj.onc.1207971; Warr MR, 2008, CURR MOL MED, V8, P138; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wendt J, 2005, ONCOGENE, V24, P4052, DOI 10.1038/sj.onc.1208580; Westphal D, 2011, BBA-MOL CELL RES, V1813, P521, DOI 10.1016/j.bbamcr.2010.12.019; Williams RT, 2006, P NATL ACAD SCI USA, V103, P6688, DOI 10.1073/pnas.0602030103; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhai DY, 2008, J BIOL CHEM, V283, P9580, DOI 10.1074/jbc.M708426200; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	67	19	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17343	17352		10.1074/jbc.M111.314898	http://dx.doi.org/10.1074/jbc.M111.314898			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22354970	Green Published, hybrid			2022-12-27	WOS:000306373000034
J	Stankiewicz, TR; Loucks, FA; Schroeder, EK; Nevalainen, MT; Tyler, KL; Aktories, K; Bouchard, RJ; Linseman, DA				Stankiewicz, Trisha R.; Loucks, F. Alexandra; Schroeder, Emily K.; Nevalainen, Marja T.; Tyler, Kenneth L.; Aktories, Klaus; Bouchard, Ron J.; Linseman, Daniel A.			Signal Transducer and Activator of Transcription-5 Mediates Neuronal Apoptosis Induced by Inhibition of Rac GTPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JANUS KINASE/SIGNAL TRANSDUCER; CEREBELLAR GRANULE NEURONS; CELL-DEATH; RHO-FAMILY; CUCURBITACIN-I; CANCER-CELLS; IFN-GAMMA; BCL-X; PATHWAY; STAT5	In several neuronal cell types, the small GTPase Rac is essential for survival. We have shown previously that the Rho family GTPase inhibitor Clostridium difficile toxin B (ToxB) induces apoptosis in primary rat cerebellar granule neurons (CGNs) principally via inhibition of Rac GTPase function. In the present study, incubation with ToxB activated a proapoptotic Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway, and a pan-JAK inhibitor protected CGNs from Rac inhibition. STAT1 expression was induced by ToxB; however, CGNs from STAT1 knock-out mice succumbed to ToxB-induced apoptosis as readily as wild-type CGNs. STAT3 displayed enhanced tyrosine phosphorylation following treatment with ToxB, and a reputed inhibitor of STAT3, cucurbitacin (JSI-124), reduced CGN apoptosis. Unexpectedly, JSI-124 failed to block STAT3 phosphorylation, and CGNs were not protected from ToxB by other known STAT3 inhibitors. In contrast, STAT5A tyrosine phosphorylation induced by ToxB was suppressed by JSI-124. In addition, roscovitine similarly inhibited STAT5A phosphorylation and protected CGNs from ToxB-induced apoptosis. Consistent with these results, adenoviral infection with a dominant negative STAT5 mutant, but not wild-type STAT5, significantly decreased ToxB-induced apoptosis of CGNs. Finally, chromatin immunoprecipitation with a STAT5 antibody revealed increased STAT5 binding to the promoter region of prosurvival Bcl-xL. STAT5 was recruited to the Bcl-xL promoter region in a ToxB-dependent manner, and this DNA binding preceded Bcl-xL down-regulation, suggesting transcriptional repression. These data indicate that a novel JAK/STAT5 proapoptotic pathway significantly contributes to neuronal apoptosis induced by the inhibition of Rac GTPase.	[Loucks, F. Alexandra; Schroeder, Emily K.; Bouchard, Ron J.; Linseman, Daniel A.] Vet Affairs Med Ctr, Res Serv, Denver, CO 80220 USA; [Stankiewicz, Trisha R.; Linseman, Daniel A.] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA; [Stankiewicz, Trisha R.; Linseman, Daniel A.] Univ Denver, Eleanor Roosevelt Inst, Denver, CO 80208 USA; [Nevalainen, Marja T.] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA; [Nevalainen, Marja T.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Tyler, Kenneth L.] Univ Colorado Denver, Dept Neurol, Aurora, CO 80045 USA; [Linseman, Daniel A.] Univ Colorado Denver, Dept Med, Div Clin Pharmacol & Toxicol, Aurora, CO 80045 USA; Univ Colorado Denver, Neurosci Program, Aurora, CO 80045 USA; [Aktories, Klaus] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, D-79104 Freiburg, Germany	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Denver; University of Denver; Jefferson University; Jefferson University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Freiburg	Linseman, DA (corresponding author), Vet Affairs Med Ctr, Res Serv, 1055 Clermont St, Denver, CO 80220 USA.	Dan.Linseman@va.gov	Aktories, Klaus/CAJ-5682-2022; Tyler, Kenneth L./J-2420-2019; Linseman, Daniel/L-3846-2019	Aktories, Klaus/0000-0002-5397-0436; Tyler, Kenneth L./0000-0003-3294-5888; 	National Institutes of Health from NINDS [R01 NS062766]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA113580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062766] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS062766 from the NINDS (to D. A. L.). This work was also supported by a merit review award from the Department of Veterans Affairs (to D. A. L.).	Ahonen TJ, 2003, J BIOL CHEM, V278, P27287, DOI 10.1074/jbc.M304307200; AlShami A, 1997, BLOOD, V89, P1035, DOI 10.1182/blood.V89.3.1035; Bingisser RM, 1998, J IMMUNOL, V160, P5729; Blaskovich MA, 2003, CANCER RES, V63, P1270; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Borland G, 2009, J BIOL CHEM, V284, P17391, DOI 10.1074/jbc.M109.015370; Byts N, 2008, CELL DEATH DIFFER, V15, P783, DOI 10.1038/cdd.2008.1; Cavalcanti E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/935764; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; Chipoy C, 2007, ONCOGENE, V26, P6653, DOI 10.1038/sj.onc.1210492; Choi JK, 2011, APOPTOSIS, V16, P127, DOI 10.1007/s10495-010-0552-2; Chughtai N, 2002, J BIOL CHEM, V277, P31107, DOI 10.1074/jbc.M200156200; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Colodner KJ, 2010, J NEUROSCI, V30, P16102, DOI 10.1523/JNEUROSCI.2491-10.2010; Contestabile A., 2002, CEREBELLUM, V1, P41; Cooney RN, 2002, SHOCK, V17, P83, DOI 10.1097/00024382-200202000-00001; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Dedoni S, 2010, J NEUROCHEM, V115, P1421, DOI 10.1111/j.1471-4159.2010.07046.x; Edamatsu H, 2000, ONCOGENE, V19, P3059, DOI 10.1038/sj.onc.1203625; Faderl S, 2003, BLOOD, V102, P630, DOI 10.1182/blood-2002-06-1890; Fukata M, 1999, J BIOL CHEM, V274, P26044, DOI 10.1074/jbc.274.37.26044; Giunta B, 2006, BRAIN RES, V1123, P216, DOI 10.1016/j.brainres.2006.09.057; Graness A, 2006, BIOCHEM PHARMACOL, V72, P32, DOI 10.1016/j.bcp.2006.04.001; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Igaz P, 2001, INFLAMM RES, V50, P435, DOI 10.1007/PL00000267; Jacquier A, 2006, ANN NEUROL, V60, P105, DOI 10.1002/ana.20886; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kaganoi J, 2007, ANN SURG ONCOL, V14, P1405, DOI 10.1245/s10434-006-9274-7; Kanekura K, 2005, J BIOL CHEM, V280, P4532, DOI 10.1074/jbc.M410508200; Kim WH, 2003, AM J PHYSIOL-GASTR L, V285, pG761, DOI 10.1152/ajpgi.00224.2003; Kobayashi K, 2004, J NEUROSCI, V24, P3480, DOI 10.1523/JNEUROSCI.0295-04.2004; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Li MT, 2001, J NEUROSCI, V21, P6544, DOI 10.1523/JNEUROSCI.21-17-06544.2001; Linseman DA, 2001, J BIOL CHEM, V276, P39123, DOI 10.1074/jbc.M103959200; Loucks FA, 2006, J NEUROCHEM, V97, P957, DOI 10.1111/j.1471-4159.2006.03802.x; Makela J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011091; Martin P, 2010, MOL CELL BIOL, V30, P4877, DOI 10.1128/MCB.00456-10; Mohapatra S, 2003, CANCER RES, V63, P8523; Moucadel V, 2005, J BIOL CHEM, V280, P13364, DOI 10.1074/jbc.M407326200; Nelson EA, 2004, J BIOL CHEM, V279, P54724, DOI 10.1074/jbc.M408464200; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Rigacci S, 2003, BIOCHEM BIOPH RES CO, V312, P360, DOI 10.1016/j.bbrc.2003.10.126; Rocha-Viegas L, 2006, J BIOL CHEM, V281, P33959, DOI 10.1074/jbc.M602408200; Rosen RL, 1996, BLOOD, V88, P1206, DOI 10.1182/blood.V88.4.1206.bloodjournal8841206; Sahni M, 2001, DEVELOPMENT, V128, P2119; Sironi JJ, 2004, J BIOL CHEM, V279, P4066, DOI 10.1074/jbc.M307774200; Soond SM, 2007, FEBS LETT, V581, P1217, DOI 10.1016/j.febslet.2007.02.049; Stephanou A, 2003, INT J EXP PATHOL, V84, P239, DOI 10.1111/j.0959-9673.2003.00363.x; Storz P, 1999, FEBS LETT, V464, P159, DOI 10.1016/S0014-5793(99)01689-0; Takagi Y, 2002, J CEREBR BLOOD F MET, V22, P1311, DOI 10.1097/01.WCB.0000034148.72481.F4; Tanaka T, 2000, J NEUROSCI, V20, P2852; Terstegen L, 2000, J BIOL CHEM, V275, P18810, DOI 10.1074/jbc.M904148199; Thomas M, 2004, CANCER RES, V64, P8357, DOI 10.1158/0008-5472.CAN-04-1864; Um M, 2006, J BIOL CHEM, V281, P5648, DOI 10.1074/jbc.M510943200; Vaudry D, 2003, J NEUROSCI RES, V72, P303, DOI 10.1002/jnr.10530; Wan J, 2010, J NEUROSCI, V30, P6873, DOI 10.1523/JNEUROSCI.0519-10.2010; Wang DM, 1996, MOL CELL BIOL, V16, P6141; WATSON CJ, 1995, BRIT J CANCER, V71, P840, DOI 10.1038/bjc.1995.162; Xu J, 2009, J NEUROSCI, V29, P2022, DOI 10.1523/JNEUROSCI.2621-08.2009; Yamauchi-Takihara K, 2000, INT J EXP PATHOL, V81, P1; Zhang J, 2008, VIROLOGY, V379, P306, DOI 10.1016/j.virol.2008.06.035; Zhu MH, 1999, CELL, V96, P121, DOI 10.1016/S0092-8674(00)80965-4	67	18	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16835	16848		10.1074/jbc.M111.302166	http://dx.doi.org/10.1074/jbc.M111.302166			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22378792	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000304030900070
J	Carroll, SH; Wigner, NA; Kulkarni, N; Johnston-Cox, H; Gerstenfeld, LC; Ravid, K				Carroll, Shannon H.; Wigner, Nathan A.; Kulkarni, Nitin; Johnston-Cox, Hillary; Gerstenfeld, Louis C.; Ravid, Katya			A2B Adenosine Receptor Promotes Mesenchymal Stem Cell Differentiation to Osteoblasts and Bone Formation in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARROW STROMAL CELLS; SMOOTH-MUSCLE-CELLS; OSTEOGENIC DIFFERENTIATION; FRACTURE REPAIR; EXPRESSION; ACTIVATION; RELEASE; PROTEIN; VITRO; GENE	The differentiation of osteoblasts from their precursors, mesenchymal stem cells, is an important component of bone homeostasis as well as fracture healing. The A2B adenosine receptor (A2BAR) is a G alpha(s)/alpha(q)-protein-coupled receptor that signals via cAMP. cAMP-mediated signaling has been demonstrated to regulate the differentiation of mesenchymal stem cells (MSCs) into various skeletal tissue lineages. Here, we studied the role of this receptor in the differentiation of MSCs to osteoblasts. In vitro differentiation of bone marrow-derived MSCs from A2BAR KO mice resulted in lower expression of osteoblast differentiation transcription factors and the development of fewer mineralized nodules, as compared with WT mice. The mechanism of effect involves, at least partially, cAMP as indicated by experiments involving activation of the A2BAR or addition of a cAMP analog during differentiation. Intriguingly, in vivo, microcomputed tomography analysis of adult femurs showed lower bone density in A2BAR KO mice as compared with WT. Furthermore, A2BAR KO mice display a delay in normal fracture physiology with lower expression of osteoblast differentiation genes. Thus, our study identified the A2BAR as a new regulator of osteoblast differentiation, bone formation, and fracture repair.	[Ravid, Katya] Boston Univ, Sch Med, CVI, Dept Biochem, Boston, MA 02118 USA; [Wigner, Nathan A.; Kulkarni, Nitin; Gerstenfeld, Louis C.] Boston Univ, Sch Med, Dept Orthoped Surg, Boston, MA 02118 USA; [Johnston-Cox, Hillary; Ravid, Katya] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Ravid, K (corresponding author), Boston Univ, Sch Med, CVI, Dept Biochem, W-601,700 Albany St, Boston, MA 02118 USA.	kravid@bu.edu		Ravid, Katya/0000-0002-9918-3024; /0000-0002-0477-1211	National Institutes of Health [HL93149, AR046121]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007501, R01HL093149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL93149 (to K. R.). This work was also supported in part by National Institutes of Health Grant AR046121.	Costa MA, 2011, J CELL PHYSIOL, V226, P1353, DOI 10.1002/jcp.22458; Aherne CM, 2011, BBA-BIOMEMBRANES, V1808, P1329, DOI 10.1016/j.bbamem.2010.05.016; Aspenberg P, 2010, ACTA ORTHOP, V81, P236, DOI 10.3109/17453671003761946; Aspenberg P, 2010, J BONE MINER RES, V25, P404, DOI 10.1359/jbmr.090731; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Borjesson AE, 2010, J BONE MINER RES, V25, P2414, DOI 10.1002/jbmr.156; Colnot C, 2004, DEV BIOL, V269, P55, DOI 10.1016/j.ydbio.2004.01.011; Datta NS, 2009, CELL SIGNAL, V21, P1245, DOI 10.1016/j.cellsig.2009.02.012; Edgar CM, 2007, BONE, V40, P1389, DOI 10.1016/j.bone.2007.01.001; Evans BAJ, 2006, J BONE MINER RES, V21, P228, DOI 10.1359/JBMR.051021; Evans K, 2006, PERCEPT MOTOR SKILL, V103, P619, DOI 10.2466/PMS.103.2.619-628; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Gharibi B, 2011, J BONE MINER RES, V26, P2112, DOI 10.1002/jbmr.424; Ghayor C, 2009, BIOCHEM BIOPH RES CO, V381, P247, DOI 10.1016/j.bbrc.2009.02.032; Gilbert L, 2002, J BIOL CHEM, V277, P2695, DOI 10.1074/jbc.M106339200; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; Gruber R, 2006, EXP GERONTOL, V41, P1080, DOI 10.1016/j.exger.2006.09.008; Hilaire CS, 2008, BIOCHEM BIOPH RES CO, V375, P292, DOI 10.1016/j.bbrc.2008.07.059; Hoebertz A, 2003, TRENDS PHARMACOL SCI, V24, P290, DOI 10.1016/S0165-6147(03)00123-8; Iwamoto T, 2010, J BIOL CHEM, V285, P18948, DOI 10.1074/jbc.M110.127027; Jepsen KJ, 2008, J BONE MINER RES, V23, P1204, DOI 10.1359/JBMR.080317; Jorgensen Niklas R, 2011, Curr Osteoporos Rep, V9, P149, DOI 10.1007/s11914-011-0065-0; Kawai M, 2011, NAT REV DRUG DISCOV, V10, P141, DOI 10.1038/nrd3299; Khosla S, 2010, STEM CELLS, V28, P2124, DOI 10.1002/stem.546; Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004; Koolpe M, 1999, ARTHRITIS RHEUM, V42, P258, DOI 10.1002/1529-0131(199902)42:2<258::AID-ANR7>3.0.CO;2-O; Lanske B, 1999, J CLIN INVEST, V104, P399, DOI 10.1172/JCI6629; Lo KWH, 2012, J TISSUE ENG REGEN M, V6, P40, DOI 10.1002/term.395; Lu XH, 2006, J BIOL CHEM, V281, P6297, DOI 10.1074/jbc.M507804200; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Mauney JR, 2005, TISSUE ENG, V11, P787, DOI 10.1089/ten.2005.11.787; Nagata A, 2009, J CELL PHYSIOL, V221, P75, DOI 10.1002/jcp.21831; Naot D, 2008, BONE, V43, P813, DOI 10.1016/j.bone.2008.07.003; Orriss IR, 2009, J CELL PHYSIOL, V220, P155, DOI 10.1002/jcp.21745; PLESHKO N, 1991, BIOPHYS J, V60, P786, DOI 10.1016/S0006-3495(91)82113-0; Ravid K, 1999, J CELL BIOCHEM, V75, P177, DOI 10.1002/(SICI)1097-4644(19991001)75:1<177::AID-JCB18>3.3.CO;2-N; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Siddappa R, 2008, P NATL ACAD SCI USA, V105, P7281, DOI 10.1073/pnas.0711190105; Siddappa R, 2009, TISSUE ENG PT A, V15, P2135, DOI 10.1089/ten.tea.2008.0512; Sugama R, 2006, BONE, V38, P206, DOI 10.1016/j.bone.2005.08.006; Tai GP, 2004, TISSUE ENG, V10, P1456, DOI 10.1089/1076327042500300; Takedachi M, 2012, J CELL PHYSIOL, V227, P2622, DOI 10.1002/jcp.23001; Tsuda M, 2003, J BIOL CHEM, V278, P27224, DOI 10.1074/jbc.M303471200; TURKSEN K, 1990, J CELL PHYSIOL, V142, P61, DOI 10.1002/jcp.1041420109; Wigner NA, 2010, J BONE MINER RES, V25, P724, DOI 10.1359/jbmr.091021; Xu Y, 2008, J BIOL CHEM, V283, P14213, DOI 10.1074/jbc.M708657200; Yang D, 2008, P NATL ACAD SCI USA, V105, P792, DOI 10.1073/pnas.0705563105; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933; Zhao ZR, 2005, MOL THER, V12, P247, DOI 10.1016/j.ymthe.2005.03.009	52	121	125	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15718	15727		10.1074/jbc.M112.344994	http://dx.doi.org/10.1074/jbc.M112.344994			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22403399	Green Published, hybrid			2022-12-27	WOS:000304006300050
J	Jalan-Sakrikar, N; Bartlett, RK; Baucum, AJ; Colbran, RJ				Jalan-Sakrikar, Nidhi; Bartlett, Ryan K.; Baucum, Anthony J., II; Colbran, Roger J.			Substrate-selective and Calcium-independent Activation of CaMKII by alpha-Actinin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-II; HIPPOCAMPAL-NEURONS; REGULATORY PHOSPHORYLATION; SYNAPTIC PLASTICITY; BINDING DOMAIN; NR2B SUBUNIT; RECEPTOR; NMDA; CALMODULIN; CALCIUM/CALMODULIN	Protein-protein interactions are thought to modulate the efficiency and specificity of Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) signaling in specific subcellular compartments. Here we show that the F-actin-binding protein alpha-actinin targets CaMKII alpha to F-actin in cells by binding to the CaMKII regulatory domain, mimicking CaM. The interaction with alpha-actinin is blocked by CaMKII autophosphorylation at Thr-306, but not by autophosphorylation at Thr-305, whereas autophosphorylation at either site blocks Ca2+/CaM binding. The binding of alpha-actinin to CaMKII is Ca2+-independent and activates the phosphorylation of a subset of substrates in vitro. In intact cells, alpha-actinin selectively stabilizes CaMKII association with GluN2B-containing glutamate receptors and enhances phosphorylation of Ser-1303 in GluN2B, but inhibits CaMKII phosphorylation of Ser-831 in glutamate receptor GluA1 subunits by competing for activation by Ca2+/CaM. These data show that Ca2+-independent binding of alpha-actinin to CaMKII differentially modulates the phosphorylation of physiological targets that play key roles in long-term synaptic plasticity.	[Colbran, Roger J.] Vanderbilt Univ, Med Ctr, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Colbran, Roger J.] Vanderbilt Univ, Vanderbilt Brain Inst, Sch Med, Nashville, TN 37232 USA; [Colbran, Roger J.] Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Colbran, RJ (corresponding author), Vanderbilt Univ, Med Ctr, Sch Med, Dept Mol Physiol & Biophys, 702 Light Hall, Nashville, TN 37232 USA.	ryan.k.bartlett@monsanto.com; roger.colbran@vanderbilt.edu	Colbran, Roger/AAU-7708-2021; Jalan-Sakrikar, Nidhi/S-8653-2019; Baucum, Anthony/I-5109-2013	Colbran, Roger/0000-0001-7401-8244; Jalan-Sakrikar, Nidhi/0000-0001-6795-0121; Baucum, Anthony/0000-0002-4756-9865	National Institutes of Health [R01-MH063232, T32-DK07563]; AHA [0815090E, 0625289B]; NIH [CA68485, DK20593, DK58404, HD15052, DK59637, EY08126]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637, P30DK058404, U2CDK059637, T32DK007563, P30DK020593, P60DK020593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part by National Institutes of Health Grants R01-MH063232 (to R. J. C.) and T32-DK07563 (to R. K. B.), and AHA Grants 0815090E (to N. J.-S.) and 0625289B (to R. K. B.). Fluorescence microscopy was performed in the VUMC Cell Imaging Shared Resource, supported by NIH grants CA68485, DK20593, DK58404, HD15052, DK59637, and EY08126.	Allison DW, 2000, J NEUROSCI, V20, P4545, DOI 10.1523/JNEUROSCI.20-12-04545.2000; Allison DW, 1998, J NEUROSCI, V18, P2423; Atkinson RA, 2001, NAT STRUCT BIOL, V8, P853, DOI 10.1038/nsb1001-853; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Baucum AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031554; Baucum AJ, 2010, MOL CELL PROTEOMICS, V9, P1243, DOI 10.1074/mcp.M900387-MCP200; Bayer KM, 2001, BIOCHEM BIOPH RES CO, V289, P917, DOI 10.1006/bbrc.2001.6063; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; BLANCHARD A, 1989, J MUSCLE RES CELL M, V10, P280, DOI 10.1007/BF01758424; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; Dhavan R, 2002, J NEUROSCI, V22, P7879; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Evans TIA, 2009, PROTEINS, V76, P47, DOI 10.1002/prot.22317; Feng BH, 2011, BRAIN RES, V1419, P46, DOI 10.1016/j.brainres.2011.08.051; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Forest A, 2008, BIOCHEMISTRY-US, V47, P10587, DOI 10.1021/bi8007033; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Griffith Leslie C, 2003, Mol Interv, V3, P386, DOI 10.1124/mi.3.7.386; Halt AR, 2012, EMBO J, V31, P1203, DOI 10.1038/emboj.2011.482; Hoffman L, 2011, EMBO J, V30, P1251, DOI 10.1038/emboj.2011.40; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Jama AM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.157057; Jiao YX, 2008, J NEUROCHEM, V105, P1746, DOI 10.1111/j.1471-4159.2008.05280.x; Jiao YX, 2011, J BIOL CHEM, V286, P24806, DOI 10.1074/jbc.M110.216010; KHOORY W, 1993, J CELL SCI, V106, P703; Kristensen AS, 2011, NAT NEUROSCI, V14, P727, DOI 10.1038/nn.2804; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Leonard AS, 2002, J BIOL CHEM, V277, P48441, DOI 10.1074/jbc.M205164200; Lin YC, 2008, P NATL ACAD SCI USA, V105, P15791, DOI 10.1073/pnas.0804399105; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; Merrill MA, 2007, BIOCHEMISTRY-US, V46, P8485, DOI 10.1021/bi0623025; Michailidis IE, 2007, J NEUROSCI, V27, P5523, DOI 10.1523/JNEUROSCI.4378-06.2007; O'Leary H, 2011, J BIOL CHEM, V286, P31272, DOI 10.1074/jbc.M111.233668; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Pi HJ, 2010, P NATL ACAD SCI USA, V107, P14437, DOI 10.1073/pnas.1009268107; Pi HJ, 2010, J NEUROSCI, V30, P8704, DOI 10.1523/JNEUROSCI.0133-10.2010; Pradeep KK, 2009, BIOCHEM J, V419, P123, DOI 10.1042/BJ20081707; Robison AJ, 2005, J BIOL CHEM, V280, P39316, DOI 10.1074/jbc.M508189200; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; Sessoms-Sikes S, 2005, MOL CELL NEUROSCI, V29, P139, DOI 10.1016/j.mcn.2005.01.006; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shifman JM, 2006, P NATL ACAD SCI USA, V103, P13968, DOI 10.1073/pnas.0606433103; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; Strack S, 2000, J BIOL CHEM, V275, P25061, DOI 10.1074/jbc.C000319200; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Swulius MT, 2008, CELL MOL LIFE SCI, V65, P2637, DOI 10.1007/s00018-008-8086-2; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Wyszynski M, 1998, J NEUROSCI, V18, P1383; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X; Zhou Y, 2007, J NEUROSCI, V27, P13843, DOI 10.1523/JNEUROSCI.4486-07.2007	62	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15275	15283		10.1074/jbc.M112.351817	http://dx.doi.org/10.1074/jbc.M112.351817			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427672	hybrid, Green Published			2022-12-27	WOS:000304006300011
J	Jones, MB; Nasirikenari, M; Lugade, AA; Thanavala, Y; Lau, JTY				Jones, Mark B.; Nasirikenari, Mehrab; Lugade, Amit A.; Thanavala, Yasmin; Lau, Joseph T. Y.			Anti-inflammatory IgG Production Requires Functional P1 Promoter in beta-Galactoside alpha 2,6-Sialyltransferase 1 (ST6Gal-1) Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-G GALACTOSYLATION; INTRAVENOUS IMMUNOGLOBULIN; SIALYLTRANSFERASE; EXPRESSION; INFLAMMATION; SIALYLATION; DEFICIENCY; MICE; PROFILE	The anti-inflammatory properties associated with intravenous immunoglobulin therapy require the sialic acid modification of the N-glycan of the Fc domain of IgG. Sialylation of the Fc fragment is mediated by beta-galactoside alpha 2,6-sialyltransferase 1 (ST6Gal-1), acting on the Gal(beta 4)GlcNAc terminal structure of the biantennary N-glycans on the Fc domain. However, little is known regarding the in vivo regulation of Fc sialylation and its role in the progression of inflammatory processes. Here, we report that decreased Fc sialylation of circulatory IgG accompanies the acute phase response elicited by turpentine exposure or upon acute exposure to either nontypeable Haemophilus influenzae or ovalbumin. However, Fc sialylation was increased 3-fold from the base line upon transition to chronic inflammation by repeated exposure to challenge. The P1 promoter of the ST6Gal-1 gene is critical for Fc sialylation, but P1 does not drive ST6Gal-1 expression in B cells. The Siat1 Delta P1 mouse, with a dysfunctional P1 promoter, was unable to produce sialylated Fc in the systemic circulation, despite the presence of Gal(beta 4) GlcNAc termini on the Fc glycans. The major contribution of P1 action is to synthesize ST6Gal-1 enzymes that are deposited into the systemic circulation. The data strongly indicate that this pool of extracellular ST6Gal-1 in the blood impacts the sialylation of IgG Fc and that defective Fc sialylation is likely a major contributing mechanism for the proinflammatory tendencies previously noted in Siat1 Delta P1 animals.	[Jones, Mark B.; Nasirikenari, Mehrab; Lau, Joseph T. Y.] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; [Lugade, Amit A.; Thanavala, Yasmin] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute	Lau, JTY (corresponding author), Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Elm & Carlton St, Buffalo, NY 14263 USA.	joseph.lau@roswellpark.org			National Institutes of Health [R01AI38193, P01HL107146, R01 AI069379]; National Cancer Institute Cancer Center [CA16056]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI069379, R01AI056082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI38193 and P01HL107146 (to J. T. Y. L.) and R01 AI069379 (to Y. T). The core facilities used in this work were supported in part by National Cancer Institute Cancer Center Support Grant CA16056 to the Roswell Park Cancer Institute.	Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Appenheimer MM, 2003, GLYCOBIOLOGY, V13, P591, DOI 10.1093/glycob/cwg066; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Blomme B, 2011, AM J PHYSIOL-GASTR L, V300, pG833, DOI 10.1152/ajpgi.00228.2010; Bruhns P, 2003, IMMUNITY, V18, P573, DOI 10.1016/S1074-7613(03)00080-3; Dalziel M, 2001, GLYCOBIOLOGY, V11, P407, DOI 10.1093/glycob/11.5.407; Gregoire-Gauthier J, 2012, BONE MARROW TRANSPL, V47, P439, DOI 10.1038/bmt.2011.93; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hu YP, 1997, GLYCOCONJUGATE J, V14, P407, DOI 10.1023/A:1018535014976; Jones MB, 2010, J BIOL CHEM, V285, P25009, DOI 10.1074/jbc.M110.104406; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kotz K, 1996, ELECTROPHORESIS, V17, P533, DOI 10.1002/elps.1150170321; Lugade AA, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00010; Lugade AA, 2011, ADV EXP MED BIOL, V780, P125, DOI 10.1007/978-1-4419-5632-3_11; Lugade AA, 2011, AM J RESP CELL MOL, V45, P557, DOI 10.1165/rcmb.2010-0321OC; Martin LT, 2002, J BIOL CHEM, V277, P32930, DOI 10.1074/jbc.M203362200; Murphy TF, 2003, CURR OPIN INFECT DIS, V16, P129, DOI 10.1097/00001432-200304000-00009; Nasirikenari M, 2006, BLOOD, V108, P3397, DOI 10.1182/blood-2006-04-014779; Nasirikenari M, 2010, J LEUKOCYTE BIOL, V87, P457, DOI 10.1189/jlb.1108704; Samuelson P, 2001, SCIENCE, V293, P2028, DOI 10.1126/science.1063764; Sokos DR, 2002, BIOL BLOOD MARROW TR, V8, P117, DOI 10.1053/bbmt.2002.v8.pm11939601; Stadlmann J, 2010, J CLIN IMMUNOL, V30, pS15, DOI 10.1007/s10875-010-9409-2; Stadlmann J, 2009, PROTEOMICS, V9, P4143, DOI 10.1002/pmic.200800931; Sullivan K M, 1996, Biol Blood Marrow Transplant, V2, P44; SULLIVAN KM, 1990, NEW ENGL J MED, V323, P705, DOI 10.1056/NEJM199009133231103; van de Geijn FE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2892; Wuensch SA, 2000, GLYCOBIOLOGY, V10, P67, DOI 10.1093/glycob/10.1.67	29	43	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15365	15370		10.1074/jbc.M112.345710	http://dx.doi.org/10.1074/jbc.M112.345710			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427662	hybrid, Green Published			2022-12-27	WOS:000304006300018
J	Tan, SH; Shui, GH; Zhou, J; Li, JJ; Bay, BH; Wenk, MR; Shen, HM				Tan, Shi Hao; Shui, Guanghou; Zhou, Jing; Li, Jasmine Jia'En; Bay, Boon-Huat; Wenk, Markus R.; Shen, Han-Ming			Induction of Autophagy by Palmitic Acid via Protein Kinase C-mediated Signaling Pathway Independent of mTOR (Mammalian Target of Rapamycin)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE INSULIN-RESISTANCE; FATTY-ACIDS; CELL-DEATH; ENDOPLASMIC-RETICULUM; MOLECULAR-MECHANISMS; INDUCED APOPTOSIS; LIPID-METABOLISM; SELF-DIGESTION; DUAL ROLE; LIPOTOXICITY	Lipotoxicity refers to the cytotoxic effects of excess fat accumulation in cells and has been implicated as one of the contributing factors to diseases like obesity, diabetes, and non-alcoholic fatty liver. In this study we sought to examine effects of palmitic acid (PA) and oleic acid, two of the common dietary fatty acids on the autophagic process. We found that PA, but not oleic acid, was able to cause an increase in autophagic flux, evidenced by LC3-II accumulation and formation of GFP-LC3 puncta. Notably, PA-induced autophagy was found to be independent of mTOR regulation. Next, in search of the mechanism mediating PA-induced autophagy, we found increased levels of diacylglycerol species and protein kinase C (PKC) activation in PA-treated cells. More importantly, inhibition of classical PKC isoforms (PKC-alpha) was able to effectively suppress PA-induced autophagy. Finally, we showed that inhibition of autophagy sensitized the cells to PA-induced apoptosis, suggesting the pro-survival function of autophagy induced by PA. Taken together, results from this study reveal a novel mechanism underlying free fatty acid-mediated autophagy. Furthermore, the pro-survival function of autophagy suggests modulation of autophagy as a potential therapeutic strategy in protection of cells against lipotoxicity and lipid-related metabolic diseases.	[Shui, Guanghou; Wenk, Markus R.] Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Li, Jasmine Jia'En; Bay, Boon-Huat] Natl Univ Singapore, Dept Anat, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Tan, Shi Hao; Zhou, Jing; Shen, Han-Ming] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117597, Singapore; [Wenk, Markus R.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Tan, Shi Hao; Wenk, Markus R.; Shen, Han-Ming] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Wenk, MR (corresponding author), Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, Singapore 117597, Singapore.	markus_wenk@nuhs.edu.sg; han-ming_shen@nuhs.edu.sg	SHEN, Han-Ming/B-5942-2011; Wenk, Markus Rene/D-1441-2014	SHEN, Han-Ming/0000-0001-7369-5227; ZHOU, JING/0000-0002-2475-7783; Shui, Guanghou/0000-0002-1621-9643	Singapore National Medical Research Council [NMRC/1260/2010]; Singapore Biomedical Research Council [BMRC/08/1/21/19/554]; NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore	Singapore National Medical Research Council(National Medical Research Council, Singapore); Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore(National University of Singapore)	This work was supported in part by research grants from the Singapore National Medical Research Council (NMRC/1260/2010) and the Singapore Biomedical Research Council (BMRC/08/1/21/19/554) (to H.-M. S.).; Supported by a research scholarship from NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore.	Chavez JA, 2010, BBA-MOL CELL BIOL L, V1801, P252, DOI 10.1016/j.bbalip.2009.09.015; Benoit SC, 2009, J CLIN INVEST, V119, P2577, DOI 10.1172/JCI36714; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Chen JL, 2009, AUTOPHAGY, V5, P244, DOI 10.4161/auto.5.2.7549; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Choi SE, 2009, ENDOCRINOLOGY, V150, P126, DOI 10.1210/en.2008-0483; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; COLEMAN R, 1976, J BIOL CHEM, V251, P4537; Coleman RA, 2011, CHEM REV, V111, P6359, DOI 10.1021/cr100404w; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Eitel K, 2003, DIABETES, V52, P991, DOI 10.2337/diabetes.52.4.991; GSCHWENDT M, 1991, TRENDS BIOCHEM SCI, V16, P167, DOI 10.1016/0968-0004(91)90064-3; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Hosokawa N, 2007, FEBS LETT, V581, P2623, DOI 10.1016/j.febslet.2006.04.008; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li LO, 2010, BBA-MOL CELL BIOL L, V1801, P246, DOI 10.1016/j.bbalip.2009.09.024; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Listenberger LL, 2007, CURR PROTOC CELL BIO, DOI [DOI 10.1002/0471143030.CB2402S35, 10.1002/0471143030.cb2402s35]; Mei S, 2011, J PHARMACOL EXP THER, V339, P487, DOI 10.1124/jpet.111.184341; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Pattingre S, 2009, J BIOL CHEM, V284, P2719, DOI 10.1074/jbc.M805920200; Piro S, 2002, METABOLISM, V51, P1340, DOI 10.1053/meta.2002.35200; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Schmitz-Peiffer C, 2008, DIABETES, V57, P1774, DOI 10.2337/db07-1769; Shahnazari S, 2010, CELL HOST MICROBE, V8, P137, DOI 10.1016/j.chom.2010.07.002; Shui GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019731; Shui GH, 2010, MOL BIOSYST, V6, P1008, DOI 10.1039/b913353d; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Wang X, 2010, EXP CLIN ENDOCR DIAB, V118, P657, DOI 10.1055/s-0030-1252069; Wu YT, 2008, AUTOPHAGY, V4, P457, DOI 10.4161/auto.5662; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	50	124	128	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14364	14376		10.1074/jbc.M111.294157	http://dx.doi.org/10.1074/jbc.M111.294157			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22408252	hybrid, Green Published			2022-12-27	WOS:000304003200005
J	Yang, Y; Yu, Y; Cheng, J; Liu, Y; Liu, DS; Wang, J; Zhu, MX; Wang, R; Xu, TL				Yang, Yang; Yu, Ye; Cheng, Jin; Liu, Yan; Liu, Di-Shi; Wang, Jin; Zhu, Michael X.; Wang, Rui; Xu, Tian-Le			Highly Conserved Salt Bridge Stabilizes Rigid Signal Patch at Extracellular Loop Critical for Surface Expression of Acid-sensing Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CURRENT; K+ CHANNEL; DOMAIN; PROTEIN; ASIC1A; CONTRIBUTES; MECHANISMS; ISCHEMIA; NEURONS; BINDING	Acid-sensing ion channels (ASICs) are non-selective cation channels activated by extracellular acidosis associated with many physiological and pathological conditions. A detailed understanding of the mechanisms that govern cell surface expression of ASICs, therefore, is critical for better understanding of the cell signaling under acidosis conditions. In this study, we examined the role of a highly conserved salt bridge residing at the extracellular loop of rat ASIC3 (Asp(107)-Arg(153)) and human ASIC1a (Asp(107)-Arg(160)) channels. Comprehensive mutagenesis and electrophysiological recordings revealed that the salt bridge is essential for functional expression of ASICs in a pH sensing-independent manner. Surface biotinylation and immunolabeling of an extracellular epitope indicated that mutations, including even minor alterations, at the salt bridge impaired cell surface expression of ASICs. Molecular dynamics simulations, normal mode analysis, and further mutagenesis studies suggested a high stability and structural constrain of the salt bridge, which serves to separate an adjacent structurally rigid signal patch, important for surface expression, from a flexible gating domain. Thus, we provide the first evidence of structural requirement that involves a stabilizing salt bridge and an exposed rigid signal patch at the destined extracellular loop for normal surface expression of ASICs. These findings will allow evaluation of new strategies aimed at preventing excessive excitability and neuronal injury associated with tissue acidosis and ASIC activation.	[Yang, Yang; Wang, Rui] Lanzhou Univ, Sch Basic Med Sci, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China; [Yang, Yang; Yu, Ye; Cheng, Jin; Liu, Yan; Liu, Di-Shi; Xu, Tian-Le] Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Yang, Yang; Yu, Ye; Cheng, Jin; Liu, Yan; Liu, Di-Shi; Xu, Tian-Le] Chinese Acad Sci, State Key Lab Neurosci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Zhu, Michael X.] Chinese Acad Sci, Shanghai Inst Mat Med, Int Scientist Workstn Neuropharmacol, Shanghai 201203, Peoples R China; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Yang, Yang; Yu, Ye; Cheng, Jin; Liu, Yan; Liu, Di-Shi; Wang, Jin; Xu, Tian-Le] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Physiol, Shanghai 200025, Peoples R China; [Yang, Yang; Yu, Ye; Cheng, Jin; Liu, Yan; Liu, Di-Shi; Wang, Jin; Xu, Tian-Le] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Biochem, Shanghai 200025, Peoples R China; [Yang, Yang; Yu, Ye; Cheng, Jin; Liu, Yan; Liu, Di-Shi; Wang, Jin; Xu, Tian-Le] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Mol Cell Biol, Shanghai 200025, Peoples R China	Lanzhou University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; University of Texas System; University of Texas Health Science Center Houston; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, R (corresponding author), 222 Tian Shui S Rd, Lanzhou 730000, Peoples R China.	wangrui@lzu.edu.cn; xu-happiness@shsmu.edu.cn			National Basic Research Program of China [2011CBA00408]; National Natural Science Foundation of China [91132303, 30830035, 31170787, 20932003]; Key National S&T Program "Major New Drug Development" [2012ZX09504001-003]; State Key Laboratory of Neuroscience	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key National S&T Program "Major New Drug Development"; State Key Laboratory of Neuroscience	This work was supported National Basic Research Program of China Grant 2011CBA00408; National Natural Science Foundation of China Grants 91132303, 30830035, 31170787, and 20932003; Key National S&T Program "Major New Drug Development" Grant 2012ZX09504001-003; and the State Key Laboratory of Neuroscience.	Anzai N, 2002, J BIOL CHEM, V277, P16655, DOI 10.1074/jbc.M201087200; Bahar I, 2010, CHEM REV, V110, P1463, DOI 10.1021/cr900095e; Bargeton B, 2010, J BIOL CHEM, V285, P13816, DOI 10.1074/jbc.M109.086843; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Chen CC, 2002, P NATL ACAD SCI USA, V99, P8992, DOI 10.1073/pnas.122245999; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Deval E, 2006, J BIOL CHEM, V281, P1796, DOI 10.1074/jbc.M509669200; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Dibb KM, 2003, J BIOL CHEM, V278, P49537, DOI 10.1074/jbc.M307723200; Donier E, 2005, J BIOL CHEM, V280, P38666, DOI 10.1074/jbc.M505981200; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Hoersch D, 2007, BIOPHYS J, V93, P1687, DOI 10.1529/biophysj.107.106633; Hruska-Hageman AM, 2004, J BIOL CHEM, V279, P46962, DOI 10.1074/jbc.M405874200; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jiang RT, 2010, J BIOL CHEM, V285, P15805, DOI 10.1074/jbc.M110.101980; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Jin WY, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-39; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kim JM, 2004, P NATL ACAD SCI USA, V101, P12508, DOI 10.1073/pnas.0404519101; Laha KT, 2011, MOL PHARMACOL, V79, P662, DOI 10.1124/mol.110.068619; Lam SY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001027; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li YF, 2003, J PHYSIOL-LONDON, V552, P73, DOI 10.1113/jphysiol.2003.047324; Mammen AL, 1997, J NEUROSCI, V17, P7351; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; Nakajo K, 2008, J PHYSIOL-LONDON, V586, P2827, DOI 10.1113/jphysiol.2007.148601; Page AJ, 2005, GUT, V54, P1408, DOI 10.1136/gut.2005.071084; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Sackin H, 2009, BIOPHYS J, V97, P1058, DOI 10.1016/j.bpj.2009.05.056; Sanchez R, 2000, METH MOL B, V143, P97; Shaikh SA, 2008, BIOPHYS J, V95, P5153, DOI 10.1529/biophysj.108.141606; Shaw DE, 2005, J COMPUT CHEM, V26, P1318, DOI 10.1002/jcc.20267; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; Vergo S, 2011, BRAIN, V134, P571, DOI 10.1093/brain/awq337; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xiong ZG, 2008, CURR OPIN PHARMACOL, V8, P25, DOI 10.1016/j.coph.2007.09.001; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151; Yu Y, 2011, J BIOL CHEM, V286, P24996, DOI 10.1074/jbc.M111.239558; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132	50	17	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14443	14455		10.1074/jbc.M111.334250	http://dx.doi.org/10.1074/jbc.M111.334250			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22399291	Green Published, hybrid			2022-12-27	WOS:000304003200012
J	Hu, D; Zhou, Z; Davidson, NE; Huang, Y; Wan, Y				Hu, Dong; Zhou, Zhuan; Davidson, Nancy E.; Huang, Yi; Wan, Yong			Novel Insight into KLF4 Proteolytic Regulation in Estrogen Receptor Signaling and Breast Carcinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR; INDUCED DNA-DAMAGE; TUMOR-SUPPRESSOR; TRANSCRIPTION FACTOR; CANCER CELLS; GROWTH-INHIBITION; PROMOTER ACTIVITY; FACTOR EXPRESSION; DOWN-REGULATION; STEM-CELLS	Kruppel-like factor 4 (KLF4), a zinc finger-containing transcriptional factor, is a pivotal regulator of cellular fate. KLF4 has attracted considerable attention for its opposing effect in carcinogenesis as tumor suppressor (e. g. colorectal cancer) or oncoprotein (e. g. breast cancer), depending on tissue context, with the underlying mechanism remaining largely unknown. Here we report that KLF4 mediates estrogen signaling in breast cancer formation. Accumulation of KLF4 by inhibiting its turnover triggers estrogen-induced transactivation. We identified Von Hippel-Lindau, pVHL, as the protein that governs KLF4 turnover in breast cancer cells and demonstrated that estrogen-induced down-regulation of pVHL facilitates accumulation of KLF4. We provide mechanistic insights into KLF4 steady-state degradation as well as its elevation in the presence of estrogen and show that elevated levels of pVHL or depletion of KLF4 attenuates the estrogen-induced transactivation and cell growth. Finally, immunohistochemical staining revealed reduced concentration of pVHL and accumulation of KLF4 in breast cancer tissues. We thus propose that suppression of pVHL in response to estrogen signaling results in elevation of KLF4, which mediates estrogen-induced mitogenic effect.	[Wan, Yong] Univ Pittsburgh, Inst Canc, Sch Med, Dept Cell Biol,Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Hu, Dong; Zhou, Zhuan; Wan, Yong] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Davidson, Nancy E.; Huang, Yi] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wan, Y (corresponding author), Univ Pittsburgh, Inst Canc, Sch Med, Dept Cell Biol,Hillman Canc Ctr, Suite 2-6C,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	yow4@pitt.edu	Huang, Yi/AAW-7892-2021	Huang, Yi/0000-0002-9982-117X	National Institutes of Health [CA115943]; Pittsburgh Woman Cancer Fund; NATIONAL CANCER INSTITUTE [R01CA115943, R01CA154695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pittsburgh Woman Cancer Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA115943. This work was also supported by the Pittsburgh Woman Cancer Fund.	Ai W, 2007, NUCLEIC ACIDS RES, V35, P6137, DOI 10.1093/nar/gkm656; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Brown RJ, 2006, SEMIN ONCOL, V33, P657, DOI 10.1053/j.seminoncol.2006.08.014; Chen C.J., 2011, PATHOL ONCO IN PRESS; Chen ZY, 2000, FEBS LETT, V477, P67, DOI 10.1016/S0014-5793(00)01764-6; Chen ZY, 2005, CANCER RES, V65, P10394, DOI 10.1158/0008-5472.CAN-05-2059; Chu PY, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-58; Cullingford TE, 2008, BBA-MOL CELL RES, V1783, P1229, DOI 10.1016/j.bbamcr.2008.03.007; Du JX, 2010, J BIOL CHEM, V285, P28298, DOI 10.1074/jbc.M110.101717; Elson DA, 2001, GENE DEV, V15, P2520, DOI 10.1101/gad.914801; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Foster KW, 2000, CANCER RES, V60, P6488; Fujita T, 2008, CLIN CANCER RES, V14, P1966, DOI 10.1158/1078-0432.CCR-07-1585; Gaughan L, 2001, J BIOL CHEM, V276, P46841, DOI 10.1074/jbc.M103710200; Geiman DE, 2000, NUCLEIC ACIDS RES, V28, P1106, DOI 10.1093/nar/28.5.1106; Ghaleb AM, 2007, ONCOGENE, V26, P2365, DOI 10.1038/sj.onc.1210022; Gluck S., 2011, BREAST CANC IN PRESS; Guan HF, 2010, BLOOD, V116, P1469, DOI 10.1182/blood-2009-12-256446; Hanstein B, 1996, P NATL ACAD SCI USA, V93, P11540, DOI 10.1073/pnas.93.21.11540; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Hu D, 2011, J BIOL CHEM, V286, P6890, DOI 10.1074/jbc.M110.179952; Hu WX, 2009, CLIN CANCER RES, V15, P5688, DOI 10.1158/1078-0432.CCR-09-0310; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kudo Y, 2004, MOL CELL BIOL, V24, P8184, DOI 10.1128/MCB.24.18.8184-8194.2004; Liu SA, 2008, MOL CANCER RES, V6, P306, DOI 10.1158/1541-7786.MCR-07-0159; Liu WJ, 2007, MOL CELL BIOL, V27, P2967, DOI 10.1128/MCB.01830-06; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Pandya AY, 2004, CLIN CANCER RES, V10, P2709, DOI 10.1158/1078-0432.CCR-03-0484; Pedram A, 2009, MOL BIOL CELL, V20, P3374, DOI 10.1091/mbc.E09-01-0085; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Schuetz A, 2011, CELL MOL LIFE SCI, V68, P3121, DOI 10.1007/s00018-010-0618-x; Seagroves TN, 2010, AM J PATHOL, V176, P2269, DOI 10.2353/ajpath.2010.090310; Shie JL, 2000, AM J PHYSIOL-GASTR L, V279, pG806, DOI 10.1152/ajpgi.2000.279.4.G806; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Signoretti S, 2002, J CLIN INVEST, V110, P633, DOI 10.1172/JCI200215795; Sourvinos G, 2001, TUMOR BIOL, V22, P131, DOI 10.1159/000050607; Sun Y, 2006, NEOPLASIA, V8, P645, DOI 10.1593/neo.06376; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tetreault MP, 2010, GASTROENTEROLOGY, V139, P171, DOI 10.1053/j.gastro.2010.03.048; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Tyson JJ, 2011, NAT REV CANCER, V11, P523, DOI 10.1038/nrc3081; Wang N, 2002, WORLD J GASTROENTERO, V8, P966, DOI 10.3748/wjg.v8.i6.966; Wei DY, 2008, CANCER RES, V68, P4631, DOI 10.1158/0008-5472.CAN-07-5953; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Williamson LM, 2011, CARCINOGENESIS, V32, P279, DOI 10.1093/carcin/bgq255; Yoon HS, 2005, ONCOGENE, V24, P4017, DOI 10.1038/sj.onc.1208576; Yoon HS, 2004, J BIOL CHEM, V279, P5035, DOI 10.1074/jbc.M307631200; Yoon HS, 2003, J BIOL CHEM, V278, P2101, DOI 10.1074/jbc.M211027200; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhou QB, 2009, CANCER RES, V69, P8284, DOI 10.1158/0008-5472.CAN-09-1345; Zia MK, 2007, INT J MOL MED, V20, P605	64	25	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13584	13597		10.1074/jbc.M112.343566	http://dx.doi.org/10.1074/jbc.M112.343566			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22389506	Green Published, hybrid			2022-12-27	WOS:000303996300015
J	Konishi, A; Arakawa, S; Yue, ZY; Shimizu, S				Konishi, Akimitsu; Arakawa, Satoko; Yue, Zhenyu; Shimizu, Shigeomi			Involvement of Beclin 1 in Engulfment of Apoptotic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; CAENORHABDITIS-ELEGANS; EMBRYONIC-DEVELOPMENT; PHAGOSOME MATURATION; DEAD CELLS; CLEARANCE; PHOSPHATIDYLSERINE; PHAGOCYTOSIS; AUTOPHAGY; IDENTIFICATION	Efficient apoptotic cell engulfment is important for both tissue homeostasis and immune response in mammals. In the present study, we report that Beclin 1 (a regulator of autophagy) is required for apoptotic cell engulfment. The engulfment process was largely abolished in Beclin 1 knock-out cells, and Beclin 1 knockdown significantly decreased apoptotic cell internalization in macrophage and fibroblast cell lines. Beclin 1 was recruited to the early phagocytic cup along with the generation of phosphatidylinositol 3-phosphate and Rac1, which regulates actin dynamics in lamellipodia. No lamellipodia were formed in Beclin 1 knock-out cells, and Beclin 1 knockdown completely inhibited the promotion of engulfment by ectopic expression of Rac1. Beclin 1 was co-immunoprecipitated with Rac1. These data indicate that Beclin 1 coordinates actin dynamics and membrane phospholipid synthesis to promote efficient apoptotic cell engulfment.	[Konishi, Akimitsu] Tokyo Med & Dent Univ, Med Res Inst, Med Top Track Program, Dept Pathol Cell Biol,Bunkyo Ku, Tokyo 1138510, Japan; [Yue, Zhenyu] Mt Sinai Sch Med, Friedman Brain Inst, Dept Neurol & Neurosci, New York, NY 10029 USA	Tokyo Medical & Dental University (TMDU); Icahn School of Medicine at Mount Sinai	Konishi, A (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Med Top Track Program, Dept Pathol Cell Biol,Bunkyo Ku, Tokyo 1138510, Japan.	konishi.mtt@mri.tmd.ac.jp; shimizu.pcb@mri.tmd.ac.jp	Arakawa, Satoko/AAM-9638-2020; Konishi, Akimitsu/J-4024-2019	Arakawa, Satoko/0000-0002-4375-1643; Konishi, Akimitsu/0000-0002-3291-0821	Program for Improvement of Research Environment for Young Researchers from Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan; National Institute of Biomedical Innovation; Takeda Science Foundation; Uehara Memorial Foundation; Sumitomo Foundation; Naito Foundation; Grants-in-Aid for Scientific Research [22570180, 22770054, 22019011, 23657084] Funding Source: KAKEN	Program for Improvement of Research Environment for Young Researchers from Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Sumitomo Foundation; Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Program for Improvement of Research Environment for Young Researchers from Special Coordination Funds for Promoting Science and Technology commissioned by the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was also supported by a Grant-in-Aid for Scientific Research on Innovative Areas, Grant-in-Aid for Scientific Research (S), a Grant-in-Aid for Challenging Exploratory Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a grant for the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation. This work was also supported by grants from the Takeda Science Foundation, the Uehara Memorial Foundation, the Sumitomo Foundation, and the Naito Foundation.	Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Kamen LA, 2007, MOL BIOL CELL, V18, P2463, DOI 10.1091/mbc.e07-01-0061; Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718; Kitano M, 2008, NATURE, V453, P241, DOI 10.1038/nature06857; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Leverrier Y, 2001, CURR BIOL, V11, P195, DOI 10.1016/S0960-9822(01)00047-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Marshall JG, 2001, J CELL BIOL, V153, P1369, DOI 10.1083/jcb.153.7.1369; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Mellen MA, 2008, CELL DEATH DIFFER, V15, P1279, DOI 10.1038/cdd.2008.40; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Nakano T, 1997, J BIOL CHEM, V272, P29411, DOI 10.1074/jbc.272.47.29411; Nakaya M, 2006, J BIOL CHEM, V281, P8836, DOI 10.1074/jbc.M510972200; Nakaya M, 2008, P NATL ACAD SCI USA, V105, P9198, DOI 10.1073/pnas.0803677105; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Qu XP, 2007, CELL, V128, P931, DOI 10.1016/j.cell.2006.12.044; Ravikumar B, 2008, J CELL SCI, V121, P1649, DOI 10.1242/jcs.025726; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	29	27	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13919	13929		10.1074/jbc.M112.348375	http://dx.doi.org/10.1074/jbc.M112.348375			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22393062	Green Published, hybrid			2022-12-27	WOS:000303996300047
J	Wei, X; Roettger, Y; Tan, BL; He, YZ; Dodel, R; Hampel, H; Wei, G; Haney, J; Gu, HY; Johnstone, BH; Liu, JY; Farlow, MR; Du, YS				Wei, Xing; Roettger, Yvonne; Tan, Bailin; He, Yongzheng; Dodel, Richard; Hampel, Harald; Wei, Gang; Haney, Jillian; Gu, Huiying; Johnstone, Brian H.; Liu, Junyi; Farlow, Martin R.; Du, Yansheng			Human Anti-prion Antibodies Block Prion Peptide Fibril Formation and Neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAUSSLER-SCHEINKER-DISEASE; CEREBELLAR GRANULE NEURONS; AMYLOID-BETA-PEPTIDE; PROTEIN-FRAGMENT; ALZHEIMERS-DISEASE; INTRAVENOUS IMMUNOGLOBULINS; MONOCLONAL-ANTIBODIES; CYSTEINE PROTEASE; CELLS; PRP	Prion diseases are a group of rare, fatal neurodegenerative disorders associated with a conformational transformation of the cellular prion protein (PrPC) into a self-replicating and proteinase K-resistant conformer, termed scrapie PrP (PrPSc). Aggregates of PrPSc deposited around neurons lead to neuropathological alterations. Currently, there is no effective treatment for these fatal illnesses; thus, the development of an effective therapy is a priority. PrP peptide-based ELISA assay methods were developed for detection and immunoaffinity chromatography capture was developed for purification of naturally occurring PrP peptide autoantibodies present in human CSF, individual donor serum, and commercial preparations of pooled intravenous immunoglobulin (IVIg). The ratio of anti-PrP autoantibodies (PrP-AA) to total IgG was similar to 1:1200. The binding epitope of purified PrP-AA was mapped to an N-terminal region comprising the PrP amino acid sequence KTNMK. Purified PrP-AA potently blocked fibril formation by a toxic 21-amino acid fragment of the PrP peptide containing the amino acid alanine to valine substitution corresponding to position 117 of the full-length peptide (A117V). Furthermore, PrP-AA attenuated the neurotoxicity of PrP(A117V) and wildtype peptides in rat cerebellar granule neuron (CGN) cultures. In contrast, IgG preparations depleted of PrP-AA had little effect on PrP fibril formation or PrP neurotoxicity. The specificity of PrP-AA was demonstrated by immunoprecipitating PrP protein in brain tissues of transgenic mice expressing the human PrP(A117V) epitope and Sc237 hamster. Based on these intriguing findings, it is suggested that human PrP-AA may be useful for interfering with the pathogenic effects of pathogenic prion proteins and, thereby has the potential to be an effective means for preventing or attenuating human prion disease progression.	[Wei, Xing; Tan, Bailin; He, Yongzheng; Wei, Gang; Haney, Jillian; Gu, Huiying; Farlow, Martin R.; Du, Yansheng] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN 46202 USA; [Roettger, Yvonne; Dodel, Richard] Univ Marburg, Dept Neurol, D-35039 Marburg, Germany; [Hampel, Harald] Goethe Univ Frankfurt, Dept Psychiat, D-60528 Frankfurt, Germany; [Liu, Junyi] Peking Univ, Sch Pharmaceut Sci, Beijing 100083, Peoples R China; [Johnstone, Brian H.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Philipps University Marburg; Goethe University Frankfurt; Peking University; Indiana University System; Indiana University Bloomington	Du, YS (corresponding author), Indiana Univ, Dept Neurol, Sch Med, 975 W Walnut St,IB 457, Indianapolis, IN 46202 USA.	ydu@iupui.edu	Du, Yansheng/L-2244-2015	Hampel, Harald/0000-0003-0894-8982				Beekes M, 2007, FEBS J, V274, P575, DOI 10.1111/j.1742-4658.2006.05629.x; Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; Brown DR, 1996, GLIA, V18, P59, DOI 10.1002/(SICI)1098-1136(199609)18:1<59::AID-GLIA6>3.0.CO;2-Z; BROWN DR, 1994, NEUROREPORT, V5, P2057, DOI 10.1097/00001756-199410270-00017; Brown DR, 2000, BIOCHEM J, V346, P785, DOI 10.1042/0264-6021:3460785; Brown DR, 1998, J NEUROSCI RES, V54, P331; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Bugiani O, 2000, MICROSC RES TECHNIQ, V50, P10, DOI 10.1002/1097-0029(20000701)50:1<10::AID-JEMT3>3.3.CO;2-Y; Ciani E, 1995, J MOL NEUROSCI, V6, P131, DOI 10.1007/BF02736772; DEARMOND SJ, 1993, P NATL ACAD SCI USA, V90, P6449, DOI 10.1073/pnas.90.14.6449; Dodel R, 2002, ANN NEUROL, V52, P253, DOI 10.1002/ana.10253; Dodel RC, 2004, J NEUROL NEUROSUR PS, V75, P1472, DOI 10.1136/jnnp.2003.033399; Dodel R, 2010, DRUGS, V70, P513, DOI 10.2165/11533070-000000000-00000; Du Y, 2001, NEUROLOGY, V57, P801, DOI 10.1212/WNL.57.5.801; Du YS, 2003, BRAIN, V126, P1935, DOI 10.1093/brain/awg191; Du YS, 1998, J NEUROCHEM, V70, P1182; Du YS, 1997, J NEUROCHEM, V69, P1382; Du YS, 1997, P NATL ACAD SCI USA, V94, P11657, DOI 10.1073/pnas.94.21.11657; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Fioriti L, 2005, MOL CELL NEUROSCI, V28, P165, DOI 10.1016/j.mcn.2004.09.006; Flego M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-38; FORLONI G, 1994, EUR J NEUROSCI, V6, P1415, DOI 10.1111/j.1460-9568.1994.tb01003.x; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; GHETTI B, 1989, NEUROLOGY, V39, P1453, DOI 10.1212/WNL.39.11.1453; Ghetti B, 1996, BRAIN PATHOL, V6, P127, DOI 10.1111/j.1750-3639.1996.tb00796.x; GIACCONE G, 1992, P NATL ACAD SCI USA, V89, P9349, DOI 10.1073/pnas.89.19.9349; Hanan E, 2001, BIOCHEM BIOPH RES CO, V280, P115, DOI 10.1006/bbrc.2000.4097; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Heppner FL, 2001, SCIENCE, V294, P178, DOI 10.1126/science.1063093; HSIAO KK, 1991, NEUROLOGY, V41, P681, DOI 10.1212/WNL.41.5.681; KIEDROWSKI L, 1992, NEUROSCI LETT, V135, P59, DOI 10.1016/0304-3940(92)90135-T; KITAMOTO T, 1986, ANN NEUROL, V20, P204, DOI 10.1002/ana.410200205; MASTRIANNI JA, 1995, NEUROLOGY, V45, P2042, DOI 10.1212/WNL.45.11.2042; Molina F, 1996, PEPTIDE RES, V9, P151; Morel N, 2004, J BIOL CHEM, V279, P30143, DOI 10.1074/jbc.M403896200; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Relkin NR, 2009, NEUROBIOL AGING, V30, P1728, DOI 10.1016/j.neurobiolaging.2007.12.021; RESINK A, 1994, BRAIN RES, V655, P222, DOI 10.1016/0006-8993(94)91617-9; Sigurdsson EM, 2002, AM J PATHOL, V161, P13, DOI 10.1016/S0002-9440(10)64151-X; Sparapani M, 1997, EXP NEUROL, V148, P157, DOI 10.1006/exnr.1997.6627; Tagliavini F, 2001, ADV PROTEIN CHEM, V57, P171; TATEISHI J, 1988, ANN NEUROL, V24, P35, DOI 10.1002/ana.410240108; Tateishi J, 1990, Tanpakushitsu Kakusan Koso, V35, P1327; Weissmann C, 2003, BRIT MED BULL, V66, P43, DOI 10.1093/bmb/66.1.43; Weissmann C, 2001, PHILOS T R SOC B, V356, P177, DOI 10.1098/rstb.2000.0763; Weksler ME, 2002, EXP GERONTOL, V37, P943, DOI 10.1016/S0531-5565(02)00029-3; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Wisniewski T, 2007, FEBS J, V274, P3784, DOI 10.1111/j.1742-4658.2007.05919.x; Wisniewski T, 2001, J ALZHEIMERS DIS, V3, P7, DOI 10.3233/JAD-2001-3104; Yokoyama T, 2001, J BIOL CHEM, V276, P11265, DOI 10.1074/jbc.M008734200	51	20	20	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12858	12866		10.1074/jbc.M111.255836	http://dx.doi.org/10.1074/jbc.M111.255836			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22362783	hybrid, Green Published			2022-12-27	WOS:000302903700025
J	Ahn, J; Hao, CL; Yan, JP; Delucia, M; Mehrens, J; Wang, CP; Gronenborn, AM; Skowronski, J				Ahn, Jinwoo; Hao, Caili; Yan, Junpeng; Delucia, Maria; Mehrens, Jennifer; Wang, Chuanping; Gronenborn, Angela M.; Skowronski, Jacek			HIV/Simian Immunodeficiency Virus (SIV) Accessory Virulence Factor Vpx Loads the Host Cell Restriction Factor SAMHD1 onto the E3 Ubiquitin Ligase Complex CRL4(DCAF1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELLS; WD40-REPEAT PROTEINS; BETA-TRCP; DEGRADATION; TRANSDUCTION; ARCHITECTURE; REPLICATION; ACTIVATION; INTERACTS; RECEPTOR	The sterile alpha motif and HD domain-containing protein-1 (SAMHD1) inhibits infection of myeloid cells by human and related primate immunodeficiency viruses (HIV and SIV). This potent inhibition is counteracted by the Vpx accessory virulence factor of HIV-2/SIVsm viruses, which targets SAMHD1 for proteasome-dependent degradation, by reprogramming cellular CRL4(DCAF1) E3 ubiquitin ligase. However, the precise mechanism of Vpx-dependent recruitment of human SAMHD1 onto the ligase, and the molecular interfaces on the respective molecules have not been defined. Here, we show that human SAMHD1 is recruited to the CRL4(DCAF1-Vpx) E3 ubiquitin ligase complex by interacting with the DCAF1 substrate receptor subunit in a Vpx-dependent manner. No stable association is detectable with DCAF1 alone. The SAMHD1 determinant for the interaction is a short peptide located distal to the SAMHD1 catalytic domain and requires the presence of Vpx for stable engagement. This peptide is sufficient to confer Vpx-dependent recruitment to CRL4(DCAF1) and ubiquitination when fused to heterologous proteins. The precise amino acid sequence of the peptide diverges among SAMHD1 proteins from different vertebrate species, explaining selective down-regulation of human SAMHD1 levels by Vpx. Critical amino acid residues of SAMHD1 and Vpx involved in the DCAF1-Vpx-SAMDH1 interaction were identified by mutagenesis. Our findings show that the N terminus of Vpx, bound to DCAF1, recruits SAMHD1 via its C terminus to CRL4, in a species-specific manner for proteasomal degradation.	[Hao, Caili; Yan, Junpeng; Wang, Chuanping; Skowronski, Jacek] Case Western Reserve Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Ahn, Jinwoo; Delucia, Maria; Mehrens, Jennifer; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Ahn, Jinwoo; Delucia, Maria; Mehrens, Jennifer; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Prot Interact, Pittsburgh, PA 15260 USA	Case Western Reserve University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Skowronski, J (corresponding author), Case Western Reserve Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.	jacek.skowronski@case.edu		Gronenborn, Angela M/0000-0001-9072-3525	National Institutes of Health [P50GM082251, R01 AI077459]; Case CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P50GM082251 (to A. M. G.), R01 AI077459 (to J. S.), and Case CFAR funds (to J. S.).	Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Barry Michele, 2006, Sci STKE, V2006, ppe21; Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Fletcher TM, 1996, EMBO J, V15, P6155, DOI 10.1002/j.1460-2075.1996.tb01003.x; Fujita M, 2008, J VIROL, V82, P7752, DOI 10.1128/JVI.01003-07; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P607, DOI 10.1089/aid.1994.10.607; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Gramberg T, 2010, J VIROL, V84, P1387, DOI 10.1128/JVI.01437-09; HARRIS P, 1985, J LEUKOCYTE BIOL, V37, P407, DOI 10.1002/jlb.37.4.407; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-5; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Janardhan A, 2004, PLOS BIOL, V2, P65, DOI 10.1371/journal.pbio.0020006; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Pertel T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-49; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; YU XF, 1991, J VIROL, V65, P5088, DOI 10.1128/JVI.65.9.5088-5091.1991; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	44	138	145	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12550	12558		10.1074/jbc.M112.340711	http://dx.doi.org/10.1074/jbc.M112.340711			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22362772	Green Published, hybrid			2022-12-27	WOS:000302782200094
J	Oh, J; Riek, AE; Weng, SR; Petty, M; Kim, D; Colonna, M; Cella, M; Bernal-Mizrachi, C				Oh, Jisu; Riek, Amy E.; Weng, Sherry; Petty, Marvin; Kim, David; Colonna, Marco; Cella, Marina; Bernal-Mizrachi, Carlos			Endoplasmic Reticulum Stress Controls M2 Macrophage Differentiation and Foam Cell Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADVANCED ATHEROSCLEROTIC LESIONS; UNFOLDED PROTEIN RESPONSE; MONOCYTE-DERIVED CELLS; E-DEFICIENT MICE; GENE-EXPRESSION; ALTERNATIVE ACTIVATION; INSULIN-RESISTANCE; IN-VITRO; APOPTOSIS; GAMMA	Macrophages are essential in atherosclerosis progression, but regulation of the M1 versus M2 phenotype and their role in cholesterol deposition are unclear. We demonstrate that endoplasmic reticulum (ER) stress is a key regulator of macrophage differentiation and cholesterol deposition. Macrophages from diabetic patients were classically or alternatively stimulated and then exposed to oxidized LDL. Alternative stimulation into M2 macrophages lead to increased foam cell formation by inducing scavenger receptor CD36 and SR-A1 expression. ER stress induced by alternative stimulation was necessary to generate the M2 phenotype through JNK activation and increased PPAR gamma expression. The absence of CD36 or SR-A1 signaling independently of modified cholesterol uptake decreased ER stress and prevented the M2 differentiation typically induced by alternative stimulation. Moreover, suppression of ER stress shifted differentiated M2 macrophages toward an M1 phenotype and subsequently suppressed foam cell formation by increasing HDL- and apoA-1-induced cholesterol efflux indicating suppression of macrophage ER stress as a potential therapy for atherosclerosis.	[Bernal-Mizrachi, Carlos] Washington Univ, Sch Med, Dept Internal Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Colonna, Marco; Cella, Marina] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Bernal-Mizrachi, Carlos] Washington Univ, Div Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Bernal-Mizrachi, C (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Endocrinol Metab & Lipid Res, 660 S Euclid Ave,Campus Box 8127, St Louis, MO 63110 USA.	cbernal@dom.wustl.edu	Cella, Marina/ABA-8564-2020	Bernal-Mizrachi, Carlos/0000-0002-8991-7522; Colonna, Marco/0000-0001-5222-4987; Cella, Marina/0000-0003-1230-1313	National Institutes of Health [R01HL094818-0, P30 DK079333, P60 20579]; American Diabetes Association [7-08-CR-08]; Endocrine Society; Endocrine Fellows Foundation; National Institutes of Health National Center for Research Resources (a component of the National Institutes of Health) [UL1 RR024992, KL2 RR024994]; National Institutes of Health Roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024994, UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Endocrine Society; Endocrine Fellows Foundation; National Institutes of Health National Center for Research Resources (a component of the National Institutes of Health); National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants R01HL094818-0, P30 DK079333, and P60 20579. This work was also supported by the American Diabetes Association (7-08-CR-08).; Supported by the Endocrine Society, the Endocrine Fellows Foundation and by Grant UL1 RR024992, Sub-award KL2 RR024994 from the National Institutes of Health National Center for Research Resources (a component of the National Institutes of Health), and the National Institutes of Health Roadmap for Medical Research.	BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Buono C, 2003, ARTERIOSCL THROM VAS, V23, P454, DOI 10.1161/01.ATV.0000059419.11002.6E; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Chinetti-Gbaguidi G, 2011, CIRC RES, V108, P985, DOI 10.1161/CIRCRESAHA.110.233775; Desvergne B, 2008, CELL METAB, V7, P467, DOI 10.1016/j.cmet.2008.05.002; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Dickhout JG, 2011, FASEB J, V25, P576, DOI 10.1096/fj.10-159319; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Feig JE, 2011, P NATL ACAD SCI USA, V108, P7166, DOI 10.1073/pnas.1016086108; Feig JE, 2011, CIRCULATION, V123, P989, DOI 10.1161/CIRCULATIONAHA.110.984146; Feig JE, 2010, J CLIN INVEST, V120, P4415, DOI 10.1172/JCI38911; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; Huo YQ, 2004, CIRCULATION, V110, P2024, DOI 10.1161/01.CIR.0000143628.37680.F6; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; King VL, 2007, AM J PATHOL, V171, P2040, DOI 10.2353/ajpath.2007.060857; King VL, 2002, ARTERIOSCL THROM VAS, V22, P456, DOI 10.1161/hq0302.104905; Kuda O, 2011, J BIOL CHEM, V286, P17785, DOI 10.1074/jbc.M111.232975; Launay S, 1999, BLOOD, V93, P4395, DOI 10.1182/blood.V93.12.4395.412k06_4395_4405; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Lim WS, 2008, CIRCULATION, V117, P940, DOI 10.1161/CIRCULATIONAHA.107.711275; Manning-Tobin JJ, 2009, ARTERIOSCL THROM VAS, V29, P19, DOI 10.1161/ATVBAHA.108.176644; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Myoishi M, 2007, CIRCULATION, V116, P1226, DOI 10.1161/CIRCULATIONAHA.106.682054; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oh J, 2009, CIRCULATION, V120, P687, DOI 10.1161/CIRCULATIONAHA.109.856070; Oslund LJP, 1999, ARTERIOSCL THROM VAS, V19, P2847, DOI 10.1161/01.ATV.19.12.2847; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Potteaux S, 2011, J CLIN INVEST, V121, P2025, DOI 10.1172/JCI43802; Rader DJ, 2005, CELL METAB, V1, P223, DOI 10.1016/j.cmet.2005.03.005; Satoh Noriko, 2010, Diabetes Care, V33, pe7, DOI 10.2337/dc09-1315; SCHAEFER A, 1994, J BIOL CHEM, V269, P8786; Schneider JG, 2006, CELL METAB, V4, P377, DOI 10.1016/j.cmet.2006.10.002; Seimon TA, 2010, CELL METAB, V12, P467, DOI 10.1016/j.cmet.2010.09.010; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Tabas I, 2010, CIRC RES, V106, P58, DOI 10.1161/CIRCRESAHA.109.208488; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Tsukano H, 2010, ARTERIOSCL THROM VAS, V30, P1925, DOI 10.1161/ATVBAHA.110.206094; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1	51	211	231	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11629	11641		10.1074/jbc.M111.338673	http://dx.doi.org/10.1074/jbc.M111.338673			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22356914	Green Published, hybrid			2022-12-27	WOS:000302782200003
J	Ben-Aissa, K; Patino-Lopez, G; Belkina, NV; Maniti, O; Rosales, T; Hao, JJ; Kruhlak, MJ; Knutson, JR; Picart, C; Shaw, S				Ben-Aissa, Khadija; Patino-Lopez, Genaro; Belkina, Natalya V.; Maniti, Ofelia; Rosales, Tilman; Hao, Jian-Jiang; Kruhlak, Michael J.; Knutson, Jay R.; Picart, Catherine; Shaw, Stephen			Activation of Moesin, a Protein That Links Actin Cytoskeleton to the Plasma Membrane, Occurs by Phosphatidylinositol 4,5-bisphosphate (PIP2) Binding Sequentially to Two Sites and Releasing an Autoinhibitory Linker	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; ERM PROTEINS; FERM DOMAIN; STRUCTURAL BASIS; IN-VIVO; EZRIN; PHOSPHORYLATION; EZRIN/RADIXIN/MOESIN; PHOSPHOINOSITIDES; RECOGNITION	Many cellular processes depend on ERM (ezrin, moesin, and radixin) proteins mediating regulated linkage between plasma membrane and actin cytoskeleton. Although conformational activation of the ERM protein is mediated by the membrane PIP2, the known properties of the two described PIP2-binding sites do not explain activation. To elucidate the structural basis of possible mechanisms, we generated informative moesin mutations and tested three attributes: membrane localization of the expressed moesin, moesin binding to PIP2, and PIP2-induced release of moesin autoinhibition. The results demonstrate for the first time that the POCKET containing inositol 1,4,5-trisphosphate on crystal structure (the "POCKET" Lys-63, Lys-278 residues) mediates all three functions. Furthermore the second described PIP2-binding site (the "PATCH," Lys253/Lys-254, Lys-262/Lys-263) is also essential for all three functions. In native autoinhibited ERM proteins, the POCKET is a cavity masked by an acidic linker, which we designate the "FLAP." Analysis of three mutant moesin constructs predicted to influence FLAP function demonstrated that the FLAP is a functional autoinhibitory region. Moreover, analysis of the cooperativity and stoichiometry demonstrate that the PATCH and POCKET do not bind PIP2 simultaneously. Based on our data and supporting published data, we propose a model of progressive activation of autoinhibited moesin by a single PIP2 molecule in the membrane. Initial transient binding of PIP2 to the PATCH initiates release of the FLAP, which enables transition of the same PIP2 molecule into the newly exposed POCKET where it binds stably and completes the conformational activation.	[Shaw, Stephen] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Rosales, Tilman; Knutson, Jay R.] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Maniti, Ofelia; Picart, Catherine] Grenoble Inst Technol, F-38016 Grenoble, France; [Maniti, Ofelia; Picart, Catherine] LMGP, CNRS, UMR 5628, F-38016 Grenoble, France	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble	Shaw, S (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	Shaws@mail.nih.gov	Patiño López, Genaro/GQI-4414-2022; Maniti, Ofélia/AAQ-5624-2021; Patino-Lopez, Genaro/O-3484-2018	Patino-Lopez, Genaro/0000-0002-8716-722X; PICART, Catherine/0000-0003-0130-1000; PICART, Catherine/0000-0002-4854-6366	National Institutes of Health of the NCI; National Institutes of Health of NHLBI; National Institutes of Health of Agence Nationale de la Recherche [ANR-08-PCVI-026]; European Research Council [GA259370]; NATIONAL CANCER INSTITUTE [ZICBC010915] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006066, ZIAHL001452, ZIAHL006065, ZIAHL006067] Funding Source: NIH RePORTER	National Institutes of Health of the NCI; National Institutes of Health of NHLBI; National Institutes of Health of Agence Nationale de la Recherche(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Programs of the NCI and NHLBI and Agence Nationale de la Recherche (ANR-08-PCVI-026) and by the European Research Council (GA259370).	Amieva MR, 1999, J CELL SCI, V112, P111; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Barret C, 2000, J CELL BIOL, V151, P1067, DOI 10.1083/jcb.151.5.1067; Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Blin G, 2008, BIOPHYS J, V94, P1021, DOI 10.1529/biophysj.107.110213; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cozier GE, 2004, CURR TOP MICROBIOL, V282, P49; Fievet B, 2007, BBA-MOL CELL RES, V1773, P653, DOI 10.1016/j.bbamcr.2006.06.013; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Finnerty CM, 2004, J CELL SCI, V117, P1547, DOI 10.1242/jcs.01038; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Hughes SC, 2007, CURR OPIN CELL BIOL, V19, P51, DOI 10.1016/j.ceb.2006.12.004; INGLEY E, 1994, J CELL BIOCHEM, V56, P436, DOI 10.1002/jcb.240560403; Jayaraman B, 2007, BIOCHEMISTRY-US, V46, P12174, DOI 10.1021/bi701281e; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Lai CL, 2010, J MOL BIOL, V402, P301, DOI 10.1016/j.jmb.2010.07.037; Lemmon MA, 2001, BIOCHEM SOC T, V29, P377, DOI 10.1042/BST0290377; Li QZ, 2007, J MOL BIOL, V365, P1446, DOI 10.1016/j.jmb.2006.10.075; Li Z, 2009, BIOPHYS J, V97, P155, DOI 10.1016/j.bpj.2009.04.037; Morales FC, 2007, MOL CELL BIOL, V27, P2527, DOI 10.1128/MCB.01372-06; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; Nakamura F, 1995, J BIOL CHEM, V270, P31377, DOI 10.1074/jbc.270.52.31377; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; Patino-Lopez G, 2010, J BIOL CHEM, V285, P8675, DOI 10.1074/jbc.M109.086959; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Raghunathan D, 2012, J BIOENERG BIOMEMBR, V44, P213, DOI 10.1007/s10863-012-9410-y; Reczek D, 1998, J BIOL CHEM, V273, P18452, DOI 10.1074/jbc.273.29.18452; Roch F, 2010, J CELL SCI, V123, P2057, DOI 10.1242/jcs.064550; Yonemura S, 2002, J CELL SCI, V115, P2569	35	37	37	4	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16311	16323		10.1074/jbc.M111.304881	http://dx.doi.org/10.1074/jbc.M111.304881			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22433855	Green Published, hybrid			2022-12-27	WOS:000304030900023
J	Kessl, JJ; Jena, N; Koh, Y; Taskent-Sezgin, H; Slaughter, A; Feng, L; de Silva, S; Wu, L; Le Grice, SFJ; Engelman, A; Fuchs, JR; Kvaratskhelia, M				Kessl, Jacques J.; Jena, Nivedita; Koh, Yasuhiro; Taskent-Sezgin, Humeyra; Slaughter, Alison; Feng, Lei; de Silva, Suresh; Wu, Li; Le Grice, Stuart F. J.; Engelman, Alan; Fuchs, James R.; Kvaratskhelia, Mamuka			Multimode, Cooperative Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; IN-VITRO; CATALYTIC DOMAIN; STRUCTURAL BASIS; COACTIVATOR P75; DNA INTEGRATION; BINDING DOMAIN; LEDGF/P75; PROTEIN; IDENTIFICATION	The multifunctional HIV-1 enzyme integrase interacts with viral DNA and its key cellular cofactor LEDGF to effectively integrate the reverse transcript into a host cell chromosome. These interactions are crucial for HIV-1 replication and present attractive targets for antiviral therapy. Recently, 2-(quinolin-3-yl) acetic acid derivatives were reported to selectively inhibit the integrase-LEDGF interaction in vitro and impair HIV-1 replication in infected cells. Here, we show that this class of compounds impairs both integrase-LEDGF binding and LEDGF-independent integrase catalytic activities with similar IC50 values, defining them as bona fide allosteric inhibitors of integrase function. Furthermore, we show that 2-(quinolin-3-yl) acetic acid derivatives block the formation of the stable synaptic complex between integrase and viral DNA by allosterically stabilizing an inactive multimeric form of integrase. In addition, these compounds inhibit LEDGF binding to the stable synaptic complex. This multimode mechanism of action concordantly results in cooperative inhibition of the concerted integration of viral DNA ends in vitro and HIV-1 replication in cell culture. Our findings, coupled with the fact that high cooperativity of antiviral inhibitors correlates with their increased instantaneous inhibitory potential, an important clinical parameter, argue strongly that improved 2-(quinolin-3-yl) acetic acid derivatives could exhibit desirable clinical properties.	[Kessl, Jacques J.; Slaughter, Alison; Feng, Lei; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Kessl, Jacques J.; Slaughter, Alison; Feng, Lei; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Jena, Nivedita; Fuchs, James R.] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, Columbus, OH 43210 USA; [Koh, Yasuhiro; Engelman, Alan] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02215 USA; [Koh, Yasuhiro; Engelman, Alan] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [de Silva, Suresh; Wu, Li] NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA; [Taskent-Sezgin, Humeyra; Le Grice, Stuart F. J.] Ohio State Univ, Dept Vet Biosci, Ctr Retrovirus Res, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Ohio; Ohio State University	Kvaratskhelia, M (corresponding author), Ohio State Univ, Coll Pharm, Ctr Retrovirus Res, 500 W 12Th Ave, Columbus, OH 43210 USA.	kvaratskhelia.1@osu.edu	Wu, Li/E-4330-2011; Kessl, Jacques/AAV-2526-2021; Wu, Li/ABB-2813-2020; Kessl, Jacques/J-6073-2015; Fuchs, James Robert/B-4625-2012; Jena, Nivedita/F-4945-2012	Wu, Li/0000-0002-5468-2487; Wu, Li/0000-0002-5468-2487; Fuchs, James/0000-0002-8743-6389	National Institutes of Health [AI081581, AI062520, CA100730, AI097044, AI039394]; NCI, National Institutes of Health, Department of Health and Human Services; NATIONAL CANCER INSTITUTE [P01CA100730, ZIABC010494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097044, R01AI062520, P30AI060354, R01AI039394, R37AI039394, R01AI081581] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health, Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI081581, AI062520, and CA100730 (to M. K.), AI097044 (to J. J. K. and J. R. F.), AI039394 (to A. E.); the Intramural Research Program of the NCI, National Institutes of Health, Department of Health and Human Services (to H. T. S. and S. F. J. L. G.).	Al-Mawsawi LQ, 2006, P NATL ACAD SCI USA, V103, P10080, DOI 10.1073/pnas.0511254103; Briones MS, 2010, IMMUNOL RES, V48, P14, DOI 10.1007/s12026-010-8164-z; Brown P. O., 1997, P161; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engelman A., 2011, HIV 1 INTEGRASE, P67, DOI [10.1002/9781118015377.ch6, DOI 10.1002/9781118015377.CH6]; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000259; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Hill A.V., 1910, J PHYSIOL-LONDON, V40, piv; Johnson AA, 2004, CURR TOP MED CHEM, V4, P1059, DOI 10.2174/1568026043388394; Kessl JJ, 2011, NUCLEIC ACIDS RES, V39, P9009, DOI 10.1093/nar/gkr581; Kessl JJ, 2009, MOL PHARMACOL, V76, P824, DOI 10.1124/mol.109.058883; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Li X, 2012, J VIROL, V86, P3861, DOI 10.1128/JVI.06386-11; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Malet I, 2008, ANTIMICROB AGENTS CH, V52, P1351, DOI 10.1128/AAC.01228-07; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mckee CJ, 2008, J BIOL CHEM, V283, P31802, DOI 10.1074/jbc.M805843200; Michel F, 2009, EMBO J, V28, P980, DOI 10.1038/emboj.2009.41; Molteni V, 2001, ACTA CRYSTALLOGR D, V57, P536, DOI 10.1107/S0907444901001652; Murray JM, 2007, AIDS, V21, P2315, DOI 10.1097/QAD.0b013e3282f12377; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nettleship Joanne E., 2008, V426, P299, DOI 10.1007/978-1-60327-058-8_19; Nilsen BM, 1996, J VIROL, V70, P1580, DOI 10.1128/JVI.70.3.1580-1587.1996; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pandey KK, 2007, J VIROL, V81, P3969, DOI 10.1128/JVI.02322-06; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Shen L, 2009, TRENDS PHARMACOL SCI, V30, P610, DOI 10.1016/j.tips.2009.09.003; Tsantrizos YS, 2007, International Patent Application, Patent No. [PCT/CA2007/000845, 2007000845]; Tsiang M, 2009, J BIOL CHEM, V284, P33580, DOI 10.1074/jbc.M109.040121; Turlure F, 2006, NUCLEIC ACIDS RES, V34, P1653, DOI 10.1093/nar/gkl052	40	144	145	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16801	16811		10.1074/jbc.M112.354373	http://dx.doi.org/10.1074/jbc.M112.354373			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22437836	Green Published, hybrid			2022-12-27	WOS:000304030900067
J	Liang, JJ; Wang, W; Sorensen, D; Medina, S; Ilchenko, S; Kiselar, J; Surewicz, WK; Booth, SA; Kong, QZ				Liang, Jingjing; Wang, Wei; Sorensen, Debra; Medina, Sarah; Ilchenko, Sergei; Kiselar, Janna; Surewicz, Witold K.; Booth, Stephanie A.; Kong, Qingzhong			Cellular Prion Protein Regulates Its Own alpha-Cleavage through ADAM8 in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUSION-BODY MYOSITIS; METALLOPROTEASE-DISINTEGRIN ADAM8; ENDOGENOUS PROTEOLYTIC CLEAVAGE; TUMOR-NECROSIS-FACTOR; TRANSGENIC MICE; SCRAPIE PRION; P38 MAPK; NEUROPROTECTIVE FUNCTION; CASPASE-3 ACTIVATION; TERMINAL CLEAVAGE	The ubiquitously expressed cellular prion protein (PrPC) is subjected to the physiological alpha-cleavage at a region critical for both PrP toxicity and the conversion of PrPC to its pathogenic prion form (PrPSc), generating the C1 and N1 fragments. The C1 fragment can activate caspase 3 while the N1 fragment is neuroprotective. Recent articles indicate that ADAM10, ADAM17, and ADAM9 may not play a prominent role in the alpha-cleavage of PrPC as previously thought, raising questions on the identity of the responsible protease(s). Here we show that, ADAM8 can directly cleave PrP to generate C1 in vitro and PrP C1/full-length ratio is greatly decreased in the skeletal muscles of ADAM8 knock-out mice; in addition, the PrP C1/full-length ratio is linearly correlated with ADAM8 protein level in myoblast cell line C2C12 and in skeletal muscle tissues of transgenic mice. These results indicate that ADAM8 is the primary protease responsible for the alpha-cleavage of PrPC in muscle cells. Moreover, we found that overexpression of PrPC led to up-regulation of ADAM8, suggesting that PrPC may regulate its own alpha-cleavage through modulating ADAM8 activity.	[Liang, Jingjing; Wang, Wei; Kong, Qingzhong] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Surewicz, Witold K.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Ilchenko, Sergei; Kiselar, Janna] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Sorensen, Debra; Medina, Sarah; Booth, Stephanie A.] Natl Microbiol Lab, Winnipeg, MB R3E 3R2, Canada	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Kong, QZ (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	qxk2@case.edu	Booth, Stephanie/AAX-6671-2020	Booth, Stephanie/0000-0001-8108-5955	National Institutes of Health [R01 NS052319]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS052319 (to Q. K.).	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Altmeppen HC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-36; ASKANAS V, 1993, NEUROREPORT, V5, P25, DOI 10.1097/00001756-199310000-00006; Bartsch JW, 2010, J NEUROSCI, V30, P12210, DOI 10.1523/JNEUROSCI.1520-10.2010; Brown DR, 1998, EUR J CELL BIOL, V75, P29, DOI 10.1016/S0171-9335(98)80043-5; Chen SE, 2005, AM J PHYSIOL-CELL PH, V289, pC1179, DOI 10.1152/ajpcell.00062.2005; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chen SE, 2007, AM J PHYSIOL-CELL PH, V292, pC1660, DOI 10.1152/ajpcell.00486.2006; Cisse MA, 2005, J BIOL CHEM, V280, P40624, DOI 10.1074/jbc.M506069200; Cisse MA, 2007, J NEUROSCI, V27, P4083, DOI 10.1523/JNEUROSCI.5293-06.2007; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; Dron M, 2010, J BIOL CHEM, V285, P10252, DOI 10.1074/jbc.M109.083857; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Endres K, 2009, NEUROBIOL DIS, V36, P233, DOI 10.1016/j.nbd.2009.07.015; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Gougoumas DD, 2007, J CELL PHYSIOL, V211, P551, DOI 10.1002/jcp.20969; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Huang SH, 2007, P NATL ACAD SCI USA, V104, P6800, DOI 10.1073/pnas.0608885104; Jimenez-Huete A, 1998, AM J PATHOL, V153, P1561, DOI 10.1016/S0002-9440(10)65744-6; Jobling MF, 1999, J NEUROCHEM, V73, P1557, DOI 10.1046/j.1471-4159.1999.0731557.x; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Kelly K, 2005, DEV DYNAM, V232, P221, DOI 10.1002/dvdy.20221; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Laffont-Proust I, 2005, FEBS LETT, V579, P6333, DOI 10.1016/j.febslet.2005.10.013; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Liang JJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-201; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Luhr KM, 2004, NEUROREPORT, V15, P1663, DOI 10.1097/01.wnr.0000134931.81690.34; Lund C, 2007, J NEUROSCI METH, V165, P183, DOI 10.1016/j.jneumeth.2007.06.005; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; Massimino ML, 2006, FEBS LETT, V580, P878, DOI 10.1016/j.febslet.2006.01.008; McMahon HEM, 2001, J BIOL CHEM, V276, P2286, DOI 10.1074/jbc.M007243200; Mehrpour M, 2010, CANCER LETT, V290, P1, DOI 10.1016/j.canlet.2009.07.009; Miele G, 2003, GENE EXPRESSION, V11, P1, DOI 10.3727/000000003783992324; Mitteregger G, 2007, BRAIN PATHOL, V17, P174, DOI 10.1111/j.1750-3639.2007.00061.x; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Moss ML, 2002, ESSAYS BIOCHEM, V38, P141, DOI 10.1042/bse0380141; Nico PBC, 2005, NEUROSCI LETT, V388, P21, DOI 10.1016/j.neulet.2005.06.033; Norstrom EM, 2005, J BIOL CHEM, V280, P27236, DOI 10.1074/jbc.M413441200; Owen JP, 2007, J VIROL, V81, P10532, DOI 10.1128/JVI.00640-07; Paitel E, 2004, J BIOL CHEM, V279, P612, DOI 10.1074/jbc.M310453200; Paitel E, 2003, J BIOL CHEM, V278, P10061, DOI 10.1074/jbc.M211580200; Paitel E, 2002, J NEUROCHEM, V83, P1208, DOI 10.1046/j.1471-4159.2002.01234.x; PAN KM, 1992, PROTEIN SCI, V1, P1343, DOI 10.1002/pro.5560011014; Pan T, 2004, J NEUROCHEM, V90, P1205, DOI 10.1111/j.1471-4159.2004.02582.x; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; PETROPOULOS CJ, 1989, MOL CELL BIOL, V9, P3785, DOI 10.1128/MCB.9.9.3785; Pradines E, 2009, J NEUROCHEM, V110, P912, DOI 10.1111/j.1471-4159.2009.06176.x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; SARKOZI E, 1994, AM J PATHOL, V145, P1280; Schlomann U, 2000, J NEUROSCI, V20, P7964; SHYNG SL, 1993, J BIOL CHEM, V268, P15922; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006115; Sorgato MC, 2009, PRION, V3, P202, DOI 10.4161/pri.3.4.10012; Steinacker P, 2010, AM J PATHOL, V176, P1409, DOI 10.2353/ajpath.2010.090355; Stella R, 2010, CELL CYCLE, V9, P4616, DOI 10.4161/cc.9.23.14135; Stella R, 2010, MOL CELL BIOL, V30, P4864, DOI 10.1128/MCB.01040-09; Sunyach C, 2007, J BIOL CHEM, V282, P1956, DOI 10.1074/jbc.M609663200; Taguchi Y, 2009, MOL BIOL CELL, V20, P233, DOI 10.1091/mbc.E08-06-0635; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Taylor DR, 2009, J BIOL CHEM, V284, P22590, DOI 10.1074/jbc.M109.032599; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Vincent B, 2000, J BIOL CHEM, V275, P35612, DOI 10.1074/jbc.M004628200; Vincent B, 2001, J BIOL CHEM, V276, P37743; Walmsley AR, 2009, MOL CELL NEUROSCI, V40, P242, DOI 10.1016/j.mcn.2008.10.012; Watt NT, 2005, J BIOL CHEM, V280, P35914, DOI 10.1074/jbc.M507327200; WESTAWAY D, 1994, CELL, V76, P117, DOI 10.1016/0092-8674(94)90177-5; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Westergard L, 2011, J BIOL CHEM, V286, P44234, DOI 10.1074/jbc.M111.286195; White JM, 2003, CURR OPIN CELL BIOL, V15, P598, DOI 10.1016/j.ceb.2003.08.001; Yadavalli R, 2004, J BIOL CHEM, V279, P21948, DOI 10.1074/jbc.M400793200; Zanusso G, 2001, BRAIN PATHOL, V11, P182; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zhan M, 2007, J CELL SCI, V120, P692, DOI 10.1242/jcs.03372; Zhang Y, 2006, BIOCHEM BIOPH RES CO, V349, P759, DOI 10.1016/j.bbrc.2006.08.116; Zou WQ, 2010, J BIOL CHEM, V285, P13874, DOI 10.1074/jbc.M109.088831	81	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16510	16520		10.1074/jbc.M112.360891	http://dx.doi.org/10.1074/jbc.M112.360891			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22447932	Green Published, hybrid			2022-12-27	WOS:000304030900041
J	Ho, CJ; Zhao, J; Malinowski, S; Chahine, M; O'Leary, ME				Ho, Cojen; Zhao, Juan; Malinowski, Steven; Chahine, Mohamed; O'Leary, Michael E.			Differential Expression of Sodium Channel beta Subunits in Dorsal Root Ganglion Sensory Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTION-POTENTIAL INITIATION; AUXILIARY SUBUNIT; ALPHA-SUBUNIT; FUNCTIONAL EXPRESSION; EXTRACELLULAR DOMAIN; RAT-BRAIN; MODULATION; NA(V)1.7; ROLES; BETA-1-SUBUNIT	The small-diameter (<25 mu m) and large-diameter (>30 mu m) sensory neurons of the dorsal root ganglion (DRG) express distinct combinations of tetrodotoxin sensitive and tetrodotoxin-resistant Na+ channels that underlie the unique electrical properties of these neurons. In vivo, these Na+ channels are formed as complexes of pore-forming alpha and auxiliary beta subunits. The goal of this study was to investigate the expression of beta subunits in DRG sensory neurons. Quantitative single-cell RTPCR revealed that beta subunit mRNA is differentially expressed in small (beta(2) and beta(3)) and large (beta(1) and beta(2)) DRG neurons. This raises the possibility that beta subunit availability and Na+ channel composition and functional regulation may differ in these subpopulations of sensory neurons. To further explore these possibilities, we quantitatively compared the mRNA expression of the beta subunit with that of Na(v)1.7, a TTX-sensitive Na+ channel widely expressed in both small and large DRG neurons. Na(v)1.7 and beta subunit mRNAs were significantly correlated in small (beta(2) and beta(3)) and large (beta(1) and beta(2)) DRG neurons, indicating that these subunits are coexpressed in the same populations. Co-immunoprecipitation and immunocytochemistry indicated that Na(v)1.7 formed stable complexes with the beta(1)-beta(3) subunits in vivo and that Na(v)1.7 and beta(3) co-localized within the plasma membranes of small DRG neurons. Heterologous expression studies showed that beta(3) induced a hyperpolarizing shift in Na(v)1.7 activation, whereas beta(1) produced a depolarizing shift in inactivation and faster recovery. The data indicate that beta(3) and beta(1) subunits are preferentially expressed in small and large DRG neurons, respectively, and that these auxiliary subunits differentially regulate the gating properties of Na(v)1.7 channels.	[Ho, Cojen; Malinowski, Steven; O'Leary, Michael E.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Zhao, Juan; Chahine, Mohamed] Univ Laval, Ctr Rech Univ Laval Robert Giffard, Quebec City, PQ G1J 2G3, Canada	Jefferson University; Laval University	O'Leary, ME (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St,JAH 473, Philadelphia, PA 19107 USA.	michael.oleary@jefferson.edu			National Institutes of Health from NIGMS [R01 GM078244]; Heart and Stroke Foundation of Quebec (HSFQ); Canadian Institutes of Health Research (CIHR) [INO-77909]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078244] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Heart and Stroke Foundation of Quebec (HSFQ); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM078244 from NIGMS (to M. E. O'L.). This work was also supported by the Heart and Stroke Foundation of Quebec (HSFQ) and Canadian Institutes of Health Research (CIHR) Grant INO-77909 (to M. C.).	Amaya F, 2000, MOL CELL NEUROSCI, V15, P331, DOI 10.1006/mcne.1999.0828; ATTWELL D, 1979, PFLUG ARCH EUR J PHY, V379, P137, DOI 10.1007/BF00586939; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Black JA, 1996, MOL BRAIN RES, V43, P117, DOI 10.1016/S0169-328X(96)00163-5; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chen CF, 1995, PFLUG ARCH EUR J PHY, V431, P186, DOI 10.1007/BF00410190; Colbert CM, 2002, NAT NEUROSCI, V5, P533, DOI 10.1038/nn857; Coward K, 2001, NEUROREPORT, V12, P483, DOI 10.1097/00001756-200103050-00012; Cummins TR, 2007, PAIN, V131, P243, DOI 10.1016/j.pain.2007.07.026; Dib-Hajj SD, 1998, P NATL ACAD SCI USA, V95, P8963, DOI 10.1073/pnas.95.15.8963; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Dib-Hajj SD, 2009, BRAIN RES REV, V60, P65, DOI 10.1016/j.brainresrev.2008.12.005; Fischer TZ, 2010, ANN NY ACAD SCI, V1184, P196, DOI 10.1111/j.1749-6632.2009.05110.x; Harty TP, 2006, J NEUROSCI, V26, P12566, DOI 10.1523/JNEUROSCI.3424-06.2006; Henze DA, 2001, NEUROSCIENCE, V105, P121, DOI 10.1016/S0306-4522(01)00167-1; Ho C, 2011, MOL CELL NEUROSCI, V46, P159, DOI 10.1016/j.mcn.2010.08.017; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Isom LL, 2002, FRONT BIOSCI, V7, P12; ISOM LL, 1995, J BIOL CHEM, V270, P3306, DOI 10.1074/jbc.270.7.3306; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; Lampert A, 2010, PFLUG ARCH EUR J PHY, V460, P249, DOI 10.1007/s00424-009-0779-3; Lopez-Santiago LF, 2006, J NEUROSCI, V26, P7984, DOI 10.1523/JNEUROSCI.2211-06.2006; Lopez-Santiago LF, 2011, J BIOL CHEM, V286, P22913, DOI 10.1074/jbc.M111.242370; McCormick KA, 1999, J BIOL CHEM, V274, P32638, DOI 10.1074/jbc.274.46.32638; McCormick KA, 1998, J BIOL CHEM, V273, P3954, DOI 10.1074/jbc.273.7.3954; Meadows LS, 2002, NEUROSCIENCE, V114, P745, DOI 10.1016/S0306-4522(02)00242-7; MESSNER DJ, 1985, J BIOL CHEM, V260, P597; Morgan K, 2000, P NATL ACAD SCI USA, V97, P2308, DOI 10.1073/pnas.030362197; OH YS, 1995, MOL BRAIN RES, V30, P357, DOI 10.1016/0169-328X(95)00052-T; Platkiewicz J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000850; Qu Y, 2001, MOL CELL NEUROSCI, V18, P570, DOI 10.1006/mcne.2001.1039; Qu YS, 1999, J BIOL CHEM, V274, P32647, DOI 10.1074/jbc.274.46.32647; ROBERTS RH, 1987, J BIOL CHEM, V262, P2298; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Sangameswaran L, 1996, J BIOL CHEM, V271, P5953, DOI 10.1074/jbc.271.11.5953; Sangameswaran L, 1997, J BIOL CHEM, V272, P14805, DOI 10.1074/jbc.272.23.14805; Shah BS, 2000, EUR J NEUROSCI, V12, P3985, DOI 10.1046/j.1460-9568.2000.00294.x; SUTKOWSKI EM, 1990, J BIOL CHEM, V265, P12393; Takahashi N, 2003, NEUROSCIENCE, V121, P441, DOI 10.1016/S0306-4522(03)00432-9; Vijayaragavan K, 2004, BIOCHEM BIOPH RES CO, V319, P531, DOI 10.1016/j.bbrc.2004.05.026; Vijayaragavan K, 2001, J NEUROSCI, V21, P7909, DOI 10.1523/JNEUROSCI.21-20-07909.2001; Yu FH, 2003, J NEUROSCI, V23, P7577; Zhao J, 2007, J NEUROPHYSIOL, V98, P467, DOI 10.1152/jn.00117.2007; Zhao J, 2011, J NEUROPHYSIOL, V106, P608, DOI 10.1152/jn.00107.2011; Zimmer T, 2002, J GEN PHYSIOL, V120, P887, DOI 10.1085/jgp.20028703	47	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15044	15053		10.1074/jbc.M111.333740	http://dx.doi.org/10.1074/jbc.M111.333740			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22408255	hybrid, Green Published			2022-12-27	WOS:000304003200066
J	Koch, S; Fritsch, MJ; Buchanan, G; Palmer, T				Koch, Sabrina; Fritsch, Maximilian J.; Buchanan, Grant; Palmer, Tracy			Escherichia coli TatA and TatB Proteins Have N-out, C-in Topology in Intact Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TWIN-ARGININE TRANSLOCASE; SEC-INDEPENDENT PROTEIN; CYSTEINE-SCANNING MUTAGENESIS; TRANSPORT SYSTEM; SIGNAL PEPTIDE; RHOMBOID PROTEASE; CLONING VECTORS; COMPONENT; EXPORT; COMPLEX	The twin arginine protein transport (Tat) system translocates folded proteins across the cytoplasmic membrane of pro-karyotes and the thylakoid membrane of chloroplasts. In Escherichia coli, TatA, TatB, and TatC are essential components of the machinery. Acomplex of TatB and TatC acts as the substrate receptor, whereas TatA is proposed to form the Tat transport channel. TatA and TatB are related proteins that comprise an N-terminal transmembrane helix and an adjacent amphipathic helix. Previous studies addressing the topological organization of TatA have given conflicting results. In this study, we have addressed the topological arrangement of TatA and TatB in intact cells by labeling of engineered cysteine residues with the membrane-impermeable thiol reagent methoxypolyethylene glycol maleimide. Our results show that TatA and TatB share an N-out, C-in topology, with no evidence that the amphipathic helices of either protein are exposed at the periplasmic side of the membrane. We further show that the N-out, C-in topology of TatA is fixed and is not affected by the absence of other Tat components or by the overproduction of a Tat substrate. These data indicate that topological reorganization of TatA is unlikely to accompany Tat-dependent protein transport.	[Koch, Sabrina; Fritsch, Maximilian J.; Buchanan, Grant; Palmer, Tracy] Univ Dundee, Div Mol Microbiol, Coll Life Sci, Dundee DD1 5EH, Scotland	University of Dundee	Palmer, T (corresponding author), Univ Dundee, Div Mol Microbiol, Coll Life Sci, Dundee DD1 5EH, Scotland.	t.palmer@dundee.ac.uk		Palmer, Tracy/0000-0001-9043-2592	Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/D011140/2, BB/D011140/1] Funding Source: researchfish; BBSRC [BB/D011140/2, BB/D011140/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council through a PhD studentship (to M. F.).	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; Bauer J, 2011, BIOCHEMISTRY-US, V50, P5925, DOI 10.1021/bi1019995; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Berthelmann F, 2008, J BIOL CHEM, V283, P25281, DOI 10.1074/jbc.M707757200; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Buchanan G, 2002, MOL MICROBIOL, V43, P1457, DOI 10.1046/j.1365-2958.2002.02853.x; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; Chan CS, 2007, BIOCHEMISTRY-US, V46, P7396, DOI 10.1021/bi7005288; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2007, ENZYMES, V25, P463, DOI 10.1016/S1874-6047(07)25018-8; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dabney-Smith C, 2009, MOL BIOL CELL, V20, P2060, DOI 10.1091/mbc.E08-12-1189; de Leeuw E, 2002, J MOL BIOL, V322, P1135, DOI 10.1016/S0022-2836(02)00820-3; De Leeuw E, 2001, FEBS LETT, V506, P143, DOI 10.1016/S0014-5793(01)02904-0; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Gouffi K, 2004, J BIOL CHEM, V279, P11608, DOI 10.1074/jbc.M313187200; Greene NP, 2007, J BIOL CHEM, V282, P23937, DOI 10.1074/jbc.M702972200; Hashimoto-Gotoh T, 2000, GENE, V241, P185, DOI 10.1016/S0378-1119(99)00434-5; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Ize B, 2003, MOL MICROBIOL, V48, P1183, DOI 10.1046/j.1365-2958.2003.03504.x; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Lee PA, 2006, J BIOL CHEM, V281, P34072, DOI 10.1074/jbc.M607295200; LEIVE L, 1968, J BIOL CHEM, V243, P2373; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; Maegawa S, 2007, MOL MICROBIOL, V64, P435, DOI 10.1111/j.1365-2958.2007.05679.x; Maldonado B, 2011, FEBS LETT, V585, P478, DOI 10.1016/j.febslet.2011.01.016; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Mori H, 1999, J CELL BIOL, V146, P45, DOI 10.1083/jcb.146.1.45; Palmer T. N., 2010, ECMWF SEM P DIAGN FO, P1; Palmer T, 2010, METHODS MOL BIOL, V619, P191, DOI 10.1007/978-1-60327-412-8_12; Porcelli I, 2002, BIOCHEMISTRY-US, V41, P13690, DOI 10.1021/bi026142i; Punginelli C, 2007, J BACTERIOL, V189, P5482, DOI 10.1128/JB.00647-07; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; Sambrook J., 2001, MOL CLONING LAB MANU; Sargent F, 2001, EUR J BIOCHEM, V268, P3361, DOI 10.1046/j.1432-1327.2001.02263.x; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Sauve V, 2007, J BIOL CHEM, V282, P23194, DOI 10.1074/jbc.M701602200; SILVESTRO A, 1988, BIOCHIM BIOPHYS ACTA, V954, P1, DOI 10.1016/0167-4838(88)90049-0; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Tarry M, 2009, J MOL BIOL, V386, P504, DOI 10.1016/j.jmb.2008.12.043; Tarry MJ, 2009, P NATL ACAD SCI USA, V106, P13284, DOI 10.1073/pnas.0901566106; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Walther TH, 2010, J AM CHEM SOC, V132, P15945, DOI 10.1021/ja106963s; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Yen MR, 2002, ARCH MICROBIOL, V177, P441, DOI 10.1007/s00203-002-0408-4	59	40	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14420	14431		10.1074/jbc.M112.354555	http://dx.doi.org/10.1074/jbc.M112.354555			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22399293	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000304003200010
J	Tang, YJ; LeMaster, DM; Nauwelaers, G; Gu, D; Langouet, S; Turesky, RJ				Tang, Yijin; LeMaster, David M.; Nauwelaers, Gwendoline; Gu, Dan; Langouet, Sophie; Turesky, Robert J.			UDP-Glucuronosyltransferase-mediated Metabolic Activation of the Tobacco Carcinogen 2-Amino-9H-pyrido[2,3-b]indole	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROCYCLIC AROMATIC-AMINES; CIGARETTE-SMOKE CONDENSATE; DNA ADDUCT FORMATION; A-ALPHA-C; MASS-SPECTROMETRY; IN-VITRO; EPIDEMIOLOGIC EVIDENCE; COLORECTAL-CANCER; N-GLUCURONIDATION; LIVER-MICROSOMES	2-Amino-9H-pyrido[2,3-b]indole (A alpha C) is a carcinogenic heterocyclic aromatic amine (HAA) that arises in tobacco smoke. UDP-glucuronosyltransferases (UGTs) are important enzymes that detoxicate many procarcinogens, including HAAs. UGTs compete with P450 enzymes, which bioactivate HAAs by N-hydroxylation of the exocyclic amine group; the resultantN-hydroxy-HAA metabolites form covalent adducts with DNA. We have characterized the UGT-catalyzed metabolic products of A alpha C and the genotoxic metabolite 2-hydroxyamino-9Hpyrido[2,3-b] indole (HONH-A alpha C) formed with human liver microsomes, recombinant human UGT isoforms, and human hepatocytes. The structures of the metabolites were elucidated by H-1 NMR and mass spectrometry. A alpha C and HONH-A alpha C underwent glucuronidation by UGTs to form, respectively, N-2-(beta-D-glucosiduronyl)- 2-amino-9H-pyrido[2,3-b] indole (A alpha C-N-2-Gl) and N-2-(beta-D-glucosidurony1)-2-hydroxyamino-9H-pyrido[2,3-b] indole (A alpha C-HON2-Gl). HONH-A alpha C also underwent glucuronidation to form a novel O-linked glucuronide conjugate, O(beta-D-glucosiduronyl)-2-hydroxyamino-9H-pyrido[2,3-b] indole (A alpha C-HN2-O-Gl). A alpha C-HN2-O-Glisabiologicallyreactivemetabolite and binds to calf thymus DNA (pH 5.0 or 7.0) to form the N-(deoxyguanosin-8-yl)-A alpha C adduct at 20-50-fold higher levels than the adduct levels formed with HONH-A alpha C. Major UGT isoforms were examined for their capacity to metabolize A alpha C and HONH-A alpha C. UGT1A4was the most catalytically efficient enzyme (V-max/K-m) at forming A alpha C-N-2-Gl (0.67 mu l.min(-1).mg of protein(-1)), and UGT1A9 was most catalytically efficient at forming A alpha C-HN-O-Gl (77.1 mu l.min(-1) mg of protein(-1)), whereasUGT1A1was most efficient at forming A alpha C-HON2-Gl (5.0 mu l.min(-1).mg of protein (-1)). Human hepatocytes produced A alpha C-N-2-Gl and A alpha C-(HNO)-O-2- Gl in abundant quantities, but A alpha C-HON2-Gl was a minor product. Thus, UGTs, usually important enzymes in the detoxication of many procarcinogens, serve as a mechanism of bioactivation of HONH-A alpha C.	[Tang, Yijin; Gu, Dan; Turesky, Robert J.] New York State Dept Hlth, Div Environm Hlth Sci, Wadsworth Ctr, Albany, NY 12201 USA; [LeMaster, David M.] New York State Dept Hlth, Div Translat Med, Wadsworth Ctr, Albany, NY 12201 USA; [Nauwelaers, Gwendoline; Langouet, Sophie] Univ Rennes 1, INSERM, U1085, IRSET,Federat Rech BioSit Rennes UMS 3480, F-35043 Rennes, France; [Nauwelaers, Gwendoline] La Haute Marche, ANSES, Fougeres Lab, Contaminant Toxicol Unit, F-35302 Fougeres, France	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; Wadsworth Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Fougeres	Turesky, RJ (corresponding author), New York State Dept Hlth, Div Environm Hlth Sci, Wadsworth Ctr, Albany, NY 12201 USA.	Rturesky@wadsworth.org	Langouet, Sophie A/I-2776-2015	Langouet, Sophie/0000-0002-0016-5425	National Institutes of Health [R01 CA122320, R01 CA134700]; INSERM, la Ligue contre le Cance; region Bretagne; Anses; College Doctoral International of the Universite Europeenne de Bretagne; NATIONAL CANCER INSTITUTE [R01CA134700, R01CA122320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INSERM, la Ligue contre le Cance; region Bretagne(Region Bretagne); Anses; College Doctoral International of the Universite Europeenne de Bretagne; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA122320 and R01 CA134700 (to R. J. T.). This work was also supported by INSERM, la Ligue contre le Cancer, the region Bretagne and Anses for financial aid (to G. N. and S. L.), and the College Doctoral International of the Universite Europeenne de Bretagne for a travel fellowship (to G. N.).	[Anonymous], 2004, IARC MON EV CARC RIS, P1005; Bessette EE, 2010, CHEM RES TOXICOL, V23, P1234, DOI 10.1021/tx100098f; Bessette EE, 2009, ANAL CHEM, V81, P809, DOI 10.1021/ac802096p; Clement B, 2001, CHEM RES TOXICOL, V14, P319, DOI 10.1021/tx000105f; CRAMER JW, 1960, J BIOL CHEM, V235, P885; FENG PCC, 1983, DRUG METAB DISPOS, V11, P103; Frederiksen H, 2005, MOL NUTR FOOD RES, V49, P263, DOI 10.1002/mnfr.200400061; Frederiksen H, 2004, FOOD CHEM TOXICOL, V42, P879, DOI 10.1016/j.fct.2004.01.011; Frederiksen H, 2003, PHARMACOL TOXICOL, V92, P246, DOI 10.1034/j.1600-0773.2003.920508.x; Giovannucci E, 2001, CANCER EPIDEM BIOMAR, V10, P725; Glatt H, 2006, WOODHEAD PUBL FOOD S, P358, DOI 10.1533/9781845692018.2.358; Goodenough AK, 2007, CHEM RES TOXICOL, V20, P263, DOI 10.1021/tx0601713; Gu D, 2012, CARCINOGENESIS, V33, P124, DOI 10.1093/carcin/bgr252; Irving C. C., 1981, NATL CANCER I MONOGR, V58, P109; Irving C. C., 1973, METAB CONJUGATION, P53; Kadlubar F. F., 1985, POLYCYCLIC HYDROCARB, P341; KADLUBAR FF, 1977, CANCER RES, V37, P805; KATO R, 1986, CRIT REV TOXICOL, V16, P307, DOI 10.3109/10408448609037466; King RS, 2000, CARCINOGENESIS, V21, P1347, DOI 10.1093/carcin/21.7.1347; KRIEK E, 1992, J CANCER RES CLIN, V118, P481, DOI 10.1007/BF01225261; Lawley P. D., 1984, ACS MONOGR SER, V1, P324; Lee YCA, 2009, INT J EPIDEMIOL, V38, P1497, DOI 10.1093/ije/dyp280; Levsen K, 2005, J CHROMATOGR A, V1067, P55, DOI 10.1016/j.chroma.2004.08.165; Luchtenborg M, 2007, CANCER EPIDEM BIOMAR, V16, P1341, DOI 10.1158/1055-9965.EPI-06-0519; Luukkanen L, 2005, DRUG METAB DISPOS, V33, P1017, DOI 10.1124/dmd.105.004093; Malfatti MA, 2004, CHEM RES TOXICOL, V17, P1137, DOI 10.1021/tx049898m; MILLER EC, 1978, CANCER RES, V38, P1479; MULDER GJ, 1977, BIOCHEM PHARMACOL, V26, P189, DOI 10.1016/0006-2952(77)90301-X; Nagar S, 2006, ONCOGENE, V25, P1659, DOI 10.1038/sj.onc.1209375; Nauwelaers G, 2011, CHEM RES TOXICOL, V24, P913, DOI 10.1021/tx200091y; Nowell SA, 1999, CARCINOGENESIS, V20, P1107, DOI 10.1093/carcin/20.6.1107; Okonogi H, 1997, CANCER LETT, V111, P105, DOI 10.1016/S0304-3835(96)04505-3; Raza H, 1996, DRUG METAB DISPOS, V24, P395; Schaber G, 2001, DRUG METAB DISPOS, V29, P923; SHIMADA T, 1991, CANCER RES, V51, P5284; Smith CJ, 2004, J CHROMATOGR A, V1046, P211, DOI 10.1016/j.chroma.2004.06.082; SNYDERWINE EG, 1992, CHEM RES TOXICOL, V5, P843, DOI 10.1021/tx00030a018; STRAUB K, 1988, DRUG METAB DISPOS, V16, P359; Sugimura T, 2004, CANCER SCI, V95, P290, DOI 10.1111/j.1349-7006.2004.tb03205.x; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; TURESKY RJ, 1991, CARCINOGENESIS, V12, P1839, DOI 10.1093/carcin/12.10.1839; TURESKY RJ, 1990, CHEM RES TOXICOL, V3, P524, DOI 10.1021/tx00018a006; Turesky RJ, 2011, CHEM RES TOXICOL, V24, P1169, DOI 10.1021/tx200135s; TURGEON J, 1992, DRUG METAB DISPOS, V20, P762; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; YOSHIDA D, 1980, CANCER LETT, V10, P141, DOI 10.1016/0304-3835(80)90037-3; YOSHIDA D, 1978, BIOCHEM BIOPH RES CO, V83, P915, DOI 10.1016/0006-291X(78)91482-1; Yuan ZX, 2007, CHEM RES TOXICOL, V20, P497, DOI 10.1021/tx600303d; Zenser TV, 2002, MUTAT RES-FUND MOL M, V506, P29, DOI 10.1016/S0027-5107(02)00149-5; Zenser TV, 1999, DRUG METAB DISPOS, V27, P1064; Zhang XB, 1996, CARCINOGENESIS, V17, P2259, DOI 10.1093/carcin/17.10.2259	51	17	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14960	14972		10.1074/jbc.M111.320093	http://dx.doi.org/10.1074/jbc.M111.320093			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22393056	Green Published, hybrid			2022-12-27	WOS:000304003200058
J	Koh, H; Kim, H; Kim, MJ; Park, J; Lee, HJ; Chung, J				Koh, Hyongjong; Kim, Hyunjin; Kim, Min Ju; Park, Jeehye; Lee, Hye-Jeong; Chung, Jongkyeong			Silent Information Regulator 2 (Sir2) and Forkhead Box O (FOXO) Complement Mitochondrial Dysfunction and Dopaminergic Neuron Loss in Drosophila PTEN-induced Kinase 1 (PINK1) Null Mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEIN LIGASE; PARKINSONS-DISEASE; DEACETYLASE ACTIVITY; OXIDATIVE STRESS; LIFE-SPAN; GENE; MUTATIONS; PATHWAY; PHOSPHORYLATION; TRANSCRIPTION	PTEN-induced kinase 1 (PINK1), which is associated with early onset Parkinson disease, encodes a serine-threonine kinase that is critical for maintaining mitochondrial function. Moreover, another Parkinson disease-linked gene, parkin, functions downstream of PINK1 in protecting mitochondria and dopaminergic (DA) neuron. In our fly genetic screening, knockdown of Sir2 blocked PINK1 overexpression-induced phenotypes. Consistently, ectopic expression of Sir2 successfully rescued mitochondrial defects in PINK1 null mutants, but unexpectedly, failed in parkin mutants. In further genetic analyses, deletion of FOXO nullified the Sir2-induced mitochondrial restoration in PINK1 null mutants. Moreover, overexpression of FOXO or its downstream target gene such as SOD2 or Thor markedly ameliorated PINK1 loss-of-function defects, suggesting that FOXO mediates the mitochondrial protecting signal induced by Sir2. Consistent with its mitochondria-protecting role, Sir2 expression prevented the DA neuron loss of PINK1 null mutants in a FOXO-dependent manner. Loss of Sir2 or FOXO induced DA neuron degeneration, which is very similar to that of PINK1 null mutants. Furthermore, PINK1 deletion had no deleterious effect on the DA neuron loss in Sir2 or FOXO mutants, supporting the idea that Sir2, FOXO, and PINK1 protect DA neuron in a common pathway. Overall, these results strongly support the role of Sir2 and FOXO in preventing mitochondrial dysfunction and DA neuron loss, further suggesting that Sir2 and FOXO function downstream of PINK1 and independently of Parkin.	[Koh, Hyongjong; Kim, Hyunjin; Kim, Min Ju; Lee, Hye-Jeong] Dong A Univ, Coll Med, Dept Pharmacol, MHRC, Pusan 602714, South Korea; [Park, Jeehye; Chung, Jongkyeong] Seoul Natl Univ, Natl Creat Res Initiat Ctr Energy Homeostasis Reg, Sch Biol Sci, Seoul 151744, South Korea; [Park, Jeehye; Chung, Jongkyeong] Seoul Natl Univ, Inst Mol Biol & Genet, Seoul 151744, South Korea	Dong A University; Seoul National University (SNU); Seoul National University (SNU)	Koh, H (corresponding author), Dong A Univ, Coll Med, Dept Pharmacol, MHRC, Dongdaeshin Dong 3-1, Pusan 602714, South Korea.	hjkoh@dau.ac.kr; jkc@snu.ac.kr		Koh, Hyongjong/0000-0003-2594-4799	National Research Foundation of Korea (NRF) [2008-0059520, 2009-0093188]; Korean government (Ministry Of Education, Science And Technology (MEST); MEST [2010-0018291]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (Ministry Of Education, Science And Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) (Grants 2008-0059520 and 2009-0093188) funded by the Korean government (Ministry Of Education, Science And Technology (MEST)) (to H. K.) and the National Creative Research Initiatives Program (Grant 2010-0018291) from MEST (to J. C.).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Griswoldt AJ, 2008, P NATL ACAD SCI USA, V105, P8673, DOI 10.1073/pnas.0803837105; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001229; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006611; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Park J, 2009, DIS MODEL MECH, V2, P336, DOI 10.1242/dmm.003178; Park J, 2009, BIOCHEM BIOPH RES CO, V378, P518, DOI 10.1016/j.bbrc.2008.11.086; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Tain LS, 2009, CELL DEATH DIFFER, V16, P1118, DOI 10.1038/cdd.2009.23; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	55	50	50	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12750	12758		10.1074/jbc.M111.337907	http://dx.doi.org/10.1074/jbc.M111.337907			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22378780	Green Published, hybrid			2022-12-27	WOS:000302903700014
J	Wang, HC; Kunz, S; Chen, G; Seebeck, T; Wan, YQ; Robinson, H; Martinelli, S; Ke, HM				Wang, Huanchen; Kunz, Stefan; Chen, Gong; Seebeck, Thomas; Wan, Yiqian; Robinson, Howard; Martinelli, Sibylla; Ke, Hengming			Biological and Structural Characterization of Trypanosoma cruzi Phosphodiesterase C and Implications for Design of Parasite Selective Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-SPECIFIC PHOSPHODIESTERASE; NUCLEOTIDE SPECIFIC PHOSPHODIESTERASES; SUBSTRATE-SPECIFICITY; DRUGS; OSMOREGULATION; LOCALIZATION; MECHANISMS; INSIGHT; ENZYMES; BINDING	Trypanosoma cruzi phosphodiesterase C (TcrPDEC) is a potential new drug target for the treatment of Chagas disease but has not been well studied. This study reports the enzymatic properties of various kinetoplastid PDECs and the crystal structures of the unliganded TcrPDEC1 catalytic domain and its complex with an inhibitor. Mutations of PDEC during the course of evolution led to inactivation of PDEC in Trypanosoma brucei/Trypanosoma evansi/Trypanosoma congolense, whereas the enzyme is active in all other kinetoplastids. The TcrPDEC1 catalytic domain hydrolyzes both cAMP and cGMP with a Km of 23.8 mu M and a k(cat) of 31 s(-1) for cAMP and a K-m of 99.1 mu M and a k(cat) of 17 s(-1) for cGMP, thus confirming its dual specificity. The crystal structures show that the N-terminal fragment wraps around the TcrPDEC catalytic domain and may thus regulate its enzymatic activity via direct interactions with the active site residues. A PDE5 selective inhibitor that has an IC50 of 230 nM for TcrPDEC1 binds to TcrPDEC1 in an orientation opposite to that of sildenafil. This observation, together with the screen of the inhibitory potency of human PDE inhibitors against TcrPDEC, implies that the scaffold of some human PDE inhibitors might be used as the starting model for design of parasite PDE inhibitors. The structural study also identified a unique parasite pocket that neighbors the active site and may thus be valuable for the design of parasite-specific inhibitors.	[Wang, Huanchen; Ke, Hengming] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Wang, Huanchen; Ke, Hengming] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Kunz, Stefan; Seebeck, Thomas] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland; [Chen, Gong; Wan, Yiqian] Sun Yat Sen Univ, Sch Chem & Chem Engn, Guangzhou 510275, Guangdong, Peoples R China; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Martinelli, Sibylla] Univ Bern, Dept Pathol, CH-3012 Bern, Switzerland	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Bern; Sun Yat Sen University; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Bern	Ke, HM (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	hke@meYnc.edu	, PEP-MX Core/AGV-4051-2022	Wang, Huanchen/0000-0003-2701-7155	National Institutes of Health [GM59791]; Swiss National Science Foundation [3100A-109245]; TI Pharma [T4-302]; Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources of National Institutes of Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); TI Pharma; Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM59791 (to H. K.). This work was also supported by Grant 3100A-109245 from the Swiss National Science Foundation and TI Pharma Project T4-302 (to T. S.), the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy, and the National Center for Research Resources of National Institutes of Health (to H. R.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alonso GD, 2006, MOL BIOCHEM PARASIT, V145, P40, DOI 10.1016/j.molbiopara.2005.09.005; Alonso GD, 2007, MOL BIOCHEM PARASIT, V152, P72, DOI 10.1016/j.molbiopara.2006.12.002; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Beavo J.A., 2006, CYCLIC NUCLEOTIDE PH; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buckner FS, 2010, CURR OPIN INFECT DIS, V23, P609, DOI 10.1097/QCO.0b013e3283402956; Burgin AB, 2010, NAT BIOTECHNOL, V28, P63, DOI 10.1038/nbt.1598; Castillo E, 2010, CURR MED CHEM, V17, P4027, DOI 10.2174/092986710793205345; D'Angelo MA, 2004, BIOCHEM J, V378, P63, DOI 10.1042/BJ20031147; De Koning HP, 2012, J INFECT DI IN PRESS; Diaz-Benjumea R, 2006, BIOCHEM J, V399, P305, DOI 10.1042/BJ20060757; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Fersht A., 1999, STRUCTURE MECH PROTE, P103; Gould MK, 2011, FEMS MICROBIOL REV, V35, P515, DOI 10.1111/j.1574-6976.2010.00262.x; Heikaus CC, 2009, STRUCTURE, V17, P1551, DOI 10.1016/j.str.2009.07.019; Hendrickson WA, 1997, METHOD ENZYMOL, V276, P494, DOI 10.1016/S0076-6879(97)76074-9; Johner A, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-25; Jones A, 2006, PROTEOMICS, V6, P259, DOI 10.1002/pmic.200500119; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Kabani S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-427; Ke HM, 2007, CURR TOP MED CHEM, V7, P391, DOI 10.2174/156802607779941242; King-Keller S, 2010, ANTIMICROB AGENTS CH, V54, P3738, DOI 10.1128/AAC.00313-10; Kunz S, 2006, MOL BIOCHEM PARASIT, V145, P133, DOI 10.1016/j.molbiopara.2005.09.018; Kunz S, 2005, FEBS J, V272, P6412, DOI 10.1111/j.1742-4658.2005.05039.x; Kunz S, 2004, EUR J BIOCHEM, V271, P637, DOI 10.1111/j.1432-1033.2003.03967.x; Laxman S, 2007, MOL INTERV, V7, P203, DOI 10.1124/mi.7.4.7; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lescure FX, 2010, LANCET INFECT DIS, V10, P556, DOI 10.1016/S1473-3099(10)70098-0; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Nilsson D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001037; Oberholzer M, 2007, FASEB J, V21, P720, DOI 10.1096/fj.06-6818com; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pils B, 2004, J MOL BIOL, V340, P399, DOI 10.1016/j.jmb.2004.04.063; Pils B, 2004, MOL BIOL EVOL, V21, P625, DOI 10.1093/molbev/msh055; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Rohloff P, 2004, J BIOL CHEM, V279, P52270, DOI 10.1074/jbc.M410372200; Salas CO, 2011, CURR MED CHEM, V18, P144; Schoijet AC, 2011, MOL MICROBIOL, V79, P50, DOI 10.1111/j.1365-2958.2010.07429.x; Seebeck T, 2004, CURR MOL MED, V4, P585, DOI 10.2174/1566524043360113; Seebeck T, 2011, FUTURE MED CHEM, V3, P1289, DOI [10.4155/fmc.11.77, 10.4155/FMC.11.77]; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Stevens J, 2001, INFECT GENET EVOL, V1, P143, DOI 10.1016/S1567-1348(01)00018-1; Wang HC, 2005, J BIOL CHEM, V280, P30949, DOI 10.1074/jbc.M504398200; Wang H, 2008, MOL PHARMACOL, V73, P104, DOI 10.1124/mol.107.040212; Wang H, 2007, MOL MICROBIOL, V66, P1029, DOI 10.1111/j.1365-2958.2007.05976.x; Wang HC, 2007, P NATL ACAD SCI USA, V104, P5782, DOI 10.1073/pnas.0700279104; Wang HC, 2006, J BIOL CHEM, V281, P21469, DOI 10.1074/jbc.M512527200; Wang HC, 2008, BIOCHEMISTRY-US, V47, P12760, DOI 10.1021/bi801487x; Wilkinson SR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001252; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047	53	23	23	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11788	11797		10.1074/jbc.M111.326777	http://dx.doi.org/10.1074/jbc.M111.326777			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22356915	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000302782200018
J	Boniecki, MT; Martinis, SA				Boniecki, Michal T.; Martinis, Susan A.			Coordination of tRNA Synthetase Active Sites for Chemical Fidelity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEIC-ACID SYNTHETASE; AMINO-ACID; ESCHERICHIA-COLI; EDITING ACTIVITY; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PROTEIN-SYNTHESIS; L-VALINE; DOMAIN; AMINOACYLATION	Statistical proteomes that are naturally occurring can result from mechanisms involving aminoacyl-tRNA synthetases (aaRSs) with inactivated hydrolytic editing active sites. In one case, Mycoplasma mobile leucyl-tRNA synthetase (LeuRS) is uniquely missing its entire amino acid editing domain, called CP1, which is otherwise present in all known LeuRSs and also isoleucyl-and valyl-tRNA synthetases. This hydrolytic CP1 domain was fused to a synthetic core composed of a Rossmann ATP-binding fold. The fusion event splits the primary structure of the Rossmann fold into two halves. Hybrid LeuRS chimeras using M. mobile LeuRS as a scaffold were constructed to investigate the evolutionary protein: protein fusion of the CP1 editing domain to the Rossmann fold domain that is ubiquitously found in kinases and dehydrogenases, in addition to class I aaRSs. Significantly, these results determined that the modular construction of aaRSs and their adaptation to accommodate more stringent amino acid specificities included CP1-dependent distal effects on amino acid discrimination in the synthetic core. As increasingly sophisticated protein synthesis machinery evolved, the addition of the CP1 domain increased specificity in the synthetic site, as well as provided a hydrolytic editing site.	[Boniecki, Michal T.; Martinis, Susan A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Martinis, SA (corresponding author), Univ Illinois, Dept Biochem, 600 S Mathews Ave,401 RAL, Urbana, IL 61801 USA.	martinis@illinois.edu		Martinis, Susan/0000-0001-5730-8346	National Institutes of Health [GM063789]; National Science Foundation [MCB0843611]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063789] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0843611] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grant GM063789 (to S. A. M. and M. T. B.). This work was also supported by National Science Foundation Grant MCB0843611.	ADAMS MJ, 1970, J MOL BIOL, V51, P31, DOI 10.1016/0022-2836(70)90267-6; BALDWIN AN, 1966, J BIOL CHEM, V241, P839; Betha AK, 2007, BIOCHEMISTRY-US, V46, P6258, DOI 10.1021/bi061965j; Bishop AC, 2002, P NATL ACAD SCI USA, V99, P585, DOI 10.1073/pnas.012611299; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; ENGLISCH S, 1986, NUCLEIC ACIDS RES, V14, P7529, DOI 10.1093/nar/14.19.7529; Fersht AR, 1998, SCIENCE, V280, P541, DOI 10.1126/science.280.5363.541; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Fukunaga R, 2005, J BIOL CHEM, V280, P29937, DOI 10.1074/jbc.M502668200; Fukunaga R, 2004, J BIOL CHEM, V279, P8396, DOI 10.1074/jbc.M312830200; Fukunaga R, 2006, J MOL BIOL, V359, P901, DOI 10.1016/j.jmb.2006.04.025; Hale SP, 1997, SCIENCE, V276, P1250, DOI 10.1126/science.276.5316.1250; Hati S, 2006, J BIOL CHEM, V281, P27862, DOI 10.1074/jbc.M605856200; Hellmann RA, 2009, J BIOL CHEM, V284, P11478, DOI 10.1074/jbc.M807395200; Ibba M, 1999, SCIENCE, V286, P1893, DOI 10.1126/science.286.5446.1893; Karkhanis VA, 2007, J BACTERIOL, V189, P8765, DOI 10.1128/JB.01215-07; Karkhanis VA, 2006, J BIOL CHEM, V281, P33217, DOI 10.1074/jbc.M607406200; Li L, 2011, P NATL ACAD SCI USA, V108, P9378, DOI 10.1073/pnas.1016460108; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; LOFTFIELD RB, 1963, BIOCHEM J, V89, P82, DOI 10.1042/bj0890082; Lue SW, 2005, BIOCHEMISTRY-US, V44, P3010, DOI 10.1021/bi047901v; Mascarenhas A. P., 2008, PROTEIN ENG, P153; Mursinna RS, 2002, J AM CHEM SOC, V124, P7286, DOI 10.1021/ja025879s; Mursinna RS, 2001, BIOCHEMISTRY-US, V40, P5376, DOI 10.1021/bi002915w; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; Nordin BE, 2003, BIOCHEMISTRY-US, V42, P12989, DOI 10.1021/bi035052q; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; Pham Y, 2010, J BIOL CHEM, V285, P38590, DOI 10.1074/jbc.M110.136911; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; SCHMIDT E, 1994, SCIENCE, V264, P265, DOI 10.1126/science.8146659; Splan KE, 2008, METHODS, V44, P119, DOI 10.1016/j.ymeth.2007.10.009; SternJohn J, 2007, P NATL ACAD SCI USA, V104, P2127, DOI 10.1073/pnas.0611110104; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; ZELWER C, 1982, J MOL BIOL, V155, P63, DOI 10.1016/0022-2836(82)90492-2; Zhang CM, 2006, J MOL BIOL, V361, P300, DOI 10.1016/j.jmb.2006.06.015	40	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11285	11289		10.1074/jbc.C111.325795	http://dx.doi.org/10.1074/jbc.C111.325795			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334703	Green Published, hybrid			2022-12-27	WOS:000302780100059
J	O'Shea, PJ; Kim, DW; Logan, JG; Davis, S; Walker, RL; Meltzer, PS; Cheng, SY; Williams, GR				O'Shea, Patrick J.; Kim, Dong Wook; Logan, John G.; Davis, Sean; Walker, Robert L.; Meltzer, Paul S.; Cheng, Sheue-yann; Williams, Graham R.			Advanced Bone Formation in Mice with a Dominant-negative Mutation in the Thyroid Hormone Receptor beta Gene due to Activation of Wnt/beta-Catenin Protein Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN D1; REGULATES EXPRESSION; SKELETAL PHENOTYPES; GROWTH; HYPERTHYROIDISM; DIFFERENTIATION; HYPOTHYROIDISM; RESISTANCE; FRACTURE; RISK	Thyroid hormone (T-3) acts in chondrocytes and bone-forming osteoblasts to control bone development and maintenance, but the signaling pathways mediating these effects are poorly understood. Thrb(PV/PV) mice have a severely impaired pituitary-thyroid axis and elevated thyroid hormone levels due to a dominant- negative mutant T-3 receptor (TR beta(PV)) that cannot bind T-3 and interferes with the actions of wild-type TR. Thrb(PV/PV) mice have accelerated skeletal development due to unknown mechanisms. Weperformed microarray studies in primary osteoblasts from wild-type mice and Thrb(PV/PV) mice. Activation of the canonical Wnt signaling in Thrb(PV/PV) mice was confirmed by in situ hybridization analysis of Wnt target gene expression in bone during postnatal growth. By contrast, T-3 treatment inhibited Wnt signaling in osteoblastic cells, suggesting that T-3 inhibits the Wnt pathway by facilitating proteasomal degradation of beta-catenin and preventing its accumulation in the nucleus. Activation of the Wnt pathway in Thrb(PV/PV) mice, however, results from a gain of function for TR beta(PV) that stabilizes beta-catenin despite the presence of increased thyroid hormone levels. These studies demonstrate novel interactions betweenT(3) and Wnt signaling pathways in the regulation of skeletal development and bone formation.	[O'Shea, Patrick J.; Kim, Dong Wook; Cheng, Sheue-yann] NCI, Gene Regulat Sect, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Davis, Sean; Walker, Robert L.; Meltzer, Paul S.] NCI, Mol Genet Sect, Genet Branch, NIH, Bethesda, MD 20892 USA; [O'Shea, Patrick J.; Logan, John G.; Williams, Graham R.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Mol Endocrinol Grp, London W12 0NN, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Imperial College London	Cheng, SY (corresponding author), NCI, Gene Regulat Sect, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	chengs@mail.nih.gov; graham.williams@imperial.ac.uk	Davis, Sean/AAD-1801-2021	Davis, Sean/0000-0002-8991-6458; Logan, John/0000-0003-2801-700X; Walker, Robert/0000-0001-8235-4686	Medical Research Council [G0501486] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC011091, ZIABC008752] Funding Source: NIH RePORTER; MRC [G0501486] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barnard JC, 2005, ENDOCRINOLOGY, V146, P5568, DOI 10.1210/en.2005-0762; Baron Roland, 2007, Curr Osteoporos Rep, V5, P73; Bassett JHD, 2008, BONE, V43, P418, DOI 10.1016/j.bone.2008.05.007; Bassett JHD, 2007, MOL ENDOCRINOL, V21, P1893, DOI 10.1210/me.2007-0157; Bassett JHD, 2007, MOL ENDOCRINOL, V21, P1095, DOI 10.1210/me.2007-0033; Bassett JHD, 2009, J MOL ENDOCRINOL, V42, P269, DOI 10.1677/JME-08-0142; Bauer DC, 2001, ANN INTERN MED, V134, P561, DOI 10.7326/0003-4819-134-7-200104030-00009; Bhat MK, 1999, THYROID, V9, P411, DOI 10.1089/thy.1999.9.411; Bieche I, 2001, THYROID, V11, P147, DOI 10.1089/105072501300042802; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Chen Y, 1997, J Biomed Opt, V2, P364, DOI 10.1117/12.281504; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Corr M, 2008, NAT CLIN PRACT RHEUM, V4, P550, DOI 10.1038/ncprheum0904; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dong YF, 2006, J CELL PHYSIOL, V208, P77, DOI 10.1002/jcp.20656; Furumoto H, 2005, MOL CELL BIOL, V25, P124, DOI 10.1128/MCB.25.1.124-135.2005; Gauthier K, 2001, MOL CELL BIOL, V21, P4748, DOI 10.1128/MCB.21.14.4748-4760.2001; Gogakos AI, 2010, ARCH BIOCHEM BIOPHYS, V503, P129, DOI 10.1016/j.abb.2010.06.021; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Guigon CJ, 2008, MOL CELL BIOL, V28, P4598, DOI 10.1128/MCB.02192-07; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; Harvey CB, 2007, ENDOCRINOLOGY, V148, P1764, DOI 10.1210/en.2006-1248; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Kaneshige M, 2000, P NATL ACAD SCI USA, V97, P13209, DOI 10.1073/pnas.230285997; Kaneshige M, 2001, P NATL ACAD SCI USA, V98, P15095, DOI 10.1073/pnas.261565798; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Khoo MLC, 2002, J CLIN ENDOCR METAB, V87, P1814, DOI 10.1210/jcem.87.4.8353; Khoo MLC, 2002, J CLIN ENDOCR METAB, V87, P1810, DOI 10.1210/jc.87.4.1810; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; LIN KH, 1991, ENDOCRINOLOGY, V128, P2601, DOI 10.1210/endo-128-5-2601; Miller LD, 2001, MOL CELL BIOL, V21, P6626, DOI 10.1128/MCB.21.19.6626-6639.2001; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; MOSEKILDE L, 1990, ENDOCRIN METAB CLIN, V19, P35, DOI 10.1016/S0889-8529(18)30338-4; Murphy E, 2010, J CLIN ENDOCR METAB, V95, P3173, DOI 10.1210/jc.2009-2630; Nimmakayalu M, 2000, BIOTECHNIQUES, V28, P518, DOI 10.2144/00283st11; O'Shea Patrick J, 2006, Nucl Recept Signal, V4, pe011; O'Shea PJ, 2005, MOL ENDOCRINOL, V19, P3045, DOI 10.1210/me.2005-0224; O'Shea PJ, 2003, MOL ENDOCRINOL, V17, P1410, DOI 10.1210/me.2002-0296; PARRILLA R, 1991, J CLIN INVEST, V88, P2123, DOI 10.1172/JCI115542; RIVKEES SA, 1988, NEW ENGL J MED, V318, P599, DOI 10.1056/NEJM198803103181003; Segni M, 1999, THYROID, V9, P871, DOI 10.1089/thy.1999.9.871; Spencer GJ, 2006, J CELL SCI, V119, P1283, DOI 10.1242/jcs.02883; Stevens DA, 2003, MOL ENDOCRINOL, V17, P1751, DOI 10.1210/me.2003-0137; Stevens DA, 2000, J BONE MINER RES, V15, P2431, DOI 10.1359/jbmr.2000.15.12.2431; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Vestergaard P, 2005, CALCIFIED TISSUE INT, V77, P139, DOI 10.1007/s00223-005-0068-x; Vestergaard P, 2003, THYROID, V13, P585, DOI 10.1089/105072503322238854; Vestergaard P, 2002, THYROID, V12, P411, DOI 10.1089/105072502760043503; Wang L, 2007, J BONE MINER RES, V22, P1988, DOI 10.1359/JBMR.070806; Wang L, 2010, J BONE MINER RES, V25, P1138, DOI 10.1002/jbmr.5; Wei W, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-16; Williams GR, 2000, MOL CELL BIOL, V20, P8329, DOI 10.1128/MCB.20.22.8329-8342.2000; Ying H, 2003, CARCINOGENESIS, V24, P1467, DOI 10.1093/carcin/bgg111	59	28	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17812	17822		10.1074/jbc.M111.311464	http://dx.doi.org/10.1074/jbc.M111.311464			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22442145	Green Published, hybrid			2022-12-27	WOS:000306373000079
J	Hart, BE; Tapping, RI				Hart, Bryan E.; Tapping, Richard I.			Cell Surface Trafficking of TLR1 Is Differentially Regulated by the Chaperones PRAT4A and PRAT4B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-SYSTEM; TOLL-LIKE RECEPTOR-2; INTRACELLULAR COMPARTMENTS; LEPROSY; RECOGNITION; MACROPHAGES; EXPRESSION; TOLL-LIKE-RECEPTOR-4; SUSCEPTIBILITY; TUBERCULOSIS	The subcellular localization of Toll-like receptors (TLRs) is critical to their ability to function as innate immune sensors of microbial infection. We previously reported that an I602S polymorphism of human TLR1 is associated with aberrant trafficking of the receptor to the cell surface, loss of responses to TLR1 agonists, and differential susceptibility to diseases caused by pathogenic mycobacteria. Through an extensive analysis of receptor deletion and point mutants we have discovered that position 602 resides within a short 6 amino acid cytoplasmic region that is required for TLR1 surface expression. This short trafficking motif, in conjunction with the adjacent transmembrane domain, is sufficient to direct TLR1 to the cell surface. A serine at position 602 interrupts this trafficking motif and prevents cell surface expression of TLR1. Additionally, we have found that ER-resident TLR chaperones, PRAT4A and PRAT4B, act as positive and negative regulators of TLR1 surface trafficking, respectively. Importantly, either over-expression of PRAT4A or knock-down of PRAT4B rescues cell surface expression of the TLR1 602S variant. We also report that IFN-gamma treatment of primary human monocytes derived from homozygous 602S individuals rescues TLR1 cell surface trafficking and cellular responses to soluble agonists. This event appears to be mediated by PRAT4A whose expression is strongly induced in human monocytes by IFN-gamma. Collectively, these results provide a mechanism for the differential trafficking of TLR1 I602S variants, and highlight the distinct roles for PRAT4A and PRAT4B in the regulation of TLR1 surface expression.	[Tapping, Richard I.] Univ Illinois, Dept Microbiol, Chem & Life Sci Lab CLSL B103, Urbana, IL 61801 USA; [Tapping, Richard I.] Univ Illinois, Coll Med, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Tapping, RI (corresponding author), Univ Illinois, Dept Microbiol, Chem & Life Sci Lab CLSL B103, MC-110,601 S Goodwin Ave, Urbana, IL 61801 USA.	tapping@illinois.edu		Hart, Bryan/0000-0001-5109-6151	National Institutes of Health, NIAID [AI052344]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052344, R21AI052344] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID R01 Grant AI052344 (to R. I. T.).	Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Chaturvedi A, 2009, TRAFFIC, V10, P621, DOI 10.1111/j.1600-0854.2009.00899.x; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Guan Y, 2010, J IMMUNOL, V184, P5094, DOI 10.4049/jimmunol.0901888; Hawn TR, 2007, EUR J IMMUNOL, V37, P2280, DOI 10.1002/eji.200737034; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kajita E, 2006, BIOCHEM BIOPH RES CO, V343, P578, DOI 10.1016/j.bbrc.2006.03.014; Konno K, 2006, BIOCHEM BIOPH RES CO, V339, P1076, DOI 10.1016/j.bbrc.2005.11.123; Krutzik SR, 2003, NAT MED, V9, P525, DOI 10.1038/nm864; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Misch EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000231; Mita Y, 2001, IMMUNOL LETT, V78, P97, DOI 10.1016/S0165-2478(01)00241-3; Nishiya T, 2005, J BIOL CHEM, V280, P37107, DOI 10.1074/jbc.M504951200; O'Mahony D Shane, 2008, Int J Med Sci, V5, P1; Omueti KO, 2005, J BIOL CHEM, V280, P36616, DOI 10.1074/jbc.M504320200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Schumann RR, 2007, EUR J IMMUNOL, V37, P2059, DOI 10.1002/eji.200737604; Schuring RP, 2009, J INFECT DIS, V199, P1816, DOI 10.1086/599121; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Tapping RI, 2009, SEMIN IMMUNOL, V21, P175, DOI 10.1016/j.smim.2009.05.003; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Uciechowski P, 2011, J LEUKOCYTE BIOL, V90, P377, DOI 10.1189/jlb.0409233; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Wakabayashi Y, 2006, J IMMUNOL, V177, P1772, DOI 10.4049/jimmunol.177.3.1772; Wang Guo-bing, 2008, Zhonghua Er Ke Za Zhi, V46, P49; Wolf AJ, 2011, J IMMUNOL, V187, P6002, DOI 10.4049/jimmunol.1100232; Wong SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000979; Yang Wei-guo, 2008, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V20, P561; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	41	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16550	16562		10.1074/jbc.M112.342717	http://dx.doi.org/10.1074/jbc.M112.342717			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22447933	Green Published, hybrid			2022-12-27	WOS:000304030900045
J	Kang, JH; Chang, YC; Maurizi, MR				Kang, Jeong Han; Chang, Young-Chae; Maurizi, Michael R.			4-O-Carboxymethyl Ascochlorin Causes ER Stress and Induced Autophagy in Human Hepatocellular Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED-PROTEIN RESPONSE; SIGNALING PATHWAY; GENE-EXPRESSION; LON PROTEASE; IN-VIVO; ACTIVATION; APOPTOSIS; CHOP; AS-6	The synthetic derivative of ascochlorin, 4-O-carboxymethyl ascochlorin (AS-6) is an agonist of the nuclear hormone receptor PPAR gamma and has been shown to induce differentiation in mouse pre-adipocytes and to ameliorate type II diabetes in a murine model. AS-6 was cytotoxic when added at micromolar concentrations to cultures of three different human cancer cell lines. We used gel electrophoresis and mass spectrometry to identify proteins with altered expression in human hepatocarcinoma cells (HepG2) cells after 12 h in the presence of AS-6 and found 58 proteins that were differentially expressed. Many of the proteins showing increased expression in cells treated with AS-6 are involved in protein quality control, including glucose-regulated protein 78 (GRP78/BiP), a regulator of ER stress responses, and the transcriptional regulator CHOP, which mediates ER stress-induced apoptosis. Cells treated with AS-6 undergo an autophagic response accompanied by increased expression of beclin1, ATG5, and LC3-II and autophagosome formation marked by the appearance of large vesicles containing LC3-II. Grp78 induction was inhibited when the PPAR gamma antagonist, GW9662, was added together with AS-6, and autophagy and cell death were partially blocked. 3-methyl-adenine (3-MA), an inhibitor of phosphatidyl inositol 3-kinase (PI3-kinase) prevented induction of ATG5 and activation of LC3-II and blocked autophagosome formation. 3-MA also blocked induction of GRP78 and CHOP, suggesting that PI3-kinase, which is known to mediate ER stress-induced autophagy, also plays a role in initiating apoptosis in response to ER stress. Together these data establish that the cytotoxicity of AS-6 operates by a mechanism dependent on ER stress-induced autophagy and apoptosis.	[Kang, Jeong Han; Maurizi, Michael R.] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Chang, Young-Chae] Catholic Univ Daegu, Sch Med, Dept Pathol, Res Inst Biomed Engn, Namgu 705718, Daegu, South Korea	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Catholic University of Daegu	Maurizi, MR (corresponding author), NCI, Cell Biol Lab, NIH, Bldg 37,Room 2128,37 Convent Dr, Bethesda, MD 20892 USA.	mmaurizi@helix.nih.gov	Kang, Jeong-Han/J-3541-2019	Kang, Jeong-Han/0000-0002-9693-0696	Center for Cancer Research, NCI, National Institutes of Health, Bethesda, MD; NATIONAL CANCER INSTITUTE [ZIABC005597] Funding Source: NIH RePORTER	Center for Cancer Research, NCI, National Institutes of Health, Bethesda, MD; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health, Bethesda, MD.	Aldridge JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000874; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Berry EA, 2010, BBA-BIOENERGETICS, V1797, P360, DOI 10.1016/j.bbabio.2009.12.003; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Chen SN, 2010, BBA-REV CANCER, V1806, P220, DOI 10.1016/j.bbcan.2010.07.003; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Entingh AJ, 2001, ENDOCRINOLOGY, V142, P221, DOI 10.1210/en.142.1.221; Fu MG, 2002, BIOCHEM BIOPH RES CO, V294, P597, DOI 10.1016/S0006-291X(02)00533-8; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Hong S, 2005, J BIOL CHEM, V280, P25202, DOI 10.1074/jbc.M413985200; Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103; HOSOKAWA T, 1985, BIOCHEM BIOPH RES CO, V127, P247, DOI 10.1016/S0006-291X(85)80151-0; HOSOKAWA T, 1985, DIABETES, V34, P267, DOI 10.2337/diabetes.34.3.267; Jeong JH, 2009, INT J CANCER, V124, P2797, DOI 10.1002/ijc.24259; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang JH, 2007, J CELL BIOCHEM, V102, P506, DOI 10.1002/jcb.21312; Kang JH, 2006, J PROTEOME RES, V5, P2620, DOI 10.1021/pr060111i; Kang JH, 2006, PROTEOMICS, V6, P1261, DOI 10.1002/pmic.200500290; Kowluru A, 2005, DIABETES, V54, P3523, DOI 10.2337/diabetes.54.12.3523; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Nakajima H, 2007, J ANTIBIOT, V60, P682, DOI 10.1038/ja.2007.87; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Park KG, 2006, LIFE SCI, V80, P120, DOI 10.1016/j.lfs.2006.08.030; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Saito S, 2003, BIOCHEM BIOPH RES CO, V311, P17, DOI 10.1016/j.bbrc.2003.09.161; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; TAMURA G, 1968, J ANTIBIOT, V21, P539, DOI 10.7164/antibiotics.21.539; Tanida I, 2008, AUTOPHAGY, V4, P131, DOI 10.4161/auto.5233; Togashi M, 2002, J ANTIBIOT, V55, P417, DOI 10.7164/antibiotics.55.417; WANG N, 1994, J BIOL CHEM, V269, P29308; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Yorimitsu T, 2007, AUTOPHAGY, V3, P160, DOI 10.4161/auto.3653; Yoshiuchi K, 2009, ENDOCR J, V56, P1103, DOI 10.1507/endocrj.K09E-140; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	42	28	29	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15661	15671		10.1074/jbc.M112.358473	http://dx.doi.org/10.1074/jbc.M112.358473			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22433868	Green Published, hybrid			2022-12-27	WOS:000304006300045
J	Lee, DM; Lee, HW; Hong, ST; Choi, BI; Kim, HW; Han, SB; Kim, IH; Bae, JY; Bae, YC; Rhyu, IJ; Sun, W; Kim, H				Lee, Dongmin; Lee, Hyun Woo; Hong, Soontaek; Choi, Byung-Il; Kim, Hyun-Wook; Han, Seung Baek; Kim, Il Hwan; Bae, Jin Young; Bae, Yong Chul; Rhyu, Im Joo; Sun, Woong; Kim, Hyun			Inositol 1,4,5-Trisphosphate 3-Kinase A Is a Novel Microtubule-associated Protein PKA-DEPENDENT PHOSPHOREGULATION OF MICROTUBULE BINDING AFFINITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; RECEPTOR ACTIVATION; TAU-PROTEIN; F-ACTIN; KINASE; PHOSPHORYLATION; EXPRESSION; DOUBLECORTIN; ISOFORMS; PURIFICATION	Inositol 1,4,5-trisphosphate 3-kinase A (IP3K-A) is a brain specific and F-actin-binding protein. We recently demonstrated that IP3K-A modulates a structural reorganization of dendritic spines through F-actin remodeling, which is required for synaptic plasticity and memory formation in brain. However, detailed functions of IP3K-A and its regulatory mechanisms involved in the neuronal cytoskeletal dynamics still remain unknown. In the present study, we identified tubulin as a candidate of IP3K-A-binding protein through proteomic screening. By various in vitro and in vivo approaches, we demonstrated that IP3K-A was a novel microtubule-associated protein (MAP), and the N terminus of IP3K-A was a critical region for direct binding to tubulin in dendritic shaft of hippocampal neurons. Moreover, PKA phosphorylated Ser-119 within IP3K-A, leading to a significant reduction of microtubule binding affinity. These results suggest that PKA-dependent phosphorylation and microtubule binding of IP3K-A are involved in its regulatory mechanism for activity-dependent neuronal events such as local calcium signaling and its synaptic targeting.	[Rhyu, Im Joo; Sun, Woong; Kim, Hyun] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea; [Kim, Il Hwan] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA; [Bae, Jin Young; Bae, Yong Chul] Kyungpook Natl Univ, Sch Dent, Dept Oral Anat & Neurobiol, Taegu, South Korea	Korea University; Korea University Medicine (KU Medicine); Duke University; Kyungpook National University	Kim, H (corresponding author), Korea Univ, Coll Med, Dept Anat, Brain Korea 21, Seoul 136705, South Korea.	kimhyun@korea.ac.kr		Lee, Dongmin/0000-0003-2039-6586; Han, Seung Baek/0000-0002-9798-0679; Kim, Hyun/0000-0002-7210-5798; sun, woong/0000-0003-1792-4894; Rhyu, Im Joo/0000-0002-5558-6278	Korea Science and Engineering Foundation (KOSEF) [2011-0019229, 2011-0019227, 2010K000830]	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation)	This work was supported by the Korea Science and Engineering Foundation (KOSEF) Grant 2011-0019229 (to H. W. L.), 2011-0019227 (to H. K.), and 2010K000830 (to H. K.).	Bae YC, 2002, J COMP NEUROL, V442, P308, DOI 10.1002/cne.10092; Baratta MV, 2002, J NEUROPHYSIOL, V88, P3078, DOI 10.1152/jn.00398.2002; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; CHOI KY, 1990, SCIENCE, V248, P64, DOI 10.1126/science.2157285; COFFEY RL, 1995, J BIOL CHEM, V270, P1035, DOI 10.1074/jbc.270.3.1035; Communi D, 1997, EMBO J, V16, P1943, DOI 10.1093/emboj/16.8.1943; FADOOL DA, 1994, P NATL ACAD SCI USA, V91, P9471, DOI 10.1073/pnas.91.20.9471; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; FULLER GM, 1976, J SUPRAMOL STR CELL, V5, P497, DOI 10.1002/jss.400050407; Gartner A, 2006, J NEUROSCI, V26, P3496, DOI 10.1523/JNEUROSCI.3792-05.2006; Goedert M, 2004, SEMIN CELL DEV BIOL, V15, P45, DOI 10.1016/j.semcdb.2003.12.015; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; Hansson MD, 2008, ANAL BIOCHEM, V375, P373, DOI 10.1016/j.ab.2007.12.005; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; He LS, 2011, CELL MOL LIFE SCI, V68, P1633, DOI 10.1007/s00018-010-0562-9; Huang SL, 2007, PLANT J, V51, P406, DOI 10.1111/j.1365-313X.2007.03153.x; Hughes JR, 2008, PLOS BIOL, V6, P785, DOI 10.1371/journal.pbio.0060098; IRVINE RF, 1986, NATURE, V320, P631, DOI 10.1038/320631a0; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Johnson HW, 2009, MOL BIOL CELL, V20, P5166, DOI 10.1091/mbc.E09-01-0083; Kapitein LC, 2011, J NEUROSCI, V31, P8194, DOI 10.1523/JNEUROSCI.6215-10.2011; Kim IH, 2004, MOL BRAIN RES, V124, P12, DOI 10.1016/j.molbrainres.2003.12.016; Kim IH, 2009, J NEUROSCI, V29, P14039, DOI 10.1523/JNEUROSCI.2483-09.2009; LEE SY, 1990, J BIOL CHEM, V265, P9434; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; MAURER RA, 1989, J BIOL CHEM, V264, P6870; Moseley JB, 2007, J BIOL CHEM, V282, P12661, DOI 10.1074/jbc.M610615200; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Paik SK, 2007, J COMP NEUROL, V503, P779, DOI 10.1002/cne.21423; Roger B, 2004, CURR BIOL, V14, P363, DOI 10.1016/j.cub.2004.01.058; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Schell MJ, 2010, CELL MOL LIFE SCI, V67, P1755, DOI 10.1007/s00018-009-0238-5; Schell MJ, 2001, J BIOL CHEM, V276, P37537, DOI 10.1074/jbc.M104101200; SCHLIWA M, 1976, J CELL BIOL, V70, P527, DOI 10.1083/jcb.70.3.527; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; SIM SS, 1990, J BIOL CHEM, V265, P10367; Szinyei C, 1999, J PHYSIOL-LONDON, V516, P855, DOI 10.1111/j.1469-7793.1999.0855u.x; Tsukada M, 2005, J BIOL CHEM, V280, P11361, DOI 10.1074/jbc.M405525200; Tsvetkov AS, 2007, CELL MOTIL CYTOSKEL, V64, P519, DOI 10.1002/cm.20201; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Windhorst S, 2008, BIOCHEM J, V414, P407, DOI 10.1042/BJ20080630; Windhorst S, 2012, CELL SIGNAL, V24, P750, DOI 10.1016/j.cellsig.2011.11.010; Woodring PJ, 1997, J BIOL CHEM, V272, P30447, DOI 10.1074/jbc.272.48.30447; Xia HJ, 2005, CELL RES, V15, P83, DOI 10.1038/sj.cr.7290270; YAMADA M, 1993, BRAIN RES, V606, P335, DOI 10.1016/0006-8993(93)91004-C; Zhong HN, 2009, NEURON, V62, P363, DOI 10.1016/j.neuron.2009.03.013	50	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15981	15995		10.1074/jbc.M112.344101	http://dx.doi.org/10.1074/jbc.M112.344101			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22389500	Green Published, hybrid			2022-12-27	WOS:000304006300076
J	Yien, YY; Bieker, JJ				Yien, Yvette Y.; Bieker, James J.			Functional Interactions between Erythroid Kruppel-like Factor (EKLF/KLF1) and Protein Phosphatase PPM1B/PP2C beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EKLF-DEFICIENT MICE; BETA-GLOBIN LOCUS; P-TEFB; TRANSCRIPTION-ELONGATION; ACTIVATION DOMAIN; GAMMA-GLOBIN; NUCLEAR-LOCALIZATION; GENE-EXPRESSION; CHIP-SEQ; IN-VIVO	Erythroid Kruppel-like factor (EKLF; KLF1) is an erythroid-specific transcription factor required for the transcription of genes that regulate erythropoiesis. In this paper, we describe the identification of a novel EKLF interactor, Ppm1b, a serine-threonine protein phosphatase that has been implicated in the attenuation of NF kappa B signaling and the regulation of Cdk9 phosphorylation status. We show that Ppm1b interacts with EKLF via its PEST1 sequence. However, its genetic regulatory role is complex. Using a promoter-reporter assay in an erythroid cell line, we show that Ppm1b superactivates EKLF at the beta-globin and BKLF promoters, dependent on intact Ppm1b phosphatase activity. Conversely, depletion of Ppm1b in CD34(+) cells leads to a higher level of endogenous beta-globin gene activation after differentiation. We also observe that Ppm1b likely has an indirect role in regulating EKLF turnover via its zinc finger domain. Together, these studies show that Ppm1b plays a multilayered role in regulating the availability and optimal activity of the EKLF protein in erythroid cells.	[Yien, Yvette Y.; Bieker, James J.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Bieker, JJ (corresponding author), Mt Sinai Sch Med, Dept Dev & Regenerat Biol, Box 1020,1 Gustave L Levy Pl, New York, NY 10029 USA.	james.bieker@mssm.edu			National Institutes of Health from USPHS [DK46865]; NYSTEM [C026435]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046865] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; NYSTEM; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK46865 from USPHS. This work was also supported by NYSTEM Contract C026435 (to J. J. B.).	Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Bianchi E, 2010, BLOOD, V116, pE99, DOI 10.1182/blood-2009-08-238311; Bieker JJ, 1996, DNA CELL BIOL, V15, P347, DOI 10.1089/dna.1996.15.347; Blau CA, 2005, J BIOL CHEM, V280, P36642, DOI 10.1074/jbc.M504402200; Bouilloux F, 2008, BLOOD, V112, P576, DOI 10.1182/blood-2007-07-098996; Chen J, 2010, P NATL ACAD SCI USA, V107, P16846, DOI 10.1073/pnas.0912896107; Chen RC, 2004, J BIOL CHEM, V279, P4153, DOI 10.1074/jbc.M310044200; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Chen XY, 2004, MOL CELL BIOL, V24, P10416, DOI 10.1128/MCB.24.23.10416-10424.2004; Chen XY, 1996, EMBO J, V15, P5888, DOI 10.1002/j.1460-2075.1996.tb00975.x; Cho S, 2010, CELL CYCLE, V9, P1697, DOI 10.4161/cc.9.9.11346; DONZE D, 1995, J BIOL CHEM, V270, P1955, DOI 10.1074/jbc.270.4.1955; Drexler HG, 2004, LEUKEMIA RES, V28, P1243, DOI 10.1016/j.leukres.2004.03.022; Drissen R, 2005, MOL CELL BIOL, V25, P5205, DOI 10.1128/MCB.25.12.5205-5214.2005; Duwel M, 2006, MOL BIOL CELL, V17, P4513, DOI 10.1091/mbc.E06-05-0390; Frontelo P, 2007, BLOOD, V110, P3871, DOI 10.1182/blood-2007-03-082065; Hodge D, 2006, BLOOD, V107, P3359, DOI 10.1182/blood-2005-07-2888; Lohmann F, 2008, DEVELOPMENT, V135, P2071, DOI 10.1242/dev.018200; Mas C, 2011, P NATL ACAD SCI USA, V108, P10484, DOI 10.1073/pnas.1017029108; Meier N, 2006, DEVELOPMENT, V133, P4913, DOI 10.1242/dev.02656; Narla G, 2005, CANCER RES, V65, P1213, DOI 10.1158/0008-5472.CAN-04-4249; Newmyer SL, 2003, DEV CELL, V4, P929, DOI 10.1016/S1534-5807(03)00157-6; Nilson DG, 2006, EXP HEMATOL, V34, P705, DOI 10.1016/j.exphem.2006.02.018; Ouyang L, 1998, J BIOL CHEM, V273, P23019, DOI 10.1074/jbc.273.36.23019; Pandya K, 2002, J BIOL CHEM, V277, P16304, DOI 10.1074/jbc.M200866200; Park JH, 2011, J BIOL CHEM, V286, P10911, DOI 10.1074/jbc.C110.210211; Perrine SP, 2009, EUR J HAEMATOL, V82, P466, DOI 10.1111/j.1600-0609.2009.01234.x; Pilon AM, 2011, BLOOD, V118, pE139, DOI 10.1182/blood-2011-05-355107; Pilon AM, 2008, MOL CELL BIOL, V28, P7394, DOI 10.1128/MCB.01087-08; Quadrini KJ, 2008, EXP CELL RES, V314, P1595, DOI 10.1016/j.yexcr.2008.01.033; Quadrini KJ, 2006, FEBS LETT, V580, P2285, DOI 10.1016/j.febslet.2006.03.039; Quadrini KJ, 2002, J BIOL CHEM, V277, P32243, DOI 10.1074/jbc.M205677200; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Sengupta T, 2008, MOL CELL BIOL, V28, P6160, DOI 10.1128/MCB.00919-08; Sengupta T, 2009, P NATL ACAD SCI USA, V106, P4213, DOI 10.1073/pnas.0808347106; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; SHOJI W, 1994, J BIOL CHEM, V269, P5078; Shyu YC, 2007, MOL CELL BIOL, V27, P2309, DOI 10.1128/MCB.01875-06; Siatecka M, 2007, MOL CELL BIOL, V27, P8547, DOI 10.1128/MCB.00589-07; Siatecka M, 2011, BLOOD, V118, P2044, DOI 10.1182/blood-2011-03-331371; Siatecka M, 2010, MOL CELL BIOL, V30, P2811, DOI 10.1128/MCB.01016-09; Song SH, 2010, BLOOD, V116, P2356, DOI 10.1182/blood-2010-03-272252; Stadhouders R, 2012, EMBO J, V31, P986, DOI 10.1038/emboj.2011.450; Sun WJ, 2009, CELL SIGNAL, V21, P95, DOI 10.1016/j.cellsig.2008.09.012; Tallack MR, 2007, J MOL BIOL, V369, P313, DOI 10.1016/j.jmb.2007.02.109; Tallack MR, 2010, IUBMB LIFE, V62, P886, DOI 10.1002/iub.404; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Tallack MR, 2009, J BIOL CHEM, V284, P20966, DOI 10.1074/jbc.M109.006346; Wang Y, 2008, J BIOL CHEM, V283, P33578, DOI 10.1074/jbc.M807495200; Woo AJ, 2008, MOL CELL BIOL, V28, P2675, DOI 10.1128/MCB.01945-07; Wu MH, 2001, BONE MARROW TRANSPL, V27, P1201, DOI 10.1038/sj.bmt.1703054; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855; Zhang WJ, 2001, MOL CELL BIOL, V21, P2413, DOI 10.1128/MCB.21.7.2413-2422.2001	55	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15193	15204		10.1074/jbc.M112.350496	http://dx.doi.org/10.1074/jbc.M112.350496			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22393050	Green Published, hybrid			2022-12-27	WOS:000304006300004
J	Wang, WY; Jiang, QY; Argentini, M; Cornu, D; Gigant, B; Knossow, M; Wang, CG				Wang, Weiyi; Jiang, Qiyang; Argentini, Manuela; Cornu, David; Gigant, Benoit; Knossow, Marcel; Wang, Chunguang			Kif2C Minimal Functional Domain Has Unusual Nucleotide Binding Properties That Are Adapted to Microtubule Depolymerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTROMERE-ASSOCIATED KINESIN; PROTEIN-LIGAND INTERACTIONS; HAND-OVER-HAND; ATP HYDROLYSIS; BETA-TUBULIN; PLUS ENDS; 8-NM STEP; MCAK; MECHANISM; DEPOLYMERASE	The kinesin-13 Kif2C hydrolyzes ATP and uses the energy released to disassemble microtubules. The mechanism by which this is achieved remains elusive. Here we show that Kif2C( sN+M), a monomeric construct consisting of the motor domain with the proximal part of the N-terminal Neck extension but devoid of its more distal, unstructured, and highly basic part, has a robust depolymerase activity. When detached from microtubules, the Kif2C-(sN+M) nucleotide-binding site is occupied by ATP at physiological concentrations of adenine nucleotides. As a consequence, Kif2C-(sN+M) starts its interaction with microtubules in that state, which differentiates kinesin-13s from motile kinesins. Moreover, in this ATP-bound conformational state, Kif2C-(sN+M) has a higher affinity for soluble tubulin compared with microtubules. We propose a mechanism in which, in the first step, the specificity of ATP-bound Kif2C for soluble tubulin causes it to stabilize a curved conformation of tubulin heterodimers at the ends of microtubules. Data from an ATPase-deficient Kif2C mutant suggest that, then, ATP hydrolysis precedes and is required for tubulin release to take place. Finally, comparison with Kif2C-Motor indicates that the binding specificity for curved tubulin and, accordingly, the microtubule depolymerase activity are conferred to the motor domain by its N-terminal Neck extension.	[Gigant, Benoit; Knossow, Marcel] CNRS, Lab Enzymol & Biochim Struct, Ctr Rech Gif, F-91198 Gif Sur Yvette, France; [Wang, Weiyi; Jiang, Qiyang; Wang, Chunguang] Tongji Univ, Inst Prot Res, Shanghai 200092, Peoples R China; [Argentini, Manuela; Cornu, David] CNRS, Inst Chim Subst Nat, Ctr Rech Gif, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Tongji University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Knossow, M (corresponding author), CNRS, Lab Enzymol & Biochim Struct, Ctr Rech Gif, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	knossow@lebs.cnrs-gif.fr; chunguangwang@tongji.edu.cn	Wang, Weiyi/GZN-0408-2022	Gigant, Benoit/0000-0002-5946-6759	Natural Science Foundation of China [30700125]; Chinese Ministry of Education [NCET-10-0604]; Science and Technology Commission of Shanghai Municipality [07pj14086, 074307039, 11JC1413100]; CNRS [PICS 4889]; Agence Nationale pour la Recherche [ANR-05-BLAN-0292, ANR-09-BLAN-0071]; Fondation pour la Recherche Medicale [DEQ20081213979]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work is supported by Natural Science Foundation of China Grant 30700125, Chinese Ministry of Education Grant NCET-10-0604, Science and Technology Commission of Shanghai Municipality Grants 07pj14086, 074307039, and 11JC1413100, CNRS through a Projet International de Cooperation Scientifique grant (PICS 4889), Agence Nationale pour la Recherche Grants ANR-05-BLAN-0292 and ANR-09-BLAN-0071, and Fondation pour la Recherche Medicale Grant DEQ20081213979.	AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Alonso MC, 2007, SCIENCE, V316, P120, DOI 10.1126/science.1136985; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; BEST D, 1981, ANAL BIOCHEM, V114, P281, DOI 10.1016/0003-2697(81)90481-4; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Clement MJ, 2005, BIOCHEMISTRY-US, V44, P14616, DOI 10.1021/bi0512492; Cooper JR, 2010, NAT STRUCT MOL BIOL, V17, P77, DOI 10.1038/nsmb.1728; Coy DL, 1999, J BIOL CHEM, V274, P3667, DOI 10.1074/jbc.274.6.3667; Crevel IMTC, 1996, J MOL BIOL, V257, P66, DOI 10.1006/jmbi.1996.0147; Cross RA, 2004, TRENDS BIOCHEM SCI, V29, P301, DOI 10.1016/j.tibs.2004.04.010; Dagenbach EM, 2004, J CELL SCI, V117, P3, DOI 10.1242/jcs.00875; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Friel CT, 2011, EMBO J, V30, P3928, DOI 10.1038/emboj.2011.290; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Gouveia SM, 2010, CURR BIOL, V20, P1717, DOI 10.1016/j.cub.2010.08.020; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hertzer KM, 2006, MOL BIOL CELL, V17, P700, DOI 10.1091/mbc.E05-08-0821; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Jameson David M., 2005, V305, P301; Jiang K, 2009, EMBO REP, V10, P857, DOI 10.1038/embor.2009.94; Kobayashi T, 2011, CELL, V145, P914, DOI 10.1016/j.cell.2011.04.028; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Maney T, 2001, J BIOL CHEM, V276, P34753, DOI 10.1074/jbc.M106626200; Moore A, 2004, TRENDS CELL BIOL, V14, P537, DOI 10.1016/j.tcb.2004.09.001; Mulder AM, 2009, J CELL BIOL, V185, P51, DOI 10.1083/jcb.200812052; Nitta R, 2004, SCIENCE, V305, P678, DOI 10.1126/science.1096621; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Press W. H., 1992, NUMERICAL RECIPES C, P178; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; ROMBERG L, 1993, NATURE, V361, P168, DOI 10.1038/361168a0; SADHU A, 1992, J BIOL CHEM, V267, P11352; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Smyczynski C, 2000, J MOL BIOL, V295, P325, DOI 10.1006/jmbi.1999.3356; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; Tan DY, 2008, STRUCTURE, V16, P1732, DOI 10.1016/j.str.2008.08.017; Tan DY, 2006, J CELL BIOL, V175, P25, DOI 10.1083/jcb.200605194; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Wagenbach M, 2008, J CELL BIOL, V183, P617, DOI 10.1083/jcb.200805145; Wang CG, 2007, BIOCHEMISTRY-US, V46, P10595, DOI 10.1021/bi701147f; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753	51	27	28	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15143	15153		10.1074/jbc.M111.317859	http://dx.doi.org/10.1074/jbc.M111.317859			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22403406	Green Published, hybrid			2022-12-27	WOS:000304003200075
J	Zoghbi, ME; Krishnan, S; Altenberg, GA				Zoghbi, Maria E.; Krishnan, Srinivasan; Altenberg, Guillermo A.			Dissociation of ATP-binding Cassette Nucleotide-binding Domain Dimers into Monomers during the Hydrolysis Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; CATALYTIC CYCLE; ABC TRANSPORTER; P-GLYCOPROTEIN; MOVEMENT; CLASSIFICATION; SPECTROSCOPY; MECHANISMS	ATP-binding cassette (ABC) proteins have two nucleotide-binding domains (NBDs) that work as dimers to bind and hydrolyze ATP, but the molecular mechanism of nucleotide hydrolysis is controversial. In particular, it is still unresolved whether hydrolysis leads to dissociation of the ATP-induced dimers or opening of the dimers, with the NBDs remaining in contact during the hydrolysis cycle. We studied a prototypical ABC NBD, the Methanococcus jannaschii MJ0796, using spectroscopic techniques. We show that fluorescence from a tryptophan positioned at the dimer interface and luminescence resonance energy transfer between probes reacted with single-cysteine mutants can be used to follow NBD association/dissociation in real time. The intermonomer distances calculated from luminescence resonance energy transfer data indicate that the NBDs separate completely following ATP hydrolysis, instead of opening. The results support ABC protein NBD association/dissociation, as opposed to constant-contact models.	[Altenberg, Guillermo A.] Texas Tech Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; Texas Tech Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University Health Science Center	Altenberg, GA (corresponding author), Texas Tech Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA.	g.altenberg@ttuhsc.edu	Krishnan, Srinivasan/M-1354-2019	Altenberg, Guillermo/0000-0002-8932-740X	National Institutes of Health [R01GM79629, 3R01GM079629-03S1]; Cancer Prevention and Research Institute of Texas [RP101073]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM79629 and 3R01GM079629-03S1 (to G. A. A.). This work was also supported by Cancer Prevention and Research Institute of Texas Grant RP101073.	Bao XY, 2007, P NATL ACAD SCI USA, V104, P4919, DOI 10.1073/pnas.0603154104; Bouige P, 2002, CURR PROTEIN PEPT SC, V3, P541, DOI 10.2174/1389203023380486; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen JY, 1999, BIOCONJUGATE CHEM, V10, P311, DOI 10.1021/bc980113w; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Jones PM, 2009, PROTEINS, V75, P387, DOI 10.1002/prot.22250; Knauf PA, 2004, BLOOD CELL MOL DIS, V32, P360, DOI 10.1016/j.bcmd.2004.01.007; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Posson DJ, 2008, NEURON, V59, P98, DOI 10.1016/j.neuron.2008.05.006; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; Rambhadran A, 2011, J BIOL CHEM, V286, P16953, DOI 10.1074/jbc.M111.224576; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Sauna ZE, 2007, MOL CANCER THER, V6, P13, DOI 10.1158/1535-7163.MCT-06-0155; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Verhalen B, 2012, J BIOL CHEM, V287, P1112, DOI 10.1074/jbc.M111.301192; Verhalen B, 2011, J BIOL CHEM, V286, P10476, DOI 10.1074/jbc.M110.193151; Zoghbi ME, 2012, J BIOL CHEM, V287, P4157, DOI 10.1074/jbc.M111.318378	26	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14994	15000		10.1074/jbc.M112.340281	http://dx.doi.org/10.1074/jbc.M112.340281			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22403405	Green Published, hybrid			2022-12-27	WOS:000304003200061
J	Arguello, JM; Raimunda, D; Gonzalez-Guerrero, M				Argueello, Jose M.; Raimunda, Daniel; Gonzalez-Guerrero, Manuel			Metal Transport across Biomembranes: Emerging Models for a Distinct Chemistry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ZINC TRANSPORTER; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; FUNCTIONAL ROLES; BINDING DOMAINS; COPPER; PROTEIN; ATPASES; CU+; RESISTANCE	Transition metals are essential components of important biomolecules, and their homeostasis is central to many life processes. Transmembrane transporters are key elements controlling the distribution of metals in various compartments. However, due to their chemical properties, transition elements require transporters with different structural-functional characteristics from those of alkali and alkali earth ions. Emerging structural information and functional studies have revealed distinctive features of metal transport. Among these are the relevance of multifaceted events involving metal transfer among participating proteins, the importance of coordination geometry at transmembrane transport sites, and the presence of the largely irreversible steps associated with vectorial transport. Here, we discuss how these characteristics shape novel transition metal ion transport models.	[Argueello, Jose M.; Raimunda, Daniel] Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01609 USA; [Gonzalez-Guerrero, Manuel] Univ Politecn Madrid, CBGP, Madrid 28223, Spain	Worcester Polytechnic Institute; Universidad Politecnica de Madrid; Centro de Investigacion en Biotecnologia Genomica de Plantas (CBGP)	Arguello, JM (corresponding author), Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01609 USA.	arguello@wpi.edu	Gonzalez-Guerrero, Manuel/E-7338-2011; Gonzalez-Guerrero, Manuel/N-2281-2019; Arguello, Jose/D-1997-2012	Gonzalez-Guerrero, Manuel/0000-0001-7334-5286; Gonzalez-Guerrero, Manuel/0000-0001-7334-5286; Arguello, Jose/0000-0003-3940-6297; Raimunda, Daniel/0000-0001-7392-1407	National Institutes of Health [1R21AI082484-01]; National Science Foundation [MCB-0743901]; National Institute of Food and Agriculture from the United States Department of Agriculture [2010-65108-20606]; Marie Curie International Reintegration Grant MENOMED; Ramon y Cajal Fellowship [RYC-2010-06363]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institute of Food and Agriculture from the United States Department of Agriculture; Marie Curie International Reintegration Grant MENOMED; Ramon y Cajal Fellowship(Spanish Government); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R21AI082484-01 (to J. M. A.). This work was also supported by National Science Foundation Grant MCB-0743901 and National Institute of Food and Agriculture Grant 2010-65108-20606 from the United States Department of Agriculture (to J. M. A.) and by Marie Curie International Reintegration Grant MENOMED and Ramon y Cajal Fellowship RYC-2010-06363 (to M. G.-G.). This is the first article in the Thematic Minireview Series on Metals in Biology 2012.	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Anton A, 2004, J BACTERIOL, V186, P7499, DOI 10.1128/JB.186.22.7499-7507.2004; Arguello JM, 2003, J MEMBRANE BIOL, V195, P93, DOI 10.1007/s00232-003-2048-2; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Bagai I, 2008, BIOCHEMISTRY-US, V47, P11408, DOI 10.1021/bi801638m; Bagai I, 2007, J BIOL CHEM, V282, P35695, DOI 10.1074/jbc.M703937200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barry AN, 2011, J BIOL CHEM, V286, P26585, DOI 10.1074/jbc.M111.229039; Bersch B, 2011, BIOCHEMISTRY-US, V50, P2194, DOI 10.1021/bi200005k; Blaudez D, 2003, PLANT CELL, V15, P2911, DOI 10.1105/tpc.017541; Blaustein M.P., 2011, CELLULAR PHYSL NEURO, V2nd ed.; Chao Y, 2004, J BIOL CHEM, V279, P12043, DOI 10.1074/jbc.M313510200; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; da Silva J. J. R. Frausto, 2001, BIOL CHEM ELEMENTS; De Angelis F, 2010, P NATL ACAD SCI USA, V107, P11038, DOI 10.1073/pnas.1003908107; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; DiDonato RJ, 2004, PLANT J, V39, P403, DOI 10.1111/j.1365-313X.2004.02128.x; Dumay QC, 2006, J MOL MICROB BIOTECH, V11, P10, DOI 10.1159/000092815; Dutta SJ, 2006, BIOCHEMISTRY-US, V45, P5923, DOI 10.1021/bi0523456; Eisses JF, 2005, J BIOL CHEM, V280, P9635, DOI 10.1074/jbc.M500116200; Eisses JF, 2002, J BIOL CHEM, V277, P29162, DOI 10.1074/jbc.M203652200; Ellis CD, 2005, J BIOL CHEM, V280, P28811, DOI 10.1074/jbc.M505500200; Ellis CD, 2004, J CELL BIOL, V166, P325, DOI 10.1083/jcb.200401157; Espariz M, 2007, MICROBIOL-SGM, V153, P2989, DOI 10.1099/mic.0.2007/006536-0; Goldberg M, 1999, J BIOL CHEM, V274, P26065, DOI 10.1074/jbc.274.37.26065; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753, DOI 10.1074/jbc.M803248200; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Gonzalez-Guerrero M, 2010, MOL MICROBIOL, V78, P1246, DOI 10.1111/j.1365-2958.2010.07402.x; Gonzalez-Guerrero M, 2009, J BIOL CHEM, V284, P20804, DOI 10.1074/jbc.M109.016329; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Haydon MJ, 2007, PLANT PHYSIOL, V143, P1705, DOI 10.1104/pp.106.092015; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Holm RH, 1996, CHEM REV, V96, P2239, DOI 10.1021/cr9500390; Hou ZJ, 2003, J BIOL CHEM, V278, P28455, DOI 10.1074/jbc.M301415200; Kaplan JH, 2009, J BIOL CHEM, V284, P25461, DOI 10.1074/jbc.R109.031286; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kim EH, 2011, J BACTERIOL, V193, P2381, DOI 10.1128/JB.01323-10; Kirschke CP, 2003, J BIOL CHEM, V278, P4096, DOI 10.1074/jbc.M207644200; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Kulathila R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015610; La Fontaine S, 2007, ARCH BIOCHEM BIOPHYS, V463, P149, DOI 10.1016/j.abb.2007.04.021; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liu JB, 2006, BIOCHEMISTRY-US, V45, P763, DOI 10.1021/bi051836n; Loftin IR, 2005, BIOCHEMISTRY-US, V44, P10533, DOI 10.1021/bi050827b; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; MacDiarmid CW, 2002, J BIOL CHEM, V277, P39187, DOI 10.1074/jbc.M205052200; Mandal AK, 2004, J BIOL CHEM, V279, P54802, DOI 10.1074/jbc.M410854200; Mandal AK, 2003, BIOCHEMISTRY-US, V42, P11040, DOI 10.1021/bi034806y; Mandal AK, 2002, J BIOL CHEM, V277, P7201, DOI 10.1074/jbc.M109964200; Morel M, 2009, PLANT PHYSIOL, V149, P894, DOI 10.1104/pp.108.130294; Morin I, 2009, FEBS J, V276, P4483, DOI 10.1111/j.1742-4658.2009.07155.x; Nevo Y, 2006, BBA-MOL CELL RES, V1763, P609, DOI 10.1016/j.bbamcr.2006.05.007; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Osman D, 2008, ADV APPL MICROBIOL, V65, P217, DOI 10.1016/S0065-2164(08)00608-4; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; PEARSON RG, 1963, J AM CHEM SOC, V85, P3533, DOI 10.1021/ja00905a001; Raimunda D, 2011, BIOMETALS, V24, P467, DOI 10.1007/s10534-010-9404-3; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Schushan M, 2010, P NATL ACAD SCI USA, V107, P10908, DOI 10.1073/pnas.0914717107; Sharma R, 2000, J BIOL CHEM, V275, P3873, DOI 10.1074/jbc.275.6.3873; Shikanai T, 2003, PLANT CELL, V15, P1333, DOI 10.1105/tpc.011817; Sinani D, 2007, J BIOL CHEM, V282, P26775, DOI 10.1074/jbc.M703973200; Su CC, 2011, NATURE, V470, P558, DOI 10.1038/nature09743; Su CC, 2011, PROTEIN SCI, V20, P6, DOI 10.1002/pro.532; Su CC, 2009, J MOL BIOL, V393, P342, DOI 10.1016/j.jmb.2009.08.029; VanZile ML, 2000, BIOCHEMISTRY-US, V39, P11818, DOI 10.1021/bi001140o; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Wei YN, 2006, J BIOL CHEM, V281, P23492, DOI 10.1074/jbc.M602254200; Wei YN, 2005, J BIOL CHEM, V280, P33716, DOI 10.1074/jbc.M506107200; Wei YN, 2004, J BIOL CHEM, V279, P39251, DOI 10.1074/jbc.M407044200; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; Xiao ZG, 2004, J AM CHEM SOC, V126, P3081, DOI 10.1021/ja0390350; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632	83	70	70	3	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13510	13517		10.1074/jbc.R111.319343	http://dx.doi.org/10.1074/jbc.R111.319343			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22389499	Green Published, hybrid			2022-12-27	WOS:000303996300002
J	Basak, JM; Verghese, PB; Yoon, H; Kim, J; Holtzman, DM				Basak, Jacob M.; Verghese, Philip B.; Yoon, Hyejin; Kim, Jungsu; Holtzman, David M.			Low-density Lipoprotein Receptor Represents an Apolipoprotein E-independent Pathway of A beta Uptake and Degradation by Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; AMYLOID DEPOSITION; DIFFUSE PLAQUES; IN-VITRO; PEPTIDE; CLEARANCE; PROTEIN; APOE; MICROGLIA	Accumulation of the amyloid beta (A beta) peptide within the brain is hypothesized to be one of the main causes underlying the pathogenic events that occur in Alzheimer disease (AD). Consequently, identifying pathways by which A beta is cleared from the brain is crucial for better understanding of the disease pathogenesis and developing novel therapeutics. Cellular uptake and degradation by glial cells is one means by which A beta may be cleared from the brain. In the current study, we demonstrate that modulating levels of the low-density lipoprotein receptor (LDLR), a cell surface receptor that regulates the amount of apolipoprotein E (apoE) in the brain, altered both the uptake and degradation of A beta by astrocytes. Deletion of LDLR caused a decrease in A beta uptake, whereas increasing LDLR levels significantly enhanced both the uptake and clearance of A beta. Increasing LDLR levels also enhanced the cellular degradation of A beta and facilitated the vesicular transport of A beta to lysosomes. Despite the fact that LDLR regulated the uptake of apoE by astrocytes, we found that the effect of LDLR on A beta uptake and clearance occurred in the absence of apoE. Finally, we provide evidence that A beta can directly bind to LDLR, suggesting that an interaction between LDLR and A beta could be responsible for LDLR- mediated A beta uptake. Therefore, these results identify LDLR as a receptor that mediates A beta uptake and clearance by astrocytes, and provide evidence that increasing glial LDLR levels may promote A beta degradation within the brain.	[Basak, Jacob M.; Verghese, Philip B.; Yoon, Hyejin; Kim, Jungsu; Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Basak, Jacob M.; Verghese, Philip B.; Yoon, Hyejin; Kim, Jungsu; Holtzman, David M.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Basak, Jacob M.; Verghese, Philip B.; Kim, Jungsu; Holtzman, David M.] Washington Univ, Sch Med, Charles F & Joanne Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Holtzman, David M.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Holtzman, DM (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	holtzman@neuro.wustl.edu	Yoon, Hyejin/AAI-8641-2021; Kim, Jungsu/F-2457-2012	Kim, Jungsu/0000-0002-6931-8581	National Institutes of Health [AG13956, NS034467, P30NS069329]; American Health Assistance Foundation AHAF; Neuroscience Blueprint Core Grant [P30 NS057105]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069329, R37NS034467, P30NS057105, R01NS034467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013956, R01AG013956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation AHAF; Neuroscience Blueprint Core Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG13956, NS034467 (to D. M. H.), and P30NS069329 (to J. K.), an American Health Assistance Foundation AHAF centennial award (to D. M. H), and Neuroscience Blueprint Core Grant P30 NS057105 (to Washington University).	Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cao DF, 2006, NEUROBIOL AGING, V27, P1632, DOI 10.1016/j.neurobiolaging.2005.09.011; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; DUNN KW, 1992, J CELL BIOL, V117, P301, DOI 10.1083/jcb.117.2.301; Elder GA, 2007, J NEUROCHEM, V102, P1220, DOI 10.1111/j.1471-4159.2007.04614.x; Fagan AM, 1999, J BIOL CHEM, V274, P30001, DOI 10.1074/jbc.274.42.30001; Fryer JD, 2005, J BIOL CHEM, V280, P25754, DOI 10.1074/jbc.M502143200; Funato H, 1998, AM J PATHOL, V152, P983; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; Kanekiyo T, 2009, J BIOL CHEM, V284, P33352, DOI 10.1074/jbc.M109.015032; Katsouri L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021880; Kim J, 2009, NEURON, V64, P632, DOI 10.1016/j.neuron.2009.11.013; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; LADU MJ, 1994, J BIOL CHEM, V269, P23403; Li MJ, 2010, J NEUROSCI METH, V189, P56, DOI 10.1016/j.jneumeth.2010.03.019; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; MANDYBUR TI, 1990, NEUROLOGY, V40, P635, DOI 10.1212/WNL.40.4.635; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Nagele RG, 2003, BRAIN RES, V971, P197, DOI 10.1016/S0006-8993(03)02361-8; Nielsen HM, 2009, GLIA, V57, P978, DOI 10.1002/glia.20822; PIKE CJ, 1995, EXP NEUROL, V132, P172, DOI 10.1016/0014-4886(95)90022-5; Saavedra L, 2007, J BIOL CHEM, V282, P35722, DOI 10.1074/jbc.M701823200; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; SHAFFER LM, 1995, NEUROBIOL AGING, V16, P737, DOI 10.1016/0197-4580(95)00055-J; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Thal DR, 1999, CLIN NEUROPATHOL, V18, P226; Thal DR, 2000, ACTA NEUROPATHOL, V100, P608, DOI 10.1007/s004010000242; Tokuda T, 2000, BIOCHEM J, V348, P359, DOI 10.1042/0264-6021:3480359; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Yamada K, 2008, J BIOL CHEM, V283, P34554, DOI 10.1074/jbc.M801487200; Yin KJ, 2006, J NEUROSCI, V26, P10939, DOI 10.1523/JNEUROSCI.2085-06.2006; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	50	133	139	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13959	13971		10.1074/jbc.M111.288746	http://dx.doi.org/10.1074/jbc.M111.288746			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22383525	Green Published, hybrid			2022-12-27	WOS:000303996300051
J	Hwangpo, TA; Jordan, JD; Premsrirut, PK; Jayamaran, G; Licht, JD; Iyengar, R; Neves, SR				Hwangpo, Tracy Anh; Jordan, J. Dedrick; Premsrirut, Prem K.; Jayamaran, Gomathi; Licht, Jonathan D.; Iyengar, Ravi; Neves, Susana R.			G Protein-regulated Inducer of Neurite Outgrowth (GRIN) Modulates Sprouty Protein Repression of Mitogen-activated Protein Kinase (MAPK) Activation by Growth Factor Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; RGS 16 FUNCTION; TYROSINE-KINASE; NA+/H+ EXCHANGER; RECEPTOR STIMULATION; SIGNALING PATHWAYS; CYSTEINE RESIDUE; DIFFERENTIATION; CELL; PHOSPHORYLATION	G alpha(o/i) interacts directly with GRIN (G protein-regulated inducer of neurite outgrowth). Using the yeast two-hybrid system, we identified Sprouty2 as an interacting partner of GRIN. G alpha(o) and Sprouty2 bind to overlapping regions of GRIN, thus competing for GRIN binding. Imaging experiments demonstrated that G alpha(o) expression promoted GRIN translocation to the plasma membrane, whereas Sprouty2 expression failed to do so. Given the role of Sprouty2 in the regulation of growth factor-mediated MAPK activation, we examined the contribution of the GRIN-Sprouty2 interaction to CB1 cannabinoid receptor regulation of FGF receptor signaling. In Neuro-2A cells, a system that expresses all of the components endogenously, modulation of GRIN levels led to regulation of MAPK activation. Overexpression of GRIN potentiated FGF activation of MAPK and decreased tyrosine phosphorylation of Sprouty2. Pretreatment with G(o/i)-coupled CB1 receptor agonist attenuated subsequent FGF activation of MAPK. Decreased expression of GRIN both diminished FGF activation of MAPK and blocked CB1R attenuation of MAPK activation. These observations indicate that G alpha(o) interacts with GRIN and outcompetes GRIN from bound Sprouty. Free Sprouty then in turn inhibits growth factor signaling. Thus, here we present a novel mechanism of how G(o/i)-coupled receptors can inhibit growth factor signaling to MAPK.	[Hwangpo, Tracy Anh; Jordan, J. Dedrick; Premsrirut, Prem K.; Jayamaran, Gomathi; Iyengar, Ravi; Neves, Susana R.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Licht, Jonathan D.] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Jordan, J. Dedrick] Univ N Carolina, Dept Neurol, Chapel Hill, NC 27599 USA; [Licht, Jonathan D.] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill; Northwestern University; Feinberg School of Medicine	Neves, SR (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, 1 Gustave L Levy Pl,Box 1215, New York, NY 10029 USA.	Susana.neves@mssm.edu	Licht, Jonathan/AAL-9184-2020; Licht, Jonathan/L-4239-2019	Licht, Jonathan/0000-0002-3942-1369; Jordan, Dedrick/0000-0002-0706-9583	National Institutes of Health [R01GM54508, 5R01DK087650, RO1 CA59998]; Systems Biology Center of New York [PSDGM071558]; Mount Sinai Medical Scientist Training Program; Cardiovascular Sciences Training Grant [HL-07824]; NATIONAL CANCER INSTITUTE [R01CA059998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054508, T32GM008444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Systems Biology Center of New York; Mount Sinai Medical Scientist Training Program; Cardiovascular Sciences Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM54508 (to R. I.) and 5R01DK087650 (to R. I. and S. R. N.) and RO1 CA59998 (to J. D. L.). This work was also supported by the Systems Biology Center of New York (Grant PSDGM071558).; Supported by the Mount Sinai Medical Scientist Training Program and by a Cardiovascular Sciences Training Grant HL-07824.	Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; Baumgartner M, 2004, AM J PHYSIOL-CELL PH, V287, pC844, DOI 10.1152/ajpcell.00094.2004; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Chandramouli S, 2008, J BIOL CHEM, V283, P1679, DOI 10.1074/jbc.M705457200; Chen LT, 1999, J BIOL CHEM, V274, P26931, DOI 10.1074/jbc.274.38.26931; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Crosby ME, 2004, CANCER BIOL THER, V3, P1208, DOI 10.4161/cbt.3.12.1494; FAURE M, 1994, J BIOL CHEM, V269, P7851; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Gross I, 2007, CELL DEATH DIFFER, V14, P1802, DOI 10.1038/sj.cdd.4402188; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hiol A, 2003, J BIOL CHEM, V278, P19301, DOI 10.1074/jbc.M210123200; INGLESE J, 1995, TRENDS BIOCHEM SCI, V20, P151, DOI 10.1016/S0968-0004(00)88992-6; Ishida M, 2007, CANCER SCI, V98, P815, DOI 10.1111/j.1349-7006.2007.00457.x; Jordan J. D, 2002, PHARM BIOL CHEM; Jordan JD, 1999, J BIOL CHEM, V274, P21507, DOI 10.1074/jbc.274.31.21507; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P79, DOI 10.1006/bbrc.1999.1638; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Lim J, 2000, J BIOL CHEM, V275, P32837, DOI 10.1074/jbc.M002156200; Luo Y, 1999, J BIOL CHEM, V274, P10685, DOI 10.1074/jbc.274.16.10685; Mason JM, 2004, MOL BIOL CELL, V15, P2176, DOI 10.1091/mbc.E03-07-0503; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Matsuyama S, 2005, J PHARMACOL SCI, V98, P239, DOI 10.1254/jphs.FP0050211; Nakata H, 2005, MOL PHARMACOL, V67, P695, DOI 10.1124/mol.104.003913; NEER EJ, 1984, J BIOL CHEM, V259, P4222; Nelson BR, 2004, DEV BIOL, V270, P322, DOI 10.1016/j.ydbio.2004.03.004; Osterhout JL, 2003, J BIOL CHEM, V278, P19309, DOI 10.1074/jbc.M210124200; Persengiev SP, 1999, MOL CELL BIOL, V19, P6048; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Rubin C, 2005, J BIOL CHEM, V280, P9735, DOI 10.1074/jbc.M408308200; Slepkov E, 2002, BIOCHEM CELL BIOL, V80, P499, DOI 10.1139/O02-151; STRITTMATTER SM, 1994, J NEUROSCI, V14, P2327; STRITTMATTER SM, 1990, NATURE, V344, P836, DOI 10.1038/344836a0; Taketomi T, 2005, NAT NEUROSCI, V8, P855, DOI 10.1038/nn1485; VANBIESEN T, 1995, NATURE, V376, P781, DOI 10.1038/376781a0; Watanabe TK, 1996, GENOMICS, V38, P273, DOI 10.1006/geno.1996.0628; YURCHAK LK, 1995, MOL CELL BIOL, V15, P6914, DOI 10.1128/mcb.15.12.6914	41	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13674	13685		10.1074/jbc.M111.320705	http://dx.doi.org/10.1074/jbc.M111.320705			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22383529	Green Published, hybrid			2022-12-27	WOS:000303996300023
J	Svensson, G; Awad, W; Hakansson, M; Mani, K; Logan, DT				Svensson, Gabriel; Awad, Wael; Hakansson, Maria; Mani, Katrin; Logan, Derek T.			Crystal Structure of N-Glycosylated Human Glypican-1 Core Protein STRUCTURE OF TWO LOOPS EVOLUTIONARILY CONSERVED IN VERTEBRATE GLYPICAN-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; DALLY-LIKE; HEPATOCELLULAR-CARCINOMA; CHAIN INITIATION; LINKAGE REGION; LINKED GLYCANS; KEY ENZYME; GENE; SEQUENCE; GROWTH	Glypicans are a family of cell-surface proteoglycans that regulate Wnt, hedgehog, bone morphogenetic protein, and fibroblast growth factor signaling. Loss-of-function mutations in glypican core proteins and in glycosaminoglycan-synthesizing enzymes have revealed that glypican core proteins and their glycosaminoglycan chains are important in shaping animal development. Glypican core proteins consist of a stable alpha-helical domain containing 14 conserved Cys residues followed by a glycosaminoglycan attachment domain that becomes exclusively substituted with heparan sulfate (HS) and presumably adopts a random coil conformation. Removal of the alpha-helical domain results in almost exclusive addition of the glycosaminoglycan chondroitin sulfate, suggesting that factors in the alpha-helical domain promote assembly of HS. Glypican-1 is involved in brain development and is one of six members of the vertebrate family of glypicans. We expressed and crystallized N-glycosylated human glypican-1 lacking HS and N-glycosylated glypican-1 lacking the HS attachment domain. The crystal structure of glypican-1 was solved using crystals of selenomethionine-labeled glypican-1 core protein lacking the HS domain. No additional electron density was observed for crystals of glypican-1 containing the HS attachment domain, and CD spectra of the two protein species were highly similar. The crystal structure of N-glycosylated human glypican-1 core protein at 2.5 angstrom, the first crystal structure of a vertebrate glypican, reveals the complete disulfide bond arrangement of the conserved Cys residues, and it also extends the structural knowledge of glypicans for one alpha-helix and two long loops. Importantly, the loops are evolutionarily conserved in vertebrate glypican-1, and one of them is involved in glycosaminoglycan class determination.	[Awad, Wael; Logan, Derek T.] Lund Univ, Ctr Mol Prot Sci, Dept Biochem & Struct Biol, SE-22100 Lund, Sweden; [Svensson, Gabriel; Mani, Katrin] Lund Univ, Biomed Ctr A13, Glycobiol Grp, Dept Expt Med Sci,Div Neurosci, SE-22184 Lund, Sweden; [Awad, Wael] Cairo Univ, Fac Sci, Dept Biophys, Giza 12613, Egypt; [Hakansson, Maria] SARom Biostruct AB, Medicon Village, SE-22381 Lund, Sweden	Lund University; Lund University; Egyptian Knowledge Bank (EKB); Cairo University	Logan, DT (corresponding author), Lund Univ, Ctr Mol Prot Sci, Dept Biochem & Struct Biol, Box 124, SE-22100 Lund, Sweden.	derek.logan@biochemistry.lu.se	awad, Wael/B-8353-2013; Logan, Derek T/A-1114-2011; Logan, Derek/O-2497-2019	Logan, Derek T/0000-0002-0098-8560; Logan, Derek/0000-0002-0098-8560; Mani, Katrin/0000-0002-1821-0634; Awad, Wael/0000-0002-7597-2133	Swedish Research Council [2006-4387, 2005-6749, 2010-3914]; Swedish Cancer Foundation; Medical Faculty of Lund University; Royal Physiographic Society in Lund; Crafoord, Wiberg, Jeanson, Segerfalk, and Kock Foundations	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Medical Faculty of Lund University; Royal Physiographic Society in Lund; Crafoord, Wiberg, Jeanson, Segerfalk, and Kock Foundations	This work was supported by Swedish Research Council Grants 2006-4387 (to D. L.) and 2005-6749 and 2010-3914 (to K. M.), the Swedish Cancer Foundation, the Medical Faculty of Lund University, the Royal Physiographic Society in Lund, and the Crafoord, Wiberg, Jeanson, Segerfalk, and Kock Foundations.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Campos-Xavier AB, 2009, AM J HUM GENET, V84, P760, DOI 10.1016/j.ajhg.2009.05.002; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; Capurro MI, 2005, CANCER RES, V65, P6245, DOI 10.1158/0008-5472.CAN-04-4244; Capurro MI, 2005, J BIOL CHEM, V280, P41201, DOI 10.1074/jbc.M507004200; Chen RL, 2001, J BIOL CHEM, V276, P7507, DOI 10.1074/jbc.M008283200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng W, 2008, CARCINOGENESIS, V29, P1319, DOI 10.1093/carcin/bgn091; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; De Cat B, 2003, J CELL BIOL, V163, P625, DOI 10.1083/jcb.200302152; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HOWELL PL, 1992, J APPL CRYSTALLOGR, V25, P81, DOI 10.1107/S0021889891010385; Jen YHLD, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-33; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Khan S, 2011, J BIOL CHEM, V286, P24842, DOI 10.1074/jbc.M111.226027; Kim MS, 2011, P NATL ACAD SCI USA, V108, P13112, DOI 10.1073/pnas.1109877108; Kirkpatrick CA, 2006, DEV BIOL, V300, P570, DOI 10.1016/j.ydbio.2006.09.011; Kitagawa H, 1999, J BIOL CHEM, V274, P13933, DOI 10.1074/jbc.274.20.13933; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; Matsumoto Y, 2007, J NEUROSCI, V27, P4342, DOI 10.1523/JNEUROSCI.0700-07.2007; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohkawara B, 2003, DEVELOPMENT, V130, P2129, DOI 10.1242/dev.00435; Okamoto K, 2011, NAT GENET, V43, P459, DOI 10.1038/ng.792; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; READ RJ, 1988, J APPL CRYSTALLOGR, V21, P490, DOI 10.1107/S002188988800562X; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Stickens D, 1996, NAT GENET, V14, P25, DOI 10.1038/ng0996-25; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Svensson G, 2011, BIOCHEMISTRY-US, V50, P9377, DOI 10.1021/bi200218s; Svensson G, 2009, BIOCHEMISTRY-US, V48, P9994, DOI 10.1021/bi901402x; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; Veugelers M, 2000, HUM MOL GENET, V9, P1321, DOI 10.1093/hmg/9.9.1321; Whiteford JR, 2006, J BIOL CHEM, V281, P32156, DOI 10.1074/jbc.M605553200; Williams EH, 2010, P NATL ACAD SCI USA, V107, P5869, DOI 10.1073/pnas.1001777107; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Yan D, 2010, DEVELOPMENT, V137, P2033, DOI 10.1242/dev.045740; ZHANG LJ, 1994, J BIOL CHEM, V269, P19295; ZHANG LJ, 1995, J BIOL CHEM, V270, P27127, DOI 10.1074/jbc.270.45.27127	55	45	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14040	14051		10.1074/jbc.M111.322487	http://dx.doi.org/10.1074/jbc.M111.322487			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22351761	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000303996300058
J	Yan, XH; Zhang, JY; Sun, QY; Tuazon, PT; Wu, XP; Traugh, JA; Chen, YG				Yan, Xiaohua; Zhang, Junyu; Sun, Qinyu; Tuazon, Polygena T.; Wu, Xiaoping; Traugh, Jolinda A.; Chen, Ye-Guang			p21-activated Kinase 2 (PAK2) Inhibits TGF-beta Signaling in Madin-Darby Canine Kidney (MDCK) Epithelial Cells by Interfering with the Receptor-Smad Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; CROSS-TALK; ACTIVATION; TRANSDUCTION; SPECIFICITY; APOPTOSIS; PATHWAYS; PROTEINS; PHOSPHORYLATION; RECOGNITION	TGF-beta (transforming growth factor beta) plays a variety of cellular functions mainly through the Smad pathway. Phosphorylation of the carboxyl SXS motif in R-Smads (Smad2 and Smad3) by the type I receptor T beta RI is a key step for their activation. It has been reported that the serine/threonine kinase PAK2 (p21-activated kinase 2) can mediate TGF-beta signaling in mesenchymal cells. Here, we report that PAK2 restricts TGF-beta-induced Smad2/3 activation and transcriptional responsiveness in MDCK epithelial cells. Mechanistically, PAK2 associates with Smad2 and Smad3 in a kinase activity-dependent manner and blocks their activation. PAK2 phosphorylates Smad2 at Ser-417, which is adjacent to the L3 loop that contributes to the T beta RI-R-Smad association. Consistently, substitution of Ser-417 with glutamic acid attenuates the interaction of Smad2 with T beta RI. Together, our results indicate that PAK2 negatively modulate TGF-beta signaling by attenuating the receptor-Smad interaction and thus Smad activation.	[Yan, Xiaohua; Zhang, Junyu; Sun, Qinyu; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Tuazon, Polygena T.; Traugh, Jolinda A.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Wu, Xiaoping] Nanchang Univ, Dept Biotechnol, Nanchang 330031, Peoples R China	Tsinghua University; University of California System; University of California Riverside; Nanchang University	Yan, XH (corresponding author), Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.	yanxiaohua@tsinghua.org.cn; ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019; Yan, Xiaohua/J-4922-2015	Yan, Xiaohua/0000-0002-7528-5771; Sun, Qinyu/0000-0003-4377-6864	China Postdoctoral Science Foundation; National Natural Science Foundation of China (NSFC) [31171340]; NSFC [30930050, 30921004]; 973 Program [2010CB833706, 2011CB943803]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	This work was supported by the China Postdoctoral Science Foundation and the National Natural Science Foundation of China (NSFC, 31171340) (to X. Y.), NSFC (30930050, 30921004), and the 973 Program (2010CB833706, 2011CB943803) (to Y. G. C.).	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Ho J, 2005, EMBO J, V24, P3247, DOI 10.1038/sj.emboj.7600794; Hong M, 2011, J BIOL CHEM, V286, P17841, DOI 10.1074/jbc.M111.233676; Hsu Y. H., 2011, J VIS EXP, V57, pe3602; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Liu T, 2010, BIOCHEM J, V430, P191, DOI 10.1042/BJ20100427; Lo RS, 1998, EMBO J, V17, P996, DOI 10.1093/emboj/17.4.996; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Massague J, 2000, GENE DEV, V14, P627; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Pacheco A, 2010, INT J BIOCHEM CELL B, V42, P13, DOI 10.1016/j.biocel.2009.09.006; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Ramjaun AR, 2007, ONCOGENE, V26, P970, DOI 10.1038/sj.onc.1209852; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Suzuki K, 2007, CANCER RES, V67, P3673, DOI 10.1158/0008-5472.CAN-06-3211; Walter BN, 1998, J BIOL CHEM, V273, P28733, DOI 10.1074/jbc.273.44.28733; Wang SN, 2005, FASEB J, V19, P1, DOI 10.1096/fj.04-2370com; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Wildey GM, 2003, J BIOL CHEM, V278, P18069, DOI 10.1074/jbc.M211958200; Wilkes MC, 2006, J BIOL CHEM, V281, P27846, DOI 10.1074/jbc.M603721200; Wilkes MC, 2009, DEV CELL, V16, P433, DOI 10.1016/j.devcel.2009.01.009; Wilkes MC, 2005, CANCER RES, V65, P10431, DOI 10.1158/0008-5472.CAN-05-1522; Wilkes MC, 2003, MOL CELL BIOL, V23, P8878, DOI 10.1128/MCB.23.23.8878-8889.2003; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Wu G, 2000, SCIENCE, V287, P92, DOI 10.1126/science.287.5450.92; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827; Yan XH, 2009, J BIOL CHEM, V284, P30097, DOI 10.1074/jbc.M109.049304; Yu J, 2008, J CELL PHYSIOL, V215, P422, DOI 10.1002/jcp.21325; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	46	21	21	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13705	13712		10.1074/jbc.M112.346221	http://dx.doi.org/10.1074/jbc.M112.346221			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22393057	Green Published, hybrid			2022-12-27	WOS:000303996300026
J	Wood, JF; Wang, JJ; Benovic, JL; Ferkey, DM				Wood, Jordan F.; Wang, Jianjun; Benovic, Jeffrey L.; Ferkey, Denise M.			Structural Domains Required for Caenorhabditis elegans G Protein-coupled Receptor Kinase 2 (GRK-2) Function in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; HETEROTRIMERIC G-PROTEINS; C-ELEGANS; HOMOLOGY DOMAIN; G-ALPHA; MOLECULAR-MECHANISMS; CHEMICAL REPELLENTS; MUTATIONAL ANALYSIS; ASH NEURONS; GENE	G protein-coupled receptor kinases (GRKs) are key regulators of signal transduction that specifically phosphorylate activated G protein-coupled receptors (GPCRs) to terminate signaling. Biochemical and crystallographic studies have provided great insight into mammalian GRK2/3 interactions and structure. However, despite extensive in vitro characterization, little is known about the in vivo contribution of these described GRK structural domains and interactions to proper GRK function in signal regulation. We took advantage of the disrupted chemosensory behavior characteristic of Caenorhabditis elegans grk-2 mutants to discern the interactions required for proper in vivo Ce-GRK-2 function. Informed by mammalian crystallographic and biochemical data, we introduced amino acid substitutions into the Ce-grk-2 coding sequence that are predicted to selectively disrupt GPCR phosphorylation, G alpha(q/11) binding, G beta gamma binding, or phospholipid binding. Changing the most amino-terminal residues, which have been shown in mammalian systems to be required specifically for GPCR phosphorylation but not phosphorylation of alternative substrates or recruitment to activated GPCRs, eliminated the ability of Ce-GRK-2 to restore chemosensory signaling. Disrupting interaction between the predicted Ce-GRK-2 amino-terminal alpha-helix and kinase domain, posited to stabilize GRKs in their active ATP- and GPCR-bound conformation, also eliminated Ce-GRK-2 chemosensory function. Finally, although changing residues within the RH domain, predicted to disrupt interaction with G alpha(q/11), did not affect Ce-GRK-2 chemosensory function, disruption of the predicted PH domain-mediated interactions with G beta gamma and phospholipids revealed that both contribute to Ce-GRK-2 function in vivo. Combined, we have demonstrated functional roles for broadly conserved GRK2/3 structural domains in the in vivo regulation of organismal behavior.	[Wood, Jordan F.; Ferkey, Denise M.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Wang, Jianjun; Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Jefferson University	Ferkey, DM (corresponding author), SUNY Buffalo, Dept Biol Sci, 109 Cooke Hall, Buffalo, NY 14260 USA.	dmferkey@buffalo.edu			National Science Foundation [MCB-0917896]; National Institutes of Health [GM44944]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044944] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant MCB-0917896 (to D. M. F.). This work was also supported in part by National Institutes of Health Grant GM44944 (to J. L. B.).	BENOVIC JL, 1991, J BIOL CHEM, V266, P14939; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BOEKHOFF I, 1994, J BIOL CHEM, V269, P37; Boguth CA, 2010, EMBO J, V29, P3249, DOI 10.1038/emboj.2010.206; Boughton AP, 2011, P NATL ACAD SCI USA, V108, pE667, DOI 10.1073/pnas.1108236108; BRENNER S, 1974, GENETICS, V77, P71; Bunemann M, 1999, J PHYSIOL-LONDON, V517, P5, DOI 10.1111/j.1469-7793.1999.0005z.x; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Chase DL, 2001, CURR BIOL, V11, P222, DOI 10.1016/S0960-9822(01)00071-9; Coureuil M, 2010, CELL, V143, P1149, DOI 10.1016/j.cell.2010.11.035; DAWSON TM, 1993, SCIENCE, V259, P825, DOI 10.1126/science.8381559; Dhami GK, 2004, J BIOL CHEM, V279, P16614, DOI 10.1074/jbc.M314090200; Esposito G, 2007, GENE, V395, P170, DOI 10.1016/j.gene.2007.03.002; Esposito G, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-138; Ezak MJ, 2010, GENETICS, V185, P233, DOI 10.1534/genetics.110.115188; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Fukuto HS, 2004, NEURON, V42, P581, DOI 10.1016/S0896-6273(04)00252-1; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Hart AC, 1999, J NEUROSCI, V19, P1952; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hilliard MA, 2004, EMBO J, V23, P1101, DOI 10.1038/sj.emboj.7600107; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; Huang CC, 2011, BIOCHEMISTRY-US, V50, P1940, DOI 10.1021/bi101606e; Huang CC, 2009, J BIOL CHEM, V284, P17206, DOI 10.1074/jbc.M809544200; Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974; Jansen G, 2002, EMBO J, V21, P986, DOI 10.1093/emboj/21.5.986; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; KONG GH, 1994, J BIOL CHEM, V269, P13084; Liu JG, 2001, BRAIN RES REV, V38, P1, DOI 10.1016/S0165-0173(01)00057-1; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Metaye T, 2002, J CLIN ENDOCR METAB, V87, P3279, DOI 10.1210/jc.87.7.3279; Noble B, 2003, J BIOL CHEM, V278, P47466, DOI 10.1074/jbc.M308257200; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Pao CS, 2009, BIOCHEMISTRY-US, V48, P7325, DOI 10.1021/bi900408g; PAO CS, 2002, SCI STKE, pPE42; Peppel K, 1997, J BIOL CHEM, V272, P25425, DOI 10.1074/jbc.272.41.25425; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Prasad BC, 1999, TRENDS GENET, V15, P150, DOI 10.1016/S0168-9525(99)01695-9; Ribas C, 2007, BBA-BIOMEMBRANES, V1768, P913, DOI 10.1016/j.bbamem.2006.09.019; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Robatzek M, 2001, CURR BIOL, V11, P288, DOI 10.1016/S0960-9822(01)00074-4; Rockman HA, 1998, J BIOL CHEM, V273, P18180, DOI 10.1074/jbc.273.29.18180; SCHLEICHER S, 1993, P NATL ACAD SCI USA, V90, P1420, DOI 10.1073/pnas.90.4.1420; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Sterne-Marr R, 2003, J BIOL CHEM, V278, P6050, DOI 10.1074/jbc.M208787200; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; TOUHARA K, 1995, J BIOL CHEM, V270, P17000, DOI 10.1074/jbc.270.28.17000; Troemel ER, 1999, BIOESSAYS, V21, P1011, DOI 10.1002/(SICI)1521-1878(199912)22:1&lt;1011::AID-BIES5&gt;3.0.CO;2-V; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; van der Linden AM, 2001, GENETICS, V158, P221; VANDERVOORN L, 1990, J MOL BIOL, V213, P17, DOI 10.1016/S0022-2836(05)80118-4; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wood WB, 1988, NEMATODE CAENORHABDI; Yamada K, 2009, GENETICS, V181, P1347, DOI 10.1534/genetics.108.099002; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175; Yang W, 2006, WORLD J GASTROENTERO, V12, P7753, DOI 10.3748/wjg.v12.i48.7753; Zwaal RR, 1996, CELL, V86, P619, DOI 10.1016/S0092-8674(00)80135-X	64	9	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12634	12644		10.1074/jbc.M111.336818	http://dx.doi.org/10.1074/jbc.M111.336818			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22375004	hybrid, Green Published			2022-12-27	WOS:000302903700004
J	Ishizaka, A; Mizutani, T; Kobayashi, K; Tando, T; Sakurai, K; Fujiwara, T; Iba, H				Ishizaka, Aya; Mizutani, Taketoshi; Kobayashi, Kazuyoshi; Tando, Toshio; Sakurai, Kouhei; Fujiwara, Toshinobu; Iba, Hideo			Double Plant Homeodomain (PHD) Finger Proteins DPF3a and-3b Are Required as Transcriptional Co-activators in SWI/SNF Complex-dependent Activation of NF-kappa B RelA/p50 Heterodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN REMODELING COMPLEX; D4 GENE FAMILY; EXPRESSION; CELLS; CANCER; SUBUNIT; BRM; PHOSPHORYLATION; INFLAMMATION; HOMODIMER	We have previously shown that DPF2 (requiem/REQ) functions as a linker protein between the SWI/SNF complex and RelB/p52 NF-kappa B heterodimer and plays important roles in NF-kappa B transactivation via its noncanonical pathway. Using sensitive 293FT reporter cell clones that had integrated a SWI/SNF-dependent NF-kappa B reporter gene, we find in this study that the overexpression of DPF1, DPF2, DPF3a, DPF3b, and PHF10 significantly potentiates the transactivating activity of typical NF-kappa B dimers. Knockdown analysis using 293FT reporter cells that endogenously express these five proteins at low levels clearly showed that DPF3a and DPF3b, which are produced from the DPF3 gene by alternative splicing, are the most critical for the RelA/p50 NF-kappa B heterodimer transactivation induced by TNF-alpha stimulation. Our data further show that this transactivation requires the SWI/SNF complex. DPF3a and DPF3b are additionally shown to interact directly with RelA, p50, and several subunits of the SWI/SNF complex in vitro and to be co-immunoprecipitated with RelA/p50 and the SWI/SNF complex from the nuclear fractions of cells treated with TNF-alpha. In ChIP experiments, we further found that endogenous DPF3a/b and the SWI/SNF complex are continuously present on HIV-1 LTR, whereas the kinetics of RelA/p50 recruitment after TNF-alpha treatment correlate well with the viral transcriptional activation levels. Additionally, re-ChIP experiments showed DPF3a/b and the SWI/SNF complex associate with RelA on the endogenous IL-6 promoter after TNF-alpha treatment. In conclusion, our present data indicate that by linking RelA/p50 to the SWI/SNF complex, DPF3a/b induces the transactivation of NF-kappa B target gene promoters in relatively inactive chromatin contexts.	[Ishizaka, Aya; Mizutani, Taketoshi; Kobayashi, Kazuyoshi; Tando, Toshio; Sakurai, Kouhei; Iba, Hideo] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Host Parasite Interact,Minato Ku, Tokyo 1088639, Japan; [Mizutani, Taketoshi] Japan Sci & Technol Agcy, PRESTO, RNA & Biofunct, Kawaguchi, Saitama 3320012, Japan; [Fujiwara, Toshinobu] Inst Microbial Chem, Lab Dis Biol, Shinagawa Ku, Tokyo 1410021, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Iba, H (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Host Parasite Interact,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	iba@ims.u-tokyo.ac.jp		Mizutani, Taketoshi/0000-0002-1329-6512; Ishizaka, Aya/0000-0003-2800-2430	Ministry of Education, Culture, Sports, Science and Technology, Japan [17016015, 22300318, 21590507]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [21590507, 22115511] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research on Priority Areas 17016015 and for Scientific Research (B) 22300318 and (C) 21590507 from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by a grant from the Japan Society for the Promotion of Science.	Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; BUCHMAN VL, 1992, NUCLEIC ACIDS RES, V20, P5579, DOI 10.1093/nar/20.21.5579; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Chestkov AV, 1996, GENOMICS, V36, P174, DOI 10.1006/geno.1996.0440; GABIG TG, 1994, J BIOL CHEM, V269, P29515; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Iba H, 2003, REV MED VIROL, V13, P99, DOI 10.1002/rmv.378; Ito T, 2001, J BIOL CHEM, V276, P2852, DOI 10.1074/jbc.M009633200; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Mizutani T, 2002, J BIOL CHEM, V277, P15859, DOI 10.1074/jbc.M112421200; Mizutani T, 2009, J VIROL, V83, P11569, DOI 10.1128/JVI.00742-09; Muchardt C, 1999, J MOL BIOL, V293, P187, DOI 10.1006/jmbi.1999.2999; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Ninkina NN, 2001, MAMM GENOME, V12, P862, DOI 10.1007/s00335-001-3039-1; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Rohr O, 2003, J LEUKOCYTE BIOL, V74, P736, DOI 10.1189/jlb.0403180; Santoro MG, 2003, EMBO J, V22, P2552, DOI 10.1093/emboj/cdg267; Satou R, 2010, AM J PHYSIOL-CELL PH, V299, pC750, DOI 10.1152/ajpcell.00078.2010; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; Stevens M, 2006, MED RES REV, V26, P595, DOI 10.1002/med.20081; Tando T, 2010, J BIOL CHEM, V285, P21951, DOI 10.1074/jbc.M109.087783; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Watanabe H, 2006, ONCOGENE, V25, P470, DOI 10.1038/sj.onc.1209068; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wu ZZ, 2011, BIOCHEM PHARMACOL, V82, P1860, DOI 10.1016/j.bcp.2011.09.010; Yamamichi N, 2009, EXP CELL RES, V315, P1779, DOI 10.1016/j.yexcr.2009.01.006; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	38	25	25	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11924	11933		10.1074/jbc.M111.322792	http://dx.doi.org/10.1074/jbc.M111.322792			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334708	hybrid, Green Published			2022-12-27	WOS:000302782200031
J	Mazina, OM; Rossi, MJ; Deakyne, JS; Huang, F; Mazin, AV				Mazina, Olga M.; Rossi, Matthew J.; Deakyne, Julianna S.; Huang, Fei; Mazin, Alexander V.			Polarity and Bypass of DNA Heterology during Branch Migration of Holliday Junctions by Human RAD54, BLM, and RECQ1 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOMS-SYNDROME HELICASE; MODEL REPLICATION FORK; SYNDROME GENE-PRODUCT; STRAND BREAK REPAIR; D-LOOPS; RECOMBINATION PROTEINS; UNWINDING ACTIVITY; ESCHERICHIA-COLI; REGRESSION; PROMOTES	Several proteins have been shown to catalyze branch migration (BM) of the Holliday junction, a key intermediate in DNA repair and recombination. Here, using joint molecules made by human RAD51 or Escherichia coli RecA, we find that the polarity of the displaced ssDNA strand of the joint molecules defines the polarity of BM of RAD54, BLM, RECQ1, and RuvAB. Our results demonstrate that RAD54, BLM, and RECQ1 promote BMpreferentially in the 3' -> 5' direction, whereas RuvAB drives it in the 5' -> 3' direction relative to the displaced ssDNA strand. Our data indicate that the helicase activity of BM proteins does not play a role in the heterology bypass. Thus, RAD54 that lacks helicase activity is more efficient in DNA heterology bypass than BLM or REQ1 helicases. Furthermore, we demonstrate that the BLM helicase and BM activities require different protein stoichiometries, indicating that different complexes, monomers and multimers, respectively, are responsible for these two activities. These results define BM as a mechanistically distinct activity of DNA translocating proteins, which may serve an important function in DNA repair and recombination.	[Mazin, Alexander V.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, NCB, Philadelphia, PA 19102 USA; [Mazin, Alexander V.] Inst Cytol & Genet, Novosibirsk 630090, Russia	Drexel University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Mazin, AV (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, NCB, 245 N 15th St,Rm 10103, Philadelphia, PA 19102 USA.	amazin@drexelmed.edu		Rossi, Matthew/0000-0002-7796-919X	National Institutes of Health [CA100839, F31 AG033484]; Leukemia and Lymphoma Society [1054-09]; NATIONAL CANCER INSTITUTE [R56CA100839, R01CA100839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG033484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA100839 (to A. V. M.) and F31 AG033484 (to M. J. R.) This work was also supported by Leukemia and Lymphoma Society Scholar Award 1054-09 (to A. V. M.).	Adams DE, 1996, J MOL BIOL, V263, P582, DOI 10.1006/jmbi.1996.0600; Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Amitani I, 2006, MOL CELL, V23, P143, DOI 10.1016/j.molcel.2006.05.009; Bachrati CZ, 2006, NUCLEIC ACIDS RES, V34, P2269, DOI 10.1093/nar/gkl258; Biswas I, 1998, J MOL BIOL, V279, P795, DOI 10.1006/jmbi.1998.1769; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Bugreev DV, 2008, J BIOL CHEM, V283, P20231, DOI 10.1074/jbc.M801582200; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Bugreev DV, 2007, NAT STRUCT MOL BIOL, V14, P746, DOI 10.1038/nsmb1268; Bugreev DV, 2006, NATURE, V442, P590, DOI 10.1038/nature04889; Bugreev DV, 2011, NUCLEIC ACIDS RES, V39, P2153, DOI 10.1093/nar/gkq1139; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Cui S, 2004, NUCLEIC ACIDS RES, V32, P2158, DOI 10.1093/nar/gkh540; Dennis C, 2004, EMBO J, V23, P2413, DOI 10.1038/sj.emboj.7600249; Gari K, 2008, MOL CELL, V29, P141, DOI 10.1016/j.molcel.2007.11.032; Harmon FG, 2001, J BIOL CHEM, V276, P232, DOI 10.1074/jbc.M006555200; Kanagaraj R, 2006, NUCLEIC ACIDS RES, V34, P5217, DOI 10.1093/nar/gkl677; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611; Kowalczykowski SC, 2008, NATURE, V453, P463, DOI 10.1038/453463a; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Liu YL, 2004, NAT REV MOL CELL BIO, V5, P937, DOI 10.1038/nrm1502; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Machwe A, 2006, BIOCHEMISTRY-US, V45, P13939, DOI 10.1021/bi0615487; Machwe A, 2011, BIOCHEMISTRY-US, V50, P6774, DOI 10.1021/bi2001054; Mazin AV, 2010, DNA REPAIR, V9, P286, DOI 10.1016/j.dnarep.2009.12.006; Mazina OM, 2007, J BIOL CHEM, V282, P21068, DOI 10.1074/jbc.M701992200; Mazina OM, 2004, J BIOL CHEM, V279, P52042, DOI 10.1074/jbc.M410244200; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8235, DOI 10.1073/pnas.121007798; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Murayama Y, 2008, NATURE, V451, P1018, DOI 10.1038/nature06609; Muzzolini L, 2007, PLOS BIOL, V5, P157, DOI 10.1371/journal.pbio.0050020; Orren DK, 2002, BIOCHEMISTRY-US, V41, P13483, DOI 10.1021/bi0266986; PANYUTIN IG, 1993, J MOL BIOL, V230, P413, DOI 10.1006/jmbi.1993.1159; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Ralf C, 2006, J BIOL CHEM, V281, P22839, DOI 10.1074/jbc.M604268200; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Rossi MJ, 2008, J BIOL CHEM, V283, P24698, DOI 10.1074/jbc.M800839200; Rossi MJ, 2011, P NATL ACAD SCI USA, V108, P6432, DOI 10.1073/pnas.1016072108; Rossi MJ, 2010, METHODS, V51, P336, DOI 10.1016/j.ymeth.2010.02.010; Rudolph CJ, 2010, DNA REPAIR, V9, P210, DOI 10.1016/j.dnarep.2009.12.014; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; UMEZU K, 1993, J MOL BIOL, V230, P1145, DOI 10.1006/jmbi.1993.1231; Unk I, 2010, DNA REPAIR, V9, P257, DOI 10.1016/j.dnarep.2009.12.013; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451	51	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11820	11832		10.1074/jbc.M112.341347	http://dx.doi.org/10.1074/jbc.M112.341347			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22356911	hybrid, Green Published			2022-12-27	WOS:000302782200021
J	Mediouni, S; Watkins, JD; Pierres, M; Bole, A; Loret, EP; Baillat, G				Mediouni, Sonia; Watkins, Jennifer D.; Pierres, Michel; Bole, Angelique; Loret, Erwann P.; Baillat, Gilbert			A Monoclonal Antibody Directed against a Conformational Epitope of the HIV-1 Trans-activator (Tat) Protein Neutralizes Cross-clade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; APOPTOSIS; GLYCOPROTEIN; COMBINATION; PERSISTENCE; INFECTION; DEFINES; ESCAPE; BLOOD; 2G12	The identification of a neutralizing mAb against extracellular HIV-1 transactivator of transcription (Tat) is important for the development of an efficient HIV-1 treatment. Tat plays an essential role in HIV-1 pathogenesis, not only for HIV-1 replication but also as an extracellular toxin able to disrupt the immune system. We showed previously that immunization of rabbits with Tat Oyi, a variant cloned from an African woman who did not develop AIDS following HIV-1 infection, raised antibodies able to recognize different Tat variants. We carried out mice immunization with Tat Oyi and selected a mAb named 7G12, which had the capacity to cross-recognize heterologous Tat variants by a common three-dimensional epitope. These results highlighted that Tat variants were able to acquire a structure, in contrast to a number of studies showing Tat as an unfolded protein. mAb 7G12 also had the capacity to neutralize the biological activities of these Tat variants by blocking the cellular uptake of extracellular Tat. This is the first study using Tat Oyi to produce a mAb able to neutralize effectively activities of extracellular Tats from different HIV-1 subtypes. This mAb has an important potential in therapeutic passive immunization and could help HIV-1 infected patients to restore their immunity.	[Mediouni, Sonia; Loret, Erwann P.; Baillat, Gilbert] Univ Mediterranee, Fac Pharm, Equipe Rech Technol 2011, F-13385 Marseille 5, France; [Watkins, Jennifer D.] Harvard Univ, Dana Farber Canc Inst, Sch Med, Boston, MA 02215 USA; [Pierres, Michel; Bole, Angelique] Univ Mediterranee UNIVMED UM631, Ctr Immunol Marseille Luminy, INSERM, CNRS,UMR S613,UMR 6102, F-13288 Marseille 9, France	UDICE-French Research Universities; Aix-Marseille Universite; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Loret, EP (corresponding author), Univ Mediterranee, Fac Pharm, Equipe Rech Technol 2011, 27 BD Jean Moulin, F-13385 Marseille 5, France.	erwann.loret@univmed.fr; gilbert.baillat@univmed.fr						Campbell GR, 2005, J BIOL CHEM, V280, P38376, DOI 10.1074/jbc.M506630200; Campbell GR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-50; Chen WZ, 2012, AIDS RES HUM RETROV, V28, P425, DOI [10.1089/aid.2011.0226, 10.1089/AID.2011.0226]; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; CULLEN BR, 1990, CELL, V63, P655, DOI 10.1016/0092-8674(90)90129-3; de Mareuil J, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-5; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Fuller S. A., 1991, CURRENT PROTOCOLS MO, P1101; FURLINI MCRG, 1995, J ACQ IMMUN DEF SYND, V10, P408, DOI 10.1097/00042560-199512000-00003; Gougeon ML, 2003, NAT REV IMMUNOL, V3, P392, DOI 10.1038/nri1087; Harakeh S, 2006, LEUKEMIA RES, V30, P869, DOI 10.1016/j.leukres.2005.11.027; Hardy F, 1997, J IMMUNOL METHODS, V200, P155, DOI 10.1016/S0022-1759(96)00201-3; Huang L, 1998, J VIROL, V72, P8952, DOI 10.1128/JVI.72.11.8952-8960.1998; HUET T, 1989, AIDS, V3, P707, DOI 10.1097/00002030-198911000-00004; Kitabwalla M, 2003, AIDS RES HUM RETROV, V19, P125, DOI 10.1089/088922203762688630; Kramer VG, 2007, CURR HIV RES, V5, P642, DOI 10.2174/157016207782418506; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Ma MH, 1997, J VIROL, V71, P2495, DOI 10.1128/JVI.71.3.2495-2499.1997; MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x; Manrique A, 2007, J VIROL, V81, P8793, DOI 10.1128/JVI.00598-07; Mediouni Sonia, 2011, Infectious Disorders - Drug Targets, V11, P57; Moreau E, 2004, J VIROL, V78, P3792, DOI 10.1128/JVI.78.7.3792-3796.2004; Moulard M, 2002, P NATL ACAD SCI USA, V99, P6913, DOI 10.1073/pnas.102562599; Opi S, 2002, J BIOL CHEM, V277, P35915, DOI 10.1074/jbc.M204393200; Peloponese JM, 1999, J BIOL CHEM, V274, P11473, DOI 10.1074/jbc.274.17.11473; Rodman TC, 2001, EXP HEMATOL, V29, P1004, DOI 10.1016/S0301-472X(01)00678-6; Saitoh A, 2002, J INFECT DIS, V185, P1409, DOI 10.1086/340614; Shojania S, 2006, J BIOL CHEM, V281, P8347, DOI 10.1074/jbc.M510748200; Siddappa NB, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-53; STEINAA L, 1994, ARCH VIROL, V139, P263, DOI 10.1007/BF01310790; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Tudor D, 2011, AIDS, V25, P751, DOI 10.1097/QAD.0b013e32834507bd; Valvatne H, 1996, AIDS RES HUM RETROV, V12, P611, DOI 10.1089/aid.1996.12.611; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Watkins JD, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-8; Watkins JD, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-83; WONGSTAAL F, 1985, NATURE, V317, P395, DOI 10.1038/317395a0; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Zhang MY, 2004, J VIROL, V78, P9233, DOI 10.1128/JVI.78.17.9233-9242.2004; Zhang MY, 2003, J IMMUNOL METHODS, V283, P17, DOI 10.1016/j.jim.2003.07.003; Zwick MB, 2003, J VIROL, V77, P5863, DOI 10.1128/JVI.77.10.5863-5876.2003; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	47	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11942	11950		10.1074/jbc.M111.319863	http://dx.doi.org/10.1074/jbc.M111.319863			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22362765	Green Published, hybrid			2022-12-27	WOS:000302782200033
J	Murase, S; McKay, RD				Murase, Sachiko; McKay, Ronald D.			Matrix Metalloproteinase-9 Regulates Survival of Neurons in Newborn Hippocampus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OCCURRING CELL-DEATH; MATRIX METALLOPROTEINASE-3; ALZHEIMERS-DISEASE; MOUSE HIPPOCAMPUS; LAMININ; EXPRESSION; RAT; SPECIFICITY; ACTIVATION; INTEGRINS	The number of neurons in the adult rodent brain is strongly influenced by events in early postnatal life that eliminate approximately half of the neurons. Recently, we reported that neurotrophins induced survival of neonatal rat hippocampal neurons by promoting neural activity and activation of the Ser/Thr kinase, Akt. The survival of neurons also depended on integrin signaling, but a role for the extracellular matrix (ECM) in this mechanism was yet to be explored. Here, we show that levels of the matrix metalloproteinase-9 (MMP9) decrease, and the level of the ECM protein laminin increases in rat hippocampus during the period of neuronal death. Hippocampi from MMP9 null mice showed higher levels of laminin expression than wild type at P1 and no further increase at P10. In vitro, the matrix metalloproteinase inhibitor FN-439 promoted survival of neurons in a laminin-integrin beta 1-dependent manner. Blocking laminin signaling attenuated activation of Akt by depolarization. In vivo, injecting FN-439 into the neonatal hippocampus increased the level of laminin and promoted neuronal survival through an integrin-dependent mechanism. These results show signals from the ECM are not simply permissive but rather actively regulated, and they interact with neuronal activity to control the number of hippocampal neurons. This work is the first to report a role for MMP9 in regulating neuronal survival through the developmental process that establishes the functional brain.	[Murase, Sachiko; McKay, Ronald D.] NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [McKay, Ronald D.] Lieber Inst Brain Dev, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Murase, S (corresponding author), NINDS, Mol Biol Lab, NIH, 35 Lincoln Dr, Bethesda, MD 20892 USA.	sachikom@ninds.nih.gov	Murase, Sachiko/AAC-5496-2022	Murase, Sachiko/0000-0002-9078-0471	National Institutes of Health from NINDS	National Institutes of Health from NINDS	This work was supported by a National Institutes of Health grant from the Intramural Research Program, NINDS.	BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Bian JH, 1997, MOL CELL BIOL, V17, P6330, DOI 10.1128/MCB.17.11.6330; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Choi DH, 2008, J NEUROCHEM, V106, P405, DOI 10.1111/j.1471-4159.2008.05399.x; CUNNINGHAM MG, 1993, J NEUROSCI METH, V47, P105, DOI 10.1016/0165-0270(93)90026-N; FERRER I, 1994, NEUROSCI LETT, V182, P77, DOI 10.1016/0304-3940(94)90210-0; GOULD E, 1991, J COMP NEUROL, V304, P408, DOI 10.1002/cne.903040306; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Hewitt JE, 2009, BBA-MOL BASIS DIS, V1792, P853, DOI 10.1016/j.bbadis.2009.06.003; Horstmann S, 2010, INT PSYCHOGERIATR, V22, P966, DOI 10.1017/S1041610210000827; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Indyk JA, 2003, NEUROSCIENCE, V116, P359, DOI 10.1016/S0306-4522(02)00704-2; IZANT JG, 1980, P NATL ACAD SCI-BIOL, V77, P4741, DOI 10.1073/pnas.77.8.4741; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kikkawa Y, 2000, J CELL SCI, V113, P869; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; MENDRICK DL, 1993, LAB INVEST, V69, P690; MORITA A, 1985, BIOCHEM J, V229, P259, DOI 10.1042/bj2290259; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Murase S, 2006, J NEUROSCI, V26, P9750, DOI 10.1523/JNEUROSCI.2745-06.2006; Murase S, 2011, EUR J NEUROSCI, V34, P374, DOI 10.1111/j.1460-9568.2011.07758.x; Murase S, 2011, J NEUROSCI, V31, P7791, DOI 10.1523/JNEUROSCI.0202-11.2011; Oh LYS, 1999, J NEUROSCI, V19, P8464; PFAFF M, 1994, CELL ADHES COMMUN, V2, P491, DOI 10.3109/15419069409014213; Plateroti M, 1997, J CELL SCI, V110, P1227; Sharif KA, 2004, NEUROSCIENCE, V126, P967, DOI 10.1016/j.neuroscience.2004.03.064; Shibata N, 2005, NEUROBIOL AGING, V26, P1011, DOI 10.1016/j.neurobiolaging.2004.09.004; Staniszewska I, 2008, J CELL SCI, V121, P504, DOI 10.1242/jcs.000232; Staun-Ram E, 2009, PLACENTA, V30, P1029, DOI 10.1016/j.placenta.2009.09.010; Sung JY, 2005, J BIOL CHEM, V280, P25216, DOI 10.1074/jbc.M503341200; SUZUKI K, 1990, BIOCHEMISTRY-US, V29, P10261, DOI 10.1021/bi00496a016; Szklarczyk A, 2002, J NEUROSCI, V22, P920, DOI 10.1523/JNEUROSCI.22-03-00920.2002; Toker A, 2000, CELL, V103, P185, DOI 10.1016/S0092-8674(00)00110-0; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Yoshiyama Y, 2000, ACTA NEUROPATHOL, V99, P91, DOI 10.1007/PL00007428	39	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12184	12194		10.1074/jbc.M111.297671	http://dx.doi.org/10.1074/jbc.M111.297671			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351756	hybrid, Green Published			2022-12-27	WOS:000302782200060
J	Goel, S; Chin, EN; Fakhraldeen, SA; Berry, SM; Beebe, DJ; Alexander, CM				Goel, Shruti; Chin, Emily N.; Fakhraldeen, Saja A.; Berry, Scott M.; Beebe, David J.; Alexander, Caroline M.			Both LRP5 and LRP6 Receptors Are Required to Respond to Physiological Wnt Ligands in Mammary Epithelial Cells and Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; CORECEPTOR LRP6; IN-VITRO; PROTEINS; MECHANISM; PATHWAY; MOUSE; EXPRESSION; GLAND; PHOSPHORYLATION	A canonical Wnt signal maintains adult mammary ductal stem cell activity, and this signal requires the Wnt signaling reception, LRP5. However, previous data from our laboratory have shown that LRP5 and LRP6 are co-expressed in mammary basal cells and that LRP6 is active, leading us to question why LRP6 is insufficient to mediate canonical signaling in the absence of LRP5. Here, we show that at endogenous levels of LRP5 and LRP6 both receptors are required to signal in response to some Wnt ligands both in vitro (in mouse embryonic fibroblasts and mammary epithelial cells) and in vivo (in mammary outgrowths). This subgroup of canonical ligands includes Wnt1, Wnt9b, and Wnt10b; the latter two are expressed in mammary gland. In contrast, the ligand commonly used experimentally, Wnt3a, prefers LRP6 and requires just one receptor regardless of cellular context. When either LRP5 or LRP6 is overexpressed, signaling remains ligand-dependent, but the requirement for both receptors is abrogated (regardless of ligand type). We have documented an LRP5-6 heteromer using immiscible filtration assisted by surface tension (IFAST) immunoprecipitation. Together, our data imply that under physiological conditions some Wnt ligands require both receptors to be present to generate a canonical signal. We have designed a model to explain our results based on the resistance of LRP5-6 heteromers to a selective inhibitor of E1/2-binding Wnt-LRP6 interaction. These data have implications for stem cell biology and for the analysis of the oncogenicity of LRP receptors that are often overexpressed in breast tumors.	[Goel, Shruti; Chin, Emily N.; Fakhraldeen, Saja A.; Alexander, Caroline M.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Berry, Scott M.; Beebe, David J.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Alexander, CM (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	alexander@oncology.wisc.edu		Fakhraldeen, Saja/0000-0003-3919-0270	Era of Hope Scholar Grant [W81XWH-06-1-0491]; Kuwait Ministry of Higher Education	Era of Hope Scholar Grant; Kuwait Ministry of Higher Education	This work was supported by Era of Hope Scholar Grant W81XWH-06-1-0491 to C. M. A.) and a scholarship from the Kuwait Ministry of Higher Education (to S. F.).	Ai LB, 2006, CARCINOGENESIS, V27, P1341, DOI 10.1093/carcin/bgi379; Alexander C. M., 2012, COLD SPRING IN PRESS; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Bennett CN, 2003, BIOCHEM BIOPH RES CO, V302, P12, DOI 10.1016/S0006-291X(03)00092-5; Berry SM, 2011, LAB CHIP, V11, P1747, DOI 10.1039/c1lc00004g; Bienz M, 2003, NAT CELL BIOL, V5, P179, DOI 10.1038/ncb0303-179; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bjorklund P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004243; Bourhis E, 2011, STRUCTURE, V19, P1433, DOI 10.1016/j.str.2011.07.005; Brennan K, 2004, ONCOGENE, V23, P4873, DOI 10.1038/sj.onc.1207642; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Britt KL, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2245; Bryja V, 2009, MOL BIOL CELL, V20, P924, DOI 10.1091/mbc.E08-07-0711; Callahan R, 2008, J MAMMARY GLAND BIOL, V13, P309, DOI 10.1007/s10911-008-9092-6; Chen S, 2011, DEV CELL, V21, P848, DOI 10.1016/j.devcel.2011.09.007; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; DU SJ, 1995, MOL CELL BIOL, V15, P2625; Ettenberg SA, 2010, P NATL ACAD SCI USA, V107, P15473, DOI 10.1073/pnas.1007428107; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Gong Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012682; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hendrickx M, 2008, DEV GROWTH DIFFER, V50, P229, DOI [10.1111/j.1440-169x.2008.01016.x, 10.1111/j.1440-169X.2008.01016.x]; Holmen SL, 2002, J BIOL CHEM, V277, P34727, DOI 10.1074/jbc.M204989200; Humphreys RC, 1997, CELL GROWTH DIFFER, V8, P839; Itasaki N, 2003, DEVELOPMENT, V130, P4295, DOI 10.1242/dev.00674; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Khan Z, 2007, MOL CELL BIOL, V27, P7291, DOI 10.1128/MCB.00773-07; Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019310; Kim YC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-55; Kim YC, 2008, CANCER RES, V68, P10145, DOI 10.1158/0008-5472.CAN-08-2992; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2008, J BIOL CHEM, V283, P16115, DOI 10.1074/jbc.M800327200; MacDonald BT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023537; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Mason JJ, 2010, J OSTEOPOROS, V2010, DOI 10.4061/2010/460120; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Mi KH, 2005, J CELL BIOCHEM, V95, P328, DOI 10.1002/jcb.20400; Niehrs C, 2010, CELL MOL LIFE SCI, V67, P2551, DOI 10.1007/s00018-010-0329-3; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Schweizer L, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-4; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002; WONG GT, 1994, MOL CELL BIOL, V14, P6278, DOI 10.1128/MCB.14.9.6278; Wright WE, 2006, NAT PROTOC, V1, P2088, DOI 10.1038/nprot.2006.374; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang J, 2010, ONCOGENE, V29, P539, DOI 10.1038/onc.2009.339	65	47	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16454	16466		10.1074/jbc.M112.362137	http://dx.doi.org/10.1074/jbc.M112.362137			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22433869	Green Published, hybrid			2022-12-27	WOS:000304030900036
J	Liu, AG; Gong, P; Hyun, SW; Wang, KZQ; Cates, EA; Perkins, D; Bannerman, DD; Puche, AC; Toshchakov, VY; Fang, SY; Auron, PE; Vogel, SN; Goldblum, SE				Liu, Anguo; Gong, Ping; Hyun, Sang W.; Wang, Kent Z. Q.; Cates, Elizabeth A.; Perkins, Darren; Bannerman, Douglas D.; Puche, Adam C.; Toshchakov, Vladimir Y.; Fang, Shengyun; Auron, Philip E.; Vogel, Stefanie N.; Goldblum, Simeon E.			TRAF6 Protein Couples Toll-like Receptor 4 Signaling to Src Family Kinase Activation and Opening of Paracellular Pathway in Human Lung Microvascular Endothelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ADAPTER PROTEINS; LIPOPOLYSACCHARIDE; ANGIOGENESIS; ENDOTOXIN; COMPLEX; DOMAIN; MYD88; IL-1; AUTOUBIQUITINATION	Gram-negative bacteria release lipopolysaccharide (LPS) into the bloodstream. Here, it engages Toll-like receptor (TLR) 4 expressed in human lung microvascular endothelia (HMVEC-Ls) to open the paracellular pathway through Src family kinase (SFK) activation. The signaling molecules that couple TLR4 to the SFK-driven barrier disruption are unknown. In HMVEC-Ls, siRNA-induced silencing of TIRAP/Mal and overexpression of dominant-negative TIRAP/Mal each blocked LPS-induced SFK activation and increases in transendothelial [C-14]albumin flux, implicating the MyD88-dependent pathway. LPS increased TRAF6 autoubiquitination and binding to IRAK1. Silencing of TRAF6, TRAF6-dominant-negative overexpression, or preincubation of HMVEC-Ls with a cell-permeable TRAF6 decoy peptide decreased both LPS-induced SFK activation and barrier disruption. LPS increased binding of both c-Src and Fyn to GST-TRAF6 but not to a GST-TRAF6 mutant in which the three prolines in the putative Src homology 3 domain-binding motif (amino acids 461-469) were substituted with alanines. A cell-permeable decoy peptide corresponding to the same proline-rich motif reduced SFK binding to WT GST-TRAF6 compared with the Pro -> Ala-substituted peptide. Finally, LPS increased binding of activated Tyr(P)(416)-SFK to GST-TRAF6, and preincubation of HMVEC-Ls with SFK-selective tyrosine kinase inhibitors, PP2 and SU6656, diminished TRAF6 binding to c-Src and Fyn. During the TRAF6-SFK association, TRAF6 catalyzed Lys(63)-linked ubiquitination of c-Src and Fyn, whereas SFK activation increased tyrosine phosphorylation of TRAF6. The TRAF6 decoy peptide blocked both LPS-induced SFK ubiquitination and TRAF6 phosphorylation. Together, these data indicate that the proline-rich Src homology 3 domain-binding motif in TRAF6 interacts directly with activated SFKs to couple LPS engagement of TLR4 to SFK activation and loss of barrier integrity in HMVEC-Ls.	[Goldblum, Simeon E.] Univ Maryland, Sch Med, Mucosal Biol Res Ctr, Baltimore, MD 21201 USA; [Liu, Anguo; Gong, Ping; Hyun, Sang W.; Bannerman, Douglas D.; Goldblum, Simeon E.] Univ Maryland, Dept Med, Baltimore, MD 21201 USA; [Perkins, Darren; Toshchakov, Vladimir Y.; Vogel, Stefanie N.] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Puche, Adam C.] Univ Maryland, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Fang, Shengyun] Univ Maryland, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Fang, Shengyun] Univ Maryland, Dept Physiol, Baltimore, MD 21201 USA; [Goldblum, Simeon E.] Vet Affairs Maryland Hlth Care Syst, Baltimore, MD 21201 USA; [Wang, Kent Z. Q.; Auron, Philip E.] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA; [Cates, Elizabeth A.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Duquesne University; University System of Maryland; University of Maryland College Park	Goldblum, SE (corresponding author), Univ Maryland, Sch Med, Mucosal Biol Res Ctr, 20 Penn St,Rm 351, Baltimore, MD 21201 USA.	sgoldblu@mbrc.umaryland.edu	Toshchakov, Vladimir/C-2798-2014; Fang, Shengyun/H-3802-2011	Toshchakov, Vladimir/0000-0002-7942-2294; Fang, Shengyun/0000-0001-7280-5463; GONZALEZ, ELIZABETH/0000-0002-6379-2354	National Institutes of Health [HL089179, AI18797, AI082299]; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018797, R56AI018797, R01AI082299, R37AI018797] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002352] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants HL089179 (to S. E. G.), AI18797 (to S. N. V.), and AI082299 (to V. Y. T.). This work was also supported by a Merit Review grant from the Department of Veterans Affairs (to S. E. G.).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Bannerman DD, 1998, INFECT IMMUN, V66, P1400, DOI 10.1128/IAI.66.4.1400-1407.1998; Bannerman DD, 1997, AM J PHYSIOL-LUNG C, V273, pL217, DOI 10.1152/ajplung.1997.273.1.L217; Benati D, 2008, CURR MED CHEM, V15, P1154, DOI 10.2174/092986708784310404; Boch JA, 2003, BIOCHEM BIOPH RES CO, V303, P525, DOI 10.1016/S0006-291X(03)00385-1; BRIGHAM KL, 1986, AM REV RESPIR DIS, V133, P913; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carpenter S, 2009, BIOCHEM J, V422, P1, DOI 10.1042/BJ20090616; Cates EA, 2009, COMP IMMUNOL MICROB, V32, P477, DOI 10.1016/j.cimid.2008.06.001; Chen HQ, 2006, FEBS LETT, V580, P3145, DOI 10.1016/j.febslet.2006.04.066; Choi YS, 2009, BLOOD, V114, P3117, DOI 10.1182/blood-2009-02-203372; Dauphinee SM, 2006, LAB INVEST, V86, P9, DOI 10.1038/labinvest.3700366; Davis CN, 2006, J NEUROCHEM, V98, P1379, DOI 10.1111/j.1471-4159.2006.03951.x; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Engen JR, 2008, CELL MOL LIFE SCI, V65, P3058, DOI 10.1007/s00018-008-8122-2; Funakoshi-Tago M, 2003, EUR J BIOCHEM, V270, P1257, DOI 10.1046/j.1432-1033.2003.03487.x; GOLDBLUM SE, 1994, J CLIN INVEST, V93, P692, DOI 10.1172/JCI117022; Gong P, 2008, J BIOL CHEM, V283, P13437, DOI 10.1074/jbc.M707986200; Harris KF, 1999, P NATL ACAD SCI USA, V96, P13738, DOI 10.1073/pnas.96.24.13738; Henneke P, 2002, CRIT CARE MED, V30, pS207, DOI 10.1097/00003246-200205001-00006; Ingley E, 2008, BBA-PROTEINS PROTEOM, V1784, P56, DOI 10.1016/j.bbapap.2007.08.012; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lamothe B, 2008, J BIOL CHEM, V283, P24871, DOI 10.1074/jbc.M802749200; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Liu AG, 2009, J BIOL CHEM, V284, P6389, DOI 10.1074/jbc.M809198200; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Mansell A, 2004, J BIOL CHEM, V279, P37227, DOI 10.1074/jbc.C400289200; Min JK, 2007, BLOOD, V109, P1495, DOI 10.1182/blood-2006-06-029298; Mukundan L, 2005, J IMMUNOL, V174, P1081, DOI 10.4049/jimmunol.174.2.1081; Nakamura I, 2002, J IMMUNOL, V168, P5103, DOI 10.4049/jimmunol.168.10.5103; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oda H, 1999, P NATL ACAD SCI USA, V96, P9557, DOI 10.1073/pnas.96.17.9557; Pollet I, 2003, BLOOD, V102, P1740, DOI 10.1182/blood-2003-01-0288; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rao NV, 2002, P NATL ACAD SCI USA, V99, P3794, DOI 10.1073/pnas.062055999; Sasai M, 2010, MOL IMMUNOL, V47, P1283, DOI 10.1016/j.molimm.2009.12.002; Sheedy FJ, 2007, J LEUKOCYTE BIOL, V82, P196, DOI 10.1189/jlb.1206750; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Sui XF, 2005, AM J PATHOL, V166, P1247, DOI 10.1016/S0002-9440(10)62343-7; Toshchakov VY, 2007, J IMMUNOL, V178, P2655, DOI 10.4049/jimmunol.178.5.2655; Toshchakov VU, 2005, J IMMUNOL, V175, P494, DOI 10.4049/jimmunol.175.1.494; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Verstak B, 2009, J BIOL CHEM, V284, P24192, DOI 10.1074/jbc.M109.023044; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Wang KZQ, 2010, J CELL BIOCHEM, V110, P763, DOI 10.1002/jcb.22589; Wang KZQ, 2006, J CELL SCI, V119, P1579, DOI 10.1242/jcs.02889; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Zeisel MB, 2005, J IMMUNOL, V174, P7393, DOI 10.4049/jimmunol.174.11.7393; Zirlik A, 2007, ARTERIOSCL THROM VAS, V27, P1101, DOI 10.1161/ATVBAHA.107.140566	58	39	40	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16132	16145		10.1074/jbc.M111.310102	http://dx.doi.org/10.1074/jbc.M111.310102			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22447928	Green Published, hybrid			2022-12-27	WOS:000304030900006
J	Scarselli, M; Annibale, P; Radenovic, A				Scarselli, Marco; Annibale, Paolo; Radenovic, Aleksandra			Cell Type-specific beta 2-Adrenergic Receptor Clusters Identified Using Photoactivated Localization Microscopy Are Not Lipid Raft Related, but Depend on Actin Cytoskeleton Integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA(2)-ADRENERGIC RECEPTOR; SEROTONIN(1A) RECEPTOR; NANOSCALE ORGANIZATION; SPATIAL-ORGANIZATION; MEMBRANE CHOLESTEROL; SIGNAL-TRANSDUCTION; CARDIAC MYOCYTES; PLASMA-MEMBRANE; DYNAMICS	Recent developments in the field of optical super-resolution techniques allow both a 10-fold increase in resolution as well as an increased ability to quantify the number of labeled molecules visualized in the fluorescence measurement. By using photoactivated localization microscopy (PALM) and an experimental approach based on the systematic comparison with a nonclustering peptide as a negative control, we found that the prototypical G protein-coupled receptor beta 2-adrenergic receptor is partially preassociated in nanoscale-sized clusters only in the cardiomyocytes, such as H9C2 cells, but not in other cell lines, such as HeLa and Chinese hamster ovary (CHO). The addition of the agonist for very short times or the addition of the inverse agonist did not significantly affect the organization of receptor assembly. To investigate the mechanism governing cluster formation, we altered plasma membrane properties with cholesterol removal and actin microfilament disruption. Although cholesterol is an essential component of cell membranes and it is supposed to be enriched in the lipid rafts, its sequestration and removal did not affect receptor clustering, whereas the inhibition of actin polymerization did decrease the number of clusters. Our findings are therefore consistent with a model in which beta 2 receptor clustering is influenced by the actin cytoskeleton, but it does not rely on lipid raft integrity, thus ruling out the possibility that cell type-specific beta 2 receptor clustering is associated with the raft.	[Scarselli, Marco; Annibale, Paolo; Radenovic, Aleksandra] Ecole Polytech Fed Lausanne, Sch Engn, Inst Bioengn, Lab Nanoscale Biol, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Radenovic, A (corresponding author), Ecole Polytech Fed Lausanne, Sch Engn, Inst Bioengn, Lab Nanoscale Biol, CH-1015 Lausanne, Switzerland.	aleksandra.radenovic@epfl.ch	Radenovic, Aleksandra/AAZ-5582-2021; Radenovic, Aleksandra/C-5350-2011; Annibale, Paolo/E-1406-2015	Radenovic, Aleksandra/0000-0001-8194-2785; Scarselli, Marco/0000-0001-5087-3182; Annibale, Paolo/0000-0003-3208-5347	Fonds National Suisse [200021-125319, 20021-132206]	Fonds National Suisse	This work was supported by Fonds National Suisse Grants 200021-125319 and 20021-132206.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Annibale P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022678; Annibale P, 2011, NAT METHODS, V8, P527, DOI 10.1038/nmeth.1627; Awasthi-Kalia M, 2001, BIOCHEM BIOPH RES CO, V287, P77, DOI 10.1006/bbrc.2001.5536; Bethani I, 2010, EMBO J, V29, P2677, DOI 10.1038/emboj.2010.175; Betzig E, 2008, CURR PROTOC CELL BIO; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Chichili GR, 2007, J BIOL CHEM, V282, P36682, DOI 10.1074/jbc.M702959200; COLLINS JJ, 1982, J LIPID RES, V23, P291; Diggle P.J., 2003, STAT ANAL SPATIAL PO; Flesch M, 2001, CARDIOVASC RES, V49, P371, DOI 10.1016/S0008-6363(00)00277-7; Fotiadis D, 2002, MICRON, V33, P385, DOI 10.1016/S0968-4328(01)00026-9; Ganguly S, 2008, BIOPHYS J, V95, P451, DOI 10.1529/biophysj.107.125732; Ganguly S, 2011, BIOPHYS J, V100, P361, DOI 10.1016/j.bpj.2010.12.3692; Ganguly S, 2010, BIOPHYS J, V99, P1397, DOI 10.1016/j.bpj.2010.06.031; Gesellchen F, 2011, METHODS MOL BIOL, V746, P297, DOI 10.1007/978-1-61779-126-0_16; HAASE P, 1995, J VEG SCI, V6, P575, DOI 10.2307/3236356; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Harding AS, 2008, TRENDS CELL BIOL, V18, P364, DOI 10.1016/j.tcb.2008.05.006; Hegener O, 2004, BIOCHEMISTRY-US, V43, P6190, DOI 10.1021/bi035928t; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; Hothersall J. D., 2011, BRIT J PHARMACOL, V164, P2; Ianoul A, 2005, NAT CHEM BIOL, V1, P196, DOI 10.1038/nchembio726; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; KASSIS S, 1984, J BIOL CHEM, V259, P4910; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Lin RW, 2001, P NATL ACAD SCI USA, V98, P5258, DOI 10.1073/pnas.011538198; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lippincott-Schwartz J, 2009, TRENDS CELL BIOL, V19, P555, DOI 10.1016/j.tcb.2009.09.003; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Manz BN, 2010, NAT REV MOL CELL BIO, V11, P342, DOI 10.1038/nrm2883; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Paila YD, 2010, SUBCELL BIOCHEM, V51, P439, DOI 10.1007/978-90-481-8622-8_16; Patel H. H., 2008, V186, P167, DOI 10.1007/978-3-540-72843-6_7; Perez JB, 2006, ADV FUNCT MATER, V16, P306, DOI 10.1002/adfm.200500236; Perez JB, 2006, J MOL BIOL, V363, P918, DOI 10.1016/j.jmb.2006.08.036; Pontier SM, 2008, J BIOL CHEM, V283, P24659, DOI 10.1074/jbc.M800778200; Powell RD, 1998, MICROSC RES TECHNIQ, V42, P2, DOI 10.1002/(SICI)1097-0029(19980701)42:1<2::AID-JEMT2>3.0.CO;2-Y; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Tanaka KAK, 2010, NAT METHODS, V7, P865, DOI 10.1038/nmeth.f.314; Valentine CD, 2011, MOL BIOL CELL, V22, P2970, DOI 10.1091/mbc.E11-01-0034; Vobornik D, 2009, BIOCHEM BIOPH RES CO, V382, P85, DOI 10.1016/j.bbrc.2009.02.144; Yano N, 2008, ENDOCRINOLOGY, V149, P6449, DOI 10.1210/en.2008-0292	49	66	67	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16768	16780		10.1074/jbc.M111.329912	http://dx.doi.org/10.1074/jbc.M111.329912			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22442147	hybrid, Green Published			2022-12-27	WOS:000304030900064
J	Zizza, P; Iurisci, C; Bonazzi, M; Cossart, P; Leslie, CC; Corda, D; Mariggio, S				Zizza, Pasquale; Iurisci, Cristiano; Bonazzi, Matteo; Cossart, Pascale; Leslie, Christina C.; Corda, Daniela; Mariggio, Stefania			Phospholipase A(2)IV alpha Regulates Phagocytosis Independent of Its Enzymatic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE-A(2)ALPHA; LISTERIA-MONOCYTOGENES; PERITONEAL-MACROPHAGES; BINDING DOMAIN; CELL-GROWTH; A(2); TRANSLOCATION; PHAGOSOMES; RECEPTORS; A(2)ALPHA	Group IV alpha phospholipase A(2) (PLA(2)IV alpha) is a lipolytic enzyme that catalyzes the hydrolysis of membrane phospholipids to generate precursors of potent inflammatory lipid mediators. Here, the role of PLA(2)IV alpha in Fc receptor (FcR)-mediated phagocytosis was investigated, demonstrating that PLA(2)IV alpha is selectively activated upon FcR-mediated phagocytosis in macrophages and that it rapidly translocates to the site of the nascent phagosome. Moreover, pharmacological inhibition of PLA(2)IV alpha by pyrrophenone reduces particle internalization by up to 50%. In parallel, fibroblasts from PLA(2)IV alpha knock-out mice overexpressing Fc gamma RIIA and able to internalize IgG-opsonized beads show 50% lower phagocytosis, compared with wild-type cells, and transfection of PLA(2)IV alpha fully recovers this impaired function. Interestingly, transfection of the catalytically inactive deleted PLA(2)IV alpha mutant (PLA(2)IV alpha(1-525)) and point mutant (PLA(2)IV alpha-S228C) also promotes recovery of this impaired function. Finally, transfection of the PLA(2)IV alpha C2 domain (which is directly involved in PLA(2)IV alpha membrane binding), but not of PLA(2)IV alpha-D43N (which cannot bind to membranes), rescues FcR-mediated phagocytosis. These data unveil a new mechanism of action for PLA(2)IV alpha, which demonstrates that the membrane binding, and not the enzymatic activity, is required for PLA(2)IV alpha modulation of FcR-mediated phagocytosis.	[Zizza, Pasquale; Corda, Daniela; Mariggio, Stefania] CNR, Inst Prot Biochem, I-80131 Naples, Italy; [Zizza, Pasquale; Iurisci, Cristiano; Corda, Daniela; Mariggio, Stefania] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, Chieti, Italy; [Bonazzi, Matteo; Cossart, Pascale] Inst Pasteur, INSERM, U604, Unite Interact Bacteries Cellules, F-75724 Paris, France; [Leslie, Christina C.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Jewish Health	Corda, D (corresponding author), CNR, Inst Prot Biochem, Via Pietro Castellino 111, I-80131 Naples, Italy.	d.corda@ibp.cnr.it; s.mariggio@ibp.cnr.it	Mariggio', Stefania/H-5467-2015; Zizza, Pasquale/K-3292-2018; Bonazzi, Matteo/AAT-2653-2020; Bonazzi, Matteo/G-1623-2011; Corda, Daniela/K-6385-2016	Mariggio', Stefania/0000-0002-6397-3016; Zizza, Pasquale/0000-0001-7281-6090; Bonazzi, Matteo/0000-0001-5499-8759; Bonazzi, Matteo/0000-0001-5499-8759; Corda, Daniela/0000-0002-3614-751X	National Institutes of Health [HL34303, HL61378]; Italian Association for Cancer Research (Milan, Italy) [IG10341, GGP030295]; European Community [202272 HEALTH-2007-2.1.1-6 (LipidomicNet)]; Italian Ministry of Economy and Finance; Italian Foundation for Cancer Research (Milan, Italy); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061378, P01HL034303] Funding Source: NIH RePORTER; Fondazione Telethon Funding Source: Custom	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Association for Cancer Research (Milan, Italy)(Fondazione AIRC per la ricerca sul cancro); European Community(European Commission); Italian Ministry of Economy and Finance; Italian Foundation for Cancer Research (Milan, Italy)(Fondazione AIRC per la ricerca sul cancro); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Fondazione Telethon(Fondazione Telethon)	This work was supported, in whole or in part, by National Institutes of Health Grants HL34303 and HL61378 (to C. C. L.). This work was also supported by Italian Association for Cancer Research Grant IG10341 (Milan, Italy) (to D. C.), Telethon Italia Grant GGP030295, MIUR (Italy), the European Community Seventh Framework Programme FP7/2007-2013, Grants 202272 HEALTH-2007-2.1.1-6 (LipidomicNet) (to D. C.), and the Italian Ministry of Economy and Finance to the National Research Council (FaReBio di Qualita) (to D. C.).; Recipient of an Italian Foundation for Cancer Research Fellowship (Milan, Italy).	Absolom D R, 1986, Methods Enzymol, V132, P95; ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445; ADEREM AA, 1985, J EXP MED, V161, P617, DOI 10.1084/jem.161.3.617; Atsumi G, 2000, J BIOL CHEM, V275, P18248, DOI 10.1074/jbc.M000271200; Balestrieri B, 2006, J BIOL CHEM, V281, P6691, DOI 10.1074/jbc.M508314200; Balestrieri B, 2009, J IMMUNOL, V182, P4891, DOI 10.4049/jimmunol.0803776; BALSINDE J, 1995, P NATL ACAD SCI USA, V92, P8527, DOI 10.1073/pnas.92.18.8527; Berrie CP, 2007, METHOD ENZYMOL, V434, P187, DOI 10.1016/S0076-6879(07)34011-1; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Boyanovsky BB, 2009, CARDIOVASC DRUG THER, V23, P61, DOI 10.1007/s10557-008-6134-7; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Burke JE, 2009, J AM CHEM SOC, V131, P8083, DOI 10.1021/ja900098y; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; Casas J, 2010, J LIPID RES, V51, P388, DOI 10.1194/jlr.M001461; Casas J, 2009, J IMMUNOL, V183, P2767, DOI 10.4049/jimmunol.0901530; Church WB, 2001, J BIOL CHEM, V276, P33156, DOI 10.1074/jbc.M101272200; Corda D, 2002, BBA-MOL CELL BIOL L, V1582, P52, DOI 10.1016/S1388-1981(02)00137-3; DIGIROLAMO M, 1991, ACTA ENDOCRINOL-COP, V125, P192, DOI 10.1530/acta.0.1250192; Dragani LK, 2004, J CHROMATOGR B, V802, P283, DOI 10.1016/j.jchromb.2003.12.002; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223; Ghosh M, 2004, AM J RESP CELL MOL, V30, P91, DOI 10.1165/rcmb.2003-0005OC; Girotti M, 2004, J BIOL CHEM, V279, P19113, DOI 10.1074/jbc.M313867200; Harlow E., 1988, ANTIBODIES LAB MANUA; Hirabayashi T, 2004, BIOL PHARM BULL, V27, P1168, DOI 10.1248/bpb.27.1168; Huang Z, 1996, BIOCHEMISTRY-US, V35, P3712, DOI 10.1021/bi952541k; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; INDIK Z, 1991, J CLIN INVEST, V88, P1766, DOI 10.1172/JCI115496; Judson BL, 2009, BIOCHEM BIOPH RES CO, V389, P473, DOI 10.1016/j.bbrc.2009.08.173; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Larsen EC, 2002, J CELL BIOL, V159, P939, DOI 10.1083/jcb.200205140; Lehmann AK, 2000, J IMMUNOL METHODS, V243, P229, DOI 10.1016/S0022-1759(00)00237-4; Leslie CC, 2004, BIOCHEM CELL BIOL, V82, P1, DOI 10.1139/o03-080; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Mariggio S, 2007, CANCER RES, V67, P11769, DOI 10.1158/0008-5472.CAN-07-1997; Mariggio S, 2006, FASEB J, V20, P2567, DOI 10.1096/fj.05-5397fje; May RC, 2001, J CELL SCI, V114, P1061; Mosiman VL, 1997, CYTOMETRY, V30, P151; Nalefski EA, 1998, J BIOL CHEM, V273, P1365, DOI 10.1074/jbc.273.3.1365; Noor S, 2008, J BIOL CHEM, V283, P4744, DOI 10.1074/jbc.M709956200; Ohto T, 2005, J BIOL CHEM, V280, P24576, DOI 10.1074/jbc.M413711200; Ono T, 2002, BIOCHEM J, V363, P727, DOI 10.1042/0264-6021:3630727; Perez-Chacon G, 2009, BBA-MOL CELL BIOL L, V1791, P1103, DOI 10.1016/j.bbalip.2009.08.007; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; Perisic O, 1998, J BIOL CHEM, V273, P1596, DOI 10.1074/jbc.273.3.1596; Pizarro-Cerda J, 2007, CELL MICROBIOL, V9, P2381, DOI 10.1111/j.1462-5822.2007.00967.x; San Pietro E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000194; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shmelzer Z, 2003, J CELL BIOL, V162, P683, DOI 10.1083/jcb.200211056; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Stewart C C, 1986, Methods Enzymol, V132, P183; Suram S, 2006, J BIOL CHEM, V281, P5506, DOI 10.1074/jbc.M509824200; Tucker DE, 2009, J BIOL CHEM, V284, P9596, DOI 10.1074/jbc.M807299200; TUIJNMAN WB, 1992, BLOOD, V79, P1651; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Uozumi N, 2002, PROSTAG OTH LIPID M, V68-9, P59, DOI 10.1016/S0090-6980(02)00021-7; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622	59	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16849	16859		10.1074/jbc.M111.309419	http://dx.doi.org/10.1074/jbc.M111.309419			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22393044	Green Published, hybrid			2022-12-27	WOS:000304030900071
J	Nusca, TD; Kim, Y; Maltseva, N; Lee, JY; Eschenfeldt, W; Stols, L; Schofield, MM; Scaglione, JB; Dixon, SD; Oves-Costales, D; Challis, GL; Hanna, PC; Pfleger, BF; Joachimiak, A; Sherman, DH				Nusca, Tyler D.; Kim, Youngchang; Maltseva, Natalia; Lee, Jung Yeop; Eschenfeldt, William; Stols, Lucy; Schofield, Michael M.; Scaglione, Jamie B.; Dixon, Shandee D.; Oves-Costales, Daniel; Challis, Gregory L.; Hanna, Philip C.; Pfleger, Brian F.; Joachimiak, Andrzej; Sherman, David H.			Functional and Structural Analysis of the Siderophore Synthetase AsbB through Reconstitution of the Petrobactin Biosynthetic Pathway from Bacillus anthracis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED IRON ACQUISITION; PATHOGENIC BACTERIA; PROTEIN-STRUCTURE; DATA-COLLECTION; IMMUNE-SYSTEM; CITRIC-ACID; I-TASSER; ENZYME; ACHROMOBACTIN; TRANSPORT	Petrobactin, a mixed catechol-carboxylate siderophore, is required for full virulence of Bacillus anthracis, the causative agent of anthrax. The asbABCDEF operon encodes the biosynthetic machinery for this secondary metabolite. Here, we show that the function of five gene products encoded by the asb operon is necessary and sufficient for conversion of endogenous precursors to petrobactin using an in vitro system. In this pathway, the siderophore synthetase AsbB catalyzes formation of amide bonds crucial for petrobactin assembly through use of biosynthetic intermediates, as opposed to primary metabolites, as carboxylate donors. In solving the crystal structure of the B. anthracis siderophore biosynthesis protein B (AsbB), we disclose a three-dimensional model of a nonribosomal peptide synthetase-independent siderophore (NIS) synthetase. Structural characteristics provide new insight into how this bifunctional condensing enzyme can bind and adenylate multiple citrate-containing substrates followed by incorporation of both natural and unnatural polyamine nucleophiles. This activity enables formation of multiple end-stage products leading to final assembly of petrobactin. Subsequent enzymatic assays with the nonribosomal peptide synthetase-like AsbC, AsbD, and AsbE polypeptides show that the alternative products of AsbB are further converted to petrobactin, verifying previously proposed convergent routes to formation of this siderophore. These studies identify potential therapeutic targets to halt deadly infections caused by B. anthracis and other pathogenic bacteria and suggest new avenues for the chemoenzymatic synthesis of novel compounds.	[Kim, Youngchang; Maltseva, Natalia; Eschenfeldt, William; Stols, Lucy; Joachimiak, Andrzej] Argonne Natl Lab, Midw Ctr Struct Genom, Argonne, IL 60439 USA; [Kim, Youngchang; Maltseva, Natalia; Eschenfeldt, William; Stols, Lucy; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA; [Nusca, Tyler D.; Lee, Jung Yeop; Schofield, Michael M.; Scaglione, Jamie B.; Pfleger, Brian F.; Sherman, David H.] Univ Michigan, Sch Med, Inst Life Sci, Ann Arbor, MI 48109 USA; [Nusca, Tyler D.; Dixon, Shandee D.; Hanna, Philip C.; Sherman, David H.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Oves-Costales, Daniel; Challis, Gregory L.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Pfleger, Brian F.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA; [Joachimiak, Andrzej] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Sherman, David H.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Warwick; University of Wisconsin System; University of Wisconsin Madison; University of Chicago; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Joachimiak, A (corresponding author), Argonne Natl Lab, Midw Ctr Struct Genom, 9700 S Cass Ave, Argonne, IL 60439 USA.	andrzejj@anl.gov; davidhs@umich.edu	Oves-Costales, Daniel/I-1543-2015; Pfleger, Brian Frederick/AAA-2559-2022	Oves-Costales, Daniel/0000-0001-9986-4623; Pfleger, Brian Frederick/0000-0002-9232-9959; Challis, Gregory/0000-0001-5976-3545; Joachimiak, Andrzej/0000-0003-2535-6209	National Institutes of Health [GM074942]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; Biotechnology and Biological Sciences Research Council [BB/F013760/1]; Great Lakes Regional Center for Excellence (GLRCE) in Biodefense and Emerging Infectious Disease [U54-AI-057153]; H. W. Vahlteich Professorship; BBSRC [BB/F013760/1] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942, U54GM094585, T32GM008353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Great Lakes Regional Center for Excellence (GLRCE) in Biodefense and Emerging Infectious Disease; H. W. Vahlteich Professorship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074942 (to A. J.). This work was also supported by the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357 (to A. J.), by the Biotechnology and Biological Sciences Research Council through Grant BB/F013760/1 (to G. L. C.), and by Great Lakes Regional Center for Excellence (GLRCE) in Biodefense and Emerging Infectious Disease Grant U54-AI-057153 and the H. W. Vahlteich Professorship (to D. H. S.).	Abergel RJ, 2008, J AM CHEM SOC, V130, P2124, DOI 10.1021/ja077202g; Abergel RJ, 2006, P NATL ACAD SCI USA, V103, P18499, DOI 10.1073/pnas.0607055103; Abergel RJ, 2006, J AM CHEM SOC, V128, P10998, DOI 10.1021/ja062476+; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Arnow LE, 1937, J BIOL CHEM, V118, P531; Barbeau K, 2002, J AM CHEM SOC, V124, P378, DOI 10.1021/ja0119088; Barry SM, 2009, CURR OPIN CHEM BIOL, V13, P205, DOI 10.1016/j.cbpa.2009.03.008; Berti AD, 2009, J BACTERIOL, V191, P4594, DOI 10.1128/JB.00457-09; Bouzianas DG, 2009, TRENDS MICROBIOL, V17, P522, DOI 10.1016/j.tim.2009.08.006; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Carlson PE, 2010, MOL MICROBIOL, V75, P900, DOI 10.1111/j.1365-2958.2009.07025.x; Casadevall A, 2010, NAT REV MICROBIOL, V8, P149, DOI 10.1038/nrmicro2299; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Cendrowski S, 2004, MOL MICROBIOL, V51, P407, DOI 10.1046/j.1365-2958.2003.03861.x; Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; Cheung J, 2009, MOL MICROBIOL, V74, P594, DOI 10.1111/j.1365-2958.2009.06880.x; Drake EJ, 2010, BIOCHEMISTRY-US, V49, P9292, DOI 10.1021/bi101226n; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eschenfeldt William H., 2010, Journal of Structural and Functional Genomics, V11, P31, DOI 10.1007/s10969-010-9082-y; Fischbach MA, 2006, NAT CHEM BIOL, V2, P132, DOI 10.1038/nchembio771; Fox DT, 2008, BIOCHEMISTRY-US, V47, P12251, DOI 10.1021/bi801876q; Franza T, 2005, MOL MICROBIOL, V55, P261, DOI 10.1111/j.1365-2958.2004.04383.x; Gupte A, 2008, J MED CHEM, V51, P7495, DOI 10.1021/jm8008037; Hanson RM, 2010, J APPL CRYSTALLOGR, V43, P1250, DOI 10.1107/S0021889810030256; Holinsworth B, 2009, BIOMETALS, V22, P625, DOI 10.1007/s10534-009-9239-y; Hotta K, 2010, MICROBIOL-SGM, V156, P1918, DOI 10.1099/mic.0.039404-0; Kadi N, 2009, METHOD ENZYMOL, V458, P431, DOI 10.1016/S0076-6879(09)04817-4; Kim Youngchang, 2004, Journal of Structural and Functional Genomics, V5, P111, DOI 10.1023/B:JSFG.0000029206.07778.fc; Koppisch AT, 2008, BIOMETALS, V21, P581, DOI 10.1007/s10534-008-9144-9; Koppisch AT, 2008, J ORG CHEM, V73, P5759, DOI 10.1021/jo800427f; Koppisch AT, 2005, BIOMETALS, V18, P577, DOI 10.1007/s10534-005-1782-6; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Laskowski RA, 2005, J MOL BIOL, V351, P614, DOI 10.1016/j.jmb.2005.05.067; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JY, 2007, J BACTERIOL, V189, P1698, DOI 10.1128/JB.01526-06; Lee JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020777; Lindley PF, 1996, REP PROG PHYS, V59, P867, DOI 10.1088/0034-4885/59/7/002; Liu HC, 2007, J AM SOC MASS SPECTR, V18, P842, DOI 10.1016/j.jasms.2007.01.005; May JJ, 2001, J BIOL CHEM, V276, P7209, DOI 10.1074/jbc.M009140200; McMahon SA, 2008, ACTA CRYSTALLOGR F, V64, P1052, DOI 10.1107/S1744309108032132; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mollmann U, 2009, BIOMETALS, V22, P615, DOI 10.1007/s10534-009-9219-2; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Navas E, 2002, CLIN MICROBIOL INFEC, V8, P534, DOI 10.1046/j.1469-0691.2002.00495.x; Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y; Oves-Costales D, 2008, CHEM COMMUN, P4034, DOI 10.1039/b809353a; Oves-Costales D, 2007, J AM CHEM SOC, V129, P8416, DOI 10.1021/ja072391o; Oves-Costales D, 2009, CHEM COMMUN, P6530, DOI 10.1039/b913092f; Oves-Costales D, 2009, CHEM COMMUN, P1389, DOI 10.1039/b823147h; Pereira LS, 2007, BIOCHEM BIOPH RES CO, V352, P953, DOI 10.1016/j.bbrc.2006.11.128; Pfleger BF, 2008, P NATL ACAD SCI USA, V105, P17133, DOI 10.1073/pnas.0808118105; Pfleger BF, 2007, BIOCHEMISTRY-US, V46, P4147, DOI 10.1021/bi6023995; Pradines B, 1996, ANTIMICROB AGENTS CH, V40, P2094, DOI 10.1128/AAC.40.9.2094; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schmelz S, 2011, J MOL BIOL, V412, P495, DOI 10.1016/j.jmb.2011.07.059; Schmelz S, 2009, NAT CHEM BIOL, V5, P174, DOI 10.1038/nchembio.145; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; TAIT GH, 1975, BIOCHEM J, V146, P191, DOI 10.1042/bj1460191; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Upson RH, 1996, ANAL BIOCHEM, V243, P41, DOI 10.1006/abio.1996.0479; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Walsh MA, 1999, ACTA CRYSTALLOGR D, V55, P1726, DOI 10.1107/S0907444999008392; Wilson DJ, 2010, ANAL BIOCHEM, V404, P56, DOI 10.1016/j.ab.2010.04.033; Wilson MK, 2006, BIOCHEM BIOPH RES CO, V348, P320, DOI 10.1016/j.bbrc.2006.07.055; Wilson MK, 2010, BIOMETALS, V23, P129, DOI 10.1007/s10534-009-9272-x; Zawadzka AM, 2009, BIOCHEMISTRY-US, V48, P3645, DOI 10.1021/bi8018674; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	70	26	30	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					16058	16072		10.1074/jbc.M112.359349	http://dx.doi.org/10.1074/jbc.M112.359349			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22408253	Green Published, hybrid			2022-12-27	WOS:000304006300083
J	Hayashi, H; Naoi, S; Nakagawa, T; Nishikawa, T; Fukuda, H; Imajoh-Ohmi, S; Kondo, A; Kubo, K; Yabuki, T; Hattori, A; Hirouchi, M; Sugiyama, Y				Hayashi, Hisamitsu; Naoi, Sotaro; Nakagawa, Takayuki; Nishikawa, Toru; Fukuda, Hiroyuki; Imajoh-Ohmi, Shinobu; Kondo, Ayano; Kubo, Kiyotaka; Yabuki, Takashi; Hattori, Asami; Hirouchi, Masakazu; Sugiyama, Yuichi			Sorting Nexin 27 Interacts with Multidrug Resistance-associated Protein 4 (MRP4) and Mediates Internalization of MRP4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PDZ DOMAIN INTERACTION; REGULATES TRAFFICKING; ANTIVIRAL DRUGS; TRANSPORT; ENDOCYTOSIS; EXPRESSION; CELLS; DEGRADATION; INVOLVEMENT; MEMBRANE	Multidrug resistance-associated protein 4 (MRP4/ABCC4) makes a vital contribution to the bodily distribution of drugs and endogenous compounds because of its cellular efflux abilities. However, little is known about the mechanism regulating its cell surface expression. MRP4 has a PDZ-binding motif, which is a potential sequence that modulates the membrane expression of MRP4 via interaction with PDZ adaptor proteins. To investigate this possible relationship, we performed GST pull-down assays and subsequent analysis with matrix-assisted laser desorption/ionization-time of flight mass spectrometry. This method identified sorting nexin 27 (SNX27) as the interacting PDZ adaptor protein with a PDZ-binding motif of MRP4. Its interaction was confirmed by a coimmunoprecipitation study using HEK293 cells. Knockdown of SNX27 by siRNA in HEK293 cells raised MRP4 expression on the plasma membrane, increased the extrusion of 6-[C-14] mercaptopurine, an MRP4 substrate, and conferred resistance against 6-[C-14] mercaptopurine. Cell surface biotinylation studies indicated that the inhibition of MRP4 internalization was responsible for these results. Immunocytochemistry and cell surface biotinylation studies using COS-1 cells showed that SNX27 localized to both the early endosome and the plasma membrane. These data suggest that SNX27 interacts with MRP4 near the plasma membrane and promotes endocytosis of MRP4 and thereby negatively regulates its cell surface expression and transport function.	[Hayashi, Hisamitsu; Naoi, Sotaro; Nakagawa, Takayuki; Kondo, Ayano; Kubo, Kiyotaka; Yabuki, Takashi; Hattori, Asami; Hirouchi, Masakazu; Sugiyama, Yuichi] Univ Tokyo, Lab Mol Pharmacokinet, Dept Med Pharmaceut, Grad Sch Pharmaceut Sci,Bunkyo Ku, Tokyo 1130033, Japan; [Nishikawa, Toru] Tokyo Med & Dent Univ, Dept Psychiat & Behav Sci, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo 1138519, Japan; [Fukuda, Hiroyuki; Imajoh-Ohmi, Shinobu] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan	University of Tokyo; Tokyo Medical & Dental University (TMDU); University of Tokyo	Hayashi, H (corresponding author), Univ Tokyo, Lab Mol Pharmacokinet, Dept Med Pharmaceut, Grad Sch Pharmaceut Sci,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hayapi@mol.f.u-tokyo.ac.jp; sugiyama@mol.f.u-tokyo.ac.jp		Hayashi, Hisamitsu/0000-0002-5247-895X	National Institute of Biomedical Innovation [23790175]	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation)	This study was supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation and Grant-in-Aid for Young Scientists (B) 23790175.	Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Cai L, 2011, MOL CELL BIOL, V31, P1734, DOI 10.1128/MCB.01044-10; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Chen ZS, 2001, J BIOL CHEM, V276, P33747, DOI 10.1074/jbc.M104833200; Done SC, 2002, J BIOL CHEM, V277, P17108, DOI 10.1074/jbc.M201326200; Hammad MM, 2010, J BIOL CHEM, V285, P34653, DOI 10.1074/jbc.M110.106591; Hayashi H, 2005, BBA-MOL CELL BIOL L, V1738, P54, DOI 10.1016/j.bbalip.2005.10.006; Hayashi H, 2005, HEPATOLOGY, V41, P916, DOI 10.1002/hep.20627; Hayashi H, 2007, HEPATOLOGY, V45, P1506, DOI 10.1002/hep.21630; Hayashi H, 2012, HEPATOLOGY, V55, P1889, DOI 10.1002/hep.25591; Hayashi H, 2009, MOL PHARMACOL, V75, P143, DOI 10.1124/mol.108.049288; Hoque MT, 2008, CANCER RES, V68, P4802, DOI 10.1158/0008-5472.CAN-07-6778; Hori N, 2011, ATHEROSCLEROSIS, V215, P383, DOI 10.1016/j.atherosclerosis.2010.12.033; Imaoka T, 2007, MOL PHARMACOL, V71, P619, DOI 10.1124/mol.106.028233; Joubert L, 2004, J CELL SCI, V117, P5367, DOI 10.1242/jcs.01379; Kajii Y, 2003, MOL PSYCHIATR, V8, P434, DOI 10.1038/sj.mp.4001258; Kool M, 1997, CANCER RES, V57, P3537; Krishnamurthy P, 2008, CANCER RES, V68, P4983, DOI 10.1158/0008-5472.CAN-07-6790; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Leggas M, 2004, MOL CELL BIOL, V24, P7612, DOI 10.1128/MCB.24.17.7612-7621.2004; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lunn ML, 2007, NAT NEUROSCI, V10, P1249, DOI 10.1038/nn1953; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Misaki R, 2007, BIOCHEM BIOPH RES CO, V360, P580, DOI 10.1016/j.bbrc.2007.06.101; Miyagawa M, 2009, J PHARMACOL EXP THER, V329, P551, DOI 10.1124/jpet.108.148411; Mizuno T, 2011, HEPATOLOGY, V54, P631, DOI 10.1002/hep.24387; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Rincon E, 2011, J CELL SCI, V124, P776, DOI 10.1242/jcs.072447; Schuetz JD, 1999, NAT MED, V5, P1048, DOI 10.1038/12487; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Sugiura T, 2011, J PHARM SCI-US, V100, P3620, DOI 10.1002/jps.22575; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Valdes JL, 2011, J BIOL CHEM, V286, P39403, DOI 10.1074/jbc.M111.260802; Wielinga PR, 2002, MOL PHARMACOL, V62, P1321, DOI 10.1124/mol.62.6.1321; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974	38	25	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15054	15065		10.1074/jbc.M111.337931	http://dx.doi.org/10.1074/jbc.M111.337931			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22411990	Green Published, hybrid			2022-12-27	WOS:000304003200067
J	Qi, XM; Zhi, HY; Lepp, A; Wang, P; Huang, J; Basir, Z; Chitambar, CR; Myers, CR; Chen, G				Qi, Xiaomei; Zhi, Huiying; Lepp, Adrienne; Wang, Phillip; Huang, Jian; Basir, Zainab; Chitambar, Christopher R.; Myers, Charles R.; Chen, Guan			p38 gamma Mitogen-activated Protein Kinase (MAPK) Confers Breast Cancer Hormone Sensitivity by Switching Estrogen Receptor (ER) Signaling from Classical to Nonclassical Pathway via Stimulating ER Phosphorylation and c-Jun Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; RAS TRANSFORMATION; DOWN-REGULATION; ALPHA; RESISTANCE; SERINE-118; EXPRESSION; TUMORS; INHIBITION; P38-ALPHA	Estrogen receptor (ER) alpha promotes breast cancer growth by regulating gene expression through classical estrogen response element (ERE) binding and nonclassical (interaction with c-Jun at AP-1 sites) pathways. ER is the target for anti-estrogens such as tamoxifen (TAM). However, the potential for classical versus nonclassical ER signaling to influence hormone sensitivity is not known. Moreover, anti-estrogens frequently activate several signaling cascades besides the target ER, and the implications of these "off-target" signaling events have not been explored. Here, we report that p38 gamma MAPK is selectively activated by treatment with TAM. This results in both phosphorylation of ER at Ser-118 and stimulation of c-Jun transcription, thus switching ER signaling from the classical to the nonclassical pathway leading to increased hormone sensitivity. Unexpectedly, phosphorylation at Ser-118 is required for ER to bind both p38 gamma and c-Jun, thereby promoting ER relocation from ERE to AP-1 promoter sites. Thus, ER/Ser-118 phosphorylation serves as a central mechanism by which p38 gamma regulates signaling transduction of ER with its inhibitor TAM.	[Qi, Xiaomei; Zhi, Huiying; Lepp, Adrienne; Wang, Phillip; Myers, Charles R.; Chen, Guan] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Huang, Jian; Basir, Zainab] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Chitambar, Christopher R.] Med Coll Wisconsin, Div Hematol & Oncol, Milwaukee, WI 53226 USA; [Chen, Guan] Zablocki Vet Affairs Med Ctr, Res Serv, Milwaukee, WI 53295 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Chen, G (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA.	gchen@mcw.edu		Myers, Charles/0000-0001-7956-3217	National Institutes of Health [R01 91576]; Veterans Affairs Merit Review; Cancer Center of Medical College of Wisconsin (Breast Cancer Show-House)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); Cancer Center of Medical College of Wisconsin (Breast Cancer Show-House)	This work was supported, whole or in part, by National Institutes of Health Grant R01 91576. This work was also supported by grants from a Veterans Affairs Merit Review and the Cancer Center of Medical College of Wisconsin (Breast Cancer Show-House).	Albanese C, 1999, J BIOL CHEM, V274, P34186, DOI 10.1074/jbc.274.48.34186; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Bedard PL, 2008, BREAST CANCER RES TR, V108, P307, DOI 10.1007/s10549-007-9606-8; Chen DS, 2002, ONCOGENE, V21, P4921, DOI 10.1038/sj.onc.1205420; Chen DS, 2000, MOL CELL, V6, P127, DOI 10.1016/S1097-2765(00)00014-9; Chen G, 2000, J BIOL CHEM, V275, P38973, DOI 10.1074/jbc.M002856200; CHEN GA, 1995, BIOCHEM PHARMACOL, V49, P1691, DOI 10.1016/0006-2952(95)00079-F; Cheng JW, 2007, ENDOCRINOLOGY, V148, P4634, DOI 10.1210/en.2007-0148; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Creighton CJ, 2006, CANCER RES, V66, P3903, DOI 10.1158/0008-5472.CAN-05-4363; Glidewell-Kenney C, 2005, MOL CELL ENDOCRINOL, V245, P53, DOI 10.1016/j.mce.2005.10.003; Gross EA, 2002, J BIOL CHEM, V277, P13873, DOI 10.1074/jbc.M111994200; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Henrich LM, 2003, MOL CELL BIOL, V23, P5979, DOI 10.1128/MCB.23.17.5979-5988.2003; Hou S., 2010, UCSD NATURE MOL PAGE, DOI [10.1038/mp.a001720.01, DOI 10.1038/MP.A001720.01]; Hou SW, 2010, CANCER RES, V70, P2901, DOI 10.1158/0008-5472.CAN-09-3229; Ishii Y, 2008, CANCER RES, V68, P852, DOI 10.1158/0008-5472.CAN-07-2879; Jordan VC, 2007, J CLIN ONCOL, V25, P5815, DOI 10.1200/JCO.2007.11.3886; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Klinge CM, 2005, J BIOL CHEM, V280, P7460, DOI 10.1074/jbc.M411565200; Kok M, 2009, JNCI-J NATL CANCER I, V101, P1725, DOI 10.1093/jnci/djp412; Kronblad A, 2005, ONCOGENE, V24, P6835, DOI 10.1038/sj.onc.1208830; Kukkonen-Macchi A, 2011, J CELL SCI, V124, P216, DOI 10.1242/jcs.068254; Lassar AB, 2009, J CELL BIOL, V187, P941, DOI 10.1083/jcb.200911123; Li L, 2006, J BIOL CHEM, V281, P1978, DOI 10.1074/jbc.M508545200; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Linderholm BK, 2011, BREAST CANCER RES TR, V125, P457, DOI 10.1007/s10549-010-1252-x; Loesch M, 2008, FRONT BIOSCI-LANDMRK, V13, P3581, DOI 10.2741/2951; Loesch M, 2010, J BIOL CHEM, V285, P15149, DOI 10.1074/jbc.M110.105429; Madeo A, 2010, ONCOGENE, V29, P978, DOI 10.1038/onc.2009.400; Mandlekar S, 2000, CANCER RES, V60, P5995; Meng FY, 2011, NEOPLASIA, V13, P472, DOI 10.1593/neo.101748; Moran N, 2011, NAT BIOTECHNOL, V29, P301, DOI 10.1038/nbt0411-301; Oh AS, 2001, MOL ENDOCRINOL, V15, P1344, DOI 10.1210/me.15.8.1344; Osborne C. K., 2008, U. S. Patent, Patent No. [7,402,402, B2, 7402402]; Oyama M, 2011, J BIOL CHEM, V286, P818, DOI 10.1074/jbc.M110.156877; Ozes O, 2008, United States Patent-US, P1, Patent No. [7,407,973, 7407973, US7407973B2]; Pan X, 2011, NAT MED, V17, P708, DOI 10.1038/nm.2369; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Qi XM, 2007, J BIOL CHEM, V282, P31398, DOI 10.1074/jbc.M703857200; Qi XM, 2006, CANCER RES, V66, P7540, DOI 10.1158/0008-5472.CAN-05-4639; Qi XM, 2011, J BIOL CHEM, V286, P35883, DOI 10.1074/jbc.M111.229260; Qi XM, 2004, J BIOL CHEM, V279, P6769, DOI 10.1074/jbc.M311492200; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Rosenthal DT, 2011, CANCER RES, V71, P6338, DOI 10.1158/0008-5472.CAN-11-1291; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Svensson S, 2005, ONCOGENE, V24, P4370, DOI 10.1038/sj.onc.1208626; Tang J, 2005, J BIOL CHEM, V280, P23910, DOI 10.1074/jbc.M500699200; Teyssier C, 2001, J BIOL CHEM, V276, P36361, DOI 10.1074/jbc.M101806200; Valley CC, 2005, MOL CELL BIOL, V25, P5417, DOI 10.1128/MCB.25.13.5417-5428.2005; Walters MR, 2002, J BIOL CHEM, V277, P1669, DOI 10.1074/jbc.M109320200; Weitsman GE, 2006, CANCER RES, V66, P10162, DOI 10.1158/0008-5472.CAN-05-4111; Wu CC, 2010, PROTEIN CELL, V1, P573, DOI 10.1007/s13238-010-0075-1; Zhi H, 2009, J PATHOL, V217, P389, DOI 10.1002/path.2456; Zhi HY, 2011, ONCOGENE, V30, P1706, DOI 10.1038/onc.2010.543	57	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14681	14691		10.1074/jbc.M112.349357	http://dx.doi.org/10.1074/jbc.M112.349357			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22399296	Green Published, hybrid			2022-12-27	WOS:000304003200034
J	Han, XB; Li, X; Yue, SC; Anandaiah, A; Hashem, F; Reinach, PS; Koziel, H; Tachado, SD				Han, Xinbing; Li, Xin; Yue, Simon C.; Anandaiah, Asha; Hashem, Falah; Reinach, Peter S.; Koziel, Henry; Tachado, Souvenir D.			Epigenetic Regulation of Tumor Necrosis Factor alpha (TNF alpha) Release in Human Macrophages by HIV-1 Single-stranded RNA (ssRNA) Is Dependent on TLR8 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; HISTONE H3; ALVEOLAR MACROPHAGES; ACETYLATION; ACTIVATION; RECOGNITION; TRANSCRIPTION; METHYLATION; EXPRESSION; INFECTION	Human macrophages at mucosal sites are essential targets for acute HIV infection. During the chronic phase of infection, they are persistent reservoirs for the AIDS virus. HIV virions gain entry into macrophages following ligation of surface CD4-CCR5 co-receptors, which leads to the release of two copies of HIV ssRNA. These events lead to reverse transcription and viral replication initiation. Toll-like receptors TLR7 and TLR8 recognize specific intracellular viral ssRNA sequences, but in human alveolar macrophages, their individual roles in TLR-mediated HIV ssRNA recognition are unclear. In the current study, HIV-1 ssRNA induced TNF alpha release in a dose-dependent manner in adherent human macrophages expressing both intracellular TLR7 and TLR8. This response was reduced by inhibiting either endocytosis (50 mu M dynasore) or endosomal acidification (1 mu g/ml chloroquine). Either MYD88 or TLR8 gene knockdown with relevant siRNA reduced HIV-1 ssRNA-mediated TNF alpha release, but silencing TLR7 had no effect on this response. Furthermore, HIV-1 ssRNA induced histone 4 acetylation at the TNF alpha promoter as well as trimethylation of histone 3 at lysine 4, whereas TLR8 gene knockdown reduced these effects. Taken together in human macrophages, TLR8 binds and internalizes HIV ssRNA, leading to endosomal acidification, chromatin remodeling, and increases in TNF alpha release. Drugs targeting macrophage TLR8-linked signaling pathways may modulate the innate immune response to acute HIV infection by reducing viral replication.	[Han, Xinbing; Li, Xin; Yue, Simon C.; Anandaiah, Asha; Hashem, Falah; Koziel, Henry; Tachado, Souvenir D.] Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02115 USA; [Han, Xinbing; Li, Xin; Yue, Simon C.; Anandaiah, Asha; Hashem, Falah; Koziel, Henry; Tachado, Souvenir D.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Reinach, Peter S.] SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; State University of New York (SUNY) System; SUNY Optometry	Tachado, SD (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, 330 Brookline Ave,Dana Bldg,Rm 652, Boston, MA 02215 USA.	stachado@bidmc.harvard.edu	Reinach, Peter/AAI-3582-2021	Tachado, Souvenir/0000-0002-8368-6102	National Institutes of Health [R01-HL092811, R01-HL063655]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092811, R01HL063655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL092811 (to S. D. T.) and R01-HL063655 (to H. K.). A preliminary account of this study was presented in part at the American Thoracic Society International Meeting, May 13-18, 2011, Denver, CO.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chang JJ, 2012, AIDS, V26, P533, DOI 10.1097/QAD.0b013e32834f3167; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Fraser IP, 1998, SEMIN IMMUNOL, V10, P363, DOI 10.1006/smim.1998.0141; Gantier MP, 2008, J IMMUNOL, V180, P2117, DOI 10.4049/jimmunol.180.4.2117; Groot F, 2008, BLOOD, V111, P4660, DOI 10.1182/blood-2007-12-130070; Hamon MA, 2007, P NATL ACAD SCI USA, V104, P13467, DOI 10.1073/pnas.0702729104; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Lee JY, 2003, J LEUKOCYTE BIOL, V73, P862, DOI 10.1189/jlb.1202618; Leng J, 2009, PARASITE IMMUNOL, V31, P717, DOI 10.1111/j.1365-3024.2009.01122.x; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li J, 2001, MOL CELL BIOL, V21, P8213, DOI 10.1128/MCB.21.23.8213-8224.2001; Li X, 2011, J IMMUNOL, V187, P6052, DOI 10.4049/jimmunol.1101532; Lyn-Kew K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011145; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; Mogensen TH, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-54; Muegge K, 2002, NAT IMMUNOL, V3, P16, DOI 10.1038/ni0102-16; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Park IW, 1999, AM J RESP CELL MOL, V20, P864, DOI 10.1165/ajrcmb.20.5.3547; Patel NR, 2007, J IMMUNOL, V179, P6973, DOI 10.4049/jimmunol.179.10.6973; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Saruta M, 2009, EUR J IMMUNOL, V39, P2195, DOI 10.1002/eji.200939216; Schmeck B, 2008, J IMMUNOL, V181, P940, DOI 10.4049/jimmunol.181.2.940; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Sullivan KE, 2007, MOL CELL BIOL, V27, P5147, DOI 10.1128/MCB.02429-06; Tachado SD, 2010, BLOOD, V115, P3606, DOI 10.1182/blood-2009-10-250787; Tsaprouni LG, 2007, CLIN EXP IMMUNOL, V150, P151, DOI 10.1111/j.1365-2249.2007.03484.x	39	39	41	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13778	13786		10.1074/jbc.M112.342683	http://dx.doi.org/10.1074/jbc.M112.342683			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22393042	Green Published, hybrid			2022-12-27	WOS:000303996300033
J	Oliver, KM; Lenihan, CR; Bruning, U; Cheong, A; Laffey, JG; McLoughlin, P; Taylor, CT; Cummins, EP				Oliver, Kathryn M.; Lenihan, Colin R.; Bruning, Ulrike; Cheong, Alex; Laffey, John G.; McLoughlin, Paul; Taylor, Cormac T.; Cummins, Eoin P.			Hypercapnia Induces Cleavage and Nuclear Localization of RelB Protein, Giving Insight into CO2 Sensing and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; NITRIC-OXIDE; ACIDOSIS; INFLAMMATION; CELLS; PH; DEGRADATION; VENTILATION	Carbon dioxide (CO2) is increasingly being appreciated as an intracellular signaling molecule that affects inflammatory and immune responses. Elevated arterial CO2 (hypercapnia) is encountered in a range of clinical conditions, including chronic obstructive pulmonary disease, and as a consequence of therapeutic ventilation in acute respiratory distress syndrome. In patients suffering from this syndrome, therapeutic hypoventilation strategy designed to reduce mechanical damage to the lungs is accompanied by systemic hypercapnia and associated acidosis, which are associated with improved patient outcome. However, the molecular mechanisms underlying the beneficial effects of hypercapnia and the relative contribution of elevated CO2 or associated acidosis to this response remain poorly understood. Recently, a role for the noncanonical NF-kappa B pathway has been postulated to be important in signaling the cellular transcriptional response to CO2. In this study, we demonstrate that in cells exposed to elevated CO2, the NF-kappa B family member RelB was cleaved to a lower molecular weight form and translocated to the nucleus in both mouse embryonic fibroblasts and human pulmonary epithelial cells (A549). Furthermore, elevated nuclear RelB was observed in vivo and correlated with hypercapnia-induced protection against LPS-induced lung injury. Hypercapnia-induced RelB processing was sensitive to proteasomal inhibition by MG-132 but was independent of the activity of glycogen synthase kinase 3 beta or MALT-1, both of which have been previously shown to mediate RelB processing. Taken together, these data demonstrate that RelB is a CO2-sensitive NF-kappa B family member that may contribute to the beneficial effects of hypercapnia in inflammatory diseases of the lung.	[Oliver, Kathryn M.; Lenihan, Colin R.; Bruning, Ulrike; Cheong, Alex; McLoughlin, Paul; Taylor, Cormac T.; Cummins, Eoin P.] Natl Univ Ireland Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland; [Cheong, Alex; Taylor, Cormac T.] Natl Univ Ireland Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Dublin 4, Ireland; [Laffey, John G.] Natl Univ Ireland, Sch Med, Galway, Ireland	University College Dublin; University College Dublin; Ollscoil na Gaillimhe-University of Galway	Taylor, CT (corresponding author), Natl Univ Ireland Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland.	cormac.taylor@ucd.ie	Cheong, Alex/E-5049-2011; Cummins, Eoin/S-7554-2019	Cheong, Alex/0000-0003-2482-9078; Cummins, Eoin/0000-0002-9346-8299; McLoughlin, Paul/0000-0001-6200-016X; Taylor, Cormac/0000-0002-0946-1247; Laffey, John/0000-0002-1246-9573	Science Foundation of Ireland; Health Research Board of Ireland; Science Foundation Ireland Centres for Science Engineering and Technology	Science Foundation of Ireland(Science Foundation Ireland); Health Research Board of Ireland; Science Foundation Ireland Centres for Science Engineering and Technology(Science Foundation Ireland)	This work was supported by a Science Foundation of Ireland grant (to C. T. T.), by a Health Research Board of Ireland clinical training fellowship (to J. G. L.), and by a Science Foundation Ireland Centres for Science Engineering and Technology grant (to Systems Biology Ireland).	Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Crummy F, 2007, RESP MED, V101, P53, DOI 10.1016/j.rmed.2006.04.013; Cummins EP, 2010, J IMMUNOL, V185, P4439, DOI 10.4049/jimmunol.1000701; Curley G, 2010, CRIT CARE, V14, DOI 10.1186/cc8926; Curley G, 2010, ANESTHESIOLOGY, V112, P462, DOI 10.1097/ALN.0b013e3181ca361f; De Smet HR, 2007, J CRIT CARE, V22, P305, DOI 10.1016/j.jcrc.2006.12.002; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Hailfinger S, 2011, P NATL ACAD SCI USA, V108, P14596, DOI 10.1073/pnas.1105020108; Helenius IT, 2009, P NATL ACAD SCI USA, V106, P18710, DOI 10.1073/pnas.0905925106; Heming TA, 2001, CLIN SCI, V101, P267, DOI 10.1042/CS20010139; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; KNOWLES RG, 1992, TRENDS BIOCHEM SCI, V17, P399, DOI 10.1016/0968-0004(92)90008-W; Kregenow DA, 2006, CRIT CARE MED, V34, P1, DOI 10.1097/01.CCM.0000194533.75481.03; Laffey JG, 2004, AM J RESP CRIT CARE, V169, P46, DOI 10.1164/rccm.200205-394OC; LERNBECHER T, 1993, NATURE, V365, P767, DOI 10.1038/365767a0; Marienfeld R, 2001, ONCOGENE, V20, P8142, DOI 10.1038/sj.onc.1204884; Marienfeld R, 2003, J BIOL CHEM, V278, P19852, DOI 10.1074/jbc.M301945200; MILBERG JA, 1995, JAMA-J AM MED ASSOC, V273, P306, DOI 10.1001/jama.273.4.306; Neumann M, 2011, ONCOGENE, V30, P2485, DOI 10.1038/onc.2010.580; Nichol AD, 2009, CRIT CARE MED, V37, P2953, DOI 10.1097/CCM.0b013e3181b028ce; O'Toole D, 2005, J CELL BIOCHEM, V96, P589, DOI 10.1002/jcb.20539; Peltekova V, 2010, INTENS CARE MED, V36, P869, DOI 10.1007/s00134-010-1787-7; Sharabi K, 2009, J CELL MOL MED, V13, P4304, DOI 10.1111/j.1582-4934.2009.00952.x; Shi Q, 2000, J INTERF CYTOK RES, V20, P1023, DOI 10.1089/10799900050198471; Steinhilb ML, 2001, J BIOL CHEM, V276, P4476, DOI 10.1074/jbc.M008793200; Tambuwala MM, 2010, GASTROENTEROLOGY, V139, P2093, DOI 10.1053/j.gastro.2010.06.068; Taylor CT, 2011, J PHYSIOL-LONDON, V589, P797, DOI 10.1113/jphysiol.2010.201467; Taylor CT, 2010, ARTERIOSCL THROM VAS, V30, P643, DOI 10.1161/ATVBAHA.108.181628; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; WEIH F, 1994, ONCOGENE, V9, P3289; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Yoza BK, 2011, CYTOKINE, V53, P145, DOI 10.1016/j.cyto.2010.10.007	33	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14004	14011		10.1074/jbc.M112.347971	http://dx.doi.org/10.1074/jbc.M112.347971			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22396550	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000303996300055
J	Knezevic, I; Patel, A; Sundaresan, NR; Gupta, MP; Solaro, RJ; Nagalingam, RS; Gupta, M				Knezevic, Ivana; Patel, Aalok; Sundaresan, Nagalingam R.; Gupta, Mahesh P.; Solaro, R. John; Nagalingam, Raghu S.; Gupta, Madhu			A Novel Cardiomyocyte-enriched MicroRNA, miR-378, Targets Insulin-like Growth Factor 1 Receptor IMPLICATIONS IN POSTNATAL CARDIAC REMODELING AND CELL SURVIVAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYOCARDIAL-INFARCTION; FAILING HUMAN HEART; TRANSGENIC MICE; DILATED CARDIOMYOPATHY; MYOCYTE APOPTOSIS; EXPRESSION; OVEREXPRESSION; HYPERTROPHY; FAILURE; PATHWAY	Postnatal cardiac remodeling is characterized by a marked decrease in the insulin-like growth factor 1 (IGF1) and IGF1 receptor (IGF1R) expression. The underlying mechanism remains unexplored. This study examined the role of microRNAs in postnatal cardiac remodeling. By expression profiling, we observed a 10-fold increase in miR-378 expression in 1-week-old neonatal mouse hearts compared with 16-day-old fetal hearts. There was also a 4-6-fold induction in expression of miR-378 in older (10 months) compared with younger (1 month) hearts. Interestingly, tissue distribution analysis identified miR-378 to be highly abundant in heart and skeletal muscles. In the heart, specific expression was observed in cardiac myocytes, which was inducible by a variety of stressors. Over-expression of miR-378 enhanced apoptosis of cardiomyocytes by direct targeting of IGF1R and reduced signaling in Akt cascade. The inhibition of miR-378 by its anti-miR protected cardiomyocytes against H2O2 and hypoxia reoxygenation-induced cell death by promoting IGF1R expression and downstream Akt signaling cascade. Additionally, our data show that miR-378 expression is inhibited by IGF1 in cardiomyocytes. In tissues such as fibroblasts and fetal hearts, where IGF1 levels are high, we found either absent or significantly low miR-378 levels, suggesting an inverse relationship between these two factors. Our study identifies miR-378 as a new cardioabundant microRNA that targets IGF1R. We also demonstrate the existence of a negative feedback loop between miR-378, IGF1R, and IGF1 that is associated with postnatal cardiac remodeling and with the regulation of cardiomyocyte survival during stress.	[Nagalingam, Raghu S.; Gupta, Madhu] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Nagalingam, Raghu S.; Gupta, Madhu] Univ Illinois, Cardiovasc Res Ctr, Chicago, IL 60612 USA; [Sundaresan, Nagalingam R.; Gupta, Mahesh P.] Univ Chicago, Comm Cellular & Mol Physiol, Dept Surg, Chicago, IL 60637 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago	Gupta, M (corresponding author), Univ Illinois, Dept Physiol & Biophys MC 901, 835 S Wolcott Ave, Chicago, IL 60607 USA.	guptam@uic.edu		Patel, Aalok/0000-0002-7635-8602	National Institutes of Health [2RO1 HL 22231, PO1 HL 062626, RO1 HL 83423, T32 HL 07692]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007692, R01HL022231, R01HL083423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant Multi P. I. Grants 2RO1 HL 22231 (to M. G. and R. J. S.), PO1 HL 062626-Project 1 (to R. J. S.), RO1 HL 83423 (to M. P. G.), and T32 HL 07692 (to I. K.).	Anversa P, 1996, CARDIOVASC RES, V32, P219, DOI 10.1016/0008-6363(96)00035-1; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Bialik S, 1997, J CLIN INVEST, V100, P1363, DOI 10.1172/JCI119656; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Chen ZY, 2001, AM J PHYSIOL-HEART C, V280, pH2313, DOI 10.1152/ajpheart.2001.280.5.H2313; CHENG W, 1995, LAB INVEST, V72, P646; Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103; Delaughter MC, 1999, FASEB J, V13, P1923, DOI 10.1096/fasebj.13.14.1923; Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Feng M, 2011, ONCOGENE, V30, P2242, DOI 10.1038/onc.2010.602; Fliss H, 1996, CIRC RES, V79, P949, DOI 10.1161/01.RES.79.5.949; Gable KL, 2006, MOL CANCER THER, V5, P1079, DOI 10.1158/1535-7163.MCT-05-0397; Guerra S, 1999, CIRC RES, V85, P856, DOI 10.1161/01.RES.85.9.856; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; KARDAMI E, 1990, MOL CELL BIOCHEM, V92, P129; Kim J, 2008, MOL ENDOCRINOL, V22, P2531, DOI 10.1210/me.2008-0265; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Malhotra R, 2011, AM J PHYSIOL-HEART C, V300, pH1733, DOI 10.1152/ajpheart.01054.2010; Martins PADC, 2008, CIRCULATION, V118, P1567, DOI 10.1161/CIRCULATIONAHA.108.769984; McMullen JR, 2004, J BIOL CHEM, V279, P4782, DOI 10.1074/jbc.M310405200; Miao WF, 2000, J MOL CELL CARDIOL, V32, P2397, DOI 10.1006/jmcc.2000.1283; Morales MP, 2000, BIOCHEM BIOPH RES CO, V270, P1029, DOI 10.1006/bbrc.2000.2550; Olivetti G, 1996, J MOL CELL CARDIOL, V28, P2005, DOI 10.1006/jmcc.1996.0193; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Palojoki E, 2001, AM J PHYSIOL-HEART C, V280, pH2726, DOI 10.1152/ajpheart.2001.280.6.H2726; Porrello ER, 2011, CIRC RES, V109, P670, DOI 10.1161/CIRCRESAHA.111.248880; REISS K, 1995, AM J PHYSIOL-HEART C, V269, pH943, DOI 10.1152/ajpheart.1995.269.3.H943; Ren J, 1999, J MOL CELL CARDIOL, V31, P2049, DOI 10.1006/jmcc.1999.1036; Ronnebaum SM, 2010, ANNU REV PHYSIOL, V72, P81, DOI 10.1146/annurev-physiol-021909-135931; Samarel AM, 2002, CIRC RES, V90, P631, DOI 10.1161/01.RES.0000015425.11187.19; Shan ZX, 2009, BIOCHEM BIOPH RES CO, V381, P597, DOI 10.1016/j.bbrc.2009.02.097; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; Sulaiman M, 2010, AM J PHYSIOL-HEART C, V298, pH833, DOI 10.1152/ajpheart.00418.2009; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; TORRESALEMAN I, 1994, J NEUROSCI RES, V39, P117, DOI 10.1002/jnr.490390202; Wang L, 1998, CIRC RES, V83, P516, DOI 10.1161/01.RES.83.5.516; Wang XW, 2009, RNA, V15, P716, DOI 10.1261/rna.1460509; Welch S, 2002, CIRC RES, V90, P641, DOI 10.1161/01.RES.0000013780.77774.75; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664	44	108	120	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12913	12926		10.1074/jbc.M111.331751	http://dx.doi.org/10.1074/jbc.M111.331751			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367207	hybrid, Green Published			2022-12-27	WOS:000302903700031
J	O'Callaghan, K; Kuliopulos, A; Covic, L				O'Callaghan, Katie; Kuliopulos, Athan; Covic, Lidija			Turning Receptors On and Off with Intracellular Pepducins: New Insights into G-protein-coupled Receptor Drug Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CELL-PENETRATING PEPDUCINS; ANGSTROM CRYSTAL-STRUCTURE; BREAST-CANCER CELLS; ACTIVATED RECEPTOR-1; AGONIST PEPDUCIN; SIGNALING SYSTEM; OVARIAN-CANCER; PAR1; INFLAMMATION; PEPTIDES	G-protein-coupled receptors (GPCRs) are a large family of remarkably versatile membrane proteins that are attractive therapeutic targets because of their involvement in a vast range of normal physiological processes and pathological diseases. Upon activation, intracellular domains of GPCRs mediate signaling to G-proteins, but these domains have yet to be effectively exploited as drug targets. Cell-penetrating lipidated peptides called pepducins target specific intracellular loops of GPCRs and have recently emerged as effective allosteric modulators of GPCR activity. The lipid moiety facilitates translocation across the plasma membrane, where pepducins then specifically modulate signaling of their cognate receptor. To date, pepducins and related lipopeptides have been shown to specifically modulate the activity of diverse GPCRs and other membrane proteins, including protease-activated receptors (PAR1, PAR2, and PAR4), chemokine receptors (CXCR1, CXCR2, and CXCR4), sphingosine 1-phosphate receptor-3 (S1P3), the melanocortin-4 receptor, the Smoothened receptor, formyl peptide receptor-2 (FPR2), the relaxin receptor (LGR7), G-proteins (G alpha(q/11/o/13)), muscarinic acetylcholine receptor and vanilloid (TRPV1) channels, and the GPIIb integrin. This minireview describes recent advances made using pepducin technology in targeting diverse GPCRs and the use of pepducins in identifying potential novel drug targets.	[O'Callaghan, Katie; Kuliopulos, Athan; Covic, Lidija] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Kuliopulos, Athan; Covic, Lidija] Tufts Med Ctr, Div Hematol Oncol, Boston, MA 02111 USA; [Kuliopulos, Athan; Covic, Lidija] Tufts Med Ctr, Dept Med, Boston, MA 02111 USA; [Kuliopulos, Athan; Covic, Lidija] Tufts Med Ctr, Dept Biochem, Boston, MA 02111 USA	Tufts Medical Center; Tufts Medical Center; Tufts Medical Center; Tufts Medical Center	Covic, L (corresponding author), Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA.	lcovic@tuftsmedicalcenter.org			National Institutes of Health [CA104406, CA122992, HL64701, HL57905]; Susan Komen [BCTR0706763, BCTR0601348]; United States Department of Defense [BC045321]; NATIONAL CANCER INSTITUTE [R01CA122992, R01CA104406] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064701, R01HL057905] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan Komen(Susan G. Komen Breast Cancer Foundation); United States Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA104406 (to L. C.) and Grants CA122992, HL64701, and HL57905 (to A. K.). This work was also supported by Susan Komen Grants BCTR0706763 (to L. C.) and BCTR0601348 (to A. K.) and United States Department of Defense Grant BC045321 (to L. C.).	Agarwal A, 2008, MOL CANCER THER, V7, P2746, DOI 10.1158/1535-7163.MCT-08-0177; Agarwal A, 2010, CANCER RES, V70, P5880, DOI 10.1158/0008-5472.CAN-09-4341; Annahazi A, 2009, PAIN, V144, P209, DOI 10.1016/j.pain.2009.04.017; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Cisowski J, 2011, AM J PATHOL, V179, P513, DOI 10.1016/j.ajpath.2011.03.025; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Covic L, 2002, NAT MED, V8, P1161, DOI 10.1038/nm760; Covic L, 2007, HDB CELL PENETRATING, P245; Dabek M, 2009, AM J PATHOL, V175, P207, DOI 10.2353/ajpath.2009.080986; Edwards RJ, 2007, NAT CHEM BIOL, V3, P108, DOI 10.1038/nchembio854; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Grenegard M, 2008, J BIOL CHEM, V283, P18493, DOI 10.1074/jbc.M800358200; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hollenberg MD, 2004, BRIT J PHARMACOL, V143, P443, DOI 10.1038/sj.bjp.0705946; Houle S, 2005, BRIT J PHARMACOL, V146, P670, DOI 10.1038/sj.bjp.0706371; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Huang JS, 2007, J BIOL CHEM, V282, P10210, DOI 10.1074/jbc.M605678200; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Janz JM, 2011, J AM CHEM SOC, V133, P15878, DOI 10.1021/ja206661w; Johannessen L, 2011, CHEMBIOCHEM, V12, P914, DOI 10.1002/cbic.201000563; Kaneider NC, 2005, NAT MED, V11, P661, DOI 10.1038/nm1245; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Kaufmann R, 2009, CARCINOGENESIS, V30, P1487, DOI 10.1093/carcin/bgp153; Keuren JFW, 2005, ARTERIOSCL THROM VAS, V25, P1499, DOI 10.1161/01.ATV.0000167526.31611.f6; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; KOLAKOWSKI LF, 1994, RECEPTOR CHANNEL, V2, P1; Kubo S, 2006, ANN NY ACAD SCI, V1091, P445, DOI 10.1196/annals.1378.087; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Lee HY, 2010, FEBS LETT, V584, P4102, DOI 10.1016/j.febslet.2010.08.036; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Licht T, 2003, BLOOD, V102, P2099, DOI 10.1182/blood-2002-12-3634; McDougall JJ, 2009, ARTHRITIS RHEUM-US, V60, P728, DOI 10.1002/art.24300; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; O'Callaghan K, 2012, BLOOD, V119, P1717, DOI 10.1182/blood-2011-04-347518; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; OKAMOTO T, 1991, CELL, V67, P723, DOI 10.1016/0092-8674(91)90067-9; Otaki JM, 2001, J THEOR BIOL, V211, P77, DOI 10.1006/jtbi.2001.2272; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; Remsberg JR, 2007, J MED CHEM, V50, P4534, DOI 10.1021/jm0705657; Robbins J, 2006, J NEUROSCI, V26, P7950, DOI 10.1523/JNEUROSCI.2138-06.2006; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sevigny LM, 2011, P NATL ACAD SCI USA, V108, P8491, DOI 10.1073/pnas.1017091108; Shpakov A O, 2007, Neurosci Behav Physiol, V37, P705, DOI 10.1007/s11055-007-0071-y; Slofstra SH, 2007, BLOOD, V110, P3176, DOI 10.1182/blood-2007-02-075440; Sroussi HY, 2012, MOL IMMUNOL, V50, P42, DOI 10.1016/j.molimm.2011.12.001; Stephens G, 1998, J BIOL CHEM, V273, P20317, DOI 10.1074/jbc.273.32.20317; Swift S, 2006, J BIOL CHEM, V281, P4109, DOI 10.1074/jbc.M509525200; Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8; Tchernychev B, 2010, P NATL ACAD SCI USA, V107, P22255, DOI 10.1073/pnas.1009633108; Tressel SL, 2011, METHODS MOL BIOL, V683, P259, DOI 10.1007/978-1-60761-919-2_19; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; Valente P, 2011, FASEB J, V25, P1628, DOI 10.1096/fj.10-174433; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Wielders SJH, 2007, J THROMB HAEMOST, V5, P571, DOI 10.1111/j.1538-7836.2007.02364.x; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Yang E, 2009, CANCER RES, V69, P6223, DOI 10.1158/0008-5472.CAN-09-0187	67	115	119	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12787	12796		10.1074/jbc.R112.355461	http://dx.doi.org/10.1074/jbc.R112.355461			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22374997	Green Published, hybrid			2022-12-27	WOS:000302903700018
J	Abu-Elheiga, L; Wu, HM; Gu, ZW; Bressler, R; Wakil, SJ				Abu-Elheiga, Lutfi; Wu, Hongmei; Gu, Ziwei; Bressler, Rubin; Wakil, Salih J.			Acetyl-CoA Carboxylase 2(-/-) Mutant Mice are Protected against Fatty Liver under High-fat, High-carbohydrate Dietary and de Novo Lipogenic Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; PEROXISOME PROLIFERATOR; GENE-TRANSCRIPTION; ENERGY-EXPENDITURE; ACID OXIDATION; KNOCKOUT MICE; GLUCOSE; BETA; EXPRESSION; STEATOSIS	Hepatic fat accumulation resulting from increased de novo fatty acid synthesis leads to hepatic steatosis and hepatic insulin resistance. We have shown previously that acetyl-CoA carboxylase 2 (Acc2(-/-)) mutant mice, when fed a high-fat (HF) or high-fat, high-carbohydrate (HFHC) diet, are protected against diet-induced obesity and maintained whole body and hepatic insulin sensitivity. To determine the effect of an ACC2 deletion on hepatic fat metabolism, we studied the regulation of the enzymes involved in the lipogenic pathway under Western HFHC dietary and de novo lipogenic conditions. After completing the HFHC regimen, Acc2(-/-) mutant mice were found to have lower body weight, smaller epididymal fat pads, lower blood levels of nonesterified fatty acids and triglycerides, and higher hepatic cholesterol than wild-type mice. Significant up-regulation of lipogenic enzymes and an elevation in hepatic peroxisome proliferator-activated receptor-gamma (PPAR-gamma) protein were found in Acc2(-/-) mutant mice under de novo lipogenic conditions. The increase in lipogenic enzyme levels was accompanied by up-regulation of the transcription factors, sterol regulatory element-binding proteins 1 and 2, and carbohydrate response element-binding protein. In contrast, hepatic levels of the PPAR-gamma and PPAR-gamma proteins were significantly lower in the Acc2(-/-) mutant mice fed an HFHC diet. When compared with wild-type mice fed the same diet, Acc2(-/-) mutant mice exhibited a similar level of AKT but with a significant increase in pAKT. Hence, deleting ACC2 ameliorates the metabolic syndrome and protects against fatty liver despite increased de novo lipogenesis and dietary conditions known to induce obesity and diabetes.	[Bressler, Rubin] Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85724 USA; [Abu-Elheiga, Lutfi; Wu, Hongmei; Gu, Ziwei; Wakil, Salih J.] Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Arizona; Baylor College of Medicine	Abu-Elheiga, L (corresponding author), 1 Baylor Plaza, Houston, TX 77030 USA.	lutfia@bcm.edu; swakil@bcm.edu		Abu-Elheiga, Lutfi/0000-0002-7366-3556	National Institutes of Health [GM-63115]; Hefni Technical Training Foundation; Medallion Foundation; McLean Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hefni Technical Training Foundation; Medallion Foundation; McLean Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-63115, the Hefni Technical Training Foundation, the Medallion Foundation (to S. J. W.), and the McLean Foundation Pilot Project (to L. A.).	Abu-Elheiga L, 2005, P NATL ACAD SCI USA, V102, P12011, DOI 10.1073/pnas.0505714102; Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; AbuElheiga L, 1997, J BIOL CHEM, V272, P10669; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Chandler CE, 2003, J LIPID RES, V44, P1887, DOI 10.1194/jlr.M300094-JLR200; Cheung O, 2010, CURR OPIN GASTROEN, V26, P202, DOI 10.1097/MOG.0b013e328337b0c4; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Delzenne NM, 1997, J HEPATOL, V26, P880, DOI 10.1016/S0168-8278(97)80256-5; Essop MF, 2008, AM J PHYSIOL-HEART C, V295, pH256, DOI 10.1152/ajpheart.91489.2007; Gu YG, 2006, J MED CHEM, V49, P3770, DOI 10.1021/jm060484v; Ha J, 1996, P NATL ACAD SCI USA, V93, P11466, DOI 10.1073/pnas.93.21.11466; Hoehn KL, 2010, CELL METAB, V11, P70, DOI 10.1016/j.cmet.2009.11.008; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Jump DB, 2005, J NUTR, V135, P2503, DOI 10.1093/jn/135.11.2503; Kim H, 2004, DIABETES, V53, pS60, DOI 10.2337/diabetes.53.2007.S60; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; NIH, 2010, GUIDE CARE USE LAB A, V8th, DOI [10.1163/1573-3912_islam_DUM_3825, DOI 10.1163/1573-3912_ISLAM_DUM_3825]; Oh WK, 2005, P NATL ACAD SCI USA, V102, P1384, DOI 10.1073/pnas.0409451102; Olson DP, 2010, P NATL ACAD SCI USA, V107, P7598, DOI 10.1073/pnas.0913492107; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Sul HS, 1998, ANNU REV NUTR, V18, P331, DOI 10.1146/annurev.nutr.18.1.331; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Way JM, 2001, ENDOCRINOLOGY, V142, P1269, DOI 10.1210/en.142.3.1269; WIGGINS D, 1992, BIOCHEM J, V284, P457, DOI 10.1042/bj2840457; WINDER WW, 1995, J APPL PHYSIOL, V78, P578, DOI 10.1152/jappl.1995.78.2.578	32	63	65	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12578	12588		10.1074/jbc.M111.309559	http://dx.doi.org/10.1074/jbc.M111.309559			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22362781	Green Published, hybrid			2022-12-27	WOS:000302782200096
J	Fong, JJ; Nguyen, BL; Bridger, R; Medrano, EE; Wells, L; Pan, SJ; Sifers, RN				Fong, Jerry J.; Nguyen, Brenda L.; Bridger, Robert; Medrano, Estela E.; Wells, Lance; Pan, Shujuan; Sifers, Richard N.			beta-N-Acetylglucosamine (O-GlcNAc) Is a Novel Regulator of Mitosis-specific Phosphorylations on Histone H3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CHROMOSOME CONDENSATION; AURORA-B; CAENORHABDITIS-ELEGANS; PROTEIN MODIFICATION; CYTOSOLIC PROTEINS; GLYCOSYLATION; CHROMATIN; KINASE; CYTOKINESIS; TRANSFERASE	O-Linked beta-N-acetylglucosamine, or O-GlcNAc, is a dynamic post-translational modification that cycles on and off serine and threonine residues of nucleocytoplasmic proteins. The O-GlcNAc modification shares a complex relationship with phosphorylation, as both modifications are capable of mutually inhibiting the occupation of each other on the same or nearby amino acid residue. In addition to diabetes, cancer, and neurodegenerative diseases, O-GlcNAc appears to play a significant role in cell growth and cell cycle progression, although the precise mechanisms are still not well understood. A recent study also found that all four core nucleosomal histones (H2A, H2B, H3, and H4) are modified with O-GlcNAc, although no specific sites on H3 were reported. Here, we describe that histone H3, a protein highly phosphorylated during mitosis, is modified with O-GlcNAc. Several biochemical assays were used to validate that H3 is modified with O-GlcNAc. Mass spectrometry analysis identified threonine 32 as a novel O-GlcNAc site. O-GlcNAc was detected at higher levels on H3 during interphase than mitosis, which inversely correlated with phosphorylation. Furthermore, increased O-GlcNAcylation was observed to reduce mitosis-specific phosphorylation at serine 10, serine 28, and threonine 32. Finally, inhibiting OGA, the enzyme responsible for removing O-GlcNAc, hindered the transition from G2 to M phase of the cell cycle, displaying a phenotype similar to preventing mitosis-specific phosphorylation on H3. Taken together, these data indicate that O-GlcNAcylation regulates mitosis-specific phosphorylations on H3, providing a mechanistic switch that orchestrates the G2-M transition of the cell cycle.	[Fong, Jerry J.; Nguyen, Brenda L.; Pan, Shujuan; Sifers, Richard N.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Medrano, Estela E.; Sifers, Richard N.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Sifers, Richard N.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Fong, Jerry J.; Medrano, Estela E.; Sifers, Richard N.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Bridger, Robert; Wells, Lance] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Bridger, Robert; Wells, Lance] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Sifers, RN (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, BCM T228,1 Baylor Plaza, Houston, TX 77030 USA.	rsifers@bcm.edu	Wells, Lance/H-3118-2013; Sifers, Richard Norman/AGQ-7262-2022	Wells, Lance/0000-0003-4956-5363; Bridger, Robert/0000-0003-2653-8813	National Institutes of Health [R01CA84282]; NATIONAL CANCER INSTITUTE [R01CA084282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA84282 (to E. E. M).	Caperta AD, 2008, CYTOGENET GENOME RES, V122, P73, DOI 10.1159/000151319; Chen YX, 2006, CHEM BIOL, V13, P937, DOI 10.1016/j.chembiol.2006.06.017; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Choi HS, 2005, CANCER RES, V65, P5818, DOI 10.1158/0008-5472.CAN-05-0197; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Daly NL, 2000, BIOCHEMISTRY-US, V39, P9039, DOI 10.1021/bi0004807; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Feser J, 2011, FEBS LETT, V585, P2041, DOI 10.1016/j.febslet.2010.11.016; Fulop N, 2007, AM J PHYSIOL-HEART C, V292, pH2227, DOI 10.1152/ajpheart.01091.2006; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Gardner KE, 2011, J MOL BIOL, V409, P36, DOI 10.1016/j.jmb.2011.01.040; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Goldberg H., 2011, AM J PHYSIOL-ENDOC M, V4, pE713; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x; Goto H, 2003, J BIOL CHEM, V278, P8526, DOI 10.1074/jbc.M210892200; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Hu P, 2010, FEBS LETT, V584, P2526, DOI 10.1016/j.febslet.2010.04.044; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Mondoux MA, 2011, GENETICS, V188, P369, DOI 10.1534/genetics.111.126490; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; Perez-Cadahia B, 2009, BIOCHEM CELL BIOL, V87, P695, DOI 10.1139/O09-053; Rahman MM, 2010, AGING-US, V2, P678, DOI 10.18632/aging.100208; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Sakabe K, 2010, J BIOL CHEM, V285, P34460, DOI 10.1074/jbc.M110.158170; Sauve DM, 1999, J CELL BIOL, V145, P225, DOI 10.1083/jcb.145.2.225; SHOEMAKER CB, 1980, J BIOL CHEM, V255, P1048; Simanek EE, 1998, J AM CHEM SOC, V120, P11567, DOI 10.1021/ja982312w; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2003, CURR OPIN STRUC BIOL, V13, P631, DOI 10.1016/j.sbi.2003.08.003; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Slawson C, 2008, MOL BIOL CELL, V19, P4130, DOI 10.1091/mbc.E07-11-1146; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Sugiyama K, 2002, ONCOGENE, V21, P3103, DOI 10.1038/sj.onc.1205432; Tavana O, 2011, CELL CYCLE, V10, P2471, DOI 10.4161/cc.10.15.16741; Van Hooser A, 1998, J CELL SCI, V111, P3497; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Yang HL, 2010, J BIOL CHEM, V285, P32242, DOI 10.1074/jbc.M110.160820; Zhang SS, 2011, J BIOL CHEM, V286, P37483, DOI 10.1074/jbc.M111.284885; Zhao P, 2011, J PROTEOME RES, V10, P4088, DOI 10.1021/pr2002726; Zhong SP, 2001, J BIOL CHEM, V276, P12932, DOI 10.1074/jbc.M010931200; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	52	84	88	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12195	12203		10.1074/jbc.M111.315804	http://dx.doi.org/10.1074/jbc.M111.315804			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22371497	Green Published, hybrid			2022-12-27	WOS:000302782200061
J	Pore, D; Mahata, N; Chakrabarti, MK				Pore, Debasis; Mahata, Nibedita; Chakrabarti, Manoj K.			Outer Membrane Protein A (OmpA) of Shigella flexneri 2a Links Innate and Adaptive Immunity in a TLR2-dependent Manner and Involvement of IL-12 and Nitric Oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; NF-KAPPA-B; KINASE-C; CHEMOTACTIC RESPONSIVENESS; CYTOKINE PRODUCTION; CUTTING EDGE; T-CELLS; EXPRESSION; ACTIVATION; MACROPHAGE	We determine that OmpA of Shigella flexneri 2a is recognized by TLR2 and consequently mediates the release of proinflammatory cytokines and activates NF-kappa B in HEK 293 cells transfected with TLR2. We also observe that in RAW macrophages TLR2 is essential to instigate the early immune response to OmpA via NF-kappa B activation and secretion of cytokines and NO. Consistent with these results, TLR2 knockdown using siRNA abolishes the initiation of immune responses. Processing and presentation of OmpA depend on TLR2; MHCII presentation of the processed antigen and expression of CD80 significantly attenuated in TLR2 knockdown macrophages. The optimum production of IFN-gamma by the macrophages: CD4(+) T cells co-culture depends on both TLR2 activation and antigen presentation. So, TLR2 is clearly recognized as a decisive factor in initiating host innate immune response to OmpA for the development of CD4(+) T cell adaptive response. Furthermore, we demonstrate in vivo that intranasal immunization of mice with OmpA selectively enhances the release of IFN-gamma and IL-2 by CD4(+) T cells. Importantly, OmpA increases the level of IFN-gamma production in Ag-primed splenocytes. The addition of neutralizing anti-IL-12p70 mAb to cell cultures results in the decreased release of OmpA-enhanced IFN-gamma by Ag-primed splenocytes. Moreover, coincubation with OmpA-pretreated macrophages enhances the production of IFN-gamma by OmpA-primed CD4(+) T cells, representing that OmpA may enhance IFN-gamma expression in CD4(+) T cells through the induction of IL-12 production in macrophages. These results demonstrate that S. flexneri 2a OmpA may play a critical role in the development of Th1 skewed adaptive immune response.	[Pore, Debasis; Mahata, Nibedita; Chakrabarti, Manoj K.] Natl Inst Cholera & Enter Dis, Div Pathophysiol, Kolkata 700010, W Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Chakrabarti, MK (corresponding author), Natl Inst Cholera & Enter Dis, Div Pathophysiol, P-33,CIT Rd, Kolkata 700010, W Bengal, India.	mkc_niced@yahoo.co.in			Indian Council of Medical Research (New Delhi, India); National Institute of Cholera and Enteric Diseases, Kolkata	Indian Council of Medical Research (New Delhi, India)(Indian Council of Medical Research (ICMR)); National Institute of Cholera and Enteric Diseases, Kolkata	This work was supported by Indian Council of Medical Research (New Delhi, India) Senior Research Fellowships to D. P. and N. M.; We thank Dr. Sekhar Chakrabarti, Director-in-charge, National Institute of Cholera and Enteric Diseases, Kolkata, for encouragement and support throughout the study.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Ashkenazi S, 2003, J ANTIMICROB CHEMOTH, V51, P427, DOI 10.1093/jac/dkg080; Biswas A, 2007, MOL IMMUNOL, V44, P812, DOI 10.1016/j.molimm.2006.04.007; Biswas A, 2009, MOL IMMUNOL, V46, P3076, DOI 10.1016/j.molimm.2009.06.006; Bleul CC, 2000, EUR J IMMUNOL, V30, P3371, DOI 10.1002/1521-4141(2000012)30:12<3371::AID-IMMU3371>3.0.CO;2-L; Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Chen CC, 1998, J IMMUNOL, V161, P6206; Cobb BA, 2004, CELL, V117, P677, DOI 10.1016/j.cell.2004.05.001; Colantonio L, 2002, EUR J IMMUNOL, V32, P1264, DOI 10.1002/1521-4141(200205)32:5<1264::AID-IMMU1264>3.0.CO;2-S; Fisette PL, 2003, J BIOL CHEM, V278, P46252, DOI 10.1074/jbc.M306587200; Galdiero M, 2003, FEMS MICROBIOL LETT, V226, P57, DOI 10.1016/S0378-1097(03)00562-7; Galdiero M, 2004, INFECT IMMUN, V72, P1204, DOI 10.1128/IAI.72.2.1204-1209.2004; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; Jeannin P, 2000, NAT IMMUNOL, V1, P502, DOI 10.1038/82751; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Langlet C, 2010, EUR J IMMUNOL, V40, P505, DOI 10.1002/eji.200939391; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; LIEW FY, 1991, IMMUNOPARASITOL TOD, pA17, DOI 10.1016/S0167-5699(05)80006-4; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Massari P, 2002, J IMMUNOL, V168, P1533, DOI 10.4049/jimmunol.168.4.1533; McGhee JR, 2005, J IMMUNOL, V175, P3, DOI 10.4049/jimmunol.175.1.3; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; NATHAN CF, 1991, CURR OPIN IMMUNOL, V3, P65, DOI 10.1016/0952-7915(91)90079-G; Niedbala W, 2002, P NATL ACAD SCI USA, V99, P16186, DOI 10.1073/pnas.252464599; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Pasare C, 2004, MICROBES INFECT, V6, P1382, DOI 10.1016/j.micinf.2004.08.018; Pasare C, 2004, SEMIN IMMUNOL, V16, P23, DOI 10.1016/j.smim.2003.10.006; Pore D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022663; Pore D, 2010, MOL IMMUNOL, V47, P1739, DOI 10.1016/j.molimm.2010.03.001; Pore D, 2009, VACCINE, V27, P5855, DOI 10.1016/j.vaccine.2009.07.054; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Soulas C, 2000, J IMMUNOL, V165, P2335, DOI 10.4049/jimmunol.165.5.2335; Tan SL, 2003, BIOCHEM J, V376, P545, DOI 10.1042/BJ20031406; Torres AG, 2006, INFECT IMMUN, V74, P2676, DOI 10.1128/IAI.74.5.2676-2685.2006; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Wang Q, 2006, J EXP MED, V203, P2853, DOI 10.1084/jem.20062008; Zhang YL, 2005, CELL MOL IMMUNOL, V2, P20	52	25	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12589	12601		10.1074/jbc.M111.335554	http://dx.doi.org/10.1074/jbc.M111.335554			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22343631	hybrid, Green Published			2022-12-27	WOS:000302782200097
J	Haag, AF; Kerscher, B; Dall'Angelo, S; Sani, M; Longhi, R; Baloban, M; Wilson, HM; Mergaert, P; Zanda, M; Ferguson, GP				Haag, Andreas F.; Kerscher, Bernhard; Dall'Angelo, Sergio; Sani, Monica; Longhi, Renato; Baloban, Mikhail; Wilson, Heather M.; Mergaert, Peter; Zanda, Matteo; Ferguson, Gail P.			Role of Cysteine Residues and Disulfide Bonds in the Activity of a Legume Root Nodule-specific, Cysteine-rich Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; PROTEIN; GENES; DIFFERENTIATION; SYMBIOSIS; GENOME	The root nodules of certain legumes including Medicago truncatula produce >300 different nodule-specific cysteine-rich (NCR) peptides. Medicago NCR antimicrobial peptides (AMPs) mediate the differentiation of the bacterium, Sinorhizobium meliloti into a nitrogen-fixing bacteroid within the legume root nodules. In vitro, NCRAMPs such as NCR247 induced bacteroid features and exhibited antimicrobial activity against S. meliloti. The bacterial BacA protein is critical to prevent S. meliloti from being hypersensitive toward NCR AMPs. NCR AMPs are cationic and have conserved cysteine residues, which form disulfide (S-S) bridges. However, the natural configuration of NCRAMP S-S bridges and the role of these in the activity of the peptide are unknown. In this study, we found that either cysteine replacements or S-S bond modifications influenced the activity of NCR247 against S. meliloti. Specifically, either substitution of cysteines for serines, changing the S-S bridges from cysteines 1-2, 3-4 to 1-3, 2-4 or oxidation of NCR247 lowered its activity against S. meliloti. We also determined that BacA specifically protected S. meliloti against oxidized NCR247. Due to the large number of different NCRs synthesized by legume root nodules and the importance of bacterial BacA proteins for prolonged hostinfections, these findings have important implications for analyzing the function of these novel peptides and the protective role of BacA in the bacterial response toward these peptides.	[Haag, Andreas F.; Kerscher, Bernhard; Wilson, Heather M.; Ferguson, Gail P.] Univ Aberdeen, Inst Med Sci, Sch Med & Dent, Aberdeen AB25 2ZD, Scotland; [Dall'Angelo, Sergio; Zanda, Matteo] Univ Aberdeen, Inst Med Sci, Sch Med Sci, Aberdeen AB25 2ZD, Scotland; [Sani, Monica; Longhi, Renato; Zanda, Matteo] CNR, Inst Chim Riconoscimento Mol, I-20131 Milan, Italy; [Sani, Monica] KemoTech Soc Responsabilita Limitata, I-09010 Cagliari, Italy; [Baloban, Mikhail; Mergaert, Peter] CNRS, Inst Sci Vegetal, F-91198 Gif Sur Yvette, France	University of Aberdeen; University of Aberdeen; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Haag, AF (corresponding author), Univ Aberdeen, Inst Med Sci, Sch Med & Dent, Aberdeen AB25 2ZD, Scotland.	a.haag@live.co.uk; bernhard.kerscher@abdn.ac.uk	Zanda, Matteo/AAC-2391-2022; Dall'Angelo, Sergio/J-5333-2014; Mergaert, Peter/M-1265-2019; Haag, Andreas F/R-8775-2019; Kerscher, Bernhard G R/B-1907-2015	Dall'Angelo, Sergio/0000-0001-9377-0474; Mergaert, Peter/0000-0002-5919-7317; Haag, Andreas F/0000-0002-6783-0231; Kerscher, Bernhard G R/0000-0001-9300-7401; Baloban, Mikhail/0000-0003-3919-1222; Wilson, Heather M/0000-0002-1407-7274	Medical Research Council [G0501107]; Agence Nationale de la Recherche [ANR-09-BLAN-0396-01]; MRC [G0501107] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Agence Nationale de la Recherche(French National Research Agency (ANR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council New Investigator Grant G0501107 (to G. P. F.).; Supported by the Agence Nationale de la Recherche Grant ANR-09-BLAN-0396-01.	Alegre-Cebollada J, 2011, NAT CHEM, V3, P882, DOI [10.1038/NCHEM.1155, 10.1038/nchem.1155]; Alkhalfioui F, 2008, PLANT PHYSIOL, V148, P424, DOI 10.1104/pp.108.123778; Alunni B, 2007, MOL PLANT MICROBE IN, V20, P1138, DOI 10.1094/MPMI-20-9-1138; Barker D. G., 1990, Plant Molecular Biology Reporter, V8, P40, DOI 10.1007/BF02668879; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Domenech P, 2009, J BACTERIOL, V191, P477, DOI 10.1128/JB.01132-08; Ferguson GP, 2002, J BACTERIOL, V184, P5625, DOI 10.1128/JB.184.20.5625-5632.2002; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Graham MA, 2004, PLANT PHYSIOL, V135, P1179, DOI 10.1104/pp.104.037531; Haag AF, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001169; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; LeVier K, 2000, SCIENCE, V287, P2492, DOI 10.1126/science.287.5462.2492; Marlow VL, 2009, J BACTERIOL, V191, P1519, DOI 10.1128/JB.01661-08; Maroti G, 2011, RES MICROBIOL, V162, P363, DOI 10.1016/j.resmic.2011.02.005; Mergaert P, 2006, P NATL ACAD SCI USA, V103, P5230, DOI 10.1073/pnas.0600912103; Mergaert P, 2003, PLANT PHYSIOL, V132, P161, DOI 10.1104/pp.102.018192; Missiakas D, 1997, J BACTERIOL, V179, P2465, DOI 10.1128/jb.179.8.2465-2471.1997; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Saeki K, 2011, CELL MOL LIFE SCI, V68, P1327, DOI 10.1007/s00018-011-0650-5; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Sochacki KA, 2011, P NATL ACAD SCI USA, V108, pE77, DOI 10.1073/pnas.1101130108; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; Wang D, 2010, SCIENCE, V327, P1126, DOI 10.1126/science.1184096; Wehmeier S, 2010, MICROBIOL-SGM, V156, P2702, DOI 10.1099/mic.0.039909-0; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625	29	59	60	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10791	10798		10.1074/jbc.M111.311316	http://dx.doi.org/10.1074/jbc.M111.311316			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22351783	Green Published, hybrid			2022-12-27	WOS:000302780100008
J	de Meis, L				de Meis, Leopoldo			How Enzymes Handle the Energy Derived from the Cleavage of High-energy Phosphate Compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; HEAT-PRODUCTION; ADENOSINE-TRIPHOSPHATASE; ATP SYNTHESIS; ENDOPLASMIC-RETICULUM; INORGANIC-PHOSPHATE; CALCIUM EFFLUX; BOUND ATP; H+-ATPASE; WATER		Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Bioquim Med, BR-21941902 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	de Meis, L (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Bioquim Med, BR-21941902 Rio De Janeiro, Brazil.	leodemeis@terra.com.br			Financiadora de Estudos e Projetos; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Most of the work described in this Reflections article was supported by the Financiadora de Estudos e Projetos, the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior.	BARLOGIE B, 1971, FEBS LETT, V12, P267, DOI 10.1016/0014-5793(71)80194-1; BEHRENS MI, 1985, EUR J BIOCHEM, V152, P221, DOI 10.1111/j.1432-1033.1985.tb09187.x; BOYER PD, 1973, P NATL ACAD SCI USA, V70, P2837, DOI 10.1073/pnas.70.10.2837; Boyer PD, 1998, BIOSCIENCE REP, V18, P97, DOI 10.1023/A:1020188311092; Cardoso CM, 1997, BIOCHEM J, V327, P795; CLAUSEN T, 1991, PHYSIOL REV, V71, P733, DOI 10.1152/physrev.1991.71.3.733; DAGLORIA M, 1976, J BIOL CHEM, V251, P3629; de Meis L, 1997, BIOPHYS CHEM, V68, P243, DOI 10.1016/S0301-4622(97)00050-1; De Meis L, 1998, AM J PHYSIOL-CELL PH, V274, pC1738, DOI 10.1152/ajpcell.1998.274.6.C1738; de Meis L, 2005, BIOSCIENCE REP, V25, P181, DOI 10.1007/s10540-005-2884-7; de Meis L, 2002, J MEMBRANE BIOL, V188, P1, DOI 10.1007/s00232-001-0171-5; de Meis L, 2001, J BIOL CHEM, V276, P25078, DOI 10.1074/jbc.M103318200; de Meis L, 1977, Biochemistry, V16, P4455, DOI 10.1021/bi00639a020; de Meis L, 2001, BIOSCIENCE REP, V21, P113, DOI 10.1023/A:1013640006611; de Meis L, 1974, Biochemistry, V13, P5032, DOI 10.1021/bi00721a026; de Meis L, 1974, Biochemistry, V13, P2057, DOI 10.1021/bi00707a009; de Meis L., 2003, SELECTED TOPICS HIST, V42, P591; de Meis L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009439; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; DEMEIS L, 1984, J BIOL CHEM, V259, P6090; DEMEIS L, 1986, EUR J BIOCHEM, V158, P149; DEMEIS L, 1989, BIOCHIM BIOPHYS ACTA, V973, P333, DOI 10.1016/S0005-2728(89)80440-2; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; DEMEIS L, 1987, FEBS LETT, V212, P323, DOI 10.1016/0014-5793(87)81369-8; DEMEIS L, 1985, BIOCHEMISTRY-US, V24, P7783, DOI 10.1021/bi00347a042; DEMEIS L, 1969, BIOCHIM BIOPHYS ACTA, V172, P340; DEMEIS L, 1989, BIOCHEM EDUC, V17, P127, DOI 10.1016/0307-4412(89)90090-3; DEMEIS L, 1969, J BIOL CHEM, V244, P3733; DEMEIS L, 1982, J BIOL CHEM, V257, P1289; DEMEIS L, 1981, SARCOPLASMIC RETICUL, V2; DEMORAES VLG, 1987, FEBS LETT, V222, P163, DOI 10.1016/0014-5793(87)80212-0; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; Fiske CH, 1925, J BIOL CHEM, V66, P375; Fortea MI, 2000, J BIOL CHEM, V275, P12521, DOI 10.1074/jbc.275.17.12521; GEORGE P, 1970, BIOCHIM BIOPHYS ACTA, V223, P1, DOI 10.1016/0005-2728(70)90126-X; GOFFEAU A, 1990, J BIOL CHEM, V265, P15503; GRYNSZPAN D, 1990, BIOCHEM EDUC, V18, P167, DOI 10.1016/0307-4412(90)90122-5; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; HAYES DM, 1978, J AM CHEM SOC, V100, P4331, DOI 10.1021/ja00482a002; JANSKY L, 1995, PHYSIOL REV, V75, P237, DOI 10.1152/physrev.1995.75.2.237; JANSON CA, 1979, J BIOL CHEM, V254, P3743; JORGENSEN PL, 1982, BIOCHIM BIOPHYS ACTA, V694, P27, DOI 10.1016/0304-4157(82)90013-2; KANAZAWA T, 1975, J BIOL CHEM, V250, P113; KANAZAWA T, 1973, J BIOL CHEM, V248, P3163; KANDPAL RP, 1987, BIOCHEMISTRY-US, V26, P1512, DOI 10.1021/bi00380a003; Keilin D., 1969, DEV CONCEPTS, P178; KNOWLES AF, 1975, J BIOL CHEM, V250, P1949; Levine James A., 1999, Science (Washington D C), V283, P212, DOI 10.1126/science.283.5399.212; Lipmann F, 1941, ADV ENZYMOL REL S BI, V1, P99, DOI 10.1002/9780470122464.ch4; Logan-Smith MJ, 2001, J BIOL CHEM, V276, P46905, DOI 10.1074/jbc.M108778200; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; LYTTON J, 1992, J BIOL CHEM, V267, P14483; MAKINOSE M, 1971, FEBS LETT, V12, P271, DOI 10.1016/0014-5793(71)80196-5; MAKINOSE M, 1972, FEBS LETT, V25, P113, DOI 10.1016/0014-5793(72)80466-6; MAKINOSE M, 1969, EUR J BIOCHEM, V10, P74; MAKINOSE M, 1971, FEBS LETT, V12, P269, DOI 10.1016/0014-5793(71)80195-3; Makinose M., 1966, 2 INT C BIOPH VIENN; MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006; MEIS LD, 1971, J BIOL CHEM, V246, P4759; MEIS LD, 1970, J BIOL CHEM, V245, P1883; MELTZER S, 1984, J BIOL CHEM, V259, P4244; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; NUNES MT, 1985, Z NATURFORSCH C, V40, P726; POST RL, 1975, J BIOL CHEM, V250, P691; PUYOU AG, 1986, EUR J BIOCHEM, V159, P133, DOI 10.1111/j.1432-1033.1986.tb09843.x; Reis M, 2001, J BIOL CHEM, V276, P42793, DOI 10.1074/jbc.M107625200; ROMERO PJ, 1989, J BIOL CHEM, V264, P7869; SAKAMOTO J, 1984, J BIOCHEM-TOKYO, V96, P483, DOI 10.1093/oxfordjournals.jbchem.a134860; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Tabor H, 1971, METHODS ENZYMOLOGY B, V17, P829; TANFORD C, 1984, CRC CR REV BIOCH MOL, V17, P123, DOI 10.3109/10409238409113603; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; WUYTACK F, 1994, J BIOL CHEM, V269, P1410; YU X, 1995, J BIOL CHEM, V270, P4361, DOI 10.1074/jbc.270.9.4361	74	2	2	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					16987	17005		10.1074/jbc.X112.363200	http://dx.doi.org/10.1074/jbc.X112.363200			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22427658	Green Published, hybrid			2022-12-27	WOS:000306373000001
J	Zhao, N; Liu, H; Lilly, B				Zhao, Ning; Liu, Hua; Lilly, Brenda			Reciprocal Regulation of Syndecan-2 and Notch Signaling in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; GENE-EXPRESSION; GROWTH-FACTOR; ANGIOGENESIS; MIGRATION; MICE; PHYSIOLOGY; MUTATION; DEFECTS; PATHWAY	Vascular cell interactions mediated through cell surface receptors play a critical role in the assembly and maintenance of blood vessels. These signaling interactions transmit important information that alters cell function through changes in protein dynamics and gene expression. Here, we identify syndecan-2 (SDC2) as a gene whose expression is induced in smooth muscle cells upon physical contact with endothelial cells. Syndecan-2 is a heparan sulfate proteoglycan that is known to be important for developmental processes, including angiogenesis. Our results show that endothelial cells induce mRNA expression of syndecan-2 in smooth muscle cells by activating Notch receptor signaling. Both NOTCH2 and NOTCH3 contribute to the increased expression of syndecan-2 and are themselves sufficient to promote its expression independent of endothelial cells. Syndecan family members serve as coreceptors for signaling molecules, and interestingly, our data show that syndecan-2 regulates Notch signaling and physically interacts with NOTCH3. Notch activity is attenuated in smooth muscle cells made deficient in syndecan-2, and this specifically prevents expression of the differentiation marker smooth muscle alpha-actin. These results show a novel mechanism in which Notch receptors control their own activity by inducing the expression of syndecan-2, which then acts to propagate Notch signaling by direct receptor interaction.	[Zhao, Ning; Lilly, Brenda] Ohio State Univ, Nationwide Childrens Hosp, Ctr Cardiovasc & Pulm Res, Columbus, OH 43205 USA; [Zhao, Ning; Lilly, Brenda] Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA; [Liu, Hua] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Georgia; Augusta University	Lilly, B (corresponding author), Nationwide Childrens Hosp Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	brenda.lilly@nationwidechildrens.org	LILLY, BRENDA/N-6867-2015	LILLY, BRENDA/0000-0002-3125-7496; Zhao, Ning/0000-0001-6514-234X	National Institutes of Health [R01 HL076428]; Nationwide Children's Hospital; American Heart Association [09PRE2220351]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076428] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nationwide Children's Hospital(Ohio State University); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL076428 (to B. L.). This work was also supported by Nationwide Children's Hospital funds (to B. L.) and American Heart Association Predoctoral Fellowship 09PRE2220351 (to H. L.).	Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Arrington CB, 2009, DEVELOPMENT, V136, P3143, DOI 10.1242/dev.031492; Baron M, 2003, SEMIN CELL DEV BIOL, V14, P113, DOI 10.1016/S1084-9521(02)00179-9; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brouillard P, 2003, CLIN GENET, V63, P340, DOI 10.1034/j.1399-0004.2003.00092.x; Chen E, 2004, BLOOD, V103, P1710, DOI 10.1182/blood-2003-06-1783; Chen LG, 2004, J BIOL CHEM, V279, P15715, DOI 10.1074/jbc.C300430200; Choi S, 2009, BIOCHEM BIOPH RES CO, V384, P231, DOI 10.1016/j.bbrc.2009.04.093; CizmeciSmith G, 1997, ARTERIOSCL THROM VAS, V17, P172, DOI 10.1161/01.ATV.17.1.172; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Essner JJ, 2006, INT J BIOCHEM CELL B, V38, P152, DOI 10.1016/j.biocel.2005.08.012; Fears CY, 2006, J BIOL CHEM, V281, P14533, DOI 10.1074/jbc.C600075200; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fukai N, 2009, ARTERIOSCL THROM VAS, V29, P1356, DOI 10.1161/ATVBAHA.109.190132; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Granes F, 1999, EXP CELL RES, V248, P439, DOI 10.1006/excr.1999.4437; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7; Halden Y, 2004, BIOCHEM J, V377, P533, DOI 10.1042/BJ20030729; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; Ikesue M, 2011, ARTERIOSCL THROM VAS, V31, P1066, DOI 10.1161/ATVBAHA.110.217703; Kennard S, 2008, J BIOL CHEM, V283, P1324, DOI 10.1074/jbc.M706651200; Kramer KL, 2002, DEV CELL, V2, P115, DOI 10.1016/S1534-5807(01)00107-1; Krebs LT, 2003, GENESIS, V37, P139, DOI 10.1002/gene.10241; Li YX, 2009, CIRCULATION, V119, P2686, DOI 10.1161/CIRCULATIONAHA.108.790485; Lilly B, 2009, PHYSIOL GENOMICS, V36, P69, DOI 10.1152/physiolgenomics.90318.2008; Liu H, 2010, CIRC RES, V107, P860, DOI 10.1161/CIRCRESAHA.110.218271; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; McCright B, 2001, DEVELOPMENT, V128, P491; Mombouli JV, 1999, J MOL CELL CARDIOL, V31, P61, DOI 10.1006/jmcc.1998.0844; Morrow D, 2008, CIRC RES, V103, P1370, DOI 10.1161/CIRCRESAHA.108.187534; Noguer O, 2009, EXP CELL RES, V315, P795, DOI 10.1016/j.yexcr.2008.11.016; Pisconti A, 2010, J CELL BIOL, V190, P427, DOI 10.1083/jcb.201003081; Rauch BH, 2005, J BIOL CHEM, V280, P17507, DOI 10.1074/jbc.M410848200; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Varadkar PA, 2009, GENESIS, V47, P573, DOI 10.1002/dvg.20537; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003	39	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16111	16120		10.1074/jbc.M111.322107	http://dx.doi.org/10.1074/jbc.M111.322107			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22437834	hybrid, Green Published			2022-12-27	WOS:000304030900004
J	Aghazadeh, Y; Rone, MB; Blonder, J; Ye, XY; Veenstra, TD; Hales, DB; Culty, M; Papadopoulos, V				Aghazadeh, Yasaman; Rone, Malena B.; Blonder, Josip; Ye, Xiaoying; Veenstra, Timothy D.; Hales, D. Buck; Culty, Martine; Papadopoulos, Vassilios			Hormone-induced 14-3-3 gamma Adaptor Protein Regulates Steroidogenic Acute Regulatory Protein Activity and Steroid Biosynthesis in MA-10 Leydig Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BENZODIAZEPINE RECEPTOR; MITOCHONDRIAL PROTEIN; CHOLESTEROL-BINDING; ADRENAL-CORTEX; TUMOR-CELLS; STAR ACTS; KINASE-C; PHOSPHORYLATION; EXPRESSION; MECHANISM	Cholesterol is the sole precursor of steroid hormones in the body. The import of cholesterol to the inner mitochondrial membrane, the rate-limiting step in steroid biosynthesis, relies on the formation of a protein complex that assembles at the outer mitochondrial membrane called the transduceosome. The transduceosome contains several mitochondrial and cytosolic components, including the steroidogenic acute regulatory protein (STAR). Human chorionic gonadotropin (hCG) induces de novo synthesis of STAR, a process shown to parallel maximal steroid production. In the hCG-dependent steroidogenic MA-10 mouse Leydig cell line, the 14-3-3 gamma protein was identified in native mitochondrial complexes by mass spectrometry and immunoblotting, and its levels increased in response to hCG treatment. The 14-3-3 proteins bind and regulate the activity of many proteins, acting via target protein activation, modification and localization. In MA-10 cells, cAMPinduces 14-3-3 gamma expression parallel to STAR expression. Silencing of 14-3-3 gamma expression potentiates hormone-induced steroidogenesis. Binding motifs of 14-3-3 gamma were identified in components of the transduceosome, including STAR. Immunoprecipitation studies demonstrate a hormone-dependent interaction between 14-3-3 gamma and STAR that coincides with reduced 14-3-3 gamma homodimerization. The binding site of 14-3-3 gamma on STAR was identified to be Ser-194 in the STAR-related sterol binding lipid transfer (START) domain, the site phosphorylated in response to hCG. Taken together, these results demonstrate that 14-3-3 gamma negatively regulates steroidogenesis by binding to Ser-194 of STAR, thus keeping STAR in an unfolded state, unable to induce maximal steroidogenesis. Over time 14-3-3 gamma homodimerizes and dissociates from STAR, allowing this protein to induce maximal mitochondrial steroid formation.	[Aghazadeh, Yasaman; Rone, Malena B.; Culty, Martine; Papadopoulos, Vassilios] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H3G 1A4, Canada; [Aghazadeh, Yasaman; Rone, Malena B.; Culty, Martine; Papadopoulos, Vassilios] McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada; [Culty, Martine; Papadopoulos, Vassilios] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1A4, Canada; [Papadopoulos, Vassilios] McGill Univ, Dept Biochem, Montreal, PQ H3G 1A4, Canada; [Blonder, Josip; Ye, Xiaoying; Veenstra, Timothy D.] NCI, Lab Prote & Analyt Technol, Adv Technol Program, SAIC Frederick Inc,NIH, Frederick, MD 21702 USA; [Hales, D. Buck] So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA	McGill University; McGill University; McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Southern Illinois University System; Southern Illinois University	Papadopoulos, V (corresponding author), McGill Univ, Ctr Hlth, Res Inst, 1650 Cedar Ave,C10-148, Montreal, PQ H3G 1A4, Canada.	vassilios.papadopoulos@mcgill.ca	Papadopoulos, Vassilios/AAI-2613-2019	Papadopoulos, Vassilios/0000-0002-1183-8568	Canadian Institutes of Health Research [MOP102647]; Canada Research Chair in Biochemical Pharmacology; Le Fonds de la Recherche du Quebec-Sante; Research Institute of McGill University Health Centre	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Biochemical Pharmacology; Le Fonds de la Recherche du Quebec-Sante; Research Institute of McGill University Health Centre	This work was supported by Canadian Institutes of Health Research Grant MOP102647 and a Canada Research Chair in Biochemical Pharmacology (to V. P.). The Research Institute of McGill University Health Centre was supported by a Center grant from Le Fonds de la Recherche du Quebec-Sante.; Supported in part by a predoctoral fellowship from the Research Institute of McGill University Health Centre.; Supported in part by a postdoctoral fellowship from the Research Institute of McGill University Health Centre.	Aitken A, 2002, BIOCHEM SOC T, V30, P351, DOI 10.1042/bst0300351; Aitken A, 2002, PLANT MOL BIOL, V50, P993, DOI 10.1023/A:1021261931561; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; ALAM R, 1994, J BIOCHEM-TOKYO, V116, P416, DOI 10.1093/oxfordjournals.jbchem.a124541; Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Arakane F, 1997, J BIOL CHEM, V272, P32656, DOI 10.1074/jbc.272.51.32656; Arakane F, 1996, P NATL ACAD SCI USA, V93, P13731, DOI 10.1073/pnas.93.24.13731; Arakane F, 1998, J BIOL CHEM, V273, P16339, DOI 10.1074/jbc.273.26.16339; Arakane F, 1998, ENDOCR RES, V24, P463, DOI 10.3109/07435809809032634; Baker BY, 2005, J BIOL CHEM, V280, P41753, DOI 10.1074/jbc.M510241200; BAKKER GH, 1983, MOL CELL ENDOCRINOL, V33, P243, DOI 10.1016/0303-7207(83)90170-3; Bose HS, 1999, P NATL ACAD SCI USA, V96, P7250, DOI 10.1073/pnas.96.13.7250; Bose HS, 2002, NATURE, V417, P87, DOI 10.1038/417087a; Bose M, 2008, J BIOL CHEM, V283, P8837, DOI 10.1074/jbc.M709221200; Bridges Dave, 2004, Sci STKE, V2004, pre10, DOI 10.1126/stke.2422004re10; BROWN AS, 1992, MOL CELL ENDOCRINOL, V83, P1, DOI 10.1016/0303-7207(92)90189-D; CLARK BJ, 1995, MOL ENDOCRINOL, V9, P1346, DOI 10.1210/me.9.10.1346; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; Dalal SN, 1999, MOL CELL BIOL, V19, P4465; Dyson MT, 2008, BIOL REPROD, V78, P267, DOI 10.1095/biolreprod.107.064238; Eilers AL, 2002, MOL CELL BIOL, V22, P8514, DOI 10.1128/MCB.22.24.8514-8526.2002; EPSTEIN LF, 1991, J BIOL CHEM, V266, P19739; Fleury A, 2004, J STEROID BIOCHEM, V91, P259, DOI 10.1016/j.jsbmb.2004.04.010; Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102; HACHIYA N, 1994, EMBO J, V13, P5146, DOI 10.1002/j.1460-2075.1994.tb06844.x; HACHIYA N, 1995, NATURE, V376, P705, DOI 10.1038/376705a0; HACHIYA N, 1993, EMBO J, V12, P1579, DOI 10.1002/j.1460-2075.1993.tb05802.x; Hansson V, 1999, J STEROID BIOCHEM, V69, P367, DOI 10.1016/S0960-0760(99)00077-1; HARTUNG S, 1995, BIOCHEM BIOPH RES CO, V215, P646, DOI 10.1006/bbrc.1995.2513; Hauet T, 2005, MOL ENDOCRINOL, V19, P540, DOI 10.1210/me.2004-0307; Hurley JH, 2000, CURR OPIN STRUC BIOL, V10, P737; Ichimura T, 1997, FEBS LETT, V413, P273, DOI 10.1016/S0014-5793(97)00910-1; Jefcoate C, 2002, J CLIN INVEST, V110, P881, DOI 10.1172/JCI200216771; Jo Y, 2005, BIOL REPROD, V73, P244, DOI 10.1095/biolreprod.104.037721; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kallen CB, 1998, MOL CELL ENDOCRINOL, V145, P39, DOI 10.1016/S0303-7207(98)00167-1; Lee JH, 2011, J BIOL CHEM, V286, P5136, DOI 10.1074/jbc.M110.190470; Li H, 2001, MOL ENDOCRINOL, V15, P2211, DOI 10.1210/me.15.12.2211; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; LIN D, 1995, SCIENCE, V267, P1828, DOI 10.1126/science.7892608; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Liu J, 2003, J STEROID BIOCHEM, V85, P275, DOI 10.1016/S0960-0760(03)00213-9; Liu J, 2006, J BIOL CHEM, V281, P38879, DOI 10.1074/jbc.M608820200; Liu MY, 2002, CANCER RES, V62, P6475; Manna PR, 2003, J MOL ENDOCRINOL, V30, P381, DOI 10.1677/jme.0.0300381; MARTENS GJM, 1992, BIOCHEM BIOPH RES CO, V184, P1456, DOI 10.1016/S0006-291X(05)80046-4; Mathieu AP, 2002, J MOL ENDOCRINOL, V29, P327, DOI 10.1677/jme.0.0290327; Mathieu AP, 2002, ENDOCR RES, V28, P419, DOI 10.1081/ERC-120016817; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Papadopoulos V, 2007, MOL CELL ENDOCRINOL, V265, P59, DOI 10.1016/j.mce.2006.12.004; PON LA, 1986, J BIOL CHEM, V261, P6594; Radhakrishnan VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011433; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Rone MB, 2009, BIOCHEMISTRY-US, V48, P6909, DOI 10.1021/bi900854z; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Rosenquist M, 2000, J MOL EVOL, V51, P446, DOI 10.1007/s002390010107; Shen YH, 2003, MOL BIOL CELL, V14, P4721, DOI 10.1091/mbc.E02-12-0821; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; STOCCO DM, 1991, J BIOL CHEM, V266, P19731; SUGAWARA T, 1995, BIOCHEMISTRY-US, V34, P12506, DOI 10.1021/bi00039a004; TOKER A, 1992, EUR J BIOCHEM, V206, P453, DOI 10.1111/j.1432-1033.1992.tb16946.x; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Tuckey RC, 2002, J BIOL CHEM, V277, P47123, DOI 10.1074/jbc.M206965200; Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777; Xiao Bing, 1995, Nature (London), V376, P188, DOI 10.1038/376188a0; Yacoubian TA, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	68	36	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15380	15394		10.1074/jbc.M112.339580	http://dx.doi.org/10.1074/jbc.M112.339580			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427666	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000304006300020
J	Feng, SS; Knodler, A; Ren, JQ; Zhang, J; Zhang, XY; Hong, YJ; Huang, SH; Peranen, J; Guo, W				Feng, Shanshan; Knoedler, Andreas; Ren, Jinqi; Zhang, Jian; Zhang, Xiaoyu; Hong, Yujuan; Huang, Shaohui; Peranen, Johan; Guo, Wei			A Rab8 Guanine Nucleotide Exchange Factor-Effector Interaction Network Regulates Primary Ciliogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY CILIUM; CILIARY MEMBRANE; SECRETORY VESICLES; SIGNALING CENTER; EXOCYST COMPLEX; MDCK CELLS; GTPASE; SEC2P; TRANSPORT; PROTEIN	Primary cilia are microtubule-based solitary membrane projections on the cell surface that play important roles in signaling and development. Recent studies have demonstrated that polarized vesicular trafficking involving the small GTPase Rab8 and its guanine nucleotide exchange factor Rabin8 is essential for primary ciliogenesis. In this study, we show that a highly conserved region of Rabin8 is pivotal for its activation as a guanine nucleotide exchange factor for Rab8. In addition, in its activated conformation, Rabin8 interacts with Sec15, a subunit of the exocyst and downstream effector of Rab8. Expression of constitutively activated Rab8 promotes the association of Sec15 with Rabin8. Using immunofluorescence microscopy, we found that Sec15 co-localized with Rab8 along the primary cilium. Inhibition of Sec15 function in cells led to defects in primary ciliogenesis. The Rabin8-Rab8-Sec15 interaction may couple the activation of Rab8 to the recruitment of the Rab8 effector and is involved in the regulation of vesicular trafficking for primary cilium formation.	[Feng, Shanshan; Knoedler, Andreas; Ren, Jinqi; Zhang, Jian; Zhang, Xiaoyu; Hong, Yujuan; Guo, Wei] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Huang, Shaohui] Univ Penn, Sch Med, Inst Environm Med, Philadelphia, PA 19104 USA; [Huang, Shaohui] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Peranen, Johan] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Helsinki	Guo, W (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	guowei@sas.upenn.edu	Ren, Jinqi/D-5545-2015; Zhang, xiaoyu/GXA-3206-2022; Shaohui Huang, Shaohui Huang Huang Shaohui/AAW-4531-2021; FENG, SHANSHAN/D-1344-2013	Ren, Jinqi/0000-0001-7461-0491; 	National Institutes of Health [R01 GM64690]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111128, R01GM064690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM64690 and the American Heart Association (to W.G.).	Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Das A, 2011, TRENDS CELL BIOL, V21, P383, DOI 10.1016/j.tcb.2011.03.006; Dong G, 2007, MOL CELL, V25, P455, DOI 10.1016/j.molcel.2007.01.013; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Guo W, 2000, TRENDS CELL BIOL, V10, P251, DOI 10.1016/S0962-8924(00)01754-2; Hattula K, 2005, METHOD ENZYMOL, V403, P284, DOI 10.1016/S0076-6879(05)03024-7; Hattula K, 2002, MOL BIOL CELL, V13, P3268, DOI 10.1091/mbc.E02-03-0143; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; Marshall WF, 2008, J CELL BIOL, V180, P17, DOI 10.1083/jcb.200710085; Medkova M, 2006, MOL BIOL CELL, V17, P2757, DOI 10.1091/mbc.E05-10-0917; Mizuno-Yamasaki E, 2010, DEV CELL, V18, P828, DOI 10.1016/j.devcel.2010.03.016; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Overgaard CE, 2009, MOL BIOL CELL, V20, P102, DOI 10.1091/mbc.E08-07-0741; Oztan A, 2007, MOL BIOL CELL, V18, P3978, DOI 10.1091/mbc.E07-02-0097; Pazour GJ, 2008, CURR TOP DEV BIOL, V85, P115, DOI 10.1016/S0070-2153(08)00805-3; Peranen J, 2011, CYTOSKELETON, V68, P527, DOI 10.1002/cm.20529; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rogers KK, 2004, BIOCHEM BIOPH RES CO, V319, P138, DOI 10.1016/j.bbrc.2004.04.165; Roth D, 1998, MOL BIOL CELL, V9, P1725, DOI 10.1091/mbc.9.7.1725; SALMINEN A, 1989, J CELL BIOL, V109, P1023, DOI 10.1083/jcb.109.3.1023; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Sato Y, 2007, P NATL ACAD SCI USA, V104, P8305, DOI 10.1073/pnas.0701550104; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Vega IE, 2001, J NEUROSCI, V21, P3839, DOI 10.1523/JNEUROSCI.21-11-03839.2001; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Westlake CJ, 2011, P NATL ACAD SCI USA, V108, P2759, DOI 10.1073/pnas.1018823108; Whyte JRC, 2002, J CELL SCI, V115, P2627; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200; Zhu HP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009226; Zhu HP, 2009, MOL BIOL CELL, V20, P4720, DOI 10.1091/mbc.E09-06-0453; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	44	87	87	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15602	15609		10.1074/jbc.M111.333245	http://dx.doi.org/10.1074/jbc.M111.333245			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22433857	hybrid, Green Published			2022-12-27	WOS:000304006300040
J	Meijnen, JP; de Winde, JH; Ruijssenaars, HJ				Meijnen, Jean-Paul; de Winde, Johannes H.; Ruijssenaars, Harald J.			Metabolic and Regulatory Rearrangements Underlying Efficient D-Xylose Utilization in Engineered Pseudomonas putida S12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE STRAINS; L-ARABINOSE; CORYNEBACTERIUM-GLUTAMICUM; CATABOLITE REPRESSION; GLUCOSE-METABOLISM; ZYMOMONAS-MOBILIS; ESCHERICHIA-COLI; PATHWAY; FERMENTATION; BACTERIOPHAGE-P1	Previously, an efficient D-xylose utilizing Pseudomonas putida S12 strain was obtained by introducing the D-xylose isomerase pathway from Escherichia coli, followed by evolutionary selection. In the present study, systemic changes associated with the evolved phenotype were identified by transcriptomics, enzyme activity analysis, and inverse engineering. A key element in improving the initially poor D-xylose utilization was the redistribution of 6-phospho-D-gluconate (6-PG) between the Entner-Doudoroff pathway and the oxidative pentose phosphate (PP) pathway. This redistribution increased the availability of 6-PG for oxidative decarboxylation to D-ribose-5-phosphate, which is essential for the utilization of D-xylose via the nonoxidative PP pathway. The metabolic redistribution of 6-PG was procured by modified HexR regulation, which in addition appeared to control periplasmic sugar oxidation. Because the absence of periplasmic D-xylonate formation was previously demonstrated to be essential for achieving a high biomass yield on D-xylose, the aberrant HexR control appeared to underlie both the improved growth rate and biomass yield of the evolved D-xylose utilizing P. putida strain. The increased oxidative PP pathway activity furthermore resulted in an elevated NADH/NAD(+) ratio that caused the metabolic flux to be redirected from the TCA cycle to the glyoxylate shunt, which was also activated transcriptionally. Clearly, these findings may serve as an important case in point to engineer and improve the utilization of non-natural carbon sources in a wide range of industrial microorganisms.	[Meijnen, Jean-Paul; de Winde, Johannes H.] Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands; [Meijnen, Jean-Paul; de Winde, Johannes H.; Ruijssenaars, Harald J.] Biobased Sustainable Ind Chem B Basic, NL-2628 BC Delft, Netherlands; [Meijnen, Jean-Paul; de Winde, Johannes H.; Ruijssenaars, Harald J.] Kluyver Ctr Genom Ind Fermentat, NL-2600 GA Delft, Netherlands; [Ruijssenaars, Harald J.] BIRD Engn BV, NL-3115 HG Schiedam, Netherlands	Delft University of Technology	de Winde, JH (corresponding author), Delft Univ Technol, Dept Biotechnol, Julianalaan 67, NL-2628 BC Delft, Netherlands.	J.H.DeWinde@tudelft.nl	Meijnen, Jean-Paul/AAC-5553-2020; de Winde, J.H./AAC-5520-2021	de Winde, J.H./0000-0002-7999-9317	Netherlands Ministry of Economic Affairs; B-Basic	Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); B-Basic	This work was supported by the Netherlands Ministry of Economic Affairs and the B-Basic partner organizations through B-Basic, a public-private NWO-Advanced Chemical Technologies for Sustainability program.	[Anonymous], 1982, MOL CLONING LAB MANU; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Daddaoua A, 2009, J BIOL CHEM, V284, P21360, DOI 10.1074/jbc.M109.014555; Deanda K, 1996, APPL ENVIRON MICROB, V62, P4465, DOI 10.1128/AEM.62.12.4465-4470.1996; del Castillo T, 2008, J BACTERIOL, V190, P2331, DOI 10.1128/JB.01726-07; del Castillo T, 2007, J BACTERIOL, V189, P5142, DOI 10.1128/JB.00203-07; FitzPatrick M, 2010, BIORESOURCE TECHNOL, V101, P8915, DOI 10.1016/j.biortech.2010.06.125; Fuhrer T, 2005, J BACTERIOL, V187, P1581, DOI 10.1128/JB.187.5.1581-1590.2005; Fuhrer T, 2009, J BACTERIOL, V191, P2112, DOI 10.1128/JB.01523-08; Gonzalez R, 2002, BIOTECHNOL PROGR, V18, P6, DOI 10.1021/bp010121i; Hahn-Hagerdal B, 2007, APPL MICROBIOL BIOT, V74, P937, DOI 10.1007/s00253-006-0827-2; HARTMANS S, 1989, APPL ENVIRON MICROB, V55, P2850, DOI 10.1128/AEM.55.11.2850-2855.1989; Kawaguchi H, 2008, APPL MICROBIOL BIOT, V77, P1053, DOI 10.1007/s00253-007-1244-x; Kawaguchi H, 2006, APPL ENVIRON MICROB, V72, P3418, DOI 10.1128/AEM.72.5.3418-3428.2006; Kim J, 2008, MICROBIOL-SGM, V154, P3905, DOI 10.1099/mic.0.2008/020362-0; Koopman F, 2010, P NATL ACAD SCI USA, V107, P4919, DOI 10.1073/pnas.0913039107; Kuyper M, 2005, FEMS YEAST RES, V5, P925, DOI 10.1016/j.femsyr.2005.04.004; Lange JP, 2007, BIOFUEL BIOPROD BIOR, V1, P39, DOI 10.1002/bbb.7; Lee JW, 2011, TRENDS BIOTECHNOL, V29, P370, DOI 10.1016/j.tibtech.2011.04.001; Matsushika A, 2009, APPL MICROBIOL BIOT, V84, P37, DOI 10.1007/s00253-009-2101-x; MATSUSHITA K, 1995, BIOSCI BIOTECH BIOCH, V59, P1548, DOI 10.1271/bbb.59.1548; Meijnen JP, 2008, APPL ENVIRON MICROB, V74, P5031, DOI 10.1128/AEM.00924-08; Meijnen JP, 2011, INT SUGAR J, V113, P24; Meijnen JP, 2009, APPL ENVIRON MICROB, V75, P2784, DOI 10.1128/AEM.02713-08; Milanesio P, 2011, ENVIRON MICROBIOL, V13, P324, DOI 10.1111/j.1462-2920.2010.02331.x; Nanchen A, 2008, J BACTERIOL, V190, P2323, DOI 10.1128/JB.01353-07; Nijkamp K, 2005, APPL MICROBIOL BIOT, V69, P170, DOI 10.1007/s00253-005-1973-7; Nijkamp K, 2007, APPL MICROBIOL BIOT, V74, P617, DOI 10.1007/s00253-006-0703-0; Octave S, 2009, BIOCHIMIE, V91, P659, DOI 10.1016/j.biochi.2009.03.015; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; TRIAS J, 1988, BIOCHIM BIOPHYS ACTA, V938, P493, DOI 10.1016/0005-2736(88)90148-4; van Maris AJA, 2007, ADV BIOCHEM ENG BIOT, V108, P179, DOI 10.1007/10_2007_057; Van Vleet JH, 2009, CURR OPIN BIOTECH, V20, P300, DOI 10.1016/j.copbio.2009.06.001; Verhoef S, 2007, J BIOTECHNOL, V132, P49, DOI 10.1016/j.jbiotec.2007.08.031; Verhoef S, 2009, APPL ENVIRON MICROB, V75, P931, DOI 10.1128/AEM.02186-08; Wierckx NJP, 2008, J BACTERIOL, V190, P2822, DOI 10.1128/JB.01379-07; Wierckx NJP, 2005, APPL ENVIRON MICROB, V71, P8221, DOI 10.1128/AEM.71.12.8221-8227.2005; Wisselink HW, 2007, APPL ENVIRON MICROB, V73, P4881, DOI 10.1128/AEM.00177-07; Wisselink HW, 2009, APPL ENVIRON MICROB, V75, P907, DOI 10.1128/AEM.02268-08; Yanase H, 2007, APPL ENVIRON MICROB, V73, P2592, DOI 10.1128/AEM.02302-06; ZHANG M, 1995, SCIENCE, V267, P240, DOI 10.1126/science.267.5195.240	43	14	14	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14606	14614		10.1074/jbc.M111.337501	http://dx.doi.org/10.1074/jbc.M111.337501			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22416130	Green Published, hybrid			2022-12-27	WOS:000304003200027
J	Li, JW; Xia, LJ; Su, YH; Liu, HC; Xia, XQ; Lu, QX; Yang, CJ; Reheman, K				Li, Jiang-Wei; Xia, Lijie; Su, Youhong; Liu, Hongchun; Xia, Xueqing; Lu, Qinxia; Yang, Chunjin; Reheman, Kalbinur			Molecular Imprint of Enzyme Active Site by Camel Nanobodies RAPID AND EFFICIENT APPROACH TO PRODUCE ABZYMES WITH ALLIINASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN ANTIBODY FRAGMENTS; HEAVY-CHAIN ANTIBODIES; FUNCTIONAL INTERNAL IMAGES; ANTIIDIOTYPIC ANTIBODIES; CATALYTIC ANTIBODIES; SPECTROPHOTOMETRIC ASSAY; CRYSTAL-STRUCTURE; ALLICIN; RECOGNITION; INHIBITORS	Screening of inhibitory Ab1 antibodies is a critical step for producing catalytic antibodies in the anti-idiotypic approach. However, the incompatible surface of the active site of the enzyme and the antigen-binding site of heterotetrameric conventional antibodies become the limiting step. Because camelid-derived nanobodies possess the potential to preferentially bind to the active site of enzymes due to their small size and long CDR3, we have developed a novel approach to produce antibodies with alliinase activities by exploiting the molecular mimicry of camel nanobodies. By screening the camelid-derived variable region of the heavy chain cDNA phage display library with alliinase, we obtained an inhibitory nanobody VHHA4 that recognizes the active site. Further screening with VHHA4 from the same variable domain of the heavy chain of a heavy-chain antibody library led to a higher incidence of anti-idiotypic Ab2 abzymes with alliinase activities. One of the abzymes, VHHC10, showed the highest activity that can be inhibited by Ab1VHHA4 and alliinase competitive inhibitor penicillamine and significantly suppressed the B16 tumor cell growth in the presence of alliin in vitro. The results highlight the feasibility of producing abzymes via anti-idiotypic nanobody approach.	[Li, Jiang-Wei] Xinjiang Univ, Coll Life Sci & Technol, Xinjiang Key Lab Biol Resources & Genet Engn, Dept Biotechnol, Urumqi 830046, Peoples R China	Xinjiang University	Li, JW (corresponding author), Xinjiang Univ, Coll Life Sci & Technol, Xinjiang Key Lab Biol Resources & Genet Engn, Dept Biotechnol, 14 Shengli Rd, Urumqi 830046, Peoples R China.	jwli67@sina.com			National Natural Science Foundation of China [31060132]; Science and Technology Support Project of Xinjiang, China [201091251]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Support Project of Xinjiang, China	This work was supported by National Natural Science Foundation of China Grant 31060132 and Science and Technology Support Project of Xinjiang, China, Grant 201091251 (to J. W. L.).	Avalle B, 1998, FASEB J, V12, P1055, DOI 10.1096/fasebj.12.11.1055; Avalle B, 1996, ANN NY ACAD SCI, V799, P172, DOI 10.1111/j.1749-6632.1996.tb33195.x; Avalle B, 2000, CHEM IMMUNOL, V77, P80, DOI 10.1159/000058798; Avalle S, 1998, ANN NY ACAD SCI, V864, P118, DOI 10.1111/j.1749-6632.1998.tb10294.x; Ban N, 1996, J MOL BIOL, V255, P617, DOI 10.1006/jmbi.1996.0051; Benedetti F, 2004, CHEMBIOCHEM, V5, P129, DOI 10.1002/cbic.200300738; BENTLEY GA, 1990, NATURE, V348, P254, DOI 10.1038/348254a0; Chong LT, 2003, J COMPUT CHEM, V24, P1371, DOI 10.1002/jcc.10293; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Desmyter A, 2002, J BIOL CHEM, V277, P23645, DOI 10.1074/jbc.M202327200; Dumoulin M, 2003, NATURE, V424, P783, DOI 10.1038/nature01870; FIELDS BA, 1995, NATURE, V374, P739, DOI 10.1038/374739a0; FRIBOULET A, 1994, APPL BIOCHEM BIOTECH, V47, P229, DOI 10.1007/BF02787937; FRIBOULET A, 1995, ANN NY ACAD SCI, V750, P265, DOI 10.1111/j.1749-6632.1995.tb19963.x; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Hilvert D, 2000, ANNU REV BIOCHEM, V69, P751, DOI 10.1146/annurev.biochem.69.1.751; Hu R, 1998, J BIOTECHNOL, V61, P109, DOI 10.1016/S0168-1656(98)00009-1; IZADYAR L, 1993, P NATL ACAD SCI USA, V90, P8876, DOI 10.1073/pnas.90.19.8876; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; Johnson G, 2002, J IMMUNOL METHODS, V269, P13, DOI 10.1016/S0022-1759(02)00222-3; Johnson G, 2000, MOL IMMUNOL, V37, P707, DOI 10.1016/S0161-5890(00)00104-8; JORON L, 1992, ANN NY ACAD SCI, V672, P216; Kim YR, 2006, J BIOL CHEM, V281, P15287, DOI 10.1074/jbc.M600937200; Koch-Nolte F, 2007, FASEB J, V21, P3490, DOI 10.1096/fj.07-8661com; Kuettner EB, 2002, ARCH BIOCHEM BIOPHYS, V402, P192, DOI 10.1016/S0003-9861(02)00088-7; Laskowski RA, 1996, PROTEIN SCI, V5, P2438; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Lu Qing-xia, 2012, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V28, P55; Manabe T, 1998, EUR J BIOCHEM, V257, P21, DOI 10.1046/j.1432-1327.1998.2570021.x; Miron T, 2003, MOL CANCER THER, V2, P1295; Miron T, 2002, ANAL BIOCHEM, V307, P76, DOI 10.1016/S0003-2697(02)00010-6; Miron T, 1998, ANAL BIOCHEM, V265, P317, DOI 10.1006/abio.1998.2924; Muyldermans S, 2001, J Biotechnol, V74, P277; Muyldermans S, 2001, TRENDS BIOCHEM SCI, V26, P230, DOI 10.1016/S0968-0004(01)01790-X; Nguyen VK, 2001, ADV IMMUNOL, V79, P261, DOI 10.1016/S0065-2776(01)79006-2; Oommen S, 2004, EUR J PHARMACOL, V485, P97, DOI 10.1016/j.ejphar.2003.11.059; Pillet D, 2002, J IMMUNOL METHODS, V269, P5, DOI 10.1016/S0022-1759(02)00221-1; POLLACK SJ, 1986, SCIENCE, V234, P1570, DOI 10.1126/science.3787262; Ponomarenko NA, 2007, BIOCHEMISTRY-US, V46, P14598, DOI 10.1021/bi7013954; TRAMONTANO A, 1986, SCIENCE, V234, P1566, DOI 10.1126/science.3787261; Wolfson W, 2006, CHEM BIOL, V13, P1243, DOI 10.1016/j.chembiol.2006.12.003	45	19	26	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13713	13721		10.1074/jbc.M111.336370	http://dx.doi.org/10.1074/jbc.M111.336370			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22374998	Green Published, hybrid			2022-12-27	WOS:000303996300027
J	Miller, DP; Bell, JK; McDowell, JV; Conrad, DH; Burgner, JW; Heroux, A; Marconi, RT				Miller, Daniel P.; Bell, Jessica K.; McDowell, John V.; Conrad, Daniel H.; Burgner, John W.; Heroux, Annie; Marconi, Richard T.			Structure of Factor H-binding Protein B (FhbB) of the Periopathogen, Treponema denticola INSIGHTS INTO PROGRESSION OF PERIODONTAL DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT FACTOR-H; C-REACTIVE PROTEIN; STRUCTURE VALIDATION; BACTERIAL DIVERSITY; REGULATORY PROTEIN; SURFACE PROTEIN; LYME-DISEASE; PATHOGEN; IDENTIFICATION; MOLPROBITY	Periodontitis is the most common disease of microbial etiology in humans. Periopathogen survival is dependent upon evasion of complement-mediated destruction. Treponema denticola, an important contributor to periodontitis, evades killing by the alternative complement cascade by binding factor H (FH) to its surface. Bound FH is rapidly cleaved by the T. denticola protease, dentilisin. In this report, the structure of the T. denticola FH-binding protein, FhbB, was solved to 1.7 angstrom resolution. FhbB possesses a unique fold that imparts high thermostability. The kinetics of the FH/FhbB interaction were assessed using surface plasmon resonance. A K-D value in the micromolar range (low affinity) was demonstrated, and rapid off kinetics were observed. Site-directed mutagenesis and sucrose octasulfate competition assays collectively indicate that the negatively charged face of FhbB binds within FH complement control protein module 7. This study provides significant new insight into the molecular basis of FH/FhbB interaction and advances our understanding of the role that T. denticola plays in the development and progression of periodontal disease.	[Miller, Daniel P.; Marconi, Richard T.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Med Coll Virginia, Richmond, VA 23298 USA; [Marconi, Richard T.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Med Coll Virginia, Richmond, VA 23298 USA; [Bell, Jessica K.; Burgner, John W.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Med Coll Virginia, Richmond, VA 23298 USA; [Heroux, Annie] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; United States Department of Energy (DOE); Brookhaven National Laboratory	Marconi, RT (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Med Coll Virginia, POB 980678, Richmond, VA 23298 USA.	rmarconi@vcu.edu	Bell, Jessica/I-3893-2013	Bell, Jessica/0000-0003-1455-3274; Miller, Daniel/0000-0002-1332-5870; McDowell, John/0000-0003-1635-5124; Marconi, Richard/0000-0002-6035-7306	National Institutes of Health from the NIAID-NIDCR [DE017401, 5K22CA122828-03, P30CA160589]; American Chemical Society [IRG9922504]; Offices of Biological and Environmental Research and Basic Energy Sciences of the United States Department of Energy; National Institutes of Health NCRR [P41RR012408]; NATIONAL CANCER INSTITUTE [K22CA122828] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017401] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID-NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Chemical Society(American Chemical Society); Offices of Biological and Environmental Research and Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE017401 from the NIAID-NIDCR (to R. T. M.), Grant 5K22CA122828-03, and Grant P30CA160589 (to SPR-Flow Cytometry Core, Virginia Commonwealth University). This work was also supported by American Chemical Society Grant IRG9922504 (to J. K. B.).; Data for this study were measured at beamline X25 of the National Synchrotron Light Source, supported principally by the Offices of Biological and Environmental Research and Basic Energy Sciences of the United States Department of Energy and by National Institutes of Health NCRR Grant P41RR012408.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOACKLE RJ, 1991, CRIT REV ORAL BIOL M, V2, P355, DOI 10.1177/10454411910020030401; BOACKLE RJ, 1978, J DENT RES, V57, P103, DOI 10.1177/00220345780570010101; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cordes FS, 2005, NAT STRUCT MOL BIOL, V12, P276, DOI 10.1038/nsmb902; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dewhirst FE, 2000, ORAL MICROBIOL IMMUN, V15, P196, DOI 10.1034/j.1399-302x.2000.150308.x; Ellen RP, 2005, PERIODONTOL 2000, V38, P13, DOI 10.1111/j.1600-0757.2005.00108.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Giannakis E, 2003, EUR J IMMUNOL, V33, P962, DOI 10.1002/eji.200323541; Gomes IS, 2011, J PERIODONTOL, V82, P969, DOI 10.1902/jop.2010.100511; Holers VM, 2008, IMMUNOL REV, V223, P300, DOI 10.1111/j.1600-065X.2008.00641.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hovis KM, 2006, INFECT IMMUN, V74, P2007, DOI 10.1128/IAI.74.4.2007-2014.2006; Jarva H, 1999, J IMMUNOL, V163, P3957; Kang YH, 2012, IMMUNOBIOLOGY, V217, P455, DOI 10.1016/j.imbio.2011.10.008; Krauss JL, 2010, PERIODONTOL 2000, V52, P141, DOI 10.1111/j.1600-0757.2009.00324.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDowell JV, 2011, MOL ORAL MICROBIOL, V26, P140, DOI 10.1111/j.2041-1014.2010.00598.x; McDowell JV, 2007, INFECT IMMUN, V75, P1050, DOI 10.1128/IAI.01458-06; McDowell JV, 2009, INFECT IMMUN, V77, P1417, DOI 10.1128/IAI.01544-08; McDowell JV, 2005, INFECT IMMUN, V73, P7126, DOI 10.1128/IAI.73.11.7126-7132.2005; McDowell JV, 2005, J BACTERIOL, V187, P1317, DOI 10.1128/JB.187.4.1317-1323.2005; McDowell JV, 2004, J IMMUNOL, V173, P7471, DOI 10.4049/jimmunol.173.12.7471; McDowell JV, 2003, INFECT IMMUN, V71, P3597, DOI 10.1128/IAI.71.6.3597-3602.2003; Miller DP, 2011, ACTA CRYSTALLOGR F, V67, P678, DOI 10.1107/S1744309111011298; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069; Rossmann E, 2007, J IMMUNOL, V178, P7292, DOI 10.4049/jimmunol.178.11.7292; RUDDY S, 1971, J IMMUNOL, V107, P742; SCHENKEIN H A, 1991, Critical Reviews in Oral Biology and Medicine, V2, P65; SCHENKEIN HA, 1977, J PERIODONTOL, V48, P772, DOI 10.1902/jop.1977.48.12.772; Schmidt CQ, 2008, CLIN EXP IMMUNOL, V151, P14, DOI 10.1111/j.1365-2249.2007.03553.x; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; UITTO VJ, 1988, INFECT IMMUN, V56, P2717, DOI 10.1128/IAI.56.10.2717-2722.1988; Van Dyke TE, 2003, J DENT RES, V82, P82, DOI 10.1177/154405910308200202; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Zipfel PF, 2007, MOL IMMUNOL, V44, P3850, DOI 10.1016/j.molimm.2007.06.149; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971	51	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12715	12722		10.1074/jbc.M112.339721	http://dx.doi.org/10.1074/jbc.M112.339721			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22371503	Green Published, hybrid			2022-12-27	WOS:000302903700011
J	Yeh, PC; Yeh, CC; Chen, YC; Juang, YL				Yeh, Pei-Chi; Yeh, Chang-Ching; Chen, Yi-Cheng; Juang, Yue-Li			RED, a Spindle Pole-associated Protein, Is Required for Kinetochore Localization of MAD1, Mitotic Progression, and Activation of the Spindle Assembly Checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOME SEGREGATION; CELLS; P31(COMET); COMPLEXES; ANAPHASE; BINDING; ZW10; SPLICEOSOME; STABILITY; DYNAMICS	The spindle assembly checkpoint (SAC) is essential for ensuring the proper attachment of kinetochores to the spindle and, thus, the precise separation of paired sister chromatids during mitosis. The SAC proteins are recruited to the unattached kinetochores for activation of the SAC in prometaphase. However, it has been less studied whether activation of the SAC also requires the proteins that do not localize to the kinetochores. Here, we show that the nuclear protein RED, also called IK, a down-regulator of human leukocyte antigen (HLA) II, interacts with the human SAC protein MAD1. Two RED-interacting regions identified in MAD1 are from amino acid residues 301-340 and 439-480, designated as MAD1(301-340) and MAD1(439-480), respectively. Our observations reveal that RED is a spindle pole-associated protein that colocalizes with MAD1 at the spindle poles in metaphase and anaphase. Depletion of RED can cause a shorter mitotic timing, a failure in the kinetochore localization of MAD1 in prometaphase, and a defect in the SAC. Furthermore, the RED-interacting peptides MAD1(301-340) and MAD1(439-480), fused to enhanced green fluorescence protein, can colocalize with RED at the spindle poles in prometaphase, and their expression can abrogate the SAC. Taken together, we conclude that RED is required for kinetochore localization of MAD1, mitotic progression, and activation of the SAC.	[Juang, Yue-Li] Tzu Chi Univ, Inst Microbiol Immunol & Biochem, Hualien 97004, Taiwan; [Yeh, Pei-Chi; Juang, Yue-Li] Tzu Chi Univ, Inst Med Sci, Hualien 97004, Taiwan; [Yeh, Chang-Ching] Tzu Chi Univ, Inst Mol Biol & Human Genet, Hualien 97004, Taiwan; [Chen, Yi-Cheng] Mackay Med Coll, Dept Med, New Taipei City 25245, Taiwan	Tzu Chi University; Tzu Chi University; Tzu Chi University; Mackay Medical College	Juang, YL (corresponding author), Tzu Chi Univ, Inst Microbiol Immunol & Biochem, 701,Chung Yang Rd,Sec 3, Hualien 97004, Taiwan.	yljylk@mail.tcu.edu.tw			National Health Research Institute, Taiwan [NHRI-EX95-9101BC]; Tzu-Chi Foundation	National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); Tzu-Chi Foundation	This work was supported by grants from the National Health Research Institute, Taiwan (NHRI-EX95-9101BC) and the Tzu-Chi Foundation (to Y. L. J.).	Assier E, 1999, GENE, V230, P145, DOI 10.1016/S0378-1119(99)00066-9; Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; Campbell MS, 2001, J CELL SCI, V114, P953; Chan GKT, 2000, NAT CELL BIOL, V2, P944, DOI 10.1038/35046598; Chen TC, 2009, PROTEOMICS, V9, P4048, DOI 10.1002/pmic.200900231; Chung EN, 2002, MOL BIOL CELL, V13, P1501, DOI 10.1091/mbc.02-01-0003; Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Iwanaga Y, 2002, J BIOL CHEM, V277, P31005, DOI 10.1074/jbc.M110666200; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Klebig C, 2009, J CELL BIOL, V185, P841, DOI 10.1083/jcb.200902128; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; KRIEF P, 1994, ONCOGENE, V9, P3449; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Lee SH, 2008, GENE DEV, V22, P2926, DOI 10.1101/gad.1677208; Lin YT, 2006, ONCOGENE, V25, P6901, DOI 10.1038/sj.onc.1209687; Logarinho E, 2008, MOL BIOL CELL, V19, P1798, DOI 10.1091/mbc.E07-07-0633; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Mayor T, 2000, J CELL BIOL, V151, P837, DOI 10.1083/jcb.151.4.837; McAinsh AD, 2006, EMBO J, V25, P4033, DOI 10.1038/sj.emboj.7601293; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Montembault E, 2007, J CELL BIOL, V179, P601, DOI 10.1083/jcb.200703133; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Osmundson EC, 2008, J CELL BIOL, V183, P267, DOI 10.1083/jcb.200801049; Rahmani Z, 2009, J CELL BIOL, V187, P597, DOI 10.1083/jcb.200905026; Rees S, 1996, BIOTECHNIQUES, V20, P102; Rogers L., 1998, CELLS LAB MANUAL, P1611; Salina D, 2003, J CELL BIOL, V162, P991, DOI 10.1083/jcb.200304080; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Trachana V, 2007, P NATL ACAD SCI USA, V104, P2691, DOI 10.1073/pnas.0611132104; Wang XS, 2001, J BIOL CHEM, V276, P26559, DOI 10.1074/jbc.M101083200; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	49	13	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11704	11716		10.1074/jbc.M111.299131	http://dx.doi.org/10.1074/jbc.M111.299131			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351768	Green Published, hybrid			2022-12-27	WOS:000302782200010
J	Galian, C; Bjorkholm, P; Bulleid, N; von Heijne, G				Galian, Carmen; Bjorkholm, Patrik; Bulleid, Neil; von Heijne, Gunnar			Efficient Glycosylphosphatidylinositol (GPI) Modification of Membrane Proteins Requires a C-terminal Anchoring Signal of Marginal Hydrophobicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XAA-THR SEQUONS; MATRIX METALLOPROTEINASES; GLYCOSYLATION EFFICIENCY; STRUCTURAL REQUIREMENTS; ER MEMBRANE; DE-NOVO; PEPTIDE; ATTACHMENT; TRANSAMIDASE; SEQUENCES	Many plasma membrane proteins are anchored to the membrane via a C-terminal glycosylphosphatidylinositol (GPI) moiety. The GPI anchor is attached to the protein in the endoplasmic reticulum by transamidation, a reaction in which a C-terminal GPI-attachment signal is cleaved off concomitantly with addition of the GPI moiety. GPI-attachment signals are poorly conserved on the sequence level but are all composed of a polar segment that includes the GPI-attachment site followed by a hydrophobic segment located at the very C terminus of the protein. Here, we show that efficient GPI modification requires that the hydrophobicity of the C-terminal segment is "marginal": less hydrophobic than type II transmembrane anchors and more hydrophobic than the most hydrophobic segments found in secreted proteins. We further show that the GPI-attachment signal can be modified by the transamidase irrespective of whether it is first released into the lumen of the endoplasmic reticulum or is retained in the endoplasmic reticulum membrane.	[Galian, Carmen; Bjorkholm, Patrik; von Heijne, Gunnar] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; [Bulleid, Neil] Univ Glasgow, CMVLS, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland; [von Heijne, Gunnar] Stockholm Univ, Sci Life Lab, SE-17177 Solna, Sweden	Stockholm University; University of Glasgow; Stockholm University	von Heijne, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se	von Heijne, Gunnar/F-5576-2011; von Heijne, Gunnar/AAH-9389-2019	von Heijne, Gunnar/0000-0002-4490-8569; Bjorkholm, Patrik/0000-0002-9131-4122; Bulleid, Neil/0000-0002-9839-5279	Swedish Cancer Foundation; Swedish Research Council; Swedish Foundation for Strategic Research; European Research Council [ERC-2008-AdG 232648]	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); European Research Council(European Research Council (ERC)European Commission)	This work was supported by grants from the Swedish Cancer Foundation, Swedish Research Council, Swedish Foundation for Strategic Research, and European Research Council Grant ERC-2008-AdG 232648 (to G. v. H.).	BERGER J, 1988, J BIOL CHEM, V263, P10016; Bitinaite J., 2009, CURR PROTOC MOL BIOL, V86, P3211; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; CARAS IW, 1991, J CELL BIOL, V113, P77, DOI 10.1083/jcb.113.1.77; CARAS IW, 1989, SCIENCE, V243, P1196, DOI 10.1126/science.2466338; Chen R, 2003, J CELL BIOCHEM, V88, P1025, DOI 10.1002/jcb.10439; Chen R, 2002, J CELL BIOCHEM, V84, P68, DOI 10.1002/jcb.1267; Cruz-Garcia F, 2003, SEED SCI RES, V13, P209, DOI 10.1079/SSR2003138; Dalley JA, 2003, J BIOL CHEM, V278, P51749, DOI 10.1074/jbc.M303978200; Doering T. L., 2001, CURR PROTOC MOL BIOL, V22, P1781; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; GERBER LD, 1992, J BIOL CHEM, V267, P12168; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; HOWELL S, 1994, J BIOL CHEM, V269, P16993; JOHANSSON M, 1993, MOL GEN GENET, V239, P251, DOI 10.1007/BF00281625; KODUKULA K, 1991, J BIOL CHEM, V266, P4464; KOZLOSKY CJ, 1995, ONCOGENE, V10, P299; Lundin C, 2007, FEBS LETT, V581, P3809, DOI 10.1016/j.febslet.2007.07.003; Meri S, 1996, BIOCHEM J, V316, P923, DOI 10.1042/bj3160923; Monne M, 1999, EUR J BIOCHEM, V263, P264, DOI 10.1046/j.1432-1327.1999.00498.x; MORAN P, 1991, J CELL BIOL, V115, P1595, DOI 10.1083/jcb.115.6.1595; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; NILSSON I, 1994, J CELL BIOL, V126, P1127, DOI 10.1083/jcb.126.5.1127; Nilsson I, 1998, J MOL BIOL, V284, P1165, DOI 10.1006/jmbi.1998.2217; Nilsson I, 2000, J BIOL CHEM, V275, P17338, DOI 10.1074/jbc.M002317200; NILSSON I, 1993, J BIOL CHEM, V268, P5798; NILSSON IM, 1991, J BIOL CHEM, V266, P3408; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Ohishi K, 2000, MOL BIOL CELL, V11, P1523, DOI 10.1091/mbc.11.5.1523; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; Poisson Guylaine, 2007, Genomics Proteomics & Bioinformatics, V5, P121, DOI 10.1016/S1672-0229(07)60022-9; ROTHMAN JE, 1977, NATURE, V269, P775, DOI 10.1038/269775a0; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Toh YK, 2011, J STRUCT BIOL, V173, P271, DOI 10.1016/j.jsb.2010.11.026; UDENFRIEND S, 1995, ANNU REV BIOCHEM, V64, P563, DOI 10.1146/annurev.bi.64.070195.003023; Vainauskas S, 2002, J BIOL CHEM, V277, P30535, DOI 10.1074/jbc.M205402200; Vidugiriene J, 2001, EUR J BIOCHEM, V268, P2290, DOI 10.1046/j.1432-1327.2001.02106.x; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Walmsley AR, 2001, EMBO J, V20, P703, DOI 10.1093/emboj/20.4.703; Walmsley AR, 2003, GLYCOBIOLOGY, V13, P641, DOI 10.1093/glycob/cwg080; Wang JY, 1999, J MOL BIOL, V286, P1303, DOI 10.1006/jmbi.1999.2584; YAN W, 1995, BIOCHEMISTRY-US, V34, P14594, DOI 10.1021/bi00044a039; Yan W, 1998, J MOL BIOL, V275, P25, DOI 10.1006/jmbi.1997.1447	48	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16399	16409		10.1074/jbc.M112.350009	http://dx.doi.org/10.1074/jbc.M112.350009			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22431723	Green Published, hybrid			2022-12-27	WOS:000304030900031
J	Nosrat, IV; Margolskee, RF; Nosrat, CA				Nosrat, Irina V.; Margolskee, Robert F.; Nosrat, Christopher A.			Targeted Taste Cell-specific Overexpression of Brain-derived Neurotrophic Factor in Adult Taste Buds Elevates Phosphorylated TrkB Protein Levels in Taste Cells, Increases Taste Bud Size, and Promotes Gustatory Innervation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-RELATED PEPTIDE; TRIGEMINAL SENSORY NEURONS; RAT CIRCUMVALLATE PAPILLAE; ADHESION MOLECULE NCAM; NERVE GROWTH-FACTOR; GENICULATE GANGLION; NEURITE OUTGROWTH; LINGUAL DEFICITS; TYROSINE KINASE; CHORDA TYMPANI	Brain-derived neurotrophic factor (BDNF) is the most potent neurotrophic factor in the peripheral taste system during embryonic development. It is also expressed in adult taste buds. There is a lack of understanding of the role of BDNF in the adult taste system. To address this, we generated novel transgenic mice in which transgene expression was driven by an alpha-gustducin promoter coupling BDNF expression to the postnatal expression of gustducin in taste cells. Immunohistochemistry revealed significantly stronger BDNF labeling in taste cells of high BDNF-expressing mouse lines compared with controls. We show that taste buds in these mice are significantly larger and have a larger number of taste cells compared with controls. To examine whether innervation was affected in Gust-BDNF mice, we used antibodies to neural cell adhesion molecule (NCAM) and ATP receptor P2X3. The total density of general innervation and specifically the gustatory innervation was markedly increased in high BDNF-expressing mice compared with controls. TrkB and NCAM gene expression in laser capture micro-dissected taste epithelia were significantly up-regulated in these mice. Up-regulation of TrkB transcripts in taste buds and elevated taste cell-specific TrkB phosphorylation in response to increased BDNF levels indicate that BDNF controls the expression and activation of its high affinity receptor in taste cells. This demonstrates a direct taste cell function for BDNF. BDNF also orchestrates and maintains taste bud innervation. We propose that the Gust-BDNF transgenic mouse models can be employed to further dissect the specific roles of BDNF in the adult taste system.	[Nosrat, Irina V.; Nosrat, Christopher A.] Univ Tennessee, Ctr Hlth Sci, Ctr Adult Canc Res, Memphis, TN 38163 USA; [Nosrat, Irina V.; Nosrat, Christopher A.] Univ Tennessee, Ctr Hlth Sci, Coll Med, Memphis, TN 38163 USA; [Nosrat, Irina V.; Nosrat, Christopher A.] Univ Tennessee, Ctr Hlth Sci, Coll Dent, Memphis, TN 38163 USA; [Margolskee, Robert F.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Monell Chemical Senses Center	Nosrat, CA (corresponding author), Univ Tennessee, Ctr Hlth Sci, Ctr Adult Canc Res, Rm 120,19 S Manassas St, Memphis, TN 38163 USA.	canosrat@gmail.com		Margolskee, Robert/0000-0002-9572-2887; Vukmanovic Nosrat, Irina/0000-0003-2879-1492	National Institutes of Health through NIDCD [R01-RDC007628]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003055, R01DC003155, R01DC007628] Funding Source: NIH RePORTER	National Institutes of Health through NIDCD; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health Grant R01-RDC007628 through the NIDCD.	ALBERS KM, 1994, J NEUROSCI, V14, P1422, DOI 10.1523/JNEUROSCI.14-03-01422.1994; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; BARLOW LA, 1995, DEV BIOL, V169, P273, DOI 10.1006/dbio.1995.1143; BARTOSHUK LM, 1994, PHYSIOL BEHAV, V56, P1165, DOI 10.1016/0031-9384(94)90361-1; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; Boughter JD, 1997, J NEUROSCI, V17, P2852; Boughter JD, 1997, PHYSIOL BEHAV, V63, P101, DOI 10.1016/S0031-9384(97)00398-3; Carr VM, 2005, NEUROSCIENCE, V134, P1301, DOI 10.1016/j.neuroscience.2005.05.034; Cassens C, 2010, J BIOL CHEM, V285, P28959, DOI 10.1074/jbc.M110.114835; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Chen LY, 2010, J NEUROSCI, V30, P15097, DOI 10.1523/JNEUROSCI.3549-10.2010; Clapp TR, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-6; COHEN S, 1954, P NATL ACAD SCI USA, V40, P1014, DOI 10.1073/pnas.40.10.1014; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; ERNFORS P, 1995, NEURON, V14, P1153, DOI 10.1016/0896-6273(95)90263-5; Fan LX, 2004, DEV BRAIN RES, V150, P23, DOI 10.1016/j.devbrainres.2004.02.008; FARBMAN AI, 1980, CELL TISSUE KINET, V13, P349, DOI 10.1111/j.1365-2184.1980.tb00474.x; Friedman WJ, 1998, NEUROSCIENCE, V84, P101, DOI 10.1016/S0306-4522(97)00526-5; Fritzsch B, 1997, TRENDS NEUROSCI, V20, P159, DOI 10.1016/S0166-2236(96)01007-7; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; Gulbransen BD, 2005, J NEUROCYTOL, V34, P117, DOI 10.1007/s11068-005-5051-y; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Ishida Y, 2009, J COMP NEUROL, V514, P131, DOI 10.1002/cne.22000; KINNMAN E, 1991, EXP NEUROL, V113, P85, DOI 10.1016/0014-4886(91)90150-B; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; KNAPP L, 1995, DIFFERENTIATION, V58, P341, DOI 10.1046/j.1432-0436.1995.5850341.x; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Krimm RF, 2001, DEV BIOL, V232, P508, DOI 10.1006/dbio.2001.0190; Krimm RF, 1998, J COMP NEUROL, V398, P13; Krimm RF, 2006, ANAT REC PART A, V288A, P1294, DOI 10.1002/ar.a.20399; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Lindemann B, 1996, CURR BIOL, V6, P1234, DOI 10.1016/S0960-9822(96)00704-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; MONTAVON P, 1991, REGUL PEPTIDES, V36, P235, DOI 10.1016/0167-0115(91)90059-P; MURRAY RG, 1967, J ULTRA MOL STRUCT R, V19, P327, DOI 10.1016/S0022-5320(67)80224-7; NELSON GM, 1993, J COMP NEUROL, V336, P507, DOI 10.1002/cne.903360404; Nosrat CA, 1997, DEVELOPMENT, V124, P1333; Nosrat IV, 2004, J NEUROCYTOL, V33, P607, DOI 10.1007/s11068-005-3330-2; Nosrat IV, 2000, J COMP NEUROL, V417, P133; Rebello MR, 2011, J HISTOCHEM CYTOCHEM, V59, P530, DOI 10.1369/0022155411402352; Ringstedt T, 1999, J NEUROSCI, V19, P3507; Simonetti M, 2008, J BIOL CHEM, V283, P18743, DOI 10.1074/jbc.M800296200; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; Vutskits L, 2001, EUR J NEUROSCI, V13, P1391, DOI 10.1046/j.0953-816x.2001.01516.x; Wong GT, 1999, J NEUROSCI, V19, P5802, DOI 10.1523/JNEUROSCI.19-14-05802.1999; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F; Yee C, 2005, J COMP NEUROL, V490, P371, DOI 10.1002/cne.20670; Yee CL, 2003, J COMP NEUROL, V459, P15, DOI 10.1002/cne.10589; Yoshii A, 2011, J NEUROSCI, V31, P11894, DOI 10.1523/JNEUROSCI.2190-11.2011; Zaidi FN, 2007, J NEUROSCI, V27, P13875, DOI 10.1523/JNEUROSCI.2517-07.2007; ZHANG CX, 1995, DIFFERENTIATION, V59, P155, DOI 10.1046/j.1432-0436.1995.5930155.x	57	20	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16791	16800		10.1074/jbc.M111.328476	http://dx.doi.org/10.1074/jbc.M111.328476			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22442142	hybrid, Green Published			2022-12-27	WOS:000304030900066
J	Colombrita, C; Onesto, E; Megiorni, F; Pizzuti, A; Baralle, FE; Buratti, E; Silani, V; Ratti, A				Colombrita, Claudia; Onesto, Elisa; Megiorni, Francesca; Pizzuti, Antonio; Baralle, Francisco E.; Buratti, Emanuele; Silani, Vincenzo; Ratti, Antonia			TDP-43 and FUS RNA-binding Proteins Bind Distinct Sets of Cytoplasmic Messenger RNAs and Differently Regulate Their Post-transcriptional Fate in Motoneuron-like Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; ENDOTHELIAL GROWTH-FACTOR; STRESS GRANULES; MUTATIONS; ALS; TARGETS; DROSOPHILA; FUS/TLS; VEGF	The RNA-binding proteins TDP-43 and FUS form abnormal cytoplasmic aggregates in affected tissues of patients with amyotrophic lateral sclerosis and frontotemporal lobar dementia. TDP-43 and FUS localize mainly in the nucleus where they regulate pre-mRNA splicing, but they are also involved in mRNA transport, stability, and translation. To better investigate their cytoplasmic activities, we applied an RNA immunoprecipitation and chip analysis to define the mRNAs associated to TDP-43 and FUS in the cytoplasmic ribonucleoprotein complexes from motoneuronal NSC-34 cells. We found that they bind different sets of mRNAs although converging on common cellular pathways. Bioinformatics analyses identified the (UG)(n) consensus motif in 80% of 3'-UTR sequences of TDP-43 targets, whereas for FUS the binding motif was less evident. By in vitro assays we validated binding to selected target 3'-UTRs, including Vegfa and Grn for TDP-43, and Vps54, Nvl, and Taf15 for FUS. We showed that TDP-43 has a destabilizing activity on Vegfa and Grn mRNAs and may ultimately affect progranulin protein content, whereas FUS does not affect mRNA stability/translation of its targets. We also demonstrated that three different point mutations in TDP-43 did not change the binding affinity for Vegfa and Grn mRNAs or their protein level. Our data indicate that TDP-43 and FUS recognize distinct sets of mRNAs and differently regulate their fate in the cytoplasm of motoneuron-like cells, therefore suggesting complementary roles in neuronal RNA metabolism and neurodegeneration.	[Colombrita, Claudia; Onesto, Elisa; Silani, Vincenzo; Ratti, Antonia] IRCCS Ist Auxol Italiano, Dept Neurol, I-20149 Milan, Italy; [Colombrita, Claudia; Onesto, Elisa; Silani, Vincenzo; Ratti, Antonia] IRCCS Ist Auxol Italiano, Neurosci Lab, I-20149 Milan, Italy; [Megiorni, Francesca; Pizzuti, Antonio] Univ Roma La Sapienza, Dept Expt Med, I-00161 Rome, Italy; [Baralle, Francisco E.; Buratti, Emanuele] Int Ctr Genet Engn & Biotechnol, I-34149 Trieste, Italy; [Silani, Vincenzo; Ratti, Antonia] Univ Milan, Dept Neurol Sci, Dino Ferrari Ctr, I-20122 Milan, Italy	IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano; Sapienza University Rome; International Center for Genetic Engineering & Biotechnology (ICGEB); University of Milan	Ratti, A (corresponding author), IRCCS Ist Auxol Italiano, Dept Neurol, Via Zucchi 18, I-20095 Milan, Italy.	antonia.ratti@unimi.it	Megiorni, Francesca/AAC-1597-2019; Silani, Vincenzo/P-4421-2017; Buratti, Emanuele/K-4691-2016; colombrita, claudia/A-3295-2009	Megiorni, Francesca/0000-0003-3705-3248; Silani, Vincenzo/0000-0002-7698-3854; Buratti, Emanuele/0000-0002-1356-9074; colombrita, claudia/0000-0001-6567-8910; PIZZUTI, Antonio/0000-0003-3245-1925	Italian Agency of Research on ALS (AriSLA); Fondazione CARIPLO [2008-2307]	Italian Agency of Research on ALS (AriSLA); Fondazione CARIPLO(Fondazione Cariplo)	This work was supported by the Italian Agency of Research on ALS (AriSLA) (Grant RBPALS) and Fondazione CARIPLO (Grant 2008-2307).	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Belly A, 2005, NEUROSCI LETT, V379, P152, DOI 10.1016/j.neulet.2004.12.071; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Borroni B, 2008, REJUV RES, V11, P773, DOI 10.1089/rej.2008.0711; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2010, RNA BIOL, V7, P420, DOI 10.4161/rna.7.4.12205; Colombrita C, 2011, ARCH ITAL BIOL, V149, P83, DOI 10.4449/aib.v149i1.1261; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Corrado L, 2009, HUM MUTAT, V30, P688, DOI 10.1002/humu.20950; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; Devos D, 2004, NEUROLOGY, V62, P2127, DOI 10.1212/01.WNL.0000129913.44351.A3; Dormann D., 2011, TRENDS NEUR IN PRESS; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Fujii R, 2005, J CELL SCI, V118, P5755, DOI 10.1242/jcs.02692; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Gal J, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.06.010; Gass J., 2012, BRAIN RES IN PRESS; Gorba T, 2006, EXP CELL RES, V312, P3060, DOI 10.1016/j.yexcr.2006.06.020; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Irwin D, 2009, J NEUROL SCI, V276, P9, DOI 10.1016/j.jns.2008.08.024; Jiao J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010551; Kawahara Y, 2012, P NATL ACAD SCI USA, V109, P3347, DOI 10.1073/pnas.1112427109; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Kovar Heinrich, 2011, Sarcoma, V2011, P1, DOI 10.1155/2011/837474; Kryndushkin D, 2011, PROTEIN CELL, V2, P223, DOI 10.1007/s13238-011-1525-0; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lanson NA, 2011, HUM MOL GENET, V20, P2510, DOI 10.1093/hmg/ddr150; Lerga A, 2001, J BIOL CHEM, V276, P6807, DOI 10.1074/jbc.M008304200; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Nagahama M, 2004, MOL BIOL CELL, V15, P5712, DOI 10.1091/mbc.E04-08-0692; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Ratti A, 2008, J BIOL CHEM, V283, P7531, DOI 10.1074/jbc.M706082200; Sathasivam S, 2008, NEUROSCI RES, V62, P71, DOI 10.1016/j.neures.2008.06.008; Schmitt-John T, 2005, NAT GENET, V37, P1213, DOI 10.1038/ng1661; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Sharma A, 2005, EXP CELL RES, V309, P185, DOI 10.1016/j.yexcr.2005.05.014; Sleegers K, 2008, NEUROLOGY, V71, P253, DOI 10.1212/01.wnl.0000289191.54852.75; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Ticozzi N, 2011, AM J MED GENET B, V156B, P285, DOI 10.1002/ajmg.b.31158; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; van Blitterswijk M, 2010, NEUROGENETICS, V11, P275, DOI 10.1007/s10048-010-0239-4; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Wang JW, 2011, J CLIN INVEST, V121, P4118, DOI 10.1172/JCI57883; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Xiao SX, 2011, MOL CELL NEUROSCI, V47, P167, DOI 10.1016/j.mcn.2011.02.013	67	184	186	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15635	15647		10.1074/jbc.M111.333450	http://dx.doi.org/10.1074/jbc.M111.333450			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427648	hybrid, Green Published			2022-12-27	WOS:000304006300043
J	Jules, J; Zhang, P; Ashley, JW; Wei, S; Shi, ZQ; Liu, JZ; Michalek, SM; Feng, X				Jules, Joel; Zhang, Ping; Ashley, Jason W.; Wei, Shi; Shi, Zhenqi; Liu, Jianzhong; Michalek, Suzanne M.; Feng, Xu			Molecular Basis of Requirement of Receptor Activator of Nuclear Factor kappa B Signaling for Interleukin 1-mediated Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; RANK CYTOPLASMIC MOTIF; BONE-RESORPTION; RHEUMATOID-ARTHRITIS; TNF-ALPHA; FAMILY-MEMBERS; DIFFERENTIATION; CELLS; LIGAND; STIMULATION	IL-1, a proinflammatory cytokine, is implicated in bone loss in various pathological conditions by promoting osteoclast formation, survival, and function. Although IL-1 alone can sufficiently prolong osteoclast survival and activate osteoclast function, IL-1-mediated osteoclastogenesis requires the receptor activator of NF-kappa B (RANK) ligand (RANKL). However, the molecular basis of the dependence of IL-1-mediated osteoclastogenesis on RANKL is not fully understood. Here we show that although IL-1 cannot activate the expression of the osteoclast genes encoding matrix metalloproteinase 9, cathepsin K, tartrate-resistant acid phosphatase, and carbonic anhydrase II in bone marrow macrophages (BMMs), RANKL renders these osteoclast genes responsive to IL-1. We further demonstrate that IL-1 alone fails to induce the expression of nuclear factor of activated T cell cytoplasmic 1 (NFATc1), a master transcriptional regulator of osteoclastogenesis), in BMMs but can up-regulate its expression in the presence of permissive levels of RANKL or with RANKL pretreatment. The RANK IVVY motif, which has been previously shown to commit BMMs to the osteoclast lineage in RANKL- and TNF alpha-mediated osteoclastogenesis, also plays a crucial role in IL-1-mediated osteoclastogenesis by changing the four osteoclast marker and NFATc1 genes to an IL-1-inducible state. Finally, we show that MyD88, a known critical component of the IL-1 receptor I signaling pathway, plays a crucial role in IL-1-mediated osteoclastogenesis from RANKL-primed BMMs by up-regulating the expression of the osteoclast marker and NFATc1 genes. This study reveals a novel mechanism of IL-1-mediated osteoclastogenesis and supports the promising potential of the IVVY motif to serve as a therapeutic target for inflammatory bone loss.	[Jules, Joel; Ashley, Jason W.; Wei, Shi; Shi, Zhenqi; Liu, Jianzhong; Feng, Xu] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Zhang, Ping; Michalek, Suzanne M.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Feng, X (corresponding author), Univ Alabama Birmingham, Dept Pathol, 1670 Univ Blvd,Volker Hall,G046B, Birmingham, AL 35294 USA.	xufeng@uab.edu	Ashley, Jason Waid/S-9142-2019	Ashley, Jason/0000-0003-1064-542X; Zhang, Ping/0000-0002-4585-9893	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health [AR47830, 5P30 AR046031]; NIAMS, National Institutes of Health Graduate Research Supplement [AR47830]; Research and Education Foundation of American College of Rheumatology; University of Alabama at Birmingham Center for Metabolic Bone Disease [T32 AR047512]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047830, P30AR046031, P30AR048311, T32AR047512] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS, National Institutes of Health Graduate Research Supplement; Research and Education Foundation of American College of Rheumatology; University of Alabama at Birmingham Center for Metabolic Bone Disease; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work is supported, in whole or in part, by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health grant AR47830 (to X. F.) NIAMS, National Institutes of Health Graduate Research Supplement to AR47830 (to J. J.), and NIAMS, National Institutes of Health Grant 5P30 AR046031 (to the University of Alabama at Birminghan Core Center for Basic Skeletal Research (CCBSR)). This work was also supported by a Within Our Reach innovative basic research grant from the Research and Education Foundation of American College of Rheumatology (to X. F.) and training fellowship T32 AR047512 from the University of Alabama at Birmingham Center for Metabolic Bone Disease (to J. W. A.).	Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; Beyaert R, 1998, CYTOKINES, P335, DOI 10.1016/B978-012498340-3/50025-7; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cappellen D, 2002, J BIOL CHEM, V277, P21971, DOI 10.1074/jbc.M200434200; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Feng X, 2005, GENE, V350, P1, DOI 10.1016/j.gene.2005.01.014; Feng X, 2001, J CLIN INVEST, V107, P1137, DOI 10.1172/JCI12040; Furst DE, 2004, CLIN THER, V26, P1960, DOI 10.1016/j.clinthera.2004.12.019; GOWEN M, 1985, J CLIN INVEST, V75, P1223, DOI 10.1172/JCI111819; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Hara Y, 1998, CALCIFIED TISSUE INT, V63, P63, DOI 10.1007/s002239900490; HEATH JK, 1985, CALCIFIED TISSUE INT, V37, P95; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Jimi E, 1998, J BIOL CHEM, V273, P8799, DOI 10.1074/jbc.273.15.8799; Jimi E, 1999, EXP CELL RES, V247, P84, DOI 10.1006/excr.1998.4320; Jules J, 2010, J BIOL CHEM, V285, P37427, DOI 10.1074/jbc.M110.149484; Karmakar S, 2010, RHEUM DIS CLIN N AM, V36, P385, DOI 10.1016/j.rdc.2010.03.003; Kim H, 2009, J CLIN INVEST, V119, P813, DOI 10.1172/JCI36809; Kim JH, 2009, J IMMUNOL, V183, P1862, DOI 10.4049/jimmunol.0803007; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Li P, 2004, J BONE MINER RES, V19, P207, DOI 10.1359/JBMR.0301233; Li XT, 2002, ENDOCRINOLOGY, V143, P3105, DOI 10.1210/en.143.8.3105; Liu W, 2005, J BIOL CHEM, V280, P43064, DOI 10.1074/jbc.M509006200; Liu W, 2004, J BIOL CHEM, V279, P54759, DOI 10.1074/jbc.M404687200; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Ma T, 2004, CYTOKINE, V26, P138, DOI 10.1016/j.cyto.2004.02.001; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Nakamura I, 2006, VITAM HORM, V74, P357, DOI 10.1016/S0083-6729(06)74015-8; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; O'Brien CA, 1999, J BIOL CHEM, V274, P19301, DOI 10.1074/jbc.274.27.19301; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Pacifici R, 1998, ENDOCRINOLOGY, V139, P2659, DOI 10.1210/en.139.6.2659; PACIFICI R, 1987, P NATL ACAD SCI USA, V84, P4616, DOI 10.1073/pnas.84.13.4616; PACIFICI R, 1991, P NATL ACAD SCI USA, V88, P5134, DOI 10.1073/pnas.88.12.5134; Strand V, 2004, RHEUMATOLOGY, V43, P10, DOI 10.1093/rheumatology/keh202; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Xu DR, 2006, J BIOL CHEM, V281, P4678, DOI 10.1074/jbc.M510383200; Xu DR, 2004, BIOCHEM J, V383, P219, DOI 10.1042/BJ20040961	45	55	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15728	15738		10.1074/jbc.M111.296228	http://dx.doi.org/10.1074/jbc.M111.296228			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22416138	Green Published, hybrid			2022-12-27	WOS:000304006300051
J	Yoo, JO; Lim, YC; Kim, YM; Ha, KS				Yoo, Je-Ok; Lim, Young-Cheol; Kim, Young-Myeong; Ha, Kwon-Soo			Transglutaminase 2 Promotes Both Caspase-dependent and Caspase-independent Apoptotic Cell Death via the Calpain/Bax Protein Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED PHOTODYNAMIC THERAPY; EPIDERMAL-GROWTH-FACTOR; TISSUE TRANSGLUTAMINASE; CANCER CELLS; ENDOPLASMIC-RETICULUM; INTRACELLULAR CA2+; ACTIVATION; STRESS; MECHANISMS; INDUCTION	Transglutaminase 2(TG2) is a versatile protein that is implicated in significant biological processes, including cell death and degenerative diseases. A possible role of TG2 in the apoptotic death of cancer cells induced by photodynamic therapy (PDT) was suggested recently; however, the mechanism by which TG2 regulates apoptotic responses to PDT remains to be elucidated. In this study, we investigated the key signaling pathways stimulated during apoptotic cell death following PDT and whether inhibition of TG2 activation using pharmacological approaches and siRNAs affects the signaling pathways. PDT caused the release of both cytochrome c and apoptosis-inducing factor (AIF) by damaging mitochondria, which resulted in caspase-dependent and caspase-independent apoptotic cell death, respectively. Released AIF translocated to the nucleus and, synergistically with the caspase-dependent pathway, led to apoptotic cell death. Both the caspase cascade and the activation of AIF following PDT were mediated by TG2 activation. In addition, PDT-activated calpain was responsible for the sequential events of Bax translocation, the collapse of Delta Psi(m), caspase-3 activation, and AIF translocation, all of which were provoked by TG2 activation. Together, these results demonstrate that PDT with a chlorin-based photosensitizer targets TG2 by activating calpain-linduced Bax translocation, which induces apoptotic cell death through both caspase-dependent and AIF-mediated pathways. Moreover, these results indicate that TG2 may be a possible therapeutic target for PDT treatment of cancer.	[Ha, Kwon-Soo] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Chunchon 200701, Kangwon Do, South Korea; Kangwon Natl Univ, Sch Med, Inst Med Sci, Chunchon 200701, Kangwon Do, South Korea	Kangwon National University; Kangwon National University	Ha, KS (corresponding author), Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Kangwondaehak Gil 1, Chunchon 200701, Kangwon Do, South Korea.	ksha@kangwon.ac.kr	Ha, Kwon-Soo/AAU-4417-2020	Ha, Kwon-Soo/0000-0002-4219-1787	Korea Research Foundation [2008-05943]; Ministry of Health and Welfare [1020420]; Korean Ministry of Education, Science, and Technology (Medical & Bio-Materials Research Center)	Korea Research Foundation(National Research Foundation of Korea); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Korean Ministry of Education, Science, and Technology (Medical & Bio-Materials Research Center)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported in part by Basic Research Program Grant 2008-05943 from the Korea Research Foundation, National R&D Program for Cancer Control Grant 1020420 from the Ministry of Health and Welfare, and the Korean Ministry of Education, Science, and Technology (Regional Core Research Program/Medical & Bio-Materials Research Center).	Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Almeida RD, 2004, BBA-REV CANCER, V1704, P59, DOI 10.1016/j.bbcan.2004.05.003; Antonyak MA, 2009, J BIOL CHEM, V284, P17914, DOI 10.1074/jbc.M109.013037; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Caccamo D, 2010, AMINO ACIDS, V38, P653, DOI 10.1007/s00726-009-0428-3; Chung PS, 2009, CANCER BIOL THER, V8, P1343, DOI 10.4161/cbt.8.14.8693; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Filiano AJ, 2010, NEUROBIOL DIS, V39, P334, DOI 10.1016/j.nbd.2010.04.018; Fok JY, 2007, APOPTOSIS, V12, P1455, DOI 10.1007/s10495-007-0079-3; Furre IE, 2005, CANCER RES, V65, P11051, DOI 10.1158/0008-5472.CAN-05-0510; Furre IE, 2006, APOPTOSIS, V11, P2031, DOI 10.1007/s10495-006-0190-x; Haggie PM, 2002, J BIOL CHEM, V277, P40782, DOI 10.1074/jbc.M207456200; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Isaeva EV, 2005, J PHYSIOL-LONDON, V565, P855, DOI 10.1113/jphysiol.2005.086280; Kao SH, 2010, J CELL BIOCHEM, V110, P660, DOI 10.1002/jcb.22577; Lee MJ, 2009, TOXICOLOGY, V264, P205, DOI 10.1016/j.tox.2009.08.012; Lee ZW, 2003, BIOCHEM BIOPH RES CO, V305, P633, DOI 10.1016/S0006-291X(03)00835-0; Lee ZW, 2000, CELL SIGNAL, V12, P91, DOI 10.1016/S0898-6568(99)00069-8; Lindfors K, 2010, AUTOIMMUN REV, V9, P744, DOI 10.1016/j.autrev.2010.06.003; Lorenzo HK, 2007, DRUG RESIST UPDATE, V10, P235, DOI 10.1016/j.drup.2007.11.001; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Mehta K, 2010, BIOCHEM PHARMACOL, V80, P1921, DOI 10.1016/j.bcp.2010.06.029; Nadalutti C, 2011, CELL PROLIFERAT, V44, P49, DOI 10.1111/j.1365-2184.2010.00716.x; Ortel B, 2009, FRONT BIOSCI-LANDMRK, V14, P4157, DOI 10.2741/3520; Park D, 2010, AMINO ACIDS, V39, P619, DOI 10.1007/s00726-010-0500-z; Robertson CA, 2009, J PHOTOCH PHOTOBIO B, V96, P1, DOI 10.1016/j.jphotobiol.2009.04.001; Robitaille K, 2008, CELL DEATH DIFFER, V15, P1522, DOI 10.1038/cdd.2008.77; Ruan QM, 2007, J NEUROCHEM, V102, P25, DOI 10.1111/j.1471-4159.2007.04491.x; Sanges D, 2006, APOPTOSIS, V11, P1629, DOI 10.1007/s10495-006-9006-2; Sarang Z, 2007, CELL DEATH DIFFER, V14, P1842, DOI 10.1038/sj.cdd.4402193; Shin DM, 2008, FASEB J, V22, P2498, DOI 10.1096/fj.07-095455; Song H, 2011, J RECEPT SIG TRANSD, V31, P66, DOI 10.3109/10799893.2010.529577; Sanchez-Gomez MV, 2011, J NEUROSCI, V31, P2996, DOI 10.1523/JNEUROSCI.5578-10.2011; Vittar NBR, 2010, INT J BIOCHEM CELL B, V42, P1123, DOI 10.1016/j.biocel.2010.03.019; Yi SJ, 2004, BIOCHEM BIOPH RES CO, V325, P819, DOI 10.1016/j.bbrc.2004.10.122; Yoo JO, 2011, J CELL BIOCHEM, V112, P3061, DOI 10.1002/jcb.23231; Yoo JO, 2005, BIOCHEM BIOPH RES CO, V337, P655, DOI 10.1016/j.bbrc.2005.09.108; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	38	31	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14377	14388		10.1074/jbc.M111.326074	http://dx.doi.org/10.1074/jbc.M111.326074			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22418443	Green Published, hybrid			2022-12-27	WOS:000304003200006
J	Santhekadur, PK; Das, SK; Gredler, R; Chen, D; Srivastava, J; Robertson, C; Baldwin, AS; Fisher, PB; Sarkar, D				Santhekadur, Prasanna Kumar; Das, Swadesh K.; Gredler, Rachel; Chen, Dong; Srivastava, Jyoti; Robertson, Chadia; Baldwin, Albert S., Jr.; Fisher, Paul B.; Sarkar, Devanand			Multifunction Protein Staphylococcal Nuclease Domain Containing 1 (SND1) Promotes Tumor Angiogenesis in Human Hepatocellular Carcinoma through Novel Pathway That Involves Nuclear Factor kappa B and miR-221	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE INTRAEPITHELIAL NEOPLASIA; CANCER PROGRESSION; P100; EXPRESSION; COACTIVATOR; METASTASIS; ACTIVATION; COMPONENT; TUDOR; AKT	Staphylococcal nuclease domain-containing 1 (SND1) is a multifunctional protein that is overexpressed in multiple cancers, including hepatocellular carcinoma (HCC). Stable overexpression of SND1 in Hep3B cells expressing a low level of SND1 augments, whereas stable knockdown of SND1 in QGY-7703 cells expressing a high level of SND1 inhibits establishment of xenografts in nude mice, indicating that SND1 promotes an aggressive tumorigenic phenotype. In this study we analyzed the role of SND1 in regulating tumor angiogenesis, a hallmark of cancer. Conditioned medium from Hep3B-SND1 cells stably overexpressing SND1 augmented, whereas that from QGY-SND1si cells stably overexpressing SND1 siRNA significantly inhibited angiogenesis, as analyzed by a chicken chorioallantoic membrane assay and a human umbilical vein endothelial cell differentiation assay. We unraveled a linear pathway in which SND1-induced activation of NF-kappa B resulted in induction of miR-221 and subsequent induction of angiogenic factors Angiogenin and CXCL16. Inhibition of either of these components resulted in significant inhibition of SND1-induced angiogenesis, thus highlighting the importance of this molecular cascade in regulating SND1 function. Because SND1 regulates NF-kappa B and miR-221, two important determinants of HCC controlling the aggressive phenotype, SND1 inhibition might be an effective strategy to counteract this fatal malady.	[Santhekadur, Prasanna Kumar; Das, Swadesh K.; Gredler, Rachel; Srivastava, Jyoti; Robertson, Chadia; Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, Dept Human & Mol Genet, Sch Med, Richmond, VA 23298 USA; [Chen, Dong] Virginia Commonwealth Univ, Dept Pathol, Sch Med, Richmond, VA 23298 USA; [Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, Inst Mol Med, Sch Med, Richmond, VA 23298 USA; [Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, Massey Canc Ctr, Sch Med, Richmond, VA 23298 USA; [Baldwin, Albert S., Jr.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of North Carolina; University of North Carolina Chapel Hill	Sarkar, D (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Sch Med, 1220 E Broad St,POB 980035, Richmond, VA 23298 USA.	dsarkar@vcu.edu	chen, dong/A-6889-2012; Santhekadur, Prasanna/O-7006-2019; Srivastava, Jyoti/AAD-7610-2022; SRIVASTAVA, JYOTI/J-6065-2014	chen, dong/0000-0001-6661-9410; Santhekadur, Prasanna/0000-0003-3338-375X; SRIVASTAVA, JYOTI/0000-0002-5727-741X	Dana Foundation; James S. McDonnell Foundation; Massey Cancer Center; National Cancer Institute [R01 CA138540, R01 CA134721]; NATIONAL CANCER INSTITUTE [R01CA134721, R01CA138540] Funding Source: NIH RePORTER	Dana Foundation; James S. McDonnell Foundation; Massey Cancer Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the Dana Foundation, the James S. McDonnell Foundation, a Massey Cancer Center pilot project grant, and National Cancer Institute Grants R01 CA138540 (to D. S.) and R01 CA134721 (to P. B. F.).	Abel S, 2004, J IMMUNOL, V172, P6362, DOI 10.4049/jimmunol.172.10.6362; Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Blanco MA, 2011, J BIOL CHEM, V286, P19982, DOI 10.1074/jbc.M111.240077; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Chandrasekar B, 2004, J BIOL CHEM, V279, P3188, DOI 10.1074/jbc.M311660200; Das SK, 2010, P NATL ACAD SCI USA, V107, P11948, DOI 10.1073/pnas.0914143107; Deng L, 2010, BBA-REV CANCER, V1806, P42, DOI 10.1016/j.bbcan.2010.01.004; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; Galardi S, 2011, NUCLEIC ACIDS RES, V39, P3892, DOI 10.1093/nar/gkr006; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Hartmann A, 1999, CANCER RES, V59, P1578; Hisai H, 2003, CLIN CANCER RES, V9, P4852; Ho J, 2009, J PROTEOME RES, V8, P583, DOI 10.1021/pr8007368; Ibaragi S, 2009, MOL CANCER RES, V7, P415, DOI 10.1158/1541-7786.MCR-08-0137; Kuruma H, 2009, AM J PATHOL, V174, P2044, DOI 10.2353/ajpath.2009.080776; Leverson JD, 1998, MOL CELL, V2, P417, DOI 10.1016/S1097-2765(00)80141-0; Li CL, 2008, NUCLEIC ACIDS RES, V36, P3579, DOI 10.1093/nar/gkn236; Li SP, 2012, J CELL PHYSIOL, V227, P1639, DOI 10.1002/jcp.22881; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Pang R, 2006, CANCER LETT, V242, P151, DOI 10.1016/j.canlet.2006.01.008; Paukku K, 2003, MOL ENDOCRINOL, V17, P1805, DOI 10.1210/me.2002-0256; Paukku K, 2008, NUCLEIC ACIDS RES, V36, P4474, DOI 10.1093/nar/gkn411; Pfeifer A, 2000, P NATL ACAD SCI USA, V97, P12227, DOI 10.1073/pnas.220399597; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Rocnik EF, 2006, J BIOL CHEM, V281, P22855, DOI 10.1074/jbc.M513463200; Sarkar D, 2008, CANCER RES, V68, P1478, DOI 10.1158/0008-5472.CAN-07-6164; Shimoyama S, 1999, CLIN CANCER RES, V5, P1125; Shimoyama S, 1996, CANCER RES, V56, P2703; Sundstrom JF, 2009, NAT CELL BIOL, V11, P1347, DOI 10.1038/ncb1979; Tello-Montoliu A, 2006, J THROMB HAEMOST, V4, P1864, DOI 10.1111/j.1538-7836.2006.01995.x; TONG X, 1995, MOL CELL BIOL, V15, P4735; Tsuchiya N, 2007, CANCER RES, V67, P9568, DOI 10.1158/0008-5472.CAN-06-2707; Wang JH, 2008, CANCER RES, V68, P10367, DOI 10.1158/0008-5472.CAN-08-2780; Yang J, 2002, EMBO J, V21, P4950, DOI 10.1093/emboj/cdf463; Yang J, 2007, NUCLEIC ACIDS RES, V35, P4485, DOI 10.1093/nar/gkm470; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; Zhu AX, 2011, NAT REV CLIN ONCOL, V8, P292, DOI 10.1038/nrclinonc.2011.30	38	104	108	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13952	13958		10.1074/jbc.M111.321646	http://dx.doi.org/10.1074/jbc.M111.321646			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22396537	Green Published, hybrid			2022-12-27	WOS:000303996300050
J	Geczy, T; Peach, ML; El Kazzouli, S; Sigano, DM; Kang, JH; Valle, CJ; Selezneva, J; Woo, W; Kedei, N; Lewin, NE; Garfield, SH; Lim, L; Mannan, P; Marquez, VE; Blumberg, PM				Geczy, Tamas; Peach, Megan L.; El Kazzouli, Said; Sigano, Dina M.; Kang, Ji-Hye; Valle, Christopher J.; Selezneva, Julia; Woo, Wonhee; Kedei, Noemi; Lewin, Nancy E.; Garfield, Susan H.; Lim, Langston; Mannan, Poonam; Marquez, Victor E.; Blumberg, Peter M.			Molecular Basis for Failure of "Atypical" C1 Domain of Vav1 to Bind Diacylglycerol/Phorbol Ester	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CONFORMATIONALLY CONSTRAINED ANALOGS; DROSOPHILA-MELANOGASTER HOMOLOG; SIGNAL TRANSDUCER PROTEIN; SITE-DIRECTED MUTAGENESIS; CYSTEINE-RICH DOMAINS; PHORBOL ESTER; BIOLOGICAL-ACTIVITIES; HUMAN MALIGNANCIES; CRYSTAL-STRUCTURE	C1 domains, the recognition motif of the second messenger diacylglycerol and of the phorbol esters, are classified as typical (ligand-responsive) or atypical (not ligand-responsive). The C1 domain of Vav1, a guanine nucleotide exchange factor, plays a critical role in regulation of Vav activity through stabilization of the Dbl homology domain, which is responsible for exchange activity of Vav. Although the C1 domain of Vav1 is classified as atypical, it retains a binding pocket geometry homologous to that of the typical C1 domains of PKCs. This study clarifies the basis for its failure to bind ligands. Substituting Vav1-specific residues into the C1b domain of PKC delta, we identified five crucial residues (Glu(9), Glu(10), Thr(11), Thr(24), and Tyr(26)) along the rim of the binding cleft that weaken binding potency in a cumulative fashion. Reciprocally, replacing these incompatible residues in the Vav1 C1 domain with the corresponding residues from PKC delta C1b (delta C1b) conferred high potency for phorbol ester binding. Computer modeling predicts that these unique residues in Vav1 increase the hydrophilicity of the rim of the binding pocket, impairing membrane association and thereby preventing formation of the ternary C1-ligand-membrane binding complex. The initial design of diacylglycerol-lactones to exploit these Vav1 unique residues showed enhanced selectivity for C1 domains incorporating these residues, suggesting a strategy for the development of ligands targeting Vav1.	[Geczy, Tamas; Valle, Christopher J.; Selezneva, Julia; Woo, Wonhee; Kedei, Noemi; Lewin, Nancy E.; Blumberg, Peter M.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Garfield, Susan H.; Lim, Langston; Mannan, Poonam] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [El Kazzouli, Said; Sigano, Dina M.; Kang, Ji-Hye; Marquez, Victor E.] NCI, Biol Chem Lab, Mol Discovery Program, Ctr Canc Res,NIH, Ft Detrick, MD 21702 USA; [Peach, Megan L.] NCI, Basic Res Program, SAIC Frederick, NIH, Ft Detrick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Blumberg, PM (corresponding author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bldg 37,Rm 4048,37 Convent Dr,MSC 4255, Bethesda, MD 20892 USA.	blumberp@dc37a.nci.nih.gov	Sigano, Dina/M-6144-2014; Marquez, Victor/AAP-3549-2021	Sigano, Dina/0000-0001-7489-9555; Geczy, Tamas/0000-0002-8199-8831; Peach, Megan/0000-0002-4290-5268	National Institutes of Health from NCI [Z1A BC 005270]; NATIONAL CANCER INSTITUTE [ZICBC010858, ZICBC010639, ZIABC005270] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Project Z1A BC 005270 from the Intramural Research Program, NCI.	AHMED S, 1991, BIOCHEM J, V280, P233, DOI 10.1042/bj2800233; Bartolome RA, 2006, CANCER RES, V66, P248, DOI 10.1158/0008-5472.CAN-05-2489; Blumberg PM, 2008, CURR DRUG TARGETS, V9, P641, DOI 10.2174/138945008785132376; Booden MA, 2002, MOL CELL BIOL, V22, P2487, DOI 10.1128/MCB.22.8.2487-2497.2002; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chen J, 2008, BIOCHEM J, V411, P333, DOI 10.1042/BJ20071334; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Chrencik JE, 2008, J MOL BIOL, V380, P828, DOI 10.1016/j.jmb.2008.05.024; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Dekel I, 2000, FEBS LETT, V472, P99, DOI 10.1016/S0014-5793(00)01413-7; DeLano W.L, PYMOL MOL GRAPHICS S; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Duan D, 2008, J MED CHEM, V51, P5198, DOI 10.1021/jm8001907; Dustin ML, 1999, SCIENCE, V283, P649, DOI 10.1126/science.283.5402.649; El Kazzouli S, 2008, J MED CHEM, V51, P5371, DOI 10.1021/jm800380b; Farah CA, 2008, MOL CELL BIOL, V28, P4719, DOI 10.1128/MCB.00178-08; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; FURET P, 1988, J MOL GRAPHICS, V6, P182, DOI 10.1016/S0263-7855(98)80001-5; Ghose AK, 1998, J PHYS CHEM A, V102, P3762, DOI 10.1021/jp980230o; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; GULBINS E, 1994, MOL CELL BIOL, V14, P4749, DOI 10.1128/MCB.14.7.4749; HEIDEN W, 1993, J COMPUT AID MOL DES, V7, P503, DOI 10.1007/BF00124359; HENSKE EP, 1995, ANN HUM GENET, V59, P25, DOI 10.1111/j.1469-1809.1995.tb01603.x; Heo J, 2005, BIOCHEMISTRY-US, V44, P6573, DOI 10.1021/bi047443q; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Hornstein I, 2003, ONCOGENE, V22, P6774, DOI 10.1038/sj.onc.1207027; Hurley JH, 1997, PROTEIN SCI, V6, P477; Irie K, 2005, CHEM REC, V5, P185, DOI 10.1002/tcr.20044; Johnson JE, 2007, BIOCHEM J, V406, P223, DOI 10.1042/BJ20070294; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Katzav S, 2007, CANCER LETT, V255, P241, DOI 10.1016/j.canlet.2007.04.015; Katzav S, 2009, INT J BIOCHEM CELL B, V41, P1245, DOI 10.1016/j.biocel.2008.11.006; KAZANIETZ MG, 1994, J BIOL CHEM, V269, P11590; Kazanietz MG, 2002, MOL PHARMACOL, V61, P759, DOI 10.1124/mol.61.4.759; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Lewin Nancy E, 2003, Methods Mol Biol, V233, P129; Marquez VE, 2003, ACCOUNTS CHEM RES, V36, P434, DOI 10.1021/ar020124b; Melowic HR, 2007, J BIOL CHEM, V282, P21467, DOI 10.1074/jbc.M700119200; Miller JM, 2010, MOL PHARMACEUT, V7, P1223, DOI 10.1021/mp100050d; Movilla N, 2001, ONCOGENE, V20, P8057, DOI 10.1038/sj.onc.1205000; Movilla N, 1999, MOL CELL BIOL, V19, P7870; NEUBERT R, 1989, PHARMACEUT RES, V6, P743, DOI 10.1023/A:1015963128124; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; Norman KR, 2005, CELL, V123, P119, DOI 10.1016/j.cell.2005.08.001; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Pak Y, 2001, J MED CHEM, V44, P1690, DOI 10.1021/jm000488e; Pellecchia M, 2004, CURR PHARM DESIGN, V10, P1371, DOI 10.2174/1381612043384907; Prieto-Sanchez RM, 2006, BRIT J HAEMATOL, V133, P642, DOI 10.1111/j.1365-2141.2006.06094.x; Pu YM, 2005, J BIOL CHEM, V280, P27329, DOI 10.1074/jbc.M414132200; Pu YM, 2006, J BIOL CHEM, V281, P33773, DOI 10.1074/jbc.M606560200; Raifman O, 2010, CHEMBIOCHEM, V11, P2003, DOI 10.1002/cbic.201000343; Rapley J, 2008, EMBO REP, V9, P655, DOI 10.1038/embor.2008.80; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Schrodinger LLC, 2010, MACROMODEL VERS 9 8; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Steinkellner G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-32; Stewart MD, 2011, J MOL BIOL, V408, P949, DOI 10.1016/j.jmb.2011.03.020; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Wang QMJ, 2001, J BIOL CHEM, V276, P19580, DOI 10.1074/jbc.M010089200; Xu RX, 1997, BIOCHEMISTRY-US, V36, P10709, DOI 10.1021/bi970833a; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Zugaza JL, 2002, J BIOL CHEM, V277, P45377, DOI 10.1074/jbc.M208039200	69	14	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13137	13158		10.1074/jbc.M111.320010	http://dx.doi.org/10.1074/jbc.M111.320010			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22351766	Green Published, hybrid			2022-12-27	WOS:000302903700053
J	Han, GY; Mamedov, F; Styring, S				Han, Guangye; Mamedov, Fikret; Styring, Stenbjorn			Misses during Water Oxidation in Photosystem II Are S State-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-EVOLVING COMPLEX; RAY-ABSORPTION SPECTROSCOPY; PHOTOSYNTHETIC O2 EVOLUTION; ELECTRON-PARAMAGNETIC-RES; MANGANESE COMPLEX; P680(+CENTER-DOT) REDUCTION; CENTERED OXIDATION; STRUCTURAL-CHANGES; CRYSTAL-STRUCTURE; ISOTOPE-EXCHANGE	The period of four oscillation of the S state intermediates of the water oxidizing complex in Photosystem II (PSII) is commonly analyzed by the Kok parameters. The important miss factor determines the efficiency for each S transition. Commonly, an equal miss factor has been used in the analysis. We have used EPR signals which probe all S states in the same sample during S cycle advancement. This allows, for the first time, to measure directly the miss parameter for each S state transition. Experiments were performed in PSII membrane preparations from spinach in the presence of electron acceptor at 1 degrees C and 20 degrees C. The data show that the miss parameter is different in different transitions and shows different temperature dependence. We found no misses at 1 degrees C and 10% misses at 20 degrees C during the S-1 -> S-2 transition. The highest miss factor was found in the S-2 -> S-3 transition which decreased from 23% to 16% with increasing temperature. For the S-3 -> S-0 transition the miss parameter was found to be 7% at 1 degrees C and decreased to 3% at 20 degrees C. For the S-0 -> S-1 transition the miss parameter was found to be approximately 10% at both temperatures. The contribution from the acceptor side in the form of recombination reactions as well as from the donor side of PSII to the uneven misses is discussed. It is suggested that the different transition efficiency in each S transition partly reflects the chemistry at the CaMn4O5 cluster. That consequently contributes to the uneven misses during S cycle turnover in PSII.	[Han, Guangye; Mamedov, Fikret; Styring, Stenbjorn] Uppsala Univ, Dept Chem Angstrom, S-75120 Uppsala, Sweden; [Han, Guangye] Umea Univ, Dept Chem, S-90187 Umea, Sweden	Uppsala University; Umea University	Mamedov, F (corresponding author), Uppsala Univ, Dept Chem Angstrom, Box 523, S-75120 Uppsala, Sweden.	fikret.mamedov@fotomol.uu.se; stenbjorn.styring@fotomol.uu.se	Styring, Stenbjörn/L-8414-2016; Mamedov, Fikret/A-1761-2016	Styring, Stenbjörn/0000-0002-2803-9244; Mamedov, Fikret/0000-0002-6218-3039	Swedish Research Council; Swedish Energy Agency; Knut and Alice Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Swedish Research Council, the Swedish Energy Agency, and the Knut and Alice Wallenberg Foundation.	Ahrling KA, 1997, BIOCHEMISTRY-US, V36, P13148, DOI 10.1021/bi971815w; Bernat G, 2002, BIOCHEMISTRY-US, V41, P5830, DOI 10.1021/bi011691u; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Chen GY, 2012, BIOCHEMISTRY-US, V51, P138, DOI 10.1021/bi200627j; Christen G, 1999, BIOCHEMISTRY-US, V38, P6082, DOI 10.1021/bi9827520; Christen G, 1999, BIOCHEMISTRY-US, V38, P2068, DOI 10.1021/bi982188t; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; de Wijn R, 2002, PHOTOSYNTH RES, V72, P217, DOI 10.1023/A:1016128632704; DELRIEU MJ, 1983, Z NATURFORSCH C, V38, P247; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; FORBUSH B, 1971, PHOTOCHEM PHOTOBIOL, V14, P307, DOI 10.1111/j.1751-1097.1971.tb06175.x; Han G., 2008, BIOCHIM BIOPHYS ACTA, V1777, P495; Haumann M, 2005, BIOCHEMISTRY-US, V44, P1894, DOI 10.1021/bi048697e; Haumann M, 2002, FEBS LETT, V512, P116, DOI 10.1016/S0014-5793(02)02237-8; Haumann M, 2008, P NATL ACAD SCI USA, V105, P17384, DOI 10.1073/pnas.0802596105; Havelius KGV, 2010, APPL MAGN RESON, V37, P151, DOI 10.1007/s00723-009-0045-z; Hwang HJ, 2007, BIOCHEMISTRY-US, V46, P11987, DOI 10.1021/bi701387b; Isgandarova S, 2003, BIOCHEMISTRY-US, V42, P8929, DOI 10.1021/bi034744b; Iuzzolino L, 1998, BIOCHEMISTRY-US, V37, P17112, DOI 10.1021/bi9817360; Jeans C, 2002, BIOCHEMISTRY-US, V41, P15754, DOI 10.1021/bi020558e; JOLIOT P, 1969, PHOTOCHEM PHOTOBIOL, V10, P309, DOI 10.1111/j.1751-1097.1969.tb05696.x; Joliot P., 1975, BIOENERG PHOTOSYNTH, P388; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Lavergne J, 1998, BIOCHEMISTRY-US, V37, P7899, DOI 10.1021/bi9801210; LAVOREL J, 1976, J THEOR BIOL, V57, P171, DOI 10.1016/S0022-5193(76)80011-2; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Mamedov F, 1998, BIOCHEMISTRY-US, V37, P14245, DOI 10.1021/bi980194j; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; MESSINGER J, 1993, BIOCHEMISTRY-US, V32, P7658, DOI 10.1021/bi00081a009; Messinger J, 2001, J AM CHEM SOC, V123, P7804, DOI 10.1021/ja004307+; MESSINGER J, 1994, BIOCHEMISTRY-US, V33, P10896, DOI 10.1021/bi00202a008; Messinger J, 2007, COMPR SER PHOTOCH, V9, P291; Meunier PC, 1996, PHOTOSYNTH RES, V47, P61, DOI 10.1007/BF00017754; MEUNIER PC, 1993, PHOTOSYNTH RES, V36, P111, DOI 10.1007/BF00016276; PACKHAM NK, 1988, PHOTOSYNTH RES, V15, P221, DOI 10.1007/BF00047354; Petrouleas V, 2005, BIOCHEMISTRY-US, V44, P6723, DOI 10.1021/bi0503201; Pushkar YL, 2008, P NATL ACAD SCI USA, V105, P1879, DOI 10.1073/pnas.0707092105; Rappaport F, 2008, COORDIN CHEM REV, V252, P259, DOI 10.1016/j.ccr.2007.07.016; REINMAN S, 1981, BIOCHIM BIOPHYS ACTA, V635, P249, DOI 10.1016/0005-2728(81)90024-4; Renger G, 2007, COMPR SER PHOTOCH, V9, P237; Robblee JH, 2001, BBA-BIOENERGETICS, V1503, P7, DOI 10.1016/S0005-2728(00)00217-6; Roelofs TA, 1996, P NATL ACAD SCI USA, V93, P3335, DOI 10.1073/pnas.93.8.3335; SAYGIN O, 1987, BIOCHIM BIOPHYS ACTA, V893, P452, DOI 10.1016/0005-2728(87)90097-1; Schlodder E, 1999, J BIOL CHEM, V274, P30387, DOI 10.1074/jbc.274.43.30387; Shevela D, 2011, P NATL ACAD SCI USA, V108, P3602, DOI 10.1073/pnas.1014249108; SHINKAREV VP, 1993, P NATL ACAD SCI USA, V90, P1834, DOI 10.1073/pnas.90.5.1834; Shinkarev VP, 2005, BIOPHYS J, V88, P412, DOI 10.1529/biophysj.104.050898; STYRING S, 1988, BIOCHIM BIOPHYS ACTA, V933, P378, DOI 10.1016/0005-2728(88)90046-1; STYRING S, 1987, BIOCHEMISTRY-US, V26, P2401, DOI 10.1021/bi00383a001; Suzuki H, 2005, BIOCHEMISTRY-US, V44, P1708, DOI 10.1021/bi0483312; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VOLKER M, 1985, BIOCHIM BIOPHYS ACTA, V806, P25, DOI 10.1016/0005-2728(85)90078-7; Wydrzynski T. J., 2005, PHOTOSYSTEM; Yano J, 2005, J AM CHEM SOC, V127, P14974, DOI 10.1021/ja054873a	55	19	19	0	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13422	13429		10.1074/jbc.M112.342543	http://dx.doi.org/10.1074/jbc.M112.342543			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22374999	Green Published, hybrid			2022-12-27	WOS:000302903700076
J	Chiba, Y; Oshima, K; Arai, H; Ishii, M; Igarashi, Y				Chiba, Yoko; Oshima, Kenro; Arai, Hiroyuki; Ishii, Masaharu; Igarashi, Yasuo			Discovery and Analysis of Cofactor-dependent Phosphoglycerate Mutase Homologs as Novel Phosphoserine Phosphatases in Hydrogenobacter thermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICARBOXYLIC-ACID CYCLE; SERINE HYDROXYMETHYLTRANSFERASE; OXIDIZING BACTERIUM; BIOSYNTHESIS; PURIFICATION; PATHWAY; CDNA; METABOLISM; ALDOLASE; SEQUENCE	Phosphoserine phosphatase (PSP) catalyzes the dephosphorylation of phosphoserine to serine and inorganic phosphate. PSPs, which have been found in all three domains of life, belong to the haloacid dehalogenase-like hydrolase superfamily. However, certain organisms, particularly bacteria, lack a classical PSP gene, although they appear to possess a functional phosphoserine synthetic pathway. The apparent lack of a PSP ortholog in Hydrogenobacter thermophilus, an obligately chemolithoautotrophic and thermophilic bacterium, represented a missing link in serine anabolism because our previous study suggested that serine should be synthesized from phosphoserine. Here, we detected PSP activity in cell-free extracts of H. thermophilus and purified two proteins with PSP activity. Surprisingly, these proteins belonged to the histidine phosphatase superfamily and had been annotated as cofactor-dependent phosphoglycerate mutase (dPGM). However, because they possessed neither mutase activity nor the residues important for the activity, we defined these proteins as novel-type PSPs. Considering the strict substrate specificity toward L-phosphoserine, kinetic parameters, and PSP activity levels in cell-free extracts, these proteins were strongly suggested to function as PSPs in vivo. We also detected PSP activity from "dPGM-like" proteins of Thermus thermophilus and Arabidopsis thaliana, suggesting that PSP activity catalyzed by dPGM-like proteins may be distributed among a broad range of organisms. In fact, a number of bacterial genera, including Firmicutes and Cyanobacteria, were proposed to be strong candidates for possessing this novel type of PSP. These findings will help to identify the missing link in serine anabolism.	[Chiba, Yoko; Arai, Hiroyuki; Ishii, Masaharu; Igarashi, Yasuo] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Oshima, Kenro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo; University of Tokyo	Ishii, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amishii@mail.ecc.u-tokyo.ac.jp		Oshima, Kenro/0000-0001-7327-4481; Chiba, Yoko/0000-0002-2734-0836	Japan Society for the Promotion of Science (JSPS) [21248010];  [23-3030]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This work was supported in part by Grant-in-aid for Scientific Research (A) 21248010 from the Japan Society for the Promotion of Science (JSPS) and Grant-in-aid for JSPS Fellows 23-3030.	Arai H, 2010, J BACTERIOL, V192, P2651, DOI 10.1128/JB.00158-10; BARTRONS R, 1982, BIOCHIM BIOPHYS ACTA, V708, P167, DOI 10.1016/0167-4838(82)90217-5; Bourgis F, 2005, J EXP BOT, V56, P1129, DOI 10.1093/jxb/eri105; Chiba Y, 2012, FEBS J, V279, P504, DOI 10.1111/j.1742-4658.2011.08443.x; Colman B, 1997, PHYSIOL PLANTARUM, V100, P133, DOI 10.1034/j.1399-3054.1997.1000114.x; D'Alession G, 1975, Methods Enzymol, V42, P139; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Florio R, 2011, BBA-PROTEINS PROTEOM, V1814, P1489, DOI 10.1016/j.bbapap.2010.10.010; Hart CE, 2007, AM J HUM GENET, V80, P931, DOI 10.1086/517888; Helgadottir S, 2007, J BACTERIOL, V189, P575, DOI 10.1128/JB.01269-06; Hills T, 2011, MOL BIOCHEM PARASIT, V179, P69, DOI 10.1016/j.molbiopara.2011.06.001; Ho CL, 1999, J BIOL CHEM, V274, P11007, DOI 10.1074/jbc.274.16.11007; Ho CL, 2001, AMINO ACIDS, V20, P243, DOI 10.1007/s007260170042; Hugler M, 2007, ENVIRON MICROBIOL, V9, P81, DOI 10.1111/j.1462-2920.2006.01118.x; Kameya M, 2006, J BIOSCI BIOENG, V102, P311, DOI 10.1263/jbb.102.311; Kameya M, 2010, FEBS J, V277, P1876, DOI 10.1111/j.1742-4658.2010.07604.x; KAWASUMI T, 1984, INT J SYST BACTERIOL, V34, P5, DOI 10.1099/00207713-34-1-5; KAWASUMI T, 1980, AGR BIOL CHEM TOKYO, V44, P1985, DOI 10.1080/00021369.1980.10864255; Knoop H, 2010, PLANT PHYSIOL, V154, P410, DOI 10.1104/pp.110.157198; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Ogawa H, 2000, INT J BIOCHEM CELL B, V32, P289, DOI 10.1016/S1357-2725(99)00113-2; Ohno S., 1970, P1; Oshima K, 2007, MOL PLANT PATHOL, V8, P481, DOI [10.1111/j.1364-3703.2007.00408.x, 10.1111/J.1364-3703.2007.00408.X]; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Rigden DJ, 2001, PROTEIN SCI, V10, P1835, DOI 10.1110/ps.15701; Rigden DJ, 1999, J MOL BIOL, V286, P1507, DOI 10.1006/jmbi.1999.2566; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Shapiro B., 1970, METHOD ENZYMOL, V17A, P910, DOI 10.1016/0076-6879(71)17305-3; SHIBA H, 1985, ARCH MICROBIOL, V141, P198, DOI 10.1007/BF00408058; SNELL K, 1984, ADV ENZYME REGUL, V22, P325, DOI 10.1016/0065-2571(84)90021-9; Suzuki M, 2001, ARCH MICROBIOL, V175, P75, DOI 10.1007/s002030000230; Szebenyi DME, 2004, BIOCHEMISTRY-US, V43, P6865, DOI 10.1021/bi049791y; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thaller MC, 1997, FEMS MICROBIOL LETT, V146, P191, DOI 10.1016/S0378-1097(96)00474-0; VEERANNA, 1990, NEUROCHEM RES, V15, P1203, DOI 10.1007/BF01208581; Wang WR, 2002, J MOL BIOL, V319, P421, DOI 10.1016/S0022-2836(02)00324-8; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yokoyama S, 2000, NAT STRUCT BIOL, V7, P943, DOI 10.1038/80712	40	20	23	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11934	11941		10.1074/jbc.M111.330621	http://dx.doi.org/10.1074/jbc.M111.330621			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337887	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000302782200032
J	Stewart, AP; Gomez-Posada, JC; McGeorge, J; Rouhani, MJ; Villarroel, A; Murrell-Lagnado, RD; Edwardson, JM				Stewart, Andrew P.; Camilo Gomez-Posada, Juan; McGeorge, Jessica; Rouhani, Maral J.; Villarroel, Alvaro; Murrell-Lagnado, Ruth D.; Edwardson, J. Michael			The Kv7.2/Kv7.3 Heterotetramer Assembles with a Random Subunit Arrangement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORCE MICROSCOPY REVEALS; KCNQ2/KCNQ3 POTASSIUM CHANNELS; K+ CHANNELS; STOICHIOMETRY; DOMAIN; EXPRESSION; KCNQ2; RECEPTORS; RESIDUE	Voltage-gated K+ channels composed of Kv7.2 and Kv7.3 are the predominant contributors to the M-current, which plays a key role in controlling neuronal activity. Various lines of evidence have indicated that Kv7.2 and Kv7.3 form a heteromeric channel. However, the subunit stoichiometry and arrangement within this putative heteromer are so far unknown. Here, we have addressed this question using atomic force microscopy imaging of complexes between isolated Kv7.2/Kv7.3 channels and antibodies to epitope tags on the two subunits, Myc on Kv7.2 and HA on Kv7.3. Initially, tsA 201 cells were transiently transfected with equal amounts of cDNA for the two subunits. The heteromer was isolated through binding of either tag to immunoaffinity beads and then decorated with antibodies to the other tag. In both cases, the distribution of angles between pairs of bound antibodies had two peaks, at around 90 and around 180, and in both cases the 90 peak was about double the size of the 180 peak. These results indicate that the Kv7.2/Kv7.3 heteromer generated by cells expressing approximately equal amounts of the two subunits assembles as a tetramer with a predominantly 2: 2 subunit stoichiometry and with a random subunit arrangement. When the DNA ratio for the two subunits was varied, copurification experiments indicated that the subunit stoichiometry was variable and not fixed at 2:2. Hence, there are no constraints on either the subunit stoichiometry or the subunit arrangement.	[Stewart, Andrew P.; McGeorge, Jessica; Rouhani, Maral J.; Murrell-Lagnado, Ruth D.; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Camilo Gomez-Posada, Juan; Villarroel, Alvaro] Univ Basque Country, Ctr Mixto, Unidad Biofis, CSIC, Leioa 48940, Spain	University of Cambridge; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika	Edwardson, JM (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	jme1000@cam.ac.uk	Villarroel, Alvaro/H-5580-2015	Murrell-Lagnado, Ruth/0000-0003-2743-7977	Jean Shanks Foundation; University of Cambridge; Department of Education, Universities, and Investigation of the Basque Government; Biotechnology and Biological Sciences Research Council; European Molecular Biology Organization	Jean Shanks Foundation; University of Cambridge(University of Cambridge); Department of Education, Universities, and Investigation of the Basque Government; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	* This work was supported by the Jean Shanks Foundation and the James Baird Fund of the University of Cambridge (to A. P. S.); the Department of Education, Universities, and Investigation of the Basque Government (to J. C. G. P.); and the Biotechnology and Biological Sciences Research Council (to R. D. M. L. and J. M. E.).; <SUP>2</SUP> Recipient of a European Molecular Biology Organization short-term fellowship.	Antonio LS, 2011, BRIT J PHARMACOL, V163, P1069, DOI 10.1111/j.1476-5381.2011.01303.x; Bal M, 2008, J BIOL CHEM, V283, P30668, DOI 10.1074/jbc.M805216200; Barrera NP, 2008, MOL PHARMACOL, V73, P960, DOI 10.1124/mol.107.042481; Barrera NP, 2005, P NATL ACAD SCI USA, V102, P12595, DOI 10.1073/pnas.0503253102; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Gomez-Posada JC, 2010, J NEUROSCI, V30, P9316, DOI 10.1523/JNEUROSCI.0851-10.2010; Etxeberria A, 2008, FASEB J, V22, P1135, DOI 10.1096/fj.07-9712com; Feng S, 2008, J BIOL CHEM, V283, P28471, DOI 10.1074/jbc.M803834200; Feng S, 2011, J BIOL CHEM, V286, P18994, DOI 10.1074/jbc.M110.192286; Giamarchi A, 2010, EMBO J, V29, P1176, DOI 10.1038/emboj.2010.18; Hadley JK, 2003, J NEUROSCI, V23, P5012; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kobori T, 2009, J BIOL CHEM, V284, P35507, DOI 10.1074/jbc.M109.060228; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Maljevic S, 2003, J PHYSIOL-LONDON, V548, P353, DOI 10.1113/jphysiol.2003.040980; Maljevic S, 2008, J PHYSIOL-LONDON, V586, P1791, DOI 10.1113/jphysiol.2008.150656; Nakajo K, 2008, J PHYSIOL-LONDON, V586, P2827, DOI 10.1113/jphysiol.2007.148601; Prole DL, 2004, BIOPHYS J, V86, P1454, DOI 10.1016/S0006-3495(04)74214-9; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Schwake M, 2006, J NEUROSCI, V26, P3757, DOI 10.1523/JNEUROSCI.5017-05.2006; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Schwake M, 2003, EMBO REP, V4, P76, DOI 10.1038/sj.embor.embor715; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; Selyanko AA, 2001, J PHYSIOL-LONDON, V534, P15, DOI 10.1111/j.1469-7793.2001.00015.x; Shah MM, 2002, J PHYSIOL-LONDON, V544, P29, DOI 10.1113/jphysiol.2002.028571; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stewart AP, 2010, BIOPHYS J, V99, P790, DOI 10.1016/j.bpj.2010.05.012; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Yang WP, 1998, J BIOL CHEM, V273, P19419, DOI 10.1074/jbc.273.31.19419	35	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11870	11877		10.1074/jbc.M111.336511	http://dx.doi.org/10.1074/jbc.M111.336511			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334706	Green Published, hybrid			2022-12-27	WOS:000302782200026
J	Ranjbarian, F; Vodnala, M; Vodnala, SM; Rofougaran, R; Thelander, L; Hofer, A				Ranjbarian, Farahnaz; Vodnala, Munender; Vodnala, Sharvani Munender; Rofougaran, Reza; Thelander, Lars; Hofer, Anders			Trypanosoma brucei Thymidine Kinase Is Tandem Protein Consisting of Two Homologous Parts, Which Together Enable Efficient Substrate Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYRIBONUCLEOSIDE KINASES; RIBONUCLEOTIDE REDUCTASE; SLEEPING SICKNESS; ADENOSINE KINASE; NUCLEOSIDE; TRANSPORTERS; FORMS; TK1	Trypanosoma brucei causes African sleeping sickness, a disease for which existing chemotherapies are limited by their toxicity or lack of efficacy. We have found that four parasites, including T. brucei, contain genes where two or four thymidine kinase (TK) sequences are fused into a single open reading frame. The T. brucei full-length enzyme as well as its two constituent parts, domain 1 and domain 2, were separately expressed and characterized. Of potential interest for nucleoside analog development, T. brucei TK was less discriminative against purines than human TK1 with the following order of catalytic efficiencies: thymidine > deoxyuridine >> deoxyinosine > deoxyguanosine. Proteins from the TK1 family are generally dimers or tetramers, and the quaternary structure is linked to substrate affinity. T. brucei TK was primarily monomeric but can be considered a two-domain pseudodimer. Independent kinetic analysis of the two domains showed that only domain 2 was active. It had a similar turnover number (k(cat)) as the full-length enzyme but could not self-dimerize efficiently and had a 5-fold reduced thymidine/deoxyuridine affinity. Domain 1, which lacks three conserved active site residues, can therefore be considered a covalently attached structural partner that enhances substrate binding to domain 2. A consequence of the non-catalytic role of domain 1 is that its active site residues are released from evolutionary pressure, which can be advantageous for developing new catalytic functions. In addition, nearly identical 89-bp sequences present in both domains suggest that the exchange of genetic material between them can further promote evolution.	[Ranjbarian, Farahnaz; Vodnala, Munender; Vodnala, Sharvani Munender; Rofougaran, Reza; Thelander, Lars; Hofer, Anders] Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden; [Rofougaran, Reza] Univ Tehran, Inst Biochem & Biophys, Dept Biochem, Tehran, Iran	Umea University; University of Tehran	Hofer, A (corresponding author), Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden.	anders.hofer@medchem.umu.se		Vodnala, Munender/0000-0002-6219-6243; Hofer, Anders/0000-0003-2890-2957	Swedish Research Council [2009-5145]; Swedish International Development Cooperation Agency [SWE-2008-069]; Kempe Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency; Kempe Foundation	This work was supported by Swedish Research Council Grant 2009-5145, Swedish International Development Cooperation Agency Grant SWE-2008-069, and the Kempe Foundation.	ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Berenstein D, 2000, J BIOL CHEM, V275, P32187, DOI 10.1074/jbc.M005325200; CHELLO PL, 1972, COMP BIOCHEM PHYSIOL, V43, P543, DOI 10.1016/0305-0491(72)90138-1; CHELLO PL, 1972, J PARASITOL, V58, P298, DOI 10.2307/3278092; Deville-Bonne D, 2010, ANTIVIR RES, V86, P101, DOI 10.1016/j.antiviral.2010.02.001; el Kouni MH, 2003, PHARMACOL THERAPEUT, V99, P283, DOI 10.1016/S0163-7258(03)00071-8; Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x; Gudin S, 2006, EXP PARASITOL, V114, P118, DOI 10.1016/j.exppara.2006.02.018; HEHL A, 1995, MOL BIOCHEM PARASIT, V70, P45, DOI 10.1016/0166-6851(95)00003-J; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Hofer A, 1997, P NATL ACAD SCI USA, V94, P6959, DOI 10.1073/pnas.94.13.6959; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; Hofer A, 2001, P NATL ACAD SCI USA, V98, P6412, DOI 10.1073/pnas.111139498; IVES DH, 1969, ANAL BIOCHEM, V28, P192, DOI 10.1016/0003-2697(69)90170-5; Landfear SM, 2004, EUKARYOT CELL, V3, P245, DOI 10.1128/EC.3.2.245-254.2004; Luscher A, 2007, ANTIMICROB AGENTS CH, V51, P3895, DOI 10.1128/AAC.00458-07; Malvy D, 2011, CLIN MICROBIOL INFEC, V17, P986, DOI 10.1111/j.1469-0691.2011.03536.x; Munch-Petersen B, 2009, FEBS J, V276, P571, DOI 10.1111/j.1742-4658.2008.06804.x; MUNCHPETERSEN B, 1993, J BIOL CHEM, V268, P15621; Parkinson FE, 2011, CURR TOP MED CHEM, V11, P948; Rottenberg ME, 2005, J INFECT DIS, V192, P1658, DOI 10.1086/496896; Vodnala M, 2008, J BIOL CHEM, V283, P5380, DOI 10.1074/jbc.M705603200; Welin M, 2004, P NATL ACAD SCI USA, V101, P17970, DOI 10.1073/pnas.0406332102	23	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17628	17636		10.1074/jbc.M112.340059	http://dx.doi.org/10.1074/jbc.M112.340059			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22442154	Green Published, hybrid			2022-12-27	WOS:000306373000061
J	Shi, SJ; Blobner, BM; Kashlan, OB; Kleyman, TR				Shi, Shujie; Blobner, Brandon M.; Kashlan, Ossama B.; Kleyman, Thomas R.			Extracellular Finger Domain Modulates the Response of the Epithelial Sodium Channel to Shear Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ SELF-INHIBITION; GAMMA-SUBUNIT; ALPHA-SUBUNIT; ENAC; PEPTIDE; FURIN; ACTIVATION; MECHANISM; PROTEASES; FLOW	The epithelial sodium channel (ENaC) is regulated by multiple extracellular stimuli, including shear stress. Previous studies suggest that the extracellular finger domains of ENaC alpha and gamma subunits contain allosteric regulatory modules. However, the role of the finger domain in the shear stress response is unknown. We examined whether mutations of specific residues in the finger domain of the alpha subunit altered the response of channels to shear stress. We observed that Trp substitutions at multiple sites within the tract alpha Lys-250-alpha Leu-290 altered the magnitude or kinetics of channel activation by shear stress. Consistent with these findings, deletion of two predicted peripheral beta strands (alpha Ile-251-alpha Tyr-268) led to slower channel activation by shear stress, suggesting that these structures participate in the shear stress response. The effects of mutations on the shear stress response did not correlate with their effects on allosteric Na+ inhibition (i.e. Na+ self-inhibition), indicating a divergence within the finger domain regarding mechanisms by which the channel responds to these two external stimuli. This result contrasts with well correlated effects we previously observed at sites near the extracellular mouth of the pore, suggesting mechanistic convergence in proximity to the pore. Our results suggest that the finger domain has an important role in the modulation of channel activity in response to shear stress.	[Shi, Shujie; Blobner, Brandon M.; Kashlan, Ossama B.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Med, Renal Elect Div, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Univ Pittsburgh, Dept Med, Renal Elect Div, A919 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu	Shi, Shujie/D-4999-2012		National Institutes of Health [R37 DK051391, K01 DK078734, P30 DK079307]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK078734, R37DK051391, P30DK079307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 DK051391, K01 DK078734, and P30 DK079307.; Supported by a postdoctoral fellowship from the American Heart Association.	Abi-Antoun T, 2011, AM J PHYSIOL-RENAL, V300, pF1089, DOI 10.1152/ajprenal.00610.2010; Althaus M, 2007, FASEB J, V21, P2389, DOI 10.1096/fj.06-7694com; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2005, J BIOL CHEM, V280, P4393, DOI 10.1074/jbc.M413123200; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Drummond HA, 2008, PHYSIOLOGY, V23, P23, DOI 10.1152/physiol.00034.2007; Guan ZR, 2009, HYPERTENSION, V54, P1062, DOI 10.1161/HYPERTENSIONAHA.109.137992; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; Kim KJ, 2011, BRIT J NUTR, V106, P1836, DOI 10.1017/S0007114511002534; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Mano I, 1999, BIOESSAYS, V21, P568, DOI 10.1002/(SICI)1521-1878(199907)21:7&lt;568::AID-BIES5&gt;3.0.CO;2-L; Morimoto T, 2006, AM J PHYSIOL-RENAL, V291, pF663, DOI 10.1152/ajprenal.00514.2005; Satlin LM, 2001, AM J PHYSIOL-RENAL, V280, pF1010, DOI 10.1152/ajprenal.2001.280.6.F1010; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Shi SJ, 2011, J BIOL CHEM, V286, P14753, DOI 10.1074/jbc.M110.191734; Winarski KL, 2010, J BIOL CHEM, V285, P26088, DOI 10.1074/jbc.M110.149963	25	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15439	15444		10.1074/jbc.M112.346551	http://dx.doi.org/10.1074/jbc.M112.346551			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22408250	Green Published, hybrid			2022-12-27	WOS:000304006300025
J	Chuang, CY; Lin, KI; Hsiao, M; Stone, L; Chen, HF; Huang, YH; Lin, SP; Ho, HN; Kuo, HC				Chuang, Ching-Yu; Lin, Kuo-I; Hsiao, Michael; Stone, Lee; Chen, Hsin-Fu; Huang, Yen-Hua; Lin, Shau-Ping; Ho, Hong-Nerng; Kuo, Hung-Chih			Meiotic Competent Human Germ Cell-like Cells Derived from Human Embryonic Stem Cells Induced by BMP4/WNT3A Signaling and OCT4/EpCAM (Epithelial Cell Adhesion Molecule) Selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FETAL OVARY; EP-CAM; EXPRESSION; MOUSE; DERIVATION; DIFFERENTIATION; MICE; SPECIFICATION; GENERATION; MIGRATION	The establishment of an effective germ cell selection/enrichment platform from in vitro differentiating human embryonic stem cells (hESCs) is crucial for studying the molecular and signaling processes governing human germ cell specification and development. In this study, we developed a germ cell-enriching system that enables us to identify signaling factors involved in germ cell-fate induction from differentiating hESCs in vitro. First, we demonstrated that selection through an OCT4-EGFP reporter system can successfully increase the percentage of meiotic-competent, germ cell-like cells from spontaneously differentiating hESCs. Furthermore, we showed that the pluripotency associated surface marker, epithelial cell adhesion molecule (EpCAM), is also expressed in human fetal gonads and can be used as an effective selection marker for germ cell enrichment from differentiating hESCs. Combining OCT4 and EpCAM selection can further enrich the meiotic-competent germ cell-like cell population. Also, with the percentage of OCT4(+)/EpCAM(+) cells as readout, we demonstrated the synergistic effect of BMP4/pSMAD1/5/8 and WNT3A/beta-CATENIN in promoting hESCs toward the germline fate. Combining BMP4/WNT3A induction and OCT4/EpCAM selection can significantly increase the putative germ cell population with meiotic competency. Co-transplantation of these cells with dissociated mouse neonatal ovary cells into SCID mice resulted in a homogenous germ cell cluster formation in vivo. The stepwise platform established in this study provides a useful tool to elucidate the molecular mechanisms of human germ cell development, which has implications not only for human fertility research but regenerative medicine in general.	[Chuang, Ching-Yu; Lin, Shau-Ping] Natl Taiwan Univ, Inst Biotechnol, Coll Bioresources & Agr, Taipei 106, Taiwan; [Chen, Hsin-Fu; Ho, Hong-Nerng] Natl Taiwan Univ, Coll Med, Grad Inst Clin Genom, Taipei 106, Taiwan; [Chuang, Ching-Yu; Lin, Kuo-I; Hsiao, Michael; Kuo, Hung-Chih] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Stone, Lee; Kuo, Hung-Chih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Lin, Shau-Ping] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Chen, Hsin-Fu; Ho, Hong-Nerng] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Taipei 100, Taiwan; [Huang, Yen-Hua] Taipei Med Univ, Dept Biochem, Grad Inst Med Sci, Sch Med, Taipei 110, Taiwan	National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; Taipei Medical University	Lin, SP (corresponding author), Natl Taiwan Univ, Inst Biotechnol, Coll Bioresources & Agr, Taipei 106, Taiwan.	shaupinglin@ntu.edu.tw; kuohuch@gate.sinica.edu.tw	Kuo, Hung-Chih/H-7810-2014; NTU, Ref07/AAX-7890-2021; Hsiao, Michael/U-6238-2019	Kuo, Hung-Chih/0000-0003-1336-1203; Hsiao, Michael/0000-0001-8529-9213; Lin, Shau-Ping/0000-0003-3423-991X; CHEN, HSIN-FU/0000-0002-7748-4440	National Science Council, Taiwan [99-3111-B-001-001, 99-3111-B-002-009, 99-3111-B-002-008]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by an intramural grant from Academia Sinica and Stem Cell Priority Grants 99-3111-B-001-001 and 99-3111-B-002-009 (to H. C. K.), and 99-3111-B-002-008 (to S. P. L.) from National Science Council, Taiwan.	Anderson R, 1999, J REPROD FERTIL, V116, P379, DOI 10.1530/jrf.0.1160379; Anderson RA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-136; Ara T, 2003, P NATL ACAD SCI USA, V100, P5319, DOI 10.1073/pnas.0730719100; BESMER P, 1993, DEVELOPMENT, P125; Bucay N, 2009, STEM CELLS, V27, P68, DOI 10.1634/stemcells.2007-1018; BUEHR M, 1993, DEV DYNAM, V198, P182, DOI 10.1002/aja.1001980304; Chen HF, 2007, HUM REPROD, V22, P567, DOI 10.1093/humrep/del412; Cirulli V, 1998, J CELL BIOL, V140, P1519, DOI 10.1083/jcb.140.6.1519; de Boer CJ, 1999, J PATHOL, V188, P201, DOI 10.1002/(SICI)1096-9896(199906)188:2<201::AID-PATH339>3.0.CO;2-8; Eguizabal C, 2011, STEM CELLS, V29, P1186, DOI 10.1002/stem.672; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Handeli S, 2008, MOL CANCER THER, V7, P521, DOI 10.1158/1535-7163.MCT-07-2063; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Huang HP, 2011, J BIOL CHEM, V286, P33520, DOI 10.1074/jbc.M111.256164; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Kanatsu-Shinohara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023663; Kee K, 2006, STEM CELLS DEV, V15, P831, DOI 10.1089/scd.2006.15.831; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kerr CL, 2008, HUM REPROD, V23, P589, DOI 10.1093/humrep/dem411; Kerr CL, 2008, STEM CELLS, V26, P412, DOI 10.1634/stemcells.2007-0605; KLEIN CE, 1987, J INVEST DERMATOL, V89, P500, DOI 10.1111/1523-1747.ep12460996; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Miettinen M, 2005, APPL IMMUNOHISTO M M, V13, P205, DOI 10.1097/01.pai.0000173054.83414.22; Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640; Nayernia K, 2006, DEV CELL, V11, P125, DOI 10.1016/j.devcel.2006.05.010; Ng VY, 2010, STEM CELLS, V28, P29, DOI 10.1002/stem.221; Nicholas CR, 2009, HUM MOL GENET, V18, P4376, DOI 10.1093/hmg/ddp393; Nicholas CR, 2009, ENDOCR REV, V30, P264, DOI 10.1210/er.2008-0034; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Panula S, 2011, HUM MOL GENET, V20, P752, DOI 10.1093/hmg/ddq520; Park TS, 2009, STEM CELLS, V27, P783, DOI 10.1002/stem.13; Psathaki OE, 2011, STEM CELLS DEV, V20, P2205, DOI 10.1089/scd.2010.0575; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Tilgner K, 2008, STEM CELLS, V26, P3075, DOI 10.1634/stemcells.2008-0289; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Ying Y, 2001, P NATL ACAD SCI USA, V98, P7858, DOI 10.1073/pnas.151242798	40	39	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14389	14401		10.1074/jbc.M111.338434	http://dx.doi.org/10.1074/jbc.M111.338434			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22396540	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000304003200007
J	Saito, A; Ariki, S; Sohma, H; Nishitani, C; Inoue, K; Ebata, N; Takahashi, M; Hasegawa, Y; Kuronuma, K; Takahashi, H; Kuroki, Y				Saito, Atsushi; Ariki, Shigeru; Sohma, Hitoshi; Nishitani, Chiaki; Inoue, Kanako; Ebata, Nobutaka; Takahashi, Motoko; Hasegawa, Yoshihiro; Kuronuma, Koji; Takahashi, Hiroki; Kuroki, Yoshio			Pulmonary Surfactant Protein A Protects Lung Epithelium from Cytotoxicity of Human beta-Defensin 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; NEUTROPHIL DEFENSINS; LEGIONELLA-PNEUMOPHILA; HUMAN BETA-DEFENSIN-2; CYTOKINE PRODUCTION; ALPHA-DEFENSINS; INNATE IMMUNITY; CELLS; EXPRESSION; MECHANISMS	Defensins are important molecules in the innate immune system that eliminate infectious microbes. They also exhibit cytotoxicity against host cells in higher concentrations. The mechanisms by which hosts protect their own cells from cytotoxicity of defensins have been poorly understood. We found that the cytotoxicity of human beta-defensin 3 (hBD3) against lung epithelial cells was dose-dependently attenuated by pulmonary surfactant protein A (SP-A), a collectin implicated in host defense and regulation of inflammatory responses in the lung. The direct interaction between SP-A and hBD3 may be an important factor in decreasing this cytotoxicity because preincubation of epithelial cells with SP-A did not affect the cytotoxicity. Consistent with in vitro analysis, intratracheal administration of hBD3 to SP-A(-/-) mice resulted in more severe tissue damage compared with that in WT mice. These data indicate that SP-A protects lung epithelium from tissue injury caused by hBD3. Furthermore, we found that the functional region of SP-A lies within Tyr(161)-Lys(201). Synthetic peptide corresponding to this region, tentatively called SP-A Y161-G200, also inhibited cytotoxicity of hBD3 in a dose-dependent manner. The SP-A Y161-G200 is a candidate as a therapeutic reagent that prevents tissue injury during inflammation.	[Ariki, Shigeru] Sapporo Med Univ, Dept Biochem, Sch Med, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Saito, Atsushi; Hasegawa, Yoshihiro; Kuronuma, Koji; Takahashi, Hiroki] Sapporo Med Univ, Dept Internal Med 3, Sch Med, Sapporo, Hokkaido 0608556, Japan; [Sohma, Hitoshi] Sapporo Med Univ, Dept Educ Dev, Ctr Med Educ, Sapporo, Hokkaido 0608556, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Ariki, S (corresponding author), Sapporo Med Univ, Dept Biochem, Sch Med, Chuo Ku, South 1,West 17, Sapporo, Hokkaido 0608556, Japan.	sarikscb@sapmed.ac.jp	Ariki, Shigeru/E-3861-2014; Saito, Atsushi/M-7382-2018; Takahashi, Motoko/I-3154-2013	Ariki, Shigeru/0000-0001-5838-499X; Saito, Atsushi/0000-0003-3430-884X; Takahashi, Motoko/0000-0002-2112-6142	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22790764] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Aarbiou J, 2004, AM J RESP CELL MOL, V30, P193, DOI 10.1165/rcmb.2002-0267OC; Aarbiou J, 2006, INFLAMM RES, V55, P119, DOI 10.1007/s00011-005-0062-9; Bai Y, 2009, BIOCHEMISTRY-US, V48, P7229, DOI 10.1021/bi900670d; Bdeir K, 2010, AM J RESP CRIT CARE, V181, P935, DOI 10.1164/rccm.200907-1128OC; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chino N, 2006, INT J PEPT RES THER, V12, P203, DOI 10.1007/s10989-006-9018-3; Dathe M, 2002, BBA-BIOMEMBRANES, V1558, P171, DOI 10.1016/S0005-2736(01)00429-1; Doss M, 2009, J IMMUNOL, V182, P7878, DOI 10.4049/jimmunol.0804049; Feng Z, 2005, J DENT RES, V84, P445, DOI 10.1177/154405910508400509; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Garcia-Verdugo I, 2003, BIOCHEMISTRY-US, V42, P9532, DOI 10.1021/bi0347196; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Hartshorn KL, 2006, J IMMUNOL, V176, P6962, DOI 10.4049/jimmunol.176.11.6962; Head JF, 2003, J BIOL CHEM, V278, P43254, DOI 10.1074/jbc.M305628200; Ishimoto H, 2006, EUR RESPIR J, V27, P253, DOI 10.1183/09031936.06.00105904; Joly S, 2005, MOL IMMUNOL, V42, P1073, DOI 10.1016/j.molimm.2004.11.001; Korfhagen TR, 1996, P NATL ACAD SCI USA, V93, P9594, DOI 10.1073/pnas.93.18.9594; Kuroki Y, 2007, CELL MICROBIOL, V9, P1871, DOI 10.1111/j.1462-5822.2007.00953.x; Kustanovich I, 2002, J BIOL CHEM, V277, P16941, DOI 10.1074/jbc.M111071200; LICHTENSTEIN A, 1986, BLOOD, V68, P1407; LICHTENSTEIN AK, 1988, J IMMUNOL, V140, P2686; Liu SP, 2008, CHEMBIOCHEM, V9, P964, DOI 10.1002/cbic.200700560; Ozaki A, 2005, FEBS J, V272, P3863, DOI 10.1111/j.1742-4658.2005.04800.x; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; RENNARD SI, 1986, J APPL PHYSIOL, V60, P532, DOI 10.1152/jappl.1986.60.2.532; Sakamoto N, 2005, AM J PHYSIOL-LUNG C, V288, pL508, DOI 10.1152/ajplung.00076.2004; Sawada K, 2010, J BIOL CHEM, V285, P8434, DOI 10.1074/jbc.M109.074765; Scharf S, 2010, AM J PHYSIOL-LUNG C, V298, pL687, DOI 10.1152/ajplung.00365.2009; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; Schneider JJ, 2005, J MOL MED, V83, P587, DOI 10.1007/s00109-005-0657-1; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Tecle T, 2010, INNATE IMMUN-LONDON, V16, P151, DOI 10.1177/1753425910365734; Tsutsumi-Ishii Y, 2003, J IMMUNOL, V170, P4226, DOI 10.4049/jimmunol.170.8.4226; VANDEGRAAF EA, 1992, J LAB CLIN MED, V120, P252; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Yamazoe M, 2008, J BIOL CHEM, V283, P35878, DOI 10.1074/jbc.M807268200; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zelezetsky I, 2005, PEPTIDES, V26, P2368, DOI 10.1016/j.peptides.2005.05.002; Zhang H, 2001, AM J PHYSIOL-LUNG C, V280, pL947, DOI 10.1152/ajplung.2001.280.5.L947; Zhou L, 2011, AMINO ACIDS, V40, P123, DOI 10.1007/s00726-010-0565-8	41	8	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15034	15043		10.1074/jbc.M111.308056	http://dx.doi.org/10.1074/jbc.M111.308056			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22418431	Green Published, hybrid			2022-12-27	WOS:000304003200065
J	Tian, LJ; McClafferty, H; Knaus, HG; Ruth, P; Shipston, MJ				Tian, Lijun; McClafferty, Heather; Knaus, Hans-Guenther; Ruth, Peter; Shipston, Michael J.			Distinct Acyl Protein Transferases and Thioesterases Control Surface Expression of Calcium-activated Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT REGULATION; CRYSTAL-STRUCTURE; PALMITOYLATION; IDENTIFICATION; LOCALIZATION; TRAFFICKING; STABILITY; MEMBRANE; SUBUNITS; REVEALS	Protein palmitoylation is rapidly emerging as an important determinant in the regulation of ion channels, including large conductance calcium-activated potassium (BK) channels. However, the enzymes that control channel palmitoylation are largely unknown. Indeed, although palmitoylation is the only reversible lipid modification of proteins, acyl thioesterases that control ion channel depalmitoylation have not been identified. Here, we demonstrate that palmitoylation of the intracellular S0-S1 loop of BK channels is controlled by two of the 23 mammalian palmitoyl-transferases, zDHHC22 and zDHHC23. Palmitoylation by these acyl transferases is essential for efficient cell surface expression of BK channels. In contrast, depalmitoylation is controlled by the cytosolic thioesterase APT1 (LYPLA1), but not APT2 (LYPLA2). In addition, we identify a splice variant of LYPLAL1, a homolog with similar to 30% identity to APT1, that also controls BK channel depalmitoylation. Thus, both palmitoyl acyltransferases and acyl thioesterases display discrete substrate specificity for BK channels. Because depalmitoylated BK channels are retarded in the trans-Golgi network, reversible protein palmitoylation provides a critical checkpoint to regulate exit from the trans-Golgi network and thus control BK channel cell surface expression.	[Tian, Lijun; McClafferty, Heather; Shipston, Michael J.] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Knaus, Hans-Guenther] Med Univ Innsbruck, Div Mol & Cellular Pharmacol, A-6020 Innsbruck, Austria; [Ruth, Peter] Univ Tubingen, Inst Pharm, D-72076 Tubingen, Germany	University of Edinburgh; Medical University of Innsbruck; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Shipston, MJ (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland.	mike.shipston@ed.ac.uk	Shipston, Mike/C-7309-2013	Shipston, Mike/0000-0001-7544-582X	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust program grant (to M. J. S., H. K., and P. R.).	Banerjee S, 2009, NEURON, V64, P871, DOI 10.1016/j.neuron.2009.11.023; Burger M, 2012, J LIPID RES, V53, P43, DOI 10.1194/jlr.M019851; Chen L, 2010, J BIOL CHEM, V285, P23263, DOI 10.1074/jbc.M110.139758; Chen ML, 2008, J MOL HISTOL, V39, P125, DOI 10.1007/s10735-007-9144-z; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Devedjiev Y, 2000, STRUCTURE, V8, P1137, DOI 10.1016/S0969-2126(00)00529-3; Duncan JA, 2002, J BIOL CHEM, V277, P31740, DOI 10.1074/jbc.M202505200; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Greaves J, 2010, J BIOL CHEM, V285, P24629, DOI 10.1074/jbc.M110.119289; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Hirano T, 2009, BBA-MOL CELL BIOL L, V1791, P797, DOI 10.1016/j.bbalip.2009.05.001; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Jeffries O, 2010, J BIOL CHEM, V285, P33307, DOI 10.1074/jbc.M110.153940; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Mitchell DA, 2010, J BIOL CHEM, V285, P38104, DOI 10.1074/jbc.M110.169102; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Rathenberg J, 2004, MOL CELL NEUROSCI, V26, P251, DOI 10.1016/j.mcn.2004.01.012; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Saitoh F, 2004, J BIOL CHEM, V279, P29461, DOI 10.1074/jbc.M401471200; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Steinberg GR, 2007, AM J PHYSIOL-ENDOC M, V293, pE958, DOI 10.1152/ajpendo.00235.2007; Tian LJ, 2010, J BIOL CHEM, V285, P23954, DOI 10.1074/jbc.M110.137802; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Tomatis VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015045; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Zeidman R, 2009, MOL MEMBR BIOL, V26, P32, DOI 10.1080/09687680802629329	34	80	85	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14718	14725		10.1074/jbc.M111.335547	http://dx.doi.org/10.1074/jbc.M111.335547			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22399288	hybrid, Green Published			2022-12-27	WOS:000304003200037
J	Kennedy, EM; Amie, SM; Bambara, RA; Kim, B				Kennedy, Edward M.; Amie, Sarah M.; Bambara, Robert A.; Kim, Baek			Frequent Incorporation of Ribonucleotides during HIV-1 Reverse Transcription and Their Attenuated Repair in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DNA-POLYMERASE; CRYSTAL-STRUCTURE; CELL-CYCLE; INFECTION; SUBSTRATE; FIDELITY; MUTAGENESIS; SELECTION; DEMENTIA	Macrophages are well known long-lived reservoirs of HIV-1. Unlike activated CD4(+) T cells, this nondividing HIV-1 target cell type contains a very low level of the deoxynucleoside triphosphates (dNTPs) required for proviral DNA synthesis whereas the ribonucleoside triphosphate (rNTP) levels remain in the millimolar range, resulting in an extremely low dNTP/rNTP ratio. Biochemical simulations demonstrate that HIV-1 reverse transcriptase (RT) efficiently incorporates ribonucleoside monophosphates (rNMPs) during DNA synthesis at this ratio, predicting frequent rNMP incorporation by the virus specifically in macrophages. Indeed, HIV-1 RT incorporates rNMPs at a remarkable rate of 1/146 nucleotides during macrophage infection. This greatly exceeds known rates for cellular replicative polymerases. In contrast, little or no rNMP incorporation is detected in CD4(+) T cells. Repair of these rNMP lesions is also substantially delayed in macrophages compared with CD4(+) T cells. Single rNMPs embedded in a DNA template are known to induce cellular DNA polymerase pausing, which mechanistically contributes to mutation synthesis. Indeed, we also observed that embedded rNMPs in a dsDNA template also induce HIV-1 RT DNA synthesis pausing. Moreover, unrepaired rNMPs incorporated into the provirus during HIV-1 reverse transcription would be generally mutagenic as was shown in Saccharomyces cerevisiae. Most importantly, the frequent incorporation of rNMPs makes them an ideal candidate for development of a new class of HIV RT inhibitors.	[Kennedy, Edward M.; Kim, Baek] Univ Rochester, Dept Microbiol & Immunol, Med Ctr, Rochester, NY 14642 USA; [Amie, Sarah M.; Bambara, Robert A.] Univ Rochester, Dept Biochem & Biophys, Med Ctr, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Kim, B (corresponding author), Univ Rochester, Dept Microbiol & Immunol, Med Ctr, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	baek_kim@urmc.rochester.edu		Kennedy, Edward/0000-0002-2817-4809	National Institutes of Health [AI077401, AI049781, GM0495763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077401, R01AI049781, R56AI049781] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI077401 (to B. K.), AI049781 (to B. K.), and GM0495763 (to R. A. B.).	Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; ACHIM CL, 1993, J CLIN INVEST, V91, P2769, DOI 10.1172/JCI116518; Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; Bagasra O, 1996, J INFECT DIS, V173, P550, DOI 10.1093/infdis/173.3.550; BAN C, 1994, J MOL BIOL, V236, P275, DOI 10.1006/jmbi.1994.1134; BJORKLUND S, 1990, BIOCHEMISTRY-US, V29, P5452; Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900; Cases-Gonzalez CE, 2000, J BIOL CHEM, V275, P19759, DOI 10.1074/jbc.M910361199; Chugh P, 2007, J MOL BIOL, V366, P67, DOI 10.1016/j.jmb.2006.11.011; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; Gendelman HE, 1998, J INFECT DIS, V178, P1000, DOI 10.1086/515693; Genovesio A, 2011, J BIOMOL SCREEN, V16, P945, DOI 10.1177/1087057111415521; Jamburuthugoda VK, 2006, J BIOL CHEM, V281, P13388, DOI 10.1074/jbc.M600291200; Jamburuthugoda VK, 2005, BIOCHEMISTRY-US, V44, P10635, DOI 10.1021/bi050611+; JI JP, 1994, NUCLEIC ACIDS RES, V22, P47, DOI 10.1093/nar/22.1.47; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; LEGRICE SFJ, 1991, EMBO J, V10, P3905, DOI 10.1002/j.1460-2075.1991.tb04960.x; LEWIS P, 1992, EMBO J, V11, P3053, DOI 10.1002/j.1460-2075.1992.tb05376.x; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; LIPKIN D, 1954, J AM CHEM SOC, V76, P2871, DOI 10.1021/ja01640a004; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; Schnell G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002286; Schrager LK, 1998, JAMA-J AM MED ASSOC, V280, P67, DOI 10.1001/jama.280.1.67; Stewart SA, 1997, J VIROL, V71, P5579, DOI 10.1128/JVI.71.7.5579-5592.1997; Wahl MC, 2000, NUCLEIC ACIDS RES, V28, P4356, DOI 10.1093/nar/28.21.4356; Weiss KK, 2004, BIOCHEMISTRY-US, V43, P4490, DOI 10.1021/bi035258r; Weiss KK, 2002, J BIOL CHEM, V277, P22662, DOI 10.1074/jbc.M200202200	34	38	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14280	14288		10.1074/jbc.M112.348482	http://dx.doi.org/10.1074/jbc.M112.348482			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22383524	Green Published, hybrid			2022-12-27	WOS:000303996300079
J	Khurana, S; Chakraborty, S; Lam, M; Liu, Y; Su, YT; Zhao, X; Saleem, MA; Mathieson, PW; Bruggeman, LA; Kao, HY				Khurana, Simran; Chakraborty, Sharmistha; Lam, Minh; Liu, Yu; Su, Yu-Ting; Zhao, Xuan; Saleem, Moin A.; Mathieson, Peter W.; Bruggeman, Leslie A.; Kao, Hung-Ying			Familial Focal Segmental Glomerulosclerosis (FSGS)-linked alpha-Actinin 4 (ACTN4) Protein Mutants Lose Ability to Activate Transcription by Nuclear Hormone Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEPHRIN GENE-EXPRESSION; PODOCYTE INJURY; SLIT DIAPHRAGM; GAMMA AGONIST; ACID RECEPTOR; ALPHA-ACTININ-4; MECHANISM; MOTIF; DIFFERENTIATION; GLUCOCORTICOIDS	Mutations in alpha-actinin 4 (ACTN4) are linked to familial forms of focal segmental glomerulosclerosis (FSGS), a kidney disease characterized by proteinuria due to podocyte injury. The mechanisms underlying ACTN4 mutant-associated FSGS are not completely understood. Although alpha-actinins are better known to cross-link actin filaments and modulate cytoskeletal organization, we have previously shown that ACTN4 interacts with transcription factors including estrogen receptor and MEF2s and potentiates their transcriptional activity. Nuclear receptors including retinoic acid receptor (RAR) have been proposed to play a protective role in podocytes. We show here that ACTN4 interacts with and enhances transcriptional activation by RAR alpha. In addition, FSGS-linked ACTN4 mutants not only mislocalized to the cytoplasm, but also lost their ability to associate with nuclear receptors. Consequently, FSGS-linked ACTN4 mutants failed to potentiate transcriptional activation by nuclear hormone receptors in podocytes. In addition, overexpression of these mutants suppressed the transcriptional activity mediated by endogenous wild-type ACTN4 possibly by a cytoplasmic sequestration mechanism. Our data provide the first link between FSGS-linked ACTN4 mutants and transcriptional activation by nuclear receptor such as RAR alpha and peroxisome proliferator-activated receptor gamma.	[Khurana, Simran; Chakraborty, Sharmistha; Liu, Yu; Su, Yu-Ting; Zhao, Xuan; Kao, Hung-Ying] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Khurana, Simran; Chakraborty, Sharmistha; Liu, Yu; Su, Yu-Ting; Zhao, Xuan; Kao, Hung-Ying] Case Western Reserve Univ, Ctr Comprehens Canc, Cleveland, OH 44106 USA; [Khurana, Simran; Chakraborty, Sharmistha; Liu, Yu; Su, Yu-Ting; Zhao, Xuan; Kao, Hung-Ying] Univ Hosp Cleveland, Res Inst, Cleveland, OH 44106 USA; [Lam, Minh] Univ Hosp, Case Med Ctr, Dept Dermatol, Cleveland, OH 44106 USA; [Bruggeman, Leslie A.] Case Western Reserve Univ, Sch Med, Rammelkamp Ctr Educ & Res, Cleveland, OH 44106 USA; [Bruggeman, Leslie A.] Case Western Reserve Univ, Sch Med, MetroHlth Med Ctr, Dept Med, Cleveland, OH 44106 USA; [Saleem, Moin A.; Mathieson, Peter W.] Univ Bristol, Southmead Hosp, Childrens Renal Unit, Bristol BS10 5NB, Avon, England; [Saleem, Moin A.; Mathieson, Peter W.] Univ Bristol, Southmead Hosp, Acad Renal Unit, Bristol BS10 5NB, Avon, England	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; MetroHealth System; Case Western Reserve University; MetroHealth System; Southmead Hospital; University of Bristol; Southmead Hospital; University of Bristol	Kao, HY (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	hxk43@cwru.edu		Saleem, Moin/0000-0002-9808-4518	National Institutes of Health [R01 DK078965, HL093269]; Comprehensive Cancer Center of Case Western Reserve University and University Hospitals of Cleveland (National Institutes of Health) [P30 CA43703-12]; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER; Medical Research Council [G0800200] Funding Source: researchfish; MRC [G0800200] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comprehensive Cancer Center of Case Western Reserve University and University Hospitals of Cleveland (National Institutes of Health); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK078965 and HL093269 (to H.-Y.K.). This work was also supported by the Confocal Microscopy Core Facility of the Comprehensive Cancer Center of Case Western Reserve University and University Hospitals of Cleveland (National Institutes of Health Grant P30 CA43703-12).	Amann PM, 2011, CURR MED CHEM, V18, P1405; Benigni A, 2006, J AM SOC NEPHROL, V17, P1624, DOI 10.1681/ASN.2005090983; Chakraborty S, 2006, J BIOL CHEM, V281, P35070, DOI 10.1074/jbc.M602474200; Cheng HF, 2010, INT J BIOCHEM CELL B, V42, P1380, DOI 10.1016/j.biocel.2010.05.014; Dandapani SV, 2007, J BIOL CHEM, V282, P467, DOI 10.1074/jbc.M605024200; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Fujii Y, 2006, KIDNEY INT, V69, P1350, DOI 10.1038/sj.ki.5000317; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Guess A, 2010, AM J PHYSIOL-RENAL, V299, pF845, DOI 10.1152/ajprenal.00161.2010; He JCJ, 2007, J AM SOC NEPHROL, V18, P93, DOI 10.1681/ASN.2006070727; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Khurana S, 2011, J BIOL CHEM, V286, P1850, DOI 10.1074/jbc.M110.162107; Kumeta M, 2010, J CELL SCI, V123, P1020, DOI 10.1242/jcs.059568; Langham RG, 2002, DIABETOLOGIA, V45, P1572, DOI 10.1007/s00125-002-0946-y; Liu H, 2004, J BIOL CHEM, V279, P45208, DOI 10.1074/jbc.M408033200; Lowik MM, 2009, EUR J PEDIATR, V168, P1291, DOI 10.1007/s00431-009-1017-x; Mahajan MA, 2005, ENDOCR REV, V26, P583, DOI 10.1210/er.2004-0012; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; Michaud JLR, 2006, KIDNEY INT, V70, P1054, DOI 10.1038/sj.ki.5001665; Michaud JLR, 2007, CLIN SCI, V112, P325, DOI 10.1042/CS20060143; Miglio G, 2011, BRIT J PHARMACOL, V162, P111, DOI 10.1111/j.1476-5381.2010.01032.x; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Mundel P, 2010, KIDNEY INT, V77, P571, DOI 10.1038/ki.2009.424; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Okamura M, 2009, NEPHROL DIAL TRANSPL, V24, P3006, DOI 10.1093/ndt/gfp243; Olefsky JM, 2001, J BIOL CHEM, V276, P36863, DOI 10.1074/jbc.R100047200; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Patrakka J, 2010, BIOCHEM BIOPH RES CO, V396, P164, DOI 10.1016/j.bbrc.2010.04.069; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; RANA B, 1994, MOL CELL BIOL, V14, P5858, DOI 10.1128/MCB.14.9.5858; Ransom RF, 2005, KIDNEY INT, V68, P2473, DOI 10.1111/j.1523-1755.2005.00723.x; Ratnam KK, 2011, KIDNEY INT, V79, P624, DOI 10.1038/ki.2010.470; Ren SY, 2005, BIOCHEM BIOPH RES CO, V338, P1818, DOI 10.1016/j.bbrc.2005.10.158; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; SCHLONDORFF D, 1990, METHOD ENZYMOL, V191, P130; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Suzuki A, 2003, J AM SOC NEPHROL, V14, P981, DOI 10.1097/01.ASN.0000057857.66268.8F; Takano Y, 2007, AM J PHYSIOL-RENAL, V292, pF1573, DOI 10.1152/ajprenal.00423.2006; Tryggvason K, 1999, J AM SOC NEPHROL, V10, P2440; Weins A, 2005, J AM SOC NEPHROL, V16, P3694, DOI 10.1681/ASN.2005070706; Xing CY, 2006, KIDNEY INT, V70, P1038, DOI 10.1038/sj.ki.5001655; Yamauchi K, 2006, KIDNEY INT, V70, P892, DOI 10.1038/sj.ki.5001625; Yang HC, 2006, KIDNEY INT, V69, P1756, DOI 10.1038/sj.ki.5000336; Yao J, 2004, PLOS BIOL, V2, P787, DOI 10.1371/journal.pbio.0020167	53	29	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12027	12035		10.1074/jbc.M112.345421	http://dx.doi.org/10.1074/jbc.M112.345421			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351778	Green Published, hybrid			2022-12-27	WOS:000302782200040
J	Liu, L; Cao, ZY; Chen, J; Li, R; Cao, YH; Zhu, CL; Wu, KL; Wu, JG; Liu, F; Zhu, Y				Liu, Li; Cao, Zhongying; Chen, Jing; Li, Rui; Cao, Yanhua; Zhu, Chengliang; Wu, Kailang; Wu, Jianguo; Liu, Fang; Zhu, Ying			Influenza A Virus Induces Interleukin-27 through Cyclooxygenase-2 and Protein Kinase A Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; RESPONSE ELEMENT; ANTIINFLAMMATORY PROPERTIES; VIRAL REPLICATION; PROSTAGLANDIN E-2; INTERFERON-GAMMA; IFN-ALPHA; CYTOKINE; ACTIVATION; IL-27	We previously reported that IL-27, which belongs to the IL-12 family of cytokines, is elevated in the serum of patients infected with influenza A virus (IAV). Here, we show that the expression of IL-27 was significantly up-regulated in A549 human lung epithelial cells and human peripheral blood mononuclear cells infected with IAV. Additionally, IAV triggered IL-27 expression through protein kinase A and cAMP-response element-binding protein signaling, which was mediated by cyclooxygenase-2-derived prostaglandin E-2. IL-27 inhibited IAV replication by STAT1/2/3 phosphorylation and activated antiviral factor protein kinase R phosphorylation. Clinical analysis showed that IL-27 levels were significantly elevated in a cohort of patients infected with IAV compared with healthy individuals and that circulating IL-27 levels were tightly and positively correlated with prostaglandin E-2 levels. These results indicate that IL-27 expression is one host immune factor produced in response to IAV infection and that elevated IL-27 levels inhibit viral replication.	[Liu, Li; Cao, Zhongying; Chen, Jing; Li, Rui; Cao, Yanhua; Zhu, Chengliang; Wu, Kailang; Wu, Jianguo; Liu, Fang; Zhu, Ying] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Zhu, Y (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	yingzhu@whu.edu.cn	Li, Hongpu/B-7707-2014	Li, Hongpu/0000-0003-2323-6107; Wu, Jianguo/0000-0002-8326-2895	Major State Basic Research Development Program of China ("973" project) [2009CB522506, 2012CB518900]; National Natural Science Foundation of China [30970144, 81171654]; National Mega Project on Major Infectious Diseases Prevention [2012ZX10004503, 2012ZX10002006-003, 2012ZX10004-207]; National Mega Project on Major Drug Development [2011ZX09401-302]	Major State Basic Research Development Program of China ("973" project)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Mega Project on Major Infectious Diseases Prevention; National Mega Project on Major Drug Development	This work was supported by research grants from the Major State Basic Research Development Program of China ("973" project numbers 2009CB522506 and 2012CB518900), National Natural Science Foundation of China Grants 30970144 and 81171654, National Mega Project on Major Infectious Diseases Prevention Grants 2012ZX10004503, 2012ZX10002006-003, and 2012ZX10004-207, and National Mega Project on Major Drug Development Grant 2011ZX09401-302.	Abel T, 2008, PROG BRAIN RES, V169, P97, DOI 10.1016/S0079-6123(07)00006-4; Anderson CF, 2009, J IMMUNOL, V183, P4619, DOI 10.4049/jimmunol.0804024; Barneda-Zahonero B, 2009, MOL BIOL CELL, V20, P5051, DOI 10.1091/mbc.E09-05-0424; Batten M, 2007, J MOL MED-JMM, V85, P661, DOI 10.1007/s00109-007-0164-7; Bender H, 2009, HEPATOLOGY, V50, P585, DOI 10.1002/hep.22988; Diegelmann J, 2012, J BIOL CHEM, V287, P286, DOI 10.1074/jbc.M111.294355; Dormond O, 2002, J BIOL CHEM, V277, P45838, DOI 10.1074/jbc.M209213200; Dwivedi Y, 2011, PROG NEURO-PSYCHOPH, V35, P831, DOI 10.1016/j.pnpbp.2010.08.025; Fakruddin JM, 2007, BLOOD, V109, P1841, DOI 10.1182/blood-2006-02-001578; Frank AC, 2010, J INTERF CYTOK RES, V30, P427, DOI 10.1089/jir.2009.0093; Fujino H, 2005, MOL PHARMACOL, V68, P251, DOI 10.1124/mol.105.011833; Goodman WA, 2011, J IMMUNOL, V186, P3336, DOI 10.4049/jimmunol.1001455; Greenwell-Wild T, 2009, BLOOD, V114, P1864, DOI 10.1182/blood-2009-03-211540; Grewal SS, 2000, J BIOL CHEM, V275, P34433, DOI 10.1074/jbc.M004728200; Guzzo C, 2010, AIDS, V24, P1371, DOI 10.1097/QAD.0b013e3283391d2b; Ho MY, 2009, J IMMUNOL, V183, P6217, DOI 10.4049/jimmunol.0901272; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Imamichi T, 2008, AIDS, V22, P39, DOI 10.1097/QAD.0b013e3282f3356c; Jonges M, 2010, J CLIN MICROBIOL, V48, P928, DOI 10.1128/JCM.02045-09; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; Julkunen I, 2001, CYTOKINE GROWTH F R, V12, P171, DOI 10.1016/S1359-6101(00)00026-5; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Laurence A, 2009, HEPATOLOGY, V50, P358, DOI 10.1002/hep.23063; Lee SMY, 2008, J INFECT DIS, V198, P525, DOI 10.1086/590499; Li JP, 2011, BRIT J HAEMATOL, V153, P764, DOI 10.1111/j.1365-2141.2010.08431.x; Li W, 2010, J IMMUNOL, V185, P5056, DOI 10.4049/jimmunol.0902667; Li W, 2009, EUR J IMMUNOL, V39, P1019, DOI 10.1002/eji.200838885; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001985; Liu L, 2011, CLIN CHIM ACTA, V412, P1081, DOI 10.1016/j.cca.2011.02.028; Liu M, 2007, FASEB J, V21, P1586, DOI 10.1096/fj.06-6589com; Merkle D, 2011, CELL SIGNAL, V23, P507, DOI 10.1016/j.cellsig.2010.08.017; Mizumura K, 2003, CLIN EXP ALLERGY, V33, P1244, DOI 10.1046/j.1365-2222.2003.01750.x; Mogensen TH, 2001, MICROBIOL MOL BIOL R, V65, P131, DOI 10.1128/MMBR.65.1.131-150.2001; Mukhtar MM, 2009, INT J BIOCHEM CELL B, V41, P554, DOI 10.1016/j.biocel.2008.07.001; Nakamura R, 2010, J VIROL, V84, P5574, DOI 10.1128/JVI.02030-09; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; Owaki T, 2008, J IMMUNOL, V180, P2903, DOI 10.4049/jimmunol.180.5.2903; Pirhonen J, 2007, J LEUKOCYTE BIOL, V82, P1185, DOI 10.1189/jlb.0307157; Poleganov MA, 2008, MOL IMMUNOL, V45, P2869, DOI 10.1016/j.molimm.2008.01.021; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; RONNI T, 1995, J IMMUNOL, V154, P2764; Shimizu M, 2006, J IMMUNOL, V176, P7317, DOI 10.4049/jimmunol.176.12.7317; Steer SA, 2003, VIRAL IMMUNOL, V16, P447, DOI 10.1089/088282403771926283; Ueda M, 2010, J VIROL, V84, P3068, DOI 10.1128/JVI.01923-09; Villarino AV, 2004, ARTHRITIS RES THER, V6, P225, DOI 10.1186/ar1227; Villarino AV, 2004, J IMMUNOL, V173, P715, DOI 10.4049/jimmunol.173.2.715; Wang JR, 2009, J IMMUNOL, V182, P1296, DOI 10.4049/jimmunol.182.3.1296; Xie DX, 2009, INT IMMUNOL, V21, P1251, DOI 10.1093/intimm/dxp087; Yoshida H, 2008, IMMUNOL REV, V226, P234, DOI 10.1111/j.1600-065X.2008.00710.x; Zanassi P, 2001, J BIOL CHEM, V276, P11487, DOI 10.1074/jbc.M007631200; Zou F, 2007, BIOCHEM BIOPH RES CO, V355, P494, DOI 10.1016/j.bbrc.2007.01.178	51	54	56	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11899	11910		10.1074/jbc.M111.308064	http://dx.doi.org/10.1074/jbc.M111.308064			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22343630	Green Published, hybrid			2022-12-27	WOS:000302782200029
J	Petropoulos, AD; Green, R				Petropoulos, Alexandros D.; Green, Rachel			Further in Vitro Exploration Fails to Support the Allosteric Three-site Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA BINDING; RIBOSOMAL ELONGATION CYCLE; PEPTIDE-BOND FORMATION; E-SITE; ESCHERICHIA-COLI; MESSENGER-RNA; EXIT-SITE; CRYSTAL-STRUCTURE; QUALITY-CONTROL; READING FRAME	Ongoing debate in the ribosome field has focused on the role of bound E-site tRNA and the Shine-Dalgarno-anti-Shine-Dalgarno (SD-aSD) interaction on A-site tRNA interactions and the fidelity of tRNA selection. Here we use an in vitro reconstituted Escherichia coli translation system to explore the reported effects of E-site-bound tRNA and SD-aSD interactions on tRNA selection events and find no evidence for allosteric coupling. A large set of experiments exploring the role of the E-site tRNA in miscoding failed to recapitulate the observations of earlier studies (Di Giacco, V., Marquez, V., Qin, Y., Pech, M., Triana-Alonso, F. J., Wilson, D. N., and Nierhaus, K. H. (2008) Proc. Natl. Acad. Sci. U.S.A. 105, 10715-10720 and Geigenmuller, U., and Nierhaus, K. H. (1990) EMBO J. 9, 4527-4533); the frequency of miscoding was unaffected by the presence of E-site-bound cognate tRNA. Moreover, our data provide clear evidence that the reported effects of the SD-aSD interaction on fidelity can be attributed to the binding of ribosomes to an unanticipated site on the mRNA (in the absence of the SD sequence) that provides a cognate pairing codon leading naturally to incorporation of the purported "noncognate" amino acid.	[Petropoulos, Alexandros D.; Green, Rachel] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, 702 PCTB,725 N Wolfe St, Baltimore, MD 21205 USA.	ragreen@jhmi.edu			University of Patras (Greece); Johns Hopkins University School of Medicine; National Institutes of Health [GM059425]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059425] Funding Source: NIH RePORTER	University of Patras (Greece); Johns Hopkins University School of Medicine(Johns Hopkins University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by a fellowship sponsored by collaboration between the University of Patras (Greece) and The Johns Hopkins University School of Medicine.; Supported by grants from the National Institutes of Health (GM059425) and the Howard Hughes Medical Institute. To whom correspondence should be addressed: Dept. of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, 702 PCTB, 725 N. Wolfe St., Baltimore, MD 21205. Tel.: 410-614-4922; Fax: 410-955-9124; E-mail: ragreen@jhmi.edu.	BARTETZKO A, 1988, METHOD ENZYMOL, V164, P650; Brunelle JL, 2006, RNA, V12, P33, DOI 10.1261/rna.2256706; Chen CL, 2011, P NATL ACAD SCI USA, V108, P16980, DOI 10.1073/pnas.1106999108; Devaraj A, 2009, RNA, V15, P255, DOI 10.1261/rna.1320109; Di Giacco V, 2008, P NATL ACAD SCI USA, V105, P10715, DOI 10.1073/pnas.0801974105; GEIGENMULLER U, 1990, EMBO J, V9, P4527, DOI 10.1002/j.1460-2075.1990.tb07904.x; GNIRKE A, 1989, J BIOL CHEM, V264, P7291; HARTZ D, 1988, METHOD ENZYMOL, V164, P419; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; Jenner L, 2007, EMBO REP, V8, P846, DOI 10.1038/sj.embor.7401044; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; LILL R, 1987, J MOL BIOL, V196, P137, DOI 10.1016/0022-2836(87)90516-X; Marquez V, 2004, CELL, V118, P45, DOI 10.1016/j.cell.2004.06.012; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; MOAZED D, 1986, CELL, V47, P985, DOI 10.1016/0092-8674(86)90813-5; Nierhaus KH, 2006, BIOCHIMIE, V88, P1013, DOI 10.1016/j.biochi.2006.02.009; RHEINBERGER HJ, 1983, EUR J BIOCHEM, V134, P421, DOI 10.1111/j.1432-1033.1983.tb07584.x; ROBERTSON JM, 1987, J MOL BIOL, V196, P525, DOI 10.1016/0022-2836(87)90030-1; Sanders CL, 2007, RNA, V13, P1483, DOI 10.1261/rna.638707; SCHILLINGBARTETZKO S, 1992, J BIOL CHEM, V267, P4703; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Semenkov YP, 1996, P NATL ACAD SCI USA, V93, P12183, DOI 10.1073/pnas.93.22.12183; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zaher HS, 2011, CELL, V147, P396, DOI 10.1016/j.cell.2011.08.045; Zaher HS, 2010, MOL CELL, V39, P110, DOI 10.1016/j.molcel.2010.06.009; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582	28	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11642	11648		10.1074/jbc.C111.330068	http://dx.doi.org/10.1074/jbc.C111.330068			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22378789	Green Published, hybrid			2022-12-27	WOS:000302782200004
J	Zhang, SZ; He, H; Day, AJ; Tseng, SCG				Zhang, Suzhen; He, Hua; Day, Anthony J.; Tseng, Scheffer C. G.			Constitutive Expression of Inter-alpha-inhibitor (I alpha I) Family Proteins and Tumor Necrosis Factor-stimulated Gene-6 (TSG-6) by Human Amniotic Membrane Epithelial and Stromal Cells Supporting Formation of the Heavy Chain-Hyaluronan (HC-HA) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URINARY TRYPSIN-INHIBITOR; HUMAN ARTICULAR CHONDROCYTES; BINDING-PROTEIN; HUMAN-PLASMA; RHEUMATOID-ARTHRITIS; EXTRACELLULAR-MATRIX; COVALENT TRANSFER; BIKUNIN PROTEINS; HUMAN-SERUM; ACID	Recently, we reported HC-HA, a covalent complex formed between heavy chains (HCs) of inter-alpha -inhibitor (I alpha I) and hyaluronan (HA) by the catalytic action of tumor necrosis factor (TNF)-stimulated gene-6 (TSG-6), is responsible for human amniotic membrane (AM) anti-inflammatory, anti-scarring, and anti-angiogenic actions. At the present time, the only well characterized source of I alpha I is serum being produced by the liver. This study showed that AM epithelial and stromal cells and stromal matrix all stained positively for HA, HC 1, 2, and 3, bikunin, and TSG-6. TSG-6 mRNA and protein were constitutively expressed by cultured AM epithelial and stromal cells without being up-regulated by TNF. In serum-free conditions, these cells expressed I alpha I, leading to the formation of HC-HA complex that contained both HC1 and HC2. In contrast, only HC1 was found in the HC-HA complex purified from AM. Local production of I alpha I, the HC-TSG-6 intermediate complex, and HC-HA were abolished when cells were treated with siRNA to HC1, HC2, bikunin (all of which impair the biosynthesis of I alpha I), or TSG-6 but not to HC3. Collectively, these results indicate that AM is another tissue in addition to the liver to constitutively produce I alpha I and that the HC-HA complex made by this tissue is different from that found at inflammatory sites (e. g. in asthma and arthritis) and in the matrix of the cumulus oocyte complex.	[Tseng, Scheffer C. G.] Ocular Surface Ctr, Miami, FL 33173 USA; [He, Hua; Tseng, Scheffer C. G.] TissueTech Inc, Miami, FL 33173 USA; [Zhang, Suzhen; Tseng, Scheffer C. G.] Ocular Surface Res & Educ Fdn, Miami, FL 33173 USA; [Day, Anthony J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	University of Manchester	Tseng, SCG (corresponding author), Ocular Surface Ctr, 7000 SW,97 Ave,Suite 213, Miami, FL 33173 USA.	stseng@ocularsurface.com	Zhang, Suzhen/J-8011-2013; Day, Anthony/O-1658-2015	Day, Anthony/0000-0002-1415-3134	National Institutes of Health through the NEI [R44 EY017497, R43 EY021045]; TissueTech, Inc.; Ocular Surface Research and Education Foundation, Miami, FL; Arthritis Research United Kingdom [18472, 19489]; Versus Arthritis [19489, 18472] Funding Source: researchfish; NATIONAL EYE INSTITUTE [R43EY021045, R44EY017497, R01EY006819] Funding Source: NIH RePORTER	National Institutes of Health through the NEI; TissueTech, Inc.; Ocular Surface Research and Education Foundation, Miami, FL; Arthritis Research United Kingdom(Versus Arthritis); Versus Arthritis(Versus Arthritis); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R44 EY017497 and R43 EY021045 through the NEI (to S. C. G. T.). This work was also supported by a research grant from TissueTech, Inc., and an unrestricted grant from Ocular Surface Research and Education Foundation, Miami, FL.; Supported by Arthritis Research United Kingdom Grants 18472 and 19489.	Blom AM, 1999, J BIOL CHEM, V274, P298, DOI 10.1074/jbc.274.1.298; BOST F, 1993, EUR J BIOCHEM, V218, P283, DOI 10.1111/j.1432-1033.1993.tb18376.x; Bouchard Charles S, 2004, Ocul Surf, V2, P201; Bourguignon J, 1999, J HISTOCHEM CYTOCHEM, V47, P1625, DOI 10.1177/002215549904701214; CAMAIONI A, 1993, J BIOL CHEM, V268, P20473; CHEN L, 1994, J BIOL CHEM, V269, P28282; Chen L, 1996, J BIOL CHEM, V271, P19409, DOI 10.1074/jbc.271.32.19409; Chen SY, 2011, TISSUE ENG PART C-ME, V17, P537, DOI [10.1089/ten.tec.2010.0609, 10.1089/ten.TEC.2010.0609]; Chen YT, 2007, STEM CELLS, V25, P1995, DOI 10.1634/stemcells.2006-0677; DAVEAU M, 1993, BIOCHEM J, V292, P485, DOI 10.1042/bj2920485; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; Diarra-Mehrpour M, 1998, J BIOL CHEM, V273, P26809, DOI 10.1074/jbc.273.41.26809; Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; ENGHILD JJ, 1989, J BIOL CHEM, V264, P15975; Flahaut C, 1998, BIOCHEM J, V333, P749, DOI 10.1042/bj3330749; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Fujimoto T, 2002, AM J PATHOL, V160, P1495, DOI 10.1016/S0002-9440(10)62575-8; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Hamm A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-25; He H, 2008, INVEST OPHTH VIS SCI, V49, P4468, DOI 10.1167/iovs.08-1781; He H, 2009, J BIOL CHEM, V284, P20136, DOI 10.1074/jbc.M109.021881; HERON A, 1994, BIOCHEM J, V302, P573, DOI 10.1042/bj3020573; Higa K, 2005, CORNEA, V24, P206, DOI 10.1097/01.ico.0000133999.45262.83; Himmelfarb M, 2004, CANCER LETT, V204, P69, DOI 10.1016/j.canlet.2003.09.011; Janssen U, 2001, KIDNEY INT, V60, P126, DOI 10.1046/j.1523-1755.2001.00779.x; JESSEN TE, 1994, BIOL CHEM H-S, V375, P521, DOI 10.1515/bchm3.1994.375.8.521; Jessen TE, 2003, REPRODUCTION, V125, P27, DOI 10.1530/rep.0.1250027; JESSEN TE, 1988, FEBS LETT, V230, P195, DOI 10.1016/0014-5793(88)80670-7; Kehlen A, 2003, ARTHRITIS RES THER, V5, pR186, DOI 10.1186/ar762; Le Naour F, 2001, J BIOL CHEM, V276, P17920, DOI 10.1074/jbc.M100156200; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; LEE TH, 1993, J BIOL CHEM, V268, P6154; LEE TH, 1990, MOL CELL BIOL, V10, P1982, DOI 10.1128/MCB.10.5.1982; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Li W, 2008, J CELL PHYSIOL, V215, P657, DOI 10.1002/jcp.21345; Mahoney DJ, 2008, J BIOL CHEM, V283, P25952, DOI 10.1074/jbc.M802138200; Maier R, 1996, ARTHRITIS RHEUM, V39, P552, DOI 10.1002/art.1780390403; Maina V, 2009, J LEUKOCYTE BIOL, V86, P123, DOI 10.1189/jlb.0608345; Margerie D, 1997, OSTEOARTHR CARTILAGE, V5, P129, DOI 10.1016/S1063-4584(97)80006-4; Martin-Vandelet N, 1999, EUR J BIOCHEM, V259, P476, DOI 10.1046/j.1432-1327.1999.00067.x; Meinert M, 2001, AM J OBSTET GYNECOL, V184, P679, DOI 10.1067/mob.2001.110294; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mizon C, 1996, J IMMUNOL METHODS, V190, P61, DOI 10.1016/0022-1759(95)00257-X; Mizushima S, 1998, BIOL PHARM BULL, V21, P167; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; MURAMATU M, 1980, J BIOCHEM-TOKYO, V88, P1317, DOI 10.1093/oxfordjournals.jbchem.a133100; Nagyova E, 2004, BIOL REPROD, V71, P1838, DOI 10.1095/biolreprod.104.029595; Nentwich HA, 2002, J BIOL CHEM, V277, P15354, DOI 10.1074/jbc.M110765200; ODUM L, 1990, BIOL CHEM H-S, V371, P1153, DOI 10.1515/bchm3.1990.371.2.1153; Pineiro M, 1999, BIOCHEM BIOPH RES CO, V263, P224, DOI 10.1006/bbrc.1999.1349; PU XP, 1994, BBA-PROTEIN STRUCT M, V1208, P338, DOI 10.1016/0167-4838(94)90122-8; Roberts S, 2005, EUR SPINE J, V14, P36, DOI 10.1007/s00586-004-0798-x; ROUET P, 1992, BIOL CHEM H-S, V373, P1019, DOI 10.1515/bchm3.1992.373.2.1019; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; SALIER JP, 1983, BIOCHIM BIOPHYS ACTA, V742, P206; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sanggaard KW, 2005, J BIOL CHEM, V280, P11936, DOI 10.1074/jbc.M409016200; Sato H, 2001, BIOCHEM BIOPH RES CO, V281, P1154, DOI 10.1006/bbrc.2001.4475; Shay E, 2011, INVEST OPHTH VIS SCI, V52, P2669, DOI 10.1167/iovs.10-5888; SJOBERG EM, 1992, ARCH BIOCHEM BIOPHYS, V295, P217, DOI 10.1016/0003-9861(92)90509-U; Tan KT, 2011, J EUR ACAD DERMATOL, V25, P317, DOI 10.1111/j.1468-3083.2010.03792.x; Tan KT, 2011, AESTHET SURG J, V31, P47, DOI 10.1177/1090820X10391778; THOGERSEN IB, 1995, J BIOL CHEM, V270, P18700; Thuveson M, 1999, J BIOL CHEM, V274, P6741, DOI 10.1074/jbc.274.10.6741; Toda A, 2007, J PHARMACOL SCI, V105, P215, DOI 10.1254/jphs.CR0070034; Tseng SCG, 2001, BIOSCIENCE REP, V21, P481, DOI 10.1023/A:1017995810755; Tseng Scheffer C G, 2004, Ocul Surf, V2, P177; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; YONEDA M, 1990, J BIOL CHEM, V265, P5247; Yoshihara Y, 2008, OSTEOARTHR CARTILAGE, V16, P1343, DOI 10.1016/j.joca.2008.04.004; Yu SJ, 2009, CELL TRANSPLANT, V18, P111, DOI 10.3727/096368909788341243; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhu L, 2008, CONNECT TISSUE RES, V49, P48, DOI 10.1080/03008200701820955; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	79	50	55	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12433	12444		10.1074/jbc.M112.342873	http://dx.doi.org/10.1074/jbc.M112.342873			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351758	Green Published, hybrid			2022-12-27	WOS:000302782200083
J	Ferrante, P; Ballottari, M; Bonente, G; Giuliano, G; Bassi, R				Ferrante, Paola; Ballottari, Matteo; Bonente, Giulia; Giuliano, Giovanni; Bassi, Roberto			LHCBM1 and LHCBM2/7 Polypeptides, Components of Major LHCII Complex, Have Distinct Functional Roles in Photosynthetic Antenna System of Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; PROTEIN-KINASE STT7; PHOTOSYSTEM-II; CHLOROPHYLL ANTENNA; STATE TRANSITIONS; HIGHER-PLANTS; HYDROGEN-PRODUCTION; MOLECULAR-HYDROGEN; GRANA MEMBRANES; CARBON-DIOXIDE	The photosystem II antenna of Chlamydomonas reinhardtii is composed of monomeric and trimeric complexes, the latter encoded by LHCBM genes. We employed artificial microRNA technology to specifically silence the LHCBM2 and LHCBM7 genes, encoding identical mature polypeptides, and the LHCBM1 gene. As a control, we studied the npq5 mutant, deficient in the LHCBM1 protein. The organization of LHCII complexes, functional antenna size, capacity for photoprotection, thermal energy dissipation and state transitions, and resistance to reactive oxygen species was studied in the various genotypes. Silencing of the LHCBM2/7 genes resulted in a decrease of an LHCII protein with an apparent molecular mass of 22 kDa, whereas silencing/lack of LHCBM1 caused the decrease/disappearance of a 23-kDa protein. A decrease in the abundance of trimeric LHCII complexes and in functional antenna size was observed in bothLHCBM2/7andLHCBM1knockouts. In agreement with previous data, depletion of LHCBM1 decreased the capacity for excess energy dissipation but not the ability to perform state transitions. The opposite was true for LHCBM2/7, implying that this polypeptide has a different functional role from LHCBM1. The abundance of LHCBM1 and LHCBM2/7 is in both cases correlated with resistance to superoxide anion, whereas only LHCBM1 is also involved in singlet oxygen scavenging. These results suggest that different LHCBM components have well defined, non-redundant functions despite their high homology, implying that engineering of LHCBM proteins can be an effective strategy for manipulating the light harvesting system of Chlamydomonas reinhardtii.	[Ballottari, Matteo; Bonente, Giulia; Bassi, Roberto] Univ Verona, Dept Biotechnol, I-37134 Verona, Italy; [Ferrante, Paola; Giuliano, Giovanni] Casaccia Res Ctr, ENEA Italian Natl Agcy New Technol Energy & Susta, I-00123 Rome, Italy; [Bassi, Roberto] ICG3 Juelich Res Ctr, D-52425 Julich, Germany	University of Verona; Italian National Agency New Technical Energy & Sustainable Economics Development	Bassi, R (corresponding author), Univ Verona, Dept Biotechnol, Str Le Grazie 15, I-37134 Verona, Italy.	roberto.bassi@univr.it	Ballottari, Matteo/N-1916-2019; Giuliano, Giovanni/A-2701-2012	Ballottari, Matteo/0000-0001-8410-3397; Giuliano, Giovanni/0000-0002-2486-0510; bassi, roberto/0000-0002-4140-8446; Ferrante, Paola/0000-0003-3071-2212	Italian Ministry of Agriculture; Euopean Union [245070 FP7-KBBE-2009-3 SUNBIOPATH]	Italian Ministry of Agriculture; Euopean Union	This work was supported by the Italian Ministry of Agriculture, Hydrobio project, and by Euopean Union Project 245070 FP7-KBBE-2009-3 SUNBIOPATH.	Andersson J, 2003, PLANT J, V35, P350, DOI 10.1046/j.1365-313X.2003.01811.x; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Ballottari M, 2012, BBA-BIOENERGETICS, V1817, P143, DOI 10.1016/j.bbabio.2011.06.005; Baroli I, 2004, J BIOL CHEM, V279, P6337, DOI 10.1074/jbc.M312919200; BASSI R, 1989, EUR J CELL BIOL, V50, P84; BASSI R, 1991, PLANTA, V183, P423, DOI 10.1007/BF00197742; Bonente G, 2012, J BIOL CHEM, V287, P5833, DOI 10.1074/jbc.M111.304279; Bonente G, 2011, PHOTOSYNTH RES, V108, P107, DOI 10.1007/s11120-011-9660-2; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Caffarri S, 2005, PROTEOMICS, V5, P758, DOI 10.1002/pmic.200402008; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Cardol P, 2008, P NATL ACAD SCI USA, V105, P7881, DOI 10.1073/pnas.0802762105; Choi SP, 2010, BIORESOURCE TECHNOL, V101, P5330, DOI 10.1016/j.biortech.2010.02.026; Croce R, 2002, BBA-BIOENERGETICS, V1556, P29, DOI 10.1016/S0005-2728(02)00304-3; DAINESE P, 1991, J BIOL CHEM, V266, P8136; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dall'Osto L, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-32; Dall'Osto L, 2007, J BIOL CHEM, V282, P35056, DOI 10.1074/jbc.M704729200; Dall'Osto L, 2007, PLANT CELL, V19, P1048, DOI 10.1105/tpc.106.049114; Dall'Osto L, 2010, MOL PLANT, V3, P576, DOI 10.1093/mp/ssp117; Damkjaer JT, 2009, PLANT CELL, V21, P3245, DOI 10.1105/tpc.108.064006; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Elrad D, 2004, CURR GENET, V45, P61, DOI 10.1007/s00294-003-0460-x; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1105/tpc.002154; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Fischer N, 2001, MOL GENET GENOMICS, V265, P888, DOI 10.1007/s004380100485; Fleischmann MM, 1999, J BIOL CHEM, V274, P30987, DOI 10.1074/jbc.274.43.30987; Fristedt R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010963; Gaffron H, 1939, NATURE, V143, P204, DOI 10.1038/143204a0; Gaffron H, 1940, AM J BOT, V27, P273, DOI 10.2307/2436697; Harrer R, 1998, EUR J BIOCHEM, V255, P196, DOI 10.1046/j.1432-1327.1998.2550196.x; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Iwai M, 2010, NATURE, V464, P1210, DOI 10.1038/nature08885; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Kim EH, 2009, BBA-BIOENERGETICS, V1787, P973, DOI 10.1016/j.bbabio.2009.04.009; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; Lagarde D, 2000, APPL ENVIRON MICROB, V66, P64, DOI 10.1128/AEM.66.1.64-72.2000; Lemeille S, 2010, PHOTOSYNTH RES, V106, P33, DOI 10.1007/s11120-010-9538-8; Lemeille S, 2009, PLOS BIOL, V7, P664, DOI 10.1371/journal.pbio.1000045; Melis A, 2004, PHOTOSYNTH RES, V80, P401, DOI 10.1023/B:PRES.0000030421.31730.cb; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Melis A, 2009, PLANT SCI, V177, P272, DOI 10.1016/j.plantsci.2009.06.005; Minagawa J, 2004, PHOTOSYNTH RES, V82, P241, DOI 10.1007/s11120-004-2079-2; Mitra M, 2008, OPT EXPRESS, V16, P21807, DOI 10.1364/OE.16.021807; Molnar A, 2009, PLANT J, V58, P165, DOI 10.1111/j.1365-313X.2008.03767.x; Morosinotto T, 2005, J BIOL CHEM, V280, P31050, DOI 10.1074/jbc.M502935200; Morosinotto T, 2002, J BIOL CHEM, V277, P36253, DOI 10.1074/jbc.M205062200; Morris EP, 1997, STRUCTURE, V5, P837, DOI 10.1016/S0969-2126(97)00237-2; Mozzo M, 2008, J BIOL CHEM, V283, P6184, DOI 10.1074/jbc.M708961200; Mussgnug JH, 2007, PLANT BIOTECHNOL J, V5, P802, DOI 10.1111/j.1467-7652.2007.00285.x; Nguyen AV, 2008, EUKARYOT CELL, V7, P1965, DOI 10.1128/EC.00418-07; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Niyogi KK, 1997, PLANT CELL, V9, P1369, DOI 10.2307/3870388; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Peterman EJG, 1997, BIOCHEMISTRY-US, V36, P12208, DOI 10.1021/bi9711689; Polle JEW, 2000, PLANTA, V211, P335, DOI 10.1007/s004250000279; Polle JEW, 2002, INT J HYDROGEN ENERG, V27, P1257, DOI 10.1016/S0360-3199(02)00116-7; Polle JEW, 2001, PLANT CELL PHYSIOL, V42, P482, DOI 10.1093/pcp/pce058; Rasala BA, 2010, PLANT BIOTECHNOL J, V8, P719, DOI 10.1111/j.1467-7652.2010.00503.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Stauber EJ, 2003, EUKARYOT CELL, V2, P978, DOI 10.1128/EC.2.5.978-994.2003; SUEOKA N, 1960, P NATL ACAD SCI USA, V46, P83, DOI 10.1073/pnas.46.1.83; SUNDBY C, 1986, BIOCHIM BIOPHYS ACTA, V851, P475, DOI 10.1016/0005-2728(86)90084-8; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tetali SD, 2007, PLANTA, V225, P813, DOI 10.1007/s00425-006-0392-z; Tokutsu R, 2009, J BIOL CHEM, V284, P7777, DOI 10.1074/jbc.M809360200; Turkina Maria V., 2007, V355, P305; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09	74	64	65	0	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16276	16288		10.1074/jbc.M111.316729	http://dx.doi.org/10.1074/jbc.M111.316729			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22431727	Green Published, hybrid			2022-12-27	WOS:000304030900020
J	Fu, K; Mende, Y; Bhetwal, BP; Baker, S; Perrino, BA; Wirth, B; Fisher, SA				Fu, Kang; Mende, Ylva; Bhetwal, Bhupal P.; Baker, Salah; Perrino, Brian A.; Wirth, Brunhilde; Fisher, Steven A.			Tra2 beta Protein Is Required for Tissue-specific Splicing of a Smooth Muscle Myosin Phosphatase Targeting Subunit Alternative Exon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; LIGHT-CHAIN PHOSPHATASE; SIGNALING PATHWAYS; PORTAL-VEIN; IN-SITU; EXPRESSION; ISOFORM; RAT; HYPERTENSION; MECHANISMS	Alternative splicing of the smooth muscle myosin phosphatase targeting subunit (Mypt1) exon 23 (E23) is tissue-specific and developmentally regulated and, thus, an attractive model for the study of smooth muscle phenotypic specification. We have proposed that Tra2 beta functions as a tissue-specific activator of Mypt1 E23 splicing on the basis of concordant expression patterns and Tra2 beta activation of Mypt1 E23 mini-gene splicing in vitro. In this study we examined the relationship between Tra2 beta and Mypt1 E23 splicing in vivo in the mouse. Tra2 beta was 2- to 5-fold more abundant in phasic smooth muscle tissues, such as the portal vein, small intestine, and small mesenteric artery, in which Mypt1 E23 is predominately included as compared with the tonic smooth muscle tissues, such as the aorta and inferior vena cava, in which Mypt1 E23 is predominately skipped. Tra2 beta was up-regulated in the small intestine postnatally, concordant with a switch to Mypt1 E23 splicing. Targeting of Tra2 beta in smooth muscle cells using SM22 alpha-Cre caused a substantial reduction in Mypt1 E23 inclusion specifically in the intestinal smooth muscle of heterozygotes, indicating sensitivity to Tra2 beta gene dosage. The switch to the Mypt1 E23 skipped isoform coding for the C-terminal leucine zipper motif caused increased sensitivity of the muscle to the relaxant effects of 8-Br-cyclic guanosine monophosphate (cGMP). We conclude that Tra2 beta is necessary for the tissue-specific splicing of Mypt1 E23 in the phasic intestinal smooth muscle. Tra2 beta, by regulating the splicing of Mypt1 E23, sets the sensitivity of smooth muscle to cGMP-mediated relaxation.	[Fu, Kang; Fisher, Steven A.] Case Western Reserve Univ, Dept Med Cardiol, Cleveland, OH 44106 USA; [Fisher, Steven A.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Mende, Ylva; Wirth, Brunhilde] Univ Cologne, Inst Genet, Inst Human Genet, D-50931 Cologne, Germany; [Mende, Ylva; Wirth, Brunhilde] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Bhetwal, Bhupal P.; Baker, Salah; Perrino, Brian A.] Univ Nevada, Sch Med, Ctr Biomed Res Excellence, Dept Physiol & Cell Biol, Reno, NV 89557 USA	Case Western Reserve University; Case Western Reserve University; University of Cologne; University of Cologne; Nevada System of Higher Education (NSHE); University of Nevada Reno	Fisher, SA (corresponding author), Univ Maryland, Sch Med, S-003C HSF-2,20 Penn St, Baltimore, MD 21201 USA.	SFisher1@medicine.umaryland.edu	Wirth, Brunhilde/H-3192-2019	BAKER, SAL/0000-0002-1514-6876; Wirth, Brunhilde/0000-0003-4051-5191	National Institutes of Health [RO1 HL-66171, GM103513, CMMC D7]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL-66171 (to S. A. F.), GM103513 (to B. A. P.), and CMMC D7 (to B. W.).	Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Bhetwal BP, 2011, NEUROGASTROENT MOTIL, V23, pE425, DOI 10.1111/j.1365-2982.2011.01769.x; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Chen XH, 2003, CELL BIOL INT, V27, P491, DOI 10.1016/S1065-6995(03)00072-6; Clery A, 2011, NAT STRUCT MOL BIOL, V18, P443, DOI 10.1038/nsmb.2001; Dirksen WP, 2000, AM J PHYSIOL-CELL PH, V278, pC589, DOI 10.1152/ajpcell.2000.278.3.C589; Eto M, 2009, J BIOL CHEM, V284, P35273, DOI 10.1074/jbc.R109.059972; Fisher SA, 2010, PHYSIOL GENOMICS, V42A, P169, DOI 10.1152/physiolgenomics.00111.2010; Frei E, 2009, AM J PHYSIOL-GASTR L, V297, pG834, DOI 10.1152/ajpgi.00095.2009; Gabella G, 2002, RES PRO CEL, V38, P1; Gooding C, 2008, ADV EXP MED BIOL, V644, P27; Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; Grellscheid S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002390; Grellscheid SN, 2011, NUCLEIC ACIDS RES, V39, P8092, DOI 10.1093/nar/gkr495; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Huang QQ, 2004, J BIOL CHEM, V279, P597, DOI 10.1074/jbc.M308496200; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Karim SM, 2004, CIRC RES, V95, P612, DOI 10.1161/01.RES.0000142736.39359.58; Khatri JJ, 2001, J BIOL CHEM, V276, P37250, DOI 10.1074/jbc.M105275200; Lepore JJ, 2005, GENESIS, V41, P179, DOI 10.1002/gene.20112; LJUNG B, 1979, ACTA PHYSIOL SCAND, V106, P271, DOI 10.1111/j.1748-1716.1979.tb06398.x; Lu Y, 2008, AM J PHYSIOL-CELL PH, V294, pC564, DOI 10.1152/ajpcell.00285.2007; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; McKee AE, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-14; Mende Y, 2010, HUM MOL GENET, V19, P2154, DOI 10.1093/hmg/ddq094; Nayler O, 1998, GENOMICS, V53, P191, DOI 10.1006/geno.1998.5471; O'Gorman W, 2005, J BIOL CHEM, V280, P36920, DOI 10.1074/jbc.M505791200; Ogut O, 2003, J MOL CELL CARDIOL, V35, P347, DOI 10.1016/S0022-2828(03)00045-2; Ogut O, 2000, AM J PHYSIOL-CELL PH, V279, pC1722, DOI 10.1152/ajpcell.2000.279.6.C1722; Park KJ, 2006, AM J PHYSIOL-CELL PH, V290, pC1411, DOI 10.1152/ajpcell.00447.2005; Payne MC, 2006, J MOL CELL CARDIOL, V40, P274, DOI 10.1016/j.yjmcc.2005.07.009; Payne MC, 2004, AM J PHYSIOL-HEART C, V286, pH1801, DOI 10.1152/ajpheart.00696.2003; Qureshi S, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01406.x; Schiaffino S, 2007, PHYSIOLOGY, V22, P269, DOI 10.1152/physiol.00009.2007; Sciabica KS, 2006, NUCLEIC ACIDS RES, V34, P6612, DOI 10.1093/nar/gkl984; Shirangi TR, 2007, DEV BIOL, V306, P10, DOI 10.1016/j.ydbio.2007.03.022; Shukla S, 2008, CIRC RES, V103, P485, DOI 10.1161/CIRCRESAHA.108.178384; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051; Surks HK, 2003, J BIOL CHEM, V278, P51484, DOI 10.1074/jbc.M305622200; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Tacke R, 1998, CELL, V93, P139, DOI 10.1016/S0092-8674(00)81153-8; TSAO C, 1971, ANAT RECORD, V171, P457, DOI 10.1002/ar.1091710403; Venables JP, 2005, HUM MOL GENET, V14, P2289, DOI 10.1093/hmg/ddi233; Verhulst EC, 2010, CURR OPIN GENET DEV, V20, P376, DOI 10.1016/j.gde.2010.05.001; Yuen S, 2011, J BIOL CHEM, V286, P37274, DOI 10.1074/jbc.M111.282905; Zhang HY, 2007, CIRC RES, V100, P730, DOI 10.1161/01.RES.0000260189.38975.35	49	14	15	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16575	16585		10.1074/jbc.M111.325761	http://dx.doi.org/10.1074/jbc.M111.325761			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22437831	Green Published, hybrid			2022-12-27	WOS:000304030900047
J	Crosby, HA; Pelletier, DA; Hurst, GB; Escalante-Semerena, JC				Crosby, Heidi A.; Pelletier, Dale A.; Hurst, Gregory B.; Escalante-Semerena, Jorge C.			System-wide Studies of N-Lysine Acetylation in Rhodopseudomonas palustris Reveal Substrate Specificity of Protein Acetyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COA SYNTHETASE; CLONING VECTORS; IDENTIFICATION; COENZYME; STRATEGIES; LIGASE; ENZYME; SIR2; PROPIONYLATION; DEACETYLATION	N-Lysine acetylation is a posttranslational modification that has been well studied in eukaryotes and is likely widespread in prokaryotes as well. The central metabolic enzyme acetyl-CoA synthetase is regulated in both bacteria and eukaryotes by acetylation of a conserved lysine residue in the active site. In the purple photosynthetic alpha-proteobacterium Rhodopseudomonas palustris, two protein acetyltransferases (RpPat and the newly identified RpKatA) and two deacetylases (RpLdaA and RpSrtN) regulate the activities of AMP-forming acyl-CoA synthetases. In this work, we used LC/MS/MS to identify other proteins regulated by the N-lysine acetylation/deacetylation system of this bacterium. Of the 24 putative acetylated proteins identified, 14 were identified more often in a strain lacking both deacetylases. Nine of these proteins were members of the AMP-forming acyl-CoA synthetase family. RpPat acetylated all nine of the acyl-CoA synthetases identified by this work, and RpLdaA deacetylated eight of them. In all cases, acetylation occurred at the conserved lysine residue in the active site, and acetylation decreased activity of the enzymes by >70%. Our results show that many different AMP-forming acyl-CoA synthetases are regulated by N-lysine acetylation. Five non-acyl-CoA synthetases were identified as possibly acetylated, including glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Rpa1177, a putative 4-oxalocrotonate tautomerase. Neither RpPat nor RpKatA acetylated either of these proteins in vitro. It has been reported that Salmonella enterica Pat (SePat) can acetylate a number of metabolic enzymes, including GAPDH, but we were unable to confirm this claim, suggesting that the substrate range of SePat is not as broad as suggested previously.	[Crosby, Heidi A.; Escalante-Semerena, Jorge C.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Pelletier, Dale A.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA; [Hurst, Gregory B.] Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN 37831 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory	Escalante-Semerena, JC (corresponding author), Univ Wisconsin, Dept Bacteriol, 1550 Linden Dr, Madison, WI 53706 USA.	escalante@bact.wisc.edu		Pelletier, Dale/0000-0002-4321-7918; Hurst, Gregory/0000-0002-7650-8009; Crosby, Heidi/0000-0002-0360-0779	National Institutes of Health [R01 GM62203]; USPHS from the NIGMS [T32 GM08349]; USPHS biotechnology training; Office of Biological and Environmental Research, United States Department of Energy [DE-AC05-00OR22725]; Oak Ridge National Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062203, T32GM008349] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS from the NIGMS; USPHS biotechnology training; Office of Biological and Environmental Research, United States Department of Energy(United States Department of Energy (DOE)); Oak Ridge National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM62203, a USPHS grant from the NIGMS (to J.C. E.-S.), and T32 GM08349, a USPHS biotechnology training grant (to H.A.C.). This work was also supported by the Genomic Science Program, Office of Biological and Environmental Research, United States Department of Energy under Contract DE-AC05-00OR22725 with Oak Ridge National Laboratory, managed and operated by UT-Battelle, LLC (for G. B. H. and D. A. P.).	Albaugh BN, 2011, CHEMBIOCHEM, V12, P290, DOI 10.1002/cbic.201000438; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bloch K. D., 1995, CURRENT PROTOCOLS MO, P311; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Chan CH, 2011, MOL MICROBIOL, V80, P168, DOI 10.1111/j.1365-2958.2011.07566.x; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Crosby HA, 2010, MOL MICROBIOL, V76, P874, DOI 10.1111/j.1365-2958.2010.07127.x; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; EGLAND PG, 1995, J BACTERIOL, V177, P6545, DOI 10.1128/jb.177.22.6545-6551.1995; Elias JE, 2004, NAT BIOTECHNOL, V22, P214, DOI 10.1038/nbt930; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gardner JG, 2006, J BACTERIOL, V188, P5460, DOI 10.1128/JB.00215-06; Garrity J, 2007, J BIOL CHEM, V282, P30239, DOI 10.1074/jbc.M704409200; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hervey WJ, 2009, J PROTEOME RES, V8, P3675, DOI 10.1021/pr801088f; Kim GW, 2011, TRENDS BIOCHEM SCI, V36, P211, DOI 10.1016/j.tibs.2010.10.001; KIM MK, 1991, FEMS MICROBIOL LETT, V83, P199, DOI 10.1016/0378-1097(91)90354-D; Koetsier MJ, 2009, BIOCHEM J, V417, P467, DOI 10.1042/BJ20081257; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liang WX, 2012, RNA, V18, P37, DOI 10.1261/rna.030213.111; Liang WX, 2011, MOL CELL, V44, P160, DOI 10.1016/j.molcel.2011.06.037; Lima BP, 2011, MOL MICROBIOL, V81, P1190, DOI 10.1111/j.1365-2958.2011.07742.x; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Meades G, 2010, NUCLEIC ACIDS RES, V38, P1217, DOI 10.1093/nar/gkp1079; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moore RE, 2002, J AM SOC MASS SPECTR, V13, P378, DOI 10.1016/S1044-0305(02)00352-5; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Schaefer AL, 2008, NATURE, V454, P595, DOI 10.1038/nature07088; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Searle BC, 2008, J PROTEOME RES, V7, P245, DOI 10.1021/pr070540w; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2003, GENETICS, V163, P545; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Strader MB, 2004, J PROTEOME RES, V3, P965, DOI 10.1021/pr049940z; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanner S, 2005, ANAL CHEM, V77, P4626, DOI 10.1021/ac050102d; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Thao S, 2011, CURR OPIN MICROBIOL, V14, P200, DOI 10.1016/j.mib.2010.12.013; Thao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015123; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Xu H, 2011, BIOCHEMISTRY-US, V50, P5883, DOI 10.1021/bi200156t; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yu BJ, 2008, J MICROBIOL BIOTECHN, V18, P1529; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI 10.1038/NCHEMBIO.495; Zheng JM, 2009, ACTA CRYSTALLOGR F, V65, P536, DOI 10.1107/S1744309109014729	59	68	68	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15590	15601		10.1074/jbc.M112.352104	http://dx.doi.org/10.1074/jbc.M112.352104			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22416131	Green Published, hybrid			2022-12-27	WOS:000304006300039
J	Kim, T; Ravilious, GE; Sept, D; Cooper, JA				Kim, Taekyung; Ravilious, Geoffrey E.; Sept, David; Cooper, John A.			Mechanism for CARMIL Protein Inhibition of Heterodimeric Actin-capping Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARBED END; CELL MORPHOLOGY; FILAMENT; DOMAIN; BINDING; IDENTIFICATION; NUCLEATION; DYNAMICS; CKIP-1; MOTIF	Capping protein (CP) controls the polymerization of actin filaments by capping their barbed ends. In lamellipodia, CP dissociates from the actin cytoskeleton rapidly, suggesting the possible existence of an uncapping factor, for which the protein CARMIL (capping protein, Arp2/3 and myosin-I linker) is a candidate. CARMIL binds to CP via two motifs. One, the CP interaction (CPI) motif, is found in a number of unrelated proteins; the other motif is unique to CARMILs, the CARMIL-specific interaction motif. A 115-aa CARMIL fragment of CARMIL with both motifs, termed the CP-binding region (CBR), binds to CP with high affinity, inhibits capping, and causes uncapping. We wanted to understand the structural basis for this function. We used a collection of mutants affecting the actin-binding surface of CP to test the possibility of a steric-blocking model, which remained open because a region of CBR was not resolved in the CBR/CP co-crystal structure. The CP actin-binding mutants bound CBR normally. In addition, a CBR mutant with all residues of the unresolved region changed showed nearly normal binding to CP. Having ruled out a steric-blocking model, we tested an allosteric model with molecular dynamics. We found that CBR binding induces changes in the conformation of the actin-binding surface of CP. In addition, similar to 30-aa truncations on the actin-binding surface of CP decreased the affinity of CBR for CP. Thus, CARMIL promotes uncapping by binding to a freely accessible site on CP bound to a filament barbed end and inducing a change in the conformation of the actin-binding surface of CP.	[Kim, Taekyung; Cooper, John A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Ravilious, Geoffrey E.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Sept, David] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Sept, David] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	Washington University (WUSTL); Washington University (WUSTL); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Cooper, JA (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Campus Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	jcooper@wustl.edu	Cooper, John/E-9389-2012; Cooper, John/D-4448-2014	Cooper, John/0000-0002-0933-4571; Sept, David/0000-0003-3719-2483	National Institutes of Health [R01GM38542, R01GM67246]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095509, R01GM067246, R01GM038542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM38542 (to J. A. C.) and R01GM67246 (to D. S.).	BEARER EL, 1991, J CELL BIOL, V115, P1629, DOI 10.1083/jcb.115.6.1629; Bruck S, 2006, J BIOL CHEM, V281, P19196, DOI 10.1074/jbc.M600166200; Canton DA, 2005, MOL CELL BIOL, V25, P3519, DOI 10.1128/MCB.25.9.3519-3534.2005; Canton DA, 2006, J BIOL CHEM, V281, P36347, DOI 10.1074/jbc.M607595200; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; COOPER JA, 1984, J CELL BIOL, V99, P217, DOI 10.1083/jcb.99.1.217; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fujiwara I, 2010, J BIOL CHEM, V285, P2707, DOI 10.1074/jbc.M109.031203; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hernandez-Valladares M, 2010, NAT STRUCT MOL BIOL, V17, P497, DOI 10.1038/nsmb.1792; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; Kim K, 2004, J CELL BIOL, V164, P567, DOI 10.1083/jcb.200308061; Kim T, 2010, J MOL BIOL, V404, P794, DOI 10.1016/j.jmb.2010.10.017; Lakowicz J. R., 1999, PRINCIPLES FLUORESCE, P370; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Liang Y, 2009, MOL BIOL CELL, V20, P5290, DOI 10.1091/mbc.E08-10-1071; Makhina EN, 2001, METHOD PHARMACOL TOX, P261; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Miyoshi T, 2006, J CELL BIOL, V175, P947, DOI 10.1083/jcb.200604176; Ohashi T, 2007, PROTEIN SCI, V16, P1429, DOI 10.1110/ps.072845607; Pavlov D, 2007, J MOL BIOL, V365, P1350, DOI 10.1016/j.jmb.2006.10.102; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Remmert K, 2004, J BIOL CHEM, V279, P3068, DOI 10.1074/jbc.M308829200; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; Takeda S, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035005; Takeda S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000416; Uruno T, 2006, J BIOL CHEM, V281, P10635, DOI 10.1074/jbc.M513186200; Wear MA, 2003, CURR BIOL, V13, P1531, DOI 10.1016/S0960-9822(03)00559-1; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4; Yamashita A, 2003, EMBO J, V22, P1529, DOI 10.1093/emboj/cdg167; Yang CS, 2005, DEV CELL, V9, P209, DOI 10.1016/j.devcel.2005.06.008; Zwolak A, 2010, J BIOL CHEM, V285, P29014, DOI 10.1074/jbc.M110.134221	36	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15251	15262		10.1074/jbc.M112.345447	http://dx.doi.org/10.1074/jbc.M112.345447			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22411988	Green Published, hybrid			2022-12-27	WOS:000304006300009
J	Li, R; Chen, DF; Zhou, R; Jia, SN; Yang, JS; Clegg, JS; Yang, WJ				Li, Ran; Chen, Dian-Fu; Zhou, Rong; Jia, Sheng-Nan; Yang, Jin-Shu; Clegg, James S.; Yang, Wei-Jun			Involvement of Polo-like Kinase 1 (Plk1) in Mitotic Arrest by Inhibition of Mitogen-activated Protein Kinase-Extracellular Signal-regulated Kinase-Ribosomal S6 Kinase 1 (MEK-ERK-RSK1) Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS OOCYTE MATURATION; CELL-CYCLE ARREST; DNA-DAMAGE; MAP KINASE; ARTEMIA-FRANCISCANA; METAPHASE ARREST; BRINE SHRIMP; EMBRYOS; MOS; IDENTIFICATION	Cell division is controlled through cooperation of different kinases. Of these, polo-like kinase 1 (Plk1) and p90 ribosomal S6 kinase 1 (RSK1) play key roles. Plk1 acts as a G(2)/M trigger, and RSK1 promotes G(1) progression. Although previous reports show that Plk1 is suppressed by RSK1 during meiosis in Xenopus oocytes, it is still not clear whether this is the case during mitosis or whether Plk1 counteracts the effects of RSK1. Few animal models are available for the study of controlled and transient cell cycle arrest. Here we show that encysted embryos (cysts) of the primitive crustacean Artemia are ideal for such research because they undergo complete cell cycle arrest when they enter diapause (a state of obligate dormancy). We found that Plk1 suppressed the activity of RSK1 during embryonic mitosis and that Plk1 was inhibited during embryonic diapause and mitotic arrest. In addition, studies on HeLa cells using Plk1 siRNA interference and overexpression showed that phosphorylation of RSK1 increased upon interference and decreased after overexpression, suggesting that Plk1 inhibits RSK1. Taken together, these findings provide insights into the regulation of Plk1 during cell division and Artemia diapause cyst formation and the correlation between the activity of Plk1 and RSK1.	[Li, Ran; Chen, Dian-Fu; Zhou, Rong; Jia, Sheng-Nan; Yang, Jin-Shu; Yang, Wei-Jun] Zhejiang Univ, Key Lab Conservat Biol Endangered Wildlife, Minist Educ, Hangzhou 310058, Zhejiang, Peoples R China; [Li, Ran; Chen, Dian-Fu; Zhou, Rong; Jia, Sheng-Nan; Yang, Jin-Shu; Yang, Wei-Jun] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Clegg, James S.] Univ Calif Davis, Sect Mol & Cellular Biol, Bodega Bay, CA 94923 USA; [Clegg, James S.] Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA	Zhejiang University; Zhejiang University; University of California System; University of California Davis; University of California System; University of California Davis	Yang, WJ (corresponding author), Zhejiang Univ, Key Lab Conservat Biol Endangered Wildlife, Minist Educ, Hangzhou 310058, Zhejiang, Peoples R China.	w_jyang@cls.zju.edu.cn		Yang, Jin-Shu/0000-0001-6680-7737; Yang, Wei-Jun/0000-0002-4591-8830; Li, Ran/0000-0002-8787-352X	National Natural Sciences Foundation of China [40876069, 40730212]; National Basic Research Program of China (973 Program) [2010CB833803]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Sciences Foundation of China (Grants 40876069 and 40730212) and the National Basic Research Program of China (973 Program Grant 2010CB833803).	Abatzopoulos T. J., 2002, ARTEMIA BASIC APPL B, P129; Bahassi EM, 2002, ONCOGENE, V21, P6633, DOI 10.1038/sj.onc.1205850; Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; CLEGG JS, 1995, EXP CELL RES, V219, P1, DOI 10.1006/excr.1995.1197; COLEMAN TR, 1994, CURR OPIN CELL BIOL, V6, P877, DOI 10.1016/0955-0674(94)90060-4; Crowe JH, 2005, INTEGR COMP BIOL, V45, P810, DOI 10.1093/icb/45.5.810; Dai JQ, 2008, J BIOL CHEM, V283, P1705, DOI 10.1074/jbc.M707853200; Dai L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020187; Dai ZM, 2011, BIOSCIENCE REP, V31, P17, DOI 10.1042/BSR20090141; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; DONOHUE PJ, 1995, J BIOL CHEM, V270, P10351, DOI 10.1074/jbc.270.17.10351; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Ferrell JE, 1999, BIOESSAYS, V21, P833, DOI 10.1002/(SICI)1521-1878(199910)21:10<833::AID-BIES5>3.0.CO;2-P; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Gebauer F, 1997, BIOESSAYS, V19, P23, DOI 10.1002/bies.950190106; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Gotoh Y, 1995, Prog Cell Cycle Res, V1, P287; GOTOH Y, 1995, J BIOL CHEM, V270, P25898, DOI 10.1074/jbc.270.43.25898; Gross SD, 1999, SCIENCE, V286, P1365, DOI 10.1126/science.286.5443.1365; Gumireddy K, 2005, CANCER CELL, V7, P275, DOI 10.1016/j.ccr.2005.02.009; HACCARD O, 1993, SCIENCE, V262, P1262, DOI 10.1126/science.8235656; HAMANAKA R, 1995, J BIOL CHEM, V270, P21086, DOI 10.1074/jbc.270.36.21086; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Inoue D, 2005, EMBO J, V24, P1057, DOI 10.1038/sj.emboj.7600567; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Lei M, 2008, ONCOGENE, V27, P3935, DOI 10.1038/onc.2008.36; Liang P, 1999, DEV BIOL, V207, P445, DOI 10.1006/dbio.1998.9138; Liby K, 2001, DNA SEQUENCE, V11, P527, DOI 10.3109/10425170109041337; Liu XQ, 2003, CELL CYCLE, V2, P424, DOI 10.4161/cc.2.5.505; Ma S, 2003, MOL CANCER RES, V1, P376; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Nakajo N, 2000, GENE DEV, V14, P328; NAKANISHI Yu.H., 1962, ANNOT ZOOL JAPON, V35, P223; Nambu Z, 2004, J EXP ZOOL PART A, V301A, P542, DOI 10.1002/jez.a.80; Okumura E, 2002, NAT CELL BIOL, V4, P111, DOI 10.1038/ncb741; Pahlavan G, 2000, DEV BIOL, V220, P392, DOI 10.1006/dbio.2000.9656; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Qian YW, 1998, MOL CELL BIOL, V18, P4262, DOI 10.1128/MCB.18.7.4262; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Sagata N, 1997, BIOESSAYS, V19, P13, DOI 10.1002/bies.950190105; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; SIMMONS DL, 1992, MOL CELL BIOL, V12, P4164, DOI 10.1128/MCB.12.9.4164; Singh B, 1997, Prog Cell Cycle Res, V3, P251; Spankuch B, 2004, JNCI-J NATL CANCER I, V96, P862, DOI 10.1093/jnci/djh146; Takai N, 2005, ONCOGENE, V24, P287, DOI 10.1038/sj.onc.1208272; Vempati RK, 2010, J BIOL CHEM, V285, P28553, DOI 10.1074/jbc.M110.149393; WATANABE N, 1991, NATURE, V352, P247, DOI 10.1038/352247a0; Xie SQ, 2001, J BIOL CHEM, V276, P43305, DOI 10.1074/jbc.M106050200; Xie SQ, 2002, CELL CYCLE, V1, P424, DOI 10.4161/cc.1.6.271; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186	53	23	24	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15923	15934		10.1074/jbc.M111.312413	http://dx.doi.org/10.1074/jbc.M111.312413			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427657	Green Published, hybrid			2022-12-27	WOS:000304006300071
J	Nucifora, LG; Burke, KA; Feng, X; Arbez, N; Zhu, SS; Miller, J; Yang, GC; Ratovitski, T; Delannoy, M; Muchowski, PJ; Finkbeiner, S; Legleiter, J; Ross, CA; Poirier, MA				Nucifora, Leslie G.; Burke, Kathleen A.; Feng, Xia; Arbez, Nicolas; Zhu, Shanshan; Miller, Jason; Yang, Guocheng; Ratovitski, Tamara; Delannoy, Michael; Muchowski, Paul J.; Finkbeiner, Steven; Legleiter, Justin; Ross, Christopher A.; Poirier, Michelle A.			Identification of Novel Potentially Toxic Oligomers Formed in Vitro from Mammalian-derived Expanded huntingtin Exon-1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL FRAGMENTS; CAG REPEAT LENGTH; MUTANT HUNTINGTIN; TRANSGENIC MICE; POLYGLUTAMINE AGGREGATION; NEUROLOGIC ABNORMALITIES; TRINUCLEOTIDE REPEAT; CLINICAL PROGRESSION; MOUSE MODEL; WILD-TYPE	Huntington disease is a genetic neurodegenerative disorder that arises from an expanded polyglutamine region in the N terminus of the HD gene product, huntingtin. Protein inclusions comprised of N-terminal fragments of mutant huntingtin are a characteristic feature of disease, though are likely to play a protective role rather than a causative one in neurodegeneration. Soluble oligomeric assemblies of huntingtin formed early in the aggregation process are candidate toxic species in HD. In the present study, we established an in vitro system to generate recombinant huntingtin in mammalian cells. Using both denaturing and native gel analysis, we have identified novel oligomeric forms of mammalian-derived expanded huntingtin exon-1 N-terminal fragment. These species are transient and were not previously detected using bacterially expressed exon-1 protein. Importantly, these species are recognized by 3B5H10, an antibody that recognizes a two-stranded hairpin conformation of expanded polyglutamine believed to be associated with a toxic form of huntingtin. Interestingly, comparable oligomeric species were not observed for expanded huntingtin shortstop, a 117-amino acid fragment of huntingtin shown previously in mammalian cell lines and transgenic mice, and here in primary cortical neurons, to be non-toxic. Further, we demonstrate that expanded huntingtin shortstop has a reduced ability to form amyloid-like fibrils characteristic of the aggregation pathway for toxic expanded polyglutamine proteins. Taken together, these data provide a possible candidate toxic species in HD. In addition, these studies demonstrate the fundamental differences in early aggregation events between mutant huntingtin exon-1 and shortstop proteins that may underlie the differences in toxicity.	[Nucifora, Leslie G.; Feng, Xia; Arbez, Nicolas; Zhu, Shanshan; Ratovitski, Tamara; Ross, Christopher A.; Poirier, Michelle A.] Johns Hopkins Univ, Sch Med, Childrens Med Surg Ctr, Dept Psychiat,Div Neurobiol, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; [Delannoy, Michael] Johns Hopkins Univ, Sch Med, Johns Hopkins Sch Med Microscope Facil, Baltimore, MD 21287 USA; [Burke, Kathleen A.; Legleiter, Justin] W Virginia Univ, C Eugene Bennett Dept Chem, Morgantown, WV 26506 USA; [Legleiter, Justin] W Virginia Univ, Ctr Neurosci, Morgantown, WV 26506 USA; [Miller, Jason] Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94158 USA; [Miller, Jason] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94158 USA; [Miller, Jason; Yang, Guocheng; Muchowski, Paul J.; Finkbeiner, Steven] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Biophys, San Francisco, CA 94158 USA; [Muchowski, Paul J.; Finkbeiner, Steven] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; West Virginia University; West Virginia University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Poirier, MA (corresponding author), Johns Hopkins Univ, Sch Med, Childrens Med Surg Ctr, Dept Psychiat,Div Neurobiol, 8-121 600 N Wolfe St, Baltimore, MD 21287 USA.	mpoirie1@jhmi.edu	Nucifora, Leslie/X-2716-2019; Ross, Christopher A/H-8395-2013	Miller, Jason/0000-0002-2784-9560; Legleiter, Justin/0000-0002-5262-1867; Feng, Xia/0000-0003-2460-192X	National Institutes of Health [R01NS053679, P01NS16375, NS0547533, 2NS45091, 1S10RR021200]; National Institutes of Health-NIGMS UCSF; University of California at San Francisco Hillblom Center for the Biology of Aging; Hereditary Disease Foundation; Huntington's Disease Society of America Coalition for the Cure; CHDI, Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039074, R01NS045091, P01NS016375, R01NS053679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health-NIGMS UCSF; University of California at San Francisco Hillblom Center for the Biology of Aging(University of California System); Hereditary Disease Foundation; Huntington's Disease Society of America Coalition for the Cure; CHDI, Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS053679 (to M. A. P.), P01NS16375 (to C. A. R.), NS0547533 (to P. J. M.), 2NS45091 (to S. F.), 1S10RR021200 (to M. D.), the National Institutes of Health-NIGMS UCSF Medical Scientist Training Program (to J. M.), and a fellowship from the University of California at San Francisco Hillblom Center for the Biology of Aging (to J. M.). This work was also supported by the Hereditary Disease Foundation, the Huntington's Disease Society of America Coalition for the Cure, and by CHDI, Inc.	Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; Arawaka S, 2010, CURR PHARM BIOTECHNO, V11, P158, DOI 10.2174/138920110790909713; Burke KA, 2011, METHODS, V53, P275, DOI 10.1016/j.ymeth.2010.12.028; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Gekko K., 1979, J PHYS CHEM-US, V83, P2707; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Heiser V, 2000, P NATL ACAD SCI USA, V97, P6739, DOI 10.1073/pnas.110138997; Ho LW, 2001, J MED GENET, V38, P450, DOI 10.1136/jmg.38.7.450; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; Kar K, 2011, NAT STRUCT MOL BIOL, V18, P328, DOI 10.1038/nsmb.1992; Khoshnan A, 2002, P NATL ACAD SCI USA, V99, P1002, DOI 10.1073/pnas.022631799; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Legleiter J, 2004, J COLLOID INTERF SCI, V278, P96, DOI 10.1016/j.jcis.2004.05.009; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; Peters MF, 2001, J BIOL CHEM, V276, P3188, DOI 10.1074/jbc.M008099200; Peters-Libeu C, 2005, ACTA CRYSTALLOGR F, V61, P1065, DOI 10.1107/S1744309105036547; Poirier MA, 2005, HUM MOL GENET, V14, P765, DOI 10.1093/hmg/ddi071; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Ratovitski T, 2007, CELL CYCLE, V6, P2970, DOI 10.4161/cc.6.23.4992; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Ravikumar Brinda, 2006, Molecular Aspects of Medicine, V27, P520, DOI 10.1016/j.mam.2006.08.008; Ravina B, 2008, MOVEMENT DISORD, V23, P1223, DOI 10.1002/mds.21988; Rosenblatt A, 2006, NEUROLOGY, V66, P1016, DOI 10.1212/01.wnl.0000204230.16619.d9; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Ross CA, 1997, MEDICINE, V76, P305, DOI 10.1097/00005792-199709000-00001; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; SQUIRE PG, 1979, ARCH BIOCHEM BIOPHYS, V196, P165, DOI 10.1016/0003-9861(79)90563-0; Tebbenkamp ATN, 2011, HUM MOL GENET, V20, P2770, DOI 10.1093/hmg/ddr176; Tebbenkamp ATN, 2011, HUM MOL GENET, V20, P1633, DOI 10.1093/hmg/ddr040; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Wacker JL, 2009, J NEUROSCI, V29, P9104, DOI 10.1523/JNEUROSCI.2250-09.2009; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Waldron-Roby E, 2012, J NEUROSCI, V32, P183, DOI 10.1523/JNEUROSCI.1305-11.2012; Walsh DM, 2005, BIOCHEM SOC T, V33, P1087, DOI 10.1042/BST0331087; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Zhang QC, 2011, J BIOL CHEM, V286, P8188, DOI 10.1074/jbc.M110.192013; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	52	75	77	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					16017	16028		10.1074/jbc.M111.252577	http://dx.doi.org/10.1074/jbc.M111.252577			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22433867	Green Published, hybrid			2022-12-27	WOS:000304006300079
J	Fielhaber, JA; Tan, J; Joung, KB; Attias, O; Huegel, S; Bader, M; Roux, PP; Kristof, AS				Fielhaber, Jill A.; Tan, Jason; Joung, Kwang-Bo; Attias, Ortal; Huegel, Stefanie; Bader, Michael; Roux, Philippe P.; Kristof, Arnold S.			Regulation of Karyopherin alpha 1 and Nuclear Import by Mammalian Target of Rapamycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; UNPHOSPHORYLATED STAT1; INTERFERON-GAMMA; BINDING PARTNER; GENE-EXPRESSION; PHOSPHATASE 2A; MTOR; TRANSCRIPTION; PHOSPHORYLATION; COMPLEX	Under conditions of reduced mitogen or nutritional substrate levels, the serine/threonine kinase target of rapamycin can augment the nuclear content of distinct transcription factors and promote the induction of stress response genes. In its latent (i.e., unphosphorylated) form, the transcription factor STAT1 regulates a subset of genes involved in immune modulation and apoptosis. Based on previous work indicating a functional relationship between mammalian target of rapamycin (mTOR) and the nuclear content of latent STAT1, we investigated the mechanism by which mTOR controls STAT1 nuclear import. By fluorescence confocal microscopy, inactivation of mTOR with rapamycin promoted the nuclear translocation of unphosphorylated STAT1, but not that of a STAT1 mutant incapable of binding its nuclear import adaptor karyopherin-alpha 1 (KPNA1). By immunoprecipitation, KPNA1 was physically associated with mTOR and STAT1 in a complex that translocated to the nucleus in response to rapamycin. Although mTOR is not a kinase for KPNA1, the mTOR-associated phosphatase protein phosphatase 2A catalytic interacted directly with KPNA1 and regulated nuclear import of the mTOR-KPNA1 complex. KPNA1, or its interaction with STAT1, was required for the nuclear import of latent STAT1, transcriptional induction of the STAT1 gene, and caspase-3 activation under conditions of reduced mTOR activity (i.e. rapamycin, glucose starvation, serum withdrawal). Therefore, at low mitogen or nutrient levels, mTOR and protein phosphatase 2A catalytically control the constitutive nuclear import of latent STAT1 by KPNA1, which are key modulators of STAT1 expression and apoptosis.	[Fielhaber, Jill A.; Tan, Jason; Joung, Kwang-Bo; Attias, Ortal; Kristof, Arnold S.] McGill Univ, Fac Med, Crit Care Div, Montreal, PQ H3A 1A1, Canada; [Fielhaber, Jill A.; Tan, Jason; Joung, Kwang-Bo; Attias, Ortal; Kristof, Arnold S.] McGill Univ, Fac Med, Div Resp, Montreal, PQ H3A 1A1, Canada; [Fielhaber, Jill A.; Tan, Jason; Joung, Kwang-Bo; Attias, Ortal; Kristof, Arnold S.] McGill Univ, Fac Med, Meakins Christie Labs, Montreal, PQ H3A 1A1, Canada; [Huegel, Stefanie; Bader, Michael] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Roux, Philippe P.] Univ Montreal, Stn Ctr Ville, Fac Med, Inst Res Immunol & Canc, Quebec City, PQ H3C 2J7, Canada	McGill University; McGill University; McGill University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Laval University; Universite de Montreal	Kristof, AS (corresponding author), McGill Univ, Royal Victoria Hosp, Ctr Hlth, 687 Pine Ave W,L3-05, Montreal, PQ H3A 1A1, Canada.	arnold.kristof@mcgill.ca	Bader, Michael/K-2124-2013; Roux, Philippe P./J-3996-2012	Roux, Philippe P./0000-0002-5962-0250; Bader, Michael/0000-0003-4780-4164	National Institutes of Health [R01-CA125436]; Canadian Cancer Society Research Institute [018311]; Canada Research Chair grant; Human Frontier Science Program Organization; Tuberous Sclerosis Alliance; Deutsche Forschungsgemeinschaft [BA1374/21-1]; NATIONAL CANCER INSTITUTE [R01CA125436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canada Research Chair grant(Canada Research Chairs); Human Frontier Science Program Organization(Human Frontier Science Program); Tuberous Sclerosis Alliance; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA125436 (to A. S. K.). This work was also supported by Canadian Cancer Society Research Institute Grant 018311, a Canada Research Chair grant, and funds from the Human Frontier Science Program Organization (to P. P. R.); funds from Tuberous Sclerosis Alliance and a Canada Research Chair grant (to A. S. K.); and Deutsche Forschungsgemeinschaft Grant BA1374/21-1 (M. B.).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bachmann RA, 2006, J BIOL CHEM, V281, P7357, DOI 10.1074/jbc.M512218200; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Carvalho J, 2001, J BIOL CHEM, V276, P25359, DOI 10.1074/jbc.M103050200; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; Faustino RS, 2007, CLIN PHARMACOL THER, V81, P880, DOI 10.1038/sj.clpt.6100141; Fielhaber JA, 2009, J BIOL CHEM, V284, P24341, DOI 10.1074/jbc.M109.033530; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harwood FC, 2008, J BIOL CHEM, V283, P2575, DOI 10.1074/jbc.M706173200; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Kristof AS, 2006, J BIOL CHEM, V281, P23958, DOI 10.1074/jbc.M513918200; Kristof AS, 2010, LYMPHAT RES BIOL, V8, P33, DOI 10.1089/lrb.2009.0019; Kristof AS, 2003, J BIOL CHEM, V278, P33637, DOI 10.1074/jbc.M301053200; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Liu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010578; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Meyer T, 2004, EUR J BIOCHEM, V271, P4606, DOI 10.1111/j.1432-1033.2004.04423.x; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Quensel C, 2004, MOL CELL BIOL, V24, P10246, DOI 10.1128/MCB.24.23.10246-10255.2004; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shmidt T, 2007, NAT CELL BIOL, V9, P1337, DOI 10.1038/ncb1207-1337; Stephanou A, 2003, INT J EXP PATHOL, V84, P239, DOI 10.1111/j.0959-9673.2003.00363.x; Tsang CK, 2010, CELL CYCLE, V9, P953, DOI 10.4161/cc.9.5.10876; Wong LH, 2002, J BIOL CHEM, V277, P19408, DOI 10.1074/jbc.M111302200; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Yasuharaa N, 2009, SEMIN CELL DEV BIOL, V20, P590, DOI 10.1016/j.semcdb.2009.05.003; Zhang XW, 2002, J BIOL CHEM, V277, P28127, DOI 10.1074/jbc.M202625200; Ziegler E. C., 2005, SCI STKE, pre6, DOI DOI 10.1126/STKE.2842005RE6; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	42	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14325	14335		10.1074/jbc.M111.246785	http://dx.doi.org/10.1074/jbc.M111.246785			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22399302	Green Published, hybrid			2022-12-27	WOS:000304003200002
J	Ono, K; Li, L; Takamura, Y; Yoshiike, Y; Zhu, LJ; Han, F; Mao, X; Ikeda, T; Takasaki, J; Nishijo, H; Takashima, A; Teplow, DB; Zagorski, MG; Yamada, M				Ono, Kenjiro; Li, Lei; Takamura, Yusaku; Yoshiike, Yuji; Zhu, Lijun; Han, Fang; Mao, Xian; Ikeda, Tokuhei; Takasaki, Jun-ichi; Nishijo, Hisao; Takashima, Akihiko; Teplow, David B.; Zagorski, Michael G.; Yamada, Masahito			Phenolic Compounds Prevent Amyloid beta-Protein Oligomerization and Synaptic Dysfunction by Site-specific Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SATURATION-TRANSFER DIFFERENCE; FIBRILS IN-VITRO; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; ALPHA-SYNUCLEIN; CROSS-LINKING; MTT REDUCTION; POLYPHENOLS; NMR; AGGREGATION	Cerebral deposition of amyloid beta protein (A beta) is an invariant feature of Alzheimer disease (AD), and epidemiological evidence suggests that moderate consumption of foods enriched with phenolic compounds reduce the incidence of AD. We reported previously that the phenolic compounds myricetin (Myr) and rosmarinic acid (RA) inhibited A beta aggregation in vitro and in vivo. To elucidate a mechanistic basis for these results, we analyzed the effects of five phenolic compounds in the A beta aggregation process and in oligomer-induced synaptic toxicities. We now report that the phenolic compounds blocked A beta oligomerization, and Myr promoted significant NMR chemical shift changes of monomeric A beta. Both Myr and RA reduced cellular toxicity and synaptic dysfunction of the A beta oligomers. These results suggest that Myr and RA may play key roles in blocking the toxicity and early assembly processes associated with A beta through different binding.	[Li, Lei; Zhu, Lijun; Han, Fang; Mao, Xian; Zagorski, Michael G.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Ono, Kenjiro; Ikeda, Tokuhei; Takasaki, Jun-ichi; Yamada, Masahito] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol & Aging, Kanazawa, Ishikawa 9208640, Japan; [Takamura, Yusaku; Nishijo, Hisao] Toyama Univ, Toyama 9300194, Japan; [Yoshiike, Yuji; Takashima, Akihiko] RIKEN, Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama 3510198, Japan; [Teplow, David B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Teplow, David B.] Univ Calif Los Angeles, David Geffen Sch Med, Mary S Easton Ctr Alzheimers Dis Res, Los Angeles, CA 90095 USA; [Teplow, David B.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Teplow, David B.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA	Case Western Reserve University; Kanazawa University; University of Toyama; RIKEN; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Zagorski, MG (corresponding author), Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA.	michael.zagorski@case.edu; m-yamada@med.kanazawa-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [22240051, 20390242]; Knowledge Cluster Initiative (High Tech Sensing and Knowledge Handling Technology (Brain Technology)) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare (Japan); Novartis Foundation for Gerontological Research; Alumni Association of Showa University School of Medicine; Japan Society for the Promotion of Science; National Institutes of Health [AG027818, AG027853]; Jim Easton Consortium for Alzheimer Drug Discovery and Biomarkers at UCLA; Grants-in-Aid for Scientific Research [22790815, 22240051] Funding Source: KAKEN; NATIONAL INSTITUTE ON AGING [P01AG027818, R01AG027853] Funding Source: NIH RePORTER	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Knowledge Cluster Initiative (High Tech Sensing and Knowledge Handling Technology (Brain Technology)) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare (Japan)(Ministry of Health, Labour and Welfare, Japan); Novartis Foundation for Gerontological Research(Novartis Foundation for Gerontological Research); Alumni Association of Showa University School of Medicine; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jim Easton Consortium for Alzheimer Drug Discovery and Biomarkers at UCLA; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Grants-in-aid for Young Scientists (B) (to K. O.), Scientific Research (A) (22240051) (to H. N.), Scientific Research (B) (20390242) (to M. Y.), and Knowledge Cluster Initiative (High Tech Sensing and Knowledge Handling Technology (Brain Technology)) (to M. Y.) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, a grant to the Amyloidosis Research Committee from the Ministry of Health, Labor, and Welfare (Japan) (to K. O. and M. Y.), Novartis Foundation for Gerontological Research (to K. O.), Alumni Association of Showa University School of Medicine (to K. O.), Japan Society for the Promotion of Science Asian Core Program (to H. N.), and National Institutes of Health Grants AG027818 (to D. B. T.) and AG027853 (to M. G. Z.), and the Jim Easton Consortium for Alzheimer Drug Discovery and Biomarkers at UCLA (to D. B. T.).	Abe K, 1998, NEUROSCI RES, V31, P295, DOI 10.1016/S0168-0102(98)00055-8; Bitan G, 2004, ACCOUNTS CHEM RES, V37, P357, DOI 10.1021/ar000214l; Bitan G, 2003, J AM CHEM SOC, V125, P15359, DOI 10.1021/ja0349296; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; Fawzi NL, 2010, J AM CHEM SOC, V132, P9948, DOI 10.1021/ja1048253; Flamini R, 2003, MASS SPECTROM REV, V22, P218, DOI 10.1002/mas.10052; Ganguli M, 2000, ARCH NEUROL-CHICAGO, V57, P824, DOI 10.1001/archneur.57.6.824; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hamaguchi T, 2009, AM J PATHOL, V175, P2557, DOI 10.2353/ajpath.2009.090417; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Huang H, 2008, J PHYS CHEM B, V112, P5795, DOI 10.1021/jp7118718; Kemperman RA, 2010, MICROBIOL-SGM, V156, P3224, DOI 10.1099/mic.0.042127-0; Leong SL, 2009, FREE RADICAL BIO MED, V46, P1328, DOI 10.1016/j.freeradbiomed.2009.02.009; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Milojevic J, 2007, J AM CHEM SOC, V129, P4282, DOI 10.1021/ja067367+; Milojevic J, 2009, BIOPHYS J, V97, P2585, DOI 10.1016/j.bpj.2009.08.028; Narayanan S, 2005, BIOCHEMISTRY-US, V44, P1444, DOI 10.1021/bi048264b; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Ong KC, 1997, GEN PHARMACOL-VASC S, V29, P121, DOI 10.1016/S0306-3623(96)00421-1; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; Ono K, 2005, BIOCHEM BIOPH RES CO, V336, P444, DOI 10.1016/j.bbrc.2005.08.148; Ono K, 2003, J NEUROCHEM, V87, P172, DOI 10.1046/j.1471-4159.2003.01976.x; Ono K, 2008, J BIOL CHEM, V283, P32176, DOI 10.1074/jbc.M806154200; Ono K, 2011, J NEUROCHEM, V117, P19, DOI 10.1111/j.1471-4159.2011.07187.x; Ono K, 2010, J BIOL CHEM, V285, P23184, DOI 10.1074/jbc.M109.086496; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Orgogozo JM, 1997, REV NEUROL-FRANCE, V153, P185; Ronicke R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003236; Rojas A, 2010, J MOL BIOL, V404, P537, DOI 10.1016/j.jmb.2010.09.057; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Shimmyo Y, 2008, BBA-GEN SUBJECTS, V1780, P819, DOI 10.1016/j.bbagen.2008.01.017; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Soeda Y, 2010, MOL ENDOCRINOL, V24, P1965, DOI 10.1210/me.2010-0163; Sultana R, 2005, J NEUROCHEM, V92, P749, DOI 10.1111/j.1471-4159.2004.02899.x; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Truelsen T, 2002, NEUROLOGY, V59, P1313, DOI 10.1212/01.WNL.0000031421.50369.E7; Wang J, 2008, J NEUROSCI, V28, P6388, DOI 10.1523/JNEUROSCI.0364-08.2008; Yan YL, 2006, J MOL BIOL, V364, P853, DOI 10.1016/j.jmb.2006.09.046; Yan YL, 2007, BIOCHEMISTRY-US, V46, P1724, DOI 10.1021/bi061314n; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200	53	168	170	1	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14631	14643		10.1074/jbc.M111.325456	http://dx.doi.org/10.1074/jbc.M111.325456			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22393064	hybrid, Green Published			2022-12-27	WOS:000304003200030
J	Scott, H; Howarth, J; Lee, YB; Wong, LF; Bantounas, I; Phylactou, L; Verkade, P; Uney, JB				Scott, Helen; Howarth, Joanna; Lee, Youn Bok; Wong, Liang-Fong; Bantounas, Ioannis; Phylactou, Leonidas; Verkade, Paul; Uney, James. B.			MiR-3120 Is a Mirror MicroRNA That Targets Heat Shock Cognate Protein 70 and Auxilin Messenger RNAs and Regulates Clathrin Vesicle Uncoating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIN ISOFORMS; IDENTIFICATION; TRANSCRIPTION; FEEDBACK; ATPASE; HSC70; BRAIN	We show that a single gene locus gives rise to two fully processed and functional miRNAs, i.e. that due to imperfect base pairing, two distinct microRNAs (miRNAs) can be produced from the fully complementary DNA strands. The antisense strand encodes miR-214, which is transcribed by its own promoter, whereas a novel miRNA, miR-3120, is co-expressed with its host gene mRNA. We also found that miR-3120 regulates important aspects of cellular function that are similar to that of its host gene, dynamin-3. miR-3120 was found to be located in neuronal cell bodies and to target Hsc70 and auxilin, and its lentivirus-mediated expression inhibited the uncoating of clathrin-coated vesicles. Finally, mirror miRNAs are likely to represent a new group of miRNAs with complex roles in coordinating gene expression.	[Scott, Helen; Howarth, Joanna; Wong, Liang-Fong; Uney, James. B.] Univ Bristol, Henry Wellcome Labs Integrated Neurosci & Endocri, Bristol BS1 3NY, Avon, England; [Lee, Youn Bok] Kings Coll London, Inst Psychiat, Ctr Neurodegenerat Res, MRC, London SE5 8AF, England; [Bantounas, Ioannis] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England; [Phylactou, Leonidas] Cyprus Inst Neurol & Genet, Dept Mol Genet Funct & Therapy, CY-1683 Nicosia, Cyprus; [Verkade, Paul] Univ Bristol, Wolfson Bioimaging Facil, Sch Biochem, Bristol BS8 1TD, Avon, England; [Verkade, Paul] Univ Bristol, Wolfson Bioimaging Facil, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England	University of Bristol; University of London; King's College London; University of Manchester; University of Bristol; University of Bristol	Uney, JB (corresponding author), Univ Bristol, Henry Wellcome Labs Integrated Neurosci & Endocri, Dorothy Hodgkin Bldg,Whitson St, Bristol BS1 3NY, Avon, England.	james.uney@bristol.ac.uk	Scott, Helen L/A-6307-2009; Verkade, Paul/N-7240-2014; Howarth, Joanna/AHC-1794-2022	Scott, Helen L/0000-0003-2656-4034; Verkade, Paul/0000-0002-2497-1026; Bantounas, Ioannis/0000-0001-7899-1068; Lee, Younbok/0000-0002-0479-9361	Wellcome Trust; Medical Research Council (NET); Biotechnology and Biological Sciences Research Council (BBSRC); Engineering and Physical Sciences Research Council [EP/E500110/1] Funding Source: researchfish; Medical Research Council [MC_G0901331, G0700986] Funding Source: researchfish; MRC [MC_G0901331, G0700986] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (NET)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust, Medical Research Council (NET), and Biotechnology and Biological Sciences Research Council (BBSRC).	Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Girard M, 2005, MOL CELL PROTEOMICS, V4, P1145, DOI 10.1074/mcp.M500043-MCP200; Gray NW, 2005, J CELL SCI, V118, P1279, DOI 10.1242/jcs.01711; Gray NW, 2003, CURR BIOL, V13, P510, DOI 10.1016/S0960-9822(03)00136-2; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Howarth JL, 2007, MOL THER, V15, P1100, DOI 10.1038/sj.mt.6300163; Jurado S, 2010, EMBO J, V29, P2827, DOI 10.1038/emboj.2010.160; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; Leuschner PJF, 2007, METHODS, V43, P105, DOI 10.1016/j.ymeth.2007.04.005; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Newmyer SL, 2003, DEV CELL, V4, P929, DOI 10.1016/S1534-5807(03)00157-6; Newmyer SL, 2001, J CELL BIOL, V152, P607, DOI 10.1083/jcb.152.3.607; PARTON RG, 1995, J HISTOCHEM CYTOCHEM, V43, P731, DOI 10.1177/43.7.7608529; Raimondi A, 2011, NEURON, V70, P1100, DOI 10.1016/j.neuron.2011.04.031; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Tyler DM, 2008, GENE DEV, V22, P26, DOI 10.1101/gad.1615208; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yim YI, 2010, P NATL ACAD SCI USA, V107, P4412, DOI 10.1073/pnas.1000738107; Zhao MJ, 2002, J BIOL CHEM, V277, P44539, DOI 10.1074/jbc.M208408200	30	37	39	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14726	14733		10.1074/jbc.M111.326041	http://dx.doi.org/10.1074/jbc.M111.326041			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22393045	hybrid, Green Published			2022-12-27	WOS:000304003200038
J	Guengerich, FP				Guengerich, F. Peter			Thematic Minireview Series: Metals in Biology 2012	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review								Metals are present in about one-half of the protein structures available and also have critical roles in nucleic acid biochemistry. This prologue introduces the fourth of the Thematic Minireview Series on Metals in Biology, which deals with several topics involving iron, manganese, copper, and other metals. The six minireviews discuss metal transport and intracellular homeostasis, including chaperones and siderophores, maturation of the diiron active sites in hydrogenases, the balance between manganese and iron, and copper homeostasis relevant to pathogens.	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 221 Kirkland Hall, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu						Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Cvetkovic A, 2010, NATURE, V466, P779, DOI 10.1038/nature09265; Guengerich FP, 2010, J BIOL CHEM, V285, P26727, DOI 10.1074/jbc.R110.150870; Guengerich FP, 2009, J BIOL CHEM, V284, P18557, DOI 10.1074/jbc.M109.003863; Guengerich FP, 2009, J BIOL CHEM, V284, P709, DOI 10.1074/jbc.R800060200; Merrill JC, 2008, PRINCIPLES METHODS T, P841; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300	7	17	17	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13508	13509		10.1074/jbc.R112.355933	http://dx.doi.org/10.1074/jbc.R112.355933			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22389507	Green Published, hybrid			2022-12-27	WOS:000303996300001
J	Martinez, J; Nguyen, LD; Hinderlich, S; Zimmer, R; Tauberger, E; Reutter, W; Saenger, W; Fan, H; Moniot, S				Martinez, Jacobo; Long Duc Nguyen; Hinderlich, Stephan; Zimmer, Reinhold; Tauberger, Eva; Reutter, Werner; Saenger, Wolfram; Fan, Hua; Moniot, Sebastien			Crystal Structures of N-Acetylmannosamine Kinase Provide Insights into Enzyme Activity and Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE; INCLUSION-BODY MYOPATHY; ATP-DEPENDENT GLUCOKINASE; UDP-GLCNAC 2-EPIMERASE; ACETYLNEURAMINIC ACID; SIALIC ACIDS; SUBSTRATE-SPECIFICITY; ESCHERICHIA-COLI; BIOSYNTHESIS; METASTASIS	Sialic acids are essential components of membrane glycoconjugates. They are responsible for the interaction, structure, and functionality of all deuterostome cells and have major functions in cellular processes in health and diseases. The key enzyme of the biosynthesis of sialic acid is the bifunctional UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase that transforms UDP-N-acetylglucosamine to N-acetylmannosamine (ManNAc) followed by its phosphorylation to ManNAc 6-phosphate and has a direct impact on the sialylation of cell surface components. Here, we present the crystal structures of the human N-acetylmannosamine kinase (MNK) domain of UDP-N-acetylglucosamine- 2-epimerase/N-acetylmannosamine kinase in complexes with ManNAc at 1.64 angstrom resolution, MNK.ManNAc.ADP (1.82 angstrom) and MNK.ManNAc 6-phosphate.ADP (2.10 angstrom). Our findings offer detailed insights in the active center of MNK and serve as a structural basis to design inhibitors. We synthesized a novel inhibitor, 6-O-acetyl-ManNAc, which is more potent than those previously tested. Specific inhibitors of sialic acid biosynthesis may serve to further study biological functions of sialic acid.	[Long Duc Nguyen; Reutter, Werner; Fan, Hua] Charite, Inst Biochem & Mol Biol, D-14195 Berlin, Germany; [Martinez, Jacobo; Tauberger, Eva; Saenger, Wolfram; Moniot, Sebastien] Free Univ Berlin, Inst Chem & Biochem Kristallog, D-14195 Berlin, Germany; [Hinderlich, Stephan] Beuth Hsch Tech Berlin, Fachbereich Life Sci & Technol, Lab Biochem, D-13347 Berlin, Germany; [Zimmer, Reinhold] Free Univ Berlin, Inst Chem & Biochem Organ Chem, D-14195 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Berliner Hochschule fur Technik; Free University of Berlin	Fan, H (corresponding author), Charite, Inst Biochem & Mol Biol, Campus Benjamin Franklin,Arnimallee 22, D-14195 Berlin, Germany.	hua.fan@charite.de; sebastien.moniot@uni-bayreuth.de			Sonnenfeld Stiftung; Roland and Elfriede Schauer Stiftung; DFG [Sonderforschungsbereich 449]; Bundesministerium fur Bildung und Forschung; German-Israeli Foundation for Research and Development; Helmholtz Zentrum Berlin fur Materialien and Energie; Freie Universitat Berlin; Humboldt-Universitat zu Berlin; Max-Delbruck Centrum; Leibniz-Institut fur Molekulare Pharmakologie	Sonnenfeld Stiftung; Roland and Elfriede Schauer Stiftung; DFG(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); German-Israeli Foundation for Research and Development(German-Israeli Foundation for Scientific Research and Development); Helmholtz Zentrum Berlin fur Materialien and Energie; Freie Universitat Berlin; Humboldt-Universitat zu Berlin; Max-Delbruck Centrum; Leibniz-Institut fur Molekulare Pharmakologie	This work was supported in part by the Sonnenfeld Stiftung, the Roland and Elfriede Schauer Stiftung, and by DFG-Sonderforschungsbereich 449.; Supported by Bundesministerium fur Bildung und Forschung and the German-Israeli Foundation for Research and Development.; We acknowledge access to beamline BL14.2 of the BESSY II storage ring (Berlin, Germany) via the Joint Berlin MX-Laboratory sponsored by the Helmholtz Zentrum Berlin fur Materialien and Energie, Freie Universitat Berlin, Humboldt-Universitat zu Berlin, Max-Delbruck Centrum, and Leibniz-Institut fur Molekulare Pharmakologie. We thank Johannes Schwan and Prof. H.-U. Reissig for help in 6-O-Ac-ManNAc synthesis.	Al-Rawi S, 2004, ANGEW CHEM INT EDIT, V43, P4366, DOI 10.1002/anie.200453863; Aleshin AE, 2000, J MOL BIOL, V296, P1001, DOI 10.1006/jmbi.1999.3494; Argov Z, 2008, NEUROTHERAPEUTICS, V5, P633, DOI 10.1016/j.nurt.2008.07.004; BHAVANANDAN V P, 1991, Glycobiology, V1, P493, DOI 10.1093/glycob/1.5.493; BRESALIER RS, 1990, CANCER RES, V50, P1299; Chen SH, 2006, METHOD ENZYMOL, V416, P371, DOI 10.1016/S0076-6879(06)16024-3; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cordeiro AT, 2007, J MOL BIOL, V372, P1215, DOI 10.1016/j.jmb.2007.07.021; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DENNIS JW, 1987, CANCER METAST REV, V5, P185, DOI 10.1007/BF00046998; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghaderi D, 2007, J MOL BIOL, V369, P746, DOI 10.1016/j.jmb.2007.03.037; GRUNHOLZ HJ, 1981, CARBOHYD RES, V96, P259, DOI 10.1016/S0008-6215(00)81876-5; Hansen T, 2002, J BACTERIOL, V184, P5955, DOI 10.1128/JB.184.21.5955-5965.2002; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313; Hinderlich S, 2000, EUR J BIOCHEM, V267, P3301, DOI 10.1046/j.1432-1327.2000.01360.x; Hinderlich S, 2004, FEBS LETT, V566, P105, DOI 10.1016/j.febslet.2004.04.013; Huizing M, 2009, BBA-MOL BASIS DIS, V1792, P881, DOI 10.1016/j.bbadis.2009.07.001; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelm S, 1997, INT REV CYTOL, V175, P137, DOI 10.1016/S0074-7696(08)62127-0; Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372; Kim YJ, 1997, GLYCOCONJUGATE J, V14, P569, DOI 10.1023/A:1018580324971; KORNFELD S, 1964, P NATL ACAD SCI USA, V52, P371, DOI 10.1073/pnas.52.2.371; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lawrence SM, 2000, J BIOL CHEM, V275, P17869, DOI 10.1074/jbc.M000217200; Lunin VV, 2004, J BACTERIOL, V186, P6915, DOI 10.1128/JB.186.20.6915-6927.2004; Mesak LR, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishimasu H, 2007, J BIOL CHEM, V282, P9923, DOI 10.1074/jbc.M610678200; Nocek B, 2011, J MOL BIOL, V406, P325, DOI 10.1016/j.jmb.2010.12.021; Penner J, 2006, BIOCHEMISTRY-US, V45, P2968, DOI 10.1021/bi0522504; Petit P, 2011, ACTA CRYSTALLOGR D, V67, P929, DOI 10.1107/S0907444911036729; Raval GN, 2003, ORAL DIS, V9, P119, DOI 10.1034/j.1601-0825.2003.01795.x; Reinke SO, 2009, BIOL CHEM, V390, P591, DOI 10.1515/BC.2009.073; ROSEMAN S, 1970, CHEM PHYS LIPIDS, V5, P270, DOI 10.1016/0009-3084(70)90024-1; SAWADA R, 1994, J BIOL CHEM, V269, P1425; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; Schiefner A, 2005, J BIOL CHEM, V280, P29073, DOI 10.1074/jbc.M504215200; Sinev MA, 1996, BIOCHEMISTRY-US, V35, P6425, DOI 10.1021/bi952687j; Stolz F, 2004, J ORG CHEM, V69, P665, DOI 10.1021/jo0353029; TITGEMEYER F, 1994, MICROBIOL-UK, V140, P2349, DOI 10.1099/13500872-140-9-2349; Tong YF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007165; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Varki NM, 2002, SEMIN THROMB HEMOST, V28, P53, DOI 10.1055/s-2002-20564; Weihofen WA, 2006, J MOL BIOL, V364, P388, DOI 10.1016/j.jmb.2006.08.085; WEISS P, 1989, J BIOL CHEM, V264, P17635; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; ZEITLER R, 1992, EUR J BIOCHEM, V204, P1165, DOI 10.1111/j.1432-1033.1992.tb16743.x	52	22	24	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13656	13665		10.1074/jbc.M111.318170	http://dx.doi.org/10.1074/jbc.M111.318170			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22343627	hybrid, Green Published			2022-12-27	WOS:000303996300021
J	Seo, JM; Park, S; Kim, JH				Seo, Ji-Min; Park, Sooyoung; Kim, Jae-Hong			Leukotriene B-4 Receptor-2 Promotes Invasiveness and Metastasis of Ovarian Cancer Cells through Signal Transducer and Activator of Transcription 3 (STAT3)-dependent Up-regulation of Matrix Metalloproteinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC-CANCER; CONSTITUTIVE ACTIVATION; GENE-EXPRESSION; OXIDASE; PATHWAY; STAT3; PROLIFERATION; INHIBITION; APOPTOSIS; INVASION	Ovarian cancer is the most lethal gynecologic malignancy in women. Despite the fact that the metastatic spread is associated with the majority of deaths from ovarian cancer, the molecular mechanisms regulating the invasive and metastatic phenotypes of ovarian cancer are poorly understood. In this study, we demonstrated that BLT2, a low affinity leukotriene B-4 receptor, is highly expressed in OVCAR-3 and SKOV-3 human ovarian cancer cells, and that this receptor plays a key role in the invasiveness and metastasis of these cells through activation of STAT3 and consequent up-regulation of matrix metalloproteinase 2 (MMP2). In addition, our results suggest that activation of NAD(P) H oxidase-4 (NOX4) and subsequent reactive oxygen species (ROS) generation lie downstream of BLT2, mediating the stimulation of STAT3-MMP2 cascade in this process. For example, knockdown of BLT2 or NOX4 using each specific siRNA suppressed STAT3 stimulation and MMP2 expression. Similarly, inhibition of STAT3 suppressed the expression of MMP2, thus leading to attenuated invasiveness of these ovarian cancer cells. Finally, the metastasis ofSKOV-3 cells in nude mice was markedly suppressed by pharmacological inhibition of BLT2. Together, our results implicate a BLT2-NOX4-ROS-STAT3-MMP2 cascade in the invasiveness and metastasis of ovarian cancer cells.	[Seo, Ji-Min; Park, Sooyoung; Kim, Jae-Hong] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea	Korea University	Kim, JH (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, 5-1 Anam Dong, Seoul 136701, South Korea.	jhongkim@korea.ac.kr	Kim, Jae-Hong/B-2530-2009	Kim, Jae-Hong/0000-0002-8019-0208	General Researcher Support Project Grant [2011-0004241]; National Research Foundation; Korean government Ministry of Education and Science Technology [2011-0027753]; Ministry of Health Welfare [A101032]	General Researcher Support Project Grant; National Research Foundation; Korean government Ministry of Education and Science Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry of Health Welfare	This work was supported by General Researcher Support Project Grant 2011-0004241 and the Bio & Medical Technology Development Program of the National Research Foundation funded by Korean government Ministry of Education and Science Technology Grant 2011-0027753. This work was also supported by Grant A101032 from the Korea Healthcare Technology R & D Project, Ministry of Health & Welfare.	Badgwell DB, 2012, ONCOGENE, V31, P68, DOI 10.1038/onc.2011.213; Bae YS, 2009, CIRC RES, V104, P210, DOI 10.1161/CIRCRESAHA.108.181040; Choi JA, 2010, CARCINOGENESIS, V31, P543, DOI 10.1093/carcin/bgp203; Davidson B, 2003, CLIN CANCER RES, V9, P1412; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Guo AM, 2011, CANCER CHEMOTH PHARM, V68, P1273, DOI 10.1007/s00280-011-1595-y; Hao M, 2009, J OBSTET GYNAECOL RE, V35, P918, DOI 10.1111/j.1447-0756.2009.01045.x; Hennig R, 2008, BRIT J CANCER, V99, P1064, DOI 10.1038/sj.bjc.6604655; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; Huang C, 2006, CANCER SCI, V97, P1417, DOI 10.1111/j.1349-7006.2006.00340.x; Huang M, 2000, GYNECOL ONCOL, V79, P67, DOI 10.1006/gyno.2000.5931; Huang SY, 2007, CLIN CANCER RES, V13, P1362, DOI 10.1158/1078-0432.CCR-06-2313; Ihara A, 2007, J PHARMACOL SCI, V103, P24, DOI 10.1254/jphs.FP0060651; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Ju KD, 2011, INFLAMM RES, V60, P791, DOI 10.1007/s00011-011-0335-4; Kenny HA, 2009, CELL CYCLE, V8, P683, DOI 10.4161/cc.8.5.7703; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim EY, 2010, ONCOGENE, V29, P1167, DOI 10.1038/onc.2009.412; Kim EY, 2010, FREE RADICAL BIO MED, V49, P1072, DOI 10.1016/j.freeradbiomed.2010.06.023; Kusaba T, 2006, ONCOL REP, V15, P1445; Landen CN, 2007, CANCER RES, V67, P10389, DOI 10.1158/0008-5472.CAN-07-0858; Lee JK, 2007, GASTROENTEROLOGY, V133, P1637, DOI 10.1053/j.gastro.2007.08.022; Li L, 2010, CANCER RES, V70, P8222, DOI 10.1158/0008-5472.CAN-10-0894; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Manea A, 2010, ARTERIOSCL THROM VAS, V30, P105, DOI 10.1161/ATVBAHA.109.193896; Masuda M, 2002, CANCER RES, V62, P3351; Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Perigny M, 2008, AM J CLIN PATHOL, V129, P226, DOI 10.1309/49LA9XCBGWJ8F2KM; Ponnusamy MP, 2010, ONCOGENE, V29, P5741, DOI 10.1038/onc.2010.309; Qin HW, 1999, J BIOL CHEM, V274, P29130, DOI 10.1074/jbc.274.41.29130; Rocconi RP, 2008, REPROD SCI, V15, P321, DOI 10.1177/1933719108316390; Rosen DG, 2006, CANCER-AM CANCER SOC, V107, P2730, DOI 10.1002/cncr.22293; Ryu HC, 2010, J INVEST DERMATOL, V130, P1095, DOI 10.1038/jid.2009.436; Saydmohammed M, 2010, J CELL BIOCHEM, V110, P447, DOI 10.1002/jcb.22558; Schieffer B, 2000, CIRC RES, V87, P1195, DOI 10.1161/01.RES.87.12.1195; Seo JM, 2011, EXP MOL MED, V43, P129, DOI 10.3858/emm.2011.43.3.014; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Shono T, 2008, INT J CANCER, V123, P787, DOI 10.1002/ijc.23569; Simon AR, 1998, AM J PHYSIOL-CELL PH, V275, pC1640, DOI 10.1152/ajpcell.1998.275.6.C1640; Thornber K, 2009, ONCOGENE, V28, P2690, DOI 10.1038/onc.2009.125; Woo CH, 2005, AM J PHYSIOL-LUNG C, V288, pL307, DOI 10.1152/ajplung.00105.2004; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Yamaura M, 2009, CANCER RES, V69, P2647, DOI 10.1158/0008-5472.CAN-08-3745; Yoo MH, 2004, ONCOGENE, V23, P9259, DOI 10.1038/sj.onc.1208151; Zhang HY, 2010, CANCER LETT, V287, P91, DOI 10.1016/j.canlet.2009.06.001	49	74	76	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13840	13849		10.1074/jbc.M111.317131	http://dx.doi.org/10.1074/jbc.M111.317131			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22396544	hybrid, Green Published			2022-12-27	WOS:000303996300039
J	Herweg, J; Schwarz, G				Herweg, Jens; Schwarz, Guenter			Splice-specific Glycine Receptor Binding, Folding, and Phosphorylation of the Scaffolding Protein Gephyrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLYBDENUM COFACTOR BIOSYNTHESIS; INHIBITORY SYNAPSES; CRYSTAL-STRUCTURE; ALPHA-1 SUBUNIT; MOLECULAR-BASIS; CYTOSKELETON; VARIANTS; DOMAINS; SITES; GENE	The multimeric scaffolding protein gephyrin forms post-synaptic clusters at inhibitory sites, thereby anchoring inhibitory glycine (GlyR) and subsets of gamma-aminobutyric acid type A (GABAA) receptors. Gephyrin is composed of three domains, the conserved N-terminal G- and C-terminal E-domain, connected by the central (C-) domain. In this study we investigated the oligomerization, folding and stability, GlyR beta-loop binding, and phosphorylation of three gephyrin splice variants (Geph, Geph-C3, Geph-C4) after expression and purification from insect cells (Sf9). In contrast to Escherichia coli-derived trimeric gephyrin, we found that Sf9 gephyrins form hexamers as basic oligomeric form. In the case of Geph and Geph-C4, also high-oligomeric forms (similar to 900 kDa) were isolated. Partial proteolysis revealed a compact folding of the Gephyrin G and C domain in one complex, whereas a much lower stability for the E domain was found. After GlyR beta-loop binding, the stability of the E domain increased in Geph and Geph-C4 significantly. In contrast, the E domain in Geph-C3 is less stable and binds the GlyR beta-loop with one order of magnitude lower affinity. Finally, we identified 18 novel phosphorylation sites in gephyrin, of which all except one are located within the C domain. We propose two models for the domain arrangement in hexameric gephyrin based on the oligomerization of either the E or C domains, with the latter being crucial for the regulation of gephyrin clustering.	Univ Cologne, Inst Biochem, Dept Chem, D-50674 Cologne, Germany; Univ Cologne, Ctr Mol Med, D-50674 Cologne, Germany	University of Cologne; University of Cologne	Schwarz, G (corresponding author), Zuelpicher Str 47, D-50674 Cologne, Germany.	gschwarz@uni-koeln.de	Schwarz, Guenter/ABE-9643-2021; Schwarz, Guenter/F-2217-2013	Schwarz, Guenter/0000-0002-2118-9338; 	German Science Foundation (DFG) [Schw 759/6-1, DFG-SFB635 TP-A11]; Fonds der Chemischen Industrie	German Science Foundation (DFG)(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the German Science Foundation (DFG Schw 759/6-1, DFG-SFB635 TP-A11 (to G. S.) and Fonds der Chemischen Industrie (to G. S.).	Bausen M, 2010, MOL CELL NEUROSCI, V44, P201, DOI 10.1016/j.mcn.2010.02.007; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Cascio M, 2001, J BIOL CHEM, V276, P20981, DOI 10.1074/jbc.M010968200; Charrier C, 2010, NAT NEUROSCI, V13, P1388, DOI 10.1038/nn.2645; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Dumoulin A, 2010, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.028.2009; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Fuhrmann JC, 2002, J NEUROSCI, V22, P5393; Giesemann T, 2003, J NEUROSCI, V23, P8330; Han GH, 2010, ELECTROPHORESIS, V31, P1080, DOI 10.1002/elps.200900493; Jockusch BM, 2004, NEUROREPORT, V15, P1535, DOI 10.1097/01.wnr.0000131673.92694.58; Kim EY, 2006, EMBO J, V25, P1385, DOI 10.1038/sj.emboj.7601029; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; KIRSCH J, 1995, J NEUROSCI, V15, P4148; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Kneussel M, 1999, J NEUROCHEM, V72, P1323, DOI 10.1046/j.1471-4159.1999.0721323.x; Kneussel M, 2000, J PHYSIOL-LONDON, V525, P1, DOI 10.1111/j.1469-7793.2000.t01-4-00001.x; LANGOSCH D, 1992, FEBS LETT, V298, P113, DOI 10.1016/0014-5793(92)80034-E; Lardi-Studler B, 2007, J CELL SCI, V120, P1371, DOI 10.1242/jcs.003905; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Meier J, 2000, MOL CELL NEUROSCI, V16, P566, DOI 10.1006/mcne.2000.0899; Mukherjee J, 2011, J NEUROSCI, V31, P14677, DOI 10.1523/JNEUROSCI.2001-11.2011; Nawrotzki R, 2012, HISTOCHEM CELL BIOL, V137, P471, DOI 10.1007/s00418-012-0914-7; Paarmann I, 2006, J BIOL CHEM, V281, P34918, DOI 10.1074/jbc.M607764200; PRIOR P, 1992, NEURON, V8, P1161, DOI 10.1016/0896-6273(92)90136-2; Ramming M, 1997, FEBS LETT, V405, P137, DOI 10.1016/S0014-5793(97)00164-6; Ramming M, 2000, P NATL ACAD SCI USA, V97, P10266, DOI 10.1073/pnas.97.18.10266; Rees MI, 2003, J BIOL CHEM, V278, P24688, DOI 10.1074/jbc.M301070200; Saiyed T, 2007, J BIOL CHEM, V282, P5625, DOI 10.1074/jbc.M610290200; Schrader N, 2004, J BIOL CHEM, V279, P18733, DOI 10.1074/jbc.M311245200; Schwarz G, 2001, J MOL BIOL, V312, P405, DOI 10.1006/jmbi.2001.4952; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Smolinsky B, 2008, J BIOL CHEM, V283, P17370, DOI 10.1074/jbc.M800985200; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; Sola M, 2001, J BIOL CHEM, V276, P25294, DOI 10.1074/jbc.M101923200; Specht CG, 2011, EMBO J, V30, P3842, DOI 10.1038/emboj.2011.276; Srinivasan S, 1999, J BIOL CHEM, V274, P26633, DOI 10.1074/jbc.274.38.26633; Stallmeyer B, 1999, P NATL ACAD SCI USA, V96, P1333, DOI 10.1073/pnas.96.4.1333; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Tretter V, 2011, J BIOL CHEM, V286, P37702, DOI 10.1074/jbc.M111.291336; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; Tyagarajan SK, 2011, P NATL ACAD SCI USA, V108, P379, DOI 10.1073/pnas.1011824108; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Xia QW, 2008, J PROTEOME RES, V7, P2845, DOI 10.1021/pr8000496; Xiang S, 2006, J MOL BIOL, V359, P35, DOI 10.1016/j.jmb.2006.03.019; Zita MM, 2007, EMBO J, V26, P1761, DOI 10.1038/sj.emboj.7601625	49	53	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12645	12656		10.1074/jbc.M112.341826	http://dx.doi.org/10.1074/jbc.M112.341826			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22351777	Green Published, hybrid			2022-12-27	WOS:000302903700005
J	Thakur, A; Chitoor, B; Goswami, AV; Pareek, G; Atreya, HS; D'Silva, P				Thakur, Anushikha; Chitoor, Balasubramanyam; Goswami, Arvind V.; Pareek, Gautam; Atreya, Hanudatta S.; D'Silva, Patrick			Structure and Mechanistic Insights into Novel Iron-mediated Moonlighting Functions of Human J-protein Cochaperone, Dph4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE; J-DOMAIN; DIPHTHAMIDE BIOSYNTHESIS; BINDING; DNAJ; RUBREDOXIN; NMR; MATURATION; COMPLEXES; REQUIRES	J-proteins are obligate cochaperones of Hsp70s and stimulate their ATPase activity via the J-domain. Although the functions of J-proteins have been well understood in the context of Hsp70s, their additional co-evolved "physiological functions" are still elusive. We report here the solution structure and mechanism of novel iron-mediated functional roles of human Dph4, a type III J-protein playing a vital role in diphthamide biosynthesis and normal development. The NMR structure of Dph4 reveals two domains: a conserved J-domain and a CSL-domain connected via a flexible linker-helix. The linker-helix modulates the conformational flexibility between the two domains, regulating thereby the protein function. Dph4 exhibits a unique ability to bind iron in tetrahedral coordination geometry through cysteines of its CSL-domain. The oxidized Fe-Dph4 shows characteristic UV-visible and electron paramagnetic resonance spectral properties similar to rubredoxins. Iron-bound Dph4 (Fe-Dph4) also undergoes oligomerization, thus potentially functioning as a transient "iron storage protein," thereby regulating the intracellular iron homeostasis. Remarkably, Fe-Dph4 exhibits vital redox and electron carrier activity, which is critical for important metabolic reactions, including diphthamide biosynthesis. Further, we observed that Fe-Dph4 is conformationally better poised to perform Hsp70-dependent functions, thus underlining the significance of iron binding in Dph4. Yeast Jjj3, a functional ortholog of human Dph4 also shows a similar iron-binding property, indicating the conserved nature of iron sequestration across species. Taken together, our findings provide invaluable evidence in favor of additional co-evolved specialized functions of J-proteins, previously not well appreciated.	[Thakur, Anushikha; Atreya, Hanudatta S.] Indian Inst Sci, NMR Res Ctr, Bangalore 560012, Karnataka, India; [Thakur, Anushikha; Chitoor, Balasubramanyam; Goswami, Arvind V.; Pareek, Gautam; D'Silva, Patrick] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Thakur, Anushikha; Atreya, Hanudatta S.] Indian Inst Sci, Solid State & Struct Chem Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Atreya, HS (corresponding author), Indian Inst Sci, NMR Res Ctr, CV Raman Ave, Bangalore 560012, Karnataka, India.	hsatreya@sif.iisc.ernet.in; patrick@biochem.iisc.ernet.in	PAREEK, GAUTAM/AAN-4638-2020; D'Silva, Patrick/L-6653-2019	PAREEK, GAUTAM/0000-0001-8430-9870; 	University Grant Commission, India; Council for Scientific and Industrial Research, India; Department of Science and Technology; Wellcome Trust in Biomedical Science [WT081643MA]	University Grant Commission, India(University Grants Commission, India); Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology(Department of Science & Technology (India)); Wellcome Trust in Biomedical Science	Supported by the University Grant Commission, India.; Supported by the Council for Scientific and Industrial Research, India.; Supported by a Department of Science and Technology research grants. To whom correspondence may be addressed: NMR Research Center, Indian Institute of Science, C. V. Raman Ave., Bangalore 560012, Karnataka, India. Tel.: 91-080-22933302; E-mail: hsatreya@sif.iisc.ernet.in.; Supported by Wellcome Trust International Senior Research Fellowship in Biomedical Science WT081643MA. To whom correspondence may be addressed: Dept. of Biochemistry, Indian Institute of Science, C. V. Raman Ave., Bangalore 560012, Karnataka, India. Tel.: 91-080-22932821; Fax: 91-080-23600814; E-mail: patrick@biochem.iisc.ernet.in.	Bar C, 2008, MOL MICROBIOL, V69, P1221, DOI 10.1111/j.1365-2958.2008.06350.x; BERTINI I, 1993, CHEM REV, V93, P2833, DOI 10.1021/cr00024a009; Bitto E, 2008, J BIOL CHEM, V283, P30184, DOI 10.1074/jbc.M804746200; Broderick JB, 2007, NAT CHEM BIOL, V3, P243, DOI 10.1038/nchembio0507-243; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Clore GM, 1998, P NATL ACAD SCI USA, V95, P5891, DOI 10.1073/pnas.95.11.5891; Craig EA, 2006, REV PHYSIOL BIOCH P, V156, P1, DOI 10.1007/s10254-005-0001-8; Craig EA, 2002, CELL MOL LIFE SCI, V59, P1658, DOI 10.1007/PL00012493; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; Fewell SW, 2002, P NATL ACAD SCI USA, V99, P2002, DOI 10.1073/pnas.042670999; Garimella R, 2006, BIOCHEMISTRY-US, V45, P6917, DOI 10.1021/bi060411d; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236; KUO CF, 1988, ANAL BIOCHEM, V170, P183, DOI 10.1016/0003-2697(88)90106-6; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; MATTHEAKIS LC, 1992, MOL CELL BIOL, V12, P4026, DOI 10.1128/MCB.12.9.4026; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mayer MP, 2002, ADV PROTEIN CHEM, V59, P1; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; Pareek G, 2011, J BIOL CHEM, V286, P19001, DOI 10.1074/jbc.M110.197434; PETITDEMANGE H, 1979, BIOCHEM BIOPH RES CO, V91, P1258, DOI 10.1016/0006-291X(79)91202-6; Proudfoot M, 2008, J MOL BIOL, V375, P301, DOI 10.1016/j.jmb.2007.10.060; RAO KK, 1972, BIOCHEM J, V129, P1063, DOI 10.1042/bj1291063; SADIS S, 1992, BIOCHEMISTRY-US, V31, P9406, DOI 10.1021/bi00154a012; Sahi C, 2007, P NATL ACAD SCI USA, V104, P7163, DOI 10.1073/pnas.0702357104; Sahi C, 2010, MOL CELL BIOL, V30, P33, DOI 10.1128/MCB.00842-09; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Sun JP, 2005, BIOCHEMISTRY-US, V44, P8801, DOI 10.1021/bi0504714; SZYPERSKI T, 1994, P NATL ACAD SCI USA, V91, P11343, DOI 10.1073/pnas.91.24.11343; SZYPERSKI T, 1993, J BIOMOL NMR, V3, P151; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Webb TR, 2008, J CELL SCI, V121, P3140, DOI 10.1242/jcs.035550; Whalen KA, 2005, J VIROL, V79, P9982, DOI 10.1128/JVI.79.15.9982-9990.2005; Wu FM, 2008, PROTEINS, V71, P514, DOI 10.1002/prot.21915; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yang C, 2008, J CELL BIOL, V180, P403, DOI 10.1083/jcb.200705069; YANG SS, 1980, BIOCHIM BIOPHYS ACTA, V590, P24, DOI 10.1016/0005-2728(80)90143-7; Yoon KS, 1999, J BIOL CHEM, V274, P29772, DOI 10.1074/jbc.274.42.29772; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i; Zhang Y, 2010, NATURE, V465, P891, DOI 10.1038/nature09138	49	17	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13194	13205		10.1074/jbc.M112.339655	http://dx.doi.org/10.1074/jbc.M112.339655			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367199	Green Published, hybrid			2022-12-27	WOS:000302903700057
J	Zhang, SZ; Widemann, E; Bernard, G; Lesot, A; Pinot, F; Pedrini, N; Keyhani, NO				Zhang, Shizhu; Widemann, Emilie; Bernard, Grausem; Lesot, Agnes; Pinot, Franck; Pedrini, Nicolas; Keyhani, Nemat O.			CYP52X1, Representing New Cytochrome P450 Subfamily, Displays Fatty Acid Hydroxylase Activity and Contributes to Virulence and Growth on Insect Cuticular Substrates in Entomopathogenic Fungus Beauveria bassiana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPICUTICULAR HYDROCARBONS; METARHIZIUM-ANISOPLIAE; EXPRESSION ANALYSIS; CORDYCEPS BASSIANA; GERMINATION; SURFACE; DEGRADATION; CUTICLE; ALKANE; YEAST	Infection of insects by the entomopathogenic fungus Beauveria bassiana proceeds via attachment and penetration of the host cuticle. The outermost epicuticular layer or waxy layer of the insect represents a structure rich in lipids including abundant amounts of hydrocarbons and fatty acids. A member of a novel cytochrome P450 subfamily, CYP52X1, implicated in fatty acid assimilation by B. bassiana was characterized. B. bassiana targeted gene knockouts lacking Bbcyp52x1 displayed reduced virulence when topically applied to Galleria mellonella, but no reduction in virulence was noted when the insect cuticle was bypassed using an intrahemoceol injection assay. No significant growth defects were noted in the mutant as compared with the wild-type parent on any lipids substrates tested including alkanes and fatty acids. Insect epicuticle germination assays, however, showed reduced germination of Delta Bbcyp52x1 conidia on grasshopper wings as compared with the wild-type parent. Complementation of the gene-knock with the full-length gene restored virulence and insect epicuticle germination to wild-type levels. Heterologous expression of CYP52X1 in yeast was used to characterize the substrate specificity of the enzyme. CYP52X1 displayed the highest activity against midrange fatty acids (C12:0 and C14:0) and epoxy stearic acid, 4-8-fold lower activity against C16:0, C18:1, and C18:2, and little to no activity against C9:0 and C18:0. Analyses of the products of the C12:0 and C18:1 reactions confirmed NADPH-dependent regioselective addition of a terminal hydroxyl to the substrates (omega-hydroxylase). These data implicate CYP52X1 as contributing to the penetration of the host cuticle via facilitating the assimilation of insect epicuticle lipids.	[Zhang, Shizhu; Keyhani, Nemat O.] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Zhang, Shizhu] Nanjing Normal Univ, Jiangsu Key Lab Microbes & Funct Genom, Jiangsu Engn & Technol Res Ctr Microbiol, Coll Life Sci, Nanjing 210046, Jiangsu, Peoples R China; [Widemann, Emilie; Bernard, Grausem; Lesot, Agnes; Pinot, Franck] Univ Strasbourg, Inst Biol Mol Plantes, CNRS, Dept Reseaux Metab,UPR 2357, F-67083 Strasbourg, France; [Pedrini, Nicolas] UNLP, Fac Ciencias Med, Inst Invest Bioquim La Plata, RA-1900 La Plata, Argentina	State University System of Florida; University of Florida; Nanjing Normal University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; National University of La Plata	Keyhani, NO (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Bldg 981,Museum Rd, Gainesville, FL 32611 USA.	keyhani@ufl.edu	Widemann, Emilie/AAH-3825-2020; Keyhani, Nemat O/I-8150-2013; Pedrini, Nicolas/Q-6386-2019; zhang, shizhu/HDO-3599-2022; Pedrini, Nicolas/G-4967-2013	Pedrini, Nicolas/0000-0002-5383-8611; Widemann, Emilie/0000-0002-6732-5497; zhang, shizhu/0000-0002-0283-3714	USDA; NSF [2010-34135-21095, IOS-1121392]	USDA(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF))	This work was support in part by USDA and NSF grants (2010-34135-21095 and IOS-1121392) to NOK.; We thank Drs. Almudena Urquiza-Ortiz and Engin Kilic for assistance with several experiments. E. W. is grateful to the French Ministry of Research for supporting her Ph.D. thesis.	BOUCIAS DG, 1988, APPL ENVIRON MICROB, V54, P1795, DOI 10.1128/AEM.54.7.1795-1805.1988; BOUCIAS DG, 1984, J INVERTEBR PATHOL, V43, P288, DOI 10.1016/0022-2011(84)90153-8; Cho EM, 2007, MICROBIOL-SGM, V153, P3438, DOI 10.1099/mic.0.2007/008532-0; Crespo R, 2008, MICROBIOL RES, V163, P148, DOI 10.1016/j.micres.2006.03.013; Crespo R, 2000, MYCOLOGIA, V92, P528, DOI 10.2307/3761512; Crespo R, 2002, BIOCONTROL, V47, P685, DOI 10.1023/A:1020545613148; de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001; Donatti AC, 2008, CURR MICROBIOL, V56, P256, DOI 10.1007/s00284-007-9071-y; EGLINTON G, 1968, ORG MASS SPECTROM, V1, P593, DOI 10.1002/oms.1210010413; Fan YH, 2012, NAT BIOTECHNOL, V30, P35, DOI 10.1038/nbt.2080; Fan YH, 2011, J INVERTEBR PATHOL, V106, P274, DOI 10.1016/j.jip.2010.11.003; Farenhorst M, 2009, P NATL ACAD SCI USA, V106, P17443, DOI 10.1073/pnas.0908530106; Fickers P, 2005, FEMS YEAST RES, V5, P527, DOI 10.1016/j.femsyr.2004.09.004; Gartner CA, 2001, PROTEIN EXPRES PURIF, V22, P443, DOI 10.1006/prep.2001.1464; HARADA N, 1988, J BIOCHEM-TOKYO, V103, P106, DOI 10.1093/oxfordjournals.jbchem.a122213; Holder DJ, 2005, APPL ENVIRON MICROB, V71, P5260, DOI 10.1128/AEM.71.9.5260-5266.2005; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Hu G, 2004, J EVOLUTION BIOL, V17, P1204, DOI 10.1111/j.1420-9101.2004.00786.x; Jarrold SL, 2007, MYCOL RES, V111, P240, DOI 10.1016/j.mycres.2006.10.007; KERWIN JL, 1984, CAN J MICROBIOL, V30, P158, DOI 10.1139/m84-025; Kirkland BH, 2004, BIOL CONTROL, V31, P414, DOI 10.1016/j.biocontrol.2004.07.007; Kirkland BH, 2004, J MED ENTOMOL, V41, P705, DOI 10.1603/0022-2585-41.4.705; KOLATTUKUDY PE, 1995, P NATL ACAD SCI USA, V92, P4080, DOI 10.1073/pnas.92.10.4080; LATGE JP, 1987, J GEN MICROBIOL, V133, P1987; LAU SMC, 1993, BIOCHEMISTRY-US, V32, P1945, DOI 10.1021/bi00059a010; LEBEAULT JM, 1971, LIPIDS, V6, P444, DOI 10.1007/BF02531226; LECUONA R, 1991, J INVERTEBR PATHOL, V58, P10, DOI 10.1016/0022-2011(91)90156-K; Lida T, 2000, YEAST, V16, P1077, DOI 10.1002/1097-0061(20000915)16:12<1077::AID-YEA601>3.0.CO;2-K; LINDLEY ND, 1995, CAN J BOT, V73, pS1034, DOI 10.1139/b95-354; Liu D, 2000, J CLIN MICROBIOL, V38, P471; Lord JC, 2004, MYCOPATHOLOGIA, V158, P211, DOI 10.1023/B:MYCO.0000041837.29478.78; Metzenberg R.L., 2000, FUNGAL GENET REP, V47, P13, DOI [10.4148/1941-4765.1209, DOI 10.4148/1941-4765.1209]; Napolitano R, 1997, ARCH BIOCHEM BIOPHYS, V344, P208, DOI 10.1006/abbi.1997.0163; Pedrini N, 2007, COMP BIOCHEM PHYS C, V146, P124, DOI 10.1016/j.cbpc.2006.08.003; Pedrini N, 2006, MYCOLOGIA, V98, P528, DOI 10.3852/mycologia.98.4.528; Pedrini N, 2010, MICROBIOL-SGM, V156, P2549, DOI 10.1099/mic.0.039735-0; Pedrini N, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000434; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; SAITO T, 1983, APPL ENTOMOL ZOOL, V18, P225, DOI 10.1303/aez.18.225; SMITH RJ, 1982, J INVERTEBR PATHOL, V39, P15, DOI 10.1016/0022-2011(82)90153-7; Sweigard JA, 1997, FUNGAL GENET NEWSL, V44, P52, DOI DOI 10.4148/1941-4765.1287; Vega FE, 2008, J INVERTEBR PATHOL, V98, P277, DOI 10.1016/j.jip.2008.01.008; Zhang SZ, 2011, MOL MICROBIOL, V80, P811, DOI 10.1111/j.1365-2958.2011.07613.x; Zhang SZ, 2010, APPL MICROBIOL BIOT, V87, P1151, DOI 10.1007/s00253-010-2636-x	44	70	73	4	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13477	13486		10.1074/jbc.M111.338947	http://dx.doi.org/10.1074/jbc.M111.338947			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22393051	Green Published, hybrid			2022-12-27	WOS:000302903700081
J	Zizak, M; Chen, T; Bartonicek, D; Sarker, R; Zachos, NC; Cha, BY; Kovbasnjuk, O; Korac, J; Mohan, S; Cole, R; Chen, YP; Tse, CM; Donowitz, M				Zizak, Mirza; Chen, Tiane; Bartonicek, Dorotea; Sarker, Rafiquel; Zachos, Nicholas C.; Cha, Boyoung; Kovbasnjuk, Olga; Korac, Jelena; Mohan, Sachin; Cole, Robert; Chen, Yueping; Tse, C. Ming; Donowitz, Mark			Calmodulin Kinase II Constitutively Binds, Phosphorylates, and Inhibits Brush Border Na+/H+ Exchanger 3 (NHE3) by a NHERF2 Protein-dependent Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-MEDIATED INHIBITION; ISOFORM NHE3; ADENOMA DRA; PDZ DOMAIN; ACTIVATION; CALCIUM; COMPLEXES; REQUIRES; E3KARP; BASAL	The epithelial brush border (BB) Na+/H+ exchanger 3 (NHE3) accounts for most renal and intestinal Na+ absorption. Ca2+/calmodulin-dependent protein kinase II (CaMKII) inhibits NHE3 activity under basal conditions in intact intestine, acting in the BB, but the mechanism is unclear. We now demonstrate that in both PS120 fibroblasts and polarized Caco-2BBe cells expressing NHE3, CaMKII inhibits basal NHE3 activity, because the CaMKII-specific inhibitors KN-93 and KN-62 stimulate NHE3 activity. This inhibition requires NHERF2. CaMKII gamma associates with NHE3 between aa 586 and 605 in the NHE3 C terminus in a Ca2+-dependent manner, with less association when Ca2+ is increased. CaMKII inhibits NHE3 by an effect on its turnover number, not changing surface expression. Back phosphorylation demonstrated that NHE3 is phosphorylated by CaMKII under basal conditions. This overall phosphorylation of NHE3 is not affected by the presence of NHERF2. Amino acids downstream of NHE3 aa 690 are required for CaMKII to inhibit basal NHE3 activity, and mutations of the three putative CaMKII phosphorylation sites downstream of aa 690 each prevented KN-93 stimulation of NHE3 activity. These studies demonstrate that CaMKII gamma is a novel NHE3-binding protein, and this association is reduced by elevated Ca2+. CaMKII inhibits basal NHE3 activity associated with phosphorylation of NHE3 by effects requiring aa downstream of NHE3 aa 690 and of the CaMKII-binding site on NHE3. CaMKII binding to and phosphorylation of the NHE3 C terminus are parts of the physiologic regulation of NHE3 that occurs in fibroblasts as well as in the BB of an intestinal Na+-absorptive cell.	[Zizak, Mirza; Chen, Tiane; Sarker, Rafiquel; Zachos, Nicholas C.; Cha, Boyoung; Kovbasnjuk, Olga; Mohan, Sachin; Chen, Yueping; Tse, C. Ming; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Div Gastroenterol, Dept Physiol & Med, Baltimore, MD 21205 USA; [Cole, Robert] Johns Hopkins Univ, Sch Med, Dept Physiol Chem, Baltimore, MD 21205 USA; [Zizak, Mirza; Bartonicek, Dorotea; Korac, Jelena] Univ Zagreb, Sch Med, Dept Physiol, Zagreb 10000, Croatia	Johns Hopkins University; Johns Hopkins University; University of Zagreb	Donowitz, M (corresponding author), Johns Hopkins Univ, Sch Med, Div Gastroenterol, Dept Physiol & Med, 720 Rutland Ave,925 Ross Res Bldg, Baltimore, MD 21205 USA.	mdonowit@jhmi.edu	Prlic, Jelena Korac/AAJ-1029-2021; mohan, sachin/H-4017-2015; Zachos, Nicholas/GWC-7914-2022; Prlic, Jelena Korac/I-7988-2012	Prlic, Jelena Korac/0000-0002-7840-9979; Prlic, Jelena Korac/0000-0002-7840-9979; Mohan, Sachin/0000-0002-6798-4767	National Institutes of Health NIDDK [R01DK26523, R01DK61765, P01DK072084, R24DK64388, P30DK089502, K08DK088950, T32DK2007632]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK088950, R24DK064388, P30DK089502, R01DK061765, P01DK072084, R01DK026523] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health NIDDK Grants R01DK26523, R01DK61765, P01DK072084, and R24DK64388 (to Hopkins Basic Research Digestive Diseases Development Core Center), P30DK089502 (to Hopkins Digestive Diseases Basic and Translational Core Center), and K08DK088950 and T32DK2007632 (to Hopkins Center for Epithelial Biology).	Ahn W, 2001, J BIOL CHEM, V276, P17236, DOI 10.1074/jbc.M011763200; Akhter S, 2002, AM J PHYSIOL-CELL PH, V283, pC927, DOI 10.1152/ajpcell.00613.2001; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bartfai T, 1979, Adv Cyclic Nucleotide Res, V10, P219; Bayer KM, 2001, BIOCHEM BIOPH RES CO, V289, P917, DOI 10.1006/bbrc.2001.6063; Bayer KU, 1999, MOL BRAIN RES, V70, P147, DOI 10.1016/S0169-328X(99)00131-X; Biemesderfer D, 1999, J BIOL CHEM, V274, P17518, DOI 10.1074/jbc.274.25.17518; Cha B, 2005, J BIOL CHEM, V280, P16642, DOI 10.1074/jbc.M500505200; Cha B., 2007, GASTROENTEROLOGY, V132, P575; Cha B, 2006, MOL BIOL CELL, V17, P2661, DOI 10.1091/mbc.E05-09-0843; COHEN ME, 1991, J CLIN INVEST, V88, P855, DOI 10.1172/JCI115387; COHEN ME, 1990, P NATL ACAD SCI USA, V87, P8990, DOI 10.1073/pnas.87.22.8990; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Donowitz M, 2009, J EXP BIOL, V212, P1638, DOI 10.1242/jeb.028605; EMMER E, 1989, J MEMBRANE BIOL, V108, P207, DOI 10.1007/BF01871735; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Gangopadhyay SS, 2003, BIOCHEM J, V372, P347, DOI 10.1042/BJ20030015; Girardi ACC, 2001, J BIOL CHEM, V276, P46671, DOI 10.1074/jbc.M106897200; Goel R, 2012, MOL BIOSYST, V8, P453, DOI 10.1039/c1mb05340j; Griffith LC, 2004, J NEUROSCI, V24, P8394, DOI 10.1523/JNEUROSCI.3604-04.2004; Harada K, 2010, J BIOL CHEM, V285, P24044, DOI 10.1074/jbc.M109.072553; Hoogerwerf WA, 1996, AM J PHYSIOL-GASTR L, V270, pG29, DOI 10.1152/ajpgi.1996.270.1.G29; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Ikeda T, 1997, J BIOCHEM-TOKYO, V121, P295; Janecki AJ, 1998, J BIOL CHEM, V273, P8790, DOI 10.1074/jbc.273.15.8790; Kocinsky HS, 2007, AM J PHYSIOL-RENAL, V293, pF212, DOI 10.1152/ajprenal.00042.2007; Lamprecht G, 1998, J BIOL CHEM, V273, P29972, DOI 10.1074/jbc.273.45.29972; Lamprecht G, 2002, BIOCHEMISTRY-US, V41, P12336, DOI 10.1021/bi0259103; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; LEVINE SA, 1995, J BIOL CHEM, V270, P13716, DOI 10.1074/jbc.270.23.13716; LEVINE SA, 1993, J BIOL CHEM, V268, P25527; Lin R, 2011, GASTROENTEROLOGY, V140, P560, DOI 10.1053/j.gastro.2010.10.042; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Melvin JE, 1999, J BIOL CHEM, V274, P22855, DOI 10.1074/jbc.274.32.22855; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; ORLOWSKI J, 1992, J BIOL CHEM, V267, P9331; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; Sarker R, 2008, MOL BIOL CELL, V19, P3859, DOI 10.1091/mbc.E08-01-0019; Sarker R, 2011, AM J PHYSIOL-CELL PH, V300, pC771, DOI 10.1152/ajpcell.00119.2010; Thwaites DT, 2002, GASTROENTEROLOGY, V122, P1322, DOI 10.1053/gast.2002.32992; TSE CM, 1992, J BIOL CHEM, V267, P9340; TSE CM, 1993, P NATL ACAD SCI USA, V90, P9110, DOI 10.1073/pnas.90.19.9110; Wang DS, 2005, AM J PHYSIOL-CELL PH, V289, pC802, DOI 10.1152/ajpcell.00597.2004; Weinman EJ, 2000, BIOCHEMISTRY-US, V39, P6123, DOI 10.1021/bi000064m; Yanaka A, 2002, AM J PHYSIOL-GASTR L, V282, pG866, DOI 10.1152/ajpgi.00150.2001; Yang EY, 1999, J BIOL CHEM, V274, P26199, DOI 10.1074/jbc.274.37.26199; Yoo BK, 2011, AM J PHYSIOL-CELL PH, V301, pC1008, DOI 10.1152/ajpcell.00231.2011; Yun CHC, 1997, P NATL ACAD SCI USA, V94, P3010, DOI 10.1073/pnas.94.7.3010; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004; Zachos NC, 2009, J BIOL CHEM, V284, P23708, DOI 10.1074/jbc.M109.012641; Zachos NC, 2009, J BIOL CHEM, V284, P19437, DOI 10.1074/jbc.M109.006098; Zhao H, 1999, J BIOL CHEM, V274, P3978, DOI 10.1074/jbc.274.7.3978; Zhu XJ, 2011, J BIOL CHEM, V286, P34486, DOI 10.1074/jbc.M111.230219; Zizak M, 1999, J BIOL CHEM, V274, P24753, DOI 10.1074/jbc.274.35.24753	56	15	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13442	13456		10.1074/jbc.M111.307256	http://dx.doi.org/10.1074/jbc.M111.307256			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22371496	Green Published, hybrid			2022-12-27	WOS:000302903700078
J	Foster, AW; Patterson, CJ; Pernil, R; Hess, CR; Robinson, NJ				Foster, Andrew W.; Patterson, Carl J.; Pernil, Rafael; Hess, Corinna R.; Robinson, Nigel J.			Cytosolic Ni(II) Sensor in Cyanobacterium NICKEL DETECTION FOLLOWS NICKEL AFFINITY ACROSS FOUR FAMILIES OF METAL SENSORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-ION SELECTIVITY; ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATION; REPRESSOR CSOR; COPPER EFFLUX; PROTEIN; NICKEL; BINDING; EXPRESSION; HYDROGEN	Efflux of surplus Ni(II) across the outer and inner membranes of Synechocystis PCC 6803 is mediated by the Nrs system under the control of a sensor of periplasmic Ni(II), NrsS. Here, we show that the product of ORF sll0176, which encodes a CsoR/RcnR-like protein now designated InrS (for internal nickel-responsive sensor), represses nrsD (NrsD is deduced to efflux Ni(II) across the inner membrane) from a cryptic promoter between the final two ORFs in the nrs operon. Transcripts initiated from the newly identified nrsD promoter accumulate in response to nickel or cobalt but not copper, and recombinant InrS forms specific, Ni(II)-inhibited complexes with the nrsD promoter region. Metal-dependent difference spectra of Ni(II)- and Cu(I)InrS are similar to Cu(I)-sensing CsoR and dissimilar to Ni(II)/Co(II)-sensing RcnR, consistent with factors beyond the primary coordination sphere switching metal selectivity. Competition with chelators mag-fura-2, nitrilotriacetic acid, EDTA, and EGTA estimate K-D Ni(II) for the tightest site of InrS as 2.05 (+/-1.5) x 10(-14) M, and weaker K-D Ni(II) for the cells' metal sensors of other types: Zn(II) co-repressor Zur, Co(II) activator CoaR, and Zn(II) derepressor ZiaR. Ni(II) transfer to InrS occurs upon addition to Ni(II) forms of each other sensor. InrS binds Ni(II) sufficiently tightly to derepress Ni(II) export at concentrations below K-D Ni(II) of the other sensors.	[Foster, Andrew W.; Patterson, Carl J.; Pernil, Rafael; Hess, Corinna R.; Robinson, Nigel J.] Univ Durham, Dept Chem, Sch Biol & Biomed Sci, Biophys Sci Inst, Durham DH1 3LE, England; [Foster, Andrew W.] Newcastle Univ, Sch Med, Inst Cell & Mol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Durham University; Newcastle University - UK	Robinson, NJ (corresponding author), Univ Durham, Dept Chem, Sch Biol & Biomed Sci, Biophys Sci Inst, South Rd, Durham DH1 3LE, England.	nigel.robinson@durham.ac.uk	Robinson, Nigel J/J-6363-2012; Hess, Corinna/J-1504-2012	Robinson, Nigel J/0000-0001-5586-1092; Hess, Corinna/0000-0002-9607-9184	Biotechnology and Biological Research Council [BB/H006052/2, BB/E001688/1]; Biotechnology and Biological Sciences Research Council [BB/E001688/1, BB/H006052/2, BB/H006052/1] Funding Source: researchfish; BBSRC [BB/H006052/2, BB/H006052/1, BB/E001688/1] Funding Source: UKRI	Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Research Council Grants BB/H006052/2 and BB/E001688/1.	Appel J, 2000, ARCH MICROBIOL, V173, P333, DOI 10.1007/s002030000139; Axelsson R, 2002, APPL ENVIRON MICROB, V68, P444, DOI 10.1128/AEM.68.1.444-447.2002; Baker J, 2011, ENVIRON MICROBIOL, V13, P2495, DOI 10.1111/j.1462-2920.2011.02522.x; BULLERJAHN GS, 1986, J BACTERIOL, V167, P396, DOI 10.1128/jb.167.1.396-399.1986; Cave JS, 2002, J BIOL CHEM, V277, P38441, DOI 10.1074/jbc.M207677200; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Cobine PA, 2002, BIOCHEMISTRY-US, V41, P5822, DOI 10.1021/bi025515c; Corbett D, 2011, MOL MICROBIOL, V81, P457, DOI 10.1111/j.1365-2958.2011.07705.x; DADAY A, 1985, J GEN MICROBIOL, V131, P231; Dainty SJ, 2010, J BIOL INORG CHEM, V15, P77, DOI 10.1007/s00775-009-0555-z; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FERRIS NS, 1979, BIOCHEM BIOPH RES CO, V88, P288, DOI 10.1016/0006-291X(79)91728-5; Festa RA, 2011, MOL MICROBIOL, V79, P133, DOI 10.1111/j.1365-2958.2010.07431.x; Garcia-Dominguez M, 2000, J BACTERIOL, V182, P1507, DOI 10.1128/JB.182.6.1507-1514.2000; Golynskiy MV, 2006, BIOCHEMISTRY-US, V45, P15359, DOI 10.1021/bi0607406; Grossoehme N, 2011, J BIOL CHEM, V286, P13522, DOI 10.1074/jbc.M111.220012; Guedon E, 2003, MOL MICROBIOL, V48, P495, DOI 10.1046/j.1365-2958.2003.03445.x; HUCKLE JW, 1993, MOL MICROBIOL, V7, P177, DOI 10.1111/j.1365-2958.1993.tb01109.x; Iwig JS, 2008, J AM CHEM SOC, V130, P7592, DOI 10.1021/ja710067d; Iwig JS, 2006, MOL MICROBIOL, V62, P252, DOI 10.1111/j.1365-2958.2006.05369.x; Iwig JS, 2009, J MOL BIOL, V393, P514, DOI 10.1016/j.jmb.2009.08.038; Jenkins RM, 2009, INORG CHEM, V48, P7280, DOI 10.1021/ic900778k; Keren N, 2004, PLANT PHYSIOL, V135, P1666, DOI 10.1104/pp.104.042770; Kumar S., 1991, P IND NATL SCI ACAD, V1357, P281; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Lopez-Maury L, 2002, MOL MICROBIOL, V43, P247, DOI 10.1046/j.1365-2958.2002.02741.x; Ma Z, 2009, J AM CHEM SOC, V131, P18044, DOI 10.1021/ja908372b; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Ma Z, 2009, BIOCHEMISTRY-US, V48, P3325, DOI 10.1021/bi900115w; MERCHANT S, 1991, EMBO J, V10, P1383, DOI 10.1002/j.1460-2075.1991.tb07658.x; ODERMATT A, 1995, J BIOL CHEM, V270, P4349, DOI 10.1074/jbc.270.9.4349; Olson JW, 1997, MOL MICROBIOL, V24, P119, DOI 10.1046/j.1365-2958.1997.3251690.x; OXELFELT F, 1995, PLANT PHYSIOL BIOCH, V33, P617; Pakrasi H. B., 2004, TRANSPORT METALS KEY, P253; Quinn JM, 2002, PLANT PHYSIOL, V128, P463, DOI 10.1104/pp.010694; Rakhimberdieva MG, 2004, FEBS LETT, V574, P85, DOI 10.1016/j.febslet.2004.07.087; Reyes-Caballero H, 2011, BIOCHEMISTRY-US, V50, P7941, DOI 10.1021/bi200737a; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Rutherford JC, 1999, J BIOL CHEM, V274, P25827, DOI 10.1074/jbc.274.36.25827; Sakamoto K, 2010, MICROBIOL-SGM, V156, P1993, DOI 10.1099/mic.0.037382-0; Sambrook J., 2001, MOL CLONING LAB MANU; Savage N, 2011, NATURE, V474, pS15, DOI 10.1038/474S015a; Smaldone GT, 2007, MICROBIOL-SGM, V153, P4123, DOI 10.1099/mic.0.2007/011742-0; So AKC, 1998, PLANT MOL BIOL, V37, P205, DOI 10.1023/A:1005959200390; Thelwell C, 1998, P NATL ACAD SCI USA, V95, P10728, DOI 10.1073/pnas.95.18.10728; Tottey S, 2001, J BIOL CHEM, V276, P19999, DOI 10.1074/jbc.M011243200; Tottey Stephen, 2007, V6, P3, DOI 10.1007/7171_2006_072; Tottey S, 2012, P NATL ACAD SCI USA, V109, P95, DOI 10.1073/pnas.1117515109; VanZile ML, 2000, BIOCHEMISTRY-US, V39, P11818, DOI 10.1021/bi001140o; VASAK M, 1981, BIOCHEMISTRY-US, V20, P6659, DOI 10.1021/bi00526a021; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010432; Wang SC, 2004, BIOCHEMISTRY-US, V43, P10018, DOI 10.1021/bi049405c; Wilson A, 2006, PLANT CELL, V18, P992, DOI 10.1105/tpc.105.040121; WOOD PM, 1978, EUR J BIOCHEM, V87, P9, DOI 10.1111/j.1432-1033.1978.tb12346.x; XIANKONG Z, 1984, Journal of General Microbiology, V130, P1815; Xiao ZG, 2011, J BIOL CHEM, V286, P11047, DOI 10.1074/jbc.M110.213074; Xiao ZG, 2010, NAT PROD REP, V27, P768, DOI 10.1039/b906690j; Zhu T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017367	60	41	41	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12142	12151		10.1074/jbc.M111.338301	http://dx.doi.org/10.1074/jbc.M111.338301			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22356910	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000302782200050
J	Guo, C; Gow, CH; Li, YL; Gardner, A; Khan, S; Zhang, JS				Guo, Chun; Gow, Chien-Hung; Li, Yali; Gardner, Amanda; Khan, Sohaib; Zhang, Jinsong			Regulated Clearance of Histone Deacetylase 3 Protects Independent Formation of Nuclear Receptor Corepressor Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-COR COREPRESSORS; TRANSCRIPTIONAL REPRESSION; HORMONE RECEPTORS; SMRT COREPRESSOR; SIGNALING PATHWAYS; SILENCING MEDIATOR; DOWN-REGULATION; IN-VIVO; HDAC3; CELL	An important step in transcriptional regulation by corepressors N-CoR and SMRT is the formation of a stable and active histone deacetylase 3 (HDAC3)-containing complex. Although N-CoR and SMRT are thought to bind HDAC3 competitively, multiple studies have shown that they do not interfere with the function of each other. How this functional independence is sustained under the competitive interaction is unclear. Here, we show that the coupling of corepressor expression with HDAC3 degradation allows cells to maintain a stable level of uncomplexed HDAC3, thereby preventing mutual interference in the assembly of N-CoR and SMRT complexes. The free uncomplexed HDAC3 is highly unstable. Unexpectedly, the rate of HDAC3 degradation is inversely correlated with the expression level of corepressors. Our results indicate that reducing one corepressor accelerates HDAC3 clearance, thus preventing an increase in complex formation between HDAC3 and the other corepressor. In addition, this study also indicates that the formation of a stable and active HDAC3-corepressor complex is a stepwise process in which the C terminus of HDAC3 plays a critical role at late steps of the assembly process.	[Guo, Chun; Gow, Chien-Hung; Li, Yali; Gardner, Amanda; Khan, Sohaib; Zhang, Jinsong] Univ Cincinnati, Coll Med, Vontz Ctr Mol Studies, Dept Canc & Cell Biol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Zhang, JS (corresponding author), Univ Cincinnati, Coll Med, Vontz Ctr Mol Studies, Dept Canc & Cell Biol, 3125 Eden Ave, Cincinnati, OH 45267 USA.	Jinsong.Zhang@uc.edu		Khan, Sohaib/0000-0002-0792-9109; Zhang, Jinsong/0000-0002-8798-7316	National Institutes of Health [R01HL093195, T32CA059268]; University of Cincinnati Cancer Center; University Research Council; NATIONAL CANCER INSTITUTE [T32CA059268] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Cincinnati Cancer Center; University Research Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL093195 (to J. Z.) and Training Grant T32CA059268 (to A. G.). This work was also supported by University of Cincinnati Cancer Center and University Research Council grants (to J. Z.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Cohen Ronald N, 2006, Nucl Recept Signal, V4, pe003; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Frasor J, 2005, P NATL ACAD SCI USA, V102, P13153, DOI 10.1073/pnas.0502782102; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Guenther MG, 2000, GENE DEV, V14, P1048; Guenther MG, 2002, GENE DEV, V16, P3130, DOI 10.1101/gad.1037502; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Guo C, 2009, MOL CELL BIOL, V29, P2644, DOI 10.1128/MCB.00073-09; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hassig CA, 1997, CURR OPIN CHEM BIOL, V1, P300, DOI 10.1016/S1367-5931(97)80066-X; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Hong SH, 2000, MOL CELL BIOL, V20, P6612, DOI 10.1128/MCB.20.17.6612-6625.2000; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu QD, 2011, MOL CELL BIOL, V31, P3223, DOI 10.1128/MCB.01365-10; Hu X, 2001, MOL CELL BIOL, V21, P1747, DOI 10.1128/MCB.21.5.1747-1758.2001; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jepsen K, 2008, GENE DEV, V22, P740, DOI 10.1101/gad.1637108; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jonas BA, 2004, J BIOL CHEM, V279, P54676, DOI 10.1074/jbc.M410128200; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Kojima T, 2001, MOL BRAIN RES, V90, P174, DOI 10.1016/S0169-328X(01)00107-3; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Miao J, 2009, MOL CELL BIOL, V29, P6170, DOI 10.1128/MCB.00825-09; Park EJ, 1999, P NATL ACAD SCI USA, V96, P3519, DOI 10.1073/pnas.96.7.3519; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Peterson TJ, 2007, MOL CELL BIOL, V27, P5933, DOI 10.1128/MCB.00237-07; Rajendran P, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-68; Spurling CC, 2008, MOL CARCINOGEN, V47, P137, DOI 10.1002/mc.20373; Xia Y, 2007, MOL CELL, V25, P219, DOI 10.1016/j.molcel.2007.01.005; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; You SH, 2010, MOL ENDOCRINOL, V24, P1359, DOI 10.1210/me.2009-0501; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005; Zhao HL, 2010, BIOCHEM BIOPH RES CO, V399, P623, DOI 10.1016/j.bbrc.2010.07.127; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011	48	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12111	12120		10.1074/jbc.M111.327023	http://dx.doi.org/10.1074/jbc.M111.327023			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337871	hybrid, Green Published			2022-12-27	WOS:000302782200047
J	Kim, SI; Na, HJ; Ding, Y; Wang, ZB; Lee, SJ; Choi, ME				Kim, Sung Il; Na, Hee-Jun; Ding, Yan; Wang, Zhibo; Lee, Seon Jin; Choi, Mary E.			Autophagy Promotes Intracellular Degradation of Type I Collagen Induced by Transforming Growth Factor (TGF)-beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ENDOPLASMIC-RETICULUM; MATRIX METALLOPROTEINASES; CARBON-MONOXIDE; FACTOR-BETA; TGF-BETA; ACTIVATES AUTOPHAGY; MESANGIAL CELLS; TUBULAR CELLS; BECLIN-1	Autophagy is a highly conserved cellular process regulating turnover of cytoplasmic proteins via a lysosome-dependent pathway. Here we show that kidneys from mice deficient in autophagic protein Beclin 1 exhibited profibrotic phenotype, with increased collagen deposition. Reduced Beclin 1 expression, through genetic disruption of beclin 1 or knockdown by specific siRNA in primary mouse mesangial cells (MMC), resulted in increased protein levels of type I collagen (Col-I). Inhibition of autolysosomal protein degradation by bafilomycin A(1) also increased Col-I protein levels and colocalization of Col-I with LC3, an autophagy marker, or LAMP-1, a lysosome marker, whereas treatment with TFP, an inducer of autophagy, resulted in decreased Col-I protein levels induced by TGF-beta 1, without alterations in Col-I alpha 1 mRNA. Heterozygous deletion of beclin 1 increased accumulation of aggregated Col-I under nonstimulated conditions, and stimulation with TGF-beta 1 further increased aggregated Col-I. These data indicate that Col-I and aggregated, insoluble procollagen I undergo intracellular degradation via autophagy. A cytoprotective role of autophagy is implicated in kidney injury, and we demonstrate that low-dose carbon monoxide, shown to exert cytoprotection against renal fibrosis, induces autophagy to suppress accumulation of Col-I induced by TGF-beta 1. We also show that TGF-beta 1 induces autophagy in MMC via TAK1-MKK3-p38 signaling pathway. The dual functions of TGF-beta 1, as both an inducer of Col-I synthesis and an inducer of autophagy and Col-I degradation, underscore the multifunctional nature of TGF-beta 1. Our findings suggest a novel role of autophagy as a cytoprotective mechanism to negatively regulate and prevent excess collagen accumulation in the kidney.	[Kim, Sung Il; Na, Hee-Jun; Ding, Yan; Wang, Zhibo; Choi, Mary E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Renal Div, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Choi, ME (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Renal Div, 4 Blackfan Circle,HIM 5, Boston, MA 02115 USA.	mchoi@rics.bwh.harvard.edu	Lee, Seon-Jin/AAJ-8258-2020; Wang, Zhibo/GSD-3371-2022	Lee, Seon-Jin/0000-0001-7214-7536	National Institutes of Health from the NIDDK [R01 DK57661]; American Society of Nephrology (ASN); American Heart Association (AHA) [0665379U]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057661] Funding Source: NIH RePORTER	National Institutes of Health from the NIDDK; American Society of Nephrology (ASN); American Heart Association (AHA)(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK57661 from the NIDDK and the M. James Scherbenske Grant from the American Society of Nephrology (to M. E. C.); Carl W. Gottschalk Research Scholar Grant from the American Society of Nephrology (ASN) and Beginning Grant-in-Aid 0665379U from the American Heart Association (AHA) (to S. I. K.).	Aranguiz-Urroz P, 2011, BBA-MOL BASIS DIS, V1812, P23, DOI 10.1016/j.bbadis.2010.07.003; Arsov I, 2008, CELL DEATH DIFFER, V15, P1385, DOI 10.1038/cdd.2008.59; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Burman C, 2010, SEMIN IMMUNOPATHOL, V32, P397, DOI 10.1007/s00281-010-0222-z; Calvaruso G, 2006, MOL CELL BIOCHEM, V287, P13, DOI 10.1007/s11010-005-9016-3; Chin BY, 2001, AM J PHYSIOL-RENAL, V280, pF495, DOI 10.1152/ajprenal.2001.280.3.F495; Ding Y, 2010, J BIOL CHEM, V285, P37909, DOI 10.1074/jbc.M109.093724; Dolcet X, 2006, J BIOL CHEM, V281, P22118, DOI 10.1074/jbc.M601350200; Doyle A, 2011, FASEB J, V25, P99, DOI 10.1096/fj.10-164152; Ecker N, 2010, AUTOPHAGY, V6, P879, DOI 10.4161/auto.6.7.12753; Fineschi S, 2006, FASEB J, V20, P562, DOI 10.1096/fj.05-4870fje; Forloni G, 2002, NEUROBIOL AGING, V23, P957, DOI 10.1016/S0197-4580(02)00076-3; Gajewska M, 2005, J Physiol Pharmacol, V56 Suppl 3, P143; Gewin L, 2010, J AM SOC NEPHROL, V21, P1334, DOI 10.1681/ASN.2010020147; Ghosh AK, 2002, EXP BIOL MED, V227, P301, DOI 10.1177/153537020222700502; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Haspel J, 2011, AUTOPHAGY, V7, P629, DOI 10.4161/auto.7.6.15100; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Kim S. I., 2007, AM J PHYSIOL-RENAL, V292, pF1471, DOI DOI 10.1152/AJPRENAL.00485.2006; Kim SI, 2008, J BIOL CHEM, V283, P10753, DOI 10.1074/jbc.M801263200; Kiyono K, 2009, CANCER RES, V69, P8844, DOI 10.1158/0008-5472.CAN-08-4401; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Lamande SR, 1999, SEMIN CELL DEV BIOL, V10, P455, DOI 10.1006/scdb.1999.0317; Lee SJ, 2011, AM J RESP CELL MOL, V45, P867, DOI 10.1165/rcmb.2010-0352OC; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li CY, 2010, J BIOL CHEM, V285, P16096, DOI 10.1074/jbc.M109.072694; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Meijer AJ, 2011, CURR BIOL, V21, pR227, DOI 10.1016/j.cub.2011.02.007; Meiners S, 2004, HYPERTENSION, V44, P471, DOI 10.1161/01.HYP.0000142772.71367.65; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mizushima N, 2009, CURR TOP MICROBIOL, V335, P71, DOI 10.1007/978-3-642-00302-8_3; Motterlini R, 2005, EXPERT OPIN INV DRUG, V14, P1305, DOI 10.1517/13543784.14.11.1305; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nakamura N, 1997, J BIOCHEM, V121, P338; Nijholt DAT, 2011, CELL DEATH DIFFER, V18, P1071, DOI 10.1038/cdd.2010.176; Pallet N, 2008, AUTOPHAGY, V4, P783, DOI 10.4161/auto.6477; Periyasamy-Thandavan S, 2008, KIDNEY INT, V74, P631, DOI 10.1038/ki.2008.214; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; SHARMA K, 1995, DIABETES, V44, P1139, DOI 10.2337/diabetes.44.10.1139; Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tannous P, 2008, P NATL ACAD SCI USA, V105, P9745, DOI 10.1073/pnas.0706802105; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang L, 2002, J BIOL CHEM, V277, P47257, DOI 10.1074/jbc.M208573200; Wang L, 2008, AM J PHYSIOL-RENAL, V294, pF508, DOI 10.1152/ajprenal.00306.2007; Webber JL, 2010, FEBS LETT, V584, P1319, DOI 10.1016/j.febslet.2010.01.020; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; YOSHIOKA K, 1990, J PATHOL, V162, P141, DOI 10.1002/path.1711620207; Yuan H, 2009, AM J PHYSIOL-HEART C, V296, pH470, DOI 10.1152/ajpheart.01051.2008; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104	68	165	188	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11677	11688		10.1074/jbc.M111.308460	http://dx.doi.org/10.1074/jbc.M111.308460			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351764	Green Published, hybrid			2022-12-27	WOS:000302782200008
J	Tran, P; Ho, SM; Kim, BG; Vuong, TA; Leem, YE; Bae, GU; Kang, JS				Phong Tran; Ho, Seok-Man; Kim, Bok-Geon; Tuan Anh Vuong; Leem, Young-Eun; Bae, Gyu-Un; Kang, Jong-Sun			TGF-beta-activated Kinase 1 (TAK1) and Apoptosis Signal-regulating Kinase 1 (ASK1) Interact with the Promyogenic Receptor Cdo to Promote Myogenic Differentiation via Activation of p38MAPK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; NEURONAL DIFFERENTIATION; P38-ALPHA/BETA MAPK; P38; STRESS; DEFICIENT; SURVIVAL; BINDING; MEMBER; MYOD	p38MAPK plays an essential role in the transition of myoblasts to differentiated myotubes through the activation of MyoD family transcription factors. A promyogenic cell surface molecule, Cdo, promotes myogenic differentiation mainly through activation of the p38MAPK pathway. Two MAP3Ks, TAK1 and ASK1, can activate p38MAPK via MKK6 in various cell systems. Moreover TAK1 has been shown to promote myogenic differentiation via p38MAPK activation. In this study, we hypothesized that TAK1 and ASK1 might function as MAP3Ks in Cdo-mediated p38MAPK activation during myoblast differentiation. Both ASK1 and TAK1 were expressed in myoblasts and interacted with the cytoplasmic tail of Cdo and a scaffold protein, JLP. The depletion of TAK1 or ASK1 in C2C12 cells decreased myoblast differentiation, whereas overexpression of TAK1 or ASK1 in C2C12 cells enhanced myotube formation. In agreement with this, overexpression of ASK1 or TAK1 resulted in enhanced p38MAPK activation, and their knockdown inhibited p38MAPK in C2C12 cells. Overexpression of TAK1 or ASK1 in Cdo(-/-) myoblasts and Cdo-depleted C2C12 cells restored p38MAPK activation as well as myotube formation. Furthermore, ASK1 and TAK1 compensated for each other in p38MAPK activation and myoblast differentiation. Taken together, these findings suggest that ASK1 and TAK1 function as MAP3Ks in Cdo-mediated p38MAPK activation to promote myogenic differentiation.	[Phong Tran; Ho, Seok-Man; Kim, Bok-Geon; Tuan Anh Vuong; Leem, Young-Eun; Bae, Gyu-Un; Kang, Jong-Sun] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 440746, South Korea; [Bae, Gyu-Un] Sookmyung Womens Univ, Coll Pharm, Seoul 140742, South Korea	Sungkyunkwan University (SKKU); Sookmyung Women's University	Bae, GU (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 440746, South Korea.	powerbg@skku.edu; kangj01@skku.edu	Tran, Phong/GZA-8504-2022		National Research Foundation (NRF) [2011-0030154, 2011-0017315]; Korean government (MEST)	National Research Foundation (NRF); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by National Research Foundation (NRF) Bio and Medical Technology Development Program Grant 2011-0030154 and NRF Grant 2011-0017315 (to J. S. K.) funded by the Korean government (MEST).	Bae GU, 2010, MOL BIOL CELL, V21, P2399, DOI 10.1091/mbc.E09-12-1011; Bae GU, 2009, MOL CELL BIOL, V29, P4130, DOI 10.1128/MCB.00199-09; Bhatnagar S, 2010, J BIOL CHEM, V285, P6401, DOI 10.1074/jbc.M109.064063; Cole F, 2004, DEV CELL, V7, P843, DOI 10.1016/j.devcel.2004.10.009; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; Faigle R, 2004, MOL CELL BIOL, V24, P280, DOI 10.1128/MCB.24.1.280-293.2004; Han JW, 2011, CELL SIGNAL, V23, P1162, DOI 10.1016/j.cellsig.2011.03.001; HuangFu WC, 2006, J BIOL CHEM, V281, P28802, DOI 10.1074/jbc.M603627200; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kang JS, 2008, J CELL BIOL, V182, P497, DOI 10.1083/jcb.200801119; Kang JS, 2003, P NATL ACAD SCI USA, V100, P3989, DOI 10.1073/pnas.0736565100; Kang JS, 2002, EMBO J, V21, P114, DOI 10.1093/emboj/21.1.114; Kang JS, 2004, J CELL BIOL, V167, P493, DOI 10.1083/jcb.200405039; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Lee H. J., 2012, MOL BIOL CE IN PRESS; Leem YE, 2011, CELL SIGNAL, V23, P2021, DOI 10.1016/j.cellsig.2011.07.016; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Lluis F, 2005, EMBO J, V24, P974, DOI 10.1038/sj.emboj.7600528; Lu M, 2010, P NATL ACAD SCI USA, V107, P4212, DOI 10.1073/pnas.0908883107; Meriane M, 2000, MOL BIOL CELL, V11, P2513, DOI 10.1091/mbc.11.8.2513; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Oh JE, 2009, FASEB J, V23, P2088, DOI 10.1096/fj.08-119255; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Ruiz-Bonilla V, 2008, CELL CYCLE, V7, P2208, DOI 10.4161/cc.7.14.6273; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sayama K, 2001, J BIOL CHEM, V276, P999, DOI 10.1074/jbc.M003425200; Sayama K, 2006, J BIOL CHEM, V281, P22013, DOI 10.1074/jbc.M601065200; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shim JH, 2009, EMBO J, V28, P2028, DOI 10.1038/emboj.2009.162; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Takaesu G, 2006, J CELL BIOL, V175, P383, DOI 10.1083/jcb.200608031; Takeda K, 2000, J BIOL CHEM, V275, P9805, DOI 10.1074/jbc.275.13.9805; Takeda K, 2008, ANNU REV PHARMACOL, V48, P199, DOI 10.1146/annurev.pharmtox.48.113006.094606; Tang MH, 2008, J EXP MED, V205, P1611, DOI 10.1084/jem.20080297; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005	45	30	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11602	11615		10.1074/jbc.M112.351601	http://dx.doi.org/10.1074/jbc.M112.351601			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337877	hybrid, Green Published			2022-12-27	WOS:000302782200001
J	Miletti-Gonzalez, KE; Murphy, K; Kumaran, MN; Ravindranath, AK; Wernyj, RP; Kaur, S; Miles, GD; Lim, E; Chan, R; Chekmareva, M; Heller, DS; Foran, D; Chen, WJ; Reiss, M; Bandera, EV; Scotto, K; Rodriguez-Rodriguez, L				Miletti-Gonzalez, Karl E.; Murphy, Kyle; Kumaran, Muthu N.; Ravindranath, Abhilash K.; Wernyj, Roman P.; Kaur, Swayamjot; Miles, Gregory D.; Lim, Elaine; Chan, Rigel; Chekmareva, Marina; Heller, Debra S.; Foran, David; Chen, Wenjin; Reiss, Michael; Bandera, Elisa V.; Scotto, Kathleen; Rodriguez-Rodriguez, Lorna			Identification of Function for CD44 Intracytoplasmic Domain (CD44-ICD) MODULATION OF MATRIX METALLOPROTEINASE 9 (MMP-9) TRANSCRIPTION VIA NOVEL PROMOTER RESPONSE ELEMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVARIAN-CANCER CELLS; MATRIX-METALLOPROTEINASE; BREAST-CANCER; TUMOR-CELLS; HYALURONAN OLIGOSACCHARIDES; INTRACELLULAR DOMAIN; GLUCOSE-METABOLISM; DRUG-RESISTANCE; GENE-EXPRESSION; INVASION	CD44 is a multifunctional cell receptor that conveys a cancer phenotype, regulates macrophage inflammatory gene expression and vascular gene activation in proatherogenic environments, and is also a marker of many cancer stem cells. CD44 undergoes sequential proteolytic cleavages that produce an intracytoplasmic domain called CD44-ICD. However, the role of CD44-ICD in cell function is unknown. We take a major step toward the elucidation of the CD44-ICD function by using a CD44-ICD-specific antibody, a modification of a ChIP assay to detect small molecules, and extensive computational analysis. We show that CD44-ICD translocates into the nucleus, where it then binds to a novel DNA consensus sequence in the promoter region of the MMP-9 gene to regulate its expression. We also show that the expression of many other genes that contain this novel response element in their promoters is up- or down-regulated by CD44-ICD. Furthermore, hypoxia-inducible factor-1 alpha (Hif1 alpha)-responsive genes also have the CD44-ICD consensus sequence and respond to CD44-ICD induction under normoxic conditions and therefore independent of Hif1 alpha expression. Additionally, CD44-ICD early responsive genes encode for critical enzymes in the glycolytic pathway, revealing how CD44 could be a gatekeeper of the Warburg effect (aerobic glycolysis) in cancer cells and possibly cancer stem cells. The link of CD44 to metabolism is novel and opens a new area of research not previously considered, particularly in the study of obesity and cancer. In summary, our results finally give a function to the CD44-ICD and will accelerate the study of the regulation of many CD44-dependent genes.	[Miletti-Gonzalez, Karl E.; Rodriguez-Rodriguez, Lorna] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Obstet & Gynecol & Reprod Sci, New Brunswick, NJ 08901 USA; [Miletti-Gonzalez, Karl E.; Murphy, Kyle; Kumaran, Muthu N.; Ravindranath, Abhilash K.; Wernyj, Roman P.; Kaur, Swayamjot; Rodriguez-Rodriguez, Lorna] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Gynecol Oncol, New Brunswick, NJ 08901 USA; [Chekmareva, Marina] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, New Brunswick, NJ 08901 USA; [Bandera, Elisa V.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Surg Oncol, New Brunswick, NJ 08901 USA; [Miletti-Gonzalez, Karl E.; Murphy, Kyle; Kumaran, Muthu N.; Ravindranath, Abhilash K.; Wernyj, Roman P.; Kaur, Swayamjot; Miles, Gregory D.; Lim, Elaine; Chan, Rigel; Foran, David; Chen, Wenjin; Reiss, Michael; Bandera, Elisa V.; Scotto, Kathleen; Rodriguez-Rodriguez, Lorna] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, New Brunswick, NJ 08901 USA; [Heller, Debra S.] Univ Med & Dent New Jersey, Dept Pathol & Lab Med, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center	Rodriguez-Rodriguez, L (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Obstet & Gynecol & Reprod Sci, New Brunswick, NJ 08901 USA.	rodriglo@umdnj.edu	Bandera, Elisa V/M-4169-2014; Lim, Elaine/H-9032-2016	Bandera, Elisa V/0000-0002-8789-2755; Heller, Debra/0000-0002-8378-4642; Reiss, Michael/0000-0001-8543-8092	National Institutes of Health [R01CA120429, R01CA156386, K22A138563]; Cancer Center Support Grant [P30-722720]; NATIONAL CANCER INSTITUTE [P30CA072720, R01CA120429, R01CA156386, K22CA138563] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by National Institutes of Health Grants R01CA120429 (to L. R. R.), R01CA156386 (to D. F.), and K22A138563 (to E. B.) and by Cancer Center Support Grant P30-722720 and its shared resources: Biospecimen Repository Service, Functional Genomics, Bioinformatics, and the Office of Human Research Services.	Abdraboh ME, 2011, AM J PATHOL, V179, P555, DOI 10.1016/j.ajpath.2011.04.042; Alaniz L, 2004, BIOCHEM BIOPH RES CO, V324, P736, DOI 10.1016/j.bbrc.2004.09.120; Bajorath J, 1998, J BIOL CHEM, V273, P338, DOI 10.1074/jbc.273.1.338; Bartrons R, 2007, J BIOENERG BIOMEMBR, V39, P223, DOI 10.1007/S10863-007-9080-3; Bourguignon LYW, 1997, J BIOL CHEM, V272, P27913, DOI 10.1074/jbc.272.44.27913; CANNISTRA SA, 1993, CANCER RES, V53, P3830; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Garbett EA, 2000, J CLIN PATHOL-MOL PA, V53, P99, DOI 10.1136/mp.53.2.99; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gorden DL, 2007, INT J CANCER, V121, P495, DOI 10.1002/ijc.22594; HodgeDufour J, 1997, J IMMUNOL, V159, P2492; Jinga DC, 2006, J CELL MOL MED, V10, P499, DOI 10.1111/j.1582-4934.2006.tb00415.x; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lakshman M, 2004, EXP MOL PATHOL, V76, P196, DOI 10.1016/j.yexmp.2003.12.009; Lammich S, 2002, J BIOL CHEM, V277, P44754, DOI 10.1074/jbc.M206872200; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Matou-Nasri S, 2009, INT J ONCOL, V35, P761, DOI 10.3892/ijo_00000389; Miletti-Gonzalez KE, 2005, CANCER RES, V65, P6660, DOI 10.1158/0008-5472.CAN-04-3478; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Muthukumaran N, 2006, MOL CANCER RES, V4, P511, DOI 10.1158/1541-7786.MCR-05-0232; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Okamoto I, 2002, AM J PATHOL, V160, P441, DOI 10.1016/S0002-9440(10)64863-8; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Pelletier L, 2006, CANCER RES, V66, P3681, DOI 10.1158/0008-5472.CAN-05-3870; Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005; Przybylowska K, 2004, J EXP CLIN CANC RES, V23, P121; Samanna V, 2007, J CELL PHYSIOL, V213, P710, DOI 10.1002/jcp.21137; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Sinnamon MJ, 2008, INT J EXP PATHOL, V89, P466, DOI 10.1111/j.1365-2613.2008.00621.x; Slomiany MG, 2009, CANCER RES, V69, P4992, DOI 10.1158/0008-5472.CAN-09-0143; Spessotto P, 2002, J CELL BIOL, V158, P1133, DOI 10.1083/jcb.200202120; Stevens JW, 1996, PROSTATE, V28, P153, DOI 10.1002/(SICI)1097-0045(199603)28:3<153::AID-PROS2>3.0.CO;2-G; Subramaniam V, 2007, EXP MOL PATHOL, V83, P207, DOI 10.1016/j.yexmp.2007.04.008; Sugahara KN, 2006, J BIOL CHEM, V281, P5861, DOI 10.1074/jbc.M506740200; Sugahara KN, 2003, J BIOL CHEM, V278, P32259, DOI 10.1074/jbc.M300347200; Takahashi K, 1999, INT J CANCER, V80, P387, DOI 10.1002/(SICI)1097-0215(19990129)80:3<387::AID-IJC9>3.3.CO;2-K; Tamada M, 2012, CANCER RES, V72, P1438, DOI 10.1158/0008-5472.CAN-11-3024; Tanimura S, 2003, BIOCHEM BIOPH RES CO, V304, P801, DOI 10.1016/S0006-291X(03)00670-3; Tzircotis G, 2005, J CELL SCI, V118, P5119, DOI 10.1242/jcs.02629; Vizoso FJ, 2007, BRIT J CANCER, V96, P903, DOI 10.1038/sj.bjc.6603666; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xie ZG, 2008, CANCER CHEMOTH PHARM, V62, P949, DOI 10.1007/s00280-008-0684-z; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yasuda M, 2001, INT IMMUNOL, V13, P1309, DOI 10.1093/intimm/13.10.1309; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Zhang LS, 2010, CELL PROLIFERAT, V43, P385, DOI 10.1111/j.1365-2184.2010.00689.x; Zhang YY, 2002, CANCER RES, V62, P3962; Zhao L, 2007, ARTERIOSCL THROM VAS, V27, P886, DOI 10.1161/01.ATV.0000259362.10882.c5	50	75	80	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					18995	19007		10.1074/jbc.M111.318774	http://dx.doi.org/10.1074/jbc.M111.318774			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22433859	Green Published, hybrid			2022-12-27	WOS:000306411900011
J	Chew, YC; Adhikary, G; Wilson, GM; Xu, W; Eckert, RL				Chew, Yap Ching; Adhikary, Gautam; Wilson, Gerald M.; Xu, Wen; Eckert, Richard L.			Sulforaphane Induction of p21(Cip1) Cyclin-dependent Kinase Inhibitor Expression Requires p53 and Sp1 Transcription Factors and Is p53-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; HISTONE DEACETYLASE INHIBITORS; CASPASE-MEDIATED APOPTOSIS; P21(WAF1/CIP1) EXPRESSION; EPITHELIAL-CELLS; SKIN CARCINOGENESIS; HUMAN KERATINOCYTES; SIGNALING PATHWAYS; PC-3 XENOGRAFTS; CARCINOMA CELLS	Sulforaphane (SFN) is an important cancer preventive agent derived from cruciferous vegetables. We show that SFN treatment suppresses normal human keratinocyte proliferation via a mechanism that involves increased expression of p21(Cip1). SFN treatment produces a concentration-dependent increase in p21(Cip1) promoter activity via a mechanism that involves stabilization of the p53 protein leading to increased p53 binding to the p21(Cip1) promoter p53 response elements. The proximal p21(Cip1) promoter GC-rich Sp1 factor binding elements are also required, as the SFN-dependent increase is lost when these sites are mutated. SFN treatment increases Sp1 binding to these elements, and the response is enhanced in the presence of exogenous Sp1 and reduced in the presence of Delta N-Sp3. CpG island methylation alters p21(Cip1) promoter activity some systems; however, expression in SFN-treated keratinocytes does not involve changes in proximal promoter methylation. The promoter is minimally methylated, and the methylation level is not altered by SFN treatment. This study indicates that SFN increases p21(Cip1) promoter transcription via a mechanism that involves SFN-dependent stabilization of p53 and increased p53 and Sp1 binding to their respective response elements in the p21(Cip1) promoter. These results are in marked contrast to the mechanisms observed in skin cancer cell lines and suggest that SFN may protect normal keratinocytes from damage while causing cancer cells to undergo apoptosis.	[Chew, Yap Ching; Adhikary, Gautam; Wilson, Gerald M.; Xu, Wen; Eckert, Richard L.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Obstet & Gynecol & Reprod Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Eckert, RL (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	reckert@umaryland.edu	Wilson, Gerald/AAF-3874-2019	Wilson, Gerald/0000-0002-1273-7507; Chew, Yap Ching/0000-0002-1686-6541	National Institutes of Health [R01 AR046494]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR046494 (to R. E.).	Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Adhikary G, 2005, INVEST OPHTH VIS SCI, V46, P3109, DOI 10.1167/iovs.05-0053; Ahmed NU, 1997, J CUTAN PATHOL, V24, P223, DOI 10.1111/j.1600-0560.1997.tb01585.x; Aliouat-Denis CM, 2005, MOL CANCER RES, V3, P627, DOI 10.1158/1541-7786.MCR-05-0121; Balasubramanian S, 2011, MOL PHARMACOL, V80, P870, DOI 10.1124/mol.111.072363; Banks EB, 1999, BIOCHEM J, V337, P507, DOI 10.1042/0264-6021:3370507; Banks EB, 1998, BIOCHEM J, V331, P61, DOI 10.1042/bj3310061; Bhamre S, 2009, PROSTATE, V69, P181, DOI 10.1002/pros.20869; Brooks CL, 2011, PROTEIN CELL, V2, P456, DOI 10.1007/s13238-011-1063-9; Charlot JF, 2006, APOPTOSIS, V11, P813, DOI 10.1007/s10495-006-5876-6; Chen MJ, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/415231; Cheng F, 2009, MOL BIOL CELL, V20, P319, DOI 10.1091/mbc.E08-07-0681; Chew YC, 2011, J BIOL CHEM, V286, P28772, DOI 10.1074/jbc.M110.205245; Cho SD, 2005, NUTR CANCER, V52, P213, DOI 10.1207/s15327914nc5202_11; Clarke JD, 2011, MOL NUTR FOOD RES, V55, P999, DOI 10.1002/mnfr.201000547; Dashwood RH, 2006, CARCINOGENESIS, V27, P344, DOI 10.1093/carcin/bgi253; Dashwood RH, 2007, SEMIN CANCER BIOL, V17, P363, DOI 10.1016/j.semcancer.2007.04.001; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Dinkova-Kostova AT, 2006, CANCER LETT, V240, P243, DOI 10.1016/j.canlet.2005.09.012; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Esposito F, 1997, EUR J BIOCHEM, V245, P730, DOI 10.1111/j.1432-1033.1997.00730.x; FRIED RM, 1988, ENDOCRINOLOGY, V122, P2467, DOI 10.1210/endo-122-6-2467; Gao XQ, 2001, P NATL ACAD SCI USA, V98, P15221, DOI 10.1073/pnas.261572998; Go JH, 2003, MODERN PATHOL, V16, P752, DOI 10.1097/01.MP.0000081728.21368.85; Gorospe M, 1999, GENE EXPRESSION, V7, P377; Hamsa TP, 2011, DRUG CHEM TOXICOL, V34, P332, DOI 10.3109/01480545.2010.538694; Hauser P, 2004, MOL CANCER RES, V2, P96; Helton ES, 2007, J CELL BIOCHEM, V100, P883, DOI 10.1002/jcb.21091; Herman-Antosiewicz A, 2007, MOL CANCER THER, V6, P1673, DOI 10.1158/1535-7163.MCT-06-0807; Ho E, 2009, J NUTR, V139, P2393, DOI 10.3945/jn.109.113332; Inohara S, 1996, BRIT J DERMATOL, V135, P717; Jakubikova J, 2005, BIOCHEM PHARMACOL, V69, P1543, DOI 10.1016/j.bcp.2005.03.015; Jeon YK, 2011, BBA-PROTEINS PROTEOM, V1814, P1340, DOI 10.1016/j.bbapap.2011.05.015; Kawamata N, 2005, EUR J HAEMATOL, V74, P424, DOI 10.1111/j.1600-0609.2005.00417.x; Kim JH, 2010, J CLIN BIOCHEM NUTR, V46, P60, DOI 10.3164/jcbn.09-65; Koutsodontis G, 2002, BIOCHEMISTRY-US, V41, P12771, DOI 10.1021/bi026141q; Kwak MK, 2010, TOXICOL APPL PHARM, V244, P66, DOI 10.1016/j.taap.2009.08.028; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Kwak MK, 2001, MUTAT RES-FUND MOL M, V480, P305, DOI 10.1016/S0027-5107(01)00190-7; Lee TH, 2000, ONCOGENE, V19, P3766, DOI 10.1038/sj.onc.1203715; Majid S, 2008, CANCER RES, V68, P2736, DOI 10.1158/0008-5472.CAN-07-2290; Mandal S, 2010, J CELL PHYSIOL, V224, P28, DOI 10.1002/jcp.22078; Matsuta M, 1997, J DERMATOL SCI, V14, P233, DOI 10.1016/S0923-1811(96)00579-8; McVean M, 2000, CARCINOGENESIS, V21, P633, DOI 10.1093/carcin/21.4.633; Meeran SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011457; Myzak MC, 2006, CARCINOGENESIS, V27, P811, DOI 10.1093/carcin/bgi265; Myzak MC, 2006, FASEB J, V20, P506, DOI 10.1096/fj.05-4785fje; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; Myzak MC, 2007, EXP BIOL MED, V232, P227; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; Ocker M, 2007, INT J BIOCHEM CELL B, V39, P1367, DOI 10.1016/j.biocel.2007.03.001; Okuyama R, 2004, J INVEST DERM SYMP P, V9, P248, DOI 10.1111/j.1087-0024.2004.09308.x; Park JW, 2001, BIOCHEM BIOPH RES CO, V280, P244, DOI 10.1006/bbrc.2000.4105; Prowse DM, 1997, J BIOL CHEM, V272, P1308, DOI 10.1074/jbc.272.2.1308; RENBAUM P, 1990, NUCLEIC ACIDS RES, V18, P1145, DOI 10.1093/nar/18.5.1145; Sakao K, 2012, J CELL BIOCHEM, V113, P599, DOI 10.1002/jcb.23386; Schavinsky-Khrapunsky Y, 2003, ONCOGENE, V22, P5315, DOI 10.1038/sj.onc.1206782; SCHWALLER J, 1995, J CLIN INVEST, V95, P973, DOI 10.1172/JCI117806; Shen GX, 2006, CANCER CHEMOTH PHARM, V57, P317, DOI 10.1007/s00280-005-0050-3; Shibata A, 2010, J NUTR BIOCHEM, V21, P702, DOI 10.1016/j.jnutbio.2009.04.007; Singh AV, 2004, CARCINOGENESIS, V25, P83, DOI 10.1093/carcin/bgg178; Traka M, 2005, J NUTR, V135, P1865, DOI 10.1093/jn/135.8.1865; UDVADIA AJ, 1995, P NATL ACAD SCI USA, V92, P3953, DOI 10.1073/pnas.92.9.3953; Wagner AE, 2010, EXP DERMATOL, V19, P137, DOI 10.1111/j.1600-0625.2009.00928.x; Weinberg WC, 1999, CANCER RES, V59, P2050; Wong PP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008369; Wu JH, 2004, ONCOGENE, V23, P8088, DOI 10.1038/sj.onc.1207996; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Xu CJ, 2006, CANCER RES, V66, P8293, DOI 10.1158/0008-5472.CAN-06-0300; Ying JM, 2004, BLOOD, V103, P743, DOI 10.1182/blood-2003-09-3193; Yokota T, 2004, ONCOGENE, V23, P5340, DOI 10.1038/sj.onc.1207689; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78; Zhu M, 2004, MOL CARCINOGEN, V41, P179, DOI 10.1002/mc.20052	76	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16168	16178		10.1074/jbc.M111.305292	http://dx.doi.org/10.1074/jbc.M111.305292			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22427654	Green Published, hybrid			2022-12-27	WOS:000304030900009
J	Gupta, S; Pawaria, S; Lu, C; Hade, MD; Singh, C; Yeh, SR; Dikshit, KL				Gupta, Sanjay; Pawaria, Sudesh; Lu, Changyuan; Hade, Mangesh Dattu; Singh, Chaahat; Yeh, Syun-Ru; Dikshit, Kanak L.			An Unconventional Hexacoordinated Flavohemoglobin from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-LACTATE DEHYDROGENASE; ESCHERICHIA-COLI FLAVOHEMOGLOBIN; RESONANCE RAMAN-SPECTROSCOPY; NITRIC-OXIDE; BACTERIAL HEMOGLOBINS; CAMPYLOBACTER-JEJUNI; NITROSATIVE STRESS; RESPIRATORY ENZYME; PURIFICATION; ADAPTATION	Being an obligate aerobe, Mycobacterium tuberculosis faces a number of energetic challenges when it encounters hypoxia and environmental stress during intracellular infection. Consequently, it has evolved innovative strategies to cope with these unfavorable conditions. Here, we report a novel flavohemoglobin (MtbFHb) from M. tuberculosis that exhibits unique features within its heme and reductase domains distinct from conventional FHbs, including the absence of the characteristic hydrogen bonding interactions within the proximal heme pocket and mutations in the FAD and NADH binding regions of the reductase domain. In contrast to conventional FHbs, it has a hexacoordinate low-spin heme with a proximal histidine ligand lacking imidazolate character and a distal heme pocket with a relatively low electrostatic potential. Additionally, MtbFHb carries a new FAD binding site in its reductase domain similar to that of D-lactate dehydrogenase (D-LDH). When overexpressed in Escherichia coli or Mycobacterium smegmatis, MtbFHb remained associated with the cell membrane and exhibited D-lactate: phenazine methosulfate reductase activity and oxidized D-lactate into pyruvate by converting the heme iron from Fe3+ to Fe2+ in a FAD-dependent manner, indicating electron transfer from D-lactate to the heme via FAD cofactor. Under oxidative stress, MtbFHb-expressing cells exhibited growth advantage with reduced levels of lipid peroxidation. Given the fact that D-lactate is a byproduct of lipid peroxidation and that M. tuberculosis lacks the gene encoding D-LDH, we propose that the novel D-lactate metabolizing activity of MtbFHb uniquely equips M. tuberculosis to balance the stress level by protecting the cell membrane from oxidative damage via cycling between the Fe3+/Fe2+ redox states.	[Gupta, Sanjay; Pawaria, Sudesh; Hade, Mangesh Dattu; Singh, Chaahat; Dikshit, Kanak L.] CSIR, Inst Microbial Technol, Chandigarh 160036, India; [Lu, Changyuan; Yeh, Syun-Ru] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Yeshiva University; Albert Einstein College of Medicine	Dikshit, KL (corresponding author), CSIR, Inst Microbial Technol, Sect 39 A, Chandigarh 160036, India.	kanak@imtech.res.in	Hade, Mangesh/AAF-7217-2019; Hade, Mangesh/ABD-8535-2021	Hade, Mangesh/0000-0002-5937-9049; Yeh, Syun-Ru/0000-0002-9858-386X	Council of Scientific and Industrial Research [SIP-10]; National Science Foundation [0956358]; DST; Council of Scientific & Industrial Research, India	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); National Science Foundation(National Science Foundation (NSF)); DST(Department of Science & Technology (India)); Council of Scientific & Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Council of Scientific and Industrial Research under Supra institutional project SIP-10 (to K. L. D.) and National Science Foundation Grant 0956358 (to S.-R. Y.).; Supported by DST.; Supported by the Council of Scientific & Industrial Research, India.	Ali MA, 2000, FREE RADICAL RES, V32, P429, DOI 10.1080/10715760000300431; Anaraku Y., 1987, TRENDS BIOCHEM SCI, V12, P262; Appleby C A, 1978, Methods Enzymol, V52, P157; Bentrup KHZ, 2001, TRENDS MICROBIOL, V9, P597, DOI 10.1016/S0966-842X(01)02238-7; Berney M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008614; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonamore A, 2003, J BIOL CHEM, V278, P22272, DOI 10.1074/jbc.M301285200; Bonamore A, 2008, IUBMB LIFE, V60, P19, DOI 10.1002/iub.9; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; D'Angelo P, 2004, BIOPHYS J, V86, P3882, DOI 10.1529/biophysj.103.034876; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Dym O, 2000, P NATL ACAD SCI USA, V97, P9413, DOI 10.1073/pnas.97.17.9413; Egawa T, 2005, J INORG BIOCHEM, V99, P72, DOI 10.1016/j.jinorgbio.2004.10.017; Frey AD, 2002, APPL ENVIRON MICROB, V68, P4835, DOI 10.1128/AEM.68.10.4835-4840.2002; Frey AD, 2003, FEMS MICROBIOL REV, V27, P525, DOI 10.1016/S0168-6445(03)00056-1; FUTAI M, 1977, J BIOL CHEM, V252, P5820; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; GEORGE KM, 1995, J BIOL CHEM, V270, P27292, DOI 10.1074/jbc.270.45.27292; Gupta S, 2011, IUBMB LIFE, V63, P337, DOI 10.1002/iub.460; Hausladen A, 1998, P NATL ACAD SCI USA, V95, P14100, DOI 10.1073/pnas.95.24.14100; Horikiri S, 2004, BIOSCI BIOTECH BIOCH, V68, P516, DOI 10.1271/bbb.68.516; Hunte C, 2005, BIOCHEM SOC T, V33, P938, DOI 10.1042/BST0330938; Jackson M, 2007, TUBERCULOSIS, V87, P78, DOI 10.1016/j.tube.2006.05.003; JAHNKE LL, 1986, J BACTERIOL, V167, P238, DOI 10.1128/jb.167.1.238-242.1986; Kimura S, 2001, J BIOCHEM, V130, P481, DOI 10.1093/oxfordjournals.jbchem.a003010; Lewis JA, 2006, J BACTERIOL, V188, P5479, DOI 10.1128/JB.00514-06; Lu CY, 2008, METHOD ENZYMOL, V437, P255, DOI 10.1016/S0076-6879(07)37014-6; Manjunatha Ujjini, 2009, Commun Integr Biol, V2, P215; MARKWELL JP, 1978, J BACTERIOL, V133, P593, DOI 10.1128/JB.133.2.593-600.1978; Megehee JA, 2006, MICROBIOL-SGM, V152, P823, DOI 10.1099/mic.0.28723-0; Membrillo-Hernandez J, 1999, J BIOL CHEM, V274, P748, DOI 10.1074/jbc.274.2.748; Mowat CG, 2010, ARCH BIOCHEM BIOPHYS, V493, P37, DOI 10.1016/j.abb.2009.10.005; Mukai M, 2001, J BIOL CHEM, V276, P7272, DOI 10.1074/jbc.M009280200; OLSON ST, 1979, BIOCHEMISTRY-US, V18, P4714, DOI 10.1021/bi00588a036; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Pathania R, 2002, J BIOL CHEM, V277, P15293, DOI 10.1074/jbc.M111478200; Pathania R, 2002, MOL MICROBIOL, V45, P1303, DOI 10.1046/j.1365-2958.2002.03095.x; Pawaria S, 2008, APPL ENVIRON MICROB, V74, P3512, DOI 10.1128/AEM.02663-07; Pinchuk GE, 2009, P NATL ACAD SCI USA, V106, P2874, DOI 10.1073/pnas.0806798106; Rachman H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000029; Rinaldi AC, 2006, BIOCHEMISTRY-US, V45, P4069, DOI 10.1021/bi052277n; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schwab U, 2009, MICROB PATHOGENESIS, V46, P185, DOI 10.1016/j.micpath.2008.12.006; Singh R, 2004, J BIOL CHEM, V279, P43098, DOI 10.1074/jbc.M406374200; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Thomas MT, 2011, ENVIRON MICROBIOL, V13, P48, DOI 10.1111/j.1462-2920.2010.02307.x; ThonyMeyer L, 1997, MICROBIOL MOL BIOL R, V61, P337; Tischler AD, 2010, CURR OPIN MICROBIOL, V13, P93, DOI 10.1016/j.mib.2009.12.007; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Zahrt TC, 2002, ANTIOXID REDOX SIGN, V4, P141, DOI 10.1089/152308602753625924; Zhou SM, 2009, BIOCHEM BIOPH RES CO, V381, P7, DOI 10.1016/j.bbrc.2009.01.112	52	10	11	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16435	16446		10.1074/jbc.M111.329920	http://dx.doi.org/10.1074/jbc.M111.329920			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22437825	hybrid, Green Published			2022-12-27	WOS:000304030900034
J	Koles, K; Nunnari, J; Korkut, C; Barria, R; Brewer, C; Li, YH; Leszyk, J; Zhang, B; Budnik, V				Koles, Kate; Nunnari, John; Korkut, Ceren; Barria, Romina; Brewer, Cassandra; Li, Yihang; Leszyk, John; Zhang, Bing; Budnik, Vivian			Mechanism of Evenness Interrupted (Evi)-Exosome Release at Synaptic Boutons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN-V; DROSOPHILA PHOTORECEPTORS; MULTIVESICULAR ENDOSOMES; GENE-EXPRESSION; NERVOUS WRECK; B-LYMPHOCYTES; RAB GTPASES; T-CELLS; EXOSOMES; PROTEIN	Wnt signaling plays critical roles during synaptic development and plasticity. However, the mechanisms by which Wnts are released and travel to target cells are unresolved. During synaptic development, the secretion of Drosophila Wnt1, Wingless, requires the function of Evenness Interrupted (Evi)/Wls, a Wingless-binding protein that is secreted along with Wingless at the neuromuscular junction. Given that Evi is a transmembrane protein, these studies suggested the presence of a novel vesicular mechanism of trans-synaptic communication, potentially in the form of exosomes. To establish the mechanisms for the release of Evi vesicles, we used a dsRNA assay in cultured cells to screen for genes that when down-regulated prevent the release of Evi vesicles. We identified two proteins, Rab11 and Syntaxin 1A (Syx1A), that were required for Evi vesicle release. To determine whether the same mechanisms were used in vivo at the neuromuscular junction, we altered the activity of Rab11 and Syx1A in motoneurons and determined the impact on Evi release. We found that Syx1A, Rab11, and its effector Myosin5 were required for proper Evi vesicle release. Furthermore, ultrastructural analysis of synaptic boutons demonstrated the presence of multivesicular bodies, organelles involved in the production and release of exosomes, and these multivesicular bodies contained Evi. We also used mass spectrometry, electron microscopy, and biochemical techniques to characterize the exosome fraction from cultured cells. Our studies revealed that secreted Evi vesicles show remarkable conservation with exosomes in other systems. In summary, our observations unravel some of the in vivo mechanisms required for Evi vesicle release.	[Koles, Kate; Nunnari, John; Korkut, Ceren; Barria, Romina; Brewer, Cassandra; Li, Yihang; Budnik, Vivian] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Leszyk, John] Univ Massachusetts, Sch Med, Prote Core, Worcester, MA 01605 USA; [Zhang, Bing] Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Oklahoma System; University of Oklahoma - Norman	Koles, K (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	kate.koles@umassmed.edu; Vivian.budnik@umassmed.edu		Tezer, Ceren/0000-0001-9276-3264	National Institutes of Health [R01 MH0700000, R01 NS06878]; Mizutani Foundation [090054]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mizutani Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 MH0700000 (to V. B.) and Grant R01 NS06878 (to the B. Z. laboratory). This work was also supported by Mizutani Foundation Grant 090054 (to K. K.).	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Aline F, 2004, INFECT IMMUN, V72, P4127, DOI 10.1128/IAI.72.7.4127-4137.2004; Babst M, 2011, CURR OPIN CELL BIOL, V23, P452, DOI 10.1016/j.ceb.2011.04.008; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Bhattacharya S, 2002, P NATL ACAD SCI USA, V99, P13867, DOI 10.1073/pnas.202335999; BRAND AH, 1993, DEVELOPMENT, V118, P401; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Chan CC, 2011, CURR BIOL, V21, P1704, DOI 10.1016/j.cub.2011.08.058; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Desnos C, 2007, BIOL CELL, V99, P411, DOI 10.1042/BC20070021; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Graf ER, 2009, NEURON, V64, P663, DOI 10.1016/j.neuron.2009.11.002; Harden N, 1996, MOL CELL BIOL, V16, P1896; Hawari FI, 2004, P NATL ACAD SCI USA, V101, P1297, DOI 10.1073/pnas.0307981100; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Hwang I, 2011, FRONT BIOSCI-LANDMRK, V16, P411, DOI 10.2741/3695; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; Johnstone RM, 2005, BLOOD CELL MOL DIS, V34, P214, DOI 10.1016/j.bcmd.2005.03.002; Khodosh R, 2006, DEVELOPMENT, V133, P4655, DOI 10.1242/dev.02650; Koles K, 2004, J BIOL CHEM, V279, P4346, DOI 10.1074/jbc.M309912200; Kolotuev I, 2009, TRAFFIC, V10, P803, DOI [10.1111/j.1600-0854.2009.00871.x, 10.1111/j.1600-0854.2008.00871.x]; Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Lachenal G, 2011, MOL CELL NEUROSCI, V46, P409, DOI 10.1016/j.mcn.2010.11.004; Lagow RD, 2007, PLOS BIOL, V5, P800, DOI 10.1371/journal.pbio.0050072; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Li BX, 2007, J CELL BIOL, V177, P659, DOI 10.1083/jcb.200610157; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubec G, 2007, CHEM REV, V107, P3568, DOI 10.1021/cr068213f; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Nolte-'t Hoen ENM, 2009, BLOOD, V113, P1977, DOI 10.1182/blood-2008-08-174094; O'Connor-Giles KM, 2008, NEURON, V58, P507, DOI 10.1016/j.neuron.2008.03.007; O'Connor-Giles KM, 2008, FLY, V2, DOI 10.4161/fly.7133; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Perrimon N, 1996, GENETICS, V144, P1681; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rodal AA, 2008, J NEUROSCI, V28, P8316, DOI 10.1523/JNEUROSCI.2304-08.2008; Rohn JL, 2011, J CELL BIOL, V194, P789, DOI 10.1083/jcb.201103168; Roland JT, 2011, P NATL ACAD SCI USA, V108, P2789, DOI 10.1073/pnas.1010754108; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Sathyanarayanan S, 2008, GENE DEV, V22, P1522, DOI 10.1101/gad.1652308; Satoh AK, 2005, DEVELOPMENT, V132, P1487, DOI 10.1242/dev.01704; Savina A, 2005, TRAFFIC, V6, P131, DOI 10.1111/j.1600-0854.2004.00257.x; Schluter OM, 2006, J NEUROSCI, V26, P1239, DOI 10.1523/JNEUROSCI.3553-05.2006; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657; Tamai K, 2010, BIOCHEM BIOPH RES CO, V399, P384, DOI 10.1016/j.bbrc.2010.07.083; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; Tsuda M, 2006, FEBS LETT, V580, P3296, DOI 10.1016/j.febslet.2006.05.005; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Watanabe M, 2005, MOL BIOL CELL, V16, P4519, DOI 10.1091/mbc.E05-03-0252; Wendler F, 2010, EMBO J, V29, P304, DOI 10.1038/emboj.2009.350; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Wu CC, 2004, MOL BIOL CELL, V15, P2907, DOI 10.1091/mbc.E04-02-0101; Yates JR, 2005, NAT REV MOL CELL BIO, V6, P702, DOI 10.1038/nrm1711; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761	72	187	194	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16820	16834		10.1074/jbc.M112.342667	http://dx.doi.org/10.1074/jbc.M112.342667			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22437826	Green Published, hybrid			2022-12-27	WOS:000304030900069
J	Marchant, J; Cowper, B; Liu, Y; Lai, L; Pinzan, C; Marq, JB; Friedrich, N; Sawmynaden, K; Liew, L; Chai, WG; Childs, RA; Saouros, S; Simpson, P; Barreira, MCR; Feizi, T; Soldati-Favre, D; Matthews, S				Marchant, Jan; Cowper, Ben; Liu, Yan; Lai, Livia; Pinzan, Camila; Marq, Jean Baptiste; Friedrich, Nikolas; Sawmynaden, Kovilen; Liew, Lloyd; Chai, Wengang; Childs, Robert A.; Saouros, Savvas; Simpson, Peter; Roque Barreira, Maria Cristina; Feizi, Ten; Soldati-Favre, Dominique; Matthews, Stephen			Galactose Recognition by the Apicomplexan Parasite Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST-CELL INVASION; NEOSPORA-CANINUM; MICRONEMAL PROTEINS; CRYSTAL-STRUCTURES; PLASMA-MEMBRANE; GM1 GANGLIOSIDE; BINDING LECTIN; APPLE DOMAINS; IDENTIFICATION; OLIGOSACCHARIDE	Toxosplasma gondii is the model parasite of the phylum Apicomplexa, which contains numerous obligate intracellular parasites of medical and veterinary importance, including Eimeria, Sarcocystis, Cryptosporidium, Cyclospora, and Plasmodium species. Members of this phylum actively enter host cells by a multistep process with the help of microneme protein (MIC) complexes that play important roles in motility, host cell attachment, moving junction formation, and invasion. T. gondii (Tg)MIC1-4-6 complex is the most extensively investigated microneme complex, which contributes to host cell recognition and attachment via the action of TgMIC1, a sialic acid-binding adhesin. Here, we report the structure of TgMIC4 and reveal its carbohydrate-binding specificity to a variety of galactose-containing carbohydrate ligands. The lectin is composed of six apple domains in which the fifth domain displays a potent galactose-binding activity, and which is cleaved from the complex during parasite invasion. We propose that galactose recognition by TgMIC4 may compromise host protection from galectin-mediated activation of the host immune system.	[Marchant, Jan; Cowper, Ben; Lai, Livia; Liew, Lloyd; Saouros, Savvas; Simpson, Peter; Matthews, Stephen] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Liu, Yan; Chai, Wengang; Childs, Robert A.; Feizi, Ten] Univ London Imperial Coll Sci Technol & Med, Dept Med, Glycosci Lab, London W12 0NN, England; [Pinzan, Camila; Roque Barreira, Maria Cristina] Univ Sao Paulo, Dept Biol Celular & Mol & Bioagentes Patogen, BR-14049900 Sao Paulo, Brazil; [Marq, Jean Baptiste; Friedrich, Nikolas; Soldati-Favre, Dominique] Univ Geneva CMU, Fac Med, Dept Genet & Microbiol, CH-1211 Geneva 4, Switzerland; [Sawmynaden, Kovilen] Natl Inst Med Res, London NW7 1AA, England	Imperial College London; Imperial College London; Universidade de Sao Paulo; University of Geneva; MRC National Institute for Medical Research	Matthews, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, S Kensington Campus, London SW7 2AZ, England.	s.j.matthews@imperial.ac.uk	Pinzan, Camila Figueiredo/C-2470-2015; Liu, Yan/D-9117-2013; Roque-Barreira, Maria-Cristina/A-4552-2008	Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; Matthews, Steve/0000-0003-0676-0927; Simpson, Pete/0000-0002-2679-9303; Liu, Yan/0000-0002-2566-6867; Feizi, Ten/0000-0001-6495-0329; Friedrich, Nikolas/0000-0003-0694-657X	Medical Research Council [G0800038, G9601454]; Swiss National Foundation UK Research Councils' Basic Technology Initiative; EPSRC [GRS/79268, EP/G037604/1]; European Union; MRC [G9601454, G0800038] Funding Source: UKRI; Engineering and Physical Sciences Research Council [GR/S79268/02, EP/G037604/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Foundation UK Research Councils' Basic Technology Initiative; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Medical Research Council Grants G0800038 (to S. J. M.) and G9601454 (to T. F.), Swiss National Foundation UK Research Councils' Basic Technology Initiative "Glycoarrays," and EPSRC Translational Grants GRS/79268 and EP/G037604/1(to T. F.).; Supported by European Union FP6 program BioMalPar.	Bhat N, 2007, J BIOL CHEM, V282, P34877, DOI 10.1074/jbc.M706950200; Blumenschein TMA, 2007, EMBO J, V26, P2808, DOI 10.1038/sj.emboj.7601704; Brecht S, 2001, J BIOL CHEM, V276, P4119, DOI 10.1074/jbc.M008294200; Brown Philip J., 2003, Journal of Structural and Functional Genomics, V4, P227, DOI 10.1023/B:JSFG.0000016118.87333.03; Campanero-Rhodes MA, 2007, J VIROL, V81, P12846, DOI 10.1128/JVI.01311-07; Carruthers VB, 2002, ACTA TROP, V81, P111, DOI 10.1016/S0001-706X(01)00201-7; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; Cerede O, 2005, J EXP MED, V201, P453, DOI 10.1084/jem.20041672; Chen ZQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003611; Coley AM, 2007, PLOS PATHOG, V3, P1827; Debierre-Grockiego F, 2010, J BIOL CHEM, V285, P32744, DOI 10.1074/jbc.M110.137588; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DOLAN SA, 1990, J CLIN INVEST, V86, P618, DOI 10.1172/JCI114753; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eswar N., 2001, CURRENT PROTOCOLS PR, P1; Feizi T, 2004, NAT REV MOL CELL BIO, V5, P582, DOI 10.1038/nrm1428; Ferguson DJP, 2000, INT J PARASITOL, V30, P1203, DOI 10.1016/S0020-7519(00)00096-5; Fielding L, 2007, PROG NUCL MAG RES SP, V51, P219, DOI 10.1016/j.pnmrs.2007.04.001; Frederick JR, 2005, GLYCOBIOLOGY, V15, p53R, DOI 10.1093/glycob/cwj007; Friedrich N, 2010, J BIOL CHEM, V285, P2064, DOI 10.1074/jbc.M109.060988; Garnett JA, 2009, PROTEIN SCI, V18, P1935, DOI 10.1002/pro.204; Gronwald W, 2008, J MOL BIOL, V381, P913, DOI 10.1016/j.jmb.2008.06.034; Hettmann C, 2000, MOL BIOL CELL, V11, P1385, DOI 10.1091/mbc.11.4.1385; Hill D, 2002, CLIN MICROBIOL INFEC, V8, P634, DOI 10.1046/j.1469-0691.2002.00485.x; Holmner A, 2011, J MOL BIOL, V406, P387, DOI 10.1016/j.jmb.2010.11.060; Keller N, 2004, INFECT IMMUN, V72, P4791, DOI 10.1128/IAI.72.8.4791-4800.2004; Keller N, 2002, INFECT IMMUN, V70, P3187, DOI 10.1128/IAI.70.6.3187-3198.2002; Lagal V, 2010, CELL MICROBIOL, V12, P1792, DOI 10.1111/j.1462-5822.2010.01509.x; Lietha D, 2001, EMBO J, V20, P5543, DOI 10.1093/emboj/20.20.5543; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Liu Y, 2007, CHEM BIOL, V14, P847, DOI 10.1016/j.chembiol.2007.06.009; Long J, 2010, J MOL BIOL, V396, P178, DOI 10.1016/j.jmb.2009.11.032; Lourenco EV, 2001, GLYCOBIOLOGY, V11, P541, DOI 10.1093/glycob/11.7.541; Marchant J, 2008, BIOMOL NMR ASSIGN, V2, P119, DOI 10.1007/s12104-008-9100-1; Matta-Camacho E, 2009, J MOL BIOL, V386, P569, DOI 10.1016/j.jmb.2008.09.086; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Muller JJ, 2001, ACTA CRYSTALLOGR D, V57, P1042, DOI 10.1107/S0907444901007284; Neu U, 2008, P NATL ACAD SCI USA, V105, P5219, DOI 10.1073/pnas.0710301105; Nudelman I, 2010, BIOCHEMISTRY-US, V49, P5117, DOI 10.1021/bi100041f; Palma AS, 2011, BIOCHEM BIOPH RES CO, V408, P548, DOI 10.1016/j.bbrc.2011.04.055; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; Papagrigoriou E, 2006, NAT STRUCT MOL BIOL, V13, P557, DOI 10.1038/nsmb1095; Periz J, 2007, J BIOL CHEM, V282, P16891, DOI 10.1074/jbc.M702407200; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Reiss M, 2001, J CELL BIOL, V152, P563, DOI 10.1083/jcb.152.3.563; RICHARDS FO, 1995, CLIN INFECT DIS, V21, pS49, DOI 10.1093/clinids/21.Supplement_1.S49; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rothova Aniki, 2003, Curr Opin Ophthalmol, V14, P384, DOI 10.1097/00055735-200312000-00011; Saouros S, 2007, PROTEIN PEPTIDE LETT, V14, P411, DOI 10.2174/092986607780782876; Saouros S, 2005, J BIOL CHEM, V280, P38583, DOI 10.1074/jbc.C500365200; Sawmynaden K, 2008, EMBO REP, V9, P1149, DOI 10.1038/embor.2008.179; Sell M, 2005, CLIN NEUROPATHOL, V24, P106; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sibley LD, 2011, IMMUNOL REV, V240, P72, DOI 10.1111/j.1600-065X.2010.00990.x; Silber AM, 2002, EXP PARASITOL, V100, P217, DOI 10.1016/S0014-4894(02)00013-9; Soldati-Favre D, 2008, PARASITE, V15, P197, DOI 10.1051/parasite/2008153197; Srinivasan S, 2007, J PARASITOL, V93, P1046, DOI 10.1645/GE-1181R1.1; SussToby E, 1996, P NATL ACAD SCI USA, V93, P8413, DOI 10.1073/pnas.93.16.8413; Vaillant V, 2005, FOODBORNE PATHOG DIS, V2, P221, DOI 10.1089/fpd.2005.2.221; Yoshida H, 2010, J BIOL CHEM, V285, P36969, DOI 10.1074/jbc.M110.163402; Young AR, 2002, GLYCOCONJUGATE J, V19, P601, DOI 10.1023/B:GLYC.0000014091.00844.0a	61	39	45	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16720	16733		10.1074/jbc.M111.325928	http://dx.doi.org/10.1074/jbc.M111.325928			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22399295	hybrid, Green Published			2022-12-27	WOS:000304030900060
J	Saito, M; Mylvaganum, M; Tam, P; Novak, A; Binnington, B; Lingwood, C				Saito, Mitsumasa; Mylvaganum, Murugespillai; Tam, Patty; Novak, Anton; Binnington, Beth; Lingwood, Clifford			Structure-dependent Pseudoreceptor Intracellular Traffic of Adamantyl Globotriaosyl Ceramide Mimics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; SHIGA-LIKE TOXIN; CHOLERA-TOXIN; RECEPTOR FUNCTION; RETROGRADE TRANSPORT; GLYCOLIPID RECEPTOR; B-SUBUNIT; VEROTOXIN BINDING; GOLGI-APPARATUS; LIPID RAFTS	The verotoxin (VT) (Shiga toxin) receptor globotriaosyl ceramide (Gb(3)), mediates VT1/VT2 retrograde transport to the endoplasmic reticulum (ER) for cytosolic A subunit access to inhibit protein synthesis. Adamantyl Gb(3) is an amphipathic competitive inhibitor of VT1/VT2 Gb(3) binding. However, Gb(3)-negative VT-resistant CHO/Jurkat cells incorporate adaGb(3) to become VT1/VT2 sensitive. CarboxyadaGb(3), urea-adaGb(3), and hydroxyethyl adaGb(3), preferentially bound by VT2, also mediate VT1/VT2 cytotoxicity. VT1/VT2 internalize to early endosomes but not to Golgi/ER. AdabisGb(3) (two deacyl Gb(3)s linked to adamantane) protects against VT1/VT2 more effectively than adaGb(3) without incorporating into Gb(3)-negative cells. AdaGb(3) (but not hydroxyethyl adaGb(3)) incorporation into Gb(3)-positive Vero cells rendered punctate cell surface VT1/VT2 binding uniform and subverted subsequent Gb(3)-dependent retrograde transport to Golgi/ER to render cytotoxicity (reduced for VT1 but not VT2) brefeldin A-resistant. VT2-induced vacuolation was maintained in adaGb(3)-treated Vero cells, but vacuolar membrane VT2 was lost. AdaGb(3) destabilized membrane cholesterol and reduced Gb(3) cholesterol stabilization in phospholipid liposomes. Cholera toxin GM1-mediated Golgi/ER targeting was unaffected by adaGb(3). We demonstrate the novel, lipid-dependent, pseudoreceptor function of Gb(3) mimics and their structure-dependent modulation of endogenous intracellular Gb(3) vesicular traffic.	[Saito, Mitsumasa; Mylvaganum, Murugespillai; Novak, Anton; Binnington, Beth; Lingwood, Clifford] Hosp Sick Children, Res Inst, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Tam, Patty; Lingwood, Clifford] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A1, Canada; [Tam, Patty; Lingwood, Clifford] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Lingwood, C (corresponding author), Hosp Sick Children, Res Inst, Clifford Lingwood Mol Struct & Funct Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	msaito@bact.med.kyushu-u.ac.jp; cling@sickkids.on.ca			Canadian Institutes of Health Research [MT 13747]; Ontario HIV Treatment Network; Canfar	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network; Canfar	This work was supported by Canadian Institutes of Health Research Grant MT 13747 and grants from Ontario HIV Treatment Network and Canfar.	Amessou M, 2008, BIOCONJUGATE CHEM, V19, P532, DOI 10.1021/bc7003999; Arab S, 1999, ONCOL RES, V11, P33; Arab S, 1996, GLYCOCONJUGATE J, V13, P159, DOI 10.1007/BF00731490; Bacia K, 2005, P NATL ACAD SCI USA, V102, P3272, DOI 10.1073/pnas.0408215102; Badizadegan K, 2004, AM J PHYSIOL-CELL PH, V287, pC1453, DOI 10.1152/ajpcell.00189.2004; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; BOYD B, 1994, EUR J BIOCHEM, V223, P873, DOI 10.1111/j.1432-1033.1994.tb19064.x; CALANDER N, 1988, BIOCHIMIE, V70, P1673, DOI 10.1016/0300-9084(88)90302-1; Chark D, 2004, EUR J BIOCHEM, V271, P405, DOI 10.1046/j.1432-1033.2003.03941.x; Devenica D, 2011, MED ONCOL, V28, pS675, DOI 10.1007/s12032-010-9732-8; Falguieres T, 2001, MOL BIOL CELL, V12, P2453, DOI 10.1091/mbc.12.8.2453; Falguieres T, 2008, MOL CANCER THER, V7, P2498, DOI 10.1158/1535-7163.MCT-08-0430; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Fritz VMR, 1997, BBA-GENE STRUCT EXPR, V1354, P153, DOI 10.1016/S0167-4781(97)00117-6; Goldwater PN, 2007, EXPERT REV ANTI-INFE, V5, P653, DOI 10.1586/14787210.5.4.653; Hall A, 2010, J PHYS CHEM B, V114, P7797, DOI 10.1021/jp912175d; Halling KK, 2008, BIOPHYS J, V95, P3861, DOI 10.1529/biophysj.108.133744; Heath-Engel Hannah M., 2003, Angiogenesis, V6, P129, DOI 10.1023/B:AGEN.0000011799.47529.fd; Hoey DEE, 2003, CELL MICROBIOL, V5, P85, DOI 10.1046/j.1462-5822.2003.00254.x; Hooper NM, 1999, MOL MEMBR BIOL, V16, P145, DOI 10.1080/096876899294607; Johannes L, 2003, TRAFFIC, V4, P323, DOI 10.1034/j.1600-0854.2003.00089.x; Johansson D., 2009, BMC CANCER, V9, P67; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kamani M, 2011, J BIOL CHEM, V286, P21413, DOI 10.1074/jbc.M110.207670; Karch H, 2006, SEMIN THROMB HEMOST, V32, P105, DOI 10.1055/s-2006-939766; Karmali MA, 2010, VET MICROBIOL, V140, P360, DOI 10.1016/j.vetmic.2009.04.011; Kawano K, 2008, EUR J CLIN MICROBIOL, V27, P227, DOI 10.1007/s10096-007-0420-3; Khan F, 2009, KIDNEY INT, V75, P1209, DOI 10.1038/ki.2009.7; Khine AA, 2004, GLYCOBIOLOGY, V14, P701, DOI 10.1093/glycob/cwh085; KIARASH A, 1994, J BIOL CHEM, V269, P11138; Kitov PI, 2008, P NATL ACAD SCI USA, V105, P16837, DOI 10.1073/pnas.0804919105; Kitov PI, 2000, NATURE, V403, P669, DOI 10.1038/35001095; LaCasse EC, 1999, BLOOD, V94, P2901; Lauvrak SU, 2004, J CELL SCI, V117, P2321, DOI 10.1242/jcs.01081; Le PU, 2003, J CELL SCI, V116, P1059, DOI 10.1242/jcs.00327; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Lingwood CA, 2010, FEBS LETT, V584, P1879, DOI 10.1016/j.febslet.2009.11.089; Lingwood CA, 1996, GLYCOCONJUGATE J, V13, P495, DOI 10.1007/BF00731435; Lingwood Clifford, 2006, V347, P305; Lingwood CA, 2010, CHEM PHYS LIPIDS, V163, P27, DOI 10.1016/j.chemphyslip.2009.09.001; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Lingwood D, 2011, NAT CHEM BIOL, V7, P260, DOI 10.1038/nchembio.551; Lund N, 2009, BLOOD, V113, P4980, DOI 10.1182/blood-2008-03-143396; Mahfoud R, 2002, J LIPID RES, V43, P1670, DOI 10.1194/jlr.M200165-JLR200; Mahfoud R, 2010, J BIOL CHEM, V285, P36049, DOI 10.1074/jbc.M110.110189; Mahfoud R, 2009, J LIPID RES, V50, P1744, DOI 10.1194/jlr.M800385-JLR200; Majoul I, 2002, J CELL SCI, V115, P817; MANGENEY M, 1991, EUR J IMMUNOL, V21, P1131, DOI 10.1002/eji.1830210507; McKenzie J, 2009, FEBS J, V276, P1581, DOI 10.1111/j.1742-4658.2009.06890.x; Muthing J, 2009, THROMB HAEMOSTASIS, V101, P252, DOI 10.1160/TH08-05-0317; Mylvaganam M, 1999, BIOCHEM BIOPH RES CO, V257, P391, DOI 10.1006/bbrc.1999.0474; Mylvaganam M., 2003, CARBOHYDRATE BASED D, P761; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nishikawa K, 2005, J INFECT DIS, V191, P2097, DOI 10.1086/430388; Niu SL, 2002, BIOPHYS J, V83, P3408, DOI 10.1016/S0006-3495(02)75340-X; NYHOLM PG, 1993, BIOCHEMISTRY-US, V32, P1225, DOI 10.1021/bi00056a005; Nyholm PG, 1996, CHEM BIOL, V3, P263, DOI 10.1016/S1074-5521(96)90106-4; OBRIEN AD, 1992, CURR TOP MICROBIOL, V180, P65; Okuda T, 2006, J BIOL CHEM, V281, P10230, DOI 10.1074/jbc.M600057200; Pagano RE, 2000, METHOD ENZYMOL, V312, P523; Pagano RE, 2000, TRAFFIC, V1, P807, DOI 10.1034/j.1600-0854.2000.011101.x; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; PETRIC M, 1987, FEMS MICROBIOL LETT, V41, P63; Puri V, 1999, NAT CELL BIOL, V1, P386, DOI 10.1038/14084; RICHARDSON SE, 1988, HUM PATHOL, V19, P1102, DOI 10.1016/S0046-8177(88)80093-5; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rutjes NWP, 2002, KIDNEY INT, V62, P832, DOI 10.1046/j.1523-1755.2002.00502.x; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Salhia B, 2002, NEOPLASIA, V4, P304, DOI 10.1038/sj.neo.7900243; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; Sandvig K, 2002, FEBS LETT, V529, P49, DOI 10.1016/S0014-5793(02)03182-4; SANDVIG K, 1989, J CELL BIOL, V108, P1331, DOI 10.1083/jcb.108.4.1331; SANDVIG K, 1994, FEBS LETT, V346, P99, DOI 10.1016/0014-5793(94)00281-9; Sandvig K, 2010, TOXICON, V56, P1181, DOI 10.1016/j.toxicon.2009.11.021; Schapiro FB, 1998, AM J PHYSIOL-CELL PH, V274, pC319, DOI 10.1152/ajpcell.1998.274.2.C319; Schwarzmann G, 2001, SEMIN CELL DEV BIOL, V12, P163, DOI 10.1006/scdb.2000.0233; Sillence DJ, 2002, J LIPID RES, V43, P1837, DOI 10.1194/jlr.M200232-JLR200; Smith DC, 2006, MOL BIOL CELL, V17, P1375, DOI 10.1091/mbc.e05-11-1035; Soltyk AM, 2002, J BIOL CHEM, V277, P5351, DOI 10.1074/jbc.M107472200; Spillsberg B, 2003, TRAFFIC, V4, P544, DOI 10.1034/j.1600-0854.2003.00111.x; SPITALNIK PF, 1995, TRANSFUS MED REV, V9, P110, DOI 10.1016/S0887-7963(05)80050-1; STHILAIRE PM, 1994, BIOCHEMISTRY-US, V33, P14452, DOI 10.1021/bi00252a011; Tam PJ, 2007, MICROBIOL-SGM, V153, P2700, DOI 10.1099/mic.0.2007/006858-0; Tam P, 2008, J CELL PHYSIOL, V216, P750, DOI 10.1002/jcp.21456; Veiga MP, 2001, BIOCHEMISTRY-US, V40, P2614, DOI 10.1021/bi0019803; Windschiegl B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006238; Wolf AA, 2008, INFECT IMMUN, V76, P1476, DOI 10.1128/IAI.01286-07; Yahi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009079; Zhang HJ, 2011, NAT CELL BIOL, V13, P1189, DOI 10.1038/ncb2328	89	7	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16073	16087		10.1074/jbc.M111.318196	http://dx.doi.org/10.1074/jbc.M111.318196			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22418442	hybrid, Green Published			2022-12-27	WOS:000304030900001
J	Cross, AS; Hyun, SW; Miranda-Ribera, A; Feng, CG; Liu, AG; Nguyen, C; Zhang, L; Luzina, IG; Atamas, SP; Twaddell, WS; Guang, W; Lillehoj, EP; Puche, AC; Huang, W; Wang, LX; Passaniti, A; Goldblum, SE				Cross, Alan S.; Hyun, Sang Won; Miranda-Ribera, Alba; Feng, Chiguang; Liu, Anguo; Chinh Nguyen; Zhang, Lei; Luzina, Irina G.; Atamas, Sergei P.; Twaddell, William S.; Guang, Wei; Lillehoj, Erik P.; Puche, Adam C.; Huang, Wei; Wang, Lai-Xi; Passaniti, Antonino; Goldblum, Simeon E.			NEU1 and NEU3 Sialidase Activity Expressed in Human Lung Microvascular Endothelia NEU1 RESTRAINS ENDOTHELIAL CELL MIGRATION, WHEREAS NEU3 DOES NOT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B16 MELANOMA-CELLS; LYSOSOMAL SIALIDASE; PLASMA-MEMBRANE; GROWTH-FACTOR; ADHESION MOLECULES; HUMAN NEUTROPHILS; TUMOR-CELLS; SIALYL-LEX; SURFACE; RECEPTOR	The microvascular endothelial surface expresses multiple molecules whose sialylation state regulates multiple aspects of endothelial function. To better regulate these sialoproteins, we asked whether endothelial cells (ECs) might express one or more catalytically active sialidases. Human lung microvascular EC lysates contained heat-labile sialidase activity for a fluorogenic substrate, 2'-(4-methylumbelliferyl)-alpha-D-N-acetylneuraminic acid (4-MU-NANA), that was dose-dependently inhibited by the competitive sialidase inhibitor, 2,3-dehydro-2-deoxy-N-acetylneuraminic acid but not its negative control. The EC lysates also contained sialidase activity for a ganglioside mixture. Using real time RT-PCR to detect mRNAs for the four known mammalian sialidases, NEU1, -2, -3, and -4, NEU1 mRNA was expressed at levels 2700-fold higher that those found for NEU2, -3, or -4. Western analyses indicated NEU1 and -3 protein expression. Using confocal microscopy and flow cytometry, NEU1 was immunolocalized to both the plasma membrane and the perinuclear region. NEU3 was detected both in the cytosol and nucleus. Prior siRNA-mediated knockdown of NEU1 and NEU3 each decreased EC sialidase activity for 4-MU-NANA by >65 and >17%, respectively, and for the ganglioside mixture by 0 and 40%, respectively. NEU1 overexpression in ECs reduced their migration into a wound by >40%, whereas NEU3 overexpression did not. Immunohistochemical studies of normal human tissues immunolocalized NEU1 and NEU3 proteins to both pulmonary and extrapulmonary vascular endothelia. These combined data indicate that human lung microvascular ECs as well as other endothelia express catalytically active NEU1 and NEU3. NEU1 restrains EC migration, whereas NEU3 does not.	[Hyun, Sang Won; Miranda-Ribera, Alba; Liu, Anguo; Chinh Nguyen; Guang, Wei; Lillehoj, Erik P.; Passaniti, Antonino; Goldblum, Simeon E.] Univ Maryland, Sch Med, Mucosal Biol Res Ctr, Baltimore, MD 21201 USA; [Cross, Alan S.; Feng, Chiguang; Zhang, Lei] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Chinh Nguyen] Univ Maryland, Sch Med, Div Infect Dis, Baltimore, MD 21201 USA; [Cross, Alan S.; Luzina, Irina G.; Atamas, Sergei P.; Goldblum, Simeon E.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Twaddell, William S.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Guang, Wei; Lillehoj, Erik P.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Puche, Adam C.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Huang, Wei; Wang, Lai-Xi] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Inst Human Virol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Goldblum, SE (corresponding author), Univ Maryland, Sch Med, Mucosal Biol Res Ctr, 20 Penn St,Rm 351, Baltimore, MD 21201 USA.	sgoldblu@mbrc.umaryland.edu	Wang, Lai-Xi/E-8790-2019; Wang, Xin/AAN-8435-2021; Wang, Lai-Xi/E-8755-2019; Huang, Wei/P-9631-2017; wang, xl/Y-8251-2019	Wang, Lai-Xi/0000-0003-4293-5819; Wang, Xin/0000-0002-4457-7376; Huang, Wei/0000-0001-6432-1848; Lillehoj, Erik/0000-0002-2710-1704; , Erik/0000-0003-0910-6074	National Institutes of Health [HL086933, HL084223]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086933, R01HL084223] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002352] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants HL086933 (to A. S. C.) and HL084223 (to S. E. G.).	Achyuthan KE, 2001, COMP BIOCHEM PHYS B, V129, P29, DOI 10.1016/S1096-4959(01)00372-4; Arabkhari M, 2010, GLYCOBIOLOGY, V20, P603, DOI 10.1093/glycob/cwq010; AUGUSTINVOSS HG, 1992, J CELL BIOL, V119, P483, DOI 10.1083/jcb.119.2.483; Bonten E, 1996, GENE DEV, V10, P3156, DOI 10.1101/gad.10.24.3156; Bonten EJ, 2000, J BIOL CHEM, V275, P37657, DOI 10.1074/jbc.M007380200; BORN GVR, 1985, BRIT J EXP PATHOL, V66, P543; BROQUET P, 1991, INT J BIOCHEM, V23, P385, DOI 10.1016/0020-711X(91)90164-I; Comelli EM, 2003, GENE, V321, P155, DOI 10.1016/j.gene.2003.08.005; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; Conway EM, 2002, J EXP MED, V196, P565, DOI 10.1084/jem.20020077; CROSS AS, 1991, J CLIN INVEST, V88, P2067, DOI 10.1172/JCI115536; Cross AS, 2003, J BIOL CHEM, V278, P4112, DOI 10.1074/jbc.M207591200; Cuniberti LA, 2005, ATHEROSCLEROSIS, V181, P225, DOI 10.1016/j.atherosclerosis.2005.01.021; D'Souza DR, 2009, J BIOL CHEM, V284, P17947, DOI 10.1074/jbc.M109.002378; Ellies LG, 2002, P NATL ACAD SCI USA, V99, P10042, DOI 10.1073/pnas.142005099; Geyer H, 1999, GLYCOBIOLOGY, V9, P915, DOI 10.1093/glycob/9.9.915; Gong P, 2008, J BIOL CHEM, V283, P13437, DOI 10.1074/jbc.M707986200; HANASAKI K, 1994, J BIOL CHEM, V269, P10637; HANASAKI K, 1995, J BIOL CHEM, V270, P7533, DOI 10.1074/jbc.270.13.7533; Hinek A, 2006, J BIOL CHEM, V281, P3698, DOI 10.1074/jbc.M508736200; Hinek A, 2008, AM J PATHOL, V173, P1042, DOI 10.2353/ajpath.2008.071081; Hyun SW, 2011, EXP LUNG RES, V37, P327, DOI 10.3109/01902148.2011.566673; IRIE S, 1988, J CLIN INVEST, V82, P508, DOI 10.1172/JCI113625; Jayanth P, 2010, CELL SIGNAL, V22, P1193, DOI 10.1016/j.cellsig.2010.03.011; Kato T, 2001, INT J CANCER, V92, P797, DOI 10.1002/ijc.1268; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Liang F, 2006, J BIOL CHEM, V281, P27526, DOI 10.1074/jbc.M605633200; LIN HY, 1995, J BIOL CHEM, V270, P2747, DOI 10.1074/jbc.270.6.2747; Liu AG, 2009, J BIOL CHEM, V284, P6389, DOI 10.1074/jbc.M809198200; Liu YH, 2006, CANCER RES, V66, P10408, DOI 10.1158/0008-5472.CAN-06-1572; Lukong KE, 2001, J BIOL CHEM, V276, P46172, DOI 10.1074/jbc.M104547200; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Monti E, 1999, GLYCOBIOLOGY, V9, P1313, DOI 10.1093/glycob/9.12.1313; Monti E, 2000, BIOCHEM J, V349, P343, DOI 10.1042/0264-6021:3490343; Monti E, 1999, GENOMICS, V57, P137, DOI 10.1006/geno.1999.5749; Monti E, 2002, NEUROCHEM RES, V27, P649, DOI 10.1023/A:1020276000901; Mukhejee P, 2008, J LIPID RES, V49, P929, DOI 10.1194/jlr.R800006-JLR200; MULLER WA, 1989, J EXP MED, V170, P399, DOI 10.1084/jem.170.2.399; Nan XL, 2007, J LEUKOCYTE BIOL, V81, P284, DOI 10.1189/jlb.1105692; Nightingale TD, 2009, J BIOL CHEM, V284, P3935, DOI 10.1074/jbc.M805105200; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; Pshezhetsky AV, 1997, NAT GENET, V15, P316, DOI 10.1038/ng0397-316; Qian J, 2009, ACTA PHARMACOL SIN, V30, P1039, DOI 10.1038/aps.2009.84; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; Rifat S, 2008, J LEUKOCYTE BIOL, V84, P1075, DOI 10.1189/jlb.0706462; Rusnati M, 1999, MOL BIOL CELL, V10, P313, DOI 10.1091/mbc.10.2.313; Sakarya S, 2004, GLYCOBIOLOGY, V14, P481, DOI 10.1093/glycob/cwh065; Sawada M, 2002, INT J CANCER, V97, P180, DOI 10.1002/ijc.1598; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; Smith CW, 2008, J ALLERGY CLIN IMMUN, V121, pS375, DOI 10.1016/j.jaci.2007.07.030; Stevens T, 2000, AM J PHYSIOL-LUNG C, V279, pL419, DOI 10.1152/ajplung.2000.279.3.L419; Tokuyama S, 1997, INT J CANCER, V73, P410, DOI 10.1002/(SICI)1097-0215(19971104)73:3<410::AID-IJC16>3.0.CO;2-G; Uemura T, 2009, ONCOGENE, V28, P1218, DOI 10.1038/onc.2008.471; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Wada T, 1999, BIOCHEM BIOPH RES CO, V261, P21, DOI 10.1006/bbrc.1999.0973; WALZ G, 1990, SCIENCE, V250, P1132, DOI 10.1126/science.1701275; Wang JF, 2009, J NEUROCHEM, V111, P547, DOI 10.1111/j.1471-4159.2009.06339.x; Weber KSC, 2004, INFLAMMATION, V28, P177, DOI 10.1023/B:IFLA.0000049042.73926.eb; YANG CL, 1995, CANCER RES, V55, P4210	65	43	44	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15966	15980		10.1074/jbc.M112.346817	http://dx.doi.org/10.1074/jbc.M112.346817			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22403397	Green Published, hybrid			2022-12-27	WOS:000304006300075
J	Jong, A; Wu, CH; Gonzales-Gomez, I; Kwon-Chung, KJ; Chang, YC; Tseng, HK; Cho, WL; Huang, SH				Jong, Ambrose; Wu, Chun-Hua; Gonzales-Gomez, Ignacio; Kwon-Chung, Kyung J.; Chang, Yun C.; Tseng, Hsiang-Kuang; Cho, Wen-Long; Huang, Sheng-He			Hyaluronic Acid Receptor CD44 Deficiency Is Associated with Decreased Cryptococcus neoformans Brain Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; BINDING-SITE; LIPID RAFTS; SIMVASTATIN; INVOLVEMENT; MICE; PATHOGENESIS; RECRUITMENT; ACTIVATION	Cryptococcus neoformans is a pathogenic yeast that can invade the brain and cause meningoencephalitis. Our previous in vitro studies suggested that the interaction between C. neoformans hyaluronic acid and human brain endothelial CD44 could be the initial step of brain invasion. In this report, we used a CD44 knock-out (KO or CD44(-/-)) mouse model to explore the importance of CD44 in C. neoformans brain invasion. Our results showed that C. neoformans-infected CD44 KO mice survived longer than the infected wild-type mice. Consistent with our in vitro results, the brain and cerebrospinal fluid fungal burden was reduced in CD44-deficient mice. Histopathological studies showed smaller and fewer cystic lesions in the brains of CD44 KO mice. Interestingly, the cystic lesions contained C. neoformans cells embedded within their polysaccharide capsule and were surrounded by host glial cells. We also found that a secondary hyaluronic acid receptor, RHAMM (receptor of hyaluronan-mediated motility), was present in the CD44 KO mice. Importantly, our studies demonstrated an in vivo blocking effect of simvastatin. These results suggest that the CD44 and RHAMM receptors function on membrane lipid rafts during invasion and that simvastatin may have a potential therapeutic role in C. neoformans infections of the brain.	[Jong, Ambrose; Wu, Chun-Hua] Childrens Hosp Los Angeles, Div Hematol Oncol, Saban Res Inst, Los Angeles, CA 90027 USA; [Huang, Sheng-He] Childrens Hosp Los Angeles, Div Infect Dis, Saban Res Inst, Los Angeles, CA 90027 USA; [Gonzales-Gomez, Ignacio] Univ S Florida, All Childrens Hosp, Dept Pathol & Lab Med, St Petersburg, FL 33701 USA; [Kwon-Chung, Kyung J.; Chang, Yun C.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Tseng, Hsiang-Kuang; Cho, Wen-Long] Mackay Mem Hosp, Dept Internal Med, New Taipei 252, Taiwan; [Tseng, Hsiang-Kuang; Cho, Wen-Long] MacKay Med Coll, New Taipei 252, Taiwan	Children's Hospital Los Angeles; Children's Hospital Los Angeles; State University System of Florida; University of South Florida; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Mackay Memorial Hospital; Mackay Medical College	Jong, A (corresponding author), Childrens Hosp Los Angeles, Div Hematol Oncol, Saban Res Inst, Mailstop 57,4650 Sunset Blvd, Los Angeles, CA 90027 USA.	ajong@chla.usc.edu			National Institutes of Health [R01-NS047599, R56-AI40635]; National Institutes of Health NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000057, R56AI040635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047599] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-NS047599 (to A. J.) and R56-AI40635 (to S. H. H.).; Supported by the National Institutes of Health NIAID intramural research program.	Bicanic T, 2005, BRIT MED BULL, V72, P99, DOI 10.1093/bmb/ldh043; Bono P, 2001, MOL BIOL CELL, V12, P891, DOI 10.1091/mbc.12.4.891; Casadevall A, 2009, TRENDS MICROBIOL, V17, P158, DOI 10.1016/j.tim.2008.12.005; Chang YC, 2006, INFECT IMMUN, V74, P3930, DOI 10.1128/IAI.00089-06; Chang YC, 2004, INFECT IMMUN, V72, P4985, DOI 10.1128/IAI.72.9.4985-4995.2004; CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912; Chen DW, 2001, J IMMUNOL, V166, P5889, DOI 10.4049/jimmunol.166.10.5889; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chretien F, 2002, J INFECT DIS, V186, P522, DOI 10.1086/341564; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; Huang SH, 2011, J BIOL CHEM, V286, P34761, DOI 10.1074/jbc.M111.219378; Jong A, 2008, CELL MICROBIOL, V10, P1313, DOI 10.1111/j.1462-5822.2008.01128.x; Jong A, 2007, EUKARYOT CELL, V6, P1486, DOI 10.1128/EC.00120-07; Lee JD, 2006, ACTA TROP, V97, P204, DOI 10.1016/j.actatropica.2005.11.003; Leemans JC, 2003, J CLIN INVEST, V111, P681, DOI 10.1172/JCI200316936; McFadden D, 2006, TRENDS MICROBIOL, V14, P497, DOI 10.1016/j.tim.2006.09.003; McKay A, 2004, J IMMUNOL, V172, P2903, DOI 10.4049/jimmunol.172.5.2903; Miida Takashi, 2004, J Atheroscler Thromb, V11, P253; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Nedvetzki S, 2004, P NATL ACAD SCI USA, V101, P18081, DOI 10.1073/pnas.0407378102; Olszewski MA, 2004, AM J PATHOL, V164, P1761, DOI 10.1016/S0002-9440(10)63734-0; Ponce J, 2008, STROKE, V39, P1269, DOI 10.1161/STROKEAHA.107.498923; Rouschop KMA, 2006, J IMMUNOL, V177, P7225, DOI 10.4049/jimmunol.177.10.7225; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Shi MQ, 2010, J CLIN INVEST, V120, P1683, DOI 10.1172/JCI41963; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Wang B, 1999, J BIOL CHEM, V274, P8291, DOI 10.1074/jbc.274.12.8291; Yauch LE, 2006, PLOS PATHOG, V2, P1060, DOI 10.1371/journal.ppat.0020120; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0	30	59	64	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15298	15306		10.1074/jbc.M112.353375	http://dx.doi.org/10.1074/jbc.M112.353375			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22418440	Green Published, hybrid			2022-12-27	WOS:000304006300013
J	Kjenseth, A; Fykerud, TA; Sirnes, S; Bruun, J; Yohannes, Z; Kolberg, M; Omori, Y; Rivedal, E; Leithe, E				Kjenseth, Ane; Fykerud, Tone A.; Sirnes, Solveig; Bruun, Jarle; Yohannes, Zeremariam; Kolberg, Matthias; Omori, Yasufumi; Rivedal, Edgar; Leithe, Edward			The Gap Junction Channel Protein Connexin 43 Is Covalently Modified and Regulated by SUMOylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR COMMUNICATION; INTRACELLULAR-TRANSPORT; PROTEASOMAL DEGRADATION; GROWTH-CONTROL; LIFE-CYCLE; UBIQUITIN; SUMO; DISEASE; CELLS; INTERNALIZATION	SUMOylation is a posttranslational modification in which a member of the small ubiquitin-like modifier (SUMO) family of proteins is conjugated to lysine residues in specific target proteins. Most known SUMOylation target proteins are located in the nucleus, but there is increasing evidence that SUMO may also be a key determinant of many extranuclear processes. Gap junctions consist of arrays of intercellular channels that provide direct transfer of ions and small molecules between adjacent cells. Gap junction channels are formed by integral membrane proteins called connexins, of which the best-studied isoform is connexin 43 (Cx43). Here we show that Cx43 is posttranslationally modified by SUMOylation. The data suggest that the SUMO system regulates the Cx43 protein level and the level of functional Cx43 gap junctions at the plasma membrane. Cx43 was found to be modified by SUMO- 1, -2, and -3. Evidence is provided that the membrane-proximal lysines at positions 144 and 237, located in the Cx43 intracellular loop and C-terminal tail, respectively, act as SUMO conjugation sites. Mutations of lysine 144 or lysine 237 resulted in reduced Cx43 SUMOylation and reduced Cx43 protein and gap junction levels. Altogether, these data identify Cx43 as a SUMOylation target protein and represent the first evidence that gap junctions are regulated by the SUMO system.	[Kjenseth, Ane; Fykerud, Tone A.; Sirnes, Solveig; Bruun, Jarle; Yohannes, Zeremariam; Kolberg, Matthias; Rivedal, Edgar; Leithe, Edward] Univ Oslo, Oslo Univ Hosp, Inst Canc Res, Dept Canc Prevent, N-0310 Oslo, Norway; [Kjenseth, Ane; Fykerud, Tone A.; Sirnes, Solveig; Bruun, Jarle; Yohannes, Zeremariam; Kolberg, Matthias; Rivedal, Edgar; Leithe, Edward] Univ Oslo, Ctr Canc Biomed, Fac Med, N-0310 Oslo, Norway; [Omori, Yasufumi] Akita Univ, Dept Mol & Tumour Pathol, Sch Med, Hondo, Akita 0108543, Japan	University of Oslo; University of Oslo; Akita University	Leithe, E (corresponding author), Univ Oslo, Oslo Univ Hosp, Inst Canc Res, Dept Canc Prevent, N-0310 Oslo, Norway.	eleithe@rr-research.no	Kolberg, Matthias/G-2784-2011; Kolberg, Matthias/AAY-3478-2021	Kolberg, Matthias/0000-0001-8288-5364; 	Norwegian Cancer Society; Norwegian Research Council	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the Norwegian Cancer Society and the Norwegian Research Council.	Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Berthoud VA, 2004, CARDIOVASC RES, V62, P256, DOI 10.1016/j.cardiores.2003.12.021; Colussi C, 2011, P NATL ACAD SCI USA, V108, P2795, DOI 10.1073/pnas.1013124108; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Girao H, 2009, EXP CELL RES, V315, P3587, DOI 10.1016/j.yexcr.2009.10.003; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Herve JC, 2007, J MEMBRANE BIOL, V217, P21, DOI 10.1007/s00232-007-9054-8; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Jordan K, 2001, J CELL SCI, V114, P763; Kang JS, 2008, NAT CELL BIOL, V10, P654, DOI 10.1038/ncb1728; Kelly SM, 2007, MOL BIOL CELL, V18, P4279, DOI 10.1091/mbc.E07-05-0487; Kim JH, 2009, BBA-MOL BASIS DIS, V1792, P155, DOI 10.1016/j.bbadis.2008.12.008; King TJ, 2000, CARCINOGENESIS, V21, P311; Kjenseth A, 2010, CELL SIGNAL, V22, P1267, DOI 10.1016/j.cellsig.2010.03.005; Koval M, 2006, TRENDS CELL BIOL, V16, P159, DOI 10.1016/j.tcb.2006.01.006; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; LARSEN WJ, 1978, TISSUE CELL, V10, P585, DOI 10.1016/S0040-8166(16)30351-2; Lee GW, 1998, J BIOL CHEM, V273, P6503, DOI 10.1074/jbc.273.11.6503; Leithe E, 2006, BIOCHEM J, V393, P59, DOI 10.1042/BJ20050674; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Leithe E, 2004, J CELL SCI, V117, P1211, DOI 10.1242/jcs.00951; Leithe E, 2003, CARCINOGENESIS, V24, P1239, DOI 10.1093/carcin/bgg066; Leithe E, 2012, BBA-BIOMEMBRANES, V1818, P1870, DOI 10.1016/j.bbamem.2011.09.029; Leithe E, 2009, J CELL SCI, V122, P3883, DOI 10.1242/jcs.053801; Lichtenstein A, 2011, J CELL SCI, V124, P910, DOI 10.1242/jcs.073072; LOEWENSTEIN WR, 1979, BIOCHIM BIOPHYS ACTA, V560, P1, DOI 10.1016/0304-419X(79)90002-7; Martin S, 2007, NAT REV NEUROSCI, V8, P948, DOI 10.1038/nrn2276; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; MUSIL LS, 1993, CELL, V74, P1065, DOI 10.1016/0092-8674(93)90728-9; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; Opsahl H, 2000, CELL ADHES COMMUN, V7, P367, DOI 10.3109/15419060009109019; Piehl M, 2007, MOL BIOL CELL, V18, P337, DOI 10.1091/mbc.E06-06-0487; Plant LD, 2010, P NATL ACAD SCI USA, V107, P10743, DOI 10.1073/pnas.1004712107; Qin H, 2003, J BIOL CHEM, V278, P30005, DOI 10.1074/jbc.M300614200; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Rivedal E, 1996, CARCINOGENESIS, V17, P2321, DOI 10.1093/carcin/17.11.2321; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Severs NJ, 2004, CARDIOVASC RES, V62, P368, DOI 10.1016/j.cardiores.2003.12.007; Sirnes S, 2008, BIOCHEM BIOPH RES CO, V373, P597, DOI 10.1016/j.bbrc.2008.06.095; Sohl G, 2003, CELL COMMUN ADHES, V10, P173, DOI 10.1080/15419060390262877; Sosinsky GE, 2005, BBA-BIOMEMBRANES, V1711, P99, DOI 10.1016/j.bbamem.2005.04.001; Vanslyke JK, 2000, MOL BIOL CELL, V11, P1933, DOI 10.1091/mbc.11.6.1933; VanSlyke JK, 2000, METHODS, V20, P156, DOI 10.1006/meth.1999.0933; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Yamasaki H, 1996, CARCINOGENESIS, V17, P1199, DOI 10.1093/carcin/17.6.1199	56	42	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15851	15861		10.1074/jbc.M111.281832	http://dx.doi.org/10.1074/jbc.M111.281832			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22411987	Green Published, hybrid			2022-12-27	WOS:000304006300064
J	Perez, B; Paquette, N; Paidassi, H; Zhai, B; White, K; Skvirsky, R; Lacy-Hulbert, A; Stuart, LM				Perez, Beatriz; Paquette, Nicholas; Paidassi, Helena; Zhai, Bo; White, Kristin; Skvirsky, Rachel; Lacy-Hulbert, Adam; Stuart, Lynda M.			Apoptotic Cells Can Deliver Chemotherapeutics to Engulfing Macrophages and Suppress Inflammatory Cytokine Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CALRETICULIN EXPOSURE; CLEARANCE; IMMUNOGENICITY; PHAGOCYTOSIS; NEUTROPHILS; CANCER; BETA	Immunosuppression via cell-cell contact with apoptotic cells is a well studied immunological phenomenon. Although the original studies of immune repression used primary cells, which undergo spontaneous cell death or apoptosis in response to irradiation, more recent studies have relied on chemotherapeutic agents to induce apoptosis in cell lines. In this work, we demonstrate that Jurkat cells induced to die with actinomycin D suppressed inflammatory cytokine production by macrophages, whereas cells treated with etoposide did not. This immune repression mediated by actinomycin D-treated cells did not require phagocytosis or cell-cell contact and thus occurs through a different mechanism from that seen with primary apoptotic neutrophils. Moreover, cells induced to die with etoposide and then treated for a short time with actinomycin D also suppressed macrophage responses, indicating that suppression was mediated by actinomycin D independent of the mechanism of cell death. Finally, phagocytosis of actinomycin D-treated cells caused apoptosis in macrophages, and suppression could be blocked by inhibition of caspase activity in the target macrophage. Together, these data indicate that apoptotic cells act as "Trojan horses," delivering actinomycin D to engulfing macrophages. Suppression of cytokine production by macrophages is therefore due to exposure to actinomycin D from apoptotic cells and is not the result of cell-receptor interactions. These data suggest that drug-induced death may not be an appropriate surrogate for the immunosuppressive activity of apoptotic cells. Furthermore, these effects of cytotoxic drugs on infiltrating immune phagocytes may have clinical ramifications for their use as antitumor therapies.	[Perez, Beatriz; Paquette, Nicholas; Paidassi, Helena; Lacy-Hulbert, Adam; Stuart, Lynda M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Program Dev Immunol, Boston, MA 02114 USA; [Zhai, Bo; White, Kristin] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cutaneous Biol Res Ctr, Boston, MA 02114 USA; [Perez, Beatriz; Skvirsky, Rachel] Univ Massachusetts Boston, Dept Biol, Boston, MA 02125 USA; [Paidassi, Helena] Univ Edinburgh, MRC Ctr Inflammat Res, Edinburgh EH16 4TJ, Midlothian, Scotland	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Boston; University of Edinburgh	Stuart, LM (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Program Dev Immunol, Jackson 14,55 Fruit St, Boston, MA 02114 USA.	lstuart@partners.org	Paidassi, Helena/M-5739-2014	Lacy-Hulbert, Adam/0000-0003-2162-0156; Paidassi, Helena/0000-0001-9915-4365	National Institutes of Health [RO1AI79198, U24A1082660, NIH R25GM076321, 5RO1 GM069541]; National Science Foundation [EHR0412390]; NIH/NERCE [U54AI057159]; UK Medical Research Council [G0802069]; Medical Research Council [G0802069] Funding Source: researchfish; MRC [G0802069] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079198, U54AI057159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069541, R25GM076321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIH/NERCE; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AI79198 and U24A1082660 (to L. M. S.), NIH R25GM076321 (to R. S.), and 5RO1 GM069541 (to K. W.) and a National Science Foundation Grant EHR0412390 (to R. S.). Additionally, N. P. was supported by NIH/NERCE Grant U54AI057159, and H. P. was supported by UK Medical Research Council Grant G0802069.	Burden DA, 1998, BBA-GENE STRUCT EXPR, V1400, P139, DOI 10.1016/S0167-4781(98)00132-8; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; Imbert TF, 1998, BIOCHIMIE, V80, P207, DOI 10.1016/S0300-9084(98)80004-7; Kozmar A, 2010, J INNATE IMMUN, V2, P248, DOI 10.1159/000295790; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lucas M, 2003, J IMMUNOL, V171, P2610, DOI 10.4049/jimmunol.171.5.2610; Lucas M, 2006, J IMMUNOL, V177, P4047, DOI 10.4049/jimmunol.177.6.4047; O'Brien BA, 2002, CELL DEATH DIFFER, V9, P457, DOI 10.1038/sj.cdd.4400973; Obeid M, 2007, CELL DEATH DIFFER, V14, P1848, DOI 10.1038/sj.cdd.4402201; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Pan JX, 2001, BBA-GEN SUBJECTS, V1527, P1, DOI 10.1016/S0304-4165(01)00152-0; Ren Y, 2003, ARTHRITIS RHEUM, V48, P2888, DOI 10.1002/art.11237; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Stuart LM, 2002, J IMMUNOL, V168, P1627, DOI 10.4049/jimmunol.168.4.1627; Vandivier RW, 2002, CHEST, V121, p89S, DOI 10.1378/chest.121.3_suppl.89S; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; WARING MJ, 1981, ANNU REV BIOCHEM, V50, P159, DOI 10.1146/annurev.bi.50.070181.001111	19	8	8	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					16029	16036		10.1074/jbc.M112.340489	http://dx.doi.org/10.1074/jbc.M112.340489			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22433861	hybrid, Green Published			2022-12-27	WOS:000304006300080
J	Tamura, Y; Onguka, O; Hobbs, AEA; Jensen, RE; Iijima, M; Claypool, SM; Sesaki, H				Tamura, Yasushi; Onguka, Ouma; Hobbs, Alyson E. Aiken; Jensen, Robert E.; Iijima, Miho; Claypool, Steven M.; Sesaki, Hiromi			Role for Two Conserved Intermembrane Space Proteins, Ups1p and Up2p, in Intra-mitochondrial Phospholipid Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; CARDIOLIPIN BIOSYNTHESIS; PRESEQUENCE TRANSLOCASE; YEAST MITOCHONDRIA; CONTACT SITES; MAINTENANCE; COMPLEX; IMPORT	Mitochondrial membranes maintain a specific phospholipid composition. Most phospholipids are synthesized in the endoplasmic reticulum (ER) and transported to mitochondria, but cardiolipin and phosphatidylethanolamine are produced in mitochondria. In the yeast Saccharomyces cerevisiae, phospholipid exchange between the ER and mitochondria relies on the ER-mitochondria encounter structure (ERMES) complex, which physically connects the ER and mitochondrial outer membrane. However, the proteins and mechanisms involved in phospholipid transport within mitochondria remain elusive. Here, we investigated the role of the conserved intermembrane space proteins, Ups1p and Ups2p, and an inner membrane protein, Mdm31p, in phospholipid metabolism. Our data show that loss of the ERMES complex, Ups1p, and Mdm31p causes similar defects in mitochondrial phospholipid metabolism, mitochondrial morphology, and cell growth. Defects in cells lacking the ERMES complex or Ups1p are suppressed by Mdm31p overexpression as well as additional loss of Ups2p, which antagonizes Ups1p. Combined loss of the ERMES complex and Ups1p exacerbates phospholipid defects. Finally, pulse-chase experiments using [C-14] serine revealed that Ups1p and Ups2p antagonistically regulate conversion of phosphatidylethanolamine to phosphatidylcholine. Our results suggest that Ups proteins and Mdm31p play important roles in phospholipid biosynthesis in mitochondria. Ups proteins may function in phospholipid trafficking between the outer and inner mitochondrial membranes.	[Tamura, Yasushi; Hobbs, Alyson E. Aiken; Jensen, Robert E.; Iijima, Miho; Sesaki, Hiromi] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Onguka, Ouma; Claypool, Steven M.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Tamura, Y (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.	ytamura1@jhmi.edu; sclaypo1@jhmi.edu; hsesaki@jhmi.edu	Tamura, Yasushi/A-9997-2013; Yasushi, TAMURA/I-7122-2014; Tamura, Yasushi/H-8270-2017	Tamura, Yasushi/0000-0002-8462-0607; Claypool, Steven/0000-0001-5316-1623	National Institutes of Health [GM084015, GM089853]; Japan Society for the Promotion of Science	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported, in whole or in part, by National Institutes of Health Grants GM084015 (to M. I.) and GM089853 (to H. S.). This work was also supported by a postdoctoral fellowship for research abroad from the Japan Society for the Promotion of Science (to Y. T.).	Adams A, 1997, METHODS YEAST GENETI; Berger KH, 1997, J CELL BIOL, V136, P545, DOI 10.1083/jcb.136.3.545; Brachmann CB, 1998, YEAST, V14, P115; BURGESS SM, 1994, J CELL BIOL, V126, P1375, DOI 10.1083/jcb.126.6.1375; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; Chen SL, 2010, J BIOL CHEM, V285, P10397, DOI 10.1074/jbc.M110.100784; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; Claypool SM, 2006, J CELL BIOL, V174, P379, DOI 10.1083/jcb.200605043; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Dimmer KS, 2005, J CELL BIOL, V168, P103, DOI 10.1083/jcb.200410030; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Frederick RL, 2008, GENETICS, V178, P825, DOI 10.1534/genetics.107.083055; Fujimoto M, 2011, INT REV CEL MOL BIO, V292, P73, DOI 10.1016/B978-0-12-386033-0.00002-5; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Harada Y, 2010, BIOCHEM BIOPH RES CO, V392, P228, DOI 10.1016/j.bbrc.2010.01.024; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; JENSEN RE, 1992, MOL CELL BIOL, V12, P4677, DOI 10.1128/MCB.12.10.4677; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024; KODAKI T, 1987, J BIOL CHEM, V262, P15428; Kopec KO, 2010, BIOINFORMATICS, V26, P1927, DOI 10.1093/bioinformatics/btq326; Kornmann B, 2011, P NATL ACAD SCI USA, V108, P14151, DOI 10.1073/pnas.1111314108; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kutik S, 2008, J CELL BIOL, V183, P1213, DOI 10.1083/jcb.200806048; Lucken-Ardjomande S, 2008, CELL DEATH DIFFER, V15, P929, DOI 10.1038/cdd.2008.9; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Mokranjac D, 2005, J BIOL CHEM, V280, P23437, DOI 10.1074/jbc.C500135200; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; PON L, 1989, J CELL BIOL, V109, P2603, DOI 10.1083/jcb.109.6.2603; Rujiviphat J, 2009, J BIOL CHEM, V284, P28682, DOI 10.1074/jbc.M109.044933; Sani MA, 2009, BBA-BIOMEMBRANES, V1788, P623, DOI 10.1016/j.bbamem.2008.12.014; Sesaki H, 2006, J CELL BIOL, V173, P651, DOI 10.1083/jcb.200603092; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Shiota T, 2011, P NATL ACAD SCI USA, V108, P15179, DOI 10.1073/pnas.1105921108; SIMBENI R, 1993, BIOCHIM BIOPHYS ACTA, V1145, P1, DOI 10.1016/0005-2736(93)90374-9; SOGO LF, 1994, J CELL BIOL, V126, P1361, DOI 10.1083/jcb.126.6.1361; Stroud DA, 2011, J MOL BIOL, V413, P743, DOI 10.1016/j.jmb.2011.09.012; Tamura Y, 2010, EMBO J, V29, P2875, DOI 10.1038/emboj.2010.149; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Tamura Y, 2009, J CELL BIOL, V184, P129, DOI 10.1083/jcb.200808068; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; VOELKER DR, 1989, J BIOL CHEM, V264, P8019; von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Youngman MJ, 2004, J CELL BIOL, V164, P677, DOI 10.1083/jcb.200308012; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057	55	75	76	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15205	15218		10.1074/jbc.M111.338665	http://dx.doi.org/10.1074/jbc.M111.338665			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22403410	hybrid, Green Published			2022-12-27	WOS:000304006300005
J	Law, IKM; Murphy, JE; Bakirtzi, K; Bunnett, NW; Pothoulakis, C				Law, Ivy Ka Man; Murphy, Jane E.; Bakirtzi, Kyriaki; Bunnett, Nigel W.; Pothoulakis, Charalabos			Neurotensin-induced Proinflammatory Signaling in Human Colonocytes Is Regulated by beta-Arrestins and Endothelin-converting Enzyme-1-dependent Endocytosis and Resensitization of Neurotensin Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; COLONIC EPITHELIAL-CELLS; MAP KINASE ACTIVATION; KAPPA-B PATHWAYS; INTERLEUKIN-8 EXPRESSION; INTESTINAL INFLAMMATION; NEUROKININ-1 RECEPTOR; EGF RECEPTOR; TRAFFICKING; ENZYME-1	The neuropeptide/hormone neurotensin (NT) mediates intestinal inflammation and cell proliferation by binding of its high affinity receptor, neurotensin receptor-1 (NTR1). NT stimulates IL-8 expression in NCM460 human colonic epithelial cells by both MAP kinase-and NF-kappa B-dependent pathways. Although the mechanism of NTR1 endocytosis has been studied, the relationship between NTR1 intracellular trafficking and inflammatory signaling remains to be elucidated. In the present study, we show that in NCM460 cells exposed to NT, beta-arrestin-1 (beta ARR1), and beta-arrestin-2 (beta ARR2) translocate to early endosomes together with NTR1. Endothelin-converting enzyme-1 (ECE-1) degrades NT in acidic conditions, and its activity is crucial for NTR1 recycling. Pretreatment of NCM460 cells with the ECE-1 inhibitor SM19712 or gene silencing of beta ARR1 or beta ARR2 inhibits NT-stimulated ERK1/2 and JNK phosphorylation, NF-kappa B p65 nuclear translocation and phosphorylation, and IL-8 secretion. Furthermore, NT-induced cell proliferation, but not IL-8 transcription, is attenuated by the JNK inhibitor, JNK(AII). Thus, NTR1 internalization and recycling in human colonic epithelial cells involves beta ARRs and ECE-1, respectively. Our results also indicate that beta ARRs and ECE-1-dependent recycling regulate MAP kinase and NF-kappa B signaling as well as cell proliferation in human colonocytes in response to NT.	[Law, Ivy Ka Man; Bakirtzi, Kyriaki; Pothoulakis, Charalabos] Univ Calif Los Angeles, Ctr Inflammatory Bowel Dis, Div Digest Dis, Los Angeles, CA 90095 USA; [Murphy, Jane E.; Bunnett, Nigel W.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Murphy, Jane E.; Bunnett, Nigel W.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Bunnett, Nigel W.] Monash Inst Pharmaceut Sci, Melbourne, Vic 3052, Australia	University of California System; University of California Los Angeles; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pothoulakis, C (corresponding author), Univ Calif Los Angeles, Ctr Inflammatory Bowel Dis, Div Digest Dis, Los Angeles, CA 90095 USA.	cpothoulakis@mednet.ucla.edu	Law, Ka Man (Ivy)/AAF-7097-2020	Law, Ka Man (Ivy)/0000-0002-7430-1215; Bunnett, Nigel W./0000-0003-3367-0644	National Institutes of Health [DK60729, P50 DK 64539, DK43207, DK39957, JCCC/P30 CA016042, CURE/P30 DK041301]; National Health and Medical Research Council Australia [633033]; Blinder Research Foundation for Crohn's Disease; Eli and Edythe Broad Chair; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, R01DK060729, R37DK039957, R01DK039957, P50DK064539, R01DK043207, R56DK043207] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Blinder Research Foundation for Crohn's Disease; Eli and Edythe Broad Chair; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK60729, P50 DK 64539 (to C. P.), DK43207, and DK39957 (to N. W. B.). This work was also supported by National Health and Medical Research Council Australia Fellowship 633033 (to N. W. B.), and the Blinder Research Foundation for Crohn's Disease and the Eli and Edythe Broad Chair (to C. P.). This work was also supported in part by National Institutes of Health Grants JCCC/P30 CA016042 and CURE/P30 DK041301.	Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Auyeung KKW, 2009, INT J MOL MED, V23, P189, DOI 10.3892/ijmm_00000116; Azarani A, 1998, BIOCHEM J, V333, P439, DOI 10.1042/bj3330439; Bakirtzi K, 2011, GASTROENTEROLOGY, V141, P1749, DOI 10.1053/j.gastro.2011.07.038; Bohm SK, 1997, BIOCHEM J, V322, P1; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Botto JM, 1998, BIOCHEM BIOPH RES CO, V243, P585, DOI 10.1006/bbrc.1997.8071; Brun P, 2005, AM J PHYSIOL-GASTR L, V288, pG621, DOI 10.1152/ajpgi.00140.2004; Castagliuolo I, 1999, J CLIN INVEST, V103, P843, DOI 10.1172/JCI4217; Cattaruzza F, 2009, BRIT J PHARMACOL, V156, P730, DOI 10.1111/j.1476-5381.2008.00039.x; Cervantes D, 2010, CIRC RES, V106, P79, DOI 10.1161/CIRCRESAHA.109.198580; Chalon P, 1996, FEBS LETT, V386, P91, DOI 10.1016/0014-5793(96)00397-3; Chao C, 2005, J SURG RES, V129, P313, DOI 10.1016/j.jss.2005.04.038; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Conner DA, 1997, CIRC RES, V81, P1021; Cottrell GS, 2009, J BIOL CHEM, V284, P22411, DOI 10.1074/jbc.M109.026674; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Ehlers RA, 2000, BIOCHEM BIOPH RES CO, V269, P704, DOI 10.1006/bbrc.2000.2335; Evers BM, 2006, PEPTIDES, V27, P2424, DOI 10.1016/j.peptides.2006.01.028; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Garland AM, 1996, MOL PHARMACOL, V49, P438; Gomez PF, 2005, J IMMUNOL, V175, P6924, DOI 10.4049/jimmunol.175.10.6924; Gui XY, 2008, PEPTIDES, V29, P1609, DOI 10.1016/j.peptides.2008.04.014; Hassan S, 2006, REGUL PEPTIDES, V133, P105, DOI 10.1016/j.regpep.2005.09.031; Hermans E, 1997, BRIT J PHARMACOL, V121, P1817, DOI 10.1038/sj.bjp.0701334; Hermans E, 1998, PHARMACOL THERAPEUT, V79, P89, DOI 10.1016/S0163-7258(98)00009-6; Hommes D, 2002, GASTROENTEROLOGY, V122, P7, DOI 10.1053/gast.2002.30770; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Johnson GD, 1999, J BIOL CHEM, V274, P4053, DOI 10.1074/jbc.274.7.4053; Kisfalvi K, 2010, J CELL PHYSIOL, V223, P309, DOI 10.1002/jcp.22036; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; Muller L, 2003, J BIOL CHEM, V278, P545, DOI 10.1074/jbc.M208949200; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Padilla BE, 2007, J CELL BIOL, V179, P981, DOI 10.1083/jcb.200704053; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; POLAK JM, 1977, NATURE, V270, P183, DOI 10.1038/270183a0; Roosterman D, 2004, J BIOL CHEM, V279, P30670, DOI 10.1074/jbc.M402479200; Roosterman D, 2003, AM J PHYSIOL-CELL PH, V284, pC1319, DOI 10.1152/ajpcell.00540.2002; Roosterman D, 2008, ENDOCRINOLOGY, V149, P2200, DOI 10.1210/en.2007-1628; Roosterman D, 2007, P NATL ACAD SCI USA, V104, P11838, DOI 10.1073/pnas.0701910104; SAKODA T, 1992, ONCOGENE, V7, P1705; Sakoda T, 1999, J MOL CELL CARDIOL, V31, P2037, DOI 10.1006/jmcc.1999.1035; Savdie C, 2006, CELL TISSUE RES, V324, P69, DOI 10.1007/s00441-005-0102-3; Schmidlin F, 2001, J BIOL CHEM, V276, P25427, DOI 10.1074/jbc.M101688200; Schweizer A, 1997, BIOCHEM J, V328, P871, DOI 10.1042/bj3280871; Scott MGH, 2006, MOL CELL BIOL, V26, P3432, DOI 10.1128/MCB.26.9.3432-3445.2006; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; TANAKA K, 1990, NEURON, V4, P847, DOI 10.1016/0896-6273(90)90137-5; Toy-Miou-Leong M, 2004, J BIOL CHEM, V279, P12636, DOI 10.1074/jbc.M303384200; Vandenbulcke F, 2000, J CELL SCI, V113, P2963; Waetzig GH, 2002, J IMMUNOL, V168, P5342, DOI 10.4049/jimmunol.168.10.5342; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999; Zhao DZ, 2007, INT J CANCER, V120, P1652, DOI 10.1002/ijc.22407; Zhao DZ, 2006, PEPTIDES, V27, P2434, DOI 10.1016/j.peptides.2005.12.016; Zhao DZ, 2011, J BIOL CHEM, V286, P6092, DOI 10.1074/jbc.M110.192534; Zhao DZ, 2005, MOL PHARMACOL, V67, P2025, DOI 10.1124/mol.104.010801; Zhao DZ, 2004, J BIOL CHEM, V279, P43547, DOI 10.1074/jbc.M401453200; Zhao DZ, 2003, AM J PHYSIOL-CELL PH, V284, pC1397, DOI 10.1152/ajpcell.00328.2002; Zhao DZ, 2001, J BIOL CHEM, V276, P44464, DOI 10.1074/jbc.M104942200	71	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15066	15075		10.1074/jbc.M111.327262	http://dx.doi.org/10.1074/jbc.M111.327262			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22416137	Green Published, hybrid			2022-12-27	WOS:000304003200068
J	Schertl, P; Sunderhaus, S; Klodmann, J; Grozeff, GEG; Bartoli, CG; Braun, HP				Schertl, Peter; Sunderhaus, Stephanie; Klodmann, Jennifer; Gergoff Grozeff, Gustavo E.; Bartoli, Carlos G.; Braun, Hans-Peter			L-Galactono-1,4-lactone dehydrogenase (GLDH) Forms Part of Three Subcomplexes of Mitochondrial Complex I in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-LACTONE DEHYDROGENASE; CARBONIC-ANHYDRASE SUBUNITS; ASCORBIC-ACID; POLYACRYLAMIDE-GELS; VITAMIN-C; 3-DIMENSIONAL STRUCTURE; PROTEOMIC APPROACH; INNER MEMBRANE; SWEET-POTATO; PLANTS	L-Galactono-1,4-lactone dehydrogenase (GLDH) catalyzes the terminal step of the Smirnoff-Wheeler pathway for vitamin C (L-ascorbate) biosynthesis in plants. A GLDH in gel activity assay was developed to biochemically investigate GLDH localization in plant mitochondria. It previously has been shown that GLDH forms part of an 850-kDa complex that represents a minor form of the respiratory NADH dehydrogenase complex (complex I). Because accumulation of complex I is disturbed in the absence of GLDH, a role of this enzyme in complex I assembly has been proposed. Here we report that GLDH is associated with two further protein complexes. Using native gel electrophoresis procedures in combination with the in gel GLDH activity assay and immunoblotting, two mitochondrial complexes of 470 and 420 kDa were identified. Both complexes are of very low abundance. Protein identifications by mass spectrometry revealed that they include subunits of complex I. Finally, the 850-kDa complex was further investigated and shown to include the complete "peripheral arm" of complex I. GLDH is attached to a membrane domain, which represents a major fragment of the "membrane arm" of complex I. Taken together, our data further support a role of GLDH during complex I formation, which is based on its binding to specific assembly intermediates.	[Schertl, Peter; Sunderhaus, Stephanie; Klodmann, Jennifer; Braun, Hans-Peter] Leibniz Univ Hannover, Inst Pflanzengenet, Abt Pflanzenprote, D-30419 Hannover, Germany; [Gergoff Grozeff, Gustavo E.; Bartoli, Carlos G.] Univ Nacl La Plata CCT CONICET La Plata, Inst Fisiol Vegetal, Fac Ciencias Agr & Forestales, RA-1900 La Plata, Buenos Aires, Argentina	Leibniz University Hannover	Braun, HP (corresponding author), Leibniz Univ Hannover, Inst Pflanzengenet, Abt Pflanzenprote, Herrenhauser Str 2, D-30419 Hannover, Germany.	braun@genetik.uni-hannover.de	Braun, Hans-Peter/E-7149-2011; Grozeff, Gustavo Esteban Gergoff/AED-8418-2022; Grozeff, Gustavo Esteban Gergoff/L-7800-2019; Klodmann, Jennifer/B-2131-2013	Braun, Hans-Peter/0000-0002-4459-9727; Grozeff, Gustavo Esteban Gergoff/0000-0003-1175-3473; Senkler, Jennifer/0000-0002-1377-3841; Schertl, Peter/0000-0002-4211-1695	Deutsche Forschungsgemeinschaft (DFG) [Br 1829/10-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant Br 1829/10-1.	Alhagdow M, 2007, PLANT PHYSIOL, V145, P1408, DOI 10.1104/pp.107.106500; Barth C, 2004, PLANT PHYSIOL, V134, P1784, DOI 10.1104/pp.103.032185; Barth C, 2006, J EXP BOT, V57, P1657, DOI 10.1093/jxb/erj198; Bartoli CG, 2000, PLANT PHYSIOL, V123, P335, DOI 10.1104/pp.123.1.335; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Braun HP, 2007, PHYSIOL PLANTARUM, V129, P114, DOI 10.1111/j.1399-3054.2006.00773.x; Bultema JB, 2009, BBA-BIOENERGETICS, V1787, P60, DOI 10.1016/j.bbabio.2008.10.010; Clason T, 2010, J STRUCT BIOL, V169, P81, DOI 10.1016/j.jsb.2009.08.017; Conklin PL, 2004, PLANT CELL ENVIRON, V27, P959, DOI 10.1111/j.1365-3040.2004.01203.x; de Pinto MC, 2006, PLANT J, V48, P784, DOI 10.1111/j.1365-313X.2006.02919.x; Dudkina NV, 2005, FEBS LETT, V579, P5769, DOI 10.1016/j.febslet.2005.09.065; EADIE MJ, 1970, HISTOCHEMISTRY, V21, P170, DOI 10.1007/BF00306184; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Gao Q, 2008, J PLANT PHYSIOL, V165, P138, DOI 10.1016/j.jplph.2007.04.002; Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668; Heazlewood JL, 2003, BBA-BIOENERGETICS, V1604, P159, DOI 10.1016/S0005-2728(03)00045-8; Heinemeyer Jesco, 2007, V355, P343; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Imai T, 1998, PLANT CELL PHYSIOL, V39, P1350, DOI 10.1093/oxfordjournals.pcp.a029341; Klodmann J, 2011, PLANT PHYSIOL, V157, P587, DOI 10.1104/pp.111.182352; Klodmann J, 2011, PHYTOCHEMISTRY, V72, P1071, DOI 10.1016/j.phytochem.2010.11.012; Klodmann J, 2011, PROTEOMICS, V11, P1834, DOI 10.1002/pmic.201000638; Klodmann J, 2010, PLANT CELL, V22, P797, DOI 10.1105/tpc.109.073726; Kruft V, 2001, PLANT PHYSIOL, V127, P1694, DOI 10.1104/pp.010474; Larkindale J, 2005, PLANT PHYSIOL, V138, P882, DOI 10.1104/pp.105.062257; Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015; Leferink NGH, 2008, FEBS J, V275, P713, DOI 10.1111/j.1742-4658.2007.06233.x; Leferink NGH, 2009, FEBS LETT, V583, P3199, DOI 10.1016/j.febslet.2009.09.004; Leferink NGH, 2009, PLANT PHYSIOL, V150, P596, DOI 10.1104/pp.109.136929; Leferink NGH, 2009, J BIOL CHEM, V284, P4392, DOI 10.1074/jbc.M808202200; MAPSON LW, 1954, BIOCHEM J, V56, P21, DOI 10.1042/bj0560021; MAPSON LW, 1958, BIOCHEM J, V68, P395, DOI 10.1042/bj0680395; Meyer EH, 2011, J BIOL CHEM, V286, P26081, DOI 10.1074/jbc.M110.209601; Millar AH, 2003, PLANT PHYSIOL, V133, P443, DOI 10.1104/pp.103.028399; Muller-Moule P, 2004, PLANT PHYSIOL, V134, P1163, DOI 10.1104/pp.103.032375; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; NEUHOFF V, 1990, ELECTROPHORESIS, V11, P101, DOI 10.1002/elps.1150110202; OBA K, 1995, J BIOCHEM, V117, P120, DOI 10.1093/oxfordjournals.jbchem.a124697; Ostergaard J, 1997, J BIOL CHEM, V272, P30009, DOI 10.1074/jbc.272.48.30009; Perales M, 2005, J MOL BIOL, V350, P263, DOI 10.1016/j.jmb.2005.04.062; Peters K, 2008, BBA-BIOENERGETICS, V1777, P84, DOI 10.1016/j.bbabio.2007.10.012; Pignocchi C, 2003, CURR OPIN PLANT BIOL, V6, P379, DOI 10.1016/S1369-5266(03)00069-4; Pineau B, 2008, J BIOL CHEM, V283, P32500, DOI 10.1074/jbc.M805320200; Radermacher M, 2006, J STRUCT BIOL, V154, P269, DOI 10.1016/j.jsb.2006.02.011; Remacle C, 2008, MOL GENET GENOMICS, V280, P93, DOI 10.1007/s00438-008-0350-5; Siendones E, 1999, PLANT PHYSIOL, V120, P907, DOI 10.1104/pp.120.3.907; Sunderhaus S, 2006, J BIOL CHEM, V281, P6482, DOI 10.1074/jbc.M511542200; Sunderhaus Stephanie, 2007, Methods Mol Biol, V372, P315, DOI 10.1007/978-1-59745-365-3_23; Vogel RO, 2007, BBA-BIOENERGETICS, V1767, P1215, DOI 10.1016/j.bbabio.2007.07.008; Werhahn W, 2001, PLANT PHYSIOL, V125, P943, DOI 10.1104/pp.125.2.943; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131	53	58	60	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14412	14419		10.1074/jbc.M111.305144	http://dx.doi.org/10.1074/jbc.M111.305144			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22378782	Green Published, hybrid			2022-12-27	WOS:000304003200009
J	Toulme, E; Khakh, BS				Toulme, Estelle; Khakh, Baljit S.			Imaging P2X4 Receptor Lateral Mobility in Microglia REGULATION BY CALCIUM AND p38 MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL-NERVE INJURY; P2X(4) RECEPTORS; SPINAL MICROGLIA; UP-REGULATION; ATP SENSORS; AMINO-ACIDS; ION-CHANNEL; QUANTUM-DOT; TRAFFICKING; IDENTIFICATION	ATP-gated ionotropic P2X4 receptors are up-regulated in activated microglia and are critical for the development of neuropathic pain, a microglia-associated disorder. However, the nature of how plasma membrane P2X4 receptors are regulated in microglia is not fully understood. We used single-molecule imaging to track quantum dot-labeled P2X4 receptors to explore P2X4 receptor mobility in the processes of resting and activated microglia. We find that plasma membrane P2X4 receptor lateral mobility in resting microglial processes is largely random, consisting of mobile and slowly mobile receptors. Moreover, lateral mobility is P2X subunit-and cell-specific, increased in an ATP activation and calcium-dependent manner, and enhanced in activated microglia by the p38 MAPK pathway that selectively regulates slowly mobile receptors. Thus, our data indicate that P2X4 receptors are dynamically regulated mobile ATP sensors, sampling more of the plasma membrane in response to ATP and during the activated state of microglia that is associated with nervous system dysfunction.	[Toulme, Estelle; Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Khakh, BS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	bkhakh@mednet.ucla.edu			National Institutes of Health [NS073980]; Johnson Johnson; Stein-Oppenheimer Foundation; UCLA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS073980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Stein-Oppenheimer Foundation; UCLA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS073980. This work was also supported by an award from Johnson & Johnson, a Stein-Oppenheimer Foundation Endowment Award, and unrestricted funds from UCLA (to B. S. K.).	Alcor D, 2009, EUR J NEUROSCI, V30, P987, DOI 10.1111/j.1460-9568.2009.06927.x; Alliot F, 1996, DEV BRAIN RES, V95, P140, DOI 10.1016/0165-3806(96)00101-0; Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; Boumechache M, 2009, J BIOL CHEM, V284, P13446, DOI 10.1074/jbc.M901255200; Bowler JW, 2003, BRIT J PHARMACOL, V140, P567, DOI 10.1038/sj.bjp.0705459; Bowser DN, 2007, J GEN PHYSIOL, V129, P485, DOI 10.1085/jgp.200709780; Chaumont S, 2004, J BIOL CHEM, V279, P29628, DOI 10.1074/jbc.M403940200; Choquet D, 2010, EUR J NEUROSCI, V32, P250, DOI 10.1111/j.1460-9568.2010.07350.x; Cook SP, 2002, PAIN, V95, P41, DOI 10.1016/S0304-3959(01)00372-4; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Dutton JL, 2000, NEUROPHARMACOLOGY, V39, P2054, DOI 10.1016/S0028-3908(00)00058-7; Egan TM, 2006, PFLUG ARCH EUR J PHY, V452, P501, DOI 10.1007/s00424-006-0078-1; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Ennion SJ, 2001, FEBS LETT, V489, P154, DOI 10.1016/S0014-5793(01)02102-0; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Gerrow K, 2010, CURR OPIN NEUROBIOL, V20, P631, DOI 10.1016/j.conb.2010.06.010; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Inoue K, 2008, CELL MOL LIFE SCI, V65, P3074, DOI 10.1007/s00018-008-8210-3; Jaiswal JK, 2007, NAT CHEM BIOL, V3, P92, DOI 10.1038/nchembio855; Jarvis MF, 2010, TRENDS NEUROSCI, V33, P48, DOI 10.1016/j.tins.2009.10.003; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Jiang LH, 2003, J NEUROSCI, V23, P8903; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 2005, J BIOL CHEM, V280, P6118, DOI 10.1074/jbc.M411324200; Khakh BS, 2001, PHARMACOL REV, V53, P107; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Lalo U, 2011, J BIOL CHEM, V286, P30591, DOI 10.1074/jbc.M111.253153; Lalo U, 2010, J NEUROCHEM, V113, P1177, DOI 10.1111/j.1471-4159.2010.06730.x; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Michalet X, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041914; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Murrell-Lagnado R, 2009, J PHYSIOL-LONDON, V587, P2713, DOI 10.1113/jphysiol.2009.174961; Murrell-Lagnado RD, 2008, MOL MEMBR BIOL, V25, P321, DOI 10.1080/09687680802050385; Nakajima K., 2005, NEUROGLIA, V2, P443; Nasu-Tada K, 2006, GLIA, V53, P769, DOI 10.1002/glia.20339; Pinaud F, 2010, NAT METHODS, V7, P275, DOI [10.1038/nmeth.1444, 10.1038/NMETH.1444]; Pinaud F, 2009, TRAFFIC, V10, P691, DOI 10.1111/j.1600-0854.2009.00902.x; Priel A, 2004, J GEN PHYSIOL, V123, P281, DOI 10.1085/jgp.200308986; Richler E, 2008, NAT METHODS, V5, P87, DOI 10.1038/NMETH1144; Richler E, 2011, J NEUROSCI, V31, P16716, DOI 10.1523/JNEUROSCI.3362-11.2011; Royle SJ, 2005, J CELL SCI, V118, P3073, DOI 10.1242/jcs.02451; Royle SJ, 2002, J BIOL CHEM, V277, P35378, DOI 10.1074/jbc.M204844200; Samways DSK, 2007, J GEN PHYSIOL, V129, P245, DOI 10.1085/jgp.200609677; Samways DSK, 2012, J BIOL CHEM, V287, P7594, DOI 10.1074/jbc.M111.322461; SAXTON MJ, 1993, BIOPHYS J, V64, P1766, DOI 10.1016/S0006-3495(93)81548-0; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; Shrivastava AN, 2011, J BIOL CHEM, V286, P14455, DOI 10.1074/jbc.M110.165282; Stokes L, 2009, EUR J IMMUNOL, V39, P986, DOI 10.1002/eji.200838818; Stoop R, 1999, MOL PHARMACOL, V56, P973, DOI 10.1124/mol.56.5.973; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Toulme E, 2010, J GEN PHYSIOL, V135, P333, DOI 10.1085/jgp.200910336; Town T, 2006, J IMMUNOL, V176, P3804, DOI 10.4049/jimmunol.176.6.3804; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Ulmann L, 2008, J NEUROSCI, V28, P11263, DOI 10.1523/JNEUROSCI.2308-08.2008; Ulmann L, 2010, EMBO J, V29, P2290, DOI 10.1038/emboj.2010.126; Young MT, 2008, J BIOL CHEM, V283, P26241, DOI 10.1074/jbc.M804458200	63	36	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14734	14748		10.1074/jbc.M111.329334	http://dx.doi.org/10.1074/jbc.M111.329334			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22393055	hybrid, Green Published			2022-12-27	WOS:000304003200039
J	Correnti, C; Strong, RK				Correnti, Colin; Strong, Roland K.			Mammalian Siderophores, Siderophore-binding Lipocalins, and the Labile Iron Pool	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GELATINASE-ASSOCIATED LIPOCALIN; TRANSFERRIN RECEPTOR; IMMUNE-SYSTEM; PATHOGENICITY ISLAND; MEDIATED SUPPRESSION; TRANSPORT COMPOUNDS; ESCHERICHIA-COLI; ENTEROBACTIN; SIDEROCALIN; HOMEOSTASIS	Bacteria use tight-binding, ferric-specific chelators called siderophores to acquire iron from the environment and from the host during infection; animals use proteins such as transferrin and ferritin to transport and store iron. Recently, candidate compounds that could serve endogenously as mammalian siderophore equivalents have been identified and characterized through associations with siderocalin, the only mammalian siderophore-binding protein currently known. Siderocalin, an antibacterial protein, acts by sequestering iron away from infecting bacteria as siderophore complexes. Candidate endogenous siderophores include compounds that only effectively transport iron as ternary complexes with siderocalin, explaining pleiotropic activities in normal cellular processes and specific disease states.	[Correnti, Colin; Strong, Roland K.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Strong, RK (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	rstrong@fhcrc.org			National Institutes of Health [AI059432, DK073462, DK091729]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073462, R21DK091729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AI059432, DK073462, and DK091729. This is the third article in the Thematic Minireview Series on Metals in Biology 2012.	Abergel RJ, 2008, J AM CHEM SOC, V130, P11524, DOI 10.1021/ja803524w; Abergel RJ, 2006, P NATL ACAD SCI USA, V103, P18499, DOI 10.1073/pnas.0607055103; Abergel RJ, 2006, J AM CHEM SOC, V128, P10998, DOI 10.1021/ja062476+; AISEN P, 1978, J BIOL CHEM, V253, P1930; Anderson GJ, 2001, IUBMB LIFE, V51, P11, DOI 10.1080/15216540152035000; Anderson GJ, 2009, CELL MOL LIFE SCI, V66, P3241, DOI 10.1007/s00018-009-0051-1; Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; Andrews NC, 1999, INT J BIOCHEM CELL B, V31, P991, DOI 10.1016/S1357-2725(99)00065-5; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; BARGHOUTHI S, 1989, J BACTERIOL, V171, P1811, DOI 10.1128/jb.171.4.1811-1816.1989; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Breuer W, 2008, INT J BIOCHEM CELL B, V40, P350, DOI 10.1016/j.biocel.2007.03.010; Carniel E, 2001, MICROBES INFECT, V3, P561, DOI 10.1016/S1286-4579(01)01412-5; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; Cherayil BJ, 2011, IMMUNOL RES, V50, P1, DOI 10.1007/s12026-010-8199-1; Clifton MC, 2009, BIOMETALS, V22, P557, DOI 10.1007/s10534-009-9207-6; Cornelissen CN, 2003, FRONT BIOSCI-LANDMRK, V8, pD836, DOI 10.2741/1076; CORNELISSEN CN, 1994, MOL MICROBIOL, V14, P843, DOI 10.1111/j.1365-2958.1994.tb01320.x; Coudevylle N, 2010, J BIOL CHEM, V285, P41646, DOI 10.1074/jbc.M110.123331; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Di Marco E, 2003, J CELL PHYSIOL, V196, P464, DOI 10.1002/jcp.10310; FERNANDEZPOL JA, 1978, CELL, V14, P489, DOI 10.1016/0092-8674(78)90235-0; Fischbach MA, 2006, P NATL ACAD SCI USA, V103, P16502, DOI 10.1073/pnas.0604636103; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Fluckinger M, 2004, ANTIMICROB AGENTS CH, V48, P3367, DOI 10.1128/AAC.48.9.3367-3372.2004; FORD S, 1988, EUR J BIOCHEM, V178, P477, DOI 10.1111/j.1432-1033.1988.tb14473.x; GARIBALDI JA, 1956, NATURE, V177, P526, DOI 10.1038/177526a0; Gentili C, 2005, J CELL PHYSIOL, V202, P683, DOI 10.1002/jcp.20165; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Graham RD, 2003, J NUTR, V133, p1502S, DOI 10.1093/jn/133.5.1502S; Guo K, 2006, J BIOL CHEM, V281, P10291, DOI 10.1074/jbc.M511346200; Halaas O, 2010, J INFECT DIS, V201, P783, DOI 10.1086/650493; Hartl M, 2003, J MOL BIOL, V333, P33, DOI 10.1016/j.jmb.2003.08.018; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hoette TM, 2008, J AM CHEM SOC, V130, P17584, DOI 10.1021/ja8074665; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; Hou ZG, 1998, INORG CHEM, V37, P6630, DOI 10.1021/ic9810182; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; JACOBS A, 1977, BLOOD, V50, P433; JONES RL, 1980, J EXP MED, V151, P418, DOI 10.1084/jem.151.2.418; Jurado RL, 1997, CLIN INFECT DIS, V25, P888, DOI 10.1086/515549; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; Kehrer JP, 2010, CELL BIOL TOXICOL, V26, P83, DOI 10.1007/s10565-009-9119-9; Klausen P, 2005, EUR J HAEMATOL, V75, P332, DOI 10.1111/j.1600-0609.2005.00511.x; Klee SR, 2000, INFECT IMMUN, V68, P2082, DOI 10.1128/IAI.68.4.2082-2095.2000; Klumpp C, 2005, BIOORG MED CHEM LETT, V15, P1721, DOI 10.1016/j.bmcl.2005.01.034; Kosman DJ, 2010, J BIOL CHEM, V285, P26729, DOI 10.1074/jbc.R110.113217; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; LEIBMAN A, 1977, BIOCHEMISTRY-US, V16, P1268, DOI 10.1021/bi00626a004; Leng X, 2008, ONCOGENE, V27, P6110, DOI 10.1038/onc.2008.209; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Lieu Pauline T., 2001, Molecular Aspects of Medicine, V22, P1, DOI 10.1016/S0098-2997(00)00006-6; Lin H, 2005, ONCOGENE, V24, P3246, DOI 10.1038/sj.onc.1208500; Liu ZM, 2011, J BIOL CHEM, V286, P20606, DOI 10.1074/jbc.M110.216549; LOOMIS LD, 1991, INORG CHEM, V30, P906, DOI 10.1021/ic00005a008; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; MULLIS KB, 1971, BIOCHEMISTRY-US, V10, P4894, DOI 10.1021/bi00802a010; Nadadur SS, 2008, INDIAN J MED RES, V128, P533; NEILANDS JB, 1981, ANNU REV BIOCHEM, V50, P715, DOI 10.1146/annurev.bi.50.070181.003435; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; OTTO BR, 1992, CRIT REV MICROBIOL, V18, P217, DOI 10.3109/10408419209114559; Pierre JL, 2002, BIOMETALS, V15, P341, DOI 10.1023/A:1020259021641; Ponka P, 1998, SEMIN HEMATOL, V35, P35; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Ratledge C, 1996, MICROBIOL-UK, V142, P2207, DOI 10.1099/13500872-142-8-2207; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; RAYMOND KN, 1979, ACCOUNTS CHEM RES, V12, P183, DOI 10.1021/ar50137a004; Recalcati S, 2010, ANTIOXID REDOX SIGN, V13, P1593, DOI 10.1089/ars.2009.2983; Sanchez P, 2005, DALTON T, P811, DOI 10.1039/b416669h; Schmidt-Ott KM, 2007, J AM SOC NEPHROL, V18, P407, DOI 10.1681/ASN.2006080882; STACK TDP, 1992, J AM CHEM SOC, V114, P1512, DOI 10.1021/ja00030a075; Theil EC, 2009, CHEM REV, V109, P4568, DOI 10.1021/cr900052g; TREFFRY A, 1992, FEBS LETT, V302, P108, DOI 10.1016/0014-5793(92)80417-F; Vallerio LG, 2007, TOXICOL MECH METHOD, V17, P497, DOI 10.1080/15376510701556690; Vokes SA, 1999, MOL MICROBIOL, V33, P63, DOI 10.1046/j.1365-2958.1999.01448.x; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Wang LJ, 2009, J INNATE IMMUN, V1, P455, DOI 10.1159/000210016; WARNER PJ, 1981, INFECT IMMUN, V33, P540, DOI 10.1128/IAI.33.2.540-545.1981; Weber KA, 2006, NAT REV MICROBIOL, V4, P752, DOI 10.1038/nrmicro1490; WEINBERG ED, 1984, PHYSIOL REV, V64, P65, DOI 10.1152/physrev.1984.64.1.65; Wessling-Resnick M, 1999, CRIT REV BIOCHEM MOL, V34, P285, DOI 10.1080/10409239991209318; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106	87	86	89	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13524	13531		10.1074/jbc.R111.311829	http://dx.doi.org/10.1074/jbc.R111.311829			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22389496	hybrid, Green Published			2022-12-27	WOS:000303996300004
J	di Tommaso, A; Juste, MO; Martin-Eauclaire, MF; Dimier-Poisson, I; Billiald, P; Aubrey, N				di Tommaso, Anne; Juste, Matthieu O.; Martin-Eauclaire, Marie-France; Dimier-Poisson, Isabelle; Billiald, Philippe; Aubrey, Nicolas			Diabody Mixture Providing Full Protection against Experimental Scorpion Envenoming with Crude Androctonus australis Venom	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BUTHUS-OCCITANUS-TUNETANUS; CHAIN ANTIBODY FRAGMENT; CLINICAL CHARACTERISTICS; ANTIVENOM IMMUNOTHERAPY; FUNCTIONAL-EVALUATION; HECTOR; TOXIN; ENVENOMATION; PHARMACOKINETICS; OPTIMIZATION	Androctonus australis is primarily involved in envenomations in North Africa, notably in Tunisia and Algeria, and constitutes a significant public health problem in this region. The toxicity of the venom is mainly due to various neurotoxins that belong to two distinct structural and immunological groups, group I (the AahI and AahIII toxins) and group II (AahII). Here, we report the use of a diabody mixture in which the molar ratio matches the characteristics of toxins and polymorphism of the venom. The mixture consists of the Db9C2 diabody (anti-group I) and the Db4C1op diabody (anti-AahII), the latter being modified to facilitate in vitro production and purification. The effectiveness of the antivenom was tested in vivo under conditions simulating scorpion envenomation. The intraperitoneal injection of 30 mu g of the diabody mixture protected almost all the mice exposed to 3 LD50 s.c. of venom. We also show that the presence of both diabodies is necessary for the animals to survive. Our results are the first demonstration of the strong protective power of small quantities of antivenom used in the context of severe envenomation with crude venom.	[Aubrey, Nicolas] Univ Tours, Fac Pharm, Infectiol & Sante Publ UMR1282, F-37200 Tours, France; [di Tommaso, Anne; Juste, Matthieu O.; Dimier-Poisson, Isabelle; Aubrey, Nicolas] INRA, Infectiol & Sante Publ UMR1282, F-37380 Nouzilly, France; [Martin-Eauclaire, Marie-France] Univ Mediterranee, CRN2M, CNRS UMR6231, F-13344 Marseille 15, France; [Billiald, Philippe] Univ Paris 11, IFR 141, F-92260 Chatenay Malabry, France	Universite de Tours; INRAE; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Aubrey, N (corresponding author), Univ Tours, Fac Pharm, Infectiol & Sante Publ UMR1282, 31 Ave Monge, F-37200 Tours, France.	aubrey@univ-tours.fr	BILLIALD, Philippe/ABF-7417-2021	BILLIALD, Philippe/0000-0001-8148-5297; , nicolas/0000-0003-3211-0186				Abroug F, 1999, LANCET, V354, P906, DOI 10.1016/S0140-6736(98)12083-4; Adi-Bessalem S, 2008, EXP TOXICOL PATHOL, V60, P373, DOI 10.1016/j.etp.2008.03.006; APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8; Aubrey N, 2004, TOXICON, V43, P233, DOI 10.1016/j.toxicon.2003.11.024; Aubrey N, 2003, CELL MOL LIFE SCI, V60, P617, DOI 10.1007/s000180300053; Ben Abderrazek R, 2009, BIOCHEM J, V424, P263, DOI 10.1042/BJ20090697; Benguedda AC, 2002, B SOC PATHOL EXOT, V95, P205; Benkhadir K, 2004, PEPTIDES, V25, P151, DOI 10.1016/j.peptides.2004.01.009; Bouaziz M, 2008, TOXICON, V52, P918, DOI 10.1016/j.toxicon.2008.09.004; Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021; Chippaux JP, 1998, TOXICON, V36, P823, DOI 10.1016/S0041-0101(97)00160-8; Chowell G, 2006, TOXICON, V47, P753, DOI 10.1016/j.toxicon.2006.02.004; Dart RC, 2001, ANN EMERG MED, V37, P181, DOI 10.1067/mem.2001.113372; DELORI P, 1981, TOXICON, V19, P393, DOI 10.1016/0041-0101(81)90044-1; Devaux C, 2004, TOXICON, V43, P661, DOI 10.1016/j.toxicon.2004.02.021; Devaux C, 2002, J IMMUNOL METHODS, V271, P37, DOI 10.1016/S0022-1759(02)00338-1; Devaux C, 2001, EUR J BIOCHEM, V268, P694, DOI 10.1046/j.1432-1327.2001.01923.x; ELAYEB M, 1985, TOXICON, V23, P755, DOI 10.1016/0041-0101(85)90005-4; ELAYEB M, 1986, BIOCHEMISTRY-US, V25, P6671, DOI 10.1021/bi00369a052; Hammoudi-Triki D, 2007, TOXICOL APPL PHARM, V218, P205, DOI 10.1016/j.taap.2006.11.003; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Hmila I, 2008, MOL IMMUNOL, V45, P3847, DOI 10.1016/j.molimm.2008.04.011; Hmila I, 2010, FASEB J, V24, P3479, DOI 10.1096/fj.09-148213; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Ismail M, 1998, TOXICON, V36, P1523, DOI 10.1016/S0041-0101(98)00144-5; Juarez-Gonzalez VR, 2005, J MOL BIOL, V346, P1287, DOI 10.1016/j.jmb.2004.12.060; Juste M, 2007, CELL MOL LIFE SCI, V64, P206, DOI 10.1007/s00018-006-6401-3; Krifi MN, 2005, TOXICON, V45, P187, DOI 10.1016/j.toxicon.2004.10.007; Krifi MN, 2001, TOXICON, V39, P1317, DOI 10.1016/S0041-0101(01)00083-6; Mansour N, 2001, Arch Inst Pasteur Tunis, V78, P25; MARTIN MF, 1986, TOXICON, V24, P1131, DOI 10.1016/0041-0101(86)90139-X; Meddeb-Mouelhi F, 2003, TOXICON, V42, P785, DOI 10.1016/j.toxicon.2003.10.021; MIRANDA F, 1970, EUR J BIOCHEM, V16, P514, DOI 10.1111/j.1432-1033.1970.tb01111.x; Mousli M, 1999, FEBS LETT, V442, P183, DOI 10.1016/S0014-5793(98)01647-0; Muyldermans S, 2001, J Biotechnol, V74, P277; Muzard J, 2009, ANAL BIOCHEM, V388, P331, DOI 10.1016/j.ab.2009.02.035; Njah M, 2001, Sante, V11, P57; Prendini L, 2005, CLADISTICS, V21, P446, DOI 10.1111/j.1096-0031.2005.00073.x; Sambrook J., 2001, MOL CLONING LAB MANU; TOMLINSON IM, 1992, J MOL BIOL, V227, P776, DOI 10.1016/0022-2836(92)90223-7	40	14	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14149	14156		10.1074/jbc.M112.348912	http://dx.doi.org/10.1074/jbc.M112.348912			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22375011	Green Published, hybrid			2022-12-27	WOS:000303996300067
J	Nicolet, Y; Fontecilla-Camps, JC				Nicolet, Yvain; Fontecilla-Camps, Juan C.			Structure-Function Relationships in [FeFe]-Hydrogenase Active Site Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HYDROGENASE H-CLUSTER; DEPENDENT RADICAL ENZYME; AMINO-ACID-SEQUENCE; IRON-SULFUR CLUSTER; FE-ONLY HYDROGENASE; CRYSTAL-STRUCTURE; DESULFOVIBRIO-DESULFURICANS; TRICHOMONAS-VAGINALIS; THERMOTOGA-MARITIMA; CARBON-MONOXIDE	Since the discovery that, despite the active site complexity, only three gene products suffice to obtain active recombinant [FeFe]-hydrogenase, significant light has been shed on this process. Both the source of the CO and CN- ligands to iron and the assembly site of the catalytic subcluster are known, and an apo structure of HydF has been published recently. However, the nature of the substrate(s) for the synthesis of the bridging dithiolate ligand to the subcluster remains to be established. From both spectroscopy and model chemistry, it is predicted that an amine function in this ligand plays a central role in catalysis, acting as a base in the heterolytic cleavage of hydrogen.	[Nicolet, Yvain; Fontecilla-Camps, Juan C.] Univ Grenoble 1, CNRS, Commissariat Energie Atom, Inst Biol Struct Jean Pierre Ebel,Metalloprot Uni, F-38027 Grenoble 1, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Fontecilla-Camps, JC (corresponding author), Univ Grenoble 1, CNRS, Commissariat Energie Atom, Inst Biol Struct Jean Pierre Ebel,Metalloprot Uni, F-38027 Grenoble 1, France.	juan.fontecilla@ibs.fr	Yvain, Nicolet/AAP-9763-2020	Yvain, Nicolet/0000-0002-4189-7067	Agence Nationale de la Recherche [ANR-08-BLAN-0224-01]; Commissariat a l'Energie Atomique et aux Energies Alternatives; CNRS	Agence Nationale de la Recherche(French National Research Agency (ANR)); Commissariat a l'Energie Atomique et aux Energies Alternatives; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Agence Nationale de la Recherche Contract ANR-08-BLAN-0224-01 and by institutional funds from the Commissariat a l'Energie Atomique et aux Energies Alternatives and CNRS. This is the fourth article in the Thematic Minireview Series on Metals in Biology 2012.	ADAMS MWW, 1990, BIOCHIM BIOPHYS ACTA, V1020, P115, DOI 10.1016/0005-2728(90)90044-5; Barton BE, 2008, J AM CHEM SOC, V130, P16834, DOI 10.1021/ja8057666; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Berto P, 2011, BIOCHEM BIOPH RES CO, V405, P678, DOI 10.1016/j.bbrc.2011.01.095; Brazzolotto X, 2006, J BIOL CHEM, V281, P769, DOI 10.1074/jbc.M510310200; Cendron L, 2011, J BIOL CHEM, V286, P43944, DOI 10.1074/jbc.M111.281956; Cornish AJ, 2011, J BIOL CHEM, V286, P38341, DOI 10.1074/jbc.M111.254664; Czech I, 2011, FEBS LETT, V585, P225, DOI 10.1016/j.febslet.2010.11.052; Czech I, 2010, FEBS LETT, V584, P638, DOI 10.1016/j.febslet.2009.12.016; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; ELLIS JE, 1992, MOL BIOCHEM PARASIT, V56, P79, DOI 10.1016/0166-6851(92)90156-E; Erdem OF, 2011, ANGEW CHEM INT EDIT, V50, P1439, DOI 10.1002/anie.201006244; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Grigoropoulos A, 2010, J BIOL INORG CHEM, V15, P1177, DOI 10.1007/s00775-010-0698-y; Grodkowski J, 2001, J PHYS CHEM B, V105, P4967, DOI 10.1021/jp004567d; HAPPE T, 1993, EUR J BIOCHEM, V214, P475, DOI 10.1111/j.1432-1033.1993.tb17944.x; HATCHIKIAN EC, 1992, EUR J BIOCHEM, V209, P357, DOI 10.1111/j.1432-1033.1992.tb17297.x; Helm ML, 2011, SCIENCE, V333, P863, DOI 10.1126/science.1205864; Jarrett JT, 2005, ARCH BIOCHEM BIOPHYS, V433, P312, DOI 10.1016/j.abb.2004.10.003; JOHNSON WR, 1971, J ORG CHEM, V36, P189, DOI 10.1021/jo00800a038; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Kriek M, 2007, ANGEW CHEM INT EDIT, V46, P9223, DOI 10.1002/anie.200702554; Kuchenreuther JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020346; Kuchenreuther JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007565; Lloyd D, 2002, MICROBIOL-SGM, V148, P727, DOI 10.1099/00221287-148-3-727; McGlynn SE, 2008, FEBS LETT, V582, P2183, DOI 10.1016/j.febslet.2008.04.063; McGlynn SE, 2007, J BIOL INORG CHEM, V12, P443, DOI 10.1007/s00775-007-0224-z; Menon S, 1996, BIOCHEMISTRY-US, V35, P15814, DOI 10.1021/bi9615598; Mulder DW, 2010, NATURE, V465, P248, DOI 10.1038/nature08993; Mulder DW, 2009, BIOCHEMISTRY-US, V48, P6240, DOI 10.1021/bi9000563; Nicolet Y, 2002, J INORG BIOCHEM, V91, P1, DOI 10.1016/S0162-0134(02)00392-6; Nicolet Y, 2004, NUCLEIC ACIDS RES, V32, P4015, DOI 10.1093/nar/gkh728; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Nicolet Y, 2001, J AM CHEM SOC, V123, P1596, DOI 10.1021/ja0020963; Nicolet Y, 2008, J BIOL CHEM, V283, P18861, DOI 10.1074/jbc.M801161200; Nicolet Y, 2010, INT J HYDROGEN ENERG, V35, P10750, DOI 10.1016/j.ijhydene.2010.02.056; Nicolet Y, 2010, FEBS LETT, V584, P4197, DOI 10.1016/j.febslet.2010.09.008; Nixon JEJ, 2003, BIOL BULL-US, V204, P1, DOI 10.2307/1543490; O'Hagan M, 2011, J AM CHEM SOC, V133, P14301, DOI 10.1021/ja201838x; Pandey AS, 2008, J AM CHEM SOC, V130, P4533, DOI 10.1021/ja711187e; PAYNE MJ, 1993, FEBS LETT, V317, P101, DOI 10.1016/0014-5793(93)81500-Y; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pilet E, 2009, FEBS LETT, V583, P506, DOI 10.1016/j.febslet.2009.01.004; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Putz S, 2006, EUKARYOT CELL, V5, P579, DOI 10.1128/EC.5.3.579-586.2006; Raulfs EC, 2008, P NATL ACAD SCI USA, V105, P8591, DOI 10.1073/pnas.0803173105; Rubach JK, 2005, FEBS LETT, V579, P5055, DOI 10.1016/j.febslet.2005.07.092; Rubio LM, 2005, J BACTERIOL, V187, P405, DOI 10.1128/JB.187.2.405-414.2005; SAINTMARTIN P, 1988, P NATL ACAD SCI USA, V85, P9378, DOI 10.1073/pnas.85.24.9378; Shepard EM, 2010, J AM CHEM SOC, V132, P9247, DOI 10.1021/ja1012273; Shepard EM, 2010, P NATL ACAD SCI USA, V107, P10448, DOI 10.1073/pnas.1001937107; Shima S, 2008, SCIENCE, V321, P572, DOI 10.1126/science.1158978; Silakov A, 2009, PHYS CHEM CHEM PHYS, V11, P6592, DOI 10.1039/b905841a; Tron C, 2011, EUR J INORG CHEM, P1121, DOI 10.1002/ejic.201001101; Verhagen MFJM, 1999, BBA-BIOENERGETICS, V1412, P212, DOI 10.1016/S0005-2728(99)00062-6	56	60	60	1	59	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13532	13540		10.1074/jbc.R111.310797	http://dx.doi.org/10.1074/jbc.R111.310797			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22389497	hybrid, Green Published			2022-12-27	WOS:000303996300005
J	Sanchez-Gallego, JI; Groeneveld, TWL; Krentz, S; Nilsson, SC; Villoutreix, BO; Blom, AM				Sanchez-Gallego, Jose I.; Groeneveld, Tom W. L.; Krentz, Stefanie; Nilsson, Sara C.; Villoutreix, Bruno O.; Blom, Anna M.			Analysis of Binding Sites on Complement Factor I Using Artificial N-Linked Glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; C3B INACTIVATOR; PROTEIN; BIOSYNTHESIS; INHIBITION; CLEAVAGE; PURIFICATION; DEFICIENCY; CONVERTASE; MUTATIONS	Factor I (FI) is a serine protease that inhibits all complement pathways by degrading activated complement components C3b and C4b. FI functions only in the presence of several cofactors, such as factor H, C4b-binding protein, complement receptor 1, and membrane cofactor protein. FI is composed of two chains linked by a disulfide bridge; the light chain comprises only the serine protease (SP) domain, whereas the heavy chain contains the FI membrane attack complex domain (FIMAC), CD5 domain, and low density lipoprotein receptor 1 (LDLr1) and LDLr2 domains. To better understand how FI inhibits complement, we used homology-based three-dimensional models of FI domains in an attempt to identify potential protein-protein interaction sites. Specific amino acids were then mutated to yield 20 recombinant mutants of FI carrying additional surface-exposed N-glycosylation sites that were expected to sterically hinder interactions. The Michaelis constant (K-m) of all FI mutants toward a small substrate was not increased. We found that many mutations in the FIMAC and SP domains nearly abolished the ability of FI to degrade C4b and C3b in the fluid phase and on the surface, irrespective of the cofactor used. On the other hand, only a few alterations in the CD5 and LDLr1/2 domains impaired this activity. In conclusion, all analyzed cofactors form similar trimolecular complexes with FI and C3b/C4b, and the accessibility of FIMAC and SP domains is crucial for the function of FI.	[Sanchez-Gallego, Jose I.; Groeneveld, Tom W. L.; Krentz, Stefanie; Nilsson, Sara C.; Blom, Anna M.] Lund Univ, Malmo Univ Hosp, Dept Lab Med, S-20502 Malmo, Sweden; [Villoutreix, Bruno O.] Univ Paris Diderot, INSERM, U973, MTi, F-75013 Paris, France	Lund University; Skane University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Blom, AM (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Lab Med, S-20502 Malmo, Sweden.	Anna.Blom@med.lu.se	Blom, Anna/AFS-7369-2022; Blom, Anna/B-9607-2009; Villoutreix, Bruno/I-4565-2015; Sánchez Gallego, José Ignacio/M-9369-2017	Blom, Anna/0000-0002-1348-1734; Villoutreix, Bruno/0000-0002-6456-7730; Sánchez Gallego, José Ignacio/0000-0001-7906-9032; Groeneveld, Tom/0000-0002-9095-3280; Groeneveld-Krentz, Stefanie/0000-0002-0612-7913	Swedish Research Council [K2009-68X-14928-06-3]; Soderberg Foundation; Swedish Foundation for Strategic Research; Foundation of Osterlund; Foundation of Greta and Johan Kock; Foundation of Knut and Alice Wallenberg; Foundation of Inga-Britt and Arne Lundberg	Swedish Research Council(Swedish Research CouncilEuropean Commission); Soderberg Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Foundation of Osterlund; Foundation of Greta and Johan Kock; Foundation of Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); Foundation of Inga-Britt and Arne Lundberg	This work was supported Swedish Research Council Grant K2009-68X-14928-06-3, the Soderberg Foundation, the Swedish Foundation for Strategic Research, and the Foundations of Osterlund, Greta and Johan Kock, Knut and Alice Wallenberg, and Inga-Britt and Arne Lundberg.	Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; CATTERALL CF, 1987, BIOCHEM J, V242, P849, DOI 10.1042/bj2420849; DAHLBACK B, 1983, BLOOD, V62, P218; DISCIPIO RG, 1992, J IMMUNOL, V149, P2592; EKDAHL KN, 1990, J IMMUNOL, V144, P4269; FEARON DT, 1977, J IMMUNOL, V119, P1248; Fremeaux-Bacchi V, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.019083; GIGLI I, 1979, P NATL ACAD SCI USA, V76, P6596, DOI 10.1073/pnas.76.12.6596; GOLDBERGER G, 1984, J BIOL CHEM, V259, P6492; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; JULEN N, 1992, EUR J IMMUNOL, V22, P213, DOI 10.1002/eji.1830220131; Kavanagh D, 2008, MOL IMMUNOL, V45, P95, DOI 10.1016/j.molimm.2007.05.004; MEDOF ME, 1984, J EXP MED, V159, P1669, DOI 10.1084/jem.159.6.1669; Nilsson SC, 2007, MOL IMMUNOL, V44, P1835, DOI 10.1016/j.molimm.2006.10.005; Nilsson SC, 2011, MOL IMMUNOL, V48, P1611, DOI 10.1016/j.molimm.2011.04.004; Nilsson SC, 2010, J BIOL CHEM, V285, P6235, DOI 10.1074/jbc.M109.097212; Nilsson SC, 2010, EUR J IMMUNOL, V40, P172, DOI 10.1002/eji.200939280; Nilsson SC, 2009, EUR J IMMUNOL, V39, P310, DOI 10.1002/eji.200838702; Okroj M, 2008, MOL IMMUNOL, V45, P169, DOI 10.1016/j.molimm.2007.04.025; PERKINS SJ, 1993, BIOCHEM J, V295, P101, DOI 10.1042/bj2950101; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Roversi P, 2011, P NATL ACAD SCI USA, V108, P12839, DOI 10.1073/pnas.1102167108; SEYA T, 1986, J EXP MED, V163, P837, DOI 10.1084/jem.163.4.837; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Spiller OB, 2003, J BIOL CHEM, V278, P9283, DOI 10.1074/jbc.M211579200; Sunyer JO, 1998, IMMUNOL TODAY, V19, P519; Timar KK, 2007, MOL IMMUNOL, V44, P2943, DOI 10.1016/j.molimm.2007.01.007; Tsiftsoglou SA, 2004, J IMMUNOL, V173, P367, DOI 10.4049/jimmunol.173.1.367; Tsiftsoglou SA, 2006, BBA-PROTEINS PROTEOM, V1764, P1757, DOI 10.1016/j.bbapap.2006.09.007; Vyse TJ, 1996, J CLIN INVEST, V97, P925, DOI 10.1172/JCI118515; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WHALEY K, 1980, J EXP MED, V151, P501, DOI 10.1084/jem.151.3.501; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755	33	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13572	13583		10.1074/jbc.M111.326298	http://dx.doi.org/10.1074/jbc.M111.326298			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22393059	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000303996300014
J	Yin, L; Dragnea, V; Bauer, CE				Yin, Liang; Dragnea, Vladimira; Bauer, Carl E.			PpsR, a Regulator of Heme and Bacteriochlorophyll Biosynthesis, Is a Heme-sensing Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHESIS GENE-EXPRESSION; RHODOBACTER-CAPSULATUS; OXYGEN SENSOR; DEPENDENT DEGRADATION; BINDING-SITES; IRR PROTEIN; DNA-BINDING; SPHAEROIDES; KINASE; REDOX	Heme-mediated regulation, presented in many biological processes, is achieved in part with proteins containing heme regulatory motif. In this study, we demonstrate that FLAG-tagged PpsR isolated from Rhodobacter sphaeroides cells contains bound heme. In vitro heme binding studies with tagless apo-PpsR show that PpsR binds heme at a near one-to-one ratio with a micromolar binding constant. Mutational and spectral assays suggest that both the second Per-Arnt-Sim (PAS) and DNA binding domains of PpsR are involved in the heme binding. Furthermore, we show that heme changes the DNA binding patterns of PpsR and induces different responses of photosystem genes expression. Thus, PpsR functions as both a redox and heme sensor to coordinate the amount of heme, bacteriochlorophyll, and photosystem apoprotein synthesis thereby providing fine tune control to avoid excess free tetrapyrrole accumulation.	[Yin, Liang; Dragnea, Vladimira; Bauer, Carl E.] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Bauer, CE (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Simon Hall MSB,212 S Hawthorne Dr, Bloomington, IN 47405 USA.	bauer@indiana.edu	Yin, Liang/H-8171-2013	Yin, Liang/0000-0001-6957-6903	National Institutes of Health [R37 GM040941]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM040941] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 GM040941 (to C. E. B.).	Atamna H, 2004, P NATL ACAD SCI USA, V101, P11153, DOI 10.1073/pnas.0404349101; Atamna H, 2002, P NATL ACAD SCI USA, V99, P14807, DOI 10.1073/pnas.192585799; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Boon EM, 2005, NAT CHEM BIOL, V1, P53, DOI 10.1038/nchembio704; Dawson R.M., 1969, DATA BIOCH RES, P316; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; Elsen S, 1998, J BIOL CHEM, V273, P30762, DOI 10.1074/jbc.273.46.30762; GILLESGONZALEZ MA, 1994, BIOCHEMISTRY-US, V33, P8067, DOI 10.1021/bi00192a011; GILLESGONZALEZ MA, 1991, NATURE, V350, P170, DOI 10.1038/350170a0; Gough SP, 2000, P NATL ACAD SCI USA, V97, P6908, DOI 10.1073/pnas.97.12.6908; Han YC, 2007, MOL MICROBIOL, V64, P1090, DOI 10.1111/j.1365-2958.2007.05724.x; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Huang LE, 1999, J BIOL CHEM, V274, P9038, DOI 10.1074/jbc.274.13.9038; Igarashi J, 2008, ACTA CHIM SLOV, V55, P67; IRACE G, 1986, ARCH BIOCHEM BIOPHYS, V244, P459, DOI 10.1016/0003-9861(86)90614-4; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; Marks G. S., 1969, HEME CHLOROPHYLL, P6; Masuda S, 2002, CELL, V110, P613, DOI 10.1016/S0092-8674(02)00876-0; Masuda S, 2002, P NATL ACAD SCI USA, V99, P7078, DOI 10.1073/pnas.102013099; MENDEZ R, 1992, J BIOL CHEM, V267, P11500; Moskvin OV, 2007, J BIOL CHEM, V282, P28740, DOI 10.1074/jbc.M703261200; Moskvin OV, 2005, J BACTERIOL, V187, P2148, DOI 10.1128/JB.187.6.2148-2156.2005; Nickens DG, 1998, J BACTERIOL, V180, P4270, DOI 10.1128/JB.180.16.4270-4277.1998; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3; Ponnampalam SN, 1997, J BIOL CHEM, V272, P18391, DOI 10.1074/jbc.272.29.18391; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Reedy CJ, 2008, NUCLEIC ACIDS RES, V36, pD307, DOI 10.1093/nar/gkm814; SAGE JT, 1991, BIOCHEMISTRY-US, V30, P1227, DOI 10.1021/bi00219a010; Shelver D, 1997, P NATL ACAD SCI USA, V94, P11216, DOI 10.1073/pnas.94.21.11216; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; Yang JH, 2005, J BIOL CHEM, V280, P7671, DOI 10.1074/jbc.M411664200; Yang JH, 2008, MOL CELL BIOL, V28, P4697, DOI 10.1128/MCB.00236-08; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; YUAN HS, 1991, P NATL ACAD SCI USA, V88, P9558, DOI 10.1073/pnas.88.21.9558; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	37	30	31	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13850	13858		10.1074/jbc.M112.346494	http://dx.doi.org/10.1074/jbc.M112.346494			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22378778	Green Published, hybrid			2022-12-27	WOS:000303996300040
J	Figuera-Losada, M; LoGrasso, PV				Figuera-Losada, Mariana; LoGrasso, Philip V.			Enzyme Kinetics and Interaction Studies for Human JNK1 beta 1 and Substrates Activating Transcription Factor 2 (ATF2) and c-Jun N-terminal kinase (c-Jun)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; SIGNAL-TRANSDUCTION; INSULIN-RESISTANCE; PEPTIDE INHIBITOR; JNK ACTIVITY; APOPTOSIS; MECHANISM; BIOSENSOR; ISOFORMS; NEURONS	c-Jun N-terminal kinase (JNK) is a stress signal transducer linked to cell death, and survival. JNK1 has been implicated in obesity, glucose intolerance, and insulin resistance. In this study we report the kinetic mechanism for JNK1 beta 1 with transcription factors ATF2 and c-Jun along with interaction kinetics for these substrates. JNK1 beta 1 followed a random sequential mechanism forming a ternary complex between JNK-substrate-ATP. K-m for ATF2 and c-Jun was 1.1 and 2.8 mu M, respectively. Inhibition studies using adenosine 5'-(beta,gamma-methylenetriphosphate) and a peptide derived from JNK interacting protein 1 (JIP1) supported the proposed kinetic mechanism. Biolayer interferometry studies showed that unphosphorylated JNK1 beta 1 bound to ATF2 with similar affinity as it did to c-Jun (K-D = 2.60 +/- 0.34 versus 1.00 +/- 0.35 mu M, respectively). The presence of ATP increased the affinity of unphosphorylated JNK1 beta 1 for ATF2 and c-Jun, to 0.80 +/- 0.04 versus 0.65 +/- 0.07 mu M, respectively. Phosphorylation of JNK1 beta 1 decreased the affinity of the kinase for ATF2 to 11.0 +/- 1.1 mu M and for c-Jun to 17.0 +/- 7.5 mu M in the absence of ATP. The presence of ATP caused a shift in the KD of the active kinase for ATF2 to 1.70 +/- 0.25 mu M and for c-Jun of 3.50 +/- 0.95 mu M. These results are the first kinetic and biochemical characterization of JNK1 beta 1 and uncover some of the differences in the enzymatic activity of JNK1 beta 1 compared with other variants and suggest that ATP binding or JNK phosphorylation could induce changes in the interactions with substrates, activators, and regulatory proteins.	Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; Scripps Res Inst, Translat Res Inst, Jupiter, FL 33458 USA	Scripps Research Institute; Scripps Research Institute	LoGrasso, PV (corresponding author), 130 Scripps Way, Jupiter, FL 33458 USA.	lograsso@scripps.edu			National Institutes of Health [NS057153]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS057153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS057153 (to P. L.).	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Arthur PG, 2007, J NEUROCHEM, V102, P65, DOI 10.1111/j.1471-4159.2007.04618.x; Barr RK, 2002, J BIOL CHEM, V277, P10987, DOI 10.1074/jbc.M107565200; Bayer E A, 1980, Methods Biochem Anal, V26, P1; Bender K, 1997, J PHOTOCH PHOTOBIO B, V37, P1, DOI 10.1016/S1011-1344(96)07459-3; Bowers S, 2011, BIOORG MED CHEM LETT, V21, P1838, DOI 10.1016/j.bmcl.2011.01.046; Bruckner SR, 2001, J NEUROCHEM, V78, P298, DOI 10.1046/j.1471-4159.2001.00400.x; Burkhard KA, 2011, J BIOL CHEM, V286, P2477, DOI 10.1074/jbc.M110.177899; Chamberlain SD, 2009, BIOORG MED CHEM LETT, V19, P360, DOI 10.1016/j.bmcl.2008.11.077; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dreskin SC, 2001, J IMMUNOL, V166, P5646, DOI 10.4049/jimmunol.166.9.5646; EDWARDS PR, 1995, ANAL BIOCHEM, V231, P210, DOI 10.1006/abio.1995.1522; Ember B, 2008, ARCH BIOCHEM BIOPHYS, V477, P324, DOI 10.1016/j.abb.2008.06.001; Ember B, 2008, BIOCHEMISTRY-US, V47, P3076, DOI 10.1021/bi701852z; Gilbert H. F., 2000, BASIC CONCEPTS BIOCH; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Hara T, 1998, BIOCHEM BIOPH RES CO, V244, P41, DOI 10.1006/bbrc.1998.8210; Hayashi T, 2000, NEUROSCI LETT, V284, P195, DOI 10.1016/S0304-3940(00)01024-7; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hom RK, 2010, BIOORG MED CHEM LETT, V20, P7303, DOI 10.1016/j.bmcl.2010.10.066; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Kamenecka T, 2010, J MED CHEM, V53, P419, DOI 10.1021/jm901351f; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; Klintworth H, 2007, TOXICOL SCI, V97, P149, DOI 10.1093/toxsci/kfm029; Kyriakis JM, 1996, BIOESSAYS, V18, P567, DOI 10.1002/bies.950180708; Leatherbarrow R.J., 2001, GRAFIT; Lisnock J, 2000, BIOCHEMISTRY-US, V39, P3141, DOI 10.1021/bi992410+; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; MOHIT AA, 1995, NEURON, V14, P67, DOI 10.1016/0896-6273(95)90241-4; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; Ngoei KRW, 2011, BIOCHEM J, V434, P399, DOI 10.1042/BJ20101244; Niu LH, 2007, BIOCHEMISTRY-US, V46, P4775, DOI 10.1021/bi602423e; OShannessy DJ, 1996, ANAL BIOCHEM, V236, P275, DOI 10.1006/abio.1996.0167; Probst GD, 2011, BIOORG MED CHEM LETT, V21, P315, DOI 10.1016/j.bmcl.2010.11.010; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Scapin G, 2003, CHEM BIOL, V10, P705, DOI 10.1016/S1074-5521(03)00159-5; Segel I.H., 1975, ENZYME KINETICS; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376, DOI 10.1128/MCB.14.12.8376; Stebbins JL, 2008, P NATL ACAD SCI USA, V105, P16809, DOI 10.1073/pnas.0805677105; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Waeber G, 2000, NAT GENET, V24, P291, DOI 10.1038/73523; WESTWICK JK, 1994, J BIOL CHEM, V269, P26396; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yang JY, 2007, CELL SIGNAL, V19, P2201, DOI 10.1016/j.cellsig.2007.07.001	51	18	18	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13291	13302		10.1074/jbc.M111.323766	http://dx.doi.org/10.1074/jbc.M111.323766			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22351776	Green Published, hybrid			2022-12-27	WOS:000302903700065
J	Li, ZQ; Wang, YQ; Zhang, M; Xu, PF; Huang, HZ; Wu, D; Meng, AM				Li, Zhiqiang; Wang, Yeqi; Zhang, Min; Xu, Pengfei; Huang, Huizhe; Wu, Di; Meng, Anming			The Amotl2 Gene Inhibits Wnt/beta-Catenin Signaling and Regulates Embryonic Development in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELL MIGRATION; BETA-CATENIN; MESODERM INDUCTION; COILED-COIL; ANGIOMOTIN; PROTEIN; PATHWAY; COMPLEX; BINDING; ANGIOGENESIS	The Motin family proteins can regulate cell polarity, cell mobility, and proliferation during embryonic development by controlling distinct signaling pathways. In this study, we demonstrate that amotl2 knockdown in zebrafish wild-type embryos results in embryonic dorsalization, and this effect can be antagonized by co-knockdown of the dorsal inducer beta-catenin2. Overexpression of amotl2 in masterblind (mbl) homozygous embryos, in which canonical Wnt signaling is up-regulated due to an axin1 mutation, transforms eyeless phenotype into smaller eyes, whereas co-knockdown of amot, amotl1, and amotl2 leads to development of smaller eyes in mbl heterozygotes. In cultured mammalian cells, Motin family members all possess the ability to attenuate Wnt/beta-catenin signaling. Focusing on Amotl2, we show that Amotl2 can associate with and trap beta-catenin in the Rab11-positive recycling endosomes, and as a result, the amount of beta-catenin in the cytosol and nucleus is reduced. Thus, our findings provide novel insights into functions of Motin family members and regulation of Wnt/beta-catenin signaling.	[Li, Zhiqiang; Wang, Yeqi; Zhang, Min; Xu, Pengfei; Huang, Huizhe; Wu, Di; Meng, Anming] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Engn, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Meng, Anming] Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Zoology, CAS	Meng, AM (corresponding author), Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Engn, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.	mengam@mail.tsinghua.edu.cn	Meng, Anming/A-4785-2012; Wang, Yeqi/V-8445-2019	Wang, Yeqi/0000-0003-2881-4607; Li, Zhiqiang/0000-0002-2768-5332	Major Science Programs of China [2011CB943800]; National Natural Science Foundation of China [30921004/C061003]	Major Science Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Major Science Programs of China (2011CB943800) and from National Natural Science Foundation of China (30921004/C061003).	Aase K, 2007, GENE DEV, V21, P2055, DOI 10.1101/gad.432007; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Bellipanni G, 2006, DEVELOPMENT, V133, P1299, DOI 10.1242/dev.02295; Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Bratt A, 2002, GENE, V298, P69, DOI 10.1016/S0378-1119(02)00928-9; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Ernkvist M, 2006, FEBS J, V273, P2000, DOI 10.1111/j.1742-4658.2006.05216.x; Ernkvist M, 2008, BBA-MOL CELL RES, V1783, P429, DOI 10.1016/j.bbamcr.2007.11.018; Gagne V, 2009, CELL MOTIL CYTOSKEL, V66, P754, DOI 10.1002/cm.20405; Gao X, 2008, J BIOL CHEM, V283, P35679, DOI 10.1074/jbc.M804088200; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Heisenberg CP, 1996, DEVELOPMENT, V123, P191; Heller B, 2010, J BIOL CHEM, V285, P12308, DOI 10.1074/jbc.M109.096230; Huang HZ, 2007, DEVELOPMENT, V134, P979, DOI 10.1242/dev.02782; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Imajo M, 2012, EMBO J, V31, P1109, DOI 10.1038/emboj.2011.487; Labbe E, 2007, CANCER RES, V67, P75, DOI 10.1158/0008-5472.CAN-06-2559; Langdon YG, 2011, ANNU REV GENET, V45, P357, DOI 10.1146/annurev-genet-110410-132517; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Leung TC, 2003, DEV DYNAM, V228, P424, DOI 10.1002/dvdy.10408; Levchenko T, 2003, J CELL SCI, V116, P3803, DOI 10.1242/jcs.00694; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Pellon-Cardenas O, 2011, CURR DRUG TARGETS, V12, P1216, DOI 10.2174/138945011795906552; Ramel MC, 2004, DEVELOPMENT, V131, P3991, DOI 10.1242/dev.01277; Ranahan WP, 2011, CANCER RES, V71, P2203, DOI 10.1158/0008-5472.CAN-10-1995; Rottbauer W, 2002, CELL, V111, P661, DOI 10.1016/S0092-8674(02)01112-1; Roudier E, 2009, J PHYSIOL-LONDON, V587, P4105, DOI 10.1113/jphysiol.2009.175554; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Stern CD, 2006, INT J DEV BIOL, V50, P3, DOI 10.1387/ijdb.052095cs; Su Y, 2007, FASEB J, V21, P682, DOI 10.1096/fj.06-6246com; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wang YQ, 2011, J BIOL CHEM, V286, P41095, DOI 10.1074/jbc.M111.296806; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; Xiong B, 2006, DEV CELL, V11, P225, DOI 10.1016/j.devcel.2006.06.012; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017; Zhang LX, 2004, SCIENCE, V306, P114, DOI 10.1126/science.1100569; Zhang Y, 2009, J CELL SCI, V122, P2197, DOI 10.1242/jcs.040659; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zheng YJ, 2009, CIRC RES, V105, P260, DOI 10.1161/CIRCRESAHA.109.195156	49	31	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13005	13015		10.1074/jbc.M112.347419	http://dx.doi.org/10.1074/jbc.M112.347419			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22362771	Green Published, hybrid			2022-12-27	WOS:000302903700039
J	Maurer, LM; Ma, WJ; Eickstaedt, NL; Johnson, IA; Tomasini-Johansson, BR; Annis, DS; Mosher, DF				Maurer, Lisa M.; Ma, Wenjiang; Eickstaedt, Nathan L.; Johnson, Ian A.; Tomasini-Johansson, Bianca R.; Annis, Douglas S.; Mosher, Deane F.			Ligation of the Fibrin-binding Domain by beta-Strand Addition Is Sufficient for Expansion of Soluble Fibronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL UPSTREAM DOMAIN; STREPTOCOCCUS-PYOGENES; COLLAGEN-BINDING; STAPHYLOCOCCUS-AUREUS; EXTRACELLULAR-MATRIX; TERMINAL MODULES; PROTEIN F1; SITES; CONFORMATION; FIBROBLASTS	How fibronectin (FN) converts from a compact plasma protein to a fibrillar component of extracellular matrix is not understood. "Functional upstream domain" (FUD), a polypeptide based on F1 adhesin of Streptococcus pyogenes, binds by anti-parallel beta-strand addition to discontinuous sets of N-terminal FN type I modules, 2-5FNI of the fibrin-binding domain and 8-9FNI of the gelatin-binding domain. Such binding blocks assembly of FN. To learn whether ligation of 2-5FNI, 8-9FNI, or the two sets in combination is important for inhibition, we tested "high affinity downstream domain" (HADD), which binds by beta-strand addition to the continuous set of FNI modules, 1-5FNI, comprising the fibrin-binding domain. HADD and FUD were similarly active in blocking fibronectin assembly. Binding of HADD or FUD to soluble plasma FN exposed the epitope to monoclonal antibody mAbIII-10 in the tenth FN type III module ((FNIII)-F-10) and caused expansion of FN as assessed by dynamic light scattering. Soluble N-terminal constructs truncated after (FNI)-F-9 or (FNIII)-F-3 competed better than soluble FN for binding of FUD or HADD to adsorbed FN, indicating that interactions involving type III modules more C-terminal than (FNIII)-F-3 limit beta-strand addition to 1-5FNI within intact soluble FN. Preincubation of FN with mAbIII-10 or heparin modestly increased binding to HADD or FUD. Thus, ligation of FNIII modules involved in binding of integrins and glycosaminoglycans, (FNIII)-F-10 and 12-14FNIII, increases accessibility of 1-5FNI. Allosteric loss of constraining interactions among 1-5FNI, (FNIII)-F-10, and 12-14FNIII likely enables assembly of FN into extracellular fibrils.	[Maurer, Lisa M.; Ma, Wenjiang; Eickstaedt, Nathan L.; Johnson, Ian A.; Tomasini-Johansson, Bianca R.; Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem & Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), Univ Wisconsin, Dept Biomol Chem & Med, 1300 Univ Ave,Rm 4285, Madison, WI 53706 USA.	dfmosher@wisc.edu		Maurer, Lisa/0000-0003-0492-9805	National Institutes of Health [R01 HL021644, T32 AG000213, T32GM008692, R21 NS07647]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL021644 (to D. F. M.), Grants T32 AG000213 and T32GM008692 (predoctoral support to L. M. M.), and Grant R21 NS07647 (to B. T. J.).	Abe Y, 2005, BIOCHEM BIOPH RES CO, V338, P1640, DOI 10.1016/j.bbrc.2005.10.134; Atkin KE, 2010, J BIOL CHEM, V285, P36977, DOI 10.1074/jbc.M110.156935; BALBONA K, 1992, J BIOL CHEM, V267, P20120; Bazigou E, 2009, DEV CELL, V17, P175, DOI 10.1016/j.devcel.2009.06.017; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Bultmann H, 1998, J BIOL CHEM, V273, P2601, DOI 10.1074/jbc.273.5.2601; Ensenberger MG, 2004, BIOPHYS CHEM, V112, P201, DOI 10.1016/j.bpc.2004.07.020; Erat MC, 2010, J BIOL CHEM, V285, P33764, DOI 10.1074/jbc.M110.139394; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Graille M, 2010, STRUCTURE, V18, P710, DOI 10.1016/j.str.2010.03.012; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; HOMANDBERG GA, 1986, BIOCHEMISTRY-US, V25, P6917, DOI 10.1021/bi00370a027; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Lower SK, 2011, P NATL ACAD SCI USA, V108, P18372, DOI 10.1073/pnas.1109071108; Marjenberg ZR, 2011, J BIOL CHEM, V286, P1884, DOI 10.1074/jbc.M110.183053; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; Maurer LM, 2010, THROMB RES, V125, P287, DOI 10.1016/j.thromres.2009.12.017; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; MOSHER DF, 1983, J BIOL CHEM, V258, P6595; Norris NC, 2011, J BIOL CHEM, V286, P38311, DOI 10.1074/jbc.M111.276592; Odermatt E., 1989, FIBRONECTIN, P29; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; PEARLSTEIN E, 1978, INT J CANCER, V22, P32, DOI 10.1002/ijc.2910220108; QUADE BJ, 1988, J BIOL CHEM, V263, P19602; ROCCO M, 1987, EMBO J, V6, P2343, DOI 10.1002/j.1460-2075.1987.tb02510.x; Sachchidanand, 2002, J BIOL CHEM, V277, P50629, DOI 10.1074/jbc.M208956200; Schwarz-Linek U, 2004, J BIOL CHEM, V279, P39017, DOI 10.1074/jbc.M405083200; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; SCHWARZBAUER JE, 1991, J CELL BIOL, V113, P1463, DOI 10.1083/jcb.113.6.1463; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; To WS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-21; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Tucker RP, 2009, INT J BIOCHEM CELL B, V41, P424, DOI 10.1016/j.biocel.2008.08.003; UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; WILLIAMS EC, 1982, J BIOL CHEM, V257, P4973; Xu JL, 2010, J BIOL CHEM, V285, P8563, DOI 10.1074/jbc.M109.062646; Xu JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004113	43	19	19	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13303	13312		10.1074/jbc.M111.294041	http://dx.doi.org/10.1074/jbc.M111.294041			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22351755	hybrid, Green Published			2022-12-27	WOS:000302903700066
J	Osei-Owusu, P; Sabharwal, R; Kaltenbronn, KM; Rhee, MH; Chapleau, MW; Dietrich, HH; Blumer, KJ				Osei-Owusu, Patrick; Sabharwal, Rasna; Kaltenbronn, Kevin M.; Rhee, Man-Hee; Chapleau, Mark W.; Dietrich, Hans H.; Blumer, Kendall J.			Regulator of G Protein Signaling 2 Deficiency Causes Endothelial Dysfunction and Impaired Endothelium-derived Hyperpolarizing Factor-mediated Relaxation by Dysregulating G(i/o) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORCINE CORONARY-ARTERIES; BLOOD-PRESSURE REGULATION; EDHF-TYPE RELAXATION; SENSITIVE G-PROTEIN; DEPENDENT RELAXATIONS; MESENTERIC-ARTERIES; GENETIC-VARIATIONS; RGS PROTEINS; HYPERTENSION; CALCIUM	Regulator of G protein signaling 2 (RGS2) is a GTPase-activating protein for G(q/11)alpha and G(i/o)alpha subunits. RGS2 deficiency is linked to hypertension in mice and humans, although causative mechanisms are not understood. Because endothelial dysfunction and increased peripheral resistance are hallmarks of hypertension, determining whether RGS2 regulates microvascular reactivity may reveal mechanisms relevant to cardiovascular disease. Here we have determined the effects of systemic versus endothelium-or vascular smooth muscle-specific deletion of RGS2 on microvascular contraction and relaxation. Contraction and relaxation of mesenteric resistance arteries were analyzed in response to phenylephrine, sodium nitroprusside, or acetylcholine with or without inhibitors of nitric oxide (NO) synthase or K+ channels that mediate endothelium-derived hyperpolarizing factor (EDHF)-dependent relaxation. The results showed that deleting RGS2 in vascular smooth muscle had minor effects. Systemic or endothelium-specific deletion of RGS2 strikingly inhibited acetylcholine-evoked relaxation. Endothelium-specific deletion of RGS2 had little effect on NO-dependent relaxation but markedly impaired EDHF-dependent relaxation. Acute, inducible deletion of RGS2 in endothelium did not affect blood pressure significantly. Impaired EDHF-mediated vasodilatation was rescued by blocking G(i/o)alpha activation with pertussis toxin. These findings indicated that systemic or endothelium-specific RGS2 deficiency causes endothelial dysfunction resulting in impaired EDHF-dependent vasodilatation. RGS2 deficiency enables endothelial G(i/o) activity to inhibit EDHF-dependent relaxation, whereas RGS2 sufficiency facilitates EDHF-evoked relaxation by squelching endothelial G(i/o) activity. Mutation or down-regulation of RGS2 in hypertension patients therefore may contribute to endothelial dysfunction and defective EDHF-dependent relaxation. Blunting G(i/o) signaling might improve endothelial function in such patients.	[Osei-Owusu, Patrick; Kaltenbronn, Kevin M.; Rhee, Man-Hee; Blumer, Kendall J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Dietrich, Hans H.] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO 63110 USA; [Sabharwal, Rasna; Chapleau, Mark W.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Chapleau, Mark W.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Chapleau, Mark W.] Vet Affairs Med Ctr, Iowa City, IA 52246 USA	Washington University (WUSTL); Washington University (WUSTL); University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Blumer, KJ (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave,Box 8228, St Louis, MO 63110 USA.	kblumer@wustl.edu	Osei-Owusu, Patrick/L-9104-2018; Blumer, Kendall J/C-5268-2012; Rhee, Man Hee/O-5705-2016; Osei-Owusu, Patrick/AAH-9063-2019	Rhee, Man Hee/0000-0002-3088-1318; Sabharwal, Rasna/0000-0001-7256-5359; Chapleau, Mark/0000-0001-6961-931X	National Institutes of Health [HL075632, GM44592, NS30555, HL041250, NS32636, HL14388]; American Heart Association [09POST2260099]; Blumer lab; Dietrich lab; Chapleau lab; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121, R01HL041250, P01HL014388, R01HL075632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030555, P01NS032636] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Blumer lab; Dietrich lab; Chapleau lab; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL075632 and GM44592 (to K. J. B.); NS30555, HL041250, and NS32636 (to H. H. D.); and HL14388 (to M. W. C.). This work was also supported by American Heart Association Postdoctoral Fellowship 09POST2260099 (to P. O.-O.).; We thank members of the Blumer, Dietrich, and Chapleau labs for providing advice and support.	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P579, DOI 10.1016/j.cellsig.2005.08.010; ADEAGBO ASO, 1990, BRIT J PHARMACOL, V100, P427, DOI 10.1111/j.1476-5381.1990.tb15823.x; Baloglu E, 2007, EUR J PHARMACOL, V564, P167, DOI 10.1016/j.ejphar.2007.02.054; Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; Boulanger CM, 1997, J VASC RES, V34, P175, DOI 10.1159/000159221; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; Bryan RM, 1996, ANESTHESIOLOGY, V85, P82, DOI 10.1097/00000542-199607000-00012; BURFORD NT, 1995, EUR J PHARM-MOLEC PH, V289, P343, DOI 10.1016/0922-4106(95)90112-4; Busse R, 2002, TRENDS PHARMACOL SCI, V23, P374, DOI 10.1016/S0165-6147(02)02050-3; Ceroni L, 2007, EUR J PHARMACOL, V560, P193, DOI 10.1016/j.ejphar.2007.01.018; Christopoulos A., 1999, Life Sciences, V64, P1; Dietrich HH, 2010, AM J PHYSIOL-HEART C, V298, pH2208, DOI 10.1152/ajpheart.00839.2009; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Feletou M, 2010, CURR HYPERTENS REP, V12, P267, DOI 10.1007/s11906-010-0118-2; FLAVAHAN NA, 1989, J PHYSIOL-LONDON, V408, P549, DOI 10.1113/jphysiol.1989.sp017475; FLAVAHAN NA, 1991, J PHARMACOL EXP THER, V256, P50; Forde A, 2002, GENESIS, V33, P191, DOI 10.1002/gene.10117; Goncalves ACD, 2008, J AM SOC HYPERTENS, V2, P403, DOI 10.1016/j.jash.2008.05.006; Griffith TM, 2002, P NATL ACAD SCI USA, V99, P6392, DOI 10.1073/pnas.092089799; Gross V, 2005, AM J PHYSIOL-REG I, V288, pR1134, DOI 10.1152/ajpregu.00246.2004; Gu S, 2008, MOL PHARMACOL, V73, P1037, DOI 10.1124/mol.107.044214; Gu S, 2009, CLIN SCI, V116, P391, DOI 10.1042/CS20080272; Gurley SB, 2010, J AM SOC NEPHROL, V21, P1847, DOI 10.1681/ASN.2009121306; Hercule HC, 2007, EXP PHYSIOL, V92, P1014, DOI 10.1113/expphysiol.2007.038240; Heximer Scott P, 2007, Sci STKE, V2007, ppe2, DOI 10.1126/stke.3702007pe2; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Heximer SP, 2003, J CLIN INVEST, V111, P445, DOI 10.1172/JC1200315598; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; HIMMEL HM, 1993, HYPERTENSION, V21, P112, DOI 10.1161/01.HYP.21.1.112; HOHLFELD J, 1990, J PHARMACOL EXP THER, V252, P260; Horiuchi T, 2003, STROKE, V34, P1473, DOI 10.1161/01.STR.0000071527.10129.65; Ingi T, 1998, J NEUROSCI, V18, P7178; Kimple AJ, 2009, J BIOL CHEM, V284, P19402, DOI 10.1074/jbc.M109.024711; Lembo G, 1997, HYPERTENSION, V30, P1128, DOI 10.1161/01.HYP.30.5.1128; Li NF, 2010, CLIN EXP HYPERTENS, V32, P256, DOI 10.3109/10641960903265253; Matsumoto T, 2003, AM J PHYSIOL-HEART C, V285, pH283, DOI 10.1152/ajpheart.00954.2002; Matsumoto T, 2006, EUR J PHARMACOL, V538, P132, DOI 10.1016/j.ejphar.2006.04.006; Michel FS, 2008, BRIT J PHARMACOL, V155, P217, DOI 10.1038/bjp.2008.256; Michel T, 2010, PFLUG ARCH EUR J PHY, V459, P807, DOI 10.1007/s00424-009-0765-9; MILLER VM, 1991, J PHARMACOL EXP THER, V257, P290; Nakaike R, 1996, AM J PHYSIOL-HEART C, V271, pH296, DOI 10.1152/ajpheart.1996.271.1.H296; Neitzel KL, 2006, SEMIN CELL DEV BIOL, V17, P383, DOI 10.1016/j.semcdb.2006.03.002; Ng KFJ, 2008, ACTA PHARMACOL SIN, V29, P1419, DOI 10.1111/j.1745-7254.2008.00905.x; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Riddle EL, 2006, HYPERTENSION, V47, P415, DOI 10.1161/01.HYP.0000200714.81990.61; Sabharwal R, 2010, HYPERTENSION, V55, P627, DOI 10.1161/HYPERTENSIONAHA.109.148171; Semplicini A, 2010, J HYPERTENS, V28, P1104, DOI 10.1097/HJH.0b013e328339930f; SHIMOKAWA H, 1989, CIRC RES, V65, P740, DOI 10.1161/01.RES.65.3.740; SHIMOKAWA H, 1987, CIRC RES, V61, P256, DOI 10.1161/01.RES.61.2.256; SHIMOKAWA H, 1991, CIRCULATION, V83, P652, DOI 10.1161/01.CIR.83.2.652; Sugimoto K, 2010, INT J HYPERTENS, V2010, DOI 10.4061/2010/196307; Sun XG, 2005, MOL PHARMACOL, V67, P631, DOI 10.1124/mol.104.007724; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Tank J, 2007, AUTON NEUROSCI-BASIC, V136, P52, DOI 10.1016/j.autneu.2007.04.001; Watanabe Y, 2010, HYPERTENS RES, V33, P129, DOI 10.1038/hr.2009.193; White R, 1997, BRIT J PHARMACOL, V122, P1573, DOI 10.1038/sj.bjp.0701546; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Wong WSF, 1996, CAN J PHYSIOL PHARM, V74, P559, DOI 10.1139/cjpp-74-5-559; Xie GX, 2007, J MOL BIOL, V366, P349, DOI 10.1016/j.jmb.2006.11.045; Yang J, 2005, J HYPERTENS, V23, P1497, DOI 10.1097/01.hjh.0000174606.41651.ae	61	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12541	12549		10.1074/jbc.M111.332130	http://dx.doi.org/10.1074/jbc.M111.332130			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22354966	hybrid, Green Published			2022-12-27	WOS:000302782200093
J	Pietrancosta, N; Anne, C; Prescher, H; Ruivo, R; Sagne, C; Debacker, C; Bertrand, HO; Brossmer, R; Acher, F; Gasnier, B				Pietrancosta, Nicolas; Anne, Christine; Prescher, Horst; Ruivo, Raquel; Sagne, Corinne; Debacker, Cecile; Bertrand, Hugues-Olivier; Brossmer, Reinhard; Acher, Francine; Gasnier, Bruno			Successful Prediction of Substrate-binding Pocket in SLC17 Transporter Sialin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLNEURAMINIC ACID; BIOLOGICAL PROPERTIES; PROTEIN; MECHANISM; IDENTIFICATION; INHIBITORS; TOPOLOGY; DOCKING; ANALOGS	Secondary active transporters from the SLC17 protein family are required for excitatory and purinergic synaptic transmission, sialic acid metabolism, and renal function, and several members are associated with inherited neurological or metabolic diseases. However, molecular tools to investigate their function or correct their genetic defects are limited or absent. Using structure-activity, homology modeling, molecular docking, and mutagenesis studies, we have located the substrate-binding site of sialin (SLC17A5), a lysosomal sialic acid exporter also recently implicated in exocytotic release of aspartate. Human sialin is defective in two inherited sialic acid storage diseases and is responsible for metabolic incorporation of the dietary nonhuman sialic acid N-glycolylneuraminic acid. We built cytosol-open and lumen-open three-dimensional models of sialin based on weak, but significant, sequence similarity with the glycerol-3-phosphate and fucose permeases from Escherichia coli, respectively. Molecular docking of 31 synthetic sialic acid analogues to both models was consistent with inhibition studies. Narrowing the sialic acid-binding site in the cytosol-open state by two phenylalanine to tyrosine mutations abrogated recognition of the most active analogue without impairing neuraminic acid transport. Moreover, a pilot virtual high-throughput screening of the cytosol-open model could identify a pseudopeptide competitive inhibitor showing > 100-fold higher affinity than the natural substrate. This validated model of human sialin and sialin-guided models of other SLC17 transporters should pave the way for the identification of inhibitors, glycoengineering tools, pharmacological chaperones, and fluorescent false neurotransmitters targeted to these proteins.	[Anne, Christine; Ruivo, Raquel; Sagne, Corinne; Debacker, Cecile; Gasnier, Bruno] Univ Paris 05, Ctr Natl Rech Sci, UMR 8192, F-75006 Paris, France; [Pietrancosta, Nicolas; Acher, Francine] Univ Paris 05, Ctr Natl Rech Sci, UMR 8601, F-75006 Paris, France; [Ruivo, Raquel] Univ Paris Sud, Grad Sch ED 419, F-94276 Le Kremlin Bicetre, France; [Prescher, Horst] G3 BioTec, D-69207 Sandhausen, Germany; [Bertrand, Hugues-Olivier] Parc Club Orsay Univ, Accelrys, F-91898 Orsay, France; [Brossmer, Reinhard] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; BIOVIA; Ruprecht Karls University Heidelberg	Gasnier, B (corresponding author), Univ Paris 05, Ctr Natl Rech Sci, UMR 8192, 45 Rue St Peres, F-75006 Paris, France.	bruno.gasnier@parisdescartes.fr	pietrancosta, nicolas/AAC-2777-2019; Ruivo, Raquel/B-2511-2013; Gasnier, Bruno/AAD-9124-2022; Anne-Longin, Christine/M-4902-2017; pietrancosta, nicolas/B-5235-2019; Ruivo, Raquel/ABB-3175-2020; Sagné, Corinne/AAY-1819-2021; Nicolas, PIetrancosta/P-4645-2017; Sagne, Corinne/K-7601-2017	pietrancosta, nicolas/0000-0002-9934-7818; Ruivo, Raquel/0000-0003-2412-8730; Gasnier, Bruno/0000-0003-4458-6296; Anne-Longin, Christine/0000-0003-0103-4272; pietrancosta, nicolas/0000-0002-9934-7818; Ruivo, Raquel/0000-0003-2412-8730; Sagné, Corinne/0000-0001-5971-4831; Nicolas, PIetrancosta/0000-0002-9934-7818; Prescher, Horst/0000-0002-4882-2252	Centre National de la Recherche Scientifique; Universite Paris Descartes	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Descartes	This work was supported by the Centre National de la Recherche Scientifique and by a transdisciplinary grant from Universite Paris Descartes (to N. P. and B. G.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Almqvist J, 2007, PROTEIN SCI, V16, P1819, DOI 10.1110/ps.072944707; ARAMORI I, 1993, MOL PHARMACOL, V43, P127; AUGE C, 1988, NEW J CHEM, V12, P733; Aula N, 2000, AM J HUM GENET, V67, P832, DOI 10.1086/303077; Aula N, 2002, MOL GENET METAB, V77, P99, DOI 10.1016/S1096-7192(02)00124-5; Bajorath F, 2002, NAT REV DRUG DISCOV, V1, P882, DOI 10.1038/nrd941; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; BAUMBERGER F, 1986, HELV CHIM ACTA, V69, P1535, DOI 10.1002/hlca.19860690702; BROSSMER R, 1994, METHOD ENZYMOL, V247, P153; BROSSMER R, 1980, BIOCHEM BIOPH RES CO, V96, P1282, DOI 10.1016/0006-291X(80)90090-X; Busch AE, 1996, P NATL ACAD SCI USA, V93, P5347, DOI 10.1073/pnas.93.11.5347; Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; Chaudhry FA, 2008, ANNU REV PHARMACOL, V48, P277, DOI 10.1146/annurev.pharmtox.46.120604.141146; Courville P, 2010, J BIOL CHEM, V285, P19316, DOI 10.1074/jbc.M110.130716; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Du J, 2009, GLYCOBIOLOGY, V19, P1382, DOI 10.1093/glycob/cwp115; Fan JQ, 2008, BIOL CHEM, V389, P1, DOI 10.1515/BC.2008.009; GROSS HJ, 1987, EUR J BIOCHEM, V168, P595, DOI 10.1111/j.1432-1033.1987.tb13458.x; GROSS HJ, 1988, FEBS LETT, V232, P145, DOI 10.1016/0014-5793(88)80404-6; Gubernator NG, 2009, SCIENCE, V324, P1441, DOI 10.1126/science.1172278; HAGEDORN HW, 1986, HELV CHIM ACTA, V69, P2127, DOI 10.1002/hlca.19860690837; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Humphrey AJ, 2002, BIOORGAN MED CHEM, V10, P3175, DOI 10.1016/S0968-0896(02)00213-4; Iharada M, 2010, J BIOL CHEM, V285, P26107, DOI 10.1074/jbc.M110.122721; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; ISECKE R, 1995, CARBOHYD RES, V274, P303, DOI 10.1016/0008-6215(95)00133-E; ISECKE R, 1994, TETRAHEDRON, V50, P7445, DOI 10.1016/S0040-4020(01)90473-9; Juge N, 2006, J BIOL CHEM, V281, P39499, DOI 10.1074/jbc.M607670200; KELM S, 1994, GLYCOCONJUGATE J, V11, P576, DOI 10.1007/BF00731309; Kiefel MJ, 2000, BIOORGAN MED CHEM, V8, P657, DOI 10.1016/S0968-0896(99)00325-9; Kirchmair J, 2005, J CHEM INF MODEL, V45, P422, DOI 10.1021/ci049753l; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KUHN R, 1966, CHEM BER-RECL, V99, P611, DOI 10.1002/cber.19660990235; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mack H, 1998, TETRAHEDRON, V54, P4539, DOI 10.1016/S0040-4020(98)00168-9; MEINDL P, 1966, MONATSH CHEM VERW TL, V97, P1628, DOI 10.1007/BF00901442; MEINDL P, 1965, MONATSH CHEM VERW TL, V96, P802, DOI 10.1007/BF00919154; MEINDL P, 1969, MONATSH CHEM, V100, P1295, DOI 10.1007/BF00903465; Miyaji T, 2008, P NATL ACAD SCI USA, V105, P11720, DOI 10.1073/pnas.0804015105; Morin P, 2004, EMBO J, V23, P4560, DOI 10.1038/sj.emboj.7600464; Oetke C, 2002, J BIOL CHEM, V277, P6688, DOI 10.1074/jbc.M109973200; OGURA H, 1987, CARBOHYD RES, V167, P77, DOI 10.1016/0008-6215(87)80269-0; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pawlita M., 2003, World Intellectual Property Organization Patent, Patent No. [WO/2003/016329, 2003016329]; Pietrancosta N, 2010, BIOORGAN MED CHEM, V18, P6922, DOI 10.1016/j.bmc.2010.06.069; Prescher JA, 2004, NATURE, V430, P873, DOI 10.1038/nature02791; Reimer RJ, 2004, PFLUG ARCH EUR J PHY, V447, P629, DOI 10.1007/s00424-003-1087-y; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; SCHAUER R, 1970, H-S Z PHYSIOL CHEM, V351, P359, DOI 10.1515/bchm2.1970.351.1.359; Thompson CM, 2005, CURR MED CHEM, V12, P2041, DOI 10.2174/0929867054637635; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Verheijen FW, 1999, NAT GENET, V23, P462, DOI 10.1038/70585; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wreden CC, 2005, J BIOL CHEM, V280, P1408, DOI 10.1074/jbc.M411295200; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; ZBIRAL E, 1988, MONATSH CHEM, V119, P127, DOI 10.1007/BF00810094	63	9	9	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11489	11497		10.1074/jbc.M111.313056	http://dx.doi.org/10.1074/jbc.M111.313056			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334707	hybrid, Green Published			2022-12-27	WOS:000302780100077
J	Bhat, KH; Chaitanya, CK; Parveen, N; Varman, R; Ghosh, S; Mukhopadhyay, S				Bhat, Khalid Hussain; Chaitanya, Chinta Krishna; Parveen, Nazia; Varman, Raja; Ghosh, Sudip; Mukhopadhyay, Sangita			Proline-Proline-Glutamic Acid (PPE) Protein Rv1168c of Mycobacterium tuberculosis Augments Transcription from HIV-1 Long Terminal Repeat Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; GENE-EXPRESSION; T-CELL; PRODUCTIVE INFECTION; IMMUNE-RESPONSES; MONOCYTE SUBSET; DENDRITIC CELLS; TYPE-1	Cells of the monocyte/macrophage lineage are shown to play a role in the pathogenesis of human immunodeficiency virus (HIV). The occurrence of HIV type 1 (HIV-1) infection is found to be accelerated in people infected with Mycobacterium tuberculosis, but the mechanism by which mycobacterial protein(s) induces HIV-1 LTR trans-activation is not clearly understood. We show here that the M. tuberculosis proline-proline-glutamic acid (PPE) protein Rv1168c (PPE17) can augment transcription from HIV-1 LTR in monocyte/macrophage cells. Rv1168c interacts specifically with Toll-like receptor-2 (TLR2) resulting in downstream activation of nuclear factor-kappa B (NF-kappa B) resulting in HIV-1 LTR trans-activation. Another PPE protein, Rv1196 (PPE18), was also found to interact with TLR2 but had no effect on HIV-1 LTR trans-activation because of its inability to activate the NF-kappa B signaling pathway. In silico docking analyses and mutation experiments have revealed that the N-terminal domain of Rv1168c specifically interacts with LRR motifs 15-20 of TLR2, and this site of interaction is different from that of Rv1196 protein (LRR motifs 11-15), indicating that the site of interaction on TLR2 dictates the downstream signaling events leading to activation of NF-kappa B. This information may help in understanding the mechanism of pathogenesis of HIV-1 during M. tuberculosis co-infection.	[Bhat, Khalid Hussain; Chaitanya, Chinta Krishna; Parveen, Nazia; Varman, Raja; Mukhopadhyay, Sangita] Ctr DNA Fingerprinting & Diagnost, Mol Cell Biol Lab, Hyderabad 500001, Andhra Pradesh, India; [Ghosh, Sudip] Natl Inst Nutr, Mol Biol Unit, Hyderabad 500007, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN)	Mukhopadhyay, S (corresponding author), Ctr DNA Fingerprinting & Diagnost, Mol Cell Biol Lab, Bldg 7,Gruhakalpa 5-4-399-B, Hyderabad 500001, Andhra Pradesh, India.	sangita@cdfd.org.in		Bhat, Dr. Khalid Hussain/0000-0002-0952-7496; Parveen, Nazia/0000-0002-2918-9498; Chinta, Krishna C./0000-0001-8425-2456; Mukhopadhyay, Sangita/0000-0002-5511-3315	Indian Council of Medical Research, Government of India; Department of Biotechnology, Government of India; Department of Biotechnology; Council of Scientific and Industrial Research, India	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Biotechnology; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by grants from the Indian Council of Medical Research, Government of India, the Department of Biotechnology, Government of India, and a core grant to the Centre for DNA Fingerprinting and Diagnostics by the Department of Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported by Research Fellowship from the Council of Scientific and Industrial Research, India.	Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Asin S, 2001, J VIROL, V75, P11408, DOI 10.1128/JVI.75.23.11408-11416.2001; Bacon J, 2004, TUBERCULOSIS, V84, P205, DOI 10.1016/j.tube.2003.12.011; Bafica A, 2003, J IMMUNOL, V171, P1123, DOI 10.4049/jimmunol.171.3.1123; Balboa L, 2011, J LEUKOCYTE BIOL, V90, P69, DOI 10.1189/jlb.1010577; Bansal K, 2010, J BIOL CHEM, V285, P36511, DOI 10.1074/jbc.M110.158055; Basu S, 2007, J BIOL CHEM, V282, P1039, DOI 10.1074/jbc.M604379200; Bernier R, 1998, J GEN VIROL, V79, P1353, DOI 10.1099/0022-1317-79-6-1353; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Brennan MJ, 2002, TRENDS MICROBIOL, V10, P246, DOI 10.1016/S0966-842X(02)02335-1; Brown A, 2006, J LEUKOCYTE BIOL, V80, P1127, DOI 10.1189/jlb.0206126; Choudhary RK, 2003, INFECT IMMUN, V71, P6338, DOI 10.1128/IAI.71.11.6338-6343.2003; Cohen OJ, 1997, IMMUNOL REV, V159, P31, DOI 10.1111/j.1600-065X.1997.tb01005.x; Coiras M, 2009, NAT REV MICROBIOL, V7, P798, DOI 10.1038/nrmicro2223; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coleman CM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-51; de Noronha ALL, 2008, PATHOL RES PRACT, V204, P155, DOI 10.1016/j.prp.2007.10.008; Delogu G, 2004, FEMS MICROBIOL LETT, V239, P33, DOI 10.1016/j.femsle.2004.08.015; Delogu G, 2006, MICROBES INFECT, V8, P2061, DOI 10.1016/j.micinf.2006.03.015; Dhiman R, 2011, J IMMUNOL, V186, P1638, DOI 10.4049/jimmunol.1003146; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Doherty TM, 1999, J IMMUNOL, V163, P1506; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; Equils O, 2003, J IMMUNOL, V170, P5159, DOI 10.4049/jimmunol.170.10.5159; Garrait V, 1997, J IMMUNOL, V159, P2824; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Ghassemi M, 2000, AIDS RES HUM RETROV, V16, P435, DOI 10.1089/088922200309098; Guex N., 1996, Experientia (Basel), V52, pA26; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Igarashi T, 2001, P NATL ACAD SCI USA, V98, P658, DOI 10.1073/pnas.021551798; Jacque JM, 1996, J VIROL, V70, P2930; Jagodzinski PP, 2001, FOLIA HISTOCHEM CYTO, V39, P47; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Khan N, 2006, BLOOD, V107, P1513, DOI 10.1182/blood-2005-04-1707; Khan N, 2008, CLIN VACCINE IMMUNOL, V15, P974, DOI 10.1128/CVI.00485-07; Khan N, 2008, CELL MICROBIOL, V10, P1711, DOI 10.1111/j.1462-5822.2008.01161.x; Khan N, 2007, INT IMMUNOL, V19, P477, DOI 10.1093/intimm/dxm012; Kilareski EM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-118; Kitaura H, 2001, FEMS IMMUNOL MED MIC, V31, P97, DOI 10.1016/S0928-8244(01)00249-8; KOYANAGI Y, 1988, SCIENCE, V241, P1673, DOI 10.1126/science.3047875; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lawn SD, 2002, MICROBES INFECT, V4, P635, DOI 10.1016/S1286-4579(02)01582-4; Li YJ, 2005, CELL MICROBIOL, V7, P539, DOI 10.1111/j.1462-5822.2004.00484.x; Lopez-Gatell H, 2007, AM J EPIDEMIOL, V165, P1134, DOI 10.1093/aje/kwk116; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Meng GX, 2003, J BIOL CHEM, V278, P39822, DOI 10.1074/jbc.M304766200; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; MOLINA JM, 1989, J CLIN INVEST, V84, P733, DOI 10.1172/JCI114230; Moriuchi M, 1998, J CLIN INVEST, V102, P1540, DOI 10.1172/JCI4151; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Mukhopadhyay S, 2002, J IMMUNOL, V168, P2914, DOI 10.4049/jimmunol.168.6.2914; Muttucumaru DGN, 2004, TUBERCULOSIS, V84, P239, DOI 10.1016/j.tube.2003.12.006; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Nair S, 2011, J IMMUNOL, V186, P5413, DOI 10.4049/jimmunol.1000773; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Newton V, 2009, VET MICROBIOL, V135, P394, DOI 10.1016/j.vetmic.2008.09.066; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; Pecora ND, 2006, J IMMUNOL, V177, P422, DOI 10.4049/jimmunol.177.1.422; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; POMERANTZ RJ, 1990, J EXP MED, V172, P253, DOI 10.1084/jem.172.1.253; Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436; Ritchie DW, 1999, J COMPUT CHEM, V20, P383, DOI 10.1002/(SICI)1096-987X(199903)20:4<383::AID-JCC1>3.0.CO;2-M; ROULSTON A, 1995, MICROBIOL REV, V59, P481, DOI 10.1128/MMBR.59.3.481-505.1995; ROY S, 1988, J LEUKOCYTE BIOL, V43, P91, DOI 10.1002/jlb.43.1.91; Sampson SL, 2001, TUBERCULOSIS, V81, P305, DOI 10.1054/tube.2001.0304; Sanchez D, 2010, CELL IMMUNOL, V260, P128, DOI 10.1016/j.cellimm.2009.10.007; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; SCHWARTZ S, 1989, P NATL ACAD SCI USA, V86, P7200, DOI 10.1073/pnas.86.18.7200; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; SHATTOCK RJ, 1994, J GEN VIROL, V75, P849, DOI 10.1099/0022-1317-75-4-849; Shen Y, 2004, J VIROL, V78, P14023, DOI 10.1128/JVI.78.24.14023-14032.2004; Singh KK, 2005, INFECT IMMUN, V73, P5004, DOI 10.1128/IAI.73.8.5004-5014.2005; Sorgen PL, 2002, P NATL ACAD SCI USA, V99, P14037, DOI 10.1073/pnas.182552199; Sweet L, 2006, J LEUKOCYTE BIOL, V80, P415, DOI 10.1189/jlb.1205702; Thieblemont N, 1995, EUR J IMMUNOL, V25, P3418, DOI 10.1002/eji.1830251232; Thomas DJ, 2006, J PHARM PRACT, V19, P10, DOI 10.1177/0897190005284100; TOOSSI Z, 1993, J EXP MED, V177, P1511, DOI 10.1084/jem.177.5.1511; Toossi Z, 1999, CLIN EXP IMMUNOL, V117, P324; UN Joint Programme on HIV/AIDS, 2010, GLOB REP UNAIDS REP; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; Wagner DH, 2002, P NATL ACAD SCI USA, V99, P3782, DOI 10.1073/pnas.052247099; Wahl SM, 1999, J INFECT DIS, V179, pS457, DOI 10.1086/314814; Wahl SM, 1998, P NATL ACAD SCI USA, V95, P12574, DOI 10.1073/pnas.95.21.12574; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Williams BG, 2005, P NATL ACAD SCI USA, V102, P9619, DOI 10.1073/pnas.0501615102; Yu MY, 2009, MINI-REV MED CHEM, V9, P60, DOI 10.2174/138955709787001677; ZHANG YH, 1995, J CLIN INVEST, V95, P2324, DOI 10.1172/JCI117924; Zhou SH, 2010, ANTIVIR RES, V87, P295, DOI 10.1016/j.antiviral.2010.06.011; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510	96	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16930	16946		10.1074/jbc.M111.327825	http://dx.doi.org/10.1074/jbc.M111.327825			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22427668	Green Published, hybrid			2022-12-27	WOS:000304030900078
J	Dunn-Siegrist, I; Tissieres, P; Drifte, G; Bauer, J; Moutel, S; Pugin, J				Dunn-Siegrist, Irene; Tissieres, Pierre; Drifte, Genevieve; Bauer, Jacques; Moutel, Stephane; Pugin, Jerome			Toll-like Receptor Activation of Human Cells by Synthetic Triacylated Lipid A-like Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; CRYSTAL-STRUCTURE; BIOPHYSICAL CHARACTERIZATION; TLR4-MD-2 COMPLEX; DENDRITIC CELLS; SEPTIC SHOCK; SOLUBLE MD-2; WHOLE-BLOOD; LIPOPOLYSACCHARIDE; TLR4	Recognition of microbial molecules by mammalian host receptors is essential to mount an immune response. Hexaacylated LPS is the prototypic example of a bacterial molecule recognized by the receptor complex TLR4/MD-2 with its lipid A moiety, whereas bacterial lipopeptides are recognized by TLR2. Here we show that a series of synthetic triacylated lipid A-like molecules are weak Toll-like receptor (TLR) agonists (mainly TLR2 agonists) but very potent TLR4/MD-2 antagonists (submicromolar range). Not only do they block human cell responses to LPS but also to whole Gram-negative bacteria, and they inhibit the phagocytosis of Gram-negative bacteria. These compounds may represent promising immunomodulatory agents.	[Dunn-Siegrist, Irene; Tissieres, Pierre; Drifte, Genevieve; Pugin, Jerome] Univ Geneva, Fac Med, Intens Care Lab, CH-1211 Geneva 14, Switzerland; [Dunn-Siegrist, Irene; Tissieres, Pierre; Drifte, Genevieve; Pugin, Jerome] Univ Geneva, Fac Med, Dept Microbiol & Mol Med, CH-1211 Geneva 14, Switzerland; [Bauer, Jacques; Moutel, Stephane] OM Pharma, CH-1217 Meyrin, Switzerland	University of Geneva; University of Geneva; Vifor Pharma	Pugin, J (corresponding author), Hop Univ Geneve, Site E,Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	jerome.pugin@unige.ch	Bauer, Jacques/M-9971-2015	Bauer, Jacques/0000-0003-2772-6111	Swiss National Foundation [122034]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Foundation for Scientific Research Grant 122034 (to J. P.).	Ahn JH, 2007, BIOORG MED CHEM LETT, V17, P2622, DOI 10.1016/j.bmcl.2007.01.111; Airhart CL, 2008, MICROBIOL-SGM, V154, P2131, DOI 10.1099/mic.0.2008/017566-0; Bas S, 2008, J IMMUNOL, V180, P1158, DOI 10.4049/jimmunol.180.2.1158; Brandenburg K, 2003, CARBOHYD RES, V338, P2477, DOI 10.1016/j.carres.2003.08.008; Brandenburg K, 2002, BIOPHYS J, V83, P322, DOI 10.1016/S0006-3495(02)75172-2; Brandenburg K, 2000, EUR J BIOCHEM, V267, P3370, DOI 10.1046/j.1432-1327.2000.01370.x; Bryant CE, 2007, VET IMMUNOL IMMUNOP, V116, P182, DOI 10.1016/j.vetimm.2007.01.013; Byl B, 2003, INT IMMUNOPHARMACOL, V3, P417, DOI 10.1016/S1567-5769(03)00008-0; Cristofaro P, 2006, DRUGS, V66, P15, DOI 10.2165/00003495-200666010-00002; Dunn-Siegrist I, 2007, J BIOL CHEM, V282, P34817, DOI 10.1074/jbc.M706440200; Elson G, 2007, BLOOD, V109, P1574, DOI 10.1182/blood-2006-06-032961; Gradisar H, 2007, J LEUKOCYTE BIOL, V82, P968, DOI 10.1189/jlb.1206727; Howe J, 2006, FEBS J, V273, P5101, DOI 10.1111/j.1742-4658.2006.05507.x; Jain V, 2008, BLOOD, V111, P4637, DOI 10.1182/blood-2007-11-126862; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; KOVACH NL, 1990, J EXP MED, V172, P77, DOI 10.1084/jem.172.1.77; Lembo A, 2008, J IMMUNOL, V180, P7574, DOI 10.4049/jimmunol.180.11.7574; Martin OR, 2006, J MED CHEM, V49, P6000, DOI 10.1021/jm060482a; Mascarell L, 2007, VACCINE, V26, P108, DOI 10.1016/j.vaccine.2007.10.050; Meng JM, 2010, J BIOL CHEM, V285, P27935, DOI 10.1074/jbc.M110.134668; Meng JM, 2010, J BIOL CHEM, V285, P8695, DOI 10.1074/jbc.M109.075127; Muroi M, 2002, INFECT IMMUN, V70, P3546, DOI 10.1128/IAI.70.7.3546-3550.2002; Nakata T, 2006, CELL MICROBIOL, V8, P1899, DOI 10.1111/j.1462-5822.2006.00756.x; Netea MG, 2002, TRENDS IMMUNOL, V23, P135, DOI 10.1016/S1471-4906(01)02169-X; Opal SM, 2002, CRIT CARE, V6, P125; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pugin J, 2004, BLOOD, V104, P4071, DOI 10.1182/blood-2003-04-1290; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Savoy F, 2006, IMMUNOBIOLOGY, V211, P767, DOI 10.1016/j.imbio.2006.06.001; Schromm AB, 2007, J BIOL CHEM, V282, P11030, DOI 10.1074/jbc.M700287200; Shin HJ, 2007, MOL CELLS, V24, P119; Singer P, 2008, INTENS CARE MED, V34, P1580, DOI 10.1007/s00134-008-1142-4; Stover AG, 2004, J BIOL CHEM, V279, P4440, DOI 10.1074/jbc.M310760200; Tissieres P, 2008, BLOOD, V111, P2122, DOI 10.1182/blood-2007-06-097782; Triantafilou M, 2004, BIOCHEM J, V381, P527, DOI 10.1042/BJ20040172; Veran J, 2004, IMMUNOBIOLOGY, V209, P67, DOI 10.1016/j.imbio.2004.02.003; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065	40	14	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16121	16131		10.1074/jbc.M112.348383	http://dx.doi.org/10.1074/jbc.M112.348383			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22433865	Green Published, hybrid			2022-12-27	WOS:000304030900005
J	Cao, Q; Wang, XJ; Liu, CW; Liu, DF; Li, LF; Gao, YQ; Su, XD				Cao, Qin; Wang, Xiao-Jun; Liu, Cheng-Wen; Liu, Dai-Fei; Li, Lan-Fen; Gao, Yi-Qin; Su, Xiao-Dong			Inhibitory Mechanism of Caspase-6 Phosphorylation Revealed by Crystal Structures, Molecular Dynamics Simulations, and Biochemical Assays	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICHAEL ACCEPTORS; IN-VITRO; ACTIVATION; CLEAVAGE; DEATH; SYSTEM; SITE; P53	The apoptotic effector caspase-6 (CASP6) has been clearly identified as a drug target due to its strong association with neurodegeneration and axonal pruning events as well as its crucial roles in Huntington disease and Alzheimer disease. CASP6 activity is suppressed by ARK5-mediated phosphorylation at Ser(257) with an unclear mechanism. In this work, we solved crystal structures of Delta proCASP6S257E and p20/p10S257E, which mimicked the phosphorylated CASP6 zymogen and activated CASP6, respectively. The structural investigation combined with extensive biochemical assay and molecular dynamics simulation studies revealed that phosphorylation on Ser(257) inhibited self-activation of CASP6 zymogen by "locking" the enzyme in the TEVD193-bound "inhibited state." The structural and biochemical results also showed that phosphorylation on Ser(257) inhibited the CASP6 activity by steric hindrance. These results disclosed the inhibition mechanism of CASP6 phosphorylation and laid the foundation for a new strategy of rational CASP6 drug design.	[Liu, Cheng-Wen; Gao, Yi-Qin] Peking Univ, Coll Chem & Mol Engn, Inst Theoret & Computat Chem, Beijing 100871, Peoples R China; [Cao, Qin; Wang, Xiao-Jun; Liu, Dai-Fei; Li, Lan-Fen; Su, Xiao-Dong] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res & Biodynam Op, Beijing 100871, Peoples R China	Peking University; Peking University	Gao, YQ (corresponding author), Peking Univ, Coll Chem & Mol Engn, Inst Theoret & Computat Chem, Beijing 100871, Peoples R China.	gaoyq@pku.edu.cn; xdsu@pku.edu.cn	Liu, Chengwen/F-5166-2019; gao, yi/HCI-8298-2022; Liu, Daifei/W-3833-2017	Liu, Chengwen/0000-0002-3930-7793; 	National Basic Research Program of China 973 [2011CB911103]; National High Technology 863 Program [2006AA02A317]; National Natural Science Foundation of China (Canada-China Joint Health Initiative) [30711120581, 21125311, 91027044]	National Basic Research Program of China 973(National Basic Research Program of China); National High Technology 863 Program; National Natural Science Foundation of China (Canada-China Joint Health Initiative)	This work was supported by grants from the National Basic Research Program of China 973 Grant 2011CB911103 (to X.-D. S.), National High Technology 863 Program 2006AA02A317 (to X.-D. S.), and National Natural Science Foundation of China (Canada-China Joint Health Initiative 30711120581 (to X.-D. S.) and 21125311, 91027044 (to Y.-Q. G.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; [Anonymous], 2008, AMBER 10; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baumgartner R, 2009, BIOCHEM J, V423, P429, DOI 10.1042/BJ20090540; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Chu WH, 2009, J MED CHEM, V52, P2188, DOI 10.1021/jm900135r; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ekici OD, 2006, J MED CHEM, V49, P5728, DOI 10.1021/jm0601405; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Graham RK, 2011, TRENDS NEUROSCI, V34, P646, DOI 10.1016/j.tins.2011.09.001; Graham RK, 2010, J NEUROSCI, V30, P15019, DOI 10.1523/JNEUROSCI.2071-10.2010; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Hou X, 2011, ONCOGENE, V30, P2933, DOI 10.1038/onc.2011.19; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Lee AW, 2010, J BIOL CHEM, V285, P31974, DOI 10.1074/jbc.M110.152744; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; MacLachan TK, 2002, P NATL ACAD SCI USA, V99, P9492, DOI 10.1073/pnas.132241599; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Muller I, 2011, BIOORG MED CHEM LETT, V21, P5244, DOI 10.1016/j.bmcl.2011.07.041; Muller I, 2011, J MOL BIOL, V410, P307, DOI 10.1016/j.jmb.2011.05.020; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Suzuki A, 2004, ONCOGENE, V23, P7067, DOI 10.1038/sj.onc.1207963; Vaidya S, 2011, J MOL BIOL, V406, P75, DOI 10.1016/j.jmb.2010.11.031; Wang XJ, 2010, EMBO REP, V11, P841, DOI 10.1038/embor.2010.141; Yan N, 2005, ANNU REV CELL DEV BI, V21, P35, DOI 10.1146/annurev.cellbio.21.012704.131040; Yang LJ, 2006, J PHYS CHEM B, V110, P13166, DOI 10.1021/jp060163v	35	27	27	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15371	15379		10.1074/jbc.M112.351213	http://dx.doi.org/10.1074/jbc.M112.351213			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22433863	Green Published, hybrid			2022-12-27	WOS:000304006300019
J	Sen, A; Alkon, DL; Nelson, TJ				Sen, Abhik; Alkon, Daniel L.; Nelson, Thomas J.			Apolipoprotein E3 (ApoE3) but Not ApoE4 Protects against Synaptic Loss through Increased Expression of Protein Kinase C epsilon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; AMYLOID PRECURSOR PROTEIN; ACTIVATES PKC-EPSILON; ALZHEIMERS-DISEASE; BETA PEPTIDE; MEMORY IMPAIRMENTS; TRANSGENIC MICE; ALPHA; NEURONS; BINDING	Synaptic loss is the earliest pathological change in Alzheimer disease (AD) and is the pathological change most directly correlated with the degree of dementia. ApoE4 is the major genetic risk factor for the age-dependent form of AD, which accounts for 95% of cases. Here we show that in synaptic networks formed from primary hippocampal neurons in culture, apoE3, but not apoE4, prevents the loss of synaptic networks produced by amyloid beta oligomers (amylospheroids). Specific activators of PKC epsilon, such as 8-(2-(2-pentyl-cyclopropylmethyl)-cyclopropyl)-octanoic acid methyl ester and bryostatin 1, protected against synaptic loss by amylospheroids, whereas PKC epsilon inhibitors blocked this synaptic protection and also blocked the protection by apoE3. Blocking LRP1, an apoE receptor on the neuronal membrane, also blocked the protection by apoE. ApoE3, but not apoE4, induced the synthesis of PKC epsilon mRNA and expression of the PKC epsilon protein. Amyloid beta specifically blocked the expression of PKC epsilon but had no effect on other isoforms. These results suggest that protection against synaptic loss by apoE is mediated by a novel intracellular PKC epsilon pathway. This apoE pathway may account for much of the protective effect of apoE and reduced risk for the age-dependent form of AD. This finding supports the potential efficacy of newly developed therapeutics for AD.	[Sen, Abhik; Alkon, Daniel L.; Nelson, Thomas J.] Blanchette Rockefeller Neurosci Inst, Morgantown, WV 26505 USA		Nelson, TJ (corresponding author), Blanchette Rockefeller Neurosci Inst, 8 Med Ctr Dr, Morgantown, WV 26505 USA.	tjnelson@brni-jhu.org	Sen, Abhik/L-2067-2017	Sen, Abhik/0000-0003-4048-0566				Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bour A, 2008, BEHAV BRAIN RES, V193, P174, DOI 10.1016/j.bbr.2008.05.008; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Cedazo-Minguez A, 2003, J NEUROCHEM, V87, P1152, DOI 10.1046/j.1471-4159.2003.02088.x; Cerf E, 2011, FASEB J, V25, P1585, DOI 10.1096/fj.10-175976; COLE G, 1988, BRAIN RES, V452, P165, DOI 10.1016/0006-8993(88)90021-2; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Dinamarca MC, 2006, MOL PSYCHIATR, V11, P1032, DOI 10.1038/sj.mp.4001866; Dumanis SB, 2009, J NEUROSCI, V29, P15317, DOI 10.1523/JNEUROSCI.4026-09.2009; Fagan AM, 1996, J BIOL CHEM, V271, P30121, DOI 10.1074/jbc.271.47.30121; Favit A, 1998, P NATL ACAD SCI USA, V95, P5562, DOI 10.1073/pnas.95.10.5562; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; Fuentealba RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011884; Hartman RE, 2001, EXP NEUROL, V170, P326, DOI 10.1006/exnr.2001.7715; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; Hayashi H, 2009, J BIOL CHEM, V284, P29605, DOI 10.1074/jbc.M109.039560; Hongpaisan J, 2007, P NATL ACAD SCI USA, V104, P19571, DOI 10.1073/pnas.0709311104; Hongpaisan J, 2011, J NEUROSCI, V31, P630, DOI 10.1523/JNEUROSCI.5209-10.2011; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Janz R, 1999, NEURON, V24, P687, DOI 10.1016/S0896-6273(00)81122-8; Ji Y, 2003, NEUROSCIENCE, V122, P305, DOI 10.1016/j.neuroscience.2003.08.007; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Jolly-Tornetta C, 2000, BIOCHEMISTRY-US, V39, P7428, DOI 10.1021/bi0003846; Kanno T, 2006, J LIPID RES, V47, P1146, DOI 10.1194/jlr.M500329-JLR200; Kanno T, 2009, J CELL PHYSIOL, V221, P183, DOI 10.1002/jcp.21838; Kelly BL, 2007, NEUROSCIENCE, V147, P60, DOI 10.1016/j.neuroscience.2007.03.047; Kim J, 2009, NEURON, V64, P632, DOI 10.1016/j.neuron.2009.11.013; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; KINOUCHI T, 1995, FEBS LETT, V364, P203, DOI 10.1016/0014-5793(95)00392-M; Kuo YM, 1996, J BIOL CHEM, V271, P4077; LADU MJ, 1994, J BIOL CHEM, V269, P23403; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lanni C, 2004, EUR J BIOCHEM, V271, P3068, DOI 10.1111/j.1432-1033.2004.04240.x; Lee W, 2004, MOL CELL NEUROSCI, V26, P222, DOI 10.1016/j.mcn.2003.10.020; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Ling M, 2005, J BIOL CHEM, V280, P17910, DOI 10.1074/jbc.M412036200; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Mehta KD, 2002, MOL CELL BIOL, V22, P3783, DOI 10.1128/MCB.22.11.3783-3793.2002; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Nelson TJ, 2009, TRENDS BIOCHEM SCI, V34, P136, DOI 10.1016/j.tibs.2008.11.006; Nelson TJ, 2009, J BIOL CHEM, V284, P34514, DOI 10.1074/jbc.M109.016683; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; Pfrieger FW, 2003, BBA-BIOMEMBRANES, V1610, P271, DOI 10.1016/S0005-2736(03)00024-5; Raffai RL, 2001, P NATL ACAD SCI USA, V98, P11587, DOI 10.1073/pnas.201279298; Rapp A, 2006, BIOCHIMIE, V88, P473, DOI 10.1016/j.biochi.2005.10.007; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Selkoe DJ, 2001, J ALZHEIMERS DIS, V3, P75, DOI 10.3233/JAD-2001-3111; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shimizu T, 2011, CELL PHYSIOL BIOCHEM, V27, P149, DOI 10.1159/000325217; SLACK BE, 1993, ANN NY ACAD SCI, V695, P128, DOI 10.1111/j.1749-6632.1993.tb23040.x; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sun MK, 2009, ARCH PHARM, V342, P689, DOI 10.1002/ardp.200900050; Tokuda T, 2000, BIOCHEM J, V348, P359, DOI 10.1042/0264-6021:3480359; Volmer R, 2006, PLOS PATHOG, V2, P195, DOI 10.1371/journal.ppat.0020019; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Ye SM, 2005, P NATL ACAD SCI USA, V102, P18700, DOI 10.1073/pnas.0508693102; Yeon SW, 2001, BIOCHEM BIOPH RES CO, V280, P782, DOI 10.1006/bbrc.2000.4181; Zhu GF, 2001, BIOCHEM BIOPH RES CO, V285, P997, DOI 10.1006/bbrc.2001.5273	61	47	51	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15947	15958		10.1074/jbc.M111.312710	http://dx.doi.org/10.1074/jbc.M111.312710			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427674	Green Published, hybrid			2022-12-27	WOS:000304006300073
J	Dogo-Isonagie, C; Lam, S; Gustchina, E; Acharya, P; Yang, YP; Shahzad-ul-Hussan, S; Clore, GM; Kwong, PD; Bewley, CA				Dogo-Isonagie, Cajetan; Lam, Son; Gustchina, Elena; Acharya, Priyamvada; Yang, Yongping; Shahzad-ul-Hussan, Syed; Clore, G. Marius; Kwong, Peter D.; Bewley, Carole A.			Peptides from Second Extracellular Loop of C-C Chemokine Receptor Type 5 (CCR5) Inhibit Diverse Strains of HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEIN-COUPLED RECEPTOR; ENVELOPE GLYCOPROTEIN; CORECEPTOR ACTIVITY; GP120 BINDING; N-TERMINUS; MONOCLONAL-ANTIBODIES; CRYSTAL-STRUCTURE; ENTRY INHIBITORS; MEMBRANE-FUSION	To initiate HIV entry, the HIV envelope protein gp120 must engage its primary receptor CD4 and a coreceptor CCR5 or CXCR4. In the absence of a high resolution structure of a gp120-coreceptor complex, biochemical studies of CCR5 have revealed the importance of its N terminus and second extracellular loop (ECL2) in binding gp120 and mediating viral entry. Using a panel of synthetic CCR5 ECL2-derived peptides, we show that the C-terminal portion of ECL2 (2C, comprising amino acids Cys-178 to Lys-191) inhibit HIV-1 entry of both CCR5- and CXCR4-using isolates at low micromolar concentrations. In functional viral assays, these peptides inhibited HIV-1 entry in a CD4-independent manner. Neutralization assays designed to measure the effects of CCR5 ECL2 peptides when combined with either with the small molecule CD4 mimetic NBD-556, soluble CD4, or the CCR5 N terminus showed additive inhibition for each, indicating that ECL2 binds gp120 at a site distinct from that of N terminus and acts independently of CD4. Using saturation transfer difference NMR, we determined the region of CCR5 ECL2 used for binding gp120, showed that it can bind to gp120 from both R5 and X4 isolates, and demonstrated that the peptide interacts with a CD4-gp120 complex in a similar manner as to gp120 alone. As the CCR5 N terminus-gp120 interactions are dependent on CD4 activation, our data suggest that gp120 has separate binding sites for the CCR5 N terminus and ECL2, the ECL2 binding site is present prior to CD4 engagement, and it is conserved across CCR5-and CXCR4-using strains. These peptides may serve as a starting point for the design of inhibitors with broad spectrum anti-HIV activity.	[Dogo-Isonagie, Cajetan; Lam, Son; Shahzad-ul-Hussan, Syed; Bewley, Carole A.] NIDDK, Bioorgan Chem Lab, Bethesda, MD 20892 USA; [Gustchina, Elena; Clore, G. Marius] NIDDK, Chem Phys Lab, Bethesda, MD 20892 USA; [Acharya, Priyamvada; Yang, Yongping; Shahzad-ul-Hussan, Syed; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Bewley, CA (corresponding author), NIDDK, Bioorgan Chem Lab, 8 Ctr Dr, Bethesda, MD 20892 USA.	caroleb@mail.nih.gov	Clore, G. Marius/A-3511-2008; Clore, G Marius/L-2546-2018	Clore, G. Marius/0000-0003-3809-1027; Clore, G Marius/0000-0003-3809-1027; Acharya, Priyamvada/0000-0002-0089-277X; Bewley, Carole/0000-0003-2203-0852	National Institutes of Health (NIDDK and NIAID); Office of the Director, National Institutes of Health; Intramural AIDS Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029023, ZIADK032103, ZIADK029038] Funding Source: NIH RePORTER	National Institutes of Health (NIDDK and NIAID); Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural AIDS Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program, National Institutes of Health (NIDDK and NIAID), and the Intramural AIDS Targeted Antiviral Program, Office of the Director, National Institutes of Health (to C. A. B. and G. M. C.).; Recipient of an Intramural AIDS Research Fellowship award.	Acharya P, 2011, ACS CHEM BIOL, V6, P1069, DOI 10.1021/cb200068b; Agrawal L, 2004, BLOOD, V103, P1211, DOI 10.1182/blood-2003-08-2669; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Blanpain C, 1999, J BIOL CHEM, V274, P18902, DOI 10.1074/jbc.274.27.18902; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CHOU TC, 1981, EUR J BIOCHEM, V115, P207, DOI 10.1111/j.1432-1033.1981.tb06218.x; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cormier EG, 2000, P NATL ACAD SCI USA, V97, P5762, DOI 10.1073/pnas.97.11.5762; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; Cormier EG, 2001, J VIROL, V75, P5541, DOI 10.1128/JVI.75.12.5541-5549.2001; Da LT, 2011, J CHEM INF MODEL, V51, P359, DOI 10.1021/ci1003448; DEEN KC, 1988, NATURE, V331, P82, DOI 10.1038/331082a0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doranz BJ, 1997, J VIROL, V71, P6305, DOI 10.1128/JVI.71.9.6305-6314.1997; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Farzan M, 2000, J BIOL CHEM, V275, P33516, DOI 10.1074/jbc.M007228200; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Farzan M, 2002, J BIOL CHEM, V277, P40397, DOI 10.1074/jbc.M206784200; FISHER RA, 1988, NATURE, V331, P76, DOI 10.1038/331076a0; FREED EO, 1995, J BIOL CHEM, V270, P23883, DOI 10.1074/jbc.270.41.23883; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Gustchina E, 2008, J VIROL, V82, P10032, DOI 10.1128/JVI.01050-08; Gustchina E, 2007, J VIROL, V81, P12946, DOI 10.1128/JVI.01260-07; Gustchina E, 2006, J MOL BIOL, V364, P283, DOI 10.1016/j.jmb.2006.09.017; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Konishi K, 2000, CHEM PHARM BULL, V48, P308; Lam SN, 2008, BIOORGAN MED CHEM, V16, P10113, DOI 10.1016/j.bmc.2008.10.005; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; Maeda K, 2008, J MOL BIOL, V381, P956, DOI 10.1016/j.jmb.2008.06.041; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Misumi S, 2001, J VIROL, V75, P11614, DOI 10.1128/JVI.75.23.11614-11620.2001; Moore JP, 1997, CURR OPIN IMMUNOL, V9, P551, DOI 10.1016/S0952-7915(97)80110-0; Neuhaus D., 1989, NUCL OVERHAUSER EFFE; NUSSBAUM O, 1994, J VIROL, V68, P5411, DOI 10.1128/JVI.68.9.5411-5422.1994; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Olson WC, 1999, J VIROL, V73, P4145, DOI 10.1128/JVI.73.5.4145-4155.1999; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Pontow S, 2001, J VIROL, V75, P11503, DOI 10.1128/JVI.75.23.11503-11514.2001; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Ross TM, 1998, J VIROL, V72, P1918, DOI 10.1128/JVI.72.3.1918-1924.1998; Schnur E, 2011, J MOL BIOL, V410, P778, DOI 10.1016/j.jmb.2011.04.023; Schon A, 2006, BIOCHEMISTRY-US, V45, P10973, DOI 10.1021/bi061193r; Shahzad-ul-Hussan S, 2011, J BIOL CHEM, V286, P20788, DOI 10.1074/jbc.M111.232678; Tarasova NI, 1999, J BIOL CHEM, V274, P34911, DOI 10.1074/jbc.274.49.34911; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Tsamis F, 2003, J VIROL, V77, P5201, DOI 10.1128/JVI.77.9.5201-5208.2003; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu LJ, 1997, J EXP MED, V186, P1373, DOI 10.1084/jem.186.8.1373; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Zhang YJ, 1999, J VIROL, V73, P3443, DOI 10.1128/JVI.73.4.3443-3448.1999; Zhao Q, 2005, VIROLOGY, V339, P213, DOI 10.1016/j.virol.2005.06.008; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	56	21	22	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15076	15086		10.1074/jbc.M111.332361	http://dx.doi.org/10.1074/jbc.M111.332361			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22403408	Green Published, hybrid			2022-12-27	WOS:000304003200069
J	Kubota, T; Hamazoe, Y; Hashiguchi, S; Ishibashi, D; Akasaka, K; Nishida, N; Katamine, S; Sakaguchi, S; Kuroki, R; Nakashima, T; Sugimura, K				Kubota, Toshiya; Hamazoe, Yuta; Hashiguchi, Shuhei; Ishibashi, Daisuke; Akasaka, Kazuyuki; Nishida, Noriyuki; Katamine, Shigeru; Sakaguchi, Suehiro; Kuroki, Ryota; Nakashima, Toshihiro; Sugimura, Kazuhisa			Direct Evidence of Generation and Accumulation of beta-Sheet-rich Prion Protein in Scrapie-infected Neuroblastoma Cells with Human IgG1 Antibody Specific for beta-Form Prion Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; CONFORMATIONAL TRANSITION; CYCLIC AMPLIFICATION; CULTURED-CELLS; IN-VITRO; CONVERSION; PRPSC; DISEASE; PHAGE; REPLICATION	We prepared beta-sheet-rich recombinant full-length prion protein (beta-form PrP) (Jackson, G. S., Hosszu, L. L., Power, A., Hill, A. F., Kenney, J., Saibil, H., Craven, C. J., Waltho, J. P., Clarke, A. R., and Collinge, J. (1999) Science 283, 1935-1937). Using this beta-form PrP and a human single chain Fv-displaying phage library, we have established a human IgG1 antibody specific to beta-form but not alpha-form PrP, PRB7 IgG. When prion-infected ScN2a cells were cultured with PRB7 IgG, they generated and accumulated PRB7-binding granules in the cytoplasm with time, consequently becoming apoptotic cells bearing very large PRB7-bound aggregates. The SAF32 antibody recognizing the N-terminal octarepeat region of full-length PrP stained distinct granules in these cells as determined by confocal laser microscopy observation. When the accumulation of proteinase K-resistant PrP was examined in prion-infected ScN2a cells cultured in the presence of PRB7 IgG or SAF32, it was strongly inhibited by SAF32 but not at all by PRB7 IgG. Thus, we demonstrated direct evidence of the generation and accumulation of beta-sheet-rich PrP in ScN2a cells de novo. These results suggest first that PRB7-bound PrP is not responsible for the accumulation of beta-form PrP aggregates, which are rather an end product resulting in the triggering of apoptotic cell death, and second that SAF32-bound PrP lacking the PRB7-recognizing beta-form may represent so-called PrPSc with prion propagation activity. PRB7 is the first human antibody specific to beta-form PrP and has become a powerful tool for the characterization of the biochemical nature of prion and its pathology.	[Kubota, Toshiya; Hamazoe, Yuta; Hashiguchi, Shuhei; Sugimura, Kazuhisa] Kagoshima Univ, Grad Sch Sci & Engn, Dept Chem Biotechnol & Chem Engn, Kagoshima 8900065, Japan; [Akasaka, Kazuyuki] Kinki Univ, Sch Biol Oriented Sci & Technol, Dept Biotechnol Sci, Kinokawa, Wakayama 6496493, Japan; [Ishibashi, Daisuke; Nishida, Noriyuki; Katamine, Shigeru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Nagasaki 8528523, Japan; [Sakaguchi, Suehiro] Univ Tokushima, Inst Enzyme Res, Div Mol Neurobiol, Tokushima 7708503, Japan; [Kuroki, Ryota] Japan Atom Energy Res Inst, Neutron Sci Res Ctr, Tokai, Ibaraki 3191195, Japan; [Nakashima, Toshihiro] Chemoserotherapeut Res Inst, Kumamoto 8691298, Japan	Kagoshima University; Kindai University (Kinki University); Nagasaki University; Tokushima University; Japan Atomic Energy Agency	Sugimura, K (corresponding author), Kagoshima Univ, Grad Sch Sci & Engn, Dept Chem Biotechnol & Chem Engn, Kagoshima 1-21-40 Korimoto, Kagoshima 8900065, Japan.	kazu@be.kagoshima-u.ac.jp		Waltho, Jonathan/0000-0002-7402-5492	Ministry of Education, Culture, Sports, Science and Technology of Japan [16613008, 22790435]; Health and Labour Sciences Research Grants on Food Safety [Shokuhin-016]; Psychiatric and Neurological Diseases and Mental Health from the Ministry of Health, Labour and Welfare; Ministry of Agriculture, Forestry and Fisheries of Japan; Super Special Consortia; Grants-in-Aid for Scientific Research [24570180] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labour Sciences Research Grants on Food Safety; Psychiatric and Neurological Diseases and Mental Health from the Ministry of Health, Labour and Welfare; Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Super Special Consortia; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research C 16613008 and for Young Scientists B 22790435 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to S. H.), Health and Labour Sciences Research Grants on Food Safety (Shokuhin-016) ( to S. H.) and Psychiatric and Neurological Diseases and Mental Health from the Ministry of Health, Labour and Welfare (to S. H. and K. S.), a grant-in-aid from the Bovine Spongiform Encephalopathy Control Project of the Ministry of Agriculture, Forestry and Fisheries of Japan (to K. S.), and Super Special Consortia for supporting the development of cutting-edge medical care from 2008 to 2012 (to K. S.).	Anaya ZEA, 2011, J BIOL CHEM, V286, P8141, DOI 10.1074/jbc.M110.165233; Atarashi R, 2006, J VIROL, V80, P7854, DOI 10.1128/JVI.00424-06; Beringue V, 2004, J BIOL CHEM, V279, P39671, DOI 10.1074/jbc.M402270200; Biasini E, 2008, J NEUROCHEM, V105, P2190, DOI 10.1111/j.1471-4159.2008.05306.x; Biasini E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007816; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Boel E, 2000, J IMMUNOL METHODS, V239, P153, DOI 10.1016/S0022-1759(00)00170-8; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; D'Castro L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015679; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Gerber R, 2007, J BIOL CHEM, V282, P6300, DOI 10.1074/jbc.M608926200; Goold R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1282; Hamasaki T, 2005, J BIOCHEM, V138, P433, DOI 10.1093/jb/mvi148; Hashiguchi S, 2003, J BIOCHEM, V133, P43, DOI 10.1093/jb/mvg001; Hnasko R, 2010, PRION, V4, P94, DOI 10.4161/pri.4.2.12622; Horiuchi M, 2009, VIROLOGY, V394, P200, DOI 10.1016/j.virol.2009.08.025; Ishibashi D, 2007, VACCINE, V25, P985, DOI 10.1016/j.vaccine.2006.09.078; Ishikawa K, 2004, J GEN VIROL, V85, P1785, DOI 10.1099/vir.0.19754-0; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Khalill-Shirazi A, 2007, BBA-PROTEINS PROTEOM, V1774, P1438, DOI 10.1016/j.bbapap.2007.08.028; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Kosmac M, 2011, MOL IMMUNOL, V48, P746, DOI 10.1016/j.molimm.2010.11.012; Kristiansen M, 2005, J BIOL CHEM, V280, P38851, DOI 10.1074/jbc.M506600200; Liu CT, 2008, MOL BIOTECHNOL, V39, P141, DOI 10.1007/s12033-008-9051-x; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pankiewicz J, 2006, EUR J NEUROSCI, V23, P2635, DOI 10.1111/j.1460-9568.2006.04805.x; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; Petsch B, 2011, J VIROL, V85, P4538, DOI 10.1128/JVI.02467-10; PRUSINER SB, 1984, CELL, V38, P127, DOI 10.1016/0092-8674(84)90533-6; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; ROGERS M, 1993, P NATL ACAD SCI USA, V90, P3182, DOI 10.1073/pnas.90.8.3182; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Sasaki K, 2008, PRION, V2, P118, DOI 10.4161/pri.2.3.7148; Sasamori E, 2010, ARCH BIOCHEM BIOPHYS, V501, P232, DOI 10.1016/j.abb.2010.06.025; Skrlj N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015783; Stanker LH, 2010, J IMMUNOL, V185, P729, DOI 10.4049/jimmunol.0902930; Tanaka K, 2011, J NEUROIMMUNOL, V236, P27, DOI 10.1016/j.jneuroim.2011.04.010; TURK E, 1988, EUR J BIOCHEM, V176, P21, DOI 10.1111/j.1432-1033.1988.tb14246.x; Uryu M, 2007, MICROBIOL IMMUNOL, V51, P661, DOI 10.1111/j.1348-0421.2007.tb03954.x; Ushiki-Kaku Y, 2010, J BIOL CHEM, V285, P11931, DOI 10.1074/jbc.M109.058859; Veith NM, 2009, EUR J CELL BIOL, V88, P45, DOI 10.1016/j.ejcb.2008.08.001; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Williamson RA, 1996, P NATL ACAD SCI USA, V93, P7279, DOI 10.1073/pnas.93.14.7279; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Yoshihara T, 2008, J BIOCHEM, V143, P475, DOI 10.1093/jb/mvm239; Yoshinaga K, 2008, J BIOCHEM, V143, P593, DOI 10.1093/jb/mvn009; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	50	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14023	14039		10.1074/jbc.M111.318352	http://dx.doi.org/10.1074/jbc.M111.318352			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22356913	Green Published, hybrid			2022-12-27	WOS:000303996300057
J	Liu, JL; Liang, XH; Su, RW; Lei, W; Jia, B; Feng, XH; Li, ZX; Yang, ZM				Liu, Ji-Long; Liang, Xiao-Huan; Su, Ren-Wei; Lei, Wei; Jia, Bo; Feng, Xu-Hui; Li, Zhi-Xiong; Yang, Zeng-Ming			Combined Analysis of MicroRNome and 3 '-UTRome Reveals a Species-specific Regulation of Progesterone Receptor Expression in the Endometrium of Rhesus Monkey	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNAS; EMBRYO IMPLANTATION; NONCODING RNAS; DNA-SEQUENCES; MOUSE UTERUS; ESTROGEN; PREGNANCY; TARGETS; GENOME; CELLS	The establishment of endometrial receptivity is a prerequisite for successful pregnancy, which is controlled by a complex mechanism. MicroRNAs (miRNAs) are small non-coding RNAs that have emerged as important regulators of gene expression. However, the contribution of miRNAs in endometrial receptivity is still unknown. Here we used rhesus monkey as an animal model and compared the endometrial miRNA expression profiles during early-secretory (pre-receptive) phase and mid-secretory (receptive) phase by deep sequencing. A set of differentially expressed miRNAs were identified, 8 of which were selected and validated using quantitative RT-PCR. To facilitate the prediction of their target genes, the 3'-UTRome was also determined using tag sequencing of mRNA 3'-termini. Surprisingly, about 50% of the 10,677 genes expressed in the rhesus monkey endometrium exhibited alternative 3'-UTRs. Of special interest, the progesterone receptor (PGR) gene, which is necessary for endometrial receptivity, processes an ultra long 3'-UTR (similar to 10 kb) along with a short variant (similar to 2.5 kb). Evolutionary analysis showed that the 3'-UTR sequences of PGR are poorly conserved between primates and rodents, suggesting a species-biased miRNA binding pattern. We further demonstrated that PGR is a valid target of miR-96 in rhesus monkey and human but not in rodents, whereas the regulation of PGR by miR-375 is rhesus monkey-specific. Additionally, we found that miR-219-5p regulates PGR expression through a primate-specific long non-coding RNA immediately downstream of the PGR locus. Our study provides new insights into the molecular mechanisms underlying endometrial receptivity and presents intriguing species-specific regulatory roles of miRNAs.	[Liu, Ji-Long; Liang, Xiao-Huan; Yang, Zeng-Ming] Shantou Univ, Dept Biol, Shantou 515063, Peoples R China; [Su, Ren-Wei; Lei, Wei] NE Agr Univ, Coll Life Sci, Harbin 150030, Peoples R China; [Jia, Bo; Feng, Xu-Hui; Yang, Zeng-Ming] Xiamen Univ, Sch Life Sci, Xiamen 361005, Peoples R China; [Li, Zhi-Xiong] Fujian Family Planning Inst, Fujian Nonhuman Primate Res Ctr, Fuzhou 350011, Peoples R China	Shantou University; Northeast Agricultural University - China; Xiamen University	Yang, ZM (corresponding author), Shantou Univ, Dept Biol, Shantou 515063, Peoples R China.	zmyang@stu.edu.cn	Lei, Wei/I-3640-2014; feng, xuhui/AAD-9832-2019; Lei, Wei/N-7611-2013; feng, xuhui/D-9450-2017; Yang, ZM/G-4627-2010	Lei, Wei/0000-0002-8342-8859; feng, xuhui/0000-0003-4649-183X; Liu, Ji-Long/0000-0002-6948-2576	National Basic Research Program of China [2011CB944402]; National Natural Science Foundation of China [30930013, 31071276]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2011CB944402) and the National Natural Science Foundation of China (30930013 and 31071276).	Alexander RP, 2010, NAT REV GENET, V11, P559, DOI 10.1038/nrg2814; Aplin JD, 1999, HUM REPROD, V14, P17, DOI 10.1093/humrep/14.suppl_2.17; Brameier Markus, 2010, BMC Res Notes, V3, P64, DOI 10.1186/1756-0500-3-64; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Conneely OM, 2001, MOL CELL ENDOCRINOL, V179, P97, DOI 10.1016/S0303-7207(01)00465-8; Creighton CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009637; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Critchley HOD, 2009, REPROD SCI, V16, P191, DOI 10.1177/1933719108331121; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; DEZIEGLER D, 1992, J CLIN ENDOCR METAB, V74, P322, DOI 10.1210/jc.74.2.322; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; GHOSH D, 1994, HUM REPROD, V9, P629, DOI 10.1093/oxfordjournals.humrep.a138561; Gidley-Baird A A, 1981, J Reprod Fertil Suppl, V29, P97; Gonzalez G, 2009, MOL REPROD DEV, V76, P678, DOI 10.1002/mrd.21010; Ho P C, 2001, Expert Opin Pharmacother, V2, P1383, DOI 10.1517/14656566.2.9.1383; Hong XM, 2008, ENDOCRINOLOGY, V149, P6207, DOI 10.1210/en.2008-0294; Horne AW, 2005, MOL REPROD DEV, V72, P216, DOI 10.1002/mrd.20307; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Jensen KP, 2011, NUCLEIC ACIDS RES, V39, P701, DOI 10.1093/nar/gkq798; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Julian J, 2005, HUM REPROD, V20, P1493, DOI 10.1093/humrep/deh801; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kuokkanen S, 2010, BIOL REPROD, V82, P791, DOI 10.1095/biolreprod.109.081059; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee KY, 2004, REPRODUCTION, V128, P679, DOI 10.1530/rep.1.00340; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liao BY, 2008, P NATL ACAD SCI USA, V105, P6987, DOI [10.1073/pnas.0800387105, 10.1073/pnas.0806419105]; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; MEYER ME, 1992, J BIOL CHEM, V267, P10882; Nagaraja AK, 2008, MOL ENDOCRINOL, V22, P2336, DOI 10.1210/me.2008-0142; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Nothnick WB, 2010, REPROD SCI, V17, P987, DOI 10.1177/1933719110377472; OMALLEY BW, 1992, BIOL REPROD, V46, P163, DOI 10.1095/biolreprod46.2.163; Palomino WA, 2005, FERTIL STERIL, V83, P587, DOI 10.1016/j.fertnstert.2004.11.020; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; PAUERSTEIN CJ, 1978, AM J OBSTET GYNECOL, V130, P876, DOI 10.1016/0002-9378(78)90264-8; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Qian K, 2009, ENDOCRINOLOGY, V150, P4734, DOI 10.1210/en.2008-1629; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rosa A, 2009, DEV CELL, V16, P517, DOI 10.1016/j.devcel.2009.02.007; Spencer TE, 2002, FRONT BIOSCI-LANDMRK, V7, pD1879, DOI 10.2741/spencer; Tabaska JE, 1999, GENE, V231, P77, DOI 10.1016/S0378-1119(99)00104-3; Tan J, 1999, ENDOCRINOLOGY, V140, P5310, DOI 10.1210/en.140.11.5310; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; WEN DX, 1994, MOL CELL BIOL, V14, P8356, DOI 10.1128/MCB.14.12.8356; Yue XA, 2010, NAT CHEM BIOL, V6, P621, DOI [10.1038/NCHEMBIO.400, 10.1038/nchembio.400]	54	27	30	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13899	13910		10.1074/jbc.M111.301275	http://dx.doi.org/10.1074/jbc.M111.301275			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22378788	Green Published, hybrid			2022-12-27	WOS:000303996300045
J	Patel, VA; Feng, LF; Lee, DJ; Massenburg, D; Pattabiraman, G; Antoni, A; Schwartz, JH; Lieberthal, W; Rauch, J; Ucker, DS; Levine, JS				Patel, Vimal A.; Feng, Lanfei; Lee, Daniel J.; Massenburg, Donald; Pattabiraman, Goutham; Antoni, Angelika; Schwartz, John H.; Lieberthal, Wilfred; Rauch, Joyce; Ucker, David S.; Levine, Jerrold S.			Recognition-dependent Signaling Events in Response to Apoptotic Targets Inhibit Epithelial Cell Viability by Multiple Mechanisms IMPLICATIONS FOR NON-IMMUNE TISSUE HOMEOSTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL TUBULAR CELLS; NECROTIC CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; T-LYMPHOCYTES; FAS LIGAND; MACROPHAGES; BETA; AKT; ACTIVATION; SURVIVAL	Apoptosis allows for the removal of damaged, aged, and/or excess cells without harm to surrounding tissue. To accomplish this, cells undergoing apoptosis acquire new activities that enable them to modulate the fate and function of nearby cells. We have shown that receptor-mediated recognition of apoptotic versus necrotic target cells by viable kidney proximal tubular epithelial cells (PTEC) modulates the activity of several signaling pathways critically involved in regulation of proliferation and survival. Generally, apoptotic and necrotic targets have opposite effects with apoptotic targets inhibiting and necrotic targets stimulating the activity of these pathways. Here we explore the consequences of these signaling differences. We show that recognition of apoptotic targets induces a profound decrease in PTEC viability through increased responder cell death and decreased proliferation. In contrast, necrotic targets promote viability through decreased death and increased proliferation. Both target types mediate their effects through a network of Akt-dependent and -independent events. Apoptotic targets modulate Akt-dependent viability in part through a reduction in cellular beta-catenin and decreased inactivation of Bad. In contrast, Akt-independent modulation of viability occurs through activation of caspase-8, suggesting that death receptor-dependent pathways are involved. Apoptotic targets also activate p38, which partially protects responders from target-induced death. The response of epithelial cells varies depending on their tissue origin. Some cell lines, like PTEC, demonstrate decreased viability, whereas others (e. g. breast-derived) show increased viability. By acting as sentinels of environmental change, apoptotic targets allow neighboring cells, especially non-migratory epithelial cells, to monitor and potentially adapt to local stresses.	[Patel, Vimal A.; Feng, Lanfei; Lee, Daniel J.; Massenburg, Donald; Levine, Jerrold S.] Univ Illinois, Dept Med, Nephrol Sect, Chicago, IL 60612 USA; [Pattabiraman, Goutham; Ucker, David S.; Levine, Jerrold S.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Patel, Vimal A.; Feng, Lanfei; Lee, Daniel J.; Massenburg, Donald; Levine, Jerrold S.] Jesse Brown Vet Affairs Hosp, Dept Med, Nephrol Sect, Chicago, IL 60612 USA; [Antoni, Angelika] Kutztown Univ Penn, Dept Biol, Kutztown, PA 19530 USA; [Schwartz, John H.] Boston Univ, Sch Med, Dept Med, Renal Sect, Boston, MA 02118 USA; [Lieberthal, Wilfred] SUNY Stony Brook, Med Ctr, Dept Med, Nephrol Sect, Stony Brook, NY 11794 USA; [Lieberthal, Wilfred] Northport Vet Affairs Hosp, Northport, NY 11768 USA; [Rauch, Joyce] McGill Univ, Ctr Hlth, Res Inst, Dept Med,Div Rheumatol, Montreal, PQ H3G 1A4, Canada	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Pennsylvania State System of Higher Education (PASSHE); Kutztown University - Pennsylvania; Boston University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; McGill University	Levine, JS (corresponding author), Univ Illinois, Dept Med, Nephrol Sect, Chicago, IL 60612 USA.	jslevine@uic.edu	Schwartz, John/AAO-8158-2021	Schwartz, John/0000-0002-1660-8681; Pattabiraman, Goutham/0000-0002-5196-8279	National Institutes of Health [DK071678, AG024234, DK059529]; Genzyme Renal Innovations Program Grant; Veterans Affairs merit award; Dialysis Clinic, Inc. [S-1774, C-3176]; Pennsylvania State System of Higher Education faculty professional development grant; Canadian Institutes of Health Research [MOP-67101, MOP-42391]; Institute of Musculoskeletal Health and Arthritis Priority Announcement [MUS-67101]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK071678, R01DK059529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG024234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genzyme Renal Innovations Program Grant; Veterans Affairs merit award(US Department of Veterans Affairs); Dialysis Clinic, Inc.; Pennsylvania State System of Higher Education faculty professional development grant; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute of Musculoskeletal Health and Arthritis Priority Announcement; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK071678 (to V. A. P.), AG024234 (to D. S. U.), and DK059529 (to J. H. S.). This work was also supported by the Genzyme Renal Innovations Program Grant (to J. S. L.), a Veterans Affairs merit award and Dialysis Clinic, Inc. Grants S-1774 and C-3176 (to W. L.), a Pennsylvania State System of Higher Education faculty professional development grant (to A. A.), Canadian Institutes of Health Research Grants MOP-67101 (to J. R.) and MOP-42391 (to J. R.), and Institute of Musculoskeletal Health and Arthritis Priority Announcement MUS-67101 (to J. R.).	Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Bellone M, 1997, J IMMUNOL, V159, P5391; Cocco RE, 2001, MOL BIOL CELL, V12, P919, DOI 10.1091/mbc.12.4.919; Cvetanovic M, 2004, J IMMUNOL, V172, P880, DOI 10.4049/jimmunol.172.2.880; Cvetanovic M, 2006, J BIOL CHEM, V281, P20055, DOI 10.1074/jbc.M603920200; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eves EM, 1998, MOL CELL BIOL, V18, P2143, DOI 10.1128/MCB.18.4.2143; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI11638; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Lieberthal W, 1998, AM J PHYSIOL-RENAL, V274, pF315, DOI 10.1152/ajprenal.1998.274.2.F315; Lieberthal W, 2011, AM J PHYSIOL-RENAL, V301, pF1177, DOI 10.1152/ajprenal.00034.2011; Linkermann A, 2011, KIDNEY INT, V79, P169, DOI 10.1038/ki.2010.317; Liu MC, 2006, J AM SOC NEPHROL, V17, P765, DOI 10.1681/ASN.2005010102; MAJNO G, 1995, AM J PATHOL, V146, P3; McDonald PP, 1999, J IMMUNOL, V163, P6164; Mosmann T., 1983, J IMMUNOL METHODS, V65, P55, DOI DOI 10.1016/0022-1759(83)90303-4; Munoz LE, 2010, AUTOIMMUN REV, V9, P425, DOI 10.1016/j.autrev.2009.11.016; Patel VA, 2006, J BIOL CHEM, V281, P4663, DOI 10.1074/jbc.M508342200; Patel VA, 2007, AUTOIMMUNITY, V40, P274, DOI 10.1080/08916930701357463; Patel VA, 2010, J BIOL CHEM, V285, P1829, DOI 10.1074/jbc.M109.018440; Patel VA, 2009, AUTOIMMUNITY, V42, P317, DOI 10.1080/08916930902832124; Reddy SM, 2002, J IMMUNOL, V169, P702, DOI 10.4049/jimmunol.169.2.702; Safirstein RL, 2011, KIDNEY INT, V79, P149, DOI 10.1038/ki.2010.441; Sinha D, 2005, AM J PHYSIOL-RENAL, V288, pF703, DOI 10.1152/ajprenal.00189.2004; Sinha D, 2003, AM J PHYSIOL-RENAL, V284, pF488, DOI 10.1152/ajprenal.00172.2002; Skoberne M, 2005, CURR TOP MICROBIOL, V289, P259; Tan KH, 2003, EXP CELL RES, V284, P283, DOI 10.1016/S0014-4827(02)00056-3; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wang ZY, 2009, J AM SOC NEPHROL, V20, P1919, DOI 10.1681/ASN.2009030253	34	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13761	13777		10.1074/jbc.M112.350843	http://dx.doi.org/10.1074/jbc.M112.350843			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22396534	Green Published, hybrid			2022-12-27	WOS:000303996300032
J	Peng, RQ; Wan, HY; Li, HF; Liu, M; Li, X; Tang, H				Peng, Rui-Qing; Wan, Hai-Ying; Li, Hai-Fang; Liu, Min; Li, Xin; Tang, Hua			MicroRNA-214 Suppresses Growth and Invasiveness of Cervical Cancer Cells by Targeting UDP-N-acetyl-alpha-D-galactosamine: Polypeptide N-Acetylgalactosaminyltransferase 7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; LUNG-CANCER; EXPRESSION; INVASION; PROLIFERATION; REPRESSES; GLYCOSYLATION; ACCUMULATION; METASTASIS; CARCINOMA	MicroRNAs are a class of small noncoding RNAs that function as key regulators of gene expression at the post-transcriptional level. In this study, we demonstrate that miR-214 is frequently down-regulated in cervical cancer, and its expression reduces the proliferation, migration, and invasiveness of cervical cancer cells, whereas inhibiting its expression results in enhanced proliferation, migration, and invasion. miR-214 binds to the 3'-UTR of UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 7 (GALNT7), thereby repressing GALNT7 expression. Furthermore, we are the first to show, using quantitative real-time PCR, that GALNT7 is frequently up-regulated in cervical cancer. The knockdown of GALNT7 markedly inhibits cervical cancer cell proliferation, migration, and invasion, whereas ectopic expression of GALNT7 significantly enhances these properties, indicating that GALNT7 might function as an oncogene in cervical cancer. The restoration of GALNT7 expression can counteract the effect of miR-214 on cell proliferation, migration, and invasiveness of cervical cancer cells. Together, these results indicate that miR-214 is a new regulator of GALNT7, and both miR-214 and GALNT7 play important roles in the pathogenesis of cervical cancer.	Tianjin Med Univ, Tianjin Life Sci Res Ctr, Tianjin 300070, Peoples R China; Tianjin Med Univ, Basic Med Sch, Tianjin 300070, Peoples R China	Tianjin Medical University; Tianjin Medical University	Tang, H (corresponding author), 22 Qi Xiang Tai Rd, Tianjin 300070, Peoples R China.	htang2002@yahoo.com			National Natural Science Foundation of China [30873017, 91029714, 31071191]; Natural Science Foundation of Tianjin [08JCZDJC23300, 09JCZDJC17500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work was supported by the National Natural Science Foundation of China (Grants 30873017 and 91029714, 31071191) and the Natural Science Foundation of Tianjin (Grants 08JCZDJC23300 and 09JCZDJC17500).	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Casey RC, 2003, CLIN EXP METASTAS, V20, P143, DOI 10.1023/A:1022670501667; Derfoul A, 2011, CARCINOGENESIS, V32, P1607, DOI 10.1093/carcin/bgr184; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Ellenson LH, 2004, CANCER CELL, V5, P533, DOI 10.1016/j.ccr.2004.05.029; Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577; Gao XN, 2011, ONCOGENE, V30, P3416, DOI 10.1038/onc.2011.62; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Guan HF, 2010, BLOOD, V116, P1469, DOI 10.1182/blood-2009-12-256446; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Karlidag T, 2007, AM J OTOLARYNG, V28, P31, DOI 10.1016/j.amjoto.2006.06.008; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai KW, 2010, EUR J CANCER, V46, P1456, DOI 10.1016/j.ejca.2010.01.036; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Noordhuis MG, 2011, INT J RADIAT ONCOL, V79, P325, DOI 10.1016/j.ijrobp.2010.09.043; Patel JB, 2011, ONCOGENE, V30, P1290, DOI 10.1038/onc.2010.510; Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102; Qiang R, 2011, INT J BIOCHEM CELL B, V43, P632, DOI 10.1016/j.biocel.2011.01.002; Rao QX, 2012, MED ONCOL, V29, P1242, DOI 10.1007/s12032-011-9830-2; Rao X, 2011, ONCOGENE, V30, P1082, DOI 10.1038/onc.2010.487; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; STROUS GJAM, 1979, P NATL ACAD SCI USA, V76, P2694, DOI 10.1073/pnas.76.6.2694; Tang H, 2008, CLIN CHIM ACTA, V394, P81, DOI 10.1016/j.cca.2008.04.012; Taniuchi K, 2011, ONCOGENE, V30, P4843, DOI 10.1038/onc.2011.194; Ten Hagen BG, 1998, J BIOL CHEM, V273, P27749; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Xiong X, 2011, PATHOL ONCOL RES, V17, P931, DOI 10.1007/s12253-011-9406-7; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang ZZ, 2009, IUBMB LIFE, V61, P1075, DOI 10.1002/iub.252; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Yeung CLA, 2011, ONCOGENE, V30, P2401, DOI 10.1038/onc.2010.613; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	43	144	152	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14301	14309		10.1074/jbc.M111.337642	http://dx.doi.org/10.1074/jbc.M111.337642			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22399294	Green Published, hybrid			2022-12-27	WOS:000303996300081
J	Tosha, T; Behera, RK; Ng, HL; Bhattasali, O; Alber, T; Theil, EC				Tosha, Takehiko; Behera, Rabindra K.; Ng, Ho-Leung; Bhattasali, Onita; Alber, Tom; Theil, Elizabeth C.			Ferritin Protein Nanocage Ion Channels GATING BY N-TERMINAL EXTENSIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; IRON RELEASE; H-FERRITIN; MECHANISM; RESIDUES; PORES; MINERALIZATION; REVEALS; DEPENDS; BINDING	Ferritin protein nanocages, self-assembled from four-alpha-helix bundle subunits, use Fe2+ and oxygen to synthesize encapsulated, ferric oxide minerals. Ferritin minerals are iron concentrates stored for cell growth. Ferritins are also antioxidants, scavenging Fenton chemistry reactants. Channels for iron entry and exit consist of helical hairpin segments surrounding the 3-fold symmetry axes of the ferritin nanocages. We now report structural differences caused by amino acid substitutions in the Fe2+ ion entry and exit channels and at the cytoplasmic pores, from high resolution (1.3-1.8 angstrom) protein crystal structures of the eukaryotic model ferritin, frog M. Mutations that eliminate conserved ionic or hydrophobic interactions between Arg-72 and Asp-122 and between Leu-110 and Leu-134 increase flexibility in the ion channels, cytoplasmic pores, and/or the N-terminal extensions of the helix bundles. Decreased ion binding in the channels and changes in ordered water are also observed. Protein structural changes coincide with increased Fe2+ exit from dissolved, ferric minerals inside ferritin protein cages; Fe2+ exit from ferritin cages depends on a complex, surface-limited process to reduce and dissolve the ferric mineral. High concentrations of bovine serum albumin or lysozyme (protein crowders) to mimic the cytoplasm restored Fe2+ exit in the variants to wild type. The data suggest that fluctuations in pore structure control gating. The newly identified role of the ferritin subunit N-terminal extensions in gating Fe2+ exit from the cytoplasmic pores strengthens the structural and functional analogies between ferritin ion channels in the water-soluble protein assembly and membrane protein ion channels gated by cytoplasmic N-terminal peptides.	[Ng, Ho-Leung; Alber, Tom] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Theil, Elizabeth C.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Tosha, Takehiko; Behera, Rabindra K.; Bhattasali, Onita] Childrens Hosp Oakland Res Inst, Oakland, CA 94609 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Alber, T (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 374B Stanley Hall 3220, Berkeley, CA 94720 USA.	tom@ucxray.berkeley.edu; etheil@chori.org	Ng, Ho Leung/B-5650-2016; Tosha, Takehiko/AAR-2404-2020; Ng, Ho Leung/E-3419-2010; Ng, Ho Leung/Q-7167-2019	Ng, Ho Leung/0000-0002-6415-1938; Tosha, Takehiko/0000-0002-8971-0759; Ng, Ho Leung/0000-0002-6415-1938; Behera, Rabindra/0000-0003-2849-3292	National Institutes of Health [DK20251, GM48958, GM70962]; Children's Hospital Oakland Research Institute Foundation; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020251, R37DK020251, R56DK020251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070962, R01GM048958] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital Oakland Research Institute Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK20251 (to E. C. T., R. K. B., B. O., and T. T.), GM48958, and GM70962 (to H.-L. N. and T. A.). This work was also supported by the Children's Hospital Oakland Research Institute Foundation (to E. C. T.) and a Japan Society for the Promotion of Science postdoctoral fellowship for research abroad (to T. T.).	BANYARD SH, 1978, NATURE, V271, P282, DOI 10.1038/271282a0; BAUMINGER ER, 1993, BIOCHEM J, V296, P709, DOI 10.1042/bj2960709; BAYNES RD, 1990, ANNU REV NUTR, V10, P133, DOI [10.1146/annurev.nutr.10.1.133, 10.1146/annurev.nu.10.070190.001025]; Briat JF, 2010, ANN BOT-LONDON, V105, P811, DOI 10.1093/aob/mcp128; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Duong-Ly KC, 2005, PROTEIN SCI, V14, P856, DOI 10.1110/ps.041185805; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Goss DJ, 2011, ACCOUNTS CHEM RES, V44, P1320, DOI 10.1021/ar2001149; Ha Y, 1997, ACTA CRYSTALLOGR D, V53, P513, DOI 10.1107/S0907444997003983; Ha Y, 1999, J BIOL INORG CHEM, V4, P243, DOI 10.1007/s007750050310; Hailemariam K, 2010, J CELL SCI, V123, P3863, DOI 10.1242/jcs.073627; Haldar S, 2011, J BIOL CHEM, V286, P25620, DOI 10.1074/jbc.M110.205278; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Inanobe A, 2011, BIOCHEM BIOPH RES CO, V407, P366, DOI 10.1016/j.bbrc.2011.03.025; Jin WL, 2001, BIOCHEMISTRY-US, V40, P7525, DOI 10.1021/bi002509c; JONES T, 1978, BIOCHEMISTRY-US, V17, P4011, DOI 10.1021/bi00612a021; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; Le Brun NE, 2010, BBA-GEN SUBJECTS, V1800, P732, DOI 10.1016/j.bbagen.2010.04.002; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Levi S, 1996, BIOCHEM J, V317, P467, DOI 10.1042/bj3170467; Li CG, 2009, J AM CHEM SOC, V131, P1368, DOI 10.1021/ja808428d; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu XF, 2003, P NATL ACAD SCI USA, V100, P3653, DOI 10.1073/pnas.0636928100; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; Liu XS, 2007, J BIOL CHEM, V282, P31821, DOI 10.1074/jbc.C700153200; Lundmark R, 2010, SEMIN CELL DEV BIOL, V21, P363, DOI 10.1016/j.semcdb.2009.11.014; Makowski L, 2008, J MOL BIOL, V375, P529, DOI 10.1016/j.jmb.2007.07.075; Masuda T, 2010, J BIOL CHEM, V285, P4049, DOI 10.1074/jbc.M109.059790; Milman N, 2012, ANN HEMATOL, V91, P143, DOI 10.1007/s00277-011-1381-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oz S, 2011, J BIOL CHEM, V286, P13945, DOI 10.1074/jbc.M110.198424; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Rosenhouse-Dantsker A, 2011, BIOPHYS J, V100, P381, DOI 10.1016/j.bpj.2010.11.086; Soveral G, 2011, BIOL CELL, V103, P35, DOI 10.1042/BC20100102; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; Takahashi T, 2003, BIOPHYS J, V84, P2256, DOI 10.1016/S0006-3495(03)75031-0; Theil EC, 2011, CURR OPIN CHEM BIOL, V15, P304, DOI 10.1016/j.cbpa.2011.01.004; Theil EC, 2009, CHEM REV, V109, P4568, DOI 10.1021/cr900052g; Tosha T, 2010, J AM CHEM SOC, V132, P14562, DOI 10.1021/ja105583d; Tosha T, 2008, P NATL ACAD SCI USA, V105, P18182, DOI 10.1073/pnas.0805083105; Turano P, 2010, P NATL ACAD SCI USA, V107, P545, DOI 10.1073/pnas.0908082106; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Valiyaveetil FI, 2006, SCIENCE, V314, P1004, DOI 10.1126/science.1133415; WALDO GS, 1993, BIOCHEMISTRY-US, V32, P13262, DOI 10.1021/bi00211a039; Yuan Z, 2003, PROTEIN ENG, V16, P109, DOI 10.1093/proeng/gzg014	53	56	58	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13016	13025		10.1074/jbc.M111.332734	http://dx.doi.org/10.1074/jbc.M111.332734			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22362775	Green Published, hybrid			2022-12-27	WOS:000302903700040
J	Zuris, JA; Ali, SS; Yeh, H; Nguyen, TA; Nechushtai, R; Paddock, ML; Jennings, PA				Zuris, John A.; Ali, Syed S.; Yeh, Howard; Nguyen, Tung A.; Nechushtai, Rachel; Paddock, Mark L.; Jennings, Patricia A.			NADPH Inhibits [2Fe-2S] Cluster Protein Transfer from Diabetes Drug Target MitoNEET to an Apo-acceptor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEINS; MITOCHONDRIAL DYSFUNCTION; INSULIN SENSITIZERS; OXIDATIVE STRESS; HUMAN-DISEASE; BIOGENESIS; MELLITUS; NUCLEOTIDES; METABOLISM; MUTATION	MitoNEET (mNT) is the founding member of the recently discovered CDGSH family of [2Fe-2S] proteins capable of [2Fe-2S] cluster transfer to apo-acceptor proteins. It is a target of the thiazolidinedione (TZD) class of anti-diabetes drugs whose binding modulate both electron transfer and cluster transfer properties. The [2Fe-2S] cluster in mNT is destabilized upon binding of NADPH, which leads to loss of the [2Fe-2S] cluster to the solution environment. Because mNT is capable of transferring [2Fe-2S] clusters to apo-acceptor proteins, we sought to determine whether NADPH binding also affects cluster transfer. We show that NADPH inhibits transfer of the [2Fe-2S] cluster to an apo-acceptor protein with an inhibition constant (K-i) of 200 mu M, which reflects that of NADPH concentrations expected under physiological conditions. In addition, we determined that the strictly conserved cluster interacting residue Asp-84 in the CDGSH domain is necessary for the NADPH-dependent inhibition of [2Fe-2S] cluster transfer. The most critical cellular function of NADPH is in the maintenance of a pool of reducing equivalents, which is essential to counteract oxidative damage. Taken together, our findings suggest that NADPH can regulate both mNT [2Fe-2S] cluster levels in the cell as well as the ability of the protein to transfer [2Fe-2S] clusters to cytosolic or mitochondrial acceptors.	[Zuris, John A.; Ali, Syed S.; Yeh, Howard; Nguyen, Tung A.; Jennings, Patricia A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Paddock, Mark L.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Nechushtai, Rachel] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, Dept Plant & Environm Sci, IL-91904 Givat Ram, Israel	University of California System; University of California San Diego; University of California System; University of California San Diego; Hebrew University of Jerusalem	Jennings, PA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pajennings@ucsd.edu			National Institutes of Health [GM41637, GM54038, DK54441]; Heme and Blood Proteins Training Grant [5T32DK007233-34]; Israel Science Foundation [863/09]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007233, P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041637, R01GM054038, R01GM101467, R29GM054038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heme and Blood Proteins Training Grant; Israel Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM41637 (to M. L. P.), GM54038 (to P. A. J.), and DK54441 (to P. A. J.). This work was also supported by Heme and Blood Proteins Training Grant 5T32DK007233-34 (to J. A. Z.) and Israel Science Foundation Grant 863/09 (to R. N.).	Abdul-Ghani MA, 2008, CURR DIABETES REP, V8, P173, DOI 10.1007/s11892-008-0030-1; Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; Amr S, 2007, AM J HUM GENET, V81, P673, DOI 10.1086/520961; ANDERSEN KB, 1977, J BIOL CHEM, V252, P4151; Bak DW, 2009, BIOCHEMISTRY-US, V48, P10193, DOI 10.1021/bi9016445; Baxter EL, 2011, P NATL ACAD SCI USA, V108, P5266, DOI 10.1073/pnas.1017604108; Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520; Chang NC, 2010, EMBO J, V29, P606, DOI 10.1038/emboj.2009.369; Chen YF, 2010, ANN NY ACAD SCI, V1201, P58, DOI 10.1111/j.1749-6632.2010.05619.x; Colca JR, 2006, EXPERT OPIN INV DRUG, V15, P205, DOI 10.1517/13543784.15.3.205; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Conlan AR, 2011, ACTA CRYSTALLOGR D, V67, P516, DOI 10.1107/S0907444911011577; Cusimano EM, 2009, ADV EMERG NURS J, V31, P54, DOI 10.1097/TME.0b013e3181956200; Dicus MM, 2010, J AM CHEM SOC, V132, P2037, DOI 10.1021/ja909359g; Dutton P L, 1978, Methods Enzymol, V54, P411; HANSEN TM, 2003, SCI STKE, pPE31; Hausmann A, 2008, J BIOL CHEM, V283, P8318, DOI 10.1074/jbc.M705570200; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hernandez C, 2000, MED CLIN-BARCELONA, V115, P21, DOI 10.1016/S0025-7753(00)71450-3; HOFMANN CA, 1992, DIABETES CARE, V15, P1075, DOI 10.2337/diacare.15.8.1075; Hou XW, 2007, J BIOL CHEM, V282, P33242, DOI 10.1074/jbc.C700172200; Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lin JZ, 2007, P NATL ACAD SCI USA, V104, P14640, DOI 10.1073/pnas.0702426104; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Martinovich GG, 2005, EUR BIOPHYS J BIOPHY, V34, P937, DOI 10.1007/s00249-005-0470-3; Napier I, 2005, BLOOD, V105, P1867, DOI 10.1182/blood-2004-10-3856; Opara EC, 2004, J INVEST MED, V52, P19, DOI 10.1136/jim-52-01-22; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Sohn YS, 2008, BLOOD, V111, P1690, DOI 10.1182/blood-2007-07-102335; Tirrell TF, 2009, BIOCHEMISTRY-US, V48, P4747, DOI 10.1021/bi900028r; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Wiley SE, 2007, J BIOL CHEM, V282, P23745, DOI 10.1074/jbc.C700107200; WOLFF SP, 1993, BRIT MED BULL, V49, P642, DOI 10.1093/oxfordjournals.bmb.a072637; Wu SP, 2003, BIOCHEMISTRY-US, V42, P5784, DOI 10.1021/bi026939+; Zhou T, 2010, BIOCHEMISTRY-US, V49, P9604, DOI 10.1021/bi101168c; Zuris JA, 2011, P NATL ACAD SCI USA, V108, P13047, DOI 10.1073/pnas.1109986108; Zuris JA, 2010, J AM CHEM SOC, V132, P13120, DOI 10.1021/ja103920k	44	24	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11649	11655		10.1074/jbc.M111.319731	http://dx.doi.org/10.1074/jbc.M111.319731			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351774	Green Published, hybrid			2022-12-27	WOS:000302782200005
J	Ma, BY; Qian, D; Nan, Q; Tan, C; An, LZ; Xiang, Y				Ma, Binyun; Qian, Dong; Nan, Qiong; Tan, Chang; An, Lizhe; Xiang, Yun			Arabidopsis Vacuolar H+-ATPase (V-ATPase) B Subunits Are Involved in Actin Cytoskeleton Remodeling via Binding to, Bundling, and Stabilizing F-actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLLEN-TUBE GROWTH; PROTON PUMPS; PROTEIN; FILAMENTS; THALIANA; COMPLEX; CELLS; ORGANIZATION; POLYMERIZATION; MICROFILAMENTS	VacuolarH(+)-ATPase (V-ATPase) is a membrane-bound multisubunit enzyme complex composed of at least 14 different subunits. The complex regulates the physiological processes of a cell by controlling the acidic environment, which is necessary for certain activities and the interaction with the actin cytoskeleton through its B and C subunits in both humans and yeast. Arabidopsis V-ATPase has three B subunits (AtVAB1, AtVAB2, and AtVAB3), which share 97.27% sequence identity and have two potential actin-binding sites, indicating that these AtVABs may have crucial functions in actin cytoskeleton remodeling and plant cell development. However, their biochemical functions are poorly understood. In this study, we demonstrated that AtVABs bind to and co-localize with F-actin, bundle F-actin to form higher order structures, and stabilize actin filaments in vitro. In addition, the AtVABs also show different degrees of activities in capping the barbed ends but no nucleating activities, and these activities were not regulated by calcium. The functional similarity and differences of the AtVABs implied that they may play cooperative and distinct roles in Arabidopsis cells.	[Ma, Binyun; Qian, Dong; Nan, Qiong; Tan, Chang; An, Lizhe; Xiang, Yun] Lanzhou Univ, Sch Life Sci, Lanzhou 730070, Peoples R China	Lanzhou University	An, LZ (corresponding author), Lanzhou Univ, Sch Life Sci, Lanzhou 730070, Peoples R China.	lizhean@lzu.edu.cn; xiangy@lzu.edu.cn	Yang, Xiaoming/GRJ-9483-2022	Yang, Xiaoming/0000-0002-1792-6921; Xiang, Yun/0000-0002-5178-0700	National Basic Research Program of China (973 Program) [2007CB108902]; Chinese Transgenic Project [2009ZX08009-029B]; National Natural Science Foundation of China [30800079]; China Postdoctoral Science Foundation [200902311]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese Transgenic Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Basic Research Program of China (973 Program) Grant 2007CB108902 and Chinese Transgenic Project Grant 2009ZX08009-029B (to L. A.), National Natural Science Foundation of China Grant 30800079, and China Postdoctoral Science Foundation Grant 200902311 (to Y. X.).	Breton S, 2000, J BIOL CHEM, V275, P18219, DOI 10.1074/jbc.M909857199; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Chen SH, 2004, J BIOL CHEM, V279, P7988, DOI 10.1074/jbc.M305351200; Cho YH, 2006, CELL, V127, P579, DOI 10.1016/j.cell.2006.09.028; Cipriano DJ, 2008, BBA-BIOENERGETICS, V1777, P599, DOI 10.1016/j.bbabio.2008.03.013; Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9; Dietz KJ, 2001, J EXP BOT, V52, P1969, DOI 10.1093/jexbot/52.363.1969; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; GLENNEY JR, 1981, CELL, V24, P471, DOI 10.1016/0092-8674(81)90338-X; Graham LA, 2003, J BIOENERG BIOMEMBR, V35, P301, DOI 10.1023/A:1025772730586; Holliday LS, 2005, J BIOENERG BIOMEMBR, V37, P419, DOI 10.1007/s10863-005-9483-y; Holliday LS, 2000, J BIOL CHEM, V275, P32331, DOI 10.1074/jbc.M004795200; Huang SJ, 2003, J BIOL CHEM, V278, P44832, DOI 10.1074/jbc.M306670200; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Khurana P, 2010, PLANT CELL, V22, P2727, DOI 10.1105/tpc.110.076240; Kim H, 2005, PLANT CELL, V17, P888, DOI 10.1105/tpc.104.028829; Li Y, 2001, PLANTA, V213, P722, DOI 10.1007/s004250100543; Ma BY, 2011, CELL SIGNAL, V23, P1244, DOI 10.1016/j.cellsig.2011.03.003; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Oda T, 2010, STRUCTURE, V18, P761, DOI 10.1016/j.str.2010.05.009; Palanivelu R, 2000, TRENDS CELL BIOL, V10, P517, DOI 10.1016/S0962-8924(00)01849-3; Papuga J, 2010, PLANT CELL, V22, P3034, DOI 10.1105/tpc.110.075960; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Shimaoka T, 2004, PLANT CELL PHYSIOL, V45, P672, DOI 10.1093/pcp/pch099; SHIMMEN T, 1995, PROTOPLASMA, V185, P188, DOI 10.1007/BF01272859; Staiger CJ, 2000, ANNU REV PLANT PHYS, V51, P257, DOI 10.1146/annurev.arplant.51.1.257; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Sze H, 2002, TRENDS PLANT SCI, V7, P157, DOI 10.1016/S1360-1385(02)02240-9; Theologis A, 2000, NATURE, V408, P816, DOI 10.1038/35048500; Thomas C, 2006, PLANT CELL, V18, P2194, DOI 10.1105/tpc.106.040956; Vitavska O, 2005, J BIOL CHEM, V280, P1070, DOI 10.1074/jbc.M406797200; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; WALSH TP, 1984, BIOCHEMISTRY-US, V23, P2613, DOI 10.1021/bi00307a012; Winder SJ, 2005, J CELL SCI, V118, P651, DOI 10.1242/jcs.01670; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wu YJ, 2010, PLANT CELL, V22, P3745, DOI 10.1105/tpc.110.080283; Xiang Y, 2007, PLANT CELL, V19, P1930, DOI 10.1105/tpc.106.048413; Yang WB, 2011, PLANT CELL, V23, P661, DOI 10.1105/tpc.110.081802; Yarmola EG, 2000, J BIOL CHEM, V275, P28120; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Zhang H, 2010, PLANT CELL, V22, P2749, DOI 10.1105/tpc.110.076257; Zhang Y, 2011, NEW PHYTOL, V190, P667, DOI 10.1111/j.1469-8137.2010.03632.x; Zhao Y, 2011, PLANT CELL, V23, P2314, DOI 10.1105/tpc.111.086546; Zuo J, 2008, J EXP BIOL, V211, P1102, DOI 10.1242/jeb.013672	51	32	34	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2012	287	23					19008	19017		10.1074/jbc.M111.281873	http://dx.doi.org/10.1074/jbc.M111.281873			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EF	22371505	hybrid, Green Published			2022-12-27	WOS:000306411900012
J	Eroglu, A; Hruszkewycz, DP; dela Sena, C; Narayanasamy, S; Riedl, KM; Kopec, RE; Schwartz, SJ; Curley, RW; Harrison, EH				Eroglu, Abdulkerim; Hruszkewycz, Damian P.; dela Sena, Carlo; Narayanasamy, Sureshbabu; Riedl, Ken M.; Kopec, Rachel E.; Schwartz, Steven J.; Curley, Robert W., Jr.; Harrison, Earl H.			Naturally Occurring Eccentric Cleavage Products of Provitamin A beta-Carotene Function as Antagonists of Retinoic Acid Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; VITAMIN-A; IN-VIVO; LUNG-CANCER; CONVERSION; BETA-APO-13-CAROTENONE; EXPRESSION; FERRETS; ALPHA; CELLS	beta-Carotene is the major dietary source of provitamin A. Central cleavage of beta-carotene catalyzed by beta-carotene oxygenase 1 yields two molecules of retinaldehyde. Subsequent oxidation produces all-trans-retinoic acid (ATRA), which functions as a ligand for a family of nuclear transcription factors, the retinoic acid receptors (RARs). Eccentric cleavage of beta-carotene at non-central double bonds is catalyzed by other enzymes and can also occur non-enzymatically. The products of these reactions are beta-apocarotenals and beta-apocarotenones, whose biological functions in mammals are unknown. We used reporter gene assays to show that none of the beta-apocarotenoids significantly activated RARs. Importantly, however, beta-apo-14'-carotenal, beta-apo-14'-carotenoic acid, and beta-apo-13-carotenone antagonized ATRA-induced transactivation of RARs. Competitive radioligand binding assays demonstrated that these putative RAR antagonists compete directly with retinoic acid for high affinity binding to purified receptors. Molecular modeling studies confirmed that beta-apo-13-carotenone can interact directly with the ligand binding site of the retinoid receptors. beta-Apo-13-carotenone and the beta-apo-14'-carotenoids inhibited ATRA-induced expression of retinoid responsive genes in Hep G2 cells. Finally, we developed an LC/MS method and found 3-5 nM beta-apo-13-carotenone was present in human plasma. These findings suggest that beta-apocarotenoids function as naturally occurring retinoid antagonists. The antagonism of retinoid signaling by these metabolites may have implications for the activities of dietary beta-carotene as a provitamin A and as a modulator of risk for cardiovascular disease and cancer.	[Eroglu, Abdulkerim; dela Sena, Carlo; Narayanasamy, Sureshbabu; Harrison, Earl H.] Ohio State Univ, Dept Human Nutr, Columbus, OH 43210 USA; [Eroglu, Abdulkerim; dela Sena, Carlo; Curley, Robert W., Jr.; Harrison, Earl H.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Hruszkewycz, Damian P.; Narayanasamy, Sureshbabu; Curley, Robert W., Jr.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Riedl, Ken M.; Kopec, Rachel E.; Schwartz, Steven J.] Ohio State Univ, Dept Food Sci & Technol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Harrison, EH (corresponding author), 350 Campbell Hall,1787 Neil Ave, Columbus, OH 43210 USA.	Harrison.304@osu.edu	Harrison, Earl H/AAN-5378-2021; NARAYANASAMY, SURESHBABU/AAN-6604-2021; Kopec, Rachel E/A-1533-2017; Riedl, Ken/K-1881-2019; Eroglu, Abdulkerim/J-5862-2019; riedl, ken/G-8621-2014	Eroglu, Abdulkerim/0000-0001-5350-450X; riedl, ken/0000-0002-9020-3471; Kopec, Rachel/0000-0002-1368-6713; Narayanasamy, Sureshbabu/0000-0002-5846-3230; Schwartz, Steven/0000-0002-1427-5780	National Institutes of Health [R01-DK044498, R01-Hl049879]; Ohio Agricultural Research and Development Center; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Agricultural Research and Development Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK044498 and R01-Hl049879 (to E. H. H.). This work was also supported by a grant from the Ohio Agricultural Research and Development Center (to E. H. H., K. M. R., and R. W. C.).	COREY EJ, 1968, J AM CHEM SOC, V90, P5616, DOI 10.1021/ja01022a059; de Lera AR, 2007, NAT REV DRUG DISCOV, V6, P811, DOI 10.1038/nrd2398; Eroglu A, 2010, ARCH BIOCHEM BIOPHYS, V504, P11, DOI 10.1016/j.abb.2010.07.025; Fleshman MK, 2011, J AGR FOOD CHEM, V59, P4448, DOI 10.1021/jf200416a; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Goodwin T. W., 1963, BIOSYNTHESIS VITAMIN, P270; Ho CC, 2007, AM J CLIN NUTR, V85, P770, DOI 10.1093/ajcn/85.3.770; Hu KQ, 2006, J BIOL CHEM, V281, P19327, DOI 10.1074/jbc.M512095200; Karrer P, 1931, HELV CHIM ACTA, V14, P1431, DOI 10.1002/hlca.19310140622; Liu C, 2000, CARCINOGENESIS, V21, P2245, DOI 10.1093/carcin/21.12.2245; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; Marsh RS, 2010, EXP BIOL MED, V235, P342, DOI 10.1258/ebm.2009.009202; Moore T, 1930, BIOCHEM J, V24, P692, DOI 10.1042/bj0240692; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Omenn GS, 1996, J NATL CANCER I, V88, P1550, DOI 10.1093/jnci/88.21.1550; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; Prakash P, 2004, J NUTR, V134, P667, DOI 10.1093/jn/134.3.667; Rarey M, 1999, BIOINFORMATICS, V15, P243, DOI 10.1093/bioinformatics/15.3.243; REPA JJ, 1993, P NATL ACAD SCI USA, V90, P7293, DOI 10.1073/pnas.90.15.7293; Russell RM, 2004, J NUTR, V134, p262S, DOI 10.1093/jn/134.1.262S; Shmarakov I, 2010, ARCH BIOCHEM BIOPHYS, V504, P3, DOI 10.1016/j.abb.2010.05.010; TANG GW, 1991, BIOCHEMISTRY-US, V30, P9829, DOI 10.1021/bi00105a003; Tay S, 2010, MOL PHARMACOL, V77, P218, DOI 10.1124/mol.109.059071; WANG XD, 1991, ARCH BIOCHEM BIOPHYS, V285, P8, DOI 10.1016/0003-9861(91)90322-A; Wang XD, 1999, J NATL CANCER I, V91, P60, DOI 10.1093/jnci/91.1.60; Ziouzenkova O, 2007, MOL ENDOCRINOL, V21, P77, DOI 10.1210/me.2006-0225	28	104	104	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15886	15895		10.1074/jbc.M111.325142	http://dx.doi.org/10.1074/jbc.M111.325142			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22418437	hybrid, Green Published			2022-12-27	WOS:000304006300067
J	Papakostas, K; Frillingos, S				Papakostas, Konstantinos; Frillingos, Stathis			Substrate Selectivity of YgfU, a Uric Acid Transporter from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING ANALYSIS; XANTHINE PERMEASE; ASPERGILLUS-NIDULANS; SIGNATURE MOTIF; FUNCTIONAL-CHARACTERIZATION; KLEBSIELLA-PNEUMONIAE; PURINE TRANSPORTERS; RUT PATHWAY; BACTERIAL; RESIDUES	The ubiquitous nucleobase-ascorbate transporter (NAT/NCS2) family includes more than 2,000 members, but only 15 have been characterized experimentally. Escherichia coli has 10 members, of which the uracil permease UraA and the xanthine permeases XanQ and XanP are functionally known. Of the remaining members, YgfU is closely related in sequence and genomic locus with XanQ. We analyzed YgfU and showed that it is a proton-gradient dependent, low-affinity (K-m 0.5 mM), and high-capacity transporter for uric acid. It also shows a low capacity for transport of xanthine at 37 degrees C but not at 25 degrees C. Based on the set of positions delineated as important from our previous Cys-scanning analysis of permease XanQ, we subjected YgfU to rationally designed site-directed mutagenesis. The results show that the conserved His-37 (TM1), Glu-270 (TM8), Asp-298 (TM9), and Gln-318 and Asn-319 (TM10) are functionally irreplaceable, and Thr-100 (TM3) is essential for the uric acid selectivity because its replacement with Ala allows efficient uptake of xanthine. The key role of these residues is corroborated by the conservation pattern and homology modeling on the recently described x-ray structure of permease UraA. In addition, site-specific replacements at TM8 (S271A, M274D, V282S) impair expression in the membrane, and V320N (TM10) inactivates the permease, whereas R327G (TM10) or S426N (TM14) reduces the affinity for uric acid (4-fold increased K-m). Our study shows that comprehensive analysis of structure-function relationships in a newly characterized transporter can be accomplished with relatively few site-directed replacements, based on the knowledge available from Cys-scanning mutagenesis of a prototypic homolog.	[Papakostas, Konstantinos; Frillingos, Stathis] Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece	University of Ioannina	Frillingos, S (corresponding author), Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece.	efriligo@cc.uoi.gr	Frillingos, Stathis/AAQ-3148-2021		EVOTRANS; European Union; Hellenic Ministry of Education, Lifelong Learning and Religious Affairs	EVOTRANS; European Union(European Commission); Hellenic Ministry of Education, Lifelong Learning and Religious Affairs	This work was supported by the research project EVOTRANS co-funded by the European Union-European Social Fund (ESF) and National Sources, in the framework of program "Thalis" through the Operational Program "Education and Life-long Learning" of the Hellenic Ministry of Education, Lifelong Learning and Religious Affairs, in the context of the National Strategic Reference Framework (SRF).	Amillis S, 2011, J MOL BIOL, V411, P567, DOI 10.1016/j.jmb.2011.06.024; ANDERSEN PS, 1995, J BACTERIOL, V177, P2008, DOI 10.1128/jb.177.8.2008-2013.1995; BURTON K, 1994, P ROY SOC B-BIOL SCI, V255, P153, DOI 10.1098/rspb.1994.0022; Cecchetto G, 2004, J BIOL CHEM, V279, P3132, DOI 10.1074/jbc.M308826200; Cho BK, 2011, NUCLEIC ACIDS RES, V39, P6456, DOI 10.1093/nar/gkr307; Cusa E, 1999, J BACTERIOL, V181, P7479, DOI 10.1128/JB.181.24.7479-7484.1999; de la Riva L, 2008, J BACTERIOL, V190, P7892, DOI 10.1128/JB.01022-08; Diallinas G, 1998, EMBO J, V17, P3827, DOI 10.1093/emboj/17.14.3827; FELLE H, 1980, BIOCHEMISTRY-US, V19, P3585, DOI 10.1021/bi00556a026; Georgopoulou E, 2010, J BIOL CHEM, V285, P19422, DOI 10.1074/jbc.M110.120543; Gournas C, 2011, FUNGAL GENET BIOL, V48, P840, DOI 10.1016/j.fgb.2011.03.004; Granseth E, 2005, J MOL BIOL, V352, P489, DOI 10.1016/j.jmb.2005.07.053; Hennebry SC, 2009, FEBS J, V276, P5367, DOI 10.1111/j.1742-4658.2009.07246.x; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; KABACK HR, 1974, ARCH BIOCHEM BIOPHYS, V160, P215, DOI 10.1016/S0003-9861(74)80028-7; Karatza P, 2005, MOL MEMBR BIOL, V22, P251, DOI 10.1080/09687860500092927; Karatza P, 2006, J BIOL CHEM, V281, P39881, DOI 10.1074/jbc.M605748200; Karena E, 2011, J BIOL CHEM, V286, P39595, DOI 10.1074/jbc.M111.299164; Karena E, 2009, J BIOL CHEM, V284, P24257, DOI 10.1074/jbc.M109.030734; Kim KS, 2010, J BACTERIOL, V192, P4089, DOI 10.1128/JB.00201-10; Kosti V, 2010, J MOL BIOL, V397, P1132, DOI 10.1016/j.jmb.2010.02.037; Koukaki M, 2005, J MOL BIOL, V350, P499, DOI 10.1016/j.jmb.2005.04.076; Lee Y, 2005, FEBS LETT, V579, P4769, DOI 10.1016/j.febslet.2005.07.056; Loh KD, 2006, P NATL ACAD SCI USA, V103, P5114, DOI 10.1073/pnas.0600521103; Lu FR, 2011, NATURE, V472, P243, DOI 10.1038/nature09885; Mansfield TA, 2009, FEBS LETT, V583, P481, DOI 10.1016/j.febslet.2008.12.048; Mermelekas G, 2010, J BIOL CHEM, V285, P35011, DOI 10.1074/jbc.M110.170415; O'Leary SE, 2009, BIOCHEMISTRY-US, V48, P3033, DOI 10.1021/bi900160b; Ormazabal V, 2010, J BIOL CHEM, V285, P36471, DOI 10.1074/jbc.M110.155630; Papageorgiou L, 2008, J MOL BIOL, V382, P1121, DOI 10.1016/j.jmb.2008.08.005; Papakostas K, 2008, J BIOL CHEM, V283, P13666, DOI 10.1074/jbc.M800261200; Parales RE, 2010, J BACTERIOL, V192, P4086, DOI 10.1128/JB.00573-10; Pope SD, 2009, J BACTERIOL, V191, P1006, DOI 10.1128/JB.01281-08; Ramazzina I, 2006, NAT CHEM BIOL, V2, P144, DOI 10.1038/nchembio768; Rintoul MR, 2002, J MOL BIOL, V324, P599, DOI 10.1016/S0022-2836(02)01134-8; Schultz AC, 2001, J BACTERIOL, V183, P3293, DOI 10.1128/JB.183.11.3293-3302.2001; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; TEATHER RM, 1980, EUR J BIOCHEM, V108, P223, DOI 10.1111/j.1432-1033.1980.tb04715.x; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Varma S, 2008, BIOCHEMISTRY-US, V47, P2952, DOI 10.1021/bi701666q; Xi HL, 2000, J BACTERIOL, V182, P5332, DOI 10.1128/JB.182.19.5332-5341.2000; Yamamoto S, 2010, J BIOL CHEM, V285, P6522, DOI 10.1074/jbc.M109.032961; Zanotti G, 2006, J MOL BIOL, V363, P1, DOI 10.1016/j.jmb.2006.07.079	44	28	29	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15684	15695		10.1074/jbc.M112.355818	http://dx.doi.org/10.1074/jbc.M112.355818			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22437829	hybrid, Green Published			2022-12-27	WOS:000304006300047
J	Gaur, P; Ranjan, P; Sharma, S; Patel, JR; Bowzard, JB; Rahman, SK; Kumari, R; Gangappa, S; Katz, JM; Cox, NJ; Lal, RB; Sambhara, S; Lal, SK				Gaur, Pratibha; Ranjan, Priya; Sharma, Shipra; Patel, Jenish R.; Bowzard, J. Bradford; Rahman, Shah K.; Kumari, Rashmi; Gangappa, Shivaprakash; Katz, Jacqueline M.; Cox, Nancy J.; Lal, Renu B.; Sambhara, Suryaprakash; Lal, Sunil K.			Influenza A Virus Neuraminidase Protein Enhances Cell Survival through Interaction with Carcinoembryonic Antigen-related Cell Adhesion Molecule 6 (CEACAM6) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC ADENOCARCINOMA CELLS; PHOSPHATIDYLINOSITOL 3-KINASE/AKT PATHWAY; NF-KAPPA-B; KINASE; ACTIVATION; BETA; SRC; OVEREXPRESSION; INFECTIONS; EXPRESSION	The influenza virus neuraminidase (NA) protein primarily aids in the release of progeny virions from infected cells. Here, we demonstrate a novel role for NA in enhancing host cell survival by activating the Src/Akt signaling axis via an interaction with carcinoembryonic antigen-related cell adhesion molecule 6/cluster of differentiation 66c (C6). NA/C6 interaction leads to increased tyrosyl phosphorylation of Src, FAK, Akt, GSK3 beta, and Bcl-2, which affects cell survival, proliferation, migration, differentiation, and apoptosis. siRNA-mediated suppression of C6 resulted inadown-regulation of activated Src, FAK, and Akt, increased apoptosis, and reduced expression of viral proteins and viral titers in influenza virus-infected human lung adenocarcinoma epithelial and normal human bronchial epithelial cells. These findings indicate that influenza NA not only aids in the release of progeny virions, but also cell survival during viral replication.	[Gaur, Pratibha; Sharma, Shipra; Rahman, Shah K.; Kumari, Rashmi; Lal, Sunil K.] Int Ctr Genet Engn & Biotechnol, Virol Grp, New Delhi 110067, India; [Ranjan, Priya; Patel, Jenish R.; Bowzard, J. Bradford; Gangappa, Shivaprakash; Katz, Jacqueline M.; Cox, Nancy J.; Lal, Renu B.; Sambhara, Suryaprakash] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30033 USA	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Centers for Disease Control & Prevention - USA	Lal, SK (corresponding author), Int Ctr Genet Engn & Biotechnol, Virol Grp, Aruna Asaf Ali Rd, New Delhi 110067, India.	sunillal@icgeb.res.in	Sambhara, Suryaprakash/AAC-4428-2021; Gaur, Pratibha/AGE-6421-2022	Gaur, Pratibha/0000-0002-3155-5944; Rahman, Shah Kamranur/0000-0002-8835-7092; Patel, Jenish/0000-0001-5310-8160	International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi; Department of Biotechnology, India; Centers for Disease Control (CDC), Atlanta	International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi; Department of Biotechnology, India(Department of Biotechnology (DBT) India); Centers for Disease Control (CDC), Atlanta	This work was supported by internal funds from the International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, a research grant from the Department of Biotechnology, India (to S. K. L.), and a training and research grant from the Centers for Disease Control (CDC), Atlanta (to S. K. L.).	Arora DJS, 1998, ARCH VIROL, V143, P2029, DOI 10.1007/s007050050439; Autret A, 2008, J VIROL, V82, P3796, DOI 10.1128/JVI.02020-07; Bhatia A, 2007, CELL MOL BIOL LETT, V12, P111, DOI 10.2478/s11658-006-0055-x; Bouchard V, 2007, J CELL PHYSIOL, V212, P717, DOI 10.1002/jcp.21096; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; DUCKER TP, 1992, J LEUKOCYTE BIOL, V52, P11, DOI 10.1002/jlb.52.1.11; Duxbury MS, 2004, ONCOGENE, V23, P5834, DOI 10.1038/sj.onc.1207775; Duxbury MS, 2004, CANCER RES, V64, P3987, DOI 10.1158/0008-5472.CAN-04-0424; Duxbury MS, 2004, J BIOL CHEM, V279, P23176, DOI 10.1074/jbc.M402051200; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Flory E, 2000, J BIOL CHEM, V275, P8307, DOI 10.1074/jbc.275.12.8307; Gaur P, 2011, MED SCI MONITOR, V17, pRA148, DOI 10.12659/MSM.881801; Hale BG, 2007, BIOCHEM SOC T, V35, P186, DOI 10.1042/BST0350186; Han SU, 2008, ONCOGENE, V27, P675, DOI 10.1038/sj.onc.1210686; Hartshorn KL, 1999, J LEUKOCYTE BIOL, V65, P614, DOI 10.1002/jlb.65.5.614; HOUDE M, 1990, CELL IMMUNOL, V129, P104, DOI 10.1016/0008-8749(90)90190-3; Kasahara K, 2002, NEUROCHEM RES, V27, P823, DOI 10.1023/A:1020265225916; Kirshner J, 2003, P NATL ACAD SCI USA, V100, P521, DOI 10.1073/pnas.232711199; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Kumar P, 2007, VIROLOGY, V366, P293, DOI 10.1016/j.virol.2007.04.029; Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005; Mannova P, 2005, J VIROL, V79, P8742, DOI 10.1128/JVI.79.14.8742-8749.2005; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Miller JL, 2003, J GEN VIROL, V84, P193, DOI 10.1099/vir.0.18590-0; Mizutani T, 2004, VIROLOGY, V327, P169, DOI 10.1016/j.virol.2004.07.005; Najjar SM, 2002, TRENDS ENDOCRIN MET, V13, P240, DOI 10.1016/S1043-2760(02)00608-2; PAHL HL, 1995, J VIROL, V69, P1480, DOI 10.1128/JVI.69.3.1480-1484.1995; Ratra R, 2009, J GEN VIROL, V90, P1359, DOI 10.1099/vir.0.009274-0; SchultzCherry S, 1996, J VIROL, V70, P8624, DOI 10.1128/JVI.70.12.8624-8629.1996; Shih WL, 2003, J BIOL CHEM, V278, P31807, DOI 10.1074/jbc.M302580200; Shin YK, 2007, J GEN VIROL, V88, P942, DOI 10.1099/vir.0.82483-0; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316	35	23	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15109	15117		10.1074/jbc.M111.328070	http://dx.doi.org/10.1074/jbc.M111.328070			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22396546	Green Published, hybrid			2022-12-27	WOS:000304003200072
J	Martin, TD; Mitin, N; Cox, AD; Yeh, JJ; Der, CJ				Martin, Timothy D.; Mitin, Natalia; Cox, Adrienne D.; Yeh, Jen Jen; Der, Channing J.			Phosphorylation by Protein Kinase C alpha Regulates RalB Small GTPase Protein Activation, Subcellular Localization, and Effector Utilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA CELLS; PLASMA-MEMBRANE; EXOCYST; TRAFFICKING; CANCER; RAIA; RAS; IDENTIFICATION; CYTOKINESIS; EXOCYTOSIS	Ras-like (Ral) small GTPases are regulated downstream of Ras and the noncanonical Ral guanine nucleotide exchange factor (RalGEF) effector pathway. Despite RalA and RalB sharing 82% sequence identity and utilization of shared effector proteins, their roles in normal and neoplastic cell growth have been shown to be highly distinct. Here, we determined that RalB function is regulated by protein kinase C alpha (PKC alpha) phosphorylation. We found that RalB phosphorylation on Ser-198 in the C-terminal membrane targeting sequence resulted in enhanced RalB endomembrane accumulation and decreased RalB association with its effector, the exocyst component Sec5. Additionally, RalB phosphorylation regulated vesicular trafficking and membrane fusion by regulating v-and t-SNARE interactions. RalB phosphorylation regulated vesicular traffic of alpha 5-integrin to the cell surface and cell attachment to fibronectin. In summary, our data suggest that phosphorylation by PKC alpha is critical for RalB-mediated vesicle trafficking and exocytosis.	[Mitin, Natalia; Cox, Adrienne D.; Yeh, Jen Jen; Der, Channing J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Martin, Timothy D.; Cox, Adrienne D.; Yeh, Jen Jen; Der, Channing J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Cox, Adrienne D.] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; [Yeh, Jen Jen] Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Der, CJ (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	cjder@med.unc.edu	Mitin, Natalia/E-8043-2012	Cox, Adrienne D./0000-0002-4901-2454; Der, Channing/0000-0002-7751-2747	National Institutes of Health [R01 CA042978, P50 CA106991, R01 CA109550]; NATIONAL CANCER INSTITUTE [R01CA140424, P50CA106991, R01CA109550, R01CA042978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA042978 and P50 CA106991 (to C. J. D.) and R01 CA109550 (to A. D. C.).	Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Brown FC, 2010, MOL MEMBR BIOL, V27, P457, DOI 10.3109/09687688.2010.501765; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Chen XW, 2006, J BIOL CHEM, V281, P38609, DOI 10.1074/jbc.M512847200; Chen XW, 2011, NAT CELL BIOL, V13, P580, DOI 10.1038/ncb2226; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Hepp G, 2005, J BIOL CHEM, V280, P6610, DOI 10.1074/jbc.M412126200; Kennedy MJ, 2010, CELL, V141, P524, DOI 10.1016/j.cell.2010.02.042; Lau CG, 2010, J NEUROSCI, V30, P242, DOI 10.1523/JNEUROSCI.4933-08.2010; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Lim KH, 2010, MOL CELL BIOL, V30, P508, DOI 10.1128/MCB.00916-08; Madigan JP, 2009, BIOCHEM J, V424, P153, DOI 10.1042/BJ20082377; Martin TD, 2011, CANCER RES, V71, P206, DOI 10.1158/0008-5472.CAN-10-1517; Masur K, 2001, MOL BIOL CELL, V12, P1973, DOI 10.1091/mbc.12.7.1973; Mitin NY, 2004, J BIOL CHEM, V279, P22353, DOI 10.1074/jbc.M312867200; Morgan A, 2005, BIOCHEM SOC T, V33, P1341, DOI 10.1042/BST0331341; Moskalenko S, 2003, J BIOL CHEM, V278, P51743, DOI 10.1074/jbc.M308702200; Neel Nicole F, 2011, Genes Cancer, V2, P275, DOI 10.1177/1947601911407329; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; Proux-Gillardeaux V, 2005, TRAFFIC, V6, P366, DOI 10.1111/j.1600-0854.2005.00288.x; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Shipitsin M, 2004, MOL CELL BIOL, V24, P5746, DOI 10.1128/MCB.24.13.5746-5756.2004; Spiczka KS, 2008, J CELL SCI, V121, P2880, DOI 10.1242/jcs.031641; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Wang H, 2010, CANCER RES, V70, P8760, DOI 10.1158/0008-5472.CAN-10-0952; Wu JC, 2005, J BIOL CHEM, V280, P9013, DOI 10.1074/jbc.M411068200	31	23	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14827	14836		10.1074/jbc.M112.344986	http://dx.doi.org/10.1074/jbc.M112.344986			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22393054	hybrid, Green Published			2022-12-27	WOS:000304003200047
J	Strande, N; Roberts, SA; Oh, S; Hendrickson, EA; Ramsden, DA				Strande, Natasha; Roberts, Steven A.; Oh, Sehyun; Hendrickson, Eric A.; Ramsden, Dale A.			Specificity of the dRP/AP Lyase of Ku Promotes Nonhomologous End Joining (NHEJ) Fidelity at Damaged Ends	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-BETA; DOUBLE-STRAND BREAKS; URACIL EXCISION; OXIDIZED BASES; NUCLEIC-ACIDS; REPAIR; COMPLEX; LESIONS; GLYCOSYLASE; MECHANISM	Nonhomologous end joining (NHEJ) is essential for efficient repair of chromosome breaks. However, the NHEJ ligation step is often obstructed by break-associated nucleotide damage, including base loss (abasic site or 5'-dRP/AP sites). Ku, a 5'-dRP/AP lyase, can excise such damage at ends in preparation for the ligation step. We show here that this activity is greatest if the abasic site is within a short 5' overhang, when this activity is necessary and sufficient to prepare such termini for ligation. In contrast, Ku is less active near 3' strand termini, where excision would leave a ligation-blocking alpha,beta-unsaturated aldehyde. The Ku AP lyase activity is also strongly suppressed by as little as two paired bases 5' of the abasic site. Importantly, in vitro end joining experiments show that abasic sites significantly embedded in double-stranded DNA do not block the NHEJ ligation step. Suppression of the excision activity of Ku in this context therefore is not essential for ligation and further helps NHEJ retain terminal sequence in junctions. We show that the DNA between the 5' terminus and the abasic site can also be retained in junctions formed by cellular NHEJ, indicating that these sites are at least partly resistant to other abasic site-cleaving activities as well. High levels of the 5'-dRP/AP lyase activity of Ku are thus restricted to substrates where excision of an abasic site is required for ligation, a degree of specificity that promotes more accurate joining.	[Strande, Natasha; Roberts, Steven A.; Ramsden, Dale A.] Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Strande, Natasha; Roberts, Steven A.; Ramsden, Dale A.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Oh, Sehyun; Hendrickson, Eric A.] Univ Minnesota, Sch Med, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Minnesota System; University of Minnesota Twin Cities	Ramsden, DA (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	dale_ramsden@med.unc.edu	Strande, Natasha T./H-9894-2019	Strande, Natasha T./0000-0001-5148-9772; Ramsden, Dale/0000-0003-1575-4748; Oh, Sehyun/0000-0002-9490-3061	National Institutes of Health [R01 CA 84442, RO1 GM088351, RO1 CA154461]; NATIONAL CANCER INSTITUTE [R01CA154461, R01CA084442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA 84442 (to D. A. R.) and RO1 GM088351 and RO1 CA154461 (to E. A. H.).	Allinson SL, 2001, EMBO J, V20, P6919, DOI 10.1093/emboj/20.23.6919; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Chen S, 2001, J BIOL CHEM, V276, P24323, DOI 10.1074/jbc.M010544200; Datta K, 2011, RADIAT RES, V175, P97, DOI 10.1667/RR2332.1; Di Noia JM, 2007, J EXP MED, V204, P3209, DOI 10.1084/jem.20071768; Dobbs TA, 2008, DNA REPAIR, V7, P1372, DOI 10.1016/j.dnarep.2008.05.001; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551; Fattah F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000855; Hashimoto M, 2001, J BIOL CHEM, V276, P12827, DOI 10.1074/jbc.M010906200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Ilina ES, 2008, BBA-PROTEINS PROTEOM, V1784, P1777, DOI 10.1016/j.bbapap.2008.08.001; JEGGO PA, 1990, MUTAT RES, V239, P1, DOI 10.1016/0165-1110(90)90028-A; Ma WJ, 2008, NUCLEIC ACIDS RES, V36, P1836, DOI 10.1093/nar/gkm1148; Malyarchuk S, 2008, NUCLEIC ACIDS RES, V36, P4872, DOI 10.1093/nar/gkn450; Malyarchuk S, 2009, DNA REPAIR, V8, P1343, DOI 10.1016/j.dnarep.2009.08.008; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; Piersen CE, 2000, MUTAT RES-DNA REPAIR, V459, P43, DOI 10.1016/S0921-8777(99)00054-3; Pogozelski WK, 1998, CHEM REV, V98, P1089, DOI 10.1021/cr960437i; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Roberts SA, 2010, NATURE, V464, P1214, DOI 10.1038/nature08926; Rooney S, 2004, IMMUNOL REV, V200, P115, DOI 10.1111/j.0105-2896.2004.00165.x; Sekiguchi JM, 1999, COLD SPRING HARB SYM, V64, P169, DOI 10.1101/sqb.1999.64.169; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; WARD JF, 1994, INT J RADIAT BIOL, V66, P427, DOI 10.1080/09553009414551401; Yang N, 2004, DNA REPAIR, V3, P1323, DOI 10.1016/j.dnarep.2004.04.014; Yoo S, 1999, J BIOL CHEM, V274, P20034, DOI 10.1074/jbc.274.28.20034	32	39	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13686	13693		10.1074/jbc.M111.329730	http://dx.doi.org/10.1074/jbc.M111.329730			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22362780	Green Published, hybrid			2022-12-27	WOS:000303996300024
J	Yu, WF; Chen, J; Xiong, Y; Pixley, FJ; Yeung, YG; Stanley, ER				Yu, Wenfeng; Chen, Jian; Xiong, Ying; Pixley, Fiona J.; Yeung, Yee-Guide; Stanley, E. Richard			Macrophage Proliferation Is Regulated through CSF-1 Receptor Tyrosines 544, 559, and 807	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATING FACTOR-I; GROWTH-FACTOR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; KINASE-ACTIVITY; PROTEIN-KINASE; JUXTAMEMBRANE DOMAIN; SIGNAL-TRANSDUCTION; ONCOGENE PRODUCT; INSULIN-RECEPTOR	Colony-stimulatingfactor-1(CSF-1)-stimulated CSF-1 receptor (CSF-1R) tyrosine phosphorylation initiates survival, proliferation, and differentiation signaling pathways in macrophages. Either activation loop Y807F or juxtamembrane domain (JMD) Y559F mutations severely compromise CSF-1-regulated proliferation and differentiation. YEF, a CSF-1R in which all eight tyrosines phosphorylated in the activated receptor were mutated to phenylalanine, lacks in vitro kinase activity and in vivo CSF-1-regulated tyrosine phosphorylation. The addition of Tyr-807 alone to the YEF backbone (Y807AB) led to CSF-1-independent but receptor kinase-dependent proliferation, without detectable activation loop Tyr-807 phosphorylation. The addition of Tyr-559 alone (Y559AB) supported a low level of CSF-1-independent proliferation that was slightly enhanced by CSF-1, indicating that Tyr-559 has a positive Tyr-807-independent effect. Consistent with the postulated autoinhibitory role of the JMD Tyr-559 and its relief by ligand-induced Tyr-559 phosphorylation, the addition of Tyr-559 to the Y807AB background suppressed proliferation in the absence of CSF-1, but restored most of the CSF-1-stimulated proliferation. Full restoration of kinase activation and proliferation required the additional add back of JMD Tyr-544. Inhibitor experiments indicate that the constitutive proliferation of Y807AB macrophages is mediated by the phosphatidylinositol 3-kinase (PI3K) and ERK1/2 pathways, whereas proliferation of WT and Y559,807AB macrophagesis, inaddition, contributed to by Srcfamily kinase (SFK)-dependent pathways. Thus Tyr-807 confers sufficient kinase activity for strong CSF-1-independent proliferation, whereas Tyr-559 maintains the receptor in an inactive state. Tyr-559 phosphorylation releases this restraint and may also contribute to the CSF-1-regulated proliferative response by activating Src family kinase.	[Yu, Wenfeng; Chen, Jian; Xiong, Ying; Pixley, Fiona J.; Yeung, Yee-Guide; Stanley, E. Richard] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Stanley, ER (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	richard.stanley@einstein.yu.edu	Pixley, Fiona/ABD-5567-2020; Stanley, Evan R/J-9154-2013	Pixley, Fiona/0000-0002-1571-2532; Stanley, Evan R/0000-0002-2910-2065	National Institutes of Health [CA26504, PO1 CA100324]; Albert Einstein College of Medicine Cancer Center [5P30-CA13330]; NATIONAL CANCER INSTITUTE [P30CA013330, P01CA100324, R37CA026504, R01CA026504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants, CA26504 and PO1 CA100324 (to E. R. S.). This work was also supported by the Albert Einstein College of Medicine Cancer Center Grant 5P30-CA13330.	Aharinejad S, 2002, CANCER RES, V62, P5317; ALONSO G, 1995, J BIOL CHEM, V270, P9840, DOI 10.1074/jbc.270.17.9840; Berg KL, 1999, J BIOL CHEM, V274, P35855, DOI 10.1074/jbc.274.50.35855; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bourette RP, 2000, GROWTH FACTORS, V17, P155, DOI 10.3109/08977190009001065; CARLBERG K, 1994, MOL BIOL CELL, V5, P81, DOI 10.1091/mbc.5.1.81; Chalhoub N, 2009, GENE DEV, V23, P1619, DOI 10.1101/gad.1799609; Chang PM, 2003, MOL CELL BIOL, V23, P3067, DOI 10.1128/MCB.23.9.3067-3078.2003; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; DiNitto JP, 2010, J BIOCHEM, V147, P601, DOI 10.1093/jb/mvq015; DOWNING JR, 1989, MOL CELL BIOL, V9, P2890, DOI 10.1128/MCB.9.7.2890; ENGLISH BK, 1993, J EXP MED, V178, P1017, DOI 10.1084/jem.178.3.1017; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Gu TL, 2007, BLOOD, V110, P323, DOI 10.1182/blood-2006-10-052282; Hamilton JA, 1997, J LEUKOCYTE BIOL, V62, P145, DOI 10.1002/jlb.62.2.145; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Jaworowski A, 1999, J BIOL CHEM, V274, P15127, DOI 10.1074/jbc.274.21.15127; Joos H, 1996, J BIOL CHEM, V271, P24476, DOI 10.1074/jbc.271.40.24476; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Lew ED, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000021; LI W, 1991, EMBO J, V10, P277, DOI 10.1002/j.1460-2075.1991.tb07948.x; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Mancini A, 1997, ONCOGENE, V15, P1565, DOI 10.1038/sj.onc.1201518; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; MORGAN C, 1987, J CELL PHYSIOL, V130, P420, DOI 10.1002/jcp.1041300316; Narayana N, 1997, STRUCTURE, V5, P921, DOI 10.1016/S0969-2126(97)00246-3; OHTSUKA M, 1990, MOL CELL BIOL, V10, P1664, DOI 10.1128/MCB.10.4.1664; Persons DA, 1999, BLOOD, V93, P488, DOI 10.1182/blood.V93.2.488.402k17_488_499; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Rohde CM, 2004, J BIOL CHEM, V279, P43448, DOI 10.1074/jbc.M314170200; Sampaio NG, 2011, J CELL SCI, V124, P2021, DOI 10.1242/jcs.075309; Scapini P, 2009, IMMUNOL REV, V228, P23, DOI 10.1111/j.1600-065X.2008.00758.x; SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; STANLEY ER, 1985, METHOD ENZYMOL, V116, P564; Takeshita S, 2007, J BIOL CHEM, V282, P18980, DOI 10.1074/jbc.M610938200; TUSHINSKI RJ, 1982, CELL, V28, P71, DOI 10.1016/0092-8674(82)90376-2; Valledor AF, 2000, J BIOL CHEM, V275, P7403, DOI 10.1074/jbc.275.10.7403; VANDERGEER P, 1993, EMBO J, V12, P5161, DOI 10.1002/j.1460-2075.1993.tb06211.x; Walter M, 2007, J MOL BIOL, V367, P839, DOI 10.1016/j.jmb.2007.01.036; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Xiong Y, 2011, J BIOL CHEM, V286, P952, DOI 10.1074/jbc.M110.166702; Yeung YG, 1998, J BIOL CHEM, V273, P17128, DOI 10.1074/jbc.273.27.17128; YEUNG YG, 1987, P NATL ACAD SCI USA, V84, P1268, DOI 10.1073/pnas.84.5.1268; Yu WF, 2008, J LEUKOCYTE BIOL, V84, P852, DOI 10.1189/jlb.0308171	51	56	58	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13694	13704		10.1074/jbc.M112.355610	http://dx.doi.org/10.1074/jbc.M112.355610			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22375015	Green Published, hybrid			2022-12-27	WOS:000303996300025
J	Aoki, R; Takeda, T; Omata, T; Ihara, K; Fujita, Y				Aoki, Rina; Takeda, Tomoya; Omata, Tatsuo; Ihara, Kunio; Fujita, Yuichi			MarR-type Transcriptional Regulator ChlR Activates Expression of Tetrapyrrole Biosynthesis Genes in Response to Low-oxygen Conditions in Cyanobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; CHLOROPHYLL BIOSYNTHESIS; DIFFERENTIAL OPERATION; PROTEIN; FAMILY; OHRR; HEME; IDENTIFICATION; MECHANISMS; REDUCTASE	Oxygen is required for three enzyme reactions in chlorophyll and bilin biosynthesis pathways: coproporphyrinogen III oxidase (HemF), heme oxygenase (HO1), and Mg-protoporphyrin IX monomethylester cyclase (ChlA(I)). The cyanobacterium Synechocystis sp. PCC 6803 has alternative enzymes, HemN, HO2, and ChlA(II), to supply chlorophyll/bilins even under low-oxygen environments. The three genes form an operon, chlA(II)-ho2-hemN, that is induced in response to low-oxygen conditions to bypass the oxygen-dependent reactions. Here we identified a transcriptional regulator for the induction of the operon in response to low-oxygen conditions. A pseudorevertant, Delta ho1R, was isolated from a HO1-lacking mutant Delta ho1 that is lethal under aerobic conditions. Delta ho1R grew well even under aerobic conditions. In Delta ho1R, HO2 that is induced only under low-oxygen conditions was anomalously expressed under aerobic conditions to complement the loss of HO1. A G-to-C transversion in sll1512 causing the amino acid change from aspartate 35 to histidine was identified as the relevant mutation by resequencing of the Delta ho1R genome. Sll1512 is a MarR-type transcriptional regulator. An sll1512-lacking mutant grew poorly under low-oxygen conditions with a remarked decrease in Chl content that would be caused by the suppressed induction of the chlA(II) and hemN genes in Chl biosynthesis under low-oxygen conditions. These results demonstrated that Sll1512 is an activator in response to low-oxygen environments and that the D35H variant becomes a constitutive activator. This hypothesis was supported by a gel shift assay showing that the Sll1512-D35H variant binds to the DNA fragment upstream of the operon. We propose to name sll1512 chlR.	[Aoki, Rina; Takeda, Tomoya; Omata, Tatsuo; Fujita, Yuichi] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Ihara, Kunio] Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 4648602, Japan; [Fujita, Yuichi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Nagoya University; Nagoya University; Japan Science & Technology Agency (JST)	Fujita, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	fujita@agr.nagoya-u.ac.jp	IHARA, Kunio/D-1952-2011; Fujita, Yuichi/G-8908-2013		Japan Society for the Promotion of Science (JSPS) [19570036, 20200063]; Advanced Low Carbon Technology Research and Development Program (ALCA); Precursory Research for Embryonic Science and Technology (PRESTO) of the Japan Science and Technology Agency (JST)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Advanced Low Carbon Technology Research and Development Program (ALCA); Precursory Research for Embryonic Science and Technology (PRESTO) of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported by Grants-in-Aid for Scientific Research 19570036 and 20200063 from Japan Society for the Promotion of Science (JSPS), by the Advanced Low Carbon Technology Research and Development Program (ALCA), and by Precursory Research for Embryonic Science and Technology (PRESTO) of the Japan Science and Technology Agency (JST).	Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Aoki R, 2011, PLANT CELL PHYSIOL, V52, P1744, DOI 10.1093/pcp/pcr108; Bernroitner M, 2008, CHEM BIODIVERS, V5, P1927, DOI 10.1002/cbdv.200890180; Chi BK, 2010, J BACTERIOL, V192, P4571, DOI 10.1128/JB.00409-10; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Fuangthong M, 2002, P NATL ACAD SCI USA, V99, P6690, DOI 10.1073/pnas.102483199; Goto T, 2010, PLANT CELL PHYSIOL, V51, P650, DOI 10.1093/pcp/pcq023; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; JORGENSEN BB, 1979, APPL ENVIRON MICROB, V38, P46; Kanesaki Y, 2012, DNA RES, V19, P67, DOI 10.1093/dnares/dsr042; Keeley J.F., 1988, PLANTS TODAY, V1, P127; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Ludwig M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00041; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Masuda T, 2008, PHOTOCH PHOTOBIO SCI, V7, P1131, DOI 10.1039/b807210h; Minamizaki K, 2008, J BIOL CHEM, V283, P2684, DOI 10.1074/jbc.M708954200; Mochizuki N, 2010, TRENDS PLANT SCI, V15, P488, DOI 10.1016/j.tplants.2010.05.012; Nishimura T, 2008, MOL MICROBIOL, V68, P98, DOI 10.1111/j.1365-2958.2008.06137.x; Nomata J, 2006, J BIOL CHEM, V281, P15021, DOI 10.1074/jbc.M601750200; Panmanee W, 2006, J BACTERIOL, V188, P1389, DOI 10.1128/JB.188.4.1389-1395.2006; Perera IC, 2010, J MOL CELL BIOL, V2, P243, DOI 10.1093/jmcb/mjq021; STAL LJ, 1995, NEW PHYTOL, V131, P1, DOI 10.1111/j.1469-8137.1995.tb03051.x; Stal LJ, 1997, FEMS MICROBIOL REV, V21, P179, DOI 10.1016/S0168-6445(97)00056-9; Stal Lucas J., 2008, P423; Stenbaek A, 2010, PHYTOCHEMISTRY, V71, P853, DOI 10.1016/j.phytochem.2010.03.022; Steunou AS, 2006, P NATL ACAD SCI USA, V103, P2398, DOI 10.1073/pnas.0507513103; Summerfield TC, 2011, MICROBIOL-SGM, V157, P301, DOI 10.1099/mic.0.041053-0; Summerfield TC, 2008, BIOCHEMISTRY-US, V47, P12939, DOI 10.1021/bi8018916; Tajima N, 2011, DNA RES, V18, P393, DOI 10.1093/dnares/dsr026; Yamamoto H, 2008, PHOTOCH PHOTOBIO SCI, V7, P1238, DOI 10.1039/b802427h; Yamazaki S, 2006, PLANT PHYSIOL, V142, P911, DOI 10.1104/pp.106.086090; Yilmaz M, 2010, PHOTOSYNTH RES, V103, P47, DOI 10.1007/s11120-009-9506-3; Yurimoto H, 2005, MOL MICROBIOL, V57, P511, DOI 10.1111/j.1365-2958.2005.04702.x	33	29	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13500	13507		10.1074/jbc.M112.346205	http://dx.doi.org/10.1074/jbc.M112.346205			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22375005	Green Published, hybrid			2022-12-27	WOS:000302903700083
J	Carattino, MD; Della Vecchia, MC				Carattino, Marcelo D.; Della Vecchia, Margaret C.			Contribution of Residues in Second Transmembrane Domain of ASIC1a Protein to Ion Selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; TOAD URINARY-BLADDER; MONO-VALENT CATIONS; NA+ CHANNEL; PORE REGION; ALPHA-SUBUNIT; AMILORIDE; ENAC; FILTER; BLOCK	Acid-sensing ion channels (ASICs) are proton-gated cation-selective channels expressed in the peripheral and central nervous systems. The ion permeation pathway of ASIC1a is defined by residues 426-450 in the second transmembrane (TM2) segment. The gate, formed by the intersection of the TM2 segments, localizes near the extracellular boundary of the plasma membrane. We explored the contribution to ion permeation and selectivity of residues in the TM2 segment of ASIC1a. Studies of accessibility with positively charged methanethiosulfonate reagents suggest that the permeation pathway in the open state constricts below the gate, restricting the passage to large ions. Substitution of residues in the intracellular vestibule at positions 437, 438, 443, or 446 significantly increased the permeability to K+ versus Na+. ASIC1a shows a selectivity sequence for alkali metals of Na+ > Li+ > K+ >> Rb+ > Cs+. Alanine and cysteine substitutions at position 438 increased, to different extents, the relative permeability to Li+, K+, Rb+, and Cs+. For these mutants, ion permeation was not a function of the diameter of the nonhydrated ion, suggesting that Gly-438 encompasses an ion coordination site that is essential for ion selectivity. M437C and A443C mutants showed slightly increased permeability to K+, Rb+, and Cs+, suggesting that substitutions at these positions influence ion discrimination by altering molecular sieving. Our results indicate that ion selectivity is accomplished by the contribution of multiple sites in the pore of ASIC1a.	[Carattino, Marcelo D.; Della Vecchia, Margaret C.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA; [Carattino, Marcelo D.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carattino, MD (corresponding author), S828 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	mdc4@pitt.edu			National Institutes of Health [R01 DK084060-02]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK084060-02 (to M. D. C.).	Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Brown AL, 2007, J GEN PHYSIOL, V129, P161, DOI 10.1085/jgp.200609672; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Derebe MG, 2011, P NATL ACAD SCI USA, V108, P598, DOI 10.1073/pnas.1013636108; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; EISENMAN G, 1962, Biophys J, V2, P259; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; GARTY H, 1988, PHYSIOL REV, V68, P309, DOI 10.1152/physrev.1988.68.2.309; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kashlan OB, 2005, J BIOL CHEM, V280, P26206, DOI 10.1074/jbc.M503500200; Kellenberger S, 2002, J PHYSIOL-LONDON, V543, P413, DOI 10.1113/jphysiol.2002.022020; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 2001, J GEN PHYSIOL, V118, P679, DOI 10.1085/jgp.118.6.679; Kellenberger S, 1999, P NATL ACAD SCI USA, V96, P4170, DOI 10.1073/pnas.96.7.4170; Kellenberger S, 1999, J GEN PHYSIOL, V114, P13, DOI 10.1085/jgp.114.1.13; LAUGER P, 1982, BIOPHYS CHEM, V15, P89, DOI 10.1016/0301-4622(82)80021-5; Li JQ, 2003, J BIOL CHEM, V278, P13867, DOI 10.1074/jbc.M300149200; Li TB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1409; Li TB, 2011, J GEN PHYSIOL, V137, P289, DOI 10.1085/jgp.201010576; Meltzer RH, 2007, J BIOL CHEM, V282, P25548, DOI 10.1074/jbc.M703825200; PALMER LG, 1984, J MEMBRANE BIOL, V80, P153, DOI 10.1007/BF01868771; PALMER LG, 1985, J MEMBRANE BIOL, V87, P191, DOI 10.1007/BF01871218; PALMER LG, 1989, BIOPHYS J, V55, P779, DOI 10.1016/S0006-3495(89)82876-0; Passero CJ, 2009, J BIOL CHEM, V284, P36473, DOI 10.1074/jbc.M109.055418; Pfister Y, 2006, J BIOL CHEM, V281, P11787, DOI 10.1074/jbc.M513692200; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; Sheng SH, 2000, J BIOL CHEM, V275, P8572, DOI 10.1074/jbc.275.12.8572; Sheng SH, 2001, J BIOL CHEM, V276, P1326, DOI 10.1074/jbc.M008117200; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Tolino LA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202366; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Zhang YY, 2006, BIOPHYS J, V91, P2901, DOI 10.1529/biophysj.106.087700	40	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12927	12934		10.1074/jbc.M111.329284	http://dx.doi.org/10.1074/jbc.M111.329284			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22371494	hybrid, Green Published			2022-12-27	WOS:000302903700032
J	Li, MD; Ruan, HB; Singh, JP; Zhao, L; Zhao, TT; Azarhoush, S; Wu, J; Evans, RM; Yang, XY				Li, Min-Dian; Ruan, Hai-Bin; Singh, Jay P.; Zhao, Lin; Zhao, Tingting; Azarhoush, Sascha; Wu, Jing; Evans, Ronald M.; Yang, Xiaoyong			O-GlcNAc Transferase Is Involved in Glucocorticoid Receptor-mediated Transrepression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; RNA-POLYMERASE-II; ACUTE LYMPHOBLASTIC-LEUKEMIA; LYMPHOID-CELL LINE; TRANSCRIPTION FACTORS; TERMINAL DOMAIN; INDUCED APOPTOSIS; RETINOIC-ACID; PPAR-ALPHA; CROSS-TALK	Recruitment of O-GlcNAc transferase (OGT) to promoters plays an important role in gene repression. Glucocorticoid signaling represses the transcriptional activities of NF-kappa B and AP-1 through direct binding, yet the molecular mechanisms remain to be elucidated. Here we report that OGT is an important component of GR-mediated transrepression. OGT associates with ligand-bound GR in a multi-protein repression complex. Overexpression of OGT potentiates the GR transrepression pathway, whereas depletion of endogenous OGT by RNA interference abolishes the repression. The recruitment of OGT by GR leads to increased O-GlcNAcylation and decreased phosphorylation of RNA polymerase II on target genes. Functionally, overexpression of OGT enhances glucocorticoid-induced apoptosis in resistant cell lines while knockdown of OGT prevents sensitive cell lines from apoptosis. These studies identify a molecular mechanism of GR transrepression, and highlight the function of O-GlcNAc in hormone signaling.	[Li, Min-Dian; Ruan, Hai-Bin; Singh, Jay P.; Zhao, Lin; Zhao, Tingting; Azarhoush, Sascha; Wu, Jing; Yang, Xiaoyong] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, Comparat Med Sect, New Haven, CT 06520 USA; [Li, Min-Dian; Ruan, Hai-Bin; Singh, Jay P.; Zhao, Lin; Zhao, Tingting; Azarhoush, Sascha; Wu, Jing; Yang, Xiaoyong] Yale Univ, Sch Med, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Zhao, Lin; Wu, Jing] Xi An Jiao Tong Univ, Sch Sci & Technol, Xian 710049, Shaanxi, Peoples R China; [Azarhoush, Sascha] Univ Cologne, Sch Med, D-50931 Cologne, Germany; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Yale University; Yale University; Xi'an Jiaotong University; University of Cologne; Howard Hughes Medical Institute; Salk Institute; Salk Institute	Yang, XY (corresponding author), 375 Congress Ave,LSOG 204C,POB 208016, New Haven, CT 06520 USA.	xiaoyong.yang@yale.edu	Evans, Ronald/AAF-4001-2019; Li, Min-Dian/F-1721-2015; Ruan, Hai-Bin/AAN-7777-2021; Zhao, Lin/AHD-2506-2022; Ruan, Hai-Bin/G-9907-2012	Evans, Ronald/0000-0002-9986-5965; Li, Min-Dian/0000-0002-3650-1507; Ruan, Hai-Bin/0000-0002-3858-1272; Zhao, Lin/0000-0002-6056-8787; Ruan, Hai-Bin/0000-0002-3858-1272	National Institutes of Health [DK066971, DK089098, DK062434, CA014195-38, HL105278]; American Diabetes Association; Ellison Medical Foundation; Helmsley Charitable Trust; China Scholarship Council; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK066971, R01DK089098, U19DK062434] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Ellison Medical Foundation(Lawrence Ellison Foundation); Helmsley Charitable Trust; China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK066971 and DK089098, American Diabetes Association, and Ellison Medical Foundation (to X. Y.), National Institutes of Health Grants DK062434, CA014195-38, and HL105278, the Ellison Medical Foundation, and the Helmsley Charitable Trust (to R. M. E.), and a fellowship from the China Scholarship Council-Yale World Scholars in the Biomedical Sciences (to M. L.).	Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Bougarne N, 2009, CELL CYCLE, V8, P2311, DOI 10.4161/cc.8.15.9220; Bougarne N, 2009, P NATL ACAD SCI USA, V106, P7397, DOI 10.1073/pnas.0806742106; Chinenov Y, 2008, P NATL ACAD SCI USA, V105, P20185, DOI 10.1073/pnas.0810863105; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; De Bosscher K, 2000, P NATL ACAD SCI USA, V97, P3919, DOI 10.1073/pnas.97.8.3919; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; De Bosscher K, 2001, MOL ENDOCRINOL, V15, P219, DOI 10.1210/me.15.2.219; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; HARMON JM, 1979, J CELL PHYSIOL, V98, P267, DOI 10.1002/jcp.1040980203; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hartmann BL, 1999, WIEN KLIN WOCHENSCHR, V111, P360; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Heck S, 1997, EMBO J, V16, P4698, DOI 10.1093/emboj/16.15.4698; Herr I, 2009, RESULTS PROBL CELL D, V49, P191, DOI 10.1007/400_2008_20; Inaba H, 2010, LANCET ONCOL, V11, P1096, DOI 10.1016/S1470-2045(10)70114-5; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; Myers SA, 2011, P NATL ACAD SCI USA, V108, P9490, DOI 10.1073/pnas.1019289108; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; NORMAN MR, 1977, CANCER RES, V37, P3785; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pascual G, 2006, TRENDS ENDOCRIN MET, V17, P321, DOI 10.1016/j.tem.2006.08.005; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Rogatsky I, 2001, EMBO J, V20, P6071, DOI 10.1093/emboj/20.21.6071; SCHULE R, 1991, P NATL ACAD SCI USA, V88, P6092, DOI 10.1073/pnas.88.14.6092; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Sionov RV, 2008, ADV CANCER RES, V101, P127, DOI 10.1016/S0065-230X(08)00406-5; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Su KH, 2000, BIOCHEM J, V348, P281, DOI 10.1042/0264-6021:3480281; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; ZHANG XK, 1991, MOL CELL BIOL, V11, P6016, DOI 10.1128/MCB.11.12.6016	43	29	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12904	12912		10.1074/jbc.M111.303792	http://dx.doi.org/10.1074/jbc.M111.303792			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22371499	Green Published, hybrid			2022-12-27	WOS:000302903700030
J	Shannon, LA; McBurney, TM; Wells, MA; Roth, ME; Calloway, PA; Bill, CA; Islam, S; Vines, CM				Shannon, Laura A.; McBurney, Tiffany M.; Wells, Melissa A.; Roth, Megan E.; Calloway, Psachal A.; Bill, Charles A.; Islam, Shamima; Vines, Charlotte M.			CCR7/CCL19 Controls Expression of EDG-1 in T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL LYMPHOID ORGANS; ACTIVATED PROTEIN-KINASE; CHEMOKINE RECEPTOR CCR7; DENDRITIC CELLS; SURVIVAL; NODES; ERK5; MOUSE; GENE; SLC	T lymphocytes circulate between the blood, tissues, and lymph. These T cells carry out immune functions, using the C-C chemokine receptor 7 (CCR7) and its cognate ligands, CCL19 and CCL21, to enter and travel through the lymph nodes. Distinct roles for each ligand in regulating T lymphocyte trafficking have remained elusive. We report that in the human T cell line HuT78 and in primary murine T lymphocytes, signaling from CCR7/CCL19 leads to increased expression and phosphorylation of extracellular signal-regulated kinase 5 (ERK5) within eight hours of stimulation. Within 48-72 h we observed peak levels of endothelial differentiation gene 1 (EDG-1), which mediates the egress of T lymphocytes from lymph nodes. The increased expression of EDG-1 was preceded by up-regulation of its transcription factor, Kruppel-like factor 2 (KLF-2). To determine the cellular effect of disrupting ERK5 signaling from CCR7, we examined the migration of ERK5(flox/flox)/Lck-Cre murine T cells to EDG-1 ligands. While CCL19-stimulated ERK5(flox/flox) naive T cells showed increased migration to EDG-1 ligands at 48 h, the migration of ERK5(flox/flox)/Lck-Cre T cells remained at a basal level. Accordingly, we define a novel signaling pathway that controls EDG-1 up-regulation following stimulation of T cells by CCR7/CCL19. This is the first report to link the two signaling events that control migration through the lymph nodes: CCR7 mediates entry into the lymph nodes and EDG-1 signaling controls their subsequent exit.	[Shannon, Laura A.; McBurney, Tiffany M.; Wells, Melissa A.; Roth, Megan E.; Calloway, Psachal A.; Bill, Charles A.; Islam, Shamima; Vines, Charlotte M.] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Vines, CM (corresponding author), 3901 Rainbow Blvd,MSN3029, Kansas City, KS 66160 USA.	cvines@kumc.edu		Roth, Megan/0000-0002-6657-9292	National Institutes of Health [P20RR016443, K12HD052027, K22AI060815]; KUMC Institute for Advancing Medical Innovation; KUMC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052027] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI060815] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KUMC Institute for Advancing Medical Innovation; KUMC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants P20RR016443, K12HD052027, and K22AI060815 and a grant from the KUMC Institute for Advancing Medical Innovation, a KUMC Bridging Award, and the KUMC Biomedical Research Training Program.	Ananieva O, 2008, EUR J IMMUNOL, V38, P2534, DOI 10.1002/eji.200737867; Arcand J, 2012, ARTHRITIS RHEUM-US, V64, P826, DOI 10.1002/art.33377; Bardi G, 2001, EUR J IMMUNOL, V31, P3291, DOI 10.1002/1521-4141(200111)31:11<3291::AID-IMMU3291>3.0.CO;2-Z; Buschbeck M, 2005, J BIOL CHEM, V280, P2659, DOI 10.1074/jbc.M412599200; Byers MA, 2008, J IMMUNOL, V181, P4723, DOI 10.4049/jimmunol.181.7.4723; Cabioglu N, 2005, CLIN CANCER RES, V11, P5686, DOI 10.1158/1078-0432.CCR-05-0014; Campbell JJ, 1998, J CELL BIOL, V141, P1053, DOI 10.1083/jcb.141.4.1053; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; DAILEY MO, 1985, J MOL CELL IMMUNOL, V2, P27; Fan L, 2000, J IMMUNOL, V164, P3955, DOI 10.4049/jimmunol.164.8.3955; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Huang YH, 2004, P NATL ACAD SCI USA, V101, P4936, DOI 10.1073/pnas.0401133101; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Nakano H, 1997, EUR J IMMUNOL, V27, P215, DOI 10.1002/eji.1830270132; Nakano H, 1998, BLOOD, V91, P2886, DOI 10.1182/blood.V91.8.2886.2886_2886_2895; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Otero C, 2008, J CELL SCI, V121, P2759, DOI 10.1242/jcs.029074; Otero C, 2006, J IMMUNOL, V177, P2314, DOI 10.4049/jimmunol.177.4.2314; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Pilkington KR, 2004, J BIOL CHEM, V279, P40276, DOI 10.1074/jbc.M405808200; Rovida E, 2008, J IMMUNOL, V180, P4166, DOI 10.4049/jimmunol.180.6.4166; Schober SL, 1999, J IMMUNOL, V163, P3662; Sohn SJ, 2005, MOL CELL BIOL, V25, P8553, DOI 10.1128/MCB.25.19.8553-8566.2005; Sohn SJ, 2008, EMBO J, V27, P1896, DOI 10.1038/emboj.2008.114; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Vines CM, 2001, IMMUNITY, V15, P507, DOI 10.1016/S1074-7613(01)00221-7	38	19	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11656	11664		10.1074/jbc.M111.310045	http://dx.doi.org/10.1074/jbc.M111.310045			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334704	Green Published, hybrid			2022-12-27	WOS:000302782200006
J	Wang, PS; Wang, J; Zheng, Y; Pallen, CJ				Wang, Pei-Shan; Wang, Jing; Zheng, Yi; Pallen, Catherine J.			Loss of Protein-tyrosine Phosphatase alpha (PTP alpha) Increases Proliferation and Delays Maturation of Oligodendrocyte Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC-FAMILY KINASES; GROWTH ARREST; RPTP-ALPHA; POSTTRANSCRIPTIONAL REGULATION; MORPHOLOGICAL-DIFFERENTIATION; INHIBITOR P27(KIP1); SIGNALING PATHWAYS; RAS ACTIVATION; MESSENGER-RNA; FYN	Tightly controlled termination of proliferation determines when oligodendrocyte progenitor cells (OPCs) can initiate differentiation and mature into myelin- forming cells. Protein- tyrosine phosphatase alpha (PTP alpha) promotes OPC differentiation, but its role in proliferation is unknown. Here we report that loss of PTP alpha enhanced in vitro proliferation and survival and decreased cell cycle exit and growth factor dependence of OPCs but not neural stem/progenitor cells. PTP alpha(-/-) mice have more oligodendrocyte lineage cells in embryonic forebrain and delayed OPC maturation. On the molecular level, PTP alpha-deficient mouse OPCs and rat CG4 cells have decreased Fyn and increased Ras, Cdc42, Rac1, and Rho activities, and reduced expression of the Cdk inhibitor p27Kip1. Moreover, Fyn was required to suppress Ras and Rho and for p27Kip1 accumulation, and Rho inhibition in PTP alpha-deficient cells restored expression of p27Kip1. We propose that PTP alpha-Fyn signaling negatively regulates OPC proliferation by down-regulating Ras and Rho, leading to p27Kip1 accumulation and cell cycle exit. Thus, PTP alpha acts in OPCs to limit self-renewal and facilitate differentiation.	[Wang, Pei-Shan; Wang, Jing; Pallen, Catherine J.] Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Wang, Pei-Shan; Pallen, Catherine J.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 4H4, Canada; [Wang, Jing; Pallen, Catherine J.] Univ British Columbia, Dept Pediat, Vancouver, BC V5Z 4H4, Canada; [Zheng, Yi] Cincinnati Childrens Hosp, Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA	Child & Family Research Institute; University of British Columbia; University of British Columbia; University of British Columbia; Cincinnati Children's Hospital Medical Center	Pallen, CJ (corresponding author), Univ British Columbia, Child & Family Res Inst, 3102-950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	cpallen@mail.ubc.ca	Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074; Pallen, Catherine/0000-0002-3576-5295	Canadian Institutes of Health Research [MOP-62759]; Multiple Sclerosis Society of Canada; Child and Family Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada; Child and Family Research Institute	This work was supported by Grant MOP-62759 from the Canadian Institutes of Health Research (to C. J. P.). P.-S. Wang was supported by a studentship from the Multiple Sclerosis Society of Canada. C. J. Pallen is the recipient of an investigator award from the Child and Family Research Institute.	Ardini E, 2000, ONCOGENE, V19, P4979, DOI 10.1038/sj.onc.1203869; Attali B, 1997, J NEUROSCI, V17, P8234; Bansal R, 2005, J NEUROSCI RES, V80, P360, DOI 10.1002/jnr.20454; BANSAL R, 1994, DEV BIOL, V162, P511, DOI 10.1006/dbio.1994.1105; BARNETT SC, 1995, CELL GROWTH DIFFER, V6, P69; Barnett SC, 1998, CARCINOGENESIS, V19, P1529, DOI 10.1093/carcin/19.9.1529; Baron W, 2000, MOL CELL NEUROSCI, V15, P314, DOI 10.1006/mcne.1999.0827; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Bennett MR, 2003, J NEUROSCI, V23, P7207, DOI 10.1523/JNEUROSCI.23-18-07207.2003; Berwanger B, 2002, CANCER CELL, V2, P377, DOI 10.1016/S1535-6108(02)00179-4; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; Cabodi S, 2000, MOL CELL, V6, P1121, DOI 10.1016/S1097-2765(00)00110-6; Casaccia-Bonnefil P, 1999, DEVELOPMENT, V126, P4027; CasacciaBonnefil P, 1997, GENE DEV, V11, P2335, DOI 10.1101/gad.11.18.2335; Chen M, 2006, J BIOL CHEM, V281, P11972, DOI 10.1074/jbc.M600561200; Chew LJ, 2010, J NEUROSCI, V30, P11011, DOI 10.1523/JNEUROSCI.2546-10.2010; Colognato H, 2004, J CELL BIOL, V167, P365, DOI 10.1083/jcb.200404076; DENHERTOG J, 1993, EMBO J, V12, P3789, DOI 10.1002/j.1460-2075.1993.tb06057.x; Durand B, 1998, CURR BIOL, V8, P431, DOI 10.1016/S0960-9822(98)70177-0; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; Friessen AJ, 1997, J NEUROSCI RES, V50, P373; HART IK, 1989, DEVELOPMENT, V105, P595; Hecker TP, 2004, ONCOGENE, V23, P3962, DOI 10.1038/sj.onc.1207541; Hu WM, 1999, J BIOL CHEM, V274, P3396, DOI 10.1074/jbc.274.6.3396; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Lee JS, 2010, HUM MOL GENET, V19, P4643, DOI 10.1093/hmg/ddq395; Li XK, 2009, J NEUROSCI, V29, P2902, DOI 10.1523/JNEUROSCI.4051-08.2009; Lu ZF, 2005, J BIOL CHEM, V280, P389, DOI 10.1074/jbc.M405973200; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; Moeller SJ, 2003, MOL CELL BIOL, V23, P3735, DOI 10.1128/MCB.23.11.3735-3752.2003; Moon SY, 2003, J BIOL CHEM, V278, P4151, DOI 10.1074/jbc.M207789200; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209; Paez PM, 2006, NEUROCHEM INT, V49, P359, DOI 10.1016/j.neuint.2006.02.009; Pallen CJ, 2003, CURR TOP MED CHEM, V3, P821, DOI 10.2174/1568026033452320; Perez MJ, 2009, J NEUROSCI RES, V87, P3378, DOI 10.1002/jnr.21962; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; Sa G, 2004, EXP CELL RES, V300, P427, DOI 10.1016/j.yexcr.2004.07.032; Samayawardhena LA, 2008, J BIOL CHEM, V283, P29175, DOI 10.1074/jbc.M804077200; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Smida M, 2007, BLOOD, V110, P596, DOI 10.1182/blood-2006-07-038752; Soliven B, 2003, AM J PHYSIOL-CELL PH, V284, pC85, DOI 10.1152/ajpcell.00145.2002; Sperber BR, 2001, J NEUROSCI RES, V63, P303, DOI 10.1002/1097-4547(20010215)63:4<303::AID-JNR1024>3.0.CO;2-A; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Tang XM, 2000, J CELL BIOCHEM, V76, P270, DOI 10.1002/(SICI)1097-4644(20000201)76:2<270::AID-JCB10>3.0.CO;2-6; Taniguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P151, DOI 10.1016/S0006-291X(03)00923-9; Thurnherr T, 2006, J NEUROSCI, V26, P10110, DOI 10.1523/JNEUROSCI.2158-06.2006; Tikoo R, 1998, J NEUROBIOL, V36, P431, DOI 10.1002/(SICI)1097-4695(19980905)36:3<431::AID-NEU10>3.3.CO;2-N; Tokumoto YM, 2002, DEV BIOL, V245, P224, DOI 10.1006/dbio.2002.0626; Vacaresse N, 2008, J BIOL CHEM, V283, P35815, DOI 10.1074/jbc.M807964200; Vidal A, 2002, J BIOL CHEM, V277, P16433, DOI 10.1074/jbc.M112090200; Wang PS, 2009, J BIOL CHEM, V284, P33692, DOI 10.1074/jbc.M109.061770; Wolf RM, 2003, GENE DEV, V17, P476, DOI 10.1101/gad.1040003; YASUDA T, 1995, J NEUROSCI RES, V40, P306, DOI 10.1002/jnr.490400304; Ye H, 2008, EMBO J, V27, P188, DOI 10.1038/sj.emboj.7601939; Zeng L, 1999, J CELL BIOL, V147, P707, DOI 10.1083/jcb.147.4.707; Zezula J, 2001, EMBO REP, V2, P27, DOI 10.1093/embo-reports/kve008; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0; Zhu YA, 2002, NAT REV CANCER, V2, P616, DOI 10.1038/nrc866	65	9	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12529	12540		10.1074/jbc.M111.312769	http://dx.doi.org/10.1074/jbc.M111.312769			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22354965	hybrid, Green Published			2022-12-27	WOS:000302782200092
J	da Costa, TPS; Tieu, W; Yap, MY; Pendini, NR; Polyak, SW; Pedersen, DS; Morona, R; Turnidge, JD; Wallace, JC; Wilce, MCJ; Booker, GW; Abell, AD				da Costa, Tatiana P. Soares; Tieu, William; Yap, Min Y.; Pendini, Nicole R.; Polyak, Steven W.; Pedersen, Daniel Sejer; Morona, Renato; Turnidge, John D.; Wallace, John C.; Wilce, Matthew C. J.; Booker, Grant W.; Abell, Andrew D.			Selective inhibition of Biotin Protein Ligase from Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPRESSOR DIMERIZATION; ESCHERICHIA-COLI; TERMINAL DOMAIN; BAD BUGS; IDENTIFICATION; ANTIBIOTICS; ADENYLATE; GENES; BIOSYNTHESIS; ATTACHMENT	There is a well documented need to replenish the antibiotic pipeline with new agents to combat the rise of drug resistant bacteria. One strategy to combat resistance is to discover new chemical classes immune to current resistance mechanisms that inhibit essential metabolic enzymes. Many of the obvious drug targets that have no homologous isozyme in the human host have now been investigated. Bacterial drug targets that have a closely related human homologue represent a new frontier in antibiotic discovery. However, to avoid potential toxicity to the host, these inhibitors must have very high selectivity for the bacterial enzyme over the human homolog. We have demonstrated that the essential enzyme biotin protein ligase (BPL) from the clinically important pathogen Staphylococcus aureus could be selectively inhibited. Linking biotin to adenosine via a 1,2,3 triazole yielded the first BPL inhibitor selective for S. aureus BPL over the human equivalent. The synthesis of new biotin 1,2,3-triazole analogues using click chemistry yielded our most potent structure (K-t 90 nM) with a > 1100-fold selectivity for the S. aureus BPL over the human homologue. X-ray crystallography confirmed the mechanism of inhibitor binding. Importantly, the inhibitor showed cytotoxicity against S. aureus but not cultured mammalian cells. The biotin 1,2,3-triazole provides a novel pharmacophore for future medicinal chemistry programs to develop this new antibiotic class.	[da Costa, Tatiana P. Soares; Pendini, Nicole R.; Polyak, Steven W.; Morona, Renato; Turnidge, John D.; Wallace, John C.; Booker, Grant W.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Tieu, William; Pedersen, Daniel Sejer; Abell, Andrew D.] Univ Adelaide, Sch Chem & Phys, Adelaide, SA 5005, Australia; [Yap, Min Y.; Pendini, Nicole R.; Wilce, Matthew C. J.] Monash Univ, Sch Biomed Sci, Clayton, Vic 3800, Australia; [Turnidge, John D.] SA Pathol Womens & Childrens Hosp, Adelaide, SA 5006, Australia	University of Adelaide; University of Adelaide; Monash University; SA Pathology	Polyak, SW (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia.	steven.polyak@adelaide.edu.au	Pedersen, Daniel Sejer/A-5974-2009; Polyak, Steven W./G-3185-2011; Tieu, William/Z-1790-2019; , John/AAP-5150-2020; Morona, Renato/B-7746-2013; Polyak, Steven W/A-7488-2019	Pedersen, Daniel Sejer/0000-0003-3926-7047; Polyak, Steven W./0000-0002-8458-5194; Tieu, William/0000-0002-7161-4152; Morona, Renato/0000-0001-7009-7440; Polyak, Steven W/0000-0002-8458-5194; Soares da Costa, Tatiana P./0000-0002-6275-7485	National Health and Medical Research Council of Australia [565506, 1011806]; Adelaide Research and Innovation's Commercial Accelerator Scheme; Carlsberg Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Adelaide Research and Innovation's Commercial Accelerator Scheme; Carlsberg Foundation(Carlsberg Foundation)	This work was supported by the National Health and Medical Research Council of Australia (applications 565506 and 1011806) and Adelaide Research and Innovation's Commercial Accelerator Scheme.; Supported by the Carlsberg Foundation. Present address: Dept. of Medicinal Chemistry, University of Copenhagen, Universitetsparken 2, Copenhagen, 2100 Denmark.	Bagautdinov B, 2005, J MOL BIOL, V353, P322, DOI 10.1016/j.jmb.2005.08.032; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernier S, 2005, BIOORGAN MED CHEM, V13, P69, DOI 10.1016/j.bmc.2004.09.055; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brown PH, 2004, J MOL BIOL, V337, P857, DOI 10.1016/j.jmb.2004.01.041; Byun Y, 2008, NUCLEOS NUCLEOT NUCL, V27, P244, DOI 10.1080/15257770701845238; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; Chapman-Smith A, 1999, J NUTR, V129, p477S, DOI 10.1093/jn/129.2.477S; Chapman-Smith A, 2001, PROTEIN SCI, V10, P2608, DOI 10.1110/ps.ps.22401; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Chen LQ, 2010, J MED CHEM, V53, P4768, DOI 10.1021/jm100424m; Colman PM, 2009, ANNU REV BIOCHEM, V78, P95, DOI 10.1146/annurev.biochem.78.082207.084029; Comstock LR, 2002, TETRAHEDRON, V58, P6019, DOI 10.1016/S0040-4020(02)00590-2; Cooper MA, 2011, NATURE, V472, P32, DOI 10.1038/472032a; Corona C, 2006, ORG LETT, V8, P1883, DOI 10.1021/ol060458r; Costantino L, 2006, CURR MED CHEM, V13, P65, DOI 10.2174/092986706775197944; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Duckworth BP, 2011, CHEM BIOL, V18, P1432, DOI 10.1016/j.chembiol.2011.08.013; El-Sagheer AH, 2010, CHEM SOC REV, V39, P1388, DOI 10.1039/b901971p; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forrest AK, 2000, BIOORG MED CHEM LETT, V10, P1871, DOI 10.1016/S0960-894X(00)00360-7; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Frearson JA, 2007, TRENDS PARASITOL, V23, P589, DOI 10.1016/j.pt.2007.08.019; Freiberg C, 2006, ANTIMICROB AGENTS CH, V50, P2707, DOI 10.1128/AAC.00012-06; Gupta V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009222; Hurdle JG, 2005, ANTIMICROB AGENTS CH, V49, P4821, DOI 10.1128/AAC.49.12.4821-4833.2005; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Lee J, 1999, BIOORG MED CHEM LETT, V9, P1365, DOI 10.1016/S0960-894X(99)00206-1; Mayende L, 2012, J MOL MED, V90, P81, DOI 10.1007/s00109-011-0811-x; Meldal M, 2008, CHEM REV, V108, P2952, DOI 10.1021/cr0783479; Naganathan S, 2007, J MOL BIOL, V373, P96, DOI 10.1016/j.jmb.2007.07.020; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; Patrone JD, 2009, J AM CHEM SOC, V131, P16340, DOI 10.1021/ja906537f; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pendini NR, 2008, BBA-PROTEINS PROTEOM, V1784, P973, DOI 10.1016/j.bbapap.2008.03.011; Pendini NR, 2008, ACTA CRYSTALLOGR F, V64, P520, DOI 10.1107/S1744309108012244; Polyak SW, 2012, APPL MICROBIOL BIOT, V93, P983, DOI 10.1007/s00253-011-3796-z; Polyak SW, 2001, J BIOL CHEM, V276, P3037, DOI 10.1074/jbc.M003968200; Polyak SW, 1999, J BIOL CHEM, V274, P32847, DOI 10.1074/jbc.274.46.32847; Poupaert J, 2005, CURR MED CHEM, V12, P877, DOI 10.2174/0929867053507388; Raman K, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-109; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Schreiber M, 2009, CURR OPIN CELL BIOL, V21, P325, DOI 10.1016/j.ceb.2009.01.026; Slavoff SA, 2008, J AM CHEM SOC, V130, P1160, DOI 10.1021/ja076655i; Somu RV, 2006, J MED CHEM, V49, P31, DOI 10.1021/jm051060o; Streaker ED, 2003, J MOL BIOL, V325, P937, DOI 10.1016/S0022-2836(02)01308-6; Tian Y, 2008, BIOCHEMISTRY-US, V47, P12434, DOI 10.1021/bi801311d; Triola G, 2009, BIOORGAN MED CHEM, V17, P1079, DOI 10.1016/j.bmc.2008.02.046; Tron CM, 2009, J MOL BIOL, V387, P129, DOI 10.1016/j.jmb.2008.12.086; Turnidge JD, 2009, MED J AUSTRALIA, V191, P368, DOI 10.5694/j.1326-5377.2009.tb02841.x; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; Wood ZA, 2006, J MOL BIOL, V357, P509, DOI 10.1016/j.jmb.2005.12.066; Xu Y, 1995, BIOCHEMISTRY-US, V34, P16624, DOI 10.1021/bi00051a010; Yonath A, 2005, ANNU REV BIOCHEM, V74, P649, DOI 10.1146/annurev.biochem.74.082803.133130; Yu XY, 1999, BIOORG MED CHEM LETT, V9, P375, DOI 10.1016/S0960-894X(98)00738-0	56	39	42	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17823	17832		10.1074/jbc.M112.356576	http://dx.doi.org/10.1074/jbc.M112.356576			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22437830	hybrid, Green Published			2022-12-27	WOS:000306373000080
J	Chen, M; Drury, JE; Christianson, DW; Penning, TM				Chen, Mo; Drury, Jason E.; Christianson, David W.; Penning, Trevor M.			Conversion of Human Steroid 5 beta-Reductase (AKR1D1) into 3 beta-Hydroxysteroid Dehydrogenase by Single Point Mutation E120H EXAMPLE OF PERFECT ENZYME ENGINEERING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KETO REDUCTASE SUPERFAMILY; CYTOSOLIC HYDROXYSTEROID DEHYDROGENASES; CRYSTAL-STRUCTURE; DELTA(5)-3-KETOSTEROID ISOMERASE; SUBSTRATE-SPECIFICITY; TESTOSTERONE; MECHANISM; DEFINES; BINDING; IDENTIFICATION	Human aldo-keto reductase 1D1 (AKR1D1) and AKR1C enzymes are essential for bile acid biosynthesis and steroid hormone metabolism. AKR1D1 catalyzes the 5 beta-reduction of Delta(4)-3-ketosteroids, whereas AKR1C enzymes are hydroxysteroid dehydrogenases (HSDs). These enzymes share high sequence identity and catalyze 4-pro-(R)-hydride transfer from NADPH to an electrophilic carbon but differ in that one residue in the conserved AKR catalytic tetrad, His(120) (AKR1D1 numbering), is substituted by a glutamate in AKR1D1. We find that the AKR1D1 E120H mutant abolishes 5 beta-reductase activity and introduces HSD activity. However, the E120H mutant unexpectedly favors dihydrosteroids with the 5 alpha-configuration and, unlike most of the AKR1C enzymes, shows a dominant stereochemical preference to act as a 3 beta-HSD as opposed to a 3 alpha-HSD. The catalytic efficiency achieved for 3 beta-HSD activity is higher than that observed for any AKR to date. High resolution crystal structures of the E120H mutant in complex with epiandrosterone, 5 beta-dihydrotestosterone, and Delta(4)-androstene-3,17-dione elucidated the structural basis for this functional change. The glutamate-histidine substitution prevents a 3-ketosteroid from penetrating the active site so that hydride transfer is directed toward the C3 carbonyl group rather than the Delta(4)-double bond and confers 3 beta-HSD activity on the 5 beta-reductase. Structures indicate that stereospecificity of HSD activity is achieved because the steroid flips over to present its alpha-face to the A-face of NADPH. This is in contrast to the AKR1C enzymes, which can invert stereochemistry when the steroid swings across the binding pocket. These studies show how a single point mutation in AKR1D1 can introduce HSD activity with unexpected configurational and stereochemical preference.	[Chen, Mo; Drury, Jason E.; Penning, Trevor M.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Chen, Mo; Drury, Jason E.; Penning, Trevor M.] Univ Penn, Perelman Sch Med, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA; [Christianson, David W.] Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Penning, TM (corresponding author), Univ Penn, Perelman Sch Med, Dept Pharmacol, 130C John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	penning@upenn.edu		Penning, Trevor/0000-0002-3937-1066	National Institutes of Health (NIH) [R01-DK40715, P30-ES013508, GM-056838]; NIH, NIDDK [F32DK089827]; National Center for Research Resources, National Institutes of Health [RR-15301, P41RR012408]; United States Department of Energy [DE-AC02-06CH11357]; Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301, P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK089827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056838] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); United States Department of Energy(United States Department of Energy (DOE)); Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants R01-DK40715 and P30-ES013508 (to T. M. P.), NIH Grant GM-056838 (to D. W. C.), and NIH, NIDDK, Grant F32DK089827 (to M. C.).; We thank Dr. Julie A. Aaron for assistance in data collecting and processing and Dr. Yi Jin for helpful discussions. Part of this work was based upon research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamline 24_ID_C (supported by National Center for Research Resources, National Institutes of Health, Grant RR-15301). Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357. Part of this work was based upon research conducted at beamline X29 of the National Synchrotron Light Source. Financial support comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy and from National Center for Research Resources, National Institutes of Health, Grant P41RR012408.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bennett MJ, 1997, STRUCTURE, V5, P799, DOI 10.1016/S0969-2126(97)00234-7; BERSEUS O, 1967, EUR J BIOCHEM, V2, P503, DOI 10.1111/j.1432-1033.1967.tb00164.x; Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen M, 2011, STEROIDS, V76, P484, DOI 10.1016/j.steroids.2011.01.003; Cho HS, 1999, J BIOL CHEM, V274, P32863, DOI 10.1074/jbc.274.46.32863; Couture JF, 2003, J MOL BIOL, V331, P593, DOI 10.1016/S0022-2836(03)00762-9; Di Costanzo L, 2008, J BIOL CHEM, V283, P16830, DOI 10.1074/jbc.M801778200; Di Costanzo L, 2009, MOL CELL ENDOCRINOL, V301, P191, DOI 10.1016/j.mce.2008.09.013; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faucher F, 2008, BIOCHEMISTRY-US, V47, P8261, DOI 10.1021/bi800572s; GRANICK S, 1967, P NATL ACAD SCI USA, V57, P1463, DOI 10.1073/pnas.57.5.1463; Jez JM, 1998, BIOCHEMISTRY-US, V37, P9695, DOI 10.1021/bi980294p; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Jin Y, 2006, STEROIDS, V71, P380, DOI 10.1016/j.steroids.2005.12.002; Jin Y, 2001, BIOCHEMISTRY-US, V40, P10161, DOI 10.1021/bi010919a; Jin Y, 2011, BIOCHEM J, V437, P53, DOI 10.1042/BJ20101804; Jin Y, 2009, J BIOL CHEM, V284, P10013, DOI 10.1074/jbc.M809465200; Kim SW, 1997, BIOCHEMISTRY-US, V36, P14030, DOI 10.1021/bi971546+; KONDO KH, 1994, EUR J BIOCHEM, V219, P357, DOI 10.1111/j.1432-1033.1994.tb19947.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEVERE RD, 1967, P NATL ACAD SCI USA, V58, P985, DOI 10.1073/pnas.58.3.985; March J., 1984, ADV ORGANIC CHEM REA, P694; Massiah MA, 1998, BIOCHEMISTRY-US, V37, P14701, DOI 10.1021/bi981447b; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; Nahoum V, 2001, J BIOL CHEM, V276, P42091, DOI 10.1074/jbc.M105610200; NORYMBERSKI JK, 1955, J CHEM SOC, P3426, DOI 10.1039/jr9550003426; OKUDA A, 1984, J BIOL CHEM, V259, P7519; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; Penning TM, 2007, ARCH BIOCHEM BIOPHYS, V464, P241, DOI 10.1016/j.abb.2007.04.024; Qiu W, 2004, MOL ENDOCRINOL, V18, P1798, DOI 10.1210/me.2004-0032; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; Schlegel BP, 1998, BIOCHEMISTRY-US, V37, P3538, DOI 10.1021/bi9723055; Sheehan PM, 2005, MOL HUM REPROD, V11, P495, DOI 10.1093/molehr/gah201; Simard J, 2005, ENDOCR REV, V26, P525, DOI 10.1210/er.2002-0050; Steckelbroeck S, 2004, J BIOL CHEM, V279, P10784, DOI 10.1074/jbc.M313308200; Thorn A, 2008, J BIOL CHEM, V283, P17260, DOI 10.1074/jbc.M706185200; Wu ZR, 1997, SCIENCE, V276, P415, DOI 10.1126/science.276.5311.415; Zhao QJ, 1997, BIOCHEMISTRY-US, V36, P14616, DOI 10.1021/bi971549m	42	14	16	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16609	16622		10.1074/jbc.M111.338780	http://dx.doi.org/10.1074/jbc.M111.338780			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22437839	hybrid, Green Published			2022-12-27	WOS:000304030900050
J	Niere, M; Mashimo, M; Agledal, L; Dolle, C; Kasamatsu, A; Kato, J; Moss, J; Ziegler, M				Niere, Marc; Mashimo, Masato; Agledal, Line; Dolle, Christian; Kasamatsu, Atsushi; Kato, Jiro; Moss, Joel; Ziegler, Mathias			ADP-ribosylhydrolase 3 (ARH3), Not Poly(ADP-ribose) Glycohydrolase (PARG) Isoforms, Is Responsible for Degradation of Mitochondrial Matrix-associated Poly(ADP-ribose)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING FACTOR; DNA-DAMAGE; CELL-DEATH; MAMMALIAN-CELLS; PROTEIN; IDENTIFICATION; LOCALIZATION; POLYMERASE; RIBOSYLATION; RIBOSE	Important cellular processes are regulated by poly(ADP-ribosyl)ation. This protein modification is catalyzed mainly by nuclear poly(ADP-ribose) polymerase (PARP) 1 in response to DNA damage. Cytosolic PARP isoforms have been described, whereas the presence of poly(ADP-ribose) (PAR) metabolism in mitochondria is controversial. PAR is degraded by poly(ADPribose) glycohydrolase (PARG). Recently, ADP-ribosylhydrolase 3 (ARH3) was also shown to catalyze PAR-degradation in vitro. PARG is encoded by a single, essential gene. One nuclear and three cytosolic isoforms result from alternative splicing. The presence and origin of a mitochondrial PARG is still unresolved. We establish here the genetic background of a human mitochondrial PARG isoform and investigate the molecular basis for mitochondrial poly(ADP-ribose) degradation. In common with a cytosolic 60-kDa human PARG isoform, the mitochondrial protein did not catalyze PAR degradation because of the absence of exon 5-encoded residues. In mice, we identified a transcript encoding an inactive cytosolic 52-kDa PARG lacking the mitochondrial targeting sequence and a substantial portion of exon 5. Thus, mammalian PARG genes encode isoforms that do not catalyze PAR degradation. On the other hand, embryonic fibroblasts from ARH3(-/-) mice lack most of the mitochondrial PAR degrading activity detected in wild-type cells, demonstrating a potential involvement of ARH3 in PAR metabolism.	[Niere, Marc; Agledal, Line; Dolle, Christian; Ziegler, Mathias] Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway; [Mashimo, Masato; Kasamatsu, Atsushi; Kato, Jiro; Moss, Joel] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA	University of Bergen; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Ziegler, M (corresponding author), Univ Bergen, Dept Mol Biol, Postbox 7803, N-5020 Bergen, Norway.	mathias.ziegler@mbi.uib.no		Mashimo, Masato/0000-0003-3922-7344; Ziegler, Mathias/0000-0001-6961-2396	National Heart, Lung, and Blood Institute, National Institutes of Health; Norwegian Cancer Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000659] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Norwegian Cancer Society(Norwegian Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported, in whole or in part, by the Intramural Research Program, National Heart, Lung, and Blood Institute, National Institutes of Health. This work was also supported by the Norwegian Cancer Society.	Affar EB, 2001, J BIOL CHEM, V276, P2935, DOI 10.1074/jbc.M007269200; Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; ALVAREZGONZALEZ R, 1987, BIOCHEMISTRY-US, V26, P3218, DOI 10.1021/bi00385a042; Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Blenn C, 2006, BIOCHEM J, V396, P419, DOI 10.1042/BJ20051696; Bonicalzi ME, 2005, CELL MOL LIFE SCI, V62, P739, DOI 10.1007/s00018-004-4505-1; Botta D, 2010, BIOCHEMISTRY-US, V49, P7674, DOI 10.1021/bi100973m; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chiarugi A, 2002, TRENDS PHARMACOL SCI, V23, P122, DOI 10.1016/S0165-6147(00)01902-7; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; Corda D, 2003, EMBO J, V22, P1953, DOI 10.1093/emboj/cdg209; Cortes U, 2004, MOL CELL BIOL, V24, P7163, DOI 10.1128/MCB.24.16.7163-7178.2004; Dantzer F, 2006, METHOD ENZYMOL, V409, P493, DOI 10.1016/S0076-6879(05)09029-4; David KK, 2009, FRONT BIOSCI-LANDMRK, V14, P1116, DOI 10.2741/3297; Di Girolamo M, 2005, FEBS J, V272, P4565, DOI 10.1111/j.1742-4658.2005.04876.x; Dolle C, 2010, CELL MOL LIFE SCI, V67, P433, DOI 10.1007/s00018-009-0190-4; Haince JF, 2006, BBA-MOL CELL RES, V1763, P226, DOI 10.1016/j.bbamcr.2005.11.015; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Kickhoefer VA, 1999, J CELL BIOL, V146, P917, DOI 10.1083/jcb.146.5.917; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Lin WS, 1997, J BIOL CHEM, V272, P11895, DOI 10.1074/jbc.272.18.11895; Lyons RJ, 2001, J BIOL CHEM, V276, P17172, DOI 10.1074/jbc.M009756200; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Meyer RG, 2007, EXP CELL RES, V313, P2920, DOI 10.1016/j.yexcr.2007.03.043; Meyer-Ficca ML, 2004, EXP CELL RES, V297, P521, DOI 10.1016/j.yexcr.2004.03.050; Mueller-Dieckmann C, 2006, P NATL ACAD SCI USA, V103, P15026, DOI 10.1073/pnas.0606762103; Niere M, 2008, MOL CELL BIOL, V28, P814, DOI 10.1128/MCB.01766-07; Oka S, 2006, J BIOL CHEM, V281, P705, DOI 10.1074/jbc.M510290200; Ono T, 2006, P NATL ACAD SCI USA, V103, P16687, DOI 10.1073/pnas.0607911103; Patel CN, 2005, BIOCHEM J, V388, P493, DOI 10.1042/BJ20040942; Rouleau M, 2007, J CELL BIOCHEM, V100, P385, DOI 10.1002/jcb.21051; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Seman M, 2004, CURR MED CHEM, V11, P857, DOI 10.2174/0929867043455611; Smith S, 1999, J CELL SCI, V112, P3649; Winstall E, 1999, EXP CELL RES, V251, P372, DOI 10.1006/excr.1999.4594; Ying WH, 2005, J NEUROSCI RES, V79, P216, DOI 10.1002/jnr.20289; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	43	93	99	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16088	16102		10.1074/jbc.M112.349183	http://dx.doi.org/10.1074/jbc.M112.349183			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22433848	hybrid, Green Published			2022-12-27	WOS:000304030900002
J	Itagaki, K; Naito, T; Iwakiri, R; Haga, M; Miura, S; Saito, Y; Owaki, T; Kamiya, S; Iyoda, T; Yajima, H; Iwashita, S; Ejiri, SI; Fukai, F				Itagaki, Keisuke; Naito, Toshihiko; Iwakiri, Ryota; Haga, Makoto; Miura, Shougo; Saito, Yohei; Owaki, Toshiyuki; Kamiya, Sadahiro; Iyoda, Takuya; Yajima, Hirofumi; Iwashita, Shintaro; Ejiri, Shin-Ichiro; Fukai, Fumio			Eukaryotic Translation Elongation Factor 1A Induces Anoikis by Triggering Cell Detachment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR TU; EXTRACELLULAR-MATRIX; ANTIADHESIVE SITE; PLASMA-MEMBRANE; FIBRONECTIN; IDENTIFICATION; PEPTIDE; PROTEINS; SURVIVAL; DEPRIVATION	Anoikis, apoptosis because of loss of cell anchorage, is crucial for tissue homeostasis. Fibronectin not only provides a scaffold for cell anchorage but also harbors a cryptic antiadhesive site capable of inducing beta 1-integrin inactivation. In this study, this cryptic antiadhesive site is implicated in spontaneous induction of anoikis. Nontransformed fibroblasts (NIH3T3) adhering to a fibronectin substratum underwent anoikis during serum starvation culture. This anoikis was caused by proteolytic exposure of the cryptic antiadhesive site in fibronectin by matrix metalloproteinase. Eukaryotic elongation factor 1A (eEF1A) was identified as a membrane receptor for the exposed antiadhesive site. Serum starvation raised the membrane residence of eEF1A, and siRNA-based disruption of this increase rendered cells anoikis-resistant. By contrast, cells became more susceptible to anoikis in parallel with increased membrane residence of eEF1A by enforced expression. These results demonstrate that eEF1A acts as a membrane receptor for the cryptic antiadhesive site of fibronectin, which contributes to cell regulation, including anoikis, through negative regulation of cell anchorage.	[Fukai, Fumio] Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Mol Pathophysiol, Noda, Chiba 2788510, Japan; [Yajima, Hirofumi] Tokyo Univ Sci, Dept Appl Chem, Noda, Chiba 2788510, Japan; [Kamiya, Sadahiro] Josai Int Univ, Fac Pharmaceut Sci, Dept Drug Informat, Togane, Chiba 2838555, Japan; [Iwashita, Shintaro; Ejiri, Shin-Ichiro] Iwaki Meisei Univ, Fac Pharm, Iwaki, Fukushima 9708551, Japan	Tokyo University of Science; Tokyo University of Science; Iwaki Meisei University	Fukai, F (corresponding author), Tokyo Univ Sci, Fac Pharmaceut Sci, Dept Mol Pathophysiol, 2641 Yamazaki, Noda, Chiba 2788510, Japan.	fukai@rs.noda.tus.ac.jp		Iwashita, Shintaro/0000-0001-8086-9192	Vehicle Racing Commemorative Foundation	Vehicle Racing Commemorative Foundation	This work was supported in part by the Vehicle Racing Commemorative Foundation.	Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Baqui M, 2003, J BIOL CHEM, V278, P1206, DOI 10.1074/jbc.M210266200; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Bialik S, 1999, CIRC RES, V85, P403, DOI 10.1161/01.RES.85.5.403; Bonavita F, 2003, FEBS LETT, V536, P85, DOI 10.1016/S0014-5793(03)00029-2; BRANDS JHGM, 1986, EUR J BIOCHEM, V155, P167, DOI 10.1111/j.1432-1033.1986.tb09472.x; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chan JR, 2001, J EXP MED, V193, P1149, DOI 10.1084/jem.193.10.1149; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; Ejiri S, 2002, BIOSCI BIOTECH BIOCH, V66, P1, DOI 10.1271/bbb.66.1; Erickson HP, 2002, J MUSCLE RES CELL M, V23, P575, DOI 10.1023/A:1023427026818; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fukai F, 1996, BIOCHEM BIOPH RES CO, V220, P394, DOI 10.1006/bbrc.1996.0416; Fukai F, 1997, J BIOCHEM-TOKYO, V121, P189; Fukai F, 1998, EXP CELL RES, V242, P92, DOI 10.1006/excr.1998.4076; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; JACOBSON GR, 1976, NATURE, V261, P23, DOI 10.1038/261023a0; Kamiya SL, 2002, BIOCHEMISTRY-US, V41, P3270, DOI 10.1021/bi015660a; Kato R, 2002, CLIN CANCER RES, V8, P2455; Kato R, 2001, EXP CELL RES, V265, P54, DOI 10.1006/excr.2001.5179; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; Kinzy TG, 2000, COLD SPRING HARBOR M, V39, P973; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lee JW, 2000, MOL BIOL CELL, V11, P1973, DOI 10.1091/mbc.11.6.1973; Matsunaga T, 2008, LEUKEMIA, V22, P353, DOI 10.1038/sj.leu.2405017; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Michel JB, 2003, ARTERIOSCL THROM VAS, V23, P2146, DOI 10.1161/01.ATV.0000099882.52647.E4; Miura S, 2007, BIOL PHARM BULL, V30, P891, DOI 10.1248/bpb.30.891; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Nishiumi S, 2007, BIOSCI BIOTECH BIOCH, V71, P2343, DOI 10.1271/bbb.70342; Peason J. P., 2005, COLONIZATION MUCOSAL, P3; Rennebeck G, 2005, CANCER RES, V65, P11230, DOI 10.1158/0008-5472.CAN-05-2763; Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1; Sabarth N, 2002, J BIOL CHEM, V277, P27896, DOI 10.1074/jbc.M204473200; Saito Y, 2007, J BIOL CHEM, V282, P34929, DOI 10.1074/jbc.M705608200; Schenk S, 2003, TRENDS CELL BIOL, V13, P366, DOI 10.1016/S0962-8924(03)00129-6; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Shinde AV, 2008, J BIOL CHEM, V283, P2858, DOI 10.1074/jbc.M708306200; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Watanabe K, 2000, BIOCHEMISTRY-US, V39, P7138, DOI 10.1021/bi992670r; ZHANG ZH, 1995, P NATL ACAD SCI USA, V92, P6161, DOI 10.1073/pnas.92.13.6161; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	47	16	19	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					16037	16046		10.1074/jbc.M111.308122	http://dx.doi.org/10.1074/jbc.M111.308122			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22399298	hybrid, Green Published			2022-12-27	WOS:000304006300081
J	Carrasco-Marin, E; Rodriguez-Del Rio, E; Frande-Cabanes, E; Tobes, R; Pareja, E; Lecea-Cuello, MJ; Ruiz-Saez, M; Madrazo-Toca, F; Holscher, C; Alvarez-Dominguez, C				Carrasco-Marin, Eugenio; Rodriguez-Del Rio, Estela; Frande-Cabanes, Elisabet; Tobes, Raquel; Pareja, Eduardo; Jesus Lecea-Cuello, M.; Ruiz-Saez, Marta; Madrazo-Toca, Fidel; Hoelscher, Christoph; Alvarez-Dominguez, Carmen			Phagosomes Induced by Cytokines Function as anti-Listeria Vaccines NOVEL ROLE FOR FUNCTIONAL COMPARTMENTALIZATION OF STAT-1 PROTEIN AND CATHEPSIN-D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATHEPSIN-D; MONOCYTOGENES INFECTION; IMMUNE-RESPONSES; INNATE; MICE; MACROPHAGES; DEFICIENT; CELLS; MODULATION; ACTIVATION	Phagosomes are critical compartments for innate immunity. However, their role in the protection against murine listeriosis has not been examined. We describe here that listericidal phago-receptosomes are induced by the function of IFN-gamma or IL-6 as centralized compartments for innate and adaptive immunity because they are able to confer protection against murine listeriosis. These phago-receptosomes elicited LLO(91-99)/CD8(+)- and LLO(189-201)/CD4(+)-specific immune responses and recruited mature dendritic cells to the vaccination sites controlled by T cells. Moreover, they present exceptional features as efficient vaccine vectors. First, they compartmentalize a novel listericidal STAT-1-mediated signaling pathway that confines multiple innate immune components to the same environment. Second, they show features of MHC class II antigen-loading competent compartments for cathepsin-D-mediated LLO processing. Third, murine cathepsin-D deficiencies fail to develop protective immunity after vaccination with listericidal phago-receptosomes induced by IFN-gamma or IL-6. Therefore, it appears that the connection of STAT-1 and cathepsin-D in a single compartment is relevant for protection against listeriosis.	[Carrasco-Marin, Eugenio; Rodriguez-Del Rio, Estela; Frande-Cabanes, Elisabet; Jesus Lecea-Cuello, M.; Ruiz-Saez, Marta; Madrazo-Toca, Fidel; Alvarez-Dominguez, Carmen] Fdn Marques de Valdecilla IFIMAV, Grp Genom Prote Infecc Bacterianas & Inflamac, Santander 39120, Cantabria, Spain; [Carrasco-Marin, Eugenio; Rodriguez-Del Rio, Estela; Frande-Cabanes, Elisabet; Jesus Lecea-Cuello, M.; Ruiz-Saez, Marta; Madrazo-Toca, Fidel; Alvarez-Dominguez, Carmen] Hosp Santa Cruz Liencres, Santander 39120, Cantabria, Spain; [Tobes, Raquel; Pareja, Eduardo] BIC Granada CEEI, Informat Technol SL Era7, Bioinformat Unit, Granada 18100, Spain; [Hoelscher, Christoph] Univ Lubeck, Res Ctr Borstel, D-23845 Borstel, Germany	Hospital Universitario Marques de Valdecilla (HUMV); Forschungszentrum Borstel; University of Lubeck	Alvarez-Dominguez, C (corresponding author), Fdn Marques de Valdecilla IFIMAV, Grp Genom Prote Infecc Bacterianas & Inflamac, Santander 39120, Cantabria, Spain.	calvarez@humv.es	Alvarez-Dominguez, Carmen/J-4675-2014; Hölscher, Christoph/O-1732-2018; Frande-Cabanes, Elisabet/F-9889-2016; Marin, Eugenio Carrasco/AAG-1578-2021	Alvarez-Dominguez, Carmen/0000-0002-4585-6959; Hölscher, Christoph/0000-0002-7520-9146; Frande-Cabanes, Elisabet/0000-0003-1748-0584; Marin, Eugenio Carrasco/0000-0002-3556-9227; Tobes, Raquel/0000-0001-7032-8720	Spanish Fondo de Investigaciones Sanitarias [00/3073, PI01/3128, PI03-1009, PI07-0289, PI10-0660]; Fundacion Marques de Valdecilla-IFIMAV [API2011/PI10-0660, API2010/03/SAF2009-08695]; Spanish Ministerio de Ciencia, Investigacion e Innovacion [BIO2002-0628, SAF2006-08968, SAF2009-08695]; Fondo de Investigaciones Sanitarias [PI04-0324]	Spanish Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacion Marques de Valdecilla-IFIMAV; Spanish Ministerio de Ciencia, Investigacion e Innovacion; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was supported in part by Spanish Fondo de Investigaciones Sanitarias Grants 00/3073, PI01/3128, PI03-1009, PI07-0289, and PI10-0660, Fundacion Marques de Valdecilla-IFIMAV Grant API2011/PI10-0660 (to E. C.-M.), Spanish Ministerio de Ciencia, Investigacion e Innovacion Grants BIO2002-0628, SAF2006-08968, and SAF2009-08695, Fondo de Investigaciones Sanitarias Grant PI04-0324, and Fundacion Marques de Valdecilla-IFIMAV Grant API2010/03/SAF2009-08695 (to C. A.-D.).	Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Alvarez-Dominguez C, 2000, IMMUNOLOGY, V101, P83, DOI 10.1046/j.1365-2567.2000.00083.x; Alvarez-Dominguez C, 2008, TRAFFIC, V9, P325, DOI 10.1111/j.1600-0854.2007.00683.x; Beauvillain C, 2009, VACCINE, V27, P1750, DOI 10.1016/j.vaccine.2009.01.022; Bhattacharya M, 2006, EMBO J, V25, P2878, DOI 10.1038/sj.emboj.7601170; Brockstedt DG, 2008, EXPERT REV VACCINES, V7, P1069, DOI 10.1586/14760584.7.7.1069; Carrasco-Marin E, 2011, J BIOL CHEM, V286, P3332, DOI 10.1074/jbc.M110.146761; Carrasco-Marin E, 2009, MOL MICROBIOL, V72, P668, DOI 10.1111/j.1365-2958.2009.06673.x; CarrascoMarin E, 1996, J IMMUNOL, V156, P450; Cervantes J, 2008, CELL MICROBIOL, V10, P41, DOI 10.1111/j.1462-5822.2007.01012.x; Cheng LW, 2005, P NATL ACAD SCI USA, V102, P13646, DOI 10.1073/pnas.0506461102; Corr SC, 2009, CELL MICROBIOL, V11, P703, DOI 10.1111/j.1462-5822.2009.01294.x; del Cerro-Vadillo E, 2006, J IMMUNOL, V176, P1321, DOI 10.4049/jimmunol.176.3.1321; Dinauer MC, 1997, J IMMUNOL, V158, P5581; Forestier C, 2000, J IMMUNOL, V165, P5202, DOI 10.4049/jimmunol.165.9.5202; Hamilton SE, 2006, J IMMUNOL, V177, P4012, DOI 10.4049/jimmunol.177.6.4012; HARDING CV, 1992, J CELL BIOL, V119, P531, DOI 10.1083/jcb.119.3.531; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Jutras I, 2008, MOL CELL PROTEOMICS, V7, P697, DOI 10.1074/mcp.M700267-MCP200; Lauer P, 2008, INFECT IMMUN, V76, P3742, DOI 10.1128/IAI.00390-08; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; Menzel K, 2006, CLIN EXP IMMUNOL, V146, P169, DOI 10.1111/j.1365-2249.2006.03188.x; Myers JT, 2003, J IMMUNOL, V171, P5447, DOI 10.4049/jimmunol.171.10.5447; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; PORTNOY DA, 1989, J EXP MED, V170, P2141, DOI 10.1084/jem.170.6.2141; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Prada-Delgado A, 2005, TRAFFIC, V6, P252, DOI 10.1111/j.1600-0854.2005.00265.x; Prada-Delgado A, 2001, J BIOL CHEM, V276, P19059, DOI 10.1074/jbc.M101639200; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Rodriguez-Del Rio Estela, 2011, Int J Biochem Mol Biol, V2, P207; Sauer JD, 2011, P NATL ACAD SCI USA, V108, P12419, DOI 10.1073/pnas.1019041108; Schramm M, 2008, CELL MICROBIOL, V10, P1839, DOI 10.1111/j.1462-5822.2008.01169.x; Schwegmann A, 2007, P NATL ACAD SCI USA, V104, P16251, DOI 10.1073/pnas.0703496104; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Singh V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016097; Skoberne M, 2002, J IMMUNOL, V169, P1410, DOI 10.4049/jimmunol.169.3.1410; Steinfeld R, 2006, AM J HUM GENET, V78, P988, DOI 10.1086/504159; Tsuchiya K, 2005, INFECT IMMUN, V73, P3869, DOI 10.1128/IAI.73.7.3869-3877.2005; Unanue ER, 1997, IMMUNOL REV, V158, P11, DOI 10.1111/j.1600-065X.1997.tb00988.x; Utermohlen O, 2003, J IMMUNOL, V170, P2621, DOI 10.4049/jimmunol.170.5.2621; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; von Delwig A, 2005, SCAND J IMMUNOL, V62, P243, DOI 10.1111/j.1365-3083.2005.01664.x; Waite JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001326; Westcott MM, 2010, INFECT IMMUN, V78, P2956, DOI 10.1128/IAI.01027-09; Zenewicz LA, 2007, MICROBES INFECT, V9, P1208, DOI 10.1016/j.micinf.2007.05.008	47	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14310	14324		10.1074/jbc.M112.348615	http://dx.doi.org/10.1074/jbc.M112.348615			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22337873	Green Published, hybrid			2022-12-27	WOS:000304003200001
J	Lee, SH; Che, X; Jeong, JH; Choi, JY; Lee, YJ; Lee, YH; Bae, SC; Lee, YM				Lee, Sun-Hee; Che, Xiangguo; Jeong, Jae-Hwan; Choi, Je-Yong; Lee, Young-Joo; Lee, Yong-Hee; Bae, Suk-Chul; Lee, You-Mie			Runx2 Protein Stabilizes Hypoxia-inducible Factor-1 alpha through Competition with von Hippel-Lindau Protein (pVHL) and Stimulates Angiogenesis in Growth Plate Hypertrophic Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCHONDRAL BONE-FORMATION; TRANSCRIPTION FACTOR; INDIAN-HEDGEHOG; VASCULAR CONTRIBUTION; GENE-EXPRESSION; CARTILAGE; DIFFERENTIATION; HIF-1-ALPHA; OSSIFICATION; CANCER	The regulation of hypoxia-inducible factor-1 alpha (HIF-1 alpha) during endochondral bone formation is not fully understood. Here, we investigated the cross-talk between HIF-1 alpha and Runt-related transcription factor 2 (Runx2) in the growth plate. Runx2 caused the accumulation of HIF-1 alpha protein in ATDC5 chondrocytes and HEK293 cells under normoxic conditions. Runx2 also increased the nuclear translocation of HIF-1 alpha when coexpressed in HEK293 cells and interacted with HIF-1 alpha at the oxygen-dependent degradation domain (ODDD). In addition, Runx2 competed with von Hippel-Lindau tumor suppressor protein by directly binding to ODDD-HIF-1 alpha and significantly inhibited the ubiquitination of HIF-1 alpha, even though Runx2 did not change the hydroxylation status of HIF-1 alpha. Furthermore, overexpression of Runx2 resulted in the significant enhancement of vascular endothelial growth factor (VEGF) promoter reporter activity and protein secretion. Runx2 significantly increased angiogenic activity in human umbilical vein endothelial cells in vitro. In wild-type mice, HIF-1 alpha and Runx2 were colocalized in hypertrophic chondrocytes in which the cluster of differentiation 31 (CD31) protein was expressed at embryonic day 15.5 (E15.5). In contrast, the expression of HIF-1 alpha was markedly reduced in areas of CD31 expression in Runx2(-/-) mice. These results suggest that Runx2 stabilizes HIF-1 alpha by binding to ODDD to block the interaction between von Hippel-Lindau protein and HIF-1 alpha. In conclusion, Runx2, HIF-1 alpha, and VEGF may regulate vascular angiogenesis spatially and temporally in the hypertrophic zone of the growth plate during endochondral bone formation.	[Lee, You-Mie] Kyungpook Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Taegu 702701, South Korea; [Lee, Sun-Hee; Lee, You-Mie] Coll Nat Sci, Sch Life Sci & Biotechnol, Taegu 702701, South Korea; [Che, Xiangguo; Jeong, Jae-Hwan; Choi, Je-Yong] Kyungpook Natl Univ, Sch Med, Taegu 700842, South Korea; [Lee, Young-Joo] Sejong Univ, Dept Biosci & Biotechnol, Seoul 142747, South Korea; [Lee, Yong-Hee; Bae, Suk-Chul] Chungbuk Natl Univ, Sch Med, Cheongju 361764, South Korea	Kyungpook National University; Kyungpook National University; Sejong University; Chungbuk National University	Lee, YM (corresponding author), Kyungpook Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, 80 Daehak Ro, Taegu 702701, South Korea.	lym@knu.ac.kr	Choi, Je-Yong/AAR-7334-2021	Choi, Je-Yong/0000-0002-5057-8842	Korea Science and Engineering Foundation [R01-2006-000-11046-0]; Korean Government Ministry of Science and Technology; National Research Foundation of Korea [2010-0026741, 2009-0084887]; Ministry of Education, Science and Technology	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korean Government Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of KoreaKorean Government); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Korea Science and Engineering Foundation Grant R01-2006-000-11046-0 funded by the Korean Government Ministry of Science and Technology and by the Mid-career Researcher Program through the National Research Foundation of Korea Grants 2010-0026741 and 2009-0084887 funded by the Ministry of Education, Science and Technology.	Anglin Ian, 2004, Cancer Treat Res, V119, P189; Brahimi-Horn C, 2001, TRENDS CELL BIOL, V11, pS32, DOI 10.1016/S0962-8924(01)02126-2; CANCEDDA FD, 1995, EUR J CELL BIOL, V66, P60; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; IYAMA K, 1991, ANAT RECORD, V229, P462, DOI 10.1002/ar.1092290405; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jang GH, 2010, FEBS LETT, V584, P141, DOI 10.1016/j.febslet.2009.11.031; Jeong JH, 2008, J CELL PHYSIOL, V217, P511, DOI 10.1002/jcp.21524; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Jung MH, 2009, CARCINOGENESIS, V30, P655, DOI 10.1093/carcin/bgp039; Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037; Khan WS, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2211; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; KUETTNER KE, 1983, CIBA F SYMP, V100, P163; Kwon TG, 2011, J CELL BIOCHEM, V112, P3582, DOI 10.1002/jcb.23289; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Lin L, 2011, MOL THER, V19, P1426, DOI 10.1038/mt.2011.101; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; NINOMIYA Y, 1986, J BIOL CHEM, V261, P5041; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Peng ZG, 2008, ONCOGENE, V27, P839, DOI 10.1038/sj.onc.1210676; Peng ZH, 2006, CLIN CANCER RES, V12, P6386, DOI 10.1158/1078-0432.CCR-05-2359; Provot S, 2007, ANN NY ACAD SCI, V1117, P26, DOI 10.1196/annals.1402.076; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Riddle RC, 2009, J MOL MED, V87, P583, DOI 10.1007/s00109-009-0477-9; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Schipani E, 2005, SEMIN CELL DEV BIOL, V16, P539, DOI 10.1016/j.semcdb.2005.03.003; Schipani E, 2001, GENE DEV, V15, P2865; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; TRUETA J, 1963, J BONE JOINT SURG BR, V45, P572, DOI 10.1302/0301-620X.45B3.572; TRUETA J, 1960, J BONE JOINT SURG BR, V42, P571, DOI 10.1302/0301-620X.42B3.571; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zelzer E, 2001, MECH DEVELOP, V106, P97, DOI 10.1016/S0925-4773(01)00428-2; Zelzer E, 2004, DEVELOPMENT, V131, P2161, DOI 10.1242/dev.01053	42	74	76	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14760	14771		10.1074/jbc.M112.340232	http://dx.doi.org/10.1074/jbc.M112.340232			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22351759	Green Published, hybrid			2022-12-27	WOS:000304003200041
J	Cheng, SB; Filardo, EJ				Cheng, Shi-Bin; Filardo, Edward J.			Trans-Golgi Network (TGN) as a Regulatory Node for beta 1-Adrenergic Receptor (beta 1AR) Down-modulation and Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; HUMAN BETA(1)-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTOR; HEART-FAILURE; MEDIATED ENDOCYTOSIS; ESTROGEN-RECEPTOR; CARDIAC MYOCYTES; ARRESTIN; TRAFFICKING; ACTIVATION	Receptor down-modulation is the key mechanism by which G protein-coupled receptors (GPCRs) prevent excessive receptor signaling in response to agonist stimulation. Recently, the trans-Golgi network (TGN) has been implicated as a key checkpoint for receptor endocytosis and degradation. Here, we investigated the involvement of the TGN in down-modulation of beta 1-adrenergic receptor in response to persistent isoprotenerol stimulation. Immunofluorescent staining showed that similar to 50% of endocytosed beta 1AR colocalized with TGN-46 at 5 h. Disruption of the TGN by brefeldin A (BFA) led to the robust accumulation of endocytosed beta 1AR in Rab11(+) recycling endosomes, inhibited beta 1AR entry into LAMP1(+) lysosomes, and as a result enhanced beta 1AR recycling to the plasma membrane. The lysosomotropic agent, chloroquine arrested the majority of endocytosed beta 1AR in the TGN by 4 h. Immunoblot analysis showed that either disruption of the TGN or blockage of the lysosome prevented beta 1AR degradation. Co-expression of GFP-arrestin-3 in beta 1AR cells increased the endocytosis of beta 1AR and facilitated its entry to the TGN but inhibited recycling to the plasma membrane. Arrestin-3-induced inhibition of beta 1AR recycling was reversed by BFA treatment, whereas chloroquine induced the accumulation of arrestin-3 with beta 1AR in the TGN. These results demonstrate for the first time that the TGN acts as a checkpoint for both the recycling and down-regulation of beta 1AR and that arrestin-3 not only mediates beta 1AR endocytosis but also its recycling through the TGN.	[Filardo, Edward J.] Rhode Isl Hosp, Dept Med, Div Hematol & Oncol, Providence, RI 02903 USA; Brown Univ, Providence, RI 02903 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Filardo, EJ (corresponding author), Rhode Isl Hosp, Dept Med, Div Hematol & Oncol, 593 Eddy St,Aldrich Bldg,Rm 708, Providence, RI 02903 USA.	edward_filardo@brown.edu		Filardo, Edward/0000-0002-3930-324X	National Institutes of Health [R01 CA119165-01A2]; NATIONAL CANCER INSTITUTE [R01CA119165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA119165-01A2 (to E. J. F.).	CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Cheng SB, 2011, J BIOL CHEM, V286, P22441, DOI 10.1074/jbc.M111.224071; Csaba Z, 2007, TRAFFIC, V8, P820, DOI 10.1111/j.1600-0854.2007.00580.x; Escola JM, 2010, J BIOL CHEM, V285, P41772, DOI 10.1074/jbc.M110.153460; Fan GH, 2003, BLOOD, V101, P2115, DOI 10.1182/blood-2002-07-1965; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Filipeanu CM, 2006, J BIOL CHEM, V281, P11097, DOI 10.1074/jbc.M511460200; Imamura T, 2001, J BIOL CHEM, V276, P43663, DOI 10.1074/jbc.M105364200; Innamorati G, 2001, J BIOL CHEM, V276, P13096, DOI 10.1074/jbc.M009780200; Jean-Alphonse F, 2011, MOL CELL ENDOCRINOL, V331, P205, DOI 10.1016/j.mce.2010.07.010; Kreuzer OJ, 2001, J NEUROENDOCRINOL, V13, P279, DOI 10.1046/j.1365-2826.2001.00630.x; Lelouvier B, 2008, J NEUROSCI, V28, P4336, DOI 10.1523/JNEUROSCI.4379-07.2008; Liang W, 2004, J BIOL CHEM, V279, P46882, DOI 10.1074/jbc.M406501200; Liang W, 2004, J CELL SCI, V117, P723, DOI 10.1242/jcs.00878; Liang W, 2003, J BIOL CHEM, V278, P39773, DOI 10.1074/jbc.M304482200; Limbird LE, 1999, P NATL ACAD SCI USA, V96, P7125, DOI 10.1073/pnas.96.13.7125; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Morisco C, 2008, CARDIOVASC RES, V78, P36, DOI 10.1093/cvr/cvn008; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Port JD, 2001, J MOL CELL CARDIOL, V33, P887, DOI 10.1006/jmcc.2001.1358; Quinn JA, 2009, MOL ENDOCRINOL, V23, P1052, DOI 10.1210/me.2008-0262; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; Rohrer DK, 1996, P NATL ACAD SCI USA, V93, P7375, DOI 10.1073/pnas.93.14.7375; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Vatner SF, 2000, CIRC RES, V86, P502, DOI 10.1161/01.RES.86.5.502; Vines CM, 2003, J BIOL CHEM, V278, P41581, DOI 10.1074/jbc.C300291200; Wagener BM, 2009, TRAFFIC, V10, P1286, DOI 10.1111/j.1600-0854.2009.00957.x; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1	31	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14178	14191		10.1074/jbc.M111.323782	http://dx.doi.org/10.1074/jbc.M111.323782			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22378779	hybrid, Green Published			2022-12-27	WOS:000303996300070
J	Vessichelli, M; Ferravante, A; Zotti, T; Reale, C; Scudiero, I; Picariello, G; Vito, P; Stilo, R				Vessichelli, Mariangela; Ferravante, Angela; Zotti, Tiziana; Reale, Carla; Scudiero, Ivan; Picariello, Gianluca; Vito, Pasquale; Stilo, Romania			Neuroepithelial Transforming Gene 1 (Net1) Binds to Caspase Activation and Recruitment Domain (CARD)- and Membrane-associated Guanylate Kinase-like Domain-containing (CARMA) Proteins and Regulates Nuclear Factor kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE FACTOR NET1; T-CELL-ACTIVATION; SIGNALING PATHWAYS; HEPATOCELLULAR-CARCINOMA; CYTOKINE PRODUCTION; GASTRIC-CANCER; LYMPHOMA; EXPRESSION; BCL10; RHOA	The molecular complexes containing CARMA proteins have been recently identified as a key components in the signal transduction pathways that regulate activation of nuclear factor kappa B (NF-kappa B) transcription factor. Here, we used immunoprecipitation coupled with mass spectrometry to identify cellular binding partners of CARMA proteins. Our data indicate that the Rho guanine nucleotide exchange factor Net1 binds to CARMA1 and CARMA3 in resting and activated cells. Net1 expression induces NF-kappa B activation and cooperates with BCL10 and CARMA proteins in inducing NF-kappa B activity. Conversely, shRNA-mediated abrogation of Net1 results in impaired NF-kappa B activation following stimuli that require correct CARMA-BCL10-MALT1 complex formation and functioning. Microarray expression data are consistent with a positive role for Net1 on NF-kappa B activation. Thus, this study identifies Net1 as a CARMA-interacting molecule and brings important information on the molecular mechanisms that control NF-kappa B transcriptional activity.	[Vessichelli, Mariangela; Ferravante, Angela; Zotti, Tiziana; Reale, Carla; Scudiero, Ivan; Vito, Pasquale; Stilo, Romania] Univ Sannio, Dipartimento Sci Biol & Ambientali, I-82100 Benevento, Italy; [Vessichelli, Mariangela; Ferravante, Angela; Zotti, Tiziana; Reale, Carla; Scudiero, Ivan; Vito, Pasquale; Stilo, Romania] Biogem Consortium, I-83031 Ariano Irpino, Italy; [Picariello, Gianluca] CNR, Ist Sci Alimentaz, I-83100 Avellino, Italy	University of Sannio; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR)	Vito, P (corresponding author), Univ Sannio, Dipartimento Sci Biol & Ambientali, Via PortArsa 11, I-82100 Benevento, Italy.	vito@unisannio.it	Zotti, Tiziana/AAV-6768-2021; vito, pasquale/ABF-5505-2020; Reale, Carla/AAB-7939-2020	Zotti, Tiziana/0000-0003-4753-116X; Reale, Carla/0000-0001-7682-4784; ferravante, angela/0000-0002-4932-3877; PICARIELLO, Gianluca/0000-0003-1290-1239; scudiero, ivan/0000-0001-5559-5548; vito, pasquale/0000-0002-5721-7716	Telethon [GGP08125B]	Telethon(Fondazione Telethon)	This work was in part supported by Telethon Grant GGP08125B.	Akagi T, 1999, ONCOGENE, V18, P5785, DOI 10.1038/sj.onc.1203018; Alberts AS, 1998, EMBO J, V17, P4075, DOI 10.1093/emboj/17.14.4075; Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Blonska M, 2011, CELL RES, V21, P55, DOI 10.1038/cr.2010.182; Carr HS, 2009, J BIOL CHEM, V284, P24269, DOI 10.1074/jbc.M109.029439; Chan AML, 1996, ONCOGENE, V12, P1259; Chen L, 2007, INT J SURG PATHOL, V15, P346, DOI 10.1177/1066896907306083; Chen YH, 2007, J IMMUNOL, V178, P49, DOI 10.4049/jimmunol.178.1.49; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Delekta PC, 2010, J BIOL CHEM, V285, P41432, DOI 10.1074/jbc.M110.158949; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Eitelhuber AC, 2011, EMBO J, V30, P594, DOI 10.1038/emboj.2010.331; Garcia-Mata R, 2007, MOL CELL BIOL, V27, P8683, DOI 10.1128/MCB.00157-07; Grabiner BC, 2007, GENE DEV, V21, P984, DOI 10.1101/gad.1502507; Gross O, 2008, BLOOD, V112, P2421, DOI 10.1182/blood-2007-11-123513; Guiet C, 2002, CELL DEATH DIFFER, V9, P138, DOI 10.1038/sj/cdd/4400947; Guiet C, 2000, J CELL BIOL, V148, P1131, DOI 10.1083/jcb.148.6.1131; Hara H, 2008, J IMMUNOL, V181, P918, DOI 10.4049/jimmunol.181.2.918; Huang YP, 2001, ONCOGENE, V20, P1094, DOI 10.1038/sj.onc.1204198; Iwanaga R, 2008, ONCOGENE, V27, P5635, DOI 10.1038/onc.2008.174; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Klemm S, 2006, J EXP MED, V203, P337, DOI 10.1084/jem.20051982; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Leyden J, 2006, BRIT J CANCER, V94, P1204, DOI 10.1038/sj.bjc.6603054; Lin X, 2004, SEMIN IMMUNOL, V16, P429, DOI 10.1016/j.smim.2004.08.022; Malarkannan S, 2007, J IMMUNOL, V179, P3752, DOI 10.4049/jimmunol.179.6.3752; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; Murray D, 2008, BRIT J CANCER, V99, P1322, DOI 10.1038/sj.bjc.6604688; Nakamura S, 2005, CANCER-AM CANCER SOC, V104, P1885, DOI 10.1002/cncr.21421; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Oshiro A, 2006, BLOOD, V107, P4500, DOI 10.1182/blood-2005-09-3801; Palkowitsch L, 2011, J BIOL CHEM, V286, P7522, DOI 10.1074/jbc.M110.155895; Prasad RC, 2009, CANCER LETT, V275, P139, DOI 10.1016/j.canlet.2008.10.007; Qin HJ, 2005, J BIOL CHEM, V280, P7603, DOI 10.1074/jbc.M412141200; Scudiero I, 2011, J CELL PHYSIOL, V226, P3121, DOI 10.1002/jcp.22667; Shen SQ, 2008, MED ONCOL, V25, P341, DOI 10.1007/s12032-008-9042-6; Stilo R, 2004, J BIOL CHEM, V279, P34323, DOI 10.1074/jbc.M402244200; Stilo R, 2008, J CELL SCI, V121, P1165, DOI 10.1242/jcs.021105; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tu YY, 2010, JPN J CLIN ONCOL, V40, P388, DOI 10.1093/jjco/hyp186; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027; Welteke V, 2009, EMBO REP, V10, P642, DOI 10.1038/embor.2009.64; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767	46	15	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13722	13730		10.1074/jbc.M111.304436	http://dx.doi.org/10.1074/jbc.M111.304436			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22343628	Green Published, hybrid			2022-12-27	WOS:000303996300028
J	Do, HT; Tselykh, TV; Makela, J; Ho, TH; Olkkonen, VM; Bornhauser, BC; Korhonen, L; Zelcer, N; Lindholm, D				Hai Thi Do; Tselykh, Timofey V.; Makela, Johanna; Ho, Tho Huu; Olkkonen, Vesa M.; Bornhauser, Beat C.; Korhonen, Laura; Zelcer, Noam; Lindholm, Dan			Fibroblast Growth Factor-21 (FGF21) Regulates Low-density Lipoprotein Receptor (LDLR) Levels in Cells via the E3-ubiquitin Ligase Mylip/Idol and the Canopy2 (Cnpy2)/Mylip-interacting Saposin-like Protein (Msap)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED INHIBITOR; PPAR-ALPHA; DEGRADATION; FGF-21; DOMAINS; CHAIN; ERM; MIR	The LDLR is a critical factor in the regulation of blood cholesterol levels that are altered in different human diseases. The level of LDLR in the cell is regulated by both transcriptional and post-transcriptional events. The E3 ubiquitin ligase, myosin regulatory light chain-interacting protein (Mylip)/inducible degrader of the LDL-R (Idol) was shown to induce degradation of LDLR via protein ubiquitination. We have here studied novel factors and mechanisms that may regulate Mylip/Idol in human hepatocyte cells and in mouse macrophages. We observed that FGF21 that is present in serum in different conditions reduced Mylip/Idol at the RNA and protein level, and increased LDLR levels and stability in the cells. FGF21 also enhanced expression of Canopy2 (Cnpy2)/MIR-interacting Saposin-like protein (Msap) that is known to interact with Mylip/Idol. Overexpression of Cnpy2/Msap increased LDLRs, and knockdown experiments showed that Cnpy2/Msap is crucial for the FGF21 effect on LDLRs. Experiments using DiI-labeled LDL particles showed that FGF21 increased lipoprotein uptake and the effect of FGF21 was additive to that of statins. Our results are consistent with an important role of FGF21 and Cnpy2/Msap in the regulation of LDLRs in cultured cells, which warrants further studies using human samples.	[Hai Thi Do; Tselykh, Timofey V.; Makela, Johanna; Korhonen, Laura; Lindholm, Dan] Univ Helsinki, Inst Biomed Biochem & Dev Biol, FIN-00290 Helsinki, Finland; [Hai Thi Do; Tselykh, Timofey V.; Makela, Johanna; Ho, Tho Huu; Olkkonen, Vesa M.; Korhonen, Laura; Lindholm, Dan] Minerva Fdn, Inst Med Res, Biomedicum 2, FIN-00290 Helsinki, Finland; [Bornhauser, Beat C.] Univ Zurich, Childrens Hosp, Dept Oncol, CH-8032 Zurich, Switzerland; [Zelcer, Noam] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands	University of Helsinki; University Children's Hospital Zurich; University of Zurich; University of Amsterdam; Academic Medical Center Amsterdam	Lindholm, D (corresponding author), Univ Helsinki, Inst Biomed Biochem & Dev Biol, Haartmaninkatu 8, FIN-00290 Helsinki, Finland.	dan.lindholm@helsinki.fi	Korhonen, Laura/AAW-3256-2020; Lindholm, Dan/B-3777-2014; Bornhauser, Beat/M-4437-2014	Olkkonen, Vesa/0000-0001-5553-7997; Korhonen, Laura/0000-0002-1837-5930; Ho, Tho/0000-0002-8363-1427; Bornhauser, Beat/0000-0003-2890-3191; Zelcer, Noam/0000-0001-6935-7532	Finska Lakaresallskapet; Sigrid Juselius Foundation; Liv och Halsa; Magnus Ehrnrooth; Minerva Foundation; Academy of Finland	Finska Lakaresallskapet; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Liv och Halsa; Magnus Ehrnrooth; Minerva Foundation; Academy of Finland(Academy of Finland)	This work was supported by Finska Lakaresallskapet, Sigrid Juselius Foundation, Liv och Halsa, Magnus Ehrnrooth, Minerva Foundation, and the Academy of Finland.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Bornhauser BC, 2003, J BIOL CHEM, V278, P35412, DOI 10.1074/jbc.M306271200; Bornhauser BC, 2005, CELL MOL LIFE SCI, V62, P1260, DOI 10.1007/s00018-005-5055-x; Bornhauser BC, 2003, FEBS LETT, V553, P195, DOI 10.1016/S0014-5793(03)01010-X; BROWN MS, 1979, P NATL ACAD SCI USA, V76, P3330, DOI 10.1073/pnas.76.7.3330; Bruhn H, 2005, BIOCHEM J, V389, P249, DOI 10.1042/BJ20050051; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hong C, 2010, J BIOL CHEM, V285, P19720, DOI 10.1074/jbc.M110.123729; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kairisalo M, 2009, EUR J NEUROSCI, V30, P958, DOI 10.1111/j.1460-9568.2009.06898.x; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Knopp RH, 1999, NEW ENGL J MED, V341, P498, DOI 10.1056/NEJM199908123410707; Korhonen L, 2001, MOL CELL NEUROSCI, V17, P364, DOI 10.1006/mcne.2000.0935; LINDHOLM D, 1988, J BIOL CHEM, V263, P16348; Lindholm D, 2009, CELL MOL LIFE SCI, V66, P3399, DOI 10.1007/s00018-009-0127-y; Mudo G, 2012, CELL MOL LIFE SCI, V69, P1153, DOI 10.1007/s00018-011-0850-z; Murata Y, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/981315; Nabel EG, 2003, NEW ENGL J MED, V349, P60, DOI 10.1056/NEJMra035098; Nagano K, 2006, EMBO J, V25, P1871, DOI 10.1038/sj.emboj.7601059; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Olsson PA, 1999, J BIOL CHEM, V274, P36288, DOI 10.1074/jbc.274.51.36288; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ryden M, 2009, CELL MOL LIFE SCI, V66, P2067, DOI 10.1007/s00018-009-0003-9; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Sorrentino V, 2011, J BIOL CHEM, V286, P30190, DOI 10.1074/jbc.M111.249557; Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yan HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024895; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	33	49	50	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12602	12611		10.1074/jbc.M112.341248	http://dx.doi.org/10.1074/jbc.M112.341248			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22378787	Green Published, hybrid			2022-12-27	WOS:000302903700001
J	Lonn, P; Vanlandewijck, M; Raja, E; Kowanetz, M; Watanabe, Y; Kowanetz, K; Vasilaki, E; Heldin, CH; Moustakas, A				Lonn, Peter; Vanlandewijck, Michael; Raja, Erna; Kowanetz, Marcin; Watanabe, Yukihide; Kowanetz, Katarzyna; Vasilaki, Eleftheria; Heldin, Carl-Henrik; Moustakas, Aristidis			Transcriptional Induction of Salt-inducible Kinase 1 by Transforming Growth Factor beta Leads to Negative Regulation of Type I Receptor Signaling in Cooperation with the Smurf2 Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR SMAD4; BREAST-CANCER CELLS; MESENCHYMAL TRANSITION; TGF; DEGRADATION; POLARITY; SIK1; PHOSPHORYLATION; IDENTIFICATION; METASTASIS	Transforming growth factor beta (TGF beta) regulates many physiological processes and requires control mechanisms to safeguard proper and timely action. We have previously described how negative regulation of TGF beta signaling is controlled by the serine/threonine kinase salt-inducible kinase 1 (SIK1). SIK1 forms complexes with the TGF beta type I receptor and with the inhibitory Smad7 and down-regulates the type I receptor. We now demonstrate that TGF beta induces SIK1 levels via a direct transcriptional mechanism that implicates the Smad proteins, and we have mapped a putative enhancer element on the SIK1 gene. We provide evidence that the ubiquitin ligase Smurf2 forms complexes and functionally cooperates with SIK1. Both the kinase activity of SIK1 and the ubiquitin ligase activity of Smurf2 are important for proper type I receptor turnover. We also show that knockdown of endogenous SIK1 and Smurf2 enhances physiological signaling by TGF beta that leads to epithelial growth arrest. In conclusion, TGF beta induces expression of Smad7, Smurf2, and SIK1, the products of which physically and functionally interlink to control the activity of this pathway.	[Lonn, Peter; Vanlandewijck, Michael; Raja, Erna; Kowanetz, Marcin; Watanabe, Yukihide; Kowanetz, Katarzyna; Vasilaki, Eleftheria; Heldin, Carl-Henrik; Moustakas, Aristidis] Uppsala Univ, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden; [Moustakas, Aristidis] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, SE-75124 Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University; Uppsala University	Moustakas, A (corresponding author), Uppsala Univ, Ludwig Inst Canc Res, Box 595 Biomed Ctr, SE-75124 Uppsala, Sweden.	aris.moustakas@licr.uu.se	Vasilaki, Eleftheria/AAY-6392-2020	Vanlandewijck, Michael/0000-0002-0709-7808	Ludwig Institute for Cancer Research; Swedish Cancer Society [4855-B03-01XAC]; Natural Sciences Foundation of Sweden [K2007-66X-14936-04-03, K2010-67X-14936-07-03]; Swedish Agency for Innovation Systems [26575-1]; Swedish Foundation for Strategic Research; Tsukuba University, Japan	Ludwig Institute for Cancer Research; Swedish Cancer Society(Swedish Cancer Society); Natural Sciences Foundation of Sweden; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Tsukuba University, Japan	The work was supported by the Ludwig Institute for Cancer Research, the Swedish Cancer Society (project 4855-B03-01XAC), the Natural Sciences Foundation of Sweden (project K2007-66X-14936-04-03 and K2010-67X-14936-07-03), and the Strategic Japanese-Swedish Cooperative Program "Multidisciplinary BIO" (Project 26575-1) supported by the Swedish Agency for Innovation Systems and the Swedish Foundation for Strategic Research.; Supported by a post-doctoral fellowship from Tsukuba University, Japan.	Al-Hakim AK, 2005, J CELL SCI, V118, P5661, DOI 10.1242/jcs.02670; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fukunaga E, 2008, J BIOL CHEM, V283, P35660, DOI 10.1074/jbc.M710496200; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Jaleel M, 2006, BIOCHEM J, V394, P545, DOI 10.1042/BJ20051844; Jin CY, 2009, CANCER RES, V69, P735, DOI 10.1158/0008-5472.CAN-08-1463; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Kowanetz M, 2008, J CELL BIOL, V182, P655, DOI 10.1083/jcb.200804107; Lanjuin A, 2002, NEURON, V33, P369, DOI 10.1016/S0896-6273(02)00572-X; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Maduzia LL, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-8; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Moren A, 2005, J BIOL CHEM, V280, P22115, DOI 10.1074/jbc.M414027200; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Ohashi N, 2005, FEBS LETT, V579, P2557, DOI 10.1016/j.febslet.2005.03.069; Okamoto M, 2004, TRENDS ENDOCRIN MET, V15, P21, DOI 10.1016/j.tem.2003.11.002; Osmundson EC, 2008, J CELL BIOL, V183, P267, DOI 10.1083/jcb.200801049; Romito A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009029; RUIZ JC, 1994, MECH DEVELOP, V48, P153, DOI 10.1016/0925-4773(94)90056-6; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Sjostrom M, 2007, P NATL ACAD SCI USA, V104, P16922, DOI 10.1073/pnas.0706838104; Takemori H, 2007, FEBS J, V274, P3202, DOI 10.1111/j.1742-4658.2007.05889.x; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yang YC, 2003, P NATL ACAD SCI USA, V100, P10269, DOI 10.1073/pnas.1834070100	43	25	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12867	12878		10.1074/jbc.M111.307249	http://dx.doi.org/10.1074/jbc.M111.307249			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22378783	Green Published, hybrid			2022-12-27	WOS:000302903700026
J	Oot, RA; Wilkens, S				Oot, Rebecca A.; Wilkens, Stephan			Subunit Interactions at the V-1-V-o Interface in Yeast Vacuolar ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; V-ATPASE; H+-ATPASE; CRYSTAL-STRUCTURE; PERIPHERAL STATOR; C VMA5P; V-1; STOICHIOMETRY; COMPLEX; PH	Eukaryotic vacuolar ATPase (V-ATPase) is regulated by a reversible dissociation mechanism that involves breaking and reforming of protein-protein interactions at the interface of the V-1-ATPase and V-o-proton channel domains. We found previously that the head domain of the single copy C subunit (C-head) binds one subunit EG heterodimer with high affinity (Oot, R.A. and Wilkens, S. (2010) J. Biol. Chem. 285, 24654-24664). Here we generated a water-soluble construct of the N-terminal domain of the V-o "a" subunit composed of amino acid residues 104-372 (a(NT(104-372))). Analytical gel filtration chromatography and sedimentation velocity analysis revealed that a(NT(104-372)) undergoes reversible dimerization in a concentration-dependent manner. A low-resolution molecular envelope was calculated for the a(NT(104-372)) dimer using small angle x-ray scattering data. Isothermal titration calorimetry experiments revealed that a(NT(104-372)) binds the C-foot and EG heterodimer with dissociation constants of 22 and 33 mu M, respectively. We speculate that the spatial closeness of the a(NT), C-foot, and EG binding sites in the intact V-ATPase results in a high-avidity interaction that is able to resist the torque of rotational catalysis, and that reversible enzyme dissociation is initiated by breaking either the a(NT(104-372))-C-foot or a(NT(104-372))-EG interaction by an as-yet unknown signaling mechanism.	[Oot, Rebecca A.; Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	wilkenss@upstate.edu			National Institutes of Health [GM058600]; National Science Foundation (NSF); National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) via NSF [DMR-093684]; NIGMS [GM-103485]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103485, R01GM058600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) via NSF; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM058600 (to S. W.). CHESS is supported by the National Science Foundation (NSF) and National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) via NSF award DMR-093684, and the MacCHESS resource is supported by NIGMS award GM-103485.	Armbruster A, 2005, FEBS LETT, V579, P1961, DOI 10.1016/j.febslet.2005.02.042; Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; Dechant R, 2011, CHANNELS, V5, P4, DOI 10.4161/chan.5.1.13846; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Diab H, 2009, J BIOL CHEM, V284, P13316, DOI 10.1074/jbc.M900475200; Diakov Theodore T, 2010, J Biol Chem, V285, P23771, DOI 10.1074/jbc.M110.110122; Diepholz M, 2008, STRUCTURE, V16, P1789, DOI 10.1016/j.str.2008.09.010; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; Fethiere J, 2005, BIOCHEMISTRY-US, V44, P15906, DOI 10.1021/bi051762f; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Hong-Hermesdorf A, 2006, FEBS LETT, V580, P932, DOI 10.1016/j.febslet.2006.01.018; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Huss M, 2007, FEBS LETT, V581, P5566, DOI 10.1016/j.febslet.2007.11.004; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones RPO, 2005, BIOCHEMISTRY-US, V44, P3933, DOI 10.1021/bi048402x; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kane PM, 2000, J EXP BIOL, V203, P81; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Laue T. M., 1992, ANAL ULTRACENTRIFUGA, P19; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; Marshansky V, 2007, BIOCHEM SOC T, V35, P1092, DOI 10.1042/BST0351092; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Merkulova M, 2011, AM J PHYSIOL-CELL PH, V300, pC1442, DOI 10.1152/ajpcell.00076.2010; Merkulova M, 2010, PROTEIN SCI, V19, P1850, DOI 10.1002/pro.470; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; OHSUMI Y, 1983, J BIOL CHEM, V258, P5614; Oot RA, 2010, J BIOL CHEM, V285, P24654, DOI 10.1074/jbc.M110.136960; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qi J, 2008, J BIOL CHEM, V283, P19274, DOI 10.1074/jbc.M802442200; Saijo S, 2011, P NATL ACAD SCI USA, V108, P19955, DOI 10.1073/pnas.1108810108; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Smardon AM, 2007, J BIOL CHEM, V282, P26185, DOI 10.1074/jbc.M703627200; Srinivasan S, 2011, J MOL BIOL, V412, P14, DOI 10.1016/j.jmb.2011.07.014; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toei M, 2011, J BIOL CHEM, V286, P35176, DOI 10.1074/jbc.M111.273409; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Yamamoto M, 2008, J BIOL CHEM, V283, P19422, DOI 10.1074/jbc.M801772200; Yokoyama K, 2003, J BIOL CHEM, V278, P42686, DOI 10.1074/jbc.M305853200; ZHANG JM, 1992, J BIOL CHEM, V267, P9773; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zhang ZY, 2006, FEBS LETT, V580, P2006, DOI 10.1016/j.febslet.2006.03.001	56	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13396	13406		10.1074/jbc.M112.343962	http://dx.doi.org/10.1074/jbc.M112.343962			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367203	Green Published, hybrid			2022-12-27	WOS:000302903700074
J	Sapp, E; Valencia, A; Li, XY; Aronin, N; Kegel, KB; Vonsattel, JP; Young, AB; Wexler, N; DiFiglia, M				Sapp, Ellen; Valencia, Antonio; Li, Xueyi; Aronin, Neil; Kegel, Kimberly B.; Vonsattel, Jean-Paul; Young, Anne B.; Wexler, Nancy; DiFiglia, Marian			Native Mutant Huntingtin in Human Brain EVIDENCE FOR PREVALENCE OF FULL-LENGTH MONOMER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN MOUSE MODEL; INTRANUCLEAR INCLUSIONS; TRANSGENIC MICE; POLYGLUTAMINE REPEAT; WILD-TYPE; DISEASE; PROTEIN; FRAGMENTS; EXPRESSION; PROTEOLYSIS	Huntington disease (HD) is caused by polyglutamine expansion in theNterminus of huntingtin (htt). Analysis of human postmortem brain lysates by SDS-PAGE and Western blot reveals htt as full-lengthandfragmented. HereweusedBlueNativePAGE(BNP) and Western blots to study native htt in human postmortem brain. Antisera against htt detected a single band broadly migrating at 575-850 kDa in control brain and at 650-885 kDa in heterozygous and Venezuelan homozygousHDbrains. Anti-polyglutamine antisera detected full-length mutant htt in HD brain. There was little htt cleavage even if lysates were pretreated with trypsin, indicating a property of native htt to resist protease cleavage. Asoluble mutant htt fragment of about 180 kDa was detected with anti-htt antibody Ab1 (htt-(1-17)) and increased when lysates were treated with denaturants (SDS, 8 M urea, DTT, or trypsin) before BNP. Wild-type htt was more resistant to denaturants. Based on migration of in vitro translated htt fragments, the 180-kDa segment terminated approximate to htt 670-880 amino acids. If second dimension SDSPAGE followed BNP, the 180-kDa mutant htt was absent, and 43-50 kDa htt fragments appeared. Brain lysates from two HD mouse models expressed native full-length htt; a mutant fragment formed if lysates were pretreated with 8 M urea + DTT. Native full-length mutant htt in embryonic HD140Q/140Q mouse primary neurons was intact during cell death and when cell lysates were exposed to denaturants before BNP. Thus, native mutant htt occurs in brain and primary neurons as a soluble full-length monomer.	[Sapp, Ellen; Valencia, Antonio; Li, Xueyi; Kegel, Kimberly B.; DiFiglia, Marian] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA 02129 USA; [Sapp, Ellen; Valencia, Antonio; Li, Xueyi; Kegel, Kimberly B.; DiFiglia, Marian] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Aronin, Neil] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Aronin, Neil] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Vonsattel, Jean-Paul] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Vonsattel, Jean-Paul] New York Presbyterian Hosp, New York, NY 10032 USA; [Vonsattel, Jean-Paul] Columbia Univ Coll Phys & Surg, New York Brain Bank, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Young, Anne B.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Wexler, Nancy] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; [Wexler, Nancy] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Wexler, Nancy] Hereditary Dis Fdn, New York, NY 10032 USA	Harvard University; Massachusetts General Hospital; Harvard University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Columbia University; NewYork-Presbyterian Hospital; Columbia University; Harvard University; Massachusetts General Hospital; Columbia University; Columbia University	DiFiglia, M (corresponding author), Massachusetts Gen Hosp E, Dept Neurol, 114 16th St,Rm 2002, Charlestown, MA 02129 USA.	difiglia@helix.mgh.harvard.edu	Young, Anne/AAF-4283-2020		National Institutes of Health (NINDS) [38194]; National Institutes of Health (NIA) [P01-AG07232, R37-AG15473, P50-AG08702]; Huntington Disease Society of America Coalition for the Cure; UMass DERC [DIC 32520]; Iseman Fund; Louis and Rachel Rudin Foundation; Hereditary Disease Foundation; W. M. Keck Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG007232, R37AG015473, P50AG008702] Funding Source: NIH RePORTER	National Institutes of Health (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Huntington Disease Society of America Coalition for the Cure; UMass DERC; Iseman Fund; Louis and Rachel Rudin Foundation; Hereditary Disease Foundation; W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants 38194 (NINDS; to N. A. and M. D.) and P01-AG07232, R37-AG15473, and P50-AG08702 (NIA; to J. P. V.). This work was also supported by the Huntington Disease Society of America Coalition for the Cure (to M. D.), the UMass DERC (DIC 32520) (to N. A.), The Iseman Fund, The Louis and Rachel Rudin Foundation (to J. P. V.), Hereditary Disease Foundation (to J. P. V. and N. W.), and the W. M. Keck Foundation (to A. B. Y. and N. W.).	ARONIN N, 1995, NEURON, V15, P1193, DOI 10.1016/0896-6273(95)90106-X; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Babavali M, 2009, BIOCHEMISTRY-US, V48, P9022, DOI 10.1021/bi901124j; Bao J, 1996, P NATL ACAD SCI USA, V93, P5037, DOI 10.1073/pnas.93.10.5037; Bhide PG, 1996, J NEUROSCI, V16, P5523; Burre Jacqueline, 2009, Methods Mol Biol, V564, P33, DOI 10.1007/978-1-60761-157-8_3; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Dyer RB, 2001, NAT GENET, V29, P270, DOI 10.1038/ng745; Finkbeiner S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007476; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Kegel KB, 2005, J BIOL CHEM, V280, P36464, DOI 10.1074/jbc.M503672200; Kegel KB, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-58; Kegel KB, 2009, J NEUROCHEM, V110, P1585, DOI 10.1111/j.1471-4159.2009.06255.x; Kim M, 1999, J NEUROSCI, V19, P964; Kim MH, 2003, EXP NEUROL, V183, P109, DOI 10.1016/S0014-4886(03)00132-8; Kim YJ, 2006, NEUROBIOL DIS, V22, P346, DOI 10.1016/j.nbd.2005.11.012; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Li W, 2006, J BIOL CHEM, V281, P15916, DOI 10.1074/jbc.M511007200; Li XY, 2010, J NEUROSCI, V30, P4552, DOI 10.1523/JNEUROSCI.5865-09.2010; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/nchembio.694, 10.1038/NCHEMBIO.694]; Qin ZH, 2004, J NEUROSCI, V24, P269, DOI 10.1523/JNEUROSCI.1409-03.2004; Reisinger V, 2008, J PROTEOMICS, V71, P277, DOI 10.1016/j.jprot.2008.05.004; Romero E, 2008, NEURON, V57, P27, DOI 10.1016/j.neuron.2007.11.025; Sandberg A, 2008, J MOL BIOL, V377, P1117, DOI 10.1016/j.jmb.2008.01.051; Sapp E, 1999, J NEUROPATH EXP NEUR, V58, P165, DOI 10.1097/00005072-199902000-00006; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schilling G, 2007, J NEUROPATH EXP NEUR, V66, P313, DOI 10.1097/nen.0b013e318040b2c8; Seong IS, 2010, HUM MOL GENET, V19, P573, DOI 10.1093/hmg/ddp524; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Toneff T, 2002, J NEUROCHEM, V82, P84, DOI 10.1046/j.1471-4159.2002.00940.x; Valencia A, 2010, J NEUROSCI RES, V88, P179, DOI 10.1002/jnr.22184; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Westmeyer GG, 2004, J BIOL CHEM, V279, P53205, DOI 10.1074/jbc.M410378200; Wexler NS, 2012, ANNU REV MED, V63, P1, DOI 10.1146/annurev-med-050710-134457; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0; Wittig I, 2008, PROTEOMICS, V8, P3974, DOI 10.1002/pmic.200800017; Zhang QC, 2011, J BIOL CHEM, V286, P8188, DOI 10.1074/jbc.M110.192013	52	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13487	13499		10.1074/jbc.M111.286609	http://dx.doi.org/10.1074/jbc.M111.286609			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22375012	Green Published, hybrid			2022-12-27	WOS:000302903700082
J	Youn, MY; Yokoyama, A; Fujiyama-Nakamura, S; Ohtake, F; Minehata, K; Yasuda, H; Suzuki, T; Kato, S; Imai, Y				Youn, Min-Young; Yokoyama, Atsushi; Fujiyama-Nakamura, Sally; Ohtake, Fumiaki; Minehata, Ken-ichi; Yasuda, Hisataka; Suzuki, Takeshi; Kato, Shigeaki; Imai, Yuuki			JMJD5, a Jumonji C (JmjC) Domain-containing Protein, Negatively Regulates Osteoclastogenesis by Facilitating NFATc1 Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; INHIBITING-HIF FIH; HISTONE DEMETHYLATION; ASPARAGINYL HYDROXYLASE; ANDROGEN RECEPTOR; BONE HOMEOSTASIS; CYCLOSPORINE-A; GIANT-CELLS; FAMILY; DIFFERENTIATION	Osteoclastogenesis is a highly regulated process governed by diverse classes of regulators. Among them, nuclear factor of activated T-cells calcineurin-dependent 1 (NFATc1) is the primary osteoclastogenic transcription factor, and its expression is transcriptionally induced during early osteoclastogenesis by receptor activation of nuclear factor kappa B ligand (RANKL), an osteoclastogenic cytokine. Here, we report the novel enzymatic function of JMJD5, which regulates NFATc1 protein stability. Among the tested Jumonji C (JmjC) domain-containing proteins, decreased mRNA expression levels during osteoclastogenesis were found for JMJD5 in RAW264 cells stimulated by RANKL. To examine the functional role of JMJD5 in osteoclast differentiation, we established stable JMJD5 knockdown cells, and osteoclast formation was assessed. Down-regulated expression of JMJD5 led to accelerated osteoclast formation together with induction of several osteoclast-specific genes such as Ctsk and DC-STAMP, suggesting that JMJD5 is a negative regulator in osteoclast differentiation. Although JMJD5 was recently reported as a histone demethylase for histone H3K36me2, no histone demethylase activity was detected in JMJD5 in vitro or in living cells, even for other methylated histone residues. Instead, JMJD5 co-repressed transcriptional activity by destabilizing NFATc1 protein. Protein hydroxylase activity mediated by the JmjC domain in JMJD5 was required for the observed functions of JMJD5. JMJD5 induced the association of hydroxylated NFATc1 with the E3 ubiquitin ligase Von Hippel-Lindau tumor suppressor (VHL), thereby presumably facilitating proteasomal degradation of NFATc1 via ubiquitination. Taken together, the present study demonstrated that JMJD5 is a post-translational co-repressor for NFATc1 that attenuates osteoclastogenesis.	[Kato, Shigeaki] Univ Tokyo, Shigeaki Kato Lab Nucl Signaling, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Minehata, Ken-ichi; Suzuki, Takeshi] Kanazawa Univ, Div Funct Genom, Mol & Cellular Targeting Translat Oncol Ctr, Canc Res Inst, Kanazawa, Ishikawa 9200934, Japan; [Yasuda, Hisataka] Oriental Yeast Co Ltd, Bioind Div, Itabashi Ku, Tokyo 1748505, Japan	University of Tokyo; Kanazawa University; Oriental Yeast Co., Ltd.	Kato, S (corresponding author), Univ Tokyo, Shigeaki Kato Lab Nucl Signaling, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	uskato@mail.ecc.u-tokyo.ac.jp; yimai@iam.u-tokyo.ac.jp	Yokoyama, Atsushi/W-3519-2019; Imai, Yuuki/ABC-4687-2020	Yokoyama, Atsushi/0000-0003-2842-4334	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan [23689066, 23659712]; Grants-in-Aid for Scientific Research [24590346, 23659712] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a postdoctoral fellowship for foreign researchers (to M.-Y. Y.) and a grant for specially promoted research (to S. K.) from the Japan Society for the Promotion of Science and Grants-in-aid 23689066 and 23659712 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to Y. I.).	Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Baba A, 2011, NAT CELL BIOL, V13, P668, DOI 10.1038/ncb2228; Bar-Shavit Z, 2007, J CELL BIOCHEM, V102, P1130, DOI 10.1002/jcb.21553; Baron R, 2004, NAT MED, V10, P458, DOI 10.1038/nm0504-458; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Day CJ, 2004, J CELL BIOCHEM, V91, P303, DOI 10.1002/jcb.10780; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Harrison P R, 1990, Immunol Ser, V49, P411; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Hsia DA, 2010, P NATL ACAD SCI USA, V107, P9671, DOI 10.1073/pnas.1000401107; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kim JH, 2010, J BIOL CHEM, V285, P5224, DOI 10.1074/jbc.M109.042812; Kim Y, 2005, J BIOL CHEM, V280, P32905, DOI 10.1074/jbc.M505820200; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Miyamoto J, 2007, MOL CELL BIOL, V27, P4807, DOI 10.1128/MCB.02039-06; Murphy LLS, 2002, J IMMUNOL, V169, P3717, DOI 10.4049/jimmunol.169.7.3717; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Porter CM, 2000, J BIOL CHEM, V275, P3543, DOI 10.1074/jbc.275.5.3543; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Sawatsubashi S, 2010, GENE DEV, V24, P159, DOI 10.1101/gad.1857410; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Vignery A, 2000, INT J EXP PATHOL, V81, P291, DOI 10.1046/j.1365-2613.2000.00164.x; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yasui T, 2011, J BONE MINER RES, V26, P2665, DOI 10.1002/jbmr.464; Youn MY, 2010, GENES CELLS, V15, P1025, DOI 10.1111/j.1365-2443.2010.01441.x; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007	43	43	44	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12994	13004		10.1074/jbc.M111.323105	http://dx.doi.org/10.1074/jbc.M111.323105			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22375008	Green Published, hybrid			2022-12-27	WOS:000302903700038
J	Borgegard, T; Jureus, A; Olsson, F; Rosqvist, S; Sabirsh, A; Rotticci, D; Paulsen, K; Klintenberg, R; Yan, HM; Waldman, M; Stromberg, K; Nord, J; Johansson, J; Regner, A; Parpal, S; Malinowsky, D; Radesater, AC; Li, TS; Singh, R; Eriksson, H; Lundkvist, J				Borgegard, Tomas; Jureus, Anders; Olsson, Fredrik; Rosqvist, Susanne; Sabirsh, Alan; Rotticci, Didier; Paulsen, Kim; Klintenberg, Rebecka; Yan, Hongmei; Waldman, Magnus; Stromberg, Kia; Nord, Johan; Johansson, Jonas; Regner, Anna; Parpal, Santiago; Malinowsky, David; Radesater, Ann-Cathrin; Li, Tingsheng; Singh, Rajeshwar; Eriksson, Hakan; Lundkvist, Johan			First and Second Generation gamma-Secretase Modulators (GSMs) Modulate Amyloid-beta (A beta) Peptide Production through Different Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; TRANSMEMBRANE DOMAIN; BINDING-SITES; PROTEIN; TARGET; INHIBITORS; PRESENILIN-1; EXPRESSION; FAILURE; PATTERN	gamma-Secretase-mediated cleavage of amyloid precursor protein (APP) results in the production of Alzheimer disease-related amyloid-beta (A beta) peptides. The A beta 42 peptide in particular plays a pivotal role in Alzheimer disease pathogenesis and represents a major drug target. Several gamma-secretase modulators (GSMs), such as the nonsteroidal anti-inflammatory drugs (R)-flurbiprofen and sulindac sulfide, have been suggested to modulate the Alzheimer-related A beta production by targeting the APP. Here, we describe novel GSMs that are selective for A beta modulation and do not impair processing of Notch, EphB2, or EphA4. The GSMs modulate A beta both in cell and cell-free systems as well as lower amyloidogenic A beta 42 levels in the mouse brain. Both radioligand binding and cellular cross-competition experiments reveal a competitive relationship between the AstraZeneca (AZ) GSMs and the established second generation GSM, E2012, but a noncompetitive interaction between AZ GSMs and the first generation GSMs (R)-flurbiprofen and sulindac sulfide. The binding of a H-3-labeledAZGSManalog does not co-localize with APP but overlaps anatomically with a gamma-secretase targeting inhibitor in rodent brains. Combined, these data provide compelling evidence of a growing class of in vivo active GSMs, which are selective for A beta modulation and have a different mechanism of action compared with the original class of GSMs described.	[Borgegard, Tomas; Jureus, Anders; Olsson, Fredrik; Rosqvist, Susanne; Sabirsh, Alan; Klintenberg, Rebecka; Stromberg, Kia; Nord, Johan; Regner, Anna; Parpal, Santiago; Malinowsky, David; Radesater, Ann-Cathrin; Eriksson, Hakan; Lundkvist, Johan] AstraZeneca, Dept Neurosci, CNS PAIN iMED, S-15185 Sodertalje, Sweden; [Rotticci, Didier; Paulsen, Kim; Waldman, Magnus; Johansson, Jonas] AstraZeneca, Dept Med Chem, CNS PAIN iMED, S-15185 Sodertalje, Sweden; [Yan, Hongmei] AstraZeneca, Dept Drug Metab & Pharmacokinet, CNS PAIN iMED, S-15185 Sodertalje, Sweden; [Li, Tingsheng; Singh, Rajeshwar] NAEJA Pharmaceut Inc, Edmonton, AB T6E 5V2, Canada	AstraZeneca; AstraZeneca; AstraZeneca	Lundkvist, J (corresponding author), AstraZeneca, Dept Neurosci, CNS PAIN iMED, Bldg 212 5th Fl, S-15185 Sodertalje, Sweden.	johan.lundkvist@astrazeneca.com		Jureus, Anders/0000-0002-8922-6377; Parpal, Santiago/0000-0003-2861-0516; Sabirsh, Alan/0000-0001-5310-0281				Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Blanchard V, 1997, BRAIN RES, V758, P209, DOI 10.1016/S0006-8993(97)00231-X; Borgegard T, 2011, ALZHEIMERS DIS RES J, V3, P29; Churcher I, 2006, BIOORG MED CHEM LETT, V16, P280, DOI 10.1016/j.bmcl.2005.10.009; Crump CJ, 2011, ACS CHEM NEUROSCI, V2, P705, DOI 10.1021/cn200098p; Ebke A, 2011, J BIOL CHEM, V286, P37181, DOI 10.1074/jbc.C111.276972; Elder GA, 1996, J NEUROSCI RES, V45, P308; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Inoue E, 2009, J CELL BIOL, V185, P551, DOI 10.1083/jcb.200809151; Jureus A, 2010, J NEUROCHEM, V114, P784, DOI 10.1111/j.1471-4159.2010.06812.x; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kretner B, 2011, J BIOL CHEM, V286, P15240, DOI 10.1074/jbc.M110.213587; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Litterst C, 2007, J BIOL CHEM, V282, P16155, DOI 10.1074/jbc.M611449200; Lundkvist J, 2007, CURR OPIN PHARMACOL, V7, P112, DOI 10.1016/j.coph.2006.10.002; Malmquist J, 2012, J LABELLED COMPD RAD, V55, P80, DOI 10.1002/jlcr.1955; McLendon C, 2000, FASEB J, V14, P2383; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Oehlrich D, 2011, J MED CHEM, V54, P669, DOI 10.1021/jm101168r; Ohki Y, 2011, EMBO J, V30, P4815, DOI 10.1038/emboj.2011.372; Portelius E, 2010, J ALZHEIMERS DIS, V21, P1005, DOI 10.3233/JAD-2010-100573; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Stromberg K, 2005, J NEUROCHEM, V95, P880, DOI 10.1111/j.1471-4159.2005.03415.x; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Tian GC, 2003, J BIOL CHEM, V278, P28968, DOI 10.1074/jbc.M300905200; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wan HI, 2009, CTS-CLIN TRANSL SCI, V2, P242, DOI 10.1111/j.1752-8062.2009.00121.x; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Yan XX, 2004, J NEUROSCI, V24, P2942, DOI 10.1523/JNEUROSCI.0092-04.2004	32	58	59	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11810	11819		10.1074/jbc.M111.305227	http://dx.doi.org/10.1074/jbc.M111.305227			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334705	Green Published, hybrid			2022-12-27	WOS:000302782200020
J	Palsgaard, J; Emanuelli, B; Winnay, JN; Sumara, G; Karsenty, G; Kahn, CR				Palsgaard, Jane; Emanuelli, Brice; Winnay, Jonathon N.; Sumara, Grzegorz; Karsenty, Gerard; Kahn, C. Ronald			Cross-talk between Insulin and Wnt Signaling in Preadipocytes ROLE OF WNT CO-RECEPTOR LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-5 (LRP5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; PROTEIN-5 LRP5; PATHWAY; PHOSPHORYLATION; ADIPOGENESIS; POLYMORPHISMS; INHIBITION; TCF7L2; BONE; GENE	Disturbed Wnt signaling has been implicated in numerous diseases, including type 2 diabetes and the metabolic syndrome. In the present study, we have investigated cross-talk between insulin and Wnt signaling pathways using preadipocytes with and without knockdown of the Wnt co-receptors LRP5 and LRP6 and with and without knock-out of insulin and IGF-1 receptors. We find that Wnt stimulation leads to phosphorylation of insulin signaling key mediators, including Akt, GSK3 beta, and ERK1/2, although with a lower fold stimulation and slower time course than observed for insulin. These Wnt effects are insulin/IGF-1 receptor-dependent and are lost in insulin/IGF-1 receptor double knock-out cells. Conversely, in LRP5 knockdown preadipocytes, insulin-induced phosphorylation of IRS1, Akt, GSK3 beta, and ERK1/2 is highly reduced. This effect is specific to insulin, as compared with IGF-1, stimulation and appears to be due to an inducible interaction between LRP5 and the insulin receptor as demonstrated by co-immunoprecipitation. These data demonstrate that Wnt and insulin signaling pathways exhibit cross-talk at multiple levels. Wnt induces phosphorylation of Akt, ERK1/2, and GSK3 beta, and this is dependent on insulin/IGF-1 receptors. Insulin signaling also involves the Wnt co-receptor LRP5, which has a positive effect on insulin signaling. Thus, altered Wnt and LRP5 activity can serve as modifiers of insulin action and insulin resistance in the pathophysiology of diabetes and metabolic syndrome.	[Palsgaard, Jane; Emanuelli, Brice; Winnay, Jonathon N.; Kahn, C. Ronald] Harvard Univ, Joslin Diabet Ctr, Sch Med, Sect Integrat Physiol & Metab, Boston, MA 02215 USA; [Sumara, Grzegorz; Karsenty, Gerard] Columbia Univ, Dept Genet & Dev, Sch Med, New York, NY 10032 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Columbia University	Kahn, CR (corresponding author), Harvard Univ, Joslin Diabet Ctr, Sch Med, Sect Integrat Physiol & Metab, 1 Joslin Pl, Boston, MA 02215 USA.	c.ronald.kahn@joslin.harvard.edu	Emanuelli, Brice/M-2097-2016; Kahn, Ronald/AAY-2435-2021	Emanuelli, Brice/0000-0001-5795-5666; Kahn, Ronald/0000-0002-7583-9228; Karsenty, Gerard/0000-0002-9253-7627; Sumara, Grzegorz/0000-0003-1502-6265	National Institutes of Health [DK31036, DK33201, DK55545]; Novo Nordisk STAR; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082659, R01DK055545, R37DK031036, R01DK031036, R01DK033201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novo Nordisk STAR; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	* This work was supported, in whole or in part, by National Institutes of Health Grants DK31036, DK33201, and DK55545.; <SUP>1</SUP> Supported by a Novo Nordisk STAR International postdoctoral fellowship.	Abiola M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008509; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Boucher J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001173; Boucher J, 2010, J BIOL CHEM, V285, P17235, DOI 10.1074/jbc.M110.118620; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Guo YF, 2006, J MED GENET, V43, P798, DOI 10.1136/jmg.2006.041715; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jin T, 2008, DIABETOLOGIA, V51, P1771, DOI 10.1007/s00125-008-1084-y; Jin T, 2008, MOL ENDOCRINOL, V22, P2383, DOI 10.1210/me.2008-0135; Jin TR, 2008, CELL SIGNAL, V20, P1697, DOI 10.1016/j.cellsig.2008.04.014; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001; Kruger M, 2008, P NATL ACAD SCI USA, V105, P2451, DOI 10.1073/pnas.0711713105; Lee SH, 2008, EXP DIABETES RES, DOI 10.1155/2008/728763; Longo KA, 2002, J BIOL CHEM, V277, P38239, DOI 10.1074/jbc.M206402200; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259; Manolopoulos KN, 2010, MOL PSYCHIATR, V15, P1046, DOI 10.1038/mp.2010.17; Naito AT, 2010, CIRC RES, V107, P1295, DOI 10.1161/CIRCRESAHA.110.223776; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; Rey JP, 2010, DEV DYNAM, V239, P102, DOI 10.1002/dvdy.22181; Riancho JA, 2011, EUR J ENDOCRINOL, V164, P123, DOI 10.1530/EJE-10-0582; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Saarinen A, 2010, CLIN ENDOCRINOL, V72, P481, DOI 10.1111/j.1365-2265.2009.03680.x; Schinner S, 2009, HORM METAB RES, V41, P159, DOI 10.1055/s-0028-1119408; Sugimura R, 2010, BIRTH DEFECTS RES C, V90, P243, DOI 10.1002/bdrc.20195; Sun J, 2008, CELL SIGNAL, V20, P219, DOI 10.1016/j.cellsig.2007.10.010; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Welters HJ, 2008, TRENDS ENDOCRIN MET, V19, P349, DOI 10.1016/j.tem.2008.08.004; Wright WS, 2007, DIABETES, V56, P295, DOI 10.2337/db06-1339; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yi FH, 2008, ENDOCRINOLOGY, V149, P2341, DOI 10.1210/en.2007-1142; Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910; Yum S, 2009, BIOCHEM BIOPH RES CO, V381, P345, DOI 10.1016/j.bbrc.2009.02.044; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	57	68	72	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12016	12026		10.1074/jbc.M111.337048	http://dx.doi.org/10.1074/jbc.M111.337048			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337886	hybrid, Green Published			2022-12-27	WOS:000302782200039
J	Young, MM; Takahashi, Y; Khan, O; Park, S; Hori, T; Yun, J; Sharma, AK; Amin, S; Hu, CD; Zhang, JK; Kester, M; Wang, HG				Young, Megan M.; Takahashi, Yoshinori; Khan, Osman; Park, Sungman; Hori, Tsukasa; Yun, Jong; Sharma, Arun K.; Amin, Shantu; Hu, Chang-Deng; Zhang, Jianke; Kester, Mark; Wang, Hong-Gang			Autophagosomal Membrane Serves as Platform for Intracellular Death-inducing Signaling Complex (iDISC)-mediated Caspase-8 Activation and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; SPHINGOSINE KINASE; MEDIATED CLEAVAGE; DEGRADATION; INHIBITION; CHLOROQUINE; BECLIN-1; BIF-1; MACROAUTOPHAGY; MITOCHONDRIA	Autophagy and apoptosis are two evolutionarily conserved processes that regulate cell fate in response to cytotoxic stress. However, the functional relationship between these two processes remains far from clear. Here, we demonstrate an autophagy-dependent mechanism of caspase-8 activation and initiation of the apoptotic cascade in response to SKI-I, a pan-sphingosine kinase inhibitor, and bortezomib, a proteasome inhibitor. Autophagy is induced concomitantly with caspase-8 activation, which is responsible for initiation of the caspase cascade and the mitochondrial amplification loop that is required for full execution of apoptosis. Inhibition of autophagosome formation by depletion of Atg5 or Atg3 results in a marked suppression of caspase-8 activation and apoptosis. Although caspase-8 self-association depends on p62/SQSTM1, its self-processing requires the autophagosomal membrane. Caspase-8 forms a complex with Atg5 and colocalizes with LC3 and p62. Moreover, FADD, an adaptor protein for caspase-8 activation, associates with Atg5 on Atg16L- and LC3-positive autophagosomal membranes and loss of FADD suppresses cell death. Taken together, these results indicate that the autophagosomal membrane serves as a platform for an intracellular death-inducing signaling complex (iDISC) that recruits self-associated caspase-8 to initiate the caspase-8/-3 cascade.	[Young, Megan M.; Takahashi, Yoshinori; Khan, Osman; Park, Sungman; Hori, Tsukasa; Yun, Jong; Sharma, Arun K.; Amin, Shantu; Kester, Mark; Wang, Hong-Gang] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Young, Megan M.; Takahashi, Yoshinori; Khan, Osman; Park, Sungman; Hori, Tsukasa; Yun, Jong; Sharma, Arun K.; Amin, Shantu; Kester, Mark; Wang, Hong-Gang] Penn State Univ, Coll Med, Penn State Hershey Canc Inst, Hershey, PA 17033 USA; [Hu, Chang-Deng] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Zhang, Jianke] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Jefferson University	Wang, HG (corresponding author), 500 Univ Dr, Hershey, PA 17033 USA.	huw11@psu.edu	Wang, Hong-Gang/A-3018-2015; Kester, Mark/ABG-4615-2020	Wang, Hong-Gang/0000-0003-0551-0571; Young, Megan/0000-0003-1751-9979; Zhang, Jianke/0000-0002-5822-2226; Sharma, Arun/0000-0002-7679-7779; Yun, Jong/0000-0001-9476-7795; Takahashi, Yoshinori/0000-0002-8004-4817	National Institutes of Health [CA82197, CA129682]; NATIONAL CANCER INSTITUTE [R01CA082197, R01CA129682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA82197 and CA129682.	Beljanski V, 2010, J PHARMACOL EXP THER, V333, P454, DOI 10.1124/jpet.109.163337; Bell BD, 2008, P NATL ACAD SCI USA, V105, P16677, DOI 10.1073/pnas.0808597105; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Bonhoure E, 2006, LEUKEMIA, V20, P95, DOI 10.1038/sj.leu.2404023; Briceno Eduardo, 2003, Neurosurg Focus, V14, pe3; Cho DH, 2009, CANCER LETT, V274, P95, DOI 10.1016/j.canlet.2008.09.004; Coroneos E, 1996, BIOCHEM J, V316, P13, DOI 10.1042/bj3160013; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Edsall LC, 2001, J NEUROCHEM, V76, P1573, DOI 10.1046/j.1471-4159.2001.00164.x; French KJ, 2006, J PHARMACOL EXP THER, V318, P596, DOI 10.1124/jpet.106.101345; French KJ, 2003, CANCER RES, V63, P5962; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Giansanti V, 2011, APOPTOSIS, V16, P321, DOI 10.1007/s10495-011-0589-x; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Hengst JA, 2010, BIOORG MED CHEM LETT, V20, P7498, DOI 10.1016/j.bmcl.2010.10.005; Hu C, 2008, BIOORGAN MED CHEM, V16, P7888, DOI 10.1016/j.bmc.2008.07.076; Jiang H, 2011, J VIROL, V85, P4720, DOI 10.1128/JVI.02032-10; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Laussmann MA, 2011, CELL DEATH DIFFER, V18, P1584, DOI 10.1038/cdd.2011.27; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Limaye V, 2005, BLOOD, V105, P3169, DOI 10.1182/blood-2004-02-0452; Loveridge C, 2010, J BIOL CHEM, V285, P38841, DOI 10.1074/jbc.M110.127993; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Martin DA, 1998, J BIOL CHEM, V273, P4345, DOI 10.1074/jbc.273.8.4345; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Mullen T. D., 2011, ANTICANCER AGENTS ME; Myeku N, 2011, J BIOL CHEM, V286, P22426, DOI 10.1074/jbc.M110.149252; Nelson DA, 2004, GENE DEV, V18, P1223, DOI 10.1101/gad.1212404; Pan JA, 2011, MOL CELL BIOL, V31, P3158, DOI 10.1128/MCB.05460-11; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2009, J BIOL CHEM, V284, P2719, DOI 10.1074/jbc.M805920200; Qin ZH, 2001, J BIOL CHEM, V276, P8079, DOI 10.1074/jbc.M007028200; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Sharma AK, 2010, EUR J MED CHEM, V45, P4149, DOI 10.1016/j.ejmech.2010.06.005; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Sotelo J, 2006, ANN INTERN MED, V144, P337, DOI 10.7326/0003-4819-144-5-200603070-00008; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200; Yamaguchi H, 2008, J BIOL CHEM, V283, P19112, DOI 10.1074/jbc.M709882200; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhao H, 2005, RADIAT RES, V164, P250, DOI 10.1667/RR3436.1	60	260	270	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12455	12468		10.1074/jbc.M111.309104	http://dx.doi.org/10.1074/jbc.M111.309104			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22362782	hybrid, Green Published			2022-12-27	WOS:000302782200085
J	Joshi, AS; Thompson, MN; Fei, N; Huttemann, M; Greenberg, ML				Joshi, Amit S.; Thompson, Morgan N.; Fei, Naomi; Huettemann, Maik; Greenberg, Miriam L.			Cardiolipin and Mitochondrial Phosphatidylethanolamine Have Overlapping Functions in Mitochondrial Fusion in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIN-RELATED GTPASE; LINKED CARDIOSKELETAL MYOPATHY; WD REPEAT PROTEIN; BARTH-SYNDROME; PHOSPHATIDYLSERINE DECARBOXYLASE; LYMPHOBLAST MITOCHONDRIA; TEMPERATURE SENSITIVITY; CARRIER PROTEIN; YEAST REQUIRES; INNER MEMBRANE	The two non-bilayer forming mitochondrial phospholipids cardiolipin (CL) and phosphatidylethanolamine (PE) play crucial roles in maintaining mitochondrial morphology. We have shown previously that CL and PE have overlapping functions, and the loss of both is synthetically lethal. Because the lack of CL does not lead to defects in the mitochondrial network in Saccharomyces cerevisiae, we hypothesized that PE may compensate for CL in the maintenance of mitochondrial tubular morphology and fusion. To test this hypothesis, we constructed a conditional mutant crd1 Delta psd1 Delta containing null alleles of CRD1 (CL synthase) and PSD1 (mitochondrial phosphatidylserine decarboxylase), in which the wild type CRD1 gene is expressed on a plasmid under control of the TETOFF promoter. In the presence of tetracycline, the mutant exhibited highly fragmented mitochondria, loss of mitochondrial DNA, and reduced membrane potential, characteristic of fusion mutants. Deletion of DNM1, required for mitochondrial fission, restored the tubular mitochondrial morphology. Loss of CL and mitochondrial PE led to reduced levels of small and large isoforms of the fusion protein Mgm1p, possibly accounting for the fusion defect. Taken together, these data demonstrate for the first time in vivo that CL and mitochondrial PE are required to maintain tubular mitochondrial morphology and have overlapping functions in mitochondrial fusion.	[Joshi, Amit S.; Thompson, Morgan N.; Fei, Naomi; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Huettemann, Maik] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Greenberg, ML (corresponding author), 5047 Gullen Mall Biol Sci Bldg, Detroit, MI 48202 USA.	mlgreen@sun.science.wayne.edu		Huttemann, Maik/0000-0001-6310-7081	National Institutes of Health [R21 HL 084218]; Barth Syndrome Foundation; Wayne State University Graduate Enhancement Research Fellowship; Graduate Enhancement Research Funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL084218] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barth Syndrome Foundation; Wayne State University Graduate Enhancement Research Fellowship; Graduate Enhancement Research Funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 HL 084218. This work was also supported by grants from The Barth Syndrome Foundation (to M. L. G.) and by Wayne State University Graduate Enhancement Research Fellowship and Graduate Enhancement Research Funds (to A. S. J.).	Acehan D, 2007, LAB INVEST, V87, P40, DOI 10.1038/labinvest.3700480; Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088; Barth PG, 1996, J INHERIT METAB DIS, V19, P157, DOI 10.1007/BF01799418; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; BOLHUIS PA, 1991, AM J HUM GENET, V48, P481; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P161, DOI 10.1016/j.bbalip.2004.09.007; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181; Chen SL, 2010, J BIOL CHEM, V285, P10397, DOI 10.1074/jbc.M110.100784; Chen S, 2008, MOL BIOL CELL, V19, P5047, DOI 10.1091/mbc.E08-05-0486; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; CULLIS PR, 1979, BIOCHIM BIOPHYS ACTA, V559, P399, DOI 10.1016/0304-4157(79)90012-1; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Dorn GW, 2011, CIRC RES, V108, P12, DOI 10.1161/CIRCRESAHA.110.236745; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Furt F, 2009, INT J BIOCHEM CELL B, V41, P1828, DOI 10.1016/j.biocel.2009.02.005; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gohil VM, 2009, J CELL BIOL, V184, P468, DOI 10.1083/jcb.200901127; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; GUAN KL, 1993, CURR GENET, V24, P141, DOI 10.1007/BF00324678; Herlan M, 2004, J CELL BIOL, V165, P167, DOI 10.1083/jcb.200403022; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Hoppins S, 2009, J CELL BIOL, V184, P569, DOI 10.1083/jcb.200809099; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Kuroda T, 2011, MOL MICROBIOL, V80, P248, DOI 10.1111/j.1365-2958.2011.07569.x; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; RAND RP, 1972, BIOCHIM BIOPHYS ACTA, V225, P484, DOI 10.1016/0005-2736(72)90152-6; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Rujiviphat J, 2009, J BIOL CHEM, V284, P28682, DOI 10.1074/jbc.M109.044933; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; SCHULLER C, 1994, EMBO J, V13, P4382, DOI 10.1002/j.1460-2075.1994.tb06758.x; Sesaki H, 2004, J BIOL CHEM, V279, P28298, DOI 10.1074/jbc.M401363200; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Sesaki H, 2001, J CELL BIOL, V152, P1123, DOI 10.1083/jcb.152.6.1123; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353; Tieu Q, 2002, J CELL BIOL, V158, P445, DOI 10.1083/jcb.200205031; TROTTER PJ, 1995, J BIOL CHEM, V270, P6071, DOI 10.1074/jbc.270.11.6071; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; WILLINGHAM MC, 1984, J HISTOCHEM CYTOCHEM, V32, P455, DOI 10.1177/32.4.6323574; Wong ED, 2003, J CELL BIOL, V160, P303, DOI 10.1083/jcb.200209015; Wong ED, 2000, J CELL BIOL, V151, P341, DOI 10.1083/jcb.151.2.341; Xu Y, 2005, LAB INVEST, V85, P823, DOI 10.1038/labinvest.3700274; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200; Zhong Q, 2007, J BIOL CHEM, V282, P15946, DOI 10.1074/jbc.M701055200; Zhou JM, 2009, J BIOL CHEM, V284, P18106, DOI 10.1074/jbc.M109.003236; Zick M, 2009, FEBS LETT, V583, P2237, DOI 10.1016/j.febslet.2009.05.053	64	133	134	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17589	17597		10.1074/jbc.M111.330167	http://dx.doi.org/10.1074/jbc.M111.330167			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22433850	Green Published, hybrid			2022-12-27	WOS:000306373000057
J	Kamimura, M; Saito, H; Niwa, R; Niimi, T; Toyoda, K; Ueno, C; Kanamori, Y; Shimura, S; Kiuchi, M				Kamimura, Manabu; Saito, Hitoshi; Niwa, Ryusuke; Niimi, Teruyuki; Toyoda, Kinuko; Ueno, Chihiro; Kanamori, Yasushi; Shimura, Sachiko; Kiuchi, Makoto			Fungal Ecdysteroid-22-oxidase, a New Tool for Manipulating Ecdysteroid Signaling and Insect Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROID-HORMONE INACTIVATION; EUROPEAN CORN-BORER; PROTHORACIC GLANDS; ECDYSONE SYNTHESIS; MOLECULAR-CLONING; BOMBYX-MORI; CYTOCHROME-P450 ENZYME; EMBRYONIC-DEVELOPMENT; BIOSYNTHETIC-PATHWAY; GENE-EXPRESSION	Steroid hormones ecdysteroids regulate varieties of developmental processes in insects. Although the ecdysteroid titer can be increased experimentally with ease, its artificial reduction, although desirable, is very difficult to achieve. Here we characterized the ecdysteroid-inactivating enzyme ecdysteroid-22-oxidase (E22O) from the entomopathogenic fungus Nomuraea rileyi and used it to develop methods for reducing ecdysteroid titer and thereby controlling insect development. K-m and K-cat values of the purified E22O for oxidizing ecdysone were 4.4 mu M and 8.4/s, respectively, indicating that E22O can inactivate ecdysone more efficiently than other ecdysteroid inactivating enzymes characterized so far. The cloned E22O cDNA encoded a FAD-dependent oxidoreductase. Injection of recombinant E22O into the silkworm Bombyx mori interfered with larval molting and metamorphosis. In the hemolymph of E22O-injected pupae, the titer of hormonally active 20-hydroxyecdysone decreased and concomitantly large amounts of inactive 22-dehydroecdysteroids accumulated. E22O injection also prevented molting of various other insects. In the larvae of the crambid moth Haritalodes basipunctalis, E22O injection induced a diapause-like developmental arrest, which, as in normal diapause, was broken by chilling. Transient expression of the E22O gene by in vivo lipofection effectively decreased the 20-hydroxyecdysone titer and blocked molting in B. mori. Transgenic expression of E22O in Drosophila melanogaster caused embryonic morphological defects, phenotypes of which were very similar to those of the ecdysteroid synthesis deficient mutants. Thus, as the first available simple but versatile tool for reducing the internal ecdysteroid titer, E22O could find use in controlling a broad range of ecdysteroid-associated developmental and physiological phenomena.	[Kamimura, Manabu] Natl Inst Agrobiol Sci, Div Insect Sci, Tsukuba, Ibaraki 3058634, Japan; [Niwa, Ryusuke] Univ Tsukuba, Grad Sch Life & Environm Sci, Initiat Promot Young Scientists Independent Res, Tsukuba, Ibaraki 3058572, Japan; [Niimi, Teruyuki] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	National Institute of Agrobiological Sciences - Japan; University of Tsukuba; Nagoya University	Kamimura, M (corresponding author), Natl Inst Agrobiol Sci, Div Insect Sci, 1-2 Owashi, Tsukuba, Ibaraki 3058634, Japan.	kamimura@affrc.go.jp		Niimi, Teruyuki/0000-0003-3981-0177	Ministry of Agriculture, Forestry and Fisheries; Ministry of Education, Culture, Sports, Science, and Technology of Japanese government;  [21580070];  [22380039]	Ministry of Agriculture, Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; 	This work was supported by a grant-in-aid (Bio Design Program) from the Ministry of Agriculture, Forestry and Fisheries, Grants-in-aid for Scientific Research 21580070 and 22380039, and the Special Coordination Funds for Promotion Science and Technology from the Ministry of Education, Culture, Sports, Science, and Technology of Japanese government.	BEAN DW, 1983, J INSECT PHYSIOL, V29, P687, DOI 10.1016/0022-1910(83)90043-4; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bialecki M, 2002, DEV CELL, V3, P209, DOI 10.1016/S1534-5807(02)00204-6; BOWEN MF, 1984, J EXP BIOL, V108, P9; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chavez VM, 2000, DEVELOPMENT, V127, P4115; CLARET J, 1978, CR ACAD SCI D NAT, V286, P639; Cory JS, 2002, EXPTL BIOL REV, P233; Denlinger DL., 2004, COMP MOL INSECT SCI, V3, P615; Endo K, 1997, ZOOL SCI, V14, P127, DOI 10.2108/zsj.14.127; Evans OP, 1998, BIOCHEM J, V330, P1265; GELMAN DB, 1983, COMP BIOCHEM PHYS A, V76, P367, DOI 10.1016/0300-9629(83)90339-0; Gibbens YY, 2011, DEVELOPMENT, V138, P2693, DOI 10.1242/dev.063412; Guittard E, 2011, DEV BIOL, V349, P35, DOI 10.1016/j.ydbio.2010.09.023; Jin JM, 2010, MOL MICROBIOL, V76, P456, DOI 10.1111/j.1365-2958.2010.07109.x; KADONOOKUDA K, 1987, DEV GROWTH DIFFER, V29, P527; Kanamori Y, 2010, J BIOL CHEM, V285, P36933, DOI 10.1074/jbc.M110.180398; Kiuchi M, 2003, ARCH INSECT BIOCHEM, V52, P35, DOI 10.1002/arch.10060; Lafont R., 2005, COMPREHENSIVE MOL IN, V3, P125, DOI DOI 10.1016/B0-44-451924-6/00035-1; Maeda S, 2008, COMP BIOCHEM PHYS B, V149, P507, DOI 10.1016/j.cbpb.2007.11.015; MORIBAYASHI A, 1988, COMP BIOCHEM PHYS A, V91, P157; Namiki T, 2005, BIOCHEM BIOPH RES CO, V337, P367, DOI 10.1016/j.bbrc.2005.09.043; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; OREILLY DR, 1995, INSECT BIOCHEM MOLEC, V25, P541, DOI 10.1016/0965-1748(94)00105-Q; Ou QX, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001160; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Raikhel A, 2005, COMPREHENSIVE MOL IN, V3, P433; Reeves CD, 2008, APPL ENVIRON MICROB, V74, P5121, DOI 10.1128/AEM.00478-08; Rewitz KF, 2010, DEV CELL, V19, P895, DOI 10.1016/j.devcel.2010.10.021; RICHARD DS, 1987, J INSECT PHYSIOL, V33, P115, DOI 10.1016/0022-1910(87)90083-7; Riddiford L.M., 1985, P37; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sonobe H, 2004, ZOOL SCI, V21, P503, DOI 10.2108/zsj.21.503; Sonobe H, 2006, J BIOL CHEM, V281, P29513, DOI 10.1074/jbc.M604035200; Sullivan AA, 2003, MOL ENDOCRINOL, V17, P2125, DOI 10.1210/me.2002-0430; TAKEDA S, 1986, Bulletin of the Sericultural Experiment Station (Tokyo), V30, P361; Takeuchi H, 2000, BIOCHEM J, V349, P239, DOI 10.1042/0264-6021:3490239; Takeuchi H, 2001, J BIOL CHEM, V276, P26819, DOI 10.1074/jbc.M104291200; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; WARREN JT, 1986, INSECT BIOCHEM, V16, P65, DOI 10.1016/0020-1790(86)90080-6; Yang HJ, 2011, ARCH INSECT BIOCHEM, V78, P17, DOI 10.1002/arch.20436; Yoshiyama T, 2006, DEVELOPMENT, V133, P2565, DOI 10.1242/dev.02428; Yoshiyama-Yanagawa T, 2011, J BIOL CHEM, V286, P25756, DOI 10.1074/jbc.M111.244384; Zhou XF, 2004, J EXP BIOL, V207, P1151, DOI 10.1242/jeb.00855	47	18	20	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16488	16498		10.1074/jbc.M112.341180	http://dx.doi.org/10.1074/jbc.M112.341180			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22427652	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000304030900039
J	Onder, O; Humphrey, PT; McOmber, B; Korobova, F; Francella, N; Greenbaum, DC; Brisson, D				Oender, Oezlem; Humphrey, Parris T.; McOmber, Brian; Korobova, Farida; Francella, Nicholas; Greenbaum, Doron C.; Brisson, Dustin			OspC Is Potent Plasminogen Receptor on Surface of Borrelia burgdorferi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYME-DISEASE SPIROCHETE; PROTEIN-C; EXTRACELLULAR-MATRIX; ACTIVATION SYSTEM; MASS-SPECTROMETRY; IXODES-SCAPULARIS; CRYSTAL-STRUCTURE; SALIVARY-GLANDS; EXPRESSION; INFECTION	Host-derived proteases are crucial for the successful infection of vertebrates by several pathogens, including the Lyme disease spirochete bacterium, Borrelia burgdorferi. B. burgdorferi must traverse tissue barriers in the tick vector during transmission to the host and during dissemination within the host, and it must disrupt immune challenges to successfully complete its infectious cycle. It has been proposed that B. burgdorferi can accomplish these tasks without an endogenous extra-cytoplasmic protease by commandeering plasminogen, the highly abundant precursor of the vertebrate protease plasmin. However, the molecular mechanism by which B. burgdorferi immobilizes plasminogen to its surface remains obscure. The data presented here demonstrate that the outer surface protein C (OspC) of B. burgdorferi is a potent plasminogen receptor on the outer membrane of the bacterium. OspC-expressing spirochetes readily bind plasminogen, whereas only background levels of plasminogen are detectable on OspC-deficient strains. Furthermore, plasminogen binding by OspC-expressing spirochetes can be significantly reduced using anti-OspC antibodies. Co-immuno-fluorescence staining assays demonstrate that wild-type bacteria immobilize plasminogen only if they are actively expressing OspC regardless of the expression of other surface proteins. The co-localization of plasminogen and OspC on OspC-expressing spirochetes further implicates OspC as a biologically relevant plasminogen receptor on the surface of live B. burgdorferi.	[Oender, Oezlem] Univ Penn, Dept Biol, Leidy Labs 326, Philadelphia, PA 19104 USA; [Greenbaum, Doron C.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Onder, O (corresponding author), Univ Penn, Dept Biol, Leidy Labs 326, 433 S Univ Ave, Philadelphia, PA 19104 USA.	ozlem@sas.upenn.edu; dbrisson@sas.upenn.edu	Onder, Ozlem/AAA-5301-2020; Brisson, Dustin/B-2428-2008	Brisson, Dustin/0000-0002-9493-7579; Onder, Ozlem/0000-0003-0850-1216	National Institutes of Health [AI076342]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076342] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI076342.	Alverson J, 2003, MOL MICROBIOL, V48, P1665, DOI 10.1046/j.1365-2958.2003.03537.x; Babb K, 2004, J BACTERIOL, V186, P2745, DOI 10.1128/JB.186.9.2745-2756.2004; BARBOUR AG, 1983, INFECT IMMUN, V41, P795, DOI 10.1128/IAI.41.2.795-804.1983; Blevins JS, 2007, APPL ENVIRON MICROB, V73, P1501, DOI 10.1128/AEM.02454-06; Boyle MDP, 1997, THROMB HAEMOSTASIS, V77, P1; Brissette CA, 2009, INFECT IMMUN, V77, P300, DOI 10.1128/IAI.01133-08; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Burns LH, 2010, NUCLEIC ACIDS RES, V38, P5443, DOI 10.1093/nar/gkq284; Carroll JA, 1999, INFECT IMMUN, V67, P3181, DOI 10.1128/IAI.67.7.3181-3187.1999; CEDERHOLMWILLIAMS SA, 1981, J CLIN PATHOL, V34, P979, DOI 10.1136/jcp.34.9.979; Coleman JL, 1999, J LAB CLIN MED, V134, P567, DOI 10.1016/S0022-2143(99)90095-1; COLEMAN JL, 1995, INFECT IMMUN, V63, P2478, DOI 10.1128/IAI.63.7.2478-2484.1995; Coleman JL, 1999, INFECT IMMUN, V67, P3929, DOI 10.1128/IAI.67.8.3929-3936.1999; Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6; Demain AL, 2009, BIOTECHNOL ADV, V27, P297, DOI 10.1016/j.biotechadv.2009.01.008; Dykhuizen DE, 2008, AM J TROP MED HYG, V78, P806, DOI 10.4269/ajtmh.2008.78.806; Earnhart CG, 2010, MOL MICROBIOL, V76, P393, DOI 10.1111/j.1365-2958.2010.07103.x; Eicken C, 2001, J BIOL CHEM, V276, P10010, DOI 10.1074/jbc.M010062200; El-Hage N, 2002, J BACTERIOL, V184, P4536, DOI 10.1128/JB.184.16.4536-4543.2002; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; FINGERLE V, 1995, J CLIN MICROBIOL, V33, P1867, DOI 10.1128/JCM.33.7.1867-1869.1995; Fingerle V, 2007, INT J MED MICROBIOL, V297, P97, DOI 10.1016/j.ijmm.2006.11.003; FUCHS H, 1994, P NATL ACAD SCI USA, V91, P12594, DOI 10.1073/pnas.91.26.12594; FUCHS R, 1992, MOL MICROBIOL, V6, P503, DOI 10.1111/j.1365-2958.1992.tb01495.x; Gebbia JA, 1999, J CLIN INVEST, V103, P81, DOI 10.1172/JCI5171; Gilmore RD, 2000, INFECT IMMUN, V68, P411, DOI 10.1128/IAI.68.1.411-414.2000; GOGUEN JD, 1995, INFECT AGENT DIS, V4, P47; Grab DJ, 2005, INFECT IMMUN, V73, P1014, DOI 10.1128/IAI.73.2.1014-1022.2005; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Hallstrom T, 2010, J INFECT DIS, V202, P490, DOI 10.1086/653825; HU LT, 1995, INFECT IMMUN, V63, P3491, DOI 10.1128/IAI.63.9.3491-3496.1995; Hu LT, 1997, INFECT IMMUN, V65, P4989, DOI 10.1128/IAI.65.12.4989-4995.1997; Inaba K, 2009, J BIOCHEM, V146, P591, DOI 10.1093/jb/mvp102; KLEMPNER MS, 1995, J INFECT DIS, V171, P1258, DOI 10.1093/infdis/171.5.1258; Klempner MS, 1996, J INFECT DIS, V174, P97, DOI 10.1093/infdis/174.1.97; Kumaran D, 2001, EMBO J, V20, P971, DOI 10.1093/emboj/20.5.971; Kumru OS, 2011, J BACTERIOL, V193, P5759, DOI 10.1128/JB.05622-11; Lagal V, 2006, MICROBES INFECT, V8, P645, DOI 10.1016/j.micinf.2005.08.017; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; MASUZAWA T, 1994, FEMS MICROBIOL LETT, V123, P319, DOI 10.1111/j.1574-6968.1994.tb07242.x; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; Moriarty TJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000090; Narasimhan S, 2002, J BACTERIOL, V184, P3122, DOI 10.1128/JB.184.11.3122-3125.2002; Nordstrand A, 2001, INFECT IMMUN, V69, P5832, DOI 10.1128/IAI.69.9.5832-5839.2001; Onder O, 2008, MOL CELL PROTEOMICS, V7, P875, DOI 10.1074/mcp.M700433-MCP200; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; Plow EF, 1999, FIBRINOLYSIS PROTEOL, V13, P49, DOI 10.1016/S0268-9499(99)90079-6; Radolf JD, 2008, MOL MICROBIOL, V69, P1, DOI 10.1111/j.1365-2958.2008.06226.x; Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014; Sarkar A, 2011, J BACTERIOL, V193, P5365, DOI 10.1128/JB.01496-10; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; Seemanapalli SV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015830; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Tokarz R, 2004, INFECT IMMUN, V72, P5419, DOI 10.1128/IAI.72.9.5419-5432.2004; TRAVIS J, 1995, TRENDS MICROBIOL, V3, P405, DOI 10.1016/S0966-842X(00)88988-X; Wiener MC, 2004, ANAL CHEM, V76, P6085, DOI 10.1021/ac0493875; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Xie F, 2011, J BIOL CHEM, V286, P25443, DOI 10.1074/jbc.R110.199703; Xu QL, 2008, MOL MICROBIOL, V69, P15, DOI 10.1111/j.1365-2958.2008.06264.x; Zuckert Wolfram R, 2007, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12c01s4	65	72	73	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16860	16868		10.1074/jbc.M111.290775	http://dx.doi.org/10.1074/jbc.M111.290775			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22433849	Green Published, hybrid			2022-12-27	WOS:000304030900072
J	Teng, YW; Ellis, JM; Coleman, RA; Zeisel, SH				Teng, Ya-Wen; Ellis, Jessica M.; Coleman, Rosalind A.; Zeisel, Steven H.			Mouse Betaine-Homocysteine S-Methyltransferase Deficiency Reduces Body Fat via Increasing Energy Expenditure and Impairing Lipid Synthesis and Enhancing Glucose Oxidation in White Adipose Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR 21; HORMONE RECEPTOR-BETA; THYROID-HORMONE; SUBCUTANEOUS FAT; GENE-EXPRESSION; PPAR-GAMMA; BILE-ACIDS; MICE; LIVER; DIET	Betaine-homocysteine S-methyltransferase (BHMT) catalyzes the synthesis of methionine from homocysteine. In our initial report, we observed a reduced body weight in Bhmt(-/-) mice. We initiated this study to investigate the potential role of BHMT in energy metabolism. Compared with the controls (Bhmt(+/+)), Bhmt(-/-) mice had less fat mass, smaller adipocytes, and better glucose and insulin sensitivities. Compared with the controls, Bhmt(-/-) mice had increased energy expenditure, with no changes in food intake, fat uptake or absorption, or in locomotor activity. The reduced adiposity in Bhmt(-/-) mice was not due to hyperthermogenesis. Bhmt(-/-) mice failed to maintain a normal body temperature upon cold exposure because of limited fuel supplies. In vivo and ex vivo tests showed that Bhmt(-/-) mice had normal lipolytic function. The rate of C-14-labeled fatty acid incorporated into [C-14]triacylglycerol was the same in Bhmt(+/+) and Bhmt(-/-) gonadal fat depots (GWAT), but it was 62% lower in Bhmt(-/-) inguinal fat depots (IWAT) compared with that of Bhmt(+/+) mice. The rate of C-14-labeled fatty acid oxidation was the same in both GWAT and IWAT from Bhmt(+/+) and Bhmt(-/-) mice. At basal level, Bhmt(-/-) GWAT had the same [C-14] glucose oxidation as did the controls. When stimulated with insulin, Bhmt(-/-) GWAT oxidized 2.4-fold more glucose than did the controls. Compared with the controls, the rate of [C-14] glucose oxidation was 2.4- and 1.8-fold higher, respectively, in Bhmt(-/-) IWAT without or with insulin stimulus. Our results show for the first time a role for BHMT in energy homeostasis.	[Teng, Ya-Wen; Ellis, Jessica M.; Coleman, Rosalind A.; Zeisel, Steven H.] Univ N Carolina, Sch Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA; [Ellis, Jessica M.] Johns Hopkins Univ, Dept Biol Chem, Baltimore, MD 21205 USA; [Zeisel, Steven H.] Univ N Carolina Chapel Hill, Inst Nutr Res, Kannapolis, NC 28081 USA	University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill	Zeisel, SH (corresponding author), 500 Laureate Way, Kannapolis, NC 28081 USA.	steven_zeisel@unc.edu			National Institutes of Health [DK55865, DK56350, DK59935, DK56598, T32-HL069768]; University of North Carolina at Chapel Hill; American Heart Association Mid-Atlantic Division; McNeil Nutritionals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350, R01DK055865, R01DK059935, R01DK056598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina at Chapel Hill; American Heart Association Mid-Atlantic Division(American Heart Association); McNeil Nutritionals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK55865 and DK56350 (to S. H. Z.), DK59935 and DK56598 (to R. A. C.), and Predoctoral Training Grant T32-HL069768 (to J. M. E.). This work was also supported by a McNeil Nutritionals predoctoral fellowship (to Y.-W. T.), a dissertation completion fellowship from the University of North Carolina at Chapel Hill (to Y.-W. T.), and a predoctoral fellowship from the American Heart Association Mid-Atlantic Division (to J. M. E.).	Adams AC, 2010, J BIOL CHEM, V285, P14078, DOI 10.1074/jbc.C110.107375; Adams M, 1997, J CLIN INVEST, V100, P3149, DOI 10.1172/JCI119870; Barrett T., 2008, U.S. Patent, Patent No. [7,433,787, 7433787]; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boudonck KJ, 2009, TOXICOL PATHOL, V37, P280, DOI 10.1177/0192623309332992; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Dasarathy S, 2011, EUR J GASTROEN HEPAT, V23, P382, DOI 10.1097/MEG.0b013e328345c8c7; Delgado-Reyes CV, 2001, ARCH BIOCHEM BIOPHYS, V393, P184, DOI 10.1006/abbi.2001.2474; Eklund M, 2005, NUTR RES REV, V18, P31, DOI 10.1079/NRR200493; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Flachs P, 2002, BIOCHEM J, V364, P369, DOI 10.1042/BJ20011438; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gullberg H, 2000, MOL ENDOCRINOL, V14, P1739, DOI 10.1210/me.14.11.1739; Gullberg H, 2002, MOL ENDOCRINOL, V16, P1767, DOI 10.1210/me.2002-0009; Iizuka K, 2009, FEBS LETT, V583, P2882, DOI 10.1016/j.febslet.2009.07.053; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Ji C, 2008, ALCOHOL CLIN EXP RES, V32, P1049, DOI 10.1111/j.1530-0277.2008.00666.x; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Le Lay J, 2009, CELL METAB, V10, P55, DOI 10.1016/j.cmet.2009.06.006; Lefebvre AM, 1998, DIABETES, V47, P98, DOI 10.2337/diabetes.47.1.98; Li K, 2012, MOL CELL ENDOCRINOL, V348, P21, DOI 10.1016/j.mce.2011.07.026; Li LO, 2009, J BIOL CHEM, V284, P27816, DOI 10.1074/jbc.M109.022467; Lillie RD, 1965, HISTOPATHOLOGIC TECH, P1; LONCAR D, 1991, CELL TISSUE RES, V266, P149, DOI 10.1007/BF00678721; Moyers JS, 2007, J CELL PHYSIOL, V210, P1, DOI 10.1002/jcp.20847; Naggert J., 2012, DIET EFFECTS BONE DE; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Oishi K, 2011, BIOL PHARM BULL, V34, P1120, DOI 10.1248/bpb.34.1120; Ortega FJ, 2009, OBESITY, V17, P2134, DOI 10.1038/oby.2009.110; Pajares MA, 2006, CELL MOL LIFE SCI, V63, P2792, DOI 10.1007/s00018-006-6249-6; PASSONNEAU JV, 1974, ANAL BIOCHEM, V60, P405, DOI 10.1016/0003-2697(74)90248-6; Rajala MW, 2004, DIABETES, V53, P1671, DOI 10.2337/diabetes.53.7.1671; Raubenheimer PJ, 2006, DIABETES, V55, P2015, DOI 10.2337/db06-0097; Reaven P, 1997, ARTERIOSCL THROM VAS, V17, P2250, DOI 10.1161/01.ATV.17.10.2250; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Rossmeisl M, 2002, EUR J BIOCHEM, V269, P19, DOI 10.1046/j.0014-2956.2002.02627.x; Sanchez J, 2009, ENDOCRINOLOGY, V150, P5341, DOI 10.1210/en.2009-0466; Sewter CP, 2002, DIABETES, V51, P718, DOI 10.2337/diabetes.51.3.718; Shin DJ, 2006, NUCLEIC ACIDS RES, V34, P3853, DOI 10.1093/nar/gkl506; Szegedi SS, 2008, J BIOL CHEM, V283, P8939, DOI 10.1074/jbc.M710449200; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Viswanadha S, 2006, J LIPID RES, V47, P1859, DOI 10.1194/jlr.D600005-JLR200; Wang YiZhen, 1999, Journal of Zhejiang Agricultural University, V25, P281; Wang YiZhen, 2000, Chinese Journal of Veterinary Science, V20, P409; Wang ZG, 2010, AM J PHYSIOL-GASTR L, V298, pG634, DOI 10.1152/ajpgi.00249.2009; Warne JP, 2006, AM J PHYSIOL-ENDOC M, V291, pE1264, DOI 10.1152/ajpendo.00655.2005; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Watanabe M, 2011, J BIOL CHEM, V286, P26913, DOI 10.1074/jbc.M111.248203; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu ZiRong, 1998, Acta Veterinaria et Zootechnica Sinica, V29, P212; Xu ZiRong, 1999, Chinese Journal of Veterinary Science, V19, P399; Yu DongYou, 2001, Chinese Journal of Veterinary Science, V21, P200; Yu DongYou, 2000, Chinese Journal of Animal Science, V36, P8; Zou X. T., 2002, SCI CHINA, V1, P1043; Zou XiaoTing, 2001, Chinese Journal of Veterinary Science, V21, P300; Zou XiaoTing, 1998, Acta Agriculturae Zhejiangensis, V10, P144	61	30	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16187	16198		10.1074/jbc.M111.303255	http://dx.doi.org/10.1074/jbc.M111.303255			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22362777	Green Published, hybrid			2022-12-27	WOS:000304030900011
J	Sun, YL; Senger, K; Baginski, TK; Mazloom, A; Chinn, Y; Pantua, H; Hamidzadeh, K; Ramani, SR; Luis, E; Tom, I; Sebrell, A; Quinones, G; Ma, Y; Mukhyala, K; Sai, T; Ding, JB; Haley, B; Shadnia, H; Kapadia, SB; Gonzalez, LC; Hass, PE; Zarrin, AA				Sun, Yonglian; Senger, Kate; Baginski, Tomasz K.; Mazloom, Anita; Chinn, Yvonne; Pantua, Homer; Hamidzadeh, Kajal; Ramani, Sree Ranjani; Luis, Elizabeth; Tom, Irene; Sebrell, Andrew; Quinones, Gabriel; Ma, Yan; Mukhyala, Kiran; Sai, Tao; Ding, Jiabing; Haley, Benjamin; Shadnia, Hooman; Kapadia, Sharookh B.; Gonzalez, Lino C.; Hass, Philip E.; Zarrin, Ali A.			Evolutionarily Conserved Paired Immunoglobulin-like Receptor alpha (PILR alpha) Domain Mediates Its Interaction with Diverse Sialylated Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 RECEPTOR; INHIBITORY RECEPTOR; SCAVENGER RECEPTOR; GLYCOPROTEIN-B; BINDING-SITE; PROTEIN; CELLS; CD99; RECOGNITION; SIALOADHESIN	Paired immunoglobulin-like receptor (PILR) alpha is an inhibitory receptor that recognizes several ligands, including mouse CD99, PILR-associating neural protein, and Herpes simplex virus-1 glycoprotein B. The physiological function(s) of interactions between PILR alpha and its cellular ligands are not well understood, as are the molecular determinants of PILR alpha/ligand interactions. To address these uncertainties, we sought to identify additional PILR alpha ligands and further define the molecular basis for PILR alpha/ligand interactions. Here, we identify two novel PILR alpha binding partners, neuronal differentiation and proliferation factor-1 (NPDC1), and collectin-12 (COLEC12). We find that sialylated O-glycans on these novel PILR alpha ligands, and on known PILR alpha ligands, are compulsory for PILR alpha binding. Sialylation-dependent ligand recognition is also a property of SIGLEC1, a member of the sialic acid-binding Ig-like lectins. SIGLEC1 Ig domain shares similar to 22% sequence identity with PILR alpha, an identity that includes a conserved arginine localized to position 97 in mouse and human SIGLEC1, position 133 in mouse PILR alpha and position 126 in human PILR alpha. We observe that PILR alpha/ligand interactions require conserved PILR alpha Arg-133 (mouse) and Arg-126 (human), in correspondence with a previously reported requirement for SIGLEC1 Arg-197 in SIGLEC1/ligand interactions. Homology modeling identifies striking similarities between PILR alpha and SIGLEC1 ligand binding pockets as well as at least one set of distinctive interactions in the galactoxyl-binding site. Binding studies suggest that PILR alpha recognizes a complex ligand domain involving both sialic acid and protein motif(s). Thus, PILR alpha is evolved to engage multiple ligands with common molecular determinants to modulate myeloid cell functions in anatomical settings where PILR alpha ligands are expressed.	[Sun, Yonglian; Senger, Kate; Hamidzadeh, Kajal; Ding, Jiabing; Zarrin, Ali A.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Baginski, Tomasz K.] Genentech Inc, Dept Prot Analyt Chem, San Francisco, CA 94080 USA; [Mazloom, Anita; Chinn, Yvonne; Ramani, Sree Ranjani; Luis, Elizabeth; Tom, Irene; Quinones, Gabriel; Haley, Benjamin; Gonzalez, Lino C.; Hass, Philip E.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Sebrell, Andrew; Sai, Tao] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Ma, Yan; Mukhyala, Kiran] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Shadnia, Hooman] Chem Comp Grp Inc, Montreal, PQ H3A 2R7, Canada	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Chemical Computing Group	Zarrin, AA (corresponding author), Genentech Inc, Dept Immunol, 1 DNA Way, San Francisco, CA 94080 USA.	zarrin.ali@gene.com	Gonzalez, Lino/E-4102-2012	Gonzalez, Lino/0000-0003-3817-6450; Hamidzadeh, Kajal/0000-0002-2949-0774				ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Banerjee A, 2010, INFECT IMMUN, V78, P1353, DOI 10.1128/IAI.00969-09; Clark AM, 2007, J CHEM INF MODEL, V47, P1933, DOI 10.1021/ci7001473; Cooper CA, 2001, PROTEOMICS, V1, P340, DOI 10.1002/1615-9861(200102)1:2<340::AID-PROT340>3.0.CO;2-B; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Fan Q, 2010, J VIROL, V84, P8664, DOI 10.1128/JVI.01039-10; Fan Q, 2009, J VIROL, V83, P7384, DOI 10.1128/JVI.00087-09; Fournier N, 2000, J IMMUNOL, V165, P1197, DOI 10.4049/jimmunol.165.3.1197; GALIANA E, 1995, P NATL ACAD SCI USA, V92, P1560, DOI 10.1073/pnas.92.5.1560; GELIN C, 1989, EMBO J, V8, P3253, DOI 10.1002/j.1460-2075.1989.tb08485.x; Gonzalez LC, 2005, P NATL ACAD SCI USA, V102, P1116, DOI 10.1073/pnas.0409071102; Ikehara Y, 2004, J BIOL CHEM, V279, P43117, DOI 10.1074/jbc.M403538200; Janssen WJ, 2008, AM J RESP CRIT CARE, V178, P158, DOI 10.1164/rccm.200711-1661OC; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Keck Rodney G., 2005, V308, P381; Kelm S, 1997, INT REV CYTOL, V175, P137, DOI 10.1016/S0074-7696(08)62127-0; Kogure A, 2011, BIOCHEM BIOPH RES CO, V405, P428, DOI 10.1016/j.bbrc.2011.01.047; Masuda K, 1999, MOL IMMUNOL, V36, P993, DOI 10.1016/S0161-5890(99)00131-5; May AP, 1998, MOL CELL, V1, P719, DOI 10.1016/S1097-2765(00)80071-4; Mousseau DD, 2000, J BIOL CHEM, V275, P4467, DOI 10.1074/jbc.275.6.4467; Munday J, 1999, J LEUKOCYTE BIOL, V66, P705, DOI 10.1002/jlb.66.5.705; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Nakamura K, 2001, BIOCHEM BIOPH RES CO, V280, P1028, DOI 10.1006/bbrc.2000.4210; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Ohtani K, 2001, J BIOL CHEM, V276, P44222, DOI 10.1074/jbc.M103942200; Olson FJ, 2005, GLYCOBIOLOGY, V15, P177, DOI 10.1093/glycob/cwh158; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; Satoh Takeshi, 2008, Virus (Nagoya), V58, P27; Schenkel AR, 2002, NAT IMMUNOL, V3, P143, DOI 10.1038/ni749; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; Tabata S, 2008, J BIOL CHEM, V283, P8893, DOI 10.1074/jbc.M709793200; Taylor L S, 2000, Rev Immunogenet, V2, P204; Vinson M, 1996, J BIOL CHEM, V271, P9267, DOI 10.1074/jbc.271.16.9267; Wang J, 2008, J IMMUNOL, V180, P1686, DOI 10.4049/jimmunol.180.3.1686; Wang J, 2009, J VIROL, V83, P13042, DOI 10.1128/JVI.00792-09; Wilson MD, 2006, PHYSIOL GENOMICS, V27, P201, DOI 10.1152/physiolgenomics.00284.2005; Wingett D, 1999, CELL IMMUNOL, V193, P17, DOI 10.1006/cimm.1999.1470	40	31	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15837	15850		10.1074/jbc.M111.286633	http://dx.doi.org/10.1074/jbc.M111.286633			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22396535	Green Published, hybrid			2022-12-27	WOS:000304006300063
J	Al-Tawashi, A; Jung, SY; Liu, D; Su, B; Qin, J				Al-Tawashi, Azza; Jung, Sung Yun; Liu, Dou; Su, Bing; Qin, Jun			Protein Implicated in Nonsyndromic Mental Retardation Regulates Protein Kinase A (PKA) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5-HT1A RECEPTOR GENE; NF-KAPPA-B; NADPH OXIDASE; ANCHORED PKA; C2 DOMAIN; CAMP; FAMILY; PHOSPHODIESTERASES; COMPLEXES; DISEASE	Mutation of the coiled-coil and C2 domain-containing 1A (CC2D1A) gene, which encodes a C2 domain and DM14 domain-containing protein, has been linked to severe autosomal recessive nonsyndromic mental retardation. Using a mouse model that produces a truncated form of CC2D1A that lacks the C2 domain and three of the four DM14 domains, we show that CC2D1A is important for neuronal differentiation and brain development. CC2D1A mutant neurons are hypersensitive to stress and have a reduced capacity to form dendrites and synapses in culture. At the biochemical level, CC2D1A transduces signals to the cyclic adenosine 3',5'-monophosphate (cAMP)-protein kinase A (PKA) pathway during neuronal cell differentiation. PKA activity is compromised, and the translocation of its catalytic subunit to the nucleus is also defective in CC2D1A mutant cells. Consistently, phosphorylation of the PKA target cAMP-responsive element-binding protein, at serine 133, is nearly abolished in CC2D1A mutant cells. The defects in cAMP/PKA signaling were observed in fibroblast, macrophage, and neuronal primary cells derived from the CC2D1A KO mice. CC2D1A associates with the cAMP-PKA complex following forskolin treatment and accumulates in vesicles or on the plasma membrane in wild-type cells, suggesting that CC2D1A may recruit the PKA complex to the membrane to facilitate signal transduction. Together, our data show that CC2D1A is an important regulator of the cAMP/PKA signaling pathway, which may be the underlying cause for impaired mental function in nonsyndromic mental retardation patients with CC2D1A mutation.	[Al-Tawashi, Azza; Jung, Sung Yun; Qin, Jun] Baylor Coll Med, Ctr Mol Discovery, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Al-Tawashi, Azza; Jung, Sung Yun; Qin, Jun] Baylor Coll Med, Ctr Mol Discovery, Verna & Marrs McLean Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Al-Tawashi, Azza] King Abdullah Univ Sci & Technol, Div Chem & Life Sci & Engn, Thuwal 23955, Saudi Arabia; [Liu, Dou; Su, Bing] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Liu, Dou; Su, Bing] Yale Univ, Sch Med, Program Vasc Biol & Therapeut, New Haven, CT 06520 USA	Baylor College of Medicine; Baylor College of Medicine; King Abdullah University of Science & Technology; Yale University; Yale University	Al-Tawashi, A (corresponding author), Baylor Coll Med, Ctr Mol Discovery, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	azza.altawashi@kaust.edu.sa; Bing.su@yale.edu; jqin@bcm.edu		Jung, Sung Yun/0000-0003-1521-7977	Division of Chemical and Life Sciences and Engineering, King Abdullah University of Science and Technology	Division of Chemical and Life Sciences and Engineering, King Abdullah University of Science and Technology	It is a pleasure to thank those who instructed A. A. on how to work with neurons: Hsiao-Tuan Chao and Paymaan Jafar-Nejad from Al Zoghbi Laboratory and Zilai Wang from Huffington Center at Baylor College of Medicine. We also thank Professor Kenneth P Minneman, Dean, Division of Chemical and Life Sciences and Engineering, King Abdullah University of Science and Technology, for guidance and support in preparing this paper.	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Barnette M S, 2000, Curr Opin Pulm Med, V6, P164, DOI 10.1097/00063198-200003000-00014; Basel-Vanagaite L, 2007, CLIN GENET, V72, P167, DOI 10.1111/j.1399-0004.2007.00881.x; Basel-Vanagaite L, 2006, J MED GENET, V43, P203, DOI 10.1136/jmg.2005.035709; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; GIBBS CS, 1992, J BIOL CHEM, V267, P4806; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Green SP, 2001, J CEREBR BLOOD F MET, V21, P374, DOI 10.1097/00004647-200104000-00006; Houslay MD, 2001, PROG NUCLEIC ACID RE, V69, P249, DOI 10.1016/S0079-6603(01)69049-4; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Josselyn Sheena A., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P481, DOI 10.2174/156800705774322058; KIKKAWA U, 1989, ANNU REV BIOCHEM, V58, P31, DOI 10.1146/annurev.bi.58.070189.000335; Lopez-Nicolas R, 2006, J MOL BIOL, V357, P1105, DOI 10.1016/j.jmb.2006.01.018; Manganiello VC, 1999, THROMB HAEMOSTASIS, V82, P407, DOI 10.1055/s-0037-1615860; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; Maurice DH, 2003, MOL PHARMACOL, V64, P533, DOI 10.1124/mol.64.3.533; Mehats C, 2003, FASEB J, V17, P1831, DOI 10.1096/fj.03-0274com; Nguyen PV, 2003, PROG NEUROBIOL, V71, P401, DOI 10.1016/j.pneurobio.2003.12.003; Ou XM, 2000, J BIOL CHEM, V275, P8161, DOI 10.1074/jbc.275.11.8161; Ou XM, 2003, J NEUROSCI, V23, P7415; Raymond FL, 2006, HUM MOL GENET, V15, pR110, DOI 10.1093/hmg/ddl189; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Rogaeva A, 2007, J NEUROSCI RES, V85, P2833, DOI 10.1002/jnr.21277; Ropers HH, 2006, CURR OPIN GENET DEV, V16, P260, DOI 10.1016/j.gde.2006.04.017; Skalhegg BS, 2002, MOL ENDOCRINOL, V16, P630, DOI 10.1210/me.16.3.630; Spina D, 2003, DRUGS, V63, P2575, DOI 10.2165/00003495-200363230-00002; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; TASKEN K, 1993, J BIOL CHEM, V268, P21276; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; Wilkinson BL, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-30; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Zhang HT, 2002, NEUROPSYCHOPHARMACOL, V27, P587	40	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14644	14658		10.1074/jbc.M111.261875	http://dx.doi.org/10.1074/jbc.M111.261875			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22375002	Green Published, hybrid			2022-12-27	WOS:000304003200031
J	Cihil, KM; Ellinger, P; Fellows, A; Stolz, DB; Madden, DR; Swiatecka-Urban, A				Cihil, Kristine M.; Ellinger, Philipp; Fellows, Abigail; Stolz, Donna Beer; Madden, Dean R.; Swiatecka-Urban, Agnieszka			Disabled-2 Protein Facilitates Assembly Polypeptide-2-independent Recruitment of Cystic Fibrosis Transmembrane Conductance Regulator to Endocytic Vesicles in Polarized Human Airway Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN ADAPTERS; HALF-LIFE; CFTR; TRAFFICKING; GENE; AP-2; DELTA-F508-CFTR; IDENTIFICATION; DEGRADATION; ENDOSOMES	Cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-activated Cl- channel expressed in the apical plasma membrane of fluid-transporting epithelia, where the plasma membrane abundance of CFTR is in part controlled by clathrin-mediated endocytosis. The protein networks that control CFTR endocytosis in epithelial cells have only been partially explored. The assembly polypeptide-2 complex (AP-2) is the prototypical endocytic adaptor critical for optimal clathrin coat formation. AP-2 is essential for recruitment of cargo proteins bearing the YXX Phi motif. Although AP-2 interacts directly with CFTR in vitro and facilitates CFTR endocytosis in some cell types, it remains unknown whether it is critical for CFTR uptake into clathrin-coated vesicles (CCVs). Disabled-2 (Dab2) is a clathrin-associated sorting protein (CLASP) that contributes to clathrin recruitment, vesicle formation, and cargo selection. In intestinal epithelial cells Dab2 was not found to play a direct role in CFTR endocytosis. By contrast, AP-2 and Dab2 were shown to facilitate CFTR endocytosis in human airway epithelial cells, although the specific mechanism remains unknown. Our data demonstrate that Dab2 mediates AP-2 independent recruitment of CFTR to CCVs in polarized human airway epithelial cells. As a result, it facilitates CFTR endocytosis and reduces CFTR abundance and stability in the plasma membrane. These effects are mediated by the DAB homology domain. Moreover, we show that in human airway epithelial cells AP-2 is not essential for CFTR recruitment to CCVs.	[Cihil, Kristine M.; Swiatecka-Urban, Agnieszka] Childrens Hosp Pittsburgh, Dept Nephrol, Pittsburgh, PA 15224 USA; [Ellinger, Philipp; Fellows, Abigail; Madden, Dean R.] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; [Stolz, Donna Beer; Swiatecka-Urban, Agnieszka] Univ Pittsburgh, Dept Cell Biol & Physiol, Sch Med, Pittsburgh, PA 15201 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Dartmouth College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Swiatecka-Urban, A (corresponding author), Childrens Hosp Pittsburgh, Dept Nephrol, Pittsburgh, PA 15224 USA.	asurban@pitt.edu	SWIATECKA-URBAN, AGNIESZKA/H-6494-2015; Swiatecka-Urban, Agnieszka/AAP-6041-2020	SWIATECKA-URBAN, AGNIESZKA/0000-0002-6575-0334; 	National Institutes of Health [R01HL090767, R01HL090767-02S1, R01DK075309]; Pennsylvania Department of Health; Hitchcock Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; Hitchcock Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health Grants R01HL090767 and R01HL090767-02S1 (to A. S.-U.) and Grant R01DK075309 (to D. R. M.). This work was also supported by the Pennsylvania Department of Health, Health Research Formula Fund to the Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center Health System (to A. S.-U.) and a Hitchcock Foundation Program Project Grant (to D. R. M.).	Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Chang CW, 1997, J NEUROCHEM, V69, P859; Collaco A, 2010, J BIOL CHEM, V285, P17177, DOI 10.1074/jbc.M110.127613; Cushing PR, 2010, ANGEW CHEM INT EDIT, V49, P9907, DOI 10.1002/anie.201005585; Fu LW, 2012, BIOCHEM J, V441, P633, DOI 10.1042/BJ20111566; Girard Martine, 2005, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0313s26; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hentchel-Franks K, 2004, AM J RESP CELL MOL, V31, P140, DOI 10.1165/rcmb.2004-0012OC; Howard M, 2000, AM J PHYSIOL-CELL PH, V279, pC375, DOI 10.1152/ajpcell.2000.279.2.C375; Hu W, 2001, BIOCHEM J, V354, P561, DOI 10.1042/0264-6021:3540561; Kues WA, 2000, BIOL REPROD, V62, P412, DOI 10.1095/biolreprod62.2.412; Lukacs GL, 1997, BIOCHEM J, V328, P353; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Okiyoneda T, 2007, BBA-MOL CELL RES, V1773, P476, DOI 10.1016/j.bbamcr.2007.01.004; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; Prince LS, 1999, J BIOL CHEM, V274, P3602, DOI 10.1074/jbc.274.6.3602; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Swiatecka-Urban A, 2006, AM J PHYSIOL-CELL PH, V290, pC862, DOI 10.1152/ajpcell.00108.2005; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Swiatecka-Urban A, 2004, J BIOL CHEM, V279, P38025, DOI 10.1074/jbc.M403141200; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Swiatecka-Urban A, 2007, J BIOL CHEM, V282, P23725, DOI 10.1074/jbc.M608531200; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; WATTS C, 1988, EMBO J, V7, P1937, DOI 10.1002/j.1460-2075.1988.tb03031.x; Weixel KM, 2001, J BIOL CHEM, V276, P46251, DOI 10.1074/jbc.M104545200; Weixel KM, 2000, J BIOL CHEM, V275, P3655, DOI 10.1074/jbc.275.5.3655; XU XX, 1995, J BIOL CHEM, V270, P14184, DOI 10.1074/jbc.270.23.14184; Ye SY, 2010, J BIOL CHEM, V285, P27008, DOI 10.1074/jbc.M110.139881; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200	37	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15087	15099		10.1074/jbc.M112.341875	http://dx.doi.org/10.1074/jbc.M112.341875			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22399289	Green Published, hybrid			2022-12-27	WOS:000304003200070
J	Kang, J; Park, KH; Kim, JJ; Jo, EK; Han, MK; Kim, UH				Kang, John; Park, Kwang-Hyun; Kim, Jwa-Jin; Jo, Eun-Kyeong; Han, Myung-Kwan; Kim, Uh-Hyun			The Role of CD38 in Fc gamma Receptor (Fc gamma R)-mediated Phagocytosis in Murine Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; ADENINE-DINUCLEOTIDE PHOSPHATE; INTRACELLULAR FREE CALCIUM; CYTOSOLIC-FREE CALCIUM; MEDIATED PHAGOCYTOSIS; MOBILIZES CA2+; POLYMORPHONUCLEAR LEUKOCYTES; MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR CHARACTERIZATION; ALVEOLAR MACROPHAGES	Phagocytosis is a crucial event in the immune system that allows cells to engulf and eliminate pathogens. This is mediated through the action of immunoglobulin (IgG)-opsonized microbes acting on Fc gamma receptors (Fc(2+)R) on macrophages, which results in sustained levels of intracellular Ca2+ through the mobilization of Ca2+ second messengers. It is known that the ADP-ribosyl cyclase is responsible for the rise in Ca2+ levels after Fc gamma R activation. However, it is unclear whether and how CD38 is involved in Fc gamma R-mediated phagocytosis. Here we show that CD38 is recruited to the forming phagosomes during phagocytosis of IgG-opsonized particles and produces cyclic-ADP-ribose, which acts on ER Ca2+ stores, thus allowing an increase in Fc(2+)R activation-mediated phagocytosis. Ca2+ data show that pretreatment of J774A.1 macrophages with 8-bromo-cADPR, ryanodine, blebbistatin, and various store-operated Ca2+ inhibitors prevented the long-lasting Ca2+ signal, which significantly reduced the number of ingested opsonized particles. Ex vivo data with macrophages extracted from CD38(-/-) mice also shows a reduced Ca2+ signaling and phagocytic index. Furthermore, a significantly reduced phagocytic index of Mycobacterium bovis BCG was shown in macrophages from CD38(-/-) mice in vivo. This study suggests a crucial role of CD38 in Fc gamma R-mediated phagocytosis through its recruitment to the phagosome and mobilization of cADPR-induced intracellular Ca2+ and store-operated extracellular Ca2+ influx.	[Kang, John; Park, Kwang-Hyun; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561180, South Korea; [Han, Myung-Kwan] Chonbuk Natl Univ, Sch Med, Dept Microbiol, Jeonju 561180, South Korea; [Park, Kwang-Hyun; Han, Myung-Kwan; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Inst Med Sci, Jeonju 561180, South Korea; [Kim, Jwa-Jin; Jo, Eun-Kyeong] Chungnam Natl Univ, Sch Med, Dept Microbiol, Taejon 301747, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Chungnam National University	Kim, UH (corresponding author), Chonbuk Natl Univ, Dept Biochem, Sch Med, Jeonju 561182, South Korea.	uhkim@chonbuk.ac.kr		Eun-Kyeong, Jo/0000-0001-7191-0587; Han, Myung-Kwan/0000-0003-1931-8898; Kim, Uh-Hyun/0000-0003-3304-7190	Korea Science and Engineering Foundation (National Research Laboratory) [R0A-2007-000-20121-0]	Korea Science and Engineering Foundation (National Research Laboratory)(Korea Science and Engineering Foundation)	This work was supported by Korea Science and Engineering Foundation (National Research Laboratory Grant R0A-2007-000-20121-0) (to U.-H. K.).	ALBERT RK, 1992, AM J RESP CELL MOL, V7, P182, DOI 10.1165/ajrcmb/7.2.182; Arora PD, 2005, MOL BIOL CELL, V16, P5175, DOI 10.1091/mbc.E05-07-0648; BENGTSSON T, 1993, EUR J CELL BIOL, V62, P49; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BIRMELIN M, 1983, EUR J BIOCHEM, V131, P539, DOI 10.1111/j.1432-1033.1983.tb07295.x; BLITZER RD, 1991, BRAIN RES, V542, P293, DOI 10.1016/0006-8993(91)91581-K; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Braun A, 2009, BLOOD, V113, P1097, DOI 10.1182/blood-2008-05-158477; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Churamani D, 2004, BIOCHEM J, V380, P449, DOI 10.1042/BJ20031754; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Cooney DS, 2001, J IMMUNOL, V167, P844, DOI 10.4049/jimmunol.167.2.844; Cuttell L, 2008, CELL, V135, P524, DOI 10.1016/j.cell.2008.08.033; De Flora A, 2000, CHEM IMMUNOL, V75, P79; DESJARDINS M, 1994, J BIOL CHEM, V269, P32194; DIETER P, 1993, BIOL CHEM H-S, V374, P171, DOI 10.1515/bchm3.1993.374.1-6.171; DOWNING JF, 1995, P NATL ACAD SCI USA, V92, P4848, DOI 10.1073/pnas.92.11.4848; DUNNE DW, 1994, P NATL ACAD SCI USA, V91, P1863, DOI 10.1073/pnas.91.5.1863; ELFERINK JGR, 1982, ARZNEIMITTELFORSCH, V32-2, P1417; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; Funaro A, 1998, J IMMUNOL, V160, P2238; Galione A, 2006, BIOCHEM SOC T, V34, P922, DOI 10.1042/BST0340922; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Genazzani AA, 1996, BIOCHEM J, V315, P721, DOI 10.1042/bj3150721; GOLDSTEIN IM, 1974, BIOCHEM BIOPH RES CO, V60, P807, DOI 10.1016/0006-291X(74)90312-X; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Graeff RM, 2003, COMB CHEM HIGH T SCR, V6, P367; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; HIRSCH CS, 1994, J IMMUNOL, V152, P743; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; ICHINOSE M, 1995, J NEUROIMMUNOL, V60, P37, DOI 10.1016/0165-5728(95)00050-C; ICHINOSE M, 1995, SCAND J IMMUNOL, V42, P311, DOI 10.1111/j.1365-3083.1995.tb03661.x; JACONI MEE, 1990, J CELL BIOL, V110, P1555, DOI 10.1083/jcb.110.5.1555; KIENER PA, 1993, J BIOL CHEM, V268, P24442; KIM E, 1992, INFECT IMMUN, V60, P1244, DOI 10.1128/IAI.60.3.1244-1248.1992; KLEIN JB, 1990, INFLAMMATION, V14, P599, DOI 10.1007/BF00914279; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Koval M, 1998, EXP CELL RES, V242, P265, DOI 10.1006/excr.1998.4110; Kusner DJ, 1999, J IMMUNOL, V162, P2266; LEE HC, 1991, CELL REGUL, V2, P203, DOI 10.1091/mbc.2.3.203; LEE HC, 1989, J BIOL CHEM, V264, P1608; LEE HC, 1994, NATURE, V370, P307, DOI 10.1038/370307a0; LEW DP, 1985, NATURE, V315, P509, DOI 10.1038/315509a0; LEW PD, 1986, J CELL BIOL, V102, P2197, DOI 10.1083/jcb.102.6.2197; Lieberman LA, 2009, ANTIMICROB AGENTS CH, V53, P756, DOI 10.1128/AAC.00607-08; Link TM, 2010, NAT IMMUNOL, V11, P232, DOI 10.1038/ni.1842; Liu DQ, 2010, ARTERIOSCL THROM VAS, V30, P575, DOI 10.1161/ATVBAHA.109.198374; LUND F, 1995, IMMUNOL TODAY, V16, P469, DOI 10.1016/0167-5699(95)80029-8; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MARKS PW, 1990, CELL CALCIUM, V11, P18, DOI 10.1016/0143-4160(90)90069-7; Matsumura Kazunori, 2006, J Nanobiotechnology, V4, P7, DOI 10.1186/1477-3155-4-7; MCLEISH KR, 1989, INFLAMMATION, V13, P681, DOI 10.1007/BF00914312; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Milara J, 2009, EUR J PHARMACOL, V609, P132, DOI 10.1016/j.ejphar.2009.03.012; Miyamoto S, 2000, BRIT J PHARMACOL, V130, P650, DOI 10.1038/sj.bjp.0703358; Munoz P, 2008, BLOOD, V111, P3653, DOI 10.1182/blood-2007-07-101600; Niedergang F, 2004, CURR OPIN CELL BIOL, V16, P422, DOI 10.1016/j.ceb.2004.06.006; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Orciani M, 2008, ANTI-CANCER DRUG, V19, P599, DOI 10.1097/CAD.0b013e3282ffd673; Pan Z, 2000, J BIOL CHEM, V275, P19978, DOI 10.1074/jbc.M908329199; Park KH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001595; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Rah SY, 2007, J BIOL CHEM, V282, P5653, DOI 10.1074/jbc.M609478200; Rah SY, 2010, J BIOL CHEM, V285, P21877, DOI 10.1074/jbc.M109.066290; Rakovic S, 1999, J BIOL CHEM, V274, P17820, DOI 10.1074/jbc.274.25.17820; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; ROSALES C, 1991, J IMMUNOL, V146, P3937; SAWYER DW, 1985, SCIENCE, V230, P663, DOI 10.1126/science.4048951; Schaff UY, 2010, BLOOD, V115, P657, DOI 10.1182/blood-2009-05-224659; Serrander L, 2000, J IMMUNOL, V165, P2451, DOI 10.4049/jimmunol.165.5.2451; Shui WQ, 2008, P NATL ACAD SCI USA, V105, P16952, DOI 10.1073/pnas.0809218105; Song EK, 2008, BIOCHEM BIOPH RES CO, V367, P156, DOI 10.1016/j.bbrc.2007.12.131; Song EK, 2011, J BIOL CHEM, V286, P44480, DOI 10.1074/jbc.M111.307645; STENDAHL O, 1994, SCIENCE, V265, P1439, DOI 10.1126/science.8073285; Strzelecka-Kiliszek A, 2002, J IMMUNOL, V169, P6787, DOI 10.4049/jimmunol.169.12.6787; TAYLOR ME, 1993, J BIOL CHEM, V268, P399; Trubiani O, 2004, INT J IMMUNOPATH PH, V17, P293, DOI 10.1177/039463200401700309; TSIEN RY, 1982, NATURE, V295, P68, DOI 10.1038/295068a0; VALERIUS NH, 1981, CELL, V24, P195, DOI 10.1016/0092-8674(81)90515-8; Wadsworth SJ, 1999, INFECT IMMUN, V67, P1770; Wilsson A, 1996, J LEUKOCYTE BIOL, V59, P902, DOI 10.1002/jlb.59.6.902; YIN HL, 1981, J CELL BIOL, V91, P901, DOI 10.1083/jcb.91.3.901; YOUNG JDE, 1984, P NATL ACAD SCI-BIOL, V81, P5430, DOI 10.1073/pnas.81.17.5430; ZABRENETZKY V, 1988, BIOCHEM J, V255, P1037, DOI 10.1042/bj2551037; Zhu MX, 2010, FEBS LETT, V584, P1966, DOI 10.1016/j.febslet.2010.02.028; Zocchi E, 1999, FASEB J, V13, P273, DOI 10.1096/fasebj.13.2.273; Zocchi E, 1996, FEBS LETT, V396, P327, DOI 10.1016/0014-5793(96)01125-8	88	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14502	14514		10.1074/jbc.M111.329003	http://dx.doi.org/10.1074/jbc.M111.329003			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22396532	Green Published, hybrid			2022-12-27	WOS:000304003200017
J	Chang, MY; Chan, CK; Braun, KR; Green, PS; O'Brien, KD; Chait, A; Day, AJ; Wight, TN				Chang, Mary Y.; Chan, Christina K.; Braun, Kathleen R.; Green, Pattie S.; O'Brien, Kevin D.; Chait, Alan; Day, Anthony J.; Wight, Thomas N.			Monocyte-to-Macrophage Differentiation SYNTHESIS AND SECRETION OF A COMPLEX EXTRACELLULAR MATRIX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTER-ALPHA-INHIBITOR; SMOOTH-MUSCLE-CELLS; CHONDROITIN SULFATE PROTEOGLYCANS; ANTIINFLAMMATORY PROTEIN TSG-6; HUMAN-PLATELET PROTEOGLYCAN; AMYLOID PRECURSOR PROTEIN; TANDEM MASS-SPECTROMETRY; LOW-DENSITY LIPOPROTEINS; BLOOD MONONUCLEAR-CELLS; SHAP-HYALURONAN COMPLEX	Although monocyte- and macrophage-derived molecules are known to promote extracellular matrix (ECM) disruption and destabilization, it is less appreciated that they also synthesize molecules contributing to ECM formation, stabilization, and function. We have identified and characterized the synthesis of proteoglycans and related proteins, some not previously known to be associated with macrophages. Proteoglycan extracts of [S-35] sulfate- and S-35-trans amino acid-radiolabeled culture media from THP-1 monocytes induced to differentiate by treatment with phorbol myristate acetate revealed three major proteins of similar to 25, 90, and 100 kDa following chondroitin ABC lyase digestion. The 25-kDa protein was predominant for monocytes, whereas the 90- and 100-kDa proteins were predominant for macrophages. Tandem mass spectrometry identified (i) the 25-kDa core protein as serglycin, (ii) the 90-kDa core protein as inter-alpha-inhibitor heavy chain 2 (I alpha IHC2), and (iii) the 100-kDa core as amyloid precursor-like protein 2 (APLP2). Differentiation was also associated with(i) a > 500-fold increase in mRNA for TNF stimulated gene-6, an essential cofactor for heavy chain-mediated matrix stabilization; (ii) a > 800-fold increase in mRNA for HAS2, which is responsible for hyaluronan synthesis; and (iii) a 3-fold increase in mRNA for versican, which interacts with hyaluronan. Biochemical evidence is also presented for an I alpha IHC2-APLP2 complex, and immunohistochemical staining of human atherosclerotic lesions demonstrates similar staining patterns for APLP2 and I alpha IHC2 with macrophages, whereas serglycin localizes to the underlying glycosaminoglycan-rich region. These findings indicate that macrophages synthesize many of the molecules participating in ECM formation and function, suggesting a novel role for these molecules in the differentiation of macrophages in the development of atherosclerosis.	[Chan, Christina K.; Braun, Kathleen R.; Wight, Thomas N.] Benaroya Res Inst, Hope Heart Matrix Biol Program, Seattle, WA 98101 USA; [Chang, Mary Y.; Chait, Alan] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Green, Pattie S.; O'Brien, Kevin D.] Univ Washington, Sch Med, Seattle, WA 98195 USA; [Day, Anthony J.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	Benaroya Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Manchester	Wight, TN (corresponding author), Benaroya Res Inst, Hope Heart Matrix Biol Program, Seattle, WA 98101 USA.	twight@benaroyaresearch.org	Day, Anthony/O-1658-2015; O'Brien, Kevin/CAH-4638-2022; O'Brien, Kevin Douglas/HDO-1461-2022	Day, Anthony/0000-0002-1415-3134; O'Brien, Kevin/0000-0002-2293-9196; O'Brien, Kevin Douglas/0000-0002-2293-9196	National Institutes of Health [HL018645, HL098067, HL092969]; Arthritis Research UK [18472, 19489]; Versus Arthritis [18472, 19489] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL092969, P01HL098067, P01HL018645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK035816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL018645 and HL098067 (to T. N. W.) and HL092969 (to A. C. and T. N. W.). This work was also supported by Arthritis Research UK Grants 18472 and 19489 (to A. J. D.).	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; ALLIEL PM, 1988, FEBS LETT, V236, P123, DOI 10.1016/0014-5793(88)80298-9; Asplund A, 2011, ATHEROSCLEROSIS, V215, P77, DOI 10.1016/j.atherosclerosis.2010.12.017; Asplund A, 2010, GLYCOBIOLOGY, V20, P33, DOI 10.1093/glycob/cwp139; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; AUWERX JH, 1988, BIOCHEMISTRY-US, V27, P2651, DOI 10.1021/bi00408a003; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Bost F, 1998, EUR J BIOCHEM, V252, P339, DOI 10.1046/j.1432-1327.1998.2520339.x; Chang MY, 2000, J BIOL CHEM, V275, P4766, DOI 10.1074/jbc.275.7.4766; Chang MY, 2006, ARTERIOSCL THROM VAS, V26, P494, DOI 10.1161/01.ATV.0000200135.61362.27; Chang MY, 1998, J BIOL CHEM, V273, P15985, DOI 10.1074/jbc.273.26.15985; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Coulson EJ, 2000, NEUROCHEM INT, V36, P175, DOI 10.1016/S0197-0186(99)00125-4; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; EDELSON PJ, 1976, IN VITRO METHODS CEL, P333; ELLIOTT JF, 1993, MOL IMMUNOL, V30, P749, DOI 10.1016/0161-5890(93)90146-3; ENGHILD JJ, 1993, J BIOL CHEM, V268, P8711; Eriksen GV, 1999, BIOCHEM J, V340, P613, DOI 10.1042/0264-6021:3400613; FLEISCHMAJER R, 1991, J STRUCT BIOL, V106, P82, DOI 10.1016/1047-8477(91)90065-5; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; GOWN AM, 1986, AM J PATHOL, V125, P191; Grujic M, 2005, J BIOL CHEM, V280, P33411, DOI 10.1074/jbc.M501708200; He H, 2009, J BIOL CHEM, V284, P20136, DOI 10.1074/jbc.M109.021881; Heng BC, 2008, J BIOL CHEM, V283, P32294, DOI 10.1074/jbc.M804155200; Kaczmarczyk A, 2002, J BIOL CHEM, V277, P13578, DOI 10.1074/jbc.M200288200; Kohro Takahide, 2004, J Atheroscler Thromb, V11, P88; Kolset SO, 1996, J LEUKOCYTE BIOL, V59, P545, DOI 10.1002/jlb.59.4.545; Kolset SO, 2008, GLYCOCONJUGATE J, V25, P305, DOI 10.1007/s10719-007-9073-9; Kuznetsova SA, 2008, MATRIX BIOL, V27, P201, DOI 10.1016/j.matbio.2007.10.003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Lebaron RG, 1996, PERSPECT DEV NEUROBI, V3, P261; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lemire JM, 2007, J CELL BIOCHEM, V101, P753, DOI 10.1002/jcb.21235; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Li QX, 1999, J LEUKOCYTE BIOL, V66, P567, DOI 10.1002/jlb.66.4.567; Libby P, 1996, CURR OPIN LIPIDOL, V7, P330, DOI 10.1097/00041433-199610000-00012; Mahoney DJ, 2008, J BIOL CHEM, V283, P25952, DOI 10.1074/jbc.M802138200; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Makatsori E, 2003, ANTICANCER RES, V23, P3303; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; McDonald TO, 2007, J HISTOCHEM CYTOCHEM, V55, P1149, DOI 10.1369/jhc.7A7221.2007; Milner CM, 2007, BIOCHEM SOC T, V35, P672, DOI 10.1042/BST0350672; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mindrescu C, 2005, BIOCHEM BIOPH RES CO, V330, P737, DOI 10.1016/j.bbrc.2005.03.040; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Niemann CU, 2004, J LEUKOCYTE BIOL, V76, P406, DOI 10.1189/jlb.1003502; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Olsen NJ, 2004, ARTHRITIS RES THER, V6, P120, DOI 10.1186/ar1190; PANGALOS MN, 1995, J NEUROCHEM, V65, P762; Parkar AA, 1997, FEBS LETT, V410, P413, DOI 10.1016/S0014-5793(97)00621-2; PERIN JP, 1988, BIOCHEM J, V255, P1007, DOI 10.1042/bj2551007; Resing KA, 2005, FEBS LETT, V579, P885, DOI 10.1016/j.febslet.2004.12.001; Riessen R, 1996, CIRCULATION, V93, P1141, DOI 10.1161/01.CIR.93.6.1141; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Russell DL, 2006, SEMIN REPROD MED, V24, P217, DOI 10.1055/s-2006-948551; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sanggaard KW, 2008, J BIOL CHEM, V283, P33919, DOI 10.1074/jbc.M804240200; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; Schonherr E, 1997, ARCH BIOCHEM BIOPHYS, V339, P353, DOI 10.1006/abbi.1996.9854; Shibata N, 2009, J LIPID RES, V50, pS277, DOI 10.1194/jlr.R800063-JLR200; Shou JY, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1883; Stewart CR, 2007, J LIPID RES, V48, P2162, DOI 10.1194/jlr.M700098-JLR200; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; Tan KT, 2011, J EUR ACAD DERMATOL, V25, P317, DOI 10.1111/j.1468-3083.2010.03792.x; TANTRAVAHI RV, 1986, P NATL ACAD SCI USA, V83, P9207, DOI 10.1073/pnas.83.23.9207; THINAKARAN G, 1994, J BIOL CHEM, V269, P22099; Toeda K, 2005, MOL CELL BIOCHEM, V280, P47, DOI 10.1007/s11010-005-8051-4; UHLINHANSEN L, 1989, J BIOL CHEM, V264, P14916; UHLINHANSEN L, 1993, BLOOD, V82, P2880; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Vehmas A, 2004, J NEUROIMMUNOL, V157, P99, DOI 10.1016/j.jneuroim.2004.08.035; Walsh DM, 2007, BIOCHEM SOC T, V35, P416, DOI 10.1042/BST0350416; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Wang AM, 2009, AUTOPHAGY, V5, P864, DOI 10.4161/auto.9041; WASTESON A, 1971, J CHROMATOGR, V59, P87, DOI 10.1016/S0021-9673(01)80009-1; WASTESON A, 1973, BIOCHEM J, V136, P1069, DOI 10.1042/bj1361069; WIGHT TN, 2005, ATHEROTHROMBOSIS COR, P421; Willeaume V, 1996, J INFLAMM, V46, P1; Winberg JO, 2003, EUR J BIOCHEM, V270, P3996, DOI 10.1046/j.1432-1033.2003.03788.x; Winberg JO, 2000, J MOL BIOL, V304, P669, DOI 10.1006/jmbi.2000.4235; Wingrove JA, 2008, CIRC-CARDIOVASC GENE, V1, P31, DOI 10.1161/CIRCGENETICS.108.782730; Wisniewski Hans-Georg, 1997, Cytokine and Growth Factor Reviews, V8, P143, DOI 10.1016/S1359-6101(97)00008-7; Wisniewski HG, 1996, J IMMUNOL, V156, P1609; Woulfe DS, 2008, BLOOD, V111, P3458, DOI 10.1182/blood-2007-07-104703; Yan W, 2004, MOL CELL PROTEOMICS, V3, P1039, DOI 10.1074/mcp.D400001-MCP200; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; Yoshida M, 2004, ARTHRITIS RES THER, V6, pR514, DOI 10.1186/ar1223; Yoshihara Y, 2008, OSTEOARTHR CARTILAGE, V16, P1343, DOI 10.1016/j.joca.2008.04.004; Zernichow L, 2006, J BIOL CHEM, V281, P26792, DOI 10.1074/jbc.M512889200; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	101	72	74	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14122	14135		10.1074/jbc.M111.324988	http://dx.doi.org/10.1074/jbc.M111.324988			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22351750	Green Published, hybrid			2022-12-27	WOS:000303996300065
J	Chen, ZY; Hu, YT; Yang, WS; He, YW; Feng, J; Wang, B; Zhao, RM; Ding, JP; Cao, ZJ; Li, WX; Wu, YL				Chen, Zong-Yun; Hu, You-Tian; Yang, Wei-Shan; He, Ya-Wen; Feng, Jing; Wang, Bin; Zhao, Rui-Ming; Ding, Jiu-Ping; Cao, Zhi-Jian; Li, Wen-Xin; Wu, Ying-Liang			Hg1, Novel Peptide Inhibitor Specific for Kv1.3 Channels from First Scorpion Kunitz-type Potassium Channel Toxin Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMORY T-CELLS; THERAPEUTIC TARGET; PROTEASE INHIBITOR; DELTA-DENDROTOXIN; STRUCTURAL BASIS; FUNCTIONAL DYAD; HIGH-AFFINITY; K+ CHANNELS; NEUROTOXIN; CONKUNITZIN-S1	The potassium channel Kv1.3 is an attractive pharmacological target for autoimmune diseases. Specific peptide inhibitors are key prospects for diagnosing and treating these diseases. Here, we identified the first scorpion Kunitz-type potassium channel toxin family with three groups and seven members. In addition to their function as trypsin inhibitors with dissociation constants of 140 nM for recombinant LmKTT-1a, 160 nM for LmKTT-1b, 124 nM for LmKTT-1c, 136 nM for BmKTT-1, 420 nM for BmKTT-2, 760 nM for BmKTT-3, and 107 nM for Hg1, all seven recombinant scorpion Kunitz-type toxins could block the Kv1.3 channel. Electrophysiological experiments showed that six of seven scorpion toxins inhibited similar to 50-80% of Kv1.3 channel currents at a concentration of 1 mu M. The exception was rBm-KTT-3, which had weak activity. The IC50 values of rBmKTT-1, rBmKTT-2, and rHg1 for Kv1.3 channels were similar to 129.7, 371.3, and 6.2 nM, respectively. Further pharmacological experiments indicated that rHg1 was a highly selective Kv1.3 channel inhibitor with weak affinity for other potassium channels. Different from classical Kunitz-type potassium channel toxins with N-terminal regions as the channel-interacting interfaces, the channel-interacting interface of Hg1 was in the C-terminal region. In conclusion, these findings describe the first scorpion Kunitz-type potassium channel toxin family, of which a novel inhibitor, Hg1, is specific for Kv1.3 channels. Their structural and functional diversity strongly suggest that Kunitz-type toxins are a new source to screen and design potential peptides for diagnosing and treating Kv1.3-mediated autoimmune diseases.	[Chen, Zong-Yun; Hu, You-Tian; Yang, Wei-Shan; He, Ya-Wen; Feng, Jing; Wang, Bin; Zhao, Rui-Ming; Cao, Zhi-Jian; Li, Wen-Xin; Wu, Ying-Liang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Ding, Jiu-Ping] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Peoples R China	Wuhan University; Huazhong University of Science & Technology	Li, WX (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	liwxlab@whu.edu.cn; ylwu@whu.edu.cn	Zhao, Ruiming/C-1817-2017; Hu, Youtian/G-5408-2014; Feng, Jing/C-1729-2018	Feng, Jing/0000-0001-6726-7912	National Basic Research Program of China [2010CB529800]; National Natural Sciences Foundation of China [30530140, 31071942, 30973636]; Hubei Province Natural Sciences Foundation of China [2009CDA076]	National Basic Research Program of China(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Province Natural Sciences Foundation of China	This work was supported by grants from the National Basic Research Program of China (2010CB529800), the National Natural Sciences Foundation of China (30530140, 31071942, and 30973636), and the Hubei Province Natural Sciences Foundation of China (2009CDA076).	Andreev YA, 2008, J BIOL CHEM, V283, P23914, DOI 10.1074/jbc.M800776200; Bayrhuber M, 2005, J BIOL CHEM, V280, P23766, DOI 10.1074/jbc.C500064200; Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Beeton Christine, 2011, Inflammation & Allergy Drug Targets, V10, P313; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; de la Vega RCR, 2003, TRENDS PHARMACOL SCI, V24, P222, DOI 10.1016/S0165-6147(02)00080-4; Dy CY, 2006, ACTA CRYSTALLOGR D, V62, P980, DOI [10.1107/S0907444906021123, 10.1107/S0907444906021122]; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Gan GL, 2008, J BIOL CHEM, V283, P24177, DOI 10.1074/jbc.M800179200; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; Han S, 2010, J PROTEOME RES, V9, P3118, DOI 10.1021/pr100027k; Harvey AL, 1997, GEN PHARMACOL-VASC S, V28, P7, DOI 10.1016/S0306-3623(96)00173-5; Imredy JP, 2000, J MOL BIOL, V296, P1283, DOI 10.1006/jmbi.2000.3522; Jin L, 2011, J MOL RECOGNIT, V24, P101, DOI 10.1002/jmr.1031; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; LANCELIN JM, 1994, NAT STRUCT BIOL, V1, P246, DOI 10.1038/nsb0494-246; Lanigan MD, 2001, BIOPOLYMERS, V58, P422, DOI 10.1002/1097-0282(20010405)58:4<422::AID-BIP1018>3.0.CO;2-T; Lebrun B, 1997, BIOCHEM J, V328, P321, DOI 10.1042/bj3280321; Lu J, 2008, PEPTIDES, V29, P369, DOI 10.1016/j.peptides.2007.11.013; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Mouhat S, 2006, MOL PHARMACOL, V69, P354, DOI 10.1124/mol.105.017210; Mouhat S, 2005, J PEPT SCI, V11, P65, DOI 10.1002/psc.630; Mouhat S, 2004, BIOCHEM J, V377, P25, DOI 10.1042/BJ20030115; Peigneur S, 2011, BIOCHEM PHARMACOL, V82, P81, DOI 10.1016/j.bcp.2011.03.023; de la Vega RCR, 2010, TOXICON, V56, P1155, DOI 10.1016/j.toxicon.2009.11.010; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; Schwartz EF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-119; SCHWEITZ H, 1994, P NATL ACAD SCI USA, V91, P878, DOI 10.1073/pnas.91.3.878; SCHWEITZ H, 1995, J BIOL CHEM, V270, P25121, DOI 10.1074/jbc.270.42.25121; SMITH LA, 1993, BIOCHEMISTRY-US, V32, P5692, DOI 10.1021/bi00072a026; Takacs Z, 2009, P NATL ACAD SCI USA, V106, P22211, DOI 10.1073/pnas.0910123106; Toldi G, 2010, IMMUNOL LETT, V133, P35, DOI 10.1016/j.imlet.2010.06.009; Wulff H, 2003, CURR OPIN DRUG DI DE, V6, P640; Yi H, 2007, J PROTEOME RES, V6, P611, DOI 10.1021/pr060368g; You DW, 2009, J BIOL CHEM, V284, P22079, DOI 10.1074/jbc.M109.013276; Yuan CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003414; Zhao RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027548; Zhu SY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002832	41	100	109	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13813	13821		10.1074/jbc.M112.343996	http://dx.doi.org/10.1074/jbc.M112.343996			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22354971	Green Published, hybrid			2022-12-27	WOS:000303996300036
J	Fabrichny, IP; Mondielli, G; Conrod, S; Martin-Eauclaire, MF; Bourne, Y; Marchot, P				Fabrichny, Igor P.; Mondielli, Gregoire; Conrod, Sandrine; Martin-Eauclaire, Marie-France; Bourne, Yves; Marchot, Pascale			Structural Insights into Antibody Sequestering and Neutralizing of Na+ Channel alpha-Type Modulator from Old World Scorpion Venom	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANDROCTONUS-AUSTRALIS-HECTOR; PROTEIN RECOGNITION SITES; TOXIN-II; MONOCLONAL-ANTIBODIES; SODIUM-CHANNELS; FUNCTIONAL-EVALUATION; STRUCTURE REFINEMENT; SECONDARY-STRUCTURE; CRYSTAL-STRUCTURES; AMM-VIII	The Old World scorpion Androctonus australis hector (Aah) produces one of the most lethal venoms for humans. Peptidic alpha-toxins AahI to AahIV are responsible for its potency, with AahII accounting for half of it. All four toxins are high affinity blockers of the fast inactivation phase of mammalian voltage-activated Na+ channels. However, the high antigenic polymorphism of alpha-toxins prevents production of a polyvalent neutralizing antiserum, whereas the determinants dictating their trapping by neutralizing antibodies remain elusive. From an anti-AahII mAb, we generated an antigen binding fragment (Fab) with high affinity and selectivity for AahII and solved a 2.3 angstrom-resolution crystal structure of the complex. Sequestering of the C-terminal region of the bound toxin within a groove formed by the Fab combining loops is associated with a toxin orientation and main and side chain conformations that dictate the AahII antigenic specificity and efficient neutralization. From an anti-AahI mAb, we also preformed and crystallized a high affinity AahI-Fab complex. The 1.6 angstrom-resolution structure solved revealed a Fab molecule devoid of a bound AahI and with combining loops involved in packing interactions, denoting expulsion of the bound antigen upon crystal formation. Comparative analysis of the groove-like combining site of the toxin-bound anti-AahII Fab and planar combining surface of the unbound anti-AahI Fab along with complementary data from a flexible docking approach suggests occurrence of distinctive trapping orientations for the two toxins relative to their respective Fab. This study provides complementary templates for designing new molecules aimed at capturing Aah alpha-toxins and suitable for immunotherapy.	[Bourne, Yves; Marchot, Pascale] Aix Marseille Univ, CNRS, UMR 7257, F-13288 Marseille 09, France; [Fabrichny, Igor P.; Mondielli, Gregoire; Conrod, Sandrine; Martin-Eauclaire, Marie-France; Marchot, Pascale] Aix Marseille Univ, CNRS, UMR 6231,CRN2M,CS80011, Inst Federatif Rech Jean Roche,Fac Med Secteur No, F-13344 Marseille 15, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Bourne, Y (corresponding author), Aix Marseille Univ, CNRS, UMR 7257, Campus Luminy Case 932, F-13288 Marseille 09, France.	fabri@ibcgenerium.ru; yves.bourne@afmb.univ-mrs.fr; pascale.marchot@univ-amu.fr	MARCHOT, Pascale/AAC-4752-2022; Bourne, Yves/AAC-4635-2022	MARCHOT, Pascale/0000-0003-0630-0541; Bourne, Yves/0000-0003-3850-0548; Mondielli, Gregoire/0000-0001-9608-7961	CNRS; Fondation pour la Recherche Medicale; Association Francaise contre les Myopathies; FRM	CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); FRM(Fondation pour la Recherche Medicale)	Recipients of postdoctoral grants from the CNRS and the Fondation pour la Recherche Medicale and Ph.D. grants from the Association Francaise contre les Myopathies and the FRM, respectively.	Alami M, 2003, BIOCHEM J, V375, P551, DOI 10.1042/BJ20030688; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Alvarenga L, 2010, VACCINE, V28, P970, DOI 10.1016/j.vaccine.2009.10.135; Aubrey N, 2004, TOXICON, V43, P233, DOI 10.1016/j.toxicon.2003.11.024; Aubrey N, 2003, CELL MOL LIFE SCI, V60, P617, DOI 10.1007/s000180300053; BAHRAOUI E, 1986, MOL IMMUNOL, V23, P357, DOI 10.1016/0161-5890(86)90133-1; BAHRAOUI E, 1988, J IMMUNOL, V141, P214; BAHRAOUI EM, 1986, J IMMUNOL, V136, P3371; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ben Abderrazek R, 2011, PROTEIN ENG DES SEL, V24, P727, DOI 10.1093/protein/gzr037; Ben Abderrazek R, 2009, BIOCHEM J, V424, P263, DOI 10.1042/BJ20090697; Canul-Tec JC, 2011, J BIOL CHEM, V286, P20892, DOI 10.1074/jbc.M111.238410; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Chakrabarti P, 2007, PROG BIOPHYS MOL BIO, V95, P83, DOI 10.1016/j.pbiomolbio.2007.03.016; Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021; Clot-Faybesse O, 1999, FEBS LETT, V458, P313, DOI 10.1016/S0014-5793(99)01179-5; CORNET B, 1995, STRUCTURE, V3, P435, DOI 10.1016/S0969-2126(01)00177-0; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; de la Vega RCR, 2007, TOXICON, V49, P171, DOI 10.1016/j.toxicon.2006.09.016; DeLano W.L, PYMOL MOL GRAPHICS S; DELORI P, 1981, TOXICON, V19, P393, DOI 10.1016/0041-0101(81)90044-1; DEVAUX C, 1993, MOL IMMUNOL, V30, P1061, DOI 10.1016/0161-5890(93)90152-2; Devaux C, 1997, FEBS LETT, V412, P456, DOI 10.1016/S0014-5793(97)00826-0; Devaux C, 2002, J IMMUNOL METHODS, V271, P37, DOI 10.1016/S0022-1759(02)00338-1; Devaux C, 2001, EUR J BIOCHEM, V268, P694, DOI 10.1046/j.1432-1327.2001.01923.x; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Duarte CG, 2010, VACCINE, V28, P1168, DOI 10.1016/j.vaccine.2009.11.039; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; ELAYEB M, 1983, MOL IMMUNOL, V20, P697, DOI 10.1016/0161-5890(83)90047-0; ELAYEB M, 1984, MOL IMMUNOL, V21, P223, DOI 10.1016/0161-5890(84)90077-4; ELAYEB M, 1986, BIOCHEMISTRY-US, V25, P6671, DOI 10.1021/bi00369a052; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espino-Solis GP, 2009, J PROTEOMICS, V72, P183, DOI 10.1016/j.jprot.2009.01.020; Gazarian KG, 2005, VACCINE, V23, P3357, DOI 10.1016/j.vaccine.2004.12.027; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GRANIER C, 1989, MOL IMMUNOL, V26, P503, DOI 10.1016/0161-5890(89)90001-1; Granier C., 2009, ANIMAL TOXINS STAT 2, P123; Guan RJ, 2004, J MOL BIOL, V341, P1189, DOI 10.1016/j.jmb.2004.06.067; Gur M, 2011, J BIOL CHEM, V286, P35209, DOI 10.1074/jbc.M111.259507; He XL, 1999, J MOL BIOL, V292, P125, DOI 10.1006/jmbi.1999.3036; Hmila I, 2008, MOL IMMUNOL, V45, P3847, DOI 10.1016/j.molimm.2008.04.011; Hmila I, 2010, FASEB J, V24, P3479, DOI 10.1096/fj.09-148213; HOUSSET D, 1994, J MOL BIOL, V238, P88, DOI 10.1006/jmbi.1994.1270; JANIN J, 1990, J BIOL CHEM, V265, P16027; JOVER E, 1978, BIOCHEM BIOPH RES CO, V85, P377, DOI 10.1016/S0006-291X(78)80053-9; Juste M, 2007, CELL MOL LIFE SCI, V64, P206, DOI 10.1007/s00018-006-6401-3; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KHARRAT R, 1990, TOXICON, V28, P509, DOI 10.1016/0041-0101(90)90295-I; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Legros C, 2005, BBA-GEN SUBJECTS, V1723, P91, DOI 10.1016/j.bbagen.2005.01.008; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Marchot P, 1996, PROTEIN SCI, V5, P672; MARTIN MF, 1987, J BIOL CHEM, V262, P4452; MARTIN MF, 1986, TOXICON, V24, P1131, DOI 10.1016/0041-0101(86)90139-X; Martin-Eauclaire M. F., 1995, Handbook of neurotoxicology., P683; Martin-Eauclaire MF, 2006, VACCINE, V24, P1990, DOI 10.1016/j.vaccine.2005.11.016; Meddeb-Mouelhi F, 2003, TOXICON, V42, P785, DOI 10.1016/j.toxicon.2003.10.021; MIKOU A, 1992, J BIOMOL NMR, V2, P57, DOI 10.1007/BF02192800; Moreau V, 2006, BIOINFORMATICS, V22, P1088, DOI 10.1093/bioinformatics/btl012; Mousli M, 1999, FEBS LETT, V442, P183, DOI 10.1016/S0014-5793(98)01647-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Quintero-Hernandez V, 2007, MOL IMMUNOL, V44, P1307, DOI 10.1016/j.molimm.2006.05.009; Riano-Umbarila L, 2005, FEBS J, V272, P2591, DOI 10.1111/j.1742-4658.2005.04687.x; Riano-Umbarila L, 2011, J BIOL CHEM, V286, P6143, DOI 10.1074/jbc.M110.189175; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sami-Merah S, 2008, INT IMMUNOPHARMACOL, V8, P1386, DOI 10.1016/j.intimp.2008.05.011; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stanfield RL, 2006, J MOL BIOL, V357, P1566, DOI 10.1016/j.jmb.2006.01.023; Sun YM, 2003, J BIOL CHEM, V278, P24125, DOI 10.1074/jbc.M211931200; YAHI N, 1992, TOXICON, V30, P723, DOI 10.1016/0041-0101(92)90006-Q; Ye X, 2005, J MOL BIOL, V353, P788, DOI 10.1016/j.jmb.2005.08.068; YPEREZ GG, 1988, TOXICON, V26, P1102	76	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14136	14148		10.1074/jbc.M111.315382	http://dx.doi.org/10.1074/jbc.M111.315382			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22371498	Green Published, hybrid			2022-12-27	WOS:000303996300066
J	McMillan, DGG; Marritt, SJ; Butt, JN; Jeuken, LJC				McMillan, Duncan G. G.; Marritt, Sophie J.; Butt, Julea N.; Jeuken, Lars J. C.			Menaquinone-7 Is Specific Cofactor in Tetraheme Quinol Dehydrogenase CymA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHEWANELLA-ONEIDENSIS MR-1; C-TYPE CYTOCHROMES; UBIQUINONE BINDING-CAPACITY; ESCHERICHIA-COLI; ANAEROBIC RESPIRATION; ELECTRON-TRANSFER; OUTER-MEMBRANE; IRON REDUCTION; Q(O) SITE; REDUCING BACTERIUM	Little is known about enzymatic quinone-quinol interconversions in the lipid membrane when compared with our knowledge of substrate transformations by globular enzymes. Here, the smallest example of a quinol dehydrogenase in nature, CymA, has been studied. CymA is a monotopic membrane tetraheme c-type cytochrome belonging to the NapC/NirT family and central to anaerobic respiration in Shewanella sp. Using protein-film electrochemistry, it is shown that vesicle-bound menaquinone-7 is not only a substrate for this enzyme but is also required as a cofactor when converting other quinones. Here, we propose that the high concentration of quinones in the membrane negates the evolutionary pressure to create a high affinity active site. However, the instability and reactivity of reaction intermediate, semiquinone, might require a cofactor that functions to minimize damaging side reactions.	[McMillan, Duncan G. G.; Jeuken, Lars J. C.] Univ Leeds, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England; [McMillan, Duncan G. G.; Jeuken, Lars J. C.] Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England; [McMillan, Duncan G. G.; Jeuken, Lars J. C.] Univ Leeds, Ctr Mol Nanosci, Leeds LS2 9JT, W Yorkshire, England; [Marritt, Sophie J.; Butt, Julea N.] Univ E Anglia, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England; [Marritt, Sophie J.; Butt, Julea N.] Univ E Anglia, Sch Chem, Norwich NR4 7TJ, Norfolk, England; [Butt, Julea N.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of Leeds; University of Leeds; University of Leeds; University of East Anglia; University of East Anglia; University of East Anglia	Jeuken, LJC (corresponding author), Univ Leeds, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England.	L.J.C.Jeuken@leeds.ac.uk	Jeuken, Lars J C/A-6234-2008; McMillan, Duncan/AAT-7415-2021; Butt, Julea/E-2133-2011	Jeuken, Lars J C/0000-0001-7810-3964; McMillan, Duncan/0000-0001-6614-4494; Butt, Julea/0000-0002-9624-5226	UK Biotechnology and Biological Sciences Research Council; Engineering and Physical Science Research Council [BB/G009228]; Biotechnology and Biological Sciences Research Council [BB/G007519/1, BB/G009228/1] Funding Source: researchfish; BBSRC [BB/G009228/1, BB/G007519/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Science Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funded by the UK Biotechnology and Biological Sciences Research Council and the Engineering and Physical Science Research Council (BB/G009228).	Abramson J, 2000, NAT STRUCT BIOL, V7, P910; Bartoschek S, 2001, J BIOL CHEM, V276, P35231, DOI 10.1074/jbc.C100365200; Bekker M, 2007, MICROBIOL-SGM, V153, P1974, DOI 10.1099/mic.0.2007/006098-0; Biffinger JC, 2007, BIOSENS BIOELECTRON, V22, P1672, DOI 10.1016/j.bios.2006.07.027; Burns JL, 2009, APPL ENVIRON MICROB, V75, P5209, DOI 10.1128/AEM.00888-09; Carpentier W, 2005, J BACTERIOL, V187, P3293, DOI 10.1128/JB.187.10.3293-3301.2005; CARTER K, 1985, J BIOL CHEM, V260, P986; Chen XX, 2002, LANGMUIR, V18, P7009, DOI 10.1021/la0204794; Clarke TA, 2008, BIOCHEM SOC T, V36, P1005, DOI 10.1042/BST0361005; Coursolle D, 2010, J BACTERIOL, V192, P467, DOI 10.1128/JB.00925-09; Ding H, 1995, BIOCHEMISTRY-US, V34, P15979, DOI 10.1021/bi00049a012; DING HG, 1992, BIOCHEMISTRY-US, V31, P3144, DOI 10.1021/bi00127a015; El Kasmi A, 1998, J AM CHEM SOC, V120, P225, DOI 10.1021/ja973417m; Field SJ, 2000, J BIOL CHEM, V275, P8515, DOI 10.1074/jbc.275.12.8515; Firer-Sherwood M, 2008, J BIOL INORG CHEM, V13, P849, DOI 10.1007/s00775-008-0398-z; Fourmond V, 2009, BIOELECTROCHEMISTRY, V76, P141, DOI 10.1016/j.bioelechem.2009.02.010; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Gao HC, 2009, ISME J, V3, P966, DOI 10.1038/ismej.2009.40; Gescher JS, 2008, MOL MICROBIOL, V68, P706, DOI 10.1111/j.1365-2958.2008.06183.x; Gralnick JA, 2006, P NATL ACAD SCI USA, V103, P4669, DOI 10.1073/pnas.0505959103; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Hellwig P, 2002, BIOCHEMISTRY-US, V41, P10675, DOI 10.1021/bi012146w; Hirst J, 1998, ANAL CHEM, V70, P5062, DOI 10.1021/ac980557l; Hook F, 1998, P NATL ACAD SCI USA, V95, P12271, DOI 10.1073/pnas.95.21.12271; Jensen HM, 2010, P NATL ACAD SCI USA, V107, P19213, DOI 10.1073/pnas.1009645107; Kim HJ, 2002, ENZYME MICROB TECH, V30, P145, DOI 10.1016/S0141-0229(01)00478-1; Leopold MC, 2002, LANGMUIR, V18, P2239, DOI 10.1021/la011456c; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; McLean JS, 2010, ENVIRON SCI TECHNOL, V44, P2721, DOI 10.1021/es903043p; Murphy JN, 2007, J BACTERIOL, V189, P2283, DOI 10.1128/JB.01698-06; MYERS CR, 1992, J BACTERIOL, V174, P3429, DOI 10.1128/JB.174.11.3429-3438.1992; MYERS CR, 1993, FEMS MICROBIOL LETT, V108, P15; MYERS CR, 1994, J APPL BACTERIOL, V76, P253, DOI 10.1111/j.1365-2672.1994.tb01624.x; MYERS CR, 1993, FEMS MICROBIOL LETT, V114, P215, DOI 10.1111/j.1574-6968.1993.tb06576.x; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; Myers JM, 2000, J BACTERIOL, V182, P67, DOI 10.1128/JB.182.1.67-75.2000; NEALSON KH, 1994, ANNU REV MICROBIOL, V48, P311, DOI 10.1146/annurev.mi.48.100194.001523; Newman DK, 2000, NATURE, V405, P94, DOI 10.1038/35011098; Okamura MY, 2000, BBA-BIOENERGETICS, V1458, P148, DOI 10.1016/S0005-2728(00)00065-7; Osyczka A, 2005, TRENDS BIOCHEM SCI, V30, P176, DOI 10.1016/j.tibs.2005.02.001; Osyczka A, 2006, BIOCHEMISTRY-US, V45, P10492, DOI 10.1021/bi060013a; Pitts KE, 2003, J BIOL CHEM, V278, P27758, DOI 10.1074/jbc.M302582200; Qian YF, 2011, BIOCHEMISTRY-US, V50, P6217, DOI 10.1021/bi2005015; Remy A, 2003, NAT STRUCT BIOL, V10, P637, DOI 10.1038/nsb954; Rodrigues ML, 2008, J MOL BIOL, V381, P341, DOI 10.1016/j.jmb.2008.05.066; Rodrigues ML, 2006, EMBO J, V25, P5951, DOI 10.1038/sj.emboj.7601439; Ross DE, 2007, APPL ENVIRON MICROB, V73, P5797, DOI 10.1128/AEM.00146-07; Ross DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016649; Rumbley JN, 1997, BBA-PROTEIN STRUCT M, V1340, P131, DOI 10.1016/S0167-4838(97)00036-8; Saffarini DA, 2002, J BACTERIOL, V184, P846, DOI 10.1128/JB.184.3.846-848.2002; Sato-Watanabe M, 1998, BIOCHEMISTRY-US, V37, P5356, DOI 10.1021/bi9727592; SATOWATANABE M, 1994, J BIOL CHEM, V269, P28908; Schwalb C, 2003, BIOCHEMISTRY-US, V42, P9491, DOI 10.1021/bi034456f; Schwalb C, 2002, BIOCHEM SOC T, V30, P658, DOI 10.1042/bst0300658; Sharp RE, 1999, BIOCHEMISTRY-US, V38, P3440, DOI 10.1021/bi982639+; Sharp RE, 1999, BIOCHEMISTRY-US, V38, P14973, DOI 10.1021/bi9914863; Shi L, 2006, J BACTERIOL, V188, P4705, DOI 10.1128/JB.01966-05; Shi L, 2005, BIOTECHNIQUES, V38, P297, DOI 10.2144/05382PT01; Stamou D, 1997, LANGMUIR, V13, P2425, DOI 10.1021/la962123w; Viamajala S, 2002, BIOTECHNOL PROGR, V18, P290, DOI 10.1021/bp0202968; Weiss SA, 2009, BIOCHEM J, V417, P555, DOI 10.1042/BJ20081345; Yap LL, 2007, J BIOL CHEM, V282, P8777, DOI 10.1074/jbc.M611595200; Yap LL, 2010, BBA-BIOENERGETICS, V1797, P1924, DOI 10.1016/j.bbabio.2010.04.011; Zargar K, 2009, ARCH MICROBIOL, V191, P797, DOI 10.1007/s00203-009-0511-x; Zhou C, 2004, LANGMUIR, V20, P5870, DOI 10.1021/la036251d	65	69	71	4	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14215	14225		10.1074/jbc.M112.348813	http://dx.doi.org/10.1074/jbc.M112.348813			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22393052	Green Published, hybrid			2022-12-27	WOS:000303996300073
J	Pathak, SK; Skold, AE; Mohanram, V; Persson, C; Johansson, U; Spetz, AL				Pathak, Sushil Kumar; Skold, Annette E.; Mohanram, Venkatramanan; Persson, Catrine; Johansson, Ulrika; Spetz, Anna-Lena			Activated Apoptotic Cells Induce Dendritic Cell Maturation via Engagement of Toll-like Receptor 4 (TLR4), Dendritic Cell-specific Intercellular Adhesion Molecule 3 (ICAM-3)grabbing Nonintegrin (DC-SIGN), and beta 2 Integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; IMMUNE-RESPONSES; DYING CELLS; PI3 KINASE; TNF-ALPHA; IN-VITRO; RECOGNITION; HMGB1; TOLERANCE	Dendritic cells (DCs) are professional antigen-presenting cells playing a central role in connecting innate and adaptive immunity. Maturation signals are, however, required for DCs to undergo phenotypic and functional changes to acquire a fully competent antigen-presenting capacity. We previously reported that activated apoptotic peripheral lymphocytes (ActApo) provide activation/maturation signals to human monocyte-derived DCs. In this paper, we have characterized the signaling pathways and molecules involved in ActApo-mediated DC maturation. We found that both cellular and supernatant fractions from ActApo are required for DC maturation signaling. ActApoSup-induced CD80 and CD86 expression was significantly blocked in the presence of neutralizing antibodies against tumor necrosis factor-alpha (TNF-alpha). Cell-cell contact-dependent signaling involved beta 2 integrins, dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN), and TLR4 because ActApo-induced up-regulation of the maturation markers CD80 and CD86 was significantly inhibited in the presence of neutralizing antibodies against CD18, CD11a, CD11b, and DC-SIGN as well as TLR4. The role of TLR4 was further confirmed by silencing of TLR4 in DCs. In addition, the endogenous adjuvant effect exerted by activated apoptotic splenocytes (ActApoSp) was reduced after immunization with human serum albumin in TLR4(-/-) mice. We detected activation of multiple signaling pathways and transcription factors in DCs upon co-culture with ActApo, including p38, JNK, PI3K-Akt, Src family kinases, NF kappa B p65, and AP1 transcription factor family members c-Jun and c-Fos, demonstrating the complex interactions occurring between ActApo and DCs. These studies provide important mechanistic insight into the responses of DCs during encounter with cells undergoing immunogenic cell death.	[Pathak, Sushil Kumar; Skold, Annette E.; Mohanram, Venkatramanan; Persson, Catrine; Johansson, Ulrika; Spetz, Anna-Lena] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Ctr Infect Med,Dept Med, S-14186 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Pathak, SK (corresponding author), Karolinska Univ, Huddinge Hosp, Karolinska Inst, Ctr Infect Med,Dept Med, S-14186 Stockholm, Sweden.	sushil.kumar.pathak@gmt.su.se; anna-lena.spetz@ki.se	Sköld, Annette/P-5718-2015; Mohanram, Venkatramanan/I-3652-2016; Spetz, Anna-Lena/C-3543-2016	Sköld, Annette/0000-0002-5309-8860; Spetz, Anna-Lena/0000-0003-3964-9512	Hedlunds Foundation, ALF-SLL; European Commission [EC-FP6-018953 Auto/AlloCell, EC-FP6-037611 EUROPRISE]; Swedish Foundation for Strategic Research	Hedlunds Foundation, ALF-SLL; European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by Hedlunds Foundation, ALF-SLL; European Commission Grant EC-FP6-018953 Auto/AlloCell and Grant EC-FP6-037611 EUROPRISE; and the Swedish Foundation for Strategic Research.	Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; Bottero V, 2006, CELL DEATH DIFFER, V13, P785, DOI 10.1038/sj.cdd.4401888; Brave A, 2010, VACCINE, V28, P2080, DOI 10.1016/j.vaccine.2009.12.040; Buttiglieri S, 2003, INT J CANCER, V106, P516, DOI 10.1002/ijc.11243; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Dumitriu IE, 2007, J LEUKOCYTE BIOL, V81, P84, DOI 10.1189/jlb.0306171; Fadok VA, 2001, J CLIN INVEST, V108, P957, DOI 10.1172/JCI14122; Feng HP, 2002, BLOOD, V100, P4108, DOI 10.1182/blood-2002-05-1389; Ferguson TA, 2002, J IMMUNOL, V168, P5589, DOI 10.4049/jimmunol.168.11.5589; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Goldszmid RS, 2003, J IMMUNOL, V171, P5940, DOI 10.4049/jimmunol.171.11.5940; Gray M, 2007, P NATL ACAD SCI USA, V104, P14080, DOI 10.1073/pnas.0700326104; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Hedlund S, 2010, HUM IMMUNOL, V71, P535, DOI 10.1016/j.humimm.2010.02.022; Hoffmann TK, 2000, CANCER RES, V60, P3542; Holmgren L, 1999, BLOOD, V93, P3956, DOI 10.1182/blood.V93.11.3956.411k05_3956_3963; Hu Y, 2008, J LEUKOCYTE BIOL, V84, P1353, DOI 10.1189/jlb.0107040; Ignatius R, 2000, J VIROL, V74, P11329, DOI 10.1128/JVI.74.23.11329-11338.2000; Ishii S, 2003, ANTICANCER RES, V23, P2457; Johansson U, 2007, J IMMUNOL, V179, P1711, DOI 10.4049/jimmunol.179.3.1711; Kabelitz D, 1997, FRONT BIOSCI, V2, P61; Kim JH, 2010, IMMUNOL LETT, V134, P47, DOI 10.1016/j.imlet.2010.08.008; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kuka M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011491; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lee JY, 2003, J BIOL CHEM, V278, P37041, DOI 10.1074/jbc.M305213200; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Mascanfroni ID, 2010, J BIOL CHEM, V285, P9569, DOI 10.1074/jbc.M109.071241; Mohanram V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021171; Morelli AE, 2003, BLOOD, V101, P611, DOI 10.1182/blood-2002-06-1769; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; Napolitani G, 2003, EUR J IMMUNOL, V33, P2832, DOI 10.1002/eji.200324073; Neves BM, 2010, AM J PATHOL, V177, P2898, DOI 10.2353/ajpath.2010.100367; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Park D, 2006, NAT BIOTECHNOL, V24, P1581, DOI 10.1038/nbt1262; Philpott NJ, 2004, P NATL ACAD SCI USA, V101, P6200, DOI 10.1073/pnas.0308368101; Rogers TH, 2011, BIOMATERIALS, V32, P1270, DOI 10.1016/j.biomaterials.2010.10.014; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Saalbach A, 2007, J IMMUNOL, V178, P4966, DOI 10.4049/jimmunol.178.8.4966; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scott MJ, 2008, J BIOL CHEM, V283, P29433, DOI 10.1074/jbc.M803905200; Singhal E, 2011, INT J BIOCHEM CELL B, V43, P1134, DOI 10.1016/j.biocel.2011.04.006; Spetz AL, 2002, J IMMUNOL, V169, P5771, DOI 10.4049/jimmunol.169.10.5771; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Stuart LM, 2002, J IMMUNOL, V168, P1627, DOI 10.4049/jimmunol.168.4.1627; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; van Stijn CMW, 2010, MOL IMMUNOL, V47, P1544, DOI 10.1016/j.molimm.2010.01.014; Varga G, 2007, BLOOD, V109, P661, DOI 10.1182/blood-2005-12-023044; Voigylander C, 2006, J IMMUNOTHER, V29, P407, DOI 10.1097/01.cji.0000210081.60178.b4; Xie J, 2005, EXP HEMATOL, V33, P564, DOI 10.1016/j.exphem.2005.03.001	62	29	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13731	13742		10.1074/jbc.M111.336545	http://dx.doi.org/10.1074/jbc.M111.336545			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22396536	Green Published, hybrid			2022-12-27	WOS:000303996300029
J	Qin, JD; Berdyshev, E; Poirer, C; Schwartz, NB; Dawson, G				Qin, Jingdong; Berdyshev, Evgeny; Poirer, Christophe; Schwartz, Nancy B.; Dawson, Glyn			Neutral Sphingomyelinase 2 Deficiency Increases Hyaluronan Synthesis by Up-regulation of Hyaluronan Synthase 2 through Decreased Ceramide Production and Activation of Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOGENESIS-IMPERFECTA; SPHINGOSINE 1-PHOSPHATE; CELLS; ACID; RAFTS; APOPTOSIS; FORM; KINASE; SIGNAL; SPHINGOSINE-1-PHOSPHATE	Fibroblasts from the fro/fro mouse, with a deletion in the Smpd3 gene coding for the active site of neutral sphingomyelinase 2 (NSMase2), secreted increased amounts of hyaluronan (HA). This was reversed by transfection with the Smpd3 gene, suggesting a connection between sphingolipid and glycosaminoglycan metabolism. The deficiency of NSMase2 resulted in storage of sphingomyelin (SM) and cholesterol with a 50% reduction in ceramides (Cer). RT-PCR and Western blot analysis showed that increased HA secretion resulted from increased hyaluronan synthase 2 (HAS2) activity localized to sphingolipid-enriched lipid rafts. Although cholesterol levels were also elevated in lipid rafts from mouse fibroblasts deficient in lysosomal acid SMase activity (deletion of the Smpd1(-/-) gene), there was no increase in HA secretion. We then showed that in fro/fro fibroblasts, the reduced ceramide was associated with decreased phosphorylation of protein phosphatase 2A (PP2A) and increased phosphorylation of its substrate Akt-p, together with PI3K, PDK1, mTOR (mammalian target of rapamycin), and p70S6K, although PTEN was unaffected. Exogenous ceramide, as well as inhibitors of Akt (Akt inhibitor VIII), PI 3-kinase (LY294002 and wortmannin), and mTOR (rapamycin) reduced secretion of HA, whereas the NSMase2 inhibitor GW4869 increased HA synthesis and secretion. We propose that NSMase2/Cer are the key mediators of the regulation of HA synthesis, via microdomains and the Akt/mTOR pathway.	[Dawson, Glyn] Univ Chicago, Pritzker Sch Med, Dept Pediat, Chicago, IL 60637 USA; [Schwartz, Nancy B.; Dawson, Glyn] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Berdyshev, Evgeny] Univ Illinois, Inst Personalized Resp Med, Dept Med, Chicago, IL 60612 USA; [Poirer, Christophe] Georgia Hlth Sci Univ, Vasc Biol Ctr, Augusta, GA 30912 USA	University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University System of Georgia; Augusta University	Dawson, G (corresponding author), Univ Chicago, Pritzker Sch Med, Dept Pediat, MC4068,5841 S Maryland Ave, Chicago, IL 60637 USA.	dawg@midway.uchicago.edu			National Institutes of Health from the United States Public Health Service [NS36866-37]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036866] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS36866-37 from the United States Public Health Service (to G. D.).	Aubin I, 2005, NAT GENET, V37, P803, DOI 10.1038/ng1603; Banno Y, 2001, J BIOL CHEM, V276, P35622, DOI 10.1074/jbc.M105673200; Bastow ER, 2008, CELL MOL LIFE SCI, V65, P395, DOI 10.1007/s00018-007-7360-z; Berdyshev EV, 2006, CELL SIGNAL, V18, P1779, DOI 10.1016/j.cellsig.2006.01.018; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Chen SW, 2006, J NEUROCHEM, V97, P631, DOI 10.1111/j.1471-4159.2006.03774.x; Galvan C, 2008, MOL BIOL CELL, V19, P509, DOI 10.1091/mbc.E07-05-0439; Glorieux FH, 2002, J BONE MINER RES, V17, P30, DOI 10.1359/jbmr.2002.17.1.30; Glorieux FH, 2000, J BONE MINER RES, V15, P1650, DOI 10.1359/jbmr.2000.15.9.1650; Goswami R, 1999, J NEUROSCI RES, V57, P884, DOI 10.1002/(SICI)1097-4547(19990915)57:6<884::AID-JNR14>3.3.CO;2-1; Goswami R, 2005, J NEUROSCI RES, V81, P541, DOI 10.1002/jnr.20550; Goswami R, 2005, J NEUROSCI RES, V81, P208, DOI 10.1002/jnr.20549; Gulbins Erich, 2002, Subcell Biochem, V36, P229; Hall BK, 1995, INT J DEV BIOL, V39, P881; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; Jenkins RW, 2011, J BIOL CHEM, V286, P3777, DOI 10.1074/jbc.M110.155234; Khavandgar Z, 2011, J CELL BIOL, V194, P277, DOI 10.1083/jcb.201102051; Kilkus J, 2003, J NEUROSCI RES, V72, P65, DOI 10.1002/jnr.10549; Kolesnick R, 1999, TRENDS BIOCHEM SCI, V24, P224, DOI 10.1016/S0968-0004(99)01408-5; Kultti A, 2010, J BIOL CHEM, V285, P22899, DOI 10.1074/jbc.M109.088435; Lee JT, 2004, J CELL BIOL, V164, P123, DOI 10.1083/jcb.200307017; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; MATUOKA K, 1985, CELL BIOL INT REP, V9, P577, DOI 10.1016/0309-1651(85)90023-2; MOSCATELLI D, 1975, NATURE, V254, P65, DOI 10.1038/254065a0; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; OTTERBACH B, 1995, CELL, V81, P1053, DOI 10.1016/S0092-8674(05)80010-8; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Qin JD, 2010, J BIOL CHEM, V285, P14134, DOI 10.1074/jbc.M109.076810; Sakr SW, 2008, J BIOL CHEM, V283, P36195, DOI 10.1074/jbc.M807772200; Sawai H, 2005, CURR PHARM DESIGN, V11, P2479, DOI 10.2174/1381612054367463; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Stoffel W, 2005, P NATL ACAD SCI USA, V102, P4554, DOI 10.1073/pnas.0406380102; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Tani M, 2007, J BIOL CHEM, V282, P10047, DOI 10.1074/jbc.M611249200; Testai FD, 2004, J NEUROSCI RES, V75, P66, DOI 10.1002/jnr.10816; Tlapak-Simmons V. L., 2011, J GLYCOM LIPIDOM, pS1; Tlapak-Simmons VL, 1999, J BIOL CHEM, V274, P4239, DOI 10.1074/jbc.274.7.4239; TURAKAINEN H, 1983, BIOCHEM J, V213, P171, DOI 10.1042/bj2130171; TURAKAINEN H, 1980, BIOCHIM BIOPHYS ACTA, V628, P388, DOI 10.1016/0304-4165(80)90388-8; VASKOVSKY VE, 1975, J CHROMATOGR, V114, P129, DOI 10.1016/S0021-9673(00)85249-8; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Vigetti D, 2010, J BIOL CHEM, V285, P24639, DOI 10.1074/jbc.M110.134536; Ward LM, 2002, BONE, V31, P12, DOI 10.1016/S8756-3282(02)00790-1; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X; Wiesner DA, 1997, J BIOL CHEM, V272, P9868; WOLFF RA, 1994, J BIOL CHEM, V269, P19605; YONEDA M, 1988, J CELL SCI, V90, P275; Zhou HL, 1998, J BIOL CHEM, V273, P16568, DOI 10.1074/jbc.273.26.16568	59	37	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13620	13632		10.1074/jbc.M111.304857	http://dx.doi.org/10.1074/jbc.M111.304857			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22383528	Green Published, hybrid			2022-12-27	WOS:000303996300018
J	Wen, HR; Ostman, J; Bubb, KJ; Panayiotou, C; Priestley, JV; Baker, MD; Ahluwalia, A				Wen, Hairuo; Oestman, Johan; Bubb, Kristen J.; Panayiotou, Catherine; Priestley, John V.; Baker, Mark D.; Ahluwalia, Amrita			20-Hydroxyeicosatetraenoic Acid (20-HETE) Is a Novel Activator of Transient Receptor Potential Vanilloid 1 (TRPV1) Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CAPSAICIN RECEPTOR; MYOGENIC CONSTRICTION; HEK-293 CELLS; PKC-EPSILON; PHOSPHORYLATION; HEAT; AUTOREGULATION; SENSITIZATION; ANTAGONIST	TRPV1 is a member of the transient receptor potential ion channel family and is gated by capsaicin, the pungent component of chili pepper. It is expressed predominantly in small diameter peripheral nerve fibers and is activated by noxious temperatures >42 degrees C. 20-Hydroxyeicosatetraenoic acid (20-HETE) is a cytochrome P-450 4A/4F-derived metabolite of the membrane phospholipid arachidonic acid. It is a powerful vasoconstrictor and has structural similarities with other TRPV1 agonists, e. g. the hydroperoxyeicosatetraenoic acid 12-HPETE, and we hypothesized that it may be an endogenous ligand for TRPV1 in sensory neurons innervating the vasculature. Here, we demonstrate that 20-HETE both activates and sensitizes mouse and human TRPV1, in a kinase-dependent manner, involving the residue Ser(502) in heterologously expressed hTRPV1, at physiologically relevant concentrations.	[Wen, Hairuo; Oestman, Johan; Bubb, Kristen J.; Panayiotou, Catherine; Ahluwalia, Amrita] Queen Mary Univ London, Barts & London Med Sch, William Harvey Res Inst, London EC1M 6BQ, England; [Wen, Hairuo; Oestman, Johan; Priestley, John V.; Baker, Mark D.] Queen Mary Univ London, Barts & London Med Sch, Blizard Inst, London EC1M 6BQ, England	University of London; Queen Mary University London; University of London; Queen Mary University London	Ahluwalia, A (corresponding author), Queen Mary Univ London, Barts & London Med Sch, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	a.ahluwalia@qmul.ac.uk	Bubb, Kristen/G-7746-2016	AHLUWALIA, Amrita/0000-0001-7626-6399	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by The Wellcome Trust ( to H. W., J. O., K. J. B., and C. P.).	Ahern GP, 2003, J BIOL CHEM, V278, P30429, DOI 10.1074/jbc.M305051200; BEVAN S, 1992, BRIT J PHARMACOL, V107, P544, DOI 10.1111/j.1476-5381.1992.tb12781.x; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Choi JS, 2001, BIOCHEM PHARMACOL, V61, P1029, DOI 10.1016/S0006-2952(01)00556-1; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Elg S, 2007, J COMP NEUROL, V503, P35, DOI 10.1002/cne.21351; Engh RA, 1996, J BIOL CHEM, V271, P26157, DOI 10.1074/jbc.271.42.26157; Frisbee JC, 2001, MICROCIRCULATION, V8, P45, DOI 10.1038/sj.mn.7300148; Gebremedhin D, 2000, CIRC RES, V87, P60, DOI 10.1161/01.RES.87.1.60; HARDER DR, 1984, CIRC RES, V55, P197, DOI 10.1161/01.RES.55.2.197; Hu KL, 2000, AM J PHYSIOL-HEART C, V279, pH2658, DOI 10.1152/ajpheart.2000.279.6.H2658; Huang A, 2005, HYPERTENSION, V46, P607, DOI 10.1161/01.HYP.0000176745.04393.4d; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Inoue R, 2009, CIRC RES, V104, P1399, DOI 10.1161/CIRCRESAHA.108.193227; Jara-Oseguera Andres, 2008, Curr Mol Pharmacol, V1, P255; Jiang B, 2002, MOL CELL BIOCHEM, V238, P69, DOI 10.1023/A:1019907104763; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; Laffer CL, 2004, HYPERTENSION, V43, P388, DOI 10.1161/01.HYP.0000112224.87290.3a; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Mandadi S, 2006, PAIN, V123, P106, DOI 10.1016/j.pain.2006.02.016; Miyata Noriyuki, 2005, Journal of Smooth Muscle Research, V41, P175, DOI 10.1540/jsmr.41.175; Scotland RS, 2004, CIRC RES, V95, P1027, DOI 10.1161/01.RES.0000148633.93110.24; Studer M, 2010, J PHYSIOL-LONDON, V588, P3743, DOI 10.1113/jphysiol.2010.190611; Tominaga M, 2005, PFLUG ARCH EUR J PHY, V451, P143, DOI 10.1007/s00424-005-1457-8; Wang MH, 2001, AM J PHYSIOL-REG I, V280, pR255, DOI 10.1152/ajpregu.2001.280.1.R255; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200; Zhang XM, 2008, NEURON, V59, P450, DOI 10.1016/j.neuron.2008.05.015; Zhao J, 2006, BIOCHEMISTRY-US, V45, P4915, DOI 10.1021/bi052082f; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	33	50	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13868	13876		10.1074/jbc.M111.334896	http://dx.doi.org/10.1074/jbc.M111.334896			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22389490	hybrid, Green Published			2022-12-27	WOS:000303996300042
J	Katschke, KJ; Wu, P; Ganesan, R; Kelley, RF; Mathieu, MA; Hass, PE; Murray, J; Kirchhofer, D; Wiesmann, C; Campagne, MV				Katschke, Kenneth J., Jr.; Wu, Ping; Ganesan, Rajkumar; Kelley, Robert F.; Mathieu, Mary A.; Hass, Philip E.; Murray, Jeremy; Kirchhofer, Daniel; Wiesmann, Christian; Campagne, Menno van Lookeren			Inhibiting Alternative Pathway Complement Activation by Targeting the Factor D Exosite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D MONOCLONAL-ANTIBODY; MACULAR DEGENERATION; CARDIOPULMONARY BYPASS; PROTEIN FAMILY; INSIGHT; MECHANISM; SYSTEM; C3B; REFINEMENT; COMPSTATIN	By virtue of its amplifying property, the alternative complement pathway has been implicated in a number of inflammatory diseases and constitutes an attractive therapeutic target. An anti-factor D Fab fragment (AFD) was generated to inhibit the alternative complement pathway in advanced dry age-related macular degeneration. AFD potently prevented factor D (FD)-mediated proteolytic activation of its macromolecular substrate C3bB, but not proteolysis of a small synthetic substrate, indicating that AFD did not block access of the substrate to the catalytic site. The crystal structures of AFD in complex with human and cynomolgus FD (at 2.4 and 2.3 angstrom, respectively) revealed the molecular details of the inhibitory mechanism. The structures show that the AFD-binding site includes surface loops of FD that form part of the FD exosite. Thus, AFD inhibits FD proteolytic function by interfering with macromolecular substrate access rather than by inhibiting FD catalysis, providing the molecular basis of AFD-mediated inhibition of a rate-limiting step in the alternative complement pathway.	[Katschke, Kenneth J., Jr.; Campagne, Menno van Lookeren] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Ganesan, Rajkumar; Kirchhofer, Daniel] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Kelley, Robert F.; Mathieu, Mary A.] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Hass, Philip E.] Genentech Inc, Dept Biol Chem, San Francisco, CA 94080 USA; [Wu, Ping; Murray, Jeremy; Wiesmann, Christian] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Campagne, MV (corresponding author), Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA.	menno@gene.com	Ganesan, Rajkumar/B-1093-2008	Ganesan, Rajkumar/0000-0002-3431-9664; Wiesmann, Christian/0000-0002-4092-9880				BARNUM SR, 1984, J IMMUNOL METHODS, V67, P303, DOI 10.1016/0022-1759(84)90470-8; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; Cole LB, 1997, ACTA CRYSTALLOGR D, V53, P143, DOI 10.1107/S0907444996012991; Cole LB, 1998, ACTA CRYSTALLOGR D, V54, P711, DOI 10.1107/S0907444997010457; DeLano W.L, PYMOL MOL GRAPHICS S; Farady CJ, 2007, J MOL BIOL, V369, P1041, DOI 10.1016/j.jmb.2007.03.078; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Fredslund F, 2008, NAT IMMUNOL, V9, P753, DOI 10.1038/ni.1625; Fung M, 2001, J THORAC CARDIOV SUR, V122, P113, DOI 10.1067/mtc.2001.114777; Ganesan R, 2011, MOL CANCER RES, V9, P1175, DOI 10.1158/1541-7786.MCR-11-0004; Ganesan R, 2010, BIOCHEM J, V430, P179, DOI 10.1042/BJ20100634; Garcia BL, 2012, J BIOL CHEM, V287, P628, DOI 10.1074/jbc.M111.298984; Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x; Hecker LA, 2010, HUM MOL GENET, V19, P209, DOI 10.1093/hmg/ddp472; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Janssen BJC, 2007, J BIOL CHEM, V282, P29241, DOI 10.1074/jbc.M704587200; Jing H, 1998, J MOL BIOL, V282, P1061, DOI 10.1006/jmbi.1998.2089; Katschke KJ, 2009, J BIOL CHEM, V284, P10473, DOI 10.1074/jbc.M809106200; KIM SH, 1995, J IMMUNOL, V154, P6073; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LESAVRE PH, 1978, J EXP MED, V148, P1498, DOI 10.1084/jem.148.6.1498; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NARAYANA SVL, 1994, J MOL BIOL, V235, P695, DOI 10.1006/jmbi.1994.1021; Reynolds R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/iovs.09-3928; Ricklin D, 2008, ADV EXP MED BIOL, V632, P273, DOI 10.1007/978-0-387-78952-1_20; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Ricklin D, 2009, J IMMUNOL, V183, P2565, DOI 10.4049/jimmunol.0901443; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Roversi P, 2007, J MOL BIOL, V369, P784, DOI 10.1016/j.jmb.2007.03.064; SANDERS PW, 1986, J CLIN INVEST, V77, P1299, DOI 10.1172/JCI112434; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Stanton CM, 2011, INVEST OPHTH VIS SCI, V52, P8828, DOI 10.1167/iovs.11-7933; Tanhehco EJ, 1999, TRANSPLANT P, V31, P2168, DOI 10.1016/S0041-1345(99)00297-3; Undar A, 2002, ANN THORAC SURG, V74, P355, DOI 10.1016/S0003-4975(02)03656-1; Undar A, 2002, EUR J CARDIO-THORAC, V22, P330, DOI 10.1016/S1010-7940(02)00298-1; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Wu Y, 2007, P NATL ACAD SCI USA, V104, P19784, DOI 10.1073/pnas.0708251104	39	61	73	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12886	12892		10.1074/jbc.M112.345082	http://dx.doi.org/10.1074/jbc.M112.345082			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22362762	Green Published, hybrid			2022-12-27	WOS:000302903700028
J	Seo, S; Lomberk, G; Mathison, A; Buttar, N; Podratz, J; Calvo, E; Iovanna, J; Brimijoin, S; Windebank, A; Urrutia, R				Seo, Seungmae; Lomberk, Gwen; Mathison, Angela; Buttar, Navtej; Podratz, Jewel; Calvo, Ezequiel; Iovanna, Juan; Brimijoin, Stephen; Windebank, Anthony; Urrutia, Raul			Kruppel-like Factor 11 Differentially Couples to Histone Acetyltransferase and Histone Methyltransferase Chromatin Remodeling Pathways to Transcriptionally Regulate Dopamine D2 Receptor in Neuronal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; NEURITE OUTGROWTH; NERVOUS-SYSTEM; FACTOR KLF7; GENE; SP1; FAMILY; NEUROGENESIS; COREPRESSOR; ACTIVATION	The importance of Kruppel-like factor (KLF)-mediated transcriptional pathways in the biochemistry of neuronal differentiation has been recognized relatively recently. Elegant studies have revealed that KLF proteins are important regulators of two major molecular and cellular processes critical for neuronal cell differentiation: neurite formation and the expression of neurotransmitter-related genes. However, whether KLF proteins mediate these key processes in a separate or coordinated fashion remains unknown. Moreover, knowledge on the contribution of chromatin dynamics to the biochemical mechanisms utilized by these proteins to perform their function is absent. Here we report the characterization of two antagonistic, chromatin-mediated mechanisms by which KLF11, also known as TIEG2 (transforming growth factor-beta-inducible early gene 2) and MODYVII (maturity onset diabetes of the young VII), regulates transcription of the fopamine D2 receptor (Drd2) gene. First, KLF11 activates transcription by binding to a distinct Sp-KLF site within the Drd2 promoter (-98 to -94) and recruiting the p300 histone acetyltransferase. Second, Drd2 transcriptional activation is partially antagonized by heterochromatin protein 1 (HP1), the code reader for histone H3 lysine 9 methylation. Interestingly, KLF11 regulates neurotransmitter receptor gene expression in differentiating neuronal cell populations without affecting neurite formation. Overall, these studies highlight histone methylation and acetylation as key biochemical mechanisms modulating KLF-mediated neurotransmitter gene transcription. These data extend our knowledge of chromatin-mediated biochemical events that maintain key phenotypic features of differentiated neuronal cells.	[Urrutia, Raul] Mayo Clin, GI Res Unit, Lab Epigenet & Chromatin Dynam, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Seo, Seungmae; Lomberk, Gwen; Mathison, Angela; Buttar, Navtej; Urrutia, Raul] Mayo Clin, Dept Med, Lab Epigenet & Chromatin Dynam, Rochester, MN 55905 USA; [Seo, Seungmae] Mayo Clin, Mayo Grad Sch, Rochester, MN 55905 USA; [Podratz, Jewel; Windebank, Anthony] Mayo Clin, Dept Neurosci, Rochester, MN 55905 USA; [Brimijoin, Stephen] Mayo Clin, Dept Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Calvo, Ezequiel] CHU Laval, Res Ctr, Mol Endocrinol & Oncol Res Ctr, Quebec City, PQ G1V 4G2, Canada; [Iovanna, Juan] Parc Sci & Technol Luminy, INSERM U624, Marseille, France	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Laval University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Urrutia, R (corresponding author), Mayo Clin, GI Res Unit, Lab Epigenet & Chromatin Dynam, Dept Biochem & Mol Biol, 200 1st St SW,Guggenheim 10, Rochester, MN 55905 USA.	urrutia.raul@mayo.edu	Lomberk, Gwen/AAL-8490-2020; Iovanna, Juan/M-9805-2017	Lomberk, Gwen/0000-0001-5463-789X; Iovanna, Juan/0000-0003-1822-2237; Mathison, Angela/0000-0002-6763-2710; Seo, Seungmae/0000-0003-2175-6440	National Institutes of Health [DK52913, CA110022-01, DK76845, P30DK084567]; Mayo Foundation; Fraternal Order of Eagles; NATIONAL CANCER INSTITUTE [R03CA110022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913, K08DK076845, P30DK084567, R56DK052913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; Fraternal Order of Eagles; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK52913 (to R. U.), CA110022-01 and DK76845 (to N. S. B.), and P30DK084567 (to the Mayo Clinic Center for Cell Signaling in Gastroenterology). This work was also supported by the Mayo Foundation and by the Fraternal Order of Eagles (to G. L.).	Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Bertolino A, 2009, NEUROSCIENCE, V164, P288, DOI 10.1016/j.neuroscience.2009.04.038; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Bonnefond A, 2011, J BIOL CHEM, V286, P28414, DOI 10.1074/jbc.M110.215822; Caiazzo M, 2011, EXP CELL RES, V317, P464, DOI 10.1016/j.yexcr.2010.11.006; Caiazzo M, 2010, EXP CELL RES, V316, P2365, DOI 10.1016/j.yexcr.2010.05.021; Conti AM, 1997, ANN NEUROL, V42, P838, DOI 10.1002/ana.410420604; Cook T, 1999, ANN NY ACAD SCI, V880, P94, DOI 10.1111/j.1749-6632.1999.tb09513.x; D'Alessandro R, 2010, CELL MOL NEUROBIOL, V30, P1295, DOI 10.1007/s10571-010-9602-0; Denver RJ, 1999, J BIOL CHEM, V274, P23128, DOI 10.1074/jbc.274.33.23128; Dijkmans TF, 2009, BRAIN RES, V1249, P19, DOI 10.1016/j.brainres.2008.10.050; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Fernandez-Zapico ME, 2011, BIOCHEM J, V435, P529, DOI 10.1042/BJ20100773; Fernandez-Zapico ME, 2009, J BIOL CHEM, V284, P36482, DOI 10.1074/jbc.M109.028852; GILL G, 1994, P NATL ACAD SCI USA, V91, P192, DOI 10.1073/pnas.91.1.192; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Hwang CK, 2001, P NATL ACAD SCI USA, V98, P7558, DOI 10.1073/pnas.121635798; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kramer PF, 2011, J NEUROSCI, V31, P126, DOI 10.1523/JNEUROSCI.4287-10.2011; Laub F, 2005, MOL CELL BIOL, V25, P5699, DOI 10.1128/MCB.25.13.5699-5711.2005; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Lomberk G, 2012, J BIOL CHEM, V287, P13026, DOI 10.1074/jbc.M112.342634; MINOWA T, 1992, BIOCHEMISTRY-US, V31, P8389, DOI 10.1021/bi00151a001; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Noble E P, 2000, Pharmacogenomics, V1, P309, DOI 10.1517/14622416.1.3.309; Noble EP, 2000, EUR PSYCHIAT, V15, P79, DOI 10.1016/S0924-9338(00)00208-X; Ou XM, 2004, J BIOL CHEM, V279, P21021, DOI 10.1074/jbc.M312638200; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; Paus S, 2008, MOVEMENT DISORD, V23, P599, DOI 10.1002/mds.21901; Scobie KN, 2009, J NEUROSCI, V29, P9875, DOI 10.1523/JNEUROSCI.2260-09.2009; Song CZ, 2003, J MOL BIOL, V329, P207, DOI 10.1016/S0022-2836(03)00429-7; Spittau G, 2010, J NEUROSCI RES, V88, P2017, DOI 10.1002/jnr.22364; Ta LE, 2006, NEUROTOXICOLOGY, V27, P992, DOI 10.1016/j.neuro.2006.04.010; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Truty MJ, 2009, J BIOL CHEM, V284, P6291, DOI 10.1074/jbc.M807791200; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001	40	31	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12723	12735		10.1074/jbc.M112.351395	http://dx.doi.org/10.1074/jbc.M112.351395			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22375010	Green Published, hybrid			2022-12-27	WOS:000302903700012
J	Wang, DD; Liang, J; Zhang, Y; Gui, B; Wang, F; Yi, X; Sun, LY; Yao, Z; Shang, YF				Wang, Dandan; Liang, Jing; Zhang, Yu; Gui, Bin; Wang, Feng; Yi, Xia; Sun, Luyang; Yao, Zhi; Shang, Yongfeng			Steroid Receptor Coactivator-interacting Protein (SIP) Inhibits Caspase-independent Apoptosis by Preventing Apoptosis-inducing Factor (AIF) from Being Released from Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(ADP-RIBOSE) PAR POLYMER; CELL-DEATH; OXIDATIVE-PHOSPHORYLATION; BREAST CARCINOGENESIS; NUCLEAR TRANSLOCATION; APAF-1 APOPTOSOME; CALPAIN-I; COMPLEX; CHROMATINOLYSIS; TRANSCRIPTION	Apoptosis-inducing factor (AIF) is a caspase-independent death effector. Normally residing in the mitochondrial intermembrane space, AIF is released and translocated to the nucleus in response to proapoptotic stimuli. Nuclear AIF binds to DNA and induces chromatin condensation and DNA fragmentation, characteristics of apoptosis. Until now, it remained to be clarified how the mitochondrial-nuclear translocation of AIF is regulated. Here we report that steroid receptor coactivator-interacting protein (SIP) interacts directly with AIF in mitochondria and specifically inhibits caspase-independent and AIF-dependent apoptosis. Challenging cells with apoptotic stimuli leads to rapid degradation of SIP, and subsequently AIF is liberated from mitochondria and translocated to the nucleus to induce apoptosis. Together, our data demonstrate that SIP is a novel regulator in caspase-independent and AIF-mediated apoptosis.	[Wang, Dandan; Liang, Jing; Zhang, Yu; Gui, Bin; Wang, Feng; Yi, Xia; Sun, Luyang; Shang, Yongfeng] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100191, Peoples R China; [Yao, Zhi; Shang, Yongfeng] Tianjin Med Univ, Dept Biochem & Mol Biol, Tianjin Key Lab Med Epigenet, Tianjin 300070, Peoples R China	Peking University; Tianjin Medical University	Shang, YF (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	yshang@hsc.pku.edu.cn			National Natural Science Foundation of China [81130048, 30921062]; Ministry of Science and Technology of China [2011CB504204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Grants 81130048 and 30921062 from the National Natural Science Foundation of China (to Y. S.) and Grant 973 of Program 2011CB504204 from the Ministry of Science and Technology of China (to Y. S.).	Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Artus C, 2010, EMBO J, V29, P1585, DOI 10.1038/emboj.2010.43; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; Benit P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003208; Cande C, 2004, ONCOGENE, V23, P1514, DOI 10.1038/sj.onc.1207279; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gurbuxani S, 2003, ONCOGENE, V22, P6669, DOI 10.1038/sj.onc.1206794; Harada JN, 2005, GENOME RES, V15, P1136, DOI 10.1101/gr.3889305; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Joshi A, 2009, EXP NEUROL, V218, P221, DOI 10.1016/j.expneurol.2009.04.013; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Li RF, 2009, EMBO J, V28, P2763, DOI 10.1038/emboj.2009.211; Li YY, 2011, J BIOL CHEM, V286, P13925, DOI 10.1074/jbc.M111.223198; Loeffler M, 2001, FASEB J, V15, P758, DOI 10.1096/fj.00-0388com; Matsumori Y, 2005, J CEREBR BLOOD F MET, V25, P899, DOI 10.1038/sj.jcbfm.9600080; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Spencer ML, 2004, J BIOL CHEM, V279, P37069, DOI 10.1074/jbc.M402507200; Sun LY, 2011, J BIOL CHEM, V286, P4226, DOI 10.1074/jbc.M110.195115; Sun LY, 2009, P NATL ACAD SCI USA, V106, P10195, DOI 10.1073/pnas.0901864106; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Susin SA, 1996, J EXP MED, V184, P1331, DOI 10.1084/jem.184.4.1331; Urbano A, 2005, EMBO J, V24, P2815, DOI 10.1038/sj.emboj.7600746; Uren RT, 2005, J BIOL CHEM, V280, P2266, DOI 10.1074/jbc.M411106200; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Yang XH, 2011, MOL CELL, V44, P39, DOI 10.1016/j.molcel.2011.07.032; Ye H, 2002, NAT STRUCT BIOL, V9, P680, DOI 10.1038/nsb836; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuste VJ, 2005, CELL DEATH DIFFER, V12, P1445, DOI 10.1038/sj.cdd.4401687; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang H, 2006, EMBO J, V25, P4223, DOI 10.1038/sj.emboj.7601306; Zhang Y, 2007, EMBO J, V26, P2645, DOI 10.1038/sj.emboj.7601710; Zhu CL, 2007, J EXP MED, V204, P1741, DOI 10.1084/jem.20070193	50	14	16	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12612	12621		10.1074/jbc.M111.334151	http://dx.doi.org/10.1074/jbc.M111.334151			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22371500	hybrid, Green Published			2022-12-27	WOS:000302903700002
J	Fujita, M; Ieguchi, K; Davari, P; Yamaji, S; Taniguchi, Y; Sekiguchi, K; Takada, YK; Takada, Y				Fujita, Masaaki; Ieguchi, Katsuaki; Davari, Parastoo; Yamaji, Satoshi; Taniguchi, Yukimasa; Sekiguchi, Kiyotoshi; Takada, Yoko K.; Takada, Yoshikazu			Cross-talk between Integrin alpha 6 beta 4 and Insulin-like Growth Factor-1 Receptor (IGF1R) through Direct alpha 6 beta 4 Binding to IGF1 and Subsequent alpha 6 beta 4-IGF1-IGF1R Ternary Complex Formation in Anchorage-independent Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; MONOCLONAL-ANTIBODIES; CELLS; CARCINOMA; ALPHA-V-BETA-3; SUBUNIT; INVASION; ADHESION; DOMAIN; SPECIFICITIES	Integrin alpha v beta 3 plays a role in insulin-like growth factor-1 (IGF1) signaling (integrin-IGF1 receptor (IGF1R) cross-talk). The specifics of the cross-talk are, however, unclear. In a current model, "ligand occupancy" of alpha v beta 3 (i.e. the binding of extracellular matrix proteins) enhances signaling induced by IGF1 binding to IGF1R. We recently reported that IGF1 directly binds to alpha v beta 3 and induces alpha v beta 3-IGF1-IGF1R ternary complex formation. Consistently, the integrin binding-defective IGF1 mutant (R36E/R37E) is defective in inducing ternary complex formation and IGF signaling, but it still binds to IGF1R. Like alpha v beta 3, integrin alpha 6 beta 4 is overexpressed in many cancers and is implicated in cancer progression. Here, we discovered that alpha 6 beta 4 directly bound to IGF1, but not to R36E/R37E. Grafting the beta 4 sequence WPNSDP (residues 167-172), which corresponds to the specificity loop of beta 3, to integrin beta 1 markedly enhanced IGF1 binding to beta 1, suggesting that the WPNSDP sequence is involved in IGF1 recognition. WT IGF1 induced alpha 6 beta 4-IGF1-IGF1R ternary complex formation, whereas R36E/R37E did not. When cells were attached to matrix, exogenous IGF1 or alpha 6 beta 4 expression had little or no effect on intracellular signaling. When cell-matrix adhesion was reduced (in poly(2-hydroxyethyl methacrylate-coated plates), IGF1 induced intracellular signaling and enhanced cell survival in an alpha 6 beta 4-dependent manner. Also IGF1 enhanced colony formation in soft agar in an alpha 6 beta 4-dependent manner. These results suggest that IGF binding to alpha 6 beta 4 plays a major role in IGF signaling in anchorage-independent conditions, which mimic the in vivo environment, and is a novel therapeutic target.	[Fujita, Masaaki; Ieguchi, Katsuaki; Davari, Parastoo; Yamaji, Satoshi; Takada, Yoko K.; Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Fujita, Masaaki; Ieguchi, Katsuaki; Davari, Parastoo; Yamaji, Satoshi; Takada, Yoko K.; Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Taniguchi, Yukimasa; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, Suita, Osaka 5650871, Japan	University of California System; University of California Davis; University of California System; University of California Davis; Osaka University	Takada, Y (corresponding author), Univ Calif Davis, Sch Med, Dept Dermatol, Res 3,Suite 3300,4645 2nd Ave, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu		takada, yoshikazu/0000-0001-5481-9589	National Institutes of Health [CA13015]; Department of Defense [W81XWH-10-1-0312]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [20370046]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA13015 and Department of Defense Grant W81XWH-10-1-0312 (to Y. T.). This work was also supported by Grant-in-aid for Scientific Research 20370046 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to K. S.).	Abdel-Ghany M, 2003, J BIOL CHEM, V278, P49406, DOI 10.1074/jbc.M309086200; Bon G, 2006, CLIN CANCER RES, V12, P3280, DOI 10.1158/1078-0432.CCR-05-2223; Borowsky AD, 2005, CLIN EXP METASTAS, V22, P47, DOI 10.1007/s10585-005-2908-5; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; BROWN PJ, 1988, EXP CELL RES, V177, P303, DOI 10.1016/0014-4827(88)90464-8; BROWN PJ, 1985, SCIENCE, V228, P1448, DOI 10.1126/science.4012302; Chung J, 2004, J BIOL CHEM, V279, P32287, DOI 10.1074/jbc.M403809200; Clemmons DR, 2007, NAT REV DRUG DISCOV, V6, P821, DOI 10.1038/nrd2359; Clemmons DR, 2005, MOL ENDOCRINOL, V19, P1, DOI 10.1210/me.2004-0376; Doerr ME, 1996, J BIOL CHEM, V271, P2443, DOI 10.1074/jbc.271.5.2443; FALCIONI R, 1986, CANCER RES, V46, P5772; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; FUKAZAWA H, 1995, ANAL BIOCHEM, V228, P83, DOI 10.1006/abio.1995.1318; Gambaletta D, 2000, J BIOL CHEM, V275, P10604, DOI 10.1074/jbc.275.14.10604; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ieguchi K, 2010, J BIOL CHEM, V285, P31388, DOI 10.1074/jbc.M110.113878; Jones JL, 1997, EXP CELL RES, V235, P325, DOI 10.1006/excr.1997.3662; Jones John I., 1995, Progress in Growth Factor Research, V6, P319, DOI 10.1016/0955-2235(95)00015-1; Kamata T, 2002, J IMMUNOL, V168, P2296, DOI 10.4049/jimmunol.168.5.2296; Lipscomb EA, 2005, CANCER METAST REV, V24, P413, DOI 10.1007/s10555-005-5133-4; Lipscomb EA, 2003, CLIN EXP METASTAS, V20, P569, DOI 10.1023/A:1025819521707; Lu S, 2008, CLIN CANCER RES, V14, P1050, DOI 10.1158/1078-0432.CCR-07-4116; Mizushima H, 2009, J CELL SCI, V122, P4277, DOI 10.1242/jcs.054551; Murgia C, 1998, EMBO J, V17, P3940, DOI 10.1093/emboj/17.14.3940; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Puzon-McLaughlin W, 2000, J BIOL CHEM, V275, P7795, DOI 10.1074/jbc.275.11.7795; Saegusa J, 2009, J BIOL CHEM, V284, P24106, DOI 10.1074/jbc.M109.013201; STEPHENSON JR, 1971, P NATL ACAD SCI USA, V68, P1542, DOI 10.1073/pnas.68.7.1542; TAKADA Y, 1993, J BIOL CHEM, V268, P17597; Takagi J, 1997, J BIOCHEM, V121, P914; Takagi J, 1997, J BIOL CHEM, V272, P19794, DOI 10.1074/jbc.272.32.19794; Yang XWH, 2008, CANCER RES, V68, P3204, DOI 10.1158/0008-5472.CAN-07-2949; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Zheng B, 1998, P NATL ACAD SCI USA, V95, P11217, DOI 10.1073/pnas.95.19.11217	35	32	36	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12491	12500		10.1074/jbc.M111.304170	http://dx.doi.org/10.1074/jbc.M111.304170			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351760	Green Published, hybrid			2022-12-27	WOS:000302782200088
J	Sjolander, J; Westermark, GT; Renstrom, E; Blom, AM				Sjolander, Jonatan; Westermark, Gunilla T.; Renstrom, Erik; Blom, Anna M.			Islet Amyloid Polypeptide Triggers Limited Complement Activation and Binds Complement Inhibitor C4b-binding Protein, Which Enhances Fibril Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELL APOPTOSIS; ALZHEIMERS-DISEASE; COMPONENT; C1Q; PURIFICATION; DEPOSITION; OLIGOMERS; PEPTIDE; INSULIN; REGION	Islet amyloid polypeptide (IAPP) is synthesized in pancreatic beta-cells and co-secreted with insulin. Aggregation and formation of IAPP-amyloid play a critical role in beta-cell death in type 2 diabetic patients. Because A beta-fibrils in Alzheimer disease activate the complement system, we have here investigated specific interactions between IAPP and complement factors. IAPP fibrils triggered limited activation of complement in vitro, involving both the classical and the alternative pathways. Direct binding assays confirmed that IAPP fibrils interact with globular head domains of complement initiator C1q. Furthermore, IAPP also bound complement inhibitors factor H and C4b-binding protein (C4BP). Recombinant C4BP mutants were used to show that complement control protein (CCP) domains 8 and 2 of the alpha-chain were responsible for the strong, hydrophobic binding of C4BP to IAPP. Immunostaining of pancreatic sections from type 2 diabetic patients revealed the presence of complement factors in the islets and varying degree of co-localization between IAPP fibrils and C1q, C3d, as well as C4BP and factor H but not membrane attack complex. Furthermore, C4BP enhanced formation of IAPP fibrils in vitro. We conclude that C4BP binds to IAPP thereby limiting complement activation and may be enhancing formation of IAPP fibrils from cytotoxic oligomers.	[Sjolander, Jonatan; Blom, Anna M.] Lund Univ, Dept Lab Med, Wallenberg Lab, Skane Univ Hosp, S-20502 Malmo, Sweden; [Westermark, Gunilla T.] Uppsala Univ, Dept Med Cell Biol, S-75123 Uppsala, Sweden; [Renstrom, Erik] Lund Univ, Dept Clin Sci, Clin Res Ctr, Skane Univ Hosp, S-20502 Malmo, Sweden	Lund University; Skane University Hospital; Uppsala University; Lund University; Skane University Hospital	Blom, AM (corresponding author), Lund Univ, Dept Lab Med, Wallenberg Lab, Skane Univ Hosp, S-20502 Malmo, Sweden.	anna.blom@med.lu.se	Blom, Anna/AFS-7369-2022; Blom, Anna/B-9607-2009	Blom, Anna/0000-0002-1348-1734	Swedish Research Council [2009-68X-14928-06-3, 2010-55X-20326-04-3]; Swedish Foundation for Strategic Research; Swedish Diabetes Foundation; Foundation of Osterlund; Foundation of Greta and Johan Kock; Foundation of Family Ernfors; Foundation of Knut and Alice Wallenberg; Foundation of Inga-Britt and Arne Lundberg; University Hospital in Malmo; Region Skane	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Diabetes Foundation; Foundation of Osterlund; Foundation of Greta and Johan Kock; Foundation of Family Ernfors; Foundation of Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); Foundation of Inga-Britt and Arne Lundberg; University Hospital in Malmo; Region Skane	This work was supported by Swedish Research Council Grants 2009-68X-14928-06-3 and 2010-55X-20326-04-3, the Swedish Foundation for Strategic Research, Swedish Diabetes Foundation and the Foundations of Osterlund, Greta and Johan Kock, Family Ernfors, Knut and Alice Wallenberg, and Inga-Britt and Arne Lundberg as well as grants for clinical research from the University Hospital in Malmo and the Region Skane.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u; BETSHOLTZ C, 1989, FEBS LETT, V251, P261, DOI 10.1016/0014-5793(89)81467-X; Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; DAHLBACK B, 1981, P NATL ACAD SCI-BIOL, V78, P2512, DOI 10.1073/pnas.78.4.2512; DE FRUTOS PG, 1995, J BIOL CHEM, V270, P26950, DOI 10.1074/jbc.270.45.26950; Ebeling P, 2001, METABOLISM, V50, P283, DOI 10.1053/meta.2001.21032; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Guardado-Mendoza R, 2009, P NATL ACAD SCI USA, V106, P13992, DOI 10.1073/pnas.0906471106; Head E, 2001, NEUROBIOL DIS, V8, P252, DOI 10.1006/nbdi.2000.0380; Hillarp A., 1990, P NATL ACAD SCI USA, V87, P1183; Hulbert EM, 2007, NUCLEIC ACIDS RES, V35, pD742, DOI 10.1093/nar/gkl933; Jaikaran ETAS, 2001, BBA-MOL BASIS DIS, V1537, P179, DOI 10.1016/S0925-4439(01)00078-3; Jurgens CA, 2011, AM J PATHOL, V178, P2632, DOI 10.1016/j.ajpath.2011.02.036; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Klegeris A, 2007, BIOCHEM BIOPH RES CO, V357, P1096, DOI 10.1016/j.bbrc.2007.04.055; Koehl J, 2006, CURR OPIN MOL THER, V8, P529; Larsson A, 2007, BIOCHEM BIOPH RES CO, V361, P822, DOI 10.1016/j.bbrc.2007.06.187; LUKINIUS A, 1989, DIABETOLOGIA, V32, P240, DOI 10.1007/BF00285291; MALOY AL, 1981, HUM PATHOL, V12, P917, DOI 10.1016/S0046-8177(81)80197-9; MANDERS EMM, 1992, J CELL SCI, V103, P857; Mollnes Tom E., 2002, Trends in Immunology, V23, P61, DOI 10.1016/S1471-4906(01)02129-9; PAQUES EP, 1979, H-S Z PHYSIOL CHEM, V360, P177, DOI 10.1515/bchm2.1979.360.1.177; Pitsavos Christos, 2007, Rev Diabet Stud, V4, P98, DOI 10.1900/RDS.2007.4.98; REID KBM, 1976, BIOCHEM J, V155, P5, DOI 10.1042/bj1550005; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rostagno A, 2002, J BIOL CHEM, V277, P49782, DOI 10.1074/jbc.M206448200; Rumora L, 2002, BIOL CHEM, V383, P1751, DOI 10.1515/BC.2002.196; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Sjoberg AP, 2008, MOL IMMUNOL, V45, P3213, DOI 10.1016/j.molimm.2008.02.023; Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600; TENNER AJ, 1981, J IMMUNOL, V127, P648; Trouw LA, 2008, MOL IMMUNOL, V45, P3649, DOI 10.1016/j.molimm.2008.04.025; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Webster S, 1997, AM J PATHOL, V150, P1531; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; ZICCARDI RJ, 1982, BIOCHEM BIOPH RES CO, V107, P618, DOI 10.1016/0006-291X(82)91536-4; Zraika S, 2010, DIABETOLOGIA, V53, P1046, DOI 10.1007/s00125-010-1671-6	42	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10824	10833		10.1074/jbc.M111.244285	http://dx.doi.org/10.1074/jbc.M111.244285			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22334700	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000302780100011
J	Tsang, TM; Annis, DS; Kronshage, M; Fenno, JT; Usselman, LD; Mosher, DF; Krukonis, ES				Tsang, Tiffany M.; Annis, Douglas S.; Kronshage, Malte; Fenno, Jesse T.; Usselman, Lisa D.; Mosher, Deane F.; Krukonis, Eric S.			Ail Protein Binds Ninth Type III Fibronectin Repeat ((FNIII)-F-9) within Central 120-kDa Region of Fibronectin to Facilitate Cell Binding by Yersinia pestis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST SURFACE-ANTIGEN; COLD-INSOLUBLE GLOBULIN; STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-PYOGENES; ESCHERICHIA-COLI; HUMAN PLASMA; HOST-CELLS; TYROSINE PHOSPHORYLATION; BACTERIAL ADHERENCE; ENDOTHELIAL-CELLS	The Yersinia pestis adhesin molecule Ail interacts with the extracellular matrix protein fibronectin (Fn) on host cells to facilitate efficient delivery of cytotoxic Yop proteins, a process essential for plague virulence. A number of bacterial pathogens are known to bind to the N-terminal region of Fn, comprising type I Fn (FNI) repeats. Using proteolytically generated Fn fragments and purified recombinant Fn fragments, we demonstrated that Ail binds the centrally located 120-kDa fragment containing type III Fn (FNIII) repeats. A panel of monoclonal antibodies (mAbs) that recognize specific epitopes within the 120-kDa fragment demonstrated that mAb binding to (FNIII)-F-9 blocks Ail-mediated bacterial binding to Fn. Epitopes of three mAbs that blocked Ail binding to Fn were mapped to a similar face of (FNIII)-F-9. Antibodies directed against (FNIII)-F-9 also inhibited Ail-dependent cell binding activity, thus demonstrating the biological relevance of this Ail binding region on Fn. Bacteria expressing Ail on their surface could also bind a minimal fragment of Fn containing repeats 9-10FNIII, and this binding was blocked by a mAb specific for 9FNIII. These data demonstrate that Ail binds to (FNIII)-F-9 of Fn and presents Fn to host cells to facilitate cell binding and delivery of Yops (cytotoxins of Y. pestis), a novel interaction, distinct from other bacterial Fn-binding proteins.	[Kronshage, Malte; Fenno, Jesse T.; Usselman, Lisa D.; Krukonis, Eric S.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Tsang, Tiffany M.; Krukonis, Eric S.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Krukonis, ES (corresponding author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, 1011 N Univ, Ann Arbor, MI 48109 USA.	ekrukoni@umich.edu			National Institutes of Health through NHLBI [R01HL021644]; National Institutes of Health through NIAID [R21AI090194, R03AI092318]; Office of the Vice President of Research (OVPR) at the University of Michigan; Department of Microbiology and Immunology at the University of Michigan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090194, R03AI092318] Funding Source: NIH RePORTER	National Institutes of Health through NHLBI; National Institutes of Health through NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of the Vice President of Research (OVPR) at the University of Michigan; Department of Microbiology and Immunology at the University of Michigan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL021644 through the NHLBI (to D. F. M.) and Grants R21AI090194 and R03AI092318 through the NIAID (to E. S. K.). This work was also supported by the Office of the Vice President of Research (OVPR) at the University of Michigan (to E. S. K.) and the Frances Wang Chin Endowed Fellowship from the Department of Microbiology and Immunology at the University of Michigan (to T. M. T.).	AKIYAMA SK, 1995, CELL ADHES COMMUN, V3, P13, DOI 10.3109/15419069509081275; Bellis SL, 1997, BIOCHEM J, V325, P375, DOI 10.1042/bj3250375; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; BOWDITCH RD, 1991, J BIOL CHEM, V266, P23323; BOZZINI S, 1992, EUR J BIOCHEM, V207, P327, DOI 10.1111/j.1432-1033.1992.tb17054.x; CHERNOUSOV MA, 1991, J BIOL CHEM, V266, P10851; Christopher RA, 1997, J CELL SCI, V110, P569; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; DAWSON JR, 1990, INFECT IMMUN, V58, P3924, DOI 10.1128/IAI.58.12.3924-3928.1990; DZAMBA BJ, 1994, J BIOL CHEM, V269, P19646; Eitel J, 2002, INFECT IMMUN, V70, P4880, DOI 10.1128/IAI.70.9.4880-4891.2002; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; Felek S, 2009, INFECT IMMUN, V77, P825, DOI 10.1128/IAI.00913-08; FROMAN G, 1987, J BIOL CHEM, V262, P6564; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; HANSKI E, 1992, P NATL ACAD SCI USA, V89, P6172, DOI 10.1073/pnas.89.13.6172; Hinnebusch BJ, 2011, INFECT IMMUN, V79, P4984, DOI 10.1128/IAI.05307-11; Hocking DC, 1998, J CELL BIOL, V141, P241, DOI 10.1083/jcb.141.1.241; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Joh D, 1999, MATRIX BIOL, V18, P211, DOI 10.1016/S0945-053X(99)00025-6; Kolodziejek AM, 2010, INFECT IMMUN, V78, P5233, DOI 10.1128/IAI.00783-10; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; KUUSELA P, 1984, INFECT IMMUN, V45, P433, DOI 10.1128/IAI.45.2.433-436.1984; KUUSELA P, 1985, INFECT IMMUN, V50, P77, DOI 10.1128/IAI.50.1.77-81.1985; KUUSELA P, 1976, IMMUNOCHEMISTRY, V13, P639, DOI 10.1016/0019-2791(76)90203-2; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Massey RC, 2001, CELL MICROBIOL, V3, P839, DOI 10.1046/j.1462-5822.2001.00157.x; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; Mejia E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040003; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; MOSESSON MW, 1975, BIOCHIM BIOPHYS ACTA, V386, P509, DOI 10.1016/0005-2795(75)90294-9; MOSHER DF, 1984, ANNU REV MED, V35, P561, DOI 10.1146/annurev.me.35.020184.003021; MOSHER DF, 1980, SCIENCE, V209, P927, DOI 10.1126/science.7403857; NAGAI T, 1991, J CELL BIOL, V114, P1295, DOI 10.1083/jcb.114.6.1295; NOJIMA Y, 1995, J BIOL CHEM, V270, P15398, DOI 10.1074/jbc.270.25.15398; OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6; Ozeri V, 1996, EMBO J, V15, P989, DOI 10.1002/j.1460-2075.1996.tb00435.x; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; PIERSCHBACHER MD, 1981, CELL, V26, P259, DOI 10.1016/0092-8674(81)90308-1; PIERSCHBACHER MD, 1982, J BIOL CHEM, V257, P9593; ROSQVIST R, 1990, MOL MICROBIOL, V4, P657, DOI 10.1111/j.1365-2958.1990.tb00635.x; RUOSLAHTI E, 1981, J BIOL CHEM, V256, P7277; RUOSLAHTI E, 1975, J EXP MED, V141, P497, DOI 10.1084/jem.141.2.497; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; RUOSLAHTI E, 1974, NATURE, V248, P789, DOI 10.1038/248789a0; SAKATA N, 1994, J BIOCHEM-TOKYO, V115, P843, DOI 10.1093/oxfordjournals.jbchem.a124427; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; SOTTILE J, 1991, J BIOL CHEM, V266, P12840; STATHAKIS NE, 1977, J CLIN INVEST, V60, P855, DOI 10.1172/JCI108840; TERTTI R, 1992, INFECT IMMUN, V60, P3021, DOI 10.1128/IAI.60.7.3021-3024.1992; THOMAS DD, 1985, J EXP MED, V161, P514, DOI 10.1084/jem.161.3.514; Tsang TM, 2010, INFECT IMMUN, V78, P3358, DOI 10.1128/IAI.00238-10; VAHERI A, 1976, J SUPRAMOL STR CELL, V4, P63, DOI 10.1002/jss.400040107; VISAI L, 1991, FEBS LETT, V290, P111, DOI 10.1016/0014-5793(91)81238-4; Vogt J, 1999, STRUCTURE, V7, P1301, DOI 10.1016/S0969-2126(00)80063-5; WESTERLUND B, 1989, FEBS LETT, V243, P199, DOI 10.1016/0014-5793(89)80129-2; Xu JL, 2010, J BIOL CHEM, V285, P8563, DOI 10.1074/jbc.M109.062646; Yamashita S, 2011, STRUCTURE, V19, P1672, DOI 10.1016/j.str.2011.08.010	62	26	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16759	16767		10.1074/jbc.M112.358978	http://dx.doi.org/10.1074/jbc.M112.358978			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22447929	Green Published, hybrid			2022-12-27	WOS:000304030900063
J	Gao, L; Gao, F; Wang, LS; Geng, CL; Chi, LL; Zhao, J; Qu, YB				Gao, Le; Gao, Feng; Wang, Lushan; Geng, Cunliang; Chi, Lianli; Zhao, Jian; Qu, Yinbo			N-Glycoform Diversity of Cellobiohydrolase I from Penicillium decumbens and Synergism of Nonhydrolytic Glycoform in Cellulose Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI; PROTEIN GLYCOSYLATION; MUTANT STRAIN; CHRYSOSPORIUM; PURIFICATION; DISRUPTION; STABILITY; STRATEGY	Four cellobiohydrolase I (CBHI) glycoforms, namely, CBHI-A, CBHI-B, CBHI-C, and CBHI-D, were purified from the cultured broth of Penicillium decumbens JU-A10. All glycoforms had the same amino acid sequence but displayed different characteristics and biological functions. The effects of the N-glycans of the glycoforms on CBH activity were analyzed using mass spectrum data. Longer N-glycan chains at the Asn-137 of CBHI increased CBH activity. After the N-glycans were removed using site-directed mutagenesis and homologous expression in P. decumbens, the specific CBH activity of the recombinant CBHI without N-glycosylation increased by 65% compared with the wild-type CBHI with the highest specific activity. However, the activity was not stable. Only the N-glycosylation at Asn-137 can improve CBH activity by 40%. rCBHI with N-glycosylation only at Asn-470 exhibited no enzymatic activity. CBH activity was affected whether or not the protein was glycosylated, together with the N-glycosylation site and N-glycan structure. N-Glycosylation not only affects CBH activity but may also bring a new feature to a nonhydrolytic CBHI glycoform (CBHI-A). By supplementing CBHI-A to different commercial cellulase preparations, the glucose yield of lignocellulose hydrolysis increased by >20%. After treatment with a low dose (5 mg/g substrate) of CBHI-A at 50 degrees C for 7 days, the hydrogen-bond intensity and crystalline degree of cotton fibers decreased by 17 and 34%, respectively. These results may provide new guidelines for cellulase engineering.	[Gao, Le; Gao, Feng; Wang, Lushan; Geng, Cunliang; Zhao, Jian; Qu, Yinbo] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Chi, Lianli; Qu, Yinbo] Shandong Univ, Natl Glycoengn Res Ctr, Jinan 250100, Peoples R China	Shandong University; Shandong University	Qu, YB (corresponding author), 27 Shandanan Rd, Jinan 250100, Peoples R China.	quyinbo@sdu.edu.cn	Chi, Lianli/B-9149-2015	Chi, Lianli/0000-0003-1126-1022	National Basic Research Program of China [2011CB707403]; National Natural Sciences Foundation of China [31030001, 31170107]	National Basic Research Program of China(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2011CB707403 and National Natural Sciences Foundation of China Grants 31030001 and 31170107.	Adney WS, 2009, CELLULOSE, V16, P699, DOI 10.1007/s10570-009-9305-1; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beckham G. T., 2011, CURR OPIN BIOTECH, V23, P1; Benoit I, 2006, FEBS LETT, V580, P5815, DOI 10.1016/j.febslet.2006.09.039; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHAHAL DS, 1985, APPL ENVIRON MICROB, V49, P205, DOI 10.1128/AEM.49.1.205-210.1985; CHANDHOKE V, 1992, FEMS MICROBIOL LETT, V90, P263, DOI 10.1111/j.1574-6968.1992.tb05164.x; Gao L, 2011, BIORESOURCE TECHNOL, V102, P8339, DOI 10.1016/j.biortech.2011.06.033; Garcia R, 2001, BIOTECHNOL APPL BIOC, V33, P141, DOI 10.1042/BA20000085; GOMI K, 1987, AGR BIOL CHEM TOKYO, V51, P2549; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; Gusakov AV, 2008, CARBOHYD RES, V343, P48, DOI 10.1016/j.carres.2007.10.014; Harrison MJ, 1998, EUR J BIOCHEM, V256, P119, DOI 10.1046/j.1432-1327.1998.2560119.x; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Kainz E, 2008, APPL ENVIRON MICROB, V74, P1076, DOI 10.1128/AEM.01058-07; Kim KH, 2007, J PROTEOME RES, V6, P4749, DOI 10.1021/pr070355i; King AJ, 2010, P NATL ACAD SCI USA, V107, P5345, DOI 10.1073/pnas.0914228107; Lee I, 2000, ULTRAMICROSCOPY, V82, P213, DOI 10.1016/S0304-3991(99)00158-8; Liu K, 2010, BIORESOURCE TECHNOL, V101, P4952, DOI 10.1016/j.biortech.2009.11.013; Marino K, 2010, NAT CHEM BIOL, V6, P713, DOI [10.1038/nchembio.437, 10.1038/NCHEMBIO.437]; MCQUEENMASON S, 1994, P NATL ACAD SCI USA, V91, P6574, DOI 10.1073/pnas.91.14.6574; Qu Y.-B., 1984, Acta Mycologica Sinica, V3, P238; Reese E. T., 1976, P SESS, V6, P9; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Sun XY, 2008, ENZYME MICROB TECH, V42, P560, DOI 10.1016/j.enzmictec.2008.01.020; Tanaka H, 2007, J BIOTECHNOL, V128, P500, DOI 10.1016/j.jbiotec.2006.12.010; Todd AE, 1999, CURR OPIN CHEM BIOL, V3, P548, DOI 10.1016/S1367-5931(99)00007-1; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang W, 2003, CURR MICROBIOL, V46, P371, DOI 10.1007/s00284-002-3864-9; Wong CH, 2005, J ORG CHEM, V70, P4219, DOI 10.1021/jo050278f; Wu GC, 2010, WORLD J MICROB BIOT, V26, P323, DOI 10.1007/s11274-009-0179-z; Yu CT, 2009, IND CROP PROD, V29, P308, DOI 10.1016/j.indcrop.2008.06.005; Zhou J, 2008, BIORESOURCE TECHNOL, V99, P6826, DOI 10.1016/j.biortech.2008.01.077	33	47	49	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15906	15915		10.1074/jbc.M111.332890	http://dx.doi.org/10.1074/jbc.M111.332890			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427663	hybrid, Green Published			2022-12-27	WOS:000304006300069
J	Lv, LH; Wan, YL; Lin, Y; Zhang, W; Yang, M; Li, GL; Lin, HM; Shang, CZ; Chen, YJ; Min, J				Lv, Li-Hong; Wan, Yun-Le; Lin, Yan; Zhang, Wei; Yang, Mei; Li, Guo-Lin; Lin, Hao-Ming; Shang, Chang-Zhen; Chen, Ya-Jin; Min, Jun			Anticancer Drugs Cause Release of Exosomes with Heat Shock Proteins from Human Hepatocellular Carcinoma Cells That Elicit Effective Natural Killer Cell Antitumor Responses in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-DERIVED EXOSOMES; IMMUNE-RESPONSE; K562 CELLS; GRANZYME-B; PHASE-II; MECHANISM; STRESS; CHEMOTHERAPY; IMPAIRMENT; RECEPTORS	Failure of immune surveillance related to inadequate host antitumor immune responses has been suggested as a possible cause of the high incidence of recurrence and poor overall survival outcome of hepatocellular carcinoma. The stress-induced heat shock proteins (HSPs) are known to act as endogenous "danger signals" that can improve tumor immunogenicity and induce natural killer (NK) cell responses. Exosome is a novel secretory pathway for HSPs. In our experiments, the immune regulatory effect of the HSP-bearing exosomes secreted by human hepatocellular carcinoma cells under stress conditions on NK cells was studied. ELISA results showed that the production of HSP60, HSP70, and HSP90 was up-regulated in both cell lines in a stress-specific manner. After exposure to hepatocellular carcinoma cell-resistant or sensitive anticancer drugs (hereafter referred to as "resistant" or "sensitive" anticancer drug), the membrane microvesicles were actively released by hepatocellular carcinoma cells, differing in their ability to present HSPs on the cell surface, which were characterized as exosomes. Acting as a decoy, the HSP-bearing exosomes efficiently stimulated NK cell cytotoxicity and granzyme B production, up-regulated the expression of inhibitory receptor CD94, and down-regulated the expression of activating receptors CD69, NKG2D, and NKp44. Notably, resistant anticancer drugs enhanced exosome release and generated more exosome-carried HSPs, which augmented the activation of the cytotoxic response. In summary, our findings demonstrated that exosomes derived from resistant anticancer drug-treated HepG2 cells conferred superior immunogenicity in inducing HSP-specific NK cell responses, which provided a clue for finding an efficient vaccine for hepatocellular carcinoma immunotherapy.	[Lv, Li-Hong; Wan, Yun-Le; Li, Guo-Lin; Lin, Hao-Ming; Shang, Chang-Zhen; Chen, Ya-Jin; Min, Jun] Sun Yat Sen Univ, Dept Hepatobiliary Surg, Sun Yat Sen Mem Hosp, Guangzhou 510120, Peoples R China; [Lin, Yan] Univ Pittsburgh, Sch Med, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15216 USA; [Zhang, Wei] Zhejiang Univ, Dept Hepatobiliary & Pancreat Surg, Affiliated Hosp 1, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Mei] Guangzhou Mil Command Peoples Liberat Army, Gen Hosp, Dept Gen Surg, Guangzhou 510010, Guangdong, Peoples R China	Sun Yat Sen University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Zhejiang University	Chen, YJ (corresponding author), Sun Yat Sen Univ, Dept Hepatobiliary Surg, Sun Yat Sen Mem Hosp, 107W Yanjiang Rd, Guangzhou 510120, Peoples R China.	cyj0509@126.com; drjmin@yahoo.cn			National High Technology Research and Development Program of China (863 Program) [2007AA02Z117]; National Natural Science Foundation of China [30571805, 30672036, 30671987, 81000065]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National High Technology Research and Development Program of China (863 Program) Grant 2007AA02Z117 and National Natural Science Foundation of China Grants 30571805, 30672036, 30671987, and 81000065.	Abusamra AJ, 2005, BLOOD CELL MOL DIS, V35, P169, DOI 10.1016/j.bcmd.2005.07.001; Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Boige V, 2006, EUR J CANCER, V42, P456, DOI 10.1016/j.ejca.2005.09.034; Boozari B, 2010, GUT, V59, P1416, DOI 10.1136/gut.2009.196519; Cai L, 2008, CLIN IMMUNOL, V129, P428, DOI 10.1016/j.clim.2008.08.012; CARMICHAEL J, 1987, CANCER RES, V47, P936; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; Clayton A, 2009, CURR ONCOL, V16, P187; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; Dai SM, 2005, CLIN CANCER RES, V11, P7554, DOI 10.1158/1078-0432.CCR-05-0810; Elsner L, 2007, J IMMUNOL, V179, P5523, DOI 10.4049/jimmunol.179.8.5523; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Geminard C, 2001, J BIOL CHEM, V276, P9910, DOI 10.1074/jbc.M009641200; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hickman-Miller HD, 2004, TRENDS IMMUNOL, V25, P427, DOI 10.1016/j.it.2004.05.011; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jinushi M, 2005, J HEPATOL, V43, P1013, DOI 10.1016/j.jhep.2005.05.026; Kapsogeorgou EK, 2005, ARTHRITIS RHEUM-US, V52, P1517, DOI 10.1002/art.21005; Knight AM, 2008, EUR J IMMUNOL, V38, P1186, DOI 10.1002/eji.200838374; Koga K, 2005, ANTICANCER RES, V25, P3703; Kuang M, 2004, CLIN CANCER RES, V10, P1574, DOI 10.1158/1078-0432.CCR-03-0071; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; Lord SJ, 2003, IMMUNOL REV, V193, P31, DOI 10.1034/j.1600-065X.2003.00044.x; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Pockley AG, 2003, LANCET, V362, P469, DOI 10.1016/S0140-6736(03)14075-5; RITOSSA P., 1962, RIV 1ST SIEROTERAPITAL, V37, P79; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Savina A, 2002, J CELL SCI, V115, P2505; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Segura E, 2005, BLOOD, V106, P216, DOI 10.1182/blood-2005-01-0220; Taylor DD, 2005, BRIT J CANCER, V92, P305, DOI 10.1038/sj.bjc.6602316; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Trapani JA, 2003, CURR OPIN IMMUNOL, V15, P533, DOI 10.1016/S0952-7915(03)00107-9; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Yeo W, 2005, JNCI-J NATL CANCER I, V97, P1532, DOI 10.1093/jnci/dji315	48	306	323	2	59	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15874	15885		10.1074/jbc.M112.340588	http://dx.doi.org/10.1074/jbc.M112.340588			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22396543	hybrid, Green Published			2022-12-27	WOS:000304006300066
J	Senavirathne, G; Jaszczur, M; Auerbach, PA; Upton, TG; Chelico, L; Goodman, MF; Rueda, D				Senavirathne, Gayan; Jaszczur, Malgorzata; Auerbach, Paul A.; Upton, Thomas G.; Chelico, Linda; Goodman, Myron F.; Rueda, David			Single-stranded DNA Scanning and Deamination by APOBEC3G Cytidine Deaminase at Single Molecule Resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 DNA; SOMATIC HYPERMUTATION; FRET; REPAIR; POLYMERASES; SPECIFICITY; DYNAMICS; DOMAIN; BASES	APOBEC3G (Apo3G) is a single-stranded (ss) DNA cytosine deaminase that eliminates HIV-1 infectivity by converting C -> U in numerous small target motifs on the minus viral cDNA. Apo3G deaminates linear ssDNA in vitro with pronounced spatial asymmetry favoring the 3' -> 5' direction. A similar polarity observed in vivo is believed responsible for initiating localized C -> T mutational gradients that inactivate the virus. When compared with double-stranded (ds) DNA scanning enzymes, e.g. DNA glycosylases that excise rare aberrant bases, there is a paucity of mechanistic studies on ssDNA scanning enzymes. Here, we investigate ssDNA scanning and motif-targeting mechanisms for Apo3G using single molecule Forster resonance energy transfer. We address the specific issue of deamination asymmetry within the general context of ssDNA scanning mechanisms and show that Apo3G scanning trajectories, ssDNA contraction, and deamination efficiencies depend on motif sequence, location, and ionic strength. Notably, we observe the presence of bidirectional quasi-localized scanning of Apo3G occurring proximal to a 5' hot motif, a motif-dependent DNA contraction greatest for 5' hot > 3' hot > 5' cold motifs, and diminished mobility at low salt. We discuss the single molecule Forster resonance energy transfer data in terms of a model in which deamination polarity occurs as a consequence of Apo3G binding to ssDNA in two orientations, one that is catalytically favorable, with the other disfavorable.	[Goodman, Myron F.] Univ So Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA; [Jaszczur, Malgorzata; Auerbach, Paul A.; Upton, Thomas G.; Chelico, Linda; Goodman, Myron F.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Senavirathne, Gayan; Rueda, David] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA	University of Southern California; University of Southern California; Wayne State University	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci, Mol & Computat Biol Sect, 1050 Childs Way, Los Angeles, CA 90089 USA.	mgoodman@usc.edu; david.rueda@wayne.edu	Rueda, David S./F-9065-2014	Rueda, David S./0000-0003-4657-6323; Senavirathne, Gayan/0000-0002-9113-4201; Chelico, Linda/0000-0003-4673-8978	National Institutes of Health [GM085116, ES13192, GM2142]; National Science Foundation [MCB-0747285]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013192, R56ES013192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085116, R01GM021422, R37GM021422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM085116 (to D. R.) and ES13192 and GM21422 (to M. F. G.). This work was also supported by National Science Foundation Grant MCB-0747285 (to D. R.).	Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chelico L, 2009, J BIOL CHEM, V284, P27761, DOI 10.1074/jbc.R109.052449; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Fogg MJ, 2002, NAT STRUCT BIOL, V9, P922, DOI 10.1038/nsb867; Friedman JI, 2010, BIOCHEMISTRY-US, V49, P4957, DOI 10.1021/bi100593a; Gorman J, 2007, MOL CELL, V28, P359, DOI 10.1016/j.molcel.2007.09.008; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Jern P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000367; Lamichhane R, 2010, METHODS, V52, P192, DOI 10.1016/j.ymeth.2010.06.010; Lamichhane R, 2010, P NATL ACAD SCI USA, V107, P4105, DOI 10.1073/pnas.0907072107; Lasken RS, 1996, J BIOL CHEM, V271, P17692, DOI 10.1074/jbc.271.30.17692; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; PETRUSKA J, 1995, J BIOL CHEM, V270, P746, DOI 10.1074/jbc.270.2.746; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pham P, 2011, J BIOL CHEM, V286, P24931, DOI 10.1074/jbc.M111.241208; Suspene R, 2006, NUCLEIC ACIDS RES, V34, P4677, DOI 10.1093/nar/gkl555; Torella JP, 2011, BIOPHYS J, V100, P1568, DOI 10.1016/j.bpj.2011.01.066; Yang B, 2007, J BIOL CHEM, V282, P11667, DOI 10.1074/jbc.M606864200; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhao R, 2009, METHODS, V49, P112, DOI 10.1016/j.ymeth.2009.04.017	34	49	49	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15826	15835		10.1074/jbc.M112.342790	http://dx.doi.org/10.1074/jbc.M112.342790			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22362763	Green Published, hybrid			2022-12-27	WOS:000304006300062
J	Katz, C; Zaltsman-Amir, Y; Mostizky, Y; Kollet, N; Gross, A; Friedler, A				Katz, Chen; Zaltsman-Amir, Yehudit; Mostizky, Yana; Kollet, Neta; Gross, Atan; Friedler, Assaf			Molecular Basis of the Interaction between Proapoptotic Truncated BID (tBID) Protein and Mitochondrial Carrier Homologue 2 (MTCH2) Protein KEY PLAYERS IN MITOCHONDRIAL DEATH PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; BCL-2 FAMILY; BAX; ACTIVATION; INHIBITORS; APOPTOSIS; THERAPY; DAMAGE; CELLS; LIFE	The molecular basis of the interaction between mitochondrial carrier homologue 2 (MTCH2) and truncated BID (tBID) was characterized. These proteins participate in the apoptotic pathway, and the interaction between them may serve as a target for anticancer lead compounds. In response to apoptotic signals, MTCH2 recruits tBID to the mitochondria, where it activates apoptosis. A combination of peptide arrays screening with biochemical and biophysical techniques was used to characterize the mechanism of the interaction between tBID and MTCH2 at the structural and molecular levels. The regions that mediate the interaction between the proteins were identified. The two specific binding sites between the proteins were determined to be tBID residues 59-73 that bind MTCH2 residues 140-161, and tBID residues 111-125 that bind MTCH2 residues 240-290. Peptides derived from tBID residues 111-125 and 59-73 induced cell death in osteosarcoma cells. These peptides may serve as lead compounds for anticancer drugs that act by targeting the tBID-MTCH2 interaction.	[Zaltsman-Amir, Yehudit; Mostizky, Yana; Gross, Atan] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Katz, Chen; Kollet, Neta; Friedler, Assaf] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem	Gross, A (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	atan.gross@weizmann.ac.il; assaf@chem.ch.huji.ac.il	Gross, Atan/ABC-2640-2020		Israel Science Foundation; United States-Israel Binational Science Foundation; Israel Ministry of Health; European Research Council [203413]	Israel Science Foundation(Israel Science Foundation); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Ministry of Health; European Research Council(European Research Council (ERC)European Commission)	Supported by grants from the Israel Science Foundation and from the United States-Israel Binational Science Foundation.; Supported by a grant from the Israel Ministry of Health and by a starting grant from the European Research Council under the European Community Seventh Framework Programme (FP7/2007-2013)/European Research Council Grant 203413.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; AQUILA H, 1982, H-S Z PHYSIOL CHEM, V363, P345; Billen LP, 2008, ONCOGENE, V27, pS93, DOI 10.1038/onc.2009.47; Bruncko M, 2007, J MED CHEM, V50, P641, DOI 10.1021/jm061152t; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Cogliati S, 2010, CELL RES, V20, P863, DOI 10.1038/cr.2010.100; Coster G, 2007, J BIOL CHEM, V282, P32053, DOI 10.1074/jbc.M705890200; del Arco A, 2005, CELL MOL LIFE SCI, V62, P2204, DOI 10.1007/s00018-005-5197-x; Friedler A, 2002, P NATL ACAD SCI USA, V99, P937, DOI 10.1073/pnas.241629998; Grinberg M, 2005, MOL CELL BIOL, V25, P4579, DOI 10.1128/MCB.25.11.4579-4590.2005; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Katz C, 2008, P NATL ACAD SCI USA, V105, P12277, DOI 10.1073/pnas.0711269105; Katz C, 2011, CHEM SOC REV, V40, P2131, DOI 10.1039/c0cs00029a; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Ng MCY, 2010, J CLIN ENDOCR METAB, V95, P2418, DOI 10.1210/jc.2009-2077; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7; Schwarz M, 2007, APOPTOSIS, V12, P869, DOI 10.1007/s10495-007-0748-2; Veresov VG, 2009, EUR BIOPHYS J BIOPHY, V38, P941, DOI 10.1007/s00249-009-0475-4; Wei MC, 2000, GENE DEV, V14, P2060; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yerushalmi GM, 2002, NEOPLASIA, V4, P510, DOI 10.1038/sj.neo.7900272; Yin XM, 2006, GENE, V369, P7, DOI 10.1016/j.gene.2005.10.038; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057; Zhang QH, 2000, GENOME RES, V10, P1546, DOI 10.1101/gr.140200; Zhao JH, 2009, OBESITY, V17, P2254, DOI 10.1038/oby.2009.159	35	29	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15016	15023		10.1074/jbc.M111.328377	http://dx.doi.org/10.1074/jbc.M111.328377			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22416135	Green Published, hybrid			2022-12-27	WOS:000304003200063
J	Morgan, JA; Cheepala, SB; Wang, Y; Neale, G; Adachi, M; Nachagari, D; Leggas, M; Zhao, WC; Boyd, K; Venkataramanan, R; Schuetz, JD				Morgan, Jessica A.; Cheepala, Satish B.; Wang, Yao; Neale, Geoff; Adachi, Masashi; Nachagari, Deepa; Leggas, Mark; Zhao, Wenchen; Boyd, Kelli; Venkataramanan, Raman; Schuetz, John D.			Deregulated Hepatic Metabolism Exacerbates Impaired Testosterone Production in Mrp4-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MULTIDRUG-RESISTANCE PROTEIN-4; MRP4 CONFERS RESISTANCE; RAT LEYDIG-CELLS; HORMONAL-REGULATION; CHORIONIC-GONADOTROPIN; HUMAN CYTOCHROME-P450; FUNCTIONAL-ANALYSIS; GENE-EXPRESSION; MOUSE-LIVER	The physiological role of multidrug resistance protein 4 (Mrp4, Abcc4) in the testes is unknown. We found that Mrp4 is expressed primarily in mouse and human Leydig cells; however, there is no current evidence that Mrp4 regulates testosterone production. We investigated its role in Leydig cells, where testosterone production is regulated by cAMP, an intracellular messenger formed when the luteinizing hormone (LH) receptor is activated. Because Mrp4 regulates cAMP, we compared testosterone levels in Mrp4(-/-) and Mrp4(-/-) mice. Young Mrp4(-/-) mice had significantly impaired gametogenesis, reduced testicular testosterone, and disruption of Leydig cell cAMP homeostasis. Both young and adult mice had impaired testosterone production. In Mrp4(-/-) primary Leydig cells treated with LH, intracellular cAMP production was impaired and cAMP-response element-binding protein(CREB) phosphorylation was strongly attenuated. Notably, expression of CREB target genes that regulate testosterone biosynthesis was reduced in Mrp4(-/-) Leydig cells in vivo. Therefore, Mrp4 is required for normal Leydig cell testosterone production. However, adult Mrp4(-/-) mice are fertile, with a normal circulating testosterone concentration. The difference is that in 3-week-old Mrp4(-/-) mice, disruption of gonadal testosterone production up-regulates hepatic Cyp2b10, a known testosterone-metabolizing enzyme. Therefore, defective testicular testosterone production de-regulates hepatic Cyp-mediated testosterone metabolism to disrupt gametogenesis. These findings have important implications for understanding the side effects of therapeutics that disrupt Mrp4 function and are reported to alter androgen production.	[Morgan, Jessica A.; Cheepala, Satish B.; Wang, Yao; Adachi, Masashi; Nachagari, Deepa; Leggas, Mark; Schuetz, John D.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Neale, Geoff] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Boyd, Kelli] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Zhao, Wenchen; Venkataramanan, Raman] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA 15261 USA; [Morgan, Jessica A.] Univ Tennessee, Hlth Sci Ctr, Integrated Program Biomed Sci, Memphis, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Tennessee System; University of Tennessee Health Science Center	Schuetz, JD (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, MS 313,262 Danny Thomas Pl, Memphis, TN 38105 USA.	John.Schuetz@stjude.org	Morgan, James/N-8104-2018; Zhao, Wenchen/D-1867-2017; Morgan, James/GRO-2905-2022	Zhao, Wenchen/0000-0002-0501-8459; Morgan, James/0000-0002-8920-1065	National Institutes of Health [2R01GM60904, P30CA21745, CA21865]; American Lebanese Associated Charities (ALSAC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants 2R01GM60904, P30CA21745, and CA21865 and by the American Lebanese Associated Charities (ALSAC).	Abla N, 2008, J PHARMACOL EXP THER, V325, P859, DOI 10.1124/jpet.108.136523; Adachi M, 2002, J BIOL CHEM, V277, P38998, DOI 10.1074/jbc.M203262200; Asada S, 2001, J HEALTH SCI, V47, P60, DOI 10.1248/jhs.47.60; Badri SNP, 2000, ENDOCR RES, V26, P247, DOI 10.3109/07435800009066165; BAIN PA, 1991, P NATL ACAD SCI USA, V88, P8870, DOI 10.1073/pnas.88.20.8870; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Bendre SV, 2005, MUTAT RES-FUND MOL M, V578, P1, DOI 10.1016/j.mrfmmm.2004.09.018; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen ZS, 2002, CANCER RES, V62, P3144; Chen ZS, 2001, J BIOL CHEM, V276, P33747, DOI 10.1074/jbc.M104833200; Choi MH, 2005, DRUG METAB DISPOS, V33, P714, DOI 10.1124/dmd.104.003327; Conte D, 1999, AM J PHYSIOL-ENDOC M, V277, pE1032, DOI 10.1152/ajpendo.1999.277.6.E1032; Dhir RN, 2006, J PHARMACOL EXP THER, V316, P87, DOI 10.1124/jpet.105.093773; DIDOLKAR AK, 1980, INT J ANDROL, V3, P585, DOI 10.1111/j.1365-2605.1980.tb00146.x; DUFAU ML, 1988, ANNU REV PHYSIOL, V50, P483, DOI 10.1146/annurev.ph.50.030188.002411; Eacker SM, 2008, MOL ENDOCRINOL, V22, P623, DOI 10.1210/me.2006-0534; El-Sheikh AAK, 2007, J PHARMACOL EXP THER, V320, P229, DOI 10.1124/jpet.106.110379; Faqi AS, 1997, HUM EXP TOXICOL, V16, P505, DOI 10.1177/096032719701600905; Ge RS, 2005, BIOL REPROD, V72, P1405, DOI 10.1095/biolreprod.104.037499; Ho LL, 2008, PROSTATE, V68, P1421, DOI 10.1002/pros.20809; HONKAKOSKI P, 1992, BIOCHEM J, V285, P979, DOI 10.1042/bj2850979; Janke D, 2008, HUM MUTAT, V29, P659, DOI 10.1002/humu.20694; Janvilisri T, 2003, J BIOL CHEM, V278, P20645, DOI 10.1074/jbc.M301358200; Kawamoto T, 2000, MOL ENDOCRINOL, V14, P1897, DOI 10.1210/me.14.11.1897; Kim JM, 2001, ENDOCRINOLOGY, V142, P3809, DOI 10.1210/en.142.9.3809; Kishi H, 1997, FEBS LETT, V402, P198, DOI 10.1016/S0014-5793(96)01528-1; Kool M, 1997, CANCER RES, V57, P3537; Krishnamurthy P, 2008, CANCER RES, V68, P4983, DOI 10.1158/0008-5472.CAN-07-6790; KRUEGER KE, 1990, J BIOL CHEM, V265, P15015; Leggas M, 2004, MOL CELL BIOL, V24, P7612, DOI 10.1128/MCB.24.17.7612-7621.2004; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Marker PC, 2003, DEV BIOL, V253, P165, DOI 10.1016/S0012-1606(02)00031-3; MCLACHLAN RI, 1994, BIOL REPROD, V50, P271, DOI 10.1095/biolreprod50.2.271; Mendis-Handagama SMLC, 1998, TISSUE CELL, V30, P64, DOI 10.1016/S0040-8166(98)80007-4; Nikolsky Y, 2009, METHODS MOL BIOL, V563, P177, DOI 10.1007/978-1-60761-175-2_10; Nozaki Y, 2007, J PHARMACOL EXP THER, V322, P1162, DOI 10.1124/jpet.107.121491; O'Shaughnessy PJ, 2002, BIOL REPROD, V66, P966, DOI 10.1095/biolreprod66.4.966; O'Shaughnessy PJ, 2002, J CELL SCI, V115, P3491; PAPADOPOULOS V, 1993, ENDOCR REV, V14, P222, DOI 10.1210/er.14.2.222; PAYNE AH, 1995, BIOL REPROD, V52, P217, DOI 10.1095/biolreprod52.2.217; Polifka JE, 2002, TERATOLOGY, V65, P240, DOI 10.1002/tera.10043; Ruwanpura SM, 2010, J ENDOCRINOL, V205, P117, DOI 10.1677/JOE-10-0025; Sakuma T, 2000, ARCH BIOCHEM BIOPHYS, V377, P153, DOI 10.1006/abbi.2000.1747; SCHUMACHER M, 1978, FEBS LETT, V91, P333, DOI 10.1016/0014-5793(78)81204-6; SEGALOFF DL, 1990, MOL ENDOCRINOL, V4, P1856, DOI 10.1210/mend-4-12-1856; Shalet SM, 2009, PEDIATR BLOOD CANCER, V53, P285, DOI 10.1002/pbc.22000; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; Suzuki T, 2003, MOL ENDOCRINOL, V17, P1203, DOI 10.1210/me.2002-0304; Vasta V, 2006, P NATL ACAD SCI USA, V103, P19925, DOI 10.1073/pnas.0609483103; Walker WH, 2009, STEROIDS, V74, P602, DOI 10.1016/j.steroids.2008.11.017; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; Wolgemuth DJ, 2002, RECENT PROG HORM RES, V57, P75, DOI 10.1210/rp.57.1.75; Wykes SM, 2003, J BIOL CHEM, V278, P29471, DOI 10.1074/jbc.M304545200; Zelcer N, 2003, BIOCHEM J, V371, P361, DOI 10.1042/BJ20021886; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zhang YY, 2009, EXPERT OPIN DRUG MET, V5, P621, DOI 10.1517/17425250902967648	58	29	29	12	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14456	14466		10.1074/jbc.M111.319681	http://dx.doi.org/10.1074/jbc.M111.319681			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22375007	hybrid, Green Published			2022-12-27	WOS:000304003200013
J	Qiang, L; Tsuchiya, K; Kim-Muller, JY; Lin, HV; Welch, C; Accili, D				Qiang, Li; Tsuchiya, Kyoichiro; Kim-Muller, Ja-Young; Lin, Hua V.; Welch, Carrie; Accili, Domenico			Increased Atherosclerosis and Endothelial Dysfunction in Mice Bearing Constitutively Deacetylated Alleles of Foxo1 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; INSULIN-RESISTANCE; GLUCOSE CONTROL; DISEASE; MECHANISMS; APOPTOSIS; STRESS; PHOSPHORYLATION; DIFFERENTIATION; ABNORMALITIES	Complications of atherosclerosis are the leading cause of death of patients with type 2 (insulin-resistant) diabetes. Understanding the mechanisms by which insulin resistance and hyperglycemia contribute to atherogenesis in key target tissues (liver, vessel wall, hematopoietic cells) can assist in the design of therapeutic approaches. We have shown that hyperglycemia induces FoxO1 deacetylation and that targeted knock-in of alleles encoding constitutively deacetylated FoxO1 in mice (Foxo1(KR/KR)) improves hepatic lipid metabolism and decreases macrophage inflammation, setting the stage for a potential anti-atherogenic effect of this mutation. Surprisingly, we report here that when Foxo1KR/KR mice are intercrossed with low density lipoprotein receptor knock-out mice (Ldlr(-/-)), they develop larger aortic root atherosclerotic lesions than Ldlr(-/-) controls despite lower plasma cholesterol and triglyceride levels. The phenotype is unaffected by transplanting bone marrow from Ldlr(-/-) mice into Foxo1KR/KR mice, indicating that it is independent of hematopoietic cells and suggesting that the primary lesion in Foxo1KR/KR mice occurs in the vessel wall. Experiments in isolated endothelial cells from Foxo1KR/KR mice indicate that deacetylation favors FoxO1 nuclear accumulation and exerts target gene-specific effects, resulting in higher Icam1 and Tnf alpha expression and increased monocyte adhesion. The data indicate that FoxO1 deacetylation can promote vascular endothelial changes conducive to atherosclerotic plaque formation.	Columbia Univ, Berrie Diabet Ctr, New York, NY 10032 USA; Columbia Univ, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University	Accili, D (corresponding author), 1150 St Nicholas Ave,Rm 238, New York, NY 10032 USA.	da230@columbia.edu		Qiang, Li/0000-0001-8322-1797; Lin, Hua/0000-0001-5001-5567	National Institutes of Health [HL87123, DK57539, DK63608]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057539, P30DK063608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL87123, DK57539, and DK63608 (to D. A.).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Banks AS, 2011, CELL METAB, V14, P587, DOI 10.1016/j.cmet.2011.09.012; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Boyle PJ, 2007, AM J MED, V120, pS12, DOI 10.1016/j.amjmed.2007.07.003; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Caro JJ, 2002, DIABETES CARE, V25, P476, DOI 10.2337/diacare.25.3.476; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; Fernandez-Hernando C, 2009, ARTERIOSCL THROM VAS, V29, P2033, DOI 10.1161/ATVBAHA.109.196394; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Haeusler RA, 2012, CELL METAB, V15, P65, DOI 10.1016/j.cmet.2011.11.010; Haeusler RA, 2010, J BIOL CHEM, V285, P26861, DOI 10.1074/jbc.M110.134023; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; Han S, 2009, J CLIN INVEST, V119, P1029, DOI 10.1172/JCI36523; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Howard G, 1996, CIRCULATION, V93, P1809, DOI 10.1161/01.CIR.93.10.1809; Kevil CG, 2001, AM J PHYSIOL-CELL PH, V281, pC1442, DOI 10.1152/ajpcell.2001.281.5.C1442; Kido Y, 2000, DIABETES, V49, P589, DOI 10.2337/diabetes.49.4.589; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Kitamura T, 2009, MOL CELL BIOL, V29, P4417, DOI 10.1128/MCB.01622-08; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Lee JW, 2011, J BIOL CHEM, V286, P6423, DOI 10.1074/jbc.M110.180661; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Qiang L, 2011, CELL METAB, V14, P758, DOI 10.1016/j.cmet.2011.10.007; Qiang L, 2010, J BIOL CHEM, V285, P27396, DOI 10.1074/jbc.M110.140228; Rask-Madsen C, 2010, CELL METAB, V11, P379, DOI 10.1016/j.cmet.2010.03.013; Rask-Madsen C, 2007, NAT CLIN PRACT ENDOC, V3, P46, DOI 10.1038/ncpendmet0366; Senokuchi T, 2008, DIABETES, V57, P2967, DOI 10.2337/db08-0520; Tabas I, 2010, CIRC RES, V106, P58, DOI 10.1161/CIRCRESAHA.109.208488; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Tanaka J, 2009, DIABETES, V58, P2344, DOI 10.2337/db09-0167; Tsuchiya K, 2012, CELL METAB, V15, P372, DOI 10.1016/j.cmet.2012.01.018; Tsuchiya K, 2011, ARTERIOSCL THROM VAS, V31, P2920, DOI 10.1161/ATVBAHA.110.219477	38	33	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13944	13951		10.1074/jbc.M111.332767	http://dx.doi.org/10.1074/jbc.M111.332767			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22389493	Green Published, hybrid			2022-12-27	WOS:000303996300049
J	Sczaniecka, M; Gladstone, K; Pettersson, S; McLaren, L; Huart, AS; Wallace, M				Sczaniecka, Matylda; Gladstone, Karen; Pettersson, Susanne; McLaren, Lorna; Huart, Anne-Sophie; Wallace, Maura			MDM2 Protein-mediated Ubiquitination of NUMB Protein IDENTIFICATION OF A SECOND PHYSIOLOGICAL SUBSTRATE OF MDM2 THAT EMPLOYS A DUAL-SITE DOCKING MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN NUMB; ONCOPROTEIN MDM2; P53 STABILITY; ACIDIC DOMAIN; PTB DOMAIN; IN-VIVO; RECOGNITION; ACTIVATION; REGULATOR; PATHWAY	The E3 ubiquitin ligase, MDM2, uses a dual-site mechanism to ubiquitinate and degrade the tumor suppressor protein p53, involving interactions with the N-terminal hydrophobic pocket and the acidic domain of MDM2. The results presented here demonstrate that MDM2 also uses this same dual-site mechanism to bind to the cell fate determinant NUMB with both the N-terminal hydrophobic pocket and the acidic domain of MDM2 also involved in forming the interaction with NUMB. Furthermore, the acidic domain interactions are crucial for MDM2-mediated ubiquitination of NUMB. Contrary to p53, where two separate domains form the interface with MDM2, only one region within the phosphotyrosine binding domain of NUMB (amino acids 113-148) mediates binding to both these regions of MDM2. By binding to both domains on MDM2, NUMB disrupts the MDM2-p53 complex and MDM2-catalyzed ubiquitination of p53. Therefore, we have identified the mechanism NUMB uses to regulate the steady-state levels of the p53 in cells. By targeting the acidic domain of MDM2 using acid domain-binding ligands we can overcome MDM2-mediated ubiquitination and degradation of NUMB impacting on the stabilization of p53 in cells. Furthermore, delivery of MDM2 acid domain-binding ligands to cancer cells promotes p53-dependent growth arrest and the induction of apoptosis. This highlights the dual-site mechanism of MDM2 on another physiological substrate and identifies the acid domain as well as N terminus as a potential target for small molecules that inhibit MDM2.	[Sczaniecka, Matylda; Gladstone, Karen; Pettersson, Susanne; McLaren, Lorna; Wallace, Maura] Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland; [Sczaniecka, Matylda; Gladstone, Karen; Pettersson, Susanne; McLaren, Lorna; Wallace, Maura] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush EH25 9RG, Midlothian, Scotland; [Huart, Anne-Sophie] Univ Edinburgh, Div Canc Biol, Inst Genet & Mol Med, CRUK Signal Transduct Grp P53, Edinburgh EH4 2XR, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh	Wallace, M (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland.	maura.wallace@roslin.ed.ac.uk		Huart, Anne-Sophie/0000-0003-0913-1501	Cancer Research UK; Breast Cancer Campaign	Cancer Research UK(Cancer Research UK); Breast Cancer Campaign	This work was also supported by Cancer Research UK and the Breast Cancer Campaign.	Arumugam M, 2009, CELL CYCLE, V8, P2828; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Bothner B, 2001, J MOL BIOL, V314, P263, DOI 10.1006/jmbi.2001.5110; Brown C. J., TRENDS PHARM SCI, V32, P53; Carter S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-221; Cheok CF, 2007, MOL CANCER RES, V5, P1133, DOI 10.1158/1541-7786.MCR-07-0161; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Dho SE, 1998, J BIOL CHEM, V273, P9179, DOI 10.1074/jbc.273.15.9179; Gulino A, 2010, EXP CELL RES, V316, P900, DOI 10.1016/j.yexcr.2009.11.017; Harada Hiroshi, 2006, Breast Cancer, V13, P16, DOI 10.2325/jbcs.13.16; Harbour JW, 2002, ARCH OPHTHALMOL-CHIC, V120, P1341, DOI 10.1001/archopht.120.10.1341; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Huart AS, 2009, J BIOL CHEM, V284, P32384, DOI 10.1074/jbc.M109.052647; Juven-Gershon T, 1998, MOL CELL BIOL, V18, P3974, DOI 10.1128/MCB.18.7.3974; Kabouridis PS, 2003, TRENDS BIOTECHNOL, V21, P498, DOI 10.1016/j.tibtech.2003.09.008; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; Liu WL, 2001, J MOL BIOL, V313, P711, DOI 10.1006/jmbi.2001.5082; Meek DW, 2010, SEMIN CANCER BIOL, V20, P19, DOI 10.1016/j.semcancer.2009.10.005; Meulmeester E, 2003, MOL CELL BIOL, V23, P4929, DOI 10.1128/MCB.23.14.4929-4938.2003; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Pamment J, 2002, ONCOGENE, V21, P7776, DOI 10.1038/sj.onc.1205981; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Pece S, 2011, BBA-REV CANCER, V1815, P26, DOI 10.1016/j.bbcan.2010.10.001; Pettersson S, 2009, BIOCHEM J, V418, P575, DOI 10.1042/BJ20082087; Sdek P, 2004, J BIOL CHEM, V279, P53317, DOI 10.1074/jbc.M406062200; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Verdi J, 1996, CURR BIOL, V6, P1134, DOI 10.1016/S0960-9822(02)70680-5; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wawrzynow B, 2007, J BIOL CHEM, V282, P32603, DOI 10.1074/jbc.M702767200; Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801; Yogosawa S, 2003, BIOCHEM BIOPH RES CO, V302, P869, DOI 10.1016/S0006-291X(03)00282-1; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200; Zhang Z, 2005, ANN NY ACAD SCI, V1058, P205, DOI 10.1196/annals.1359.030; Zwahlen C, 2000, EMBO J, V19, P1505, DOI 10.1093/emboj/19.7.1505	42	38	39	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14052	14068		10.1074/jbc.M111.303875	http://dx.doi.org/10.1074/jbc.M111.303875			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22337874	Green Published, hybrid			2022-12-27	WOS:000303996300059
J	Kamath-Loeb, AS; Shen, JC; Schmitt, MW; Loeb, LA				Kamath-Loeb, Ashwini S.; Shen, Jiang-Cheng; Schmitt, Michael W.; Loeb, Lawrence A.			The Werner Syndrome Exonuclease Facilitates DNA Degradation and High Fidelity DNA Polymerization by Human DNA Polymerase delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME PROTEIN; REPLICATION FORK; P12 SUBUNIT; FUNCTIONAL INTERACTION; REPEAT SEQUENCE; IN-VITRO; HELICASE; DAMAGE; WRN; MUTATIONS	DNA Polymerase delta (Pol delta) and the Werner syndrome protein, WRN, are involved in maintaining cellular genomic stability. Pol delta synthesizes the lagging strand during replication of genomic DNA and also functions in the synthesis steps of DNA repair and recombination. WRN is a member of the RecQ helicase family, loss of which results in the premature aging and cancer-prone disorder, Werner syndrome. Both Pol delta and WRN encode 3' -> 5' DNA exonuclease activities. Pol delta exonuclease removes 3'-terminal mismatched nucleotides incorporated during replication to ensure high fidelity DNA synthesis. WRN exonuclease degrades DNA containing alternate secondary structures to prevent formation and enable resolution of stalled replication forks. We now observe that similarly to WRN, Pol delta degrades alternate DNA structures including bubbles, four-way junctions, and D-loops. Moreover, WRN and Pol delta form a complex with enhanced ability to hydrolyze these structures. We also present evidence that WRN can proofread for Pol delta; WRN excises 3'-terminal mismatches to enable primer extension by Pol delta. Consistent with our in vitro observations, we show that WRN contributes to the maintenance of DNA synthesis fidelity in vivo. Cells expressing limiting amounts (similar to 10% of normal) of WRN have elevated mutation frequencies compared with wildtype cells. Together, our data highlight the importance of WRN exonuclease activity and its cooperativity with Pol delta -in preserving genome stability, which is compromised by the loss of WRN in Werner syndrome.	[Schmitt, Michael W.; Loeb, Lawrence A.] Univ Washington, Dept Pathol & Biochem, Seattle, WA 98195 USA; [Kamath-Loeb, Ashwini S.; Shen, Jiang-Cheng] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Loeb, LA (corresponding author), Univ Washington, Dept Pathol & Biochem, 1959 NE Pacific St, Seattle, WA 98195 USA.	laloeb@uw.edu			National Institutes of Health [P01-CA77852, R01-CA102029, P01-AG0751]; NATIONAL CANCER INSTITUTE [P01CA077852, R01CA102029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01-CA77852, R01-CA102029, and P01-AG0751 (to L. A. L.).	Bacolla A, 2011, J BIOL CHEM, V286, P10017, DOI 10.1074/jbc.M110.176636; Bielas JH, 2005, NAT METHODS, V2, P285, DOI 10.1038/NMETH751; Brosh RM, 2001, J BIOL CHEM, V276, P3024, DOI 10.1074/jbc.M006784200; Compton SA, 2008, J BIOL CHEM, V283, P24478, DOI 10.1074/jbc.M803370200; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; Fazlieva R, 2009, NUCLEIC ACIDS RES, V37, P2854, DOI 10.1093/nar/gkp155; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893; Gerik KJ, 1998, J BIOL CHEM, V273, P19747, DOI 10.1074/jbc.273.31.19747; Goldsby RE, 2001, NAT MED, V7, P638, DOI 10.1038/88963; Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239; Grandori C, 2003, GENE DEV, V17, P1569, DOI 10.1101/gad.1100303; Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100; Harrigan JA, 2006, NUCLEIC ACIDS RES, V34, P745, DOI 10.1093/nar/gkj475; Hsu JJ, 2010, MOL CARCINOGEN, V49, P166, DOI 10.1002/mc.20586; Hubscher U., 2010, DNA POLYM DISCOVERY; Kamath-Loeb AS, 2000, P NATL ACAD SCI USA, V97, P4603, DOI 10.1073/pnas.97.9.4603; Kamath-Loeb AS, 1998, J BIOL CHEM, V273, P34145, DOI 10.1074/jbc.273.51.34145; Kamath-Loeb AS, 2001, J BIOL CHEM, V276, P16439, DOI 10.1074/jbc.M100253200; Kamath-Loeb AS, 2007, P NATL ACAD SCI USA, V104, P10394, DOI 10.1073/pnas.0702513104; Li BM, 2000, J BIOL CHEM, V275, P28349, DOI 10.1074/jbc.C000289200; Li BM, 2001, J BIOL CHEM, V276, P9896, DOI 10.1074/jbc.M008575200; Machwe A, 2007, NUCLEIC ACIDS RES, V35, P5729, DOI 10.1093/nar/gkm561; Machwe A, 2011, BIOCHEMISTRY-US, V50, P6774, DOI 10.1021/bi2001054; Maloisel L, 2004, GENETICS, V167, P1133, DOI 10.1534/genetics.104.026260; Maloisel L, 2008, MOL CELL BIOL, V28, P1373, DOI 10.1128/MCB.01651-07; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Meng X, 2010, BIOCHEMISTRY-US, V49, P3545, DOI 10.1021/bi100042b; Meng X, 2009, NUCLEIC ACIDS RES, V37, P647, DOI 10.1093/nar/gkn1000; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; Mushegian AR, 1997, P NATL ACAD SCI USA, V94, P5831, DOI 10.1073/pnas.94.11.5831; Orren DK, 2002, BIOCHEMISTRY-US, V41, P13483, DOI 10.1021/bi0266986; Podust VN, 2002, J BIOL CHEM, V277, P3894, DOI 10.1074/jbc.M109684200; Rossi ML, 2010, DNA REPAIR, V9, P331, DOI 10.1016/j.dnarep.2009.12.011; Sambrook J, 2001, MOL CLONING LAB MANU; Schmitt MW, 2009, BIOCHIMIE, V91, P1163, DOI 10.1016/j.biochi.2009.06.007; Shah SN, 2010, NUCLEIC ACIDS RES, V38, P1149, DOI 10.1093/nar/gkp1131; Shen JC, 2000, NUCLEIC ACIDS RES, V28, P3260, DOI 10.1093/nar/28.17.3260; Shen JC, 1998, J BIOL CHEM, V273, P34139, DOI 10.1074/jbc.273.51.34139; Shevelev IV, 2002, NAT REV MOL CELL BIO, V3, P364, DOI 10.1038/nrm804; Sidorova JM, 2008, CELL CYCLE, V7, P796, DOI 10.4161/cc.7.6.5566; Szekely AM, 2000, P NATL ACAD SCI USA, V97, P11365, DOI 10.1073/pnas.97.21.11365; Wright JH, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr142; Zhang SF, 2007, J BIOL CHEM, V282, P15330, DOI 10.1074/jbc.M610356200	46	34	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12480	12490		10.1074/jbc.M111.332577	http://dx.doi.org/10.1074/jbc.M111.332577			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351772	Green Published, hybrid			2022-12-27	WOS:000302782200087
J	Kim, D; Song, J; Kim, S; Park, HM; Chun, CH; Sonn, J; Jin, EJ				Kim, Dongkyun; Song, Jinsoo; Kim, Sunhyo; Park, Hyang Mi; Chun, Churl-Hong; Sonn, Jongkyung; Jin, Eun-Jung			RETRACTED: MicroRNA-34a Modulates Cytoskeletal Dynamics through Regulating RhoA/Rac1 Cross-talk in Chondroblasts (Retracted article. See vol. 295, pg. 668, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							ACTIN STRESS FIBERS; PROTEIN-KINASE-C; DOWN-REGULATION; CHONDROGENIC DIFFERENTIATION; TUMOR-SUPPRESSOR; FOCAL ADHESIONS; CELL-ADHESION; N-CADHERIN; EXPRESSION; CONDENSATION	MicroRNAs (miRNAs) have been implicated in various cellular processes, such as cell fate determination, cell death, and tumorigenesis. In the present study, we investigated the role of miRNA-34a (miR-34a) in the reorganization of the actin cytoskeleton, which is essential for chondrocyte differentiation. miRNA arrays to identify genes that appeared to be up-regulated or down-regulated during chondrogenesis were applied with chondrogenic progenitors treated with JNK inhibitor. PNA-based antisense oligonucleotides and miRNA precursor were used for investigation of the functional roles of miR-34a. We found that, in chick chondroprogenitors treated with JNK inhibitor, which suppresses chondrogenic differentiation, the expression levels of miR-34a and RhoA1 are up-regulated through modulation of Rac1 expression. Blockade of miR-34a via the use of PNA-based antisense oligonucleotides was associated with decreased protein expression of RhoA (a known modulator of stress fiber expression), down-regulation of stress fibers, up-regulation of Rac1, and recovery of protein level of type II collagen. miR-34a regulates RhoA/Rac1 cross-talk and negatively modulates reorganization of the actin cytoskeleton, which is one of the essential processes for establishing chondrocyte-specific morphology.	[Kim, Dongkyun; Song, Jinsoo; Kim, Sunhyo; Jin, Eun-Jung] Wonkwang Univ, Coll Nat Sci, Dept Biol Sci, Iksan 570749, Chunbuk, South Korea; [Chun, Churl-Hong] Wonkwang Univ, Sch Med, Dept Orthoped Surg, Iksan 570749, Chunbuk, South Korea; [Sonn, Jongkyung] Kyungpook Natl Univ, Coll Nat Sci, Dept Biol Sci, Taegu 730090, South Korea; [Park, Hyang Mi] Natl Inst Crop Sci, RDA, Suwon 441857, South Korea	Wonkwang University; Wonkwang University; Kyungpook National University; Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science	Jin, EJ (corresponding author), Wonkwang Univ, Coll Nat Sci, Dept Biol Sci, Iksan 570749, Chunbuk, South Korea.	jineunjung@wku.ac.kr			National Research Foundation of Korea [KRF-2011-0005719]; Korean Government	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government)	This work was supported by National Research Foundation of Korea Grant KRF-2011-0005719 funded by the Korean Government.	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Ballock R. Tracy, 2003, Birth Defects Research, V69, P123, DOI 10.1002/bdrc.10014; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; CHOI B, 1995, BIOCHEM BIOPH RES CO, V216, P1034, DOI 10.1006/bbrc.1995.2724; Connelly JT, 2008, J CELL PHYSIOL, V217, P145, DOI 10.1002/jcp.21484; DANIELS K, 1991, J CELL SCI, V100, P249; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Friedman LM, 2009, P NATL ACAD SCI USA, V106, P7915, DOI 10.1073/pnas.0812446106; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Hwang SG, 2005, FEBS LETT, V579, P4837, DOI 10.1016/j.febslet.2005.07.067; Idowu BD, 2000, HISTOCHEM J, V32, P165, DOI 10.1023/A:1004095207330; Jin EJ, 2007, DEV BIOL, V308, P474, DOI 10.1016/j.ydbio.2007.06.003; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kasinath BS, 2009, AM J PHYSIOL-RENAL, V297, pF1153, DOI 10.1152/ajprenal.90748.2008; Kim D, 2010, J BIOL CHEM, V285, P26900, DOI 10.1074/jbc.M110.115105; Kim SH, 2003, FEBS LETT, V553, P433, DOI 10.1016/S0014-5793(03)01047-0; KULYK WM, 1992, J CRAN GENET DEV BIO, V12, P90; Langelier E, 2000, J HISTOCHEM CYTOCHEM, V48, P1307, DOI 10.1177/002215540004801002; Lee VA, 2007, MOL CELLS, V24, P9; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Lim YB, 2003, J CELL BIOCHEM, V88, P713, DOI 10.1002/jcb.10389; Lu L, 2008, BIOPHYS J, V95, P6060, DOI 10.1529/biophysj.108.133462; Martino S, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/654346; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Nakahara K, 2004, CURR OPIN CELL BIOL, V16, P127, DOI 10.1016/j.ceb.2004.02.006; Nakajima M, 2004, BIOCHEM BIOPH RES CO, V320, P1069, DOI 10.1016/j.bbrc.2004.06.057; Niessen CM, 2006, CELL, V127, P875, DOI 10.1016/j.cell.2006.11.014; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Oh CD, 2000, J BIOL CHEM, V275, P5613, DOI 10.1074/jbc.275.8.5613; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Pang RTK, 2010, CARCINOGENESIS, V31, P1037, DOI 10.1093/carcin/bgq066; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Shum L, 2002, ARTHRITIS RES, V4, P94, DOI 10.1186/ar396; Skaftnesmo KO, 2007, CURR PHARM BIOTECHNO, V8, P320, DOI 10.2174/138920107783018390; SONN JK, 1993, DIFFERENTIATION, V53, P155, DOI 10.1111/j.1432-0436.1993.tb00704.x; Sossey-Alaoui K, 2009, J BIOL CHEM, V284, P33019, DOI 10.1074/jbc.M109.034553; Soukup GA, 2009, DEV BIOL, V328, P328, DOI 10.1016/j.ydbio.2009.01.037; Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200; VONDERMARK K, 1977, J BONE JOINT SURG BR, V59, P458, DOI 10.1302/0301-620X.59B4.72756; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200; Woods A, 2007, J BIOL CHEM, V282, P23500, DOI 10.1074/jbc.M700680200; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Zelzer E, 2003, NATURE, V423, P343, DOI 10.1038/nature01659	56	35	35	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12501	12509		10.1074/jbc.M111.264382	http://dx.doi.org/10.1074/jbc.M111.264382			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351754	hybrid, Green Published			2022-12-27	WOS:000302782200089
J	Dolezal, D; Jones, CE; Lai, XQ; Brister, JR; Mueser, TC; Nossal, NG; Hinton, DM				Dolezal, Darin; Jones, Charles E.; Lai, Xiaoqin; Brister, J. Rodney; Mueser, Timothy C.; Nossal, Nancy G.; Hinton, Deborah M.			Mutational Analysis of the T4 Gp59 Helicase Loader Reveals Its Sites for Interaction with Helicase, Single-stranded Binding Protein, and DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE 59 PROTEIN; VIROLOGY JOURNAL SERIES; REPLICATION FORK; ASSEMBLY PROTEIN; LOADING PROTEIN; BACTERIOPHAGE-T4 REPLISOME; CRYSTAL-STRUCTURE; PURIFICATION; POLYMERASE; COMPLEX	Efficient DNA replication involves coordinated interactions among DNA polymerase, multiple factors, and the DNA. From bacteriophage T4 to eukaryotes, these factors include a helicase to unwind the DNA ahead of the replication fork, a single-stranded binding protein (SSB) to bind to the ssDNA on the lagging strand, and a helicase loader that associates with the fork, helicase, and SSB. The previously reported structure of the helicase loader in the T4 system, gene product (gp) 59, has revealed an N-terminal domain, which shares structural homology with the high mobility group (HMG) proteins from eukaryotic organisms. Modeling of this structure with fork DNA has suggested that the HMG-like domain could bind to the duplex DNA ahead of the fork, whereas the C-terminal portion of gp59 would provide the docking sites for helicase (T4 gp41), SSB (T4 gp32), and the ssDNA fork arms. To test this model, we have used random and targeted mutagenesis to generate mutations throughout gp59. We have assayed the ability of the mutant proteins to bind to fork, primed fork, and ssDNAs, to interact with SSB, to stimulate helicase activity, and to function in leading and lagging strand DNA synthesis. Our results provide strong biochemical support for the role of the N-terminal gp59 HMG motif in fork binding and the interaction of the C-terminal portion of gp59 with helicase and SSB. Our results also suggest that processive replication may involve the switching of gp59 between its interactions with helicase and SSB.	[Dolezal, Darin; Jones, Charles E.; Lai, Xiaoqin; Brister, J. Rodney; Nossal, Nancy G.; Hinton, Deborah M.] NIDDK, Gene Express & Regulat Sect, Lab Cell & Mol Biol, NIH, Bethesda, MD 20892 USA; [Mueser, Timothy C.] Univ Toledo, Dept Chem, Toledo, OH 43606 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University System of Ohio; University of Toledo	Jones, CE (corresponding author), Bldg 8,Rm 202, Bethesda, MD 20892 USA.	CharlesJ@niddk.nih.gov; dhinton@helix.nih.gov	Hinton, Deborah/AAQ-2596-2021; Jones, Charles/GVS-9497-2022		National Institutes of Health; NIDDK; National Science Foundation [0346960]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK057816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, a grant from the NIDDK, and National Science Foundation Career Award 0346960 (to T. C. M.).	Arumugam SR, 2009, J BIOL CHEM, V284, P29283, DOI 10.1074/jbc.M109.029926; BARRY J, 1994, J BIOL CHEM, V269, P33049; Giese K, 1997, P NATL ACAD SCI USA, V94, P12845, DOI 10.1073/pnas.94.24.12845; Hinerman JM, 2012, J BIOL CHEM, V287, P18608, DOI 10.1074/jbc.M111.333476; Ishmael FT, 2003, J BIOL CHEM, V278, P3145, DOI 10.1074/jbc.M209858200; Ishmael FT, 2002, J BIOL CHEM, V277, P20555, DOI 10.1074/jbc.M111951200; Ishmael FT, 2001, J BIOL CHEM, V276, P25236, DOI 10.1074/jbc.M100783200; JENSEN DE, 1976, J BIOL CHEM, V251, P7215; Jones CE, 2004, J BIOL CHEM, V279, P25721, DOI 10.1074/jbc.M402128200; Jones CE, 2004, J BIOL CHEM, V279, P12067, DOI 10.1074/jbc.M313840200; Jones CE, 2001, P NATL ACAD SCI USA, V98, P8312, DOI 10.1073/pnas.121009398; Jones CE, 2000, J BIOL CHEM, V275, P27145; Kreuzer KN, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-358; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lefebvre SD, 1997, J MOL BIOL, V272, P312, DOI 10.1006/jmbi.1997.1264; Lefebvre SD, 1999, J BIOL CHEM, V274, P22830, DOI 10.1074/jbc.274.32.22830; Li V, 2010, J MOL BIOL, V400, P295, DOI 10.1016/j.jmb.2010.05.030; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; MORRICAL SW, 1994, J BIOL CHEM, V269, P33069; Morrical SW, 1996, J BIOL CHEM, V271, P20198, DOI 10.1074/jbc.271.33.20198; Mueser TC, 2000, J MOL BIOL, V296, P597, DOI 10.1006/jmbi.1999.3438; Mueser TC, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-359; Nelson SW, 2009, BIOCHEMISTRY-US, V48, P1036, DOI 10.1021/bi801792q; Nelson SW, 2006, J BIOL CHEM, V281, P8697, DOI 10.1074/jbc.M512185200; Nossal NG, 2007, J BIOL CHEM, V282, P1098, DOI 10.1074/jbc.M606772200; Nossal NG, 1995, METHOD ENZYMOL, V262, P560; Nossal NG, 2001, MOL CELL, V7, P31, DOI 10.1016/S1097-2765(01)00152-6; NOSSAL NG, 1992, FASEB J, V6, P871, DOI 10.1096/fasebj.6.3.1310946; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; SPACCIAPOLI P, 1994, J BIOL CHEM, V269, P447; Spiering MM, 2008, MOL BIOSYST, V4, P1070, DOI 10.1039/b812163j; Subramanian D, 2005, J BIOL CHEM, V280, P42568, DOI 10.1074/jbc.M506348200; TARUMI K, 1995, J BIOL CHEM, V270, P2614, DOI 10.1074/jbc.270.6.2614; Valentine AM, 2001, BIOCHEMISTRY-US, V40, P15074, DOI 10.1021/bi0108554; VENKATESAN M, 1982, J BIOL CHEM, V257, P2426; YONESAKI T, 1994, J BIOL CHEM, V269, P1284	36	1	1	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18596	18607		10.1074/jbc.M111.332080	http://dx.doi.org/10.1074/jbc.M111.332080			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22427673	Green Published, hybrid			2022-12-27	WOS:000306411600070
J	Shajahan, AN; Dobbin, ZC; Hickman, FE; Dakshanamurthy, S; Clarke, R				Shajahan, Ayesha N.; Dobbin, Zachary C.; Hickman, F. Edward; Dakshanamurthy, Sivanesan; Clarke, Robert			Tyrosine-phosphorylated Caveolin-1 (Tyr-14) Increases Sensitivity to Paclitaxel by Inhibiting BCL2 and BCLxL Proteins via c-Jun N-terminal Kinase (JNK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; CELL-DEATH; ADJUVANT CHEMOTHERAPY; MEDIATED ENDOCYTOSIS; NH2-TERMINAL KINASE; IN-VIVO; APOPTOSIS; PATHWAY; IDENTIFICATION; TAXOL	Paclitaxel, an anti-microtubule agent, is an effective chemotherapeutic drug in breast cancer. Nonetheless, resistance to paclitaxel remains a major clinical challenge. The need to better understand the resistant phenotype and to find biomarkers that could predict tumor response to paclitaxel is evident. In estrogen receptor alpha-positive (ER+) breast cancer cells, phosphorylation of caveolin-1 (CAV1) on Tyr-14 facilitates mitochondrial apoptosis by increasing BCL2 phosphorylation in response to low dose paclitaxel (10 nM). However, two variants of CAV1 exist: the full-length form, CAV1 alpha (wild-type CAV1 or wtCAV1), and a truncated form, CAV1 beta. Only wtCAV1 has the Tyr-14 region at the N terminus. The precise cellular functions of CAV1 variants are unknown. We now show that CAV1 variants play distinct roles in paclitaxel-mediated cell death/survival. CAV1 beta expression is increased in paclitaxel-resistant cells when compared with sensitive cells. Expression of CAV1 beta in sensitive cells significantly reduces their responsiveness to paclitaxel. These activities reflect an essential role for Tyr-14 phosphorylation because wtCAV1 expression, but not a phosphorylation-deficient mutant (Y14F), inactivates BCL2 and BCLxL through activation of c-Jun N-terminal kinase (JNK). MCF-7 cells that express Y14F are resistant to paclitaxel and are resensitized by co-treatment with ABT-737, a BH3-mimetic small molecule inhibitor. Using structural homology modeling, we propose that phosphorylation on Tyr-14 enables a favorable conformation for proteins to bind to the CAV1 scaffolding domain. Thus, we highlight novel roles for CAV1 variants in cell death; wtCAV1 promotes cell death, whereas CAV1 beta promotes cell survival by preventing inactivation of BCL2 and BCLxL via JNK in paclitaxel-mediated apoptosis.	[Shajahan, Ayesha N.; Dobbin, Zachary C.; Hickman, F. Edward; Dakshanamurthy, Sivanesan; Clarke, Robert] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA	Georgetown University	Shajahan, AN (corresponding author), 3970 Reservoir Rd NW,NRB W405B, Washington, DC 20057 USA.	ans33@georgetown.edu	Clarke, Robert/A-6485-2008; Dakshanamurthy, Sivanesan/CAF-4258-2022	Clarke, Robert/0000-0002-9278-0854; Dakshanamurthy, Sivanesan/0000-0003-3681-4121; Shajahan-Haq, Ayesha/0000-0001-7616-320X	National Institutes of Health from USPHS [1P30-CA-51008, U54-CA149147]; Susan G. Komen for the Cure Fellowship [PDF0600477]; American Cancer Society [IRG 92-152-17]; NATIONAL CANCER INSTITUTE [P30CA051008, U54CA149147] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; Susan G. Komen for the Cure Fellowship(Susan G. Komen Breast Cancer Foundation); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Michael Johnson (Georgetown University) for helpful discussions and critical review of this manuscript. Technical services were provided by the Flow Cytometry and Cell Sorting, Tissue Culture Core and Microscopy, and Imaging Shared Resources Center, which were funded through National Institutes of Health Award 1P30-CA-51008 from the USPHS (Lombardi Comprehensive Cancer Center Support Grant).; This work was supported, in whole or in part, by National Institutes of Health Grant U54-CA149147 (to R. C.) from the USPHS. This work was also supported by a Susan G. Komen for the Cure Fellowship (PDF0600477) and American Cancer Society Institutional Research Grant IRG 92-152-17 (to A. N. S.).	Ahmed N, 2008, FEBS LETT, V582, P3595, DOI 10.1016/j.febslet.2008.09.029; Amato SF, 1998, CANCER RES, V58, P241; Basu A, 2006, FRONT BIOSCI-LANDMRK, V11, P1508, DOI 10.2741/1900; Basu A, 2003, FEBS LETT, V538, P41, DOI 10.1016/S0014-5793(03)00131-5; Basu A, 2000, INT J ONCOL, V16, P497; Blagosklonny MV, 2001, BIOESSAYS, V23, P947, DOI 10.1002/bies.1135; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Bouker KB, 2004, CANCER RES, V64, P4030, DOI 10.1158/0008-5472.CAN-03-3602; Burgermeister E, 2008, CANCER LETT, V268, P187, DOI 10.1016/j.canlet.2008.03.055; Case D, 2006, AMBER 9; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Fang PK, 2006, AM J PATHOL, V169, P2209, DOI 10.2353/ajpath.2006.060562; Fang Y, 2004, BIOCHEM BIOPH RES CO, V323, P269, DOI 10.1016/j.bbrc.2004.08.100; Ferlini C, 2003, MOL PHARMACOL, V64, P51, DOI 10.1124/mol.64.1.51; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Hanson RN, 2003, J MED CHEM, V46, P2865, DOI 10.1021/jm0205806; Henderson IC, 2003, J CLIN ONCOL, V21, P976, DOI 10.1200/JCO.2003.02.063; Kutuk O, 2008, CANCER RES, V68, P7985, DOI 10.1158/0008-5472.CAN-08-1418; Lee LF, 1998, J BIOL CHEM, V273, P28253, DOI 10.1074/jbc.273.43.28253; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Li SW, 1996, J BIOL CHEM, V271, P3863; Liu PS, 1999, NAT CELL BIOL, V1, P369, DOI 10.1038/14067; Luo D, 2000, BIOCHEM CELL BIOL, V78, P119, DOI 10.1139/bcb-78-2-119; Machleidt T, 2000, J CELL BIOL, V148, P17, DOI 10.1083/jcb.148.1.17; MacKeigan JP, 2000, J BIOL CHEM, V275, P38953, DOI 10.1074/jbc.C000684200; Mamounas EP, 2005, J CLIN ONCOL, V23, P3686, DOI 10.1200/JCO.2005.10.517; McGrogan BT, 2008, BBA-REV CANCER, V1785, P96, DOI 10.1016/j.bbcan.2007.10.004; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Paridaens R, 2000, J CLIN ONCOL, V18, P724, DOI 10.1200/JCO.2000.18.4.724; Patani N, 2012, BREAST CANCER RES TR, V131, P1, DOI 10.1007/s10549-011-1751-4; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Quest AFG, 2008, J CELL MOL MED, V12, P1130, DOI 10.1111/j.1582-4934.2008.00331.x; Romanelli S, 1998, CANCER CHEMOTH PHARM, V41, P385, DOI 10.1007/s002800050755; Savage K, 2007, CLIN CANCER RES, V13, P90, DOI 10.1158/1078-0432.CCR-06-1371; SCHERER PE, 1995, J BIOL CHEM, V270, P16395, DOI 10.1074/jbc.270.27.16395; Seidman R, 2001, EXP CELL RES, V268, P84, DOI 10.1006/excr.2001.5262; Selimovic D, 2008, CELL SIGNAL, V20, P311, DOI 10.1016/j.cellsig.2007.10.015; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; Shajahan AN, 2007, J BIOL CHEM, V282, P5934, DOI 10.1074/jbc.M608857200; Sunters A, 2006, CANCER RES, V66, P212, DOI 10.1158/0008-5472.CAN-05-1997; Sverdlov M, 2007, J CELL MOL MED, V11, P1239, DOI 10.1111/j.1582-4934.2007.00127.x; Tabuchi Y, 2009, INT J ONCOL, V34, P313, DOI 10.3892/ijo_00000153; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469	46	46	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17682	17692		10.1074/jbc.M111.304022	http://dx.doi.org/10.1074/jbc.M111.304022			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22433870	Green Published, hybrid			2022-12-27	WOS:000306373000067
J	Cunningham, MR; McIntosh, KA; Pediani, JD; Robben, J; Cooke, AE; Nilsson, M; Gould, GW; Mundell, S; Milligan, G; Plevin, R				Cunningham, Margaret R.; McIntosh, Kathryn A.; Pediani, John D.; Robben, Joris; Cooke, Alexandra E.; Nilsson, Mary; Gould, Gwyn W.; Mundell, Stuart; Milligan, Graeme; Plevin, Robin			Novel Role for Proteinase-activated Receptor 2 (PAR(2)) in Membrane Trafficking of Proteinase-activated Receptor 4 (PAR(4))	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; THROMBIN-RECEPTOR; SURFACE EXPRESSION; ENDOTHELIAL-CELLS; INTRACELLULAR TRAFFICKING; MECHANISMS; INTERNALIZATION; LOCALIZATION; RESENSITIZATION; ARTHRITIS	Proteinase-activated receptors 4 (PAR(4)) is a class A G protein-coupled receptor (GPCR) recognized through the ability of serine proteases such as thrombin and trypsin to mediate receptor activation. Due to the irreversible nature of activation, a fresh supply of receptor is required to be mobilized to the cell surface for responsiveness to agonist to be sustained. Unlike other PAR subtypes, the mechanisms regulating receptor trafficking of PAR(4) remain unknown. Here, we report novel features of the intracellular trafficking of PAR(4) to the plasma membrane. PAR(4) was poorly expressed at the plasma membrane and largely retained in the endoplasmic reticulum (ER) in a complex with the COPI protein subunit beta-COP1. Analysis of the PAR(4) protein sequence identified an arginine-based (RXR) ER retention sequence located within intracellular loop-2 (R(183)AR -> 3 A(183)AA), mutation of which allowed efficient membrane delivery of PAR(4). Interestingly, co-expression with PAR(2) facilitated plasma membrane delivery of PAR(4), an effect produced through disruption of beta-COP1 binding and facilitation of interaction with the chaperone protein 14-3-3 zeta. Intermolecular FRET studies confirmed heterodimerization between PAR(2) and PAR(4). PAR(2) also enhanced glycosylation of PAR(4) and activation of PAR(4) signaling. Our results identify a novel regulatory role for PAR(2) in the anterograde traffic of PAR(4). PAR(2) was shown to both facilitate and abrogate protein interactions with PAR(4), impacting upon receptor localization and cell signal transduction. This work is likely to impact markedly upon the understanding of the receptor pharmacology of PAR(4) in normal physiology and disease.	[Cunningham, Margaret R.; Cooke, Alexandra E.; Mundell, Stuart] Univ Bristol, Sch Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Cunningham, Margaret R.; McIntosh, Kathryn A.; Nilsson, Mary; Plevin, Robin] Univ Strathclyde, Strathclyde Inst Biomed Sci, Dept Physiol & Pharmacol, Glasgow G4 0NR, Lanark, Scotland; [Pediani, John D.; Robben, Joris; Milligan, Graeme] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland; [Gould, Gwyn W.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Henry Wellcome Lab Cell Biol, Glasgow G12 8QQ, Lanark, Scotland; [Robben, Joris] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands	University of Bristol; University of Strathclyde; University of Glasgow; University of Glasgow; Radboud University Nijmegen	Cunningham, MR (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Med Sci Bldg, Bristol BS8 1TD, Avon, England.	margaret.cunningham@bristol.ac.uk	Gould, Gwyn/AAF-6721-2019; Milligan, Graeme/F-9426-2011; Pediani, John/F-2708-2019	Gould, Gwyn/0000-0001-6571-2875; Milligan, Graeme/0000-0002-6946-3519; Pediani, John/0000-0001-6615-537X; Plevin, Robin/0000-0002-7849-1220; Mundell, Stuart/0000-0001-7754-3271; Conibear, Alexandra/0000-0001-5471-1375; Cunningham, Margaret/0000-0001-6454-8671	Wellcome Trust [08444/Z/09/Z]; British Heart Foundation [BHF-FS/05/014]; Medical Research Council [G0900050]; British Pharmacological Society; British Heart Foundation [PG/09/091/28074] Funding Source: researchfish; MRC [G0900050] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Pharmacological Society; British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Wellcome Trust Grant 08444/Z/09/Z (to R. P.), British Heart Foundation Grant BHF-FS/05/014 (to R. P.), and Medical Research Council Grant G0900050 (to G. M.).; Recipient of the 2006 British Pharmacological Society AJ Clark Ph. D. Student award. To whom correspondence should be addressed: School of Physiology and Pharmacology, Medical Sciences Building, University of Bristol, Bristol BS8 1TD, United Kingdom. Tel.: 44-01173311433; E-mail: margaret. cunningham@bristol.ac.uk.	Ando S, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-31; ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875; BARLOWE C, 1993, J BIOL CHEM, V268, P873; Barlowe C, 2000, TRAFFIC, V1, P371, DOI 10.1034/j.1600-0854.2000.010501.x; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bohm SK, 1996, J BIOL CHEM, V271, P22003; BOUTON MC, 1995, BIOCHEM J, V305, P635, DOI 10.1042/bj3050635; Boyd GW, 2003, J BIOL CHEM, V278, P27681, DOI 10.1074/jbc.M304938200; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; Duvernay MT, 2005, CELL SIGNAL, V17, P1457, DOI 10.1016/j.cellsig.2005.05.020; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Ferrell WR, 2003, J CLIN INVEST, V111, P35, DOI 10.1172/JCI200316913; Fonseca JM, 2009, MOL PHARMACOL, V75, P1296, DOI 10.1124/mol.108.053876; Gandhi PS, 2011, IUBMB LIFE, V63, P375, DOI 10.1002/iub.461; Gassmann M, 2005, MOL PHARMACOL, V68, P137, DOI 10.1124/mol.104.010256; Hamilton JR, 2001, CIRC RES, V89, P92, DOI 10.1161/hh1301.092661; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Hirano K, 2007, J PHARMACOL EXP THER, V322, P668, DOI 10.1124/jpet.107.121038; HOXIE JA, 1993, J BIOL CHEM, V268, P13756; ISHII K, 1995, J BIOL CHEM, V270, P16435, DOI 10.1074/jbc.270.27.16435; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kanke T, 2001, J BIOL CHEM, V276, P31657, DOI 10.1074/jbc.M100377200; Karpa KD, 1999, MOL PHARMACOL, V56, P1071, DOI 10.1124/mol.56.5.1071; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Luo WB, 2007, J BIOL CHEM, V282, P30246, DOI 10.1074/jbc.M703205200; Luo WB, 2011, J NEUROCHEM, V117, P71, DOI 10.1111/j.1471-4159.2011.07173.x; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; McDougall JJ, 2009, ARTHRITIS RHEUM-US, V60, P728, DOI 10.1002/art.24300; McIntosh KA, 2007, CURR OPIN PHARMACOL, V7, P334, DOI 10.1016/j.coph.2007.01.002; McLaughlin JN, 2007, P NATL ACAD SCI USA, V104, P5662, DOI 10.1073/pnas.0700763104; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Nasu-Nishimura Y, 2006, J NEUROSCI, V26, P7014, DOI 10.1523/JNEUROSCI.0573-06.2006; Okamoto Y, 2011, J BIOL CHEM, V286, P7171, DOI 10.1074/jbc.M110.199695; Pagano A, 2001, J NEUROSCI, V21, P1189; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; PLEVIN R, 1994, BRIT J PHARMACOL, V112, P311, DOI 10.1111/j.1476-5381.1994.tb13070.x; Proctor KM, 2006, BIOCHEM BIOPH RES CO, V347, P433, DOI 10.1016/j.bbrc.2006.06.135; Ren Z, 2003, J NEUROSCI, V23, P6608; Ritchie E, 2007, BRIT J PHARMACOL, V150, P1044, DOI 10.1038/sj.bjp.0707150; Roosterman D, 2003, AM J PHYSIOL-CELL PH, V284, pC1319, DOI 10.1152/ajpcell.00540.2002; Russell FA, 2009, INFLAMM RES, V58, P119, DOI 10.1007/s00011-009-8087-0; Russell FA, 2010, J NEUROPHYSIOL, V103, P155, DOI 10.1152/jn.00486.2009; Sabri A, 2003, J BIOL CHEM, V278, P11714, DOI 10.1074/jbc.M213091200; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; Shapiro MJ, 2000, J BIOL CHEM, V275, P25216, DOI 10.1074/jbc.M004589200; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; Shikano S, 2006, TRENDS CELL BIOL, V16, P370, DOI 10.1016/j.tcb.2006.05.006; Stalheim L, 2005, MOL PHARMACOL, V67, P78, DOI 10.1124/mol.104.006072; Tiruppathi C, 2000, P NATL ACAD SCI USA, V97, P7440, DOI 10.1073/pnas.97.13.7440; Vivithanaporn P, 2006, J BIOL CHEM, V281, P15475, DOI 10.1074/jbc.M512098200; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Wilson S, 2005, J BIOL CHEM, V280, P28663, DOI 10.1074/jbc.M413475200; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Wu CC, 2010, BRIT J PHARMACOL, V161, P643, DOI 10.1111/j.1476-5381.2010.00921.x; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	63	33	34	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16656	16669		10.1074/jbc.M111.315911	http://dx.doi.org/10.1074/jbc.M111.315911			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22411985	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000304030900054
J	Lorents, A; Kodavali, PK; Oskolkov, N; Langel, U; Hallbrink, M; Pooga, M				Lorents, Annely; Kodavali, Praveen Kumar; Oskolkov, Nikita; Langel, Uelo; Haellbrink, Mattias; Pooga, Margus			Cell-penetrating Peptides Split into Two Groups Based on Modulation of Intracellular Calcium Concentration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE-REPAIR; ARGININE-RICH PEPTIDES; TAT PEPTIDE; IN-VIVO; ENDOCYTOSIS; EXOCYTOSIS; DELIVERY; MACROPINOCYTOSIS; PROTEINS; CARGO	Cell-penetrating peptides (CPPs) promote the uptake of different cargo molecules, e.g. therapeutic compounds, making the harnessing of CPPs a promising strategy for drug design and delivery. However, the internalization mechanisms of CPPs are still under discussion, and it is not clear how cells compensate the disturbances induced by peptides in the plasma membrane. In this study, we demonstrate that the uptake of various CPPs enhances the intracellular Ca2+ levels in Jurkat and HeLa cells. The elevated Ca2+ concentration in turn triggers plasma membrane blebbing, lysosomal exocytosis, and membrane repair response. Our results indicate that CPPs split into two major classes: (i) amphipathic CPPs that modulate the plasma membrane integrity inducing influx of Ca2+ and activating downstream responses starting from low concentrations; (ii) non-amphipathic CPPs that do not evoke changes at relevant concentrations. Triggering of the membrane repair response may help cells to replace distorted plasma membrane regions and cells can recover from the influx of Ca2+ if its level is not drastically elevated.	[Lorents, Annely; Pooga, Margus] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Kodavali, Praveen Kumar; Langel, Uelo; Haellbrink, Mattias] Stockholm Univ, Arrhenius Labs, Dept Neurochem, SE-10691 Stockholm, Sweden; [Oskolkov, Nikita; Langel, Uelo] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia	University of Tartu; Stockholm University; University of Tartu	Pooga, M (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Riia 23, EE-51010 Tartu, Estonia.	mpooga@ebc.ee	Pooga, Margus/A-8575-2011; Oskolkov, Nikita/AAJ-8377-2020	Pooga, Margus/0000-0003-4532-4087; Langel, Ulo/0000-0001-6107-0844; Lorents, Annely/0000-0002-2823-5202	Estonian Science Foundation (ESF) [7058, 8705]; Estonian Ministry of Education and Research [0180019s11, 0180027s08]; Swedish Research Council (VR-NT); Center for Biomembrane Research (Stockholm, Sweden); Knut and Alice Wallenberg's Foundation; European Union through Center of Excellence in Chemical Biology	Estonian Science Foundation (ESF); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Swedish Research Council (VR-NT)(Swedish Research Council); Center for Biomembrane Research (Stockholm, Sweden); Knut and Alice Wallenberg's Foundation(Knut & Alice Wallenberg Foundation); European Union through Center of Excellence in Chemical Biology	This work was supported by grants from the Estonian Science Foundation (ESF 7058 and 8705) and the Estonian Ministry of Education and Research (0180019s11 and 0180027s08).; Supported by the Swedish Research Council (VR-NT); the Center for Biomembrane Research (Stockholm, Sweden); by the Knut and Alice Wallenberg's Foundation; and the European Union through the European Regional Development Fund through the Center of Excellence in Chemical Biology.	Babiychuk EB, 2011, CELL DEATH DIFFER, V18, P80, DOI 10.1038/cdd.2010.81; Babiychuk EB, 2009, CELL DEATH DIFFER, V16, P1126, DOI 10.1038/cdd.2009.30; Barany-Wallje E, 2007, FEBS LETT, V581, P2389, DOI 10.1016/j.febslet.2007.04.046; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; Brakenhoff GJ, 1996, J MICROSC-OXFORD, V183, P140, DOI 10.1046/j.1365-2818.1996.870647.x; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Cocucci E, 2007, TRAFFIC, V8, P742, DOI 10.1111/j.1600-0854.2007.00566.x; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; El-Andaloussi S, 2007, BIOCHEM J, V407, P285, DOI 10.1042/BJ20070507; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Fittipaldi A, 2003, J BIOL CHEM, V278, P34141, DOI 10.1074/jbc.M303045200; Fretz MM, 2007, BIOCHEM J, V403, P335, DOI 10.1042/BJ20061808; Guterstam P, 2009, BBA-BIOMEMBRANES, V1788, P2509, DOI 10.1016/j.bbamem.2009.09.014; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Jiao CY, 2009, J BIOL CHEM, V284, P33957, DOI 10.1074/jbc.M109.056309; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; MALGAROLI A, 1987, J CELL BIOL, V105, P2145, DOI 10.1083/jcb.105.5.2145; McNeil PL, 2000, J CELL SCI, V113, P1891; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; Mishra A, 2011, P NATL ACAD SCI USA, V108, P16883, DOI 10.1073/pnas.1108795108; Miyake K, 2001, J CELL SCI, V114, P3487; Miyake K, 1995, J CELL BIOL, V131, P1737, DOI 10.1083/jcb.131.6.1737; Myrberg H, 2008, BIOCONJUGATE CHEM, V19, P70, DOI 10.1021/bc0701139; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Ninomiya Y, 1996, J BIOL CHEM, V271, P17751, DOI 10.1074/jbc.271.30.17751; Padari K, 2005, BIOCONJUGATE CHEM, V16, P1399, DOI 10.1021/bc050125z; Padari K, 2010, BIOCONJUGATE CHEM, V21, P774, DOI 10.1021/bc900577e; Palm-Apergi C, 2009, FASEB J, V23, P214, DOI 10.1096/fj.08-110254; Pooga M, 1998, NAT BIOTECHNOL, V16, P857, DOI 10.1038/nbt0998-857; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; ROE MW, 1990, CELL CALCIUM, V11, P63, DOI 10.1016/0143-4160(90)90060-8; Rothbard JB, 2000, NAT MED, V6, P1253, DOI 10.1038/81359; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; SMITH MW, 1991, P NATL ACAD SCI USA, V88, P4926, DOI 10.1073/pnas.88.11.4926; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; TOKUMITSU T, 1967, J CELL BIOL, V34, P677, DOI 10.1083/jcb.34.2.677; Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com; van Blitterswijk WJ, 2003, BIOCHEM J, V369, P199, DOI 10.1042/BJ20021528; Zha XH, 1998, J CELL BIOL, V140, P39, DOI 10.1083/jcb.140.1.39; Ziegler A, 2008, ADV DRUG DELIVER REV, V60, P580, DOI 10.1016/j.addr.2007.10.005	45	33	35	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16880	16889		10.1074/jbc.M111.318063	http://dx.doi.org/10.1074/jbc.M111.318063			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22437827	hybrid, Green Published			2022-12-27	WOS:000304030900074
J	Chalat, M; Menon, I; Turan, Z; Menon, AK				Chalat, Madhavan; Menon, Indu; Turan, Zeynep; Menon, Anant K.			Reconstitution of Glucosylceramide Flip-Flop across Endoplasmic Reticulum IMPLICATIONS FOR MECHANISM OF GLYCOSPHINGOLIPID BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE PROTEINS; TRANSBILAYER MOVEMENT; PHOSPHOLIPID FLIPPASE; DETERGENT EXTRACTS; GOLGI-APPARATUS; YEAST; TRANSLOCATION; LACTOSYLCERAMIDE; IDENTIFICATION; SPHINGOLIPIDS	Most glycosphingolipids are synthesized by the sequential addition of monosaccharides to glucosylceramide (GlcCer) in the lumen of the Golgi apparatus. Because GlcCer is synthesized on the cytoplasmic face of Golgi membranes, it must be flipped to the non-cytoplasmic face by a lipid flippase in order to nucleate glycosphingolipid synthesis. Halter et al. (Halter, D., Neumann, S., van Dijk, S. M., Wolthoorn, J., de Maziere, A. M., Vieira, O. V., Mattjus, P., Klumperman, J., van Meer, G., and Sprong, H. (2007) Pre- and post-Golgi translocation of glucosylceramide in glycosphingolipid synthesis. J. Cell Biol. 179, 101115) proposed that this essential flipping step is accomplished via a complex trafficking itinerary; GlcCer is moved from the cytoplasmic face of the Golgi to the endoplasmic reticulum (ER) by FAPP2, a cytoplasmic lipid transfer protein, flipped across the ER membrane, then delivered to the lumen of the Golgi complex by vesicular transport. We now report biochemical reconstitution studies to analyze GlcCer flipping at the ER. Using proteoliposomes reconstituted from Triton X-100-solubilized rat liver ER membrane proteins, we demonstrate rapid (t(1/2) < 20 s), ATP-independent flip-flop of N-(6-((7-nitro-2-1,3-benzoxadiazol- 4-yl) amino) hexanoyl)-D-glucosyl-beta 1-1'-sphingosine, a fluorescent GlcCer analog. Further studies involving protein modification, biochemical fractionation, and analyses of flip-flop in proteoliposomes reconstituted with ER membrane proteins from yeast indicate that GlcCer translocation is facilitated by well characterized ER phospholipid flippases that remain to be identified at the molecular level. By reason of their abundance and membrane bending activity, we considered that the ER reticulons and the related Yop1 protein could function as phospholipid-GlcCer flippases. Direct tests showed that these proteins have no flippase activity.	[Chalat, Madhavan; Menon, Indu; Turan, Zeynep; Menon, Anant K.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA	Cornell University	Menon, AK (corresponding author), Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10065 USA.	akm2003@med.cornell.edu	Menon, Anant/AAN-8663-2021	Menon, Anant/0000-0001-6924-2698; Chalat, Madhavan/0000-0002-6484-4574	National Institutes of Health [GM71041]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM71041.	BACKER JM, 1987, NATURE, V327, P341, DOI 10.1038/327341a0; BARTLES JR, 1985, J BIOL CHEM, V260, P2792; BISHOP WR, 1985, CELL, V42, P51, DOI 10.1016/S0092-8674(85)80100-8; Burger KNJ, 1996, J CELL BIOL, V133, P15, DOI 10.1083/jcb.133.1.15; Buton X, 2002, BIOCHEMISTRY-US, V41, P13106, DOI 10.1021/bi020385t; Caffaro CE, 2006, ACCOUNTS CHEM RES, V39, P805, DOI 10.1021/ar0400239; Calero M, 2001, J BIOL CHEM, V276, P12100, DOI 10.1074/jbc.M008439200; Chang QL, 2004, BIOCHEMISTRY-US, V43, P10710, DOI 10.1021/bi049063a; De Craene JO, 2006, MOL BIOL CELL, V17, P3009, DOI 10.1091/mbc.e06-01-0080; DePierre J., 1976, BIOCH ANAL MEMBRANES, P79; Devaux PF, 2002, CHEM PHYS LIPIDS, V116, P115, DOI 10.1016/S0009-3084(02)00023-3; Dickson RC, 1999, BBA-MOL CELL BIOL L, V1438, P305, DOI 10.1016/S1388-1981(99)00068-2; Eckford PDW, 2005, BIOCHEM J, V389, P517, DOI 10.1042/BJ20050047; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; GARVIN JE, 1956, J BIOL CHEM, V221, P211; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gummadi SN, 2002, J BIOL CHEM, V277, P25337, DOI 10.1074/jbc.M203809200; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hrafnsdottir S, 2000, J BACTERIOL, V182, P4198, DOI 10.1128/JB.182.15.4198-4206.2000; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Hu JJ, 2011, CELL, V147, P1226, DOI 10.1016/j.cell.2011.11.022; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; KREIBICH G, 1978, J CELL BIOL, V77, P464, DOI 10.1083/jcb.77.2.464; LANNERT H, 1994, FEBS LETT, V342, P91, DOI 10.1016/0014-5793(94)80591-1; Lannert H, 1998, J BIOL CHEM, V273, P2939, DOI 10.1074/jbc.273.5.2939; Levine TP, 2007, J CELL BIOL, V179, P11, DOI 10.1083/jcb.200709055; Lingwood CA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004788; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Ma JY, 1996, J BIOL CHEM, V271, P7758, DOI 10.1074/jbc.271.13.7758; MCINTYRE JC, 1991, BIOCHEMISTRY-US, V30, P11819, DOI 10.1021/bi00115a012; Menon AK, 2000, CURR BIOL, V10, P241, DOI 10.1016/S0960-9822(00)00356-0; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; Muller DJ, 2008, PHARMACOL REV, V60, P43, DOI 10.1124/pr.107.07111; Nicolson T, 2000, FEBS LETT, V476, P277, DOI 10.1016/S0014-5793(00)01684-7; Perktold A, 2007, FEMS YEAST RES, V7, P629, DOI 10.1111/j.1567-1364.2007.00226.x; Petrache HI, 2000, BIOPHYS J, V79, P3172, DOI 10.1016/S0006-3495(00)76551-9; QUINN P, 1984, J CELL BIOL, V98, P2142, DOI 10.1083/jcb.98.6.2142; Saito K, 2006, APPL MICROBIOL BIOT, V71, P515, DOI 10.1007/s00253-005-0187-3; Sanyal S, 2008, BIOCHEMISTRY-US, V47, P7937, DOI 10.1021/bi800723n; Sanyal S, 2010, P NATL ACAD SCI USA, V107, P11289, DOI 10.1073/pnas.1002408107; Sanyal S, 2009, P NATL ACAD SCI USA, V106, P767, DOI 10.1073/pnas.0810225106; Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d; Schulze H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004804; Stanley P, 2009, ESSENTIALS GLYCOBIOL; VANHEYNINGEN S, 1974, SCIENCE, V183, P656, DOI 10.1126/science.183.4125.656; Vehring S, 2007, EUKARYOT CELL, V6, P1625, DOI 10.1128/EC.00198-07; Vishwakarma RA, 2005, CHEM COMMUN, P453, DOI 10.1039/b413196g; Vishwakarma RA, 2005, ORG BIOMOL CHEM, V3, P1275, DOI 10.1039/b500300h; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142	52	29	29	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15523	15532		10.1074/jbc.M112.343038	http://dx.doi.org/10.1074/jbc.M112.343038			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427661	hybrid, Green Published			2022-12-27	WOS:000304006300033
J	Yaneva, N; Schuster, J; Schafer, F; Lede, V; Przybylski, D; Paproth, T; Harms, H; Muller, RH; Rohwerder, T				Yaneva, Nadya; Schuster, Judith; Schaefer, Franziska; Lede, Vera; Przybylski, Denise; Paproth, Torsten; Harms, Hauke; Mueller, Roland H.; Rohwerder, Thore			Bacterial Acyl-CoA Mutase Specifically Catalyzes Coenzyme B-12-dependent Isomerization of 2-Hydroxyisobutyryl-CoA and (S)-3-Hydroxybutyryl-CoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERT-BUTYL ETHER; GEN. NOV.; A MUTASE; ACID; ENZYME; DEGRADATION; CLONING; BIOSYNTHESIS; METABOLISM; PROTECTION	Coenzyme B-12-dependent acyl-CoA mutases are radical enzymes catalyzing reversible carbon skeleton rearrangements in carboxylic acids. Here, we describe 2-hydroxyisobutyryl-CoA mutase (HCM) found in the bacterium Aquincola tertiaricarbonis as a novel member of the mutase family. HCM specifically catalyzes the interconversion of 2-hydroxyisobutyryl- and (S)-3-hydroxybutyryl-CoA. Like isobutyryl-CoA mutase, HCM consists of a large substrate- and a small B-12-binding subunit, HcmA and HcmB, respectively. However, it is thus far the only acyl-CoA mutase showing substrate specificity for hydroxylated carboxylic acids. Complete loss of 2-hydroxyisobutyric acid degradation capacity in hcmA and hcmB knock-out mutants established the central role of HCM in A. tertiaricarbonis for degrading substrates bearing a tert-butyl moiety, such as the fuel oxygenate methyl tert-butyl ether (MTBE) and its metabolites. Sequence analysis revealed several HCM-like enzymes in other bacterial strains not related to MTBE degradation, indicating that HCM may also be involved in other pathways. In all strains, hcmA and hcmB are associated with genes encoding for a putative acyl-CoA synthetase and a MeaB-like chaperone. Activity and substrate specificity of wild-type enzyme and active site mutants HcmA I90V, I90F, and I90Y clearly demonstrated that HCM belongs to a new subfamily of B-12-dependent acyl-CoA mutases.	[Yaneva, Nadya; Schuster, Judith; Schaefer, Franziska; Lede, Vera; Przybylski, Denise; Paproth, Torsten; Harms, Hauke; Mueller, Roland H.; Rohwerder, Thore] UFZ Helmholtz Ctr Environm Res, Dept Environm Microbiol, D-04318 Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Rohwerder, T (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Environm Microbiol, D-04318 Leipzig, Germany.	thore.rohwerder@ufz.de	Harms, Hauke/I-4406-2012; Lede, Vera/C-7258-2014	Harms, Hauke/0000-0002-7316-7341; Lede, Vera/0000-0001-6045-2605; Rohwerder, Thore/0000-0001-7877-8953	Helmholtz Centre for Environmental Research; Evonik Industries	Helmholtz Centre for Environmental Research(Helmholtz Association); Evonik Industries	This work was supported by the Helmholtz Centre for Environmental Research within the Chemicals in the Environment program and by Evonik Industries.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAUER W, 2002, ULLMANNS ENCY IND CH, V21, P585; BIRCH A, 1993, J BACTERIOL, V175, P3511, DOI 10.1128/jb.175.11.3511-3519.1993; Chisholm MS, 2000, J CHEM EDUC, V77, P841, DOI 10.1021/ed077p841; Cracan V, 2012, J BIOL CHEM, V287, P3723, DOI 10.1074/jbc.M111.320051; Cracan V, 2010, J BIOL CHEM, V285, P655, DOI 10.1074/jbc.M109.062182; Dalluge JJ, 2002, ANAL BIOANAL CHEM, V374, P835, DOI 10.1007/s00216-002-1554-x; Erb TJ, 2008, J BIOL CHEM, V283, P32283, DOI 10.1074/jbc.M805527200; Forslund K, 2004, PLANT PHYSIOL, V135, P71, DOI 10.1104/pp.103.038059; HermansLokkerbol A, 1996, J CHROMATOGR A, V752, P123, DOI 10.1016/S0021-9673(96)00526-2; HOLOWACH LP, 1994, ACS SYM SER, V575, P202; Hristova KR, 2007, APPL ENVIRON MICROB, V73, P7347, DOI 10.1128/AEM.01604-07; Kane SR, 2007, J BACTERIOL, V189, P1931, DOI 10.1128/JB.01259-06; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; Kumps A, 2002, CLIN CHEM, V48, P708; Lechner U, 2007, INT J SYST EVOL MICR, V57, P1295, DOI 10.1099/ijs.0.64663-0; MOORE BS, 1995, J AM CHEM SOC, V117, P11285, DOI 10.1021/ja00150a028; Moran MJ, 2005, GROUND WATER, V43, P615, DOI 10.1111/j.1745-6584.2005.0113.x; Muller RH, 2008, MICROBIOL-SGM, V154, P1414, DOI 10.1099/mic.0.2007/014159-0; Nakatsu CH, 2006, INT J SYST EVOL MICR, V56, P983, DOI 10.1099/ijs.0.63524-0; PADMAKUMAR R, 1993, ANAL BIOCHEM, V214, P318, DOI 10.1006/abio.1993.1494; Padovani D, 2006, BIOCHEMISTRY-US, V45, P9300, DOI 10.1021/bi0604532; Probian C, 2003, APPL ENVIRON MICROB, V69, P1866, DOI 10.1128/AEM.69.3.1866-1870.2003; Ratnatilleke A, 1999, J BIOL CHEM, V274, P31679, DOI 10.1074/jbc.274.44.31679; REYNOLDS KA, 1988, J CHEM SOC PERK T 1, P3195, DOI 10.1039/p19880003195; ROHWERDER T, 2007, P 3 EUR C MTRF OTH O, P11; ROHWERDER T, 2007, VITAMIN B NEW RES, P81; Rohwerder T, 2006, APPL ENVIRON MICROB, V72, P4128, DOI 10.1128/AEM.00080-06; Rohwerder T, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-13; Schafer F, 2011, APPL ENVIRON MICROB, V77, P5981, DOI 10.1128/AEM.00093-11; Schuster J, 2012, J BACTERIOL, V194, P972, DOI 10.1128/JB.06384-11; SIMON EJ, 1953, J AM CHEM SOC, V75, P2520, DOI 10.1021/ja01106a522; SPRECHER M, 1966, J BIOL CHEM, V241, P872; Starkey RL, 1934, J BACTERIOL, V28, P365, DOI 10.1128/JB.28.4.365-386.1934; Steffan RJ, 1997, APPL ENVIRON MICROB, V63, P4216, DOI 10.1128/AEM.63.11.4216-4222.1997; VALENTIN HE, 1993, APPL MICROBIOL BIOT, V39, P309, DOI 10.1007/BF00192084; Vlasie MD, 2004, BIOCHEMISTRY-US, V43, P8410, DOI 10.1021/bi036299q	37	27	33	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15502	15511		10.1074/jbc.M111.314690	http://dx.doi.org/10.1074/jbc.M111.314690			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22433853	Green Published, hybrid			2022-12-27	WOS:000304006300031
J	Yun, J; Kim, YS; Jung, JH; Seo, PJ; Park, CM				Yun, Ju; Kim, Youn-Sung; Jung, Jae-Hoon; Seo, Pil Joon; Park, Chung-Mo			The AT-hook Motif-containing Protein AHL22 Regulates Flowering Initiation by Modifying FLOWERING LOCUS T Chromatin in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATTACHMENT REGIONS; BINDING PROTEINS; GENE-EXPRESSION; HISTONE H3; TIME; PLANTS; OVEREXPRESSION; METHYLATION; ACTIVATION; THALIANA	Coordination of the onset of flowering with developmental status and seasonal cues is critical for reproductive success in plants. Molecular genetic studies on Arabidopsis mutants that have alterations in flowering time have identified a wide array of genes that belong to distinct genetic flowering pathways. The flowering time genes are regulated through versatile molecular and biochemical mechanisms, such as controlled RNA metabolism and chromatin modifications. Recent studies have shown that a group of AT-hook DNA-binding motif-containing proteins plays a role in plant developmental processes and stress responses. Here, we demonstrate that the AT-hook protein AHL22 (AT-hook motif nuclear localized 22) regulates flowering time by modifying FLOWERING LOCUS T (FT) chromatin in Arabidopsis. AHL22 binds to a stretch of the AT-rich sequence in the FT locus. It interacts with a subset of histone deacetylases. An Arabidopsis mutant overexpressing the AHL22 gene (OE-AHL22) exhibited delayed flowering, and FT transcription was significantly reduced in the mutant. Consistent with the delayed flowering and FT suppression in the OE-AHL22 mutant, histone 3 (H3) acetylation was reduced and H3 lysine 9 dimethylation was elevated in the FT chromatin. We propose that AHL22 acts as a chromatin remodeling factor that modifies the architecture of FT chromatin by modulating both H3 acetylation and methylation.	[Yun, Ju; Jung, Jae-Hoon; Seo, Pil Joon; Park, Chung-Mo] Seoul Natl Univ, Dept Chem, Seoul 151742, South Korea; [Kim, Youn-Sung] Gendocs Inc, Taejon 305301, South Korea; [Park, Chung-Mo] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Park, CM (corresponding author), Seoul Natl Univ, Dept Chem, 1 Gwanak Ro, Seoul 151742, South Korea.	cmpark@snu.ac.kr	Seo, Pil Joon/AAR-9426-2020; Park, Chung-Mo/B-6175-2012; Kim, Youn/AAT-3380-2021		Leaping Research Program [20110016440]; National Research Foundation of Korea; Plant Molecular Breeding Center [PJ008103]; Rural Development Administration; Plant Signaling Network Research Center [20110001099]; National Research Foundation of Korea [20110027355]; Agricultural R & D Promotion Center [309017-03]; Korea Ministry for Food, Agriculture, Forestry and Fisheries	Leaping Research Program; National Research Foundation of Korea(National Research Foundation of Korea); Plant Molecular Breeding Center; Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Plant Signaling Network Research Center; National Research Foundation of Korea(National Research Foundation of Korea); Agricultural R & D Promotion Center; Korea Ministry for Food, Agriculture, Forestry and Fisheries	This work was supported by Leaping Research Program Grant 20110016440 provided by the National Research Foundation of Korea, the Next-Generation BioGreen 21 program (Plant Molecular Breeding Center No. PJ008103) provided by the Rural Development Administration, and Plant Signaling Network Research Center Grant 20110001099, National Research Foundation of Korea Grant 20110027355, the Agricultural R & D Promotion Center Grant 309017-03, and the Korea Ministry for Food, Agriculture, Forestry and Fisheries.	Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Castillejo C, 2008, CURR BIOL, V18, P1338, DOI 10.1016/j.cub.2008.07.075; Fujimoto S, 2004, PLANT MOL BIOL, V56, P225, DOI 10.1007/s11103-004-3249-5; He YH, 2009, MOL PLANT, V2, P554, DOI 10.1093/mp/ssp005; Hollender C, 2008, J INTEGR PLANT BIOL, V50, P875, DOI 10.1111/j.1744-7909.2008.00704.x; Hong SY, 2011, J BIOL CHEM, V286, P1659, DOI 10.1074/jbc.M110.167692; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kim YS, 2006, PLANT CELL, V18, P3132, DOI 10.1105/tpc.106.043018; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Lim PO, 2007, PLANT J, V52, P1140, DOI 10.1111/j.1365-313X.2007.03317.x; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Lu HB, 2010, J INTEGR PLANT BIOL, V52, P801, DOI 10.1111/j.1744-7909.2010.00969.x; Matsushita A, 2007, PLANT PHYSIOL, V143, P1152, DOI 10.1104/pp.106.093542; Metcalf CE, 2006, J BIOL CHEM, V281, P30015, DOI 10.1074/jbc.M606289200; Ng KH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000251; Parviz F, 1998, J BACTERIOL, V180, P4508, DOI 10.1128/JB.180.17.4508-4515.1998; Pederson T, 2000, MOL BIOL CELL, V11, P799, DOI 10.1091/mbc.11.3.799; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; Rudd S, 2004, PLANT PHYSIOL, V135, P715, DOI 10.1104/pp.103.037861; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SCHENA M, 1992, P NATL ACAD SCI USA, V89, P3894, DOI 10.1073/pnas.89.9.3894; SESSA G, 1993, EMBO J, V12, P3507, DOI 10.1002/j.1460-2075.1993.tb06025.x; Silverstein RA, 2003, CURR BIOL, V13, P68, DOI 10.1016/S0960-9822(02)01401-X; Simpson GG, 2004, CURR OPIN PLANT BIOL, V7, P570, DOI 10.1016/j.pbi.2004.07.002; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Street IH, 2008, PLANT J, V54, P1, DOI 10.1111/j.1365-313X.2007.03393.x; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Tetko IV, 2006, PLOS COMPUT BIOL, V2, P136, DOI 10.1371/journal.pcbi.0020021; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; Wang TY, 2010, MOL BIOL REP, V37, P3553, DOI 10.1007/s11033-010-0003-8; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Xiao CW, 2009, PLANT MOL BIOL, V71, P39, DOI 10.1007/s11103-009-9507-9; Yaish MW, 2011, J EXP BOT, V62, P3727, DOI 10.1093/jxb/err177; Yang SD, 2011, PLANT CELL, V23, P2155, DOI 10.1105/tpc.111.084913; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	40	60	72	7	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15307	15316		10.1074/jbc.M111.318477	http://dx.doi.org/10.1074/jbc.M111.318477			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22442143	Green Published, hybrid			2022-12-27	WOS:000304006300014
J	Bouvier, N; Fougeray, S; Beaune, P; Thervet, E; Pallet, N				Bouvier, Nicolas; Fougeray, Sophie; Beaune, Philippe; Thervet, Eric; Pallet, Nicolas			The Unfolded Protein Response Regulates an Angiogenic Response by the Kidney Epithelium during Ischemic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; RENAL-DISEASE; ER STRESS; A EXPRESSION; TUMOR-GROWTH; HYPOXIA; PATHWAY; INJURY; CELLS; VEGF	Ischemic injuries permanently affect kidney tissue and challenge cell viability, promoting inflammation and fibrogenesis. Ischemia results in nutrient deprivation, which triggers endoplasmic reticulum stress, ultimately resulting in the unfolded protein response (UPR). The aim of this study was to test whether the UPR could promote an angiogenic response independently of the HIF-1 alpha pathway during ischemic stress in the human kidney epithelium. Glucose deprivation induced the secretion of vascular endothelial growth factor A (VEGFA), basic fibroblast growth factor (bFGF) and angiogenin (ANG) in human kidney epithelial cells independently of HIF-1 alpha. Glucose deprivation, but not hypoxia, triggered endoplasmic reticulum stress and activated the UPR. RNA interference-mediated inhibition of the gene encoding the kinase PERK decreased VEGFA and bFGF expression, but neither gene was affected by the inhibition of IRE1 alpha or ATF6. Furthermore, we show that the expression of angiogenin, which inhibits protein synthesis, is regulated by both IRE1 alpha and PERK, which could constitute a complementary function of the UPR in the repression of translation. In a rat model of acute ischemic stress, we show that the UPR is activated in parallel with VEGFA, bFGF, and ANG expression and independently of HIF-1 alpha.	[Bouvier, Nicolas; Fougeray, Sophie; Beaune, Philippe; Thervet, Eric; Pallet, Nicolas] Ctr Univ St Peres, INSERM U775, F-75006 Paris, France; [Thervet, Eric] Hop Europeen Georges Pompidou, Serv Nephrol, F-70115 Paris, France; [Bouvier, Nicolas; Fougeray, Sophie; Beaune, Philippe; Thervet, Eric; Pallet, Nicolas] Univ Paris 05, F-75065 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Pallet, N (corresponding author), Ctr Univ St Peres, INSERM U775, 45 Rue St Peres, F-75006 Paris, France.	npallet@yahoo.fr	Fougeray, Sophie/M-2310-2015	Fougeray, Sophie/0000-0002-5745-3831; Beaune, Philippe/0000-0002-6569-9014; Pallet, Nicolas/0000-0002-8486-3596	Institut National de la Sante et de la Recherche Medicale (INSERM)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by a grant from the Institut National de la Sante et de la Recherche Medicale (INSERM).	Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chade AR, 2011, AM J PHYSIOL-REG I, V300, pR783, DOI 10.1152/ajpregu.00657.2010; Choi YJ, 2000, HUM PATHOL, V31, P1491, DOI 10.1053/hupa.2000.20373; Drogat B, 2007, CANCER RES, V67, P6700, DOI 10.1158/0008-5472.CAN-06-3235; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Fine L. G., 2008, KIDNEY INT; FLORKIEWICZ RZ, 1995, J CELL PHYSIOL, V162, P388, DOI 10.1002/jcp.1041620311; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; Ghosh R, 2010, PLOS ONE, V5, pA104, DOI 10.1371/journal.pone.0009575; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Leonard EC, 2008, AM J PHYSIOL-RENAL, V295, pF1648, DOI 10.1152/ajprenal.00099.2008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Marjon PL, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-4; Mayer G, 2011, NEPHROL DIAL TRANSPL, V26, P1132, DOI 10.1093/ndt/gfq832; Mimura I, 2010, NAT REV NEPHROL, V6, P667, DOI 10.1038/nrneph.2010.124; Nakamura M, 2006, NEPHROL DIAL TRANSPL, V21, P1489, DOI 10.1093/ndt/gfl041; Oskolkova OV, 2008, BLOOD, V112, P330, DOI 10.1182/blood-2007-09-112870; Pallet N, 2008, AM J TRANSPLANT, V8, P2283, DOI 10.1111/j.1600-6143.2008.02396.x; Pallet N, 2005, KIDNEY INT, V67, P2422, DOI 10.1111/j.1523-1755.2005.00350.x; Pereira ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012521; Racusen LC, 2010, KIDNEY INT, V78, pS27, DOI 10.1038/ki.2010.419; Rajnoch J, 2005, TRANSPL P, V37, P352, DOI 10.1016/j.transproceed.2004.12.154; Reinders MEJ, 2006, J AM SOC NEPHROL, V17, P932, DOI 10.1681/ASN.2005121250; Rudnicki M, 2009, LAB INVEST, V89, P337, DOI 10.1038/labinvest.2008.158; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Strutz F, 2002, KIDNEY INT, V61, P1714, DOI 10.1046/j.1523-1755.2002.00333.x; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	38	16	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14557	14568		10.1074/jbc.M112.340570	http://dx.doi.org/10.1074/jbc.M112.340570			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22403402	Green Published, hybrid			2022-12-27	WOS:000304003200022
J	Shim, H; Wang, CT; Chen, YL; Chau, VQ; Fu, KG; Yang, JQ; McQuiston, AR; Fisher, RA; Chen, CK				Shim, Hoon; Wang, Chih-Ting; Chen, Yen-Lin; Chau, Viet Q.; Fu, Kevin G.; Yang, Jianqi; McQuiston, A. Rory; Fisher, Rory A.; Chen, Ching-Kang			Defective Retinal Depolarizing Bipolar Cells in Regulators of G Protein Signaling (RGS) 7 and 11 Double Null Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEBRATE RETINA; LIGHT RESPONSE; MOUSE; MGLUR6; PHOTOTRANSDUCTION; ACTIVATION; EXPRESSION; DENDRITES; SUBUNITS; RECOVERY	Two members of the R7 subfamily of regulators of G protein signaling, RGS7 and RGS11, are present at dendritic tips of retinal depolarizing bipolar cells (DBCs). Their involvement in the mGluR6/G alpha(o)/TRPM1 pathway that mediates DBC light responses has been implicated. However, previous genetic studies employed an RGS7 mutant mouse that is hypomorphic, and hence the exact role of RGS7 in DBCs remains unclear. We have made a true RGS7-null mouse line with exons 6-8 deleted. The RGS7(-/-) mouse is viable and fertile but smaller in body size. Electroretinogram (ERG) b-wave implicit time in young RGS7(-/-) mice is prolonged at eye opening, but the phenotype disappears at 2 months of age. Expression levels of RGS6 and RGS11 are unchanged in RGS7(-/-) retina, but the G beta 5S level is significantly reduced. By characterizing a complete RGS7 and RGS11 double knock-out (711dKO) mouse line, we found that G beta 5S expression in the retinal outer plexiform layer is eliminated, as is the ERGb-wave. Ultrastructural defects akin to those of G beta 5(-/-) mice are evident in 711dKO mice. In retinas of mice lacking RGS6, RGS7, and RGS11, G beta 5S is undetectable, whereas levels of the photoreceptor-specific G beta 5L remain unchanged. Whereas RGS6 alone sustains a significant amount of G beta 5S expression in retina, the DBC-related defects in G beta 5(-/-) mice are caused solely by a combined loss of RGS7 and RGS11. Our data support the notion that the role of G beta 5 in the retina, and likely in the entire nervous system, is mediated exclusively by R7 RGS proteins.	[Shim, Hoon; Wang, Chih-Ting; Chen, Yen-Lin; Chau, Viet Q.; Fu, Kevin G.; Chen, Ching-Kang] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Richmond, VA 23298 USA; [McQuiston, A. Rory] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Sch Med, Richmond, VA 23298 USA; [Yang, Jianqi; Fisher, Rory A.] Univ Iowa, Dept Pharmacol, Coll Med, Iowa City, IA 52242 USA	Virginia Commonwealth University; Virginia Commonwealth University; University of Iowa	Chen, CK (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, 1101 E Marshall St,Rm 2-032B,Box 980614, Richmond, VA 23298 USA.	cjchen@vcu.edu	McQuiston, Adam Rory/A-3072-2008	Chau, Viet/0000-0002-6958-6156; Chen, Yen-Lin/0000-0003-1149-394X; Fisher, Rory/0000-0003-3108-4836	National Institutes of Health [EY013811, MH094626, GM075033]; NINDS/National Institutes of Health Center [5P30NS047463-02]; NATIONAL EYE INSTITUTE [R56EY013811, R01EY013811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS/National Institutes of Health Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY013811 (to C.-K. C.), MH094626 (to A. R. M.), and GM075033 (to R. A. F.).; Confocal and electron microscopy was performed at the Virginia Commonwealth University Department of Anatomy and Neurobiology Microscopy Facility, supported in part with funding from NINDS/National Institutes of Health Center Core Grant 5P30NS047463-02.	Cao Y, 2009, J NEUROSCI, V29, P9301, DOI 10.1523/JNEUROSCI.1367-09.2009; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Chen CK, 2005, REV PHYSIOL BIOCH P, V154, P101, DOI 10.1007/s10254-005-0004-5; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Chen FS, 2010, INVEST OPHTH VIS SCI, V51, P686, DOI 10.1167/iovs.09-4084; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Gregg RG, 2003, INVEST OPHTH VIS SCI, V44, P378, DOI 10.1167/iovs.02-0501; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Li Q., 2009, 2009 NEUR M PLANN OC; Li S, 2005, GENESIS, V41, P73, DOI 10.1002/gene.20097; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; Mojumder DK, 2009, J NEUROSCI, V29, P7753, DOI 10.1523/JNEUROSCI.1794-09.2009; Morgans CW, 2007, EUR J NEUROSCI, V26, P2899, DOI 10.1111/j.1460-9568.2007.05867.x; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Nawy S, 1999, J NEUROSCI, V19, P2938; Pardue MT, 1998, INVEST OPHTH VIS SCI, V39, P2443; Pearring JN, 2011, J NEUROSCI, V31, P10060, DOI 10.1523/JNEUROSCI.1014-11.2011; Rao A, 2007, J NEUROSCI, V27, P14199, DOI 10.1523/JNEUROSCI.4934-07.2007; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Snellman J, 2004, J NEUROSCI, V24, P6621, DOI 10.1523/JNEUROSCI.1474-04.2004; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Song JH, 2007, MOL CELL NEUROSCI, V35, P311, DOI 10.1016/j.mcn.2007.03.006; Watson AJ, 1996, J BIOL CHEM, V271, P28154, DOI 10.1074/jbc.271.45.28154; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Yoshikawa DM, 2000, BIOCHEMISTRY-US, V39, P11340, DOI 10.1021/bi0005557; Yost EA, 2007, MOL PHARMACOL, V72, P812, DOI 10.1124/mol.107.038075; Zhang JH, 2011, J NEUROCHEM, V119, P544, DOI 10.1111/j.1471-4159.2011.07457.x; Zhang JM, 2010, INVEST OPHTH VIS SCI, V51, P1121, DOI 10.1167/iovs.09-4163	31	37	38	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14873	14879		10.1074/jbc.M112.345751	http://dx.doi.org/10.1074/jbc.M112.345751			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22371490	Green Published, hybrid			2022-12-27	WOS:000304003200051
J	Zhang, YQ; Wu, LP; Wang, Y; Zhang, MC; Li, LM; Zhu, DH; Li, XH; Gu, HW; Zhang, CY; Zen, K				Zhang, Yaqin; Wu, Linping; Wang, Yang; Zhang, Mingcao; Li, Limin; Zhu, Dihan; Li, Xihan; Gu, Hongwei; Zhang, Chen-Yu; Zen, Ke			Protective Role of Estrogen-induced miRNA-29 Expression in Carbon Tetrachloride-induced Mouse Liver Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC STELLATE CELL; HEPATOCELLULAR-CARCINOMA; MESSENGER-RNA; FIBROSIS; MICRORNAS; ACTIVATION; ESTRADIOL; RISK; SEX; QUANTITATION	Previous studies have indicated that female animals are more resistant to carbon tetrachloride (CCl4)-induced liver fibrosis than male animals, and that estradiol (E-2) treatment can inhibit CCl4-induced animal hepatic fibrosis. The underlying mechanism governing these phenomena, however, has not been fully elucidated. Here we reported the role of estrogen-induced miRNA-29 (miR-29) expression in CCl4-induced mouse liver injury. Hepatic miR-29 levels were differentially regulated in female and male mice during CCl4 treatment. Specifically, the levels of miR-29a and miR-29b expression were significantly decreased in the livers of male, but not female, mice following 4 weeks of CCl4 treatment. The down-regulation of miR-29a and miR-29b in male mouse livers correlated with the early development of liver fibrosis, as indicated by increased expressions of fibrotic markers in male mice relative to female mice. In addition, E-2 was maintained at a higher level in female mice than in male mice. In contrast to TGF-beta 1 that decreased miR-29a/b expression in murine hepatoma IAR20 cells and normal hepatocytes, E-2 enhanced the expression of miR-29a/b through suppression of the nuclear factor-kappa B (NF-kappa B) signal pathway, which negatively regulates miR-29 expression. Furthermore, both E-2 treatment and intravenous injection of the recombinant adenovirus expressing miR-29a/b markedly increased the miR-29a/b level and attenuated the expression of fibrotic markers in mouse livers during CCl4 treatment, supporting the protective role of E-2-induced miR-29 in CCl4-induced hepatic injury. In conclusion, our results collectively demonstrate that estrogen can inhibit CCl4-induced hepatic injury through the induction of hepatic miR-29.	[Zhang, Yaqin; Wu, Linping; Wang, Yang; Li, Limin; Zhu, Dihan; Li, Xihan; Gu, Hongwei; Zhang, Chen-Yu; Zen, Ke] Nanjing Univ, Sch Life Sci, JERC MBB, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China; [Zhang, Mingcao] Nanjing Univ, Sch Med, Jingling Hosp, Chinese Peoples Liberat Army,Inst Kidney Dis, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Zhang, CY (corresponding author), Nanjing Univ, Sch Life Sci, JERC MBB, State Key Lab Pharmaceut Biotechnol, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.	cyzhang@nju.edu.cn; kzen@nju.edu.cn			National Basic Research Program of China [2012CB517603, 2011CB504803863]; National Natural Science Foundation of China [30871019, 30890044, 30988003]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2012CB517603 and 2011CB504803863 and National Natural Science Foundation of China Grants 30871019, 30890044, and 30988003.	Akiyoshi H, 1999, J HEPATOL, V30, P433, DOI 10.1016/S0168-8278(99)80102-0; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arias M, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-29; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Becker U, 1996, HEPATOLOGY, V23, P1025, DOI 10.1002/hep.510230513; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; Bissell DM, 1999, HEPATOLOGY, V29, P988, DOI 10.1002/hep.510290351; Chen WZ, 2006, J VIROL, V80, P3559, DOI 10.1128/JVI.80.7.3559-3566.2006; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; Dai RJ, 2009, J IMMUNOL, V183, P6998, DOI 10.4049/jimmunol.0901737; Domenicali M, 2009, J HEPATOL, V51, P991, DOI 10.1016/j.jhep.2009.09.008; EAGON PK, 1991, DIGEST DIS SCI, V36, P1303, DOI 10.1007/BF01307527; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Giannitrapani L, 2006, ANN NY ACAD SCI, V1089, P228, DOI 10.1196/annals.1386.044; Guo CJ, 2009, FEBS J, V276, P5163, DOI 10.1111/j.1742-4658.2009.07213.x; Guo CJ, 2009, J HEPATOL, V50, P766, DOI 10.1016/j.jhep.2008.11.025; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hellerbrand C, 2001, DIGEST DIS, V19, P345, DOI 10.1159/000050702; Idogawa M, 2009, CLIN CANCER RES, V15, P3725, DOI 10.1158/1078-0432.CCR-08-2396; Imaoka M, 2009, TOXICOL PATHOL, V37, P218, DOI 10.1177/0192623308329283; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Jarvelainen HA, 2001, J HEPATOL, V35, P46, DOI 10.1016/S0168-8278(01)00050-2; Jiang XH, 2010, MOL CELL ENDOCRINOL, V315, P74, DOI 10.1016/j.mce.2009.09.018; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Liu QH, 2004, WORLD J GASTROENTERO, V10, P1315; LOPEZDELEON A, 1985, J HISTOCHEM CYTOCHEM, V33, P737, DOI 10.1177/33.8.2410480; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Muriel P, 2003, J APPL TOXICOL, V23, P103, DOI 10.1002/jat.892; Murphy AJ, 2010, J IMMUNOL, V184, P5029, DOI 10.4049/jimmunol.0903463; Pinzani M, 2001, J HEPATOL, V34, P764, DOI 10.1016/S0168-8278(01)00055-1; PORTER LE, 1983, GASTROENTEROLOGY, V84, P704; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Shimizu I, 1999, GUT, V44, P127, DOI 10.1136/gut.44.1.127; Shimizu I, 2003, LIVER INT, V23, P63, DOI 10.1034/j.1600-0676.2003.00811.x; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; VILLA E, 1995, CANCER RES, V55, P498; VILLA E, 1988, CANCER-AM CANCER SOC, V62, P611, DOI 10.1002/1097-0142(19880801)62:3<611::AID-CNCR2820620328>3.0.CO;2-0; Xu JW, 2002, WORLD J GASTROENTERO, V8, P883, DOI 10.3748/wjg.v8.i5.883; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Yasuda M, 1999, HEPATOLOGY, V29, P719, DOI 10.1002/hep.510290307	45	77	85	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14851	14862		10.1074/jbc.M111.314922	http://dx.doi.org/10.1074/jbc.M111.314922			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22393047	hybrid, Green Published			2022-12-27	WOS:000304003200049
J	de Baaij, JHF; Stuiver, M; Meij, IC; Lainez, S; Kopplin, K; Venselaar, H; Muller, D; Bindels, RJM; Hoenderop, JGJ				de Baaij, Jeroen H. F.; Stuiver, Marchel; Meij, Iwan C.; Lainez, Sergio; Kopplin, Kathrin; Venselaar, Hanka; Mueller, Dominik; Bindels, Rene J. M.; Hoenderop, Joost G. J.			Membrane Topology and Intracellular Processing of Cyclin M2 (CNNM2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONE-ROD DYSTROPHY; EPITOPE INSERTION; SIGNAL PEPTIDES; DOMAIN; PROTEIN; CA2+; MUTATIONS; ASSOCIATION; PREDICTION; TRANSPORT	Recently, mutations in the cyclin M2 (CNNM2) gene were identified to be causative for severe hypomagnesemia. In kidney, CNNM2 is a basolaterally expressed protein with predominant expression in the distal convoluted tubule. Transcellular magnesium (Mg2+) reabsorption in the distal convoluted tubule represents the final step before Mg2+ is excreted into the urine, thus fine-tuning its final excretion via a tightly regulated mechanism. The present study aims to get insight in the structure of CNNM2 and to characterize its post-translational modifications. Here, membrane topology studies using intramolecular epitopes and immunocytochemistry showed that CNNM2 has an extracellular N terminus and an intracellular C terminus. This suggests that one of the predicted transmembrane regions might be reentrant. By homology modeling, we demonstrated that the loss-of-function mutation as found in patients disturbs the potential ATP binding by the intracellular cystathionine beta-synthase domains. In addition, the cellular processing pathway of CNNM2 was exposed in detail. In the endoplasmic reticulum, the signal peptidase complex cleaves off a large N-terminal signal peptide of about 64 amino acids. Mutagenesis screening showed that CNNM2 is glycosylated at residue Asn-112, stabilizing CNNM2 on the plasma membrane. Interestingly, co-immunoprecipitation studies evidenced that CNNM2a forms heterodimers with the smaller isoform CNNM2b. These new findings on CNNM2 structure and processing may aid to elucidate the physiological role of CNNM2 in Mg2+ reabsorption in the kidney.	[de Baaij, Jeroen H. F.; Lainez, Sergio; Bindels, Rene J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Physiol, NL-6500 HB Nijmegen, Netherlands; [Stuiver, Marchel; Kopplin, Kathrin; Mueller, Dominik] Charite, Dept Pediat Nephrol, D-13353 Berlin, Germany; [Stuiver, Marchel; Kopplin, Kathrin; Mueller, Dominik] Charite, Ctr Cardiovasc Res, D-10115 Berlin, Germany; [Meij, Iwan C.] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Venselaar, Hanka] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Radboud University Nijmegen	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Physiol 286, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.hoenderop@fysiol.umcn.nl	Venselaar, Hanka/D-2009-2016; Hoenderop, Joost G.J./H-8047-2014; de Baaij, Jeroen/P-5704-2015; Bindels, René JM/B-9824-2013	Venselaar, Hanka/0000-0001-9824-6559; Hoenderop, Joost G.J./0000-0002-1816-8544; de Baaij, Jeroen/0000-0003-2372-8486; Bindels, René JM/0000-0003-1167-1339; Stuiver, Marchel/0000-0003-3437-4468	Netherlands Organization for Scientific Research [ZonMw 9120.8026, EURYI 2006]; European Community [EUNEFRON 201590]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Community(European Commission)	This work was supported by the Netherlands Organization for Scientific Research Grants ZonMw 9120.8026 and EURYI 2006 (to J. G. J. H.) and by grants from the European Community, FP7 (EUNEFRON 201590) (to I. C. M. and D. M.).	Alderton A, 2007, J NEUROCHEM, V103, P312, DOI 10.1111/j.1471-1471-4159.2007.04751.x; Baykov AA, 2011, ACS CHEM BIOL, V6, P1156, DOI 10.1021/cb200231c; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Biemans-Oldehinkel E, 2006, P NATL ACAD SCI USA, V103, P10624, DOI 10.1073/pnas.0603871103; BINDELS RJM, 1991, AM J PHYSIOL, V261, pF799, DOI 10.1152/ajprenal.1991.261.5.F799; Czachorowski M, 2009, BIOCHEMISTRY-US, V48, P8422, DOI 10.1021/bi900606y; Glaudemans B, 2010, KIDNEY INT, V77, P17, DOI 10.1038/ki.2009.358; Garcia IG, 2011, ACTA CRYSTALLOGR F, V67, P349, DOI 10.1107/S1744309110053856; Goytain A, 2005, PHYSIOL GENOMICS, V22, P382, DOI 10.1152/physiolgenomics.00058.2005; Gunzel D, 2009, J CELL SCI, V122, P1507, DOI 10.1242/jcs.040113; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; Hiss JA, 2009, BRIEF BIOINFORM, V10, P569, DOI 10.1093/bib/bbp030; Hoenderop JGJ, 2002, FASEB J, V16, P1398, DOI 10.1096/fj.02-0225com; Hofmeister MV, 2009, AM J PHYSIOL-RENAL, V296, pF194, DOI 10.1152/ajprenal.90495.2008; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Ishitani R, 2008, P NATL ACAD SCI USA, V105, P15393, DOI 10.1073/pnas.0802991105; Kast C, 1997, J BIOL CHEM, V272, P26479, DOI 10.1074/jbc.272.42.26479; KAST C, 1995, BIOCHEMISTRY-US, V34, P4402, DOI 10.1021/bi00013a032; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Loffing J, 2004, J AM SOC NEPHROL, V15, P2276, DOI 10.1097/01.ASN.0000138234.18569.63; Meij IC, 2003, NEPHROL DIAL TRANSPL, V18, P512, DOI 10.1093/ndt/18.3.512; Meyer AH, 2002, J NEUROSCI, V22, P7055; Meyer TE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001045; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nijenhuis T, 2003, KIDNEY INT, V64, P555, DOI 10.1046/j.1523-1755.2003.00128.x; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Parry DA, 2009, AM J HUM GENET, V84, P266, DOI 10.1016/j.ajhg.2009.01.009; Polok B, 2009, AM J HUM GENET, V84, P259, DOI 10.1016/j.ajhg.2009.01.006; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sponder G, 2010, MAGNESIUM RES, V23, P105, DOI 10.1684/mrh.2010.0206; Stuiver M, 2011, AM J HUM GENET, V88, P333, DOI 10.1016/j.ajhg.2011.02.005; Takeuchi F, 2010, CIRCULATION, V121, P2302, DOI 10.1161/CIRCULATIONAHA.109.904664; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wabakken T, 2003, BIOCHEM BIOPH RES CO, V306, P718, DOI 10.1016/S0006-291X(03)01030-1; Wang CY, 2003, GENE, V306, P37, DOI 10.1016/S0378-1119(02)01210-6; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03	41	66	73	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13644	13655		10.1074/jbc.M112.342204	http://dx.doi.org/10.1074/jbc.M112.342204			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22399287	hybrid, Green Published			2022-12-27	WOS:000303996300020
J	Tollefsen, S; Hotta, K; Chen, X; Simonsen, B; Swaminathan, K; Mathews, II; Sollid, LM; Kim, CY				Tollefsen, Stig; Hotta, Kinya; Chen, Xi; Simonsen, Bjorg; Swaminathan, Kunchithapadam; Mathews, Irimpan I.; Sollid, Ludvig M.; Kim, Chu-Young			Structural and Functional Studies of trans-Encoded HLA-DQ2.3 (DQA1*03:01/DQB1*02:01) Protein Molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 DIABETES RISK; CLASS-II MOLECULES; CELIAC-DISEASE; MAXIMUM-LIKELIHOOD; SURFACE EXPRESSION; BINDING; PEPTIDE; SUSCEPTIBILITY; ASSOCIATIONS; REFINEMENT	MHC class II molecules are composed of one alpha-chain and one beta-chain whose membrane distal interface forms the peptide binding groove. Most of the existing knowledge on MHC class II molecules comes from the cis-encoded variants where the alpha- and beta-chain are encoded on the same chromosome. However, trans-encoded class II MHC molecules, where the alpha- and beta-chain are encoded on opposite chromosomes, can also be expressed. We have studied the trans-encoded class II HLA molecule DQ2.3 (DQA1*03:01/DQB1*02:01) that has received particular attention as it may explain the increased risk of certain individuals to type 1 diabetes. We report the x-ray crystal structure of this HLA molecule complexed with a gluten epitope at 3.05 angstrom resolution. The gluten epitope, which is the only known HLA-DQ2.3-restricted epitope, is preferentially recognized in the context of the DQ2.3 molecule by T-cell clones of a DQ8/DQ2.5 heterozygous celiac disease patient. This preferential recognition can be explained by improved HLA binding as the epitope combines the peptide-binding motif of DQ2.5 (negative charge at P4) and DQ8 (negative charge at P1). The analysis of the structure of DQ2.3 together with all other available DQ crystal structures and sequences led us to categorize DQA1 and DQB1 genes into two groups where any alpha-chain and beta-chain belonging to the same group are expected to form a stable heterodimer.	[Tollefsen, Stig; Simonsen, Bjorg; Sollid, Ludvig M.] Univ Oslo, Ctr Immune Regulat, N-0027 Oslo, Norway; [Tollefsen, Stig; Simonsen, Bjorg; Sollid, Ludvig M.] Univ Oslo, Dept Immunol, N-0027 Oslo, Norway; [Tollefsen, Stig; Simonsen, Bjorg; Sollid, Ludvig M.] Oslo Univ Hosp, Rikshosp, N-0027 Oslo, Norway; [Hotta, Kinya; Chen, Xi; Swaminathan, Kunchithapadam; Kim, Chu-Young] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Mathews, Irimpan I.] Stanford Linear Accelerator Ctr, Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 95124 USA	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; National University of Singapore; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Sollid, LM (corresponding author), Univ Oslo, Ctr Immune Regulat, N-0027 Oslo, Norway.	l.m.sollid@medisin.uio.no; chuyoung@nus.edu.sg	Sollid, Ludvig/N-9691-2015; Kim, Chu-Young/D-8849-2012; Hotta, Kinya/A-2574-2009	Sollid, Ludvig/0000-0001-8860-704X; Kim, Chu-Young/0000-0003-3744-7802; Hotta, Kinya/0000-0002-9427-0081	Novo Nordisk Foundation; Juvenile Diabetes Research Foundation; Research Council of Norway; Singapore Biomedical Research Council [07/1/21/19/546]; Norwegian Extra Foundation for Health and Rehabilitation; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources; NIGMS; Biomedical Technology Program	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Research Council of Norway(Research Council of Norway); Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Norwegian Extra Foundation for Health and Rehabilitation; Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biomedical Technology Program	This work was supported by grants from the Novo Nordisk Foundation, the Juvenile Diabetes Research Foundation, and the Research Council of Norway (to L. M. S.) and by Singapore Biomedical Research Council Grant 07/1/21/19/546 (to C. Y. K.).; Present address: Norwegian Veterinary Institute, 0106 Oslo, Norway. Supported by a postdoctoral grant from the Norwegian Extra Foundation for Health and Rehabilitation.; We thank Marit Sandvik for technical assistance and Elizabeth Mellins for providing the pRmHa3 plasmid. Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory (SSRL), a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and NIGMS.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; BRAUNSTEIN NS, 1987, P NATL ACAD SCI USA, V84, P2921, DOI 10.1073/pnas.84.9.2921; CHARRON DJ, 1984, NATURE, V312, P157, DOI 10.1038/312157a0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Fallang LE, 2009, NAT IMMUNOL, V10, P1096, DOI 10.1038/ni.1780; Helmberg W, 2004, NUCLEIC ACIDS RES, V32, pW173, DOI 10.1093/nar/gkh424; Juse U, 2009, IMMUNOGENETICS, V61, P81, DOI 10.1007/s00251-008-0338-7; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Koeleman BPC, 2004, GENES IMMUN, V5, P381, DOI 10.1038/sj.gene.6364106; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; KWOK WW, 1993, J IMMUNOL, V150, P2263; KWOK WW, 1988, J IMMUNOL, V141, P3123; KWOK WW, 1991, BAILLIERE CLIN ENDOC, V5, P375, DOI 10.1016/S0950-351X(05)80137-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LECHLER RI, 1990, J IMMUNOL, V144, P329; LOTTEAU V, 1987, NATURE, V329, P339, DOI 10.1038/329339a0; MAGALHAES A, 1994, J PROTEIN CHEM, V13, P195, DOI 10.1007/BF01891978; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McFarland BJ, 2002, MED RES REV, V22, P168, DOI 10.1002/med.10006; Molberg O, 2003, GASTROENTEROLOGY, V125, P337, DOI 10.1016/S0016-5085(03)00890-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493; Noble JA, 2011, TISSUE ANTIGENS, V78, P348, DOI 10.1111/j.1399-0039.2011.01772.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quarsten H, 2001, J IMMUNOL, V167, P4861, DOI 10.4049/jimmunol.167.9.4861; Reichstetter S, 1999, TISSUE ANTIGENS, V53, P101, DOI 10.1034/j.1399-0039.1999.530111.x; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; SPENCER JS, 1993, J IMMUNOL, V151, P6822; Thorsby E, 1997, HUM IMMUNOL, V53, P1, DOI 10.1016/S0198-8859(97)00024-4; TODD JA, 1989, NATURE, V338, P587, DOI 10.1038/338587a0; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tollefsen S, 2006, J CLIN INVEST, V116, P2226, DOI 10.1172/JCI27620; Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Vartdal F, 1996, EUR J IMMUNOL, V26, P2764, DOI 10.1002/eji.1830261132; WILMOT CM, 1988, J MOL BIOL, V203, P221, DOI 10.1016/0022-2836(88)90103-9; Zhu YR, 2003, J MOL BIOL, V326, P1157, DOI 10.1016/S0022-2836(02)01437-7	40	45	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13611	13619		10.1074/jbc.M111.320374	http://dx.doi.org/10.1074/jbc.M111.320374			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22362761	Green Published, hybrid			2022-12-27	WOS:000303996300017
J	Zhang, SX; Zhu, C; Ba, Y; Chen, D; Zhou, XL; Cao, R; Wang, LP; Ren, Y; Wu, XZ				Zhang, Shuang-Xia; Zhu, Cong; Ba, Yi; Chen, Dan; Zhou, Xing-Long; Cao, Rui; Wang, Li-Ping; Ren, Yuan; Wu, Xiong-Zhi			Gekko-sulfated Glycopeptide Inhibits Tumor Angiogenesis by Targeting Basic Fibroblast Growth Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELL PROLIFERATION; HEPATOMA SMMC-7721 CELLS; HEPARAN-SULFATE; HEPATOCELLULAR-CARCINOMA; INTERFERON-ALPHA; DRUG DISCOVERY; THERAPY; DIFFERENTIATION; EXPRESSION; MIGRATION	Basic fibroblast growth factor (bFGF) is a therapeutic target of anti-angiogenesis. Here, we report that a novel sulfated glycopeptide derived from Gekko swinhonis Guenther (GSPP), an anticancer drug in traditional Chinese medicine, inhibits tumor angiogenesis by targeting bFGF. GSPP significantly decreased the production of bFGF in hepatoma cells by suppressing early growth response-1. GSPP inhibited the release of bFGF from extracellular matrix by blocking heparanase enzymatic activity. Moreover, GSPP competitively inhibited bFGF binding to heparin/heparan sulfate via direct binding to bFGF. Importantly, GSPP abrogated the bFGF-stimulated proliferation and migration of endothelial cells, whereas it had no inhibitory effect on endothelial cells in the absence of bFGF. Further study revealed that GSPP prevented bFGF-induced neovascularization and inhibited tumor angiogenesis and tumor growth in a xenograft mouse model. These results demonstrate that GSPP inhibits tumor angiogenesis by blocking bFGF production, release from the extracellular matrix, and binding to its low affinity receptor, heparin/heparan sulfate.	[Wu, Xiong-Zhi] Tianjin Med Univ Canc Inst & Hosp, Zhong Shan Men In Patient Dept, Tianjin 300060, Peoples R China; [Chen, Dan] Tianjin Med Univ, Sch Basic Med Sci, Dept Pharmacol, Tianjin 300070, Peoples R China; [Zhou, Xing-Long; Ren, Yuan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Tianjin Medical University; Tianjin Medical University; Nankai University	Wu, XZ (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Zhong Shan Men In Patient Dept, Huan Hu Xi Rd, Tianjin 300060, Peoples R China.	ilwxz@163.com	Wu, Xiong-Zhi/P-4045-2019; Ren, Yuan/R-6175-2018	Ren, Yuan/0000-0001-7155-7664	National Science Foundation of China [30801495]; Education Committee of Tianjin [ZD-0715]; Health Bureau of Tianjin [30772484]; Tianjin Medical University [2010ky03]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Committee of Tianjin; Health Bureau of Tianjin; Tianjin Medical University	This work was supported by grants from the National Science Foundation of China (No. 30801495), Education Committee of Tianjin (No. ZD-0715), Health Bureau of Tianjin (No. 30772484), and Tianjin Medical University (No. 2010ky03).	Abdel-Malak NA, 2009, ARTERIOSCL THROM VAS, V29, P209, DOI 10.1161/ATVBAHA.108.181073; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Biesiada E, 1996, J BIOL CHEM, V271, P18576, DOI 10.1074/jbc.271.31.18576; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chen D, 2010, J ETHNOPHARMACOL, V127, P702, DOI 10.1016/j.jep.2009.12.003; DANESI R, 1993, BRIT J CANCER, V68, P932, DOI 10.1038/bjc.1993.457; Ellis LM, 2008, CLIN CANCER RES, V14, P6371, DOI 10.1158/1078-0432.CCR-07-5287; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gandhi NS, 2010, DRUG DISCOV TODAY, V15, P1058, DOI 10.1016/j.drudis.2010.10.009; Goldshmidt O, 2002, P NATL ACAD SCI USA, V99, P10031, DOI 10.1073/pnas.152070599; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Harmer NJ, 2006, BIOCHEM SOC T, V34, P442, DOI 10.1042/BST0340442; Jain RK, 2009, NAT REV CLIN ONCOL, V6, P327, DOI 10.1038/nrclinonc.2009.63; Kathir KM, 2006, BIOCHEMISTRY-US, V45, P899, DOI 10.1021/bi051389b; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; Liu CJ, 2009, J HEPATOL, V50, P958, DOI 10.1016/j.jhep.2008.12.023; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Presta M, 2003, CURR PHARM DESIGN, V9, P553, DOI 10.2174/1381612033391379; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Reiland J, 2006, NEOPLASIA, V8, P596, DOI 10.1593/neo.06244; Rusnati M, 2007, CURR PHARM DESIGN, V13, P2025; Sasisekharan R, 1997, Angiogenesis, V1, P45, DOI 10.1023/A:1018318914258; SINGH RK, 1995, P NATL ACAD SCI USA, V92, P4562, DOI 10.1073/pnas.92.10.4562; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Wang D, 1997, ONCOGENE, V14, P2291, DOI 10.1038/sj.onc.1201069; Wang L, 2000, HEPATOLOGY, V32, P43, DOI 10.1053/jhep.2000.8525; Wang YP, 1997, NAT MED, V3, P887, DOI 10.1038/nm0897-887; Wu XZ, 2011, MOLECULES, V16, P4958, DOI 10.3390/molecules16064958; Wu XZ, 2006, CELL BIOL INT, V30, P659, DOI 10.1016/j.cellbi.2006.04.005; Zhu G, 2000, J PHARMACEUT BIOMED, V24, P281, DOI 10.1016/S0731-7085(00)00417-9	34	17	18	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13206	13215		10.1074/jbc.M111.321521	http://dx.doi.org/10.1074/jbc.M111.321521			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22371501	hybrid, Green Published			2022-12-27	WOS:000302903700058
J	Ahn, KH; Mahmoud, MM; Kendall, DA				Ahn, Kwang H.; Mahmoud, Mariam M.; Kendall, Debra A.			Allosteric Modulator ORG27569 Induces CB1 Cannabinoid Receptor High Affinity Agonist Binding State, Receptor Internalization, and G(i) Protein-independent ERK1/2 Kinase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTORS; SIGNAL-REGULATED KINASES; COUPLED RECEPTORS; 7-TRANSMEMBRANE RECEPTORS; SPHINGOMYELIN HYDROLYSIS; CONSTITUTIVE ACTIVATION; HORMONE RECEPTOR; DOWN-REGULATION; HELIX 8; TRANSDUCTION	The cannabinoid receptor 1 (CB1), a member of the class A G protein-coupled receptor family, is expressed in brain tissue where agonist stimulation primarily activates the pertussis toxin-sensitive inhibitory G protein (G(i)). Ligands such as CP55940 ((1R,3R,4R)-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-4-(3-hydroxypropyl)cyclohexan-1-ol) and Delta(9)-tetrahydrocannabinolare orthosteric agonists for the receptor, bind the conventional binding pocket, and trigger G(i)-mediated effects including inhibition of adenylate cyclase. ORG27569 (5-chloro-3-ethyl-1H-indole-2-carboxylic acid [2-(4-piperidin-1-yl-phenyl)ethyl]amide) has been identified as an allosteric modulator that displays positive co-operativity for CP55940 binding to CB1 yet acts as an antagonist of G protein coupling. To examine this apparent conundrum, we used the wild-type CB1 and two mutants, T210A and T210I (D'Antona, A. M., Ahn, K. H., andKendall, D. A.(2006) Biochemistry45,5606-5617), which collectively cover a spectrum of receptor states from inactive to partially active to more fully constitutively active. Using these receptors, we demonstrated that ORG27569 induces a CB1 receptor state that is characterized by enhanced agonist affinity and decreased inverse agonist affinity consistent with an active conformation. Also consistent with this conformation, the impact of ORG27569 binding was most dramatic on the inactive T210A receptor and less pronounced on the already active T210I receptor. Although ORG27569 antagonized CP55940-induced guanosine 5'-3-O-(thio)triphosphate binding, which is indicative of G protein coupling inhibition in a concentration-dependent manner, the ORG27569-induced conformational change of the CB1 receptor led to cellular internalization and downstream activation of ERK signaling, providing the first case of allosteric ligand-biased signaling via CB1. ORG27569-induced ERK phosphorylation persisted even after pertussis toxin treatment to abrogate G(i) and occurs in HEK293 and neuronal cells.	[Ahn, Kwang H.; Kendall, Debra A.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA; [Mahmoud, Mariam M.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut	Kendall, DA (corresponding author), Univ Connecticut, Dept Pharmaceut Sci, 69 N Eagleville Rd, Storrs, CT 06269 USA.	debra.kendall@uconn.edu		Mahmoud, Mariam/0000-0002-0491-1544	National Institutes of Health [DA020763]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA020763 (to D. A. K.).	Abadji V, 1999, J NEUROCHEM, V72, P2032, DOI 10.1046/j.1471-4159.1999.0722032.x; Ahn KH, 2010, BIOCHEMISTRY-US, V49, P502, DOI 10.1021/bi901619r; Ahn KH, 2009, MOL PHARMACOL, V76, P833, DOI 10.1124/mol.109.057356; Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Ballesteros J, 1998, J BIOL CHEM, V273, P10445, DOI 10.1074/jbc.273.17.10445; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bosier B, 2008, FEBS LETT, V582, P3861, DOI 10.1016/j.febslet.2008.10.022; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; Bouaboula M, 1999, FEBS LETT, V449, P61, DOI 10.1016/S0014-5793(99)00395-6; Brailoiu GC, 2011, J BIOL CHEM, V286, P29166, DOI 10.1074/jbc.M110.217463; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; D'Antona AM, 2006, BRAIN RES, V1108, P1, DOI 10.1016/j.brainres.2006.05.042; D'Antona AM, 2006, BIOCHEMISTRY-US, V45, P5606, DOI 10.1021/bi060067k; Daigle TL, 2008, J NEUROCHEM, V106, P70, DOI 10.1111/j.1471-4159.2008.05336.x; Davis AA, 2010, ACS CHEM NEUROSCI, V1, P542, DOI 10.1021/cn100011e; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Derkinderen P, 2003, J NEUROSCI, V23, P2371; Derkinderen P, 2001, J NEUROCHEM, V77, P957, DOI 10.1046/j.1471-4159.2001.00333.x; Dowal L, 2011, P NATL ACAD SCI USA, V108, P2951, DOI 10.1073/pnas.1014863108; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Gardner EL, 1998, NEUROBIOL DIS, V5, P502, DOI 10.1006/nbdi.1998.0219; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gregory KJ, 2007, CURR NEUROPHARMACOL, V5, P157, DOI 10.2174/157015907781695946; Gregory KJ, 2010, J BIOL CHEM, V285, P7459, DOI 10.1074/jbc.M109.094011; Grimsey NL, 2010, BIOCHEM PHARMACOL, V80, P1050, DOI 10.1016/j.bcp.2010.06.007; Guzman M, 1999, LIFE SCI, V65, P657, DOI 10.1016/S0024-3205(99)00288-X; Harkany T, 2007, TRENDS PHARMACOL SCI, V28, P83, DOI 10.1016/j.tips.2006.12.004; Horswill JG, 2007, BRIT J PHARMACOL, V152, P805, DOI 10.1038/sj.bjp.0707347; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Howlett AC, 2005, HANDB EXP PHARMACOL, V168, P53; Howlett AC, 2000, CHEM PHYS LIPIDS, V108, P53, DOI 10.1016/S0009-3084(00)00187-0; Hsieh C, 1999, J NEUROCHEM, V73, P493, DOI 10.1046/j.1471-4159.1999.0730493.x; Jin WZ, 1999, J NEUROSCI, V19, P3773; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kendall RT, 2011, J BIOL CHEM, V286, P19880, DOI 10.1074/jbc.M111.233080; Klaasse EC, 2005, EUR J PHARMACOL, V522, P1, DOI 10.1016/j.ejphar.2005.08.052; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Langmead CJ, 2006, TRENDS PHARMACOL SCI, V27, P475, DOI 10.1016/j.tips.2006.07.009; Leterrier C, 2006, J NEUROSCI, V26, P3141, DOI 10.1523/JNEUROSCI.5437-05.2006; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Lim CS, 2008, CELL SIGNAL, V20, P825, DOI 10.1016/j.cellsig.2007.12.013; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Martini L, 2007, FASEB J, V21, P802, DOI 10.1096/fj.06-7132com; McDonald NA, 2007, MOL PHARMACOL, V71, P976, DOI 10.1124/mol.106.029348; Murphy JW, 2003, BIOCHEM PHARMACOL, V65, P1623, DOI 10.1016/S0006-2952(03)00155-2; Pelkey KA, 2007, NEUROPHARMACOLOGY, V52, P108, DOI 10.1016/j.neuropharm.2006.07.020; Porter AC, 2001, PHARMACOL THERAPEUT, V90, P45, DOI 10.1016/S0163-7258(01)00130-9; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Przybyla JA, 2010, J PHARMACOL EXP THER, V332, P710, DOI 10.1124/jpet.109.162701; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rozenfeld R, 2008, FASEB J, V22, P2311, DOI 10.1096/fj.07-102731; Rueda D, 2000, MOL PHARMACOL, V58, P814, DOI 10.1124/mol.58.4.814; Sanchez C, 2001, MOL PHARMACOL, V59, P955, DOI 10.1124/mol.59.5.955; Sanchez C, 1998, MOL PHARMACOL, V54, P834, DOI 10.1124/mol.54.5.834; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; Song ZH, 1999, MOL PHARMACOL, V56, P834; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Thomas RL, 2009, J PHARMACOL EXP THER, V331, P1086, DOI 10.1124/jpet.109.160242; Tschammer N, 2011, MOL PHARMACOL, V79, P575, DOI 10.1124/mol.110.068106; Turu G, 2010, J MOL ENDOCRINOL, V44, P75, DOI 10.1677/JME-08-0190; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Zhang RD, 2005, MOL PHARMACOL, V68, P69, DOI 10.1124/mol.104.007823; Zheng H, 2008, MOL PHARMACOL, V73, P178, DOI 10.1124/mol.107.039842	74	107	111	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12070	12082		10.1074/jbc.M111.316463	http://dx.doi.org/10.1074/jbc.M111.316463			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22343625	Green Published, hybrid			2022-12-27	WOS:000302782200044
J	Zhang, T; Berrocal, JG; Yao, J; DuMond, ME; Krishnakumar, R; Ruhl, DD; Ryu, KW; Gamble, MJ; Kraus, WL				Zhang, Tong; Berrocal, Jhoanna G.; Yao, Jie; DuMond, Michelle E.; Krishnakumar, Raga; Ruhl, Donald D.; Ryu, Keun Woo; Gamble, Matthew J.; Kraus, W. Lee			Regulation of Poly(ADP-ribose) Polymerase-1-dependent Gene Expression through Promoter-directed Recruitment of a Nuclear NAD(+) Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; COLONY-ENHANCING FACTOR; CHROMATIN-STRUCTURE; DNA-BINDING; WALLERIAN DEGENERATION; BIOSYNTHETIC ENZYME; AXON DEGENERATION; CATALYTIC DOMAINS; POLYMERASE PARP; TRANSCRIPTION	NMNAT-1 and PARP-1, two key enzymes in the NAD(+) metabolic pathway, localize to the nucleus where integration of their enzymatic activities has the potential to control a variety of nuclear processes. Using a variety of biochemical, molecular, cell-based, and genomic assays, we show that NMNAT-1 and PARP-1 physically and functionally interact at target gene promoters in MCF-7 cells. Specifically, we show that PARP-1 recruits NMNAT-1 to promoters where it produces NAD(+) to support PARP-1 catalytic activity, but also enhances the enzymatic activity of PARP-1 independently of NAD(+) production. Furthermore, using two-photon excitation microscopy, we show that NMNAT-1 catalyzes the production of NAD(+) in a nuclear pool that may be distinct from other cellular compartments. In expression microarray experiments, depletion of NMNAT-1 or PARP-1 alters the expression of about 200 protein-coding genes each, with about 10% overlap between the two gene sets. NMNAT-1 enzymatic activity is required for PARP-1-dependent poly(ADP-ribosyl)ation at the promoters of commonly regulated target genes, as well as the expression of those target genes. Collectively, our studies link the enzymatic activities of NMNAT-1 and PARP-1 to the regulation of a set of common target genes through functional interactions at target gene promoters.	[Ryu, Keun Woo; Kraus, W. Lee] Univ Texas SW Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; [Ryu, Keun Woo; Kraus, W. Lee] Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Basic Res Div, Dallas, TX 75390 USA; [Zhang, Tong; Berrocal, Jhoanna G.; Yao, Jie; DuMond, Michelle E.; Krishnakumar, Raga; Ruhl, Donald D.; Gamble, Matthew J.; Kraus, W. Lee] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Berrocal, Jhoanna G.; Yao, Jie; Krishnakumar, Raga; Kraus, W. Lee] Cornell Univ, Grad Field Biochem Mol & Cell Biol, Ithaca, NY 14853 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cornell University; Cornell University	Kraus, WL (corresponding author), Univ Texas SW Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	lee.kraus@utsouthwestern.edu	Yao, Jie/E-2229-2017	Yao, Jie/0000-0002-7640-4840; Krishnakumar, Raga/0000-0002-2479-754X	National Institutes of Health from the NIDDK [R01 DK069710]; National Research Service from the NIDDK; Endocrine Society; New York State Health Research Science Board; American Heart Association (AHA); Susan G. Komen Breast Cancer Foundation; Alfred P. Sloan Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069710] Funding Source: NIH RePORTER	National Institutes of Health from the NIDDK; National Research Service from the NIDDK; Endocrine Society; New York State Health Research Science Board; American Heart Association (AHA)(American Heart Association); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK069710 from the NIDDK (to W. L. K.) and a National Research Service award postdoctoral fellowship from the NIDDK (to M. J. G.). This work was also supported by a grant from the Endocrine Society (to W. L. K.); postdoctoral fellowships from the New York State Health Research Science Board (to T. Z.), the American Heart Association (AHA) (to M. J. G.), and the Susan G. Komen Breast Cancer Foundation (to D. D. R.).; and predoctoral fellowships from the Alfred P. Sloan Foundation (to J. G. B.) and the AHA (to R. K.).	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Berger F, 2007, P NATL ACAD SCI USA, V104, P3765, DOI 10.1073/pnas.0609211104; Bulger M., 1994, METH MOL G, V5, P241; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Emanuelli M, 2001, J BIOL CHEM, V276, P406, DOI 10.1074/jbc.M008700200; Frizzell KM, 2009, J BIOL CHEM, V284, P33926, DOI 10.1074/jbc.M109.023879; Grubisha O, 2005, FEBS J, V272, P4607, DOI 10.1111/j.1742-4658.2005.04862.x; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; KEITH G, 1990, ANAL BIOCHEM, V191, P309, DOI 10.1016/0003-2697(90)90224-W; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kininis M, 2007, MOL CELL BIOL, V27, P5090, DOI 10.1128/MCB.00083-07; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Kraus WL, 1999, STEROID NUCL RECEPTO, P167; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Langelier MF, 2010, J BIOL CHEM, V285, P18877, DOI 10.1074/jbc.M110.105668; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Raffaelli N, 2002, BIOCHEM BIOPH RES CO, V297, P835, DOI 10.1016/S0006-291X(02)02285-4; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; Schweiger M, 2001, FEBS LETT, V492, P95, DOI 10.1016/S0014-5793(01)02180-9; Simbulan-Rosenthal CM, 2003, ONCOGENE, V22, P8460, DOI 10.1038/sj.onc.1206897; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Vishwasrao HD, 2005, J BIOL CHEM, V280, P25119, DOI 10.1074/jbc.M502475200; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; WILLIAMS RM, 1994, FASEB J, V8, P804, DOI 10.1096/fasebj.8.11.8070629; Yalowitz JA, 2004, BIOCHEM J, V377, P317, DOI 10.1042/BJ20030518; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Zhang J, 2003, BIOESSAYS, V25, P808, DOI 10.1002/bies.10317; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang T, 2010, BBA-PROTEINS PROTEOM, V1804, P1666, DOI 10.1016/j.bbapap.2009.10.022; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469	51	78	82	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12405	12416		10.1074/jbc.M111.304469	http://dx.doi.org/10.1074/jbc.M111.304469			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334709	hybrid, Green Published			2022-12-27	WOS:000302782200080
J	Suzuki, N; Kim, YM; Fujimoto, Z; Momma, M; Okuyama, M; Mori, H; Funane, K; Kimura, A				Suzuki, Nobuhiro; Kim, Young-Min; Fujimoto, Zui; Momma, Mitsuru; Okuyama, Masayuki; Mori, Haruhide; Funane, Kazumi; Kimura, Atsuo			Structural Elucidation of Dextran Degradation Mechanism by Streptococcus mutans Dextranase Belonging to Glycoside Hydrolase Family 66	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; IMMUNOGLOBULIN SUPERFAMILY; HYDROLYZING ENZYMES; ALPHA-GALACTOSIDASE; CRYSTAL-STRUCTURES; SEQUENCE-ANALYSIS; CELL-SURFACE; GENE; BINDING; REFINEMENT	Dextranase is an enzyme that hydrolyzes dextran alpha-1,6 linkages. Streptococcus mutans dextranase belongs to glycoside hydrolase family 66, producing isomaltooligosaccharides of various sizes and consisting of at least five amino acid sequence regions. The crystal structure of the conserved fragment from Gln(100) to Ile(732) of S. mutans dextranase, devoid of its N- and C-terminal variable regions, was determined at 1.6 angstrom resolution and found to contain three structural domains. Domain N possessed an immunoglobulin-like beta-sandwich fold; domain A contained the enzyme's catalytic module, comprising a (beta/alpha)(8)-barrel; and domain C formed a beta-sandwich structure containing two Greek key motifs. Two ligand complex structures were also determined, and, in the enzyme-isomaltotriose complex structure, the bound isomaltooligosaccharide with four glucose moieties was observed in the catalytic glycone cleft and considered to be the transglycosylation product of the enzyme, indicating the presence of four subsites, -4 to -1, in the catalytic cleft. The complexed structure with 4',5'-epoxypentyl-alpha-D-glucopyranoside, a suicide substrate of the enzyme, revealed that the epoxide ring reacted to form a covalent bond with the Asp(385) side chain. These structures collectively indicated that Asp(385) was the catalytic nucleophile and that Glu(453) was the acid/base of the double displacement mechanism, in which the enzyme showed a retaining catalytic character. This is the first structural report for the enzyme belonging to glycoside hydrolase family 66, elucidating the enzyme's catalytic machinery.	[Suzuki, Nobuhiro; Kim, Young-Min; Fujimoto, Zui; Momma, Mitsuru] Natl Inst Agrobiol Sci, Biomol Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Kim, Young-Min; Okuyama, Masayuki; Mori, Haruhide; Kimura, Atsuo] Hokkaido Univ, Res Fac Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Funane, Kazumi] Natl Agr & Food Res Org, Natl Food Res Inst, Appl Microbiol Div, Tsukuba, Ibaraki 3058642, Japan	National Institute of Agrobiological Sciences - Japan; Hokkaido University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Fujimoto, Z (corresponding author), Natl Inst Agrobiol Sci, Biomol Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	zui@affrc.go.jp; kimura@abs.agr.hokudai.ac.jp	Mori, Haruhide/AAV-6374-2021; Mori, Haruhide/B-7777-2012; Okuyama, Masayuki/D-8739-2012; Suzuki, Nobuhiro/M-7238-2015	Mori, Haruhide/0000-0001-7346-9131; Okuyama, Masayuki/0000-0001-7013-6032; Suzuki, Nobuhiro/0000-0001-8420-5852; Fujimoto, Zui/0000-0002-3551-6854	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Japan Society for the Promotion of Science [17-05467]; Grants-in-Aid for Scientific Research [22780082] Funding Source: KAKEN	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in part, by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN).; Supported by Japan Society for the Promotion of Science Postdoctoral Fellowship for Foreign Researchers Grant-in-aid 17-05467. Present address: Korea Research Institute of Bioscience and Biotechnology, Jeonbul Branch Institute, Bioindustry Research Center, 1404 Sinjeong-dong, Jeongeup-si, Jeonbuk 580-185, Korea.	Aoki H, 1997, BIOCHEM J, V323, P859, DOI 10.1042/bj3230859; Bruel L, 2011, J BIOL CHEM, V286, P40814, DOI 10.1074/jbc.M111.286039; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; COLBY SM, 1995, MICROBIOL-SGM, V141, P2929, DOI 10.1099/13500872-141-11-2929; Copeland A, 2009, STAND GENOMIC SCI, V1, P119, DOI [10.4056/sigs.17259, 10.4056/sigs.29547]; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fredslund F, 2011, J MOL BIOL, V412, P466, DOI 10.1016/j.jmb.2011.07.057; Funane K, 2011, BBA-PROTEINS PROTEOM, V1814, P428, DOI 10.1016/j.bbapap.2010.12.009; Golubev AM, 2004, J MOL BIOL, V339, P413, DOI 10.1016/j.jmb.2004.03.062; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; Hendrickson WA, 1997, METHOD ENZYMOL, V276, P494, DOI 10.1016/S0076-6879(97)76074-9; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Ichinose H, 2009, J BIOL CHEM, V284, P25097, DOI 10.1074/jbc.M109.022723; IGARASHI T, 1995, MICROBIOL IMMUNOL, V39, P387, DOI 10.1111/j.1348-0421.1995.tb02217.x; IGARASHI T, 1992, MICROBIOL IMMUNOL, V36, P969, DOI 10.1111/j.1348-0421.1992.tb02100.x; Igarashi T, 2004, ORAL MICROBIOL IMMUN, V19, P102, DOI 10.1046/j.0902-0055.2003.00123.x; Igarashi T, 2002, ORAL MICROBIOL IMMUN, V17, P193, DOI 10.1034/j.1399-302X.2002.170310.x; IWAI A, 1994, J BACTERIOL, V176, P7730, DOI 10.1128/JB.176.24.7730-7734.1994; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Kamitori S, 2002, J MOL BIOL, V318, P443, DOI 10.1016/S0022-2836(02)00111-0; Kang H. K., 2010, J APPL GLYCOSCI, V57, P269; Khalikova E, 2005, MICROBIOL MOL BIOL R, V69, P306, DOI 10.1128/MMBR.69.2.306-325.2005; Kim YM, 2012, J BIOL CHEM, V287, P19927, DOI 10.1074/jbc.M111.339036; Kim YM, 2011, APPL MICROBIOL BIOT, V91, P329, DOI 10.1007/s00253-011-3201-y; Kim YM, 2010, APPL MICROBIOL BIOT, V85, P581, DOI 10.1007/s00253-009-2121-6; Kimura A., 2000, Journal of Applied Glycoscience, V47, P235; Kitamura M, 2005, ACTA CRYSTALLOGR F, V61, P178, DOI 10.1107/S1744309104033202; Larsbrink J, 2011, BIOCHEM J, V436, P567, DOI 10.1042/BJ20110299; Lee HS, 2002, J BIOL CHEM, V277, P21891, DOI 10.1074/jbc.M201623200; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lovering AL, 2005, J BIOL CHEM, V280, P2105, DOI 10.1074/jbc.M410468200; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Morisaki H, 2002, LETT APPL MICROBIOL, V35, P223, DOI 10.1046/j.1472-765X.2002.01160.x; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Newstead S, 2005, BIOCHEMISTRY-US, V44, P9117, DOI 10.1021/bi050517t; OGUMA T, 1993, APPL MICROBIOL BIOT, V39, P197, DOI 10.1007/BF00228606; OGUMA T, 1994, FEBS LETT, V345, P135, DOI 10.1016/0014-5793(94)00418-8; Ohtaki A, 2004, J BIOL CHEM, V279, P31033, DOI 10.1074/jbc.M404311200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Suzuki N, 2011, ACTA CRYSTALLOGR F, V67, P1542, DOI 10.1107/S1744309111038425; Suzuki R., 2012, BIOCH BIOPH IN PRESS; Tailford LE, 2007, J BIOL CHEM, V282, P11291, DOI 10.1074/jbc.M610964200; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; WALKER GJ, 1981, J GEN MICROBIOL, V127, P201; WANDA SY, 1994, J BACTERIOL, V176, P3839, DOI 10.1128/JB.176.13.3839-3850.1994; WILLIAMS AF, 1989, COLD SPRING HARB SYM, V54, P637; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WITHERS SG, 1995, PROTEIN SCI, V4, P361; Yamamoto T, 2006, BIOSCI BIOTECH BIOCH, V70, P1947, DOI 10.1271/bbb.60105	61	27	35	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2012	287	24					19916	19926		10.1074/jbc.M112.342444	http://dx.doi.org/10.1074/jbc.M112.342444			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974FB	22337884	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000306414500014
J	Liu, XJ; Lu, Y; Zhang, Y; Li, YY; Zhou, JZ; Yuan, YM; Gao, XF; Su, ZD; He, C				Liu, Xiujie; Lu, Yan; Zhang, Yong; Li, Yuanyuan; Zhou, Jiazhen; Yuan, Yimin; Gao, Xiaofei; Su, Zhida; He, Cheng			Slit2 Regulates the Dispersal of Oligodendrocyte Precursor Cells via Fyn/RhoA Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC FAMILY KINASES; NEURONAL MIGRATION; SPINAL-CORD; RHO-GTPASES; DIRECTIONAL GUIDANCE; VERTEBRATE SLIT; TYROSINE KINASE; AXON OUTGROWTH; NEURAL-TUBE; P190 RHOGAP	Oligodendrocyte precursor cells (OPCs) are a unique type of glia that are responsible for the myelination of the central nervous system. OPC migration is important for myelin formation during central nervous system development and repair. However, the precise extracellular and intracellular mechanisms that regulate OPC migration remain elusive. Slits were reported to regulate neurodevelopmental processes such as migration, adhesion, axon guidance, and elongation through binding to roundabout receptors (Robos). However, the potential roles of Slits/Robos in oligodendrocytes remain unknown. In this study, Slit2 was found to be involved in regulating the dispersal of OPCs through the association between Robo1 and Fyn. Initially, we examined the expression of Robos in OPCs both in vitro and in vivo. Subsequently, the Boyden chamber assay showed that Slit2 could inhibit OPC migration. RoboN, a specific inhibitor of Robos, could significantly attenuate this effect. The effects were confirmed through the explant migration assay. Furthermore, treating OPCs with Slit2 protein deactivated Fyn and increased the level of activated RhoA-GTP. Finally, Fyn was found to form complexes with Robo1, but this association was decreased after Slit2 stimulation. Thus, we demonstrate for the first time that Slit2 regulates the dispersal of oligodendrocyte precursor cells through Fyn and RhoA signaling.	[He, Cheng] Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Inst Neurosci, Shanghai 200433, Peoples R China; Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, MOE Key Lab Mol Neurobiol, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University	He, C (corresponding author), Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Inst Neurosci, Shanghai 200433, Peoples R China.	chenghe@smmu.edu.cn	Su, Zhida/G-6094-2015; li, yuanyuan/GZA-4435-2022		National Key Basic Research Program [2011CB504401]; National Natural Science Foundation [30970999, 31130024, 31070922]	National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Basic Research Program Grant 2011CB504401 and National Natural Science Foundation Grants 30970999, 31130024, and 31070922.	Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Challa AK, 2001, MECH DEVELOP, V101, P249, DOI 10.1016/S0925-4773(00)00570-0; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Cohen RI, 2003, J NEUROCHEM, V85, P1262, DOI 10.1046/j.1471-4159.2003.01722.x; Colognato H, 2004, J CELL BIOL, V167, P365, DOI 10.1083/jcb.200404076; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Guan CB, 2007, CELL, V129, P385, DOI 10.1016/j.cell.2007.01.051; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Holmes GP, 1998, MECH DEVELOP, V79, P57, DOI 10.1016/S0925-4773(98)00174-9; Jarjour AA, 2003, J NEUROSCI, V23, P3735; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kuo E, 2010, J NEUROCHEM, V113, P200, DOI 10.1111/j.1471-4159.2010.06596.x; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Liu XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021058; Liu XJ, 2009, MOL CELL NEUROSCI, V41, P51, DOI 10.1016/j.mcn.2009.01.009; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Miller RH, 2007, NAT NEUROSCI, V10, P1351, DOI 10.1038/nn1995; Miyamoto Y, 2008, J NEUROSCI, V28, P8326, DOI 10.1523/JNEUROSCI.1482-08.2008; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209; Prasad A, 2007, J LEUKOCYTE BIOL, V82, P465, DOI 10.1189/jlb.1106678; Prestoz L, 2004, NEURON GLIA BIOL, V1, P73, DOI 10.1017/s1740925x04000109; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; Rajasekharan S, 2010, J NEUROCHEM, V113, P1589, DOI 10.1111/j.1471-4159.2010.06717.x; Rajasekharan S, 2009, DEVELOPMENT, V136, P415, DOI 10.1242/dev.018234; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Ridley AJ, 2001, FEBS LETT, V498, P168, DOI 10.1016/S0014-5793(01)02481-4; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Spassky N, 2002, J NEUROSCI, V22, P5992; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Stevenson NJ, 2010, FEBS LETT, V584, P4469, DOI 10.1016/j.febslet.2010.10.007; Su ZD, 2007, J CELL SCI, V120, P1877, DOI 10.1242/jcs.03448; Tabu K, 2007, MOL CANCER RES, V5, P1099, DOI 10.1158/1541-7786.MCR-07-0096; Tong XP, 2009, J CELL BIOL, V186, P113, DOI 10.1083/jcb.200811071; Tsai HH, 2006, J NEUROSCI, V26, P1913, DOI 10.1523/JNEUROSCI.3571-05.2006; Tsai HH, 2003, DEVELOPMENT, V130, P2095, DOI 10.1242/dev.00424; Tsuji T, 2002, J CELL BIOL, V157, P819, DOI 10.1083/jcb.200112107; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wolf RM, 2001, J NEUROBIOL, V49, P62, DOI 10.1002/neu.1066; Wong EV, 2004, J NEUROBIOL, V59, P66, DOI 10.1002/neu.10342; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Xu HT, 2004, P NATL ACAD SCI USA, V101, P4296, DOI 10.1073/pnas.0303893101; Xu Y, 2010, NEUROSCI BULL, V26, P474, DOI 10.1007/s12264-010-0730-9; Yeo MG, 2011, J CELL PHYSIOL, V226, P236, DOI 10.1002/jcp.22335; Ypsilanti AR, 2010, DEVELOPMENT, V137, P1939, DOI 10.1242/dev.044511; Zhu XQ, 2008, NEURON GLIA BIOL, V4, P19, DOI 10.1017/S1740925X09000015	59	26	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17503	17516		10.1074/jbc.M111.317610	http://dx.doi.org/10.1074/jbc.M111.317610			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22433866	hybrid, Green Published			2022-12-27	WOS:000306373000050
J	Poillot, C; Bichraoui, H; Tisseyre, C; Bahemberae, E; Andreotti, N; Sabatier, JM; Ronjat, M; De Waard, M				Poillot, Cathy; Bichraoui, Hicham; Tisseyre, Celine; Bahemberae, Eloi; Andreotti, Nicolas; Sabatier, Jean-Marc; Ronjat, Michel; De Waard, Michel			Small Efficient Cell-penetrating Peptides Derived from Scorpion Toxin Maurocalcine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL RYANODINE RECEPTOR; AMINO-ACID-RESIDUES; II-III-LOOP; CA2+ RELEASE; DIHYDROPYRIDINE RECEPTOR; PHARMACOLOGICALLY INERT; MUSCLE; MACROPINOCYTOSIS; ANALOG	Maurocalcine is the first demonstrated example of an animal toxin peptide with efficient cell penetration properties. Although it is a highly competitive cell-penetrating peptide (CPP), its relatively large size of 33 amino acids and the presence of three internal disulfide bridges may hamper its development for in vitro and in vivo applications. Here, we demonstrate that several efficient CPPs can be derived from maurocalcine by replacing Cys residues by isosteric 2-aminobutyric acid residues and sequence truncation down to peptides of up to 9 residues in length. A surprising finding is that all of the truncated maurocalcine analogues possessed cell penetration properties, indicating that the maurocalcine is a highly specialized CPP. Careful examination of the cell penetration properties of the truncated analogues indicates that several maurocalcine-derived peptides should be of great interest for cell delivery applications where peptide size matters.	[Poillot, Cathy; Bichraoui, Hicham; Tisseyre, Celine; Bahemberae, Eloi; Ronjat, Michel; De Waard, Michel] Grenoble Neurosci Inst, INSERM, U836, F-38042 Grenoble 9, France; [Poillot, Cathy; Bichraoui, Hicham; Tisseyre, Celine; Bahemberae, Eloi; Ronjat, Michel; De Waard, Michel] Univ Grenoble 1, F-38041 Grenoble, France; [Andreotti, Nicolas; Sabatier, Jean-Marc] INSERM, UMR1097, F-13288 Marseille, France; [De Waard, Michel] Smartox Biotechnol, Biopolis, F-3870 La Tronche, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	De Waard, M (corresponding author), Grenoble Neurosci Inst, INSERM, U836, Site Sante La Tronche,Chemin Fortune Ferrini,BP 1, F-38042 Grenoble 9, France.	michel.dewaard@ujf-grenoble.fr	De Waard, Michel/G-7406-2014	De Waard, Michel/0000-0002-2782-9615; SABATIER, Jean-Marc/0000-0002-9040-5647; Ronjat, Michel/0000-0002-9728-6425	Technology pour la Sante (Program TIMOMA2 of the Commissariat a l'Energie Atomique); Agence Nationale pour la Recherche PNANO	Technology pour la Sante (Program TIMOMA2 of the Commissariat a l'Energie Atomique); Agence Nationale pour la Recherche PNANO(French National Research Agency (ANR))	This work was supported by grants from Technology pour la Sante (Program TIMOMA2 of the Commissariat a l'Energie Atomique) and from Agence Nationale pour la Recherche PNANO (Programs SYNERGIE and NanoFret). Mass spectrometry analyses were performed by the Centre d'Investigation Clinique of Grenoble under the direction of Dr. Michel Seve.	Altafaj X, 2005, J BIOL CHEM, V280, P4013, DOI 10.1074/jbc.C400433200; Aroui S, 2010, BIOCHEM BIOPH RES CO, V391, P419, DOI 10.1016/j.bbrc.2009.11.073; Aroui S, 2009, CANCER LETT, V285, P28, DOI 10.1016/j.canlet.2009.04.044; Aroui S, 2009, APOPTOSIS, V14, P1352, DOI 10.1007/s10495-009-0397-8; Aroui S, 2009, PHARM RES-DORDR, V26, P836, DOI 10.1007/s11095-008-9782-1; Boisseau S, 2006, BBA-BIOMEMBRANES, V1758, P308, DOI 10.1016/j.bbamem.2006.02.007; Chen L, 2003, J BIOL CHEM, V278, P16095, DOI 10.1074/jbc.M209501200; Esteve E, 2005, J BIOL CHEM, V280, P12833, DOI 10.1074/jbc.M412521200; Esteve E, 2003, J BIOL CHEM, V278, P37822, DOI 10.1074/jbc.M305798200; Fajloun Z, 2000, FEBS LETT, V469, P179, DOI 10.1016/S0014-5793(00)01239-4; Gurrola GB, 1999, J BIOL CHEM, V274, P7879, DOI 10.1074/jbc.274.12.7879; KIM DH, 1983, J BIOL CHEM, V258, P9662; Lukacs B, 2008, BIOPHYS J, V95, P3497, DOI 10.1529/biophysj.107.120840; Mabrouk K, 2007, BBA-BIOMEMBRANES, V1768, P2528, DOI 10.1016/j.bbamem.2007.06.030; Meier O, 2002, J CELL BIOL, V158, P1119, DOI 10.1083/jcb.200112067; MERRIFIELD RB, 1969, ADV ENZYMOL RAMB, V32, P221; Mosbah A, 2000, PROTEINS, V40, P436, DOI 10.1002/1097-0134(20000815)40:3&lt;436::AID-PROT90&gt;3.0.CO;2-9; Poillot C, 2010, J BIOL CHEM, V285, P34168, DOI 10.1074/jbc.M110.104919; Pouvreau S, 2006, BIOPHYS J, V91, P2206, DOI 10.1529/biophysj.105.078089; Ram N, 2008, J BIOL CHEM, V283, P27048, DOI 10.1074/jbc.M804727200; Ram N, 2008, J BIOL CHEM, V283, P24274, DOI 10.1074/jbc.M709971200; Szappanos H, 2005, J PHYSIOL-LONDON, V565, P843, DOI 10.1113/jphysiol.2005.086074; Veithen A, 1996, J CELL SCI, V109, P2005; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731	24	24	27	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17331	17342		10.1074/jbc.M112.360628	http://dx.doi.org/10.1074/jbc.M112.360628			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22433862	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000306373000033
J	Miao, F; Chen, Z; Zhang, LX; Liu, Z; Wu, XW; Yuan, YC; Natarajan, R				Miao, Feng; Chen, Zhuo; Zhang, Lingxiao; Liu, Zheng; Wu, Xiwei; Yuan, Yate-Ching; Natarajan, Rama			Profiles of Epigenetic Histone Post-translational Modifications at Type 1 Diabetes Susceptible Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; GENOME-WIDE ANALYSIS; METHYLATION; TRANSCRIPTION; EXPRESSION; GENETICS; PATHOGENESIS; LOCATION; ENZYMES; BINDING	Both genetic and environmental factors are implicated in type 1 diabetes (T1D). Because environmental factors can trigger epigenetic changes, we hypothesized that variations in histone post-translational modifications (PTMs) at the promoter/enhancer regions of T1D susceptible genes may be associated with T1D. We therefore evaluated histone PTM variations at known T1D susceptible genes in blood cells from T1D patients versus healthy nondiabetic controls, and explored their connections to T1D. We used the chromatin immunoprecipitation-linked to microarray approach to profile key histone PTMs, including H3-lysine 4 trimethylation (H3K4me3), H3K27me3, H3K9me3, H3K9 acetylation (H3K9Ac), and H4K16Ac at genes within the T1D susceptible loci in lymphocytes, and H3K4me3, H3K9me2, H3K9Ac, and H4K16Ac at the insulin-dependent diabetes mellitus 1 region in monocytes of T1D patients and healthy controls separately. We screened for potential variations in histone PTMs using computational methods to compare datasets from T1D and controls. Interestingly, we observed marked variations in H3K9Ac levels at the upstream regions of HLA-DRB1 and HLA-DQB1 within the insulin-dependent diabetes mellitus 1 locus in T1D monocytes relative to controls. Additional experiments with THP-1 monocytes demonstrated increased expression of HLA-DRB1 and HLA-DQB1 in response to interferon-gamma and TNF-alpha treatment that were accompanied by changes in H3K9Ac at the same promoter regions as that seen in the patient monocytes. These results suggest that the H3K9Ac status of HLA-DRB1 and HLA-DQB1, two genes highly associated with T1D, may be relevant to their regulation and transcriptional response toward external stimuli. Thus, the promoter/enhancer architecture and chromatin status of key susceptible loci could be important determinants in their functional association to T1D susceptibility.	[Miao, Feng; Chen, Zhuo; Zhang, Lingxiao; Natarajan, Rama] City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet & Bioinformat Core, Duarte, CA 91010 USA; [Liu, Zheng; Wu, Xiwei; Yuan, Yate-Ching] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Natarajan, R (corresponding author), 1500 E Duarte Rd, Duarte, CA 91010 USA.	RNatarajan@coh.org		Liu, Zheng/0000-0002-1635-1556	National Institutes of Health [R01 DK065073, R01 HL087864]; Juvenile Diabetes Research Foundation; General Clinical Research Center from National Center for Research Resources [M01RR00043]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000043] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); General Clinical Research Center from National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK065073 and R01 HL087864 and the Juvenile Diabetes Research Foundation (to R. N.), and General Clinical Research Center Grant M01RR00043 from National Center for Research Resources (to City of Hope).	Aly TA, 2006, DIABETES, V55, P1265, DOI 10.2337/db05-1276; Aly TA, 2006, P NATL ACAD SCI USA, V103, P14074, DOI 10.1073/pnas.0606349103; ARENZANASEISDEDOS F, 1988, P NATL ACAD SCI USA, V85, P6087, DOI 10.1073/pnas.85.16.6087; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Brasacchio D, 2009, DIABETES, V58, P1229, DOI 10.2337/db08-1666; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Choi NM, 2011, CURR OPIN IMMUNOL, V23, P81, DOI 10.1016/j.coi.2010.09.007; Concannon P, 2009, NEW ENGL J MED, V360, P1646, DOI 10.1056/NEJMra0808284; DAUSSET J, 1981, SCIENCE, V213, P1469, DOI 10.1126/science.6792704; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Eisenbarth GS, 2010, DIABETES, V59, P759, DOI 10.2337/db09-1855; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; Harjutsalo V, 2008, LANCET, V371, P1777, DOI 10.1016/S0140-6736(08)60765-5; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; KLUG A, 1980, NATURE, V287, P509, DOI 10.1038/287509a0; Litherland SA, 2008, DIABETES, V57, P3184, DOI 10.2337/db08-1275; Majumder P, 2008, J EXP MED, V205, P785, DOI 10.1084/jem.20071843; Majumder P, 2010, MOL CELL BIOL, V30, P4211, DOI 10.1128/MCB.00327-10; Masternak K, 2000, GENE DEV, V14, P1156; Masternak K, 2003, NAT IMMUNOL, V4, P132, DOI 10.1038/ni883; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; Miao F, 2004, J BIOL CHEM, V279, P18091, DOI 10.1074/jbc.M311786200; Miao F, 2007, J BIOL CHEM, V282, P13854, DOI 10.1074/jbc.M609446200; Miao F, 2008, DIABETES, V57, P3189, DOI 10.2337/db08-0645; NERUP J, 1974, LANCET, V2, P864; Peng H, 2006, REV ENDOCR METAB DIS, V7, P149, DOI 10.1007/s11154-006-9024-y; Pirola L, 2011, GENOME RES, V21, P1601, DOI 10.1101/gr.116095.110; Pociot F, 2010, DIABETES, V59, P1561, DOI 10.2337/db10-0076; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Seydel F, 2008, J AUTOIMMUN, V31, P377, DOI 10.1016/j.jaut.2008.08.010; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Smith E, 2010, MOL CELL, V40, P689, DOI 10.1016/j.molcel.2010.11.031; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun GD, 2010, J AM SOC NEPHROL, V21, P2069, DOI 10.1681/ASN.2010060633; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Vandiedonck Claire, 2009, Briefings in Functional Genomics & Proteomics, V8, P379, DOI 10.1093/bfgp/elp010; Villeneuve LM, 2008, P NATL ACAD SCI USA, V105, P9047, DOI 10.1073/pnas.0803623105; Villeneuve LM, 2010, AM J PHYSIOL-RENAL, V299, pF14, DOI 10.1152/ajprenal.00200.2010; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	50	71	77	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16335	16345		10.1074/jbc.M111.330373	http://dx.doi.org/10.1074/jbc.M111.330373			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22431725	hybrid, Green Published			2022-12-27	WOS:000304030900025
J	Boyle, NR; Page, MD; Liu, BS; Blaby, IK; Casero, D; Kropat, J; Cokus, SJ; Hong-Hermesdorf, A; Shaw, J; Karpowicz, SJ; Gallaher, SD; Johnson, S; Benning, C; Pellegrini, M; Grossman, A; Merchant, SS				Boyle, Nanette R.; Page, Mark Dudley; Liu, Bensheng; Blaby, Ian K.; Casero, David; Kropat, Janette; Cokus, Shawn J.; Hong-Hermesdorf, Anne; Shaw, Johnathan; Karpowicz, Steven J.; Gallaher, Sean D.; Johnson, Shannon; Benning, Christoph; Pellegrini, Matteo; Grossman, Arthur; Merchant, Sabeeha S.			Three Acyltransferases and Nitrogen-responsive Regulator Are Implicated in Nitrogen Starvation-induced Triacylglycerol Accumulation in Chlamydomonas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIACYLGLYCEROL ACYLTRANSFERASE; ENDOPLASMIC-RETICULUM; COPPER DEFICIENCY; OIL ACCUMULATION; LIPID-SYNTHESIS; HUMAN GENOME; OLEIC-ACID; PCR DATA; RNA-SEQ; REINHARDTII	Algae have recently gained attention as a potential source for biodiesel; however, much is still unknown about the biological triggers that cause the production of triacylglycerols. We used RNA-Seq as a tool for discovering genes responsible for triacylglycerol (TAG) production in Chlamydomonas and for the regulatory components that activate the pathway. Three genes encoding acyltransferases, DGAT1, DGTT1, and PDAT1, are induced by nitrogen starvation and are likely to have a role in TAG accumulation based on their patterns of expression. DGAT1 and DGTT1 also show increased mRNA abundance in other TAG-accumulating conditions (minus sulfur, minus phosphorus, minus zinc, and minus iron). Insertional mutants, pdat1-1 and pdat1-2, accumulate 25% less TAG compared with the parent strain, CC-4425, which demonstrates the relevance of the trans-acylation pathway in Chlamydomonas. The biochemical functions of DGTT1 and PDAT1 were validated by rescue of oleic acid sensitivity and restoration of TAG accumulation in a yeast strain lacking all acyltransferase activity. Time course analyses suggest than a SQUAMOSA promoter-binding protein domain transcription factor, whose mRNA increases precede that of lipid biosynthesis genes like DGAT1, is a candidate regulator of the nitrogen deficiency responses. An insertional mutant, nrr1-1, accumulates only 50% of the TAG compared with the parental strain in nitrogen-starvation conditions and is unaffected by other nutrient stresses, suggesting the specificity of this regulator for nitrogen-deprivation conditions.	[Boyle, Nanette R.; Page, Mark Dudley; Blaby, Ian K.; Kropat, Janette; Hong-Hermesdorf, Anne; Shaw, Johnathan; Karpowicz, Steven J.; Gallaher, Sean D.; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Liu, Bensheng; Benning, Christoph] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Casero, David; Cokus, Shawn J.; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Johnson, Shannon] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Grossman, Arthur] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Casero, David; Pellegrini, Matteo; Merchant, Sabeeha S.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Michigan State University; University of California System; University of California Los Angeles; United States Department of Energy (DOE); Los Alamos National Laboratory; Carnegie Institution for Science; University of California System; University of California Los Angeles	Merchant, SS (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	merchant@chem.ucla.edu	Benning, Christoph/Y-2528-2019; Casero, David/E-7365-2010; Johnson, Shannon Lyn/H-2799-2019; Blaby, Ian/C-3292-2014	Benning, Christoph/0000-0001-8585-3667; Casero, David/0000-0002-7347-3330; Johnson, Shannon Lyn/0000-0002-3972-9208; Gallaher, Sean/0000-0002-9773-6051; Pellegrini, Matteo/0000-0001-9355-9564	Air Force Office of Science Research [FA 9550-10-1-0095, FA9550-08-0165]; Department of Energy [DE-EE0003046]; German Academic Exchange Service [D/08/47579]; Office of Science of the United States Department of Energy [DE-AC02-05CH11231]; National Institutes of Health [T32 GM07185, T32 ES015457]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES015457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER; Direct For Biological Sciences [0951094] Funding Source: National Science Foundation	Air Force Office of Science Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Department of Energy(United States Department of Energy (DOE)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Office of Science of the United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 GM07185 and T32 ES015457 (to S. J. K. and I. K. B). This work was also supported by Air Force Office of Science Research Grants FA 9550-10-1-0095 (to S. M. and M. P.) and FA9550-08-0165 (to C. B.), Department of Energy Contract DE-EE0003046 (to the National Alliance for Advance Biofuels and Bioproducts Consortium, including S. M., M. P., and S. J.), and the German Academic Exchange Service Grant D/08/47579 (to A. H.).; We thank Jane Grimwood (Hudson Alpha) for access to the version 5 assembly prior to release and Sepp Kohlwein (University of Graz) for yeast strains and plasmids. Some sequencing (454 ESTs) was conducted by the United States Department of Energy Joint Genome Institute, which is supported by the Office of Science of the United States Department of Energy under Contract No. DE-AC02-05CH11231.	Allen MD, 2007, EUKARYOT CELL, V6, P1841, DOI 10.1128/EC.00205-07; Banilas G, 2011, J EXP BOT, V62, P521, DOI 10.1093/jxb/erq286; Benning C, 2010, ENZYME DIRECTED OIL; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chisti Y, 2008, TRENDS BIOTECHNOL, V26, P126, DOI 10.1016/j.tibtech.2007.12.002; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Fan JL, 2011, FEBS LETT, V585, P1985, DOI 10.1016/j.febslet.2011.05.018; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GIROUD C, 1988, PLANT CELL PHYSIOL, V29, P587; Gonzalez-Ballester D, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-24; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; Goodson C, 2011, EUKARYOT CELL, V10, P1592, DOI 10.1128/EC.05242-11; Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7; Harris E.H, 2009, INTRO CHLAMYDOMONAS; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; HILL KL, 1991, J BIOL CHEM, V266, P15060; Hockin NL, 2012, PLANT PHYSIOL, V158, P299, DOI 10.1104/pp.111.184333; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; James GO, 2011, BIORESOURCE TECHNOL, V102, P3343, DOI 10.1016/j.biortech.2010.11.051; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kropat J, 2011, PLANT J, V66, P770, DOI 10.1111/j.1365-313X.2011.04537.x; Lacey DJ, 1996, PLANTA, V199, P545, DOI 10.1007/BF00195185; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; Li RZ, 2010, LIPIDS, V45, P145, DOI 10.1007/s11745-010-3385-4; Li YT, 2010, BIOTECHNOL BIOENG, V107, P258, DOI 10.1002/bit.22807; Li YT, 2010, METAB ENG, V12, P387, DOI 10.1016/j.ymben.2010.02.002; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Matsui K, 2004, FEBS LETT, V569, P195, DOI 10.1016/j.febslet.2004.05.064; Matthew T, 2009, J BIOL CHEM, V284, P23415, DOI 10.1074/jbc.M109.003541; Merchant S. S., 2012, CURR OPIN BIOTECH, V23, P1; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Miller R., 2010, PLANT PHYSIOL, V110; Moellering ER, 2010, EUKARYOT CELL, V9, P97, DOI 10.1128/EC.00203-09; Moellering ER, 2009, ADV PHOTOSYNTH RESP, V30, P139; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moseley J, 2000, EMBO J, V19, P2139, DOI 10.1093/emboj/19.10.2139; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Nguyen HM, 2011, PROTEOMICS, V11, P4266, DOI 10.1002/pmic.201100114; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Peng FY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-286; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Pollock SV, 2003, PLANT PHYSIOL, V133, P1854, DOI 10.1104/pp.103.032078; Pootakham W, 2010, PLANT PHYSIOL, V153, P1653, DOI 10.1104/pp.110.157875; Quinn JM, 1998, METHOD ENZYMOL, V297, P263; Quisel JD, 1996, PLANT PHYSIOL, V111, P839, DOI 10.1104/pp.111.3.839; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Riekhof W.R., 2009, CHLAMYDOMONAS SOURCE, P41; Riekhof WR, 2005, EUKARYOT CELL, V4, P242, DOI 10.1128/EC.4.2.242-252.2005; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosenberg JN, 2008, CURR OPIN BIOTECH, V19, P430, DOI 10.1016/j.copbio.2008.07.008; Rossak M, 1997, ARCH BIOCHEM BIOPHYS, V340, P219, DOI 10.1006/abbi.1997.9931; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Saha S, 2006, PLANT PHYSIOL, V141, P1533, DOI 10.1104/pp.106.082198; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Schenk PM, 2008, BIOENERG RES, V1, P20, DOI 10.1007/s12155-008-9008-8; SCHNELL RA, 1993, GENETICS, V134, P737; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Siaut M, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-7; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; STOBART AK, 1986, PLANTA, V169, P33, DOI 10.1007/BF01369772; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Stymne S., 1987, Biochemistry of Plants, V9, P175; Toida J, 1998, BIOSCI BIOTECH BIOCH, V62, P759, DOI 10.1271/bbb.62.759; Vieler A, 2007, CHEM PHYS LIPIDS, V150, P143, DOI 10.1016/j.chemphyslip.2007.06.224; Waltz E, 2009, NAT BIOTECHNOL, V27, P15, DOI [10.1038/461027a, 10.1038/nbt0109-15]; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09; Weers PMM, 1997, LIMNOL OCEANOGR, V42, P1584, DOI 10.4319/lo.1997.42.7.1584; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; Work VH, 2010, EUKARYOT CELL, V9, P1251, DOI 10.1128/EC.00075-10; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xie ZY, 1996, J BIOL CHEM, V271, P4632; Yohn C., 2011, U.S. Patent, Patent No. [US 2011 023406, 2011023406]; Zhang M, 2009, PLANT CELL, V21, P3885, DOI 10.1105/tpc.109.071795; Zhekisheva M, 2002, J PHYCOL, V38, P325, DOI 10.1046/j.1529-8817.2002.01107.x	82	306	322	4	174	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15811	15825		10.1074/jbc.M111.334052	http://dx.doi.org/10.1074/jbc.M111.334052			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22403401	Green Published, hybrid			2022-12-27	WOS:000304006300061
J	Wu, ZH; Luo, HY; Thorin, E; Tremblay, J; Peng, JZ; Lavoie, JL; Wang, YJ; Qi, SJ; Wu, T; Wu, JP				Wu, Zenghui; Luo, Hongyu; Thorin, Eric; Tremblay, Johanne; Peng, Junzheng; Lavoie, Julie L.; Wang, Yujia; Qi, Shijie; Wu, Tao; Wu, Jiangping			Possible Role of Efnb1 Protein, a Ligand of Eph Receptor Tyrosine Kinases, in Modulating Blood Pressure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; CRE RECOMBINASE; TRANSGENIC MICE; EXPRESSION; EPHRIN-B2; ARTERIAL; CELLS; RHO; NEOVASCULARIZATION; HOMEOSTASIS	Eph kinases constitute the largest receptor tyrosine kinase family, and their ligands, ephrins (Efns), are also cell surface molecules. Although they are ligands, Efns can transduce signals reversely into cells. We have no prior knowledge of the role played by any members of this family of kinases or their ligands in blood pressure (BP) regulation. In the present studies, we investigated the role of Efnb1 in vascular smooth muscle cell (VSMC) contractility and BP regulation. We revealed that reverse signaling through Efnb1 led to a reduction of RhoA activation and VSMC contractility in vitro. Consistent with this finding, ex vivo, there was an increase of RhoA activity accompanied by augmented myosin light chain phosphorylation in mesenteric arteries from mice with smooth muscle-specific conditional Efnb1 gene knock-out (KO). Small interfering RNA knockdown of Grip1, a molecule associated with the Efnb1 intracellular tail, partially eliminated the effect of Efnb1 on VSMC contractility and myosin light chain phosphorylation. In support of these in vitro and ex vivo results, Efnb1 KO mice on a high salt diet showed a statistically significant heightened increment of BP at multiple time points during stress compared with wild type litter-mates. Our results demonstrate that Efnb1 is apreviously unknown negative regulator of VSMC contractility and BP and that it exerts such effects via reverse signaling through Grip1.	[Wu, Jiangping] Ctr Hosp Univ Montreal CRCHUM, Dept Nephrol, Montreal, PQ H2L 4M1, Canada; [Wu, Zenghui; Luo, Hongyu; Tremblay, Johanne; Peng, Junzheng; Lavoie, Julie L.; Wang, Yujia; Qi, Shijie; Wu, Tao; Wu, Jiangping] Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Montreal, PQ H2L 4M1, Canada; [Thorin, Eric] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Wu, Tao] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Inst Cardiol, Hangzhou 310003, Zhejiang, Peoples R China	Universite de Montreal; Universite de Montreal; Universite de Montreal; Zhejiang University	Wu, JP (corresponding author), Notre Dame Hosp, CRCHUM, DeSeve Pavil,Rm Y-5616,1560 Sherbrooke St E, Montreal, PQ H2L 4M1, Canada.	jianping.wu@umontreal.ca	Cossette, Suzanne/I-8008-2016; Thorin, Eric/K-3978-2013; Lavoie, Julie/F-2288-2013; Tremblay, Johanne/E-2154-2013	Thorin, Eric/0000-0001-5827-8935; Lavoie, Julie/0000-0001-6316-2769; 	Canadian Institutes of Health Research [MOP57697, MOP69089, PPP85159, IMH 79565, MOP97829, MOP14496]; Canadian Institutes of Health Research; Heart and Stroke Foundation of Quebec; Quebec Ministry of Economic Development, Innovation and Export Trade [PSR-SIIRI-069]; J.-Louis Levesque Foundation; Fonds de la recherche en sante du Quebec for Transfusional and Hemovigilance Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec; Quebec Ministry of Economic Development, Innovation and Export Trade; J.-Louis Levesque Foundation; Fonds de la recherche en sante du Quebec for Transfusional and Hemovigilance Medical Research	This work was supported in part by Canadian Institutes of Health Research Grants MOP57697, MOP69089, and PPP85159 (to J.W.), IMH 79565 and MOP97829 (to H.L.), and MOP14496 (to E.T.); a Canadian Institutes of Health Research grant (to J.T.); grants from the Heart and Stroke Foundation of Quebec, the Quebec Ministry of Economic Development, Innovation and Export Trade (Grant PSR-SIIRI-069), and the J.-Louis Levesque Foundation (to J.W.); and a group grant from the Fonds de la recherche en sante du Quebec for Transfusional and Hemovigilance Medical Research (to J.W.).	Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Carlson SH, 1998, HYPERTENSION, V32, P46, DOI 10.1161/01.HYP.32.1.46; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; Dravis C, 2007, HEARING RES, V223, P93, DOI 10.1016/j.heares.2006.10.007; Dumas P, 2000, HYPERTENSION, V35, P568, DOI 10.1161/01.HYP.35.2.568; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Flanagan JG, 1997, CELL, V90, P403; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gale NW, 2001, DEV BIOL, V230, P151, DOI 10.1006/dbio.2000.0112; Golovina VA, 2006, NAT PROTOC, V1, P2681, DOI 10.1038/nprot.2006.425; Han YJ, 2008, AM J HYPERTENS, V21, P860, DOI 10.1038/ajh.2008.199; Hashimoto T, 2007, KIDNEY INT, V72, P954, DOI 10.1038/sj.ki.5002454; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Lavoie JL, 2004, AM J PHYSIOL-RENAL, V286, pF965, DOI 10.1152/ajprenal.00402.2003; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Luo HY, 2012, J BIOL CHEM, V287, P6819, DOI 10.1074/jbc.M111.293365; Luo HY, 2011, J BIOL CHEM, V286, P41135, DOI 10.1074/jbc.M111.302596; Ogita H, 2003, CIRC RES, V93, P23, DOI 10.1161/01.RES.0000079310.81429.C8; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Schulz TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001013; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Su LF, 2002, J BIOL CHEM, V277, P37037, DOI 10.1074/jbc.M111607200; Tanaka M, 2003, EMBO J, V22, P847, DOI 10.1093/emboj/cdg088; Thorin E, 1998, CIRC RES, V82, P1323, DOI 10.1161/01.RES.82.12.1323; Wamhoff BR, 2006, CIRC RES, V98, P868, DOI 10.1161/01.RES.0000216596.73005.3c; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wilkinson DG, 2000, INT REV CYTOL, V196, P177; Wu Jiangping, 2005, Curr Opin Hematol, V12, P292, DOI 10.1097/01.moh.0000166497.26397.9f; Xin HB, 2002, PHYSIOL GENOMICS, V10, P211, DOI 10.1152/physiolgenomics.00054.2002; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	38	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15557	15569		10.1074/jbc.M112.340869	http://dx.doi.org/10.1074/jbc.M112.340869			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22393061	hybrid, Green Published			2022-12-27	WOS:000304006300036
J	Chan, KM; Zhang, ZG				Chan, Kui Ming; Zhang, Zhiguo			Leucine-rich Repeat and WD Repeat-containing Protein 1 Is Recruited to Pericentric Heterochromatin by Trimethylated Lysine 9 of Histone H3 and Maintains Heterochromatin Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIGIN RECOGNITION COMPLEX; X-CHROMOSOME INACTIVATION; FACULTATIVE HETEROCHROMATIN; SATELLITE REPEATS; DNA-REPLICATION; GENOME; CHROMATIN; METHYLATION; BINDING; HP1	Lrwd1, a protein containing a leucine-rich repeat and a WD40 repeat domain, interacts with the origin replication complex (ORC), a protein complex involved in both initiation of DNA replication and heterochromatin silencing. Lrwd1 and ORC are known to co-purify with repressive histone marks (trimethylated lysine 9 of histone H3 (H3K9me3) and trimethylated lysine 20 of histone H4 (H4K20me3)) and localize to pericentric heterochromatin. However, how the Lrwd1 is recruited to heterochromatin and the functional significance of the localization of Lrwd1 to the heterochromatin are not known. Here, we show that Lrwd1 preferentially binds to trimethylated repressive histone marks in vitro, which is dependent on an intact WD40 domain but independent of ORC proteins. The localization of Lrwd1 and Orc2 at pericentric heterochromatin in mouse cells is lost in cells lacking H3K9me3 but not in cells lacking H4K20me3. In addition, depletion of HP1 alpha has little impact on the localization of Lrwd1 on pericentric heterochromatin. Finally, depletion of Lrwd1 and Orc2 in mouse cells leads to increased transcription of major satellite repeats. These results indicate that the Lrwd1 is recruited to pericentric heterochromatin through binding to H3K9me3 and that the association of Lrwd1 with pericentric heterochromatin is required for heterochromatin silencing and maintenance.	[Chan, Kui Ming; Zhang, Zhiguo] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic	Zhang, ZG (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.	zhang.zhiguo@mayo.edu	Chan, Kui Ming June/G-4330-2013	CHAN, Kui Ming/0000-0001-6430-3340	National Institutes of Health [GM99722, GM81838]; NATIONAL CANCER INSTITUTE [P50CA108961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099722, R01GM081838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported, in whole or in part, by National Institutes of Health Grants GM99722 and GM81838.	Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Chan KM, 2011, P NATL ACAD SCI USA, V108, P16699, DOI 10.1073/pnas.1107616108; EHRENHOFERMURRAY AE, 1995, SCIENCE, V270, P1671, DOI 10.1126/science.270.5242.1671; Eustermann S, 2011, NAT STRUCT MOL BIOL, V18, P777, DOI 10.1038/nsmb.2070; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Prasanth SG, 2010, P NATL ACAD SCI USA, V107, P15093, DOI 10.1073/pnas.1009945107; Probst AV, 2011, TRENDS GENET, V27, P177, DOI 10.1016/j.tig.2011.02.002; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Shen Z, 2010, MOL CELL, V40, P99, DOI 10.1016/j.molcel.2010.09.021; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tattermusch A, 2011, HUM GENET, V130, P247, DOI 10.1007/s00439-011-1027-4; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Wysocka J, 2006, METHODS, V40, P339, DOI 10.1016/j.ymeth.2006.05.028; Zeng W, 2010, EPIGENETICS-US, V5, P287, DOI 10.4161/epi.5.4.11683; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371	32	29	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15024	15033		10.1074/jbc.M111.337980	http://dx.doi.org/10.1074/jbc.M111.337980			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22427655	Green Published, hybrid			2022-12-27	WOS:000304003200064
J	Moon, SH; Jenkins, CM; Liu, XP; Guan, SP; Mancuso, DJ; Gross, RW				Moon, Sung Ho; Jenkins, Christopher M.; Liu, Xinping; Guan, Shaoping; Mancuso, David J.; Gross, Richard W.			Activation of Mitochondrial Calcium-independent Phospholipase A(2)gamma (iPLA(2)gamma) by Divalent Cations Mediating Arachidonate Release and Production of Downstream Eicosanoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMALOGEN-SELECTIVE PHOSPHOLIPASE-A2; SPONTANEOUSLY HYPERTENSIVE-RATS; ACYL-COA ESTERS; PERMEABILITY TRANSITION; CELL-DEATH; EPOXYEICOSATRIENOIC ACIDS; OXIDATIVE-PHOSPHORYLATION; INTRAMITOCHONDRIAL METABOLISM; PYRUVATE-DEHYDROGENASE; VENTRICULAR MYOCYTES	Calcium-independent phospholipase A(2)gamma (iPLA(2)gamma) (PNPLA8) is the predominant phospholipase activity in mammalian mitochondria. However, the chemical mechanisms that regulate its activity are unknown. Here, we utilize iPLA(2)gamma gain of function and loss of function genetic models to demonstrate the robust activation of iPLA(2)gamma in murine myocardial mitochondria by Ca2+ or Mg2+ ions. Calcium ion stimulated the production of 2-arachidonoyl-lysophosphatidylcholine (2-AA-LPC) from 1-palmitoyl-2-[14C] arachidonoyl- sn-glycero-3-phosphocholine during incubations with wild-type heart mitochondrial homogenates. Furthermore, incubation of mitochondrial homogenates from transgenic myocardium expressing iPLA(2)gamma resulted in 13- and 25-fold increases in the initial rate of radiolabeled 2-AA-LPC and arachidonic acid (AA) production, respectively, in the presence of calcium ion. Mass spectrometric analysis of the products of calcium-activated hydrolysis of endogenous mitochondrial phospholipids in transgenic iPLA(2)gamma mitochondria revealed the robust production of AA, 2-AA-LPC, and 2-docosahexaenoyl-LPC that was over 10-fold greater than wild-type mitochondria. The mechanism- based inhibitor (R)-(E)-6-(bromomethylene)-3-(1-naphthalenyl)- 2H-tetrahydropyran-2-one (BEL) (iPLA(2)gamma selective), but not its enantiomer, (S)-BEL (iPLA(2)gamma selective) or pyrrolidine (cytosolic PLA(2)gamma selective), markedly attenuated Ca2+ -dependent fatty acid release and polyunsaturated LPC production. Moreover, Ca2+-induced iPLA(2)gamma activation was accompanied by the production of downstream eicosanoid metabolites that were nearly completely ablated by (R)-BEL or by genetic ablation of iPLA(2)gamma. Intriguingly, Ca2+ -induced iPLA(2)gamma activation was completely inhibited by long-chain acyl-CoA (IC50 similar to 20 mu M) as well as by a nonhydrolyzable acyl-CoA thioether analog. Collectively, these results demonstrate that mitochondrial iPLA(2)gamma is activated by divalent cations and inhibited by acyl-CoA modulating the generation of biologically active metabolites that regulate mitochondrial bioenergetic and signaling functions.	[Moon, Sung Ho; Jenkins, Christopher M.; Liu, Xinping; Guan, Shaoping; Mancuso, David J.; Gross, Richard W.] Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Med, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Dev Biol, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gross, RW (corresponding author), Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, Dept Med, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63110 USA.	rgross@wustl.edu			National Institutes of Health [5PO1HL57278, RO1HL41250]; LipoSpectrum and Platomics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041250, P01HL057278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LipoSpectrum and Platomics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5PO1HL57278 and RO1HL41250. R. W. G. has financial relationships with LipoSpectrum and Platomics.	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Benitah JP, 2010, J MOL CELL CARDIOL, V48, P26, DOI 10.1016/j.yjmcc.2009.07.026; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Blum JL, 2011, TOXICOL IN VITRO, V25, P1001, DOI 10.1016/j.tiv.2011.03.014; Bollinger JG, 2010, ANAL CHEM, V82, P6790, DOI 10.1021/ac100720p; Broekemeier KM, 2002, BIOCHEMISTRY-US, V41, P7771, DOI 10.1021/bi020157z; Chen JY, 1999, MOL PHARMACOL, V55, P288, DOI 10.1124/mol.55.2.288; Cocco T, 1999, FREE RADICAL BIO MED, V27, P51, DOI 10.1016/S0891-5849(99)00034-9; DANIELS SB, 1983, J BIOL CHEM, V258, P5046; DAS AM, 1990, AM J PHYSIOL, V259, pH1264, DOI 10.1152/ajpheart.1990.259.4.H1264; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DENTON RM, 1990, ANNU REV PHYSIOL, V52, P451, DOI 10.1146/annurev.ph.52.030190.002315; Di Paola M, 2006, FEBS LETT, V580, P775, DOI 10.1016/j.febslet.2005.12.090; DiMarzo V, 1996, BIOCHEM BIOPH RES CO, V227, P281, DOI 10.1006/bbrc.1996.1501; Dransfeld O, 2002, ANN NY ACAD SCI, V967, P208; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Fonteriz RI, 2010, CELL CALCIUM, V48, P61, DOI 10.1016/j.ceca.2010.07.001; FORD DA, 1991, J CLIN INVEST, V88, P331, DOI 10.1172/JCI115296; Fuentes L, 2003, J BIOL CHEM, V278, P44683, DOI 10.1074/jbc.M307209200; Gadd ME, 2006, J BIOL CHEM, V281, P6931, DOI 10.1074/jbc.M510845200; Gaur N, 2011, BIOPHYS J, V100, P2904, DOI 10.1016/j.bpj.2011.05.031; Ghosh M, 2006, J BIOL CHEM, V281, P16615, DOI 10.1074/jbc.M601770200; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Griffiths EJ, 2009, BBA-BIOENERGETICS, V1787, P1324, DOI 10.1016/j.bbabio.2009.01.019; Gross GJ, 2007, J MOL CELL CARDIOL, V42, P687, DOI 10.1016/j.yjmcc.2006.11.020; Han XL, 2004, BIOCHEMISTRY-US, V43, P15584, DOI 10.1021/bi048307o; Han XL, 1996, J AM CHEM SOC, V118, P451, DOI 10.1021/ja952326r; HANSFORD RG, 1985, BIOCHEM J, V227, P129, DOI 10.1042/bj2270129; Harmancey R, 2010, J LIPID RES, V51, P1380, DOI 10.1194/jlr.M001230; Haworth RA, 2010, AM J PHYSIOL-HEART C, V299, pH165, DOI 10.1152/ajpheart.00906.2009; HAZEN SL, 1991, J BIOL CHEM, V266, P5629; IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310; Jain MK, 2006, CURR OPIN CHEM BIOL, V10, P473, DOI 10.1016/j.cbpa.2006.08.015; Jenkins CM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203661; Jenkins CM, 2009, CARDIOVASC RES, V82, P240, DOI 10.1093/cvr/cvn346; Jenkins CM, 2001, J BIOL CHEM, V276, P7129, DOI 10.1074/jbc.M010439200; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Katragadda D, 2009, J MOL CELL CARDIOL, V46, P867, DOI 10.1016/j.yjmcc.2009.02.028; Kinsey GR, 2008, J LIPID RES, V49, P1477, DOI 10.1194/jlr.M800030-JLR200; Kinsey GR, 2007, J PHARMACOL EXP THER, V321, P707, DOI 10.1124/jpet.107.119545; KOBAYASHI A, 1994, J MOL CELL CARDIOL, V26, P499, DOI 10.1006/jmcc.1994.1060; Korge P, 2003, AM J PHYSIOL-HEART C, V285, pH259, DOI 10.1152/ajpheart.01028.2002; Lee HC, 1999, J PHYSIOL-LONDON, V519, P153, DOI 10.1111/j.1469-7793.1999.0153o.x; Lei XY, 2008, J BIOL CHEM, V283, P34819, DOI 10.1074/jbc.M807409200; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Leslie CC, 2004, BIOCHEM CELL BIOL, V82, P1, DOI 10.1139/o03-080; Liu SJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1594, DOI 10.1152/ajpcell.00284.2007; Lombardi A, 2010, J BIOL CHEM, V285, P16599, DOI 10.1074/jbc.M110.102699; Maack C, 2007, BASIC RES CARDIOL, V102, P369, DOI 10.1007/s00395-007-0666-z; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Mancuso DJ, 2007, J BIOL CHEM, V282, P9216, DOI 10.1074/jbc.M607307200; Mancuso DJ, 2004, EUR J BIOCHEM, V271, P4709, DOI 10.1111/j.1432-1033.2004.04435.x; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; Marinovic J, 2008, AM J PHYSIOL-HEART C, V294, pH1317, DOI 10.1152/ajpheart.00840.2007; MASSARI S, 1972, BIOCHIM BIOPHYS ACTA, V238, P23, DOI 10.1016/0005-2728(72)90094-1; MCCORMACK JG, 1984, BIOCHEM J, V218, P235, DOI 10.1042/bj2180235; MCCORMACK JG, 1990, P NUTR SOC, V49, P57, DOI 10.1079/PNS19900009; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; Moon SH, 2008, J BIOL CHEM, V283, P33975, DOI 10.1074/jbc.M805817200; MORENOSANCHEZ R, 1985, J BIOL CHEM, V260, P4028; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Nalefski EA, 1998, J BIOL CHEM, V273, P1365, DOI 10.1074/jbc.273.3.1365; Nazarewicz RR, 2007, ARCH BIOCHEM BIOPHYS, V468, P114, DOI 10.1016/j.abb.2007.09.018; Nazarewicz RR, 2007, CANCER RES, V67, P1282, DOI 10.1158/0008-5472.CAN-06-3099; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pete MJ, 1996, J BIOL CHEM, V271, P18114, DOI 10.1074/jbc.271.30.18114; Rasola A, 2011, CELL CALCIUM, V50, P222, DOI 10.1016/j.ceca.2011.04.007; ROSENDAL J, 1993, BIOCHEM J, V290, P321, DOI 10.1042/bj2900321; Seubert J, 2004, CIRC RES, V95, P506, DOI 10.1161/01.RES.0000139436.89654.c8; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; Territo PR, 2001, J BIOL CHEM, V276, P2586, DOI 10.1074/jbc.M002923200; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; van Tienhoven M, 2002, J BIOL CHEM, V277, P20942, DOI 10.1074/jbc.M200330200; VANSCHAIK RHN, 1993, BIOCHIM BIOPHYS ACTA, V1169, P1, DOI 10.1016/0005-2760(93)90075-K; VERHEIJ HM, 1980, BIOCHEMISTRY-US, V19, P743, DOI 10.1021/bi00545a021; WALLUKAT G, 1994, J BIOL CHEM, V269, P29055; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Wolf MJ, 1996, J BIOL CHEM, V271, P30879, DOI 10.1074/jbc.271.48.30879; WOLF RA, 1985, J BIOL CHEM, V260, P7295; Xiao B, 2010, J PHARMACOL EXP THER, V334, P784, DOI 10.1124/jpet.110.167510; Xiao YF, 1998, J PHYSIOL-LONDON, V508, P777, DOI 10.1111/j.1469-7793.1998.777bp.x; Yan W, 2005, J BIOL CHEM, V280, P26669, DOI 10.1074/jbc.M502358200; Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104; Zima AV, 2008, CIRC RES, V103, pE105, DOI 10.1161/CIRCRESAHA.107.183236	86	52	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14880	14895		10.1074/jbc.M111.336776	http://dx.doi.org/10.1074/jbc.M111.336776			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22389508	hybrid, Green Published			2022-12-27	WOS:000304003200052
J	Tan, JHY; Canals, M; Ludeman, JP; Wedderburn, J; Boston, C; Butler, SJ; Carrick, AM; Parody, TR; Taleski, D; Christopoulos, A; Payne, RJ; Stone, MJ				Tan, Joshua H. Y.; Canals, Meritxell; Ludeman, Justin P.; Wedderburn, Jamie; Boston, Christopher; Butler, Stephen J.; Carrick, Ann Marie; Parody, Todd R.; Taleski, Deni; Christopoulos, Arthur; Payne, Richard J.; Stone, Martin J.			Design and Receptor Interactions of Obligate Dimeric Mutant of Chemokine Monocyte Chemoattractant Protein-1 (MCP-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOTACTIC PROTEIN-1; CXCR4 SULFOTYROSINE; CCR5 RECEPTOR; BINDING; INTERLEUKIN-8; RECOGNITION; ACTIVATION; NMR; IDENTIFICATION; ANTAGONISM	Chemokine-receptor interactions regulate leukocyte trafficking during inflammation. CC chemokines exist in equilibrium between monomeric and dimeric forms. Although the monomers can activate chemokine receptors, dimerization is required for leukocyte recruitment in vivo, and it remains controversial whether dimeric CC chemokines can bind and activate their receptors. We have developed an obligate dimeric mutant of the chemokine monocyte chemoattractant protein-1 (MCP-1) by substituting Thr10 at the dimer interface with Cys. Biophysical analysis showed that MCP-1(T10C) forms a covalent dimer with similar structure to the wild type MCP-1 dimer. Initial cell-based assays indicated that MCP-1(T10C) could activate chemokine receptor CCR2 with potency reduced 1 to 2 orders of magnitude relative to wild type MCP-1. However, analysis of size exclusion chromatography fractions demonstrated that the observed activity was due to a small proportion of MCP-1(T10C) being monomeric and highly potent, whereas the majority dimeric form could neither bind nor activate CCR2 at concentrations up to 1 mu M. These observations help to reconcile previous conflicting results and indicate that dimeric CC chemokines do not bind to their receptors with affinities approaching those of the corresponding monomeric chemokines.	[Tan, Joshua H. Y.; Ludeman, Justin P.; Wedderburn, Jamie; Stone, Martin J.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Canals, Meritxell; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Boston, Christopher; Carrick, Ann Marie; Parody, Todd R.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Boston, Christopher; Carrick, Ann Marie; Parody, Todd R.] Indiana Univ, Interdisciplinary Program Biochem, Bloomington, IN 47405 USA; [Butler, Stephen J.; Taleski, Deni; Payne, Richard J.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia	Monash University; Monash University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Sydney	Stone, MJ (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Bldg 76,Wellington Rd, Clayton, Vic 3800, Australia.	martin.stone@monash.edu	Butler, Stephen/K-7050-2013; Christopoulos, Arthur/B-6207-2013; Stone, Martin/C-2492-2012	Butler, Stephen/0000-0001-8109-3330; Christopoulos, Arthur/0000-0003-4442-3294; Payne, Richard/0000-0002-3618-9226; Stone, Martin/0000-0002-6468-4427; Canals, Meritxell/0000-0002-7942-5006	Australian Research Council [DP0881570, LE0989504, DP1094884]; Australian National Health and Medical Research Council [519461]; Monash Medicine, Nursing, and Health Science International Honours Scholarship; American Heart Association; Australia Postgraduate Award	Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Monash Medicine, Nursing, and Health Science International Honours Scholarship; American Heart Association(American Heart Association); Australia Postgraduate Award	This work was supported in part by Australian Research Council Grants DP0881570 and LE0989504 (to M. J. S.) and DP1094884 (to R. J. P. and M. J. S.) and by Australian National Health and Medical Research Council Grant 519461 (to A. C.).; Supported by a Monash Medicine, Nursing, and Health Science International Honours Scholarship.; Supported by a predoctoral fellowship from the American Heart Association.; Supported by an Australia Postgraduate Award.	CHUNG CW, 1995, BIOCHEMISTRY-US, V34, P9307, DOI 10.1021/bi00029a005; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; CLUBB RT, 1994, FEBS LETT, V338, P93, DOI 10.1016/0014-5793(94)80123-1; Das ST, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011754; Duma L, 2007, J MOL BIOL, V365, P1063, DOI 10.1016/j.jmb.2006.10.040; Handel TM, 1996, BIOCHEMISTRY-US, V35, P6569, DOI 10.1021/bi9602270; Hemmerich S, 1999, BIOCHEMISTRY-US, V38, P13013, DOI 10.1021/bi991029m; Jarnagin K, 1999, BIOCHEMISTRY-US, V38, P16167, DOI 10.1021/bi9912239; Jin HJ, 2007, J BIOL CHEM, V282, P27976, DOI 10.1074/jbc.M702654200; Lau E. K., 2004, ADV PROTEIN CHEM, V68, P141; Laurence JS, 2000, BIOCHEMISTRY-US, V39, P3401, DOI 10.1021/bi9923196; LODI PJ, 1994, SCIENCE, V263, P1762, DOI 10.1126/science.8134838; Mayer KL, 2000, BIOCHEMISTRY-US, V39, P8382, DOI 10.1021/bi000523j; Mayer MR, 2004, FEBS LETT, V571, P166, DOI 10.1016/j.febslet.2004.06.079; Monteclaro FS, 1997, J BIOL CHEM, V272, P23186, DOI 10.1074/jbc.272.37.23186; Nasser MW, 2009, J IMMUNOL, V183, P3425, DOI 10.4049/jimmunol.0900305; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; PAOLINI JF, 1994, J IMMUNOL, V153, P2704; Parody TR, 2004, CYTOKINE, V27, P38, DOI 10.1016/j.cyto.2004.03.013; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; RAJARATHNAM K, 1994, SCIENCE, V264, P90, DOI 10.1126/science.8140420; Rajarathnam K, 2006, BIOCHEMISTRY-US, V45, P7882, DOI 10.1021/bi0605944; Ravindran A, 2009, BIOCHEMISTRY-US, V48, P8795, DOI 10.1021/bi901194p; Simpson LS, 2009, CHEM BIOL, V16, P153, DOI 10.1016/j.chembiol.2008.12.007; Skelton NJ, 1999, STRUCTURE, V7, P157, DOI 10.1016/S0969-2126(99)80022-7; Taleski D, 2011, CHEM-ASIAN J, V6, P1316, DOI 10.1002/asia.201100232; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052; Wells TNC, 1996, J LEUKOCYTE BIOL, V59, P53, DOI 10.1002/jlb.59.1.53; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Ye JP, 2000, J BIOL CHEM, V275, P27250; ZHANG YJ, 1995, MOL CELL BIOL, V15, P4851; Zhu JZ, 2011, BIOCHEMISTRY-US, V50, P1524, DOI 10.1021/bi101240v	33	39	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14692	14702		10.1074/jbc.M111.334201	http://dx.doi.org/10.1074/jbc.M111.334201			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22396538	Green Published, hybrid			2022-12-27	WOS:000304003200035
J	Yu, W; Dittenhafer-Reed, KE; Denu, JM				Yu, Wei; Dittenhafer-Reed, Kristin E.; Denu, John M.			SIRT3 Protein Deacetylates Isocitrate Dehydrogenase 2 (IDH2) and Regulates Mitochondrial Redox Status	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; CALORIC RESTRICTION; LYSINE ACETYLATION; METABOLISM; CANCER; STRESS; ROS; SUPPRESSOR; HYPOXIA; DAMAGE	Mitochondria play a central role in oxidative energy metabolism and age-related diseases such as cancer. Accumulation of spurious oxidative damage can cause cellular dysfunction. Antioxidant pathways that rely on NADPH are needed for the reduction of glutathione and maintenance of proper redox status. The mitochondrial matrix protein isocitrate dehydrogenase 2 (IDH2) is a major source of NADPH. Previously, we demonstrated that the NAD(+)-dependent deacetylase SIRT3 was essential for the prevention of age-related hearing loss in mice fed a calorically restricted diet. Here we provide direct biochemical and biological evidence establishing an exquisite regulatory relationship between IDH2 and SIRT3 under acute and chronic caloric restriction. The regulated site of acetylation was mapped to Lys-413, an evolutionarily invariant residue. Site-specific, genetic incorporation of N-e-acetyllysine into position 413 of IDH2 revealed that acetylated IDH2 displays a dramatic 44-fold loss in activity. Deacetylation by SIRT3 fully restored maximum IDH2 activity. The ability of SIRT3 to protect cells from oxidative stress was dependent on IDH2, and the deacetylated mimic, IDH2(K413R) variant was able to protect Sirt3(-/-) mouse embryonic fibroblasts from oxidative stress through increased reduced glutathione levels. Together these results uncover a previously unknown mechanism by which SIRT3 regulates IDH2 under dietary restriction. Recent findings demonstrate that IDH2 activities are a major factor in cancer, and as such, these results implicate SIRT3 as a potential regulator of IDH2-dependent functions in cancer cell metabolism.	[Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Wisconsin Inst Discovery 2140, Madison, WI 53715 USA; Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Denu, JM (corresponding author), Univ Wisconsin, Dept Biomol Chem, Wisconsin Inst Discovery 2140, 330 N Orchard St, Madison, WI 53715 USA.	jmdenu@wisc.edu	YU, WEI/G-4128-2013; YU, WEI/C-3822-2012	Dittenhafer-Reed, Kristin/0000-0001-7317-3912; YU, WEI/0000-0001-9898-4607	National Institutes of Health [GM065386]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM059785, R01GM065386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM065386 (to J. M. D.). This work was also supported by the National Science Foundation Graduate Research Fellowship Program (to K. E. D.).	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Albaugh BN, 2011, J BIOL CHEM, V286, P24694, DOI 10.1074/jbc.M111.251579; Alhazzazi TY, 2011, BBA-REV CANCER, V1816, P80, DOI 10.1016/j.bbcan.2011.04.004; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; DiMatteo MA, 1997, APOPTOSIS, V2, P164, DOI 10.1023/A:1026412414666; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kornberg A., 1955, METHOD ENZYMOL, V1, P3; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee JH, 2003, J BIOL CHEM, V278, P51360, DOI 10.1074/jbc.M302332200; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Peng YJ, 2008, PROTEIN SCI, V17, P1542, DOI 10.1110/ps.035675.108; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Singh KK, 2006, ANN NY ACAD SCI, V1067, P182, DOI 10.1196/annals.1354.022; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; UHR ML, 1974, J BIOL CHEM, V249, P2920; Vogel R, 1999, NEUROSCI LETT, V275, P97, DOI 10.1016/S0304-3940(99)00748-X; Wagner G. R., 2012, HUM MOL GEN IN PRESS; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Weindruch R., 1988, RETARDATION AGING DI; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Yang YJ, 2010, J BIOL CHEM, V285, P7417, DOI 10.1074/jbc.M109.053421; Yin F, 2012, BBA-BIOENERGETICS, V1817, P401, DOI 10.1016/j.bbabio.2011.12.004; ZEREZ CR, 1987, ANAL BIOCHEM, V164, P367, DOI 10.1016/0003-2697(87)90506-9; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	51	300	309	3	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14078	14086		10.1074/jbc.M112.355206	http://dx.doi.org/10.1074/jbc.M112.355206			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22416140	hybrid, Green Published			2022-12-27	WOS:000303996300061
J	Grou, CP; Francisco, T; Rodrigues, TA; Freitas, MO; Pinto, MP; Carvalho, AF; Domingues, P; Wood, SA; Rodriguez-Borges, JE; Sa-Miranda, C; Fransen, M; Azevedo, JE				Grou, Claudia P.; Francisco, Tania; Rodrigues, Tony A.; Freitas, Marta O.; Pinto, Manuel P.; Carvalho, Andreia F.; Domingues, Pedro; Wood, Stephen A.; Rodriguez-Borges, Jose E.; Sa-Miranda, Clara; Fransen, Marc; Azevedo, Jorge E.			Identification of Ubiquitin-specific Protease 9X (USP9X) as a Deubiquitinase Acting on Ubiquitin-Peroxin 5 (PEX5) Thioester Conjugate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAM DEUBIQUITYLATING ENZYME; PTS1 RECEPTOR; CYCLING RECEPTOR; IN-VITRO; EXPRESSION ANALYSIS; TARGETING SIGNAL-1; CONSERVED CYSTEINE; OXIDATIVE STRESS; GEL-FILTRATION; IMPORT	Peroxin 5 (PEX5), the peroxisomal protein shuttling receptor, binds newly synthesized peroxisomal matrix proteins in the cytosol and promotes their translocation across the organelle membrane. During the translocation step, PEX5 itself becomes inserted into the peroxisomal docking/translocation machinery. PEX5 is then monoubiquitinated at a conserved cysteine residue and extracted back into the cytosol in an ATP-dependent manner. We have previously shown that the ubiquitin-PEX5 thioester conjugate (Ub-PEX5) released into the cytosol can be efficiently disrupted by physiological concentrations of glutathione, raising the possibility that a fraction of Ub-PEX5 is nonenzymatically deubiquitinated in vivo. However, data suggesting that Ub-PEX5 is also a target of a deubiquitinase were also obtained in that work. Here, we used an unbiased biochemical approach to identify this enzyme. Our results suggest that ubiquitin-specific protease 9X (USP9X) is by far the most active deubiquitinase acting on Ub-PEX5, both in female rat liver and HeLa cells. We also show that USP9X is an elongated monomeric protein with the capacity to hydrolyze thioester, isopeptide, and peptide bonds. The strategy described here will be useful in identifying deubiquitinases acting on other ubiquitin conjugates.	[Grou, Claudia P.; Francisco, Tania; Rodrigues, Tony A.; Freitas, Marta O.; Pinto, Manuel P.; Carvalho, Andreia F.; Sa-Miranda, Clara; Azevedo, Jorge E.] Univ Porto, IBMC, P-4150180 Oporto, Portugal; [Francisco, Tania; Rodrigues, Tony A.; Freitas, Marta O.; Azevedo, Jorge E.] Univ Porto, ICBAS, P-4009003 Oporto, Portugal; [Domingues, Pedro] Univ Aveiro, Dept Quim, P-3810193 Aveiro, Portugal; [Wood, Stephen A.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia; [Rodriguez-Borges, Jose E.] Univ Porto, Fac Ciencias, Ctr Invest Quim, Dept Quim & Bioquim, P-4169007 Oporto, Portugal; [Fransen, Marc] Katholieke Univ Leuven, Dept Cellulaire Mol Geneeskunde, B-3000 Louvain, Belgium	Universidade do Porto; Universidade do Porto; Universidade de Aveiro; Griffith University; Universidade do Porto; KU Leuven	Azevedo, JE (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	jazevedo@ibmc.up.pt	Francisco, Tânia/AAK-9920-2020; Rodriguez-Borges, José Enrique/Y-5092-2019; Carvalho, Andreia/J-9013-2015; Wood, Stephen A/E-8357-2011; Rodriguez-Borges, J. E./F-2430-2011; Rodrigues, Tony A. Q./K-1141-2014; Grou, Claudia P/K-5472-2013; Pinto, Manuel/K-6425-2013; Fransen, Marc/ADL-0723-2022; Domingues, Pedro/E-5202-2010; Francisco, Tânia FAG/K-5545-2013; Freitas, Marta/J-8699-2013; Fransen, Marc/C-6262-2008; sá Miranda, Maria Clara/K-3920-2013; Azevedo, Jorge E/A-4113-2008	Francisco, Tânia/0000-0003-3571-5164; Rodriguez-Borges, José Enrique/0000-0002-9104-1670; Carvalho, Andreia/0000-0001-8781-5680; Wood, Stephen A/0000-0002-2576-7457; Rodriguez-Borges, J. E./0000-0002-9104-1670; Rodrigues, Tony A. Q./0000-0003-2311-8258; Grou, Claudia P/0000-0001-5197-2270; Pinto, Manuel/0000-0001-9778-2093; Domingues, Pedro/0000-0002-8060-7675; Francisco, Tânia FAG/0000-0003-3571-5164; Freitas, Marta/0000-0001-5779-2289; Fransen, Marc/0000-0001-9284-1197; sá Miranda, Maria Clara/0000-0003-0123-5525; Azevedo, Jorge E/0000-0001-7714-5302	Fundacao para a Ciencia e Tecnologia; Fundo Europeu de Desenvolvimento Regional through COMPETE-Programa Operacional Factores de Competitividade in the context of QREN, Portugal [PEst-C/SAU/LA0002/2011, PEst-C/QUI/UI0062/2011, PTDC/BIA-BCM/64771/2006]; Fundacao para a Ciencia e Tecnologia, Programa Operacional Potencial Humano do QREN; Fundo Social Europeu; Programa Ciencia; POPH-QREN-Tipologia 4.2-Promocao do Emprego Cientifico; Ministerio da Ciencia, Tecnologia e Ensino Superior; National Health and Medical Research Council of Australia; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen; Onderzoeksproject [G.0754.09]; Bijzonder Onderzoeksfonds van de Katholieke Universiteit Leuven [OT/09/045]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundo Europeu de Desenvolvimento Regional through COMPETE-Programa Operacional Factores de Competitividade in the context of QREN, Portugal; Fundacao para a Ciencia e Tecnologia, Programa Operacional Potencial Humano do QREN; Fundo Social Europeu; Programa Ciencia(Spanish Government); POPH-QREN-Tipologia 4.2-Promocao do Emprego Cientifico; Ministerio da Ciencia, Tecnologia e Ensino Superior; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); Onderzoeksproject; Bijzonder Onderzoeksfonds van de Katholieke Universiteit Leuven	This work was supported in part by Fundacao para a Ciencia e Tecnologia and Fundo Europeu de Desenvolvimento Regional through COMPETE-Programa Operacional Factores de Competitividade in the context of QREN, Portugal, Grants PEst-C/SAU/LA0002/2011, PEst-C/QUI/UI0062/2011, and PTDC/BIA-BCM/64771/2006.; Supported by Fundacao para a Ciencia e Tecnologia, Programa Operacional Potencial Humano do QREN and Fundo Social Europeu.; Supported by Programa Ciencia (funded by POPH-QREN-Tipologia 4.2-Promocao do Emprego Cientifico), by Fundo Social Europeu, and by national funds from Ministerio da Ciencia, Tecnologia e Ensino Superior.; Supported by the National Health and Medical Research Council of Australia.; Supported by Fonds voor Wetenschappelijk Onderzoek-Vlaanderen, Onderzoeksproject G.0754.09, and the Bijzonder Onderzoeksfonds van de Katholieke Universiteit Leuven Grant OT/09/045.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Alencastre IS, 2009, J BIOL CHEM, V284, P27243, DOI 10.1074/jbc.M109.032565; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Brown GM, 1998, HUM MOL GENET, V7, P97, DOI 10.1093/hmg/7.1.97; Buus R, 2009, CURR BIOL, V19, P1463, DOI 10.1016/j.cub.2009.07.040; Carvalho AF, 2006, J MOL BIOL, V356, P864, DOI 10.1016/j.jmb.2005.12.002; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Carvalho AF, 2012, MOL BIOTECHNOL, V51, P254, DOI 10.1007/s12033-011-9463-x; Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000381; Costa-Rodrigues J, 2005, J BIOL CHEM, V280, P24404, DOI 10.1074/jbc.M501985200; Debelyy MO, 2011, J BIOL CHEM, V286, P28223, DOI 10.1074/jbc.M111.238600; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Ferro A, 2007, BBA-MOL CELL RES, V1773, P1619, DOI 10.1016/j.bbamcr.2007.07.012; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; Freitas MO, 2011, J BIOL CHEM, V286, P40509, DOI 10.1074/jbc.M111.287201; Galland N, 2007, BBA-MOL CELL RES, V1773, P521, DOI 10.1016/j.bbamcr.2007.01.006; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Gouveia AM, 2003, J BIOL CHEM, V278, P226, DOI 10.1074/jbc.M209498200; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; Grou CP, 2009, CELL MOL LIFE SCI, V66, P254, DOI 10.1007/s00018-008-8415-5; Grou CP, 2008, J BIOL CHEM, V283, P14190, DOI 10.1074/jbc.M800402200; Grou CP, 2009, J BIOL CHEM, V284, P10504, DOI 10.1074/jbc.M808978200; Gunkel K, 2004, MOL BIOL CELL, V15, P1347, DOI 10.1091/mbc.E03-04-0258; HAAS AL, 1983, BIOCHEMISTRY-US, V22, P4388, DOI 10.1021/bi00288a007; HERSHKO A, 1987, P NATL ACAD SCI USA, V84, P1829, DOI 10.1073/pnas.84.7.1829; Ivashchenko O, 2011, MOL BIOL CELL, V22, P1440, DOI 10.1091/mbc.E10-11-0919; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; Jones MH, 1996, HUM MOL GENET, V5, P1695, DOI 10.1093/hmg/5.11.1695; Joo HY, 2011, J BIOL CHEM, V286, P7190, DOI 10.1074/jbc.M110.158311; Klein ATJ, 2002, J BIOL CHEM, V277, P25011, DOI 10.1074/jbc.M203254200; KOSTER A, 1986, BIOCHEM BIOPH RES CO, V137, P626, DOI 10.1016/0006-291X(86)91124-1; Kouranti I, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000471; Lanyon-Hogg T, 2010, BIOL CELL, V102, P245, DOI 10.1042/BC20090159; Lazarow PB, 2006, BBA-MOL CELL RES, V1763, P1599, DOI 10.1016/j.bbamcr.2006.08.011; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Luddi A, 2009, NEW ENGL J MED, V360, P881, DOI 10.1056/NEJMoa0806218; Ma C, 2009, IUBMB LIFE, V61, P713, DOI 10.1002/iub.196; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Murray RZ, 2004, MOL BIOL CELL, V15, P1591, DOI 10.1091/mbc.E03-08-0630; Nagai H, 2009, MOL CELL, V36, P805, DOI 10.1016/j.molcel.2009.10.016; Nathan JA, 2008, TRAFFIC, V9, P1130, DOI 10.1111/j.1600-0854.2008.00747.x; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Okumoto K, 2011, TRAFFIC, V12, P1067, DOI 10.1111/j.1600-0854.2011.01217.x; Oliveira ME, 2003, J BIOL CHEM, V278, P39483, DOI 10.1074/jbc.M305089200; Oliveira MEM, 2002, BBA-BIOMEMBRANES, V1567, P13, DOI 10.1016/S0005-2736(02)00635-1; Oshima Y, 2008, PLANT CELL PHYSIOL, V49, P671, DOI 10.1093/pcp/pcn038; Otera H, 1998, MOL CELL BIOL, V18, P388, DOI 10.1128/MCB.18.1.388; Otera H, 2002, MOL CELL BIOL, V22, P1639, DOI 10.1128/MCB.22.6.1639-1655.2002; Pantaleon M, 2001, MECH DEVELOP, V109, P151, DOI 10.1016/S0925-4773(01)00551-2; Parsons JL, 2011, MOL CELL, V41, P609, DOI 10.1016/j.molcel.2011.02.016; Pinto MP, 2009, BBA-MOL CELL RES, V1793, P1669, DOI 10.1016/j.bbamcr.2009.08.007; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Puente XS, 2004, GENOME RES, V14, P609, DOI 10.1101/gr.1946304; Reguenga C, 2001, J BIOL CHEM, V276, P29935, DOI 10.1074/jbc.M104114200; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rott R, 2011, P NATL ACAD SCI USA, V108, P18666, DOI 10.1073/pnas.1105725108; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Schliebs W, 2006, BBA-MOL CELL RES, V1763, P1605, DOI 10.1016/j.bbamcr.2006.08.051; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Shiozawa K, 2009, J BIOL CHEM, V284, P25334, DOI 10.1074/jbc.M109.002311; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stanley WA, 2006, BBA-MOL CELL RES, V1763, P1592, DOI 10.1016/j.bbamcr.2006.10.015; Stanley WA, 2006, MOL CELL, V24, P653, DOI 10.1016/j.molcel.2006.10.024; Theard D, 2010, EMBO J, V29, P1499, DOI 10.1038/emboj.2010.46; VANDERKLEI IJ, 1995, J BIOL CHEM, V270, P17229, DOI 10.1074/jbc.270.29.17229; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Wilkinson KD, 2005, METHOD ENZYMOL, V399, P37, DOI 10.1016/S0076-6879(05)99003-4; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Wolf J, 2010, FEBS J, V277, P3268, DOI 10.1111/j.1742-4658.2010.07739.x; Wood SA, 1997, MECH DEVELOP, V63, P29, DOI 10.1016/S0925-4773(97)00672-2; Woodward AW, 2005, MOL BIOL CELL, V16, P573, DOI 10.1091/mbc.E04-05-0422; Xu J, 2002, HUM MOL GENET, V11, P1409, DOI 10.1093/hmg/11.12.1409	85	62	66	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12815	12827		10.1074/jbc.M112.340158	http://dx.doi.org/10.1074/jbc.M112.340158			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22371489	hybrid, Green Published			2022-12-27	WOS:000302903700021
J	Stanford, JC; Morris, AJ; Sunkara, M; Popa, GJ; Larson, KL; Ozcan, S				Stanford, Jamie Cantrell; Morris, Andrew J.; Sunkara, Manjula; Popa, Gabriel J.; Larson, Kara L.; Oezcan, Sabire			Sphingosine 1-Phosphate (S1P) Regulates Glucose-stimulated Insulin Secretion in Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED PHOSPHORYLATION; CERAMIDE SYNTHESIS; MAFA EXPRESSION; SKELETAL-MUSCLE; KINASE-ACTIVITY; INS-1 CELLS; SPHINGOSINE-1-PHOSPHATE; RESISTANCE; ACTIVATION; ISLETS	Recent studies suggest that sphingolipid metabolism is altered during type 2 diabetes. Increased levels of the sphingolipid ceramide are associated with insulin resistance. However, a role for sphingolipids in pancreatic beta cell function, or insulin production, and release remains to be established. Our studies in MIN6 cells and mouse pancreatic islets demonstrate that glucose stimulates an intracellular rise in the sphingolipid, sphingosine 1-phosphate (S1P), whereas the levels of ceramide and sphingomyelin remain unchanged. The increase in S1P levels by glucose is due to activation of sphingosine kinase 2 (SphK2). Interestingly, rises in S1P correlate with increased glucose-stimulated insulin secretion (GSIS). Decreasing S1P levels by treatment of MIN6 cells or primary islets with the sphingosine kinase inhibitor reduces GSIS. Moreover, knockdown of SphK2 alone results in decreased GSIS, whereas knockdown of the S1P phosphatase, Sgpp1, leads to a rise in GSIS. Treatment of mice with the sphingosine kinase inhibitor impairs glucose disposal due to decreased plasma insulin levels. Altogether, our data suggest that glucose activates SphK2 in pancreatic beta cells leading to a rise in S1P levels, which is important for GSIS.	[Stanford, Jamie Cantrell; Popa, Gabriel J.; Larson, Kara L.; Oezcan, Sabire] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Morris, Andrew J.; Sunkara, Manjula] Univ Kentucky, Cardiovasc Res Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Ozcan, S (corresponding author), 741 S Limestone St,BBSRB,B155, Lexington, KY 40536 USA.	sozcan@uky.edu	sunkara, Manjula/H-7944-2016	sunkara, Manjula/0000-0001-6151-1929; Larson, Kara/0000-0002-4678-634X	National Institutes of Health [DK067581, P20RR020171]; American Diabetes Association [1-05-CD-15]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171, S10RR024598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK067581, R01DK067581] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK067581 and P20RR020171 (to S. O.). This work was also supported by American Diabetes Association Grant 1-05-CD-15.	Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Andrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200; Boden G, 2008, DIABETOLOGIA, V51, P1095, DOI 10.1007/s00125-008-1015-y; Buehrer BM, 1996, BBA-LIPID LIPID MET, V1303, P233, DOI 10.1016/0005-2760(96)00092-6; Ding G, 2007, J BIOL CHEM, V282, P27493, DOI 10.1074/jbc.M701641200; Guo J, 2010, MOL CELL BIOCHEM, V338, P283, DOI 10.1007/s11010-009-0362-4; Hait NC, 2007, J BIOL CHEM, V282, P12058, DOI 10.1074/jbc.M609559200; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Kelpe CL, 2003, J BIOL CHEM, V278, P30015, DOI 10.1074/jbc.M302548200; Kim RH, 2009, BBA-MOL CELL BIOL L, V1791, P692, DOI 10.1016/j.bbalip.2009.02.011; Laychock SG, 2003, DIABETES, V52, P1986, DOI 10.2337/diabetes.52.8.1986; Laychock SG, 2006, ENDOCRINOLOGY, V147, P4705, DOI 10.1210/en.2006-0456; Ma MM, 2007, DIABETOLOGIA, V50, P891, DOI 10.1007/s00125-006-0589-5; Maceyka M, 2005, PROSTAG OTH LIPID M, V77, P15, DOI 10.1016/j.prostaglandins.2004.09.010; Major CD, 1999, DIABETES, V48, P1372, DOI 10.2337/diabetes.48.7.1372; Mastrandrea LD, 2010, J LIPID RES, V51, P2171, DOI 10.1194/jlr.M000802; Mastrandrea LD, 2005, DIABETES, V54, P1429, DOI 10.2337/diabetes.54.5.1429; Mathews TP, 2010, J MED CHEM, V53, P2766, DOI 10.1021/jm901860h; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Olivera A, 1996, J CELL BIOCHEM, V60, P529, DOI 10.1002/(SICI)1097-4644(19960315)60:4<529::AID-JCB9>3.0.CO;2-U; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pickersgill L, 2007, J BIOL CHEM, V282, P12583, DOI 10.1074/jbc.M611157200; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pyne NJ, 2009, ADV ENZYME REGUL, V49, P214, DOI 10.1016/j.advenzreg.2009.01.011; Pyne S, 2009, CELL SIGNAL, V21, P14, DOI 10.1016/j.cellsig.2008.08.008; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Shimizu H, 2000, ENDOCR J, V47, P261, DOI 10.1507/endocrj.47.261; Straczkowski M, 2007, DIABETOLOGIA, V50, P2366, DOI 10.1007/s00125-007-0781-2; Straczkowski Marek, 2008, Rev Diabet Stud, V5, P13, DOI 10.1900/RDS.2008.5.13; Summers SA, 2010, CURR OPIN LIPIDOL, V21, P128, DOI 10.1097/MOL.0b013e3283373b66; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Vanderford NL, 2008, ARCH BIOCHEM BIOPHYS, V480, P138, DOI 10.1016/j.abb.2008.10.001; Vanderford NL, 2007, J BIOL CHEM, V282, P1577, DOI 10.1074/jbc.M605064200; Wang LJ, 2005, CIRC RES, V97, P891, DOI 10.1161/01.RES.0000187469.82595.15; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719	40	67	71	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13457	13464		10.1074/jbc.M111.268185	http://dx.doi.org/10.1074/jbc.M111.268185			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22389505	Green Published, hybrid			2022-12-27	WOS:000302903700079
J	Telleria, EL; Sant'Anna, MRV; Ortigao-Farias, JR; Pitaluga, AN; Dillon, VM; Bates, PA; Traub-Cseko, YM; Dillon, RJ				Telleria, Erich L.; Sant'Anna, Mauricio R. V.; Ortigao-Farias, Joao R.; Pitaluga, Andre N.; Dillon, Viv M.; Bates, Paul A.; Traub-Csekoe, Yara M.; Dillon, Rod J.			Caspar-like Gene Depletion Reduces Leishmania Infection in Sand Fly Host Lutzomyia longipalpis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VISCERAL LEISHMANIASIS; BACTERIAL; FLIES; GUT; RESPONSES; IMMUNITY; DIPTERA; MIDGUT; TRANSMISSION; EXPRESSION	Female phlebotomine sand flies Lutzomyia longipalpis naturally harbor populations of the medically important Leishmania infantum (syn. Leishmania chagasi) parasite in the gut, but the extent to which the parasite interacts with the immune system of the insect vector is unknown. To investigate the sand fly immune response and its interaction with the Leishmania parasite, we identified a homologue for caspar, a negative regulator of immune deficiency signaling pathway. We found that feeding antibiotics to adult female L. longipalpis resulted in an up-regulation of caspar expression relative to controls. caspar was differentially expressed when females were fed on Gram-negative and Gram-positive bacterial species. caspar expression was significantly down-regulated in females between 3 and 6 days after a blood feed containing Leishmania mexicana amastigotes. RNA interference was used to deplete caspar expression in female L. longipalpis, which were subsequently fed with Leishmania in a blood meal. Sand fly gut populations of both L. mexicana and L. infantum were significantly reduced in caspar-depleted females. The prevalence of L. infantum infection in the females fell from 85 to 45%. Our results provide the first insight into the operation of immune homeostasis in phlebotomine sand flies during the growth of bacterial and Leishmania populations in the digestive tract. We have demonstrated that the activation of the sand fly immune system, via depletion of a single gene, can lead to the abortion of Leishmania development and the disruption of transmission by the phlebotomine sand fly.	[Sant'Anna, Mauricio R. V.; Bates, Paul A.; Dillon, Rod J.] Univ Lancaster, Fac Hlth & Med, Lancaster LA1 4YQ, England; [Telleria, Erich L.; Ortigao-Farias, Joao R.; Pitaluga, Andre N.; Traub-Csekoe, Yara M.] Fiocruz MS, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil; [Dillon, Viv M.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 72B, Merseyside, England	Lancaster University; Fundacao Oswaldo Cruz; University of Liverpool	Dillon, RJ (corresponding author), Univ Lancaster, Fac Hlth & Med, Lancaster LA1 4YQ, England.	r.dillon@lancaster.ac.uk	Sant'Anna, Mauricio Roberto Viana/AAQ-4093-2021; Telleria, Erich L/F-1580-2015; Sant'Anna, Mauricio Roberto Via/AAQ-6084-2021; Traub-Cseko, Yara M/F-2723-2015; Pitaluga, Andre/B-2610-2015	Sant'Anna, Mauricio Roberto Viana/0000-0002-2504-0979; Telleria, Erich L/0000-0003-0006-0057; Dillon, Rod/0000-0002-3551-0030; Bates, Paul/0000-0001-6861-5421; Pitaluga, Andre/0000-0001-6745-5542	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; FAPERJ-PPPG (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do, Estado do Rio de Janeiro); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); Fundacao Oswaldo Cruz; Leverhulme Trust [F/00 808/C]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ-PPPG (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do, Estado do Rio de Janeiro); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Oswaldo Cruz; Leverhulme Trust(Leverhulme Trust)	This work was funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, FAPERJ-PPPG (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do, Estado do Rio de Janeiro), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), Fundacao Oswaldo Cruz, and Leverhulme Trust Grant F/00 808/C.	Boulanger N, 2004, INFECT IMMUN, V72, P7140, DOI 10.1128/IAI.72.12.7140-7146.2004; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Diaz-Albiter H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017486; Dillon RJ, 2008, J INVERTEBR PATHOL, V97, P265, DOI 10.1016/j.jip.2007.09.010; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dillon RJ, 1996, ANN TROP MED PARASIT, V90, P669, DOI 10.1080/00034983.1996.11813102; Dillon RJ, 2006, GENOMICS, V88, P831, DOI 10.1016/j.ygeno.2006.06.011; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Erickson SM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000529; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gossage SA, 2003, INT J PARASITOL, V33, P1027, DOI 10.1016/S0020-7519(03)00142-5; Gouveia C, 2008, NEOTROP ENTOMOL, V37, P597, DOI 10.1590/S1519-566X2008000500016; Hao ZR, 2001, P NATL ACAD SCI USA, V98, P12648, DOI 10.1073/pnas.221363798; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Jochim RC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-15; Kim M, 2006, P NATL ACAD SCI USA, V103, P16358, DOI 10.1073/pnas.0603238103; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; Leulier F, 2009, NAT IMMUNOL, V10, P936, DOI 10.1038/ni0909-936; Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Modi G. B., 1997, The molecular biology of insect disease vectors: a methods manual., P21; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Nimmo DD, 1997, MED VET ENTOMOL, V11, P324, DOI 10.1111/j.1365-2915.1997.tb00417.x; Pagni M, 2004, NUCLEIC ACIDS RES, V32, pW332, DOI 10.1093/nar/gkh479; Pitaluga AN, 2008, DEV COMP IMMUNOL, V32, P191, DOI 10.1016/j.dci.2007.06.008; Pitaluga AN, 2009, MOL GENET GENOMICS, V282, P307, DOI 10.1007/s00438-009-0466-2; Ramalho-Ortigao JM, 2001, MEM I OSWALDO CRUZ, V96, P105, DOI 10.1590/S0074-02762001000100012; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Rogers ME, 2007, PLOS PATHOG, V3, P818, DOI 10.1371/journal.ppat.0030091; Rogers ME, 2004, NATURE, V430, P463, DOI 10.1038/nature02675; Rosetto M, 2003, ITAL J ZOOL, V70, P221, DOI 10.1080/11250000309356520; Ryu JH, 2010, DEV COMP IMMUNOL, V34, P369, DOI 10.1016/j.dci.2009.11.010; Ryu SW, 1999, BIOCHEM BIOPH RES CO, V262, P388, DOI 10.1006/bbrc.1999.1217; Sant'Anna MRV, 2008, INSECT BIOCHEM MOLEC, V38, P652, DOI 10.1016/j.ibmb.2008.03.012; Sant'Anna MRV, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-62; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Volf P, 2002, FOLIA PARASIT, V49, P73, DOI 10.14411/fp.2002.014; Warburg A, 2011, J VECTOR ECOL, V36, pS10, DOI 10.1111/j.1948-7134.2011.00107.x	43	34	35	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12985	12993		10.1074/jbc.M111.331561	http://dx.doi.org/10.1074/jbc.M111.331561			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22375009	hybrid, Green Published			2022-12-27	WOS:000302903700037
J	Zhu, JY; Yang, Y; Han, HJ; Betzi, S; Olesen, SH; Marsilio, F; Schonbrunn, E				Zhu, Jin-Yi; Yang, Yan; Han, Huijong; Betzi, Stephane; Olesen, Sanne H.; Marsilio, Frank; Schoenbrunn, Ernst			Functional Consequence of Covalent Reaction of Phosphoenolpyruvate with UDP-N-acetylglucosamine 1-Carboxyvinyltransferase (MurA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENOLPYRUVYL TRANSFERASE MURA; INDUCED-FIT MECHANISM; CRYSTAL-STRUCTURE; BACTERIAL PEPTIDOGLYCAN; DIFFRACTION DATA; ENZYME; TARGET; CRYSTALLOGRAPHY; INACTIVATION; INHIBITOR	The enzyme MurA has been an established antibiotic target since the discovery of fosfomycin, which specifically inhibits MurA by covalent modification of the active site residue Cys-115. Early biochemical studies established that Cys-115 also covalently reacts with substrate phosphoenolpyruvate (PEP) to yield a phospholactoyl adduct, but the structural and functional consequences of this reaction remained obscure. We captured and depicted the Cys-115-PEP adduct of Enterobacter cloacae MurA in various reaction states by X-ray crystallography. The data suggest that cellular MurA predominantly exists in a tightly locked complex with UDP-N-acetylmuramic acid (UNAM), the product of the MurB reaction, with PEP covalently attached to Cys-115. The uniqueness and rigidity of this "dormant" complex was previously not recognized and presumably accounts for the failure of drug discovery efforts toward the identification of novel and effective MurA inhibitors. We demonstrate that recently published crystal structures of MurA from various organisms determined by different laboratories were indeed misinterpreted and actually contain UNAM and covalently bound PEP. The Cys-115-PEP adduct was also captured in vitro during the reaction of free MurA and substrate UDP-N-acetylglucosamine or isomer UDP-N-acetylgalactosamine. The now available series of crystal structures allows a comprehensive view of the reaction cycle of MurA. It appears that the covalent reaction of MurA with PEP fulfills dual functions by tightening the complex with UNAM for the efficient feedback regulation of murein biosynthesis and by priming the PEP molecule for instantaneous reaction with substrate UDP-N-acetylglucosamine.	[Zhu, Jin-Yi; Yang, Yan; Han, Huijong; Betzi, Stephane; Olesen, Sanne H.; Marsilio, Frank; Schoenbrunn, Ernst] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Dept, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Schonbrunn, E (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Dept, 12902 Magnolia Dr, Tampa, FL 33612 USA.	ernst.schonbrunn@moffitt.org	Betzi, Stephane/AAC-6103-2022; Zhu, Jinyi/H-6466-2011	Betzi, Stephane/0000-0001-5935-5058; Zhu, Jinyi/0000-0001-5436-4262; Schonbrunn, Ernst/0000-0002-3589-3510; Han, Huijong/0000-0002-1197-3014	National Institutes of Health [5R01GM070633]; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01GM070633.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernhardt TG, 2001, SCIENCE, V292, P2326, DOI 10.1126/science.1058289; BROWN ED, 1994, BIOCHEMISTRY-US, V33, P10638, DOI 10.1021/bi00201a010; BROWN ED, 1995, J BACTERIOL, V177, P4194, DOI 10.1128/jb.177.14.4194-4197.1995; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eschenburg S, 2003, J BIOL CHEM, V278, P49215, DOI 10.1074/jbc.M309741200; Eschenburg S, 2000, PROTEINS, V40, P290, DOI 10.1002/(SICI)1097-0134(20000801)40:2<290::AID-PROT90>3.0.CO;2-0; Eschenburg S, 2005, J BIOL CHEM, V280, P3757, DOI 10.1074/jbc.M411325200; Eschenburg S, 2005, J BIOL CHEM, V280, P14070, DOI 10.1074/jbc.M414412200; Han HJ, 2010, BIOCHEMISTRY-US, V49, P4276, DOI 10.1021/bi100365b; Jackson SG, 2009, BIOCHEMISTRY-US, V48, P11715, DOI 10.1021/bi901524q; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KAHAN FM, 1974, ANN NY ACAD SCI, V235, P364, DOI 10.1111/j.1749-6632.1974.tb43277.x; Kim DH, 1996, BIOCHEMISTRY-US, V35, P4923, DOI 10.1021/bi952937w; MARQUARDT JL, 1994, BIOCHEMISTRY-US, V33, P10646, DOI 10.1021/bi00201a011; Mizyed S, 2005, BIOCHEMISTRY-US, V44, P4011, DOI 10.1021/bi047704w; Samland AK, 1999, BIOCHEMISTRY-US, V38, P13162, DOI 10.1021/bi991041e; Schonbrunn E, 1998, EUR J BIOCHEM, V253, P406, DOI 10.1046/j.1432-1327.1998.2530406.x; Schonbrunn E, 1996, STRUCTURE, V4, P1065, DOI 10.1016/S0969-2126(96)00113-X; Schonbrunn E, 2000, P NATL ACAD SCI USA, V97, P6345, DOI 10.1073/pnas.120120397; Schonbrunn E, 2000, BIOCHEMISTRY-US, V39, P2164, DOI 10.1021/bi991091j; Skarzynski T, 1998, BIOCHEMISTRY-US, V37, P2572, DOI 10.1021/bi9722608; Skarzynski T, 1996, STRUCTURE, V4, P1465, DOI 10.1016/S0969-2126(96)00153-0; Steinbach A, 2008, J MED CHEM, V51, P5143, DOI 10.1021/jm800609p; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; WANKE C, 1993, EUR J BIOCHEM, V218, P861, DOI 10.1111/j.1432-1033.1993.tb18442.x; Yoon HJ, 2008, PROTEINS, V71, P1032, DOI 10.1002/prot.21959	31	32	38	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12657	12667		10.1074/jbc.M112.342725	http://dx.doi.org/10.1074/jbc.M112.342725			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22378791	Green Published, hybrid			2022-12-27	WOS:000302903700006
J	Dryden, NH; Sperone, A; Martin-Almedina, S; Hannah, RL; Birdsey, GM; Khan, ST; Layhadi, JA; Mason, JC; Haskard, DO; Gottgens, B; Randi, AM				Dryden, Nicola H.; Sperone, Andrea; Martin-Almedina, Silvia; Hannah, Rebecca L.; Birdsey, Graeme M.; Khan, Samia Taufiq; Layhadi, Janice A.; Mason, Justin C.; Haskard, Dorian O.; Goettgens, Berthold; Randi, Anna M.			The Transcription Factor Erg Controls Endothelial Cell Quiescence by Repressing Activity of Nuclear Factor (NF)-kappa B p65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTERCELLULAR-ADHESION MOLECULE-1; TUMOR-NECROSIS-FACTOR; ICAM-1 GENE-TRANSCRIPTION; SET ENRICHMENT ANALYSIS; GENOME-WIDE ANALYSIS; ETS-FAMILY; IN-VIVO; REGULATORY ELEMENTS; EXPRESSION PROFILES	The interaction of transcription factors with specific DNA sequences is critical for activation of gene expression programs. In endothelial cells (EC), the transcription factor NF-kappa B is important in the switch from quiescence to activation, and is tightly controlled to avoid excessive inflammation and organ damage. Here we describe a novel mechanism that controls the activation of NF-kappa B in EC. The transcription factor Erg, the most highly expressed ETS member in resting EC, controls quiescence by repressing proinflammatory gene expression. Focusing on intercellular adhesion molecule 1(ICAM)-1 as a model, we identify two ETS binding sites (EBS - 118 and - 181) within the ICAM-1 promoter required for Erg-mediated repression. We show that Erg binds to both EBS - 118 and EBS - 181, the latter located within the NF-kappa B binding site. Interestingly, inhibition of Erg expression in quiescent EC results in increased NF-kappa B-dependent ICAM-1 expression, indicating that Erg represses basal NF-kappa B activity. Erg prevents NF-kappa B p65 from binding to the ICAM-1 promoter, suggesting a direct mechanism of interference. Gene set enrichment analysis of transcriptome profiles of Erg and NF-kappa B-dependent genes, together with chromatin immunoprecipitation (ChIP) studies, reveals that this mechanism is common to other proinflammatory genes, including cIAP-2 and IL-8. These results identify a role for Erg as a gatekeeper controlling vascular inflammation, thus providing an important barrier to protect against inappropriate endothelial activation.	[Dryden, Nicola H.; Sperone, Andrea; Martin-Almedina, Silvia; Birdsey, Graeme M.; Khan, Samia Taufiq; Layhadi, Janice A.; Mason, Justin C.; Haskard, Dorian O.; Randi, Anna M.] Univ London Imperial Coll Sci Technol & Med, NHLI Cardiovasc Sci Unit, Hammersmith Hosp, London W12 0NN, England; [Hannah, Rebecca L.; Goettgens, Berthold] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England	Imperial College London; University of Cambridge	Randi, AM (corresponding author), Univ London Imperial Coll Sci Technol & Med, NHLI Cardiovasc Sci Unit, Hammersmith Hosp, Du Cane Rd, London W12 0NN, England.	a.randi@imperial.ac.uk	Layhadi, Janice/AAU-8807-2020	Layhadi, Janice/0000-0002-5242-1806; Birdsey, Graeme M./0000-0002-0981-8672; Mason, Justin/0000-0001-7783-1660	British Heart Foundation; Leukemia and Lymphoma Research; National Institute for Health Research Cambridge Bio-medical Research Centre; BBSRC [BB/I00050X/1] Funding Source: UKRI; MRC [G0800784] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I00050X/1] Funding Source: researchfish; British Heart Foundation [PG/10/94/28651] Funding Source: researchfish; Cancer Research UK [12765] Funding Source: researchfish; Medical Research Council [G0800784B, G0800784] Funding Source: researchfish; National Centre for the Replacement [G0900729/1] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Leukemia and Lymphoma Research; National Institute for Health Research Cambridge Bio-medical Research Centre(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement	This work was supported by grants from the British Heart Foundation (to N. H. D., S. A. M., G. M. B., S. T. K., and A. S.) and Leukemia and Lymphoma Research and the National Institute for Health Research Cambridge Biomedical Research Centre (to R. L. H. and B. G.).	Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Birdsey GM, 2012, BLOOD, V119, P894, DOI 10.1182/blood-2011-04-350025; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Carrere S, 1998, ONCOGENE, V16, P3261, DOI 10.1038/sj.onc.1201868; Chen W, 2008, J BIOL CHEM, V283, P16293, DOI 10.1074/jbc.M801803200; Cheng C, 2011, CIRC RES, V109, P385, DOI 10.1161/CIRCRESAHA.111.243444; de Launoit Y, 1998, ONCOGENE, V16, P2065, DOI 10.1038/sj.onc.1201726; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Deramaudt BMJM, 1999, J CELL BIOCHEM, V72, P311, DOI 10.1002/(SICI)1097-4644(19990301)72:3<311::AID-JCB1>3.3.CO;2-7; Furusu A, 2001, KIDNEY INT, V60, P579, DOI 10.1046/j.1523-1755.2001.060002579.x; Goetze S, 2001, ATHEROSCLEROSIS, V159, P93, DOI 10.1016/S0021-9150(01)00497-X; GOTTSCHALK LR, 1993, J EXP MED, V178, P1681, DOI 10.1084/jem.178.5.1681; Grall F, 2003, ARTHRITIS RHEUM, V48, P1249, DOI 10.1002/art.10942; Gri G, 1998, J BIOL CHEM, V273, P6431, DOI 10.1074/jbc.273.11.6431; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; HOU JZ, 1994, P NATL ACAD SCI USA, V91, P11641, DOI 10.1073/pnas.91.24.11641; HultgardhNilsson A, 1996, CIRC RES, V78, P589, DOI 10.1161/01.RES.78.4.589; Jeong BC, 2006, FEBS LETT, V580, P669, DOI 10.1016/j.febslet.2005.12.086; JOHN S, 1995, MOL CELL BIOL, V15, P1786; KARIM FD, 1990, GENE DEV, V4, P1451, DOI 10.1101/gad.4.9.1451; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Maurer P, 2003, ONCOGENE, V22, P3319, DOI 10.1038/sj.onc.1206572; McLaughlin F, 1999, J CELL SCI, V112, P4695; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Okada Y, 2007, CIRC RES, V100, P1712, DOI 10.1161/01.RES.0000269779.10644.dc; PAN JL, 1995, J BIOL CHEM, V270, P23077, DOI 10.1074/jbc.270.39.23077; Payankaulam S, 2010, CURR BIOL, V20, pR764, DOI 10.1016/j.cub.2010.06.037; Peter M, 1997, ONCOGENE, V14, P1159, DOI 10.1038/sj.onc.1200933; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Pimanda JE, 2006, BLOOD, V107, P4737, DOI 10.1182/blood-2005-12-4929; PRASAD DDK, 1992, CANCER RES, V52, P5833; Redlich K, 2001, ARTHRITIS RHEUM, V44, P266, DOI 10.1002/1529-0131(200102)44:2<266::AID-ANR43>3.3.CO;2-7; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; ROEBUCK KA, 1995, J BIOL CHEM, V270, P18966, DOI 10.1074/jbc.270.32.18966; Rudders S, 2001, J BIOL CHEM, V276, P3302, DOI 10.1074/jbc.M006507200; Sana TR, 2005, CYTOKINE, V29, P256, DOI 10.1016/j.cyto.2004.11.003; Shiraya S, 2006, HYPERTENSION, V48, P628, DOI 10.1161/01.HYP.0000240266.26185.57; Sperone A, 2011, ARTERIOSCL THROM VAS, V31, P142, DOI 10.1161/ATVBAHA.110.216473; STRIETER RM, 1989, SCIENCE, V243, P1467, DOI 10.1126/science.2648570; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Thomas RS, 1997, ONCOGENE, V14, P2845, DOI 10.1038/sj.onc.1201125; VORABERGER G, 1991, J IMMUNOL, V147, P2777; Wang JG, 2006, BLOOD, V107, P558, DOI 10.1182/blood-2005-05-2152; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Xue JP, 2009, PHYSIOL GENOMICS, V38, P42, DOI 10.1152/physiolgenomics.00012.2009; Yang L, 2002, ONCOGENE, V21, P148, DOI 10.1038/sj.onc.1204998; Yang L, 2003, BIOCHEM J, V369, P651, DOI 10.1042/BJ20020854; Yockell-Lelievre J, 2009, BIOCHEM CELL BIOL, V87, P905, DOI [10.1139/O09-055, 10.1139/o09-055]; Yuan L, 2009, CIRC RES, V104, P1049, DOI 10.1161/CIRCRESAHA.108.190751; Zhang YX, 2008, CANCER RES, V68, P9519, DOI 10.1158/0008-5472.CAN-08-1549	59	36	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12331	12342		10.1074/jbc.M112.346791	http://dx.doi.org/10.1074/jbc.M112.346791			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337883	Green Published, hybrid			2022-12-27	WOS:000302782200072
J	Sepramaniam, S; Ying, LK; Armugam, A; Wintour, EM; Jeyaseelan, K				Sepramaniam, Sugunavathi; Ying, Lim Kai; Armugam, Arunmozhiarasi; Wintour, E. M.; Jeyaseelan, Kandiah			MicroRNA-130a Represses Transcriptional Activity of Aquaporin 4 M1 Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CEREBRAL-ISCHEMIA; EPITHELIAL-CELLS; MAMMALIAN-CELLS; RAT ASTROCYTES; BRAIN EDEMA; GLIAL-CELLS; EXPRESSION; GENE; MIRNA	Aquaporins (AQPs) are transmembrane water channels ubiquitously expressed in mammalian tissues. They play prominent roles in maintaining cellular fluid balance. Although expression of AQP1, -3, -4, -5, -8, -9, and -11 has been reported in the central nervous system, it is AQP4 that is predominately expressed. Its importance in fluid regulation in cerebral edema conditions has been highlighted in several studies, and we have also shown that translational regulation of AQP4 by miR-320a could prove to be useful in infarct volume reduction in middle cerebral artery occluded rat brain. There is evidence for the existence of two AQP4 transcripts (M1 and M23) in the brain arising from two alternative promoters. Because the AQP4 M1 isoform exhibits greater water permeability, in this study, we explored the possibility of microRNA-based transcriptional regulation of the AQP4 M1 promoter. Using RegRNA software, we identified 34 microRNAs predicted to target the AQP4 M1 promoter region. MicroRNA profiling, quantitative stem-loop PCR, and luciferase reporter assays revealed that miR-130a, -152, -668, -939, and -1280, which were highly expressed in astrocytes, could regulate the promoter activity. Of these, miR-130a was identified as a strong transcriptional repressor of the AQP4 M1 isoform. In vivo studies revealed that LNA(TM) anti-miR-130a could up-regulate the AQP4 M1 transcript and its protein to bring about a reduction in cerebral infarct and promote recovery.	[Sepramaniam, Sugunavathi; Ying, Lim Kai; Armugam, Arunmozhiarasi; Jeyaseelan, Kandiah] Natl Univ Singapore, Natl Univ Hlth Syst, Dept Biochem, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Sepramaniam, Sugunavathi; Ying, Lim Kai; Armugam, Arunmozhiarasi; Jeyaseelan, Kandiah] Natl Univ Singapore, Natl Univ Hlth Syst, Ctr Translat Med, Yong Loo Lin Sch Med,Neurosci Res Ctr, Singapore 117597, Singapore; [Wintour, E. M.; Jeyaseelan, Kandiah] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia	National University of Singapore; National University of Singapore; Monash University	Jeyaseelan, K (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Dept Biochem, Yong Loo Lin Sch Med, 8 Med Dr, Singapore 117597, Singapore.	bchjeya@nus.edu.sg		Armugam, Arunmozhiarasi/0000-0002-6064-1980	Singapore National Research Foundation [R-184-002-165-281]; National Medical Research Council [R-183-000-290-213]	Singapore National Research Foundation(National Research Foundation, Singapore); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Research Grants R-184-002-165-281 and R-183-000-290-213 from the Singapore National Research Foundation and National Medical Research Council, respectively.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arima H, 2003, J BIOL CHEM, V278, P44525, DOI 10.1074/jbc.M304368200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; COGSWELL JP, 1994, J IMMUNOL, V153, P712; Fenton RA, 2010, CELL MOL LIFE SCI, V67, P829, DOI 10.1007/s00018-009-0218-9; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Greco SJ, 2007, P NATL ACAD SCI USA, V104, P15484, DOI 10.1073/pnas.0703037104; Hirt L, 2009, J CEREBR BLOOD F MET, V29, P423, DOI 10.1038/jcbfm.2008.133; Huang HY, 2006, NUCLEIC ACIDS RES, V34, pW429, DOI 10.1093/nar/gkl333; Ito H, 2006, J NEUROCHEM, V99, P107, DOI 10.1111/j.1471-4159.2006.04036.x; Janowski BA, 2005, NAT CHEM BIOL, V1, P216, DOI 10.1038/nchembio725; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Lee Y, 2008, NAT NEUROSCI, V11, P1137, DOI 10.1038/nn.2183; Lim KY, 2010, TRANSL STROKE RES, V1, P287, DOI 10.1007/s12975-010-0035-3; Majid S, 2010, CANCER-AM CANCER SOC, V116, P5637, DOI 10.1002/cncr.25488; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; MOYNAGH PN, 1993, BIOCHEM J, V294, P343, DOI 10.1042/bj2940343; Nielsen S, 1997, J NEUROSCI, V17, P171; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Papadopoulos MC, 2005, J BIOL CHEM, V280, P13906, DOI 10.1074/jbc.M413627200; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Satoh J, 2007, NEUROPATHOLOGY, V27, P245, DOI 10.1111/j.1440-1789.2007.00774.x; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; Sepramaniam S, 2010, J BIOL CHEM, V285, P29223, DOI 10.1074/jbc.M110.144576; Silberstein C, 2004, AM J PHYSIOL-RENAL, V287, pF501, DOI 10.1152/ajprenal.00439.2003; Sorbo JG, 2008, BIOCHEMISTRY-US, V47, P2631, DOI 10.1021/bi702146k; Tourdias T, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-143; Umenishi F, 1998, GENOMICS, V50, P373, DOI 10.1006/geno.1998.5337; YAMASAKI Y, 1995, STROKE, V26, P676, DOI 10.1161/01.STR.26.4.676; Younger ST, 2011, NUCLEIC ACIDS RES, V39, P5682, DOI 10.1093/nar/gkr155; Zhou R, 2010, NUCLEIC ACIDS RES, V38, P3222, DOI 10.1093/nar/gkq056	36	57	66	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12006	12015		10.1074/jbc.M111.280701	http://dx.doi.org/10.1074/jbc.M111.280701			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334710	Green Published, hybrid			2022-12-27	WOS:000302782200038
J	Ader, N; Brindley, MA; Avila, M; Origgi, FC; Langedijk, JPM; Orvell, C; Vandevelde, M; Zurbriggen, A; Plemper, RK; Plattet, P				Ader, Nadine; Brindley, Melinda A.; Avila, Mislay; Origgi, Francesco C.; Langedijk, Johannes P. M.; Orvell, Claes; Vandevelde, Marc; Zurbriggen, Andreas; Plemper, Richard K.; Plattet, Philippe			Structural Rearrangements of the Central Region of the Morbillivirus Attachment Protein Stalk Domain Trigger F Protein Refolding for Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANINE-DISTEMPER VIRUS; NEWCASTLE-DISEASE VIRUS; HEMAGGLUTININ-NEURAMINIDASE PROTEIN; MEASLES-VIRUS; CELL-FUSION; NIPAH VIRUS; FUNCTIONAL INTERACTION; 4-HELIX BUNDLE; HENDRA VIRUS; SWISS-MODEL	It is unknown how receptor binding by the paramyxovirus attachment proteins (HN, H, or G) triggers the fusion (F) protein to fuse with the plasma membrane for cell entry. H-proteins of the morbillivirus genus consist of a stalk ectodomain supporting a cuboidal head; physiological oligomers consist of non-covalent dimer-of-dimers. We report here the successful engineering of intermolecular disulfide bonds within the central region (residues 91-115) of the morbillivirus H-stalk; a sub-domain that also encompasses the putative F-contacting section (residues 111-118). Remarkably, several intersubunit crosslinks abrogated membrane fusion, but bioactivity was restored under reducing conditions. This phenotype extended equally to H proteins derived from virulent and attenuated morbillivirus strains and was independent of the nature of the contacted receptor. Our data reveal that the morbillivirus H-stalk domain is composed of four tightly-packed subunits. Upon receptor binding, these subunits structurally rearrange, possibly inducing conformational changes within the central region of the stalk, which, in turn, promote fusion. Given that the fundamental architecture appears conserved among paramyxovirus attachment protein stalk domains, we predict that these motions may act as a universal paramyxovirus F-triggering mechanism.	[Ader, Nadine; Avila, Mislay; Zurbriggen, Andreas; Plattet, Philippe] Univ Bern, Vetsuisse Fac, DCR VPH, Div Expt Clin Res,Neurovirol Unit, CH-3001 Bern, Switzerland; [Brindley, Melinda A.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; Childrens Healthcare Atlanta, Atlanta, GA USA; [Vandevelde, Marc] Univ Bern, Vetsuisse Fac, DCV, Div Neurol, CH-3001 Bern, Switzerland; [Origgi, Francesco C.] Univ Bern, Vetsuisse Fac, DIP, Ctr Fish & Wildlife Hlth FIWI ITPA, CH-3012 Bern, Switzerland; [Langedijk, Johannes P. M.] Crucell Holland BV, Innovat & Discovery Lab, NL-2301 CA Leiden, Netherlands; [Orvell, Claes] Karolinska Univ Hosp Huddinge, Lab Clin Virol, SE-19186 Stockholm, Sweden	University of Bern; Emory University; Children's Healthcare of Atlanta (CHOA); University of Bern; University of Bern; Johnson & Johnson; Karolinska Institutet; Karolinska University Hospital	Plattet, P (corresponding author), Bremgartenstr 109A, CH-3001 Bern, Switzerland.	philippe.plattet@vetsuisse.unibe.ch			Swiss National Science Foundation [310030_132887]; United States Public Health Service [AI083402]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI083402, R01AI083402] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Swiss National Science Foundation (Ref. No. 310030_132887; to P. P.) and, in part, by United States Public Health Service Grant AI083402 (to R. K. P.).	Aguilar HC, 2009, J BIOL CHEM, V284, P1628, DOI 10.1074/jbc.M807469200; Bishop KA, 2008, J VIROL, V82, P11398, DOI 10.1128/JVI.02654-07; Bonaparte MI, 2005, P NATL ACAD SCI USA, V102, P10652, DOI 10.1073/pnas.0504887102; Bose S, 2011, J VIROL, V85, P12855, DOI 10.1128/JVI.06350-11; Brindley MA, 2010, J VIROL, V84, P12174, DOI 10.1128/JVI.01222-10; Chen SY, 2011, J INFECT DIS, V203, P1517, DOI 10.1093/infdis/jir115; Cherpillod P, 1999, J VIROL, V73, P2263, DOI 10.1128/JVI.73.3.2263-2269.1999; Colf LA, 2007, NAT STRUCT MOL BIOL, V14, P1227, DOI 10.1038/nsmb1342; Deng R, 1997, ARCH VIROL, P115; Deng RT, 1999, VIROLOGY, V253, P43, DOI 10.1006/viro.1998.9501; DENG RT, 1995, VIROLOGY, V209, P457, DOI 10.1006/viro.1995.1278; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Feige MJ, 2011, CURR OPIN CELL BIOL, V23, P167, DOI 10.1016/j.ceb.2010.10.012; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; Hashiguchi T, 2011, NAT STRUCT MOL BIOL, V18, P135, DOI 10.1038/nsmb.1969; Lamb R, 2007, PARAMYXOVIRIDAE VIRU, V5th; Langedijk JPM, 2011, J VIROL, V85, P11242, DOI 10.1128/JVI.05340-11; Lee JK, 2008, J BIOL CHEM, V283, P16561, DOI 10.1074/jbc.M801018200; Navaratnarajah CK, 2011, NAT STRUCT MOL BIOL, V18, P128, DOI 10.1038/nsmb.1967; Negrete OA, 2005, NATURE, V436, P401, DOI 10.1038/nature03838; Negrete Oscar A, 2006, PLoS Pathog, V2, pe7; NUSSBAUM O, 1994, J VIROL, V68, P5411, DOI 10.1128/JVI.68.9.5411-5422.1994; Origgi F. C., 2012, VET PATHOL IN PRESS; ORVELL C, 1985, J GEN VIROL, V66, P443, DOI 10.1099/0022-1317-66-3-443; Paal T, 2009, J VIROL, V83, P10480, DOI 10.1128/JVI.01195-09; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Plattet P, 2007, J VIROL, V81, P11413, DOI 10.1128/JVI.01287-07; Plemper RK, 2011, CURR OPIN VIROL, V1, P92, DOI 10.1016/j.coviro.2011.06.002; Plemper RK, 2000, J VIROL, V74, P6485, DOI 10.1128/JVI.74.14.6485-6493.2000; Santiago C, 2010, NAT STRUCT MOL BIOL, V17, P124, DOI 10.1038/nsmb.1726; Singethan K, 2010, J GEN VIROL, V91, P2762, DOI 10.1099/vir.0.025650-0; Sun AM, 2006, J MED CHEM, V49, P5080, DOI 10.1021/jm0602559; SUTTER G, 1995, FEBS LETT, V371, P9, DOI 10.1016/0014-5793(95)00843-X; Tanabayashi K, 1996, J VIROL, V70, P6112, DOI 10.1128/JVI.70.9.6112-6118.1996; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Tatsuo H, 2001, J VIROL, V75, P5842, DOI 10.1128/JVI.75.13.5842-5850.2001; Tsurudome M, 1998, J GEN VIROL, V79, P279, DOI 10.1099/0022-1317-79-2-279; TSURUDOME M, 1995, VIROLOGY, V213, P190, DOI 10.1006/viro.1995.1559; Tsurudome M, 2011, J VIROL, V85, P3153, DOI 10.1128/JVI.01666-10; Wang ZY, 2004, VIRUS RES, V99, P177, DOI 10.1016/j.virusres.2003.11.010; WILD TF, 1994, J VIROL, V68, P7546, DOI 10.1128/JVI.68.11.7546-7548.1994; Yuan P, 2005, STRUCTURE, V13, P803, DOI 10.1016/j.str.2005.02.019; Yuan P, 2011, P NATL ACAD SCI USA, V108, P14920, DOI 10.1073/pnas.1111691108; Yuchi ZG, 2008, FEBS J, V275, P6228, DOI 10.1111/j.1742-4658.2008.06747.x; Zipperle L, 2010, J VIROL, V84, P9618, DOI 10.1128/JVI.01077-10	47	58	58	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16324	16334		10.1074/jbc.M112.342493	http://dx.doi.org/10.1074/jbc.M112.342493			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22431728	Green Published, hybrid			2022-12-27	WOS:000304030900024
J	Inazuka, F; Sugiyama, N; Tomita, M; Abe, T; Shioi, G; Esumi, H				Inazuka, Fumika; Sugiyama, Naoyuki; Tomita, Masaru; Abe, Takaya; Shioi, Go; Esumi, Hiroyasu			Muscle-specific Knock-out of NUAK Family SNF1-like Kinase 1 (NUAK1) Prevents High Fat Diet-induced Glucose Intolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INDUCED INSULIN-RESISTANCE; MOUSE SKELETAL-MUSCLE; C-THETA; GLYCOGEN-SYNTHASE; TISSUE SITES; CONTRACTION; TRANSPORT; GLUT4; LKB1	NUAK1 is a member of the AMP-activated protein kinase-related kinase family. Recent studies have shown that NUAK1 is involved in cellular senescence and motility in epithelial cells and fibroblasts. However, the physiological roles of NUAK1 are poorly understood because of embryonic lethality in NUAK1 null mice. The purpose of this study was to elucidate the roles of NUAK1 in adult tissues. We determined the tissue distribution of NUAK1 and generated muscle-specific NUAK1 knock-out (MNUAK1KO) mice. For phenotypic analysis, whole body glucose homeostasis and muscle glucose metabolism were examined. Quantitative phosphoproteome analysis of soleus muscle was performed to understand the molecular mechanisms underlying the knock-out phenotype. Nuak1 mRNA was preferentially expressed in highly oxidative tissues such as brain, heart, and soleus muscle. On a high fat diet, MNUAK1KO mice had a lower fasting blood glucose level, greater glucose tolerance, higher insulin sensitivity, and higher concentration of muscle glycogen than control mice. Phosphoproteome analysis revealed that phosphorylation of IRS1 Ser-1097 was markedly decreased in NUAK1-deficient muscle. Consistent with this, insulin signaling was enhanced in the soleus muscle of MNUAK1KO mice, as evidenced by increased phosphorylation of IRS1 Tyr-608, AKT Thr-308, and TBC1D4 Thr-649. These observations suggest that a physiological role of NUAK1 is to suppress glucose uptake through negative regulation of insulin signaling in oxidative muscle.	[Inazuka, Fumika; Esumi, Hiroyasu] Natl Canc Ctr Hosp E, Res Ctr Innovat Oncol, Canc Physiol Project, Kashiwa, Chiba 2778577, Japan; [Inazuka, Fumika; Esumi, Hiroyasu] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778561, Japan; [Sugiyama, Naoyuki; Tomita, Masaru] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970017, Japan; [Abe, Takaya; Shioi, Go] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo 6500047, Japan	National Cancer Center - Japan; University of Tokyo; Keio University; RIKEN	Esumi, H (corresponding author), Natl Canc Ctr Hosp E, Res Ctr Innovat Oncol, Canc Physiol Project, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	hesumi@ncc.go.jp		Sugiyama, Naoyuki/0000-0001-7633-8495	Ministry of Health, Labour and Welfare Japan	Ministry of Health, Labour and Welfare Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a Grant for the 3rd Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare Japan.	Al-Hakim AK, 2005, J CELL SCI, V118, P5661, DOI 10.1242/jcs.02670; Alkhateeb H, 2007, AM J PHYSIOL-ENDOC M, V293, pE783, DOI 10.1152/ajpendo.00685.2006; BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; DEFRONZO RA, 1981, J CLIN INVEST, V68, P1468, DOI 10.1172/JCI110399; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Fujii N, 2005, J BIOL CHEM, V280, P39033, DOI 10.1074/jbc.M504208200; Fujii N, 2008, DIABETES, V57, P2958, DOI 10.2337/db07-1187; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Hirano M, 2006, DEV DYNAM, V235, P2229, DOI 10.1002/dvdy.20823; Hoppe PE, 2010, GENETICS, V184, P79, DOI 10.1534/genetics.109.110189; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Hou X, 2011, ONCOGENE, V30, P2933, DOI 10.1038/onc.2011.19; Humbert N, 2010, EMBO J, V29, P376, DOI 10.1038/emboj.2009.342; Itani SI, 2001, METABOLISM, V50, P553, DOI 10.1053/meta.2001.22512; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; KIM YB, 1994, BIOCHEM BIOPH RES CO, V202, P519, DOI 10.1006/bbrc.1994.1959; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Koh HJ, 2010, P NATL ACAD SCI USA, V107, P15541, DOI 10.1073/pnas.1008131107; Kramer HF, 2006, J BIOL CHEM, V281, P31478, DOI 10.1074/jbc.M605461200; Kusakai G, 2004, J EXP CLIN CANC RES, V23, P263; LANG CH, 1992, P SOC EXP BIOL MED, V199, P81; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu HY, 2009, AM J PHYSIOL-ENDOC M, V297, pE898, DOI 10.1152/ajpendo.00374.2009; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McGee SL, 2006, FASEB J, V20, P348, DOI 10.1096/fj.05-4671fje; Montell E, 2001, AM J PHYSIOL-ENDOC M, V280, pE229, DOI 10.1152/ajpendo.2001.280.2.E229; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Nagase T, 1998, DNA Res, V5, P31, DOI 10.1093/dnares/5.1.31; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Niesler CU, 2007, EXP PHYSIOL, V92, P207, DOI 10.1113/expphysiol.2006.034736; Qu X, 1999, J ENDOCRINOL, V162, P207, DOI 10.1677/joe.0.1620207; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; RICHARDSON JM, 1991, J BIOL CHEM, V266, P12690; ROACH PJ, 1990, FASEB J, V4, P2961, DOI 10.1096/fasebj.4.12.2168324; Saito H, 2006, J PROTEOME RES, V5, P1803, DOI 10.1021/pr0601178; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Scott JW, 2007, EMBO J, V26, P806, DOI 10.1038/sj.emboj.7601542; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; SHILLABEER G, 1995, BIOCHEM BIOPH RES CO, V207, P768, DOI 10.1006/bbrc.1995.1253; Sugiyama N, 2007, MOL CELL PROTEOMICS, V6, P1103, DOI 10.1074/mcp.T600060-MCP200; Suzuki A, 2003, J BIOL CHEM, V278, P48, DOI 10.1074/jbc.M206025200; Thong FSL, 2007, DIABETES, V56, P414, DOI 10.2337/db06-0900; TREADWAY JL, 1994, J BIOL CHEM, V269, P29956; Tsao TS, 1999, DIABETES, V48, P775, DOI 10.2337/diabetes.48.4.775; Yamamoto H, 2008, BIOCHEM BIOPH RES CO, V365, P541, DOI 10.1016/j.bbrc.2007.11.013; Zagorska A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000616	59	24	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16379	16389		10.1074/jbc.M111.302687	http://dx.doi.org/10.1074/jbc.M111.302687			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22418434	hybrid, Green Published			2022-12-27	WOS:000304030900029
J	Lu, ZK; Shen, M; Cao, Y; Zhang, HM; Yao, LL; Li, XD				Lu, Zekuan; Shen, Mei; Cao, Yang; Zhang, Hai-Man; Yao, Lin-Lin; Li, Xiang-dong			Calmodulin Bound to the First IQ Motif Is Responsible for Calcium-dependent Regulation of Myosin 5a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE MYOSIN; GLOBULAR TAIL DOMAIN; LIGHT-CHAIN; MOTOR-ACTIVITY; UNCONVENTIONAL MYOSIN; CONFORMATIONAL-CHANGE; HEAVY-MEROMYOSIN; ATPASE ACTIVITY; BINDING DOMAIN; VA	Myosin 5a is as yet the best-characterized unconventional myosin motor involved in transport of organelles along actin filaments. It is well-established that myosin 5a is regulated by its tail in a Ca2+-dependent manner. The fact that the actin-activated ATPase activity of myosin 5a is stimulated by micromolar concentrations of Ca2+ and that calmodulin (CaM) binds to IQ motifs of the myosin 5a heavy chain indicates that Ca2+ regulates myosin 5a function via bound CaM. However, it is not known which IQ motif and bound CaM are responsible for the Ca2+-dependent regulation and how the head-tail interaction is affected by Ca2+. Here, we found that the CaM in the first IQ motif (IQ1) is responsible for Ca2+ regulation of myosin 5a. In addition, we demonstrate that the C-lobe fragment of CaM in IQ1 is necessary for mediating Ca2+ regulation of myosin 5a, suggesting that the C-lobe fragment of CaM in IQ1 participates in the interaction between the head and the tail. We propose that Ca2+ induces a conformational change of the C-lobe of CaM in IQ1 and prevents interaction between the head and the tail, thus activating motor function.	[Lu, Zekuan; Shen, Mei; Cao, Yang; Zhang, Hai-Man; Yao, Lin-Lin; Li, Xiang-dong] Chinese Acad Sci, Inst Zool, Grp Cell Motil & Muscle Contract, Natl Lab Integrated Management Insect Pests & Rod, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Li, XD (corresponding author), Chinese Acad Sci, Inst Zool, Grp Cell Motil & Muscle Contract, Natl Lab Integrated Management Insect Pests & Rod, Beijing 100101, Peoples R China.	lixd@ioz.ac.cn			National Natural Science Foundation of China [31171367, 31071973]; Chinese Academy of Sciences; National Basic Research Program of China [2012CB114102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (No. 31171367 and 31071973), Hundred Talent Program from Chinese Academy of Sciences, and National Basic Research Program of China (No. 2012CB114102).	BECKINGHAM K, 1991, J BIOL CHEM, V266, P6027; Burgess SA, 2007, J MOL BIOL, V372, P1165, DOI 10.1016/j.jmb.2007.07.014; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; De la Cruz EM, 2000, BIOCHEMISTRY-US, V39, P14196, DOI 10.1021/bi001701b; Fukuda M, 2004, J CELL SCI, V117, P583, DOI 10.1242/jcs.00891; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; IKEBE M, 1994, J BIOL CHEM, V269, P28165; Ikebe M, 2008, BIOCHEM BIOPH RES CO, V369, P157, DOI 10.1016/j.bbrc.2008.01.057; IKURA M, 1990, BIOCHEM PHARMACOL, V40, P153; Koide H, 2006, BIOCHEMISTRY-US, V45, P11598, DOI 10.1021/bi0613877; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Li XD, 2005, J BIOL CHEM, V280, P17815, DOI 10.1074/jbc.M413295200; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Li XD, 2006, J BIOL CHEM, V281, P21789, DOI 10.1074/jbc.M602957200; Lowey S, 2010, J BIOL CHEM, V285, P16403, DOI 10.1074/jbc.R109.025551; Martin SR, 2004, FEBS LETT, V567, P166, DOI 10.1016/j.febslet.2004.04.053; Nascimento AAC, 1996, J BIOL CHEM, V271, P17561, DOI 10.1074/jbc.271.29.17561; Sakai T, 2011, P NATL ACAD SCI USA, V108, P7028, DOI 10.1073/pnas.1009188108; SEPERACK PK, 1995, EMBO J, V14, P2326, DOI 10.1002/j.1460-2075.1995.tb07227.x; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Terrak M, 2005, P NATL ACAD SCI USA, V102, P12718, DOI 10.1073/pnas.0503899102; Terrak M, 2003, EMBO J, V22, P362, DOI 10.1093/emboj/cdg058; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Trybus KM, 2007, J BIOL CHEM, V282, P23316, DOI 10.1074/jbc.M701636200; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Umeki N, 2011, NAT STRUCT MOL BIOL, V18, P783, DOI 10.1038/nsmb.2065; Umeki N, 2009, P NATL ACAD SCI USA, V106, P8483, DOI 10.1073/pnas.0812930106; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; Wu XF, 2002, MOL BIOL CELL, V13, P1735, DOI 10.1091/mbc.01-12-0595; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106; Zhu T, 1998, J BIOL CHEM, V273, P20481, DOI 10.1074/jbc.273.32.20481	37	22	22	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16530	16540		10.1074/jbc.M112.343079	http://dx.doi.org/10.1074/jbc.M112.343079			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22437832	hybrid, Green Published			2022-12-27	WOS:000304030900043
J	Noda, NN; Kobayashi, T; Adachi, W; Fujioka, Y; Ohsumi, Y; Inagaki, F				Noda, Nobuo N.; Kobayashi, Takafumi; Adachi, Wakana; Fujioka, Yuko; Ohsumi, Yoshinori; Inagaki, Fuyuhiko			Structure of the Novel C-terminal Domain of Vacuolar Protein Sorting 30/Autophagy-related Protein 6 and Its Specific Role in Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE COMPLEXES; VPS34 PTDINS 3-KINASE; SACCHAROMYCES-CEREVISIAE; BECLIN 1; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; BINDING-PROTEIN; MOLECULAR-BASIS; ATG PROTEINS; YEAST	Vacuolar protein sorting 30 (Vps30)/autophagy-related protein 6 (Atg6) is a common component of two distinct phosphatidylinositol 3-kinase complexes. In complex I, Atg14 links Vps30 to Vps34 lipid kinase and exerts its specific role in autophagy, whereas in complex II, Vps38 links Vps30 to Vps34 and plays a crucial role in vacuolar protein sorting. However, the molecular role of Vps30 in each pathway remains unclear. Here, we report the crystal structure of the carboxyl-terminal domain of Vps30. The structure is a novel globular fold comprised of three beta-sheet-alpha-helix repeats. Truncation analyses showed that the domain is dispensable for the construction of both complexes, but is specifically required for autophagy through the targeting of complex I to the pre-autophagosomal structure. Thus, the domain is named the beta-alpha repeated, autophagy-specific (BARA) domain. On the other hand, the N-terminal region of Vps30 was shown to be specifically required for vacuolar protein sorting. These structural and functional investigations of Vps30 domains, which are also conserved in the mammalian ortholog, Beclin 1, will form the basis for studying the molecular functions of this protein family in various biological processes.	[Noda, Nobuo N.; Fujioka, Yuko] Inst Microbial Chem, Tokyo 1410021, Japan; [Kobayashi, Takafumi; Ohsumi, Yoshinori] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268503, Japan; [Adachi, Wakana; Inagaki, Fuyuhiko] Hokkaido Univ, Fac Adv Life Sci, Dept Biol Struct, Sapporo, Hokkaido 0010021, Japan	Tokyo Institute of Technology; Hokkaido University	Noda, NN (corresponding author), Kamiosaki 3-14-23,Shinagawa Ku, Tokyo 1410021, Japan.	nn@bikaken.or.jp; finagaki@pharm.hokudai.ac.jp	Ohsumi, Yoshinori/C-6449-2009; Noda, Nobuo/P-1397-2015	Ohsumi, Yoshinori/0000-0003-2384-2166; Fujioka, Yuko/0000-0002-6905-0669; Noda, Nobuo/0000-0002-6940-8069	Ministry of Education, Culture, Sports, Science and Technology of Japan; Sumitomo Foundation; Leave a Nest grant BioGarage award	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sumitomo Foundation; Leave a Nest grant BioGarage award	This work was supported in part by Grants-in-aid for Scientific Research on Priority Areas (to N. N. N.) and Targeted Proteins Research Program (to F. I. and Y. O.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by Grant for Basic Science Research Projects from The Sumitomo Foundation (to N. N. N.), and by a Leave a Nest grant BioGarage award (to T. K.).	Amberg DC., 2005, METHODS YEAST GENETI; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng W, 2007, J MOL BIOL, V372, P223, DOI 10.1016/j.jmb.2007.06.069; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Gabriely G, 2007, MOL CELL BIOL, V27, P526, DOI 10.1128/MCB.00577-06; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Huang WJ, 2012, CELL RES, V22, P473, DOI 10.1038/cr.2012.24; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kametaka S, 1998, J BIOL CHEM, V273, P22284, DOI 10.1074/jbc.273.35.22284; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Ku B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040025; Li XH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1648; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Noda T, 2008, METHOD ENZYMOL, V451, P33, DOI 10.1016/S0076-6879(08)03203-5; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Obara K, 2008, J BIOL CHEM, V283, P23972, DOI 10.1074/jbc.M803180200; Obara K, 2008, GENES CELLS, V13, P537, DOI 10.1111/j.1365-2443.2008.01188.x; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Seaman MNJ, 1997, J CELL BIOL, V137, P79, DOI 10.1083/jcb.137.1.79; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Sinha S, 2008, AUTOPHAGY, V4, P989, DOI 10.4161/auto.6803; STACK JH, 1995, J CELL BIOL, V129, P321, DOI 10.1083/jcb.129.2.321; STACK JH, 1993, EMBO J, V12, P2195, DOI 10.1002/j.1460-2075.1993.tb05867.x; Stromhaug PE, 2004, MOL BIOL CELL, V15, P3553, DOI 10.1091/mbc.E04-02-0147; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki K, 2010, FEBS LETT, V584, P1280, DOI 10.1016/j.febslet.2010.02.001; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	49	52	55	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16256	16266		10.1074/jbc.M112.348250	http://dx.doi.org/10.1074/jbc.M112.348250			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22437838	Green Published, hybrid			2022-12-27	WOS:000304030900018
J	Ahmed, SF; Deb, S; Paul, I; Chatterjee, A; Mandal, T; Chatterjee, U; Ghosh, MK				Ahmed, Syed Feroj; Deb, Satamita; Paul, Indranil; Chatterjee, Anirban; Mandal, Tapashi; Chatterjee, Uttara; Ghosh, Mrinal K.			The Chaperone-assisted E3 Ligase C Terminus of Hsc70-interacting Protein (CHIP) Targets PTEN for Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; UBIQUITIN LIGASE; GERMLINE MUTATIONS; CARBOXYL-TERMINUS; TUMOR SUPPRESSION; PROSTATE-CANCER; P53; CELLS; PROMOTES; REGULATOR	The tumor suppressor, PTEN is key to the regulation of diverse cellular processes, making it a prime candidate to be tightly regulated. The PTEN level is controlled in a major way by E3 ligase-mediated degradation through the Ubiquitin-Proteasome System (UPS). Nedd 4-1, XIAP, and WWP2 have been shown to maintain PTEN turnover. Here, we report that CHIP, the chaperone-associated E3 ligase, induces ubiquitination and regulates the proteasomal turnover of PTEN. It was apparent from our findings that PTEN transiently associates with the molecular chaperones and thereby gets diverted to the degradation pathway through its interaction with CHIP. The TPR domain of CHIP and parts of the N-terminal domain of PTEN are required for their interaction. Overexpression of CHIP leads to elevated ubiquitination and a shortened half-life of endogenous PTEN. On the other hand, depletion of endogenous CHIP stabilizes PTEN. CHIP is also shown to regulate PTEN-dependent transcription presumably through its down-regulation. PTEN shared an inverse correlation with CHIP in human prostate cancer patient samples, thereby triggering the prospects of a more complex mode of PTEN regulation in cancer.	[Ahmed, Syed Feroj; Deb, Satamita; Paul, Indranil; Chatterjee, Anirban; Mandal, Tapashi; Ghosh, Mrinal K.] CSIR IICB, Signal Tranduct Canc & Stem Cells Lab, Kolkata 700032, W Bengal, India; [Chatterjee, Uttara] IPGMER, Dept Pathol, Kolkata 700020, India; [Chatterjee, Uttara] SSKM Hosp, Kolkata 700020, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Ghosh, MK (corresponding author), CSIR IICB, Signal Tranduct Canc & Stem Cells Lab, 4 Raja S C Mullick Rd, Kolkata 700032, W Bengal, India.	mrinal.res@gmail.com	Paul, Indranil/AAX-7638-2021; Ahmed, Syed Feroj/D-7860-2014	Paul, Indranil/0000-0003-0327-5002; Ahmed, Syed Feroj/0000-0003-1033-2538; Chatterjee, Anirban/0000-0002-9082-2221; Deb, Satamita/0000-0003-0315-7030	Council of Scientific and Industrial Research, CSIR [OLP-002]; DST [SR/SO/HS126/2007]	Council of Scientific and Industrial Research, CSIR(Council of Scientific & Industrial Research (CSIR) - India); DST(Department of Science & Technology (India))	This work was supported by grants provided by the Council of Scientific and Industrial Research, CSIR (OLP-002) and DST (SR/SO/HS126/2007) (to M. K. G.).	Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Blumenthal GM, 2008, EUR J HUM GENET, V16, P1289, DOI 10.1038/ejhg.2008.162; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; Ghosh MK, 2003, MOL CELL, V12, P255, DOI 10.1016/S1097-2765(03)00225-9; Ghosh MK, 2005, ONCOGENE, V24, P7290, DOI 10.1038/sj.onc.1208894; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Guha M, 2009, CANCER RES, V69, P4954, DOI 10.1158/0008-5472.CAN-09-0584; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lee JH, 2010, J BIOL CHEM, V285, P42033, DOI 10.1074/jbc.M110.149831; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; McDonough H, 2009, J BIOL CHEM, V284, P20649, DOI 10.1074/jbc.M109.011767; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Narayan V, 2011, J BIOL CHEM, V286, P607, DOI 10.1074/jbc.M110.153122; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Oh KH, 2011, CELL DEATH DIFFER, V18, P1326, DOI 10.1038/cdd.2011.3; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200; Sha JF, 2010, J VIROL, V84, P4050, DOI 10.1128/JVI.02131-09; Shang Y, 2009, BIOCHEM BIOPH RES CO, V386, P242, DOI 10.1016/j.bbrc.2009.06.043; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Sutphen R, 1999, AM J MED GENET, V82, P290, DOI 10.1002/(SICI)1096-8628(19990212)82:4<290::AID-AJMG3>3.0.CO;2-0; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Teng DHF, 1997, CANCER RES, V57, P5221; Tian T, 2010, CARCINOGENESIS, V31, P1211, DOI 10.1093/carcin/bgq085; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; van Duijn PW, 2010, PROSTATE, V70, P135, DOI 10.1002/pros.21045; Van Themsche C, 2009, J BIOL CHEM, V284, P20462, DOI 10.1074/jbc.C109.009522; Wang X, 2008, ONCOGENE, V27, P5454, DOI 10.1038/onc.2008.242; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Xu T, 2011, CANCER SCI, V102, P959, DOI 10.1111/j.1349-7006.2011.01888.x; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703	57	110	113	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15996	16006		10.1074/jbc.M111.321083	http://dx.doi.org/10.1074/jbc.M111.321083			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427670	Green Published, hybrid			2022-12-27	WOS:000304006300077
J	Batra, J; Robinson, J; Soares, AS; Fields, AP; Radisky, DC; Radisky, ES				Batra, Jyotica; Robinson, Jessica; Soares, Alexei S.; Fields, Alan P.; Radisky, Derek C.; Radisky, Evette S.			Matrix Metalloproteinase-10 (MMP-10) Interaction with Tissue Inhibitors of Metalloproteinases TIMP-1 and TIMP-2 BINDING STUDIES AND CRYSTAL STRUCTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING ENZYME; BIFURCATED HYDROGEN-BONDS; CATALYTIC DOMAIN; PROTEASE-INHIBITOR; 1-MATRIX METALLOPROTEINASE; CHYMOTRYPSIN INHIBITOR-2; VERTEBRATE COLLAGENASE; ESCHERICHIA-COLI; TERMINAL DOMAIN; CANCER-THERAPY	Matrix metalloproteinase 10 (MMP-10, stromelysin-2) is a secreted metalloproteinase with functions in skeletal development, wound healing, and vascular remodeling; its overexpression is also implicated in lung tumorigenesis and tumor progression. To understand the regulation of MMP-10 by tissue inhibitors of metalloproteinases (TIMPs), we have assessed equilibrium inhibition constants (K-i) of putative physiological inhibitors TIMP-1 and TIMP-2 for the active catalytic domain of human MMP-10 (MMP-10cd) using multiple kinetic approaches. We find that TIMP-1 inhibits the MMP-10cd with a K-i of 1.1 x 10(-9) M; this interaction is 10-fold weaker than the inhibition of the similar MMP-3 (stromelysin-1) catalytic domain (MMP-3cd) by TIMP-1. TIMP-2 inhibits the MMP-10cd with a K-i of 5.8 x 10(-9) M, which is again 10-fold weaker than the inhibition of MMP-3cd by this inhibitor (K-i = 5.5 x 10(-10) M). We solved the x-ray crystal structure of TIMP-1 bound to the MMP-10cd at 1.9 angstrom resolution; the structure was solved by molecular replacement and refined with an R-factor of 0.215 (R-free = 0.266). Comparing our structure of MMP-10cd.TIMP-1 with the previously solved structure of MMP-3cd.TIMP-1 (Protein Data Bank entry 1UEA), we see substantial differences at the binding interface that provide insight into the differential binding of stromelysin family members to TIMP-1. This structural information may ultimately assist in the design of more selective TIMP-based inhibitors tailored for specificity toward individual members of the stromelysin family, with potential therapeutic applications.	[Batra, Jyotica; Robinson, Jessica; Fields, Alan P.; Radisky, Derek C.; Radisky, Evette S.] Mayo Clin, Dept Canc Biol, Ctr Comprehens Canc, Jacksonville, FL 32224 USA; [Soares, Alexei S.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Mayo Clinic; United States Department of Energy (DOE); Brookhaven National Laboratory	Radisky, ES (corresponding author), Mayo Clin, Dept Canc Biol, Ctr Comprehens Canc, 310 Griffin Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	radisky.evette@mayo.edu	Soares, Alexei S/F-4800-2014; Radisky, Derek/B-6569-2018; Radisky, Evette S/C-8526-2012	Soares, Alexei S/0000-0002-6565-8503; Radisky, Derek/0000-0002-1962-8784; Radisky, Evette S/0000-0003-3121-109X	National Institutes of Health, NCI [R01 CA122086, R01 CA081436-14]; Florida Department of Health [08KN12, 09BB17, 1BD01]; Mayo Clinic Breast Cancer Specialized Program of Research Excellence [P50 CA116201]; Offices of Biological and Environmental Research; Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources of the National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA081436, P50CA116201, R01CA122086] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Florida Department of Health; Mayo Clinic Breast Cancer Specialized Program of Research Excellence; Offices of Biological and Environmental Research; Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grants R01 CA122086 (to D. C. R.) and R01 CA081436-14 (to A. P. F.). This work was also supported by Florida Department of Health Grants 08KN12 and 09BB17 (to E. S. R.) and 1BD01 (to J. B.) and by Mayo Clinic Breast Cancer Specialized Program of Research Excellence Grant P50 CA116201 (principal investigator James Ingle). Diffraction data were measured at beamline X12-C of the National Synchrotron Light Source, which is supported by the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy and the National Center for Research Resources of the National Institutes of Health.	Arumugam S, 2003, J MOL BIOL, V327, P719, DOI 10.1016/S0022-2836(03)00180-3; Bahudhanapati H, 2011, J BIOL CHEM, V286, P31761, DOI 10.1074/jbc.M111.253328; Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Bertini I, 2004, J MOL BIOL, V336, P707, DOI 10.1016/j.jmb.2003.12.033; Bord S, 1998, BONE, V23, P7, DOI 10.1016/S8756-3282(98)00064-7; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Burrage PS, 2007, CURR DRUG TARGETS, V8, P293, DOI 10.2174/138945007779940098; Butler GS, 1999, J BIOL CHEM, V274, P20391, DOI 10.1074/jbc.274.29.20391; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Cho NH, 2004, ONCOGENE, V23, P845, DOI 10.1038/sj.onc.1207140; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Crombez L, 2005, BIOCHEM BIOPH RES CO, V337, P908, DOI 10.1016/j.bbrc.2005.09.136; Deraz EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025438; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Fingleton B, 2008, SEMIN CELL DEV BIOL, V19, P61, DOI 10.1016/j.semcdb.2007.06.006; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; Gill JH, 2004, NEOPLASIA, V6, P777, DOI 10.1593/neo.04283; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Grossman M, 2010, BIOCHEMISTRY-US, V49, P6184, DOI 10.1021/bi902141x; Hamze AB, 2007, PROTEIN SCI, V16, P1905, DOI 10.1110/ps.072978507; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Huang W, 1996, FEBS LETT, V384, P155, DOI 10.1016/0014-5793(96)00304-3; Iyer S, 2007, J BIOL CHEM, V282, P364, DOI 10.1074/jbc.M607625200; Justilien V., 2012, PLOS ONE IN PRESS; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI M, 1971, ENZYMES, V3, P375; Lee JE, 2009, NAT PROTOC, V4, P592, DOI 10.1038/nprot.2009.29; Lee MH, 2010, CANCER LETT, V290, P114, DOI 10.1016/j.canlet.2009.08.029; Lee MH, 2005, J BIOL CHEM, V280, P15967, DOI 10.1074/jbc.M500897200; Lee MH, 2004, J BIOL CHEM, V279, P45121, DOI 10.1074/jbc.M406611200; Lee MH, 2004, J BIOL CHEM, V279, P17562, DOI 10.1074/jbc.M312589200; Lee MH, 2003, J BIOL CHEM, V278, P40224, DOI 10.1074/jbc.M305678200; Lee MH, 2002, PROTEIN SCI, V11, P2493, DOI 10.1110/ps.0216202; Lee MH, 2002, BIOCHEM J, V364, P227, DOI 10.1042/bj3640227; LONGSTAFF C, 1990, BIOCHEMISTRY-US, V29, P7339, DOI 10.1021/bi00483a025; MARCY AI, 1991, BIOCHEMISTRY-US, V30, P6476, DOI 10.1021/bi00240a018; Maskos K, 2007, J MOL BIOL, V366, P1222, DOI 10.1016/j.jmb.2006.11.072; Maskos K, 2003, MOL BIOTECHNOL, V25, P241, DOI 10.1385/MB:25:3:241; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Meng Q, 1999, J BIOL CHEM, V274, P10184, DOI 10.1074/jbc.274.15.10184; MURPHY G, 1995, METHOD ENZYMOL, V248, P496; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAGASE H, 1995, METHOD ENZYMOL, V248, P449; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; NAGASE H, 1990, BIOCHEMISTRY-US, V29, P5783, DOI 10.1021/bi00476a020; Nagase H, 2002, ARTHRITIS RES THER, V4, pS51, DOI 10.1186/ar573; Nakamura H, 1998, EUR J BIOCHEM, V253, P67, DOI 10.1046/j.1432-1327.1998.2530067.x; NICHOLSON R, 1989, BIOCHEMISTRY-US, V28, P5195, DOI 10.1021/bi00438a042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overall CM, 2006, BRIT J CANCER, V94, P941, DOI 10.1038/sj.bjc.6603043; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Radisky ES, 2005, BIOCHEMISTRY-US, V44, P6823, DOI 10.1021/bi047301w; Radisky ES, 2004, BIOCHEMISTRY-US, V43, P13648, DOI 10.1021/bi048797k; Radisky ES, 2003, BIOCHEMISTRY-US, V42, P6484, DOI 10.1021/bi034275d; Radisky ES, 2010, J MAMMARY GLAND BIOL, V15, P201, DOI 10.1007/s10911-010-9177-x; Regala RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026439; Rodriguez JA, 2008, FRONT BIOSCI-LANDMRK, V13, P2916, DOI 10.2741/2896; Rozas I, 1998, J PHYS CHEM A, V102, P9925, DOI 10.1021/jp9824813; SAARIALHOKERE UK, 1994, J CLIN INVEST, V94, P79, DOI 10.1172/JCI117351; Salameh MA, 2008, J BIOL CHEM, V283, P4115, DOI 10.1074/jbc.M708268200; Salameh MA, 2010, J BIOL CHEM, V285, P1939, DOI 10.1074/jbc.M109.057216; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; SUZUKI K, 1990, BIOCHEMISTRY-US, V29, P10261, DOI 10.1021/bi00496a016; Suzuki K, 1998, BIOL CHEM, V379, P185, DOI 10.1515/bchm.1998.379.2.185; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; Torshin IY, 2002, PROTEIN ENG, V15, P359, DOI 10.1093/protein/15.5.359; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Van Themsche C, 2004, J IMMUNOL, V173, P3605, DOI 10.4049/jimmunol.173.6.3605; Wei S, 2003, J BIOL CHEM, V278, P9831, DOI 10.1074/jbc.M211793200; WEINGARTEN H, 1985, BIOCHEMISTRY-US, V24, P6730, DOI 10.1021/bi00344a064; WEINGARTEN H, 1985, ANAL BIOCHEM, V147, P437, DOI 10.1016/0003-2697(85)90294-5; Williamson RA, 2001, J BIOL CHEM, V276, P32966, DOI 10.1074/jbc.M101843200; WINDSOR LJ, 1993, J BIOL CHEM, V268, P17341; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wiseman BS, 2003, J CELL BIOL, V162, P1123, DOI 10.1083/jcb.200302090; Wu B, 2000, J MOL BIOL, V295, P257, DOI 10.1006/jmbi.1999.3362; Wu Y, 2011, J BIOL CHEM, V286, P16891, DOI 10.1074/jbc.M111.222307; Gomis-Ruth FX, 2012, BBA-PROTEINS PROTEOM, V1824, P157, DOI 10.1016/j.bbapap.2011.04.014; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Xu D, 1997, PROTEIN ENG, V10, P999, DOI 10.1093/protein/10.9.999; Xu D, 1997, J MOL BIOL, V265, P68, DOI 10.1006/jmbi.1996.0712; Zhou P, 2009, PROTEINS, V76, P151, DOI 10.1002/prot.22327	87	71	74	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15935	15946		10.1074/jbc.M112.341156	http://dx.doi.org/10.1074/jbc.M112.341156			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427646	Green Published, hybrid			2022-12-27	WOS:000304006300072
J	Jash, A; Sahoo, A; Kim, GC; Chae, CS; Hwang, JS; Kim, JE; Im, SH				Jash, Arijita; Sahoo, Anupama; Kim, Gi-Cheon; Chae, Chang-Suk; Hwang, Ji-Sun; Kim, Jung-Eun; Im, Sin-Hyeog			Nuclear Factor of Activated T Cells 1 (NFAT1)-induced Permissive Chromatin Modification Facilitates Nuclear Factor-kappa B (NF-kappa B)-mediated Interleukin-9 (IL-9) Transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; DISTINCT ROLES; NFAT; DIFFERENTIATION; RECEPTOR; GROWTH; BINDING; BETA	IL-9 regulates diverse inflammatory immune responses. Although the functional importance of IL-9 has been investigated in various pathophysiological conditions, molecular mechanisms by which TCR stimulation induced IL-9 gene expression are still unclear. In this study, we investigated the functional importance of the NFAT1 and NF-kappa B (p65) in IL-9 gene transcription in CD4(+) T cells. In vivo binding of NFAT1 and NF-kappa B (p65) to the IL-9 promoter was observed. NFAT1 binding induced a transcriptionally active chromatin configuration at the IL-9 promoter locus, whereas NF-kappa B (p65) binding transactivated the IL-9 promoter. Mouse deficient in NFAT1 shows a significant down-regulation of IL-9 expression that resulted from an inaccessible chromatin configuration at the IL-9 promoter. In parallel, knockdown of NF-kappa B (p65) also resulted in reduced IL-9 expression. In this process, NFAT1 plays a pivotal role as a core protein that creates an accessible platform for the assembly of transcription activators. The presence of NFAT1 correlates with recruitment of NF-kappa B (p65), p300, and active histone markers on the IL-9 promoter, resulting in a transcriptionally competent promoter. NFAT1 deficiency significantly reduced the recruitment of the above activation complex to the IL-9 promoter. In summary, our data suggest that functional cooperation of NFAT1 and NF-kappa B synergistically enhances IL-9 transcription in CD4(+) T cells.	[Jash, Arijita; Sahoo, Anupama; Kim, Gi-Cheon; Chae, Chang-Suk; Hwang, Ji-Sun; Kim, Jung-Eun; Im, Sin-Hyeog] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju 500712, South Korea; [Jash, Arijita; Sahoo, Anupama; Kim, Gi-Cheon; Chae, Chang-Suk; Hwang, Ji-Sun; Kim, Jung-Eun; Im, Sin-Hyeog] Gwangju Inst Sci & Technol, Immune Synapse Res Ctr, Kwangju 500712, South Korea; [Sahoo, Anupama] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); University of Texas System; UTMD Anderson Cancer Center	Im, SH (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, 123 Cheomdan Gwagiro, Kwangju 500712, South Korea.	imsh@gist.ac.kr	Im, Sin-Hyeog/E-6811-2013; Im, Sin-Hyeog/AAM-9586-2021	Im, Sin-Hyeog/0000-0002-3173-1856; Im, Sin-Hyeog/0000-0002-3173-1856; Sahoo, Anupama/0000-0002-0928-958X	National Research Foundation [2011-0028529]; Korean government; Gwangju Institute of Science and Technology	National Research Foundation; Korean government(Korean Government); Gwangju Institute of Science and Technology	This work was supported by National Research Foundation Grant 2011-0028529, funded by the Korean government, and by a Systems Biology Infrastructure Establishment Grant provided by the Gwangju Institute of Science and Technology in 2012.	BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Cakouros D, 2001, J IMMUNOL, V167, P302, DOI 10.4049/jimmunol.167.1.302; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Carey M., 2002, TRANSCRIPTIONAL REGU, P144; Chan HM, 2001, J CELL SCI, V114, P2363; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Cron RQ, 2000, CLIN IMMUNOL, V94, P179, DOI 10.1006/clim.1999.4831; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Demoulin JB, 1999, J BIOL CHEM, V274, P25855, DOI 10.1074/jbc.274.36.25855; Eller K, 2011, J IMMUNOL, V186, P83, DOI 10.4049/jimmunol.1001183; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Farrow MA, 2011, J BIOL CHEM, V286, P2567, DOI 10.1074/jbc.M110.154377; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; Garcia-Rodriguez C, 1998, J EXP MED, V187, P2031, DOI 10.1084/jem.187.12.2031; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; GESSNER A, 1993, IMMUNOBIOLOGY, V189, P419, DOI 10.1016/S0171-2985(11)80414-6; Gibson HM, 2007, J IMMUNOL, V179, P3831, DOI 10.4049/jimmunol.179.6.3831; Goswami R, 2012, J IMMUNOL, V188, P968, DOI 10.4049/jimmunol.1102840; Grumont RJ, 2000, J EXP MED, V191, P1281, DOI 10.1084/jem.191.8.1281; Hauber HP, 2004, INT ARCH ALLERGY IMM, V134, P79, DOI 10.1159/000078384; Hermann-Kleiter N, 2010, BLOOD, V115, P2989, DOI 10.1182/blood-2009-10-233585; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Holz L. E., 2005, J INFLAMM-LOND, V2, P1; HULTNER L, 1990, EUR J IMMUNOL, V20, P1413, DOI 10.1002/eji.1830200632; Im SH, 2004, MOL CELLS, V18, P1; Im SH, 2004, J BIOL CHEM, V279, P46818, DOI 10.1074/jbc.M401722200; Ishihara S, 2011, J IMMUNOL, V187, P3292, DOI 10.4049/jimmunol.1003173; Johnson BV, 2004, MOL CELL BIOL, V24, P7914, DOI 10.1128/MCB.24.18.7914-7930.2004; Kadereit S, 1999, BLOOD, V94, P3101, DOI 10.1182/blood.V94.9.3101.421k04_3101_3107; Kaminski BA, 2003, BLOOD, V102, P4608, DOI 10.1182/blood-2003-05-1732; Koenig A, 2010, GASTROENTEROLOGY, V138, P1189, DOI 10.1053/j.gastro.2009.10.045; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Lee CG, 2009, MOL IMMUNOL, V46, P613, DOI 10.1016/j.molimm.2008.07.037; Lerner L, 2003, GENE DEV, V17, P2564, DOI 10.1101/gad.1135003; Li HM, 2010, J IMMUNOL, V185, P4095, DOI 10.4049/jimmunol.1000986; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; MCCAFFREY PG, 1992, J BIOL CHEM, V267, P1864; Mehta DS, 2005, P NATL ACAD SCI USA, V102, P2016, DOI 10.1073/pnas.0409512102; Monteyne P, 1997, J IMMUNOL, V159, P2616; Na SY, 1998, J BIOL CHEM, V273, P10831, DOI 10.1074/jbc.273.18.10831; Noelle RJ, 2010, NAT REV IMMUNOL, V10, P683, DOI 10.1038/nri2848; Nowak EC, 2009, CELL CYCLE, V8, P3798, DOI 10.4161/cc.8.23.10069; Nowak EC, 2009, J EXP MED, V206, P1653, DOI 10.1084/jem.20090246; Perumal NB, 2011, TRENDS IMMUNOL, V32, P146, DOI 10.1016/j.it.2011.01.006; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rao S, 2003, J IMMUNOL, V170, P3724, DOI 10.4049/jimmunol.170.7.3724; Refaat A, 2011, J BIOL CHEM, V286, P21092, DOI 10.1074/jbc.M110.200907; RENAULD JC, 1992, P NATL ACAD SCI USA, V89, P5690, DOI 10.1073/pnas.89.12.5690; RENAULD JC, 1995, J LEUKOCYTE BIOL, V57, P353, DOI 10.1002/jlb.57.3.353; Rengarajan J, 2002, J EXP MED, V195, P1003, DOI 10.1084/jem.20011128; Sahoo A, 2011, J IMMUNOL, V186, P4098, DOI 10.4049/jimmunol.1002620; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Stassen M, 2001, J IMMUNOL, V166, P4391, DOI 10.4049/jimmunol.166.7.4391; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Steenwinckel V, 2009, J IMMUNOL, V182, P4737, DOI 10.4049/jimmunol.0801941; Stephens GL, 2011, EUR J IMMUNOL, V41, P952, DOI 10.1002/eji.201040879; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Temann UA, 2007, INT IMMUNOL, V19, P1, DOI 10.1093/intimm/dxl117; Timmerman LA, 1997, J IMMUNOL, V159, P2735; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Townsend MJ, 2000, IMMUNITY, V13, P573, DOI 10.1016/S1074-7613(00)00056-X; Tsytsykova AV, 2007, P NATL ACAD SCI USA, V104, P16850, DOI 10.1073/pnas.0708210104; UYTTENHOVE C, 1988, P NATL ACAD SCI USA, V85, P6934, DOI 10.1073/pnas.85.18.6934; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wong MT, 2010, IMMUNOL CELL BIOL, V88, P624, DOI 10.1038/icb.2010.53; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Xu LH, 2006, CANCER RES, V66, P11859, DOI 10.1158/0008-5472.CAN-06-1445; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu YX, 1996, J BIOL CHEM, V271, P15815, DOI 10.1074/jbc.271.26.15815	77	55	59	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15445	15457		10.1074/jbc.M112.340356	http://dx.doi.org/10.1074/jbc.M112.340356			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427656	Green Published, hybrid			2022-12-27	WOS:000304006300026
J	Kalynych, S; Yao, DQ; Magee, J; Cygler, M				Kalynych, Sergei; Yao, Deqiang; Magee, James; Cygler, Miroslaw			Structural Characterization of Closely Related O-antigen Lipopolysaccharide (LPS) Chain Length Regulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; OUTER-MEMBRANE; PROTEIN; MODEL; EXPORT; WZZ; POLYSACCHARIDES; IDENTIFICATION; BIOSYNTHESIS; TYPHIMURIUM	The surface O-antigen polymers of Gram-negative bacteria exhibit a modal length distribution that depends on dedicated chain length regulator periplasmic proteins (polysaccharide co-polymerases, PCPs) anchored in the inner membrane by two transmembrane helices. In an attempt to determine whether structural changes underlie the O-antigen modal length specification, we have determined the crystal structures of several closely related PCPs, namely two chimeric PCP-1 family members solved at 1.6 and 2.8 angstrom and a wild-type PCP-1 from Shigella flexneri solved at 2.8 angstrom. The chimeric proteins form circular octamers, whereas the wild-type WzzB from S. flexneri was found to be an open trimer. We also present the structure of a Wzz(FepE) mutant, which exhibits severe attenuation in its ability to produce very long O-antigen polymers. Our findings suggest that the differences in the modal length distribution depend primarily on the surface-exposed amino acids in specific regions rather than on the differences in the oligomeric state of the PCP protomers.	[Yao, Deqiang; Cygler, Miroslaw] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Kalynych, Sergei; Magee, James; Cygler, Miroslaw] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada	University of Saskatchewan; McGill University	Cygler, M (corresponding author), Univ Saskatchewan, Dept Biochem, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	miroslaw.cygler@usask.ca			Canadian Institutes of Health Research [MOP-89787]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant MOP-89787 from the Canadian Institutes of Health Research (to M.C.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BATCHELOR RA, 1991, J BACTERIOL, V173, P5699, DOI 10.1128/jb.173.18.5699-5704.1991; Bechet E, 2010, MOL MICROBIOL, V77, P1315, DOI 10.1111/j.1365-2958.2010.07291.x; Clay CD, 2008, J IMMUNOL, V181, P5568, DOI 10.4049/jimmunol.181.8.5568; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; Daniels C, 1999, MOL MICROBIOL, V34, P181, DOI 10.1046/j.1365-2958.1999.01591.x; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Duerr CU, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000567; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franco AV, 1998, J BACTERIOL, V180, P2670, DOI 10.1128/JB.180.10.2670-2675.1998; He Y, 2007, ACTA CRYSTALLOGR D, V63, P793, DOI 10.1107/S0907444907023451; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Islam ST, 2011, J BIOL CHEM, V286, P20600, DOI 10.1074/jbc.C110.204651; Kalynych S, 2011, J BACTERIOL, V193, P3710, DOI 10.1128/JB.00059-11; Kintz EN, 2011, J BIOL CHEM, V286, P44277, DOI 10.1074/jbc.M111.273979; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larue K, 2009, J BIOL CHEM, V284, P7395, DOI 10.1074/jbc.M809068200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morona R, 2000, MICROBIOL-UK, V146, P1, DOI 10.1099/00221287-146-1-1; Morona R, 2009, TRENDS BIOCHEM SCI, V34, P78, DOI 10.1016/j.tibs.2008.11.001; Murray GL, 2006, J BACTERIOL, V188, P2735, DOI 10.1128/JB.188.7.2735-2739.2006; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Paixao TA, 2009, INFECT IMMUN, V77, P4197, DOI 10.1128/IAI.00417-09; Paulsen IT, 1997, MICROBIOL-SGM, V143, P2685, DOI 10.1099/00221287-143-8-2685; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Purins L, 2008, MICROBIOL-SGM, V154, P1104, DOI 10.1099/mic.0.2007/014225-0; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; ROSENOW C, 1995, J BACTERIOL, V177, P1137, DOI 10.1128/jb.177.5.1137-1143.1995; Saldias MS, 2009, J MED MICROBIOL, V58, P1542, DOI 10.1099/jmm.0.013235-0; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Tang KH, 2007, BIOCHEMISTRY-US, V46, P11744, DOI 10.1021/bi701181r; Tocilj A, 2008, NAT STRUCT MOL BIOL, V15, P130, DOI 10.1038/nsmb.1374; Valvano MA, 2003, FRONT BIOSCI-LANDMRK, V8, pS452, DOI 10.2741/1079; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Woodward R, 2010, NAT CHEM BIOL, V6, P418, DOI 10.1038/nchembio.351; Yao DQ, 2006, ACTA CRYSTALLOGR D, V62, P883, DOI [10.1107/S0907444906006445, 10.1107/S0907444906445]	42	21	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15696	15705		10.1074/jbc.M112.354837	http://dx.doi.org/10.1074/jbc.M112.354837			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22437828	Green Published, hybrid			2022-12-27	WOS:000304006300048
J	Brzeska, H; Guag, J; Preston, GM; Titus, MA; Korn, ED				Brzeska, Hanna; Guag, Jake; Preston, G. Michael; Titus, Margaret A.; Korn, Edward D.			Molecular Basis of Dynamic Relocalization of Dictyostelium Myosin IB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; ARP2/3 COMPLEX; SH3 DOMAIN; TEDS RULE; WILD-TYPE; ACTIN; LOCALIZATION; ACANTHAMOEBA; MUTANTS; BINDING	Class I myosins have a single heavy chain comprising an N-terminal motor domain with actin-activated ATPase activity and a C-terminal globular tail with a basic region that binds to acidic phospholipids. These myosins contribute to the formation of actin-rich protrusions such as pseudopodia, but regulation of the dynamic localization to these structures is not understood. Previously, we found that Acanthamoeba myosin IC binds to acidic phospholipids in vitro through a short sequence of basic and hydrophobic amino acids, BH site, based on the charge density of the phospholipids. The tail of Dictyostelium myosin IB (DMIB) also contains a BH site. We now report that the BH site is essential for DMIB binding to the plasma membrane and describe the molecular basis of the dynamic relocalization of DMIB in live cells. Endogenous DMIB is localized uniformly on the plasma membrane of resting cells, at active protrusions and cell-cell contacts of randomly moving cells, and at the front of motile polarized cells. The BH site is required for association of DMIB with the plasma membrane at all stages where it colocalizes with phosphoinositide bisphosphate/phosphoinositide trisphosphate (PIP2/PIP3). The charge-based specificity of the BH site allows for in vivo specificity of DMIB for PIP2/PIP3 similar to the PH domain-based specificity of other class I myosins. However, DMIB-head is required for relocalization of DMIB to the front of migrating cells. Motor activity is not essential, but the actin binding site in the head is important. Thus, dynamic relocalization of DMIB is determined principally by the local PIP2/PIP3 concentration in the plasma membrane and cytoplasmic F-actin.	[Brzeska, Hanna; Guag, Jake; Preston, G. Michael; Korn, Edward D.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Titus, Margaret A.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Minnesota System; University of Minnesota Twin Cities	Brzeska, H (corresponding author), NHLBI, Cell Biol Lab, NIH, 9000 Rockville Pike,Bldg 50,Rm 2515, Bethesda, MD 20892 USA.	brzeskah@mail.nih.gov		Korn, Edward/0000-0003-3867-6295	National Institutes of Health [GM046486]; NHLBI Intramural Research, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046486] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI Intramural Research, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM046486 (to M. A. T.). This work was also supported by the NHLBI Intramural Research Program, National Institutes of Health.	Almeida CG, 2011, NAT CELL BIOL, V13, P779, DOI 10.1038/ncb2262; Bagorda A, 2008, J CELL SCI, V121, P2621, DOI 10.1242/jcs.018077; BEMENT WM, 1995, CELL MOTIL CYTOSKEL, V31, P87, DOI 10.1002/cm.970310202; Benesh AE, 2010, MOL BIOL CELL, V21, P970, DOI 10.1091/mbc.E09-07-0638; Brawley CM, 2009, P NATL ACAD SCI USA, V106, P9685, DOI 10.1073/pnas.0810451106; Bretschneider T, 2009, BIOPHYS J, V96, P2888, DOI 10.1016/j.bpj.2008.12.3942; BRZESKA H, 1989, J BIOL CHEM, V264, P19340; Brzeska H, 2004, CELL MOTIL CYTOSKEL, V58, P186, DOI 10.1002/cm.20009; Brzeska H, 1996, J BIOL CHEM, V271, P16983, DOI 10.1074/jbc.271.29.16983; Brzeska H, 2008, J BIOL CHEM, V283, P32014, DOI 10.1074/jbc.M804828200; Brzeska H, 2010, J BIOL CHEM, V285, P5738, DOI 10.1074/jbc.M109.066910; Coluccio L.M., 2008, MYOS SUP MOL MOT, P95; Corner FI, 2005, CURR BIOL, V15, P134, DOI 10.1016/j.cub.2005.01.007; de la Roche MA, 2001, BBA-GEN SUBJECTS, V1525, P245, DOI 10.1016/S0304-4165(01)00110-6; DOBERSTEIN SK, 1992, J CELL BIOL, V117, P1241, DOI 10.1083/jcb.117.6.1241; Dormann D, 2004, J CELL SCI, V117, P6497, DOI 10.1242/jcs.01579; Dormann D, 2002, CURR BIOL, V12, P1178, DOI 10.1016/S0960-9822(02)00950-8; Falk DL, 2003, J CELL SCI, V116, P3985, DOI 10.1242/jcs.00696; Feeser EA, 2010, BIOCHEMISTRY-US, V49, P9353, DOI 10.1021/bi1012657; Friedman AL, 1998, BIOCHEMISTRY-US, V37, P9679, DOI 10.1021/bi973143f; FUKUI Y, 1989, NATURE, V341, P328, DOI 10.1038/341328a0; Fukui Y, 1997, CELL MOTIL CYTOSKEL, V36, P339; Gaudet P, 2007, NAT PROTOC, V2, P1317, DOI 10.1038/nprot.2007.179; Gerisch G, 2004, BIOPHYS J, V87, P3493, DOI 10.1529/biophysj.104.047589; Gerisch G, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-42; GIFFARD RG, 1983, J MUSCLE RES CELL M, V4, P115, DOI 10.1007/BF00711962; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Hartman MA, 2011, ANNU REV CELL DEV BI, V27, P133, DOI 10.1146/annurev-cellbio-100809-151502; Hettmann C, 2000, MOL BIOL CELL, V11, P1385, DOI 10.1091/mbc.11.4.1385; Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Hwang KJ, 2007, P NATL ACAD SCI USA, V104, P784, DOI 10.1073/pnas.0610231104; Iglesias PA, 2008, CURR OPIN CELL BIOL, V20, P35, DOI 10.1016/j.ceb.2007.11.011; Janetopoulos C, 2008, FEBS LETT, V582, P2075, DOI 10.1016/j.febslet.2008.04.035; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; JUNG G, 1990, J CELL BIOL, V110, P1955, DOI 10.1083/jcb.110.6.1955; Jung G, 1996, J CELL BIOL, V133, P305, DOI 10.1083/jcb.133.2.305; Kerber ML, 2009, CURR BIOL, V19, P967, DOI 10.1016/j.cub.2009.03.067; Kim SV, 2008, CELL MOL LIFE SCI, V65, P2128, DOI 10.1007/s00018-008-7435-5; Komaba S, 2010, J BIOL CHEM, V285, P27686, DOI 10.1074/jbc.M109.087270; Kong HH, 2002, J CELL SCI, V115, P4993, DOI 10.1242/jcs.00159; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Krendel M, 2007, FEBS LETT, V581, P644, DOI 10.1016/j.febslet.2007.01.021; Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342; Lee WL, 2000, J CELL BIOL, V151, P789, DOI 10.1083/jcb.151.4.789; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Levi S, 2000, PLASMID, V44, P231, DOI 10.1006/plas.2000.1487; Liu X, 2001, P NATL ACAD SCI USA, V98, P9122, DOI 10.1073/pnas.161285698; Maravillas-Montero JL, 2011, J IMMUNOL, V187, P3053, DOI 10.4049/jimmunol.1004018; Morita YS, 1996, EUR J CELL BIOL, V71, P371; Myers SA, 2005, MOL BIOL CELL, V16, P2191, DOI 10.1091/mbc.E04-09-0844; Neuhaus EM, 2000, J CELL BIOL, V150, P1013, DOI 10.1083/jcb.150.5.1013; Novak KD, 1997, J CELL BIOL, V136, P633, DOI 10.1083/jcb.136.3.633; NOVAK KD, 1995, J CELL BIOL, V131, P1205, DOI 10.1083/jcb.131.5.1205; Novak KD, 1998, MOL BIOL CELL, V9, P75, DOI 10.1091/mbc.9.1.75; Oikawa T, 2004, NAT CELL BIOL, V6, P420, DOI 10.1038/ncb1125; Olety B, 2010, FEBS LETT, V584, P493, DOI 10.1016/j.febslet.2009.11.096; Ostap EM, 1996, J CELL BIOL, V133, P221, DOI 10.1083/jcb.133.2.221; Pang KM, 1998, CURR BIOL, V8, P405, DOI 10.1016/S0960-9822(98)70159-9; Patino-Lopez G, 2010, J BIOL CHEM, V285, P8675, DOI 10.1074/jbc.M109.086959; PATTERSON B, 1995, GENETICS, V140, P505; POLLARD TD, 1991, ANNU REV PHYSIOL, V53, P653, DOI 10.1146/annurev.ph.53.030191.003253; ROSENFELD SS, 1994, BIOCHEMISTRY-US, V33, P2322, DOI 10.1021/bi00174a045; Ruppel KM, 1996, MOL BIOL CELL, V7, P1123, DOI 10.1091/mbc.7.7.1123; RUPPERT C, 1995, J CELL SCI, V108, P3775; Sasaki AT, 2007, J CELL BIOL, V178, P185, DOI 10.1083/jcb.200611138; Schroth-Diez B, 2009, HFSP J, V3, P412, DOI 10.2976/1.3239407; Senda S, 2001, J BIOL CHEM, V276, P2898, DOI 10.1074/jbc.M008059200; Senda S, 2000, FEBS LETT, V484, P125, DOI 10.1016/S0014-5793(00)02137-2; Shimada T, 1997, BIOCHEMISTRY-US, V36, P14037, DOI 10.1021/bi971837i; Sokac AM, 2006, DEV CELL, V11, P629, DOI 10.1016/j.devcel.2006.09.002; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Stoffler HE, 1998, J CELL SCI, V111, P2779; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Tang NY, 2001, CURR BIOL, V11, P1131, DOI 10.1016/S0960-9822(01)00320-7; Titus MA, 2006, DEV CELL, V11, P594, DOI 10.1016/j.devcel.2006.10.014; Tsiavaliaris G, 2008, J BIOL CHEM, V283, P4520, DOI 10.1074/jbc.M708113200; Tuxworth RI, 2000, TRAFFIC, V1, P11, DOI 10.1034/j.1600-0854.2000.010103.x; Tyska MJ, 2002, BIOPHYS J, V82, P1869, DOI 10.1016/S0006-3495(02)75537-9; Vicker MG, 2002, EXP CELL RES, V275, P54, DOI 10.1006/excr.2001.5466; Weijer CJ, 2009, J CELL SCI, V122, P3215, DOI 10.1242/jcs.036517; WESSELS D, 1991, CELL MOTIL CYTOSKEL, V20, P301, DOI 10.1002/cm.970200406; Yamashita RA, 2000, CELL MOTIL CYTOSKEL, V45, P163, DOI 10.1002/(SICI)1097-0169(200002)45:2<163::AID-CM7>3.0.CO;2-D; Yengo CM, 2008, BIOPHYS J, V94, pL5, DOI 10.1529/biophysj.107.122689	85	14	14	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14923	14936		10.1074/jbc.M111.318667	http://dx.doi.org/10.1074/jbc.M111.318667			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22367211	hybrid, Green Published			2022-12-27	WOS:000304003200055
J	Gonzalez, DJ; Okumura, CY; Hollands, A; Kersten, R; Akong-Moore, K; Pence, MA; Malone, CL; Derieux, J; Moore, BS; Horswill, AR; Dixon, JE; Dorrestein, PC; Nizet, V				Gonzalez, David J.; Okumura, Cheryl Y.; Hollands, Andrew; Kersten, Roland; Akong-Moore, Kathryn; Pence, Morgan A.; Malone, Cheryl L.; Derieux, Jaclyn; Moore, Bradley S.; Horswill, Alexander R.; Dixon, Jack E.; Dorrestein, Pieter C.; Nizet, Victor			Novel Phenol-soluble Modulin Derivatives in Community-associated Methicillin-resistant Staphylococcus aureus Identified through Imaging Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANTON-VALENTINE LEUKOCIDIN; METABOLIC EXCHANGE; STREPTOLYSIN-S; VIRULENCE	Staphylococcus aureus causes a wide range of human disease ranging from localized skin and soft tissue infections to potentially lethal systemic infections. S. aureus has the biosynthetic ability to generate numerous virulence factors that assist in circumventing the innate immune system during disease pathogenesis. Recent studies have uncovered a set of extracellular peptides produced by community-associated methicillin-resistant S. aureus (CA-MRSA) with homology to the phenol-soluble modulins (PSMs) from Staphylococcus epidermidis. CA-MRSA PSMs contribute to skin infection and recruit and lyse neutrophils, and truncated versions of these peptides possess antimicrobial activity. In this study, novel CA-MRSA PSM derivatives were discovered by the use of microbial imaging mass spectrometry. The novel PSM derivatives are compared with their parent full-length peptides for changes in hemolytic, cytolytic, and neutrophil-stimulating activity. A potential contribution of the major S. aureus secreted protease aureolysin in processing PSMs is demonstrated. Finally, we show that PSM processing occurs in multiple CA-MRSA strains by structural confirmation of additional novel derivatives. This work demonstrates that IMS can serve as a useful tool to go beyond genome predictions and expand our understanding of the important family of small peptide virulence factors.	[Kersten, Roland; Moore, Bradley S.; Dorrestein, Pieter C.; Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Gonzalez, David J.; Okumura, Cheryl Y.; Hollands, Andrew; Akong-Moore, Kathryn; Pence, Morgan A.; Derieux, Jaclyn; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Dixon, Jack E.; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Moore, Bradley S.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Dixon, Jack E.; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Dixon, Jack E.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Dixon, Jack E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Malone, Cheryl L.; Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of Iowa	Dorrestein, PC (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr,Mail Code 0636, La Jolla, CA 92093 USA.	pdorrestein@ucsd.edu; vnizet@ucsd.edu	Pence, Morgan A./N-1620-2019; Dorrestein, Pieter/ABF-2930-2020; Nizet, Victor/AAF-3190-2019	Pence, Morgan A./0000-0003-0239-0228; Moore, Bradley/0000-0002-4652-1253; Nizet, Victor/0000-0003-3847-0422	National Institutes of Health [GM086283, GM094802, AI077780, AR05278]; Bruker Therapeutic Discovery Mass Spectrometry Center at the University of California at San Diego; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078921, R01AI077780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094802, R01GM086283, R01GM090328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bruker Therapeutic Discovery Mass Spectrometry Center at the University of California at San Diego; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health grants GM086283 and GM094802 (to P. C. D.) and AI077780 and AR05278 (to V. N.).; We appreciate the support of the Bruker Therapeutic Discovery Mass Spectrometry Center at the University of California at San Diego.	Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Beaufort N, 2008, BIOCHEM J, V410, P157, DOI 10.1042/BJ20070650; Datta V, 2005, MOL MICROBIOL, V56, P681, DOI 10.1111/j.1365-2958.2005.04583.x; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; Gonzalez DJ, 2011, MICROBIOL-SGM, V157, P2485, DOI 10.1099/mic.0.048736-0; Gorak EJ, 1999, CLIN INFECT DIS, V29, P797, DOI 10.1086/520437; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Huang YC, 2008, CLIN MICROBIOL INFEC, V14, P1167, DOI 10.1111/j.1469-0691.2008.02115.x; Joo HS, 2011, J BIOL CHEM, V286, P8933, DOI 10.1074/jbc.M111.221382; Kavanaugh JS, 2007, MOL MICROBIOL, V65, P780, DOI 10.1111/j.1365-2958.2007.05830.x; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Kerr ID, 1996, PROTEIN ENG, V9, P161, DOI 10.1093/protein/9.2.161; Kersten RD, 2011, NAT CHEM BIOL, V7, P794, DOI 10.1038/nchembio.684; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Kobayashi SD, 2009, CURR OPIN PHARMACOL, V9, P545, DOI 10.1016/j.coph.2009.07.009; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Li M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-4; Lipinska U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022864; Liu WT, 2010, P NATL ACAD SCI USA, V107, P16286, DOI 10.1073/pnas.1008368107; Maree CL, 2007, EMERG INFECT DIS, V13, P236, DOI 10.3201/eid1302.060781; Molloy EM, 2011, NAT REV MICROBIOL, V9, P670, DOI 10.1038/nrmicro2624; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Reynolds J, 2011, J MOL BIOL, V412, P862, DOI 10.1016/j.jmb.2011.06.018; Sieprawska-Lupa M, 2004, ANTIMICROB AGENTS CH, V48, P4673, DOI 10.1128/AAC.48.12.4673-4679.2004; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053; Watrous JD, 2011, NAT REV MICROBIOL, V9, P683, DOI 10.1038/nrmicro2634; Yang YL, 2009, NAT CHEM BIOL, V5, P885, DOI 10.1038/nchembio.252; Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004	31	41	45	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13889	13898		10.1074/jbc.M112.349860	http://dx.doi.org/10.1074/jbc.M112.349860			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22371493	hybrid, Green Published			2022-12-27	WOS:000303996300044
J	Eckert, B; Collins, K				Eckert, Barbara; Collins, Kathleen			Roles of Telomerase Reverse Transcriptase N-terminal Domain in Assembly and Activity of Tetrahymena Telomerase Holoenzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPEAT ADDITION PROCESSIVITY; RNA; DNA; BINDING; ELONGATION; SUBUNIT; PROTEINS; LOOP	Telomerase extends chromosome ends by the addition of single-stranded telomeric repeats. To support processive repeat synthesis, it has been proposed that coordination occurs between DNA interactions with the telomerase RNA template, the active site in the telomerase reverse transcriptase (TERT) core, a TERT N-terminal (TEN) domain, and additional subunits of the telomerase holoenzyme required for telomere elongation in vivo. The roles of TEN domain surface residues in primer binding and product elongation have been studied largely using assays of minimal recombinant telomerase enzymes, which lack holoenzyme subunits that properly fold and conformationally stabilize the ribonucleoprotein and/or control its association with telomere substrates in vivo. Here, we use Tetrahymena telomerase holoenzyme reconstitution in vitro to assess TEN domain sequence requirements in the physiological enzyme context. We find that TEN domain sequence substitutions in the Tetrahymena telomerase holoenzyme influence synthesis initiation and elongation rate but not processivity. Functional and direct physical interaction assays pinpoint a conserved TEN domain surface required for holoenzyme subunit association and for high repeat addition processivity. Our results add to the understanding of telomerase holoenzyme architecture and TERT domain functions with direct implications for the unique mechanism of single-stranded repeat synthesis.	[Eckert, Barbara; Collins, Kathleen] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Collins, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kcollins@berkeley.edu			National Institutes of Health [GM54198]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54198.	Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Blackburn E. H., 2010, RNA WORLDS, P205; Chang M, 2007, GENE DEV, V21, P2485, DOI 10.1101/gad.1588807; Collins K, 2002, ONCOGENE, V21, P564, DOI 10.1038/sj.onc.1205083; Collins K, 2011, CURR OPIN CHEM BIOL, V15, P643, DOI 10.1016/j.cbpa.2011.07.011; Collins Kathleen, 2009, V13, P285, DOI 10.1007/978-3-540-70840-7_14; Cunningham DD, 2005, MOL CELL BIOL, V25, P4442, DOI 10.1128/MCB.25.11.4442-4454.2005; Greene EC, 1998, GENE DEV, V12, P2921, DOI 10.1101/gad.12.18.2921; GREIDER CW, 1991, MOL CELL BIOL, V11, P4572, DOI 10.1128/MCB.11.9.4572; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hardy CD, 2001, J BIOL CHEM, V276, P4863, DOI 10.1074/jbc.M005158200; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Jacobs SA, 2006, NAT STRUCT MOL BIOL, V13, P218, DOI 10.1038/nsmb1054; Lai CK, 2001, MOL CELL BIOL, V21, P990, DOI 10.1128/MCB.21.4.990-1000.2001; Lee SR, 2003, J BIOL CHEM, V278, P52531, DOI 10.1074/jbc.M311359200; Licht JD, 1999, GENE DEV, V13, P1116, DOI 10.1101/gad.13.9.1116; MCCORMICKGRAHAM M, 1995, NUCLEIC ACIDS RES, V23, P1091, DOI 10.1093/nar/23.7.1091; Min BS, 2010, J BIOL CHEM, V285, P16434, DOI 10.1074/jbc.M110.119172; Min BS, 2009, MOL CELL, V36, P609, DOI 10.1016/j.molcel.2009.09.041; O'Connor CM, 2005, J BIOL CHEM, V280, P17533, DOI 10.1074/jbc.M501211200; Robart AR, 2011, MOL CELL, V42, P308, DOI 10.1016/j.molcel.2011.03.012; Robart AR, 2010, RNA, V16, P563, DOI 10.1261/rna.1936410; Romi E, 2007, P NATL ACAD SCI USA, V104, P8791, DOI 10.1073/pnas.0703157104; Rosenfeld KK, 2011, J MOL BIOL, V410, P77, DOI 10.1016/j.jmb.2011.04.040; Shay JW, 2010, FEBS LETT, V584, P3819, DOI 10.1016/j.febslet.2010.05.026; Sperger JM, 2001, BIOCHEMISTRY-US, V40, P7005, DOI 10.1021/bi0103359; Witkin KL, 2007, MOL CELL BIOL, V27, P2074, DOI 10.1128/MCB.02105-06; Witkin KL, 2004, GENE DEV, V18, P1107, DOI 10.1101/gad.1201704; Wu JY, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1033; Yen WF, 2011, P NATL ACAD SCI USA, V108, P20370, DOI 10.1073/pnas.1017855108; Zaug AJ, 2008, NAT STRUCT MOL BIOL, V15, P871, DOI 10.1038/nsmb.1462; Zaug AJ, 2010, GENE DEV, V24, P613, DOI 10.1101/gad.1881810; Zeng ZX, 2011, P NATL ACAD SCI USA, V108, P20357, DOI 10.1073/pnas.1113624108; Zhao Y, 2011, MOL CELL, V42, P297, DOI 10.1016/j.molcel.2011.03.020	34	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12805	12814		10.1074/jbc.M112.339853	http://dx.doi.org/10.1074/jbc.M112.339853			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367200	Green Published, hybrid			2022-12-27	WOS:000302903700020
J	Mazerik, JN; Tyska, MJ				Mazerik, Jessica N.; Tyska, Matthew J.			Myosin-1A Targets to Microvilli Using Multiple Membrane Binding Motifs in the Tail Homology 1 (TH1) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PLASMA-MEMBRANE; DEAFNESS MUTATION; SURFACE-CHARGE; ACTIN BUNDLES; HIGH-AFFINITY; I-TASSER; PROTEIN; CELL	One of the most abundant components of the enterocyte brush border is the actin-based monomeric motor, myosin-1a (Myo1a). Within brush border microvilli, Myo1a carries out a number of critical functions at the interface between membrane and actin cytoskeleton. Proper physiological function of Myo1a depends on its ability to bind to microvillar membrane, an interaction mediated by a C-terminal tail homology 1 (TH1) domain. However, little is known about the mechanistic details of the Myo1a-TH1/membrane interaction. Structure-function analysis of Myo1a-TH1 targeting in epithelial cells revealed that an N-terminal motif conserved among class I myosins and a C-terminal motif unique to Myo1a-TH1 are both required for steady state microvillar enrichment. Purified Myo1a bound to liposomes composed of phosphatidylserine and phosphoinositol 4,5-bisphosphate, with moderate affinity in a charge-dependent manner. Additionally, peptides of the N- and C-terminal regions required for targeting were able to compete with Myo1a for binding to highly charged liposomes in vitro. Single molecule total internal reflection fluorescence microscopy showed that these motifs are also necessary for slowing the membrane detachment rate in cells. Finally, Myo1a-TH1 co-localized with both lactadherin-C2 (a phosphatidylserine-binding protein) and PLC delta 1-PH (a phosphoinositol 4,5-bisphosphate-binding protein) in microvilli, but only lactaderin-C2 expression reduced brush border targeting of Myo1a-TH1. Together, our results suggest that Myo1a targeting to microvilli is driven by membrane binding potential that is distributed throughout TH1 rather than localized to a single motif. These data highlight the diversity of mechanisms that enable different class I myosins to target membranes in distinct biological contexts.	[Mazerik, Jessica N.; Tyska, Matthew J.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Vanderbilt University	Tyska, MJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, 3150 Med Res Bldg 3,465 21st Ave S, Nashville, TN 37232 USA.	matthew.tyska@vanderbilt.edu			National Institutes of Health [R01-DK075555]; American Heart Association [09GRNT2310188, 11PRE7390066]; Vanderbilt University Medical Center [T32-GM008320]; Vanderbilt University; Tyska laboratory; Vanderbilt University Epithelial Biology Center Imaging Resource; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Vanderbilt University Medical Center; Vanderbilt University; Tyska laboratory; Vanderbilt University Epithelial Biology Center Imaging Resource; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-DK075555 (to M. J. T.). This work was also supported by American Heart Association Grants 09GRNT2310188 (to M. J. T.) and 11PRE7390066 (to J. N. M.), Vanderbilt University Medical Center Molecular Biophysics Training Program Training Grant T32-GM008320 (to Dr. Walter Chazin), and a Vanderbilt University IDEAs award (to M. J. T.).; We thank all members of the Tyska laboratory for advice and support; Dr. Kristen Verhey, Dr. Chris Yengo, Dr. Kathy Trybus, Dr. Tamas Balla, Dr. Jim Goldenring, and Dr. Todd Graham for generously sharing reagents; and Dr. Ryoma Ohi, Chauca English Moore, and Dr. Elena Krementsova for assistance with SF9 culture and reagents. We also thank the Vanderbilt University Epithelial Biology Center Imaging Resource for generous support.	Balla Tamas, 2009, Curr Protoc Cell Biol, VChapter 24, DOI 10.1002/0471143030.cb2404s42; Benesh AE, 2010, MOL BIOL CELL, V21, P970, DOI 10.1091/mbc.E09-07-0638; Brzeska H, 2008, J BIOL CHEM, V283, P32014, DOI 10.1074/jbc.M804828200; Brzeska H, 2010, J BIOL CHEM, V285, P5738, DOI 10.1074/jbc.M109.066910; Cai DW, 2007, BIOPHYS J, V92, P4137, DOI 10.1529/biophysj.106.100206; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; COLLINS JH, 1984, J BIOL CHEM, V259, P4128; Coluccio L. M., 2008, MYOSIN, P95; CROTHERS DM, 1972, IMMUNOCHEMISTRY, V9, P341, DOI 10.1016/0019-2791(72)90097-3; Fairn GD, 2011, NAT CELL BIOL, V13, P1424, DOI 10.1038/ncb2351; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Feeser EA, 2010, BIOCHEMISTRY-US, V49, P9353, DOI 10.1021/bi1012657; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Gorelik R, 2011, MOL BIOL CELL, V22, P189, DOI 10.1091/mbc.E10-03-0256; HAYDEN SM, 1990, J CELL BIOL, V111, P443, DOI 10.1083/jcb.111.2.443; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Hokanson DE, 2006, P NATL ACAD SCI USA, V103, P3118, DOI 10.1073/pnas.0505685103; JONTES JD, 1995, NATURE, V378, P751, DOI 10.1038/378751a0; Knight JD, 2010, BIOPHYS J, V99, P2879, DOI 10.1016/j.bpj.2010.08.046; Komaba S, 2010, J BIOL CHEM, V285, P27686, DOI 10.1074/jbc.M109.087270; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Loomis PA, 2003, J CELL BIOL, V163, P1045, DOI 10.1083/jcb.200309093; MATSUDAIRA PT, 1979, J CELL BIOL, V83, P667, DOI 10.1083/jcb.83.3.667; Mazzolini R, 2012, P NATL ACAD SCI USA, V109, P1530, DOI 10.1073/pnas.1108411109; McConnell RE, 2007, J CELL BIOL, V177, P671, DOI 10.1083/jcb.200701144; McConnell RE, 2010, TRENDS CELL BIOL, V20, P418, DOI 10.1016/j.tcb.2010.04.004; McConnell RE, 2009, J CELL BIOL, V185, P1285, DOI 10.1083/jcb.200902147; McKenna JMD, 2009, J BIOL CHEM, V284, P28650, DOI 10.1074/jbc.M109.049791; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; MOOSEKER MS, 1975, J CELL BIOL, V67, P725, DOI 10.1083/jcb.67.3.725; Nagata K, 2008, P NATL ACAD SCI USA, V105, P353, DOI 10.1073/pnas.0707963105; Nambiar R, 2010, CELL MOL LIFE SCI, V67, P1239, DOI 10.1007/s00018-009-0254-5; Nambiar R, 2009, P NATL ACAD SCI USA, V106, P11972, DOI 10.1073/pnas.0901641106; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Olety B, 2010, FEBS LETT, V584, P493, DOI 10.1016/j.febslet.2009.11.096; Patino-Lopez G, 2010, J BIOL CHEM, V285, P8675, DOI 10.1074/jbc.M109.086959; Pyrpassopoulos S, 2010, BIOPHYS J, V99, P3916, DOI 10.1016/j.bpj.2010.10.043; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Skowron JF, 1999, J EXP ZOOL, V283, P242, DOI 10.1002/(SICI)1097-010X(19990215)283:3<242::AID-JEZ3>3.3.CO;2-6; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; Tang NY, 2002, J BIOL CHEM, V277, P42763, DOI 10.1074/jbc.M206388200; Toprak E, 2010, METHOD ENZYMOL, V475, P1, DOI 10.1016/S0076-6879(10)75001-1; Tyska MJ, 2002, BIOPHYS J, V82, P1869, DOI 10.1016/S0006-3495(02)75537-9; Tyska MJ, 2005, MOL BIOL CELL, V16, P2443, DOI 10.1091/mbc.E04-12-1116; Tyska MJ, 2004, J CELL BIOL, V165, P395, DOI 10.1083/jcb.200310031; Vallotton P, 2003, BIOPHYS J, V85, P1289, DOI 10.1016/S0006-3495(03)74564-0; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Yengo CM, 2008, BIOPHYS J, V94, pL5, DOI 10.1529/biophysj.107.122689; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	57	32	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13104	13115		10.1074/jbc.M111.336313	http://dx.doi.org/10.1074/jbc.M111.336313			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367206	Green Published, hybrid			2022-12-27	WOS:000302903700050
J	Sugiura, M; Ogami, S; Kusumi, M; Un, S; Rappaport, F; Boussac, A				Sugiura, Miwa; Ogami, Shogo; Kusumi, Mai; Un, Sun; Rappaport, Fabrice; Boussac, Alain			Environment of Tyr(Z) in Photosystem II from Thermosynechococcus elongatus in which PsbA2 Is the D1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC WATER OXIDATION; SITE-DIRECTED MUTAGENESIS; OXYGEN-EVOLVING COMPLEX; HIGH-FIELD EPR; TYROSINE Y-Z; THERMOPHILIC CYANOBACTERIUM; ELECTRON-TRANSFER; PROTON RELEASE; P680(+CENTER-DOT) REDUCTION; TEMPERATURE-DEPENDENCE	The main cofactors that determine the photosystem II (PSII) oxygen evolution activity are borne by the D1 and D2 subunits. In the cyanobacterium Thermosynechococcus elongatus, there are three psbA genes coding for D1. Among the 344 residues constituting D1, there are 21 substitutions between PsbA1 and PsbA3, 31 between PsbA1 and PsbA2, and 27 between PsbA2 and PsbA3. Here, we present the first study of PsbA2-PSII. Using EPR and UV-visible time-resolved absorption spectroscopy, we show that: (i) the time-resolved EPR spectrum of Tyr(Z)(center dot) in the (S(3)Tyr(Z)(center dot))' is slightly modified; (ii) the split EPR signal arising from Tyr(Z)(center dot) in the (S(2)Tyr(Z)(center dot))' state induced by near-infrared illumination at 4.2 K of the S(3)Tyr(Z) state is significantly modified; and (iii) the slow phases of P-680(+). reduction by Tyr(Z) are slowed down from the hundreds of mu s time range to the ms time range, whereas both the S(1)Tyr(Z)(center dot) -> S(2)Tyr(Z) and the S(3)Tyr(Z)(center dot) -> 3 S(0)Tyr(Z) + O-2 transition kinetics remained similar to those in PsbA(1/3)-PSII. These results show that the geometry of the Tyr(Z) phenol and its environment, likely the Tyr-O center dot center dot center dot H center dot center dot center dot N epsilon-His bonding, are modified in PsbA2-PSII when compared with PsbA(1/3)-PSII. They also point to the dynamics of the proton-coupled electron transfer processes associated with the oxidation of Tyr(Z) being affected. From sequence comparison, we propose that the C144P and P173M substitutions in PsbA2-PSII versus PsbA(1/3)-PSII, respectively located upstream of the alpha-helix bearing Tyr(Z) and between the two alpha-helices bearing Tyr(Z) and its hydrogen-bonded partner, His-190, are responsible for these changes.	[Sugiura, Miwa] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime 7908577, Japan; [Sugiura, Miwa] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Sugiura, Miwa; Ogami, Shogo; Kusumi, Mai] Ehime Univ, Dept Chem, Grad Sch Sci & Technol, Matsuyama, Ehime 7908577, Japan; [Un, Sun; Boussac, Alain] CEA Saclay, CNRS, UMR 8221, iBiTec S, F-91191 Gif Sur Yvette, France; [Rappaport, Fabrice] CNRS, Inst Biol Physicochim, UMR 7141, F-75005 Paris, France; [Rappaport, Fabrice] Univ Paris 06, F-75005 Paris, France	Ehime University; Japan Science & Technology Agency (JST); Ehime University; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Sugiura, M (corresponding author), Ehime Univ, Cell Free Sci & Technol Res Ctr, Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	miwa.sugiura@ehime-u.ac.jp; alain.boussac@cea.fr		Rappaport, Fabrice/0000-0001-9377-4934	JST [4018]; Ministry of Education, Science, Sports, Culture and Technology [21612007]	JST(Japan Science & Technology Agency (JST)); Ministry of Education, Science, Sports, Culture and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Supported by the JST-PRESTO program (4018) and Grant-in-aid for Scientific Research 21612007 from the Ministry of Education, Science, Sports, Culture and Technology. To whom correspondence may be addressed: Cell-Free Science and Technology Research Center, Ehime University, Bunkyo-cho, Matsuyama Ehime 790- 8577, Japan. E-mail: miwa.sugiura@ehime-u.ac.jp.	Beal D, 1999, REV SCI INSTRUM, V70, P202, DOI 10.1063/1.1149566; Boussac A, 2005, PLANT CELL PHYSIOL, V46, P837, DOI 10.1093/pcp/pci088; Boussac A, 2008, PHILOS T R SOC B, V363, P1203, DOI 10.1098/rstb.2007.2216; Boussac A, 2011, BBA-BIOENERGETICS, V1807, P119, DOI 10.1016/j.bbabio.2010.10.004; Boussac A, 2009, J AM CHEM SOC, V131, P5050, DOI 10.1021/ja900680t; Christen G, 1999, BIOCHEMISTRY-US, V38, P6082, DOI 10.1021/bi9827520; Christen G, 1999, BIOCHEMISTRY-US, V38, P2068, DOI 10.1021/bi982188t; CLARKE AK, 1993, P NATL ACAD SCI USA, V90, P9973, DOI 10.1073/pnas.90.21.9973; Cox N, 2011, J AM CHEM SOC, V133, P3635, DOI 10.1021/ja110145v; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V726, P149, DOI 10.1016/0304-4173(83)90004-6; Cuni A, 2004, PHYS CHEM CHEM PHYS, V6, P4825, DOI 10.1039/b407511k; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; de Wijn R, 2002, BBA-BIOENERGETICS, V1553, P302, DOI 10.1016/S0005-2728(02)00183-4; Debus RJ, 2008, COORDIN CHEM REV, V252, P244, DOI 10.1016/j.ccr.2007.09.022; Diner BA, 2002, ANNU REV PLANT BIOL, V53, P551, DOI 10.1146/annurev.arplant.53.100301.135238; Dorlet P, 1999, J PHYS CHEM B, V103, P10945, DOI 10.1021/jp992420k; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; FORSTER V, 1985, PHOTOCHEM PHOTOBIOL, V41, P183, DOI 10.1111/j.1751-1097.1985.tb03469.x; Gerencser L, 2010, BIOCHEMISTRY-US, V49, P10098, DOI 10.1021/bi101198n; GOLDEN SS, 1995, J BACTERIOL, V177, P1651, DOI 10.1128/jb.177.7.1651-1654.1995; Groot ML, 2005, P NATL ACAD SCI USA, V102, P13087, DOI 10.1073/pnas.0503483102; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Haumann M, 2005, SCIENCE, V310, P1019, DOI 10.1126/science.1117551; Hays AMA, 1999, BIOCHEMISTRY-US, V38, P11851, DOI 10.1021/bi990716a; Holzwarth AR, 2006, P NATL ACAD SCI USA, V103, P6895, DOI 10.1073/pnas.0505371103; Ioannidis N, 2000, BIOCHEMISTRY-US, V39, P5246, DOI 10.1021/bi000131c; Ishida N, 2008, J BIOL CHEM, V283, P13330, DOI 10.1074/jbc.M710583200; JAHNS P, 1991, BIOCHIM BIOPHYS ACTA, V1057, P313, DOI 10.1016/S0005-2728(05)80142-2; Joliot P., 1975, BIOENERG PHOTOSYNTH, P387; Kato Y, 2009, P NATL ACAD SCI USA, V106, P17365, DOI 10.1073/pnas.0905388106; KOIKE H, 1987, BIOCHIM BIOPHYS ACTA, V893, P524, DOI 10.1016/0005-2728(87)90104-6; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Komenda J, 2000, PLANT MOL BIOL, V42, P635, DOI 10.1023/A:1006305308196; Kos PB, 2008, BBA-BIOENERGETICS, V1777, P74, DOI 10.1016/j.bbabio.2007.10.015; Koulougliotis D, 2004, PHYS CHEM CHEM PHYS, V6, P4859, DOI 10.1039/b407355j; Kuhn P, 2004, PHYS CHEM CHEM PHYS, V6, P4838, DOI 10.1039/b407656g; Lavergne J, 1998, BIOCHEMISTRY-US, V37, P7899, DOI 10.1021/bi9801210; LAVERGNE J, 1984, FEBS LETT, V173, P9, DOI 10.1016/0014-5793(84)81006-6; LAVERGNE J, 1991, BIOCHIM BIOPHYS ACTA, V1060, P175, DOI 10.1016/S0005-2728(09)91005-2; LAVERGNE J, 1993, PHOTOSYNTH RES, V38, P279, DOI 10.1007/BF00046752; Loll B, 2008, BIOL CHEM, V389, P609, DOI 10.1515/BC.2008.058; Matsuoka H, 2011, J AM CHEM SOC, V133, P4655, DOI 10.1021/ja2000566; Merry SAP, 1998, BIOCHEMISTRY-US, V37, P17439, DOI 10.1021/bi980502d; MINO H, 1994, BBA-BIOENERGETICS, V1185, P213, DOI 10.1016/0005-2728(94)90212-7; Mulo P, 2009, CELL MOL LIFE SCI, V66, P3697, DOI 10.1007/s00018-009-0103-6; Nakamura Y, 2002, DNA RES, V9, P123, DOI 10.1093/dnares/9.4.123; Ogami S, 2012, BBA-BIOENERGETICS, V1817, P1322, DOI 10.1016/j.bbabio.2012.01.015; Petrouleas V, 2005, BIOCHEMISTRY-US, V44, P6723, DOI 10.1021/bi0503201; Pushkar YL, 2008, P NATL ACAD SCI USA, V105, P1879, DOI 10.1073/pnas.0707092105; RAPPAPORT F, 1994, BBA-BIOENERGETICS, V1184, P178, DOI 10.1016/0005-2728(94)90222-4; Rappaport F, 2001, BBA-BIOENERGETICS, V1503, P246, DOI 10.1016/S0005-2728(00)00228-0; RAPPAPORT F, 1991, BIOCHEMISTRY-US, V30, P10004, DOI 10.1021/bi00105a027; Rappaport F, 2011, ENERG ENVIRON SCI, V4, P2520, DOI 10.1039/c1ee01408k; Rappaport F, 2009, J AM CHEM SOC, V131, P4425, DOI 10.1021/ja808604h; Razeghifard MR, 1999, BIOCHEMISTRY-US, V38, P1252, DOI 10.1021/bi9811765; Renger G, 2011, J PHOTOCH PHOTOBIO B, V104, P35, DOI 10.1016/j.jphotobiol.2011.01.023; Saito K, 2011, BIOCHEMISTRY-US, V50, P9836, DOI 10.1021/bi201366j; Sanakis Y, 2001, J AM CHEM SOC, V123, P10766, DOI 10.1021/ja016418u; Sander J, 2010, J BIOL CHEM, V285, P29851, DOI 10.1074/jbc.M110.127142; Schilstra MJ, 1998, BIOCHEMISTRY-US, V37, P3974, DOI 10.1021/bi9713815; SHINKAREV VP, 1993, P NATL ACAD SCI USA, V90, P1834, DOI 10.1073/pnas.90.5.1834; Sicora CI, 2006, BBA-BIOENERGETICS, V1757, P47, DOI 10.1016/j.bbabio.2005.11.002; Sicora CI, 2009, BBA-BIOENERGETICS, V1787, P105, DOI 10.1016/j.bbabio.2008.12.002; Sproviero EM, 2008, J AM CHEM SOC, V130, P3428, DOI 10.1021/ja076130q; STYRING S, 1987, BIOCHEMISTRY-US, V26, P2401, DOI 10.1021/bi00383a001; Sugiura M, 1999, PLANT CELL PHYSIOL, V40, P1219, DOI 10.1093/oxfordjournals.pcp.a029510; Sugiura M, 2004, BIOCHEMISTRY-US, V43, P13549, DOI 10.1021/bi048732h; Sugiura M, 2008, BBA-BIOENERGETICS, V1777, P331, DOI 10.1016/j.bbabio.2008.01.007; Sugiura M, 2010, J BIOL CHEM, V285, P30008, DOI 10.1074/jbc.M110.136945; Sugiura M, 2010, BBA-BIOENERGETICS, V1797, P1491, DOI 10.1016/j.bbabio.2010.03.022; TOMMOS C, 1995, J AM CHEM SOC, V117, P10325, DOI 10.1021/ja00146a017; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Un S, 2001, APPL MAGN RESON, V21, P341, DOI 10.1007/BF03162413; Un S, 2007, BIOCHEMISTRY-US, V46, P3138, DOI 10.1021/bi062084f; VELTHUYS BR, 1974, BIOCHIM BIOPHYS ACTA, V333, P85, DOI 10.1016/0005-2728(74)90165-0; Westphal KL, 2000, CURR OPIN PLANT BIOL, V3, P236, DOI 10.1016/S1369-5266(00)80071-0; Zhang MT, 2011, J AM CHEM SOC, V133, P13224, DOI 10.1021/ja203483j	77	19	19	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13336	13347		10.1074/jbc.M112.340323	http://dx.doi.org/10.1074/jbc.M112.340323			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22362776	hybrid, Green Published			2022-12-27	WOS:000302903700069
J	Mei, S; Gu, HH; Ward, A; Yang, XF; Guo, HL; He, K; Liu, ZQ; Cao, WH				Mei, Shuang; Gu, Haihua; Ward, Adam; Yang, Xuefeng; Guo, Huailan; He, Ka; Liu, Zhenqi; Cao, Wenhong			p38 Mitogen-activated Protein Kinase (MAPK) Promotes Cholesterol Ester Accumulation in Macrophages through Inhibition of Macroautophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE-CHEMOATTRACTANT PROTEIN-1; SIGNAL-TRANSDUCTION PATHWAY; SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; TRANSGENIC EXPRESSION; CHEMOKINE PRODUCTION; FOAM CELLS; AUTOPHAGY; ATHEROSCLEROSIS; MIGRATION	p38 MAPK has been strongly implicated in the development of atherosclerosis, but its role in cholesterol ester accumulation in macrophages and formation of foam cells, an early step in the development of atherosclerosis, has not been investigated. We addressed this issue and made some brand new observations. First, elevated intracellular cholesterol level induced by the exposure to LDL-activated p38 MAPK and activation of p38 MAPK with anisomycin increased the ratio of cholesterol esters over free cholesterol, whereas inhibition of p38 MAPK with SB203580 or siRNA reduced the LDL loading-induced intracellular accumulation of free cholesterol and cholesterol esters in macrophages. Second, exposure to LDL cholesterol inhibited autophagy in macrophages, and inhibition of autophagy with 3-methyladenine increased intracellular accumulation of cholesterol (free cholesterol and cholesterol esters), whereas activation of autophagy with rapamycin decreased intracellular accumulation of free cholesterol and cholesterol esters induced by the exposure to LDL cholesterol. Third, LDL cholesterol loading-induced inhibition of autophagy was prevented by blockade of p38 MAPK with SB203580 or siRNA. Neutral cholesterol ester hydrolase was co-localized with autophagosomes. Finally, LDL cholesterol loading and p38 activation suppressed expression of the key autophagy gene, ulk1, in macrophages. Together, our results provide brand new insight about cholesterol ester accumulation in macrophages and foam cell formation.	[Mei, Shuang; Gu, Haihua; Ward, Adam; Yang, Xuefeng; Guo, Huailan; He, Ka; Cao, Wenhong] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27559 USA; [Yang, Xuefeng] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Nutr & Food Hyg, Wuhan 430030, Hubei, Peoples R China; [Guo, Huailan] Hubei Univ Med, Dept Prevent Med, Shiyan 442000, Hubei, Peoples R China; [Liu, Zhenqi] Univ Virginia Hlth Syst, Dept Med Endocrinol, Charlottesville, VA 22908 USA; [Cao, Wenhong] Duke Univ, Sch Med, Dept Med Endocrinol & Metab, Durham, NC 27705 USA	University of North Carolina; University of North Carolina Chapel Hill; Huazhong University of Science & Technology; Hubei University of Medicine; University of Virginia; Duke University	Cao, WH (corresponding author), Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27559 USA.	caow@unc.edu		Ward, Adam/0000-0002-7038-5597	National Institutes of Health [R01DK076039]; American Diabetes Association [7-09-BS-27]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK076039 (to W. C.). This work was also supported by the American Diabetes Association (7-09-BS-27) (to W. C.).	Ashida N, 2001, J BIOL CHEM, V276, P16555, DOI 10.1074/jbc.M009068200; Ayala JM, 2000, J LEUKOCYTE BIOL, V67, P869, DOI 10.1002/jlb.67.6.869; Bie JH, 2010, J BIOL CHEM, V285, P13630, DOI 10.1074/jbc.M109.069781; Cambien B, 2001, BLOOD, V97, P359, DOI 10.1182/blood.V97.2.359; Cao Wen-Hong, 2007, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V32, P1; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Collins QF, 2006, J BIOL CHEM, V281, P24336, DOI 10.1074/jbc.M602177200; Dobreva I, 2005, BIOL CHEM, V386, P909, DOI 10.1515/BC.2005.106; Domoto K, 2003, ATHEROSCLEROSIS, V171, P193, DOI 10.1016/j.atherosclerosis.2003.08.016; Dubois PM, 1996, J IMMUNOL, V156, P1356; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ghosh S, 2010, VASC PHARMACOL, V52, P1, DOI 10.1016/j.vph.2009.10.002; Goebeler M, 1999, BLOOD, V93, P857, DOI 10.1182/blood.V93.3.857.403k03_857_865; Griffin EE, 2005, J LIPID RES, V46, P2052, DOI 10.1194/jlr.M500059-JLR200; Hayama M, 2002, AM J PHYSIOL-RENAL, V282, pF485, DOI 10.1152/ajprenal.00210.2001; Hong T, 2011, AM J PHYSIOL-ENDOC M, V300, pE500, DOI 10.1152/ajpendo.00225.2010; Igarashi M, 1997, HORM METAB RES, V29, P444, DOI 10.1055/s-2007-979074; Kuki S, 2006, CIRC J, V70, P1076, DOI 10.1253/circj.70.1076; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liu HY, 2007, J BIOL CHEM, V282, P14205, DOI 10.1074/jbc.M609701200; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Marin V, 2001, BLOOD, V98, P667, DOI 10.1182/blood.V98.3.667; Martinet W, 2008, CURR ATHEROSCLER REP, V10, P216, DOI 10.1007/s11883-008-0034-y; Martinet W, 2009, CIRC RES, V104, P304, DOI 10.1161/CIRCRESAHA.108.188318; Matsuyama W, 2004, J IMMUNOL, V172, P2332, DOI 10.4049/jimmunol.172.4.2332; McGinn S, 2003, AM J PHYSIOL-ENDOC M, V285, pE708, DOI 10.1152/ajpendo.00572.2002; McMullen ME, 2005, J BIOL CHEM, V280, P20995, DOI 10.1074/jbc.M407060200; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nagelin MH, 2009, J BIOL CHEM, V284, P31303, DOI 10.1074/jbc.M109.028910; Nakagami H, 2001, DIABETES, V50, P1472, DOI 10.2337/diabetes.50.6.1472; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; Seeger FH, 2005, CIRCULATION, V111, P1184, DOI 10.1161/01.CIR.0000157156.85397.A1; Sekiya M, 2009, CELL METAB, V10, P219, DOI 10.1016/j.cmet.2009.08.004; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Srinivasan S, 2004, J BIOL CHEM, V279, P31930, DOI 10.1074/jbc.M400753200; Surapisitchat J, 2001, P NATL ACAD SCI USA, V98, P6476, DOI 10.1073/pnas.101134098; Suzuki E, 2004, CIRC RES, V95, P42, DOI 10.1161/01.RES.0000134631.75684.4A; Vitale S, 2004, J IMMUNOL, V172, P585, DOI 10.4049/jimmunol.172.1.585; Wang XL, 2006, DIABETES, V55, P2301, DOI 10.2337/db05-1574; Webber JL, 2010, EMBO J, V29, P27, DOI 10.1038/emboj.2009.321; Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200; Yamaguchi H, 2004, ARTERIOSCL THROM VAS, V24, P2095, DOI 10.1161/01.ATV.0000144009.35400.65; Yin XM, 2008, HEPATOLOGY, V47, P1773, DOI 10.1002/hep.22146; Zeng XK, 2003, CIRC RES, V93, P311, DOI 10.1161/01.RES.0000087642.01082.E4; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106; Zhao B, 2007, J CLIN INVEST, V117, P2983, DOI 10.1172/JCI30485	51	54	55	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11761	11768		10.1074/jbc.M111.333575	http://dx.doi.org/10.1074/jbc.M111.333575			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22354961	Green Published, hybrid			2022-12-27	WOS:000302782200015
J	Zhang, W; Zhao, Y; Guo, Y; Ye, KQ				Zhang, Wei; Zhao, Yang; Guo, Yan; Ye, Keqiong			Plant Actin-binding Protein SCAB1 Is Dimeric Actin Cross-linker with Atypical Pleckstrin Homology Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS VILLIN1; BUNDLING PROTEIN; COILED COILS; CYTOSKELETON; WLIM1	SCAB1 is a novel plant-specific actin-binding protein that binds, bundles, and stabilizes actin filaments and regulates stomatal movement. Here, we dissected the structure and function of SCAB1 by structural and biochemical approaches. We show that SCAB1 is composed of an actin-binding domain, two coiled-coil (CC) domains, and a fused immunoglobulin and pleckstrin homology (Ig-PH) domain. We determined crystal structures for the CC1 and Ig-PH domains at 1.9 and 1.7 angstrom resolution, respectively. The CC1 domain adopts an antiparallel helical hairpin that further dimerizes into a four-helix bundle. The CC2 domain also mediates dimerization. At least one of the coiled coils is required for actin binding, indicating that SCAB1 is a bivalent actin cross-linker. The key residues required for actin binding were identified. The PH domain lacks a canonical basic phosphoinositide-binding pocket but can bind weakly to inositol phosphates via a basic surface patch, implying the involvement of inositol signaling in SCAB1 regulation. Our results provide novel insights into the functional organization of SCAB1.	[Zhang, Wei; Ye, Keqiong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Zhang, Wei; Zhao, Yang; Guo, Yan] China Agr Univ, Coll Biol Sci, Beijing 100193, Peoples R China	National Institute of Biological Sciences, Beijing; China Agricultural University	Ye, KQ (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd, Beijing 102206, Peoples R China.	yekeqiong@nibs.ac.cn	Guo, Yan/X-1245-2019; Zhao, Yang/H-2827-2014	Zhao, Yang/0000-0003-0302-3470	Chinese Ministry of Science and Technology [2010CB835402, 2008AA022310]; Beijing Municipal Government; China National Funds for Distinguished Young Scientists [31025003]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Beijing Municipal Government; China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Ministry of Science and Technology 973 Project 2010CB835402 and 863 Project 2008AA022310 and the Beijing Municipal Government (to K. Y.) and by China National Funds for Distinguished Young Scientists Grant 31025003 (to Y. G.).	Akarsu H, 2003, EMBO J, V22, P4646, DOI 10.1093/emboj/cdg449; Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Banuelos S, 1998, STRUCTURE, V6, P1419, DOI 10.1016/S0969-2126(98)00141-5; Blanchoin L, 2010, CURR OPIN PLANT BIOL, V13, P714, DOI 10.1016/j.pbi.2010.09.013; Blanchoin L, 2010, BBA-MOL CELL RES, V1803, P201, DOI 10.1016/j.bbamcr.2008.09.015; Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; George SP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703617200; Higaki T, 2007, CURR OPIN PLANT BIOL, V10, P549, DOI 10.1016/j.pbi.2007.08.012; Higaki T, 2010, PLANT SIGNAL BEHAV, V5, P484, DOI 10.4161/psb.10947; Higaki T, 2010, PLANT J, V61, P156, DOI 10.1111/j.1365-313X.2009.04032.x; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Huang S, 2005, PLANT CELL, V17, P486, DOI 10.1105/tpc.104.028555; Hussey PJ, 2006, ANNU REV PLANT BIOL, V57, P109, DOI 10.1146/annurev.arplant.57.032905.105206; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; Khurana P, 2010, PLANT CELL, V22, P2727, DOI 10.1105/tpc.110.076240; Klahre U, 2000, PLANT PHYSIOL, V122, P35, DOI 10.1104/pp.122.1.35; Klein DE, 1998, J BIOL CHEM, V273, P27725, DOI 10.1074/jbc.273.42.27725; Kovar DR, 2000, PLANT J, V24, P625, DOI 10.1046/j.1365-313x.2000.00907.x; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Michelot A, 2005, PLANT CELL, V17, P2296, DOI 10.1105/tpc.105.030908; Michelot A, 2006, CURR BIOL, V16, P1924, DOI 10.1016/j.cub.2006.07.054; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papuga J, 2010, PLANT CELL, V22, P3034, DOI 10.1105/tpc.110.075960; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Thomas C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703691200; Thomas C, 2006, PLANT CELL, V18, P2194, DOI 10.1105/tpc.106.040956; Thomas C, 2009, CELL MOTIL CYTOSKEL, V66, P940, DOI 10.1002/cm.20389; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Willis MA, 2000, STRUCTURE, V8, P1319, DOI 10.1016/S0969-2126(00)00544-X; Wu YJ, 2010, PLANT CELL, V22, P3745, DOI 10.1105/tpc.110.080283; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Yokota E, 1998, PLANT PHYSIOL, V116, P1421, DOI 10.1104/pp.116.4.1421; Yokota E, 2003, PLANT CELL PHYSIOL, V44, P1088, DOI 10.1093/pcp/pcg132; Zhang H, 2010, PLANT CELL, V22, P2749, DOI 10.1105/tpc.110.076257; Zhao Y, 2011, PLANT CELL, V23, P2314, DOI 10.1105/tpc.111.086546	49	14	17	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11981	11990		10.1074/jbc.M111.338525	http://dx.doi.org/10.1074/jbc.M111.338525			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22356912	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000302782200036
J	Hunt, J; Keeble, AH; Dale, RE; Corbett, MK; Beavil, RL; Levitt, J; Swann, MJ; Suhling, K; Ameer-Beg, S; Sutton, BJ; Beavil, AJ				Hunt, James; Keeble, Anthony H.; Dale, Robert E.; Corbett, Melissa K.; Beavil, Rebecca L.; Levitt, James; Swann, Marcus J.; Suhling, Klaus; Ameer-Beg, Simon; Sutton, Brian J.; Beavil, Andrew J.			A Fluorescent Biosensor Reveals Conformational Changes in Human Immunoglobulin E Fc IMPLICATIONS FOR MECHANISMS OF RECEPTOR BINDING, INHIBITION, AND ALLERGEN RECOGNITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCITED-STATE DYNAMICS; EPSILON-RI-ALPHA; HUMAN IGE-FC; SEGMENTAL FLEXIBILITY; CRYSTAL-STRUCTURE; ENERGY-TRANSFER; LIVING CELLS; HOMO-FRET; MONOCLONAL-ANTIBODY; GAMMA RECEPTOR	IgE binding to its high affinity receptor Fc epsilon RI on mast cells and basophils is a key step in the mechanism of allergic disease and a target for therapeutic intervention. Early indications that IgE adopts a bent structure in solution have been confirmed by recent x-ray crystallographic studies of IgEFc, which further showed that the bend, contrary to expectation, is enhanced in the crystal structure of the complex with receptor. To investigate the structure of IgEFc and its conformational changes that accompany receptor binding in solution, we created a Forster resonance energy transfer (FRET) biosensor using biologically encoded fluorescent proteins fused to the N- and C-terminal IgEFc domains (C epsilon 2 and C epsilon 4, respectively) together with the theoretical basis for quantitating its behavior. This revealed not only that the IgEFc exists in a bent conformation in solution but also that the bend is indeed enhanced upon Fc epsilon RI binding. No change in the degree of bending was seen upon binding to the B cell receptor for IgE, CD23 (Fc epsilon RII), but in contrast, binding of the anti-IgE therapeutic antibody omalizumab decreases the extent of the bend, implying a conformational change that opposes Fc epsilon RI engagement. HomoFRET measurements further revealed that the (C epsilon 2)(2) and (C epsilon 4)(2) domain pairs behave as rigid units flanking the conformational change in the C epsilon 3 domains. Finally, modeling of the accessible conformations of the two Fab arms in Fc epsilon RI-bound IgE revealed a mutual exclusion not seen in IgG and Fab orientations relative to the membrane that may predispose receptor-bound IgE to cross-linking by allergens.	[Hunt, James; Keeble, Anthony H.; Dale, Robert E.; Corbett, Melissa K.; Beavil, Rebecca L.; Ameer-Beg, Simon; Sutton, Brian J.; Beavil, Andrew J.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Hunt, James; Keeble, Anthony H.; Beavil, Rebecca L.; Sutton, Brian J.; Beavil, Andrew J.] Kings Coll London, MRC, London SE1 1UL, England; [Hunt, James; Keeble, Anthony H.; Beavil, Rebecca L.; Sutton, Brian J.; Beavil, Andrew J.] Kings Coll London, Asthma UK Ctr Allerg Mech Asthma, London SE1 1UL, England; [Hunt, James; Keeble, Anthony H.; Beavil, Rebecca L.; Beavil, Andrew J.] Kings Coll London, Div Asthma Allergy & Lung Biol, London SE1 1UL, England; [Levitt, James; Suhling, Klaus] Kings Coll London, Dept Phys, London WC2R 2LS, England; [Swann, Marcus J.] Farfield Grp Ltd, Voyager, Manchester M90 3DQ, Lancs, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London	Beavil, AJ (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, New Hunts House,Guys Campus, London SE1 1UL, England.	andrew.beavil@kcl.ac.uk	Beavil, Andrew/B-5624-2009	Beavil, Andrew/0000-0002-0768-122X; Keeble, Anthony/0000-0002-4873-6960; suhling, klaus/0000-0001-8797-5430; Ameer-Beg, Simon/0000-0001-5227-575X	Asthma UK; Medical Research Council (UK); Biotechnology and Biological Sciences Research Council [BB/D011086/1] Funding Source: researchfish; Medical Research Council [G1000758, G0501494, G1000758B, G1100090] Funding Source: researchfish; BBSRC [BB/D011086/1] Funding Source: UKRI; MRC [G0501494, G1100090] Funding Source: UKRI	Asthma UK; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from Asthma UK and the Medical Research Council (UK).	BAIRD B, 1985, BIOCHEMISTRY-US, V24, P6252, DOI 10.1021/bi00343a032; Barber PR, 2009, J R SOC INTERFACE, V6, pS93, DOI 10.1098/rsif.2008.0451.focus; BASTIAENS PIH, 1992, BIOPHYS J, V63, P839, DOI 10.1016/S0006-3495(92)81659-4; BEAVIL AJ, 1995, BIOCHEMISTRY-US, V34, P14449, DOI 10.1021/bi00044a023; BLUMBERG WE, 1974, BIOPOLYMERS, V13, P1607, DOI 10.1002/bip.1974.360130808; BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Cook JPD, 1997, BIOCHEMISTRY-US, V36, P15579, DOI 10.1021/bi9713005; Cotlet M, 2001, J PHYS CHEM B, V105, P4999, DOI 10.1021/jp003813i; DALE RE, 1979, BIOPHYS J, V26, P161, DOI 10.1016/S0006-3495(79)85243-1; DALE RE, 1980, BIOPHYS J, V30, P365; DAVIS KG, 1990, BIOCHEM SOC T, V18, P935, DOI 10.1042/bst0180935; DeLano WL, 2011, PYMOL MOL GRAPHICS S; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Forster, 1951, FLUORESZENZ ORGANISC; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Gould HJ, 2003, ANNU REV IMMUNOL, V21, P579, DOI 10.1146/annurev.immunol.21.120601.141103; GOUNNI AS, 1994, NATURE, V367, P183, DOI 10.1038/367183a0; Harris LJ, 1997, BIOCHEMISTRY-US, V36, P1581, DOI 10.1021/bi962514+; Harrison PT, 1998, PROTEIN ENG, V11, P225, DOI 10.1093/protein/11.3.225; Heikal AA, 2001, CHEM PHYS, V274, P37, DOI 10.1016/S0301-0104(01)00486-4; Hink MA, 2000, J BIOL CHEM, V275, P17556, DOI 10.1074/jbc.M001348200; Holdom MD, 2011, NAT STRUCT MOL BIOL, V18, P571, DOI 10.1038/nsmb.2044; Holgate S, 2005, J ALLERGY CLIN IMMUN, V115, P459, DOI 10.1016/j.jaci.2004.11.053; HOLOWKA D, 1990, BIOCHEMISTRY-US, V29, P4607, DOI 10.1021/bi00471a015; Hunt J, 2008, J BIOL CHEM, V283, P29882, DOI 10.1074/jbc.M804742200; KEOWN MB, 1995, P NATL ACAD SCI USA, V92, P1841, DOI 10.1073/pnas.92.6.1841; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Li M, 2008, J BIOL CHEM, V283, P22806, DOI 10.1074/jbc.M800937200; Li XQ, 1997, J BIOL CHEM, V272, P28545, DOI 10.1074/jbc.272.45.28545; Lu JH, 2011, J BIOL CHEM, V286, P40608, DOI 10.1074/jbc.M111.257550; McDonnell JM, 2001, NAT STRUCT BIOL, V8, P437, DOI 10.1038/87603; MILLER L, 1989, SCIENCE, V244, P334, DOI 10.1126/science.2523561; Niemi M, 2007, STRUCTURE, V15, P1413, DOI 10.1016/j.str.2007.09.012; OI VT, 1984, NATURE, V307, P136, DOI 10.1038/307136a0; Paar JM, 2002, J IMMUNOL, V169, P856, DOI 10.4049/jimmunol.169.2.856; PADLAN EA, 1986, MOL IMMUNOL, V23, P1063, DOI 10.1016/0161-5890(86)90005-2; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; Pham E, 2007, STRUCTURE, V15, P515, DOI 10.1016/j.str.2007.03.009; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Roux KH, 1998, J IMMUNOL, V161, P4083; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Sayers I, 2004, J BIOL CHEM, V279, P35320, DOI 10.1074/jbc.M404575200; SCHWEITZERSTENNER R, 1987, BIOCHEMISTRY-US, V26, P3602, DOI 10.1021/bi00386a053; Seward HE, 2009, CHEM SOC REV, V38, P2842, DOI 10.1039/b901355p; Shi JG, 1997, BIOCHEMISTRY-US, V36, P2112, DOI 10.1021/bi961231e; Shi XH, 2007, BIOCHEMISTRY-US, V46, P14403, DOI 10.1021/bi701575n; Sil D, 2007, ACS CHEM BIOL, V2, P674, DOI 10.1021/cb7001472; SLATTERY J, 1985, BIOCHEMISTRY-US, V24, P7810, DOI 10.1021/bi00347a046; Squire A, 2004, J STRUCT BIOL, V147, P62, DOI 10.1016/j.jsb.2003.10.013; Suhling K, 2002, BIOPHYS J, V83, P3589, DOI 10.1016/S0006-3495(02)75359-9; Suhling K, 2002, J FLUORESC, V12, P91, DOI 10.1023/A:1015323606154; Swann MJ, 2004, ANAL BIOCHEM, V329, P190, DOI 10.1016/j.ab.2004.02.019; TANAKA F, 1979, PHOTOCHEM PHOTOBIOL, V29, P1091, DOI 10.1111/j.1751-1097.1979.tb07825.x; Thaler C, 2009, P NATL ACAD SCI USA, V106, P6369, DOI 10.1073/pnas.0901913106; Uskova MA, 2000, BIOPHYS CHEM, V87, P73, DOI 10.1016/S0301-4622(00)00184-8; van der Meer B W, 2002, J Biotechnol, V82, P181, DOI 10.1016/S1389-0352(01)00037-X; Vogel S. S., 2010, FLIM MICROSCOPY BIOL, P245; Wan SB, 2007, BIOPHYS CHEM, V129, P218, DOI 10.1016/j.bpc.2007.06.003; Wan T, 2002, NAT IMMUNOL, V3, P681, DOI 10.1038/ni811; WANK SA, 1983, BIOCHEMISTRY-US, V22, P954, DOI 10.1021/bi00273a038; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yeow EKL, 2007, BIOPHYS J, V92, P3098, DOI [10.1529/biophysj.106.099424, 10.1529/biophysj. 106.099424]; YOUNG RJ, 1995, PROTEIN ENG, V8, P193, DOI 10.1093/protein/8.2.193; ZHENG Y, 1992, BIOCHEMISTRY-US, V31, P7446, DOI 10.1021/bi00148a004; ZHENG Y, 1991, BIOCHEMISTRY-US, V30, P9125, DOI 10.1021/bi00102a002	69	33	34	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17459	17470		10.1074/jbc.M111.331967	http://dx.doi.org/10.1074/jbc.M111.331967			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22442150	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000306373000046
J	Goehring, I; Gerencser, AA; Schmidt, S; Brand, MD; Mulder, H; Nicholls, DG				Goehring, Isabel; Gerencser, Akos A.; Schmidt, Sara; Brand, Martin D.; Mulder, Hindrik; Nicholls, David G.			Plasma Membrane Potential Oscillations in Insulin Secreting Ins-1 832/13 Cells Do Not Require Glycolysis and Are Not Initiated by Fluctuations in Mitochondrial Bioenergetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; CYTOPLASMIC FREE CA2+; OXYGEN-CONSUMPTION; GLUCOSE; METABOLISM; CALCIUM; ISLETS; VISUALIZATION; EXOCYTOSIS; ENERGETICS	Oscillations in plasma membrane potential play a central role in glucose-induced insulin secretion from pancreatic beta-cells and related insulinoma cell lines. We have employed a novel fluorescent plasma membrane potential (Delta psi(p)) indicator in combination with indicators of cytoplasmic free Ca2+ ([Ca2+](c)), mitochondrial membrane potential (Delta psi(m)), matrix ATP concentration, and NAD(P)H fluorescence to investigate the role of mitochondria in the generation of plasma membrane potential oscillations in clonal INS-1 832/13 beta-cells. Elevated glucose caused oscillations in plasma membrane potential and cytoplasmic free Ca2+ concentration over the same concentration range required for insulin release, although considerable cell-to-cell heterogeneity was observed. Exogenous pyruvate was as effective as glucose in inducing oscillations, both in the presence and absence of 2.8mM glucose. Increased glucose and pyruvate each produced a concentration-dependent mitochondrial hyperpolarization. The causal relationships between pairs of parameters (Delta psi(p) and [Ca2+](c), Delta psi(p) and NAD(P)H, matrix ATP and [Ca2+](c), and Delta psi(m) and [Ca2+](c)) were investigated at single cell level. It is concluded that, in these beta-cells, depolarizing oscillations in Delta psi(p) are not initiated by mitochondrial bioenergetic changes. Instead, regardless of substrate, it appears that the mitochondria may simply be required to exceed a critical bioenergetic threshold to allow release of insulin. Once this threshold is exceeded, an autonomous Delta psi(p) oscillatory mechanism is initiated.	[Nicholls, David G.] Lund Univ, Ctr Diabet, Scania Univ Hosp, Dept Clin Sci,Unit Mol Metab,CRC, S-20502 Malmo, Sweden; [Gerencser, Akos A.; Brand, Martin D.; Nicholls, David G.] Buck Inst Res Aging, Novato, CA 94945 USA	Lund University; Buck Institute for Research on Aging	Nicholls, DG (corresponding author), Lund Univ, Ctr Diabet, Scania Univ Hosp, Dept Clin Sci,Unit Mol Metab,CRC, S-20502 Malmo, Sweden.	david.nicholls@med.lu.se	Brand, Martin D/A-9423-2012; NICHOLLS, DAVID G/K-4300-2012; Mulder, Hindrik/E-1045-2012	Brand, Martin D/0000-0003-4418-6153; Mulder, Hindrik/0000-0002-6593-8417	National Institutes of Health [P01 AG025901, P30 AG025708]; Swedish Research Council; Knut and Alice Wallenberg Foundation; NATIONAL INSTITUTE ON AGING [P01AG025901, P30AG025708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 AG025901 and P30 AG025708. This work was also supported by the Swedish Research Council and the Knut and Alice Wallenberg Foundation (to I. G., S. S., and H. M.).	Ainscow EK, 2002, DIABETES, V51, pS162, DOI 10.2337/diabetes.51.2007.S162; Antinozzi PA, 2002, J BIOL CHEM, V277, P11746, DOI 10.1074/jbc.M108462200; ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; Baxter DF, 2002, J BIOMOL SCREEN, V7, P79, DOI 10.1177/108705710200700110; Beauvois MC, 2006, AM J PHYSIOL-CELL PH, V290, pC1503, DOI 10.1152/ajpcell.00400.2005; Bergsten P, 2002, DIABETES, V51, pS171, DOI 10.2337/diabetes.51.2007.S171; Bertram R., 2007, AM J PHYSIOL-ENDOC M, V56, pE890; Brown LJ, 2009, J BIOL CHEM, V284, P35359, DOI 10.1074/jbc.M109.040394; Civelek VN, 1997, DIABETES, V46, P51, DOI 10.2337/diabetes.46.1.51; Cunningham MD, 1999, METH MOL B, V128, P179; Dahgren GM, 2005, BBA-GEN SUBJECTS, V1724, P23, DOI 10.1016/j.bbagen.2005.04.007; DUCHEN MR, 1992, BIOCHEM J, V283, P41, DOI 10.1042/bj2830041; DUCHEN MR, 1992, J PHYSIOL-LONDON, V450, P33, DOI 10.1113/jphysiol.1992.sp019115; Gerencser AA, 2009, J NEUROCHEM, V110, P990, DOI 10.1111/j.1471-4159.2009.06194.x; GILON P, 1993, J BIOL CHEM, V268, P22265; GILON P, 1992, J BIOL CHEM, V267, P20713; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Heart E., 2005, AM J PHYSIOL-ENDOC M, V290, P143; Heart E, 2007, BIOCHEM J, V403, P197, DOI 10.1042/BJ20061209; Hjortoe GM, 2004, ACTA DIABETOL, V41, P185, DOI 10.1007/s00592-004-0164-9; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Ishihara H, 1999, J CLIN INVEST, V104, P1621, DOI 10.1172/JCI7515; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jing XJ, 2005, J CLIN INVEST, V115, P146, DOI 10.1172/JCI200522518; Jung SK, 2000, J BIOL CHEM, V275, P6642, DOI 10.1074/jbc.275.9.6642; Kanno T, 2004, METHODS, V33, P302, DOI 10.1016/j.ymeth.2004.01.003; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Kindmark H, 2001, J BIOL CHEM, V276, P34530, DOI 10.1074/jbc.M102492200; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Krippeit-Drews P, 2000, BIOCHEM BIOPH RES CO, V267, P179, DOI 10.1006/bbrc.1999.1921; Liu T, 2009, J BIOENERG BIOMEMBR, V41, P127, DOI 10.1007/s10863-009-9216-8; Luciani DS, 2006, J PHYSIOL-LONDON, V572, P379, DOI 10.1113/jphysiol.2005.101766; MacDonald MJ, 2008, AM J PHYSIOL-CELL PH, V294, pC442, DOI 10.1152/ajpcell.00368.2007; MacDonald MJ, 2007, J BIOL CHEM, V282, P6043, DOI 10.1074/jbc.M606652200; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Magnus G, 1997, AM J PHYSIOL-CELL PH, V273, pC717, DOI 10.1152/ajpcell.1997.273.2.C717; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Nakano M, 2011, ACS CHEM BIOL, V6, P709, DOI 10.1021/cb100313n; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; Nilsson T, 1996, BIOCHEM J, V314, P91, DOI 10.1042/bj3140091; Nunemaker CS, 2004, ENDOCRINE, V25, P61, DOI 10.1385/ENDO:25:1:61; Porksen N, 2002, DIABETES, V51, pS245, DOI 10.2337/diabetes.51.2007.S245; PRALONG WF, 1994, J BIOL CHEM, V269, P27310; Rutter GA, 2004, CELL BIOCHEM BIOPHYS, P179; Song SH, 2000, J CLIN ENDOCR METAB, V85, P4491, DOI 10.1210/jc.85.12.4491; Ullrich S, 1996, PFLUG ARCH EUR J PHY, V432, P630, DOI 10.1007/s004240050179; Ward MW, 2000, J NEUROSCI, V20, P7208; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Wiederkehr A, 2009, EMBO J, V28, P417, DOI 10.1038/emboj.2008.302	51	31	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15706	15717		10.1074/jbc.M111.314567	http://dx.doi.org/10.1074/jbc.M111.314567			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22418435	hybrid, Green Published			2022-12-27	WOS:000304006300049
J	Ho, WC; Pikor, L; Gao, Y; Elliott, BE; Greer, PA				Ho, Wai-chi; Pikor, Larissa; Gao, Yan; Elliott, Bruce E.; Greer, Peter A.			Calpain 2 Regulates Akt-FoxO-p27(Kip1) Protein Signaling Pathway in Mammary Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-SUBUNIT GENE; UBIQUITOUS CALPAINS; EMBRYONIC-DEVELOPMENT; MEDIATED PROTEOLYSIS; TUMOR-SUPPRESSOR; CELL-MIGRATION; P27(KIP1); APOPTOSIS; CANCER; ACTIVATION	We investigated the role of the ubiquitously expressed calpain 2 isoform in breast tumor cell growth, migration, signaling, and tumorigenesis. RNAi-mediated knockdown of the capn2 transcript was used to manipulate expression of the catalytic subunit of calpain 2 in the AC2M2 mouse mammary carcinoma cell line. Stable knockdown of capn2 correlated with reduced in vitro proliferation rates, soft agar colony formation efficiency, and migration rates, indicating roles for calpain 2 in mitogenesis, survival, and motogenesis. Biochemical analysis showed increased levels of protein phosphatase 2A and reduced levels of activated Akt in calpain 2-deficient cells, and this correlated with increased levels of the FoxO3a target gene product p27(Kip1), a key regulator of cell proliferation. Calpain 2 deficiency in the AC2M2 cells correlated with enhanced nuclear localization of FoxO3a, consistent with it being in a derepressed state capable of regulating transcriptional targets. Orthotopically engrafted calpain 2 knockdown AC2M2 cells generated tumors with reduced growth rates and enhanced in vivo expression of p27(Kip1). In summary, calpain 2 deficiency correlated with reduced Akt activity, increased protein phosphatase 2A levels, derepression of FoxO3a, and enhanced expression of the p27(Kip1) tumor suppressor. These observations argue that calpain 2 promotes tumor cell growth both in vitro and in vivo through the PI3K-Akt-FoxO-p27(Kip1) signaling cascade. Inhibition of calpain 2 might therefore provide therapeutic benefits in the treatment of cancer.	[Ho, Wai-chi; Pikor, Larissa; Gao, Yan; Elliott, Bruce E.; Greer, Peter A.] Queens Univ, Dept Pathol & Mol Med, Div Canc Biol & Genet, Queens Canc Res Inst, Kingston, ON K7L 3N6, Canada	McMaster University; Queens University - Canada	Greer, PA (corresponding author), Queens Univ, Dept Pathol & Mol Med, Div Canc Biol & Genet, Queens Canc Res Inst, Kingston, ON K7L 3N6, Canada.	greerp@queensu.ca			Canadian Institutes of Health Research [81189]; Canadian Breast Cancer Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	This work was supported by Canadian Institutes of Health Research Grant 81189 (to P.A.G.) and a fellowship award from the Canadian Breast Cancer Foundation (to W.H.).	Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Bertoli C, 2009, ONCOGENE, V28, P721, DOI 10.1038/onc.2008.425; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Blain SW, 2002, NAT MED, V8, P1076, DOI 10.1038/nm1002-1076; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; Cortesio CL, 2011, J BIOL CHEM, V286, P9998, DOI 10.1074/jbc.M110.187294; Delmas C, 2003, J BIOL CHEM, V278, P12443, DOI 10.1074/jbc.M209523200; Demarchi F, 2005, CELL DEATH DIFFER, V12, P512, DOI 10.1038/sj.cdd.4401592; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Dutt P, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-3; ELLIOTT BE, 1992, INT J CANCER, V51, P416, DOI 10.1002/ijc.2910510314; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guan N, 2006, INT J ONCOL, V29, P655; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Kashiwagi A, 2010, MOL CELL BIOL, V30, P2799, DOI 10.1128/MCB.00157-10; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Kuchay SM, 2007, CURR OPIN HEMATOL, V14, P249, DOI 10.1097/MOH.0b013e3280ef68f8; Kulkarni S, 2010, ONCOGENE, V29, P1339, DOI 10.1038/onc.2009.422; Lakshmikuttyamma A, 2004, CANCER EPIDEM BIOMAR, V13, P1604; Le XF, 2005, CELL CYCLE, V4, P87, DOI 10.4161/cc.4.1.1360; Mamoune A, 2003, CANCER RES, V63, P4632; Mellgren RL, 2009, BBA-MOL CELL RES, V1793, P1886, DOI 10.1016/j.bbamcr.2009.09.013; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Nahta R, 2004, CANCER RES, V64, P3981, DOI 10.1158/0008-5472.CAN-03-3900; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Patel YM, 2000, J BIOL CHEM, V275, P17653, DOI 10.1074/jbc.M910445199; Perrin BJ, 2006, MOL BIOL CELL, V17, P239, DOI 10.1091/mbc.e05-06-0488; Philipp-Staheli J, 2001, EXP CELL RES, V264, P148, DOI 10.1006/excr.2000.5143; Sawhney RS, 2006, J BIOL CHEM, V281, P8497, DOI 10.1074/jbc.M600787200; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; Sriuranpong V, 2004, CLIN CANCER RES, V10, P4944, DOI 10.1158/1078-0432.CCR-03-0757; Tan YF, 2006, J BIOL CHEM, V281, P16016, DOI 10.1074/jbc.M601299200; Tan Y, 2006, GENESIS, V44, P297, DOI 10.1002/dvg.20216; Tan Y, 2006, J BIOL CHEM, V281, P17689, DOI 10.1074/jbc.M601978200; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Wernimont SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010513; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200; Zimmerman UJP, 2000, IUBMB LIFE, V50, P63	48	36	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15458	15465		10.1074/jbc.M112.349308	http://dx.doi.org/10.1074/jbc.M112.349308			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427650	Green Published, hybrid			2022-12-27	WOS:000304006300027
J	Jung, JH; Seo, PJ; Ahn, JH; Park, CM				Jung, Jae-Hoon; Seo, Pil Joon; Ahn, Ji Hoon; Park, Chung-Mo			Arabidopsis RNA-binding Protein FCA Regulates MicroRNA172 Processing in Thermosensory Flowering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMBIENT-TEMPERATURE; FLORAL TRANSITION; TIME; PLANTS; THALIANA; GENE; TRANSCRIPTION; APETALA2; MIR172; PERCEPTION	Ambient temperature fluctuates diurnally and seasonally. It profoundly influences the timing of flowering in plants. The floral integrator FLOWERING LOCUS T (FT) mediates ambient temperature signals via the thermosensory pathway in Arabidopsis flowering. microRNA172 (miR172), which promotes flowering by inducing FT, also responds to changes in ambient temperature. However, it is largely unknown how miR172 integrates ambient temperature signals into the flowering genetic network. Here, we show that Arabidopsis RNA-binding protein FCA promotes the processing of primary microRNA172 transcripts (pri-miR172) in response to changes in ambient temperature. Ambient temperature regulates miR172 biogenesis primarily at the pri-miR172 processing step. miR172 abundance is elevated at 23 degrees C but not at 16 degrees C. miR172 accumulation at 23 degrees C requires functional FCA. FCA binds to the flanking sequences of the stem-loop within the pri-miR172 transcripts via the RNA recognition motif. FCA also binds to the primary transcripts of other temperature-responsive miRNAs, such as miR398 and miR399. Notably, levels of FCA mRNAs and proteins increase at 23 degrees C but remain low at 16 degrees C, supporting the role of FCA in temperature perception. Our data show that FCA regulation of miR172 processing is an early event in the thermosensory flowering pathway. We propose that the FCA-miR172 regulon provides an adaptive strategy that fine tunes the onset of flowering under fluctuating ambient temperature conditions.	[Jung, Jae-Hoon; Seo, Pil Joon; Park, Chung-Mo] Seoul Natl Univ, Dept Chem, Seoul 151742, South Korea; [Park, Chung-Mo] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul 151742, South Korea; [Ahn, Ji Hoon] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea University	Park, CM (corresponding author), Seoul Natl Univ, Dept Chem, 1 Gwanak Ro, Seoul 151742, South Korea.	cmpark@snu.ac.kr	Seo, Pil Joon/AAR-9426-2020; Ahn, Ji Hoon/A-4141-2011; Park, Chung-Mo/B-6175-2012	Ahn, Ji Hoon/0000-0003-0347-3922; 	Leaping Research Program [20110016440]; National Research Foundation of Korea; Plant Molecular Breeding Center [PJ008103]; Rural Development Administration; Plant Signaling Network Research Center [20110001099]; Agricultural Research and Development Promotion Center, Korea Ministry for Food, Agriculture, Forestry and Fisheries [30901703]; Creative Research Initiatives of the National Research Foundation for the Ministry of Education, Science and Technology [R16-2008-106-01000-0]	Leaping Research Program; National Research Foundation of Korea(National Research Foundation of Korea); Plant Molecular Breeding Center; Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Plant Signaling Network Research Center; Agricultural Research and Development Promotion Center, Korea Ministry for Food, Agriculture, Forestry and Fisheries; Creative Research Initiatives of the National Research Foundation for the Ministry of Education, Science and Technology	This work was supported by the Leaping Research Program (Grant 20110016440) provided by the National Research Foundation of Korea; the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center Number PJ008103) provided by the Rural Development Administration; the Plant Signaling Network Research Center (Grant 20110001099); the Agricultural Research and Development Promotion Center (Grant 30901703), Korea Ministry for Food, Agriculture, Forestry and Fisheries; and the Creative Research Initiatives of the National Research Foundation for the Ministry of Education, Science and Technology (Grant R16-2008-106-01000-0 to J. H. A.).	Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; Baurle I, 2007, SCIENCE, V318, P109, DOI 10.1126/science.1146565; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Baurle I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002733; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; Grigorova B, 2011, DEVELOPMENT, V138, P2451, DOI 10.1242/dev.058362; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Hornyik C, 2010, DEV CELL, V18, P203, DOI 10.1016/j.devcel.2009.12.009; Jiao XF, 2002, BIOL REPROD, V66, P475, DOI 10.1095/biolreprod66.2.475; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Jung JH, 2011, PLANT MOL BIOL, V76, P35, DOI 10.1007/s11103-011-9759-z; Kim YK, 2010, CELL, V143, P703, DOI 10.1016/j.cell.2010.11.018; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Lee H, 2010, NUCLEIC ACIDS RES, V38, P3081, DOI 10.1093/nar/gkp1240; LEE I, 1995, PLANT PHYSIOL, V108, P157, DOI 10.1104/pp.108.1.157; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Lim MH, 2004, PLANT CELL, V16, P731, DOI 10.1105/tpc.019331; Liu FQ, 2007, MOL CELL, V28, P398, DOI 10.1016/j.molcel.2007.10.018; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Lorkovic ZJ, 2009, TRENDS PLANT SCI, V14, P229, DOI 10.1016/j.tplants.2009.01.007; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Macknight R, 2002, PLANT CELL, V14, P877, DOI 10.1105/tpc.010456; Mathieu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000148; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Samach A, 2005, CURR OPIN PLANT BIOL, V8, P483, DOI 10.1016/j.pbi.2005.07.011; Seo PJ, 2010, PLANT J, V61, P661, DOI 10.1111/j.1365-313X.2009.04091.x; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Sire C, 2009, FEBS LETT, V583, P1039, DOI 10.1016/j.febslet.2009.02.024; Sonmez C, 2011, P NATL ACAD SCI USA, V108, P8508, DOI 10.1073/pnas.1105334108; Strasser B, 2009, PLANT J, V58, P629, DOI 10.1111/j.1365-313X.2009.03811.x; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Telfer A, 1997, DEVELOPMENT, V124, P645; Terzi LC, 2009, PLANT J, V59, P163, DOI 10.1111/j.1365-313X.2009.03859.x; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wollmann H, 2010, DEVELOPMENT, V137, P3633, DOI 10.1242/dev.036673; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xie ZX, 2010, SEMIN CELL DEV BIOL, V21, P790, DOI 10.1016/j.semcdb.2010.03.012; Yang L, 2006, PLANT J, V47, P841, DOI 10.1111/j.1365-313X.2006.02835.x; Yant L, 2010, PLANT CELL, V22, P2156, DOI 10.1105/tpc.110.075606	50	64	79	5	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					16007	16016		10.1074/jbc.M111.337485	http://dx.doi.org/10.1074/jbc.M111.337485			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22431732	Green Published, hybrid			2022-12-27	WOS:000304006300078
J	Lei, W; Feng, XH; Deng, WB; Ni, H; Zhang, ZR; Jia, B; Yang, XL; Wang, TS; Liu, JL; Su, RW; Liang, XH; Qi, QR; Yang, ZM				Lei, Wei; Feng, Xu-Hui; Deng, Wen-Bo; Ni, Hua; Zhang, Zhi-Rong; Jia, Bo; Yang, Xin-Ling; Wang, Tong-Song; Liu, Ji-Long; Su, Ren-Wei; Liang, Xiao-Huan; Qi, Qian-Rong; Yang, Zeng-Ming			Progesterone and DNA Damage Encourage Uterine Cell Proliferation and Decidualization through Up-regulating Ribonucleotide Reductase 2 Expression during Early Pregnancy in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOMETRIAL STROMAL CELLS; EMBRYO IMPLANTATION; MOUSE UTERUS; DIFFERENTIAL EXPRESSION; TOPOISOMERASE-I; GENE-EXPRESSION; REPLICATION; SUBUNIT; CHECKPOINT; INHIBITION	Embryo implantation into the maternal uterus is a crucial step for the successful establishment of mammalian pregnancy. Following the attachment of embryo to the uterine luminal epithelium, uterine stromal cells undergo steroid hormone-dependent decidualization, which is characterized by stromal cell proliferation and differentiation. The mechanisms underlying steroid hormone-induced stromal cell proliferation and differentiation during decidualization are still poorly understood. Ribonucleotide reductase, consisting of two subunits (RRM1 and RRM2), is a rate-limiting enzyme in deoxynucleotide production for DNA synthesis and plays an important role in cell proliferation and tumorgenicity. Based on our microarray analysis, Rrm2 expression was significantly higher at implantation sites compared with interimplantation sites in mouse uterus. However, the expression, regulation, and function of RRM2 in mouse uterus during embryo implantation and decidualization are still unknown. Here we show that although both RRM1 and RRM2 expression are markedly induced in mouse uterine stromal cells undergoing decidualization, only RRM2 is regulated by progesterone, a key regulator of decidualization. Further studies showed that the induction of progesterone on RRM2 expression in stromal cells is mediated by the AKT/c-MYC pathway. RRM2 can also be induced by replication stress and DNA damage during decidualization through the ATR/ATM-CHK1-E2F1 pathway. The weight of implantation sites and deciduoma was effectively reduced by specific inhibitors for RRM2. The expression of decidual/trophoblast prolactin-related protein (Dtprp), a reliable marker for decidualization in mice, was significantly reduced in deciduoma and steroid-induced decidual cells after HU treatment. Therefore, RRM2 may be an important effector of progesterone signaling to induce cell proliferation and decidualization in mouse uterus.	[Lei, Wei; Wang, Tong-Song; Liu, Ji-Long; Qi, Qian-Rong; Yang, Zeng-Ming] Shantou Univ, Dept Biol, Shantou 515063, Peoples R China; [Lei, Wei; Ni, Hua; Su, Ren-Wei] NE Agr Univ, Coll Life Sci, Harbin 150030, Peoples R China; [Feng, Xu-Hui; Deng, Wen-Bo; Zhang, Zhi-Rong; Jia, Bo; Yang, Xin-Ling; Liang, Xiao-Huan; Yang, Zeng-Ming] Xiamen Univ, Coll Life Sci, Xiamen 361005, Peoples R China	Shantou University; Northeast Agricultural University - China; Xiamen University	Yang, ZM (corresponding author), Shantou Univ, Dept Biol, Shantou 515063, Peoples R China.	zmyang@stu.edu.cn	yang, xin/HGU-9981-2022; feng, xuhui/D-9450-2017; Lei, Wei/N-7611-2013; Lei, Wei/I-3640-2014; ZHANG, Zhirong/A-3422-2015; Qi, Qian-Rong/AAV-7553-2020; Yang, xinling/HHC-1621-2022; Yang, ZM/G-4627-2010; feng, xuhui/AAD-9832-2019	feng, xuhui/0000-0003-4649-183X; Lei, Wei/0000-0002-8342-8859; ZHANG, Zhirong/0000-0002-7331-783X; Qi, Qian-Rong/0000-0003-0276-7187; Liu, Ji-Long/0000-0002-6948-2576	National Basic Research Program of China [2011CB944402]; National Natural Science Foundation of China [30930013, 31071276]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2011CB944402 and National Natural Science Foundation of China Grants 30930013 and 31071276.	Ai NP, 2011, NUCLEIC ACIDS RES, V39, P9592, DOI 10.1093/nar/gkr698; ANSELL JD, 1974, J EMBRYOL EXP MORPH, V31, P223; BJORKLUND S, 1990, BIOCHEMISTRY-US, V29, P5452; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031; Dominguez-Caceres MA, 2004, ONCOGENE, V23, P7378, DOI 10.1038/sj.onc.1208002; ENGSTROM Y, 1985, J BIOL CHEM, V260, P9114; ERIKSSON S, 1984, J BIOL CHEM, V259, P1695; Franco HL, 2008, SEMIN CELL DEV BIOL, V19, P178, DOI 10.1016/j.semcdb.2007.12.001; Fritzer-Szekeres M, 2002, BIOCHEM PHARMACOL, V64, P481, DOI 10.1016/S0006-2952(02)01186-3; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Herrler Andreas, 2003, Reprod Biomed Online, V6, P244; HOLM C, 1989, CANCER RES, V49, P6365; HSIANG YH, 1989, CANCER RES, V49, P5077; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Hu Zhang-Zhi, 2008, J Proteomics Bioinform, V1, P47; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; HUETHUDSON YM, 1989, ENDOCRINOLOGY, V125, P1683, DOI 10.1210/endo-125-3-1683; Kajihara T, 2011, PLACENTA, V32, P592, DOI 10.1016/j.placenta.2011.05.002; Kajihara T, 2006, MOL ENDOCRINOL, V20, P2444, DOI 10.1210/me.2006-0118; Kimura F, 2001, GYNECOL ENDOCRINOL, V15, P426, DOI 10.1080/713602980; Kuschak TI, 1999, GENE, V238, P351, DOI 10.1016/S0378-1119(99)00341-8; Labied S, 2006, MOL ENDOCRINOL, V20, P35, DOI 10.1210/me.2005-0275; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Liang XH, 2010, ENDOCRINOLOGY, V151, P5007, DOI 10.1210/en.2010-0170; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Ma XH, 2006, J BIOL CHEM, V281, P9351, DOI 10.1074/jbc.M511512200; Ma XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026774; MANN GJ, 1988, CANCER RES, V48, P5151; Ni H, 2002, BIOL REPROD, V67, P351, DOI 10.1095/biolreprod67.1.351; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Paria BC, 1999, ENDOCRINOLOGY, V140, P2704, DOI 10.1210/en.140.6.2704; Reese J, 2001, J BIOL CHEM, V276, P44137, DOI 10.1074/jbc.M107563200; REICHARD P, 1993, SCIENCE, V260, P1773, DOI 10.1126/science.8511586; Saban N, 2009, CANCER CHEMOTH PHARM, V64, P213, DOI 10.1007/s00280-009-0991-z; Shao JM, 2004, CANCER RES, V64, P1, DOI 10.1158/0008-5472.CAN-03-3048; Spencer F, 2000, J APPL TOXICOL, V20, P407, DOI 10.1002/1099-1263(200009/10)20:5<407::AID-JAT704>3.0.CO;2-T; SZEKERES T, 1994, CANCER CHEMOTH PHARM, V34, P63, DOI 10.1007/BF00686113; Tan Y, 2004, DEV BIOL, V265, P181, DOI 10.1016/j.ydbio.2003.09.019; Wang CX, 2006, PLANT CELL, V18, P350, DOI 10.1105/tpc.105.037044; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Ward IM, 2004, J BIOL CHEM, V279, P9677, DOI 10.1074/jbc.C300554200; Wilsker D, 2008, P NATL ACAD SCI USA, V105, P20752, DOI 10.1073/pnas.0806917106; Xavier LL, 2005, BRAIN RES PROTOC, V16, P58, DOI 10.1016/j.brainresprot.2005.10.002; Zhang YW, 2009, J BIOL CHEM, V284, P18085, DOI 10.1074/jbc.M109.003020; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BS, 2003, CANCER RES, V63, P6583	49	55	58	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15174	15192		10.1074/jbc.M111.308023	http://dx.doi.org/10.1074/jbc.M111.308023			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22403396	hybrid, Green Published			2022-12-27	WOS:000304006300003
J	Laussmann, MA; Passante, E; Hellwig, CT; Tomiczek, B; Flanagan, L; Prehn, JHM; Huber, HJ; Rehm, M				Laussmann, Maike A.; Passante, Egle; Hellwig, Christian T.; Tomiczek, Bartlomiej; Flanagan, Lorna; Prehn, Jochen H. M.; Huber, Heinrich J.; Rehm, Markus			Proteasome Inhibition Can Impair Caspase-8 Activation upon Submaximal Stimulation of Apoptotic Tumor Necrosis Factor-related Apoptosis Inducing Ligand (TRAIL) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; CYTOCHROME-C; DEATH; PATHWAY; PS-341; FLIP; REVEALS; PROTEIN; BAX; RESISTANCE	Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) can induce extrinsic apoptosis, resulting in caspase-8 activation, but may also initiate transcription-dependent pro-survival signaling. Proteasome inhibitors were suggested to promote TRAIL signal transduction through the death-inducing signaling complex (DISC) by modulating the relative abundance of core DISC components, thereby enhancing caspase-8 activation and apoptosis. To test this hypothesis, we quantified the changes in DISC protein levels as an early consequence of proteasome inhibition in HeLa cervical cancer cells and, based on these data, mathematically modeled the proapoptotic TRAIL signaling toward caspase-8 activation. Modeling results surprisingly suggested that caspase-8 activation might be delayed in presence of proteasome inhibitors, in particular at submaximal TRAIL doses. Subsequent FRET-based single cell time-lapse imaging at conditions where transcription dependent pro-survival signaling was blocked confirmed this hypothesis: caspase-8 activity was delayed by hours in the presence of proteasome inhibitors epoxomicin or bortezomib. Corresponding delays were detected for effector caspase processing and cell death. Contrary to current models, we therefore provide evidence that synergies between TRAIL and proteasome inhibitors do not result from changes in the levels of core DISC signaling proteins.	[Laussmann, Maike A.; Passante, Egle; Hellwig, Christian T.; Tomiczek, Bartlomiej; Flanagan, Lorna; Prehn, Jochen H. M.; Huber, Heinrich J.; Rehm, Markus] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Passante, Egle; Hellwig, Christian T.; Flanagan, Lorna; Prehn, Jochen H. M.; Huber, Heinrich J.; Rehm, Markus] Royal Coll Surgeons Ireland, Ctr Syst Med, Dublin 2, Ireland	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland	Rehm, M (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, RCSI York House,York St, Dublin 2, Ireland.	mrehm@rcsi.ie	Rehm, Markus/C-3398-2012; Prehn, Jochen HM/A-3928-2010	Rehm, Markus/0000-0001-6149-9261; Prehn, Jochen HM/0000-0003-3479-7794; Tomiczek, Bartlomiej/0000-0001-9295-663X	Science Foundation Ireland [07/RFP/BICF601, 06/UR/B920]; Health Research Board Ireland [(RP/2006/258, RP/2008/7]; Royal College of Surgeons in Ireland Research Committee; National Biophotonics and Imaging Platform (HEA PRTLI Cycle 4); European Union	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board Ireland; Royal College of Surgeons in Ireland Research Committee; National Biophotonics and Imaging Platform (HEA PRTLI Cycle 4); European Union(European Commission)	This work was supported by grants from the Science Foundation Ireland (07/RFP/BICF601), the Health Research Board Ireland (RP/2006/258, RP/2008/7), the Royal College of Surgeons in Ireland Research Committee, the National Biophotonics and Imaging Platform (HEA PRTLI Cycle 4), and the European Union Framework Programme 7 (APO-SYS).; Supported by an undergraduate research experience and knowledge award from the Science Foundation Ireland (06/UR/B920).	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Brancolini Claudio, 2008, Curr Mol Pharmacol, V1, P24; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Concannon CG, 2007, ONCOGENE, V26, P1681, DOI 10.1038/sj.onc.1209974; Cusack JC, 2001, CANCER RES, V61, P3535; Dussmann H, 2010, CELL DEATH DIFFER, V17, P278, DOI 10.1038/cdd.2009.123; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Fricker N, 2010, J CELL BIOL, V190, P377, DOI 10.1083/jcb.201002060; Guo F, 2004, CANCER RES, V64, P2580, DOI 10.1158/0008-5472.CAN-03-2629; Harper N, 2003, J BIOL CHEM, V278, P44338, DOI 10.1074/jbc.M307376200; He Q, 2004, ONCOGENE, V23, P2554, DOI 10.1038/sj.onc.1207351; Hellwig CT, 2008, J BIOL CHEM, V283, P21676, DOI 10.1074/jbc.M802889200; Hellwig CT, 2012, MOL CANCER THER, V11, P3, DOI 10.1158/1535-7163.MCT-11-0434; Huber HJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.2; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Johnson TR, 2003, ONCOGENE, V22, P4953, DOI 10.1038/sj.onc.1206656; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Konstantinova IM, 2008, INT REV CEL MOL BIO, V267, P59, DOI 10.1016/S1937-6448(08)00602-3; Kreuz S, 2004, J CELL BIOL, V166, P369, DOI 10.1083/jcb.200401036; Laussmann MA, 2011, CELL DEATH DIFFER, V18, P1584, DOI 10.1038/cdd.2011.27; Li WH, 2007, CANCER RES, V67, P2247, DOI 10.1158/0008-5472.CAN-06-3793; Liu XG, 2007, CANCER RES, V67, P4981, DOI 10.1158/0008-5472.CAN-06-4274; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; MacFarlane M, 1997, J BIOL CHEM, V272, P25417, DOI 10.1074/jbc.272.41.25417; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pennarun B, 2010, BBA-REV CANCER, V1805, P123, DOI 10.1016/j.bbcan.2009.11.004; Rehm M, 2006, EMBO J, V25, P4338, DOI 10.1038/sj.emboj.7601295; Sayers TJ, 2003, BLOOD, V102, P303, DOI 10.1182/blood-2002-09-2975; Soderstrom TS, 2002, J IMMUNOL, V169, P2851, DOI 10.4049/jimmunol.169.6.2851; Sohn D, 2006, MOL CELL BIOL, V26, P1967, DOI 10.1128/MCB.26.5.1967-1978.2006; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Zhang L, 2011, CELL DEATH DIFFER, V18, P864, DOI 10.1038/cdd.2010.152	36	30	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14402	14411		10.1074/jbc.M111.304378	http://dx.doi.org/10.1074/jbc.M111.304378			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22408249	Green Published, hybrid			2022-12-27	WOS:000304003200008
J	Hodgkinson, V; Petris, MJ				Hodgkinson, Victoria; Petris, Michael J.			Copper Homeostasis at the Host-Pathogen Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MULTICOPPER OXIDASE CUEO; ACUTE-PHASE RESPONSE; MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; TRACE-ELEMENTS; PSEUDOMONAS-AERUGINOSA; SALMONELLA-TYPHIMURIUM; DEFICIENT RATS; MENKES DISEASE; INFLAMED RATS	The trace element copper is indispensable for all aerobic life forms. Its ability to cycle between two oxidation states, Cu1+ and Cu2+, has been harnessed by a wide array of metalloenzymes that catalyze electron transfer reactions. The metabolic needs for copper are sustained by a complex series of transporters and carrier proteins that regulate its intracellular accumulation and distribution in both pathogenic microbes and their animal hosts. However, copper is also potentially toxic due in part to its ability to generate reactive oxygen species. Recent studies suggest that the macrophage phagosome accumulates copper during bacterial infection, which may constitute an important mechanism of killing. Bacterial countermeasures include the up-regulation of copper export and detoxification genes during infection, which studies suggest are important determinants of virulence. In this minireview, we summarize recent developments that suggest an emerging role for copper as an unexpected component in determining the outcome of host-pathogen interactions.	[Hodgkinson, Victoria; Petris, Michael J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Petris, Michael J.] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO 65211 USA; [Hodgkinson, Victoria; Petris, Michael J.] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Petris, MJ (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	petrism@missouri.edu	Johnson, Michael D. L./B-4352-2012		National Institutes of Health [DK59893, DK093866]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059893, R01DK093866] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK59893 and DK093866. This is the sixth article in the Thematic Minireview Series on Metals in Biology 2012.	Achard MES, 2010, INFECT IMMUN, V78, P2312, DOI 10.1128/IAI.01208-09; Agertt F, 2007, ARQ NEURO-PSIQUIAT, V65, P157, DOI 10.1590/S0004-282X2007000100032; Akcil E, 2003, BIOL TRACE ELEM RES, V93, P95, DOI 10.1385/BTER:93:1-3:95; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; AUER DE, 1989, VET REC, V124, P235, DOI 10.1136/vr.124.10.235; BABU U, 1990, J NUTR, V120, P1700, DOI 10.1093/jn/120.12.1700; BABU U, 1990, J NUTR, V120, P1692, DOI 10.1093/jn/120.12.1692; BEVERIDGE SJ, 1985, AGENTS ACTIONS, V17, P104, DOI 10.1007/BF01966692; Borkow G, 2005, CURR MED CHEM, V12, P2163, DOI 10.2174/0929867054637617; BOYNE R, 1981, J COMP PATHOL, V91, P271, DOI 10.1016/0021-9975(81)90032-3; Casey AL, 2010, J HOSP INFECT, V74, P72, DOI 10.1016/j.jhin.2009.08.018; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Checa SK, 2007, MOL MICROBIOL, V63, P1307, DOI 10.1111/j.1365-2958.2007.05590.x; Cobine P, 1999, FEBS LETT, V445, P27, DOI 10.1016/S0014-5793(99)00091-5; CONFORTI A, 1983, BRIT J PHARMACOL, V79, P45, DOI 10.1111/j.1476-5381.1983.tb10493.x; CROCKER A, 1992, J NATL MED ASSOC, V84, P697; DOLLWET HHA, 1985, TRACE ELEM MED, V2, P80; Elguindi J, 2009, J APPL MICROBIOL, V106, P1448, DOI 10.1111/j.1365-2672.2009.04148.x; Fang FC, 1999, P NATL ACAD SCI USA, V96, P7502, DOI 10.1073/pnas.96.13.7502; Festa RA, 2011, MOL MICROBIOL, V79, P133, DOI 10.1111/j.1365-2958.2010.07431.x; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; FOX PL, 1995, LIFE SCI, V56, P1749, DOI 10.1016/0024-3205(95)00146-W; Francis MS, 1997, MICROB PATHOGENESIS, V22, P67, DOI 10.1006/mpat.1996.0092; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Gold B, 2008, NAT CHEM BIOL, V4, P609, DOI 10.1038/nchembio.109; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Grass G, 2004, J BACTERIOL, V186, P5826, DOI 10.1128/JB.186.17.5826-5833.2004; Grass G, 2001, BIOCHEM BIOPH RES CO, V286, P902, DOI 10.1006/bbrc.2001.5474; GUNN TR, 1984, CLIN PEDIATR, V23, P514, DOI 10.1177/000992288402300915; Gupta A, 2009, FUTURE MED CHEM, V1, P1125, DOI 10.4155/FMC.09.84; HALLGREN R, 1987, J RHEUMATOL, V14, P548; Heithoff DM, 1997, P NATL ACAD SCI USA, V94, P934, DOI 10.1073/pnas.94.3.934; JONES DG, 1981, RES VET SCI, V31, P151, DOI 10.1016/S0034-5288(18)32485-8; JONES DG, 1983, J COMP PATHOL, V93, P143, DOI 10.1016/0021-9975(83)90052-X; Jones P W, 2001, J Wound Care, V10, P205; Kadiiska MB, 2002, SPECTROCHIM ACTA A, V58, P1227, DOI 10.1016/S1386-1425(01)00713-2; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Kim JS, 2002, FEMS MICROBIOL LETT, V210, P99, DOI 10.1111/j.1574-6968.2002.tb11166.x; Koyanagi A, 2004, ANN TROP MED PARASIT, V98, P391, DOI 10.1179/000349804225003424; KREUDER J, 1993, EUR J PEDIATR, V152, P828, DOI 10.1007/BF02073380; Lin YE, 2011, INFECT CONT HOSP EP, V32, P166, DOI 10.1086/657934; Liochev SI, 2002, REDOX REP, V7, P55, DOI 10.1179/135100002125000190; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; MILANINO R, 1993, AGENTS ACTIONS, V39, P195, DOI 10.1007/BF01998974; MORIMOTO A, 1989, AM J PHYSIOL, V256, pR35, DOI 10.1152/ajpregu.1989.256.1.R35; Nevitt T, 2011, BIOMETALS, V24, P547, DOI 10.1007/s10534-011-9431-8; NEWBERNE PM, 1968, BRIT J EXP PATHOL, V49, P448; Noyce JO, 2006, J HOSP INFECT, V63, P289, DOI 10.1016/j.jhin.2005.12.008; Osman D, 2010, J BIOL CHEM, V285, P25259, DOI 10.1074/jbc.M110.145953; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Outten FW, 2000, J BIOL CHEM, V275, P31024, DOI 10.1074/jbc.M006508200; Piddington DL, 2001, INFECT IMMUN, V69, P4980, DOI 10.1128/IAI.69.8.4980-4987.2001; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Pontel LB, 2007, MOL MICROBIOL, V66, P814, DOI 10.1111/j.1365-2958.2007.05963.x; Pontel LB, 2009, MOL MICROBIOL, V73, P212, DOI 10.1111/j.1365-2958.2009.06763.x; Rosenzweig SD, 2008, J CLIN IMMUNOL, V28, pS67, DOI 10.1007/s10875-007-9160-5; Santo CE, 2008, APPL ENVIRON MICROB, V74, P977, DOI 10.1128/AEM.01938-07; Santo CE, 2011, APPL ENVIRON MICROB, V77, P794, DOI 10.1128/AEM.01599-10; Scaletti RW, 2003, J DAIRY SCI, V86, P1240, DOI 10.3168/jds.S0022-0302(03)73708-4; Schwan WR, 2005, INT J MED MICROBIOL, V295, P237, DOI 10.1016/j.ijmm.2005.05.005; Seyrek A, 2005, BIOL TRACE ELEM RES, V106, P107, DOI 10.1385/BTER:106:2:107; Shafeeq S, 2011, MOL MICROBIOL, V81, P1255, DOI 10.1111/j.1365-2958.2011.07758.x; SHAH I, 1983, CANCER-AM CANCER SOC, V51, P851, DOI 10.1002/1097-0142(19830301)51:5<851::AID-CNCR2820510518>3.0.CO;2-Y; Singh SK, 2011, J BIOL CHEM, V286, P37849, DOI 10.1074/jbc.M111.293589; Smaldone GT, 2007, MICROBIOL-SGM, V153, P4123, DOI 10.1099/mic.0.2007/011742-0; Smith AD, 2008, J NUTR, V138, P849, DOI 10.1093/jn/138.5.849; Solioz M, 2010, J BIOL INORG CHEM, V15, P3, DOI 10.1007/s00775-009-0588-3; SRINIVAS U, 1988, SCAND J CLIN LAB INV, V48, P495, DOI 10.3109/00365518809085763; Stoyanov JV, 2001, MOL MICROBIOL, V39, P502, DOI 10.1046/j.1365-2958.2001.02264.x; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Torre Patrick M., 1995, Journal of Nutritional Immunology, V3, P3; Uno H, 1987, Am J Med Genet Suppl, V3, P367; Voruganti VS, 2005, BURNS, V31, P711, DOI 10.1016/j.burns.2005.04.026; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Ward SK, 2010, MOL MICROBIOL, V77, P1096, DOI 10.1111/j.1365-2958.2010.07273.x; WARD WF, 1989, ADV EXP MED BIOL, V258, P287; Wardman P, 1996, RADIAT RES, V145, P523, DOI 10.2307/3579270; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; White C, 2009, J CELL SCI, V122, P1315, DOI 10.1242/jcs.043216; Wolschendorf F, 2011, P NATL ACAD SCI USA, V108, P1621, DOI 10.1073/pnas.1009261108; Yilmaz A, 2005, CLIN RHEUMATOL, V24, P331, DOI 10.1007/s10067-004-1028-y	86	194	201	5	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13549	13555		10.1074/jbc.R111.316406	http://dx.doi.org/10.1074/jbc.R111.316406			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22389498	Green Published, hybrid			2022-12-27	WOS:000303996300007
J	Timofeeva, OA; Chasovskikh, S; Lonskaya, I; Tarasova, NI; Khavrutskii, L; Tarasov, SG; Zhang, XP; Korostyshevskiy, VR; Cheema, A; Zhang, LH; Dakshanamurthy, S; Brown, ML; Dritschilo, A				Timofeeva, Olga A.; Chasovskikh, Sergey; Lonskaya, Irina; Tarasova, Nadya I.; Khavrutskii, Lyuba; Tarasov, Sergey G.; Zhang, Xueping; Korostyshevskiy, Valeriy R.; Cheema, Amrita; Zhang, Lihua; Dakshanamurthy, Sivanesan; Brown, Milton L.; Dritschilo, Anatoly			Mechanisms of Unphosphorylated STAT3 Transcription actor Binding to DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRUCIFORM STRUCTURES; PROTEINS; GENE; EXPRESSION; IDENTIFICATION; SPECIFICITY; RECOGNITION; ACTIVATORS; ELEMENTS; DOMAINS	Phosphorylation of signal transducer and activator of transcription 3 (STAT3) on a single tyrosine residue in response to growth factors, cytokines, interferons, and oncogenes activates its dimerization, translocation to the nucleus, binding to the interferon gamma (gamma)-activated sequence (GAS) DNA-binding site and activation of transcription of target genes. STAT3 is constitutively phosphorylated in various cancers and drives gene expression from GAS-containing promoters to promote tumorigenesis. Recently, roles for unphosphorylated STAT3 (U-STAT3) have been described in response to cytokine stimulation, in cancers, and in maintenance of heterochromatin stability. However, the mechanisms underlying U-STAT3 binding to DNA has not been fully investigated. Here, we explore STAT3-DNA interactions by atomic force microscopy (AFM) imaging. We observed that U-STAT3 molecules bind to the GAS DNA-binding site as dimers and monomers. In addition, we observed that U-STAT3 binds to AT-rich DNA sequence sites and recognizes specific DNA structures, such as 4-way junctions and DNA nodes, within negatively supercoiled plasmid DNA. These structures are important for chromatin organization and our data suggest a role for U-STAT3 as a chromatin/genome organizer. Unexpectedly, we found that a C-terminal truncated 67.5-kDa STAT3 isoform recognizes single-stranded spacers within cruciform structures that also have a role in chromatin organization and gene expression. This isoform appears to be abundant in the nuclei of cancer cells and, therefore, may have a role in regulation of gene expression. Taken together, our data highlight novel mechanisms by which U-STAT3 binds to DNA and supports U-STAT3 function as a transcriptional activator and a chromatin/genomic organizer.	[Timofeeva, Olga A.; Zhang, Xueping; Cheema, Amrita; Zhang, Lihua; Dakshanamurthy, Sivanesan; Brown, Milton L.; Dritschilo, Anatoly] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20057 USA; [Timofeeva, Olga A.; Chasovskikh, Sergey; Zhang, Xueping; Dritschilo, Anatoly] Georgetown Univ, Med Ctr, Dept Radiat Med, Washington, DC 20057 USA; [Lonskaya, Irina; Brown, Milton L.] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20057 USA; [Korostyshevskiy, Valeriy R.] Georgetown Univ, Med Ctr, Dept Biostat Bioinformat & Biomath, Washington, DC 20057 USA; [Brown, Milton L.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Drug Discovery Program, Washington, DC 20057 USA; [Tarasova, Nadya I.; Khavrutskii, Lyuba] NCI Frederick, Canc & Inflammat Program, Frederick, MD 21702 USA; [Tarasova, Nadya I.] NCI Frederick, Struct Biophys Lab, Biophys Resource Core, Frederick, MD 21702 USA	Georgetown University; Georgetown University; Georgetown University; Georgetown University; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Timofeeva, OA (corresponding author), Georgetown Univ, Med Ctr, Dept Oncol, Res Bldg,R E216,3970 Reservoir Rd NW, Washington, DC 20057 USA.	oat@georgetown.edu	Dakshanamurthy, Sivanesan/CAF-4258-2022; Korostyshevskiy, Valeriy R./O-5341-2019	Dakshanamurthy, Sivanesan/0000-0003-3681-4121; Tarasova, Nadya/0000-0002-4949-0069; Korostyshevskiy, Valeriy/0000-0001-7888-8626	National Institutes of Health [CA56036-08]; American Cancer Society [IRG 97-152-17]; National Institutes of Health of the NCI Center for Cancer Research; NATIONAL CANCER INSTITUTE [P30CA056036, ZIABC011306, ZICBC010965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Institutes of Health of the NCI Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Grant CA56036-08, American Cancer Society Grant IRG 97-152-17 (to O. T.) and by the National Institutes of Health Intramural Research Program of the NCI Center for Cancer Research.	Azam M, 1997, IMMUNITY, V6, P691, DOI 10.1016/S1074-7613(00)80445-8; Brazda V, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-33; Bromberg J, 2001, METHOD ENZYMOL, V333, P138; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chasovskikh S, 2005, CYTOM PART A, V68A, P21, DOI 10.1002/cyto.a.20187; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Chen B, 2010, BIOCHEMISTRY-US, V49, P1590, DOI 10.1021/bi901881c; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Christova R, 2007, J CELL SCI, V120, P3262, DOI 10.1242/jcs.012328; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Darnowski JW, 2006, J BIOL CHEM, V281, P17707, DOI 10.1074/jbc.M600088200; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Fordyce PM, 2010, NAT BIOTECHNOL, V28, P970, DOI 10.1038/nbt.1675; Hevehan DL, 2002, BLOOD, V99, P1627, DOI 10.1182/blood.V99.5.1627; Humphrey-Dixon EL, 2011, GENOME, V54, P934, DOI [10.1139/g11-058, 10.1139/G11-058]; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; LeBlanc JF, 1998, BIOCHEMISTRY-US, V37, P6015, DOI 10.1021/bi9730792; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li WX, 2008, TRENDS CELL BIOL, V18, P545, DOI 10.1016/j.tcb.2008.08.008; Liebich I, 2002, NUCLEIC ACIDS RES, V30, P372, DOI 10.1093/nar/30.1.372; Liebich I, 2002, NUCLEIC ACIDS RES, V30, P3433, DOI 10.1093/nar/gkf446; Lim CP, 2006, MOL BIOSYST, V2, P536, DOI 10.1039/b606246f; Lobov IB, 2001, J CELL BIOCHEM, V83, P218, DOI 10.1002/jcb.1220; Lonskaya I, 2005, J BIOL CHEM, V280, P17076, DOI 10.1074/jbc.M413483200; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Lu L, 2007, FUNCT INTEGR GENOMIC, V7, P221, DOI 10.1007/s10142-007-0047-6; MOREAU J, 1982, NATURE, V295, P260, DOI 10.1038/295260a0; Oda A, 2002, BLOOD, V99, P1850, DOI 10.1182/blood.V99.5.1850; OOSUMI T, 1995, P NATL ACAD SCI USA, V92, P8886, DOI 10.1073/pnas.92.19.8886; Oussatcheva EA, 1999, J MOL BIOL, V292, P75, DOI 10.1006/jmbi.1999.3043; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Pietrasanta LI, 1999, P NATL ACAD SCI USA, V96, P3757, DOI 10.1073/pnas.96.7.3757; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramos Haydee L, 2007, Biochem J, V404, pe1; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Shi M, 2008, IMMUNITY, V28, P763, DOI 10.1016/j.immuni.2008.04.016; Shi S, 2008, NAT CELL BIOL, V10, P491, DOI 10.1038/ncb1713; Shi S, 2006, NAT GENET, V38, P1071, DOI 10.1038/ng1860; Timofeeva OA, 2006, ONCOGENE, V25, P7555, DOI 10.1038/sj.onc.1209742; Timofeeva OA, 2007, ACS CHEM BIOL, V2, P799, DOI 10.1021/cb700186x; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Yang J, 2005, CANCER RES, V65, P939; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Yoo JY, 2001, J BIOL CHEM, V276, P26421, DOI 10.1074/jbc.M009935200; Yu Q, 2007, EMBO J, V26, P2052, DOI 10.1038/sj.emboj.7601653; Zillner K, 2012, METHODS MOL BIOL, V815, P241, DOI 10.1007/978-1-61779-424-7_18; Zlatanova J, 1998, FASEB J, V12, P421, DOI 10.1096/fasebj.12.6.421	53	95	101	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14192	14200		10.1074/jbc.M111.323899	http://dx.doi.org/10.1074/jbc.M111.323899			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22378781	Green Published, hybrid			2022-12-27	WOS:000303996300071
J	Mouledous, L; Froment, C; Dauvillier, S; Burlet-Schiltz, O; Zajac, JM; Mollereau, C				Mouledous, Lionel; Froment, Carine; Dauvillier, Stephanie; Burlet-Schiltz, Odile; Zajac, Jean-Marie; Mollereau, Catherine			GRK2 Protein-mediated Transphosphorylation Contributes to Loss of Function of mu-Opioid Receptors Induced by Neuropeptide FF (NPFF2) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; CONDITIONED PLACE PREFERENCE; SH-SY5Y NEUROBLASTOMA-CELLS; COUPLED RECEPTORS; BETA-ARRESTINS; PHOSPHORYLATION; DESENSITIZATION; MORPHINE; AGONIST; MECHANISMS	Neuropeptide FF (NPFF) interacts with specific receptors to modulate opioid functions in the central nervous system. On dissociated neurons and neuroblastoma cells (SH-SY5Y) transfected with NPFF receptors, NPFF acts as a functional antagonist of mu-opioid (MOP) receptors by attenuating the opioid-induced inhibition of calcium conductance. In the SH-SY5Y model, MOP and NPFF2 receptors have been shown to heteromerize. To understand the molecular mechanism involved in the anti-opioid activity of NPFF, we have investigated the phosphorylation status of the MOP receptor using phospho-specific antibody and mass spectrometry. Similarly to direct opioid receptor stimulation, activation of the NPFF2 receptor by [D-Tyr-1-(NMe)Phe-3]NPFF (1DMe), an analog of NPFF, induced the phosphorylation of Ser-377 of the human MOP receptor. This heterologous phosphorylation was unaffected by inhibition of second messenger-dependent kinases and, contrarily to homologous phosphorylation, was prevented by inactivation of G(i/o) proteins by pertussis toxin. Using siRNA knockdown we could demonstrate that 1DMe-induced Ser-377 cross-phosphorylation and MOP receptor loss of function were mediated by the G protein receptor kinase GRK2. In addition, mass spectrometric analysis revealed that the phosphorylation pattern of MOP receptors was qualitatively similar after treatment with the MOP agonist Tyr-D-Ala-Gly (NMe)-Phe-Gly-ol (DAMGO) or after treatment with the NPFF agonist 1DMe, but the level of multiple phosphorylation was more intense after DAMGO. Finally, NPFF2 receptor activation was sufficient to recruit beta-arrestin2 to the MOP receptor but not to induce its internalization. These data show that NPFF-induced heterologous desensitization of MOP receptor signaling is mediated by GRK2 and could involve transphosphorylation within the heteromeric receptor complex.	[Mouledous, Lionel; Froment, Carine; Dauvillier, Stephanie; Burlet-Schiltz, Odile; Zajac, Jean-Marie; Mollereau, Catherine] Univ Toulouse, CNRS, Inst Pharmacol & Biol Struct, UMR 5089, F-31077 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Mouledous, L (corresponding author), Univ Toulouse, CNRS, Inst Pharmacol & Biol Struct, UMR 5089, 205 Route Narbonne, F-31077 Toulouse, France.	lionel.mouledous@ipbs.fr; catherine.mollereau-manaute@ipbs.fr	Zajac, jean-marie/E-5129-2010	Mouledous, Lionel/0000-0002-7675-3493; Mollereau, Catherine/0000-0003-1543-5624; Schiltz, Odile/0000-0002-3606-2356	French Agence Nationale de la Recherche [ANR-09-PIRI-0008-01, piribio09_445026]	French Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by French Agence Nationale de la Recherche Grant ANR-09-PIRI-0008-01, piribio09_445026.	Bailey CP, 2005, CURR OPIN PHARMACOL, V5, P60, DOI 10.1016/j.coph.2004.08.012; Breton B, 2010, FASEB J, V24, P4733, DOI 10.1096/fj.10-164061; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Butcher AJ, 2011, J BIOL CHEM, V286, P11506, DOI 10.1074/jbc.M110.154526; Celver JP, 2001, J BIOL CHEM, V276, P4894, DOI 10.1074/jbc.M007437200; Chen CG, 2004, EUR J PHARMACOL, V483, P175, DOI 10.1016/j.ejphar.2003.10.033; Chen YJ, 2008, MOL BIOL CELL, V19, P2973, DOI 10.1091/mbc.E07-10-1058; Christie MJ, 2008, BRIT J PHARMACOL, V154, P384, DOI 10.1038/bjp.2008.100; Chu J, 2008, CELL SIGNAL, V20, P1616, DOI 10.1016/j.cellsig.2008.05.004; Chuang TT, 1996, TRENDS PHARMACOL SCI, V17, P416, DOI 10.1016/S0165-6147(96)10048-1; Dang VC, 2012, BRIT J PHARMACOL, V165, P1704, DOI 10.1111/j.1476-5381.2011.01482.x; Doll C, 2011, BRIT J PHARMACOL, V164, P298, DOI 10.1111/j.1476-5381.2011.01382.x; DUPOUY V, 1995, REGUL PEPTIDES, V59, P349, DOI 10.1016/0167-0115(95)00091-O; Dupouy V, 1997, EUR J PHARMACOL, V330, P129, DOI 10.1016/S0014-2999(97)01017-0; El Kouhen R, 2001, J BIOL CHEM, V276, P12774, DOI 10.1074/jbc.M009571200; Elhabazi K, 2012, BRIT J PHARMACOL, V165, P424, DOI 10.1111/j.1476-5381.2011.01563.x; Estes AM, 2011, AMINO ACIDS, V40, P371, DOI 10.1007/s00726-010-0642-z; Evans RM, 2010, J BIOL CHEM, V285, P1032, DOI 10.1074/jbc.M109.040634; Feng B, 2011, MOL PHARMACOL, V79, P768, DOI 10.1124/mol.110.069096; Fernandez N, 2011, J BIOL CHEM, V286, P28697, DOI 10.1074/jbc.M111.269613; GICQUEL S, 1992, EUR J PHARMACOL, V222, P61, DOI 10.1016/0014-2999(92)90463-E; Groer CE, 2011, J BIOL CHEM, V286, P31731, DOI 10.1074/jbc.M111.248310; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Huttenrach F, 2005, J BIOL CHEM, V280, P37503, DOI 10.1074/jbc.M500535200; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Kersante F, 2010, NEUROCHEM INT, V56, P768, DOI 10.1016/j.neuint.2010.02.014; Kilpatrick LE, 2010, BRIT J PHARMACOL, V160, P892, DOI 10.1111/j.1476-5381.2010.00676.x; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Kotlinska J, 2007, PEPTIDES, V28, P2235, DOI 10.1016/j.peptides.2007.08.006; Lau EK, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001748; Law PY, 2005, J BIOL CHEM, V280, P11152, DOI 10.1074/jbc.M500171200; Marchand S, 2006, PEPTIDES, V27, P964, DOI 10.1016/j.peptides.2005.07.023; Martini L, 2007, CURR OPIN NEUROBIOL, V17, P556, DOI 10.1016/j.conb.2007.10.004; Maurice P, 2011, TRENDS PHARMACOL SCI, V32, P514, DOI 10.1016/j.tips.2011.05.006; McPherson J, 2010, MOL PHARMACOL, V78, P756, DOI 10.1124/mol.110.066613; Mollereau C, 2005, CURR TOP MED CHEM, V5, P341, DOI 10.2174/1568026053544515; Mollereau C, 2005, MOL PHARMACOL, V67, P965, DOI 10.1124/mol.104.004614; Mouledous L, 2008, BIOCHEM BIOPH RES CO, V373, P80, DOI 10.1016/j.bbrc.2008.05.174; Mouledous L, 2010, BIOFACTORS, V36, P423, DOI 10.1002/biof.116; Mouledous L, 2010, SYNAPSE, V64, P672, DOI 10.1002/syn.20774; Mouton-Barbosa E, 2010, MOL CELL PROTEOMICS, V9, P1006, DOI 10.1074/mcp.M900513-MCP200; Namkung Y, 2009, J BIOL CHEM, V284, P34103, DOI 10.1074/jbc.M109.055707; OFFERMANNS S, 1993, BIOCHEM J, V294, P545, DOI 10.1042/bj2940545; Ossipov MH, 2005, BIOPOLYMERS, V80, P319, DOI 10.1002/bip.20254; Ozsoy HZ, 2005, MOL PHARMACOL, V68, P447, DOI 10.1124/mol.105.011536; Pak Y, 1997, J BIOL CHEM, V272, P24961, DOI 10.1074/jbc.272.40.24961; Panula P, 1996, PROG NEUROBIOL, V48, P461, DOI 10.1016/0301-0082(96)00001-9; Pao Christina S, 2002, Sci STKE, V2002, ppe42, DOI 10.1126/stke.2002.153.pe42; Parker SL, 2007, REGUL PEPTIDES, V144, P72, DOI 10.1016/j.regpep.2007.06.004; Pfeiffer M, 2002, J BIOL CHEM, V277, P19762, DOI 10.1074/jbc.M110373200; Pfeiffer M, 2003, J BIOL CHEM, V278, P51630, DOI 10.1074/jbc.M307095200; Porrello ER, 2011, CELL SIGNAL, V23, P1767, DOI 10.1016/j.cellsig.2011.06.011; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Raehal KM, 2011, PHARMACOL REV, V63, P1001, DOI 10.1124/pr.111.004598; Rebeyrolles S, 1996, NEUROREPORT, V7, P2979, DOI 10.1097/00001756-199611250-00036; Rose RH, 2010, BRIT J PHARMACOL, V159, P738, DOI 10.1111/j.1476-5381.2009.00480.x; Roumy M, 2007, J BIOL CHEM, V282, P8332, DOI 10.1074/jbc.M606946200; Rozenfeld R, 2010, TRENDS PHARMACOL SCI, V31, P124, DOI 10.1016/j.tips.2009.11.008; Schulz S, 2004, EMBO J, V23, P3282, DOI 10.1038/sj.emboj.7600334; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi GW, 2005, J BIOL CHEM, V280, P41184, DOI 10.1074/jbc.M506935200; Simonin F, 2006, P NATL ACAD SCI USA, V103, P466, DOI 10.1073/pnas.0502090103; Talmont F, 2009, NEUROCHEM INT, V55, P815, DOI 10.1016/j.neuint.2009.08.004; Tan M, 2009, J BIOL CHEM, V284, P6270, DOI 10.1074/jbc.M806742200; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; van Rijn RM, 2010, CURR OPIN PHARMACOL, V10, P73, DOI 10.1016/j.coph.2009.09.007; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Vilim FS, 1999, MOL PHARMACOL, V55, P804; Yang HYT, 2008, NEUROPEPTIDES, V42, P1, DOI 10.1016/j.npep.2007.06.004; YANG HYT, 1985, P NATL ACAD SCI USA, V82, P7757, DOI 10.1073/pnas.82.22.7757; Zajac JM, 2001, TRENDS PHARMACOL SCI, V22, P63, DOI 10.1016/S0165-6147(00)01610-2; Zheng H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.177089	72	35	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12736	12749		10.1074/jbc.M111.314617	http://dx.doi.org/10.1074/jbc.M111.314617			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22375000	Green Published, hybrid			2022-12-27	WOS:000302903700013
J	Smith, CA; Toth, M; Frase, H; Byrnes, LJ; Vakulenko, SB				Smith, Clyde A.; Toth, Marta; Frase, Hilary; Byrnes, Laura J.; Vakulenko, Sergei B.			Aminoglycoside 2 ''-Phosphotransferase IIIa (APH(2 '')-IIIa) Prefers GTP over ATP STRUCTURAL TEMPLATES FOR NUCLEOTIDE RECOGNITION IN THE BACTERIAL AMINOGLYCOSIDE-2 '' KINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CRYSTAL-STRUCTURE; PHOSPHORYL TRANSFER; ACTIVE-SITE; INHIBITORS; ANTIBIOTICS; COMPLEXES; MECHANISM; SUBSTRATE; BINDING	Contrary to the accepted dogma that ATP is the canonical phosphate donor in aminoglycoside kinases and protein kinases, it was recently demonstrated that all members of the bacterial aminoglycoside 2 ''-phosphotransferase IIIa (APH(2 '')) aminoglycoside kinase family are unique in their ability to utilize GTP as a cofactor for antibiotic modification. Here we describe the structural determinants for GTP recognition in these enzymes. The crystal structure of the GTP-dependent APH(2 '')-IIIa shows that although this enzyme has templates for both ATP and GTP binding superimposed on a single nucleotide specificity motif, access to the ATP-binding template is blocked by a bulky tyrosine residue. Substitution of this tyrosine by a smaller amino acid opens access to the ATP template. Similar GTP binding templates are conserved in other bacterial aminoglycoside kinases, whereas in the structurally related eukaryotic protein kinases this template is less conserved. The aminoglycoside kinases are important antibiotic resistance enzymes in bacteria, whose wide dissemination severely limits available therapeutic options, and the GTP binding templates could be exploited as new, previously unexplored targets for inhibitors of these clinically important enzymes.	[Smith, Clyde A.; Byrnes, Laura J.] Stanford Univ, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Toth, Marta; Frase, Hilary; Vakulenko, Sergei B.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	Stanford University; University of Notre Dame	Smith, CA (corresponding author), 2575 Sand Hill Rd, Menlo Pk, CA 94025 USA.	csmith@slac.stanford.edu			National Institutes of Health [AI057393, 5 P41 RR001209]; Science Undergraduate Laboratory Internship program; Department of Energy (Offices of Basic Energy Sciences and Biological and Environmental Research); National Institutes of Health (Center for Research Resources, National Institute of General Medical Sciences); NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Undergraduate Laboratory Internship program; Department of Energy (Offices of Basic Energy Sciences and Biological and Environmental Research)(United States Department of Energy (DOE)); National Institutes of Health (Center for Research Resources, National Institute of General Medical Sciences); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI057393 (to S. B. V.) and 5 P41 RR001209 (Center for Research Resources).; Supported by the Science Undergraduate Laboratory Internship program.; Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Department of Energy (Offices of Basic Energy Sciences and Biological and Environmental Research) and by the National Institutes of Health (Center for Research Resources, National Institute of General Medical Sciences).	Adams J, 2002, CURR OPIN CHEM BIOL, V6, P486, DOI 10.1016/S1367-5931(02)00357-5; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aimes RT, 2000, BIOCHEMISTRY-US, V39, P8325, DOI 10.1021/bi992800w; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barouch-Bentov R, 2009, MOL CELL, V33, P43, DOI 10.1016/j.molcel.2008.12.024; Boehr DD, 2005, BIOCHEMISTRY-US, V44, P12445, DOI 10.1021/bi051085p; Boehr DD, 2001, J BIOL CHEM, V276, P23929, DOI 10.1074/jbc.M100540200; Bostrom SL, 2009, BIOCHEM BIOPH RES CO, V390, P1154, DOI 10.1016/j.bbrc.2009.10.107; Burk DL, 2001, BIOCHEMISTRY-US, V40, P8756, DOI 10.1021/bi010504p; Byrnes LJ, 2008, ACTA CRYSTALLOGR F, V64, P126, DOI 10.1107/S1744309108001450; COZZONE AJ, 1993, J CELL BIOCHEM, V51, P7, DOI 10.1002/jcb.240510103; DeLano W.L, PYMOL MOL GRAPHICS S; EDSON RS, 1991, MAYO CLIN PROC, V66, P1158, DOI 10.1016/S0025-6196(12)65798-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fong DH, 2010, J BIOL CHEM, V285, P9545, DOI 10.1074/jbc.M109.038364; Fong DH, 2002, EMBO J, V21, P2323, DOI 10.1093/emboj/21.10.2323; Garcia-Echeverria C, 2000, MED RES REV, V20, P28, DOI 10.1002/(SICI)1098-1128(200001)20:1<28::AID-MED2>3.3.CO;2-U; Girard E, 2003, ACTA CRYSTALLOGR D, V59, P1914, DOI 10.1107/S0907444903020511; GSCHWENDT M, 1995, BIOCHEM BIOPH RES CO, V206, P614, DOI 10.1006/bbrc.1995.1087; Hon WC, 1997, CELL, V89, P887, DOI 10.1016/S0092-8674(00)80274-3; Johnson LN, 2009, Q REV BIOPHYS, V42, P1, DOI 10.1017/S0033583508004745; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KARIMI R, 1994, EUR J BIOCHEM, V226, P355, DOI 10.1111/j.1432-1033.1994.tb20059.x; Kim C, 2005, BIOORG CHEM, V33, P149, DOI 10.1016/j.bioorg.2004.11.001; Kim S, 2011, PROTEINS, V79, P2983, DOI 10.1002/prot.23119; KOCABIYIK S, 1992, BIOCHEM BIOPH RES CO, V185, P925, DOI 10.1016/0006-291X(92)91715-3; LaRonde-LeBlanc N, 2005, FEBS J, V272, P3698, DOI 10.1111/j.1742-4658.2005.04796.x; LaRonde-LeBlanc N, 2004, STRUCTURE, V12, P1585, DOI 10.1016/j.str.2004.06.016; Lee HK, 2002, ANTIMICROB AGENTS CH, V46, P3253, DOI 10.1128/AAC.46.10.3253-3256.2002; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Niefind K, 1999, NAT STRUCT BIOL, V6, P1100, DOI 10.1038/70033; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Nurizzo D, 2003, J MOL BIOL, V327, P491, DOI 10.1016/S0022-2836(03)00121-9; Ortiz-Lombardia M, 2003, J BIOL CHEM, V278, P13094, DOI 10.1074/jbc.M300660200; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; Schinkmann K, 1997, J BIOL CHEM, V272, P28695, DOI 10.1074/jbc.272.45.28695; Shakya T, 2010, ANTIMICROB AGENTS CH, V54, P1909, DOI 10.1128/AAC.01570-09; Shi K, 2011, BIOCHEMISTRY-US, V50, P6237, DOI 10.1021/bi200747f; Shugar D, 1996, ACTA BIOCHIM POL, V43, P9; Smith Clyde A., 2002, Current Drug Targets - Infectious Disorders, V2, P143, DOI 10.2174/1568005023342533; Stogios PJ, 2011, J BIOL CHEM, V286, P1966, DOI 10.1074/jbc.M110.194266; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Thompson PR, 2002, BIOCHEMISTRY-US, V41, P7001, DOI 10.1021/bi0256680; Toth M, 2010, PROTEIN SCI, V19, P1565, DOI 10.1002/pro.437; Toth M, 2009, J BIOL CHEM, V284, P6690, DOI 10.1074/jbc.M808148200; Traxler P, 1999, PHARMACOL THERAPEUT, V82, P195, DOI 10.1016/S0163-7258(98)00044-8; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; Valiev M, 2003, J AM CHEM SOC, V125, P9926, DOI 10.1021/ja029618u; Wirmer J, 2006, METHOD ENZYMOL, V415, P180, DOI 10.1016/S0076-6879(06)15012-0; Wright GD, 1999, CURR OPIN MICROBIOL, V2, P499, DOI 10.1016/S1369-5274(99)00007-7; Wright Gerard D., 1999, Frontiers in Bioscience, V4, pD9, DOI 10.2741/Wright; Young PG, 2009, J BACTERIOL, V191, P4133, DOI 10.1128/JB.00149-09; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005; Zheng JM, 2007, MOL MICROBIOL, V63, P1360, DOI 10.1111/j.1365-2958.2007.05611.x	57	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12893	12903		10.1074/jbc.M112.341206	http://dx.doi.org/10.1074/jbc.M112.341206			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367198	Green Published, hybrid			2022-12-27	WOS:000302903700029
J	Arrizabalaga, O; Lacerda, HM; Zubiaga, AM; Zugaza, JL				Arrizabalaga, Onetsine; Lacerda, Hadriano M.; Zubiaga, Ana M.; Zugaza, Jose L.			Rac1 Protein Regulates Glycogen Phosphorylase Activation and Controls Interleukin (IL)-2-dependent T Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-BINDING DOMAIN; RHO GTPASES; HUMAN-LIVER; GROWTH; CDC42; IL-2; IDENTIFICATION; KINASE; ISOENZYMES; 3-KINASE	Small GTPases of the Rho family have been implicated in important cellular processes such as cell migration and adhesion, protein secretion, and/or gene transcription. In the lymphoid system, these GTPases participate in the signaling cascades that are activated after engagement of antigen receptors. However, little is known about the role that Rho GTPases play in IL-2-mediated responses. Here, we show that IL-2 induces Rac1 activation in Kit 225 T cells. We identified by mass spectrometry the muscle isoform of glycogen phosphorylase (PYGM) as a novel Rac1 effector molecule in IL-2-stimulated cells. The interaction between the active form of Rac1 (Rac1-GTP) and PYGM was established directly through a domain comprising amino acids 191-270 of PYGM that exhibits significant homology with the Rac binding domain of PAK1. The integrity of this region was crucial for PYGM activation. Importantly, IL-2-dependent cellular proliferation was inhibited upon blocking both the activation of Rac1 and the activity of PYGM. These results reveal a new role for Rac1 in cell signaling, showing that this GTPase triggers T cell proliferation upon IL-2 stimulation by associating with PYGM and modulating its enzymatic activity.	[Arrizabalaga, Onetsine; Zubiaga, Ana M.; Zugaza, Jose L.] Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Leioa 48940, Spain; [Arrizabalaga, Onetsine; Zugaza, Jose L.] Ctr Cooperat Res CIC BioGUNE, Derio 48160, Spain; [Lacerda, Hadriano M.] Univ Turin, Dept Biomed Sci & Human Oncol, Canc Epidemiol Unit, I-10124 Turin, Italy; [Zugaza, Jose L.] Basque Fdn Sci, IKERBASQUE, Bilbao 48011, Spain	University of Basque Country; CIC bioGUNE; University of Turin; Basque Foundation for Science	Zubiaga, AM (corresponding author), Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Barrio Sarriena S-N, Leioa 48940, Spain.	ana.zubiaga@ehu.es; joseluis.zugaza@ehu.es	zubiaga, ana/S-3457-2019; Bustelo, Xose R./A-9526-2010	zubiaga, ana/0000-0002-2132-9708; Bustelo, Xose R./0000-0001-9398-6072; ZUGAZA GURRUCHAGA, JOSE LUIS/0000-0003-2287-6671	Spanish Ministry of Science and Innovation [SAF2005-07930-C02-02, CIT-300000-2008-8, CSD2007-00017, SAF2009-12037]; Basque Government Education Department [GIC07/157-212]; Spanish Ministry of Education and Science [FPU_AP-2004-3064]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Basque Government Education Department; Spanish Ministry of Education and Science(Spanish Government)	* This work was supported by grants from the Spanish Ministry of Science and Innovation (Grants SAF2005-07930-C02-02 and CIT-300000-2008-8 to J. L. Z. and Grants CSD2007-00017 and SAF2009-12037 to A. M. Z.) and the Basque Government Education Department (Grant GIC07/157-212 to A. M. Z.).; <SUP>1</SUP> Supported by a fellowship from the Spanish Ministry of Education and Science (Program FPU_AP-2004-3064).	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Andersen B, 2002, BIOCHEM J, V367, P443, DOI 10.1042/BJ20020153; Arnaud M, 2004, BIOCHEM J, V382, P545, DOI 10.1042/BJ20040103; Arrieumerlou C, 1998, EUR J IMMUNOL, V28, P1877, DOI 10.1002/(SICI)1521-4141(199806)28:06<1877::AID-IMMU1877>3.3.CO;2-9; Arrieumerlou C, 2000, J IMMUNOL, V165, P3182, DOI 10.4049/jimmunol.165.6.3182; Baumer AT, 2008, J BIOL CHEM, V283, P7864, DOI 10.1074/jbc.M704997200; BARFORD D, 1992, PROTEIN SCI, V1, P472; Beier I, 2008, ATHEROSCLEROSIS, V196, P92, DOI 10.1016/j.atherosclerosis.2007.02.003; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Brennan P, 1997, IMMUNITY, V7, P679, DOI 10.1016/S1074-7613(00)80388-X; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Caloca MJ, 2008, CELL SIGNAL, V20, P758, DOI 10.1016/j.cellsig.2007.12.015; Chen CJ, 2004, J IMMUNOL, V172, P3544, DOI 10.4049/jimmunol.172.6.3544; Chiariello M, 2010, METHODS MOL BIOL, V661, P137, DOI 10.1007/978-1-60761-795-2_8; Cianferoni A, 2005, J ALLERGY CLIN IMMUN, V116, P1364, DOI 10.1016/j.jaci.2005.09.006; Frauwirth KA, 2004, J IMMUNOL, V172, P4661, DOI 10.4049/jimmunol.172.8.4661; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gerard A, 2009, BLOOD, V113, P6138, DOI 10.1182/blood-2008-07-167668; Gomez TS, 2008, ADV IMMUNOL, V97, P1, DOI 10.1016/S0065-2776(08)00001-1; Greenberg CC, 2006, AM J PHYSIOL-ENDOC M, V291, pE1, DOI 10.1152/ajpendo.00652.2005; Haddad E, 2001, BLOOD, V97, P33, DOI 10.1182/blood.V97.1.33; HIDAKA H, 1991, METHOD ENZYMOL, V201, P328; HORI T, 1987, BLOOD, V70, P1069; HUDSON JW, 1993, J MOL BIOL, V234, P700, DOI 10.1006/jmbi.1993.1621; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Joneson T, 1996, SCIENCE, V274, P1374, DOI 10.1126/science.274.5291.1374; Joneson T, 1998, J BIOL CHEM, V273, P17991, DOI 10.1074/jbc.273.29.17991; Katzav S, 2007, CANCER LETT, V255, P241, DOI 10.1016/j.canlet.2007.04.015; Kelsall IR, 2009, CELL SIGNAL, V21, P1123, DOI 10.1016/j.cellsig.2009.03.001; Kirken RA, 2000, J IMMUNOL, V165, P5097, DOI 10.4049/jimmunol.165.9.5097; Klabunde T, 2005, J MED CHEM, V48, P6178, DOI 10.1021/jm049034y; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAVIS VR, 1980, J CELL PHYSIOL, V103, P55, DOI 10.1002/jcp.1041030109; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lin JX, 1996, J BIOL CHEM, V271, P10738, DOI 10.1074/jbc.271.18.10738; Lin Q, 2006, J BIOL CHEM, V281, P35253, DOI 10.1074/jbc.M606248200; Lord JD, 2000, J IMMUNOL, V164, P2533, DOI 10.4049/jimmunol.164.5.2533; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; McInerney M, 2002, BBA-GEN SUBJECTS, V1570, P53, DOI 10.1016/S0304-4165(02)00154-X; Moon JJ, 2001, J IMMUNOL, V167, P2714, DOI 10.4049/jimmunol.167.5.2714; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Mortellaro A, 1999, J IMMUNOL, V162, P7102; NEWGARD CB, 1988, J BIOL CHEM, V263, P3850; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Pelletier S, 2003, MOL CELL BIOL, V23, P1316, DOI 10.1128/MCB.23.4.1316-1333.2003; Poppe D, 2006, J IMMUNOL, V176, P640, DOI 10.4049/jimmunol.176.1.640; PROUX D, 1974, CLIN CHIM ACTA, V57, P211, DOI 10.1016/0009-8981(74)90399-4; PROUX D, 1973, CLIN CHIM ACTA, V48, P167, DOI 10.1016/0009-8981(73)90362-8; Rath VL, 2000, MOL CELL, V6, P139, DOI 10.1016/S1097-2765(00)00015-0; Ravichandran KS, 1996, P NATL ACAD SCI USA, V93, P5275, DOI 10.1073/pnas.93.11.5275; Ravichandran KS, 1995, ANN NY ACAD SCI, V766, P202, DOI 10.1111/j.1749-6632.1995.tb26663.x; Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556; Ross JA, 2010, J BIOL CHEM, V285, P3582, DOI 10.1074/jbc.M109.053843; Schnier JB, 2003, BIOCHEM BIOPH RES CO, V309, P126, DOI 10.1016/S0006-291X(03)01542-0; SEAMON KB, 1986, ADV CYCLIC NUCL PROT, V20, P1; Shen SL, 2011, BBA-MOL BASIS DIS, V1812, P703, DOI 10.1016/j.bbadis.2011.03.004; Sudo K, 2006, NEUROSCI RES, V56, P347, DOI 10.1016/j.neures.2006.08.003; Terakado M, 2011, AM J PHYSIOL-LUNG C, V300, pL56, DOI 10.1152/ajplung.00159.2010; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Villalba M, 2000, IMMUNITY, V12, P151, DOI 10.1016/S1074-7613(00)80168-5; Wery-Zennaro S, 2000, ONCOGENE, V19, P1596, DOI 10.1038/sj.onc.1203458; YUNIS AA, 1968, BIOCHEM BIOPH RES CO, V33, P119, DOI 10.1016/0006-291X(68)90265-9; Zhang JS, 2011, MOL BIOL CELL, V22, P2119, DOI 10.1091/mbc.E10-12-0969; Zugaza JL, 2004, ONCOGENE, V23, P5823, DOI 10.1038/sj.onc.1207768	68	26	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11878	11890		10.1074/jbc.M111.297804	http://dx.doi.org/10.1074/jbc.M111.297804			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337875	hybrid, Green Published			2022-12-27	WOS:000302782200027
J	Zerbe, P; Chiang, A; Yuen, M; Hamberger, B; Hamberger, B; Draper, JA; Britton, R; Bohlmann, J				Zerbe, Philipp; Chiang, Angela; Yuen, Macaire; Hamberger, Bjoern; Hamberger, Britta; Draper, Jason A.; Britton, Robert; Bohlmann, Joerg			Bifunctional cis-Abienol Synthase from Abies balsamea Discovered by Transcriptome Sequencing and Its Implications for Diterpenoid Fragrance Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENT-KAURENE SYNTHASE; ABIETADIENOL/ABIETADIENAL OXIDASE PTAO; RESIN ACID BIOSYNTHESIS; CELL-FREE-EXTRACTS; ABIETADIENE SYNTHASE; FUNCTIONAL-CHARACTERIZATION; INITIATED CYCLIZATION; MUTATIONAL ANALYSIS; TERPENE SYNTHASES; CONIFER DEFENSE	The labdanoid diterpene alcohol cis-abienol is a major component of the aromatic oleoresin of balsam fir (Abies balsamea) and serves as a valuable bioproduct material for the fragrance industry. Using high-throughput 454 transcriptome sequencing and metabolite profiling of balsam fir bark tissue, we identified candidate diterpene synthase sequences for full-length cDNA cloning and functional characterization. We discovered a bifunctional class I/II cis-abienol synthase (AbCAS), along with the paralogous levopimaradiene/abietadiene synthase and isopimaradiene synthase, all of which are members of the gymnosperm-specific TPS-d subfamily. The AbCAS-catalyzed formation of cis-abienol proceeds via cyclization and hydroxylation at carbon C-8 of a postulated carbocation intermediate in the class II active site, followed by cleavage of the diphosphate group and termination of the reaction sequence without further cyclization in the class I active site. This reaction mechanism is distinct from that of synthases of the isopimaradiene- or levopimaradiene/abietadiene synthase type, which employ deprotonation reactions in the class II active site and secondary cyclizations in the class I active site, leading to tricyclic diterpenes. Comparative homology modeling suggested the active site residues Asp-348, Leu-617, Phe-696, and Gly-723 as potentially important for the specificity of AbCAS. As a class I/II bifunctional enzyme, AbCAS is a promising target for metabolic engineering of cis-abienol production.	[Zerbe, Philipp; Chiang, Angela; Yuen, Macaire; Hamberger, Bjoern; Hamberger, Britta; Bohlmann, Joerg] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Draper, Jason A.; Britton, Robert] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	University of British Columbia; Simon Fraser University	Bohlmann, J (corresponding author), Univ British Columbia, Michael Smith Labs, 301-2185 East Mall, Vancouver, BC V6T 1Z4, Canada.	bohlmann@msl.ubc.ca	Hamberger, Bjoern/I-2122-2012; Zerbe, Philipp/A-2590-2013; Zerbe, Philipp/H-8348-2015	Hamberger, Bjoern/0000-0003-1249-1807; Zerbe, Philipp/0000-0001-5163-9523	Genome Alberta; Genome British Columbia; Genome Quebec; Government of Canada through Genome Canada; Natural Sciences and Engineering Research Council of Canada; University of British Columbia; Novo Nordisk Fonden [NNF12OC0000798] Funding Source: researchfish	Genome Alberta; Genome British Columbia; Genome Quebec; Government of Canada through Genome Canada(Genome Canada); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of British Columbia; Novo Nordisk Fonden(Novo Nordisk Foundation)	* This research was supported by Genome Alberta, Genome British Columbia, Genome Quebec, and the Government of Canada through Genome Canada in support of the PhytoMetaSyn Project and by grants from the Natural Sciences and Engineering Research Council of Canada (to J. B.).; <SUP>2</SUP> Supported in part by the University of British Columbia Distinguished University Scholars program. To whom correspondence should be addressed. Tel.: 604-822-0282; Fax: 604-822-2114; E-mail: bohlmann@msl.ubc.ca.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BARRERO AF, 1993, TETRAHEDRON, V49, P10405, DOI 10.1016/S0040-4020(01)80567-6; Barrero RA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-600; Bleeker PM, 2011, PLANT MOL BIOL, V77, P323, DOI 10.1007/s11103-011-9813-x; Bohlmann J, 1999, ARCH BIOCHEM BIOPHYS, V368, P232, DOI 10.1006/abbi.1999.1332; Bohlmann J, 2008, PLANT J, V54, P656, DOI 10.1111/j.1365-313X.2008.03449.x; CARMAN RM, 1993, AUST J CHEM, V46, P1105, DOI 10.1071/CH9931105; CARMAN RM, 1966, AUST J CHEM, V19, P1535, DOI 10.1071/CH9661535; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; de la Bastide Melissa, 2007, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1104s17; Ding L, 2007, CHROMATOGRAPHIA, V66, P529, DOI 10.1365/s10337-007-0365-9; Falara V, 2010, PLANT PHYSIOL, V154, P301, DOI 10.1104/pp.110.159566; GRAY PS, 1964, J CHEM SOC, VS, P5822; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; GUO ZH, 1994, ARCH BIOCHEM BIOPHYS, V308, P103, DOI 10.1006/abbi.1994.1015; GUO ZH, 1995, PLANTA, V197, P627, DOI 10.1007/BF00191570; Hamberger B, 2006, BIOCHEM SOC T, V34, P1209, DOI 10.1042/BST0341209; Hamberger B, 2011, PLANT PHYSIOL, V157, P1677, DOI 10.1104/pp.111.185843; Hayashi K, 2006, FEBS LETT, V580, P6175, DOI 10.1016/j.febslet.2006.10.018; Hillwig ML, 2011, BIOPOLYMERS, V95, P71, DOI 10.1002/bip.21538; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Kawaide H, 2011, FEBS J, V278, P123, DOI 10.1111/j.1742-4658.2010.07938.x; Keeling CI, 2008, P NATL ACAD SCI USA, V105, P1085, DOI 10.1073/pnas.0709466105; Keeling CI, 2006, PHYTOCHEMISTRY, V67, P2415, DOI 10.1016/j.phytochem.2006.08.019; Keeling CI, 2011, J BIOL CHEM, V286, P21145, DOI 10.1074/jbc.M111.245951; Keeling CI, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-43; Keeling CI, 2006, NEW PHYTOL, V170, P657, DOI 10.1111/j.1469-8137.2006.01716.x; Koksal M, 2011, NATURE, V469, P116, DOI 10.1038/nature09628; Kolosova N, 2004, BIOTECHNIQUES, V36, P821, DOI 10.2144/04365ST06; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonard E, 2010, P NATL ACAD SCI USA, V107, P13654, DOI 10.1073/pnas.1006138107; LEWINSOHN E, 1993, PLANT PHYSIOL, V101, P1021, DOI 10.1104/pp.101.3.1021; Mafu S, 2011, CHEMBIOCHEM, V12, P1984, DOI 10.1002/cbic.201100336; Martin DM, 2004, PLANT PHYSIOL, V135, P1908, DOI 10.1104/pp.104.042028; Miller B, 2005, PLANT PHYSIOL, V137, P369, DOI 10.1104/pp.104.050187; MILLS JS, 1967, J CHEM SOC C, P2514, DOI 10.1039/j39670002514; Miyazawa M, 2008, J ESSENT OIL RES, V20, P12, DOI 10.1080/10412905.2008.9699409; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Peralta-Yahya PP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1494; Peters RJ, 2003, BIOCHEMISTRY-US, V42, P2700, DOI 10.1021/bi020492n; Peters RJ, 2002, BIOCHEMISTRY-US, V41, P1836, DOI 10.1021/bi011879d; Peters RJ, 2002, P NATL ACAD SCI USA, V99, P580, DOI 10.1073/pnas.022627099; Peters RJ, 2001, J AM CHEM SOC, V123, P8974, DOI 10.1021/ja010670k; Peters RJ, 2000, BIOCHEMISTRY-US, V39, P15592, DOI 10.1021/bi001997l; Ro DK, 2006, PHYTOCHEMISTRY, V67, P1572, DOI 10.1016/j.phytochem.2006.01.011; Ro DK, 2005, P NATL ACAD SCI USA, V102, P8060, DOI 10.1073/pnas.0500825102; Sallaud C., 2008, International Patent, Patent No. [WO/2008/007031, 2008007031]; Schalk M., 2009, International Patent, Patent No. [WO 2009/101126 A1, 2009101126]; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SEVERSON RF, 1984, J AGR FOOD CHEM, V32, P566, DOI 10.1021/jf00123a037; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Trapp S, 2001, ANNU REV PLANT PHYS, V52, P689, DOI 10.1146/annurev.arplant.52.1.689; Vlad P. F., 1974, KHIM PRIR SOEDIN, V1, P30; Vogel BS, 1996, J BIOL CHEM, V271, P23262, DOI 10.1074/jbc.271.38.23262; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wilderman PR, 2007, J AM CHEM SOC, V129, P15736, DOI 10.1021/ja074977g; Yang XW, 2010, BIOORGAN MED CHEM, V18, P744, DOI 10.1016/j.bmc.2009.11.055; Zerbe P, 2012, PHYTOCHEMISTRY, V74, P30, DOI 10.1016/j.phytochem.2011.11.004; Zhou K, 2009, PHYTOCHEMISTRY, V70, P366, DOI 10.1016/j.phytochem.2008.12.022	59	58	75	2	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12121	12131		10.1074/jbc.M111.317669	http://dx.doi.org/10.1074/jbc.M111.317669			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337889	Green Published, hybrid			2022-12-27	WOS:000302782200048
J	Singhal, J; Agrawal, N; Vashishta, M; Priya, NG; Tiwari, BK; Singh, Y; Raman, R; Natarajan, K				Singhal, Jhalak; Agrawal, Neha; Vashishta, Mohit; Priya, N. Gayatri; Tiwari, Brijendra K.; Singh, Yogendra; Raman, Rajagopal; Natarajan, Krishnamurthy			Suppression of Dendritic Cell-mediated Responses by Genes in Calcium and Cysteine Protease Pathways during Mycobacterium tuberculosis Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTECTIVE IMMUNITY; SIGNALING PATHWAYS; BONE-MARROW; RNAI SCREEN; IN-VIVO; DC-SIGN; KINASE; EXPRESSION; INHIBITION; AUTOPHAGY	Background: RNA interference (RNAi) is a useful tool to know the function of a gene in a cell under any kind of stress. Results: RNAi-mediated knockdown of genes in dendritic cells identified unreported genes and pathways that regulate its various functions during Mycobacterium tuberculosis infection. Conclusion: The identified genes could be potential targets in drug and vaccine designing. Significance: Understanding the role of host factors that regulate priming of immune responses is crucial to study host-pathogen interactions.	[Singhal, Jhalak; Agrawal, Neha; Vashishta, Mohit; Natarajan, Krishnamurthy] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Infect Dis Immunol Lab, Delhi 110007, India; [Priya, N. Gayatri; Raman, Rajagopal] Univ Delhi, Dept Zool, Gut Biol Lab, Delhi 110007, India; [Tiwari, Brijendra K.; Singh, Yogendra] CSIR, Inst Genom & Integrat Biol, Allergy & Infect Dis Lab, Delhi 110007, India	University of Delhi; University of Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Natarajan, K (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Infect Dis Immunol Lab, Delhi 110007, India.	knatarajan@acbr.du.ac.in	Tiwari, Brijesh Kumar/K-6227-2013; Singhal, Jhalak/GRE-9090-2022	Tiwari, Brijesh Kumar/0000-0002-4834-6831; Agrawal, Neha/0000-0001-8506-6559	Department of Biotechnology, Ministry of Science and Technology, Government of India	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by grants from the Department of Biotechnology, Ministry of Science and Technology, Government of India (to K. N.).	Agrawal-Singh S, 2010, BLOOD, V115, P4507, DOI 10.1182/blood-2009-03-210070; Alenzi FQB, 2004, BRIT J BIOMED SCI, V61, P99, DOI 10.1080/09674845.2004.11732652; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; Bodnar KA, 2001, INFECT IMMUN, V69, P800, DOI 10.1128/IAI.69.2.800-809.2001; Connolly SF, 2007, IMMUNOL RES, V39, P115, DOI 10.1007/s12026-007-0076-1; Cullen LM, 2005, IMMUNOL CELL BIOL, V83, P217, DOI 10.1111/j.1440-1711.2005.01332.x; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Foote S, 1999, NAT GENET, V21, P345, DOI 10.1038/7663; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Gan-Erdene T, 2003, J BIOL CHEM, V278, P28892, DOI 10.1074/jbc.M302890200; Ganesan AK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000298; Gawenda J, 2007, BREAST CANCER RES TR, V102, P1, DOI 10.1007/s10549-006-9311-z; Gupta D, 2010, J IMMUNOL, V184, P5444, DOI 10.4049/jimmunol.0903283; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005305; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hess J, 2000, ADV IMMUNOL, V75, P1, DOI 10.1016/S0065-2776(00)75001-2; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Ito M, 2005, FEBS LETT, V579, P5988, DOI 10.1016/j.febslet.2005.08.015; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Jaleel M, 2005, FEBS LETT, V579, P1417, DOI 10.1016/j.febslet.2005.01.042; Kaufmann SHE, 2003, J EXP MED, V197, P1, DOI 10.1084/jem.20021964; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Koh KW, 2009, MOL IMMUNOL, V46, P1312, DOI 10.1016/j.molimm.2008.11.008; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Krausz C, 2006, HUM MOL GENET, V15, P2673, DOI 10.1093/hmg/ddl198; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; Latchumanan VK, 2002, J IMMUNOL, V169, P6856, DOI 10.4049/jimmunol.169.12.6856; Lee JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015394; Li ST, 2006, MOL CELL, V24, P497, DOI 10.1016/j.molcel.2006.10.015; Lin PT, 2000, J NEUROSCI, V20, P9152; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Malik ZA, 2003, J IMMUNOL, V170, P2811, DOI 10.4049/jimmunol.170.6.2811; Manabe YC, 2000, NAT MED, V6, P1327, DOI 10.1038/82139; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; Nguyen A, 2004, FEBS LETT, V572, P307, DOI 10.1016/j.febslet.2004.06.061; Noble A, 2000, J IMMUNOL, V164, P1807, DOI 10.4049/jimmunol.164.4.1807; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; Ottenhoff THM, 2009, EUR J IMMUNOL, V39, P2014, DOI 10.1002/eji.200939518; Ovcharenko D, 2007, CANCER RES, V67, P10782, DOI 10.1158/0008-5472.CAN-07-1484; Pecora ND, 2009, CELL IMMUNOL, V254, P94, DOI 10.1016/j.cellimm.2008.07.002; Pramanik K, 2009, BLOOD, V113, P1184, DOI 10.1182/blood-2008-06-162180; Salam N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002869; Sinha A, 2006, J IMMUNOL, V177, P468, DOI 10.4049/jimmunol.177.1.468; Snapinn KW, 2011, PARKINSONISM RELAT D, V17, P473, DOI 10.1016/j.parkreldis.2011.01.019; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Sousa CRE, 2001, IMMUNITY, V14, P495; Srivastava V, 2011, IMMUNOL CELL BIOL, V89, P786, DOI 10.1038/icb.2011.1; Srivastava V, 2009, J BIOL CHEM, V284, P25532, DOI 10.1074/jbc.M109.006221; Steinman R. M., 1999, FUNDAMENTAL IMMUNOLO, pE47; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Tian T, 2005, J IMMUNOL, V175, P3268, DOI 10.4049/jimmunol.175.5.3268; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; World Health Organization, 2009, WHO FACT SHEET; Yadav UCS, 2009, J IMMUNOL, V183, P4723, DOI 10.4049/jimmunol.0901177; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; Young DL, 2009, EUR J IMMUNOL, V39, P2011, DOI 10.1002/eji.200939542	60	16	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11108	11121		10.1074/jbc.M111.300319	http://dx.doi.org/10.1074/jbc.M111.300319			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22337888	Green Published, hybrid			2022-12-27	WOS:000302780100039
J	Simoni, R				Simoni, Robert			Exploring the World of Phospholipids and Their Interactions with Proteins: The Work of William Dowhan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									Stanford Univ, Stanford, CA 94305 USA	Stanford University	Simoni, R (corresponding author), Stanford Univ, Stanford, CA 94305 USA.							BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; NEWMAN MJ, 1981, J BIOL CHEM, V256, P1804; WIRTZ KWA, 1969, BIOCHIM BIOPHYS ACTA, V193, P105, DOI 10.1016/0005-2736(69)90063-7	4	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2012	287	12					9509	9511		10.1074/jbc.O112.000002	http://dx.doi.org/10.1074/jbc.O112.000002			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	912KV	22427432	Green Published, hybrid			2022-12-27	WOS:000301797800079
J	Schushan, M; Rimon, A; Haliloglu, T; Forrest, LR; Padan, E; Ben-Tal, N				Schushan, Maya; Rimon, Abraham; Haliloglu, Turkan; Forrest, Lucy R.; Padan, Etana; Ben-Tal, Nir			A Model-Structure of a Periplasm-facing State of the NhaA Antiporter Suggests the Molecular Underpinnings of pH-induced Conformational Changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-VIII-IX; NA+/H+-ANTIPORTER; ESCHERICHIA-COLI; TRANSMEMBRANE DOMAIN; HELICOBACTER-PYLORI; CRYSTAL-STRUCTURE; CATION PASSAGE; MEMBRANE; MECHANISM; DYNAMICS	The Escherichia coli NhaA antiporter couples the transport of H+ and Na+ (or Li+) ions to maintain the proper pH range and Na+ concentration in cells. A crystal structure of NhaA, solved at pH 4, comprises 12 transmembrane helices (TMs), arranged in two domains, with a large cytoplasm-facing funnel and a smaller periplasm-facing funnel. NhaA undergoes conformational changes, e. g. after pH elevation to alkaline ranges, and we used two computational approaches to explore them. On the basis of pseudo-symmetric features of the crystal structure, we predicted the structural architecture of an alternate, periplasm-facing state. In contrast to the crystal structure, the model presents a closed cytoplasmic funnel, and a periplasmic funnel of greater volume. To examine the transporter functional direction of motion, we conducted elastic network analysis of the crystal structure and detected two main normal modes of motion. Notably, both analyses predicted similar trends of conformational changes, consisting of an overall rotational motion of the two domains around a putative symmetry axis at the funnel centers, perpendicular to the membrane plane. This motion, along with conformational changes within specific helices, resulted in closure at the cytoplasmic end and opening at the periplasmic end. Cross-linking experiments, performed between segments on opposite sides of the cytoplasmic funnel, revealed pH-dependent interactions consistent with the proposed conformational changes. We suggest that the model-structure and predicted motion represent alkaline pH-induced conformational changes, mediated by a cluster of evolutionarily conserved, titratable residues, at the cytoplasmic ends of TMs II, V, and IX.	[Schushan, Maya; Ben-Tal, Nir] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Ramat Aviv, Israel; [Rimon, Abraham; Padan, Etana] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Haliloglu, Turkan] Bogazici Univ, Life Sci & Technol Res Ctr, Polymer Res Ctr, Dept Chem Engn, TR-34342 Istanbul, Turkey; [Forrest, Lucy R.] Max Planck Inst Biophys, Computat Struct Biol Grp, D-60438 Frankfurt, Germany	Tel Aviv University; Hebrew University of Jerusalem; Bogazici University; Max Planck Society	Ben-Tal, N (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Ramat Aviv, Israel.	nirb@tauex.tau.ac.il	; Forrest, Lucy/E-8113-2016	Ben-Tal, Nir/0000-0001-6901-832X; Forrest, Lucy/0000-0003-1855-7985	Israel Science Foundation [1331/11]; NATO [CBP.MD.CLG 983009]; Edmond J. Safra Center for Bioinformatics at Tel-Aviv University; EDICT (European Drug Initiative on Channels and Transporters) [EU EP7]; USA-Israel Binational Science Foundation [BSF 20050130]; DFG (German Research Foundation); Collaborative Research Center;  [CBD.MD.CL6.984340]	Israel Science Foundation(Israel Science Foundation); NATO(NATO (North Atlantic Treaty Organisation)); Edmond J. Safra Center for Bioinformatics at Tel-Aviv University; EDICT (European Drug Initiative on Channels and Transporters); USA-Israel Binational Science Foundation(US-Israel Binational Science Foundation); DFG (German Research Foundation)(German Research Foundation (DFG)); Collaborative Research Center; 	This work was supported in part by Grant 1331/11 from the Israel Science Foundation (to N. B-T.), and by NATO Traveling Grant No. CBP.MD.CLG 983009 (to T. H. and N. B-T.). This work was also supported in part by a fellowship from the Edmond J. Safra Center for Bioinformatics at Tel-Aviv University (to M. S.); by EDICT (European Drug Initiative on Channels and Transporters) Grant Number: EU EP7, and The USA-Israel Binational Science Foundation Grant Number: BSF 20050130 (to E. P.); by the DFG (German Research Foundation), Collaborative Research Center 807 "Transport and Communication across Biological Membranes" (to L. R. F.); and by Grant CBD.MD.CL6.984340 (to T. H.).	Adamian L, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-13; Appel M, 2009, J MOL BIOL, V388, P659, DOI 10.1016/j.jmb.2009.03.010; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I, 1997, PROTEINS, V29, P292, DOI 10.1002/(SICI)1097-0134(199711)29:3<292::AID-PROT4>3.3.CO;2-5; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Bahar I, 2010, J GEN PHYSIOL, V135, P563, DOI 10.1085/jgp.200910368; Bahar I, 2010, CHEM REV, V110, P1463, DOI 10.1021/cr900095e; Boudker O, 2010, TRENDS PHARMACOL SCI, V31, P418, DOI 10.1016/j.tips.2010.06.004; Bowie JU, 2006, NAT STRUCT MOL BIOL, V13, P94, DOI 10.1038/nsmb0206-94; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Cui Q., 2006, NORMAL MODE ANAL THE; Diab M, 2011, J MOL BIOL, V413, P604, DOI 10.1016/j.jmb.2011.08.046; Dzafic E, 2009, SPECTROCHIM ACTA A, V72, P102, DOI 10.1016/j.saa.2008.08.015; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fleishman SJ, 2006, CURR OPIN STRUC BIOL, V16, P496, DOI 10.1016/j.sbi.2006.06.003; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2006, BIOPHYS J, V91, P508, DOI 10.1529/biophysj.106.082313; Galili L, 2004, J BIOL CHEM, V279, P23104, DOI 10.1074/jbc.M400288200; Galili L, 2002, BIOCHEMISTRY-US, V41, P609, DOI 10.1021/bi011655v; Gerchman Y, 1999, J BIOL CHEM, V274, P24617, DOI 10.1074/jbc.274.35.24617; Gerchman Y, 2001, BIOCHEMISTRY-US, V40, P3403, DOI 10.1021/bi002669o; Guan L, 2007, NAT PROTOC, V2, P2012, DOI 10.1038/nprot.2007.275; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Herz K, 2010, J BIOL CHEM, V285, P2211, DOI 10.1074/jbc.M109.047134; Hu NJ, 2011, NATURE, V478, P408, DOI 10.1038/nature10450; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Illergard K, 2011, PROTEINS, V79, P79, DOI 10.1002/prot.22859; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kaback HR, 2005, CR BIOL, V328, P557, DOI 10.1016/j.crvi.2005.03.008; Karasawa A, 2005, J BIOL CHEM, V280, P41900, DOI 10.1074/jbc.M510795200; Kessel A, 2002, CURR TOP MEMBR, V52, P205; Kessel A., 2010, PROTEINS STRUCTURE F; Kozachkov L, 2007, BIOCHEMISTRY-US, V46, P2419, DOI 10.1021/bi602393s; Kozachkov L, 2011, P NATL ACAD SCI USA, V108, P15769, DOI 10.1073/pnas.1109256108; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kuwabara N, 2004, J BIOL CHEM, V279, P40567, DOI 10.1074/jbc.M401132200; Kuwabara N, 2006, BIOCHEMISTRY-US, V45, P14834, DOI 10.1021/bi061048d; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Mager T, 2011, J BIOL CHEM, V286, P23570, DOI 10.1074/jbc.M111.230235; Olkhova E, 2006, P NATL ACAD SCI USA, V103, P2629, DOI 10.1073/pnas.0510914103; Olkhova E, 2007, BIOPHYS J, V92, P3784, DOI 10.1529/biophysj.106.098269; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Padan E, 2004, BBA-BIOENERGETICS, V1658, P2, DOI 10.1016/j.bbabio.2004.04.018; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; Petrey D, 2003, METHOD ENZYMOL, V374, P492, DOI 10.1016/S0076-6879(03)74021-X; Pornillos O, 2006, FEBS LETT, V580, P358, DOI 10.1016/j.febslet.2005.12.054; Radestock S, 2011, J MOL BIOL, V407, P698, DOI 10.1016/j.jmb.2011.02.008; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Rimon A, 2002, BIOCHEMISTRY-US, V41, P14897, DOI 10.1021/bi0261342; Rothman A, 1997, BIOCHEMISTRY-US, V36, P14572, DOI 10.1021/bi971800y; Schushan M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.L110.159202; Schushan M, 2010, J MOL BIOL, V396, P1181, DOI 10.1016/j.jmb.2009.12.055; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; Tzubery T, 2004, J BIOL CHEM, V279, P3265, DOI 10.1074/jbc.M309021200; Tzubery T, 2008, J BIOL CHEM, V283, P15975, DOI 10.1074/jbc.M800482200; Venturi M, 2000, J BIOL CHEM, V275, P4734, DOI 10.1074/jbc.275.7.4734; Vinothkumar KR, 2005, EMBO J, V24, P2720, DOI 10.1038/sj.emboj.7600727; WEST IC, 1974, BIOCHEM J, V144, P87, DOI 10.1042/bj1440087	69	25	25	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18249	18261		10.1074/jbc.M111.336446	http://dx.doi.org/10.1074/jbc.M111.336446			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22431724	hybrid, Green Published			2022-12-27	WOS:000306411600032
J	Weissgerber, P; Kriebs, U; Tsvilovskyy, V; Olausson, J; Kretz, O; Stoerger, C; Mannebach, S; Wissenbach, U; Vennekens, R; Middendorff, R; Flockerzi, V; Freichel, M				Weissgerber, Petra; Kriebs, Ulrich; Tsvilovskyy, Volodymyr; Olausson, Jenny; Kretz, Oliver; Stoerger, Christof; Mannebach, Stefanie; Wissenbach, Ulrich; Vennekens, Rudi; Middendorff, Ralf; Flockerzi, Veit; Freichel, Marc			Excision of Trpv6 Gene Leads to Severe Defects in Epididymal Ca2+ Absorption and Male Fertility Much Like Single D541A Pore Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNELS TRPV5; SEMINIFEROUS TUBULES; CAT-LIKE; EXPRESSION; IDENTIFICATION; INHIBITION; RECEPTOR; DELTA-2; FLUID; ENTRY	Replacement of aspartate residue 541 by alanine (D541A) in the pore of TRPV6 channels in mice disrupts Ca2+ absorption by the epididymal epithelium, resulting in abnormally high Ca2+ concentrations in epididymal luminal fluid and in a dramatic but incomplete loss of sperm motility and fertilization capacity, raising the possibility of residual activity of channels formed by TRPV6(D541A) proteins (Weissgerber, P., Kriebs, U., Tsvilovskyy, V., Olausson, J., Kretz, O., Stoerger, C., Vennekens, R., Wissen-bach, U., Middendorff, R., Flockerzi, V., and Freichel, M. (2011) Sci. Signal. 4, ra27). It is known from other cation channels that introducing pore mutations even if they largely affect their conductivity and permeability can evoke considerably different phenotypes compared with the deletion of the corresponding protein. Therefore, we generated TRPV6-deficient mice (Trpv6(-/-)) by deleting exons encoding transmembrane domains with the pore-forming region and the complete cytosolic C terminus harboring binding sites for TRPV6-associated proteins that regulate its activity and plasma membrane anchoring. Using this strategy, we aimed to determine whether the TRPV6(D541A) pore mutant still contributes to residual channel activity and/or channel-independent functions in vivo. Trpv6(-/-) males reveal severe defects in fertility and motility and viability of sperm and a significant increase in epididymal luminal Ca2+ concentration that is mirrored by a lack of Ca2+ uptake by the epididymal epithelium. Therewith, Trpv6 excision affects epididymal Ca2+ handling and male fertility to the same extent as the introduction of the D541A pore mutation, arguing against residual functions of the TRPV6(D541A) pore mutant in epididymal epithelial cells.	[Tsvilovskyy, Volodymyr; Freichel, Marc] Heidelberg Univ, Inst Pharmakol, D-69120 Heidelberg, Germany; [Weissgerber, Petra; Kriebs, Ulrich; Tsvilovskyy, Volodymyr; Olausson, Jenny; Stoerger, Christof; Mannebach, Stefanie; Wissenbach, Ulrich; Vennekens, Rudi; Flockerzi, Veit; Freichel, Marc] Univ Saarland, D-66421 Homburg, Germany; [Middendorff, Ralf] Univ Giessen, Inst Anat & Zellbiol, D-35385 Giessen, Germany; [Kretz, Oliver] Univ Freiburg, Zentrum Neurowissensch, D-79104 Freiburg, Germany	Ruprecht Karls University Heidelberg; Saarland University; Justus Liebig University Giessen; University of Freiburg	Freichel, M (corresponding author), Heidelberg Univ, Inst Pharmakol, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.	marc.freichel@pharma.uni-heidelberg.de	Vennekens, Rudi/AAQ-1664-2020	Vennekens, Rudi/0000-0002-2564-5150; Kretz, Oliver/0000-0003-1152-5956	Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie and Sander-Stiftung; LOEWE program; Landes-Offensive zur Ent-wicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE); Homburger Forschungsforderungsprogramm (HOMFOR); Forschungsausschuss der Universitat des Saarlandes	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie and Sander-Stiftung(Fonds der Chemischen Industrie); LOEWE program; Landes-Offensive zur Ent-wicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE); Homburger Forschungsforderungsprogramm (HOMFOR); Forschungsausschuss der Universitat des Saarlandes	This work was supported by the Deutsche Forschungsgemeinschaft (to M.F., V.F., P.W., and R.M.), Fonds der Chemischen Industrie and Sander-Stiftung (to V.F.), LOEWE program (to R.M.), and Landes-Offensive zur Ent-wicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE), Homburger Forschungsforderungsprogramm (HOMFOR) and Forschungsausschuss der Universitat des Saarlandes (to M.F., V.F., P.W., and V.T.).	ACOTT TS, 1984, BIOL REPROD, V30, P926, DOI 10.1095/biolreprod30.4.926; Bianco SDC, 2007, J BONE MINER RES, V22, P274, DOI 10.1359/JBMR.061110; Darszon A, 2006, REPRODUCTION, V131, P977, DOI 10.1530/rep.1.00612; Evans JP, 2002, NAT CELL BIOL, V4, pS57, DOI 10.1038/ncb-nm-fertilityS57; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Freichel M, 1998, FEBS LETT, V422, P354, DOI 10.1016/S0014-5793(98)00041-6; Hirnet D, 2003, CELL CALCIUM, V33, P509, DOI 10.1016/S0143-4160(03)00066-6; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Hoenderop JGJ, 2003, PFLUG ARCH EUR J PHY, V446, P304, DOI 10.1007/s00424-003-1045-8; Hoenderop JGJ, 1999, J BIOL CHEM, V274, P8375, DOI 10.1074/jbc.274.13.8375; Jarolimek W, 1998, J NEUROSCI, V18, P4001; JENKINS AD, 1980, BIOL REPROD, V23, P981, DOI 10.1095/biolreprod23.5.981; Kakegawa W, 2007, J PHYSIOL-LONDON, V579, P729, DOI 10.1113/jphysiol.2006.127100; Lambers TT, 2004, J BIOL CHEM, V279, P28855, DOI 10.1074/jbc.M313637200; LEVINE N, 1971, J PHYSIOL-LONDON, V213, P557, DOI 10.1113/jphysiol.1971.sp009400; LEVINE N, 1978, J REPROD FERTIL, V52, P333, DOI 10.1530/jrf.0.0520333; Luo HY, 2004, J CLIN INVEST, V114, P1762, DOI 10.1172/JCI200421846; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Niemeyer BA, 2001, P NATL ACAD SCI USA, V98, P3600, DOI 10.1073/pnas.051511398; Peng JB, 2003, J PHYSIOL-LONDON, V551, P729, DOI 10.1113/jphysiol.2003.043349; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; Shimoyama M, 2002, BIOCHEM BIOPH RES CO, V298, P87, DOI 10.1016/S0006-291X(02)02399-9; TURNER TT, 1991, ANN NY ACAD SCI, V637, P364, DOI 10.1111/j.1749-6632.1991.tb27323.x; van de Graaf SFJ, 2006, AM J PHYSIOL-RENAL, V290, pF1295, DOI 10.1152/ajprenal.00443.2005; van de Graaf SFJ, 2006, MOL CELL BIOL, V26, P303, DOI 10.1128/MCB.26.1.303-312.2006; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; van de Graaf SFJ, 2006, PFLUG ARCH EUR J PHY, V452, P407, DOI 10.1007/s00424-006-0051-z; Vennekens R, 2000, J BIOL CHEM, V275, P3963, DOI 10.1074/jbc.275.6.3963; Voets T, 2003, J GEN PHYSIOL, V121, P245, DOI 10.1085/jgp.20028752; Weissgerber P, 2011, SCI SIGNAL, V4, P6, DOI 10.1126/scisignal.2001791; Wissenbach U, 2001, J BIOL CHEM, V276, P19461, DOI 10.1074/jbc.M009895200; Wollmuth LP, 2000, J NEUROSCI, V20, P5973, DOI 10.1523/JNEUROSCI.20-16-05973.2000	32	47	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					17930	17941		10.1074/jbc.M111.328286	http://dx.doi.org/10.1074/jbc.M111.328286			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22427671	hybrid, Green Published			2022-12-27	WOS:000306411600003
J	Kacena, MA; Eleniste, PP; Cheng, YH; Huang, S; Shivanna, M; Meijome, TE; Mayo, LD; Bruzzaniti, A				Kacena, Melissa A.; Eleniste, Pierre P.; Cheng, Ying-Hua; Huang, Su; Shivanna, Mahesh; Meijome, Tomas E.; Mayo, Lindsey D.; Bruzzaniti, Angela			Megakaryocytes Regulate Expression of Pyk2 Isoforms and Caspase-mediated Cleavage of Actin in Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH TYROSINE KINASE-2; FOCAL ADHESION KINASE; ALPHA(V)BETA(3) INTEGRIN; NUCLEAR TRANSLOCATION; CONNEXIN45 INTERACTS; CELL-PROLIFERATION; ZONULA OCCLUDENS-1; BONE; ACTIVATION; DIFFERENTIATION	The proliferation and differentiation of osteoblast (OB) precursors are essential for elaborating the bone-forming activity of mature OBs. However, the mechanisms regulating OB proliferation and function are largely unknown. We reported that OB proliferation is enhanced by megakaryocytes (MKs) via a process that is regulated in part by integrin signaling. The tyrosine kinase Pyk2 has been shown to regulate cell proliferation and survival in a variety of cells. Pyk2 is also activated by integrin signaling and regulates actin remodeling in bone-resorbing osteoclasts. In this study, we examined the role of Pyk2 and actin in the MK-mediated increase in OB proliferation. Calvarial OBs were cultured in the presence of MKs for various times, and Pyk2 signaling cascades in OBs were examined by Western blotting, subcellular fractionation, and microscopy. We found that MKs regulate the temporal expression of Pyk2 and its subcellular localization. We also found that MKs regulate the expression of two alternatively spliced isoforms of Pyk2 in OBs, which may regulate OB differentiation and proliferation. MKs also induced cytoskeletal reorganization in OBs, which was associated with the caspase-mediated cleavage of actin, an increase in focal adhesions, and the formation of apical membrane ruffles. Moreover, BrdU incorporation in MK-stimulated OBs was blocked by the actin-polymerizing agent, jasplakinolide. Collectively, our studies reveal that Pyk2 and actin play an important role in MK-regulated signaling cascades that control OB proliferation and may be important for therapeutic interventions aimed at increasing bone formation in metabolic diseases of the skeleton.	[Kacena, Melissa A.; Cheng, Ying-Hua; Meijome, Tomas E.] Indiana Univ, Sch Med, Dept Orthopaed Surg, Indianapolis, IN 46202 USA; [Mayo, Lindsey D.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Eleniste, Pierre P.; Huang, Su; Shivanna, Mahesh; Bruzzaniti, Angela] Indiana Univ, Sch Dent, Dept Oral Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Kacena, MA (corresponding author), Indiana Univ, Sch Med, Dept Orthopaed Surg, 1120 S Dr,FH115, Indianapolis, IN 46202 USA.	mkacena@iupui.edu; abruzzan@iupui.edu	Bruzzaniti, Angela/AAP-2225-2020		National Institutes of Health [P30 CA082709, RR025760, RR025761, R03 AR055269, R01 AR060332, R01 CA109262]; Indiana School of Dentistry; Department of Orthopaedic Surgery at Indiana University School of Medicine; Biomedical Research Grant; Indiana University School of Medicine; Indiana-Clinical and Translational Sciences Institute; NATIONAL CANCER INSTITUTE [P30CA082709, R01CA109262] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025761, KL2RR025760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060332, R03AR055269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana School of Dentistry; Department of Orthopaedic Surgery at Indiana University School of Medicine; Biomedical Research Grant; Indiana University School of Medicine; Indiana-Clinical and Translational Sciences Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We sincerely thank Dr. Fredrick Pavalko, Dr. Robyn Fuchs, Dr. Edward Srour, and Dr. Brian Bloomquist for helpful discussion and advice. We also thank Dr. Brahmananda Chitteti and the operators of the Indiana University Melvin and Bren Simon Cancer Center Flow Cytometry Resource Facility for their technical help and support. The Flow Cytometry Resource Facility is partially funded by National Institutes of Health Grant P30 CA082709.; This work was supported in part by National Institutes of Health Grants RR025760 and RR025761 (to A.B.and M. A. K.) and Grants R03 AR055269 (to M. A. K.), R01 AR060332 (to A. B. and M. A. K.), and R01 CA109262 (to L. D. M.). This work was also supported by in part by funds from the Indiana School of Dentistry (to A. B.), the Department of Orthopaedic Surgery at Indiana University School of Medicine (to M. A. K.), a Biomedical Research Grant and Pilot Funding for Research Use of Core Facilities Award both from Indiana University School of Medicine (to M. A. K.), and the Indiana-Clinical and Translational Sciences Institute.	Aoto H, 2002, CELL STRUCT FUNCT, V27, P47, DOI 10.1247/csf.27.47; Bartholomew JN, 2009, CANCER RES, V69, P2878, DOI 10.1158/0008-5472.CAN-08-2857; Bayer AL, 2003, J MOL CELL CARDIOL, V35, P1121, DOI 10.1016/S0022-2828(03)00228-1; Bethel Monique, 2011, Curr Osteoporos Rep, V9, P96, DOI 10.1007/s11914-011-0048-1; Blaschke F, 2002, BASIC RES CARDIOL, V97, P334, DOI 10.1007/s00395-002-0357-8; Boutahar N, 2004, J BIOL CHEM, V279, P30588, DOI 10.1074/jbc.M313244200; Bruzzaniti A., 2010, J BONE MINER RES  S1, V25; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Buckbinder L, 2007, P NATL ACAD SCI USA, V104, P10619, DOI 10.1073/pnas.0701421104; Ciovacco WA, 2010, J CELL BIOCHEM, V109, P774, DOI 10.1002/jcb.22456; Ciovacco WA, 2009, BONE, V44, P80, DOI 10.1016/j.bone.2008.08.117; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Conconi MT, 2002, INT J MOL MED, V10, P451; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Depraetere V, 1998, SCAND J IMMUNOL, V47, P523; Dikic I, 1998, J BIOL CHEM, V273, P14301, DOI 10.1074/jbc.273.23.14301; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Duong LT, 1998, J CLIN INVEST, V102, P881, DOI 10.1172/JCI3212; Emkey R, 1997, J BIOL CHEM, V272, P31182, DOI 10.1074/jbc.272.49.31182; Faure C, 2007, J CELL SCI, V120, P3034, DOI 10.1242/jcs.009613; GERSTENFELD LC, 1987, DEV BIOL, V122, P49, DOI 10.1016/0012-1606(87)90331-9; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Guignandon A, 2006, BIOCHEM BIOPH RES CO, V343, P407, DOI 10.1016/j.bbrc.2006.02.162; Haglund K, 2004, J CELL SCI, V117, P2557, DOI 10.1242/jcs.01148; Han S, 2009, J BIOL CHEM, V284, P13193, DOI 10.1074/jbc.M809038200; HOROWITZ MC, 1994, ENDOCRINOLOGY, V135, P1032, DOI 10.1210/en.135.3.1032; Jetmore A, 2002, BLOOD, V99, P1585, DOI 10.1182/blood.V99.5.1585; JILKA RL, 1981, ENDOCRINOLOGY, V109, P743, DOI 10.1210/endo-109-3-743; Kacena MA, 2005, BONE, V36, P215, DOI 10.1016/j.bone.2004.09.024; Kacena MA, 2004, J BONE MINER RES, V19, P652, DOI 10.1359/JBMR.0301254; Kacena MA, 2006, BONE, V39, P991, DOI 10.1016/j.bone.2006.05.004; Kacena MA, 2006, BONE, V39, P978, DOI 10.1016/j.bone.2006.05.019; Keogh RJ, 2002, BIOCHEM BIOPH RES CO, V290, P1470, DOI 10.1006/bbrc.2002.6350; Kim JB, 2007, BONE, V41, P39, DOI 10.1016/j.bone.2007.01.024; Kisslinger A, 2009, CANCER BIOL THER, V8, P232; Klemm AH, 2010, BIOCHEM BIOPH RES CO, V393, P694, DOI 10.1016/j.bbrc.2010.02.059; Laing JG, 2001, CELL COMMUN ADHES, V8, P209, DOI 10.3109/15419060109080725; Laing JG, 2001, J BIOL CHEM, V276, P23051, DOI 10.1074/jbc.M100303200; Lakkakorpi PT, 2003, J BIOL CHEM, V278, P11502, DOI 10.1074/jbc.M206579200; Langlois S, 2008, MOL BIOL CELL, V19, P912, DOI 10.1091/mbc.E07-06-0596; Lee SH, 2010, J IMMUNOL, V185, P917, DOI 10.4049/jimmunol.1000784; Lemieux JM, 2010, J CELL BIOCHEM, V109, P927, DOI 10.1002/jcb.22468; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Lim ST, 2010, J BIOL CHEM, V285, P1743, DOI 10.1074/jbc.M109.064212; Litvak V, 2000, J BIOL CHEM, V275, P32736, DOI 10.1074/jbc.M004200200; Mashima T, 1999, ONCOGENE, V18, P2423, DOI 10.1038/sj.onc.1202558; Mashima T, 1995, BIOCHEM BIOPH RES CO, V217, P1185, DOI 10.1006/bbrc.1995.2894; Mogi M, 2004, BONE, V35, P507, DOI 10.1016/j.bone.2004.03.003; Ohmori T, 2000, BIOCHEM J, V347, P561, DOI 10.1042/0264-6021:3470561; Perez J, 2011, AM J PHYSIOL-CELL PH, V301, pC242, DOI 10.1152/ajpcell.00315.2010; Ren XD, 2000, J CELL SCI, V113, P3673; Richardson A, 1996, NATURE, V380, P538, DOI 10.1038/380538a0; Rohn TT, 2004, EXP CELL RES, V295, P215, DOI 10.1016/j.yexcr.2003.12.029; Sancho D, 2002, J IMMUNOL, V169, P292, DOI 10.4049/jimmunol.169.1.292; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Schinke T, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 1, 3RD EDITION, P109, DOI 10.1016/B978-0-12-373884-4.00027-6; Schubert AL, 2002, BIOCHEMISTRY-US, V41, P5754, DOI 10.1021/bi0121656; SIMMONS DJ, 1982, CALCIFIED TISSUE INT, V34, P291, DOI 10.1007/BF02411253; STEVENSON BR, 1994, J CELL SCI, V107, P367; Sun CK, 2008, CARCINOGENESIS, V29, P2096, DOI 10.1093/carcin/bgn203; Sunters A, 2004, J BIOL CHEM, V279, P9882, DOI 10.1074/jbc.M310184200; van der Zande M, 2008, J BIOMED MATER RES A, V86A, P788, DOI 10.1002/jbm.a.31645; WONG GL, 1975, P NATL ACAD SCI USA, V72, P3167, DOI 10.1073/pnas.72.8.3167; Wozniak M, 2000, J BONE MINER RES, V15, P1731, DOI 10.1359/jbmr.2000.15.9.1731; Wu X, 2007, CELL DEATH DIFFER, V14, P1792, DOI 10.1038/sj.cdd.4402190; Xiong WC, 2003, FRONT BIOSCI-LANDMRK, V8, pD1219, DOI 10.2741/1117; Xiong WC, 1998, J CELL SCI, V111, P1981	67	21	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17257	17268		10.1074/jbc.M111.309880	http://dx.doi.org/10.1074/jbc.M111.309880			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22447931	Green Published, hybrid			2022-12-27	WOS:000306373000026
J	Schiefner, A; Gebauer, M; Skerra, A				Schiefner, Andre; Gebauer, Michaela; Skerra, Arne			Extra-domain B in Oncofetal Fibronectin Structurally Promotes Fibrillar Head-to-tail Dimerization of Extracellular Matrix Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BINDING DOMAIN; SECONDARY-STRUCTURE; BIOLOGICAL-ACTIVITY; TUMOR VASCULATURE; CRYSTAL-STRUCTURE; CRYPTIC SEQUENCE; CELL-ADHESION; SYNERGY SITE; ED-B; INTEGRIN	The type III extra-domain B (ED-B) is specifically spliced into fibronectin (Fn) during embryogenesis and neoangiogenesis, including many cancers. The x-ray structure of the recombinant four-domain fragment Fn(III)7B89 reveals a tightly associated, extended head-to-tail dimer, which is stabilized via pair-wise shape and charge complementarity. A tendency toward ED-B-dependent dimer formation in solution was supported by size exclusion chromatography and analytical ultracentrifugation. When amending the model with the known three-dimensional structure of the Fn(III)10 domain, its RGD loop as well as the adhesion synergy region in Fn(III)9-10 become displayed on the same face of the dimer; this should allow simultaneous binding of at least two integrins and, thus, receptor clustering on the cell surface and intracellular signaling. Insertion of ED-B appears to stabilize overall head-to-tail dimerization of two separate Fn chains, which, together with alternating homodimer formation via disulfide bridges at the C-terminal Fn tail, should lead to the known macromolecular fibril formation.	[Skerra, Arne] Tech Univ Munich, Lehrstuhl Biol Chem, D-85350 Freising Weihenstephan, Germany; Tech Univ Munich, Munich Ctr Integrated Prot Sci CIPS M, D-85350 Freising Weihenstephan, Germany	Technical University of Munich; Technical University of Munich	Skerra, A (corresponding author), Tech Univ Munich, Lehrstuhl Biol Chem, Emil Erlenmeyer Forum 5, D-85350 Freising Weihenstephan, Germany.	skerra@tum.de	Skerra, Arne/A-2269-2013	Skerra, Arne/0000-0002-5717-498X; Schiefner, Andre/0000-0001-5215-4122	Deutsche Forschungsgemeinschaft [Forschergruppe 411]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Forschergruppe 411 of the Deutsche Forschungsgemeinschaft.	AGUIRRE KM, 1994, J BIOL CHEM, V269, P27863; AOTA S, 1994, J BIOL CHEM, V269, P24756; Astrof S, 2007, DEV BIOL, V311, P11, DOI 10.1016/j.ydbio.2007.07.005; Bae E, 2004, J BIOL CHEM, V279, P35749, DOI 10.1074/jbc.M406283200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balza E, 2009, INT J CANCER, V125, P751, DOI 10.1002/ijc.24473; Bencharit S, 2007, J MOL BIOL, V367, P303, DOI 10.1016/j.jmb.2006.10.017; Bultmann H, 1998, J BIOL CHEM, V273, P2601, DOI 10.1074/jbc.273.5.2601; CARNEMOLLA B, 1989, J CELL BIOL, V108, P1139, DOI 10.1083/jcb.108.3.1139; CARNEMOLLA B, 1992, J BIOL CHEM, V267, P24689; Chauhan AK, 2008, ARTERIOSCL THROM VAS, V28, P296, DOI 10.1161/ATVBAHA.107.149146; Cho J, 2006, J THROMB HAEMOST, V4, P1461, DOI 10.1111/j.1538-7836.2006.01943.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DZAMBA BJ, 1991, J CELL SCI, V100, P605; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSEN LO, 1994, J MOL BIOL, V238, P226, DOI 10.1006/jmbi.1994.1284; Fattorusso R, 1999, STRUCTURE, V7, P381, DOI 10.1016/S0969-2126(99)80051-3; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; Fukuda T, 2002, CANCER RES, V62, P5603; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; George EL, 1997, BLOOD, V90, P3073, DOI 10.1182/blood.V90.8.3073; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Graille M, 2010, STRUCTURE, V18, P710, DOI 10.1016/j.str.2010.03.012; Grant RP, 1997, J BIOL CHEM, V272, P6159, DOI 10.1074/jbc.272.10.6159; HashimotoUoshima M, 1997, J CELL SCI, V110, P2271; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Hohenester E, 2002, MATRIX BIOL, V21, P115, DOI 10.1016/S0945-053X(01)00191-3; Hynes R.O., 1990, FIBRONECTINS, P546; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kauf ACW, 2001, BIOCHEMISTRY-US, V40, P9159, DOI 10.1021/bi010503x; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Kleywegt Gerard J, 2007, Methods Mol Biol, V364, P255; KORNBLIHTT AR, 1984, NUCLEIC ACIDS RES, V12, P5853, DOI 10.1093/nar/12.14.5853; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Liu T, 2005, J PROTEOME RES, V4, P2070, DOI 10.1021/pr0502065; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282; Muether PS, 2007, EXP EYE RES, V85, P356, DOI 10.1016/j.exer.2007.06.004; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; PLOW EF, 1985, P NATL ACAD SCI USA, V82, P8057, DOI 10.1073/pnas.82.23.8057; Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521; Ruoslahti E, 2002, NAT REV CANCER, V2, P83, DOI 10.1038/nrc724; Schiefner A, 2010, ACTA CRYSTALLOGR D, V66, P1308, DOI 10.1107/S0907444910039375; Schliemann C, 2007, BBA-REV CANCER, V1776, P175, DOI 10.1016/j.bbcan.2007.08.002; SCHWARZBAUER JE, 1987, EMBO J, V6, P2573, DOI 10.1002/j.1460-2075.1987.tb02547.x; SCHWARZBAUER JE, 1991, J CELL BIOL, V113, P1463, DOI 10.1083/jcb.113.6.1463; Sechler JL, 1997, MOL BIOL CELL, V8, P2563, DOI 10.1091/mbc.8.12.2563; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; SKERRA A, 1994, GENE, V141, P79, DOI 10.1016/0378-1119(94)90131-7; SKERRA A, 1994, GENE, V151, P131, DOI 10.1016/0378-1119(94)90643-2; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; TAMKUN JW, 1983, J BIOL CHEM, V258, P4641; Tan MH, 2004, BLOOD, V104, P11, DOI 10.1182/blood-2003-09-3363; Tarli L, 1999, BLOOD, V94, P192, DOI 10.1182/blood.V94.1.192.413k22_192_198; Ventura E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009145; White ES, 2008, J PATHOL, V216, P1, DOI 10.1002/path.2388; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Wijelath ES, 2006, CIRC RES, V99, P853, DOI 10.1161/01.RES.0000246849.17887.66; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; ZARDI L, 1987, EMBO J, V6, P2337, DOI 10.1002/j.1460-2075.1987.tb02509.x	72	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17578	17588		10.1074/jbc.M111.303131	http://dx.doi.org/10.1074/jbc.M111.303131			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22442152	Green Published, hybrid			2022-12-27	WOS:000306373000056
J	Aryal, RP; Ju, TZ; Cummings, RD				Aryal, Rajindra P.; Ju, Tongzhong; Cummings, Richard D.			Tight Complex Formation between Cosmc Chaperone and Its Specific Client Non-native T-synthase Leads to Enzyme Activity and Client-driven Dissociation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN O-GLYCOSYLATION; ENDOPLASMIC-RETICULUM; MOLECULAR CHAPERONE; CORE-1 BETA-1,3-GALACTOSYLTRANSFERASE; DROSOPHILA-MELANOGASTER; IDENTIFICATION; PURIFICATION; INFLAMMATION; EXPRESSION; MUTATIONS	The interaction of the endoplasmic reticulum molecular chaperone Cosmc with its specific client T-synthase (Core 1 beta 1-3-galactosyltransferase) is required for folding of the enzyme and eventual movement of the T-synthase to the Golgi, but the mechanism of interaction is unclear. Here we show that the lumenal domain of recombinant Cosmc directly interacts specifically in either free form or covalently bound to solid supports with denatured T-synthase but not with the active dimeric form of the enzyme. This leads to formation of a relatively stable complex of Cosmc and denatured T-synthase accompanied by formation of reactivated enzyme in an ATP-independent fashion that is not regulated by redox, calcium, pH, or intermolecular disulfide bond formation. The partly refolded and active T-synthase remains tightly bound noncovalently to Cosmc. Dissociation of T-synthase from the complex is promoted by further interactions of the complex with free forms of either native or non-native T-synthase. Taken together, these results demonstrate a novel mechanism in which Cosmc cycles to bind non-native T-synthase, leading to enzyme activity and release in a client-driven process.	[Aryal, Rajindra P.; Ju, Tongzhong; Cummings, Richard D.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Cummings, RD (corresponding author), O Wayne Rollins Res Ctr, 1510 Clifton Rd,Suite 4001, Atlanta, GA 30322 USA.	rdcummi@emory.edu		Ju, Tongzhong/0000-0002-4429-1976; Aryal, Rajindra P/0000-0001-8718-636X	National Institutes of Health [RO1 GM068559]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM068559 (to R. D. C.).	Alexander WS, 2006, P NATL ACAD SCI USA, V103, P16442, DOI 10.1073/pnas.0607872103; Aryal RP, 2010, J BIOL CHEM, V285, P2456, DOI 10.1074/jbc.M109.065169; Betts S, 1999, STRUCT FOLD DES, V7, pR131, DOI 10.1016/S0969-2126(99)80078-1; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Brillet T, 2010, J BIOL CHEM, V285, P17986, DOI 10.1074/jbc.M109.098491; Brockhausen I, 1998, ACTA ANAT, V161, P36; Brockhausen I, 2009, ESSENTIALS GLYCOBIOL, P115; Crew VK, 2008, BRIT J HAEMATOL, V142, P657, DOI 10.1111/j.1365-2141.2008.07215.x; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ellis R J, 1990, Semin Cell Biol, V1, P1; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Fomenko DE, 2002, PROTEIN SCI, V11, P2285, DOI 10.1110/ps.0218302; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; Hang HC, 2005, BIOORGAN MED CHEM, V13, P5021, DOI 10.1016/j.bmc.2005.04.085; Huang BX, 2004, J AM SOC MASS SPECTR, V15, P1237, DOI 10.1016/j.jasms.2004.05.004; Huang HH, 2010, J CELL BIOL, V190, P893, DOI 10.1083/jcb.201004102; Inoue S, 2000, BIOCHEM BIOPH RES CO, V268, P553, DOI 10.1006/bbrc.2000.2170; Johswich A, 2009, J CELL BIOL, V184, P173, DOI 10.1083/jcb.200801071; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Ju TZ, 2008, CANCER RES, V68, P1636, DOI 10.1158/0008-5472.CAN-07-2345; Ju TZ, 2006, GLYCOBIOLOGY, V16, P947, DOI 10.1093/glycob/cwl008; Ju TZ, 2011, GLYCOBIOLOGY, V21, P352, DOI 10.1093/glycob/cwq168; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P169, DOI 10.1074/jbc.M109056200; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Kriegenburg F, 2012, FEBS J, V279, P532, DOI 10.1111/j.1742-4658.2011.08456.x; Kumagai T, 2010, GLYCOCONJUGATE J, V27, P685, DOI 10.1007/s10719-010-9313-2; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li YH, 2002, BIOCHEMISTRY-US, V41, P4921, DOI 10.1021/bi011894i; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; McCormick CD, 2004, OPHTHAL PLAST RECONS, V20, P347, DOI 10.1097/01.IOP.0000134248.64325.C7; McEver RP, 1997, J CLIN INVEST, V100, pS97; Muller R, 2005, FEBS J, V272, P4295, DOI 10.1111/j.1742-4658.2005.04838.x; Narimatsu Y, 2008, BIOCHEM BIOPH RES CO, V366, P199, DOI 10.1016/j.bbrc.2007.11.121; Narimatsu Y, 2011, FEBS LETT, V585, P1276, DOI 10.1016/j.febslet.2011.04.010; NIGAM SK, 1994, J BIOL CHEM, V269, P1744; PALLEROS DR, 1994, J BIOL CHEM, V269, P13107; RAO PV, 1993, BIOCHEM BIOPH RES CO, V190, P786, DOI 10.1006/bbrc.1993.1118; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; SAGA S, 1987, J CELL BIOL, V105, P517, DOI 10.1083/jcb.105.1.517; Schietinger A, 2006, SCIENCE, V314, P304, DOI 10.1126/science.1129200; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Sun QA, 2011, J BIOL CHEM, V286, P11529, DOI 10.1074/jbc.M110.173591; Szolajska E, 2011, CELL MOL LIFE SCI, V68, P3307, DOI 10.1007/s00018-011-0740-4; Trilla JA, 1999, J CELL BIOL, V145, P1153, DOI 10.1083/jcb.145.6.1153; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Yoshida H, 2008, GLYCOBIOLOGY, V18, P1094, DOI 10.1093/glycob/cwn094; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566	55	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15317	15329		10.1074/jbc.M111.312587	http://dx.doi.org/10.1074/jbc.M111.312587			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22416136	Green Published, hybrid			2022-12-27	WOS:000304006300015
J	Brodehl, A; Hedde, PN; Dieding, M; Fatima, A; Walhorn, V; Gayda, S; Saric, T; Klauke, B; Gummert, J; Anselmetti, D; Heilemann, M; Nienhaus, GU; Milting, H				Brodehl, Andreas; Hedde, Per Niklas; Dieding, Mareike; Fatima, Azra; Walhorn, Volker; Gayda, Susan; Saric, Tomos; Klauke, Baerbel; Gummert, Jan; Anselmetti, Dario; Heilemann, Mike; Nienhaus, Gerd Ulrich; Milting, Hendrik			Dual Color Photoactivation Localization Microscopy of Cardiomyopathy-associated Desmin Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; INTERMEDIATE-FILAMENTS; MARKER PROTEIN; MUTATIONS; SKELETAL; EOSFP; MYOPATHY; BIOLOGY	Mutations in the DES gene coding for the intermediate filament protein desmin may cause skeletal and cardiac myopathies, which are frequently characterized by cytoplasmic aggregates of desmin and associated proteins at the cellular level. By atomic force microscopy, we demonstrated filament formation defects of desmin mutants, associated with arrhythmogenic right ventricular cardiomyopathy. To understand the pathogenesis of this disease, it is essential to analyze desmin filament structures under conditions in which both healthy and mutant desmin are expressed at equimolar levels mimicking an in vivo situation. Here, we applied dual color photoactivation localization microscopy using photoactivatable fluorescent proteins genetically fused to desmin and characterized the heterozygous status in living cells lacking endogenous desmin. In addition, we applied fluorescence resonance energy transfer to unravel short distance structural patterns of desmin mutants in filaments. For the first time, we present consistent high resolution data on the structural effects of five heterozygous desmin mutations on filament formation in vitro and in living cells. Our results may contribute to the molecular understanding of the pathological filament formation defects of heterozygous DES mutations in cardiomyopathies.	[Brodehl, Andreas; Klauke, Baerbel; Milting, Hendrik] Ruhr Univ Bochum, E&H Klessmann Inst Cardiovasc Res & Dev, Heart & Diabet Ctr NRW, D-32545 Bad Oeynhausen, Germany; [Gummert, Jan] Ruhr Univ Bochum, Clin Cardiothorac Surg, Heart & Diabet Ctr NRW, D-32545 Bad Oeynhausen, Germany; [Hedde, Per Niklas; Gayda, Susan; Nienhaus, Gerd Ulrich] Karlsruhe Inst Technol, Inst Appl Phys, D-76128 Karlsruhe, Germany; [Hedde, Per Niklas; Gayda, Susan; Nienhaus, Gerd Ulrich] Karlsruhe Inst Technol, Ctr Funct Nanostruct, D-76128 Karlsruhe, Germany; [Dieding, Mareike; Walhorn, Volker; Anselmetti, Dario] Univ Bielefeld, Fac Phys, D-33615 Bielefeld, Germany; [Dieding, Mareike; Walhorn, Volker; Anselmetti, Dario] Univ Bielefeld, Bielefeld Inst Biophys & Nanosci BINAS, D-33615 Bielefeld, Germany; [Fatima, Azra; Saric, Tomos] Univ Cologne, Med Ctr, Inst Neurophysiol, D-50931 Cologne, Germany; [Heilemann, Mike] Univ Wurzburg, Dept Biotechnol & Biophys, D-97074 Wurzburg, Germany; [Nienhaus, Gerd Ulrich] Univ Illinois, Dept Phys, Urbana, IL 61801 USA	Ruhr University Bochum; Ruhr University Bochum; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; University of Bielefeld; University of Bielefeld; University of Cologne; University of Wurzburg; University of Illinois System; University of Illinois Urbana-Champaign	Milting, H (corresponding author), Ruhr Univ Bochum, E&H Klessmann Inst Cardiovasc Res & Dev, Heart & Diabet Ctr NRW, D-32545 Bad Oeynhausen, Germany.	hmilting@hdz-nrw.de	Saric, Tomo/B-3415-2015; Walhorn, Volker/F-3803-2011; Brodehl, Andreas/C-6450-2013; Nienhaus, Gerd Ulrich/G-8698-2012; Anselmetti, Dario/F-1664-2011	Saric, Tomo/0000-0001-8344-1095; Brodehl, Andreas/0000-0001-9202-2343; Nienhaus, Gerd Ulrich/0000-0002-5027-3192; Anselmetti, Dario/0000-0002-8720-4369; Heilemann, Mike/0000-0002-9821-3578	German Ministry of Education and Research (BMBF) [O1 GN 0824]	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by Grant O1 GN 0824 from the German Ministry of Education and Research (BMBF) to (T. S.).	Adam V, 2008, P NATL ACAD SCI USA, V105, P18343, DOI 10.1073/pnas.0805949105; Ando S, 2004, BBA-PROTEINS PROTEOM, V1702, P53, DOI 10.1016/j.bbapap.2004.07.008; Andresen M, 2008, NAT BIOTECHNOL, V26, P1035, DOI 10.1038/nbt.1493; Bar H, 2010, J MOL BIOL, V397, P1188, DOI 10.1016/j.jmb.2010.02.024; Bar H, 2005, HUM MOL GENET, V14, P1251, DOI 10.1093/hmg/ddi136; Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003; Bar H, 2005, P NATL ACAD SCI USA, V102, P15099, DOI 10.1073/pnas.0504568102; Bar H, 2007, HUM MUTAT, V28, P374, DOI 10.1002/humu.20459; Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033; Chernyatina A. A., 2011, 7 EUR C INT FIL HLTH; Chourbagi O, 2011, EXP CELL RES, V317, P886, DOI 10.1016/j.yexcr.2011.01.013; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Dalakas MC, 2003, NEUROMUSCULAR DISORD, V13, P252, DOI 10.1016/S0960-8966(02)00271-7; Fuchs J, 2010, NAT METHODS, V7, P627, DOI [10.1038/NMETH.1477, 10.1038/nmeth.1477]; Goldfarb LG, 2009, J CLIN INVEST, V119, P1806, DOI 10.1172/JCI38027; Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300; Gupta MK, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-98; Hachet-Haas M, 2006, MICROSC RES TECHNIQ, V69, P941, DOI 10.1002/jemt.20376; HEDBERG KK, 1986, EXP CELL RES, V163, P509, DOI 10.1016/0014-4827(86)90081-9; Hedde Per Niklas, 2010, Biophys Rev, V2, P147, DOI 10.1007/s12551-010-0037-0; Hedde PN, 2009, NAT METHODS, V6, P689, DOI 10.1038/nmeth1009-689; Helfand BT, 2003, ANNU REV CELL DEV BI, V19, P445, DOI 10.1146/annurev.cellbio.19.111401.092306; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Hong D, 2011, NEUROPATH APPL NEURO, V37, P257, DOI 10.1111/j.1365-2990.2010.01112.x; KARTENBECK J, 1983, EMBO J, V2, P735, DOI 10.1002/j.1460-2075.1983.tb01493.x; KITAMURA S, 1989, J BIOL CHEM, V264, P5674; Klauke B, 2010, HUM MOL GENET, V19, P4595, DOI 10.1093/hmg/ddq387; Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092; Levin J, 2010, J NEUROPATH EXP NEUR, V69, P415, DOI 10.1097/NEN.0b013e3181d71305; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Munoz-Marmol AM, 1998, P NATL ACAD SCI USA, V95, P11312, DOI 10.1073/pnas.95.19.11312; Nicolet S, 2010, J STRUCT BIOL, V170, P369, DOI 10.1016/j.jsb.2010.02.012; Nienhaus GU, 2006, PHOTOCHEM PHOTOBIOL, V82, P351, DOI 10.1562/2005-05-19-RA-533; Nienhaus K, 2005, P NATL ACAD SCI USA, V102, P9156, DOI 10.1073/pnas.0501874102; Otten E, 2010, HEART RHYTHM, V7, P1058, DOI 10.1016/j.hrthm.2010.04.023; Pica EC, 2008, NEUROMUSCULAR DISORD, V18, P178, DOI 10.1016/j.nmd.2007.09.011; RAATS JMH, 1990, J CELL BIOL, V111, P1971, DOI 10.1083/jcb.111.5.1971; Sharma S, 2009, J MOL MED, V87, P1207, DOI 10.1007/s00109-009-0521-9; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; van Spaendonck-Zwarts K., 2010, CLIN GENET, V89, P354; van Tintelen JP, 2009, HEART RHYTHM, V6, P1574, DOI 10.1016/j.hrthm.2009.07.041; Vernengo L, 2010, NEUROMUSCULAR DISORD, V20, P178, DOI 10.1016/j.nmd.2010.01.001; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Wiedenmann J, 2011, J BIOPHOTONICS, V4, P377, DOI 10.1002/jbio.201000122; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	47	39	39	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					16047	16057		10.1074/jbc.M111.313841	http://dx.doi.org/10.1074/jbc.M111.313841			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22403400	Green Published, hybrid			2022-12-27	WOS:000304006300082
J	DeAngelis, JP; Wakabayashi, H; Fay, PJ				DeAngelis, Jennifer P.; Wakabayashi, Hironao; Fay, Philip J.			Sequences Flanking Arg(336) in Factor VIIIa Modulate Factor Xa-catalyzed Cleavage Rates at this Site and Cofactor Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-PROTEIN-C; THROMBIN GENERATION; A1/A3-C1-C2 DIMER; A1 SUBUNIT; FACTOR-IXA; A2 DOMAIN; RESIDUES; INACTIVATION; MECHANISMS; IDENTIFICATION	Factor (F)VIII can be activated to FVIIIa by FXa following cleavages at Arg(372), Arg(740), and Arg(1689). FXa also cleaves FVIII/FVIIIa at Arg(336) and Arg(562) resulting in inactivation of the cofactor. These inactivating cleavages occur on a slower time scale than the activating ones. We assessed the contributions to cleavage rate and cofactor function of residues flanking Arg(336), the primary site yielding FVIII(a) inactivation, following replacement of these residues with those flanking the faster-reacting Arg(740) and Arg(372) sites and the slower-reacting Arg(562) site. Replacing P4-P3' residues flanking Arg(336) with those from Arg(372) or Arg(740) resulted in similar to 4-6-fold increases in rates of FXa-catalyzed inactivation of FVIIIa, which paralleled the rates of proteolysis at Arg(336). Examination of partial sequence replacements showed a predominant contribution of prime residues flanking the scissile bonds to the enhanced rates. Conversely, replacement of this sequence with residues flanking the slow-reacting Arg(562) site yielded inactivation and cleavage rates that were similar to 40% that of the WT values. The capacity for FXa to activate FVIII variants where cleavage at Arg(336) was accelerated due to flanking sequence replacement showed marked reductions in peak activity, whereas reducing the cleavage rate at this site enhanced peak activity. Furthermore, plasma-based thrombin generation assays employing the variants revealed significant reductions in multiple parameter values with acceleration of Arg(336) cleavage suggesting increased down-regulation of FXase. Overall, these results are consistent with a model of competition for activating and inactivating cleavages catalyzed by FXa that is modulated in large part by sequences flanking the scissile bonds.	[DeAngelis, Jennifer P.; Wakabayashi, Hironao; Fay, Philip J.] Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Fay, PJ (corresponding author), POB 712,601 Elmwood Ave, Rochester, NY 14642 USA.	philip_fay@urmc.rochester.edu			National Institutes of Health [HL76213, HL38199]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038199, R01HL076213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL76213 and HL38199.	Ansong C, 2006, J THROMB HAEMOST, V4, P842, DOI 10.1111/j.1538-7836.2006.01831.x; Bianchini EP, 2002, J BIOL CHEM, V277, P20527, DOI 10.1074/jbc.M201139200; Bode W, 1997, THROMB HAEMOSTASIS, V78, P501; DeAngelis JP, 2011, THROMB RES, V128, P470, DOI 10.1016/j.thromres.2011.03.007; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; Fay PJ, 2005, BLOOD REV, V19, P15, DOI 10.1016/j.blre.2004.02.003; FAY PJ, 1994, J BIOL CHEM, V269, P20522; Fay PJ, 1996, J BIOL CHEM, V271, P6027, DOI 10.1074/jbc.271.11.6027; FAY PJ, 1991, J BIOL CHEM, V266, P20139; FAY PJ, 1992, J BIOL CHEM, V267, P13246; FAY PJ, 1991, J BIOL CHEM, V266, P8957; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; HEMKER HC, 1995, THROMB HAEMOSTASIS, V74, P134; Hockin MF, 2002, J BIOL CHEM, V277, P18322, DOI 10.1074/jbc.M201173200; Jenkins PV, 2002, BLOOD, V100, P501, DOI 10.1182/blood-2001-12-0361; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; LOLLAR P, 1991, J BIOL CHEM, V266, P12481; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; Nogami K, 2005, BLOOD, V105, P4362, DOI 10.1182/blood-2004-10-3939; Nogami K, 2004, J BIOL CHEM, V279, P33104, DOI 10.1074/jbc.M405537200; Nogami K, 2003, J BIOL CHEM, V278, P1634, DOI 10.1074/jbc.M209811200; Nogami K, 2004, J BIOL CHEM, V279, P15763, DOI 10.1074/jbc.M400568200; Nogami K, 1999, J BIOL CHEM, V274, P31000, DOI 10.1074/jbc.274.43.31000; Nogami K, 2003, J BIOL CHEM, V278, P16502, DOI 10.1074/jbc.M213044200; Nogami K, 2007, J BIOL CHEM, V282, P5287, DOI 10.1074/jbc.M607816200; Plantier JL, 2010, J THROMB HAEMOST, V8, P286, DOI 10.1111/j.1538-7836.2009.03675.x; Varfaj F, 2007, J BIOL CHEM, V282, P20264, DOI 10.1074/jbc.M701327200; Varfaj F, 2006, BIOCHEM J, V396, P355, DOI 10.1042/BJ20060117; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; Wakabayashi H, 2004, J BIOL CHEM, V279, P12677, DOI 10.1074/jbc.M311042200; Wakabayashi H, 2008, BLOOD, V112, P2761, DOI 10.1182/blood-2008-02-142158	32	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15409	15417		10.1074/jbc.M111.333948	http://dx.doi.org/10.1074/jbc.M111.333948			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22411993	hybrid, Green Published			2022-12-27	WOS:000304006300022
J	Gustin, JK; Douglas, JL; Bai, Y; Moses, AV				Gustin, Jean K.; Douglas, Janet L.; Bai, Ying; Moses, Ashlee V.			Ubiquitination of BST-2 Protein by HIV-1 Vpu Protein Does Not Require Lysine, Serine, or Threonine Residues within the BST-2 Cytoplasmic Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; GROWTH-HORMONE RECEPTOR; SARCOMA-ASSOCIATED HERPESVIRUS; CLATHRIN-MEDIATED ENDOCYTOSIS; BETA-TRCP; PARTICLE RELEASE; DOWN-REGULATION; CELL-SURFACE; F-BOX; ENDOPLASMIC-RETICULUM	The cellular protein BST-2/CD317/Tetherin has been shown to inhibit the release of HIV-1 and other enveloped viruses from infected cells. The HIV-1 accessory protein Vpu binds to both BST-2 and beta TrCP, a substrate-recognition subunit for the SCF (Skip1-Cullin1-F-box protein) E3 ubiquitin ligase complex. This interaction leads to both the degradation of BST-2 and the enhancement of viral egress. Recently BST-2 was shown to be ubiquitinated in this process. Here we have confirmed the Vpu- and beta TrCP-dependent multi/polyubiquitination of BST-2. Ubiquitinated BST-2 accumulated in cells treated with a lysosomal inhibitor but not a proteasomal inhibitor. Additionally, we observed that a BST-2 mutant deleted for its cytosolically exposed lysine residues is also ubiquitinated. Subsequent experiments suggested that Vpu promotes BST-2 ubiquitination upon amino acid residues bearing hydroxyl-but not thiol-bearing side chains. However, a BST-2 mutant bearing substitutions for its cytoplasmically exposed Ser, Thr, and Lys residues was still down-regulated, ubiquitinated, and degraded in a Vpu-dependent manner. Our results suggest that Vpu may target either the BST-2 cytoplasmic Tyr residues or the NH2 terminus itself for ubiquitination.	[Gustin, Jean K.; Douglas, Janet L.; Bai, Ying; Moses, Ashlee V.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA	Oregon Health & Science University	Gustin, JK (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, 505 NW 185th Ave, Beaverton, OR 97006 USA.	gustinj@ohsu.edu			National Institutes of Health [R01-AI090490-01A1, 5-R01-AI063938-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063938, R01AI090490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AI090490-01A1 and 5-R01-AI063938-03.	Andrew AJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-80; Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Belaidouni N, 2007, BIOCHEM BIOPH RES CO, V357, P688, DOI 10.1016/j.bbrc.2007.03.195; Besnard-Guerin C, 2004, J BIOL CHEM, V279, P788, DOI 10.1074/jbc.M308068200; Binette J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-75; BOUR S, 1995, J VIROL, V69, P1510, DOI 10.1128/JVI.69.3.1510-1520.1995; Bour S, 1996, J VIROL, V70, P820, DOI 10.1128/JVI.70.2.820-829.1996; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Butticaz C, 2007, J VIROL, V81, P1502, DOI 10.1128/JVI.01711-06; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Cadwell K, 2008, J VIROL, V82, P4184, DOI 10.1128/JVI.02264-07; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Deng L, 2007, MOL ENDOCRINOL, V21, P1537, DOI 10.1210/me.2007-0138; Derdeyn CA, 2001, J VIROL, V75, P8605, DOI 10.1128/JVI.75.18.8605-8614.2001; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2011, TRAFFIC, V12, P1714, DOI 10.1111/j.1600-0854.2011.01277.x; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Estrabaud E, 2007, PLOS PATHOG, V3, P995, DOI 10.1371/journal.ppat.0030104; Geimonen E, 2003, J VIROL, V77, P10760, DOI 10.1128/JVI.77.20.10760-10768.2003; Goffinet C, 2010, J VIROL, V84, P4089, DOI 10.1128/JVI.01549-09; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOTO T, 1994, BLOOD, V84, P1922; Gustin JK, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00161; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kumar KGS, 2003, EMBO J, V22, P5480; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Lau D, 2011, J VIROL, V85, P9834, DOI 10.1128/JVI.02633-10; Li Y, 2004, MOL CELL BIOL, V24, P4038, DOI 10.1128/MCB.24.9.4038-4048.2004; Li Y, 2004, J BIOL CHEM, V279, P11074, DOI 10.1074/jbc.M312301200; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Mansouri M, 2009, J VIROL, V83, P9672, DOI 10.1128/JVI.00597-09; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Masuyama N, 2009, J BIOL CHEM, V284, P15927, DOI 10.1074/jbc.M109.005124; Meusser B, 2004, MOL CELL, V14, P247, DOI 10.1016/S1097-2765(04)00212-6; Meyer L, 2007, BLOOD, V109, P5215, DOI 10.1182/blood-2006-10-055350; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Pardieu C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000843; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Ritter GD, 1996, J VIROL, V70, P2669, DOI 10.1128/JVI.70.4.2669-2673.1996; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Schmidt S, 2011, MBIO, V2, DOI 10.1128/mBio.00036-11; SCHUBERT U, 1992, EUR J BIOCHEM, V204, P875, DOI 10.1111/j.1432-1033.1992.tb16707.x; SCHUBERT U, 1994, J VIROL, V68, P2260, DOI 10.1128/JVI.68.4.2260-2271.1994; Schubert U, 1998, J VIROL, V72, P2280, DOI 10.1128/JVI.72.3.2280-2288.1998; Skasko M, 2011, VIROLOGY, V411, P65, DOI 10.1016/j.virol.2010.12.038; Spallek T, 2009, CELL MICROBIOL, V11, P1425, DOI 10.1111/j.1462-5822.2009.01346.x; Strous GJ, 1996, EMBO J, V15, P3806, DOI 10.1002/j.1460-2075.1996.tb00754.x; Tokarev AA, 2011, J VIROL, V85, P51, DOI 10.1128/JVI.01795-10; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; van Kerkhof P, 2007, J BIOL CHEM, V282, P20475, DOI 10.1074/jbc.M702610200; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2009, J CELL BIOL, V187, P655, DOI 10.1083/jcb.200908036; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	71	31	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14837	14850		10.1074/jbc.M112.349928	http://dx.doi.org/10.1074/jbc.M112.349928			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22383521	Green Published, hybrid			2022-12-27	WOS:000304003200048
J	Takayama, Y; Clore, GM				Takayama, Yuki; Clore, G. Marius			Interplay between Minor and Major Groove-binding Transcription Factors Sox2 and Oct1 in Translocation on DNA Studied by Paramagnetic and Diamagnetic NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-STRUCTURE DETERMINATION; PROTEIN-PROTEIN ASSOCIATION; RELAXATION ENHANCEMENT; POU DOMAIN; EXCHANGE SPECTROSCOPY; COGNATE SITES; XPLOR-NIH; COMPLEXES; MACROMOLECULES; VISUALIZATION	The pathways whereby Sox2 scans DNA to locate its specific binding site are investigated by NMR in specific and nonspecific Sox2.DNA complexes and in a specific ternary complex with Oct1 on the Hoxb1 regulatory element. Direct transfer of Sox2 between nonspecific sites on different DNA molecules occurs without dissociation into free solution at a rate of similar to 10(6) M-1 s(-1), whereas one-dimensional sliding proceeds with a diffusion constant of >= 0.1 mu m(2).s(-1). Translocation of Sox2 from one specific DNA site to another occurs via jumping, involving complete dissociation into free solution (k(d)similar to 5-6 s(-1)) followed by reassociation (k(a)similar to 5 x 10(8) M-1 s(-1)). In the presence of Oct1 bound to an adjacent specific site, k(d) is reduced by more than 10-fold. Paramagnetic relaxation measurements, however, demonstrate that sparsely populated (<1%), transient states involving nonspecifically bound Sox2 in rapid exchange with specifically bound Sox2 are sampled in both binary Sox2.DNA- and ternary Oct1.Sox2.Hoxb1-DNA-specific complexes. Moreover, Sox2 modulates the mechanism of translocation of Oct1. Both Sox2 and the Oct1 POUHD domain are transiently released from the specific ternary complex by sliding to an adjacent nonspecific site, followed by direct transfer to another DNA molecule, whereas the Oct1 POUS domain is fixed to its specific site through direct interactions with Sox2. Intermolecular translocation of POUHD results in the formation of a bridged intermediate spanning two DNA molecules, enhancing the probability of complete intermolecular translocation of Oct1. By way of contrast, in the specific Oct1.DNA binary complex, POUS undergoes direct intermolecular translocation, whereas POUHD scans the DNA by sliding.	[Takayama, Yuki; Clore, G. Marius] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Clore, GM (corresponding author), NIDDK, Chem Phys Lab, NIH, Bldg 5, Bethesda, MD 20892 USA.	mariusc@intra.niddk.nih.gov	Clore, G Marius/L-2546-2018; Clore, G. Marius/A-3511-2008	Clore, G Marius/0000-0003-3809-1027; Clore, G. Marius/0000-0003-3809-1027	National Institutes of Health, NIDDK; Office of the Director of the National Institutes of Health; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029023] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health, NIDDK, Intramural Program and by the AIDS Targeted Antiviral Program of the Office of the Director of the National Institutes of Health (to G. M. C.).; Supported by a Japan Society for the Promotion of Science Research Fellowship for Japanese Biomedical and Behavioral Researchers at the National Institutes of Health.	Andersen B, 2001, ENDOCR REV, V22, P2, DOI 10.1210/er.22.1.2; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Clore GM, 2011, J BIOMOL NMR, V51, P209, DOI 10.1007/s10858-011-9555-8; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Dailey L, 2001, J CELL PHYSIOL, V186, P315, DOI 10.1002/1097-4652(2001)9999:9999<000::AID-JCP1046>3.0.CO;2-Y; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Rocco G, 2001, J BIOL CHEM, V276, P20506, DOI 10.1074/jbc.M011175200; Doucleff M, 2008, P NATL ACAD SCI USA, V105, P13871, DOI 10.1073/pnas.0805050105; Fawzi NL, 2010, P NATL ACAD SCI USA, V107, P1379, DOI 10.1073/pnas.0909370107; Gorman J, 2010, NAT STRUCT MOL BIOL, V17, P932, DOI 10.1038/nsmb.1858; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Iwahara J, 2006, J AM CHEM SOC, V128, P404, DOI 10.1021/ja056786o; Iwahara J, 2004, J AM CHEM SOC, V126, P12800, DOI 10.1021/ja046246b; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Iwahara J, 2003, J AM CHEM SOC, V125, P6634, DOI 10.1021/ja034488q; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; Iwahara J, 2006, P NATL ACAD SCI USA, V103, P15062, DOI 10.1073/pnas.0605868103; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; KLEMM JD, 1994, CELL, V77, P21, DOI 10.1016/0092-8674(94)90231-3; Levy Y, 2007, J AM CHEM SOC, V129, P738, DOI 10.1021/ja065531n; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; Murphy EC, 2001, J MOL BIOL, V312, P481, DOI 10.1006/jmbi.2001.4977; Sahu D, 2007, J AM CHEM SOC, V129, P13232, DOI 10.1021/ja074604f; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; Takayama Y, 2011, P NATL ACAD SCI USA, V108, pE169, DOI 10.1073/pnas.1100050108; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Vuzman D, 2010, BIOPHYS J, V99, P1202, DOI 10.1016/j.bpj.2010.06.007; Vuzman D, 2010, J MOL BIOL, V396, P674, DOI 10.1016/j.jmb.2009.11.056; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200	37	24	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14349	14363		10.1074/jbc.M112.352864	http://dx.doi.org/10.1074/jbc.M112.352864			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22396547	Green Published, hybrid			2022-12-27	WOS:000304003200004
J	Burkinshaw, BJ; Prehna, G; Worrall, LJ; Strynadka, NCJ				Burkinshaw, Brianne J.; Prehna, Gerd; Worrall, Liam J.; Strynadka, Natalie C. J.			Structure of Salmonella Effector Protein SopB N-terminal Domain in Complex with Host Rho GTPase Cdc42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; BINDING DOMAIN; GLOBAL BURDEN; TYPHIMURIUM; MEMBRANE; CELL; IDENTIFICATION; PHOSPHATASE; ACTIVATION; INVASION	SopB is a type III secreted Salmonella effector protein with phosphoinositide phosphatase activity and a distinct GTPase binding domain. The latter interacts with host Cdc42, an essential Rho GTPase that regulates critical events in eukaryotic cytoskeleton organization and membrane trafficking. Structural and biochemical analysis of the SopB GTPase binding domain in complex with Cdc42 shows for the first time that SopB structurally and functionally mimics a host guanine nucleotide dissociation inhibitor (GDI) by contacting key residues in the regulatory switch regions of Cdc42 and slowing Cdc42 nucleotide exchange.	[Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Ctr, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Life Sci Ctr, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	ncjs@mail.ubc.ca		Prehna, Gerd/0000-0001-5539-7533	Canadian Institute for Health Research; Canadian Foundation of Innovation; British Columbia Knowledge Development Fund; Natural Sciences and Engineering Research Council of Canada	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation of Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Canadian Institute for Health Research, the Canadian Foundation of Innovation, and the British Columbia Knowledge Development Fund. G. P. and L. J. W. are Michael Smith Foundation for Health Research (MSFHR) postdoctoral fellows.; Recipient of a Natural Sciences and Engineering Research Council of Canada Alexander Graham Bell Canada graduate scholarship.	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Afonine P. V., 2005, COLLABORATIVE COMPUT, V42; Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; Aleman A, 2005, CELL MICROBIOL, V7, P1432, DOI 10.1111/j.1462-5822.2005.00568.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakowski MA, 2010, CELL HOST MICROBE, V7, P453, DOI 10.1016/j.chom.2010.05.011; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Buchwald G, 2002, EMBO J, V21, P3286, DOI 10.1093/emboj/cdf329; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dukuzumuremyi JM, 2000, J BIOL CHEM, V275, P35281, DOI 10.1074/jbc.M003009200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaran J, 2008, TRENDS BIOCHEM SCI, V33, P394, DOI 10.1016/j.tibs.2008.06.002; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Ibarra JA, 2009, CELL MICROBIOL, V11, P1579, DOI 10.1111/j.1462-5822.2009.01368.x; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Knodler LA, 2009, CELL MICROBIOL, V11, P1652, DOI 10.1111/j.1462-5822.2009.01356.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kubori T, 2003, CELL, V115, P333, DOI 10.1016/S0092-8674(03)00849-3; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Patel JC, 2009, CELL, V137, P283, DOI 10.1016/j.cell.2009.01.056; Prehna G, 2006, CELL, V126, P869, DOI 10.1016/j.cell.2006.06.056; Rodiguez-Escudero I, 2006, MICROBIOL-SGM, V152, P3437, DOI 10.1099/mic.0.29186-0; Rodriguez-Escudero I, 2011, MOL MICROBIOL, V80, P1220, DOI 10.1111/j.1365-2958.2011.07639.x; Rogers LD, 2008, J PROTEOMICS, V71, P97, DOI 10.1016/j.jprot.2008.01.011; Sinha S, 2008, CELL SIGNAL, V20, P1927, DOI 10.1016/j.cellsig.2008.05.002; Stebbins CE, 2000, MOL CELL, V6, P1449, DOI 10.1016/S1097-2765(00)00141-6; Stender S, 2000, MOL MICROBIOL, V36, P1206, DOI 10.1046/j.1365-2958.2000.01933.x; Terebiznik MR, 2002, NAT CELL BIOL, V4, P766, DOI 10.1038/ncb854; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153	39	15	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13348	13355		10.1074/jbc.M111.331330	http://dx.doi.org/10.1074/jbc.M111.331330			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22362774	Green Published, hybrid			2022-12-27	WOS:000302903700070
J	Montalvo-Ortiz, BL; Castillo-Pichardo, L; Hernandez, E; Humphries-Bickley, T; De La Mota-Peynado, A; Cubano, LA; Vlaar, CP; Dharmawardhane, S				Montalvo-Ortiz, Brenda L.; Castillo-Pichardo, Linette; Hernandez, Eliud; Humphries-Bickley, Tessa; De La Mota-Peynado, Alina; Cubano, Luis A.; Vlaar, Cornelis P.; Dharmawardhane, Suranganie			Characterization of EHop-016, Novel Small Molecule Inhibitor of Rac GTPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; NUCLEOTIDE-EXCHANGE FACTORS; FAMILY SMALL GTPASES; RHO-GTPASES; THERAPEUTIC TARGETS; SIGNALING PATHWAYS; RATIONAL DESIGN; SPLICE VARIANT; VAV PROTEINS; INVASION	The Rho GTPase Rac regulates actin cytoskeleton reorganization to form cell surface extensions (lamellipodia) required for cell migration/invasion during cancer metastasis. Rac hyperactivation and overexpression are associated with aggressive cancers; thus, interference of the interaction of Rac with its direct upstream activators, guanine nucleotide exchange factors (GEFs), is a viable strategy for inhibiting Rac activity. We synthesized EHop-016, a novel inhibitor of Rac activity, based on the structure of the established Rac/Rac GEF inhibitor NSC23766. Herein, we demonstrate that EHop-016 inhibits Rac activity in the MDA-MB-435 metastatic cancer cells that overexpress Rac and exhibits high endogenous Rac activity. The IC50 of 1.1 mu M for Rac inhibition by EHop-016 is similar to 100-fold lower than for NSC23766. EHop-016 is specific for Rac1 and Rac3 at concentrations of <= 5 mu M. At higher concentrations, EHop-016 inhibits the close homolog Cdc42. In MDA-MB-435 cells that demonstrate high active levels of the Rac GEF Vav2, EHop-016 inhibits the association of Vav2 with a nucleotide-free Rac1(G15A), which has a high affinity for activated GEFs. EHop-016 also inhibits the Rac activity of MDA-MB-231 metastatic breast cancer cells and reduces Rac-directed lamellipodia formation in both cell lines. EHop-016 decreases Rac downstream effects of PAK1 (p21-activated kinase 1) activity and directed migration of metastatic cancer cells. Moreover, at effective concentrations (<5 mu M), EHop-016 does not affect the viability of viability of MDA-MB-435 cells by only 20%. Therefore, EHop-016 holds promise as a targeted therapeutic agent for the treatment of metastatic cancers with high Rac activity.	[Montalvo-Ortiz, Brenda L.; Castillo-Pichardo, Linette; Humphries-Bickley, Tessa; Dharmawardhane, Suranganie] Univ Puerto Rico, Sch Med, Dept Biochem, San Juan, PR 00936 USA; [Hernandez, Eliud; Vlaar, Cornelis P.] Univ Puerto Rico, Sch Pharm, Dept Pharmaceut Sci, San Juan, PR 00936 USA; [Castillo-Pichardo, Linette; De La Mota-Peynado, Alina; Cubano, Luis A.] Univ Cent Caribe, Dept Anat & Cell Biol, Bayamon, PR 00960 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Vlaar, CP (corresponding author), POB 365067, San Juan, PR 00936 USA.	cornelis.vlaar@upr.edu; su.d@upr.edu	Vlaar, Cornelis/X-4169-2018	Vlaar, Cornelis/0000-0001-5145-8300	National Institutes of Health, NCRR [G12RR035051, 5U54CA096297, G12RR03035]; Department of Defense/United States Army [W81XWH-07-1-0330, 3SC3GM084824-02S1]; NATIONAL CANCER INSTITUTE [U54CA096297] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003035, G12RR003051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM084824] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Defense/United States Army; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health, NCRR, Grants G12RR035051 (to the University of Puerto Rico Medical Sciences Campus), 5U54CA096297 (to the University of Puerto Rico Medical Sciences Campus), and G12RR03035 (to Universidad Central del Caribe). This work was also supported by Department of Defense/United States Army Breast Cancer Research Program Grants W81XWH-07-1-0330 and 3SC3GM084824-02S1 (to S. D.). A provisional patent application, number 61/536,069, "Novel Small-Molecule Inhibitors of Rac 1 in Metastatic Breast Cancer," is pending.	Abe K, 2000, J BIOL CHEM, V275, P10141, DOI 10.1074/jbc.275.14.10141; Akbar H, 2006, METHOD ENZYMOL, V406, P554, DOI 10.1016/S0076-6879(06)06043-5; Azios NG, 2007, NEOPLASIA, V9, P147, DOI 10.1593/neo.06778; Baranwal S, 2011, CURR DRUG TARGETS, V12, P1194, DOI 10.2174/138945011795906534; Baugher PJ, 2005, BREAST CANCER RES, V7, pR965, DOI 10.1186/bcr1329; Beausoleil E, 2009, BIOORG MED CHEM LETT, V19, P5594, DOI 10.1016/j.bmcl.2009.08.037; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Binker MG, 2008, EXP PHYSIOL, V93, P1091, DOI 10.1113/expphysiol.2008.043141; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bouquier N, 2009, CHEM BIOL, V16, P657, DOI 10.1016/j.chembiol.2009.04.012; Brantley-Sieders DM, 2009, MOL CANCER RES, V7, P615, DOI 10.1158/1541-7786.MCR-08-0401; Burbelo P, 2004, BREAST CANCER RES TR, V84, P43, DOI 10.1023/B:BREA.0000018422.02237.f9; Chan A, 2007, MOL MED, V13, P297, DOI 10.2119/2007-00025.Chan; Chan AY, 2005, ONCOGENE, V24, P7821, DOI 10.1038/sj.onc.1208909; Chrencik JE, 2008, J MOL BIOL, V380, P828, DOI 10.1016/j.jmb.2008.05.024; Deacon S. W., 2008, V186, P431, DOI 10.1007/978-3-540-72843-6_18; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Dokmanovic M, 2009, MOL CANCER THER, V8, P1557, DOI 10.1158/1535-7163.MCT-09-0140; Duan L, 2010, J BIOL CHEM, V285, P1555, DOI 10.1074/jbc.M109.057976; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Ferri N, 2009, J MED CHEM, V52, P4087, DOI 10.1021/jm8015987; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gao Y, 2001, J BIOL CHEM, V276, P47530, DOI 10.1074/jbc.M108865200; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Han G, 2008, ONCOL REP, V20, P929, DOI 10.3892/or_00000093; Hernandez E, 2010, P R HEALTH SCI J, V29, P348; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jordan P, 1999, ONCOGENE, V18, P6835, DOI 10.1038/sj.onc.1203233; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Karnoub AE, 2001, NAT STRUCT BIOL, V8, P1037, DOI 10.1038/nsb719; Kichina JV, 2010, EXPERT OPIN THER TAR, V14, P703, DOI 10.1517/14728222.2010.492779; Kirui JK, 2010, J PHARMACOL EXP THER, V333, P393, DOI 10.1124/jpet.109.164814; Kleer CG, 2005, BREAST CANCER RES TR, V93, P101, DOI 10.1007/s10549-005-4170-6; Lazer G, 2011, CELL SIGNAL, V23, P969, DOI 10.1016/j.cellsig.2010.10.022; Lin M, 2004, BREAST CANCER RES TR, V84, P49, DOI 10.1023/B:BREA.0000018424.43445.f3; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Mack NA, 2011, CELL CYCLE, V10, P1571, DOI 10.4161/cc.10.10.15612; Matos P, 2008, MOL CANCER RES, V6, P1178, DOI 10.1158/1541-7786.MCR-08-0008; Miller SL, 2005, MOL ENDOCRINOL, V19, P939, DOI 10.1210/me.2004-0443; Minard ME, 2004, BREAST CANCER RES TR, V84, P21, DOI 10.1023/B:BREA.0000018421.31632.e6; Mira JP, 2000, P NATL ACAD SCI USA, V97, P185, DOI 10.1073/pnas.97.1.185; Montero JC, 2011, ONCOGENE, V30, P1059, DOI 10.1038/onc.2010.489; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Movilla N, 2001, ONCOGENE, V20, P8057, DOI 10.1038/sj.onc.1205000; Mulloy JC, 2010, BLOOD, V115, P936, DOI 10.1182/blood-2009-09-198127; Murga C, 2002, ONCOGENE, V21, P207, DOI 10.1038/sj.onc.1205036; Nassar N, 2006, CURR TOP MED CHEM, V6, P1109, DOI 10.2174/156802606777812095; Nethe M, 2010, J CELL SCI, V123, P1948, DOI 10.1242/jcs.062919; Onesto C, 2008, METHOD ENZYMOL, V439, P111, DOI 10.1016/S0076-6879(07)00409-0; Pai SY, 2010, DIS MARKERS, V29, P177, DOI [10.1155/2010/380291, 10.3233/DMA-2010-0738]; Palmby TR, 2004, MOL CANCER RES, V2, P702; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Patel V, 2007, CARCINOGENESIS, V28, P1145, DOI 10.1093/carcin/bgm008; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; Rapley J, 2008, EMBO REP, V9, P655, DOI 10.1038/embor.2008.80; Renshaw MW, 1996, CURR BIOL, V6, P76, DOI 10.1016/S0960-9822(02)00424-4; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rosenblatt AE, 2011, ENDOCR-RELAT CANCER, V18, P207, DOI 10.1677/ERC-10-0049; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Sala G, 2008, CANCER RES, V68, P10187, DOI 10.1158/0008-5472.CAN-08-1181; Sastry SK, 2006, J BIOL CHEM, V281, P11627, DOI 10.1074/jbc.M600897200; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Schunke D, 2007, CANCER RES, V67, P10694, DOI 10.1158/0008-5472.CAN-07-1621; Servitja JM, 2003, J BIOL CHEM, V278, P34339, DOI 10.1074/jbc.M302960200; Shi HY, 2007, CELL MOTIL CYTOSKEL, V64, P338, DOI 10.1002/cm.20187; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Singh A, 2004, ONCOGENE, V23, P9369, DOI 10.1038/sj.onc.1208182; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Stallings-Mann M, 2007, CELLS TISSUES ORGANS, V185, P104, DOI 10.1159/000101310; Sun D, 2006, DRUG RESIST UPDATE, V9, P274, DOI 10.1016/j.drup.2006.12.001; Tang Y, 2008, FRONT BIOSCI-LANDMRK, V13, P759, DOI 10.2741/2718; Thomas EK, 2007, CANCER CELL, V12, P467, DOI 10.1016/j.ccr.2007.10.015; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Whale A, 2011, FRONT BIOSCI-LANDMRK, V16, P849, DOI 10.2741/3724; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yi CL, 2010, BIOCHEM PHARMACOL, V80, P683, DOI 10.1016/j.bcp.2010.03.012; Yoshida T, 2010, MOL CANCER THER, V9, P1657, DOI 10.1158/1535-7163.MCT-09-0906; Zheng Y., 2010, U.S. Patent, Patent No. [17,826,982, 17826982]; Zugaza JL, 2002, J BIOL CHEM, V277, P45377, DOI 10.1074/jbc.M208039200	87	146	154	4	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13228	13238		10.1074/jbc.M111.334524	http://dx.doi.org/10.1074/jbc.M111.334524			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22383527	hybrid, Green Published			2022-12-27	WOS:000302903700060
J	Mustafa, S; See, HB; Seeber, RM; Armstrong, SP; White, CW; Ventura, S; Ayoub, MA; Pfleger, KDG				Mustafa, Sanam; See, Heng B.; Seeber, Ruth M.; Armstrong, Stephen P.; White, Carl W.; Ventura, Sabatino; Ayoub, Mohammed Akli; Pfleger, Kevin D. G.			Identification and Profiling of Novel alpha(1A)-Adrenoceptor-CXC Chemokine Receptor 2 Heteromer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; ENERGY-TRANSFER BRET; BENIGN PROSTATIC HYPERTROPHY; BETA-ARRESTIN; CXCR2 RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; LIVE CELLS; PHOSPHORYLATION; SUBTYPES; ALPHA(1)-ADRENOCEPTORS	We have provided the first evidence for specific heteromerization between the alpha(1A)-adrenoceptor (alpha(1A)AR) and CXC chemokine receptor 2 (CXCR2) in live cells. alpha(1A)AR and CXCR2 are both expressed in areas such as the stromal smooth muscle layer of the prostate. By utilizing the G protein-coupled receptor (GPCR) heteromer identification technology on the live cell-based bioluminescence resonance energy transfer (BRET) assay platform, our studies in human embryonic kidney 293 cells have identified norepinephrine-dependent beta-arrestin recruitment that was in turn dependent upon co-expression of alpha(1A)AR with CXCR2. These findings have been supported by co-localization observed using confocal microscopy. This norepinephrine-dependent beta-arrestin recruitment was inhibited not only by the alpha(1)AR antagonist Terazosin but also by the CXCR2-specific allosteric inverse agonist SB265610. Furthermore, Labetalol, which is marketed for hypertension as a nonselective beta-adrenoceptor antagonist with alpha(1)AR antagonist properties, was identified as a heteromer-specific-biased agonist exhibiting partial agonism for inositol phosphate production but essentially full agonism for beta-arrestin recruitment at the alpha(1A)AR-CXCR2 heteromer. Finally, bioluminescence resonance energy transfer studies with both receptors tagged suggest that alpha(1A)AR-CXCR2 heteromerization occurs constitutively and is not modulated by ligand. These findings support the concept of GPCR heteromer complexes exhibiting distinct pharmacology, thereby providing additional mechanisms through which GPCRs can potentially achieve their diverse biological functions. This has important implications for the use and future development of pharmaceuticals targeting these receptors.	[Pfleger, Kevin D. G.] Univ Western Australia, Western Australian Inst Med Res, QEII Med Ctr, Lab Mol Endocrinol G Prot Coupled Receptors, Perth, WA 6009, Australia; [Mustafa, Sanam; See, Heng B.; Seeber, Ruth M.; Armstrong, Stephen P.; Ayoub, Mohammed Akli; Pfleger, Kevin D. G.] Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia; [White, Carl W.; Ventura, Sabatino] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Pfleger, Kevin D. G.] Dimerix Biosci Pty Ltd, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia; Monash University	Pfleger, KDG (corresponding author), Univ Western Australia, Western Australian Inst Med Res, QEII Med Ctr, Lab Mol Endocrinol G Prot Coupled Receptors, B Block, Perth, WA 6009, Australia.	kevin.pfleger@waimr.uwa.edu.au	Pfleger, Kevin/H-5629-2014; Seeber, Ruth/AAS-9411-2021	Seeber, Ruth/0000-0003-3265-7931; Mustafa, Sanam/0000-0002-8677-5151; White, Carl/0000-0002-4975-6189; Pfleger, Kevin/0000-0001-8261-9189; AYOUB, Mohammed Akli/0000-0003-0022-578X	National Health and Medical Research Council of Australia [566736]; Dimerix Bioscience Pty Ltd.	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Dimerix Bioscience Pty Ltd.	This research was funded by National Health and Medical Research Council of Australia Project Grant 566736 and Dimerix Bioscience Pty Ltd. K. D. G. P. is an Australian Research Council Future Fellow (FT100100271) as well as Chief Scientific Officer of Dimerix Bioscience Pty Ltd, a spin-out company of the University of Western Australia that has been assigned the rights to the GPCR-HIT technology. K. D. G. P. has a minor shareholding in Dimerix.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; [Anonymous], 2010, Drug Discov Today Technol, V7, pe1, DOI 10.1016/j.ddtec.2010.06.003; Ayoub MA, 2010, CURR OPIN PHARMACOL, V10, P44, DOI 10.1016/j.coph.2009.09.012; Bradley ME, 2009, BRIT J PHARMACOL, V158, P328, DOI 10.1111/j.1476-5381.2009.00182.x; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Butcher AJ, 2011, J BIOL CHEM, V286, P11506, DOI 10.1074/jbc.M110.154526; Cotecchia S, 2010, J RECEPT SIG TRANSD, V30, P410, DOI 10.3109/10799893.2010.518152; Dalrymple MB, 2011, J BIOL CHEM, V286, P16726, DOI 10.1074/jbc.M111.223537; ECKERT RE, 1995, UROL INT, V54, P6, DOI 10.1159/000282685; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Ford APDW, 1996, MOL PHARMACOL, V49, P209; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Gray KT, 2008, BRIT J PHARMACOL, V155, P103, DOI 10.1038/bjp.2008.245; Hennenberg M, 2011, WORLD J UROL, V29, P157, DOI 10.1007/s00345-010-0634-3; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Hieble JP, 1996, PHARMACOL RES, V33, P145, DOI 10.1006/phrs.1996.0022; Jensen BC, 2009, N-S ARCH PHARMACOL, V379, P409, DOI 10.1007/s00210-008-0368-6; Kenakin TP, 2009, NAT REV DRUG DISCOV, V8, P617, DOI 10.1038/nrd2838; Kocan M, 2008, J BIOMOL SCREEN, V13, P888, DOI 10.1177/1087057108324032; Kocan M, 2009, MOL ENDOCRINOL, V23, P559, DOI 10.1210/me.2008-0321; Kojima Y, 2009, NAT CLIN PRACT UROL, V6, P44, DOI 10.1038/ncpuro1276; Kuszak AJ, 2009, J BIOL CHEM, V284, P26732, DOI 10.1074/jbc.M109.026922; LaRocca TJ, 2010, J CARDIOVASC PHARM, V56, P548, DOI 10.1097/FJC.0b013e3181f713fe; Levoye A, 2006, EMBO J, V25, P3012, DOI 10.1038/sj.emboj.7601193; Liggett SB, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002331; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Lohse MJ, 2010, CURR OPIN PHARMACOL, V10, P53, DOI 10.1016/j.coph.2009.10.007; Munoz LM, 2009, J IMMUNOL, V183, P7337, DOI 10.4049/jimmunol.0901802; Maurice P, 2011, TRENDS PHARMACOL SCI, V32, P514, DOI 10.1016/j.tips.2011.05.006; Milligan G, 2008, BRIT J PHARMACOL, V153, pS216, DOI 10.1038/sj.bjp.0707490; Moldobaeva A, 2005, AM J PHYSIOL-LUNG C, V288, pL1117, DOI 10.1152/ajplung.00370.2004; Morishima S, 2010, J UROLOGY, V183, P812, DOI 10.1016/j.juro.2009.09.078; MURAMATSU I, 1994, BRIT J UROL, V74, P572, DOI 10.1111/j.1464-410X.1994.tb09186.x; Muramatsu I, 2005, J PHARMACOL SCI, V98, P331, DOI 10.1254/jphs.CPJ05001X; Mustafa S, 2011, JALA-J LAB AUTOM, V16, P285, DOI 10.1016/j.jala.2011.03.002; Nishimune A, 2010, J PHARMACOL SCI, V113, P169, DOI 10.1254/jphs.10093FP; Nishimune A, 2010, INT J UROL, V17, P31, DOI 10.1111/j.1442-2042.2009.02368.x; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Parenty G, 2008, BIOCHEM J, V412, P245, DOI 10.1042/BJ20071689; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Pfleger KDG, 2006, CELL SIGNAL, V18, P1664, DOI 10.1016/j.cellsig.2006.01.004; Porrello ER, 2011, CELL SIGNAL, V23, P1767, DOI 10.1016/j.cellsig.2011.06.011; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Ramsay D, 2004, MOL PHARMACOL, V66, P228, DOI 10.1124/mol.66.2.228; Rovira X, 2010, TRENDS PHARMACOL SCI, V31, P15, DOI 10.1016/j.tips.2009.10.008; Salchow K, 2010, BRIT J PHARMACOL, V159, P1429, DOI 10.1111/j.1476-5381.2009.00623.x; Schelshorn D, 2012, MOL PHARMACOL, V81, P309, DOI 10.1124/mol.111.074757; See HB, 2011, ASSAY DRUG DEV TECHN, V9, P21, DOI 10.1089/adt.2010.0336; Shibata K, 1996, BRIT J PHARMACOL, V118, P1403, DOI 10.1111/j.1476-5381.1996.tb15552.x; Stanasila L, 2008, MOL PHARMACOL, V74, P562, DOI 10.1124/mol.107.043422; Sugimoto N, 2008, J IMMUNOL, V181, P2145, DOI 10.4049/jimmunol.181.3.2145; Suzuki F, 2000, BRIT J PHARMACOL, V129, P1569, DOI 10.1038/sj.bjp.0703242; Thorsteinsson A, 2008, PEDIATR ANESTH, V18, P435, DOI 10.1111/j.1460-9592.2008.02501.x; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Trettel F, 2003, J BIOL CHEM, V278, P40980, DOI 10.1074/jbc.M306815200; Trinquet E, 2006, ANAL BIOCHEM, V358, P126, DOI 10.1016/j.ab.2006.08.002; Uberti MA, 2003, MOL PHARMACOL, V64, P1379, DOI 10.1124/mol.64.6.1379; Vazquez-Prado J, 2000, J BIOL CHEM, V275, P6553, DOI 10.1074/jbc.275.9.6553; Wang YF, 2007, EUR J NEUROSCI, V26, P3159, DOI 10.1111/j.1460-9568.2007.05938.x; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wilson S, 2005, J BIOL CHEM, V280, P28663, DOI 10.1074/jbc.M413475200; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104	67	45	47	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12952	12965		10.1074/jbc.M111.322834	http://dx.doi.org/10.1074/jbc.M111.322834			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22371491	Green Published, hybrid			2022-12-27	WOS:000302903700034
J	Yoneda, K; Sakuraba, H; Araki, T; Ohshima, T				Yoneda, Kazunari; Sakuraba, Haruhiko; Araki, Tomohiro; Ohshima, Toshihisa			Crystal Structure of Binary and Ternary Complexes of Archaeal UDP-galactose 4-Epimerase-like L-Threonine Dehydrogenase from Thermoplasma volcanium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODEL	A gene from the thermophilic archaeon Thermoplasma volcanium encoding an L-threonine dehydrogenase (L-ThrDH) with a predicted amino acid sequence that was remarkably similar to the sequence of UDP-galactose 4-epimerase (GalE) was overexpressed in Escherichia coli, and its product was purified and characterized. The expressed enzyme was moderately thermostable, retaining more than 90% of its activity after incubation for 10 min at up to 70 degrees C. The catalytic residue was assessed using site-directed mutagenesis, and Tyr(137) was found to be essential for catalysis. To clarify the structural basis of the catalytic mechanism, four different crystal structures were determined using the molecular replacement method: L-ThrDH-NAD(+), L-ThrDH in complex with NAD(+) and pyruvate, Y137F mutant in complex with NAD(+) and L-threonine, and Y137F in complex with NAD(+) and L-3-hydroxynorvaline. Each monomer consisted of a Rossmann-fold domain and a C-terminal catalytic domain, and the fold of the catalytic domain showed notable similarity to that of the GalE-like L-ThrDH from the psychrophilic bacterium Flavobacterium frigidimaris KUC-1. The substrate binding model suggests that the reaction proceeds through abstraction of the beta-hydroxyl hydrogen of L-threonine via direct proton transfer driven by Tyr(137). The factors contributing to the thermostability of T. volcanium L-ThrDH were analyzed by comparing its structure to that of F. frigidimaris L-ThrDH. This comparison showed that the presence of extensive inter-and intrasubunit ion pair networks are likely responsible for the thermostability of T. volcanium L-ThrDH. This is the first description of the molecular basis for the substrate recognition and thermostability of a GalE-like L-ThrDH.	[Ohshima, Toshihisa] Kyushu Univ, Fac Agr, Inst Genet Resources, Fukuoka 8128581, Japan; [Yoneda, Kazunari; Araki, Tomohiro] Tokai Univ, Sch Agr, Dept Biosci, Kumamoto 8691404, Japan; [Sakuraba, Haruhiko] Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Miki, Kagawa 7610795, Japan	Kyushu University; Tokai University; Kagawa University	Ohshima, T (corresponding author), Kyushu Univ, Fac Agr, Inst Genet Resources, Fukuoka 8128581, Japan.	ohshima@agr.kyushu-u.ac.jp		Yoneda, Kazunari/0000-0001-9152-8772	Agricultural Chemical Research Foundation; Japan Science Society; Tokai University Educational System; Grants-in-Aid for Scientific Research [24780105] Funding Source: KAKEN	Agricultural Chemical Research Foundation(Agricultural Chemical Research Foundation, Japan); Japan Science Society; Tokai University Educational System; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Agricultural Chemical Research Foundation, the Sasakawa Scientific Research Grant from the Japan Science Society, and the Tokai University Educational System (to K. Y.) and a grant for Scientific Research (A) (to T. O.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AOYAMA Y, 1981, J BIOL CHEM, V256, P2367; ARONSON BD, 1989, J BIOL CHEM, V264, P5226; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Bashir Q, 2009, J BIOCHEM, V146, P95, DOI 10.1093/jb/mvp051; Bowyer A, 2009, J STRUCT BIOL, V168, P294, DOI 10.1016/j.jsb.2009.07.011; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeDecker BS, 1996, J MOL BIOL, V264, P1072, DOI 10.1006/jmbi.1996.0697; ELLIOTT WH, 1958, BIOCHIM BIOPHYS ACTA, V29, P446, DOI 10.1016/0006-3002(58)90215-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hennig M, 1995, STRUCTURE, V3, P1295, DOI 10.1016/S0969-2126(01)00267-2; Higashi N, 2005, J BIOSCI BIOENG, V99, P175, DOI 10.1263/jbb.99.175; Higashi N, 2008, J BIOCHEM, V144, P77, DOI 10.1093/jb/mvn041; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Ishikawa K, 2007, J MOL BIOL, V366, P857, DOI 10.1016/j.jmb.2006.11.060; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kazuoka T, 2003, J BACTERIOL, V185, P4483, DOI 10.1128/JB.185.15.4483-4489.2003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lim JH, 1997, J MOL BIOL, V270, P259, DOI 10.1006/jmbi.1997.1105; Liu YJ, 1997, BIOCHEMISTRY-US, V36, P10675, DOI 10.1021/bi970430a; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCGILVRAY D, 1969, BIOCHEM J, V112, P657, DOI 10.1042/bj1120657; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OHSHIMA T, 1978, J BIOL CHEM, V253, P5719; Ohshima T., 2000, STEREOSELECTIVE BIOC, P877; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523; Shimizu Y, 2005, EXTREMOPHILES, V9, P317, DOI 10.1007/s00792-005-0447-2; Thoden JB, 2000, BIOCHEMISTRY-US, V39, P5691, DOI 10.1021/bi000215l; Thoden JB, 1996, PROTEIN SCI, V5, P2149, DOI 10.1002/pro.5560051102; Thoden JB, 1996, BIOCHEMISTRY-US, V35, P2557, DOI 10.1021/bi952715y; Thoden JB, 1996, BIOCHEMISTRY-US, V35, P5137, DOI 10.1021/bi9601114; Ueatrongchit T, 2011, ANAL BIOCHEM, V410, P44, DOI 10.1016/j.ab.2010.11.003; Yoneda K, 2010, FEBS J, V277, P5124, DOI 10.1111/j.1742-4658.2010.07916.x	39	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12966	12974		10.1074/jbc.M111.336958	http://dx.doi.org/10.1074/jbc.M111.336958			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22374996	Green Published, hybrid			2022-12-27	WOS:000302903700035
J	Zoufaly, S; Frobel, J; Rose, P; Flecken, T; Maurer, C; Moser, M; Muller, M				Zoufaly, Stefan; Froebel, Julia; Rose, Patrick; Flecken, Tobias; Maurer, Carlo; Moser, Michael; Mueller, Matthias			Mapping Precursor-binding Site on TatC Subunit of Twin Arginine-specific Protein Translocase by Site-specific Photo Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL PEPTIDE BINDING; ESCHERICHIA-COLI; TRANSPORT SYSTEM; IN-VITRO; SUBSTRATE-BINDING; MEMBRANE-BINDING; FOLDED PROTEINS; COMPONENT; PATHWAY; COMPLEXES	A number of secreted precursor proteins of bacteria, archaea, and plant chloroplasts stand out by a conserved twin arginine-containing sequence motif in their signal peptides. Many of these precursor proteins are secreted in a completely folded conformation by specific twin arginine translocation (Tat) machineries. Tat machineries are high molecular mass complexes consisting of two types of membrane proteins, a hexahelical TatC protein, and usually one or two single-spanning membrane proteins, called TatA and TatB. TatC has previously been shown to be involved in the recognition of twin arginine signal peptides. We have performed an extensive site-specific cross-linking analysis of the Escherichia coli TatC protein under resting and translocating conditions. This strategy allowed us to map the recognition site for twin arginine signal peptides to the cytosolic N-terminal region and first cytosolic loop of TatC. In addition, discrete contact sites between TatC, TatB, and TatA were revealed. We discuss a tentative model of how a twin arginine signal sequence might be accommodated in the Tat translocase.	[Zoufaly, Stefan; Froebel, Julia; Rose, Patrick; Flecken, Tobias; Maurer, Carlo; Moser, Michael; Mueller, Matthias] Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, D-79104 Freiburg, Germany; [Froebel, Julia; Rose, Patrick] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Muller, M (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, Stefan Meier Str 17, D-79104 Freiburg, Germany.	matthias.mueller@biochemie.uni-freiburg.de	Flecken, Tobias/AAH-6351-2019	Flecken, Tobias/0000-0001-5095-8493; Maurer, H. Carlo/0000-0002-2193-6014	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 746, Forschergruppe 929]; University of Freiburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Freiburg	This work was supported by Sonderforschungsbereich 746 and Forschergruppe 929 of the Deutsche Forschungsgemeinschaft and an F. F. Nord grant by the University of Freiburg (to S. Z.).	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Alami M, 2002, J BIOL CHEM, V277, P20499, DOI 10.1074/jbc.M201711200; Alder NN, 2003, FEBS LETT, V540, P96, DOI 10.1016/S0014-5793(03)00231-X; Bageshwar UK, 2007, J CELL BIOL, V179, P87, DOI 10.1083/jcb.200702082; Bageshwar UK, 2009, MOL MICROBIOL, V74, P209, DOI 10.1111/j.1365-2958.2009.06862.x; Baglieri J, 2012, J BIOL CHEM, V287, P7335, DOI 10.1074/jbc.M111.326355; Barrett CML, 2005, J MOL BIOL, V347, P453, DOI 10.1016/j.jmb.2005.01.026; Behrendt J, 2004, FEMS MICROBIOL LETT, V234, P303, DOI 10.1016/j.femsle.2004.03.048; Behrendt J, 2007, FEBS LETT, V581, P4085, DOI 10.1016/j.febslet.2007.07.045; Blaudeck N, 2003, J BACTERIOL, V185, P2811, DOI 10.1128/JB.185.9.2811-2819.2003; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Buchanan G, 2002, MOL MICROBIOL, V43, P1457, DOI 10.1046/j.1365-2958.2002.02853.x; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2007, EMBO J, V26, P3039, DOI 10.1038/sj.emboj.7601759; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; de Leeuw E, 2002, J MOL BIOL, V322, P1135, DOI 10.1016/S0022-2836(02)00820-3; Fincher V, 1998, FEBS LETT, V423, P66, DOI 10.1016/S0014-5793(98)00066-0; Frobel J, 2012, PHILOS T R SOC B, V367, P1029, DOI 10.1098/rstb.2011.0202; Frobel J, 2011, J BIOL CHEM, V286, P43679, DOI 10.1074/jbc.M111.292565; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gerard F, 2007, J BIOL CHEM, V282, P5263, DOI 10.1074/jbc.M610337200; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Hou B, 2006, J MOL BIOL, V355, P957, DOI 10.1016/j.jmb.2005.11.029; Jeong KJ, 2004, J MOL BIOL, V341, P901, DOI 10.1016/j.jmb.2004.05.078; Kostecki JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009225; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; LESLEY SA, 1991, J BIOL CHEM, V266, P2632; Ma XY, 2010, EMBO J, V29, P1477, DOI 10.1038/emboj.2010.44; Maldonado B, 2011, J MOL MICROB BIOTECH, V20, P168, DOI 10.1159/000329076; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; McDevitt CA, 2005, BIOCHEM BIOPH RES CO, V329, P693, DOI 10.1016/j.bbrc.2005.02.038; McDevitt CA, 2006, FEBS J, V273, P5656, DOI 10.1111/j.1742-4658.2006.05554.x; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Moser Michael, 2007, V390, P63; Oates J, 2005, J MOL BIOL, V346, P295, DOI 10.1016/j.jmb.2004.11.047; Orriss GL, 2007, FEBS LETT, V581, P4091, DOI 10.1016/j.febslet.2007.07.044; Palmer T., 2010, ECOSAL ESCHERICHIA C; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Punginelli C, 2007, J BACTERIOL, V189, P5482, DOI 10.1128/JB.00647-07; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; Robinson C, 2011, BBA-BIOMEMBRANES, V1808, P876, DOI 10.1016/j.bbamem.2010.11.023; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Schlesier R, 2010, BIOL CHEM, V391, P1411, DOI 10.1515/BC.2010.138; Strauch EM, 2007, J MOL BIOL, V374, P283, DOI 10.1016/j.jmb.2007.09.050; Tarry MJ, 2009, P NATL ACAD SCI USA, V106, P13284, DOI 10.1073/pnas.0901566106; White GF, 2010, J BIOL CHEM, V285, P2294, DOI 10.1074/jbc.M109.065458; Yahr TL, 2001, EMBO J, V20, P2472, DOI 10.1093/emboj/20.10.2472	49	53	54	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13430	13441		10.1074/jbc.M112.343798	http://dx.doi.org/10.1074/jbc.M112.343798			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22362773	Green Published, hybrid			2022-12-27	WOS:000302903700077
J	Bongiovanni, A; Romancino, DP; Campos, Y; Paterniti, G; Qiu, XH; Moshiach, S; Di Felice, V; Vergani, N; Ustek, D; d'Azzo, A				Bongiovanni, Antonella; Romancino, Daniele P.; Campos, Yvan; Paterniti, Gaetano; Qiu, Xiaohui; Moshiach, Simon; Di Felice, Valentina; Vergani, Naja; Ustek, Duran; d'Azzo, Alessandra			Alix Protein Is Substrate of Ozz-E3 Ligase and Modulates Actin Remodeling in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR DOWN-REGULATION; UBIQUITIN LIGASE; CORTICAL ACTIN; CELL-MIGRATION; HIV-1 RELEASE; ESCRT; DYNAMICS; CYTOSKELETON; CYTOKINESIS; ENDOCYTOSIS	Alix/AIP1 is a multifunctional adaptor protein that participates in basic cellular processes, including membrane trafficking and actin cytoskeleton assembly, by binding selectively to a variety of partner proteins. However, the mechanisms regulating Alix turnover, subcellular distribution, and function in muscle cells are unknown. We now report that Alix is expressed in skeletal muscle throughout myogenic differentiation. In myotubes, a specific pool of Alix colocalizes with Ozz, the substrate-binding component of the muscle-specific ubiquitin ligase complex Ozz-E3. We found that interaction of the two endogenous proteins in the differentiated muscle fibers changes Alix conformation and promotes its ubiquitination. This in turn regulates the levels of the protein in specific subcompartments, in particular the one containing the actin polymerization factor cortactin. In Ozz(-/-) myotubes, the levels of filamentous (F)-actin is perturbed, and Alix accumulates in large puncta positive for cortactin. In line with this observation, we show that the knockdown of Alix expression in C2C12 muscle cells affects the amount and distribution of F-actin, which consequently leads to changes in cell morphology, impaired formation of sarcolemmal protrusions, and defective cell motility. These findings suggest that the Ozz-E3 ligase regulates Alix at sites where the actin cytoskeleton undergoes remodeling.	[Bongiovanni, Antonella; Romancino, Daniele P.; Paterniti, Gaetano] CNR, Inst Biomed & Mol Immunol, I-90146 Palermo, Italy; [Campos, Yvan; Qiu, Xiaohui; Moshiach, Simon; Vergani, Naja; Ustek, Duran; d'Azzo, Alessandra] St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA; [Di Felice, Valentina] Univ Palermo, Dept Expt Biomed & Clin Neurosci, I-90127 Palermo, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); St Jude Children's Research Hospital; University of Palermo	Bongiovanni, A (corresponding author), CNR, Inst Biomed & Mol Immunol, Via Ugo La Malfa 153, I-90146 Palermo, Italy.	bongiovanni@ibim.cnr.it; sandra.dazzo@stjude.org	Romancino, Daniele/C-3031-2015; Ustek, Duran/C-3484-2009; Di Felice, Valentina/AAG-3740-2021; Di Felice, Valentina/A-4457-2009; Bongiovanni, Antonella/AAX-5051-2020	Ustek, Duran/0000-0002-0060-2859; Di Felice, Valentina/0000-0002-4132-1260; Di Felice, Valentina/0000-0002-4132-1260; Bongiovanni, Antonella/0000-0002-0307-4043; Romancino, Daniele/0000-0003-2041-0122	National Institutes of Health from USPHS [AR049867, CA021765]; National Institutes of Health from NCI; Assisi Foundation of Memphis; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049867] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Assisi Foundation of Memphis; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR049867 and CA021765 from USPHS and NCI (to A. d'A.). This work was also supported by the Assisi Foundation of Memphis and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital (to A. d'A.).	Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Cabezas A, 2005, J CELL SCI, V118, P2625, DOI 10.1242/jcs.02382; Campos Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009866; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; CONDEELIS J, 1993, ANNU REV CELL BIOL, V9, P411, DOI 10.1146/annurev.cb.09.110193.002211; Cory GOC, 2007, CURR BIOL, V17, pR455, DOI 10.1016/j.cub.2007.04.015; Di Felice V, 2007, BIOL CELL, V99, P689, DOI 10.1042/BC20070043; Di Felice V, 2009, J CELL PHYSIOL, V221, P729, DOI 10.1002/jcp.21912; Dunn G. A., 1980, BSCB S, V3, P409; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Grinnell F, 1978, Int Rev Cytol, V53, P65; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; Lynch DK, 2003, J BIOL CHEM, V278, P21805, DOI 10.1074/jbc.M211407200; Marquette ML, 2008, IN VITRO CELL DEV-AN, V44, P105, DOI 10.1007/s11626-007-9078-5; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Nastasi T, 2004, DEV CELL, V6, P269, DOI 10.1016/S1534-5807(04)00020-6; Nikko E, 2007, EUKARYOT CELL, V6, P1266, DOI 10.1128/EC.00024-07; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Odorizzi G, 2006, J CELL SCI, V119, P3025, DOI 10.1242/jcs.03072; ORDAHL CP, 1992, DEVELOPMENT, V114, P339; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pan S, 2006, J BIOL CHEM, V281, P34640, DOI 10.1074/jbc.M602263200; Persons DA, 1999, BLOOD, V93, P488, DOI 10.1182/blood.V93.2.488.402k17_488_499; Pires R, 2009, STRUCTURE, V17, P843, DOI 10.1016/j.str.2009.04.007; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Richter C, 2007, EMBO J, V26, P2454, DOI 10.1038/sj.emboj.7601692; Schmidt MHH, 2004, MOL CELL BIOL, V24, P8981, DOI 10.1128/MCB.24.20.8981-8993.2004; Sette P, 2010, J VIROL, V84, P8181, DOI 10.1128/JVI.00634-10; Somogyi K, 2004, MECH DEVELOP, V121, P57, DOI 10.1016/j.mod.2003.10.003; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Vito P, 1999, J BIOL CHEM, V274, P1533, DOI 10.1074/jbc.274.3.1533; Votteler J, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-12; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Welch MD, 1997, CURR OPIN CELL BIOL, V9, P54, DOI 10.1016/S0955-0674(97)80152-4; Zhai QT, 2011, J VIROL, V85, P9222, DOI 10.1128/JVI.02653-10; Zhou X, 2008, BIOCHEM J, V414, P215, DOI 10.1042/BJ20080642	43	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12159	12171		10.1074/jbc.M111.297036	http://dx.doi.org/10.1074/jbc.M111.297036			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22334701	Green Published, hybrid			2022-12-27	WOS:000302782200058
J	Duverger, O; Zah, A; Isaac, J; Sun, HW; Bartels, AK; Lian, JB; Berdal, A; Hwang, J; Morasso, MI				Duverger, Olivier; Zah, Angela; Isaac, Juliane; Sun, Hong-Wei; Bartels, Anne K.; Lian, Jane B.; Berdal, Ariane; Hwang, Joonsung; Morasso, Maria I.			Neural Crest Deletion of Dlx3 Leads to Major Dentin Defects through Down-regulation of Dspp	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHIP-SEQ DATA; TRICHODENTOOSSEOUS SYNDROME; SIALOPHOSPHOPROTEIN EXPRESSION; TOOTH DEVELOPMENT; MURINE DENTITION; GENE-EXPRESSION; HOMEOBOX GENES; ENAMEL DEFECTS; DIFFERENTIATION; MUTATION	During development, Dlx3 is expressed in ectodermal appendages such as hair and teeth. Thus far, the evidence that Dlx3 plays a crucial role in tooth development comes from reports showing that autosomal dominant mutations in DLX3 result in severe enamel and dentin defects leading to abscesses and infections. However, the normal function of DLX3 in odontogenesis remains unknown. Here, we use a mouse model to demonstrate that the absence of Dlx3 in the neural crest results in major impairment of odontoblast differentiation and dentin production. Mutant mice develop brittle teeth with hypoplastic dentin and molars with an enlarged pulp chamber and underdeveloped roots. Using this mouse model, we found that dentin sialophosphoprotein (Dspp), a major component of the dentin matrix, is strongly down-regulated in odontoblasts lacking Dlx3. Using ChIP-seq, we further demonstrate the direct binding of Dlx3 to the Dspp promoter in vivo. Luciferase reporter assays determined that Dlx3 positively regulates Dspp expression. This establishes a regulatory pathway where the transcription factor Dlx3 is essential in dentin formation by directly regulating a crucial matrix protein.	[Duverger, Olivier; Zah, Angela; Isaac, Juliane; Bartels, Anne K.; Hwang, Joonsung; Morasso, Maria I.] NIAMS, Dev Skin Biol Sect, NIH, Bethesda, MD 20892 USA; [Sun, Hong-Wei] NIAMS, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA; [Lian, Jane B.] Univ Massachusetts, Dept Cell Biol, Sch Med, Worcester, MA 01655 USA; [Lian, Jane B.] Univ Massachusetts, Dept Orthoped Surg, Sch Med, Worcester, MA 01655 USA; [Berdal, Ariane] Univ Paris 05, INSERM, UMRS 872, Team 5, F-75006 Paris, France; [Berdal, Ariane] Univ Paris 06, INSERM, UMRS 872, Team 5, F-75006 Paris, France	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Morasso, MI (corresponding author), NIAMS, Dev Skin Biol Sect, NIH, 50 South Dr,Room 1523, Bethesda, MD 20892 USA.	morasso@nih.gov	Berdal, Ariane/AAC-8745-2022; Isaac, Juliane/AAV-5765-2021; Isaac, Juliane/AAD-8395-2022; Isaac, Juliane/G-4944-2017	Berdal, Ariane/0000-0001-5833-5813; Isaac, Juliane/0000-0001-7898-022X; Isaac, Juliane/0000-0001-7898-022X	NIAMS, National Institutes of Health; National Institutes of Health [R37 DE012528]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZICAR041186, ZIHAR041173, ZIAAR041171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012528] Funding Source: NIH RePORTER	NIAMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Intramural Research Program of the NIAMS, National Institutes of Health.; Supported by National Institutes of Health Grant R37 DE012528.	Bartlett JD, 2004, J DENT RES, V83, P909, DOI 10.1177/154405910408301204; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chen S, 2004, J BIOL CHEM, V279, P42182, DOI 10.1074/jbc.M402476200; Chen S, 2008, J BIOL CHEM, V283, P19359, DOI 10.1074/jbc.M709492200; Cho YD, 2010, J BIOL CHEM, V285, P36369, DOI 10.1074/jbc.M110.103093; Choi SJ, 2010, DEV BIOL, V344, P682, DOI 10.1016/j.ydbio.2010.05.499; Choi SJ, 2009, DEV BIOL, V325, P129, DOI 10.1016/j.ydbio.2008.10.014; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Depew MJ, 2005, J ANAT, V207, P501, DOI 10.1111/j.1469-7580.2005.00487.x; Dong J, 2005, AM J MED GENET A, V133A, P138, DOI 10.1002/ajmg.a.30521; Duverger O, 2008, J BIOL CHEM, V283, P20198, DOI 10.1074/jbc.M709562200; Duverger O, 2011, J CELL BIOCHEM, V112, P445, DOI 10.1002/jcb.22891; Feledy JA, 1999, NUCLEIC ACIDS RES, V27, P764, DOI 10.1093/nar/27.3.764; Feng JQ, 1998, J BIOL CHEM, V273, P9457, DOI 10.1074/jbc.273.16.9457; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; He PP, 2010, MATRIX BIOL, V29, P411, DOI 10.1016/j.matbio.2010.03.001; Hu JCC, 2008, J BIOL CHEM, V283, P10858, DOI 10.1074/jbc.M710565200; Hu JCC, 2002, EUR J ORAL SCI, V110, P307, DOI 10.1034/j.1600-0722.2002.21301.x; Hwang J, 2008, DEVELOPMENT, V135, P3149, DOI 10.1242/dev.022202; Hwang J, 2011, P NATL ACAD SCI USA, V108, P11566, DOI 10.1073/pnas.1019658108; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Kim JW, 2005, HUM GENET, V116, P186, DOI 10.1007/s00439-004-1223-6; Laajala TD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-618; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee SK, 2008, J DENT RES, V87, P354, DOI 10.1177/154405910808700402; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lezot F, 2008, J CELL PHYSIOL, V216, P688, DOI 10.1002/jcp.21448; Mayer DEY, 2010, J DTSCH DERMATOL GES, V8, P102, DOI [10.1111/j.1610-0387.2009.07125_supp.x, 10.1111/j.1610-0387.2009.07159.x]; McGuinness T, 1996, GENOMICS, V35, P473, DOI 10.1006/geno.1996.0387; Morasso MI, 2010, METHODS MOL BIOL, V585, P253, DOI 10.1007/978-1-60761-380-0_17; Morasso MI, 1999, P NATL ACAD SCI USA, V96, P162, DOI 10.1073/pnas.96.1.162; Nakamura S, 1996, GENOMICS, V38, P314, DOI 10.1006/geno.1996.0634; Narayanan K, 2006, J BIOL CHEM, V281, P19064, DOI 10.1074/jbc.M600714200; Nieminen P, 2011, CELLS TISSUES ORGANS, V194, P49, DOI 10.1159/000322561; Ogbureke KUE, 2004, J DENT RES, V83, P664, DOI 10.1177/154405910408300902; Opsahl S, 2005, ARCH ORAL BIOL, V50, P279, DOI 10.1016/j.archoralbio.2004.09.009; Park JC, 2007, J PERIODONTOL, V78, P1795, DOI 10.1902/jop.2007.060363; Price JA, 1998, HUM MOL GENET, V7, P563, DOI 10.1093/hmg/7.3.563; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; ROBINSON GW, 1994, MECH DEVELOP, V48, P199, DOI 10.1016/0925-4773(94)90060-4; Simmer JP, 2009, J BIOL CHEM, V284, P19110, DOI 10.1074/jbc.M109.013623; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Thesleff I, 2006, AM J MED GENET A, V140A, P2530, DOI 10.1002/ajmg.a.31360; Thomas BL, 1997, DEVELOPMENT, V124, P4811; Wright JT, 2008, AM J MED GENET A, V146A, P343, DOI 10.1002/ajmg.a.32132; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yamakoshi Y, 2006, J BIOL CHEM, V281, P38235, DOI 10.1074/jbc.M607767200; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhao ZY, 2000, DEV GENES EVOL, V210, P270, DOI 10.1007/s004270050314	51	49	51	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12230	12240		10.1074/jbc.M111.326900	http://dx.doi.org/10.1074/jbc.M111.326900			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351765	Green Published, hybrid			2022-12-27	WOS:000302782200064
J	Shi, JH; Zheng, B; Chen, S; Ma, GY; Wen, JK				Shi, Jian-hong; Zheng, Bin; Chen, Si; Ma, Guo-yan; Wen, Jin-kun			Retinoic Acid Receptor alpha Mediates All-trans-retinoic Acid-induced Klf4 Gene Expression by Regulating Klf4 Promoter Activity in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR; GROWTH-INHIBITION; HDAC2 PHOSPHORYLATION; INDUCED ACTIVATION; INTERFERON-GAMMA; BINDING PROTEIN; CAROTID-ARTERY; RAR-ALPHA; TRANSCRIPTION; FACTOR-4	The transcription factor Kruppel-like factor 4 (KLF4) plays a critical role in vascular smooth muscle cell (VSMC) differentiation induced by all-trans-retinoic acid (ATRA). Although it has been demonstrated that ATRA stimulation augments both KLF4 protein and mRNA levels in VSMCs, the molecular mechanisms by which ATRA regulates Klf4 transcription are unknown. In this study, we examined the roles of ATRA-selective nuclear retinoic acid receptors (RARs) in the transcriptional regulation of Klf4. The introduction of small interfering RNA and an RAR antagonist demonstrated that RAR alpha, but not RAR beta or RAR gamma, mediated ATRA-induced Klf4 expression. A luciferase assay for the Klf4 promoter showed that three GC boxes in the proximal Klf4 promoter were indispensible for ATRA-induced Klf4 transcription and that RAR alpha enhanced Klf4 promoter activity in a GC box-dependent manner. Furthermore, chromatin immunoprecipitation and oligonucleotide pulldown assays demonstrated that the transcription factors KLF4, Sp1, and YB1 directly bound to the GC boxes of the proximal Klf4 promoter. Upon RAR alpha agonist stimulation, RAR alpha was recruited to the Klf4 promoter through its interaction with KLF4, Sp1, and YB1 to form a transcriptional activation complex on the three GC boxes of the Klf4 promoter. These results suggest that RAR alpha serves as an essential co-activator for ATRA signaling and that the recruitment of RAR alpha to the KLF4-Sp1-YB1 complex, which leads to Klf4 expression in VSMCs, is independent of a retinoic acid response element.	[Shi, Jian-hong; Zheng, Bin; Chen, Si; Ma, Guo-yan; Wen, Jin-kun] Hebei Med Univ, Dept Biochem & Mol Biol, Key Lab Neurobiol & Vasc Biol, China Adm Educ, Shijiazhuang 050017, Peoples R China; [Shi, Jian-hong] Hebei Univ, Basic Med Sch, Baoding 071000, Peoples R China	Hebei Medical University; Hebei University	Wen, JK (corresponding author), Hebei Med Univ, Dept Biochem & Mol Biol, Key Lab Neurobiol & Vasc Biol, China Adm Educ, 361 Zhongshan E Rd, Shijiazhuang 050017, Peoples R China.	wjk@hebmu.edu.cn	Shi, Jian-hong/AAF-6078-2019; Shi, Jian-hong/AAP-5703-2021	Shi, Jian-hong/0000-0003-2232-1000; Wen, Jinkun/0000-0002-8453-4549	National Natural Science Foundation of China [30971457, 90919035, 30871272, 31071003]; National Basic Research Program of China [2012CB518601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work is supported by National Natural Science Foundation of China Grants 30971457, 90919035, 30871272, and 31071003 and National Basic Research Program of China Grant 2012CB518601.	Axel DI, 2001, CARDIOVASC RES, V49, P851, DOI 10.1016/S0008-6363(00)00312-6; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Charoensit P, 2010, CANCER GENE THER, V17, P512, DOI 10.1038/cgt.2010.12; Chen ZY, 2000, FEBS LETT, V477, P67, DOI 10.1016/S0014-5793(00)01764-6; Chen ZY, 2005, CANCER RES, V65, P10394, DOI 10.1158/0008-5472.CAN-05-2059; Chen ZY, 2004, J NUTR, V134, P792, DOI 10.1093/jn/134.4.792; Cullingford TE, 2008, BBA-MOL CELL RES, V1783, P1229, DOI 10.1016/j.bbamcr.2008.03.007; Dang DT, 2002, NUCLEIC ACIDS RES, V30, P2736, DOI 10.1093/nar/gkf400; Deaton RA, 2009, AM J PHYSIOL-HEART C, V296, pH1027, DOI 10.1152/ajpheart.01230.2008; En-Nia A, 2005, J BIOL CHEM, V280, P7702, DOI 10.1074/jbc.M413353200; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Garvey SM, 2010, J PHARMACOL EXP THER, V333, P34, DOI 10.1124/jpet.109.163949; Ghaleb AM, 2008, CURR COLORECT CANC R, V4, P59, DOI 10.1007/s11888-008-0011-4; Han M, 2006, AM J PHYSIOL-CELL PH, V291, pC50, DOI 10.1152/ajpcell.00524.2005; Han M, 2009, FEBS J, V276, P1720, DOI 10.1111/j.1742-4658.2009.06902.x; Herdeg C, 2003, CARDIOVASC RES, V57, P544, DOI 10.1016/S0008-6363(02)00709-5; Jurchott K, 2003, J BIOL CHEM, V278, P27988, DOI 10.1074/jbc.M212966200; Krohn R, 2007, CIRCULATION, V116, P1812, DOI 10.1161/CIRCULATIONAHA.107.708016; Kumar P, 2010, J BIOL CHEM, V285, P37521, DOI 10.1074/jbc.M110.132795; Li HX, 2010, J BIOL CHEM, V285, P17846, DOI 10.1074/jbc.M109.076992; Liu SA, 2008, MOL CANCER RES, V6, P306, DOI 10.1158/1541-7786.MCR-07-0159; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Loudig O, 2000, MOL ENDOCRINOL, V14, P1483, DOI 10.1210/me.14.9.1483; Mahatan CS, 1999, NUCLEIC ACIDS RES, V27, P4562, DOI 10.1093/nar/27.23.4562; Makkonen KM, 2009, J BIOL CHEM, V284, P18270, DOI 10.1074/jbc.M109.012492; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; Meng F, 2009, BIOCHEM BIOPH RES CO, V387, P13, DOI 10.1016/j.bbrc.2009.05.112; Miano JM, 1996, CIRCULATION, V93, P1886, DOI 10.1161/01.CIR.93.10.1886; Miano JM, 1998, CIRCULATION, V98, P1219, DOI 10.1161/01.CIR.98.12.1219; Nemer M, 2007, CELL CYCLE, V6, P117, DOI 10.4161/cc.6.2.3718; Sengupta S, 2011, ONCOGENE, V30, P482, DOI 10.1038/onc.2010.435; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Si JT, 2002, BLOOD, V100, P4401, DOI 10.1182/blood-2001-12-0374; TING JPY, 1994, J EXP MED, V179, P1605, DOI 10.1084/jem.179.5.1605; Wang C, 2008, J BIOCHEM, V144, P313, DOI 10.1093/jb/mvn068; Wiegman PJ, 2000, ARTERIOSCL THROM VAS, V20, P89, DOI 10.1161/01.ATV.20.1.89; Wu JB, 2009, J BIOL CHEM, V284, P16723, DOI 10.1074/jbc.M901779200; Yu K, 2011, CARDIOVASC RES, V90, P464, DOI 10.1093/cvr/cvr017; Zhang R, 2010, ACTA PHARMACOL SIN, V31, P1293, DOI 10.1038/aps.2010.96; Zhang XH, 2009, FEBS LETT, V583, P1231, DOI 10.1016/j.febslet.2009.03.016; Zheng B, 2011, CELL RES, V21, P1487, DOI 10.1038/cr.2011.34; Zheng B, 2010, IUBMB LIFE, V62, P132, DOI 10.1002/iub.298; Zheng B, 2009, J BIOL CHEM, V284, P22773, DOI 10.1074/jbc.M109.026989	45	36	42	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10799	10811		10.1074/jbc.M111.321836	http://dx.doi.org/10.1074/jbc.M111.321836			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22337869	Green Published, hybrid			2022-12-27	WOS:000302780100009
J	Liu, LS; Qiu, W; Wang, H; Li, Y; Zhou, JB; Xia, M; Shan, K; Pang, RR; Zhou, Y; Zhao, D; Wang, YW				Liu, Lisha; Qiu, Wen; Wang, Hui; Li, Yan; Zhou, Jianbo; Xia, Mei; Shan, Kai; Pang, Rongrong; Zhou, Ying; Zhao, Dan; Wang, Yingwei			Sublytic C5b-9 Complexes Induce Apoptosis of Glomerular Mesangial Cells in Rats with Thy-1 Nephritis through Role of Interferon Regulatory Factor-1-dependent Caspase 8 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION PROFILE; FACTOR-I; MICROARRAY ANALYSIS; IGA NEPHROPATHY; CANCER-CELLS; MULTIPLE-SCLEROSIS; COMPLEMENT C5B-9; UP-REGULATION; DNA-DAMAGE; INJURY	The apoptosis of glomerular mesangial cells (GMC) in rat Thy-1 nephritis (Thy-1N), a model of human mesangioproliferative glomerulonephritis, is accompanied by sublytic C5b-9 deposition, but the mechanism of sublytic C5b-9-mediated GMC apoptosis has not been elucidated. In the present study, the gene expression profiles both in the GMC stimulated by sublytic C5b-9 and the rat renal tissue of Thy-1N were detected using microarrays. Among the co-up-regulated genes, the up-regulation of interferon regulatory factor-1 (IRF-1) was further confirmed. Increased caspase 8 and caspase 3 expression and caspase 8 promoter activity in the GMC were also identified. Meanwhile, overexpression or knockdown of IRF-1 not only enhanced or inhibited GMC apoptosis and caspase 8 and 3 induction but also increased or decreased caspase 8 promoter activity, respectively. The element of IRF-1 binding to the caspase 8 promoter was first revealed. Furthermore, silencing IRF-1 or repressing the activation of caspases 8 and 3 significantly reduced GMC apoptosis, including other pathologic changes of Thy-1N. These novel findings indicate that GMC apoptosis of Thy-1N is associated with the IRF-1-activated caspase 8 pathway.	[Liu, Lisha; Qiu, Wen; Wang, Hui; Li, Yan; Zhou, Jianbo; Xia, Mei; Shan, Kai; Pang, Rongrong; Zhou, Ying; Zhao, Dan; Wang, Yingwei] Nanjing Med Univ, Dept Microbiol & Immunol, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University	Wang, YW (corresponding author), Nanjing Med Univ, Dept Microbiol & Immunol, 140 Nanjing Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China.	wangyw1508@njmu.edu.cn	Shan, Kai/GSJ-6217-2022	Li, Yan/0000-0003-0420-4222	National Natural Science Foundations of China [31000396, 81072402]; Natural Science Foundations of Jiangsu Province in China [BK2009417, 10KJB310006, 09hx43]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundations of Jiangsu Province in China	This work was supported by National Natural Science Foundations of China Grants 31000396 and 81072402 and Natural Science Foundations of Jiangsu Province in China Grants BK2009417, 10KJB310006, and 09hx43.	Amore A, 2000, NEPHRON, V86, P99, DOI 10.1159/000045725; Blanco JCG, 2000, J EXP MED, V191, P2131, DOI 10.1084/jem.191.12.2131; Bouker KB, 2005, CARCINOGENESIS, V26, P1527, DOI 10.1093/carcin/bgi113; Brandt J, 1996, KIDNEY INT, V49, P335, DOI 10.1038/ki.1996.50; Colonna M, 2007, EUR J IMMUNOL, V37, P306, DOI 10.1002/eji.200637009; Cudrici C, 2006, J REHABIL RES DEV, V43, P123, DOI 10.1682/JRRD.2004.08.0111; Cybulsky AV, 2005, AM J PHYSIOL-RENAL, V289, pF593, DOI 10.1152/ajprenal.00066.2005; Darvill AM, 2006, J LAB CLIN MED, V147, P301, DOI 10.1016/j.lab.2006.02.001; De Ambrosis A, 2007, INT J CANCER, V120, P39, DOI 10.1002/ijc.22173; Ekmekcioglu S, 2008, CYTOKINE, V43, P34, DOI 10.1016/j.cyto.2008.04.010; Fantuzzi G, 2001, EUR J IMMUNOL, V31, P369, DOI 10.1002/1521-4141(200102)31:2<369::AID-IMMU369>3.0.CO;2-Y; Gao J, 2010, CELL DEATH DIFFER, V17, P699, DOI 10.1038/cdd.2009.156; Gao L, 2009, CELL PROLIFERAT, V42, P83, DOI 10.1111/j.1365-2184.2008.00575.x; Inaba H, 2004, PEDIATR BLOOD CANCER, V43, P729, DOI 10.1002/pbc.20151; Jiang XM, 2010, CELL MOL IMMUNOL, V7, P143, DOI 10.1038/cmi.2009.109; Kawasaki Yukihiko, 2008, Fukushima J Med Sci, V54, P43; Li Zhen, 2009, Chinese Medical Sciences Journal, V24, P91; Lin F, 2004, J IMMUNOL, V172, P2636, DOI 10.4049/jimmunol.172.4.2636; Lu XCM, 2004, J NEUROSCI RES, V77, P843, DOI 10.1002/jnr.20218; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; Nakazawa T, 2001, J AUTOIMMUN, V17, P119, DOI 10.1006/jaut.2001.0531; Ochi H, 2002, EUR J IMMUNOL, V32, P1821, DOI 10.1002/1521-4141(200207)32:7<1821::AID-IMMU1821>3.0.CO;2-A; Pamment J, 2002, ONCOGENE, V21, P7776, DOI 10.1038/sj.onc.1205981; Papageorgiou A, 2007, CANCER BIOL THER, V6, P872, DOI 10.4161/cbt.6.6.4088; Park SY, 2004, EUR J BIOCHEM, V271, P4222, DOI 10.1111/j.1432-1033.2004.04362.x; Pippin JW, 2003, J CLIN INVEST, V111, P877, DOI 10.1172/JCI200315645; Preston GA, 2004, KIDNEY INT, V65, P420, DOI 10.1111/j.1523-1755.2004.00398.x; Qiu W, 2009, EUR J IMMUNOL, V39, P3251, DOI 10.1002/eji.200939264; Reilly CM, 2006, EUR J IMMUNOL, V36, P1296, DOI 10.1002/eji.200535245; Ren G, 2008, MOL IMMUNOL, V45, P2236, DOI 10.1016/j.molimm.2007.11.013; Ruiz-Ruiz C, 2004, J BIOL CHEM, V279, P19712, DOI 10.1074/jbc.M313023200; Rus H, 2005, ANN MED, V37, P97, DOI 10.1080/07853890510007278; Sanceau J, 2000, ONCOGENE, V19, P3372, DOI 10.1038/sj.onc.1203670; Sanceau J, 2002, J BIOL CHEM, V277, P35766, DOI 10.1074/jbc.M202959200; Sato T, 1999, J AM SOC NEPHROL, V10, P1242; Schwab K, 2004, AM J NEPHROL, V24, P438, DOI 10.1159/000080188; Shi Y, 2010, MOL BIOL REP, V37, P1483, DOI 10.1007/s11033-009-9544-0; Shimizu A, 2000, NEPHRON, V86, P152, DOI 10.1159/000045734; Stang MT, 2007, ONCOGENE, V26, P6420, DOI 10.1038/sj.onc.1210470; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Tanaka N, 1996, NATURE, V382, P816, DOI 10.1038/382816a0; Tanaka T, 2005, KIDNEY INT, V68, P2714, DOI 10.1111/j.1523-1755.2005.00742.x; Teramoto K, 2008, J PHARMACOL SCI, V106, P56, DOI 10.1254/jphs.FP0071337; Turnberg D, 2005, CURR OPIN NEPHROL HY, V14, P223, DOI 10.1097/01.mnh.0000165887.75501.24; Wada J, 2003, SEMIN NEPHROL, V23, P556, DOI 10.1053/S0270-9295(03)00134-7; Wang J, 2009, CARCINOGENESIS, V30, P222, DOI 10.1093/carcin/bgn271; Wang YW, 2006, LIFE SCI, V79, P182, DOI 10.1016/j.lfs.2005.12.053; Xu JH, 2006, CELL TISSUE RES, V326, P159, DOI 10.1007/s00441-006-0214-4; YAMAMOTO T, 1987, J IMMUNOL, V138, P3758; Yang ZQ, 2009, ARTERIOSCL THROM VAS, V29, P1213, DOI 10.1161/ATVBAHA.109.189407	50	28	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16410	16423		10.1074/jbc.M111.319566	http://dx.doi.org/10.1074/jbc.M111.319566			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22427665	Green Published, hybrid			2022-12-27	WOS:000304030900032
J	Waluk, DP; Sucharski, F; Sipos, L; Silberring, J; Hunt, MC				Waluk, Dominik P.; Sucharski, Filip; Sipos, Laszlo; Silberring, Jerzy; Hunt, Mary C.			Reversible Lysine Acetylation Regulates Activity of Human Glycine N-Acyltransferase-like 2 (hGLYATL2) IMPLICATIONS FOR PRODUCTION OF GLYCINE-CONJUGATED SIGNALING MOLECULES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATIONS; ARACHIDONOYL GLYCINE; ACYL GLYCINES; IN-VITRO; IDENTIFICATION; METABOLISM; ACIDS; ARACHIDONYLGLYCINE; ANANDAMIDE; DIVERSITY	Lysine acetylation is a major post-translational modification of proteins and regulates many physiological processes such as metabolism, cell migration, aging, and inflammation. Proteomic studies have identified numerous lysine-acetylated proteins in human and mouse models (Kim, S. C., Sprung, R., Chen, Y., Xu, Y., Ball, H., Pei, J., Cheng, T., Kho, Y., Xiao, H., Xiao, L., Grishin, N. V., White, M., Yang, X. J., and Zhao, Y. (2006) Mol. Cell 23, 607-618). One family of proteins identified in this study was the murine glycine N-acyltransferase (GLYAT) enzymes, which are acetylated on lysine 19. Lysine 19 is a conserved residue in human glycine N-acyltransferase-like 2 (hGLYATL2) and in several other species, showing that this residue may be important for enzyme function. Mutation of lysine 19 in recombinant hGLYATL2 to glutamine (K19Q) and arginine (K19R) resulted in a 50-80% lower production of N-oleoyl glycine and N-arachidonoylglycine, indicating that lysine 19 is important for enzyme function. LC/MS/MS confirmed that Lys-19 is not acetylated in wild-type hGLYATL2, indicating that Lys-19 requires to be deacetylated for full activity. The hGLYATL2 enzyme conjugates medium-and long-chain saturated and unsaturated acyl-CoA esters to glycine, resulting in the production of N-oleoyl glycine and also N-arachidonoyl glycine. N-Oleoyl glycine and N-arachidonoyl glycine are structurally and functionally related to endocannabinoids and have been identified as signaling molecules that regulate functions like the perception of pain and body temperature and also have anti-inflammatory properties. In conclusion, acetylation of lysine(s) in hGLYATL2 regulates the enzyme activity, thus linking post-translational modification of proteins with the production of biological signaling molecules, the N-acyl glycines.	[Hunt, Mary C.] Dublin Inst Technol, Sch Biol Sci, Dublin 8, Ireland; Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden; [Sucharski, Filip; Silberring, Jerzy] AGH Univ Sci & Technol, Fac Mat Sci & Ceram, Dept Biochem & Neurobiol, PL-30059 Krakow, Poland	Technological University Dublin; Stockholm University; AGH University of Science & Technology	Hunt, MC (corresponding author), Dublin Inst Technol, Sch Biol Sci, Kevin St, Dublin 8, Ireland.	mary.hunt@dit.ie	Silberring, Jerzy/AGA-5631-2022	Silberring, Jerzy/0000-0002-4362-8362; Hunt, Mary/0000-0001-6415-2992	Swedish Research Council; Carl Tryggers Foundation; Professor Nanna Svartz Fond; Ake Wibergs Stiftelse; fellowship Doctus-Lesser Poland donation program for PhD students	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Tryggers Foundation; Professor Nanna Svartz Fond; Ake Wibergs Stiftelse; fellowship Doctus-Lesser Poland donation program for PhD students	This work was supported by the Swedish Research Council, Carl Tryggers Foundation, Professor Nanna Svartz Fond, and Ake Wibergs Stiftelse and by the fellowship Doctus-Lesser Poland donation program for PhD students.	Badenhorst CPS, 2012, DRUG METAB DISPOS, V40, P346, DOI 10.1124/dmd.111.041657; Bienvenut WV, 2011, PROTEOMICS, V11, P1734, DOI 10.1002/pmic.201000634; Bradshaw HB, 2009, VITAM HORM, V81, P191, DOI 10.1016/S0083-6729(09)81008-X; BROWNELL JE, 1995, P NATL ACAD SCI USA, V92, P6364, DOI 10.1073/pnas.92.14.6364; Burstein SH, 2000, PROSTAG OTH LIPID M, V61, P29, DOI 10.1016/S0090-6980(00)00053-8; Burstein S, 2008, NEUROPHARMACOLOGY, V55, P1259, DOI 10.1016/j.neuropharm.2007.11.011; Chaturvedi S, 2006, PROSTAG OTH LIPID M, V81, P136, DOI 10.1016/j.prostaglandins.2006.09.001; Close P, 2010, CELL MOL LIFE SCI, V67, P1255, DOI 10.1007/s00018-009-0252-7; CRAVATT BF, 1995, SCIENCE, V268, P1506, DOI 10.1126/science.7770779; GREGERSEN N, 1986, BIOCHEM MED METAB B, V35, P210, DOI 10.1016/0885-4505(86)90076-9; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hannedouche S., 2010, U.S.A, Patent No. [7824866B2, 7824866]; Hiley CR, 2007, CARDIOVASC DRUG REV, V25, P46, DOI 10.1111/j.1527-3466.2007.00004.x; Huang SM, 2001, J BIOL CHEM, V276, P42639, DOI 10.1074/jbc.M107351200; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Knights KM, 2007, EXPERT OPIN DRUG MET, V3, P159, DOI 10.1517/17425255.3.2.159; Kohno M, 2006, BIOCHEM BIOPH RES CO, V347, P827, DOI 10.1016/j.bbrc.2006.06.175; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Mccue JM, 2008, BIOCHEM BIOPH RES CO, V365, P322, DOI 10.1016/j.bbrc.2007.10.175; McHugh D, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-44; Merkler DJ, 2004, BIOCHEMISTRY-US, V43, P12667, DOI 10.1021/bi049529p; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Oh DY, 2008, J BIOL CHEM, V283, P21054, DOI 10.1074/jbc.M708908200; PHILLIPS DM, 1963, BIOCHEM J, V87, P258, DOI 10.1042/bj0870258; Polevoda B, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-5-reviews0006; Riccio A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3103pe1; SCHACHTER D, 1954, J BIOL CHEM, V208, P263; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Ventura M, 2010, INT J BIOCHEM CELL B, V42, P1672, DOI 10.1016/j.biocel.2010.06.014; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Waluk DP, 2010, FASEB J, V24, P2795, DOI 10.1096/fj.09-148551; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yu W, 2009, J BIOL CHEM, V284, P13669, DOI 10.1074/jbc.M901921200; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	37	14	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16158	16167		10.1074/jbc.M112.347260	http://dx.doi.org/10.1074/jbc.M112.347260			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22408254	Green Published, hybrid			2022-12-27	WOS:000304030900008
J	Funkelstein, L; Lu, WD; Koch, B; Mosier, C; Toneff, T; Taupenot, L; O'Connor, DT; Reinheckel, T; Peters, C; Hook, V				Funkelstein, Lydiane; Lu, W. Douglas; Koch, Britta; Mosier, Charles; Toneff, Thomas; Taupenot, Laurent; O'Connor, Daniel T.; Reinheckel, Thomas; Peters, Christoph; Hook, Vivian			Human Cathepsin V Protease Participates in Production of Enkephalin and NPY Neuropeptide Neurotransmitters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY VESICLES; CHROMAFFIN GRANULES; GENE KNOCKOUT; PEPTIDE NEUROTRANSMITTER; ALZHEIMERS-DISEASE; PROCESSING ENZYME; CYSTEINE PROTEASE; MASS-SPECTROMETRY; EXPRESSION; CELLS	Proteases are required for processing precursors into active neuropeptides that function as neurotransmitters for cell-cell communication. This study demonstrates the novel function of human cathepsin V protease for producing the neuropeptides enkephalin and neuropeptide Y (NPY). Cathepsin V is a human-specific cysteine protease gene. Findings here show that expression of cathepsin V in neuroendocrine PC12 cells and human neuronal SK-N-MC cells results in production of (Met) enkephalin from proenkephalin. Gene silencing of cathepsin V by siRNA in human SK-N-MC cells results in reduction of (Met) enkephalin by more than 80%, illustrating the prominent role of cathepsin V for neuropeptide production. In vitro processing of proenkephalin by cathepsin V occurs at dibasic residue sites to generate enkephalin-containing peptides and an similar to 24-kDa intermediate present in human brain. Cathepsin V is present in human brain cortex and hippocampus where enkephalin and NPY are produced and is present in purified human neuropeptide secretory vesicles. Colocalization of cathepsin V with enkephalin and NPY in secretory vesicles of human neuroblastoma cells was illustrated by confocal microscopy. Furthermore, expression of cathepsin V with proNPY results in NPY production. These findings indicate the unique function of human cathepsin V for producing enkephalin and NPY neuropeptides required for neurotransmission in health and neurological diseases.	[Hook, Vivian] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Neurosci, La Jolla, CA 92093 USA; [Funkelstein, Lydiane; Lu, W. Douglas; Mosier, Charles; Toneff, Thomas; Hook, Vivian] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92093 USA; [Koch, Britta; Reinheckel, Thomas; Peters, Christoph] Univ Freiburg, Inst Mol Med & Zellforsch, D-79104 Freiburg, Germany; [Reinheckel, Thomas; Peters, Christoph] BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany; [Taupenot, Laurent; O'Connor, Daniel T.; Hook, Vivian] Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA; [Hook, Vivian] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Hook, Vivian] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Freiburg; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Hook, V (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Neurosci, 9500 Gilman Dr,MC 0744, La Jolla, CA 92093 USA.	vhook@ucsd.edu	Reinheckel, Thomas/AAL-9761-2021	Reinheckel, Thomas/0000-0001-9866-9105; Taupenot, Laurent/0000-0003-2316-3825	National Institutes of Health [R01 DA04271, R01 MH077305, T32 DA07315, P01 HL58120]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007315, R01DA004271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DA04271, R01 MH077305, and T32 DA07315 (to V. H.), and P01 HL58120 (to D. T. O. and V. H.).	Adachi W, 1998, INVEST OPHTH VIS SCI, V39, P1789; Akil H, 1998, DRUG ALCOHOL DEPEN, V51, P127, DOI 10.1016/S0376-8716(98)00071-4; Baltatzi M, 2008, INT J CLIN PRACT, V62, P1432, DOI 10.1111/j.1742-1241.2008.01823.x; Beinfeld MC, 2009, PEPTIDES, V30, P1882, DOI 10.1016/j.peptides.2009.06.030; Bernard D, 2003, J INVEST DERMATOL, V120, P592, DOI 10.1046/j.1523-1747.2003.12086.x; Biswas N, 2009, ENDOCRINOLOGY, V150, P3547, DOI 10.1210/en.2008-1613; Bromme D, 1999, BIOCHEMISTRY-US, V38, P2377, DOI 10.1021/bi982175f; Bromme D., 2004, HDB PROTEOLYTIC ENZY, P1107; Chen NN, 2006, J INVEST DERMATOL, V126, P2345, DOI 10.1038/sj.jid.5700409; Dennemarker J, 2010, ONCOGENE, V29, P1611, DOI 10.1038/onc.2009.466; Dozio E, 2008, PEPTIDES, V29, P491, DOI 10.1016/j.peptides.2007.11.001; FOLKESSON R, 1988, MOL BRAIN RES, V3, P147, DOI 10.1016/0169-328X(88)90060-5; Funkelstein L, 2008, J NEUROCHEM, V106, P384, DOI 10.1111/j.1471-4159.2008.05408.x; Funkelstein L, 2008, J BIOL CHEM, V283, P35652, DOI 10.1074/jbc.M709010200; Gehlert DR, 1999, NEUROPEPTIDES, V33, P329, DOI 10.1054/npep.1999.0057; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; Gupta N, 2010, J PROTEOME RES, V9, P5065, DOI 10.1021/pr100358b; Hagemann S, 2004, EUR J CELL BIOL, V83, P775, DOI 10.1078/0171-9335-00404; Holden JE, 2005, AACN ADV CRIT CARE, V16, P291, DOI 10.1097/00044067-200507000-00003; Hook V, 2008, ANNU REV PHARMACOL, V48, P393, DOI 10.1146/annurev.pharmtox.48.113006.094812; HOOK VYH, 1984, FEBS LETT, V172, P212, DOI 10.1016/0014-5793(84)81128-X; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Hwang SR, 2007, J BIOL CHEM, V282, P9556, DOI 10.1074/jbc.M605510200; Hwang SR, 2007, J NEUROCHEM, V100, P1340, DOI 10.1111/j.1471-4159.2006.04325.x; Hwang SR, 1999, J BIOL CHEM, V274, P1821, DOI 10.1074/jbc.274.3.1821; Kieffer BL, 2002, PROG NEUROBIOL, V66, P285, DOI 10.1016/S0301-0082(02)00008-4; LOH YP, 1984, J BIOL CHEM, V259, P8238; Lu WD, 2009, BIOCHEMISTRY-US, V48, P1604, DOI 10.1021/bi801888j; Magni P, 2000, NEUROPHARMACOLOGY, V39, P1628, DOI 10.1016/S0028-3908(99)00231-2; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Miller R, 2003, NEUROPEPTIDES, V37, P140, DOI 10.1016/S0143-4179(03)00027-1; Minokadeh A, 2010, MOL CELL NEUROSCI, V43, P98, DOI 10.1016/j.mcn.2009.10.001; Munglani R, 1996, DRUGS, V52, P371, DOI 10.2165/00003495-199652030-00004; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Santamaria I, 1998, CANCER RES, V58, P1624; Sato N, 2009, EXPERT OPIN THER PAT, V19, P1401, DOI 10.1517/13543770903251722; Seidah NG, 2002, ESSAYS BIOCHEM, V38, P79, DOI 10.1042/bse0380079; Sevenich L, 2010, BIOCHIMIE, V92, P1674, DOI 10.1016/j.biochi.2010.03.014; Steiner RA, 2001, P NATL ACAD SCI USA, V98, P4184, DOI 10.1073/pnas.061445598; Tedelind S, 2010, BIOL CHEM, V391, P923, DOI 10.1515/BC.2010.109; Tolosa E, 2003, J CLIN INVEST, V112, P517, DOI 10.1172/JCI200318028; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; VERBEECK MAE, 1990, J BIOL CHEM, V265, P18087; Wang H, 2005, NEUROSCI BIOBEHAV R, V29, P1361, DOI 10.1016/j.neubiorev.2005.05.008; Wegrzyn J, 2007, J PROTEOME RES, V6, P1652, DOI 10.1021/pr060503p; Wegrzyn JL, 2010, J PROTEOME RES, V9, P5002, DOI 10.1021/pr1003104; Wieland HA, 2000, EXPERT OPIN INV DRUG, V9, P1327, DOI 10.1517/13543784.9.6.1327; Yasothornsrikul S, 2003, P NATL ACAD SCI USA, V100, P9590, DOI 10.1073/pnas.1531542100; Yasothornsrikul S, 1998, J NEUROCHEM, V70, P153; Yasuda Y, 2004, J BIOL CHEM, V279, P36761, DOI 10.1074/jbc.M403986200; Zeeuwen PLJM, 2007, J INVEST DERMATOL, V127, P120, DOI 10.1038/sj.jid.5700480; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745	53	22	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15232	15241		10.1074/jbc.M111.310607	http://dx.doi.org/10.1074/jbc.M111.310607			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22393040	Green Published, hybrid			2022-12-27	WOS:000304006300007
J	Koshimizu, T; Kawai, M; Kondou, H; Tachikawa, K; Sakai, N; Ozono, K; Michigami, T				Koshimizu, Takao; Kawai, Masanobu; Kondou, Hiroki; Tachikawa, Kanako; Sakai, Norio; Ozono, Keiichi; Michigami, Toshimi			Vinculin Functions as Regulator of Chondrogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERTROPHIC CHONDROCYTE DIFFERENTIATION; TYROSINE-PHOSPHATASE SHP-2; ACTIVATED PROTEIN-KINASE; GENE-TRAP MUTAGENESIS; BINDING-SITE; MAP KINASE; CELL-LINE; IN-VITRO; EXPRESSION; CARTILAGE	To identify the genes involved in chondrocytic differentiation, we applied gene trap mutagenesis to a murine mesenchymal chondrogenic cell line ATDC5 and isolated a clone in which the gene encoding vinculin was trapped. The trapped allele was assumed to express a fusion protein containing a truncated vinculin lacking the tail domain and the geo product derived from the trap vector. The truncated vinculin was suggested to exert a dominant negative effect. Impaired functioning of vinculin caused by gene trapping in ATDC5 cells or knockdown in primary chondrocytes resulted in the reduced expression of chondrocyte-specific genes, including Col2a1, aggrecan, and Col10a1. The expression of Runx2 also was suppressed by the dysfunctional vinculin. On the other hand, the expression of Sox9, encoding a key transcription factor for chondrogenesis, was retained. Knockdown of vinculin in metatarsal organ cultures impaired the growth of the explants and reduced the expression of Col2a1 and aggrecan. Gene trapping or knockdown of vinculin decreased the phosphorylation of ERK1/2 but increased that of Src homology 2 domain-containing tyrosine phosphatase 2 (SHP2) and Akt during chondrocytic differentiation, suggesting a disturbance of signaling by insulin-like growth factor I (IGF-I). Knockdown of vinculin in the metatarsal organ culture abrogated the IGF-I-induced growth and inhibited the up-regulation of Col2a1 and aggrecan expression by IGF-I. Loss of vinculin function in differentiating chondrocytes impaired the activation of the p38 MAPK pathway also, suggesting its involvement in the regulation of chondrogenesis by vinculin. Our results indicate a tissue-specific function of vinculin in cartilage whereby it controls chondrocytic differentiation.	[Michigami, Toshimi] Osaka Med Ctr, Dept Bone & Mineral Res, Izumi, Osaka 5941101, Japan; [Michigami, Toshimi] Res Inst Maternal & Child Hlth, Izumi, Osaka 5941101, Japan; [Sakai, Norio; Ozono, Keiichi] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka 5650871, Japan; [Sakai, Norio; Ozono, Keiichi] Osaka Univ, Grad Sch Med, Dept Pediat & Neonatal Perinatal Res, Suita, Osaka 5650871, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka University; Osaka University	Michigami, T (corresponding author), Osaka Med Ctr, Dept Bone & Mineral Res, 840 Murodo Cho, Izumi, Osaka 5941101, Japan.	michigami@mch.pref.osaka.jp	Michigami, Toshimi/AAU-2326-2021	Kawai, Masanobu/0000-0003-4466-1559	Ministry of Education, Science, and Culture of Japan; Foundation of Growth Science; Grants-in-Aid for Scientific Research [23591227] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation of Growth Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (to T. M.) and a grant from the Foundation of Growth Science (to T. M.).	Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Chong ZZ, 2007, HISTOL HISTOPATHOL, V22, P1251, DOI 10.14670/HH-22.1251; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; COLL JL, 1995, P NATL ACAD SCI USA, V92, P9161, DOI 10.1073/pnas.92.20.9161; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; Greenberg RS, 2006, FASEB J, V20, P1006, DOI 10.1096/fj.05-4838fje; Haaijman A, 1997, J BONE MINER RES, V12, P1815, DOI 10.1359/jbmr.1997.12.11.1815; Hirao M, 2006, J BIOL CHEM, V281, P31079, DOI 10.1074/jbc.M602296200; Ihara-Watanabe M, 2004, J CELL BIOCHEM, V93, P418, DOI 10.1002/jcb.20185; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; JOHNSON RP, 1995, BIOCHEM BIOPH RES CO, V210, P159, DOI 10.1006/bbrc.1995.1641; JONES P, 1989, J CELL BIOL, V109, P2917, DOI 10.1083/jcb.109.6.2917; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; LEFEBVRE V, 1994, MATRIX BIOL, V14, P329, DOI 10.1016/0945-053X(94)90199-6; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Li FF, 2011, J BONE MINER RES, V26, P2899, DOI 10.1002/jbmr.504; Lopez J, 2011, MOL CELL, V42, P569, DOI 10.1016/j.molcel.2011.04.008; MacGillivray M, 2003, J BIOL CHEM, V278, P27190, DOI 10.1074/jbc.M213083200; Mainguy G, 2000, NAT BIOTECHNOL, V18, P746, DOI 10.1038/77312; Matozaki T, 2009, CANCER SCI, V100, P1786, DOI 10.1111/j.1349-7006.2009.01257.x; MILARSKI KL, 1994, J BIOL CHEM, V269, P21239; Murakami S, 2004, GENE DEV, V18, P290, DOI 10.1101/gad.1179104; Namdari S, 2008, ARTHRITIS RHEUM, V58, P3520, DOI 10.1002/art.23999; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; Terpstra L, 2003, J CELL BIOL, V162, P139, DOI 10.1083/jcb.200302066; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Uchihashi T, 2007, BONE, V41, P1025, DOI 10.1016/j.bone.2007.08.028; Ulici V, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-40; VOLBERG T, 1995, J CELL SCI, V108, P2253; Xu WM, 1998, DEVELOPMENT, V125, P327; Xu WM, 1998, J CELL SCI, V111, P1535; Yin WH, 2009, J BIOL CHEM, V284, P31972, DOI 10.1074/jbc.M109.056838; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004; Zito CI, 2004, J CELL PHYSIOL, V199, P227, DOI 10.1002/jcp.10446; Zuscik MJ, 2008, J CLIN INVEST, V118, P429, DOI 10.1172/JCI34174	43	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15760	15775		10.1074/jbc.M111.308072	http://dx.doi.org/10.1074/jbc.M111.308072			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22416133	Green Published, hybrid			2022-12-27	WOS:000304006300054
J	Poulsen, H; Nissen, P; Mouritsen, OG; Khandelia, H				Poulsen, Hanne; Nissen, Poul; Mouritsen, Ole G.; Khandelia, Himanshu			Protein Kinase A (PKA) Phosphorylation of Na+/K+-ATPase Opens Intracellular C-terminal Water Pathway Leading to Third Na+-binding site in Molecular Dynamics Simulations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINEAR CONSTRAINT SOLVER; K+-ATPASE; NA+,K+-ATPASE ACTIVITY; CRYSTAL-STRUCTURE; XENOPUS-OOCYTES; ALPHA-SUBUNIT; FORCE-FIELD; NA,K-ATPASE; MEMBRANE; TRANSPORT	Phosphorylation is one of the major mechanisms for posttranscriptional modification of proteins. The addition of a compact, negatively charged moiety to a protein can significantly change its function and localization by affecting its structure and interaction network. We have used all-atom Molecular Dynamics simulations to investigate the structural consequences of phosphorylating the Na+/K+-ATPase (NKA) residue Ser(936), which is the best characterized phosphorylation site in NKA, targeted in vivo by protein kinase A (PKA). The Molecular Dynamics simulations suggest that Ser(936) phosphorylation opens a C-terminal hydrated pathway leading to Asp(926), a transmembrane residue proposed to form part of the third sodium ion-binding site. Simulations of a S936E mutant form, for which only subtle effects are observed when expressed in Xenopus oocytes and studied with electrophysiology, does not mimic the effects of Ser(936) phosphorylation. The results establish a structural association of Ser(936) with the C terminus of NKA and indicate that phosphorylation of Ser(936) can modulate pumping activity by changing the accessibility to the ion-binding site.	[Mouritsen, Ole G.; Khandelia, Himanshu] Univ So Denmark, MEMPHYS Ctr Biomembrane Phys, DK-5230 Odense M, Denmark; [Poulsen, Hanne; Nissen, Poul] Aarhus Univ, PUMPKIN Ctr Membrane Pumps Cells & Dis, DK-8000 Aarhus C, Denmark	University of Southern Denmark; Aarhus University	Khandelia, H (corresponding author), Univ So Denmark, MEMPHYS Ctr Biomembrane Phys, DK-5230 Odense M, Denmark.	hkhandel@memphys.sdu.dk		Khandelia, Himanshu/0000-0001-9913-6394; Mouritsen, Ole G./0000-0002-4258-8960; Nissen, Poul/0000-0003-0948-6628	Danish National Research Foundation; Lundbeck Foundation; Lundbeck Foundation [R82-2011-7280] Funding Source: researchfish	Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	MEMPHYS-Center for Biomembrane Physics is supported by the Danish National Research Foundation. The computations were done at the SDU node of the Danish Center for Scientific Computing (DCSC). PUMPKIN is a Center of Excellence funded by the Danish National Research Foundation.; Supported by a Lundbeck Foundation young investigator grant.	Andersson RM, 1998, ACTA PHYSIOL SCAND, V164, P39; Awayda MS, 1996, J GEN PHYSIOL, V108, P49, DOI 10.1085/jgp.108.1.49; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; BERTORELLO AM, 1991, P NATL ACAD SCI USA, V88, P11359, DOI 10.1073/pnas.88.24.11359; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Chakrabarti N, 2010, BIOPHYS J, V98, P784, DOI 10.1016/j.bpj.2009.11.009; Cheng SXJ, 1999, J PHYSIOL-LONDON, V518, P37, DOI 10.1111/j.1469-7793.1999.0037r.x; Cheng XJ, 1997, AM J PHYSIOL-CELL PH, V273, pC893, DOI 10.1152/ajpcell.1997.273.3.C893; CHIBALIN AV, 1992, J BIOL CHEM, V267, P22378; Codina J, 2006, J AM SOC NEPHROL, V17, P1833, DOI 10.1681/ASN.2006010032; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Espinoza-Fonseca LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026936; FESCHENKO MS, 1994, J BIOL CHEM, V269, P30436; Groban ES, 2006, PLOS COMPUT BIOL, V2, P238, DOI 10.1371/journal.pcbi.0020032; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kristensen B, 2003, J MEMBRANE BIOL, V191, P25, DOI 10.1007/s00232-002-1043-3; Law RJ, 2008, BIOPHYS J, V95, P2739, DOI 10.1529/biophysj.107.128025; Leach A. R., 2001, MOL MODELLING PRINCI, P356; Lee YS, 2000, NEUROSCI LETT, V288, P57, DOI 10.1016/S0304-3940(00)01208-8; Meier S, 2010, J GEN PHYSIOL, V135, P115, DOI 10.1085/jgp.200910301; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Morth JP, 2009, PHILOS T R SOC B, V364, P217, DOI 10.1098/rstb.2008.0201; Musgaard M, 2011, BIOCHEMISTRY-US, V50, P11109, DOI 10.1021/bi201164b; Oliveira MS, 2009, J NEUROCHEM, V109, P416, DOI 10.1111/j.1471-4159.2009.05961.x; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; Poulsen H, 2010, FEBS LETT, V584, P2589, DOI 10.1016/j.febslet.2010.04.035; Provasi D, 2009, BIOCHEMISTRY-US, V48, P10020, DOI 10.1021/bi901494n; Ramachandran S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000367; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Stansfeld PJ, 2011, STRUCTURE, V19, P1562, DOI 10.1016/j.str.2011.10.002; Tavraz NN, 2008, J BIOL CHEM, V283, P31097, DOI 10.1074/jbc.M802771200; Teixeira VL, 2003, ANN NY ACAD SCI, V986, P587, DOI 10.1111/j.1749-6632.2003.tb07257.x; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Tieleman DP, 2006, J PHYS-CONDENS MAT, V18, pS1221, DOI 10.1088/0953-8984/18/28/S07; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Venosa RA, 2005, ACTA PHYSIOL SCAND, V185, P329, DOI 10.1111/j.1365-201X.2005.01493.x; Vinciguerra M, 2003, MOL BIOL CELL, V14, P2677, DOI 10.1091/mbc.E02-11-0720; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041; Witzke S, 2010, J PHYS CHEM B, V114, P15825, DOI 10.1021/jp108675b; Wu ZQ, 2007, MOL PHARMACOL, V71, P519, DOI 10.1124/mol.106.029561; Yaragatupalli S, 2009, P NATL ACAD SCI USA, V106, P15507, DOI 10.1073/pnas.0903752106	51	21	21	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15959	15965		10.1074/jbc.M112.340406	http://dx.doi.org/10.1074/jbc.M112.340406			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22433860	hybrid, Green Published			2022-12-27	WOS:000304006300074
J	Dastidar, SG; Narayanan, S; Stifani, S; D'Mello, SR				Dastidar, Somasish Ghosh; Narayanan, Sriram; Stifani, Stefano; D'Mello, Santosh R.			Transducin-like Enhancer of Split-1 (TLE1) Combines with Forkhead Box Protein G1 (FoxG1) to Promote Neuronal Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEACETYLASE-RELATED PROTEIN; HELIX TRANSCRIPTION FACTOR; HEAD GENE FAMILY; CEREBRAL HEMISPHERES; POSTMITOTIC NEURONS; DROSOPHILA GROUCHO; FACTOR-I; Q-DOMAIN; DIFFERENTIATION; REPRESSOR	Transducin-like enhancer of split-1 (TLE1) plays a critical role in the regulation of neurogenesis by inhibiting the differentiation of neural progenitor cells into neurons. Although TLE1 is also expressed highly in the postnatal brain and through adulthood, its role in postmitotic neurons is not clear. Using cultures of cerebellar granule neurons, we show that expression of TLE1 is reduced in neurons primed to die. Reestablishment of elevated TLE1 levels by ectopic expression protects neurons from death, whereas suppression of TLE1 expression in otherwise healthy neurons induces cell death. These results show that TLE1 is necessary for the maintenance of neuronal survival. Experiments using pharmacological inhibitors as well as expression of point mutants indicate that phosphorylation of TLE1 by casein kinase-2 (CK2) at Ser-239 and Ser-253 is necessary for its survival-promoting activity. TLE1-mediated survival is also inhibited by pharmacological inhibition of PI3K-Akt signaling but not by inhibitors of Raf-MEK-ERK signaling or other molecules, including histone deacetylases, calcium calmodulin kinase, or CK1. The survival-promoting activity of TLE1 depends critically on interaction with FoxG1, another protein involved in the regulation of neurogenesis and shown previously to promote survival of postmitotic neurons. Likewise, the ability of FoxG1 to promote neuronal survival depends on TLE1. Taken together, our study demonstrates that TLE1 cooperates with FoxG1 to promote neuronal survival in a CK2- and PI3K-Akt-dependent manner.	[Dastidar, Somasish Ghosh; Narayanan, Sriram; D'Mello, Santosh R.] Univ Texas Richardson, Dept Mol & Cell Biol, Richardson, TX 75080 USA; [D'Mello, Santosh R.] Univ Texas Richardson, Sch Behav & Brain Sci, Richardson, TX 75080 USA; [Stifani, Stefano] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas; McGill University	D'Mello, SR (corresponding author), Univ Texas Dallas, Dept Mol & Cell Biol, 2601 N Floyd Rd, Richardson, TX 75083 USA.	dmello@utdallas.edu	D'Mello, Santosh/AAO-7192-2020; D'Mello, Santosh/AAM-3644-2020	D'Mello, Santosh/0000-0002-7652-1334; Stifani, Stefano/0000-0002-2376-7701; Ghosh Dastidar, Somasish/0000-0003-4123-1801	National Institutes of Health [NS40408, NS058462]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040408, R21NS058462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS40408 and NS058462 (to S. R. D.).	Beagle B, 2010, DEV DYNAM, V239, P2795, DOI 10.1002/dvdy.22439; Borodezt K, 1998, J NEUROSCI RES, V53, P531, DOI 10.1002/(SICI)1097-4547(19980901)53:5<531::AID-JNR3>3.3.CO;2-0; Bourguignon C, 1998, DEVELOPMENT, V125, P4889; Buscarlet M, 2008, J BIOL CHEM, V283, P24881, DOI 10.1074/jbc.M800722200; Buscarlet M, 2007, TRENDS CELL BIOL, V17, P353, DOI 10.1016/j.tcb.2007.07.002; Buscarlet M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008107; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Choi CY, 2005, J BIOL CHEM, V280, P21427, DOI 10.1074/jbc.M500496200; D'Mello SR, 2005, CNS NEUROL DISORD-DR, V4, P3, DOI 10.2174/1568007053005118; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Dastidar SG, 2011, J NEUROSCI, V31, P402, DOI 10.1523/JNEUROSCI.2897-10.2011; DEHNI G, 1995, MECH DEVELOP, V53, P369, DOI 10.1016/0925-4773(95)00452-1; Grbavec D, 1998, EUR J BIOCHEM, V258, P339, DOI 10.1046/j.1432-1327.1998.2580339.x; Hanashima C, 2002, J NEUROSCI, V22, P6526; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Hasson P, 2005, NAT GENET, V37, P101, DOI 10.1038/ng1486; Jan YW, 2004, CELL, V116, P751, DOI 10.1016/S0092-8674(04)00204-1; Lepourcelet M, 2002, J BIOL CHEM, V277, P47732, DOI 10.1074/jbc.M208154200; LI J, 1995, CANCER RES, V55, P5540; Liu F, 2002, MOL CELL BIOCHEM, V232, P163, DOI 10.1023/A:1014880813692; Marcal N, 2005, MOL CELL BIOL, V25, P10916, DOI 10.1128/MCB.25.24.10916-10929.2005; Milili M, 2002, IMMUNOLOGY, V106, P447, DOI 10.1046/j.1365-2567.2002.01456.x; Morrison BE, 2006, MOL CELL BIOL, V26, P3550, DOI 10.1128/MCB.26.9.3550-3564.2006; MURPHY DB, 1994, GENOMICS, V21, P551, DOI 10.1006/geno.1994.1313; Nuthall HN, 2004, MOL CELL BIOL, V24, P8395, DOI 10.1128/MCB.24.19.8395-8407.2004; Obendorf M, 2007, J STEROID BIOCHEM, V104, P195, DOI 10.1016/j.jsbmb.2007.03.012; Pinto M, 1996, J BIOL CHEM, V271, P33026, DOI 10.1074/jbc.271.51.33026; Regad T, 2007, NAT CELL BIOL, V9, P531, DOI 10.1038/ncb1573; Sonderegger CK, 2003, ONCOGENE, V22, P1749, DOI 10.1038/sj.onc.1206308; Stewart L, 2005, MOL BRAIN RES, V140, P106, DOI 10.1016/j.molbrainres.2005.06.016; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Yao J, 1998, DEV GROWTH DIFFER, V40, P133; Yao J, 2001, MOL CELL BIOL, V21, P1962, DOI 10.1128/MCB.21.6.1962-1972.2001; Yao J, 2000, MECH DEVELOP, V93, P105, DOI 10.1016/S0925-4773(00)00278-1; Zhang XG, 2008, J NEUROSCI RES, V86, P2423, DOI 10.1002/jnr.21680	36	21	21	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14749	14759		10.1074/jbc.M111.328336	http://dx.doi.org/10.1074/jbc.M111.328336			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22354967	hybrid, Green Published			2022-12-27	WOS:000304003200040
J	Herr, RA; Wang, XL; Loh, J; Virgin, HW; Hansen, TH				Herr, Roger A.; Wang, Xiaoli; Loh, Joy; Virgin, Herbert W.; Hansen, Ted H.			Newly Discovered Viral E3 Ligase pK3 Induces Endoplasmic Reticulum-associated Degradation of Class I Major Histocompatibility Proteins and Their Membrane-bound Chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; PEPTIDE-LOADING COMPLEX; UBIQUITIN LIGASES; DOWN-REGULATION; HERPESVIRUS K3; IMMUNE EVASION; CELL-SURFACE; TRANSMEMBRANE HELIX; FINGER PROTEIN; TAPASIN	Viral immune invasion proteins are highly effective probes for studying physiological pathways. We report here the characterization of a new viral ubiquitin ligase pK3 expressed by rodent herpesvirus Peru (RHVP) that establishes acute and latent infection in laboratory mice. Our findings show that pK3 binds directly and specifically to class I major histocompatibility proteins (MHCI) in a transmembrane-dependent manner. This binding results in the rapid degradation of the pK3/MHCI complex by a mechanism dependent upon catalytically active pK3. Subsequently, the rapid degradation of pK3/MHCI secondarily causes the slow degradation of membrane bound components of the MHCI peptide loading complex, tapasin, and transporter associated with antigen processing (TAP). Interestingly, this secondary event occurs by cellular endoplasmic reticulum-associated degradation. Cumulatively, our findings show pK3 uses a unique mechanism of substrate detection and degradation compared with other viral or cellular E3 ligases. More importantly, our findings reveal that in the absence of nascent MHCI proteins in the endoplasmic reticulum, the transmembrane proteins TAP and tapasin that facilitate peptide binding to MHCI proteins are degraded by cellular quality control mechanisms.	[Herr, Roger A.; Wang, Xiaoli; Loh, Joy; Virgin, Herbert W.; Hansen, Ted H.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Hansen, TH (corresponding author), 660 S Euclid Ave, St Louis, MO 63110 USA.	hansen@wustl.edu		Virgin, Herbert/0000-0001-8580-7628	National Institutes of Health [R01 AI019687, R01 CA096511]; Project 3 [U54 AI057160]; Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Disease Research; NATIONAL CANCER INSTITUTE [R01CA096511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019687, U54AI057160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Project 3; Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Disease Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by a National Institutes of Health grants R01 AI019687, R01 CA096511, and Project 3 of U54 AI057160. This work was also supported by the Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Disease Research.	Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Boname JM, 2004, IMMUNITY, V20, P305, DOI 10.1016/S1074-7613(04)00047-0; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; Cadwell K, 2008, J VIROL, V82, P4184, DOI 10.1128/JVI.02264-07; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; CARRENO BM, 1995, J IMMUNOL, V155, P4726; Corcoran K, 2009, J BIOL CHEM, V284, P17475, DOI 10.1074/jbc.M808258200; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; CRUMPACKER DB, 1992, J IMMUNOL, V148, P3004; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Fruh K, 2002, VIRUS RES, V88, P55, DOI 10.1016/S0168-1702(02)00120-X; Garbi N, 2003, EUR J IMMUNOL, V33, P264, DOI 10.1002/immu.200390029; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; Harris MR, 2001, J IMMUNOL, V166, P6686, DOI 10.4049/jimmunol.166.11.6686; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; Hirsch C, 2004, BBA-MOL CELL RES, V1695, P215, DOI 10.1016/j.bbamcr.2004.10.006; Hjerpe R, 2008, BIOCHEM SOC T, V36, P823, DOI 10.1042/BST0360823; Ishido S, 2000, IMMUNITY, V13, P365, DOI 10.1016/S1074-7613(00)00036-4; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Ishido S, 2010, MOL CELLS, V29, P229, DOI 10.1007/s10059-010-0051-x; Kreft SG, 2011, J BIOL CHEM, V286, P20163, DOI 10.1074/jbc.M110.196360; Lehner PJ, 2005, IMMUNOL REV, V207, P112, DOI 10.1111/j.0105-2896.2005.00314.x; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Li QL, 2007, J VIROL, V81, P2117, DOI 10.1128/JVI.01961-06; Loh J, 2011, J VIROL, V85, P2642, DOI 10.1128/JVI.01661-10; Lorenzo ME, 2002, J VIROL, V76, P5522, DOI 10.1128/JVI.76.11.5522-5531.2002; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; Mansouri M, 2006, BLOOD, V108, P1932, DOI 10.1182/blood-2005-11-4404; Myers NB, 2000, J IMMUNOL, V165, P5656, DOI 10.4049/jimmunol.165.10.5656; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Papadopoulos M, 2007, J BIOL CHEM, V282, P9401, DOI 10.1074/jbc.M610429200; Petersen JL, 2005, J IMMUNOL, V174, P962, DOI 10.4049/jimmunol.174.2.962; Raghuraman G, 2002, J BIOL CHEM, V277, P41786, DOI 10.1074/jbc.M207128200; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Sanchez DJ, 2005, J CLIN INVEST, V115, P1369, DOI 10.1172/JCI200524041; Sanchez DJ, 2002, J BIOL CHEM, V277, P6124, DOI 10.1074/jbc.M110265200; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Simone LC, 2009, MOL IMMUNOL, V46, P2147, DOI 10.1016/j.molimm.2009.03.006; Simone LC, 2009, IMMUNOGENETICS, V61, P43, DOI 10.1007/s00251-008-0335-x; SMITH JD, 1993, J EXP MED, V178, P2035, DOI 10.1084/jem.178.6.2035; SMITH JD, 1995, MOL IMMUNOL, V32, P531, DOI 10.1016/0161-5890(95)00013-5; Thomas M, 2008, P NATL ACAD SCI USA, V105, P1656, DOI 10.1073/pnas.0707883105; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2009, J CELL BIOL, V187, P655, DOI 10.1083/jcb.200908036; Wang XL, 2008, SEMIN CANCER BIOL, V18, P441, DOI 10.1016/j.semcancer.2008.09.002; Wang XL, 2005, J VIROL, V79, P4099, DOI 10.1128/JVI.79.7.4099-4108.2005; Wang XL, 2004, J VIROL, V78, P8673, DOI 10.1128/JVI.78.16.8673-8686.2004; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Yu YYL, 1999, INT IMMUNOL, V11, P1897, DOI 10.1093/intimm/11.12.1897; Yu YYL, 2002, J VIROL, V76, P2796, DOI 10.1128/JVI.76.6.2796-2803.2002	57	12	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14467	14479		10.1074/jbc.M111.325340	http://dx.doi.org/10.1074/jbc.M111.325340			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22403403	hybrid, Green Published			2022-12-27	WOS:000304003200014
J	Mir, SUR; Jin, L; Craven, RJ				Mir, Shakeel U. R.; Jin, Ling; Craven, Rolf J.			Neutrophil Gelatinase-associated Lipocalin ( NGAL) Expression Is Dependent on the Tumor-associated Sigma-2 Receptor S2R(Pgrmc1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME-BINDING PROTEIN; MEMBRANE COMPONENT 1; PROGESTERONES ANTIAPOPTOTIC ACTION; BREAST-CANCER CELLS; INNER ZONE ANTIGEN; SACCHAROMYCES-CEREVISIAE; ANTINEOPLASTIC DRUGS; GENE-EXPRESSION; DOMAIN PROTEIN; YEAST DAP1P	Tumor invasion is a critical step in the spread of cancer. S2R (sigma-2 receptor)/Pgrmc1 (progesterone receptor membrane component 1) is a cytochrome b(5)-related drug-binding orphan receptor essential for tumor formation and invasion. Secretory proteins drive these processes, so we screened for S2R(Pgrmc1)-dependent secreted proteins using antibody arrays. S2R(Pgrmc1) markedly regulated the expression of NGAL/LCN2 (neutrophil gelatinase-associated lipocalin/lipocalin 2), a secreted glycoprotein that binds to MMP-9 (matrix metalloproteinase 9) and protects it from degradation. S2RPgrmc1 knock-down blocked NGAL/LCN2 expression at the protein and RNA levels and decreased MMP9 activity. NGAL expression was required for MMP-9 activity and tumor formation. S2R(Pgrmc1) associates with EGFR and increases EGFR levels at the plasma membrane, and the EGFR inhibitors erlotinib and AG1478, as well as Akt and ERK inhibitors, suppressed the NGAL/LCN2 RNA and protein levels. NGAL is transcriptionally regulated by NF kappa B, and S2R(Pgrmc1) knock-down decreased the NF kappa B subunit p65/RelA acetylation, phosphorylation, and activation. In S2R(Pgrmc1) knock-down cells, p65 acetylation was reversed by inhibitors of histone deacetylase 1, and the inhibitors partially restored NGAL levels. Our results are consistent with a model in which S2R(Pgrmc1) increases NGAL/LCN2 levels by activating NF kappa B via EGFR.	[Mir, Shakeel U. R.; Jin, Ling; Craven, Rolf J.] Univ Kentucky, Dept Mol & Biomed Pharmacol, Markey Canc Ctr, Lexington, KY 40536 USA	University of Kentucky	Craven, RJ (corresponding author), Univ Kentucky, Dept Mol & Biomed Pharmacol, Markey Canc Ctr, Lexington, KY 40536 USA.	rolf.craven@uky.edu			Kentucky Lung Cancer Research Program; Kentucky Science and Education Fund	Kentucky Lung Cancer Research Program; Kentucky Science and Education Fund	This work was supported by the Kentucky Lung Cancer Research Program, Cycles 8 and 10, and by the Kentucky Science and Education Fund.	Ahmed IS, 2010, J BIOL CHEM, V285, P24775, DOI 10.1074/jbc.M110.134585; Ahmed IS, 2010, J PHARMACOL EXP THER, V333, P564, DOI 10.1124/jpet.109.164210; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Basseres DS, 2010, CANCER RES, V70, P3537, DOI 10.1158/0008-5472.CAN-09-4290; Bolignano D, 2010, CANCER LETT, V288, P10, DOI 10.1016/j.canlet.2009.05.027; Borras C, 2011, FREE RADICAL RES, V45, P643, DOI 10.3109/10715762.2011.571685; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Craven RJ, 2007, J BIOL CHEM, V282, P36543, DOI 10.1074/jbc.M706770200; Crawford KW, 2002, CANCER RES, V62, P313; Crudden G, 2006, J PHARMACOL EXP THER, V316, P448, DOI 10.1124/jpet.105.094631; Crudden G, 2005, TUMOR BIOL, V26, P142, DOI 10.1159/000086485; Delom F, 2007, CELL DEATH DIFFER, V14, P586, DOI 10.1038/sj.cdd.4402012; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Doyle K, 2010, J BIOL CHEM, V285, P17417, DOI 10.1074/jbc.M109.089250; Dressman HK, 2006, CLIN CANCER RES, V12, P819, DOI 10.1158/1078-0432.CCR-05-1447; Falkenstein E, 1996, BIOCHEM BIOPH RES CO, V229, P86, DOI 10.1006/bbrc.1996.1761; Gerdes D, 1998, BIOL CHEM, V379, P907; Ghosh K, 2005, BIOCHEMISTRY-US, V44, P16729, DOI 10.1021/bi0511585; Hand RA, 2003, J CELL BIOCHEM, V90, P534, DOI 10.1002/jcb.10648; Hand RA, 2003, EUKARYOT CELL, V2, P306, DOI 10.1128/EC.2.2.306-317.2003; Hughes AL, 2007, CELL METAB, V5, P143, DOI 10.1016/j.cmet.2006.12.009; KROES RA, 1991, P NATL ACAD SCI USA, V88, P4825, DOI 10.1073/pnas.88.11.4825; Lannetti A, 2008, P NATL ACAD SCI USA, V105, P14058, DOI 10.1073/pnas.0710846105; Laurent-Matha V, 2006, J BIOCHEM, V139, P363, DOI 10.1093/jb/mvj037; Leng XH, 2009, CANCER RES, V69, P8579, DOI 10.1158/0008-5472.CAN-09-1934; Li SH, 2009, CANCER RES, V69, P9163, DOI 10.1158/0008-5472.CAN-09-2483; Liu Y, 2006, MOL CELL BIOL, V26, P8683, DOI 10.1128/MCB.00940-06; Mallory JC, 2005, MOL PHARMACOL, V68, P1747, DOI 10.1124/mol.105.016519; Mallory JC, 2005, MOL CELL BIOL, V25, P1669, DOI 10.1128/MCB.25.5.1669-1679.2005; Mifsud W, 2002, GENOME BIOL, V3; Min L, 2005, FEBS J, V272, P5832, DOI 10.1111/j.1742-4658.2005.04977.x; Min L, 2004, MOL CELL ENDOCRINOL, V215, P143, DOI 10.1016/j.mce.2003.11.025; Neubauer H, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2155; Nuntagowat C, 2010, CLIN EXP METASTAS, V27, P295, DOI 10.1007/s10585-010-9327-y; OKADA Y, 1992, J BIOL CHEM, V267, P21712; Ostenfeld MS, 2005, CANCER RES, V65, P8975, DOI 10.1158/0008-5472.CAN-05-0269; Peluso JJ, 2006, ENDOCRINOLOGY, V147, P3133, DOI 10.1210/en.2006-0114; Peluso JJ, 2005, BIOL REPROD, V73, P261, DOI 10.1095/biolreprod.105.041061; Peluso JJ, 2008, J CLIN ENDOCR METAB, V93, P1592, DOI 10.1210/jc.2007-2771; Peluso JJ, 2008, ENDOCRINOLOGY, V149, P534, DOI 10.1210/en.2007-1050; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Richardson DR, 2005, CELL, V123, P1175, DOI 10.1016/j.cell.2005.12.008; Rohe HJ, 2009, PHARMACOL THERAPEUT, V121, P14, DOI 10.1016/j.pharmthera.2008.09.006; Thompson AM, 2007, BIOCHEMISTRY-US, V46, P14629, DOI 10.1021/bi7013739; Tong ZM, 2008, CANCER RES, V68, P6100, DOI 10.1158/0008-5472.CAN-08-0540; Tong ZM, 2005, BIOCHEM J, V391, P441, DOI 10.1042/BJ20051020; Wehling M, 2007, STEROIDS, V72, P107, DOI 10.1016/j.steroids.2006.11.007; Xu JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1386; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yoshitani N, 2005, PROTEOMICS, V5, P1472, DOI 10.1002/pmic.200401032	52	27	30	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14494	14501		10.1074/jbc.M111.324921	http://dx.doi.org/10.1074/jbc.M111.324921			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22418433	hybrid, Green Published			2022-12-27	WOS:000304003200016
J	Refaie, S; Gagnon, S; Gagnon, H; Desjardins, R; D'Anjou, F; D'Orleans-Juste, P; Zhu, XR; Steiner, DF; Seidah, NG; Lazure, C; Salzet, M; Day, R				Refaie, Sarah; Gagnon, Sandra; Gagnon, Hugo; Desjardins, Roxane; D'Anjou, Francois; D'Orleans-Juste, Pedro; Zhu, Xiaorong; Steiner, Donald F.; Seidah, Nabil G.; Lazure, Claude; Salzet, Michel; Day, Robert			Disruption of Proprotein Convertase 1/3 (PC1/3) Expression in Mice Causes Innate Immune Defects and Uncontrolled Cytokine Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE PERITONEAL-MACROPHAGES; MONOCYTE-DERIVED MACROPHAGES; TOLL-LIKE RECEPTORS; REGULATORY T-CELLS; PROHORMONE CONVERTASES; IN-VIVO; IFN-GAMMA; INFLAMMATORY RESPONSES; MOLECULAR-MECHANISMS; SIGNAL-TRANSDUCTION	The proprotein convertase 1/3 is expressed in the regulated secretory pathway of neural and endocrine cells. Its major function is in the post-translational processing and activation of precursor proteins. The PC1/3 knock-out (KO) mouse model has allowed us to elucidate its physiological functions in studies focused primarily on neuroendocrine tissues. However, PC1/3 is also expressed in cells of the immune system, mainly in macrophages. The present study explores the effects of innate immune challenge in the PC1/3 KO mouse. PC1/3 KO mice have an enlarged spleen with marked disorganization of the marginal zone and red pulp. Immunohistochemical studies using various markers demonstrate a depletion of dendritic cells in PC1/3 KO spleens. When challenged with lipopolysaccharide, PC1/3 KO mice are more susceptible to septic shock than wild-type controls or other PC KO mice, such as PC2 and PC7 null mice. Plasma levels of proinflammatory cytokines (IL-6, IL-1 beta, and TNF-alpha) were very significantly elevated in PC1/3 KO mice, consistent with a hypercytokinemia, i.e. indicative of a major systemic uncontrolled inflammatory response or cytokine storm. Peritoneal macrophages isolated from PC1/3 KO mice also demonstrate elevated cytokine secretion when treated with LPS. Electron micrographs show morphological features indicating a prolonged activation of these cells following LPS stimulation. We also present evidence that the proinflammatory Th1 pathway is dominant in the PC1/3 KO mouse model. We conclude that aside from its important role in neuroendocrine functions PC1/3 also has an important role in the regulation of the innate immune system, most likely through the regulation of cytokine secretion in macrophages.	[Day, Robert] Univ Sherbrooke, FMSS, IPS, Sherbrooke, PQ J1H 5N4, Canada; [Zhu, Xiaorong; Steiner, Donald F.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Seidah, Nabil G.; Lazure, Claude] IRCM, Montreal, PQ H2W 1R7, Canada; [Gagnon, Hugo; Salzet, Michel] Univ Lille 1, Lab Spectrometrie Masse Biol Fondamentale & Appl, EA4550, IFR 147, F-59655 Villeneuve Dascq, France	University of Sherbrooke; University of Chicago; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Lille - ISITE; Universite de Lille	Day, R (corresponding author), Univ Sherbrooke, FMSS, IPS, 3001 12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	Robert.day@usherbrooke.ca	Salzet, Michel/A-7675-2011; Seidah, Nabil/I-3596-2013	Salzet, Michel/0000-0003-4318-0817; Seidah, Nabil/0000-0001-6503-9342	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Canadian Institutes of Health Research.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Anderson CF, 2002, J IMMUNOL, V168, P3697, DOI 10.4049/jimmunol.168.8.3697; Baecher-Allan C, 2006, IMMUNOL REV, V212, P203, DOI 10.1111/j.0105-2896.2006.00417.x; BENJANNET S, 1993, BIOCHEM J, V294, P735, DOI 10.1042/bj2940735; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Constam DB, 2000, GENE DEV, V14, P1146; Cope A, 2011, TRENDS IMMUNOL, V32, P278, DOI 10.1016/j.it.2011.03.010; Cottrez F, 2000, J IMMUNOL, V165, P4848, DOI 10.4049/jimmunol.165.9.4848; CREEMERS JWM, 1995, J BIOL CHEM, V270, P2695, DOI 10.1074/jbc.270.6.2695; CREEMERS JWM, 1993, J BIOL CHEM, V268, P21826; D'Anjou F, 2011, TRANSL ONCOL, V4, P157, DOI 10.1593/tlo.10295; Day R, 2002, NEUROENDOCRINOL LETT, V23, P447; DAY R, 1992, MOL ENDOCRINOL, V6, P485, DOI 10.1210/me.6.3.485; Dey A, 2003, J BIOL CHEM, V278, P15007, DOI 10.1074/jbc.M212128200; Dikeakos JD, 2007, J CELL BIOL, V177, P191, DOI 10.1083/jcb.200701024; Dikeakos JD, 2009, P NATL ACAD SCI USA, V106, P7408, DOI 10.1073/pnas.0809576106; Duitman EH, 2011, EUR J CELL BIOL, V90, P476, DOI 10.1016/j.ejcb.2011.01.010; Essalmani R, 2006, MOL CELL BIOL, V26, P354, DOI 10.1128/MCB.26.1.354-361.2006; Essalmani R, 2008, P NATL ACAD SCI USA, V105, P5750, DOI 10.1073/pnas.0709428105; Farooqi IS, 2007, J CLIN ENDOCR METAB, V92, P3369, DOI 10.1210/jc.2007-0687; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Furuta M, 1997, P NATL ACAD SCI USA, V94, P6646, DOI 10.1073/pnas.94.13.6646; Furuta M, 2001, J BIOL CHEM, V276, P27197, DOI 10.1074/jbc.M103362200; Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grenier C, 2006, J NEUROCHEM, V97, P1456, DOI 10.1111/j.1471-4159.2006.03837.x; Haddad JJ, 2002, J NEUROIMMUNOL, V133, P1, DOI 10.1016/S0165-5728(02)00357-0; HARDING CV, 1995, TRENDS CELL BIOL, V5, P105, DOI 10.1016/S0962-8924(00)88959-X; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Isaac BM, 2010, EXP CELL RES, V316, P3406, DOI 10.1016/j.yexcr.2010.06.011; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; JEAN F, 1993, BIOCHEM J, V292, P891, DOI 10.1042/bj2920891; Jia T, 2009, SCIENCE, V325, P549, DOI 10.1126/science.1178329; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim R, 2005, CANCER BIOL THER, V4, P924, DOI 10.4161/cbt.4.9.2101; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; LaMendola J, 1997, FEBS LETT, V404, P19, DOI 10.1016/S0014-5793(97)00078-1; Lansac G, 2006, J NEUROIMMUNOL, V171, P57, DOI 10.1016/j.jneuroim.2005.09.019; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Marzban L, 2004, DIABETES, V53, P141, DOI 10.2337/diabetes.53.1.141; Mbikay M, 1997, P NATL ACAD SCI USA, V94, P6842, DOI 10.1073/pnas.94.13.6842; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Miyake K, 2003, INT IMMUNOPHARMACOL, V3, P119, DOI 10.1016/S1567-5769(02)00258-8; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; MURRAY HW, 1985, J IMMUNOL, V134, P1619; Nacife VP, 2004, CELL STRUCT FUNCT, V29, P27, DOI 10.1247/csf.29.27; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; ORAHILLY S, 1995, NEW ENGL J MED, V333, P1386, DOI 10.1056/NEJM199511233332104; Pan H, 2006, J NEUROCHEM, V98, P1763, DOI 10.1111/j.1471-4159.2006.04067.x; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Polati R, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-4; Portela-Gomes GM, 2008, REGUL PEPTIDES, V146, P117, DOI 10.1016/j.regpep.2007.09.019; Puddu P, 1997, J IMMUNOL, V159, P3490; Rautajoki KJ, 2008, ANN MED, V40, P322, DOI 10.1080/07853890802068582; Rholam M, 2009, CELL MOL LIFE SCI, V66, P2075, DOI 10.1007/s00018-009-0007-5; Rittig MG, 1999, MICROBES INFECT, V1, P727, DOI 10.1016/S1286-4579(99)80074-4; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Salzet M, 2000, TRENDS NEUROSCI, V23, P550, DOI 10.1016/S0166-2236(00)01642-8; Salzet M, 2001, NEUROENDOCRINOL LETT, V22, P467; SCHAFER MKH, 1993, J NEUROSCI, V13, P1258; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Seidah NG, 2006, BIOL CHEM, V387, P871, DOI 10.1515/BC.2006.110; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Seidah NG, 1998, ANN NY ACAD SCI, V839, P9, DOI 10.1111/j.1749-6632.1998.tb10727.x; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Stow JL, 2009, IMMUNOBIOLOGY, V214, P601, DOI 10.1016/j.imbio.2008.11.005; Straub RH, 2000, J NEUROCHEM, V75, P2464, DOI 10.1046/j.1471-4159.2000.0752464.x; Taams LS, 2005, HUM IMMUNOL, V66, P222, DOI 10.1016/j.humimm.2004.12.006; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Tumanov AV, 2003, IMMUNOL REV, V195, P106, DOI 10.1034/j.1600-065X.2003.00071.x; Ugleholdt R, 2004, ENDOCRINOLOGY, V145, P1349, DOI 10.1210/en.2003-0801; Ugleholdt R, 2006, J BIOL CHEM, V281, P11050, DOI 10.1074/jbc.M601203200; Villeneuve P, 2002, J NEUROCHEM, V82, P783, DOI 10.1046/j.1471-4159.2002.00988.x; VINDROLA O, 1994, NEUROPEPTIDES, V27, P235, DOI 10.1016/0143-4179(94)90004-3; Wang YC, 2010, CANCER RES, V70, P4840, DOI 10.1158/0008-5472.CAN-10-0269; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Wardman JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028152; Wardman JH, 2010, J NEUROCHEM, V114, P215, DOI 10.1111/j.1471-4159.2010.06760.x; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598; You Y, 2011, J IMMUNOL, V186, P2172, DOI 10.4049/jimmunol.1002106; Zanoni Ivan, 2009, Current Immunology Reviews, V5, P311; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599	98	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14703	14717		10.1074/jbc.M111.323220	http://dx.doi.org/10.1074/jbc.M111.323220			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22396549	Green Published, hybrid			2022-12-27	WOS:000304003200036
J	Ye, MY; Khoo, KK; Xu, SQ; Zhou, M; Boonyalai, N; Perugini, MA; Shao, XX; Chi, CW; Galea, CA; Wang, CG; Norton, RS				Ye, Mingyu; Khoo, Keith K.; Xu, Shaoqiong; Zhou, Mi; Boonyalai, Nonlawat; Perugini, Matthew A.; Shao, Xiaoxia; Chi, Chengwu; Galea, Charles A.; Wang, Chunguang; Norton, Raymond S.			A Helical Conotoxin from Conus imperialis Has a Novel Cysteine Framework and Defines a New Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH SOURCE; CBL-B; NMR; THERAPEUTICS; PROGRAM; VENOMS; LEADS	Cone snail venoms are a rich source of peptides, many of which are potent and selective modulators of ion channels and receptors. Here we report the isolation and characterization of two novel conotoxins from the venom of Conus imperialis. These two toxins contain a novel cysteine framework, C-C-C-CC-C, which has not been found in other conotoxins described to date. We name it framework XXIII and designate the two toxins im23a and im23b; cDNAs of these toxins exhibit a novel signal peptide sequence, which defines a new K-superfamily. The disulfide connectivity of im23a has been mapped by chemical mapping of partially reduced intermediates and by NMR structure calculations, both of which establish a I-II, III-IV, V-VI pattern of disulfide bridges. This pattern was also confirmed by synthesis of im23a with orthogonal protection of individual cysteine residues. The solution structure of im23a reveals that im23a adopts a novel helical hairpin fold. A cluster of acidic residues on the surface of the molecule is able to bind calcium. The biological activity of the native and recombinant peptides was tested by injection into mice intracranially and intravenously to assess the effects on the central and peripheral nervous systems, respectively. Intracranial injection of im23a or im23b into mice induced excitatory symptoms; however, the biological target of these new toxins has yet to be identified.	[Ye, Mingyu; Xu, Shaoqiong; Zhou, Mi; Shao, Xiaoxia; Chi, Chengwu; Wang, Chunguang] Tongji Univ, Inst Prot Res, Shanghai 20092, Peoples R China; [Khoo, Keith K.; Galea, Charles A.; Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Khoo, Keith K.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Khoo, Keith K.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Boonyalai, Nonlawat] Kasetsart Univ, Dept Biochem, Fac Sci, Bangkok 10900, Thailand; [Perugini, Matthew A.] La Trobe Univ, Dept Biochem, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia; [Chi, Chengwu] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Tongji University; Monash University; Walter & Eliza Hall Institute; University of Melbourne; Kasetsart University; La Trobe University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, CG (corresponding author), Tongji Univ, Inst Prot Res, 1239 Siping Rd, Shanghai 20092, Peoples R China.	chunguangwang@tongji.edu.cn; ray.norton@monash.edu	Galea, Charles/C-5074-2013; Ye, Mingyu/R-6778-2017; Khoo, Keith/N-5468-2019; Galea, Charles/O-8800-2014; Boonyalai, Nonlawat/O-6446-2018	Galea, Charles/0000-0003-0485-7709; Ye, Mingyu/0000-0001-8560-4345; Khoo, Keith/0000-0002-3334-6564; Galea, Charles/0000-0003-2730-1105; Boonyalai, Nonlawat/0000-0002-9058-0840; Norton, Raymond/0000-0001-8893-0584; Perugini, Matthew/0000-0001-8052-5584	Chinese Ministry of Science and Technology [2010CB529802]; Chinese Ministry of Education [NCET-10-0604]; Australian National Health and Medical Research Council	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Ministry of Education(Ministry of Education, China); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by Chinese Ministry of Science and Technology Grant 2010CB529802 and by Chinese Ministry of Education Grant NCET-10-0604.; Supported by the Australian National Health and Medical Research Council.	Armishaw CJ, 2005, CURR PROTEIN PEPT SC, V6, P221, DOI 10.2174/1389203054065437; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Buczek O, 2007, BIOCHEMISTRY-US, V46, P9929, DOI 10.1021/bi700797f; DeLano W.L, PYMOL MOL GRAPHICS S; Han TS, 2008, CURR PHARM DESIGN, V14, P2462, DOI 10.2174/138161208785777469; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kaas Q, 2008, BIOINFORMATICS, V24, P445, DOI 10.1093/bioinformatics/btm596; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Livett BG, 2004, CURR MED CHEM, V11, P1715, DOI 10.2174/0929867043364928; McIntosh J M, 1999, Methods Enzymol, V294, P605; Norton RS, 2006, TOXICON, V48, P780, DOI 10.1016/j.toxicon.2006.07.022; Norton RS, 2010, MOLECULES, V15, P2825, DOI 10.3390/molecules15042825; Pallaghy PK, 1997, FEBS LETT, V419, P191, DOI 10.1016/S0014-5793(97)01452-X; Peschard P, 2007, MOL CELL, V27, P474, DOI 10.1016/j.molcel.2007.06.023; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schmidtko A, 2010, LANCET, V375, P1569, DOI 10.1016/S0140-6736(10)60354-6; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Wang XH, 2000, NAT STRUCT BIOL, V7, P505, DOI 10.1038/75921; Zhou ZR, 2008, PROTEIN SCI, V17, P1805, DOI 10.1110/ps.036384.108	26	29	36	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14973	14983		10.1074/jbc.M111.334615	http://dx.doi.org/10.1074/jbc.M111.334615			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22399292	Green Published, hybrid			2022-12-27	WOS:000304003200059
J	Hu, W; Wan, DD; Yu, XM; Cao, JG; Guo, PY; Li, HS; Han, JH				Hu, Wen; Wan, Didi; Yu, Xiaoming; Cao, Jinguo; Guo, Peiyi; Li, Hong-sheng; Han, Junhai			Protein G(q) Modulates Termination of Phototransduction and Prevents Retinal Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-SENSITIVE CHANNELS; RHODOPSIN IN-VIVO; DROSOPHILA PHOTORECEPTORS; VISUAL TRANSDUCTION; CALMODULIN-BINDING; GENETIC DISSECTION; ARRESTIN; RECEPTOR; KINASE; DEACTIVATION	Appropriate termination of the phototransduction cascade is critical for photoreceptors to achieve high temporal resolution and to prevent excessive Ca2+-induced cell toxicity. Using a genetic screen to identify defective photoresponse mutants in Drosophila, we isolated and identified a novel G alpha(q) mutant allele, which has defects in both activation and deactivation. We revealed that G(q) modulates the termination of the light response and that metarhodopsin/G(q) interaction affects subsequent arrestin-rhodopsin (Arr2-Rh1) binding, which mediates the deactivation of metarhodopsin. We further showed that the G alpha(q) mutant undergoes light-dependent retinal degeneration, which is due to the slow accumulation of stable Arr2-Rh1 complexes. Our study revealed the roles of Gq in mediating photoresponse termination and in preventing retinal degeneration. This pathway may represent a general rapid feedback regulation of G protein-coupled receptor signaling.	[Hu, Wen; Wan, Didi; Cao, Jinguo; Han, Junhai] Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Nanjing 210096, Jiangsu, Peoples R China; [Yu, Xiaoming; Han, Junhai] Southeast Univ, Sch Med, Nanjing 210009, Peoples R China; [Guo, Peiyi; Li, Hong-sheng] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	Southeast University - China; Southeast University - China; University of Massachusetts System; University of Massachusetts Worcester	Han, JH (corresponding author), Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, 2 Sipailou Rd, Nanjing 210096, Jiangsu, Peoples R China.	junhaihan@seu.edu.cn	Jinde, Cao/L-2658-2017		National Natural Science Foundation of China [30970663, 31070683]; NATIONAL INSTITUTE ON AGING [R01AG022508] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Natural Science Foundation of China Grants 30970663 and 31070683 (to J. H.).	Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; Alloway PG, 1999, P NATL ACAD SCI USA, V96, P6072, DOI 10.1073/pnas.96.11.6072; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Cao JG, 2011, EMBO J, V30, P3701, DOI 10.1038/emboj.2011.254; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Han J, 2007, EMBO J, V26, P4966, DOI 10.1038/sj.emboj.7601929; Han JH, 2006, CELL, V127, P847, DOI 10.1016/j.cell.2006.09.030; HARDIE RC, 1994, J GEN PHYSIOL, V103, P409, DOI 10.1085/jgp.103.3.409; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; HOTTA Y, 1970, P NATL ACAD SCI USA, V67, P1156, DOI 10.1073/pnas.67.3.1156; Iakhine R, 2004, J NEUROSCI, V24, P2516, DOI 10.1523/JNEUROSCI.5426-03.2004; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; Kirchberg K, 2011, P NATL ACAD SCI USA, V108, P18690, DOI 10.1073/pnas.1015461108; Kiselev A, 1997, BIOCHEMISTRY-US, V36, P2188, DOI 10.1021/bi9621268; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; LEE YJ, 1994, NEURON, V13, P1143, DOI 10.1016/0896-6273(94)90052-3; Liu CH, 2008, NEURON, V59, P778, DOI 10.1016/j.neuron.2008.07.007; MATSUMOTO H, 1994, NEURON, V12, P997, DOI 10.1016/0896-6273(94)90309-3; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; PORTER JA, 1992, J CELL BIOL, V116, P683, DOI 10.1083/jcb.116.3.683; PORTER JA, 1995, EMBO J, V14, P4450, DOI 10.1002/j.1460-2075.1995.tb00124.x; PORTER JA, 1993, SCIENCE, V262, P1038, DOI 10.1126/science.8235618; Raghu P, 2000, NEURON, V26, P169, DOI 10.1016/S0896-6273(00)81147-2; RANGANATHAN R, 1995, CELL, V81, P841, DOI 10.1016/0092-8674(95)90004-7; RANGANATHAN R, 1994, NEURON, V13, P837, DOI 10.1016/0896-6273(94)90250-X; RANGANATHAN R, 1991, NATURE, V354, P230, DOI 10.1038/354230a0; Ratnaparkhi A, 2002, J NEUROSCI, V22, P4499, DOI 10.1523/JNEUROSCI.22-11-04499.2002; Satoh AK, 2005, CURR BIOL, V15, P1722, DOI 10.1016/j.cub.2005.08.064; Satoh AK, 2010, NEURON, V67, P997, DOI 10.1016/j.neuron.2010.08.024; SCAVARDA NJ, 1983, P NATL ACAD SCI-BIOL, V80, P4441, DOI 10.1073/pnas.80.14.4441; Schulz S, 1999, J BIOL CHEM, V274, P37605, DOI 10.1074/jbc.274.53.37605; Scott K, 1997, TRENDS BIOCHEM SCI, V22, P350, DOI 10.1016/S0968-0004(97)01100-6; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; Stowers RS, 1999, GENETICS, V152, P1631; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1	46	8	9	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13911	13918		10.1074/jbc.M112.339895	http://dx.doi.org/10.1074/jbc.M112.339895			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22389492	Green Published, hybrid			2022-12-27	WOS:000303996300046
J	Peshenko, IV; Olshevskaya, EV; Lim, S; Ames, JB; Dizhoor, AM				Peshenko, Igor V.; Olshevskaya, Elena V.; Lim, Sunghyuk; Ames, James B.; Dizhoor, Alexander M.			Calcium-Myristoyl Tug Is a New Mechanism for Intramolecular Tuning of Calcium Sensitivity and Target Enzyme Interaction for Guanylyl Cyclase-activating Protein 1 DYNAMIC CONNECTION BETWEEN N-FATTY ACYL GROUP AND EF-HAND CONTROLS CALCIUM SENSITIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; BINDING-PROPERTIES; GCAP1; CA2+; RECOVERIN; MUTATION; RETGC; RODS	Guanylyl cyclase-activating protein 1 (GCAP1), a myristoylated Ca2+ sensor in vision, regulates retinal guanylyl cyclase (RetGC). We show that protein-myristoyl group interactions control Ca2+ sensitivity, apparent affinity for RetGC, and maximal level of cyclase activation. Mutating residues near the myristoyl moiety affected the affinity of Ca2+ binding to EF-hand 4. Inserting Phe residues in the cavity around the myristoyl group increased both the affinity of GCAP1 for RetGC and maximal activation of the cyclase. NMR spectra show that the myristoyl group in the L80F/L176F/V180F mutant remained sequestered inside GCAP1 in both Ca2+-bound and Mg2+-bound states. This mutant displayed much higher affinity for the cyclase but reduced Ca2+ sensitivity of the cyclase regulation. The L176F substitution improved affinity of myristoylated and non-acylated GCAP1 for the cyclase but simultaneously reduced the affinity of Ca2+ binding to EF-hand 4 and Ca2+ sensitivity of the cyclase regulation by acylated GCAP1. The replacement of amino acids near both ends of the myristoyl moiety (Leu(80) and Val(180)) minimally affected regulatory properties of GCAP1. N-Lauryl- and N-myristoyl-GCAP1 activated RetGC in a similar fashion. Thus, protein interactions with the central region of the fatty acyl chain optimize GCAP1 binding to RetGC and maximize activation of the cyclase. We propose a dynamic connection (or "tug") between the fatty acyl group and EF-hand 4 via the C-terminal helix that attenuates the efficiency of RetGC activation in exchange for optimal Ca2+ sensitivity.	[Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.] Salus Univ, Dept Basic Sci, Elkins Pk, PA 19027 USA; [Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.] Salus Univ, Penn Coll Optometry, Elkins Pk, PA 19027 USA; [Lim, Sunghyuk; Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California Davis	Dizhoor, AM (corresponding author), Salus Univ, Dept Basic Sci, 8360 Old York Rd, Elkins Pk, PA 19027 USA.	adizhoor@salus.edu		Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health from the NEI [EY11522, EY012347]; NATIONAL EYE INSTITUTE [R01EY012347, R01EY011522] Funding Source: NIH RePORTER	National Institutes of Health from the NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY11522 (to A. M. D.) and EY012347 (to J. B. A.) from the NEI. This work was also supported by a formula grant from the Pennsylvania Department of Health.	Ames JB, 2012, FRONT MOL NEUROSCI, V5, DOI [10.3389/fnmol.2012.00010, 10.1016/j.bbagen.2011.10.003]; Ames JB, 1995, J BIOL CHEM, V270, P30909, DOI 10.1074/jbc.270.52.30909; Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Dell'Orco D, 2010, CELL MOL LIFE SCI, V67, P973, DOI 10.1007/s00018-009-0243-8; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1992, J BIOL CHEM, V267, P16033; DIZHOOR AM, 1993, SCIENCE, V259, P829, DOI 10.1126/science.8430337; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Dizhoor AM, 1996, J BIOL CHEM, V271, P19346, DOI 10.1074/jbc.271.32.19346; Duda T, 1996, BIOCHEMISTRY-US, V35, P8478, DOI 10.1021/bi960752z; Ermilov AN, 2001, J BIOL CHEM, V276, P48143, DOI 10.1074/jbc.M107539200; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; GORCZYCA WA, 1994, P NATL ACAD SCI USA, V91, P4014, DOI 10.1073/pnas.91.9.4014; GRAYKELLER MP, 1994, NEURON, V13, P849, DOI 10.1016/0896-6273(94)90251-8; Helten A, 2007, BIOCHEM BIOPH RES CO, V356, P687, DOI 10.1016/j.bbrc.2007.03.023; Howes KA, 2002, EMBO J, V21, P1545, DOI 10.1093/emboj/21.7.1545; Hughes RE, 1998, PROTEIN SCI, V7, P2675, DOI 10.1002/pro.5560071222; Hwang JY, 2004, EUR J BIOCHEM, V271, P3785, DOI 10.1111/j.1432-1033.2004.04320.x; Hwang JY, 2003, EUR J BIOCHEM, V270, P3814, DOI 10.1046/j.1432-1033.2003.03770.x; Hwang JY, 2002, BIOCHEMISTRY-US, V41, P13021, DOI 10.1021/bi026618y; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Jiang L, 2011, P NATL ACAD SCI USA, V108, P18476, DOI 10.1073/pnas.1112758108; JOHNSON RS, 1994, J BIOL CHEM, V269, P21067; Kawamura S, 2002, ADV EXP MED BIOL, V514, P61; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KOCH KW, 1991, J BIOL CHEM, V266, P8634; LADANT D, 1995, J BIOL CHEM, V270, P3179; LEE W, 1994, FEBS LETT, V350, P87, DOI 10.1016/0014-5793(94)00740-3; Lim S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208868; Lim S, 2009, BIOCHEMISTRY-US, V48, P850, DOI 10.1021/bi801897p; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; MARKS PW, 1991, ANAL BIOCHEM, V193, P61, DOI 10.1016/0003-2697(91)90044-T; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Nakatani K, 2002, ADV EXP MED BIOL, V514, P1; Olshevskaya EV, 1997, J BIOL CHEM, V272, P14327, DOI 10.1074/jbc.272.22.14327; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; OttoBruc A, 1997, BIOCHEMISTRY-US, V36, P4295, DOI 10.1021/bi963000d; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Pennesi ME, 2003, P NATL ACAD SCI USA, V100, P6783, DOI 10.1073/pnas.1130102100; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00019; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2004, BIOCHEMISTRY-US, V43, P13796, DOI 10.1021/bi048943m; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Pugh EN, 1997, BIOSCIENCE REP, V17, P429; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Sampath AP, 1999, J GEN PHYSIOL, V113, P267, DOI 10.1085/jgp.113.2.267; Scholten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023117; Sokal I, 2001, J BIOL CHEM, V276, P43361, DOI 10.1074/jbc.M103614200; Sokal I, 1999, J BIOL CHEM, V274, P19829, DOI 10.1074/jbc.274.28.19829; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; Stephen R, 2006, J MOL BIOL, V359, P266, DOI 10.1016/j.jmb.2006.03.042; Takemoto N, 2009, P NATL ACAD SCI USA, V106, P11788, DOI 10.1073/pnas.0812781106; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; Wilkie SE, 2001, AM J HUM GENET, V69, P471, DOI 10.1086/323265; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569	69	31	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13972	13984		10.1074/jbc.M112.341883	http://dx.doi.org/10.1074/jbc.M112.341883			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22383530	Green Published, hybrid			2022-12-27	WOS:000303996300052
J	Puvirajesinghe, TM; Elantak, L; Lignon, S; Franche, N; Ilbert, M; Ansaldi, M				Puvirajesinghe, Tania M.; Elantak, Latifa; Lignon, Sabrina; Franche, Nathalie; Ilbert, Marianne; Ansaldi, Mireille			DnaJ (Hsp40 Protein) Binding to Folded Substrate Impacts KplE1 Prophage Excision Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSE REGULATOR INHIBITOR; ESCHERICHIA-COLI; CHAPERONE MACHINES; IN-VIVO; HSP70; RECOMBINATION; REPLICATION; SPECIFICITY; GROEL; PHAGE	Temperate phages mediate gene transfer and can modify the properties of their host organisms through the acquisition of novel genes, a process called lysogeny. The KplE1 prophage is one of the 10 prophage regions in Escherichia coli K12 MG1655. KplE1 is defective for lysis but fully competent for site-specific recombination. The TorI recombination directionality factor is strictly required for prophage excision from the host genome. We have previously shown that DnaJ promotes KplE1 excision by increasing the affinity of TorI for its site-specific recombination DNA target. Here, we provide evidence of a direct association between TorI and DnaJ using in vitro cross-linking assays and limited proteolysis experiments that show that this interaction allows both proteins to be transiently protected from trypsin digestion. Interestingly, NMR titration experiments showed that binding of DnaJ involves specific regions of the TorI structure. These regions, mainly composed of alpha-helices, are located on a surface opposite the DNA-binding site. Taken together, we propose that DnaJ, without the aid of DnaK/GrpE, is capable of increasing the efficiency of KplE1 excision by causing a conformational stabilization that allows TorI to adopt a more favorable conformation for binding to its specific DNA target.	[Puvirajesinghe, Tania M.; Franche, Nathalie; Ansaldi, Mireille] Aix Marseille Univ, CNRS UMR7283, Chim Bacterienne Lab, F-13402 Marseille 20, France; [Elantak, Latifa] Aix Marseille Univ, CNRS UMR7255, Lab Ingn Syst Macromol, F-13402 Marseille 20, France; [Lignon, Sabrina] Aix Marseille Univ, Prote Facil MaP Marseille Prote IBiSA, F-13402 Marseille 20, France; [Ilbert, Marianne] Aix Marseille Univ, Inst Microbiol Mediterranee, Bioenerget & Ingn Prot CNRS UMR7281, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Ansaldi, M (corresponding author), Aix Marseille Univ, Inst Microbiol Mediterranee, CNRS UMR7283, Chim Bacterienne Lab, 31 Chemin Joseph Aiguier, F-13009 Marseille, France.	ansaldi@imm.cnrs.fr	Puvirajesinghe, Tania/AAD-9137-2020; Ilbert, marianne/ABG-5015-2021; ELANTAK, Latifa/S-7004-2019	ANSALDI, Mireille/0000-0002-2878-0702; ilbert, marianne/0000-0002-9070-2334; Puvirajesinghe, Tania/0000-0002-8304-9824	CNRS; French Research Ministry (Ministere de l'Education Nationale, de la Recherche et de la Technologie); National Research Agency [ANR-08-BLAN-0122-01]	CNRS(Centre National de la Recherche Scientifique (CNRS)); French Research Ministry (Ministere de l'Education Nationale, de la Recherche et de la Technologie)(Ministry of Research, France); National Research Agency(French National Research Agency (ANR))	This work was supported by CNRS, the French Research Ministry (Ministere de l'Education Nationale, de la Recherche et de la Technologie), and National Research Agency Grant ANR-08-BLAN-0122-01.	Ansaldi M, 1996, ANAL BIOCHEM, V234, P110, DOI 10.1006/abio.1996.0060; Ansaldi M, 2004, P NATL ACAD SCI USA, V101, P9423, DOI 10.1073/pnas.0401927101; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cajo GC, 2006, J BIOL CHEM, V281, P12436, DOI 10.1074/jbc.M511192200; Canchaya C, 2003, CURR OPIN MICROBIOL, V6, P417, DOI 10.1016/S1369-5274(03)00086-9; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Champ S, 2011, J BIOL CHEM, V286, P38876, DOI 10.1074/jbc.M111.281865; DECROUYCHANEL A, 1995, J BIOL CHEM, V270, P22669, DOI 10.1074/jbc.270.39.22669; ElAntak L, 2005, J BIOL CHEM, V280, P36802, DOI 10.1074/jbc.M507409200; Erales J, 2009, J BIOL CHEM, V284, P12735, DOI 10.1074/jbc.M808254200; Esposito D, 1997, VIROLOGY, V234, P267, DOI 10.1006/viro.1997.8646; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Georgopoulos C, 2006, GENETICS, V174, P1699, DOI 10.1534/genetics.104.68262; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Lewis JA, 2001, NUCLEIC ACIDS RES, V29, P2205, DOI 10.1093/nar/29.11.2205; Nash H, 1996, ESCHERICHIA COLI SAL, P2363; Panis G, 2007, J BIOL CHEM, V282, P21798, DOI 10.1074/jbc.M701827200; Panis G, 2010, VIROLOGY, V404, P41, DOI 10.1016/j.virol.2010.04.027; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Rudd KE, 1999, RES MICROBIOL, V150, P653, DOI 10.1016/S0923-2508(99)00126-6; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Shimizu T, 2009, ARCH VIROL, V154, P959, DOI 10.1007/s00705-009-0397-6; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; ZYLICZ M, 1989, EMBO J, V8, P1601, DOI 10.1002/j.1460-2075.1989.tb03544.x; ZYLICZ M, 1993, PHILOS T ROY SOC B, V339, P271, DOI 10.1098/rstb.1993.0025	30	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14169	14177		10.1074/jbc.M111.331462	http://dx.doi.org/10.1074/jbc.M111.331462			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22378785	hybrid, Green Published			2022-12-27	WOS:000303996300069
J	Sarto-Jackson, I; Milenkovic, I; Smalla, KH; Gundelfinger, ED; Kaehne, T; Herrera-Molina, R; Thomas, S; Kiebler, MA; Sieghart, W				Sarto-Jackson, Isabella; Milenkovic, Ivan; Smalla, Karl-Heinz; Gundelfinger, Eckart D.; Kaehne, Thilo; Herrera-Molina, Rodrigo; Thomas, Sabine; Kiebler, Michael A.; Sieghart, Werner			The Cell Adhesion Molecule Neuroplastin-65 Is a Novel Interaction Partner of gamma-Aminobutyric Acid Type A Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC GABA(A) RECEPTORS; LONG-TERM POTENTIATION; INHIBITORY SYNAPSES; HIPPOCAMPAL-NEURONS; IMMUNOGLOBULIN SUPERFAMILY; POSTSYNAPTIC DENSITIES; GLUTAMATE RECEPTORS; BETA(3) SUBUNITS; ERM FAMILY; GEPHYRIN	gamma-Aminobutyric acid type A (GABA(A)) receptors are pentameric ligand-gated ion channels that mediate fast inhibition in the central nervous system. Depending on their subunit composition, these receptors exhibit distinct pharmacological properties and differ in their ability to interact with proteins involved in receptor anchoring at synaptic or extra-synaptic sites. Whereas GABA(A) receptors containing alpha 1, alpha 2, or alpha 3 subunits are mainly located synaptically where they interact with the submembranous scaffolding protein gephyrin, receptors containing alpha 5 subunits are predominantly found extra-synaptically and seem to interact with radixin for anchorage. Neuroplastin is a cell adhesion molecule of the immunoglobulin superfamily that is involved in hippocampal synaptic plasticity. Our results reveal that neuroplastin and GABA(A) receptors can be co-purified from rat brain and exhibit a direct physical interaction as demonstrated by co-precipitation and Forster resonance energy transfer (FRET) analysis in a heterologous expression system. The brain-specific isoform neuroplastin-65 co-localizes with GABA(A) receptors as shown in brain sections as well as in neuronal cultures, and such complexes can either contain gephyrin or be devoid of gephyrin. Neuroplastin-65 specifically co-localizes with alpha 1 or alpha 2 but not with alpha 3 subunits at GABAergic synapses. In addition, neuroplastin-65 also co-localizes with GABA(A) receptor alpha 5 subunits at extra-synaptic sites. Down-regulation of neuroplastin-65 by shRNA causes a loss of GABA(A) receptor alpha 2 subunits at GABAergic synapses. These results suggest that neuroplastin-65 can co-localize with a subset of GABA(A) receptor subtypes and might contribute to anchoring and/or confining GABA(A) receptors to particular synaptic or extra-synaptic sites, thus affecting receptor mobility and synaptic strength.	[Sarto-Jackson, Isabella; Milenkovic, Ivan; Sieghart, Werner] Med Univ Vienna, Dept Biochem & Mol Biol Nervous Syst, Ctr Brain Res, A-1090 Vienna, Austria; [Smalla, Karl-Heinz; Gundelfinger, Eckart D.; Herrera-Molina, Rodrigo] Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, D-39118 Magdeburg, Germany; [Kaehne, Thilo] Otto Von Guericke Univ, Sch Med, Inst Expt Internal Med, D-39120 Magdeburg, Germany; [Thomas, Sabine; Kiebler, Michael A.] Med Univ Vienna, Dept Neuronal Cell Biol, Ctr Brain Res, A-1090 Vienna, Austria	Medical University of Vienna; Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University; Medical University of Vienna	Sarto-Jackson, I (corresponding author), Med Univ Vienna, Dept Biochem & Mol Biol Nervous Syst, Ctr Brain Res, A-1090 Vienna, Austria.	Isabella.sarto-jackson@meduniwien.ac.at	Smalla, Dr. Karl-Heinz/C-3950-2012; Kaehne, Thilo/E-4858-2012; Sieghart, Werner/A-4877-2013; Herrera-Molina, Rodrigo/GLU-3904-2022	Smalla, Dr. Karl-Heinz/0000-0002-0269-0311; Sieghart, Werner/0000-0002-0443-0302; Kiebler, Michael/0000-0002-8850-6297; Milenkovic, Ivan/0000-0002-2990-0243	Deutsche Forschungsgemeinschaft [SFB 779]; Pakt fur Forschung und Innovation of the Leibniz Society (Wissensgemeinschaft Gottfried Wilhelm Leibniz (WGL)); European Union [2007-2013]; Medical University Vienna, Center for Brain Research	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Pakt fur Forschung und Innovation of the Leibniz Society (Wissensgemeinschaft Gottfried Wilhelm Leibniz (WGL)); European Union(European Commission); Medical University Vienna, Center for Brain Research	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 779 (to T. K. and E. D. G.), the Pakt fur Forschung und Innovation of the Leibniz Society (Wissensgemeinschaft Gottfried Wilhelm Leibniz (WGL)) (to E. D. G.), European Union Structural Funds 2007-2013 (to K. H. S.), and grants from The Medical University Vienna, Center for Brain Research (to I. S.-J., W. S., M. A. K., and S. T.).	Bannai H, 2009, NEURON, V62, P670, DOI 10.1016/j.neuron.2009.04.023; Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Christie SB, 2002, NEUROREPORT, V13, P2355, DOI 10.1097/00001756-200212030-00037; Craig AM, 1996, J NEUROSCI, V16, P3166; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dahm R, 2008, METHOD CELL BIOL, V85, P293, DOI 10.1016/S0091-679X(08)85013-3; Danglot L, 2003, MOL CELL NEUROSCI, V23, P264, DOI 10.1016/S1044-7431(03)00069-1; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Dickson TC, 2002, J CELL BIOL, V157, P1105, DOI 10.1083/jcb.200111076; Dobie FA, 2011, J NEUROSCI, V31, P10481, DOI 10.1523/JNEUROSCI.6023-10.2011; Ehya N, 2003, J NEUROCHEM, V84, P127, DOI 10.1046/j.1471-4159.2003.01509.x; Empson RM, 2006, J NEUROCHEM, V99, P850, DOI 10.1111/j.1471-4159.2006.04123.x; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Fritschy JM, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.005.2008; Furutani Y, 2007, J NEUROSCI, V27, P8866, DOI 10.1523/JNEUROSCI.1047-07.2007; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; HILL IE, 1988, BRAIN RES, V461, P27, DOI 10.1016/0006-8993(88)90722-6; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Kang YH, 2008, J BIOL CHEM, V283, P2323, DOI 10.1074/jbc.M703957200; Klausberger T, 2000, J BIOL CHEM, V275, P8921, DOI 10.1074/jbc.275.12.8921; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kneussel M, 2000, J PHYSIOL-LONDON, V525, P1, DOI 10.1111/j.1469-7793.2000.t01-4-00001.x; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Kohsaka H, 2007, J CELL BIOL, V179, P1289, DOI 10.1083/jcb.200705154; Langnaese K, 1997, J BIOL CHEM, V272, P821, DOI 10.1074/jbc.272.2.821; Levi S, 2008, NEURON, V59, P261, DOI 10.1016/j.neuron.2008.05.030; Li HL, 2009, NEURON, V61, P527, DOI 10.1016/j.neuron.2009.01.010; Loebrich S, 2006, EMBO J, V25, P987, DOI 10.1038/sj.emboj.7600995; Luscher B, 2004, PHARMACOL THERAPEUT, V102, P195, DOI 10.1016/j.pharmthera.2004.04.003; Milan-Lobo L, 2009, MOL PHARMACOL, V76, P1196, DOI 10.1124/mol.109.059139; Mohler H, 2006, J RECEPT SIG TRANSD, V26, P731, DOI 10.1080/10799890600920035; Neville D M Jr, 1974, Methods Enzymol, V32, P92; Nishimura K, 2003, J CELL BIOL, V163, P1077, DOI 10.1083/jcb.200303060; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Owczarek S, 2011, J NEUROCHEM, V117, P984, DOI 10.1111/j.1471-4159.2011.07269.x; Owczarek S, 2010, FASEB J, V24, P1139, DOI 10.1096/fj.09-140509; Panzanelli P, 2005, J COMP NEUROL, V484, P121, DOI 10.1002/cne.20440; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Saiepour L, 2010, J BIOL CHEM, V285, P29623, DOI 10.1074/jbc.M110.121368; Sarto I, 2002, J BIOL CHEM, V277, P30656, DOI 10.1074/jbc.M203597200; Sarto-Jackson I, 2007, J BIOL CHEM, V282, P4354, DOI 10.1074/jbc.M609676200; Sassoe-Pognetto M, 2000, J COMP NEUROL, V420, P481, DOI 10.1002/(SICI)1096-9861(20000515)420:4<481::AID-CNE6>3.0.CO;2-5; Schicker K, 2009, BBA-MOL CELL RES, V1793, P325, DOI 10.1016/j.bbamcr.2008.09.014; Shrivastava AN, 2011, J BIOL CHEM, V286, P14455, DOI 10.1074/jbc.M110.165282; Smalla KH, 2000, P NATL ACAD SCI USA, V97, P4327, DOI 10.1073/pnas.080389297; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; Stork O, 1999, J NEUROBIOL, V40, P343, DOI 10.1002/(SICI)1097-4695(19990905)40:3<343::AID-NEU6>3.0.CO;2-S; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tretter V, 1997, J NEUROSCI, V17, P2728; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Tretter V, 2011, J BIOL CHEM, V286, P37702, DOI 10.1074/jbc.M111.291336; Tretter V, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.007.2008; Tyagarajan SK, 2010, J PHYSIOL-LONDON, V588, P101, DOI 10.1113/jphysiol.2009.178517; Uryu K, 1999, J COMP NEUROL, V405, P216, DOI 10.1002/(SICI)1096-9861(19990308)405:2<216::AID-CNE6>3.0.CO;2-6; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Xiao MF, 2009, J NEUROSCI, V29, P14752, DOI 10.1523/JNEUROSCI.4860-09.2009; Yoshida S, 2000, EUR J BIOCHEM, V267, P4372, DOI 10.1046/j.1432-1327.2000.01482.x; Zeitelhofer M, 2007, NAT PROTOC, V2, P1692, DOI 10.1038/nprot.2007.226; Zhang C, 2010, NEURON, V66, P403, DOI 10.1016/j.neuron.2010.04.008	71	33	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14201	14214		10.1074/jbc.M111.293175	http://dx.doi.org/10.1074/jbc.M111.293175			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22389504	Green Published, hybrid			2022-12-27	WOS:000303996300072
J	Yamaguchi, F; Umeda, Y; Shimamoto, S; Tsuchiya, M; Tokumitsu, H; Tokuda, M; Kobayashi, R				Yamaguchi, Fuminori; Umeda, Yoshinori; Shimamoto, Seiko; Tsuchiya, Mitsumasa; Tokumitsu, Hiroshi; Tokuda, Masaaki; Kobayashi, Ryoji			S100 Proteins Modulate Protein Phosphatase 5 Function A LINK BETWEEN CA(2+) SIGNAL TRANSDUCTION AND PROTEIN DEPHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRATRICOPEPTIDE REPEAT DOMAIN; ABNORMALLY PHOSPHORYLATED-TAU; ALZHEIMERS-DISEASE; SERINE/THREONINE PHOSPHATASE; FEEDBACK-REGULATION; TPR DOMAIN; BINDING; FAMILY; BRAIN; PROTEIN-PHOSPHATASE-5	PP5 is a unique member of serine/threonine phosphatases comprising a regulatory tetratricopeptide repeat (TPR) domain and functions in signaling pathways that control many cellular responses. We reported previously that Ca2+/S100 proteins directly associate with several TPR-containing proteins and lead to dissociate the interactions of TPR proteins with their client proteins. Here, we identified protein phosphatase 5 (PP5) as a novel target of S100 proteins. In vitro binding studies demonstrated that S100A1, S100A2, S100A6, and S100B proteins specifically interact with PP5-TPR and inhibited the PP5-Hsp90 interaction. In addition, the S100 proteins activate PP5 by using a synthetic phosphopeptide and a physiological protein substrate, Tau. Overexpression of S100A1 in COS-7 cells induced dephosphorylation of Tau. However, S100A1 and permanently active S100P inhibited the apoptosis signal-regulating kinase 1 (ASK1) and PP5 interaction, resulting the inhibition of dephosphorylation of phospho-ASK1 by PP5. The association of the S100 proteins with PP5 provides a Ca2+-dependent regulatory mechanism for the phosphorylation status of intracellular proteins through the regulation of PP5 enzymatic activity or PP5-client protein interaction.	[Shimamoto, Seiko; Tsuchiya, Mitsumasa; Tokumitsu, Hiroshi; Kobayashi, Ryoji] Kagawa Univ, Fac Med, Dept Signal Transduct Sci, Miki, Kagawa 7610793, Japan; [Yamaguchi, Fuminori; Tokuda, Masaaki] Kagawa Univ, Fac Med, Dept Cell Physiol, Miki, Kagawa 7610793, Japan; [Umeda, Yoshinori] Kagawa Univ, Fac Agr, Dept Life Sci, Miki, Kagawa 7610795, Japan	Kagawa University; Kagawa University; Kagawa University	Kobayashi, R (corresponding author), Kagawa Univ, Fac Med, Dept Signal Transduct Sci, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	ryoji@med.kagawa-u.ac.jp	Tokumitsu, Hiroshi/M-3978-2015	Tokumitsu, Hiroshi/0000-0002-2193-6794	Kagawa University	Kagawa University	This research is supported by the Kagawa University Characteristic Prior Research Fund 2010.	Austermann J, 2009, BBA-MOL CELL RES, V1793, P1078, DOI 10.1016/j.bbamcr.2008.11.012; BECKER W, 1994, J BIOL CHEM, V269, P22586; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Chen MS, 1996, J BIOL CHEM, V271, P32315, DOI 10.1074/jbc.271.50.32315; CHEN MX, 1994, EMBO J, V13, P4278, DOI 10.1002/j.1460-2075.1994.tb06748.x; Chen MX, 1997, FEBS LETT, V400, P136, DOI 10.1016/S0014-5793(96)01427-5; Chinkers M, 2001, TRENDS ENDOCRIN MET, V12, P28, DOI 10.1016/S1043-2760(00)00335-0; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; DREWES G, 1993, FEBS LETT, V336, P425, DOI 10.1016/0014-5793(93)80850-T; Fujisawa T, 2007, MOL BIOTECHNOL, V37, P13, DOI 10.1007/s12033-007-0053-x; GOEDERT M, 1995, J NEUROCHEM, V65, P2804; Gong CX, 2004, J NEUROCHEM, V88, P298, DOI 10.1046/j.1471-4159.2003.02147.x; GONG CX, 1994, NEUROSCIENCE, V61, P765, DOI 10.1016/0306-4522(94)90400-6; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; GONG CX, 1994, FEBS LETT, V341, P94, DOI 10.1016/0014-5793(94)80247-5; GONG CX, 1994, J NEUROCHEM, V62, P803; Hinds TD, 2008, INT J BIOCHEM CELL B, V40, P2358, DOI 10.1016/j.biocel.2007.08.010; Liu F, 2005, J BIOL CHEM, V280, P1790, DOI 10.1074/jbc.M410775200; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Okada M, 2004, J BIOL CHEM, V279, P4221, DOI 10.1074/jbc.M309014200; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Ramsey AJ, 2000, J BIOL CHEM, V275, P17857, DOI 10.1074/jbc.M001625200; Ramsey AJ, 2002, BIOCHEMISTRY-US, V41, P5625, DOI 10.1021/bi016090h; Russell LC, 1999, J BIOL CHEM, V274, P20060, DOI 10.1074/jbc.274.29.20060; Sanchez-Ortiz E, 2009, J NEUROCHEM, V111, P391, DOI 10.1111/j.1471-4159.2009.06337.x; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Shimamoto S, 2008, J BIOL CHEM, V283, P28246, DOI 10.1074/jbc.M801473200; Shimamoto S, 2010, FEBS LETT, V584, P1119, DOI 10.1016/j.febslet.2010.02.055; Silverstein AM, 1997, J BIOL CHEM, V272, P16224, DOI 10.1074/jbc.272.26.16224; Takeda S, 2008, SCIENCE, V319, P1241, DOI 10.1126/science.1152505; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Yamaguchi Y, 2002, CURR BIOL, V12, P1353, DOI 10.1016/S0960-9822(02)01034-5; YAMAMOTO H, 1988, J NEUROCHEM, V50, P1614, DOI 10.1111/j.1471-4159.1988.tb03051.x; Yamashita K, 1999, PROTEIN EXPRES PURIF, V16, P47, DOI 10.1006/prep.1998.1026; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Zeke T, 2005, BIOCHEM J, V385, P45, DOI 10.1042/BJ20040690	38	47	57	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13787	13798		10.1074/jbc.M111.329771	http://dx.doi.org/10.1074/jbc.M111.329771			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22399290	Green Published, hybrid			2022-12-27	WOS:000303996300034
J	Chen, YY; Farquhar, ER; Chance, MR; Palczewski, K; Kiser, PD				Chen, Yuanyuan; Farquhar, Erik R.; Chance, Mark R.; Palczewski, Krzysztof; Kiser, Philip D.			Insights into Substrate Specificity and Metal Activation of Mammalian Tetrahedral Aspartyl Aminopeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENIN-ANGIOTENSIN SYSTEM; RAY-ABSORPTION SPECTROSCOPY; CRYSTAL-STRUCTURE; CONVERTING ENZYME; MODEL; IDENTIFICATION; PROTEIN; INHIBITORS; EXPRESSION; CLASSIFICATION	Aminopeptidases are key enzymes involved in the regulation of signaling peptide activity. Here, we present a detailed biochemical and structural analysis of an evolutionary highly conserved aspartyl aminopeptidase called DNPEP. We show that this peptidase can cleave multiple physiologically relevant substrates, including angiotensins, and thus may play a key role in regulating neuron function. Using a combination of x-ray crystallography, x-ray absorption spectroscopy, and single particle electron microscopy analysis, we provide the first detailed structural analysis of DNPEP. We show that this enzyme possesses a binuclear zinc-active site in which one of the zinc ions is readily exchangeable with other divalent cations such as manganese, which strongly stimulates the enzymatic activity of the protein. The plasticity of this metal-binding site suggests a mechanism for regulation of DNPEP activity. We also demonstrate that DNPEP assembles into a functionally relevant tetrahedral complex that restricts access of peptide substrates to the active site. These structural data allow rationalization of the enzyme's preference for short peptide substrates with N-terminal acidic residues. This study provides a structural basis for understanding the physiology and bioinorganic chemistry of DNPEP and other M18 family aminopeptidases.	[Chen, Yuanyuan; Palczewski, Krzysztof; Kiser, Philip D.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Farquhar, Erik R.; Chance, Mark R.] Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Ctr Synchrotron Biosci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu; pdk7@case.edu	Chen, Yuanyuan/E-1556-2013	Chen, Yuanyuan/0000-0001-9625-1610; Farquhar, Erik/0000-0002-6419-038X	National Institutes of Health [EY009339, P30 EY11373]; National Institute of Health from the NCRR [RR-15301]; United States Department of Energy, Office of Basic Energy Sciences [W-31-109-ENG-38]; National Institutes of Health NIBIB [P30-EB-009998]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009339, P30EY011373, R01EY008061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health from the NCRR; United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants EY009339 and P30 EY11373.; We thank Drs. Andreas Engel, Vera Moiseenkova-Bell, Yaroslav Tsybovsky, David Lodowski at Case Western Reserve University and Steve Ludtke at Baylor Medical Institute for their advice on electron microscopy and single particle analysis. We thank Debarshi Mustafi for sharing RNA-seq data prior to publication and Dr. Marcin Golczak for assistance with mass spectrometry. This work is based upon research conducted at the Northeastern Collaborative Access Team beam lines of the Advanced Photon Source, supported by National Institute of Health Award RR-15301 from the NCRR. Use of the Advanced Photon Source is supported by the United States Department of Energy, Office of Basic Energy Sciences, under Contract W-31-109-ENG-38. XAS experiments were carried out at beamline X3B of the National Synchrotron Light Source at Brookhaven National Laboratory. Beamline X3B is operated by the Case Center for Synchrotron Biosciences, supported by National Institutes of Health NIBIB Grant P30-EB-009998. National Synchrotron Light Source is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-98CH10886.	Ankudinov AL, 1998, PHYS REV B, V58, P7565, DOI 10.1103/PhysRevB.58.7565; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARRETT AJ, 1994, METHOD ENZYMOL, V244, P1; BERKA JL, 1995, INVEST OPHTH VIS SCI, V36, P1450; Borissenko L, 2005, J MOL BIOL, V346, P1207, DOI 10.1016/j.jmb.2004.12.056; BROWN ID, 1985, ACTA CRYSTALLOGR B, V41, P244, DOI 10.1107/S0108768185002063; CHAN AWE, 1993, PROTEIN SCI, V2, P1574, DOI 10.1002/pro.5560021004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHEUNG HS, 1971, BIOCHIM BIOPHYS ACTA, V242, P190, DOI 10.1016/0005-2744(71)90098-2; CHEVRIER B, 1994, STRUCTURE, V2, P283, DOI 10.1016/S0969-2126(00)00030-7; Costagliola C, 1995, Eur J Ophthalmol, V5, P19; Danser AHJ, 1996, MOL CELL BIOCHEM, V157, P211; DANSER AHJ, 1994, INVEST OPHTH VIS SCI, V35, P1008; DEINUM J, 1989, J HYPERTENS, V7, pS216, DOI 10.1097/00004872-198900076-00104; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Downie LE, 2009, NEUROSCIENCE, V161, P195, DOI 10.1016/j.neuroscience.2009.02.084; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans G, 2001, J APPL CRYSTALLOGR, V34, P82, DOI 10.1107/S0021889800014655; FERRARIDILEO G, 1988, INVEST OPHTH VIS SCI, V29, P876; Fletcher EL, 2010, PROG RETIN EYE RES, V29, P284, DOI 10.1016/j.preteyeres.2010.03.003; Franzetti B, 2002, EMBO J, V21, P2132, DOI 10.1093/emboj/21.9.2132; Goto Y, 2006, J BIOL CHEM, V281, P23503, DOI 10.1074/jbc.M603191200; Greenblatt HM, 1997, J MOL BIOL, V265, P620, DOI 10.1006/jmbi.1996.0729; GUYTON AC, 2000, TXB MED PHYSL, P195; Holm RH, 1996, CHEM REV, V96, P2239, DOI 10.1021/cr9500390; Jabs A, 1999, J MOL BIOL, V286, P291, DOI 10.1006/jmbi.1998.2459; JACOBI PC, 1994, INVEST OPHTH VIS SCI, V35, P973; Jacquamet L, 1998, BIOCHEMISTRY-US, V37, P2564, DOI 10.1021/bi9721344; JENSEN LL, 1989, BRAIN RES, V490, P48, DOI 10.1016/0006-8993(89)90429-0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KELLY JA, 1983, J NEUROCHEM, V40, P1727, DOI 10.1111/j.1471-4159.1983.tb08148.x; Krause MW, 2011, KIDNEY INT, V80, P245, DOI 10.1038/ki.2011.142; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kurihara T, 2006, INVEST OPHTH VIS SCI, V47, P5545, DOI 10.1167/iovs.06-0478; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lavoie JL, 2003, ENDOCRINOLOGY, V144, P2179, DOI 10.1210/en.2003-0150; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LIU WT, 1993, INORG CHEM, V32, P4102, DOI 10.1021/ic00071a023; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; METZ G, 1976, BIOCHIM BIOPHYS ACTA, V429, P933, DOI 10.1016/0005-2744(76)90338-7; Milenkovic VM, 2010, AM J PHYSIOL-RENAL, V299, pF396, DOI 10.1152/ajprenal.00576.2009; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Mustafi D, 2011, FASEB J, V25, P3157, DOI 10.1096/fj.11-186767; Nagai N, 2005, INVEST OPHTH VIS SCI, V46, P2925, DOI 10.1167/iovs.04-1476; Otani A, 1998, CIRC RES, V82, P619, DOI 10.1161/01.RES.82.5.619; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pickering I. J., 2000, EXAFSPAK; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Read RJ, 2011, ACTA CRYSTALLOGR D, V67, P338, DOI 10.1107/S0907444910051371; Reaux A, 1999, P NATL ACAD SCI USA, V96, P13415, DOI 10.1073/pnas.96.23.13415; REID IA, 1978, ANNU REV PHYSIOL, V40, P377, DOI 10.1146/annurev.ph.40.030178.002113; Riggs-Gelasco P., 1995, THESIS U MICHIGAN; RIGGSGELASCO PJ, 1995, COORDIN CHEM REV, V144, P245, DOI 10.1016/0010-8545(95)01144-E; Rowsell S, 1997, STRUCTURE, V5, P337, DOI 10.1016/S0969-2126(97)00191-3; Russo S, 2004, J BIOL CHEM, V279, P51275, DOI 10.1074/jbc.M409455200; Schu P, 2008, METHOD ENZYMOL, V451, P67, DOI 10.1016/S0076-6879(08)03206-0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Silva KC, 2009, DIABETES, V58, P1382, DOI 10.2337/db09-0166; Sim M K, 1994, Blood Press, V3, P260, DOI 10.3109/08037059409102267; Stemmler TL, 1997, BIOCHEMISTRY-US, V36, P9847, DOI 10.1021/bi9702795; Sukumar N, 2011, J INORG BIOCHEM, V105, P1638, DOI 10.1016/j.jinorgbio.2011.08.002; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; TAYLOR A, 1993, FASEB J, V7, P290, DOI 10.1096/fasebj.7.2.8440407; Teuscher F, 2007, J BIOL CHEM, V282, P30817, DOI 10.1074/jbc.M704938200; Unger T, 2002, AM J CARDIOL, V89, p3A; Vaajanen A, 2011, BASIC CLIN PHARMACOL, V109, P217, DOI 10.1111/j.1742-7843.2011.00729.x; Vetro J.A., 2004, AMINOPEPTIDASES BIOL; Vettori MV, 1999, TOXICOL IN VITRO, V13, P931, DOI 10.1016/S0887-2333(99)00073-9; Wagner J, 1996, BRIT J OPHTHALMOL, V80, P159, DOI 10.1136/bjo.80.2.159; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wilk S, 2002, ARCH BIOCHEM BIOPHYS, V407, P176, DOI 10.1016/S0003-9861(02)00494-0; Wilk S, 1998, J BIOL CHEM, V273, P15961, DOI 10.1074/jbc.273.26.15961; Yokoyama R, 2006, FEBS J, V273, P192, DOI 10.1111/j.1742-4658.2005.05057.x; Yoshimoto T, 2004, J MOL BIOL, V337, P399, DOI 10.1016/j.jmb.2004.01.022; Zini S, 1996, P NATL ACAD SCI USA, V93, P11968, DOI 10.1073/pnas.93.21.11968	78	28	29	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13356	13370		10.1074/jbc.M112.347518	http://dx.doi.org/10.1074/jbc.M112.347518			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22356908	Green Published, hybrid			2022-12-27	WOS:000302903700071
J	Cousins, SL; Stephenson, FA				Cousins, Sarah L.; Stephenson, F. Anne			Identification of N-Methyl-D-aspartic Acid (NMDA) Receptor Subtype-specific Binding Sites That Mediate Direct Interactions with Scaffold Protein PSD-95	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMOLECULAR INTERACTION; SH3 DOMAIN; SUBUNITS; RECOGNITION; EXPRESSION; SURFACE; CELLS; SRC; MECHANISM; RESIDUES	N-methyl-D-aspartate (NMDA) neurotransmitter receptors and the postsynaptic density-95 (PSD-95) membrane-associated guanylate kinase (MAGUK) family of scaffolding proteins are integral components of post-synaptic macromolecular signaling complexes that serve to propagate glutamate responses intracellularly. Classically, NMDA receptor NR2 subunits associate with PSD-95 MAGUKs via a conserved ES(E/D) V amino acid sequence located at their C termini. We previously challenged this dogma to demonstrate a second non-ES(E/D) V PSD-95-binding site in both NMDA receptor NR2A and NR2B subunits. Here, using a combination of co-immunoprecipitations from transfected mammalian cells, yeast two-hybrid interaction assays, and glutathione S-transferase (GST) pulldown assays, we show that NR2A subunits interact directly with PSD-95 via the C-terminal ESDV motif and additionally via an Src homology 3 domain-binding motif that associates with the Src homology 3 domain of PSD-95. Peptide inhibition of co-immunoprecipitations of NR2A and PSD-95 demonstrates that both the ESDV and non-ESDV sites are required for association in native brain tissue. Furthermore, we refine the non-ESDV site within NR2B to residues 1149-1157. These findings provide a molecular basis for the differential association of NMDA receptor subtypes with PSD-95 MAGUK scaffold proteins. These selective interactions may contribute to the organization, lateral mobility, and ultimately the function of NMDA receptor subtypes at synapses. Furthermore, they provide a more general molecular mechanism by which the scaffold, PSD-95, may discriminate between potential interacting partner proteins.	[Cousins, Sarah L.; Stephenson, F. Anne] UCL, Sch Pharm, London WC1N 1AX, England	University of London; University College London; University of London School of Pharmacy	Stephenson, FA (corresponding author), UCL, Sch Pharm, 29-39 Brunswick Sq, London WC1N 1AX, England.	anne.stephenson@pharmacy.ac.uk			Biotechnology and Biological Sciences Research Council (United Kingdom); Biotechnology and Biological Sciences Research Council [BB/G003718/1] Funding Source: researchfish; BBSRC [BB/G003718/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (United Kingdom).	Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Arbuckle MI, 2010, EMBO REP, V11, P473, DOI 10.1038/embor.2010.63; Bard L, 2010, P NATL ACAD SCI USA, V107, P19561, DOI 10.1073/pnas.1002690107; Bassand P, 1999, EUR J NEUROSCI, V11, P2031, DOI 10.1046/j.1460-9568.1999.00611.x; CHAZOT PL, 1992, J NEUROCHEM, V59, P1176, DOI 10.1111/j.1471-4159.1992.tb08364.x; CHAZOT PL, 1994, J BIOL CHEM, V269, P24403; Chen BS, 2011, J NEUROSCI, V31, P89, DOI 10.1523/JNEUROSCI.1034-10.2011; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; CIK M, 1993, BIOCHEM J, V296, P877, DOI 10.1042/bj2960877; Cousins SL, 2009, NEUROSCIENCE, V158, P89, DOI 10.1016/j.neuroscience.2007.12.051; Cousins SL, 2008, J NEUROCHEM, V104, P903, DOI 10.1111/j.1471-4159.2007.05067.x; Cousins SL, 2009, J NEUROCHEM, V111, P1501, DOI 10.1111/j.1471-4159.2009.06424.x; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; ERPEL T, 1995, EMBO J, V14, P963, DOI 10.1002/j.1460-2075.1995.tb07077.x; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hawkins LM, 1999, J BIOL CHEM, V274, P27211, DOI 10.1074/jbc.274.38.27211; Kalia LV, 2006, EMBO J, V25, P4971, DOI 10.1038/sj.emboj.7601342; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; LIM WA, 1994, NAT STRUCT BIOL, V1, P221, DOI 10.1038/nsb0494-221; MAYER BJ, 1995, CURR BIOL, V5, P364, DOI 10.1016/S0960-9822(95)00073-X; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Niethammer M, 1996, J NEUROSCI, V16, P2157; Okabe S, 2007, MOL CELL NEUROSCI, V34, P503, DOI 10.1016/j.mcn.2007.01.006; Pan LF, 2011, J BIOL CHEM, V286, P40069, DOI 10.1074/jbc.C111.293084; Papadakis M, 2004, J BIOL CHEM, V279, P14703, DOI 10.1074/jbc.M313446200; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Rutter AR, 2000, J NEUROCHEM, V75, P2501, DOI 10.1046/j.1471-4159.2000.0752501.x; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stephenson FA, 2008, MOL MEMBR BIOL, V25, P311, DOI 10.1080/09687680801971367; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200	40	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13465	13476		10.1074/jbc.M111.292862	http://dx.doi.org/10.1074/jbc.M111.292862			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22375001	hybrid, Green Published			2022-12-27	WOS:000302903700080
J	Latchoumycandane, C; Marathe, GK; Zhang, RL; McIntyre, TM				Latchoumycandane, Calivarathan; Marathe, Gopal K.; Zhang, Renliang; McIntyre, Thomas M.			Oxidatively Truncated Phospholipids Are Required Agents of Tumor Necrosis Factor alpha (TNF alpha)-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING-FACTOR-ACETYLHYDROLASE; TANDEM MASS-SPECTROMETRY; LOW-DENSITY LIPOPROTEINS; MEDIATED GENE-TRANSFER; NECROTIC CELL-DEATH; TNF-ALPHA; GLUTATHIONE-PEROXIDASE; OXIDIZED PHOSPHOLIPIDS; HUMAN-PLASMA; PAF-ACETYLHYDROLASE	TNF alpha generates reactive oxygen species (ROS) at the cell surface that induce cell death, but how ROS communicate to mitochondria and their specific apoptotic action(s) are both undefined. ROS oxidize phospholipids to hydroperoxides that are friable and fragment adjacent to the ( hydro) peroxide function, forming truncated phospholipids, such as azelaoyl phosphatidylcholine (Az-PC). Az-PC is relatively soluble, and exogenous Az-PC rapidly enters cells to damage mitochondrial integrity and initiate intrinsic apoptosis. We determined whether this toxic phospholipid is formed within cells during TNF alpha stimulation in sufficient quantities to induce apoptosis and if they are essential in TNF alpha-induced cytotoxicity. We found that TNF alpha induced ROS formation and phospholipid peroxidation in Jurkat cells, and either chemical interference with NADPH oxidase activity or siRNA suppression of the NADPH oxidase-4 subunit blocked ROS accumulation and phospholipid peroxidation. Mass spectrometry showed that phospholipid peroxides and then Az-PC increased after TNF alpha exposure, whereas ROS inhibition abolished Az-PC accumulation and TNF alpha-induced cell death. Glutathione peroxidase-4 (GPx4), which specifically metabolizes lipid hydroperoxides, fell in TNF alpha-stimulated cells prior to death. Ectopic GPx4 overcame this, reduced peroxidized phospholipid accumulation, blocked Az-PC accumulation, and prevented death. Conversely, GPx4 siRNA knockdown enhanced phospholipid peroxidation, increasing TNF alpha-stimulated Az-PC formation and apoptosis. Truncated phospholipids were essential elements of TNF alpha- induced apoptosis because overexpression of PAFAH2 ( a phospholipase A(2) that selectively hydrolyzes truncated phospholipids) blocked TNF alpha-induced Az-PC accumulation without affecting phospholipid peroxidation. PAFAH2 also abolished apoptosis. Thus, phospholipid oxidation and truncation to apoptotic phospholipids comprise an essential element connecting TNF alpha receptor signaling to mitochondrial damage and apoptotic death.	[Latchoumycandane, Calivarathan; Marathe, Gopal K.; Zhang, Renliang; McIntyre, Thomas M.] Lerner Coll Med, Lerner Res Inst, Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation	McIntyre, TM (corresponding author), Lerner Coll Med, Lerner Res Inst NE10, Cleveland Clin, Dept Cell Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	mcintyt@ccf.org	Latchoumycandane, Calivarathan/GPP-5175-2022	Latchoumycandane, Calivarathan/0000-0002-6637-369X	National Institutes of Health [AA017748, HL092747]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA017748 and HL092747.	Avery SV, 2011, BIOCHEM J, V434, P201, DOI 10.1042/BJ20101695; Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Chen R, 2007, J BIOL CHEM, V282, P24842, DOI 10.1074/jbc.M702865200; Chen R, 2011, J IMMUNOL, V186, P3215, DOI 10.4049/jimmunol.1002710; Chen R, 2009, J BIOL CHEM, V284, P26297, DOI 10.1074/jbc.M109.018978; Conrad M, 2010, P NATL ACAD SCI USA, V107, P15774, DOI 10.1073/pnas.1007909107; Davies SS, 2001, J BIOL CHEM, V276, P16015, DOI 10.1074/jbc.M100878200; Esposti MD, 2001, MOL CELL BIOL, V21, P7268, DOI 10.1128/MCB.21.21.7268-7276.2001; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Fisher AB, 1999, J BIOL CHEM, V274, P21326, DOI 10.1074/jbc.274.30.21326; Foulks JM, 2008, FREE RADICAL BIO MED, V45, P434, DOI 10.1016/j.freeradbiomed.2008.04.034; FRANKEL EN, 1984, PROG LIPID RES, V23, P197, DOI 10.1016/0163-7827(84)90011-0; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Han D, 2006, FREE RADICAL BIO MED, V41, P627, DOI 10.1016/j.freeradbiomed.2006.05.002; Han D, 2009, ANTIOXID REDOX SIGN, V11, P2245, DOI [10.1089/ars.2009.2611, 10.1089/ARS.2009.2611]; Harrison KA, 2000, J MASS SPECTROM, V35, P224, DOI 10.1002/(SICI)1096-9888(200002)35:2<224::AID-JMS933>3.0.CO;2-G; HATTORI K, 1995, J BIOL CHEM, V270, P22308, DOI 10.1074/jbc.270.38.22308; Hattori K, 1996, J BIOL CHEM, V271, P33032, DOI 10.1074/jbc.271.51.33032; HATTORI M, 1994, J BIOL CHEM, V269, P23150; Hirashima Y, 2000, BRAIN RES, V885, P128, DOI 10.1016/S0006-8993(00)02852-3; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Kanner J, 1988, Basic Life Sci, V49, P145; KAYGANICHHARRISON KA, 1994, ANAL BIOCHEM, V221, P16, DOI 10.1006/abio.1994.1372; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Kono N, 2008, J BIOL CHEM, V283, P1628, DOI 10.1074/jbc.M708622200; Loscalzo J, 2008, CELL METAB, V8, P182, DOI 10.1016/j.cmet.2008.08.004; Marathe GK, 1999, J BIOL CHEM, V274, P28395, DOI 10.1074/jbc.274.40.28395; Mariappan N, 2007, AM J PHYSIOL-HEART C, V293, pH2726, DOI 10.1152/ajpheart.00376.2007; Matsuzawa A, 1997, J BIOL CHEM, V272, P32315, DOI 10.1074/jbc.272.51.32315; Milne GL, 2005, J LIPID RES, V46, P307, DOI 10.1194/jlr.M400311-JLR200; Montero J, 2010, BBA-BIOENERGETICS, V1797, P1217, DOI 10.1016/j.bbabio.2010.02.010; Morgan MJ, 2010, MOL CELLS, V30, P1, DOI 10.1007/s10059-010-0105-0; ODONNELL VB, 1995, BIOCHEM J, V310, P133, DOI 10.1042/bj3100133; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Quarck R, 2001, CIRCULATION, V103, P2495; Ran QT, 2004, J BIOL CHEM, V279, P55137, DOI 10.1074/jbc.M410387200; Reis A, 2004, RAPID COMMUN MASS SP, V18, P2849, DOI 10.1002/rcm.1686; Roede JR, 2009, J PHARMACOL EXP THER, V330, P79, DOI 10.1124/jpet.109.152983; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; Schafer ZT, 2006, DEV CELL, V10, P549, DOI 10.1016/j.devcel.2006.04.008; Shakibaei M, 2010, ANTIOXID REDOX SIGN, V13, P821, DOI 10.1089/ars.2009.3036; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; STAFFORINI DM, 1987, J BIOL CHEM, V262, P4223; STREMLER KE, 1989, J BIOL CHEM, V264, P5331; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; Tchikov V, 2011, EUR J CELL BIOL, V90, P467, DOI 10.1016/j.ejcb.2010.11.002; Thomas CP, 2010, J BIOL CHEM, V285, P6891, DOI 10.1074/jbc.M109.078428; TJOELKER LW, 1995, J BIOL CHEM, V270, P25481, DOI 10.1074/jbc.270.43.25481; Tokumura A, 2000, J LIPID RES, V41, P953; Turunen P, 2004, J LIPID RES, V45, P1633, DOI 10.1194/jlr.M400176-JLR200; Umemura K, 2007, STROKE, V38, P1063, DOI 10.1161/01.STR.0000257981.09329.d2; URSINI F, 1987, CHEM PHYS LIPIDS, V44, P255, DOI 10.1016/0009-3084(87)90053-3; Van Buul JD, 2005, ANTIOXID REDOX SIGN, V7, P308, DOI 10.1089/ars.2005.7.308; Vanden Berghe T, 2007, MOL CELL, V26, P769, DOI 10.1016/j.molcel.2007.06.002; Votyakova TV, 2004, ARCH BIOCHEM BIOPHYS, V431, P138, DOI 10.1016/j.abb.2004.07.025; Yagi K, 1996, BIOCHEM BIOPH RES CO, V219, P486, DOI 10.1006/bbrc.1996.0260; Yang LL, 2010, J BIOL CHEM, V285, P22211, DOI 10.1074/jbc.M110.119982	64	34	34	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17693	17705		10.1074/jbc.M111.300012	http://dx.doi.org/10.1074/jbc.M111.300012			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22433871	Green Published, hybrid			2022-12-27	WOS:000306373000068
J	Kang, MA; So, EY; Ouchi, T				Kang, Meyke Ausman; So, Eui-Young; Ouchi, Toru			Deregulation of DNA Damage Response Pathway by Intercellular Contact	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX PHOSPHORYLATION; BETA-CATENIN; GENOMIC INSTABILITY; IONIZING-RADIATION; PLAKOGLOBIN; PROTEIN; ATM; CADHERIN; CANCER	Deregulation of the DNA damage response (DDR) pathway could compromise genomic integrity in normal cells and reduce cancer cell sensitivity to anticancer treatments. We found that intercellular contact stabilizes histone H2AX and gamma H2AX (H2AX phosphorylated on Ser-139) by up-regulating N/E-cadherin and gamma-catenin. gamma-catenin and its DNA-binding partner LEF-1 indirectly increase levels of H2AX by suppressing the promoter of the RNF8 ubiquitin ligase, which decreases levels of H2AX protein under conditions of low intercellular contact. Hyperphosphorylation of DDR proteins is induced by up-regulated H2AX. Constitutive apoptosis is caused in confluent cells but is not further induced by DNA damage. This is conceivably due to insufficient p53 activation because ChIP assay shows that its DNA binding ability is not induced in those cells. Together, our results illustrate a novel mechanism of the regulation of DDR proteins by the cadherin-catenin pathway.	[So, Eui-Young; Ouchi, Toru] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Kang, Meyke Ausman; Ouchi, Toru] Northwestern Univ, Dept Mol Biosci, Interdept Biol Sci Program, Evanston, IL 60201 USA; [Kang, Meyke Ausman; So, Eui-Young; Ouchi, Toru] Univ Chicago, Natl Univ Hlth Sci, Syst Biol Program, Dept Med, Evanston, IL 60201 USA	Roswell Park Cancer Institute; Northwestern University; University of Chicago	Ouchi, T (corresponding author), Roswell Pk Canc Inst, Dept Canc Genet, Elm & Carlton St, Buffalo, NY 14263 USA.	Toru.Ouchi@RoswellPark.org			National Institutes of Health [R01CA79892, R01CA90631]; Susan Komen Foundation; NATIONAL CANCER INSTITUTE [R01CA079892, R01CA090631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA79892 and R01CA90631. This work is also supported by a Breast Cancer Research Grant from the Susan Komen Foundation (to T. O.).	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; BUTZ S, 1992, SCIENCE, V257, P1142, DOI 10.1126/science.257.5073.1142-a; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; COWIN P, 1986, CELL, V46, P1063, DOI 10.1016/0092-8674(86)90706-3; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huen MSY, 2010, TRENDS BIOCHEM SCI, V35, P101, DOI 10.1016/j.tibs.2009.09.001; Kang M. A., 2011, CELL DEATH IN PRESS; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Maeda O, 2004, ONCOGENE, V23, P964, DOI 10.1038/sj.onc.1207254; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; NAGAFUCHI A, 1991, CELL, V65, P849, DOI 10.1016/0092-8674(91)90392-C; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Sadot E, 2000, ONCOGENE, V19, P1992, DOI 10.1038/sj.onc.1203519; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Simcha I, 1998, J CELL BIOL, V141, P1433, DOI 10.1083/jcb.141.6.1433; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	39	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16246	16255		10.1074/jbc.M111.337212	http://dx.doi.org/10.1074/jbc.M111.337212			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22431734	Green Published, hybrid			2022-12-27	WOS:000304030900017
J	Fang, D; Pan, C; Lin, HJ; Lin, Y; Zhang, GY; Wang, HZ; He, MX; Xie, LP; Zhang, RQ				Fang, Dong; Pan, Cong; Lin, Huijuan; Lin, Ya; Zhang, Guiyou; Wang, Hongzhong; He, Maoxian; Xie, Liping; Zhang, Rongqing			Novel Basic Protein, PfN23, Functions as Key Macromolecule during Nacre Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX PROTEIN; CALCIUM-CARBONATE; PEARL OYSTER; PRISMATIC LAYER; DUAL ROLE; SHELL; BIOMINERALIZATION; MINERALIZATION; CRYSTALLIZATION; ARAGONITE	The fine microstructure of nacre (mother of pearl) illustrates the beauty of nature. Proteins found in nacre were believed to be "natural hands" that control nacre formation. In the classical view of nacre formation, nucleation of the main minerals, calcium carbonate, is induced on and by the acidic proteins in nacre. However, the basic proteins were not expected to be components of nacre. Here, we reported that a novel basic protein, PfN23, was a key accelerator in the control over crystal growth in nacre. The expression profile, in situ immunostaining, and in vitro immunodetection assays showed that PfN23 was localized within calcium carbonate crystals in the nacre. Knocking down the expression of PfN23 in adults via double-stranded RNA injection led to a disordered nacre surface in adults. Blocking the translation of PfN23 in embryos using morpholino oligomers led to the arrest of larval development. The in vitro crystallization assay showed that PfN23 increases the rate of calcium carbonate deposition and induced the formation of aragonite crystals with characteristics close to nacre. In addition, we constructed the peptides and truncations of different regions of this protein and found that the positively charged C-terminal region was a key region for the function of PfN23 Taken together, the basic protein PfN23 may be a key accelerator in the control of crystal growth in nacre. This provides a valuable balance to the classic view that acidic proteins control calcium carbonate deposition in nacre.	[Fang, Dong; Pan, Cong; Lin, Huijuan; Lin, Ya; Zhang, Guiyou; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China; [Fang, Dong; Pan, Cong; Lin, Huijuan; Lin, Ya; Zhang, Guiyou; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Prot Sci Lab, Minist Educ, Beijing 100084, Peoples R China; [He, Maoxian] Chinese Acad Sci, Guangzhou 510301, Guangdong, Peoples R China	Tsinghua University; Tsinghua University; Chinese Academy of Sciences	Xie, LP (corresponding author), Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Rm 206,Old Bldg, Beijing 100084, Peoples R China.	lpxie@mail.tsinghua.edu.cn; rqzhang@mail.tsinghua.edu.cn			National Basic Research Program of China [2010CB126405]; National High Technology Research and Development Program of China [2010AA09Z405]; National Natural Science Foundation of China [31172382, 40876068, U0831001]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20090002110055]; Tsinghua University [20111080964]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Tsinghua University	This work was supported by National Basic Research Program of China Grant 2010CB126405, National High Technology Research and Development Program of China 2010AA09Z405, National Natural Science Foundation of China Grants 31172382, 40876068, and U0831001 (Joint Fund with Guangdong), Specialized Research Fund for the Doctoral Program of Higher Education of China Grant 20090002110055, and Independent Research Projects of Tsinghua University Grant 20111080964.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Addadi L, 1997, NATURE, V389, P912, DOI 10.1038/40010; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; BORBAS JE, 1991, J EXP ZOOL, V258, P1, DOI 10.1002/jez.1402580102; Chan XY, 2011, DEV BIOL, V349, P102, DOI 10.1016/j.ydbio.2010.10.001; Contri MB, 1996, AM J PATHOL, V148, P569; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Fang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021860; Feng Q., 2011, PRINCIPLES CALCIUM B, P141; Fujimura Takuya, 1995, Venus the Japanese Journal of Malacology, V54, P25; Glazer L, 2010, J BIOL CHEM, V285, P12831, DOI 10.1074/jbc.M109.071068; Gotliv BA, 2003, CHEMBIOCHEM, V4, P522, DOI 10.1002/cbic.200200548; Henry JQ, 2010, INTEGR COMP BIOL, V50, P707, DOI 10.1093/icb/icq076; Inoue H, 2004, BIOCHEM BIOPH RES CO, V318, P649, DOI 10.1016/j.bbrc.2004.04.075; KITANO Y, 1962, J GEOPHYS RES, V67, P4873, DOI 10.1029/JZ067i012p04873; Kniep R., 2010, FLUORAPATITE GELATIN, P73; Kong YW, 2009, J BIOL CHEM, V284, P10841, DOI 10.1074/jbc.M808357200; Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372; Li XD, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.075502; LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198; LOWENSTAM HA, 1975, SCIENCE, V188, P363, DOI 10.1126/science.1118730; Ma ZJ, 2007, J BIOL CHEM, V282, P23253, DOI 10.1074/jbc.M700001200; Mann K, 2007, BIOPHYS J, V93, P1246, DOI 10.1529/biophysj.106.100636; MANN S, 1993, SCIENCE, V261, P1286, DOI 10.1126/science.261.5126.1286; Marelli B, 2012, BIOMATERIALS, V33, P102, DOI 10.1016/j.biomaterials.2011.09.039; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Rabinowitz JS, 2008, CURR BIOL, V18, P331, DOI 10.1016/j.cub.2008.01.055; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Shechter A, 2008, P NATL ACAD SCI USA, V105, P7129, DOI 10.1073/pnas.0800193105; Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472; SIMKISS K, 1977, CALC TISS RES, V24, P199, DOI 10.1007/BF02223316; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906; Treccani L, 2006, BIOPHYS J, V91, P2601, DOI 10.1529/biophysj.106.086108; WEINER S, 1984, PHILOS T ROY SOC B, V304, P425, DOI 10.1098/rstb.1984.0036; Weiner S, 2011, ANNU REV MATER RES, V41, P21, DOI 10.1146/annurev-matsci-062910-095803; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907; WILKINSON BH, 1979, GEOLOGY, V7, P524, DOI 10.1130/0091-7613(1979)7<524:BPATEO>2.0.CO;2; Xu GF, 1998, J AM CHEM SOC, V120, P11977, DOI 10.1021/ja9819108; Yano M, 2007, BIOCHEM BIOPH RES CO, V362, P158, DOI 10.1016/j.bbrc.2007.07.172; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004	45	48	52	2	58	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15776	15785		10.1074/jbc.M112.341594	http://dx.doi.org/10.1074/jbc.M112.341594			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22416139	Green Published, hybrid			2022-12-27	WOS:000304006300055
J	Jin, W; Reddy, MA; Chen, Z; Putta, S; Lanting, L; Kato, M; Park, JT; Chandra, M; Wang, C; Tangirala, RK; Natarajan, R				Jin, Wen; Reddy, Marpadga A.; Chen, Zhuo; Putta, Sumanth; Lanting, Linda; Kato, Mitsuo; Park, Jung Tak; Chandra, Manasa; Wang, Charles; Tangirala, Rajendra K.; Natarajan, Rama			Small RNA Sequencing Reveals MicroRNAs That Modulate Angiotensin II Effects in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; MONOCYTE CHEMOATTRACTANT PROTEIN-1; FACTOR-KAPPA-B; NEOINTIMAL LESION FORMATION; TUMOR-SUPPRESSOR PROTEIN; ACCELERATED ATHEROSCLEROSIS; GENE-EXPRESSION; DEFICIENT MICE; PTEN; INHIBITION	Angiotensin II (Ang II)-mediated vascular smooth muscle cell dysfunction plays a critical role in cardiovascular diseases. However, the role of microRNAs (miRNAs) in this process is unclear. We used small RNA deep sequencing to profile Ang II-regulated miRNAs in rat vascular smooth muscle cells (VSMC) and evaluated their role in VSMC dysfunction. Sequencing results revealed several Ang II-responsive miRNAs, and bioinformatics analysis showed that their predicted targets can modulate biological processes relevant to cardiovascular diseases. Further studies with the most highly induced miR-132 and miR-212 cluster (miR-132/212) showed time- and dose-dependent upregulation of miR-132/212 by Ang II through the Ang II Type 1 receptor. We identified phosphatase and tensin homolog (PTEN) as a novel target of miR-132 and demonstrated that miR-132 induces monocyte chemoattractant protein-1 at least in part via PTEN repression in rat VSMC. Moreover, miR-132 overexpression enhanced cyclic AMP-response element-binding protein (CREB) phosphorylation via RASA1 (p120 Ras GTPase-activating protein 1) down-regulation, whereas miR-132 inhibition attenuated Ang II-induced CREB activation. Furthermore, miR-132 up-regulation by Ang II required CREB activation, demonstrating a positive feedback loop. Notably, aortas from Ang II-infused mice displayed similar up-regulation of miR-132/212 and monocyte chemoattractant protein-1, supporting in vivo relevance. In addition, microarray analysis and reverse transcriptase-quantitative PCR validation revealed additional novel miR-132 targets among Ang II-down-regulated genes implicated in cell cycle, motility, and cardiovascular functions. These results suggest that miR132/212 can serve as a novel cellular node to fine-tune and amplify Ang II actions in VSMC.	[Jin, Wen; Reddy, Marpadga A.; Chen, Zhuo; Putta, Sumanth; Lanting, Linda; Kato, Mitsuo; Park, Jung Tak; Natarajan, Rama] City Hope Natl Med Ctr, Dept Diabet, Beckman Res Inst, Div Mol Diabet Res, Duarte, CA 91010 USA; [Jin, Wen; Chandra, Manasa; Natarajan, Rama] City Hope Natl Med Ctr, Irell & Manella Grad Sch Biol Sci, Beckman Res Inst, Duarte, CA 91010 USA; [Wang, Charles] City Hope Natl Med Ctr, Funct Genom Core, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Tangirala, Rajendra K.] Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Natarajan, R (corresponding author), City Hope Natl Med Ctr, Dept Diabet, Beckman Res Inst, Div Mol Diabet Res, 1500 E Duarte Rd, Duarte, CA 91010 USA.	RNatarajan@coh.org	Kato, Mitsuo/D-5411-2009	Kato, Mitsuo/0000-0002-1783-1084; Reddy, Marpadga A/0000-0001-9259-7243; Park, Jung Tak/0000-0002-2325-8982	National Institutes of Health [NIH RO1 HL087864, NIH RO1 HL106089]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087864, R01HL106089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants NIH RO1 HL087864 and NIH RO1 HL106089 (NHLBI; to R. N.).	Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Chen WJ, 2004, CIRCULATION, V110, P1313, DOI 10.1161/01.CIR.0000140764.15398.F3; Chen XL, 1998, CIRC RES, V83, P952; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Daugherty A, 1999, ANN NY ACAD SCI, V892, P108, DOI 10.1111/j.1749-6632.1999.tb07789.x; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2004, TRENDS CARDIOVAS MED, V14, P117, DOI 10.1016/j.tcm.2004.01.002; DUFF JL, 1995, CARDIOVASC RES, V30, P511, DOI 10.1016/0008-6363(95)00088-7; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Funakoshi Y, 2002, J BIOL CHEM, V277, P18710, DOI 10.1074/jbc.M110430200; Furgeson SB, 2010, CARDIOVASC RES, V86, P274, DOI 10.1093/cvr/cvp425; GIBBONS GH, 1992, J CLIN INVEST, V90, P456, DOI 10.1172/JCI115881; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Han YQ, 1999, CIRC RES, V84, P695, DOI 10.1161/01.RES.84.6.695; HernandezPresa M, 1997, CIRCULATION, V95, P1532; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang JH, 2002, ARTERIOSCL THROM VAS, V22, P745, DOI 10.1161/01.ATV.0000016358.05294.8D; Hur W, 2010, CARCINOGENESIS, V31, P1298, DOI 10.1093/carcin/bgq072; Ichiki T, 2006, ARTERIOSCL THROM VAS, V26, P449, DOI 10.1161/01.ATV.0000196747.79349.d1; Ichiki T, 2003, HYPERTENSION, V42, P177, DOI 10.1161/01.HYP.0000079791.26014.04; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kligys K, 2007, J BIOL CHEM, V282, P32520, DOI 10.1074/jbc.M707041200; Koide S, 2007, AM J PHYSIOL-HEART C, V292, pH2824, DOI 10.1152/ajpheart.01221.2006; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lee J, 2007, PLOS COMPUT BIOL, V3, P721, DOI 10.1371/journal.pcbi.0030067; Lin Y, 2009, J BIOL CHEM, V284, P7903, DOI 10.1074/jbc.M806920200; Littlewood TD, 2007, CIRC RES, V100, P302, DOI 10.1161/01.RES.0000259101.39931.d3; Liu XJ, 2011, J BIOL CHEM, V286, P42371, DOI 10.1074/jbc.M111.261065; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Marchesi C, 2008, TRENDS PHARMACOL SCI, V29, P367, DOI 10.1016/j.tips.2008.05.003; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Mejlvang J, 2007, MOL BIOL CELL, V18, P4615, DOI 10.1091/mbc.E07-05-0406; NATARAJAN R, 1994, HYPERTENSION, V23, pI142, DOI 10.1161/01.HYP.23.1_Suppl.I142; Nemenoff RA, 2008, CIRC RES, V102, P1036, DOI 10.1161/CIRCRESAHA.107.169896; Panizzi JR, 2007, DEVELOPMENT, V134, P921, DOI 10.1242/dev.02776; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Reddy MA, 2002, J BIOL CHEM, V277, P9920, DOI 10.1074/jbc.M111305200; Reusch JEB, 2011, ARTERIOSCL THROM VAS, V31, P1955, DOI 10.1161/ATVBAHA.111.232645; Sahar S, 2007, ARTERIOSCL THROM VAS, V27, P1528, DOI 10.1161/ATVBAHA.107.145862; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Strum JC, 2009, MOL ENDOCRINOL, V23, P1876, DOI 10.1210/me.2009-0117; Viedt C, 2002, ARTERIOSCL THROM VAS, V22, P914, DOI 10.1161/01.ATV.0000019009.73586.7F; Villeneuve LM, 2010, DIABETES, V59, P2904, DOI 10.2337/db10-0208; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Yam PY, 2002, MOL THER, V5, P479, DOI 10.1006/mthe.2002.0558	57	71	75	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15672	15683		10.1074/jbc.M111.322669	http://dx.doi.org/10.1074/jbc.M111.322669			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22431733	hybrid, Green Published			2022-12-27	WOS:000304006300046
J	Kurihara, D; Yamashita, T				Kurihara, Dai; Yamashita, Toshihide			Chondroitin Sulfate Proteoglycans Down-regulate Spine Formation in Cortical Neurons by Targeting Tropomyosin-related Kinase B (TrkB) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P75 NEUROTROPHIN RECEPTOR; DENDRITIC SPINE; NERVOUS-SYSTEM; VISUAL-CORTEX; FUNCTIONAL RECOVERY; PTP-SIGMA; BRAIN; BDNF; EXPRESSION; PLASTICITY	Chondroitin sulfate proteoglycans (CSPGs) are components of the extracellular matrix that inhibit axonal sprouting and experience-dependent plasticity. Although protein-tyrosine phosphatase sigma (PTP sigma) has been proven to be a receptor for CSPGs, its downstream signaling has remained a mystery. Here, we show that CSPGs target and dephosphorylate tropomyosin-related kinase B, the receptor of brain-derived neurotrophic factor (BDNF), via PTP sigma in embryonic cortical neurons in vitro. Whereas BDNF promoted dendritic spine formation in embryonic cortical neurons, CSPGs abolished the effects of BDNF and eliminated existing dendritic spines when BDNF was present. The latter effect was dependent on the p75 receptor, presumably because BDNF binding to the p75 receptor elicits elimination of dendritic spines. These results suggest that the inhibitory activity of CSPGs on dendritic spine formation operates through the targeting of neurotrophins at the receptor level.	[Kurihara, Dai; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka 5650871, Japan; [Kurihara, Dai; Yamashita, Toshihide] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Osaka University; Japan Science & Technology Agency (JST)	Yamashita, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yamashita@molneu.med.osaka-u.ac.jp		Yamashita, Toshihide/0000-0003-4559-7018; Kurihara, Dai/0000-0002-0319-3958				Alonso M, 2004, LEARN MEMORY, V11, P172, DOI 10.1101/lm.67804; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Dalby B, 2004, METHODS, V33, P95, DOI 10.1016/j.ymeth.2003.11.023; Egashira Y, 2010, J NEUROSCI RES, V88, P3433, DOI 10.1002/jnr.22505; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; Faux C, 2007, BBA-MOL CELL RES, V1773, P1689, DOI 10.1016/j.bbamcr.2007.06.008; Fox K, 2002, SCIENCE, V298, P1187, DOI 10.1126/science.1079224; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Galuske RAW, 1996, EUR J NEUROSCI, V8, P1554, DOI 10.1111/j.1460-9568.1996.tb01618.x; Gehler S, 2004, J NEUROSCI, V24, P4363, DOI 10.1523/JNEUROSCI.0404-04.2004; Gorba T, 1999, CEREB CORTEX, V9, P864, DOI 10.1093/cercor/9.8.864; Harms KJ, 2007, BRAIN RES, V1184, P65, DOI 10.1016/j.brainres.2006.02.094; Johnson KG, 2001, J NEUROBIOL, V49, P99, DOI 10.1002/neu.1068; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Lee CC, 2011, NEUROPHARMACOLOGY, V61, P867, DOI 10.1016/j.neuropharm.2011.06.003; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MUNOZCUETO JA, 1990, BRAIN RES, V515, P64; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489; Schweigreiter R, 2004, MOL CELL NEUROSCI, V27, P163, DOI 10.1016/j.mcn.2004.06.004; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Shimada A, 1998, J NEUROSCI, V18, P8559; Sotthibundhu A, 2008, J NEUROSCI, V28, P3941, DOI 10.1523/JNEUROSCI.0350-08.2008; Takei N, 1997, J NEUROCHEM, V68, P370; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005	30	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13822	13828		10.1074/jbc.M111.314070	http://dx.doi.org/10.1074/jbc.M111.314070			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22389491	Green Published, hybrid			2022-12-27	WOS:000303996300037
J	Yu, JX; Zhang, DY; Liu, JY; Li, JX; Yu, YH; Wu, XR; Huang, CS				Yu, Jianxiu; Zhang, Dongyun; Liu, Jinyi; Li, Jingxia; Yu, Yonghui; Wu, Xue-Ru; Huang, Chuanshu			RhoGDI SUMOylation at Lys-138 Increases Its Binding Activity to Rho GTPase and Its Inhibiting Cancer Cell Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED INHIBITOR; GDP DISSOCIATION INHIBITOR; APOPTOSIS PROTEIN XIAP; SUMO; UBIQUITIN; IAPS; PHOSPHORYLATION; CDC42; RAC1	The Rho GDP dissociation inhibitor (RhoGDI) can bind to small GTPases and keep them in a biologically inactive state in cytoplasm, through which it affects actin polymerization and cell motility. However, mechanisms underlying how RhoGDI regulates Rho GTPase complex formation/membrane extraction/GTPase dissociation remain largely unexplored. Our previous studies reported that X-linked inhibitor of apoptosis protein (XIAP) interacted with RhoGDI via its RING domain and negatively modulated RhoGDI SUMOylation and HCT116 cancer cell migration. Here, we identified that RhoGDI SUMOylation specifically occurred at Lys-138, which was inhibited by XIAP domain. We further demonstrated that RhoGDI SUMOylation at Lys-138 was crucial for inhibiting actin polymerization and cytoskeleton formation as well as cancer cell motility. Moreover, SUMO-RhoGDI had a much higher binding affinity to small Rho GTPase compared with the un-SUMOylated form of RhoGDI. Taken together, our study demonstrated a novel modification of RhoGDI, SUMOylation at Lys-138, which played a key role in regulating Rho GTPase activation in cancer cells. The physiological regulation of RhoGDI SUMOylation by the RING domain of XIAP may account for modulation of cancer cell invasion and metastasis by XIAP.	[Yu, Jianxiu; Zhang, Dongyun; Liu, Jinyi; Li, Jingxia; Yu, Yonghui; Huang, Chuanshu] NYU, Nelson Inst Environm Med, Sch Med, Tuxedo Pk, NY 10987 USA; [Wu, Xue-Ru] NYU, Dept Urol, Sch Med, Tuxedo Pk, NY 10987 USA; [Wu, Xue-Ru] NYU, Dept Pathol, Sch Med, Tuxedo Pk, NY 10987 USA	New York University; New York University; New York University	Huang, CS (corresponding author), NYU, Nelson Inst Environm Med, Sch Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	chuanshu.huang@nyumc.org	Yu, Yonghui/AAZ-4093-2021	Huang, Chuanshu/0000-0003-4133-5096; Wu, Xue-Ru/0000-0001-6058-6291	National Institutes of Health from NCI [CA112557]; NIEHS [ES000260, ES010344]; National Science Foundation of China [NSFC30928023, NSFC30971516]; NATIONAL CANCER INSTITUTE [R01CA112557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260, P42ES010344] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA112557 from NCI and Grants ES000260, ES010344 from NIEHS. This work was also supported by National Science Foundation of China Grants NSFC30928023 and NSFC30971516.	Castillo-Lluva S, 2010, NAT CELL BIOL, V12, P1078, DOI 10.1038/ncb2112; Cummins JM, 2004, CANCER RES, V64, P3006, DOI 10.1158/0008-5472.CAN-04-0046; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Dogan T, 2008, NAT CELL BIOL, V10, P1447, DOI 10.1038/ncb1804; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Lewis J, 2004, J BIOL CHEM, V279, P9023, DOI 10.1074/jbc.M312891200; Liu JY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176982; Oberoi TK, 2012, EMBO J, V31, P14, DOI 10.1038/emboj.2011.423; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Pal S, 2010, J VIROL METHODS, V163, P498, DOI 10.1016/j.jviromet.2009.11.010; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; Song L, 2007, MOL CELL BIOL, V27, P2713, DOI 10.1128/MCB.00657-06; Song L, 2006, J CELL BIOL, V175, P607, DOI 10.1083/jcb.200602149; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Tu S, 2003, J BIOL CHEM, V278, P49293, DOI 10.1074/jbc.M307021200; Watts FZ, 2004, SEMIN CELL DEV BIOL, V15, P211, DOI 10.1016/j.semcdb.2003.12.002; Wilson Van G, 2005, Sci STKE, V2005, ppe32, DOI 10.1126/stke.2902005pe32; Yu JX, 2009, EMBO J, V28, P21, DOI 10.1038/emboj.2008.238	26	52	53	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13752	13760		10.1074/jbc.M111.337469	http://dx.doi.org/10.1074/jbc.M111.337469			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22393046	Green Published, hybrid			2022-12-27	WOS:000303996300031
J	Sharp, JD; Cruz, JW; Raman, S; Inouye, M; Husson, RN; Woychik, NA				Sharp, Jared D.; Cruz, Jonathan W.; Raman, Sahadevan; Inouye, Masayori; Husson, Robert N.; Woychik, Nancy A.			Growth and Translation Inhibition through Sequence-specific RNA Binding by Mycobacterium tuberculosis VapC Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-LEVEL EXPRESSION; ESCHERICHIA-COLI; PIN-DOMAIN; CRYSTAL-STRUCTURE; PERSISTER CELLS; MESSENGER-RNAS; ANTITOXIN LOCI; PROTEIN; CLEAVAGE; INTERFERASES	The Mycobacterium tuberculosis genome harbors an unusually large number of toxin-antitoxin (TA) modules. Curiously, over half of these are VapBC (virulence-associated protein) family members. Nonetheless, the cellular target, precise mode of action, and physiological role of the VapC toxins in this important pathogen remain unclear. To better understand the function of this toxin family, we studied the features and biochemical properties of a prototype M. tuberculosis VapBC TA system, vapBC-mt4 (Rv0596c-Rv0595c). VapC-mt4 expression resulted in growth arrest, a hallmark of all TA toxins, in Escherichia coli, Mycobacterium smegmatis, and M. tuberculosis. Its expression led to translation inhibition accompanied by a gradual decrease in the steady-state levels of several mRNAs. VapC-mt4 exhibited sequence-specific endoribonuclease activity on mRNA templates at ACGC and AC(A/U)GC sequences. However, the cleavage activity of VapC-mt4 was comparatively weak relative to the TA toxin MazF-mt1 (Rv2801c). Unlike other TA toxins, translation inhibition and growth arrest preceded mRNA cleavage, suggesting that the RNA binding property of VapC-mt4, not RNA cleavage, initiates toxicity. In support of this hypothesis, expression of VapC-mt4 led to an increase in the recovery of total RNA with time in contrast to TA toxins that inhibit translation via direct mRNA cleavage. Additionally, VapC-mt4 exhibited stable, sequence-specific RNA binding in an electrophoretic mobility shift assay. Finally, VapC-mt4 inhibited protein synthesis in a cell-free system without cleaving the corresponding mRNA. Therefore, the activity of VapC-mt4 is mechanistically distinct from other TA toxins because it appears to primarily inhibit translation through selective, stable binding to RNA.	[Sharp, Jared D.; Raman, Sahadevan; Husson, Robert N.] Harvard Univ, Div Infect Dis, Childrens Hosp Boston, Sch Med, Boston, MA 02115 USA; [Sharp, Jared D.; Cruz, Jonathan W.; Woychik, Nancy A.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA; [Inouye, Masayori] Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Dept Biochem, Piscataway, NJ 08854 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Husson, RN (corresponding author), Harvard Univ, Div Infect Dis, Childrens Hosp Boston, Sch Med, 300 Longwood Ave, Boston, MA 02115 USA.	Robert.Husson@childrens.harvard.edu; nancy.woychik@umdnj.edu	Husson, Robert/Y-7288-2019	Raman, Sahadevan/0000-0001-5309-8169	National Institutes of Health from NIAID [AI072399]; T32 Training Grant [AI07403]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI072399, T32AI007403, R01AI037901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095693] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); T32 Training Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI072399 from the NIAID R21 (to R. N. H. and N. A. W.) and T32 Training Grant AI07403, Virus-Host Interactions in Eukaryotic Cells, from the NIAID (to J. D. S. and J. W. C. (awarded to G. Brewer)).	Arcus VL, 2005, TRENDS MICROBIOL, V13, P360, DOI 10.1016/j.tim.2005.06.008; Arcus VL, 2004, J BIOL CHEM, V279, P16471, DOI 10.1074/jbc.M313833200; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Budde PP, 2007, J BACTERIOL, V189, P491, DOI 10.1128/JB.00909-06; Bunker RD, 2008, PROTEINS, V72, P510, DOI 10.1002/prot.22048; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; Clissold PM, 2000, CURR BIOL, V10, pR888, DOI 10.1016/S0960-9822(00)00858-7; Daines DA, 2007, J BACTERIOL, V189, P5041, DOI 10.1128/JB.00290-07; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Glavan F, 2006, EMBO J, V25, P5117, DOI 10.1038/sj.emboj.7601377; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Hurley JM, 2009, J BIOL CHEM, V284, P18605, DOI 10.1074/jbc.M109.008763; INOUYE S, 1985, NUCLEIC ACIDS RES, V13, P3101, DOI 10.1093/nar/13.9.3101; Jeyakanthan J, 2005, ACTA CRYSTALLOGR F, V61, P463, DOI 10.1107/S1744309105012406; Jiang Y, 2002, MOL MICROBIOL, V44, P971, DOI 10.1046/j.1365-2958.2002.02921.x; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Levin I, 2004, PROTEINS, V56, P404, DOI 10.1002/prot.20090; Lewis K, 2005, BIOCHEMISTRY-MOSCOW+, V70, P267, DOI 10.1007/s10541-005-0111-6; MASUI Y, 1984, BIO-TECHNOL, V2, P81, DOI 10.1038/nbt0184-81; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; Miallau L, 2009, J BIOL CHEM, V284, P276, DOI 10.1074/jbc.M805061200; Munoz-Gomez AJ, 2004, FEBS LETT, V567, P316, DOI 10.1016/j.febslet.2004.05.005; Mwinga A, 2004, TROP MED INT HEALTH, V9, P827, DOI 10.1111/j.1365-3156.2004.01274.x; NAKANO ET, 1987, J VIROL, V61, P302, DOI 10.1128/JVI.61.2.302-307.1987; Neubauer C, 2009, CELL, V139, P1084, DOI 10.1016/j.cell.2009.11.015; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; POWERS T, 1990, P NATL ACAD SCI USA, V87, P1042, DOI 10.1073/pnas.87.3.1042; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; RON EZ, 1966, SCIENCE, V153, P1119, DOI 10.1126/science.153.3740.1119; Russo E, 2005, SCIENTIST, V19, P22; Singh R, 2010, J BACTERIOL, V192, P1279, DOI 10.1128/JB.01285-09; Singletary LA, 2009, J BACTERIOL, V191, P7456, DOI 10.1128/JB.00963-09; Sisido M, 2005, METHODS, V36, P270, DOI 10.1016/j.ymeth.2005.04.009; Suzuki M, 2005, MOL CELL, V18, P253, DOI 10.1016/j.molcel.2005.03.011; Tai P C, 1979, Methods Enzymol, V59, P362; Takeshita D, 2006, ACTA CRYSTALLOGR F, V62, P656, DOI 10.1107/S1744309106020057; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; Winther KS, 2009, MOL MICROBIOL, V72, P918, DOI 10.1111/j.1365-2958.2009.06694.x; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhu L, 2008, MOL MICROBIOL, V69, P559, DOI 10.1111/j.1365-2958.2008.06284.x; Zhu L, 2006, J BIOL CHEM, V281, P18638, DOI 10.1074/jbc.M512693200	52	43	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12835	12847		10.1074/jbc.M112.340109	http://dx.doi.org/10.1074/jbc.M112.340109			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22354968	hybrid, Green Published			2022-12-27	WOS:000302903700023
J	Starr, AE; Bellac, CL; Dufour, A; Goebeler, V; Overall, CM				Starr, Amanda E.; Bellac, Caroline L.; Dufour, Antoine; Goebeler, Verena; Overall, Christopher M.			Biochemical Characterization and N-terminomics Analysis of Leukolysin, the Membrane-type 6 Matrix Metalloprotease (MMP25) CHEMOKINE AND VIMENTIN CLEAVAGES ENHANCE CELL MIGRATION AND MACROPHAGE PHAGOCYTIC ACTIVITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE LIBRARIES; PROTEOMIC IDENTIFICATION; NEUTROPHIL APOPTOSIS; GELATINASE-A; PROTEINS; MT6-MMP; INSULIN; BINDING; INFLAMMATION; RECOGNITION	The neutrophil-specific protease membrane-type 6 matrix metalloproteinase (MT6-MMP)/MMP-25/leukolysin is implicated in multiple sclerosis and cancer yet remains poorly characterized. To characterize the biological roles of MT6-MMP, it is critical to identify its substrates for which only seven are currently known. Here, we biochemically characterized MT6-MMP, profiled its tissue inhibitor of metalloproteinase inhibitory spectrum, performed degradomics analyses, and screened 26 chemokines for cleavage using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. MT6-MMP processes seven each of the CXC and CC chemokine subfamilies. Notably, cleavage of the neutrophil chemoattractant CXCL5 activates the chemokine, thereby increasing its agonist activity, indicating a feed-forward mechanism for neutrophil recruitment. Likewise, cleavage also activated CCL15 and CCL23 to increase monocyte recruitment. Utilizing the proteomics approach proteomic identification of cleavage site specificity (PICS), we identified 286 peptidic cleavage sites spanning from P6 to P6' from which an unusual glutamate preference in P1 was identified. The degradomics screen terminal amine isotopic labeling of substrates (TAILS), which enriches for neo-N-terminal peptides of cleaved substrates, was used to identify 58 new native substrates in fibroblast secretomes after incubation with MT6-MMP. Vimentin, cystatin C, galectin-1, IGFBP-7, and secreted protein, acidic and rich in cysteine (SPARC) were among those substrates we biochemically confirmed. An extracellular "moonlighting" form of vimentin is a chemoattractant for THP-1 cells, but MT6-MMP cleavage abolished monocyte recruitment. Unexpectedly, the MT6-MMP-cleaved vimentin potently stimulated phagocytosis, which was not a property of the full-length protein. Hence, MT6-MMP regulates neutrophil and monocyte chemotaxis and by generating "eat-me" signals upon vimentin cleavage potentially increases phagocytic removal of neutrophils to resolve inflammation.	[Overall, Christopher M.] Univ British Columbia, Ctr Blood Res, Life Sci Inst 4 401, Vancouver, BC V6T 1Z3, Canada; [Starr, Amanda E.; Overall, Christopher M.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Bellac, Caroline L.; Dufour, Antoine; Goebeler, Verena; Overall, Christopher M.] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Overall, CM (corresponding author), Univ British Columbia, Ctr Blood Res, Life Sci Inst 4 401, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	chris.overall@ubc.ca	Dufour, Antoine/AAB-7886-2019; Goebeler, Verena/K-4873-2012		Canadian Institutes of Health Research [STP-53877]; Natural Sciences and Engineering Research Council of Canada; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported in part by a Canadian Institutes of Health Research grant, an infrastructure grant from the Michael Smith Research Foundation (University of British Columbia Centre for Blood Research), and the British Columbia Proteomics Network.; Supported by the Natural Sciences and Engineering Research Council of Canada, the Michael Smith Foundation for Health Research, and Canadian Institutes of Health Research Strategic Training Program Grant STP-53877.	Almkvist J, 2002, GLYCOCONJUGATE J, V19, P575, DOI 10.1023/B:GLYC.0000014088.21242.e0; Andolfo A, 2002, THROMB HAEMOSTASIS, V88, P298; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f; Butler GS, 2004, J BIOL CHEM, V279, P15615, DOI 10.1074/jbc.M312727200; Chlenski A, 2010, SEMIN CELL DEV BIOL, V21, P55, DOI 10.1016/j.semcdb.2009.11.018; ClarkLewis I, 1997, METHOD ENZYMOL, V287, P233; Clemmons DR, 2007, J CLIN ENDOCR METAB, V92, P2652, DOI 10.1210/jc.2006-2699; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Cox JH, 2008, J BIOL CHEM, V283, P19389, DOI 10.1074/jbc.M800266200; Cox JH, 2010, ARTHRITIS RHEUM-US, V62, P3645, DOI 10.1002/art.27757; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; Dean RA, 2007, MOL CELL PROTEOMICS, V6, P611, DOI 10.1074/mcp.M600341-MCP200; English WR, 2001, FEBS LETT, V491, P137, DOI 10.1016/S0014-5793(01)02150-0; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fortin CF, 2010, INT IMMUNOL, V22, P637, DOI 10.1093/intimm/dxq048; Guzik K, 2007, CELL DEATH DIFFER, V14, P171, DOI 10.1038/sj.cdd.4401927; Guzik K, 2008, BIOCHIMIE, V90, P405, DOI 10.1016/j.biochi.2007.09.008; Kang TB, 2001, J BIOL CHEM, V276, P21960, DOI 10.1074/jbc.M007997200; Keller UAD, 2010, MOL CELL PROTEOMICS, V9, P912, DOI 10.1074/mcp.M000032-MCP201; Kennedy AD, 2009, IMMUNOL RES, V43, P25, DOI 10.1007/s12026-008-8049-6; King AG, 2000, J IMMUNOL, V164, P3774, DOI 10.4049/jimmunol.164.7.3774; Kleifeld O, 2011, NAT PROTOC, V6, P1578, DOI 10.1038/nprot.2011.382; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; Kojima S, 2000, FEBS LETT, V480, P142, DOI 10.1016/S0014-5793(00)01919-0; Laurence JS, 1998, BIOCHEMISTRY-US, V37, P9346, DOI 10.1021/bi980329l; LIU XJ, 1993, ENDOCRINOLOGY, V132, P1176, DOI 10.1210/en.132.3.1176; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Malik RKJ, 2009, GLYCOBIOLOGY, V19, P1402, DOI 10.1093/glycob/cwp077; Matsuda A, 2003, J BIOL CHEM, V278, P36350, DOI 10.1074/jbc.M301509200; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Moisan E, 2006, J LEUKOCYTE BIOL, V79, P489, DOI 10.1189/jlb.0405190; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Mortier A, 2011, EXP CELL RES, V317, P642, DOI 10.1016/j.yexcr.2010.11.016; Nie J, 2004, EXP CELL RES, V296, P145, DOI 10.1016/j.yexcr.2004.02.008; Nufer O, 1999, BIOCHEMISTRY-US, V38, P636, DOI 10.1021/bi981294s; Oppenheim JJ, 2005, J LEUKOCYTE BIOL, V77, P854, DOI 10.1189/jlb.1004623; Parente L, 2004, INFLAMM RES, V53, P125, DOI 10.1007/s00011-003-1235-z; Pedrioli PGA, 2010, METHODS MOL BIOL, V604, P213, DOI 10.1007/978-1-60761-444-9_15; Pei DQ, 1999, CELL RES, V9, P291, DOI 10.1038/sj.cr.7290028; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Prudova A, 2010, MOL CELL PROTEOMICS, V9, P894, DOI 10.1074/mcp.M000050-MCP201; Radichev IA, 2010, J BIOL CHEM, V285, P16076, DOI 10.1074/jbc.M110.107094; REINEMER P, 1994, FEBS LETT, V338, P227, DOI 10.1016/0014-5793(94)80370-6; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Schilling O, 2011, BIOL CHEM, V392, P1031, DOI 10.1515/BC.2011.158; Schilling O, 2011, NAT PROTOC, V6, P111, DOI 10.1038/nprot.2010.178; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shiryaev SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004952; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Starr AE, 2012, J BIOL CHEM, V287, P5848, DOI 10.1074/jbc.M111.314609; Starr AE, 2009, METHOD ENZYMOL, V461, P281, DOI 10.1016/S0076-6879(09)05413-5; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Van den Steen PE, 2003, EUR J BIOCHEM, V270, P3739, DOI 10.1046/j.1432-1033.2003.03760.x; Wuyts A, 1999, J IMMUNOL, V163, P6155; Zhang KY, 2003, NAT NEUROSCI, V6, P1064, DOI 10.1038/nn1127; Zhao HR, 2008, J BIOL CHEM, V283, P35023, DOI 10.1074/jbc.M806553200	62	65	65	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13382	13395		10.1074/jbc.M111.314179	http://dx.doi.org/10.1074/jbc.M111.314179			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367194	Green Published, hybrid			2022-12-27	WOS:000302903700073
J	Noguchi, S; Mori, T; Otsuka, Y; Yamada, N; Yasui, Y; Iwasaki, J; Kumazaki, M; Maruo, K; Akao, Y				Noguchi, Shunsuke; Mori, Takashi; Otsuka, Yusami; Yamada, Nami; Yasui, Yuki; Iwasaki, Junya; Kumazaki, Minami; Maruo, Kohji; Akao, Yukihiro			Anti-oncogenic MicroRNA-203 Induces Senescence by Targeting E2F3 Protein in Human Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR ZBP-89; MALIGNANT-MELANOMA; EMERGING ROLES; EXPRESSION; CANCER; APOPTOSIS; PROLIFERATION; PATHWAY; GROWTH; MECHANISM	MicroRNAs regulate gene expression by repressing translation or directing sequence-specific degradation of their complementary mRNA. We recently reported that miR-203 is down-regulated, and its exogenous expression inhibits cell growth in canine oral malignant melanoma tissue specimens as well as in canine and human malignant melanoma cells. A microRNA target database predicted E2F3 and ZBP-89 as putative targets of microRNA-203 (miR-203). The expression levels of E2F3a, E2F3b, and ZBP-89 were markedly up-regulated in human malignant melanoma Mewo cells compared with those in human epidermal melanocytes. miR-203 significantly suppressed the luciferase activity of reporter plasmids containing the 3'-UTR sequence of either E2F3 or ZBP-89 complementary to miR-203. The ectopic expression of miR-203 in melanoma cells reduced the levels of E2F3a, E2F3b, and ZBP-89 protein expression. At the same time, miR-203 induced cell cycle arrest and senescence phenotypes, such as elevated expression of hypophosphorylated retinoblastoma and other markers for senescence. Silencing of E2F3, but not of ZBP-89, inhibited cell growth and induced cell cycle arrest and senescence. These results demonstrate a novel role for miR-203 as a tumor suppressor acting by inducing senescence in melanoma cells.	[Noguchi, Shunsuke; Yamada, Nami; Yasui, Yuki; Iwasaki, Junya; Kumazaki, Minami; Akao, Yukihiro] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu 5011193, Japan; [Noguchi, Shunsuke; Yamada, Nami] Gifu Univ, United Grad Sch Vet Sci, Gifu 5011193, Japan; [Mori, Takashi; Otsuka, Yusami; Maruo, Kohji] Gifu Univ, Fac Appl Biol Sci, Dept Vet Clin Oncol, Gifu 5011193, Japan; [Otsuka, Yusami; Maruo, Kohji; Akao, Yukihiro] Gifu Univ, Comparat Canc Ctr, Gifu 5011193, Japan; [Yasui, Yuki; Iwasaki, Junya; Kumazaki, Minami] Gifu Univ, Fac Engn, Dept Biomol Sci, Gifu 5011193, Japan	Gifu University; Gifu University; Gifu University; Gifu University; Gifu University	Akao, Y (corresponding author), Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, 1-1 Yanagido, Gifu 5011193, Japan.	yakao@gifu-u.ac.jp		Yamada, Nami/0000-0002-1220-0814				Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cannell IG, 2008, BIOCHEM SOC T, V36, P1224, DOI 10.1042/BST0361224; Chen DN, 2009, NATURE, V462, P925, DOI 10.1038/nature08544; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Dar AA, 2011, J BIOL CHEM, V286, P16606, DOI 10.1074/jbc.M111.227611; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Eggermont A. M., 2011, EUR J CANCER, V104, P397; Feng YP, 2009, FEBS J, V276, P4197, DOI 10.1111/j.1742-4658.2009.07128.x; Gorospe M, 2011, TRENDS GENET, V27, P233, DOI 10.1016/j.tig.2011.03.005; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Ho CK, 2005, BRIT J DERMATOL, V153, P900, DOI 10.1111/j.1365-2133.2005.06810.x; Hurst CD, 2008, ONCOGENE, V27, P2716, DOI 10.1038/sj.onc.1210934; Bueno MJ, 2011, BBA-MOL BASIS DIS, V1812, P592, DOI 10.1016/j.bbadis.2011.02.002; Kaddar T, 2009, BIOL CELL, V101, P511, DOI 10.1042/BC20080213; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; Liu FJ, 2012, AGEING RES REV, V11, P41, DOI 10.1016/j.arr.2011.06.001; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Macleod K, 1999, CURR OPIN GENET DEV, V9, P31, DOI 10.1016/S0959-437X(99)80005-7; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Noguchi S., 2012, VET COMP ON IN PRESS; Noguchi S, 2012, J VET MED SCI, V74, P1, DOI 10.1292/jvms.11-0264; Noguchi S, 2011, CANCER LETT, V307, P211, DOI 10.1016/j.canlet.2011.04.005; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pacheco I, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S146239941100202X; Russo AE, 2009, INT J ONCOL, V34, P1481, DOI 10.3892/ijo_00000277; Smedley D, 2000, GENE CHROMOSOME CANC, V28, P121, DOI 10.1002/(SICI)1098-2264(200005)28:1<121::AID-GCC14>3.0.CO;2-O; Sun BS, 2008, HEPATOLOGY, V48, P1834, DOI 10.1002/hep.22531; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Udelhoven M, 2010, J ENDOCRINOL, V204, P199, DOI 10.1677/JOE-09-0266; Uziel T, 2009, P NATL ACAD SCI USA, V106, P2812, DOI 10.1073/pnas.0809579106; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Zhang CZY, 2010, BBA-REV CANCER, V1806, P36, DOI 10.1016/j.bbcan.2010.03.002; Zhang J, 2009, BLOOD, V113, P4586, DOI 10.1182/blood-2008-09-178186	37	92	97	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11769	11777		10.1074/jbc.M111.325027	http://dx.doi.org/10.1074/jbc.M111.325027			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22354972	Green Published, hybrid			2022-12-27	WOS:000302782200016
J	Wu, D; Chapman, JR; Wang, LF; Harris, TE; Shabanowitz, J; Hunt, DF; Fu, Z				Wu, Di; Chapman, Jessica R.; Wang, Lifu; Harris, Thurl E.; Shabanowitz, Jeffrey; Hunt, Donald F.; Fu, Zheng			Intestinal Cell Kinase (ICK) Promotes Activation of mTOR Complex 1 (mTORC1) through Phosphorylation of Raptor Thr-908	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; MAP KINASE; CYCLE PROGRESSION; MOLECULAR-CLONING; SEQUENCE-ANALYSIS; RAPAMYCIN MTOR; GENE-PRODUCTS; RAG GTPASES; GROWTH; INSULIN	Intestinal cell kinase (ICK), named after its cloning origin, the intestine, is actually a ubiquitously expressed and highly conserved serine/threonine protein kinase. Recently we reported that ICK supports cell proliferation and G(1) cell cycle progression. ICK deficiency significantly disrupted the mammalian target of rapamycin (mTOR) complex 1 (mTORC1) signaling events. However, the biological substrates that mediate the downstream signaling effects of ICK in proliferation and the molecular mechanisms by which ICK interacts with mTORC1 are not well defined. Our prior studies also provided biochemical evidence that ICK interacts with the mTOR/Raptor complex in cells and phosphorylates Raptor in vitro. In this report, we investigated whether and how ICK targets Raptor to regulate the activity of mTORC1. Using the ICK substrate consensus sequence [R-P-X-S/T-P/A/T/S], we identified a putative phosphorylation site, RPGT908T, for ICK in human Raptor. By mass spectrometry and a phospho-specific antibody, we showed that Raptor Thr-908 is a novel in vivo phosphorylation site. ICK is able to phosphorylate Raptor Thr-908 both in vitro and in vivo and when Raptor exists in protein complexes with or without mTOR. Although expression of the Raptor T908A mutant did not affect the mTORC1 integrity, it markedly impaired the mTORC1 activation by insulin or by overexpression of the small GTP-binding protein RheB under nutrient starvation. Our findings demonstrate an important role for ICK in modulating the activity of mTORC1 through phosphorylation of Raptor Thr-908 and thus implicate a potential signaling mechanism by which ICK regulates cell proliferation and division.	[Wu, Di; Fu, Zheng] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Chapman, Jessica R.; Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22908 USA; [Hunt, Donald F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA; [Wang, Lifu; Harris, Thurl E.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Fu, Zheng] Univ Virginia, Digest Hlth Res Ctr, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Fu, Z (corresponding author), Univ Virginia, Dept Med, POB 800708,2 Jefferson Pk Ave,Lee St,MSB 2091, Charlottesville, VA 22908 USA.	zf6n@virginia.edu	wang, lifu/E-1436-2012; Hunt, Donald F/I-6936-2012	Hunt, Donald F/0000-0003-2815-6368; /0000-0002-4080-8667	National Institutes of Health [DK082614, GM37537]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK082614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK082614 (to Z. F.) and GM37537 (to D. F. H.).	Abe S, 1995, ONCOGENE, V11, P2187; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Ekim B, 2011, MOL CELL BIOL, V31, P2787, DOI 10.1128/MCB.05437-11; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637; Fu Z, 2005, MOL CELL BIOL, V25, P6047, DOI 10.1128/MCB.25.14.6047-6064.2005; Fu Z, 2006, MOL CELL BIOL, V26, P8639, DOI 10.1128/MCB.00816-06; Fu Z, 2009, AM J PHYSIOL-GASTR L, V297, pG632, DOI 10.1152/ajpgi.00066.2009; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009; Hanrahan J, 2006, METHOD ENZYMOL, V407, P542, DOI 10.1016/S0076-6879(05)07044-8; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hinds TD, 2008, INT J BIOCHEM CELL B, V40, P2358, DOI 10.1016/j.biocel.2007.08.010; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2003, CURR TOP MICROBIOL, V279, P259; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Lahiry P, 2009, AM J HUM GENET, V84, P134, DOI 10.1016/j.ajhg.2008.12.017; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Liu Y, 2004, J BIOL CHEM, V279, P4507, DOI 10.1074/jbc.M309995200; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma AH, 2006, CANCER RES, V66, P8439, DOI 10.1158/0008-5472.CAN-06-1636; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MATSUSHIME H, 1990, MOL CELL BIOL, V10, P2261, DOI 10.1128/MCB.10.5.2261; Miyata Y, 1999, GENES CELLS, V4, P299, DOI 10.1046/j.1365-2443.1999.00261.x; Miyata Y, 1999, BIOCHEM BIOPH RES CO, V266, P291, DOI 10.1006/bbrc.1999.1705; Nascimento Emmani B. M., 2009, Archives of Physiology and Biochemistry, V115, P163, DOI 10.1080/13813450902988580; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Proud CG, 2004, BIOCHEM BIOPH RES CO, V313, P429, DOI 10.1016/j.bbrc.2003.07.015; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; Shinkai Y, 2002, MOL CELL BIOL, V22, P3276, DOI 10.1128/MCB.22.10.3276-3280.2002; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Togawa K, 2000, J CELL PHYSIOL, V183, P129, DOI 10.1002/(SICI)1097-4652(200004)183:1<129::AID-JCP15>3.0.CO;2-S; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200; Wang L, 2009, J BIOL CHEM, V284, P14693, DOI 10.1074/jbc.C109.002907; Wohlbold L, 2006, CELL CYCLE, V5, P546, DOI 10.4161/cc.5.5.2541; Xia L, 2002, J BIOL CHEM, V277, P35422, DOI 10.1074/jbc.M203940200	50	24	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12510	12519		10.1074/jbc.M111.302117	http://dx.doi.org/10.1074/jbc.M111.302117			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22356909	hybrid, Green Published			2022-12-27	WOS:000302782200090
J	Sanchez, EJ; Lewis, KM; Danna, BR; Kang, C				Sanchez, Emiliano J.; Lewis, Kevin M.; Danna, Benjamin R.; Kang, ChulHee			High-capacity Ca2+ Binding of Human Skeletal Calsequestrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE CHANNEL; CARDIAC CALSEQUESTRIN; SARCOPLASMIC-RETICULUM; MUSCLE; PHOSPHORYLATION; MECHANISM; JUNCTIN; DOMAIN; STORE; ROLES	Calsequestrin, the major calcium storage protein in both cardiac and skeletal muscle, binds large amounts of Ca2+ in the sarcoplasmic reticulum and releases them during muscle contraction. For the first time, the crystal structures of Ca2+ complexes for both human (hCASQ1) and rabbit (rCASQ1) skeletal calsequestrin were determined, clearly defining their Ca2+ sequestration capabilities through resolution of high- and low-affinity Ca2+-binding sites. rCASQ1 crystallized in low CaCl2 buffer reveals three high-affinity Ca2+ sites with trigonal bipyramidal, octahedral, and pentagonal bipyramidal coordination geometries, along with three low-affinity Ca2+ sites. hCASQ1 crystallized in high CaCl2 shows 15 Ca2+ ions, including the six Ca2+ ions in rCASQ1. Most of the low-affinity sites, some of which are mu-carboxylate-bridged, are established by the rotation of dimer interfaces, indicating cooperative Ca2+ binding that is consistent with our atomic absorption spectroscopic data. On the basis of these findings, we propose a mechanism for the observed in vitro and in vivo dynamic high-capacity and low-affinity Ca2+-binding activity of calsequestrin.	[Sanchez, Emiliano J.; Danna, Benjamin R.; Kang, ChulHee] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Lewis, Kevin M.; Kang, ChulHee] Washington State Univ, Dept Chem, Pullman, WA 99164 USA	Washington State University; Washington State University	Kang, C (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	chkang@wsu.edu		Kang, ChulHee/0000-0002-0693-7860; Lewis, Kevin/0000-0003-3403-9520	American Heart Association [850084Z]; National Science Foundations [MCB 1021148, DBI 0959778]; M. J. Murdock Charitable Trust	American Heart Association(American Heart Association); National Science Foundations(National Science Foundation (NSF)); M. J. Murdock Charitable Trust	This work was supported by American Heart Association Grant 850084Z, National Science Foundations Grants MCB 1021148 and DBI 0959778, and the M. J. Murdock Charitable Trust.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001; Dainese M, 2009, FASEB J, V23, P1710, DOI 10.1096/fj.08-121335; Dulhunty A, 2009, J PHYSIOL-LONDON, V587, P3135, DOI 10.1113/jphysiol.2009.171959; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; FRANZINIARMSTRONG C, 1987, J CELL BIOL, V105, P49, DOI 10.1083/jcb.105.1.49; Gyorke S, 2009, J PHYSIOL-LONDON, V587, P3091, DOI 10.1113/jphysiol.2009.172049; HARDMAN KD, 1982, J MOL BIOL, V157, P69, DOI 10.1016/0022-2836(82)90513-7; Kang CH, 2010, EUR J PHARMACOL, V646, P12, DOI 10.1016/j.ejphar.2010.08.001; Kim E, 2007, J MOL BIOL, V373, P1047, DOI 10.1016/j.jmb.2007.08.055; Knollmann BC, 2009, J PHYSIOL-LONDON, V587, P3081, DOI 10.1113/jphysiol.2009.172098; Lee KW, 2012, J BIOL CHEM, V287, P1679, DOI 10.1074/jbc.M111.254045; MacLennan DH, 2009, J PHYSIOL-LONDON, V587, P3113, DOI 10.1113/jphysiol.2009.172155; MacLennan DH, 1998, NAT STRUCT BIOL, V5, P409, DOI 10.1038/nsb0698-409; Meissner G, 2009, J PHYSIOL-LONDON, V587, P3089, DOI 10.1113/jphysiol.2009.171835; Nori A, 2000, EXP CELL RES, V260, P40, DOI 10.1006/excr.2000.4989; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park HJ, 2003, J BIOL CHEM, V278, P16176, DOI 10.1074/jbc.M300120200; Park HJ, 2004, J BIOL CHEM, V279, P18026, DOI 10.1074/jbc.M311553200; Protasi F, 2009, J PHYSIOL-LONDON, V587, P3095, DOI 10.1113/jphysiol.2009.171967; Royer L, 2009, J PHYSIOL-LONDON, V587, P3101, DOI 10.1113/jphysiol.2009.171934; Sanchez EJ, 2012, J BIOL CHEM, V287, P3042, DOI 10.1074/jbc.M111.326363; Sanchez EJ, 2011, MOL CELL BIOCHEM, V353, P195, DOI 10.1007/s11010-011-0787-4; SORIANOGARCIA M, 1992, BIOCHEMISTRY-US, V31, P2554, DOI 10.1021/bi00124a016; Terentyev D, 2006, CIRC RES, V98, P1151, DOI 10.1161/01.RES.0000220647.93982.08; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476	27	45	48	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11592	11601		10.1074/jbc.M111.335075	http://dx.doi.org/10.1074/jbc.M111.335075			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22337878	Green Published, hybrid			2022-12-27	WOS:000302780100086
J	Trip, H; Mulder, NL; Lolkema, JS				Trip, Hein; Mulder, Niels L.; Lolkema, Juke S.			Improved Acid Stress Survival of Lactococcus lactis Expressing the Histidine Decarboxylation Pathway of Streptococcus thermophilus CHCC1524	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-MOTIVE FORCE; TRANSCRIPTIONAL ANALYSIS; LACTOBACILLUS-BUCHNERI; ESCHERICHIA-COLI; BIOGENIC-AMINES; RESISTANCE; MECHANISM; ARGININE; OPERON; GENERATION	Background: Degradative amino acid decarboxylation pathways in bacteria have diverse physiological functions. Results: A histidine decarboxylation pathway introduced in L. lactis improves acid stress survival, and synergy with the glycolytic pathway is demonstrated. Conclusion: The physiological benefit of the new pathway is strongly dependent on the properties of the host organism. Significance: Acquisition of the histidine decarboxylation pathway mimics successful horizontal gene transfer.	[Trip, Hein; Mulder, Niels L.; Lolkema, Juke S.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands	University of Groningen	Lolkema, JS (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands.	j.s.lolkema@rug.nl			European Community [211441-BIAMFOOD]; Netherlands Organization for Scientific Research (NWO-ALW)	European Community(European Commission); Netherlands Organization for Scientific Research (NWO-ALW)(Netherlands Organization for Scientific Research (NWO))	This work was supported by European Community Seventh Framework Programme Grant Agreement No. 211441-BIAMFOOD and by The Netherlands Organization for Scientific Research (NWO-ALW).	Abe K, 2002, J BACTERIOL, V184, P2906, DOI 10.1128/JB.184.11.2906-2913.2002; Abe K, 1996, J BIOL CHEM, V271, P3079, DOI 10.1074/jbc.271.6.3079; Calles-Enriquez M, 2010, APPL ENVIRON MICROB, V76, P6231, DOI 10.1128/AEM.00827-10; Coton E, 2010, APPL ENVIRON MICROB, V76, P5570, DOI 10.1128/AEM.00441-10; Coton M, 2011, MICROBIOL-SGM, V157, P1841, DOI 10.1099/mic.0.046367-0; Cotter PD, 2001, MOL MICROBIOL, V40, P465, DOI 10.1046/j.1365-2958.2001.02398.x; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Fernandez M, 2006, CRIT REV MICROBIOL, V32, P155, DOI 10.1080/10408410600880643; Giles TN, 2007, J BACTERIOL, V189, P7376, DOI 10.1128/JB.00772-07; Gong S, 2003, J BACTERIOL, V185, P4402, DOI 10.1128/JB.185.15.4402-4409.2003; Guimont C, 2002, INT DAIRY J, V12, P729, DOI 10.1016/S0958-6946(02)00068-7; GUIRARD BM, 1980, J BIOL CHEM, V255, P5960; Kieboom J, 2006, J BACTERIOL, V188, P5650, DOI 10.1128/JB.00323-06; Lucas PM, 2007, MICROBIOL-SGM, V153, P2221, DOI 10.1099/mic.0.2007/006320-0; Lucas PM, 2005, APPL ENVIRON MICROB, V71, P1417, DOI 10.1128/AEM.71.3.1417-1424.2005; Martin MC, 2005, MICROBIOL-SGM, V151, P1219, DOI 10.1099/mic.0.27459-0; MATSUMOTO T, 1984, ANAL BIOCHEM, V138, P133, DOI 10.1016/0003-2697(84)90780-2; MOLENAAR D, 1991, BIOCHIM BIOPHYS ACTA, V1115, P75, DOI 10.1016/0304-4165(91)90014-8; MOLENAAR D, 1993, J BACTERIOL, V175, P2864, DOI 10.1128/JB.175.10.2864-2870.1993; Pereira CI, 2009, J APPL MICROBIOL, V107, P1894, DOI 10.1111/j.1365-2672.2009.04371.x; Pereira CI, 2009, APPL ENVIRON MICROB, V75, P345, DOI 10.1128/AEM.01958-08; POOLMAN B, 1987, MICROBIOL REV, V51, P498, DOI 10.1128/MMBR.51.4.498-508.1987; Rossi F, 2011, APPL ENVIRON MICROB, V77, P2817, DOI 10.1128/AEM.02531-10; Sanders JW, 1998, MOL MICROBIOL, V27, P299, DOI 10.1046/j.1365-2958.1998.00676.x; Santos MHS, 1996, INT J FOOD MICROBIOL, V29, P213, DOI 10.1016/0168-1605(95)00032-1; SIP M, 1990, J PHOTOCH PHOTOBIO B, V4, P321, DOI 10.1016/1011-1344(90)85037-W; Soksawatmaekhin W, 2004, MOL MICROBIOL, V51, P1401, DOI 10.1046/j.1365-2958.2003.03913.x; Spano G, 2010, EUR J CLIN NUTR, V64, pS95, DOI 10.1038/ejcn.2010.218; Tanaka Y, 2008, J APPL MICROBIOL, V104, P1283, DOI 10.1111/j.1365-2672.2007.03652.x; Trip H, 2011, MOL MICROBIOL, V79, P861, DOI 10.1111/j.1365-2958.2010.07492.x; VANPOELJE PD, 1990, ANNU REV BIOCHEM, V59, P29, DOI 10.1146/annurev.bi.59.070190.000333; Wolken WAM, 2006, J BACTERIOL, V188, P2198, DOI 10.1128/JB.188.6.2198-2206.2006; Zhao BY, 2010, BIOCHEM CELL BIOL, V88, P301, DOI [10.1139/O09-182, 10.1139/o09-182]	33	35	39	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11195	11204		10.1074/jbc.M111.330704	http://dx.doi.org/10.1074/jbc.M111.330704			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22351775	Green Published, hybrid			2022-12-27	WOS:000302780100047
J	Nambi, S; Badireddy, S; Visweswariah, SS; Anand, GS				Nambi, Subhalaxmi; Badireddy, Suguna; Visweswariah, Sandhya S.; Anand, Ganesh S.			Cyclic AMP-induced Conformational Changes in Mycobacterial Protein Acetyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP-BINDING; KINASE-A; REGULATORY SUBUNIT; ALLOSTERIC CONTROL; CGMP-BINDING; RI-ALPHA; TUBERCULOSIS; ACTIVATION; PRECURSOR; ANCIENT	The activities of a number of proteins are regulated by the binding of cAMP and cGMP to cyclic nucleotide binding (CNB) domains that are found associated with one or more effector domains with diverse functions. Although the conserved architecture of CNB domains has been extensively studied by x-ray crystallography, the key to unraveling the mechanisms of cAMP action has been protein dynamics analyses. Recently, we have identified a novel cAMP-binding protein from mycobacteria, where cAMP regulates the activity of an associated protein acetyltransferase domain. In the current study, we have monitored the conformational changes that occur upon cAMP binding to the CNB domain in these proteins, using a combination of bioluminescence resonance energy transfer and amide hydrogen/deuterium exchange mass spectrometry. Coupled with mutational analyses, our studies reveal the critical role of the linker region (positioned between the CNB domain and the acetyltransferase domain) in allosteric coupling of cAMP binding to activation of acetyltransferase catalysis. Importantly, major differences in conformational change upon cAMP binding were accompanied by stabilization of the CNB and linker domain alone. This is in contrast to other cAMP-binding proteins, where cyclic nucleotide binding has been shown to involve intricate and parallel allosteric relays. Finally, this powerful convergence of results from bioluminescence resonance energy transfer and hydrogen/deuterium exchange mass spectrometry reaffirms the power of solution biophysical tools in unraveling mechanistic bases of regulation of proteins in the absence of high resolution structural information.	[Nambi, Subhalaxmi; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Badireddy, Suguna; Anand, Ganesh S.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Indian Institute of Science (IISC) - Bangalore; National University of Singapore	Visweswariah, SS (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India.	sandhya@mrdg.iisc.ernet.in; dbsgsa@nus.edu.sg	Visweswariah, Sandhya/Q-7500-2019; Anand, Ganesh/H-8473-2012	Visweswariah, Sandhya/0000-0003-2786-7344; Nambi, Subhalaxmi/0000-0001-7104-659X	Department of Biotechnology, Government of India; Academic Research Council, National University of Singapore (NUS); Singapore and Waters Center of Innovation Program	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Academic Research Council, National University of Singapore (NUS); Singapore and Waters Center of Innovation Program	This work was supported by funds from the Department of Biotechnology, Government of India (to S. S. V.) and the Academic Research Council, National University of Singapore (NUS), Singapore and Waters Center of Innovation Program (to G. S. A.). Support for personnel exchanges between laboratories was from the NUS-India Research Initiative.	Abu-Abed M, 2007, PROTEINS, V69, P112, DOI 10.1002/prot.21446; Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Anand GS, 2010, MOL CELL PROTEOMICS, V9, P2225, DOI 10.1074/mcp.M900388-MCP200; Anand GS, 2002, J MOL BIOL, V323, P377, DOI 10.1016/S0022-2836(02)00919-1; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Badireddy S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.110.004390; Bai GC, 2005, J BACTERIOL, V187, P7795, DOI 10.1128/JB.187.22.7795-7804.2005; Bai GC, 2009, FEMS IMMUNOL MED MIC, V55, P68, DOI 10.1111/j.1574-695X.2008.00500.x; Bateman RH, 2002, J AM SOC MASS SPECTR, V13, P792, DOI 10.1016/S1044-0305(02)00420-8; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Biswas KH, 2011, J BIOL CHEM, V286, P8545, DOI 10.1074/jbc.M110.193185; Biswas KH, 2008, BIOCHEMISTRY-US, V47, P3534, DOI 10.1021/bi702025w; Brock M, 2007, J BIOL CHEM, V282, P32256, DOI 10.1074/jbc.M706231200; Das R, 2007, P NATL ACAD SCI USA, V104, P93, DOI 10.1073/pnas.0609033103; Das R, 2007, J BIOL CHEM, V282, P581, DOI 10.1074/jbc.M607706200; Das R, 2008, J BIOL CHEM, V283, P19691, DOI 10.1074/jbc.M802164200; Dass BKM, 2008, J BACTERIOL, V190, P3824, DOI 10.1128/JB.00138-08; DOSTMANN WRG, 1991, BIOCHEMISTRY-US, V30, P8710, DOI 10.1021/bi00099a032; Engen JR, 2008, CELL MOL LIFE SCI, V65, P3058, DOI 10.1007/s00018-008-8122-2; Gazdik MA, 2009, MOL MICROBIOL, V71, P434, DOI 10.1111/j.1365-2958.2008.06541.x; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Gibson RM, 1997, J BIOL CHEM, V272, P16343, DOI 10.1074/jbc.272.26.16343; Gould CM, 2009, J BIOL CHEM, V284, P4921, DOI 10.1074/jbc.M808436200; Hamuro Y, 2004, J MOL BIOL, V340, P1185, DOI 10.1016/j.jmb.2004.05.042; Harper SM, 2008, J BIOL CHEM, V283, P6501, DOI 10.1074/jbc.M707849200; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Kalamidas SA, 2006, J CELL SCI, V119, P3686, DOI 10.1242/jcs.03091; Kannan N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r264; Kornev AP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000056; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; Mandell JG, 2001, J MOL BIOL, V306, P575, DOI 10.1006/jmbi.2000.4416; Nambi S, 2010, J BIOL CHEM, V285, P24313, DOI 10.1074/jbc.M110.118398; Osborne BW, 2011, STRUCTURE, V19, P1317, DOI 10.1016/j.str.2011.06.012; Petersen TN, 2000, PROTEINS, V41, P17, DOI 10.1002/1097-0134(20001001)41:1<17::AID-PROT40>3.0.CO;2-F; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Podobnik M, 2009, J BIOL CHEM, V284, P32846, DOI 10.1074/jbc.M109.049635; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Rickman L, 2005, MOL MICROBIOL, V56, P1274, DOI 10.1111/j.1365-2958.2005.04609.x; Saha S, 2009, J BIOL CHEM, V284, P27135, DOI 10.1074/jbc.M109.020032; Schultz Joachim E., 2009, V191, P93, DOI 10.1007/978-3-540-68964-5_6; Schwede F, 2000, PHARMACOL THERAPEUT, V87, P199, DOI 10.1016/S0163-7258(00)00051-6; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; SHABB JB, 1990, J BIOL CHEM, V265, P16031; Shen Z, 2009, MOL CELL PROTEOMICS, V8, P2443, DOI 10.1074/mcp.M900187-MCP200; Shenoy AR, 2005, BIOCHEMISTRY-US, V44, P15695, DOI 10.1021/bi0512391; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Shenoy AR, 2006, FEBS LETT, V580, P3344, DOI 10.1016/j.febslet.2006.05.034; Shenoy AR, 2006, TRENDS MICROBIOL, V14, P543, DOI 10.1016/j.tim.2006.10.005; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Stapleton M, 2010, J BIOL CHEM, V285, P7016, DOI 10.1074/jbc.M109.047720; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; VanSchouwen B, 2011, J BIOL CHEM, V286, P42655, DOI 10.1074/jbc.M111.277723; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025; Xu H, 2011, BIOCHEMISTRY-US, V50, P5883, DOI 10.1021/bi200156t	58	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2012	287	22					18115	18129		10.1074/jbc.M111.328112	http://dx.doi.org/10.1074/jbc.M111.328112			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	974EC	22447926	Green Published, hybrid			2022-12-27	WOS:000306411600020
J	Chen, J; Guo, KX; Kastan, MB				Chen, Jing; Guo, Kexiao; Kastan, Michael B.			Interactions of Nucleolin and Ribosomal Protein L26 (RPL26) in Translational Control of Human p53 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; BINDING PROTEINS; GENE-EXPRESSION; RECOGNITION; IRRADIATION; ACTIVATION; REPRESSION; INDUCTION	Ribosomal protein RPL26 enhances p53 translation after DNA damage, and this regulation depends upon interactions between the 5'- and 3'-UTRs of human p53 mRNA (Takagi, M., Absalon, M. J., McLure, K. G., and Kastan, M. B. (2005) Cell 123, 49-63; Chen, J., and Kastan, M. B. (2010) Genes Dev. 24, 2146-2156). In contrast, nucleolin (NCL) suppresses the translation of p53 mRNA and its induction after DNA damage. We confirmed reports that RPL26 and NCL interact with each other and then explored the potential role of this interaction in the translational control of p53 after stress. NCL repression of p53 translation utilizes both the 5'- and 3'-UTRs of p53 mRNA, and NCL binds to the same 5'-3'-UTR interaction region that is critical for the recruitment of RPL26 to p53 mRNA after DNA damage. We also found that NCL is able to oligomerize, consistent with a model in which NCL stabilizes this double-stranded RNA structure. We found that the RNA-binding domain of NCL participates in binding to p53 mRNA, is required for both NCL dimerization and NCL-mediated translational repression, and is the domain of NCL that interacts with RPL26. Excessive RPL26 disrupts NCL dimerization, and point mutations in the NCL-interacting region of RPL26 reduce NCL-RPL26 interactions and attenuate both RPL26 binding to human p53 mRNA and p53 induction by RPL26. These observations suggest a model in which the base pairings in the p53 UTR interaction regions are critical for both translational repression and stress induction of p53 by NCL and RPL26, respectively, and that disruption of a NCL-NCL homodimer by RPL26 may be the switch between translational repression and activation after stress.	[Chen, Jing; Guo, Kexiao; Kastan, Michael B.] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Kastan, MB (corresponding author), Duke Canc Inst, Dept Pharmacol & Canc Biol, Seeley Mudd Bldg,Mail Box 3917,10 Bryan Searle Dr, Durham, NC 27710 USA.	michael.kastan@duke.edu	Ogunwobi, Olorunseun/F-3172-2010		National Institutes of Health [R37ES05777, P50CA21765]; American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES005777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37ES05777 and P50CA21765. This work was also supported by the American Lebanese Syrian Associated Charities (ALSAC) of St. Jude Children's Research Hospital.	Allain FHT, 2000, EMBO J, V19, P6870, DOI 10.1093/emboj/19.24.6870; Ashcroft M, 1999, ONCOGENE, V18, P7637, DOI 10.1038/sj.onc.1203012; Bouvet P, 1997, EMBO J, V16, P5235, DOI 10.1093/emboj/16.17.5235; Bouvet P, 2001, J MOL BIOL, V309, P763, DOI 10.1006/jmbi.2001.4691; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chen J, 2010, GENE DEV, V24, P2146, DOI 10.1101/gad.1968910; DICKINSON LA, 1995, MOL CELL BIOL, V15, P456, DOI 10.1128/MCB.15.1.456; Fahling M, 2006, J BIOL CHEM, V281, P26089, DOI 10.1074/jbc.M604939200; Fu LN, 1997, EMBO J, V16, P4117, DOI 10.1093/emboj/16.13.4117; Ginisty H, 1999, J CELL SCI, V112, P761; Hall KB, 2002, CURR OPIN STRUC BIOL, V12, P283, DOI 10.1016/S0959-440X(02)00323-8; Hanakahi LA, 2000, BIOCHEMISTRY-US, V39, P15493, DOI 10.1021/bi001683y; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kishore S, 2010, BRIEF FUNCT GENOMICS, V9, P391, DOI 10.1093/bfgp/elq028; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Mongelard F, 2007, TRENDS CELL BIOL, V17, P80, DOI 10.1016/j.tcb.2006.11.010; Morelli X, 2011, CURR OPIN CHEM BIOL, V15, P475, DOI 10.1016/j.cbpa.2011.05.024; Mori M, 2011, CURR PHARM DESIGN, V17, P3713, DOI 10.2174/138161211798220972; MOSNER J, 1995, EMBO J, V14, P4442, DOI 10.1002/j.1460-2075.1995.tb00123.x; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Schumacher B, 2005, CELL, V120, P357, DOI 10.1016/j.cell.2004.12.009; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Thyagarajan B, 1998, SOMAT CELL MOLEC GEN, V24, P263, DOI 10.1023/B:SCAM.0000007129.98789.1f; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Westphal CH, 1998, CANCER RES, V58, P5637; Yanagida M, 2001, PROTEOMICS, V1, P1390, DOI 10.1002/1615-9861(200111)1:11<1390::AID-PROT1390>3.0.CO;2-Z; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251; Zhang J, 2008, CANCER RES, V68, P1046, DOI 10.1158/0008-5472.CAN-07-1927; Zhang YD, 2006, NUCLEIC ACIDS RES, V34, P485, DOI 10.1093/nar/gkj459	30	79	81	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16467	16476		10.1074/jbc.M112.349274	http://dx.doi.org/10.1074/jbc.M112.349274			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22433872	Green Published, hybrid			2022-12-27	WOS:000304030900037
J	Yu, LP; Phillips, RL; Zhang, DS; Teghanemt, A; Weiss, JP; Gioannini, TL				Yu, Liping; Phillips, Rachel L.; Zhang, DeSheng; Teghanemt, Athmane; Weiss, Jerrold P.; Gioannini, Theresa L.			NMR Studies of Hexaacylated Endotoxin Bound to Wild-type and F126A Mutant MD-2 and MD-2.TLR4 Ectodomain Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TLR4-MD-2 COMPLEX; TOLL-LIKE-RECEPTOR-4 ECTODOMAIN; LIPOPOLYSACCHARIDE RECOGNITION; NEISSERIA-MENINGITIDIS; MONOMERIC ENDOTOXIN; PROTEIN COMPLEXES; CELL ACTIVATION; INNATE IMMUNITY; RECEPTOR 4; LIPID IVA	Host response to invasion by many Gram-negative bacteria depends upon activation of Toll-like receptor 4 (TLR4) by endotoxin presented as a monomer bound to myeloid differentiation factor 2 (MD-2). Metabolic labeling of hexaacylated endotoxin (LOS) from Neisseria meningitidis with [C-13]acetate allowed the use of NMR to examine structural properties of the fatty acyl chains of LOS present in TLR4-agonistic and -antagonistic binary and ternary complexes with, respectively, wild-type or mutant (F126A) MD-2 +/- TLR4 ectodomain. Chemical shift perturbation indicates that Phe(126) affects the environment and/or position of each of the bound fatty acyl chains both in the binary LOS.MD-2 complex and in the ternary LOS.MD-2.TLR4 ectodomain complex. In both wild-type and mutant LOS.MD-2 complexes, one of the six fatty acyl chains of LOS is more susceptible to paramagnetic attenuation, suggesting protrusion of that fatty acyl chain from the hydrophobic pocket of MD-2, independent of association with TLR4. These findings indicate that re-orientation of the aromatic side chain of Phe(126) is induced by binding of hexaacylated E, preceding interaction with TLR4. This re-arrangement of Phe(126) may act as a "hydrophobic switch," driving agonist-dependent contacts needed for TLR4 dimerization and activation.	[Gioannini, Theresa L.] Dept Vet Affairs Med Ctr, Iowa City, IA 52246 USA; [Yu, Liping] Univ Iowa, Roy A & Lucille J Carver Coll Med, NMR Core Facil, Iowa City, IA 52241 USA; [Yu, Liping; Gioannini, Theresa L.] Univ Iowa, Roy A & Lucille J Carver Coll Med, Dept Biochem, Iowa City, IA 52241 USA; [Phillips, Rachel L.; Zhang, DeSheng; Teghanemt, Athmane; Weiss, Jerrold P.; Gioannini, Theresa L.] Univ Iowa, Roy A & Lucille J Carver Coll Med, Inflammat Program, Dept Internal Med, Iowa City, IA 52241 USA; [Weiss, Jerrold P.] Univ Iowa, Roy A & Lucille J Carver Coll Med, Dept Microbiol, Iowa City, IA 52241 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Gioannini, TL (corresponding author), Dept Vet Affairs Med Ctr, Iowa City, IA 52246 USA.	theresa-gioannini@uiowa.edu		Weiss, Jerrold/0000-0003-1476-4485; Yu, Liping/0000-0003-3536-6427	Dept. of Veterans' Affairs; NIAID, National Institutes of Health [AI05732]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059372] Funding Source: NIH RePORTER	Dept. of Veterans' Affairs(US Department of Veterans Affairs); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by grants from the Dept. of Veterans' Affairs, Merit Grant (to T. L. G.) and from NIAID, National Institutes of Health Grant AI05732 (to J. P. W.).	Akira SZ, 2009, P JPN ACAD B-PHYS, V85, P143, DOI 10.2183/pjab.85.143; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeMarco ML, 2011, MOL IMMUNOL, V49, P124, DOI 10.1016/j.molimm.2011.08.003; Esparza G. A., 2012, INNATE IMMU IN PRESS; Fitzgerald KA, 2006, CELL, V125, P834, DOI 10.1016/j.cell.2006.05.014; Giardina PC, 2001, J BIOL CHEM, V276, P5883, DOI 10.1074/jbc.M009273200; Gioannini TL, 2005, J ENDOTOXIN RES, V11, P117, DOI 10.1179/096805105X35198; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawasaki K, 2003, J IMMUNOL, V170, P413, DOI 10.4049/jimmunol.170.1.413; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Lewis K. E., 1992, J AM CHEM SOC, V114, P10663; Madl T, 2009, ANGEW CHEM INT EDIT, V48, P8259, DOI 10.1002/anie.200902561; Meng JM, 2011, J IMMUNOL, V187, P3683, DOI 10.4049/jimmunol.1101397; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Miyake K, 2003, INT IMMUNOPHARMACOL, V3, P119, DOI 10.1016/S1567-5769(02)00258-8; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Ostuni R, 2010, CELL MOL LIFE SCI, V67, P4109, DOI 10.1007/s00018-010-0464-x; Panter G, 2011, J BIOL CHEM, V286, P23334, DOI 10.1074/jbc.M110.205419; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pintacuda G, 2002, J AM CHEM SOC, V124, P372, DOI 10.1021/ja016985h; Post DMB, 2006, J ENDOTOXIN RES, V12, P93, DOI 10.1177/09680519060120020501; Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200; Resman N, 2009, J BIOL CHEM, V284, P15052, DOI 10.1074/jbc.M901429200; Respondek M, 2007, J AM CHEM SOC, V129, P5228, DOI 10.1021/ja069004f; Teghanemt A, 2005, J IMMUNOL, V175, P4669, DOI 10.4049/jimmunol.175.7.4669; Teghanemt A, 2008, J BIOL CHEM, V283, P21881, DOI 10.1074/jbc.M800672200; Teghanemt A, 2008, J BIOL CHEM, V283, P1257, DOI 10.1074/jbc.M705994200; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245; Wang Y, 2010, J BIOL CHEM, V285, P36836, DOI 10.1074/jbc.M110.167973; Yamamoto M, 2009, ADV EXP MED BIOL, V667, P59, DOI 10.1007/978-1-4419-1603-7_6	37	36	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16346	16355		10.1074/jbc.M112.343467	http://dx.doi.org/10.1074/jbc.M112.343467			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22433852	Green Published, hybrid			2022-12-27	WOS:000304030900026
J	Du, M; Wang, GZ; Ismail, TM; Gross, S; Fernig, DG; Barraclough, R; Rudland, PS				Du, Min; Wang, Guozheng; Ismail, Thamir M.; Gross, Stephane; Fernig, David G.; Barraclough, Roger; Rudland, Philip S.			S100P Dissociates Myosin IIA Filaments and Focal Adhesion Sites to Reduce Cell Adhesion and Enhance Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFETIME IMAGING MICROSCOPY; CALCIUM-BINDING PROTEIN; HEAVY-CHAIN PHOSPHORYLATION; METASTASIS-INDUCING PROTEIN; PANCREATIC-CANCER GROWTH; NONMUSCLE MYOSIN; BREAST-CANCER; MTS1 S100A4; IN-VITRO; CENTER STAGE	S100 proteins promote cancer cell migration and metastasis. To investigate their roles in the process of migration we have constructed inducible systems for S100P in rat mammary and human HeLa cells that show a linear relationship between its intracellular levels and cell migration. S100P, like S100A4, differentially interacts with the isoforms of nonmuscle myosin II (NMIIA, K-d = 0.5 mu M; IIB, K-d = 8 mu M; IIC, K-d = 1.0 mu M). Accordingly, S100P dissociates NMIIA and IIC filaments but not IIB in vitro. NMIIA knockdown increases migration in non-induced cells and there is no further increase upon induction of S100P, whereas NMIIB knockdown reduces cell migration whether or not S100P is induced. NMIIC knockdown does not affect S100P-enhanced cell migration. Further study shows that NMIIA physically interacts with S100P in living cells. In the cytoplasm, S100P occurs in discrete nodules along NMIIA-containing filaments. Induction of S100P causes more peripheral distribution of NMIIA filaments. This change is paralleled by a significant drop in vinculin-containing, actin-terminating focal adhesion sites ( FAS) per cell. The induction of S100P, consequently, causes significant reduction in cellular adhesion. Addition of a focal adhesion kinase ( FAK) inhibitor reduces disassembly of FAS and thereby suppresses S100P-enhanced cell migration. In conclusion, this work has demonstrated a mechanism whereby the S100P-induced dissociation of NMIIA filaments leads to a weakening of FAS, reduced cell adhesion, and enhanced cell migration, the first major step in the metastatic cascade.	[Wang, Guozheng] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7ZB, Merseyside, England; [Du, Min; Ismail, Thamir M.; Fernig, David G.; Barraclough, Roger; Rudland, Philip S.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England; [Gross, Stephane] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	University of Liverpool; University of Liverpool; Aston University	Wang, GZ (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Crown St, Liverpool L69 7ZB, Merseyside, England.	wangg@liv.ac.uk; rudland@liv.ac.uk	Fernig, David G/A-3590-2008; Barraclough, Roger/AAH-6516-2020	Fernig, David G/0000-0003-4875-4293; gross, stephane/0000-0002-0867-8866; Barraclough, Roger/0000-0002-7203-1194	Cancer and Polio Research Fund; North West Cancer Research Fund	Cancer and Polio Research Fund; North West Cancer Research Fund	This work was supported by the Cancer and Polio Research Fund and the North West Cancer Research Fund.	ALBINI A, 1987, CANCER RES, V47, P3239; Anderson S, 2004, EXP CELL RES, V298, P574, DOI 10.1016/j.yexcr.2004.05.005; Arumugam T, 2004, J BIOL CHEM, V279, P5059, DOI 10.1074/jbc.M310124200; Arumugam T, 2005, CLIN CANCER RES, V11, P5356, DOI 10.1158/1078-0432.CCR-05-0092; Arumugam T, 2006, J NATL CANCER I, V98, P1806, DOI 10.1093/jnci/djj498; Badyal SK, 2011, J MOL BIOL, V405, P1004, DOI 10.1016/j.jmb.2010.11.036; Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Breckenridge MT, 2009, MOL BIOL CELL, V20, P338, DOI 10.1091/mbc.E08-04-0372; Bronckart Y, 2001, HISTOL HISTOPATHOL, V16, P707, DOI 10.14670/HH-16.707; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cairns RA, 2003, CURR MOL MED, V3, P659, DOI 10.2174/1566524033479447; Chen HL, 2001, BIOCHEM BIOPH RES CO, V286, P1212, DOI 10.1006/bbrc.2001.5517; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Darenfed H, 2007, CELL MOTIL CYTOSKEL, V64, P97, DOI 10.1002/cm.20168; DAVIES BR, 1993, ONCOGENE, V8, P999; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Dulyaninova NG, 2007, MOL BIOL CELL, V18, P3144, DOI 10.1091/mbc.E06-11-1056; Dulyaninova NG, 2005, BIOCHEMISTRY-US, V44, P6867, DOI 10.1021/bi0500776; Dumbauld DW, 2010, J CELL PHYSIOL, V223, P746, DOI 10.1002/jcp.22084; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Elangovan M, 2002, J MICROSC-OXFORD, V205, P3, DOI 10.1046/j.0022-2720.2001.00984.x; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Fernig D G, 2001, Methods Mol Biol, V171, P505; Ford HL, 1997, BIOCHEMISTRY-US, V36, P16321, DOI 10.1021/bi971182l; FORD HL, 1995, ONCOGENE, V10, P1597; Fuentes MK, 2007, DIS COLON RECTUM, V50, P1230, DOI 10.1007/s10350-006-0850-5; GIBBS FEM, 1994, J BIOL CHEM, V269, P18992; Gilmore AP, 1996, MOL BIOL CELL, V7, P1209, DOI 10.1091/mbc.7.8.1209; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Humphries Martin J., 2009, V522, P203, DOI 10.1007/978-1-59745-413-1_14; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Ismail T. M., 2011, MONTR INT S ANG MET, P101; Ismail TM, 2010, J BIOL CHEM, V285, P914, DOI 10.1074/jbc.M109.010892; Ismail TM, 2008, CARCINOGENESIS, V29, P2259, DOI 10.1093/carcin/bgn217; Jenkinson SR, 2004, BRIT J CANCER, V90, P253, DOI 10.1038/sj.bjc.6601483; Kriajevska M, 1998, J BIOL CHEM, V273, P9852, DOI 10.1074/jbc.273.16.9852; Kriajevska M, 2000, BBA-MOL CELL RES, V1498, P252, DOI 10.1016/S0167-4889(00)00100-2; KRIAJEVSKA MV, 1994, J BIOL CHEM, V269, P19679; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamartina S, 2003, MOL THER, V7, P271, DOI 10.1016/S1525-0016(02)00051-5; Li ZH, 2003, BIOCHEMISTRY-US, V42, P14258, DOI 10.1021/bi0354379; Li ZH, 2006, CANCER RES, V66, P5173, DOI 10.1158/0008-5472.CAN-05-3087; Li ZH, 2010, MOL BIOL CELL, V21, P2598, DOI 10.1091/mbc.E09-07-0609; Liu ZA, 2010, BRIT J PHARMACOL, V159, P304, DOI 10.1111/j.1476-5381.2009.00477.x; Lo CM, 2004, MOL BIOL CELL, V15, P982, DOI 10.1091/mbc.E03-06-0359; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Murakami N, 1995, BIOCHEMISTRY-US, V34, P16046, DOI 10.1021/bi00049a019; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Pepperkok R, 1999, CURR BIOL, V9, P269, DOI 10.1016/S0960-9822(99)80117-1; Perez D, 2007, J INVEST SURG, V20, P181, DOI 10.1080/08941930701366349; Ren XD, 2000, J CELL SCI, V113, P3673; Rudland PS, 2000, CANCER RES, V60, P1595; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Sieg DJ, 1999, J CELL SCI, V112, P2677; Swailes NT, 2006, J CELL SCI, V119, P3561, DOI 10.1242/jcs.03096; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; Uren D, 2000, J CLIN INVEST, V105, P663, DOI 10.1172/JCI8199; Vallely KM, 2002, BIOCHEMISTRY-US, V41, P12670, DOI 10.1021/bi020365r; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wang GZ, 2006, CANCER RES, V66, P1199, DOI 10.1158/0008-5472.CAN-05-2605; Wang GZ, 2005, ONCOGENE, V24, P1445, DOI 10.1038/sj.onc.1208291; Wang GZ, 2004, BIOCHEM J, V382, P375, DOI 10.1042/BJ20040142; Wang GZ, 2000, J BIOL CHEM, V275, P11141, DOI 10.1074/jbc.275.15.11141; Wang GZ, 2000, MOL CELL BIOL, V20, P6970, DOI 10.1128/MCB.20.18.6970-6983.2000; Wang ZG, 2008, ONCOL REP, V20, P1473, DOI 10.3892/or_00000168; Watanabe T, 2005, NOVART FDN SYMP, V269, P223; Watanabe T, 2005, NOVART FDN SYMP, V269, P101; Watanabe Takashi, 2005, Novartis Found Symp, V269, P92; Whiteman HJ, 2007, CANCER RES, V67, P8633, DOI 10.1158/0008-5472.CAN-07-0545; Wylie SR, 2008, MOL BIOL CELL, V19, P3956, DOI 10.1091/mbc.E07-08-0744; Zhang HM, 2003, J MOL BIOL, V325, P785, DOI 10.1016/S0022-2836(02)01278-0; Zhang S, 2005, ONCOGENE, V24, P4401, DOI 10.1038/sj.onc.1208663; Zhang S, 2005, EUR BIOPHYS J BIOPHY, V34, P19, DOI 10.1007/s00249-004-0428-x	85	47	49	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15330	15344		10.1074/jbc.M112.349787	http://dx.doi.org/10.1074/jbc.M112.349787			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22399300	Green Accepted, Green Submitted, Green Published, hybrid			2022-12-27	WOS:000304006300016
J	Truong, K; Lee, TD; Chen, Y				Khue Truong; Lee, Terry D.; Chen, Yuan			Small Ubiquitin-like Modifier (SUMO) Modification of E1 Cys Domain Inhibits E1 Cys Domain Enzymatic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING ENZYME; E1-E2 INTERACTION; HEAT-SHOCK; E3 LIGASE; IDENTIFICATION; CONJUGATION; BINDING; UBC9; SITE; E2	Although it is well established that ubiquitin-like modifications are tightly regulated, it has been unclear how their E1 activities are controlled. In this study, we found that the SAE2 subunit of the small ubiquitin-like modifier (SUMO) E1 is auto-SUMOylated at residue Lys-236, and SUMOylation was catalyzed by Ubc9 at several additional Lys residues surrounding the catalytic Cys-173 of SAE2. AutoSUMOylation of SAE2 did not affect SUMO adenylation or formation of E1.SUMO thioester, but did significantly inhibit the transfer of SUMO from E1 to E2 and overall SUMO conjugations to target proteins due to the altered interaction between E1 and E2. Upon heat shock, SUMOylation of SAE2 was reduced, which corresponded with an increase in global SUMOylation, suggesting that SUMOylation of the Cys domain of SAE2 is a mechanism for "storing" a pool of E1 that can be quickly activated in response to environmental changes. This study is the first to show how E1 activity is controlled by post-translational modifications, and similar regulation likely exists across the homologous E1s of ubiquitin-like modifications.	[Khue Truong; Chen, Yuan] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Khue Truong] City Hope Natl Med Ctr, Beckman Res Inst, Grad Sch Biol Sci, Duarte, CA 91010 USA; [Lee, Terry D.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Chen, Y (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, 1450 E Duarte Rd, Duarte, CA 91010 USA.	ychen@coh.org			National Institutes of Health through the NIGMS [R01 GM086171, R01 GM074748]; National Institutes of Health [P30 CA033572]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086171, R01GM074748] Funding Source: NIH RePORTER	National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM086171 and R01 GM074748 (to Y. C.) through the NIGMS and National Institutes of Health Grant P30 CA033572 from the NCI.	Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; Evans TC, 1999, BIOPOLYMERS, V51, P333, DOI 10.1002/(SICI)1097-0282(1999)51:5<333::AID-BIP3>3.3.CO;2-R; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; HAAS AL, 1982, J BIOL CHEM, V257, P329; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hong YL, 2001, J BIOL CHEM, V276, P40263, DOI 10.1074/jbc.M104714200; Hsiao HH, 2009, MOL CELL PROTEOMICS, V8, P2664, DOI 10.1074/mcp.M900087-MCP200; Huang DT, 2008, NAT STRUCT MOL BIOL, V15, P280, DOI 10.1038/nsmb.1387; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Lin DH, 2002, J BIOL CHEM, V277, P21740, DOI 10.1074/jbc.M108418200; Liu Q, 1999, J BIOL CHEM, V274, P16979, DOI 10.1074/jbc.274.24.16979; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Miller MJ, 2011, PLANT SIGNAL BEHAV, V6, P130, DOI 10.4161/psb.6.1.14256; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Sramko M, 2006, J BIOL CHEM, V281, P40065, DOI 10.1074/jbc.M609404200; Subramaniam S, 2010, J BIOL CHEM, V285, P20428, DOI 10.1074/jbc.C110.127191; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P9959, DOI 10.1021/bi0345283; Truong K, 2011, BIOCHEMISTRY-US, V50, P5757, DOI 10.1021/bi2001856; Ulrich Helle D., 2009, V497, P3, DOI 10.1007/978-1-59745-566-4_1; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Wang JH, 2010, J BIOL CHEM, V285, P33457, DOI 10.1074/jbc.M110.135582; Wang JH, 2009, J BIOL CHEM, V284, P20340, DOI 10.1074/jbc.M109.000257	33	24	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15154	15163		10.1074/jbc.M112.353789	http://dx.doi.org/10.1074/jbc.M112.353789			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22403398	hybrid, Green Published			2022-12-27	WOS:000304006300001
J	Ortiz, C; Caja, L; Bertran, E; Gonzalez-Rodriguez, A; Valverde, AM; Fabregat, I; Sancho, P				Ortiz, Conrad; Caja, Laia; Bertran, Esther; Gonzalez-Rodriguez, Agueda; Valverde, Angela M.; Fabregat, Isabel; Sancho, Patricia			Protein-tyrosine Phosphatase 1B (PTP1B) Deficiency Confers Resistance to Transforming Growth Factor-beta (TGF-beta)-induced Suppressor Effects in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; FETAL-RAT HEPATOCYTES; SMOOTH-MUSCLE-CELLS; TGF-BETA; NADPH OXIDASE; INDUCED-APOPTOSIS; SIGNAL-TRANSDUCTION; FACTOR RECEPTOR; UP-REGULATION; OXIDATIVE STRESS	Transforming growth factor-beta (TGF-beta) plays a dual role in hepatocytes, mediating both tumor suppressor and promoter effects. The suppressor effects of the cytokine can be negatively regulated by activation of survival signals, mostly dependent on tyrosine kinase activity. The aim of our work was to study the role of the protein-tyrosine phosphatase 1B (PTP1B) on the cellular responses to TGF-beta, using for this purpose immortalized neonatal hepatocytes isolated from both PTP1B(+/+) and PTP1B(-/-) mice. We have found that PTP1B deficiency conferred resistance to TGF-beta suppressor effects, such as apoptosis and growth inhibition, correlating with lower Smad2/Smad3 activation. Both responses were recovered in the presence of the general tyrosine kinase inhibitor genistein. PTP1B(-/-) cells showed elevated NF-kappa B activation in response to TGF-beta. Knockdown of the NF-kappa B p65 subunit increased cell response in terms of Smads phosphorylation and apoptosis. Interestingly, these effects were accompanied by inhibition of Smad7 up-regulation. In addition, lack of PTP1B promoted an altered NADPH oxidase (NOX) expression pattern in response to TGF-beta, strongly increasing the NOX1/NOX4 ratio, which was reverted by genistein and p65 knockdown. Importantly, NOX1 knockdown inhibited nuclear translocation of p65, promoted Smad phosphorylation, and decreased Smad7 levels. In summary, our results suggest that PTP1B deficiency confers resistance to TGF-beta through Smad inhibition, an effect that is mediated by NOX1-dependent NF-kappa B activation, which in turn, increases the level of the Smad inhibitor Smad7 and participates in a positive feedback loop on NOX1 up-regulation.	[Ortiz, Conrad; Caja, Laia; Bertran, Esther; Fabregat, Isabel; Sancho, Patricia] Bellvitge Biomed Res Inst IDIBELL, Biol Clues Invas & Metastat Phenotype Grp, Barcelona 08908, Spain; [Gonzalez-Rodriguez, Agueda; Valverde, Angela M.] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, E-28049 Madrid, Spain; [Gonzalez-Rodriguez, Agueda; Valverde, Angela M.] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid 28040, Spain; [Fabregat, Isabel] Univ Barcelona, Dept Ciencies Fisiol 2, E-08007 Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; University of Barcelona	Fabregat, I (corresponding author), IDIBELL, Biol Clues Invas & Metastat Phenotype Grp, Gran Via LHospitalet 199, Barcelona 08907, Spain.	ifabregat@idibell.cat; psancho@idibell.cat	Bertran, Esther/GZK-5458-2022; González-Rodróguez, Águeda/D-7651-2012; Chaitoglou, Stefanos/M-1658-2014; Sancho, Patricia/ABH-5258-2020; Caja, Laia/J-4618-2019; Fabregat, Isabel/H-7038-2015	González-Rodróguez, Águeda/0000-0001-6559-0847; Chaitoglou, Stefanos/0000-0001-6074-1853; Sancho, Patricia/0000-0002-1092-5395; Caja, Laia/0000-0002-8786-8763; Martinez Valverde, Angela/0000-0003-1192-9045; Bertran Rodriguez, Esther/0000-0001-9356-7409; Fabregat, Isabel/0000-0003-0136-8440	Ministerio de Ciencia e Innovacion, Spain [BFU2009-07219, ISCIII-RTICC RD06/0020, SAF2009]; Agencia de Gestio d'Ajuts Universitari i de Recerca-Generalitat de Catalunya [2009SGR-312]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agencia de Gestio d'Ajuts Universitari i de Recerca-Generalitat de Catalunya	This work was supported by Ministerio de Ciencia e Innovacion, Spain, Grants BFU2009-07219 and ISCIII-RTICC RD06/0020 (to I. F.) and SAF2009-08114 (to A. M. V.) and by Agencia de Gestio d'Ajuts Universitari i de Recerca-Generalitat de Catalunya Grant 2009SGR-312 (to I. F.).	Arsura M, 2003, ONCOGENE, V22, P412, DOI 10.1038/sj.onc.1206132; Arsura M, 1997, CELL GROWTH DIFFER, V8, P1049; Arsura M, 2000, MOL CELL BIOL, V20, P5381, DOI 10.1128/MCB.20.15.5381-5391.2000; Banerjee S, 2008, CANCER LETT, V269, P226, DOI 10.1016/j.canlet.2008.03.052; Bitzer M, 2000, GENE DEV, V14, P187; Caja L, 2007, CELL SIGNAL, V19, P683, DOI 10.1016/j.cellsig.2006.09.002; Caja L, 2011, J HEPATOL, V55, P351, DOI 10.1016/j.jhep.2010.10.041; Caja L, 2009, CANCER RES, V69, P7595, DOI 10.1158/0008-5472.CAN-09-1482; Carmona-Cuenca I, 2006, J CELL PHYSIOL, V207, P322, DOI 10.1002/jcp.20568; Carmona-Cuenca I, 2008, J HEPATOL, V49, P965, DOI 10.1016/j.jhep.2008.07.021; CARR BI, 1986, CANCER RES, V46, P2330; Chacon PJ, 2010, MOL CELL NEUROSCI, V43, P384, DOI 10.1016/j.mcn.2010.01.005; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283; Fabregat I, 2000, HEPATOLOGY, V32, P528, DOI 10.1053/jhep.2000.9774; Franco DL, 2010, J CELL SCI, V123, P3467, DOI 10.1242/jcs.068692; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Fukuyama M, 2005, CANCER LETT, V221, P97, DOI 10.1016/j.canlet.2004.08.031; Gonzalez-Rodriguez A, 2007, J CELL PHYSIOL, V212, P76, DOI 10.1002/jcp.21004; Gonzalez-Rodriguez A, 2007, ENDOCRINOLOGY, V148, P594, DOI 10.1210/en.2006-0644; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Herrera B, 2001, FASEB J, V15, P741, DOI 10.1096/fj.00-0267com; Hunter T, 1998, Harvey Lect, V94, P81; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Krakowski AR, 2005, P NATL ACAD SCI USA, V102, P12437, DOI 10.1073/pnas.0504107102; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Manea A, 2010, BIOCHEM BIOPH RES CO, V396, P901, DOI 10.1016/j.bbrc.2010.05.019; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mayoral R, 2010, J BIOL CHEM, V285, P3633, DOI 10.1074/jbc.M109.072900; Miller FJ, 2007, CIRC RES, V101, P663, DOI 10.1161/CIRCRESAHA.107.151076; Miranda S, 2010, CELL SIGNAL, V22, P645, DOI 10.1016/j.cellsig.2009.11.019; Murillo MM, 2007, BIOCHEM J, V405, P251, DOI 10.1042/BJ20061846; Murillo MM, 2005, ONCOGENE, V24, P4580, DOI 10.1038/sj.onc.1208664; Nagarajan RP, 2000, BIOCHEM J, V348, P591, DOI 10.1042/0264-6021:3480591; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; OBERHAMMER FA, 1992, P NATL ACAD SCI USA, V89, P5408, DOI 10.1073/pnas.89.12.5408; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Salmeen A, 2005, ANTIOXID REDOX SIGN, V7, P560, DOI 10.1089/ars.2005.7.560; San Martin A, 2007, FREE RADICAL BIO MED, V42, P1671, DOI 10.1016/j.freeradbiomed.2007.02.002; Sanchez A, 1996, J BIOL CHEM, V271, P7416, DOI 10.1074/jbc.271.13.7416; Sancho P, 2011, BIOCHEM PHARMACOL, V81, P917, DOI 10.1016/j.bcp.2011.01.007; Sancho P, 2010, J BIOL CHEM, V285, P24815, DOI 10.1074/jbc.M110.114280; Sancho P, 2009, BBA-MOL CELL RES, V1793, P253, DOI 10.1016/j.bbamcr.2008.09.003; Sangwan V, 2006, J BIOL CHEM, V281, P221, DOI 10.1074/jbc.M507858200; Stuible M, 2010, TRENDS CELL BIOL, V20, P672, DOI 10.1016/j.tcb.2010.08.013; Valdes F, 2004, EXP CELL RES, V292, P209, DOI 10.1016/j.yexcr.2003.08.015; Valverde Angela M., 2011, Archives of Physiology and Biochemistry, V117, P105, DOI 10.3109/13813455.2011.557386; Wang R, 2011, INT J CANCER, V128, P2581, DOI 10.1002/ijc.25610	50	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15263	15274		10.1074/jbc.M111.303958	http://dx.doi.org/10.1074/jbc.M111.303958			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427664	Green Published, hybrid			2022-12-27	WOS:000304006300010
J	Soares, LM; Buratowski, S				Soares, Luis M.; Buratowski, Stephen			Yeast Swd2 Is Essential Because of Antagonism between Set1 Histone Methyltransferase Complex and APT (Associated with Pta1) Termination Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; LYSINE-4 METHYLATION; TRANSCRIPTION TERMINATION; GENE-EXPRESSION; MESSENGER-RNA; POLYADENYLATION FACTOR; H3K4 TRIMETHYLATION; 3'-END FORMATION; BINDING PROTEIN	The Set1 complex (also known as complex associated with Set1 or COMPASS) methylates histone H3 on lysine 4, with different levels of methylation affecting transcription by recruiting various factors to distinct regions of active genes. Neither Set1 nor its associated proteins are essential for viability with the notable exception of Swd2, a WD repeat protein that is also a subunit of the essential transcription termination factor APT (associated with Pta1). Cells lacking Set1 lose COMPASS recruitment but show increased promoter cross-linking of TFIIE large subunit and the serine 5 phosphorylated form of the Rpb1 C-terminal domain. Although Swd2 is normally required for bringing APT to genes, deletion of SET1 restores both viability and APT recruitment to a strain lacking Swd2. We propose a model in which Swd2 is required for APT to overcome antagonism by COMPASS.	[Soares, Luis M.; Buratowski, Stephen] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Buratowski, S (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	SteveB@hms.harvard.edu			National Institutes of Health [GM46498, GM56663]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046498, R01GM056663, R29GM046498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM46498 and GM56663 (to S. B.).	Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Boa S, 2003, YEAST, V20, P827, DOI 10.1002/yea.995; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Carvin CD, 2004, J BIOL CHEM, V279, P33057, DOI 10.1074/jbc.M405033200; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Cheng HL, 2004, MOL CELL BIOL, V24, P2932, DOI 10.1128/MCB.24.7.2932-2943.2004; Dehe PM, 2006, BIOCHEM CELL BIOL, V84, P536, DOI 10.1139/O06-081; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Dehe PM, 2005, J MOL BIOL, V353, P477, DOI 10.1016/j.jmb.2005.08.059; Demae M, 2007, FEMS MICROBIOL LETT, V277, P70, DOI 10.1111/j.1574-6968.2007.00947.x; Dheur S, 2003, EMBO J, V22, P2831, DOI 10.1093/emboj/cdg253; Dichtl E, 2004, RNA, V10, P965, DOI 10.1261/rna.7090104; Fingerman IM, 2005, J BIOL CHEM, V280, P28761, DOI 10.1074/jbc.C500097200; Ganem C, 2003, EMBO J, V22, P1588, DOI 10.1093/emboj/cdg141; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Grohmann D, 2011, MOL CELL, V43, P263, DOI 10.1016/j.molcel.2011.05.030; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Krishnamurthy S, 2004, MOL CELL, V14, P387, DOI 10.1016/S1097-2765(04)00235-7; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Kuldell NH, 1997, MOL CELL BIOL, V17, P5288, DOI 10.1128/MCB.17.9.5288; Lee JH, 2008, MOL CELL BIOL, V28, P609, DOI 10.1128/MCB.01356-07; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Mosley AL, 2009, MOL CELL, V34, P168, DOI 10.1016/j.molcel.2009.02.025; Muramoto T, 2010, CURR BIOL, V20, P397, DOI 10.1016/j.cub.2010.01.017; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nedea E, 2003, J BIOL CHEM, V278, P33000, DOI 10.1074/jbc.M304454200; Nedea E, 2008, MOL CELL, V29, P577, DOI 10.1016/j.molcel.2007.12.031; Neumann S, 2003, EMBO REP, V4, P1156, DOI 10.1038/sj.embor.7400026; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; OHKUMA Y, 1994, NATURE, V368, P160, DOI 10.1038/368160a0; OHKUMA Y, 1995, MOL CELL BIOL, V15, P4856; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Sakurai H, 1998, J BIOL CHEM, V273, P9534, DOI 10.1074/jbc.273.16.9534; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schlichter A, 2005, EMBO J, V24, P1222, DOI 10.1038/sj.emboj.7600607; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Somesh BP, 2007, CELL, V129, P57, DOI 10.1016/j.cell.2007.01.046; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Terzi N, 2011, MOL CELL BIOL, V31, P3569, DOI 10.1128/MCB.05590-11; Tresaugues L, 2006, J MOL BIOL, V359, P1170, DOI 10.1016/j.jmb.2006.04.050; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vitaliano-Prunier A, 2008, NAT CELL BIOL, V10, P1365, DOI 10.1038/ncb1796; WARREN SL, 1992, J CELL SCI, V103, P381; Xiao TJ, 2007, MOL CELL BIOL, V27, P721, DOI 10.1128/MCB.01628-06	62	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15219	15231		10.1074/jbc.M112.341412	http://dx.doi.org/10.1074/jbc.M112.341412			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22431730	Green Published, hybrid			2022-12-27	WOS:000304006300006
J	van Loo, KMJ; Schaub, C; Pernhorst, K; Yaari, Y; Beck, H; Schoch, S; Becker, AJ				van Loo, Karen M. J.; Schaub, Christina; Pernhorst, Katharina; Yaari, Yoel; Beck, Heinz; Schoch, Susanne; Becker, Albert J.			Transcriptional Regulation of T-type Calcium Channel Ca(V)3.2 BI-DIRECTIONALITY BY EARLY GROWTH RESPONSE 1 (Egr1) AND REPRESSOR ELEMENT 1 (RE-1) PROTEIN-SILENCING TRANSCRIPTION FACTOR (REST)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; ABSENCE EPILEPSY; CA2+ CHANNELS; IN-VIVO; NEURONAL EXCITABILITY; BIOLOGICAL-ACTIVITY; STATUS EPILEPTICUS; UP-REGULATION; RAT-BRAIN; DNA	The pore-forming Ca2+ channel subunit Ca(V)3.2 mediates a low voltage-activated (T-type) Ca2+ current (I-CaT) that contributes pivotally to neuronal and cardiac pacemaker activity. Despite the importance of tightly regulated Ca(V)3.2 levels, the mechanisms regulating its transcriptional dynamics are not well understood. Here, we have identified two key factors that up-and down-regulate the expression of the gene encoding Ca(V)3.2 (Cacna1h). First, we determined the promoter region and observed several stimulatory and inhibitory clusters. Furthermore, we found binding sites for the transcription factor early growth response 1 (Egr1/Zif268/Krox-24) to be highly overrepresented within the CaV3.2 promoter region. mRNA expression analyses and dual-luciferase promoter assays revealed that the CaV3.2 promoter was strongly activated by Egr1 overexpression in vitro and in vivo. Subsequent chromatin immunoprecipitation assays in NG108-15 cells and mouse hippocampi confirmed specific Egr1 binding to the Ca(V)3.2 promoter. Congruently, whole-cell ICaT values were significantly larger after Egr1 overexpression. Intriguingly, Egr1-induced activation of the Ca(V)3.2 promoter was effectively counteracted by the repressor element 1-silencing transcription factor (REST). Thus, Egr1 and REST can bi-directionally regulate Ca(V)3.2 promoter activity and mRNA expression and, hence, the size of I-CaT. This mechanism has critical implications for the regulation of neuronal and cardiac Ca2+ homeostasis under physiological conditions and in episodic disorders such as arrhythmias and epilepsy.	[van Loo, Karen M. J.; Pernhorst, Katharina; Schoch, Susanne; Becker, Albert J.] Univ Bonn, Med Ctr, Dept Neuropathol, D-53105 Bonn, Germany; [Schaub, Christina; Beck, Heinz] Univ Bonn, Med Ctr, Dept Epileptol, D-53105 Bonn, Germany; [Schaub, Christina] Univ Bonn, Med Ctr, Dept Neurol, D-53105 Bonn, Germany; [Yaari, Yoel] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Med Neurobiol, IL-91120 Jerusalem, Israel; [Beck, Heinz] Deutsch Zentrum Neurodegenerat Erkrankungen, D-53175 Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; Hebrew University of Jerusalem; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	van Loo, KMJ (corresponding author), Univ Bonn, Med Ctr, Dept Neuropathol, Sigmund Freud Str 25, D-53105 Bonn, Germany.	karen.van_loo@ukb.uni-bonn.de	Schoch, Susanne/F-7741-2012; Becker, Albert J/F-6248-2012		Deutsche Forschungsgemeinschaft [SFB/TR3, KFO 177, SFB-645]; GIF; NGFNplus EMINET; European Union; Euroepinomics Network of the European Science Foundation; Else Kroner-Fresenius-Stiftung; BMBF "Independent research groups in neurosciences"; University of Bonn Medical Center	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); GIF(German-Israeli Foundation for Scientific Research and Development); NGFNplus EMINET; European Union(European Commission); Euroepinomics Network of the European Science Foundation; Else Kroner-Fresenius-Stiftung; BMBF "Independent research groups in neurosciences"(Federal Ministry of Education & Research (BMBF)); University of Bonn Medical Center	This work was supported by Deutsche Forschungsgemeinschaft (SFB/TR3, KFO 177, SFB-645; to A.J.B., Y.Y., H.B., and S.S.), GIF (to A.J.B., S.S., and Y.Y.), NGFNplus EMINET (to A.J.B., H.B., and S.S.), European Union EPICURE (to A.J.B. and H.B.), Euroepinomics Network of the European Science Foundation (to K.v L. and A.J.B.), Else Kroner-Fresenius-Stiftung (to A.J.B.), and BMBF "Independent research groups in neurosciences" (to S.S.) as well as the BONFOR program of the University of Bonn Medical Center.	ACKERMAN SL, 1991, P NATL ACAD SCI USA, V88, P7523, DOI 10.1073/pnas.88.17.7523; Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; Becker AJ, 2008, J NEUROSCI, V28, P13341, DOI 10.1523/JNEUROSCI.1421-08.2008; Beckmann AM, 1997, J NEUROCHEM, V69, P2227; Bosch MA, 2009, J COMP NEUROL, V512, P347, DOI 10.1002/cne.21901; Calderone A, 2003, J NEUROSCI, V23, P2112; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Chemin J, 2006, CELL CALCIUM, V40, P121, DOI 10.1016/j.ceca.2006.04.015; Cribbs LL, 2010, CHANNELS, V4, P447, DOI 10.4161/chan.4.6.12870; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Gannon AM, 2009, J MOL BIOL, V394, P29, DOI 10.1016/j.jmb.2009.09.007; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; Graef JD, 2009, J NEUROSCI, V29, P4430, DOI 10.1523/JNEUROSCI.0198-09.2009; Helbig I, 2008, EPILEPSIA, V49, P1546, DOI 10.1111/j.1528-1167.2008.01630.x; Hertel KJ, 1997, CURR OPIN CELL BIOL, V9, P350, DOI 10.1016/S0955-0674(97)80007-5; Heynen AJ, 2001, J NEUROSCI, V21, P9801, DOI 10.1523/JNEUROSCI.21-24-09801.2001; Huang RP, 1997, J CELL BIOCHEM, V66, P489, DOI 10.1002/(SICI)1097-4644(19970915)66:4<489::AID-JCB8>3.0.CO;2-H; HUGHES P, 1994, MOL BRAIN RES, V24, P166, DOI 10.1016/0169-328X(94)90129-5; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Khosravani H, 2005, ANN NEUROL, V57, P745, DOI 10.1002/ana.20458; Khosravani H, 2004, J BIOL CHEM, V279, P9681, DOI 10.1074/jbc.C400006200; Klockner U, 1999, EUR J NEUROSCI, V11, P4171, DOI 10.1046/j.1460-9568.1999.00849.x; Kumbrink J, 2005, J BIOL CHEM, V280, P42785, DOI 10.1074/jbc.M511079200; Kuwahara K, 2005, J PHARMACOL SCI, V99, P211, DOI 10.1254/jphs.FMJ05002X4; Kuwahara K, 2003, EMBO J, V22, P6310, DOI 10.1093/emboj/cdg601; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; Lee JH, 1999, J NEUROSCI, V19, P1912; Leuranguer V, 2000, AM J PHYSIOL-HEART C, V279, pH2540, DOI 10.1152/ajpheart.2000.279.5.H2540; Lietz M, 2001, EUR J NEUROSCI, V14, P1303, DOI 10.1046/j.0953-816x.2001.01762.x; Lifanov AP, 2003, GENOME RES, V13, P579, DOI 10.1101/gr.668403; Liu CT, 1998, CANCER GENE THER, V5, P3; Maturana A, 2009, ENDOCRINOLOGY, V150, P3726, DOI 10.1210/en.2008-1727; McClelland S, 2011, ANN NEUROL, V70, P454, DOI 10.1002/ana.22479; McDade DM, 2009, BIOCHEM SOC T, V37, P1375, DOI 10.1042/BST0371375; McKay BE, 2006, EUR J NEUROSCI, V24, P2581, DOI 10.1111/j.1460-9568.2006.05136.x; Molineux ML, 2006, P NATL ACAD SCI USA, V103, P5555, DOI 10.1073/pnas.0601261103; Mucha M, 2010, J NEUROSCI, V30, P13235, DOI 10.1523/JNEUROSCI.1981-10.2010; Palm K, 1998, J NEUROSCI, V18, P1280; Powell KL, 2009, J NEUROSCI, V29, P371, DOI 10.1523/JNEUROSCI.5295-08.2009; RUSSO MW, 1995, P NATL ACAD SCI USA, V92, P6873, DOI 10.1073/pnas.92.15.6873; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Shimojo M, 1999, MOL CELL BIOL, V19, P6788; Spencer EM, 2006, NEUROBIOL DIS, V24, P41, DOI 10.1016/j.nbd.2006.04.020; Su H, 2002, J NEUROSCI, V22, P3645; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Thiel G, 1998, J BIOL CHEM, V273, P26891, DOI 10.1074/jbc.273.41.26891; THIEL G, 1994, J BIOL CHEM, V269, P15294; Uchida H, 2010, J NEUROSCI, V30, P4806, DOI 10.1523/JNEUROSCI.5541-09.2010; Wei F, 2000, J CELL BIOL, V149, P1325, DOI 10.1083/jcb.149.7.1325	53	53	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15489	15501		10.1074/jbc.M111.310763	http://dx.doi.org/10.1074/jbc.M111.310763			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22431737	Green Published, hybrid			2022-12-27	WOS:000304006300030
J	Dai, RY; Li, JJ; Fu, J; Chen, Y; Yu, LX; Zhao, XF; Qian, YW; Zhang, HL; Chen, HY; Ren, YB; Su, B; Luo, T; Zhu, JJ; Wang, HY				Dai, Rongyang; Li, Juanjuan; Fu, Jing; Chen, Yao; Yu, Lexing; Zhao, Xiaofang; Qian, Youwen; Zhang, Huilu; Chen, Haiyang; Ren, Yibin; Su, Bo; Luo, Tao; Zhu, Junjie; Wang, Hongyang			Disturbance of Ca2+ Homeostasis Converts Pro-Met into Non-canonical Tyrosine Kinase p190Met(NC) in Response to Endoplasmic Reticulum Stress in MHCC97 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; HEPATOCYTE GROWTH-FACTOR; HUMAN HEPATOCELLULAR-CARCINOMA; ER STRESS; C-MET; INDUCED APOPTOSIS; REGULATOR GRP78/BIP; ADAPTIVE CAPACITY; INVASIVE GROWTH; CHAPERONE GRP78	c-Met, the tyrosine-kinase receptor for hepatocyte growth factor, plays a critical role in the tumorigenesis of hepatocellular carcinoma (HCC). However, the underlying mechanism remains incompletely understood. The mature c-Met protein p190Met(alpha beta) (consists of a alpha subunit and a beta subunit) is processed from pro-Met. Here we show that pro-Met is processed into p190Met(NC) by sarco/endoplasmic reticulum calcium-ATPase (SERCA) inhibitor thapsigargin. p190MetNC compensates for the degradation of p190Met(alpha beta) and protects human HCC cells from apoptosis mediated by endoplasmic reticulum (ER) stress. In comparison with p190Met(alpha beta), p190Met(NC) is not cleaved and is expressed as a single-chain polypeptide. Thapsigargin-initiated p190Met(NC) expression depends on the disturbance of ER calcium homeostasis. Once induced, p190Met(NC) is activated independent of hepatocyte growth factor engagement. p190Met(NC) contributes to sustained high basal activation of c-Met downstream pathways during ER calcium disturbance-mediated ER stress. Both p38 MAPK-promoted glucose-regulated protein 78 (GRP78) expression and sustained high basal activation of PI3K/Akt and MEK/ERK are involved in the cytoprotective function of p190Met(NC). Importantly, the expression of p190Met(NC) is detected in some HCC cases. Taken together, these data provide a potential mechanism to explain how c-Met promotes HCC cells survival in response to ER stress. We propose that context-specific processing of c-Met protein is implicated in HCC progression in stressful microenvironments.	[Dai, Rongyang; Li, Juanjuan; Fu, Jing; Chen, Yao; Yu, Lexing; Zhao, Xiaofang; Qian, Youwen; Zhang, Huilu; Chen, Haiyang; Ren, Yibin; Su, Bo; Luo, Tao; Zhu, Junjie; Wang, Hongyang] Second Mil Med Univ, Eastern Hepatobiliary Surg Inst, Int Cooperat Lab Signal Transduct, Shanghai 200438, Peoples R China; [Dai, Rongyang; Wang, Hongyang] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Inst Canc, Renji Hosp, Shanghai 200032, Peoples R China; [Dai, Rongyang] Luzhou Med Coll, Dept Biochem, Luzhou 646000, Sichuan, Peoples R China	Naval Medical University; Shanghai Jiao Tong University; Southwest Medical University	Wang, HY (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Inst, Int Cooperat Lab Signal Transduct, Shanghai 200438, Peoples R China.	hywangk@vip.sina.com	Yu, Lexing/AGP-5427-2022	Yu, Lexing/0000-0001-9619-8004; Dai, Rong-yang/0000-0002-7126-1713	National Natural Science Foundation of China [81000886, 81170377, 81101714, 30921006, 91029732]; State Key Project for Infectious Diseases [2012ZX10002-009]; New Century Excellent Talents in University; State Key Laboratory of Oncogenes and Related Genes [91-10-02, 90-10-03, 90-09-06, 10JC1418500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Project for Infectious Diseases; New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); State Key Laboratory of Oncogenes and Related Genes	This work was supported by the projects from National Natural Science Foundation of China (81000886, 81170377, 81101714, 30921006, 91029732), the State Key Project for Infectious Diseases (2012ZX10002-009), New Century Excellent Talents in University, and the State Key Laboratory of Oncogenes and Related Genes (91-10-02, 90-10-03, 90-09-06), and 10JC1418500.	Bellon SF, 2008, J BIOL CHEM, V283, P2675, DOI 10.1074/jbc.M705774200; Benvenuti S, 2007, J CELL PHYSIOL, V213, P316, DOI 10.1002/jcp.21183; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Dai RY, 2010, FOLIA BIOL-PRAGUE, V56, P37; Dai RY, 2009, CELL RES, V19, P1243, DOI 10.1038/cr.2009.104; Dai RY, 2009, INT J ONCOL, V34, P1749, DOI 10.3892/ijo_00000306; Desiderio MA, 2007, CELL MOL LIFE SCI, V64, P1341, DOI 10.1007/s00018-007-7050-x; FERRACINI R, 1991, J BIOL CHEM, V266, P19558; GIORDANO S, 1989, ONCOGENE, V4, P1383; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hosoi T, 2007, BRAIN RES, V1152, P27, DOI 10.1016/j.brainres.2007.03.052; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kermorgant S, 2003, J BIOL CHEM, V278, P28921, DOI 10.1074/jbc.M302116200; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu YF, 2011, CELL RES, V21, P867, DOI 10.1038/cr.2011.75; Luo S, 2002, BIOCHEM J, V366, P787, DOI 10.1042/BJ20011802; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; MONDINO A, 1991, MOL CELL BIOL, V11, P6084, DOI 10.1128/MCB.11.12.6084; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Novosyadlyy R, 2008, CELL DEATH DIFFER, V15, P1304, DOI 10.1038/cdd.2008.52; Nozaki S, 2001, ONCOGENE, V20, P2178, DOI 10.1038/sj.onc.1204292; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ou DSC, 2011, CELL RES, V21, P642, DOI 10.1038/cr.2011.10; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shuda M, 2003, J HEPATOL, V38, P605, DOI 10.1016/S0168-8278(03)00029-1; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Ueki T, 1997, HEPATOLOGY, V25, P862, DOI 10.1002/hep.510250413; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; Wang R, 2001, J CELL BIOL, V153, P1023, DOI 10.1083/jcb.153.5.1023; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Yeung BHY, 2008, ONCOGENE, V27, P6782, DOI 10.1038/onc.2008.290; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; You HN, 2011, HEPATOLOGY, V54, P879, DOI 10.1002/hep.24450; Zhang LJ, 2009, CANCER LETT, V274, P40, DOI 10.1016/j.canlet.2008.08.030	44	13	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14586	14597		10.1074/jbc.M111.333435	http://dx.doi.org/10.1074/jbc.M111.333435			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22418436	hybrid, Green Published			2022-12-27	WOS:000304003200025
J	Durand, E; Zoued, A; Spinelli, S; Watson, PJH; Aschtgen, MS; Journet, L; Cambillau, C; Cascales, E				Durand, Eric; Zoued, Abdelrahim; Spinelli, Silvia; Watson, Paul J. H.; Aschtgen, Marie-Stephanie; Journet, Laure; Cambillau, Christian; Cascales, Eric			Structural Characterization and Oligomerization of the TssL Protein, a Component Shared by Bacterial Type VI and Type IVb Secretion Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROAGGREGATIVE ESCHERICHIA-COLI; LEGIONELLA-PNEUMOPHILA; TAILED PHAGES; TARGET-CELLS; EXPRESSION; DOTU; ICMF; TRANSLOCATION; LIPOPROTEIN; APPARATUS	The Type VI secretion system (T6SS) is a macromolecular system distributed in Gram-negative bacteria, responsible for the secretion of effector proteins into target cells. The T6SS has a broad versatility as it can target both eukaryotic and prokaryotic cells. It is therefore involved in host pathogenesis or killing neighboring bacterial cells to colonize a new niche. At the architecture level, the T6SS core apparatus is composed of 13 proteins, which assemble in two subcomplexes. One of these subcomplexes, composed of subunits that share structural similarities with bacteriophage tail and baseplate components, is anchored to the cell envelope by the membrane subcomplex. This latter is constituted of at least three proteins, TssL, TssM, and TssJ. The crystal structure of the TssJ outer membrane lipoprotein and its interaction with the inner membrane TssM protein have been recently reported. TssL and TssM share sequence homology and characteristics with two components of the Type IVb secretion system (T4bSS), IcmH/DotU and IcmF, respectively. In this study, we report the crystal structure of the cytoplasmic domain of the TssL inner membrane protein from the enteroaggregative Escherichia coli Sci-1 T6SS. It folds as a hook-like structure composed of two three-helix bundles. Two TssL molecules associate to form a functional complex. Although the TssL trans-membrane segment is the main determinant of self-interaction, contacts between the cytoplasmic domains are required for TssL function. Based on sequence homology and secondary structure prediction, we propose that the TssL structure is the prototype for the members of the TssL and IcmH/DotU families.	[Cambillau, Christian] Aix Marseille Univ, CNRS UMR6098, F-13288 Marseille 09, France; [Durand, Eric; Spinelli, Silvia; Watson, Paul J. H.; Cambillau, Christian] CNRS, UMR 6098, F-13288 Marseille 09, France; [Zoued, Abdelrahim; Aschtgen, Marie-Stephanie; Journet, Laure; Cascales, Eric] Aix Marseille Univ, UMR 7255, CNRS, Inst Microbiol Mediterranee,Lab Ingn Syst Macromo, F-13402 Marseille 20, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Cambillau, C (corresponding author), Aix Marseille Univ, CNRS UMR6098, 163 Ave Luminy, F-13288 Marseille 09, France.	cambillau@afmb.univ-mrs.fr; cascales@imm.cnrs.fr	CASCALES, ERIC/G-7420-2011; Durand, Eric/E-6739-2017	CASCALES, ERIC/0000-0003-0611-9179; Durand, Eric/0000-0002-0577-8220; aschtgen, marie-stephanie/0000-0003-2413-8226; Zoued, Abdelrahim/0000-0002-6973-1755; Journet, Laure/0000-0002-5847-2962	CNRS; Agence Nationale de la Recherche [ANR-10-JCJC-1303-03]; Universite de la Mediterranee; Marseille-Nice Genopole, IBiSA; Fondation de la Recherche Medicale [FRM DEQ2011-0421282]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Universite de la Mediterranee; Marseille-Nice Genopole, IBiSA; Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the CNRS and funded by a grant from the Agence Nationale de la Recherche (Grant ANR-10-JCJC-1303-03) (to E. C) and by the CNRS, the Universite de la Mediterranee, and grants from the Marseille-Nice Genopole, IBiSA, and the Fondation de la Recherche Medicale (Grant FRM DEQ2011-0421282) (to C. C.).	Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Aschtgen MS, 2012, MICROBIOLOGYOPEN, V1, P71, DOI 10.1002/mbo3.9; Aschtgen MS, 2010, VIRULENCE, V1, P535, DOI 10.4161/viru.1.6.13732; Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x; Battesti A, 2008, PROTEOMICS, V8, P4768, DOI 10.1002/pmic.200800270; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Brunet YR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002205; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; de Bruin OM, 2011, MICROBIOL-SGM, V157, P3483, DOI 10.1099/mic.0.052308-0; de Pace F, 2010, INFECT IMMUN, V78, P4990, DOI 10.1128/IAI.00531-10; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Kanamaru S, 2009, P NATL ACAD SCI USA, V106, P4067, DOI 10.1073/pnas.0901205106; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Murdoch SL, 2011, J BACTERIOL, V193, P6057, DOI 10.1128/JB.05671-11; Nagai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00136; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Rao VA, 2011, ACTA CRYSTALLOGR D, V67, P1065, DOI 10.1107/S0907444911046300; Records AR, 2011, MOL PLANT MICROBE IN, V24, P751, DOI 10.1094/MPMI-11-10-0262; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Segal G, 2005, FEMS MICROBIOL REV, V29, P65, DOI 10.1016/j.femsre.2004.07.001; Sexton JA, 2004, INFECT IMMUN, V72, P5983, DOI 10.1128/IAI.72.10.5983-5992.2004; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Sulzenbacher G, 2002, ACTA CRYSTALLOGR D, V58, P2109, DOI 10.1107/S0907444902013938; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; VanRheenen SM, 2004, INFECT IMMUN, V72, P5972, DOI 10.1128/IAI.72.10.5972-5982.2004; Vincentelli R, 2005, ANAL BIOCHEM, V346, P77, DOI 10.1016/j.ab.2005.07.039; Weber B, 2009, ENVIRON MICROBIOL, V11, P3018, DOI 10.1111/j.1462-2920.2009.02005.x; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x	57	66	66	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14157	14168		10.1074/jbc.M111.338731	http://dx.doi.org/10.1074/jbc.M111.338731			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22371492	Green Published, hybrid			2022-12-27	WOS:000303996300068
J	Hausmann, R; Bodnar, M; Woltersdorf, R; Wang, HH; Fuchs, M; Messemer, N; Qin, Y; Gunther, J; Riedel, T; Grohmann, M; Nieber, K; Schmalzing, G; Rubini, P; Illes, P				Hausmann, Ralf; Bodnar, Mandy; Woltersdorf, Ronja; Wang, Haihong; Fuchs, Martin; Messemer, Nanette; Qin, Ying; Guenther, Janka; Riedel, Thomas; Grohmann, Marcus; Nieber, Karen; Schmalzing, Guenther; Rubini, Patrizia; Illes, Peter			ATP Binding Site Mutagenesis Reveals Different Subunit Stoichiometry of Functional P2X2/3 and P2X2/6 Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION CHANNELS; P2X(3) RECEPTORS; P2Y RECEPTORS; COEXPRESSION; STATE; DESENSITIZATION; PHARMACOLOGY; ARRANGEMENT; PHYSIOLOGY; TRIMERS	The aim of the present experiments was to clarify the subunit stoichiometry of P2X2/3 and P2X2/6 receptors, where the same subunit (P2X2) forms a receptor with two different partners (P2X3 or P2X6). For this purpose, four non-functional Ala mutants of the P2X2, P2X3, and P2X6 subunits were generated by replacing single, homologous amino acids particularly important for agonist binding. Co-expression of these mutants in HEK293 cells to yield the P2X2 WT/P2X3 mutant or P2X2 mutant/P2X3 WT receptors resulted in a selective blockade of agonist responses in the former combination only. In contrast, of the P2X2 WT/P2X6 mutant and P2X2 mutant/P2X6 WT receptors, only the latter combination failed to respond to agonists. The effects of alpha,beta-methylene-ATP and 2-methylthio-ATP were determined by measuring transmembrane currents by the patch clamp technique and intracellular Ca2+ transients by the Ca2+-imaging method. Protein labeling, purification, and PAGE confirmed the assembly and surface trafficking of the investigated WT and WT/mutant combinations in Xenopus laevis oocytes. In conclusion, both electrophysiological and biochemical investigations uniformly indicate that one subunit of P2X2 and two subunits of P2X3 form P2X2/3 heteromeric receptors, whereas two subunits of P2X2 and one subunit of P2X6 constitute P2X2/6 receptors. Further, it was shown that already two binding sites of the three possible ones are sufficient to allow these receptors to react with their agonists.	[Bodnar, Mandy; Wang, Haihong; Fuchs, Martin; Messemer, Nanette; Qin, Ying; Riedel, Thomas; Grohmann, Marcus; Rubini, Patrizia; Illes, Peter] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, D-04107 Leipzig, Germany; [Hausmann, Ralf; Woltersdorf, Ronja; Guenther, Janka; Grohmann, Marcus; Schmalzing, Guenther] Univ Aachen, Dept Mol Pharmacol, Univ Hosp Rhein Westfael TH, D-52074 Aachen, Germany; [Nieber, Karen] Univ Leipzig, Inst Pharm, Dept Pharmacol Nat Sci, D-04103 Leipzig, Germany	Leipzig University; RWTH Aachen University; Leipzig University	Illes, P (corresponding author), Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Haertelstr 16-18, D-04107 Leipzig, Germany.	Peter.Illes@medizin.uni-leipzig.de	Riedel, Thomas/A-5079-2012		Deutsche Forschungsgemeinschaft [FOR 748]; Volkswagen Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen)	This work was supported by Deutsche Forschungsgemeinschaft Grant FOR 748 and the Volkswagen Foundation.	Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; Barrera NP, 2007, BIOPHYS J, V93, P505, DOI 10.1529/biophysj.106.101048; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Becker D, 2008, J BIOL CHEM, V283, P25725, DOI 10.1074/jbc.M803855200; Bodnar M, 2011, J BIOL CHEM, V286, P2739, DOI 10.1074/jbc.M110.167437; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; Burnstock G, 2006, PHARMACOL THERAPEUT, V110, P433, DOI 10.1016/j.pharmthera.2005.08.013; Chizh BA, 2001, PHARMACOL REV, V53, P553; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Collo G, 1996, J NEUROSCI, V16, P2495; Ding SH, 1999, J GEN PHYSIOL, V113, P695, DOI 10.1085/jgp.113.5.695; Egan TM, 2004, CURR TOP MED CHEM, V4, P821, DOI 10.2174/1568026043451005; Evans RJ, 2010, BRIT J PHARMACOL, V161, P961, DOI 10.1111/j.1476-5381.2010.00728.x; Fallah G, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004697; Fischer W, 2003, J NEUROCHEM, V85, P779, DOI 10.1046/j.1471-4159.2003.01716.x; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gerevich Z, 2007, BRIT J PHARMACOL, V151, P226, DOI 10.1038/sj.bjp.0707217; Griffon N, 1999, EMBO J, V18, P4711, DOI 10.1093/emboj/18.17.4711; Guo C, 2007, MOL PHARMACOL, V72, P1447, DOI 10.1124/mol.107.035980; Haines WR, 1999, MOL PHARMACOL, V56, P720; Hausmann R, 2006, MOL PHARMACOL, V69, P2058, DOI 10.1124/mol.106.022665; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jiang LH, 2003, J NEUROSCI, V23, P8903; Jones CA, 2004, MOL PHARMACOL, V65, P979, DOI 10.1124/mol.65.4.979; Karoly R, 2008, MOL PHARMACOL, V73, P224, DOI 10.1124/mol.107.038901; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2001, PHARMACOL REV, V53, P107; King BF, 1997, BRIT J PHARMACOL, V121, P1445, DOI 10.1038/sj.bjp.0701286; King BF, 1999, BRIT J PHARMACOL, V128, P981, DOI 10.1038/sj.bjp.0702876; King BF, 2000, J NEUROSCI, V20, P4871; Klausberger T, 2001, J NEUROSCI, V21, P9124, DOI 10.1523/JNEUROSCI.21-23-09124.2001; Koles L, 2007, CURR PHARM DESIGN, V13, P2368; Lalo U, 2008, J NEUROSCI, V28, P5473, DOI 10.1523/JNEUROSCI.1149-08.2008; Le KT, 1998, J NEUROSCI, V18, P7152; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Mager PP, 2004, CURR TOP MED CHEM, V4, P1657, DOI 10.2174/1568026043387197; Majumder P, 2007, PURINERG SIGNAL, V3, P317, DOI 10.1007/s11302-007-9074-y; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Nicke A, 2005, J NEUROCHEM, V92, P925, DOI 10.1111/j.1471-4159.2004.02939.x; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Nicke A, 2008, BIOCHEM BIOPH RES CO, V377, P803, DOI 10.1016/j.bbrc.2008.10.042; Norenberg W, 2000, N-S ARCH PHARMACOL, V362, P324, DOI 10.1007/s002100000311; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ormond SJ, 2006, MOL PHARMACOL, V69, P1692, DOI 10.1124/mol.105.020404; Palygin O, 2010, CELL CALCIUM, V48, P225, DOI 10.1016/j.ceca.2010.09.004; Roberts JA, 2006, PFLUG ARCH EUR J PHY, V452, P486, DOI 10.1007/s00424-006-0073-6; Schuler T, 2008, J BIOL CHEM, V283, P37, DOI 10.1074/jbc.M703539200; Schwindt TT, 2011, J MOL NEUROSCI, V44, P141, DOI 10.1007/s12031-010-9417-y; Sokolova E, 2006, MOL PHARMACOL, V70, P373, DOI 10.1124/mol.106.023564; Soto M, 1996, BIOCHEM BIOPH RES CO, V223, P456, DOI 10.1006/bbrc.1996.0915; Stojilkovic SS, 2010, CELL MOL NEUROBIOL, V30, P1251, DOI 10.1007/s10571-010-9568-y; Torres GE, 1998, MOL PHARMACOL, V54, P989, DOI 10.1124/mol.54.6.989; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; von Kugelgen I, 2011, ADV PHARMACOL, V61, P373, DOI 10.1016/B978-0-12-385526-8.00012-6; Wilkinson WJ, 2006, MOL PHARMACOL, V70, P1159, DOI 10.1124/mol.106.026658; Wirkner K, 2007, MOL NEUROBIOL, V36, P165, DOI 10.1007/s12035-007-0033-y; Zhou Y, 2003, J NEUROSCI, V23, P9004	58	22	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13930	13943		10.1074/jbc.M112.345207	http://dx.doi.org/10.1074/jbc.M112.345207			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22378790	Green Published, hybrid			2022-12-27	WOS:000303996300048
J	Punchihewa, C; Inoue, A; Hishiki, A; Fujikawa, Y; Connelly, M; Evison, B; Shao, YM; Heath, R; Kuraoka, I; Rodrigues, P; Hashimoto, H; Kawanishi, M; Sato, M; Yagi, T; Fujii, N				Punchihewa, Chandanamali; Inoue, Akira; Hishiki, Asami; Fujikawa, Yoshihiro; Connelly, Michele; Evison, Benjamin; Shao, Youming; Heath, Richard; Kuraoka, Isao; Rodrigues, Patrick; Hashimoto, Hiroshi; Kawanishi, Masanobu; Sato, Mamoru; Yagi, Takashi; Fujii, Naoaki			Identification of Small Molecule Proliferating Cell Nuclear Antigen (PCNA) Inhibitor That Disrupts Interactions with PIP-box Proteins and Inhibits DNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-THERAPY; TRANSLESION SYNTHESIS; ONCOGENE ADDICTION; EXCISION-REPAIR; POLYMERASE-ETA; MECHANISMS; RESISTANCE; DOMAINS; COMPLEX; PHOSPHORYLATION	We have discovered that 3,3',5-triiodothyronine (T3) inhibits binding of a PIP-box sequence peptide to proliferating cell nuclear antigen (PCNA) protein by competing for the same binding site, as evidenced by the co-crystal structure of the PCNA-T3 complex at 2.1 angstrom resolution. Based on this observation, we have designed a novel, non-peptide small molecule PCNA inhibitor, T2 amino alcohol (T2AA), a T3 derivative that lacks thyroid hormone activity. T2AA inhibited interaction of PCNA/PIP-box peptide with an IC50 of similar to 1 mu M and also PCNA and full-length p21 protein, the tightest PCNA ligand protein known to date. T2AA abolished interaction of PCNA and DNA polymerase delta in cellular chromatin. De novo DNA synthesis was inhibited by T2AA, and the cells were arrested in S-phase. T2AA inhibited growth of cancer cells with induction of early apoptosis. Concurrently, Chk1 and RPA32 in the chromatin are phosphorylated, suggesting that T2AA causes DNA replication stress by stalling DNA replication forks. T2AA significantly inhibited translesion DNA synthesis on a cisplatin-cross-linked template in cells. When cells were treated with a combination of cisplatin and T2AA, a significant increase in phospho(Ser(139))histone H2AX induction and cell growth inhibition was observed.	[Punchihewa, Chandanamali; Inoue, Akira; Connelly, Michele; Evison, Benjamin; Fujii, Naoaki] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Shao, Youming; Heath, Richard] St Jude Childrens Res Hosp, Prot Prod Facil, Memphis, TN 38105 USA; [Hishiki, Asami; Hashimoto, Hiroshi; Sato, Mamoru] Yokohama City Univ, Dept Supramol Biol, Grad Sch Integrated Sci, Yokohama, Kanagawa 2300045, Japan; [Fujikawa, Yoshihiro; Kawanishi, Masanobu; Yagi, Takashi] Osaka Prefecture Univ, Lab Mol & Cellular Genet, Dept Biol, Grad Sch Sci, Sakai, Osaka 5998570, Japan; [Kuraoka, Isao] Osaka Univ, Biol Chem Grp, Div Chem, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Yokohama City University; Osaka Metropolitan University; Osaka University	Fujii, N (corresponding author), St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	naoaki.fujii@stjude.org	Yagi, Takashi/AAR-7673-2021; Fujii, Naoaki/I-6423-2013	Kuraoka, Isao/0000-0001-6391-3411; Heath, Richard/0000-0002-1795-1254; Hashimoto, Hiroshi/0000-0003-1503-6789	American Lebanese Syrian Associated Charities; American Cancer Society [RSG CDD-120969]; Ministry of Education, Culture, Sports, Science and Technology, Japan [B 19710058]; KAKENHI; Grants-in-Aid for Scientific Research [23770125] Funding Source: KAKEN	American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); American Cancer Society(American Cancer Society); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the American Lebanese Syrian Associated Charities, American Cancer Society Research Scholar Grant RSG CDD-120969 (to A. I. and N. F.), Grant-in-aid for Scientific Research for Young Scientists B 19710058 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to M. K.), and KAKENHI and the Targeted Proteins Research Program from MEXT, Japan (to A. H., H. H., and M. S.).	Acharya N, 2008, P NATL ACAD SCI USA, V105, P17724, DOI 10.1073/pnas.0809844105; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Banath JP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-4; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; Chilkova O, 2007, NUCLEIC ACIDS RES, V35, P6588, DOI 10.1093/nar/gkm741; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Galea AM, 2010, CHEM BIOL DRUG DES, V75, P578, DOI 10.1111/j.1747-0285.2010.00969.x; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Haracska L, 2001, MOL CELL BIOL, V21, P7199, DOI 10.1128/MCB.21.21.7199-7206.2001; Hishiki A, 2008, ACTA CRYSTALLOGR F, V64, P819, DOI 10.1107/S174430910802277X; Hishiki A, 2009, J BIOL CHEM, V284, P10552, DOI 10.1074/jbc.M809745200; Iida T, 2002, GENES CELLS, V7, P997, DOI 10.1046/j.1365-2443.2002.00584.x; Inoue A, 2007, CELL CYCLE, V6, P1646, DOI 10.4161/cc.6.13.4411; Kawanishi M, 1998, CHEM RES TOXICOL, V11, P1468, DOI 10.1021/tx9801054; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; LEESON PD, 1988, J MED CHEM, V31, P37, DOI 10.1021/jm00396a008; Lehmann AR, 2006, EXP CELL RES, V312, P2673, DOI 10.1016/j.yexcr.2006.06.010; Levin DS, 2000, CURR BIOL, V10, P919, DOI 10.1016/S0960-9822(00)00619-9; LI R, 1994, NATURE, V371, P534, DOI 10.1038/371534a0; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; MATSUMOTO K, 1987, EMBO J, V6, P637, DOI 10.1002/j.1460-2075.1987.tb04802.x; Matsumoto M, 2007, J CELL SCI, V120, P1104, DOI 10.1242/jcs.03391; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Ohta S, 2002, J BIOL CHEM, V277, P40362, DOI 10.1074/jbc.M206194200; Sawai T., 2009, GENES ENV, V31, P24; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Shimura T, 2008, J MOL BIOL, V375, P1152, DOI 10.1016/j.jmb.2007.11.006; Shivji Mahmud K K, 2006, Methods Mol Biol, V314, P435; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Stolimenov I, 2009, BIOCHEM SOC T, V37, P605, DOI 10.1042/BST0370605; Taddei A, 1999, J CELL BIOL, V147, P1153, DOI 10.1083/jcb.147.6.1153; Vassin VM, 2009, J CELL SCI, V122, P4070, DOI 10.1242/jcs.053702; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386	44	93	94	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14289	14300		10.1074/jbc.M112.353201	http://dx.doi.org/10.1074/jbc.M112.353201			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22383522	Green Published, hybrid			2022-12-27	WOS:000303996300080
J	Urzica, EI; Adler, LN; Page, MD; Linster, CL; Arbing, MA; Casero, D; Pellegrini, M; Merchant, SS; Clarke, SG				Urzica, Eugen I.; Adler, Lital N.; Page, M. Dudley; Linster, Carole L.; Arbing, Mark A.; Casero, David; Pellegrini, Matteo; Merchant, Sabeeha S.; Clarke, Steven G.			Impact of Oxidative Stress on Ascorbate Biosynthesis in Chlamydomonas via Regulation of the VTC2 Gene Encoding a GDP-L-galactose Phosphorylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERT-BUTYL HYDROPEROXIDE; DE-NOVO BIOSYNTHESIS; VITAMIN-C CONTENT; ACID BIOSYNTHESIS; MONODEHYDROASCORBATE REDUCTASE; ARABIDOPSIS-THALIANA; ENHANCED TOLERANCE; HYDROGEN-PEROXIDE; PLANTS; PATHWAY	The L-galactose (Smirnoff-Wheeler) pathway represents the major route to L-ascorbic acid (vitamin C) biosynthesis in higher plants. Arabidopsis thaliana VTC2 and its paralogue VTC5 function as GDP-L-galactose phosphorylases converting GDP-L-galactose to L-galactose-1-P, thus catalyzing the first committed step in the biosynthesis of L-ascorbate. Here we report that the L-galactose pathway of ascorbate biosynthesis described in higher plants is conserved in green algae. The Chlamydomonas reinhardtii genome encodes all the enzymes required for vitamin C biosynthesis via the L-galactose pathway. We have characterized recombinant C. reinhardtii VTC2 as an active GDP-L-galactose phosphorylase. C. reinhardtii cells exposed to oxidative stress show increased VTC2 mRNA and L-ascorbate levels. Genes encoding enzymatic components of the ascorbate-glutathione system (e.g. ascorbate peroxidase, manganese super oxide dismutase, and dehydro ascorbate reductase) are also up-regulated in response to increased oxidative stress. These results indicate that C. reinhardtii VTC2, like its plant homologs, is a highly regulated enzyme in ascorbate biosynthesis in green algae and that, together with the ascorbate recycling system, the L-galactose pathway represents the major route for providing protective levels of ascorbate in oxidatively stressed algal cells.	[Urzica, Eugen I.; Adler, Lital N.; Page, M. Dudley; Linster, Carole L.; Merchant, Sabeeha S.; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Casero, David; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Arbing, Mark A.; Pellegrini, Matteo; Merchant, Sabeeha S.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Merchant, Sabeeha S.; Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Linster, Carole L.] Catholic Univ Louvain, de Duve Inst, BCHM 7539, B-1200 Brussels, Belgium	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Universite Catholique Louvain	Merchant, SS (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	sabeeha@chem.ucla.edu; clarke@mbi.ucla.edu	Urzica, Eugen Ioan/GXV-9546-2022; Casero, David/E-7365-2010; Urzica, Eugen I/B-7903-2013	Urzica, Eugen Ioan/0000-0002-1028-7442; Casero, David/0000-0002-7347-3330; Linster, Carole/0000-0001-7143-0719; Pellegrini, Matteo/0000-0001-9355-9564	National Institutes of Health [GM026020]; Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FD02-04ER15529]; Ellison Medical Foundation; UCLA; Department of Energy [DE-FC03-02ER63421]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026020, R01GM026020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); Ellison Medical Foundation(Lawrence Ellison Foundation); UCLA; Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM026020 (to S. G. C.), the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy Grant DE-FD02-04ER15529 (to S. S. M.), an Ellison Medical Foundation Senior Scholar Award (to S. G. C.), and UCLA Philip Whitcome and Graduate Division Dissertation Year Fellowships (to L. N. A.). The preparation of recombinant VTC2 enzyme was supported by the Department of Energy Grant DE-FC03-02ER63421 (to David Eisenberg).	Adler LN, 2011, J BIOL CHEM, V286, P21511, DOI 10.1074/jbc.M111.238774; Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Alia M, 2005, J BIOCHEM MOL TOXIC, V19, P119, DOI 10.1002/jbt.20061; Allen MD, 2007, EUKARYOT CELL, V6, P1841, DOI 10.1128/EC.00205-07; Allen MD, 2007, PLANT PHYSIOL, V143, P263, DOI 10.1104/pp.106.088609; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Brenner C., 2007, ENCY LIFE SCI, P1; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Chen Z, 2005, PLANT PHYSIOL, V138, P1673, DOI 10.1104/pp.105.062000; Chen Z, 2003, P NATL ACAD SCI USA, V100, P3525, DOI 10.1073/pnas.0635176100; Conklin PL, 1996, P NATL ACAD SCI USA, V93, P9970, DOI 10.1073/pnas.93.18.9970; CRAIGIE RA, 1982, J CELL SCI, V54, P173; Daskalopoulos R, 2002, GLIA, V39, P124, DOI 10.1002/glia.10099; DIMATTEO A, 2003, COMP BIOCH PHYSL A, V134, pS155; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; Drahota Z, 2005, PHYSIOL RES, V54, P67, DOI 10.33549/physiolres.930578; Eltayeb AE, 2007, PLANTA, V225, P1255, DOI 10.1007/s00425-006-0417-7; Filkowski J, 2004, PLANT J, V38, P60, DOI 10.1111/j.1365-313X.2004.02020.x; Fischer BB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-279; Fox Jeffrey D, 2003, Methods Mol Biol, V205, P99; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; GLASCOTT PA, 1995, MOL PHARMACOL, V48, P80; GRUN M, 1984, PLANTA, V160, P6, DOI 10.1007/BF00392459; Guranowski A, 2010, FEBS LETT, V584, P93, DOI 10.1016/j.febslet.2009.11.003; Hancock RD, 2005, CRIT REV PLANT SCI, V24, P167, DOI 10.1080/07352680591002165; Harris E.H, 2009, INTRO CHLAMYDOMONAS; HELSPER JP, 1982, PLANT PHYSIOL, V69, P465, DOI 10.1104/pp.69.2.465; Ishikawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P1143, DOI 10.1271/bbb.80062; Ishikawa Takahiro, 2008, J Biol Chem, V283, P31133, DOI 10.1074/jbc.M803930200; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; Laing WA, 2007, P NATL ACAD SCI USA, V104, P9534, DOI 10.1073/pnas.0701625104; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkindale J, 2005, PLANT PHYSIOL, V138, P882, DOI 10.1104/pp.105.062257; Ledford HK, 2007, EUKARYOT CELL, V6, P919, DOI 10.1128/EC.00207-06; Leferink NGH, 2008, FEBS J, V275, P713, DOI 10.1111/j.1742-4658.2007.06233.x; Li F, 2010, PHYSIOL PLANTARUM, V139, P421, DOI 10.1111/j.1399-3054.2010.01369.x; Linster CL, 2008, J BIOL CHEM, V283, P18483, DOI 10.1074/jbc.M802594200; Linster CL, 2007, J BIOL CHEM, V282, P18879, DOI 10.1074/jbc.M702094200; Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x; Linster CL, 2008, TRENDS PLANT SCI, V13, P567, DOI 10.1016/j.tplants.2008.08.005; Long JC, 2008, PHOTOCHEM PHOTOBIOL, V84, P1395, DOI 10.1111/j.1751-1097.2008.00451.x; May JM, 1997, J BIOL CHEM, V272, P22607, DOI 10.1074/jbc.272.36.22607; Mori S, 2010, PROTEIN EXPRES PURIF, V69, P99, DOI 10.1016/j.pep.2009.09.010; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muller-Moule P, 2008, PLANT MOL BIOL, V68, P31, DOI 10.1007/s11103-008-9350-4; Muller-Moule P, 2004, PLANT PHYSIOL, V134, P1163, DOI 10.1104/pp.103.032375; Novoselov SV, 2002, EMBO J, V21, P3681, DOI 10.1093/emboj/cdf372; Novoselov SV, 2003, PROTEIN SCI, V12, P372, DOI 10.1110/ps.0226503; Pineau B, 2008, J BIOL CHEM, V283, P32500, DOI 10.1074/jbc.M805320200; Quinn JM, 1998, METHOD ENZYMOL, V297, P263; Radzio JA, 2003, PLANT MOL BIOL, V53, P837, DOI 10.1023/B:PLAN.0000023671.99451.1d; RENSTROM B, 1983, PLANT SCI LETT, V28, P299, DOI 10.1016/S0304-4211(83)80022-4; Running JA, 2003, J EXP BOT, V54, P1841, DOI 10.1093/jxb/erg207; Sanmartin M, 2003, PLANTA, V216, P918, DOI 10.1007/s00425-002-0944-9; SCHLOSS JA, 1990, MOL GEN GENET, V221, P443, DOI 10.1007/BF00259410; SHIGEOKA S, 1979, J NUTR SCI VITAMINOL, V25, P299; Smirnoff N, 2001, ANNU REV PLANT PHYS, V52, P437, DOI 10.1146/annurev.arplant.52.1.437; Smirnoff N, 2000, PHILOS T R SOC B, V355, P1455, DOI 10.1098/rstb.2000.0706; Smirnoff N, 2000, CRIT REV BIOCHEM MOL, V35, P291, DOI 10.1080/10409230008984166; Takeda T, 1997, PHYSIOL PLANTARUM, V99, P49, DOI 10.1111/j.1399-3054.1997.tb03429.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang ZN, 2010, J INTEGR PLANT BIOL, V52, P400, DOI 10.1111/j.1744-7909.2010.00921.x; Watanabe K, 2006, PHYTOCHEMISTRY, V67, P338, DOI 10.1016/j.phytochem.2005.12.003; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wolucka BA, 2003, J BIOL CHEM, V278, P47483, DOI 10.1074/jbc.M309135200; Wolucka BA, 2007, PHYTOCHEMISTRY, V68, P2602, DOI 10.1016/j.phytochem.2007.08.034; Yabuta Y, 2008, BIOSCI BIOTECH BIOCH, V72, P2598, DOI 10.1271/bbb.80284; Zsigmond L, 2011, PLANT PHYSIOL BIOCH, V49, P809, DOI 10.1016/j.plaphy.2011.04.013	70	76	77	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14234	14245		10.1074/jbc.M112.341982	http://dx.doi.org/10.1074/jbc.M112.341982			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22393048	Green Published, hybrid			2022-12-27	WOS:000303996300075
J	Dahl, JM; Mai, AH; Cherf, GM; Jetha, NN; Garalde, DR; Marziali, A; Akeson, M; Wang, HY; Lieberman, KR				Dahl, Joseph M.; Mai, Ai H.; Cherf, Gerald M.; Jetha, Nahid N.; Garalde, Daniel R.; Marziali, Andre; Akeson, Mark; Wang, Hongyun; Lieberman, Kate R.			Direct Observation of Translocation in Individual DNA Polymerase Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAPID CONFORMATIONAL-CHANGES; EXONUCLEASE ACTIVE-SITE; I KLENOW FRAGMENT; CRYSTAL-STRUCTURE; REPLICATION; NANOPORE; FLUORESCENCE; RESOLUTION; SNAPSHOTS; MOLECULES	Complexes of phi29 DNA polymerase and DNA fluctuate on the millisecond time scale between two ionic current amplitude states when captured atop the alpha-hemolysin nanopore in an applied field. The lower amplitude state is stabilized by complementary dNTP and thus corresponds to complexes in the post-translocation state. We have demonstrated that in the upper amplitude state, the DNA is displaced by a distance of one nucleotide from the post-translocation state. We propose that the upper amplitude state corresponds to complexes in the pre-translocation state. Force exerted on the template strand biases the complexes toward the pre-translocation state. Based on the results of voltage and dNTP titrations, we concluded through mathematical modeling that complementary dNTP binds only to the post-translocation state, and we estimated the binding affinity. The equilibrium between the two states is influenced by active site-proximal DNA sequences. Consistent with the assignment of the upper amplitude state as the pre-translocation state, a DNA substrate that favors the pre-translocation state in complexes on the nanopore is a superior substrate in bulk phase for pyrophosphorolysis. There is also a correlation between DNA sequences that bias complexes toward the pre-translocation state and the rate of exonucleolysis in bulk phase, suggesting that during DNA synthesis the pathway for transfer of the primer strand from the polymerase to exonuclease active site initiates in the pre-translocation state.	[Wang, Hongyun] Univ Calif Santa Cruz, Baskin Sch Engn, Dept Appl Math & Stat, Santa Cruz, CA 95064 USA; [Dahl, Joseph M.; Mai, Ai H.; Cherf, Gerald M.; Akeson, Mark; Lieberman, Kate R.] Univ Calif Santa Cruz, Baskin Sch Engn, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Garalde, Daniel R.] Univ Calif Santa Cruz, Baskin Sch Engn, Dept Comp Engn, Santa Cruz, CA 95064 USA; [Jetha, Nahid N.; Marziali, Andre] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of British Columbia	Wang, HY (corresponding author), Univ Calif Santa Cruz, Baskin Sch Engn, Dept Appl Math & Stat, 1156 High St,MS SOE2, Santa Cruz, CA 95064 USA.	hongwang@soe.ucsc.edu; krlieberman@gmail.com	Akeson, Mark/HCH-3046-2022		National Institutes of Health from NIGMS [1R01GM087484-01A2]; NHGRI [1RC2HG005553, R01HG003248]; National Science Foundation [DMS-0719361]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003248, RC2HG005553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087484] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01GM087484-01A2 from NIGMS (to K. R. L. and M. A.) and 1RC2HG005553 (to M. A.) and R01HG003248 (to N. N. J. and A. M.) from NHGRI. This work was also supported by National Science Foundation Grant DMS-0719361 (to H. W.).	Baker RP, 1998, P NATL ACAD SCI USA, V95, P3507, DOI 10.1073/pnas.95.7.3507; BEESE LS, 1993, BIOCHEMISTRY-US, V32, P14095, DOI 10.1021/bi00214a004; Benner S, 2007, NAT NANOTECHNOL, V2, P718, DOI 10.1038/nnano.2007.344; Berman AJ, 2007, EMBO J, V26, P3494, DOI 10.1038/sj.emboj.7601780; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; Blanco L, 1996, J BIOL CHEM, V271, P8509, DOI 10.1074/jbc.271.15.8509; Cockroft SL, 2008, J AM CHEM SOC, V130, P818, DOI 10.1021/ja077082c; de Vega M, 1999, J MOL BIOL, V292, P39, DOI 10.1006/jmbi.1999.3052; deVega M, 1996, EMBO J, V15, P1182, DOI 10.1002/j.1460-2075.1996.tb00457.x; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Eom SH, 1996, NATURE, V382, P278, DOI 10.1038/382278a0; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Garalde DR, 2011, J BIOL CHEM, V286, P14480, DOI 10.1074/jbc.M111.218750; GARMENDIA C, 1992, J BIOL CHEM, V267, P2594; Hariharan C, 2006, BIOCHEMISTRY-US, V45, P2836, DOI 10.1021/bi051644s; Hariharan C, 2005, BIOCHEMISTRY-US, V44, P15674, DOI 10.1021/bi051462y; Hogg M, 2004, EMBO J, V23, P1483, DOI 10.1038/sj.emboj.7600150; Hurt N, 2009, J AM CHEM SOC, V131, P3772, DOI 10.1021/ja809663f; Ibarra B, 2009, EMBO J, V28, P2794, DOI 10.1038/emboj.2009.219; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Joyce CM, 2008, BIOCHEMISTRY-US, V47, P6103, DOI 10.1021/bi7021848; JOYCE CM, 1989, J BIOL CHEM, V264, P10858; Kamtekar S, 2004, MOL CELL, V16, P609, DOI 10.1016/j.molcel.2004.10.019; Lieberman KR, 2010, J AM CHEM SOC, V132, P17961, DOI 10.1021/ja1087612; Olasagasti F, 2010, NAT NANOTECHNOL, V5, P798, DOI [10.1038/nnano.2010.177, 10.1038/NNANO.2010.177]; Salas M, 2008, IUBMB LIFE, V60, P82, DOI 10.1002/iub.19; Santoso Y, 2010, P NATL ACAD SCI USA, V107, P715, DOI 10.1073/pnas.0910909107; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; Zahn KE, 2011, J BIOL CHEM, V286, P25246, DOI 10.1074/jbc.M111.248864; Zhang H, 2007, NUCLEIC ACIDS RES, V35, P6052, DOI 10.1093/nar/gkm587	30	25	32	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13407	13421		10.1074/jbc.M111.338418	http://dx.doi.org/10.1074/jbc.M111.338418			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22378784	Green Published, hybrid			2022-12-27	WOS:000302903700075
J	Fujimura, T; Esteban, R				Fujimura, Tsutomu; Esteban, Rosa			Cap Snatching of Yeast L-A Double-stranded RNA Virus Can Operate in Trans and Requires Viral Polymerase Actively Engaging in Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC MESSENGER-RNA; POL FUSION PROTEIN; SACCHAROMYCES-CEREVISIAE; CAPPING ENZYME; STRUCTURAL BASIS; VACCINIA VIRUS; GUANYLYLTRANSFERASE; RECOGNITION; BINDING; PARTICLES	Eukaryotic mRNA bears a cap structure (m(7)GpppX-) at the 5' terminus crucial for efficient translation and stability. The yeast L-A double-stranded RNA virus furnishes its mRNA with this structure by a novel cap-snatching mechanism in which the virus transfers an m(7)Gp moiety from host mRNA to the diphosphorylated 5' terminus of the viral transcript, thus forming on it an authentic cap structure (referred to as cap0) in the budding yeast. This capping reaction is essential for efficient viral expression. His-154 of the capsid protein Gag is involved in the cap transfer. Here we show that the virus can utilize an externally added viral transcript as acceptor in the capping reaction. The acceptor needs to be 5' diphosphorylated, consistent with the fact that the viral transcript bears diphosphate at the 5' terminus. A 5' triphosphorylated or monophosphorylated transcript does not function as acceptor. N7 methylation at the 5' cap guanine of mRNA is essential for cap donor activity. We also demonstrate that the capping reaction requires the viral polymerase actively engaging in transcription. Because the cap-snatching site of Gag is located at the cytoplasmic surface of the virion, whereas Pol is confined inside the virion, the result indicates coordination between the cap-snatching and polymerization sites. This will allow L-A virus to efficiently produce capsid proteins to form new virions when Pol is actively engaging in transcription. The coordination may also minimize the risk of accidental capping of nonviral RNA when Pol is dormant.	[Fujimura, Tsutomu; Esteban, Rosa] Univ Salamanca, CSIC, Inst Biol Func & Genom, Salamanca 37007, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Fujimura, T (corresponding author), Univ Salamanca, CSIC, Inst Biol Func & Genom, Edificio Dept,Avda Campo Charro S-N, Salamanca 37007, Spain.	tfujimura@usal.es	Fujimura, Tsutomu/K-5807-2014; Esteban, Rosa/K-4356-2014	Fujimura, Tsutomu/0000-0002-9457-6769; Esteban, Rosa/0000-0001-6804-7209	Spanish Ministry of Education and Science [BFU2010-15768]; Fundacion Ramon Areces	Spanish Ministry of Education and Science(Spanish Government); Fundacion Ramon Areces	This work was supported by Grant BFU2010-15768 from the Spanish Ministry of Education and Science and by Fundacion Ramon Areces.	BLANC A, 1994, MOL CELL BIOL, V14, P2664, DOI 10.1128/MCB.14.4.2664; BLANC A, 1992, MOL CELL BIOL, V12, P3390, DOI 10.1128/MCB.12.8.3390; Boivin S, 2010, J BIOL CHEM, V285, P28411, DOI 10.1074/jbc.R110.117531; Chu C, 2011, P NATL ACAD SCI USA, V108, P10104, DOI 10.1073/pnas.1106610108; DINMAN JD, 1991, P NATL ACAD SCI USA, V88, P174, DOI 10.1073/pnas.88.1.174; ESTEBAN R, 1988, P NATL ACAD SCI USA, V85, P4411, DOI 10.1073/pnas.85.12.4411; Fechter P, 2005, J GEN VIROL, V86, P1239, DOI 10.1099/vir.0.80755-0; FUJIMURA T, 1992, J BIOL CHEM, V267, P2708; FUJIMURA T, 1992, NATURE, V359, P746, DOI 10.1038/359746a0; FUJIMURA T, 1986, P NATL ACAD SCI USA, V83, P4433, DOI 10.1073/pnas.83.12.4433; Fujimura T, 2011, P NATL ACAD SCI USA, V108, P17667, DOI 10.1073/pnas.1111900108; Fujimura T, 2010, J BIOL CHEM, V285, P22909, DOI 10.1074/jbc.M110.138982; FURUICHI Y, 1977, NATURE, V266, P235, DOI 10.1038/266235a0; GEORGOPOULOS DE, 1987, YEAST, V3, P117, DOI 10.1002/yea.320030208; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; Hu GH, 1999, P NATL ACAD SCI USA, V96, P7149, DOI 10.1073/pnas.96.13.7149; Huang YL, 2005, J BIOL CHEM, V280, P13153, DOI 10.1074/jbc.M412619200; ICHO T, 1989, J BIOL CHEM, V264, P6716; Liu HD, 2002, EMBO J, V21, P4699, DOI 10.1093/emboj/cdf448; Maniatis T., 1982, MOL CLONING LABORATO, P156; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; MARTIN SA, 1975, J BIOL CHEM, V250, P9330; MUTHUKRISHNAN S, 1975, NATURE, V255, P33, DOI 10.1038/255033a0; Naitow H, 2002, NAT STRUCT BIOL, V9, P725, DOI 10.1038/nsb844; Ogino T, 2010, P NATL ACAD SCI USA, V107, P3463, DOI 10.1073/pnas.0913083107; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Rahmeh AA, 2009, J VIROL, V83, P11043, DOI 10.1128/JVI.01426-09; Rodriguez CR, 1999, NUCLEIC ACIDS RES, V27, P2181, DOI 10.1093/nar/27.10.2181; SHUMAN S, 1980, J BIOL CHEM, V255, P5396; SHUMAN S, 1995, PROG NUCLEIC ACID RE, V50, P101, DOI 10.1016/S0079-6603(08)60812-0; Tang JH, 2005, J MOL RECOGNIT, V18, P158, DOI 10.1002/jmr.724; VENKATESAN S, 1980, J BIOL CHEM, V255, P903; Wang ZR, 2001, CELL, V107, P751, DOI 10.1016/S0092-8674(01)00592-X; Wickner R.B., 2007, FIELDS VIROLOGY, P737	35	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12797	12804		10.1074/jbc.M111.327676	http://dx.doi.org/10.1074/jbc.M111.327676			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367202	Green Published, hybrid			2022-12-27	WOS:000302903700019
J	Islam, KN; Koch, WJ				Islam, Kazi N.; Koch, Walter J.			Involvement of Nuclear Factor kappa B (NF-kappa B) Signaling Pathway in Regulation of Cardiac G Protein-coupled Receptor Kinase 5 (GRK5) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CARDIOMYOCYTE HYPERTROPHY; A GENE-EXPRESSION; HEART-FAILURE; IN-VIVO; ACTIVATION; ALPHA; TRANSCRIPTION; MECHANISMS; OXYGEN; CELLS	G protein-coupled receptor kinase 5 (GRK5) plays a key role in cardiac signaling regulation, and its expression is increased in heart failure. Recently, increased expression of GRK5 in the myocardium of mice has been shown to be detrimental in the setting of pressure-overload hypertrophy. The ubiquitous nuclear transcription factor kappa B (NF-kappa B) is involved in the regulation of numerous genes in various tissues, and activation of NF-kappa B has been shown to be associated with heart disease. Here, we investigated the role of NF-kappa B signaling in the regulation of the GRK5 gene and expression of this kinase in cardiomyocytes. First, in analyzing the 5 '-flanking DNA of GRK5, the presence of a potential NF-kappa B binding site was observed in the promoter region. Phorbol myristate acetate, a known stimulator of NF-kappa B, increased the levels of GRK5 in myocytes whereas treatment of cells with N-acetyl cysteine, a known inhibitor of NF-kappa B, or with SC 514, an inhibitor of I kappa B kinase 2 decreased GRK5. Utilizing EMSA or ChIP assays, we found that both p50 and p65 NF-kappa B could interact with the promoter of GRK5 following myocytes NF-kappa B activation. Importantly, short interfering RNA (siRNA)-mediated loss of p65 in myocytes decreased the stimulated increased levels of GRK5 mRNA and protein. Finally, adenovirus-mediated overexpression of a dominant-negative I kappa B alpha in myocytes inhibited the levels of GRK5. Taken together, our study demonstrates that NF-kappa B plays a critical role in the regulation of GRK5 transcription in myocytes and that this may translate to the significant expression changes seen in heart disease.	[Islam, Kazi N.; Koch, Walter J.] Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA	Jefferson University	Islam, KN (corresponding author), Temple Univ, Sch Med, Ctr Translat Med, 3500 N Broad St,904B MERB, Philadelphia, PA 19140 USA.	kazi.islam@temple.edu; walter.koch@temple.edu			National Institute of Heath [P01 HL091799, R37 HL061690, P01 HL075443, R01 HL085503]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL091799, R01HL085503, P01HL075443, R37HL061690] Funding Source: NIH RePORTER	National Institute of Heath; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institute of Heath Grants P01 HL091799 (Project 1) (to W. J. K), R37 HL061690 (to W. J. K), P01 HL075443 (Project 2) (to W. J. K), R01 HL085503 (to W. J. K.).	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Akhter SA, 1998, SCIENCE, V280, P574, DOI 10.1126/science.280.5363.574; Brinks Henriette, 2010, Drug Discov Today Dis Mech, V7, pe129, DOI 10.1016/j.ddmec.2010.07.007; Brinks H, 2010, CIRC RES, V107, P1140, DOI 10.1161/CIRCRESAHA.110.221010; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Freund C, 2005, CIRCULATION, V111, P2319, DOI 10.1161/01.CIR.0000164237.58200.5A; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Grabellus F, 2002, CARDIOVASC RES, V53, P124, DOI 10.1016/S0008-6363(01)00433-3; Higuchi Y, 2002, J MOL CELL CARDIOL, V34, P233, DOI 10.1006/jmcc.2001.1505; Hirotani S, 2002, CIRCULATION, V105, P509, DOI 10.1161/hc0402.102863; Huang ZM, 2011, FRONT BIOSCI-LANDMRK, V16, P3047, DOI 10.2741/3898; Islam KN, 2008, MOL ENDOCRINOL, V22, P585, DOI 10.1210/me.2007-0412; Islam KN, 2006, MOL CELL BIOL, V26, P2901, DOI 10.1128/MCB.26.8.2901-2912.2006; Johnson LR, 2004, MOL CELL BIOL, V24, P10169, DOI 10.1128/MCB.24.23.10169-10179.2004; Jones WK, 2005, CARDIOVASC TOXICOL, V5, P183, DOI 10.1385/CT:5:2:183; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Lee HB, 2004, KIDNEY INT, V65, P1170, DOI 10.1111/j.1523-1755.2004.00491.x; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Luedde Mark, 2006, Recent Pat Cardiovasc Drug Discov, V1, P1, DOI 10.2174/157489006775244290; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Patial S, 2011, J CELL PHYSIOL, V226, P1323, DOI 10.1002/jcp.22460; Patial S, 2010, BIOCHEM J, V425, P169, DOI 10.1042/BJ20090908; Peppel K, 2005, CARDIOVASC RES, V65, P674, DOI 10.1016/j.cardiores.2004.10.031; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Purcell NH, 2001, P NATL ACAD SCI USA, V98, P6668, DOI 10.1073/pnas.111155798; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Sorriento D, 2010, HYPERTENSION, V56, P696, DOI 10.1161/HYPERTENSIONAHA.110.155960; Sorriento D, 2008, P NATL ACAD SCI USA, V105, P17818, DOI 10.1073/pnas.0804446105; Valen G, 2001, J AM COLL CARDIOL, V38, P307, DOI 10.1016/S0735-1097(01)01377-8; Vijayan K, 2004, AM J PHYSIOL-HEART C, V287, pH2777, DOI 10.1152/ajpheart.00171.2004; Yi YP, 2002, HYPERTENSION, V39, P1058, DOI 10.1161/01.HYP0000019130.09167.3B; Zelarayan L, 2009, CARDIOVASC RES, V84, P416, DOI 10.1093/cvr/cvp237; Zhang Y, 2011, CIRC-HEART FAIL, V4, P659, DOI 10.1161/CIRCHEARTFAILURE.111.962563	37	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12771	12778		10.1074/jbc.M111.324566	http://dx.doi.org/10.1074/jbc.M111.324566			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22389501	Green Published, hybrid			2022-12-27	WOS:000302903700016
J	Kashima, L; Idogawa, M; Mita, H; Shitashige, M; Yamada, T; Ogi, K; Suzuki, H; Toyota, M; Ariga, H; Sasaki, Y; Tokino, T				Kashima, Lisa; Idogawa, Masashi; Mita, Hiroaki; Shitashige, Miki; Yamada, Tesshi; Ogi, Kazuhiro; Suzuki, Hiromu; Toyota, Minoru; Ariga, Hiroyoshi; Sasaki, Yasushi; Tokino, Takashi			CHFR Protein Regulates Mitotic Checkpoint by Targeting PARP-1 Protein for Ubiquitination and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(ADP-RIBOSE) POLYMERASE-1; EPIGENETIC INACTIVATION; MICROTUBULE INHIBITORS; COLORECTAL-CANCER; BETA-CATENIN; CELL-CYCLE; GENE; EXPRESSION; DNA; INSTABILITY	The mitotic checkpoint gene CHFR (checkpoint with fork-head-associated (FHA) and RING finger domains) is silenced by promoter hypermethylation or mutated in various human cancers, suggesting that CHFR is an important tumor suppressor. Recent studies have reported that CHFR functions as an E3 ubiquitin ligase, resulting in the degradation of target proteins. To better understand how CHFR suppresses cell cycle progression and tumorigenesis, we sought to identify CHFR-interacting proteins using affinity purification combined with mass spectrometry. Here we show poly(ADP-ribose) polymerase 1 (PARP-1) to be a novel CHFR-interacting protein. In CHFR-expressing cells, mitotic stress induced the autoPARylation of PARP-1, resulting in an enhanced interaction between CHFR and PARP-1 and an increase in the polyubiquitination/degradation of PARP-1. The decrease in PARP-1 protein levels promoted cell cycle arrest at prophase, supporting that the cells expressing CHFR were resistant to microtubule inhibitors. In contrast, in CHFR-silenced cells, polyubiquitination was not induced in response to mitotic stress. Thus, PARP-1 protein levels did not decrease, and cells progressed into mitosis under mitotic stress, suggesting that CHFR-silenced cancer cells were sensitized to microtubule inhibitors. Furthermore, we found that cells from Chfr knockout mice and CHFR-silenced primary gastric cancer tissues expressed higher levels of PARP-1 protein, strongly supporting our data that the interaction between CHFR and PARP-1 plays an important role in cell cycle regulation and cancer therapeutic strategies. On the basis of our studies, we demonstrate a significant advantage for use of combinational chemotherapy with PARP inhibitors for cancer cells resistant to microtubule inhibitors.	[Tokino, Takashi] Sapporo Med Univ, Dept Med Genome Sci, Res Inst Frontier Med, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Shitashige, Miki; Yamada, Tesshi] Natl Inst Canc Res, Div Chemotherapy, Tokyo 1040045, Japan; [Shitashige, Miki; Yamada, Tesshi] Natl Inst Canc Res, Canc Prote Project, Tokyo 1040045, Japan; [Suzuki, Hiromu; Toyota, Minoru] Sapporo Med Univ, Dept Mol Biol, Sapporo, Hokkaido 0608556, Japan; [Kashima, Lisa; Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan	Sapporo Medical University; National Cancer Center - Japan; National Cancer Center - Japan; Sapporo Medical University; Hokkaido University	Tokino, T (corresponding author), Sapporo Med Univ, Dept Med Genome Sci, Res Inst Frontier Med, Chuo Ku, S-1,W-17, Sapporo, Hokkaido 0608556, Japan.	tokino@sapmed.ac.jp	Ariga, Hiroyoshi/B-5895-2013; Tokino, Takashi/AAI-9887-2021; Sasaki, Yasushi/AAA-3079-2019; Idogawa, Masashi/B-5208-2008	Ariga, Hiroyoshi/0000-0001-7384-2143; Sasaki, Yasushi/0000-0002-3500-8059; Idogawa, Masashi/0000-0002-8507-1726	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Kanzawa Medical Research Foundation; Grants-in-Aid for Scientific Research [21390014] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T. T.) and the Kanzawa Medical Research Foundation (to L. K.).	Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Annunziata CM, 2010, CLIN CANCER RES, V16, P4517, DOI 10.1158/1078-0432.CCR-10-0526; Bieche I, 1996, CLIN CANCER RES, V2, P1163; Bothos J, 2003, ONCOGENE, V22, P7101, DOI 10.1038/sj.onc.1206831; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Chang P, 2004, NATURE, V432, P645, DOI 10.1038/nature03061; Chaturvedi P, 2002, CANCER RES, V62, P1797; Idogawa M, 2005, GASTROENTEROLOGY, V128, P1919, DOI 10.1053/j.gastro.2005.03.007; Idogawa M, 2007, CANCER RES, V67, P911, DOI 10.1158/0008-5472.CAN-06-2360; Igarashi S, 2010, CLIN CANCER RES, V16, P5114, DOI 10.1158/1078-0432.CCR-10-0581; Kang DM, 2002, J CELL BIOL, V156, P249, DOI 10.1083/jcb.200108016; Kashima L, 2009, ONCOGENE, V28, P2643, DOI 10.1038/onc.2009.123; Kawasaki T, 2008, MODERN PATHOL, V21, P245, DOI 10.1038/modpathol.3800982; Martin N, 2009, EMBO J, V28, P3534, DOI 10.1038/emboj.2009.279; Miwa M, 2007, CANCER SCI, V98, P1528, DOI 10.1111/j.1349-7006.2007.00567.x; Ogi K, 2005, CANCER BIOL THER, V4, P773, DOI 10.4161/cbt.4.7.1896; Privette LM, 2008, TRANSL ONCOL, V1, P57, DOI 10.1593/tlo.08109; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Satoh A, 2003, CANCER RES, V63, P8606; Saxena A, 2002, J BIOL CHEM, V277, P26921, DOI 10.1074/jbc.M200620200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Shimizu S, 2004, ONCOL REP, V12, P821; Soldatenkov VA, 1999, ONCOGENE, V18, P3954, DOI 10.1038/sj.onc.1202778; Suzuki H, 2000, CANCER RES, V60, P4353; TANUMA S, 1982, J BIOL CHEM, V257, P6565; Tentori L, 2010, CURR CANCER DRUG TAR, V10, P368, DOI 10.2174/156800910791208571; TOMODA T, 1991, AM J HEMATOL, V37, P223, DOI 10.1002/ajh.2830370402; Toyota M, 2003, P NATL ACAD SCI USA, V100, P7818, DOI 10.1073/pnas.1337066100; Wang T, 2008, J CELL BIOCHEM, V104, P318, DOI 10.1002/jcb.21624; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wesierska-Gadek J, 2004, CANCER RES, V64, P4487, DOI 10.1158/0008-5472.CAN-03-3410; Yu XC, 2005, NAT GENET, V37, P401, DOI 10.1038/ng1538	33	70	74	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12975	12984		10.1074/jbc.M111.321828	http://dx.doi.org/10.1074/jbc.M111.321828			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22337872	hybrid, Green Published			2022-12-27	WOS:000302903700036
J	Kuhbacher, A; Dambournet, D; Echard, A; Cossart, P; Pizarro-Cerda, J				Kuehbacher, Andreas; Dambournet, Daphne; Echard, Arnaud; Cossart, Pascale; Pizarro-Cerda, Javier			Phosphatidylinositol 5-Phosphatase Oculocerebrorenal Syndrome of Lowe Protein (OCRL) Controls Actin Dynamics during Early Steps of Listeria monocytogenes Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE METABOLISM; MEMBRANE TRAFFICKING; BACTERIAL PATHOGENS; MET RECEPTOR; INVASION; 3-KINASE; BINDING; CELLS; PATHWAY; KINASE	Listeria monocytogenes is a bacterial pathogen that induces its own entry into a broad range of mammalian cells through interaction of the bacterial surface protein InlB with the cellular receptor Met, promoting an actin polymerization/depolymerization process that leads to pathogen engulfment. Phosphatidylinositol bisphosphate (PI[4,5]P-2) and trisphosphate (PI[3,4,5]P-3) are two major phosphoinositide species that function as molecular scaffolds, recruiting cellular effectors that regulate actin dynamics during L. monocytogenes infection. Because the phosphatidylinositol 5'-phosphatase OCRL dephosphorylates PI(4,5)P-2 and to a lesser extent PI(3,4,5)P-3, we investigated whether this phosphatase modulates cell invasion by L. monocytogenes. Inactivation of OCRL by small interfering RNA( siRNA) leads to an increase in the internalization levels of L. monocytogenes in HeLa cells. Interestingly, OCRL depletion does not increase but rather decreases the surface expression of the receptor Met, suggesting that OCRL controls bacterial internalization by modulating signaling cascades downstream of Met. Immuno-fluorescence microscopy reveals that endogenous and overexpressed OCRL are present at L. monocytogenes invasion foci; live-cell imaging additionally shows that actin depolymerization coincides with EGFP-OCRL-a accumulation around invading bacteria. Together, these observations suggest that OCRL promotes actin depolymerization during L. monocytogenes infection; in agreement with this hypothesis, OCRL depletion leads to an increase in actin, PI(4,5)P-2, and PI(3,4,5)P3 levels at bacterial internalization foci. Furthermore, in cells knocked down for OCRL, transfection of enzymatically active EGFP-OCRL-a (but not of a phosphatase-dead enzyme) decreases the levels of intracellular L. monocytogenes and of actin associated with invading bacteria. These results demonstrate that through its phosphatase activity, OCRL restricts L. monocytogenes invasion by modulating actin dynamics at bacterial internalization sites.	[Kuehbacher, Andreas; Cossart, Pascale; Pizarro-Cerda, Javier] Inst Pasteur, INSERM, U604, Unite Interact Bacteries Cellules,INRA,USC2020, F-75724 Paris 15, France; [Dambournet, Daphne] Univ Paris 06, Cellule Pasteur UPMC, F-75015 Paris, France; [Dambournet, Daphne; Echard, Arnaud] Inst Pasteur, Unite Traff Membranaire, F-75724 Paris 15, France; [Dambournet, Daphne; Echard, Arnaud] Inst Pasteur, Div Cellulaire, F-75724 Paris 15, France; [Dambournet, Daphne; Echard, Arnaud] CNRS, URA2582, F-75015 Paris, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Pizarro-Cerda, J (corresponding author), Inst Pasteur, INSERM, U604, Unite Interact Bacteries Cellules,INRA,USC2020, 28 Rue Docteur Roux, F-75724 Paris 15, France.	pizarroj@pasteur.fr		Echard, Arnaud/0000-0001-7402-1398	Pasteur Institute; European Research Council [233348]; INSERM; INRA; CNRS; Louis-Jeantet Foundation; La Fondation Le Roch-Les Mousquetaires; Agence Nationale de la Recherche [ANR-09-MIEN-020, ANR-07-JCJC-0089]; Schlumberger Foundation for Education and Research; Ministere de la Recherche et de l'Enseignement Superieur; Association pour la Recherche sur le Cancer; Institut Carnot Maladies Infectieuses	Pasteur Institute; European Research Council(European Research Council (ERC)European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INRA; CNRS(Centre National de la Recherche Scientifique (CNRS)); Louis-Jeantet Foundation; La Fondation Le Roch-Les Mousquetaires; Agence Nationale de la Recherche(French National Research Agency (ANR)); Schlumberger Foundation for Education and Research(Schlumberger); Ministere de la Recherche et de l'Enseignement Superieur; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut Carnot Maladies Infectieuses	This work was supported by the Pasteur Institute, the European Research Council Grant 233348, INSERM, INRA, CNRS, the Louis-Jeantet Foundation, La Fondation Le Roch-Les Mousquetaires, Agence Nationale de la Recherche Grant ANR-09-MIEN-020 (to P. C.) and Grant ANR-07-JCJC-0089 (to A. E.), and the Schlumberger Foundation for Education and Research (to A. E.).; Recipient of a scholarship from the Pasteur-Paris University International Doctoral Program/Institut Carnot Maladies Infectieuses.; Supported by the Ministere de la Recherche et de l'Enseignement Superieur and by the Association pour la Recherche sur le Cancer.	Bierne H, 2005, J CELL SCI, V118, P1537, DOI 10.1242/jcs.02285; Bierne H, 2001, J CELL BIOL, V155, P101, DOI 10.1083/jcb.200104037; Choudhury R, 2009, J BIOL CHEM, V284, P9965, DOI 10.1074/jbc.M807442200; Cossart P, 2011, P NATL ACAD SCI USA, V108, P19484, DOI 10.1073/pnas.1112371108; Dambournet D, 2011, NAT CELL BIOL, V13, P981, DOI 10.1038/ncb2279; El Kadhi KB, 2011, CURR BIOL, V21, P1074, DOI 10.1016/j.cub.2011.05.030; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Hou XM, 2011, EMBO J, V30, P1659, DOI 10.1038/emboj.2011.60; Ireton K, 1999, J BIOL CHEM, V274, P17025, DOI 10.1074/jbc.274.24.17025; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; Lawrence DW, 2012, IMMUNOL INVEST, V41, P129, DOI 10.3109/08820139.2011.595471; Loi M, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-16; Lowe M, 2005, TRAFFIC, V6, P711, DOI 10.1111/j.1600-0854.2005.00311.x; Mao YX, 2009, EMBO J, V28, P1831, DOI 10.1038/emboj.2009.155; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Moorhead AM, 2010, INFECT IMMUN, V78, P1990, DOI 10.1128/IAI.01340-09; Noakes CJ, 2011, MOL BIOL CELL, V22, P606, DOI 10.1091/mbc.E10-08-0730; Pizarro-Cerda J, 2004, NAT CELL BIOL, V6, P1026, DOI 10.1038/ncb1104-1026; Pizarro-Cerda J, 2002, METHOD MICROBIOL, V31, P161, DOI 10.1016/S0580-9517(02)31009-2; Pizarro-Cerda J, 2007, CELL MICROBIOL, V9, P2381, DOI 10.1111/j.1462-5822.2007.00967.x; Pizarro-Cerda J, 2009, ANNU REV CELL DEV BI, V25, P649, DOI 10.1146/annurev.cellbio.042308.113331; Seveau S, 2007, CELL MICROBIOL, V9, P790, DOI 10.1111/j.1462-5822.2006.00832.x; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Stavru F, 2011, IMMUNOL REV, V240, P160, DOI 10.1111/j.1600-065X.2010.00993.x; Swan LE, 2010, P NATL ACAD SCI USA, V107, P3511, DOI 10.1073/pnas.0914658107; Vicinanza M, 2011, EMBO J, V30, P4970, DOI 10.1038/emboj.2011.354; Weber SS, 2009, CELL MICROBIOL, V11, P442, DOI 10.1111/j.1462-5822.2008.01266.x; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	28	32	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13128	13136		10.1074/jbc.M111.315788	http://dx.doi.org/10.1074/jbc.M111.315788			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22351770	Green Published, hybrid			2022-12-27	WOS:000302903700052
J	Qi, HY; Zhu, HF; Lou, M; Fan, YF; Liu, H; Shen, J; Li, ZJ; Lv, X; Shan, JZ; Zhu, LJ; Chin, YE; Shao, JM				Qi, Hongyan; Zhu, Huifang; Lou, Meng; Fan, Yanfeng; Liu, Hong; Shen, Jing; Li, Zhongjie; Lv, Xue; Shan, Jianzhen; Zhu, Lijun; Chin, Y. Eugene; Shao, Jimin			Interferon Regulatory Factor 1 Transactivates Expression of Human DNA Polymerase eta in Response to Carcinogen N-Methyl-N '-nitro-N-nitrosoguanidine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIGMENTOSUM VARIANT GENE; GROWTH-FACTOR RECEPTOR; TRANSLESION SYNTHESIS; PROTEIN; BINDING; ACETYLATION; IRF-1; P53; ACTIVATION; CELLS	DNA polymerase eta (Pol eta) implements translesion DNA synthesis but has low fidelity in replication. We have previously shown that Pol eta plays an important role in the genesis of non-targeted mutations at undamaged DNA sites in cells exposed to the carcinogen N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Here, we report that MNNG-induced Pol eta expression in an interferon regulatory factor 1 (IRF1)-dependent manner in human cells. Mutagenesis analysis showed that four critical residues (Arg-82, Cys-83, Asn-86, and Ser-87) located in the IRF family conserved DNA binding domain-helix alpha 3 were involved in DNA binding and POLH transactivation by IRF1. Furthermore, Pol eta up-regulation induced by IRF1 was responsible for the increase of mutation frequency in a SupF shuttle plasmid replicated in the MNNG-exposed cells. Interestingly, IRF1 was acetylated by the histone acetyltransferase CBP in these cells. Lys -> Arg substitution revealed that Lys-78 of helix alpha 3 was the major acetylation site, and the IRF1-K78R mutation partially inhibited DNA binding and its transcriptional activity. Thus, we propose that IRF1 activation is responsible for MNNG-induced Pol eta up-regulation, which contributes to mutagenesis and ultimately carcinogenesis in cells.	[Qi, Hongyan; Zhu, Huifang; Lou, Meng; Fan, Yanfeng; Liu, Hong; Shen, Jing; Li, Zhongjie; Lv, Xue; Shan, Jianzhen; Zhu, Lijun; Shao, Jimin] Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, Hangzhou 310058, Zhejiang, Peoples R China; [Chin, Y. Eugene] Brown Univ, Sch Med, Dept Surg, Providence, RI 02903 USA	Zhejiang University; Brown University	Shao, JM (corresponding author), Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, Hangzhou 310058, Zhejiang, Peoples R China.	Y_Eugene_Chin@brown.edu; shaojimin@zju.edu.cn			National Natural Science Foundation of China [30770831, 81000893, 30800413, 30873094, 81090421]; Ministry of Education of China [J20100041]; Zhejiang Provincial Science Foundation [R207153, 2008C23070, J20110353]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Zhejiang Provincial Science Foundation	This work was supported by National Natural Science Foundation of China Grants 30770831, 81000893, 30800413, 30873094, and 81090421, Ministry of Education of China Grant J20100041, and Zhejiang Provincial Science Foundation Grants R207153, 2008C23070, and J20110353.	Acharya N, 2008, P NATL ACAD SCI USA, V105, P17724, DOI 10.1073/pnas.0809844105; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Caillaud A, 2002, J BIOL CHEM, V277, P49417, DOI 10.1074/jbc.M207484200; Caron C, 2005, BIOESSAYS, V27, P408, DOI 10.1002/bies.20210; Chaney SG, 2005, CRIT REV ONCOL HEMAT, V53, P3, DOI 10.1016/j.critrevonc.2004.08.008; Chen YW, 2008, P NATL ACAD SCI USA, V105, P16578, DOI 10.1073/pnas.0808589105; Choi JH, 2005, DNA REPAIR, V4, P211, DOI 10.1016/j.dnarep.2004.09.006; Dornan D, 2004, MOL CELL BIOL, V24, P10083, DOI 10.1128/MCB.24.22.10083-10098.2004; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; FENG Z, 1999, CHIN J PHARM TOXICOL, V13, P217; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Frontini M, 2009, NUCLEIC ACIDS RES, V37, P1073, DOI 10.1093/nar/gkn1051; Gao ZH, 2005, MUTAT RES-FUND MOL M, V570, P175, DOI 10.1016/j.mrfmmm.2004.11.012; Haracska L, 2001, MOL CELL BIOL, V21, P7199, DOI 10.1128/MCB.21.21.7199-7206.2001; Hirsch JD, 2002, ANAL BIOCHEM, V308, P343, DOI 10.1016/S0003-2697(02)00201-4; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Inui H, 2008, J INVEST DERMATOL, V128, P2055, DOI 10.1038/jid.2008.48; [蒋余圣 JIANG Yusheng], 2006, [中国病理生理杂志, Chinese Journal of Pathophysiology], V22, P1249; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Kawamoto T, 2005, MOL CELL, V20, P793, DOI 10.1016/j.molcel.2005.10.016; Kim SH, 2008, MOL CELL, V32, P757, DOI 10.1016/j.molcel.2008.11.016; Kim SH, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2562; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Li HJ, 2008, MUTAT RES-FUND MOL M, V644, P1, DOI 10.1016/j.mrfmmm.2008.06.013; Li K, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012286, 10.1371/journal.pone.0010341]; Lin YM, 2004, ARTERIOSCL THROM VAS, V24, P257, DOI 10.1161/01.ATV.0000109170.43400.2f; Liu G, 2006, MUTAT RES-FUND MOL M, V596, P12, DOI 10.1016/j.mrfmmm.2005.10.015; Liu G, 2006, MOL CELL BIOL, V26, P1398, DOI 10.1128/MCB.26.4.1398-1413.2006; Livneh Z, 2006, CELL CYCLE, V5, P1918, DOI 10.4161/cc.5.17.3193; Luo Yue-qiu, 2003, Zhejiang Da Xue Xue Bao Yi Xue Ban, V32, P398; Marsili G., 2006, ANN NY ACAD SCI, V13, P636; Masumi A, 2003, J BIOL CHEM, V278, P25401, DOI 10.1074/jbc.M213037200; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; McAlexander MB, 2001, FEBS LETT, V488, P91, DOI 10.1016/S0014-5793(00)02385-1; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Pamment J, 2002, ONCOGENE, V21, P7776, DOI 10.1038/sj.onc.1205981; Percario ZA, 1999, CELL GROWTH DIFFER, V10, P263; Pine R, 1997, NUCLEIC ACIDS RES, V25, P4346, DOI 10.1093/nar/25.21.4346; Prost S, 1998, FASEB J, V12, P181, DOI 10.1096/fasebj.12.2.181; Shen J, 2006, J PROTEOME RES, V5, P385, DOI 10.1021/pr0502875; Shen J, 2008, J PROTEOME RES, V7, P2999, DOI 10.1021/pr800133q; Shi BS, 2004, MUTAT RES-FUND MOL M, V556, P1, DOI 10.1016/j.mrfmmm.2004.05.014; SMITH HO, 1973, J MOL BIOL, V81, P419, DOI 10.1016/0022-2836(73)90152-6; Suhara W, 2002, J BIOL CHEM, V277, P22304, DOI 10.1074/jbc.M200192200; Tanaka N, 1996, NATURE, V382, P816, DOI 10.1038/382816a0; Tanaka N, 2000, SEMIN CANCER BIOL, V10, P73, DOI 10.1006/scbi.2000.0310; Wang Z, 2003, MUTAT RES-FUND MOL M, V528, P29, DOI 10.1016/S0027-5107(03)00079-4; Yamashita S, 2004, MUTAT RES-FUND MOL M, V549, P185, DOI 10.1016/j.mrfmmm.2003.10.009; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4717, DOI 10.1093/nar/28.23.4717; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhu HF, 2010, ENVIRON TOXICOL PHAR, V29, P79, DOI 10.1016/j.etap.2009.11.001	57	15	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12622	12633		10.1074/jbc.M111.313429	http://dx.doi.org/10.1074/jbc.M111.313429			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367195	Green Published, hybrid			2022-12-27	WOS:000302903700003
J	Toriyama, M; Mizuno, N; Fukami, T; Iguchi, T; Toriyama, M; Tago, K; Itoh, H				Toriyama, Manami; Mizuno, Norikazu; Fukami, Takashi; Iguchi, Tokuichi; Toriyama, Michinori; Tago, Kenji; Itoh, Hiroshi			Phosphorylation of Doublecortin by Protein Kinase A Orchestrates Microtubule and Actin Dynamics to Promote Neuronal Progenitor Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; DEVELOPING CEREBRAL-CORTEX; MESSENGER-RNA; NEURITE OUTGROWTH; EXCHANGE FACTOR; NEURABIN-II; RAT-BRAIN; RECEPTOR; DCX; DEPHOSPHORYLATION	Doublecortin (DCX) is a microtubule-associated protein that is specifically expressed in neuronal cells. Genetic mutation of DCX causes lissencephaly disease. Although the abnormal cortical lamination in lissencephaly is thought to be attributable to neuronal cell migration defects, the regulatory mechanisms governing interactions between DCX and cytoskeleton in the migration of neuronal progenitor cells remain obscure. In this study we found that the G(s) and protein kinase A (PKA) signal elicited by pituitary adenylate cyclase-activating polypeptide promotes neuronal progenitor cells migration. Stimulation of G(s)-PKA signaling prevented microtubule bundling and induced the dissociation of DCX from microtubules in cells. PKA phosphorylated DCX at Ser-47, and the phospho-mimicking mutant DCX-S47E promoted cell migration. Activation of PKA and DCX-S47E induced lamellipodium formation. Pituitary adenylate cyclase-activating polypeptide and DCX-S47E stimulated the activation of Rac1, and DCX-S47E interacted with Asef2, a guanine nucleotide exchange factor for Rac1. Our data reveal a dual reciprocal role for DCX phosphorylation in the regulation of microtubule and actin dynamics that is indispensable for proper brain lamination.	[Toriyama, Manami; Mizuno, Norikazu; Fukami, Takashi; Iguchi, Tokuichi; Toriyama, Michinori; Tago, Kenji; Itoh, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan	Nara Institute of Science & Technology	Mizuno, N (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300192, Japan.	nmizuno@bs.naist.jp; hitoh@bs.naist.jp		Toriyama, Manami/0000-0002-2754-293X; Iguchi, Tokuichi/0000-0003-4025-8770; TORIYAMA, Michinori/0000-0003-2551-4334	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21370056, 21590094]; Mitsubishi Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation	This work was supported by Ministry of Education, Culture, Sports, Science, and Technology of Japan Research Grants 21370056 and 21590094 and by the Mitsubishi Foundation.	Amano M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008704; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Bielas SL, 2007, CELL, V129, P579, DOI 10.1016/j.cell.2007.03.023; Bilimoria PM, 2010, J NEUROSCI, V30, P16766, DOI 10.1523/JNEUROSCI.1362-10.2010; Borrell V, 2006, NAT NEUROSCI, V9, P1284, DOI 10.1038/nn1764; Cameron DB, 2007, NEUROSCIENCE, V146, P697, DOI 10.1016/j.neuroscience.2007.02.025; de Rouvroit CL, 2001, MECH DEVELOP, V105, P47, DOI 10.1016/S0925-4773(01)00396-3; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Falluel-Morel A, 2005, P NATL ACAD SCI USA, V102, P2637, DOI 10.1073/pnas.0409681102; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Hamann MJ, 2007, MOL CELL BIOL, V27, P1380, DOI 10.1128/MCB.01608-06; Hashimoto H, 1996, J COMP NEUROL, V371, P567; Hayashi K, 2008, PROTEIN EXPRES PURIF, V62, P120, DOI 10.1016/j.pep.2008.07.007; Heng JIT, 2010, TRENDS NEUROSCI, V33, P38, DOI 10.1016/j.tins.2009.09.003; Horesh D, 1999, HUM MOL GENET, V8, P1599, DOI 10.1093/hmg/8.9.1599; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Jaworski DM, 2000, DEV BRAIN RES, V120, P27, DOI 10.1016/S0165-3806(99)00192-3; Jin J, 2010, DEV NEUROBIOL, V70, P929, DOI 10.1002/dneu.20833; Kawasaki Y, 2007, ONCOGENE, V26, P7620, DOI 10.1038/sj.onc.1210574; Kerjan G, 2007, TRENDS GENET, V23, P623, DOI 10.1016/j.tig.2007.09.003; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Luo R, 2011, P NATL ACAD SCI USA, V108, P12925, DOI 10.1073/pnas.1104821108; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Maruyama Y, 2002, CIRC RES, V91, P961, DOI 10.1161/01.RES.0000043282.39776.7C; Mizuno N, 2005, P NATL ACAD SCI USA, V102, P12365, DOI 10.1073/pnas.0506101102; Moores CA, 2006, EMBO J, V25, P4448, DOI 10.1038/sj.emboj.7601335; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Sagara M, 2009, ONCOGENE, V28, P1357, DOI 10.1038/onc.2008.478; Sarrouilhe D, 2006, BIOCHIMIE, V88, P1099, DOI 10.1016/j.biochi.2006.04.010; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Shelly M, 2010, SCIENCE, V327, P547, DOI 10.1126/science.1179735; Shmueli A, 2006, MOL CELL NEUROSCI, V32, P15, DOI 10.1016/j.mcn.2006.01.014; Shmueli O, 2001, HUM MOL GENET, V10, P1061, DOI 10.1093/hmg/10.10.1061; Skoglosa Y, 1999, MOL BRAIN RES, V65, P1, DOI 10.1016/S0169-328X(98)00294-0; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; SOLOMON F, 1986, METHOD ENZYMOL, V134, P139; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; Suh JH, 2001, NAT NEUROSCI, V4, P123, DOI 10.1038/83936; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Taylor KR, 2000, J BIOL CHEM, V275, P34442, DOI 10.1074/jbc.M007078200; Tsukada M, 2006, BIOCHEM BIOPH RES CO, V343, P839, DOI 10.1016/j.bbrc.2006.03.045; Tsukada M, 2005, J BIOL CHEM, V280, P11361, DOI 10.1074/jbc.M405525200; Woodcock SA, 2009, J PROTEOME RES, V8, P5629, DOI 10.1021/pr900716e; Yoshizawa M, 2003, GENE EXPR PATTERNS, V3, P375, DOI 10.1016/S1567-133X(03)00002-4; Zhou FQ, 2004, J NEUROBIOL, V58, P84, DOI 10.1002/neu.10278; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014	57	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12691	12702		10.1074/jbc.M111.316307	http://dx.doi.org/10.1074/jbc.M111.316307			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367209	Green Published, hybrid			2022-12-27	WOS:000302903700009
J	Yamada, KH; Kozlowski, DA; Seidl, SE; Lance, S; Wieschhaus, AJ; Sundivakkam, P; Tiruppathi, C; Chishti, I; Herman, IM; Kuchay, SM; Chishti, AH				Yamada, Kaori H.; Kozlowski, Dorothy A.; Seidl, Stacey E.; Lance, Steven; Wieschhaus, Adam J.; Sundivakkam, Premanand; Tiruppathi, Chinnaswamy; Chishti, Imran; Herman, Ira M.; Kuchay, Shafi M.; Chishti, Athar H.			Targeted Gene Inactivation of Calpain-1 Suppresses Cortical Degeneration Due to Traumatic Brain Injury and Neuronal Apoptosis Induced by Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; MU-CALPAIN; CROSS-TALK; CLEAVAGE; ACTIVATION; INHIBITOR; CASPASE; CALCIUM; PROTEIN; IMPACT	Calpains are calcium-regulated cysteine proteases that have been implicated in the regulation of cell death pathways. Here, we used our calpain-1 null mouse model to evaluate the function of calpain-1 in neural degeneration following a rodent model of traumatic brain injury. In vivo, calpain-1 null mice show significantly less neural degeneration and apoptosis and a smaller contusion 3 days post-injury than wild type littermates. Protection from traumatic brain injury corroborated with the resistance of calpain-1 neurons to apoptosis induced by oxidative stress. Biochemical analysis revealed that caspase-3 activation, extracellular calcium entry, mitochondrial membrane permeability, and release of apoptosis-inducing factor from mitochondria are partially blocked in the calpain-1 null neurons. These findings suggest that the calpain-1 knock-out mice may serve as a useful model system for neuronal protection and apoptosis in traumatic brain injury and other neurodegenerative disorders in which oxidative stress plays a role.	[Yamada, Kaori H.; Wieschhaus, Adam J.; Herman, Ira M.; Chishti, Athar H.] Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Boston, MA 02111 USA; [Wieschhaus, Adam J.; Chishti, Athar H.] Univ Illinois, Coll Med, Sackler Sch Program Physiol, Chicago, IL 60612 USA; [Wieschhaus, Adam J.; Chishti, Imran] Univ Illinois, Coll Med, Sackler Sch Program Pharmacol, Chicago, IL 60612 USA; [Wieschhaus, Adam J.; Chishti, Imran] Univ Illinois, Coll Med, Sackler Sch Program Microbiol, Chicago, IL 60612 USA; [Yamada, Kaori H.; Wieschhaus, Adam J.; Sundivakkam, Premanand; Tiruppathi, Chinnaswamy; Chishti, Imran; Kuchay, Shafi M.; Chishti, Athar H.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; [Kozlowski, Dorothy A.; Seidl, Stacey E.; Lance, Steven] Depaul Univ, Dept Biol Sci, Chicago, IL 60614 USA	Tufts University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; DePaul University	Chishti, AH (corresponding author), Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Boston, MA 02111 USA.	athar.chishti@tufts.edu		Yamada, Kaori/0000-0003-4075-9866	National Institutes of Health [HL089517, HL095050, HL051445]; DePaul University Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL051445, R01HL051445, R01HL089517, R01HL095050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DePaul University Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL089517, HL095050, and HL051445 (to A. H. C.). This work was also supported by DePaul University Research Council (to D. A. K.).	Azam M, 2001, MOL CELL BIOL, V21, P2213, DOI 10.1128/MCB.21.6.2213-2220.2001; Badugu R, 2008, J BIOL CHEM, V283, P3409, DOI 10.1074/jbc.M706851200; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Bertipaglia I., 2007, V45, P29; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dipolo R, 2006, PHYSIOL REV, V86, P155, DOI 10.1152/physrev.00018.2005; Dixon C. E., 1996, FLUID PERCUSSION COR, P1337; Fedrizzi L, 2011, BIOFACTORS, V37, P189, DOI 10.1002/biof.157; Gafni J, 2009, J BIOL CHEM, V284, P25441, DOI 10.1074/jbc.M109.038174; Gao G, 2000, J CELL BIOCHEM, V80, P53; Geddes JW, 2010, EXP NEUROL, V226, P6, DOI 10.1016/j.expneurol.2010.07.025; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Harper AGS, 2007, CELL CALCIUM, V41, P169, DOI 10.1016/j.ceca.2006.05.008; Higgins GC, 2010, J ALZHEIMERS DIS, V20, pS453, DOI 10.3233/JAD-2010-100321; Horiguchi K, 2006, J CELL BIOL, V174, P425, DOI 10.1083/jcb.200604031; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kobayashi S, 2002, J BIOL CHEM, V277, P33968, DOI 10.1074/jbc.M203350200; Kuchay SM, 2007, MOL CELL BIOL, V27, P6038, DOI 10.1128/MCB.00522-07; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Kuwako K, 2002, MOL BRAIN RES, V107, P166, DOI 10.1016/S0169-328X(02)00489-8; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Neumar RW, 2003, J BIOL CHEM, V278, P14162, DOI 10.1074/jbc.M212255200; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Ray SK, 2003, J CHEM NEUROANAT, V26, P119, DOI 10.1016/S0891-0618(03)00044-9; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Saatman KE, 2000, J CEREBR BLOOD F MET, V20, P66, DOI 10.1097/00004647-200001000-00010; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Sareen D, 2007, MOL PHARMACOL, V72, P1466, DOI 10.1124/mol.107.039040; Satoh T, 1997, J NEUROSCI RES, V50, P413, DOI 10.1002/(SICI)1097-4547(19971101)50:3<413::AID-JNR7>3.0.CO;2-L; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Sundivakkam PC, 2009, AM J PHYSIOL-CELL PH, V296, pC403, DOI 10.1152/ajpcell.00470.2008; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Volbracht C, 2001, NEUROREPORT, V12, P3645, DOI 10.1097/00001756-200112040-00008; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Waters SL, 1997, J PHARMACOL EXP THER, V283, P1177; Weber JT, 2004, CURR NEUROVASC RES, V1, P151, DOI 10.2174/1567202043480134; Wood DE, 1998, ONCOGENE, V17, P1069, DOI 10.1038/sj.onc.1202034; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001; Zhao XR, 1998, J CEREBR BLOOD F MET, V18, P161, DOI 10.1097/00004647-199802000-00006	57	54	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13182	13193		10.1074/jbc.M111.302612	http://dx.doi.org/10.1074/jbc.M111.302612			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367208	Green Published, hybrid			2022-12-27	WOS:000302903700056
J	Konsavage, WM; Kyler, SL; Rennoll, SA; Jin, G; Yochum, GS				Konsavage, Wesley M., Jr.; Kyler, Sydney L.; Rennoll, Sherri A.; Jin, Ge; Yochum, Gregory S.			Wnt/beta-Catenin Signaling Regulates Yes-associated Protein (YAP) Gene Expression in Colorectal Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGAN SIZE CONTROL; HIPPO PATHWAY; TRANSCRIPTIONAL COACTIVATOR; CHROMATIN OCCUPANCY; PROMOTES APOPTOSIS; CONTACT INHIBITION; TUMOR-SUPPRESSOR; ALPHA-CATENIN; EFFECTOR YAP; WNT PATHWAY	Mutations in the Wnt/beta-catenin pathway occur in most colorectal cancers (CRCs), and these mutations lead to increased nuclear accumulation of the beta-catenin transcriptional co-activator. In the nucleus, beta-catenin associates with TCF/LEF sequence specific transcription factors to activate target gene expression. The Hippo pathway restricts cellular growth by preventing nuclear accumulation of the Yes-associated protein (YAP) transcriptional co-activator. YAP expression is elevated in CRCs suggesting that, like Wnt/beta-catenin signaling, the Hippo pathway may contribute to colorectal carcinogenesis. Regulation of YAP at the post-translational level has been well studied but the transcription factors that control YAP gene expression are unknown. Here we demonstrate that beta-catenin/TCF4 complexes bind a DNA enhancer element within the first intron of the YAP gene to drive YAP expression in CRC cells. As such, reducing beta-catenin expression in CRC cells using shRNAs leads to decreased YAP mRNA and protein levels. YAP is abundantly expressed in the cytoplasm and nuclei of several established human colon cancer cell lines and this localization pattern is insensitive to plating density. Finally, we show that YAP expression is elevated in the majority of a panel of primary human colorectal tumors compared with its expression in uninvolved colonic mucosa, and that YAP and beta-catenin localize to the nuclear compartment of tumor cells. Together, these results implicate YAP as an oncogene whose expression is driven by aberrant Wnt/beta-catenin signaling in human CRC cells.	[Konsavage, Wesley M., Jr.; Kyler, Sydney L.; Rennoll, Sherri A.; Jin, Ge; Yochum, Gregory S.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Yochum, GS (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Room C5757,500 Univ Dr, Hershey, PA 17033 USA.	gsy3@psu.edu	Raup-Konsavage, Wesley/ABB-1910-2020	Raup-Konsavage, Wesley/0000-0001-9413-9852	National Institutes of Health [R01DK080805]; Pennsylvania State University College of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania State University College of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK080805 (to G. S. Y.) and institutional funds provided by the Pennsylvania State University College of Medicine.	Anderson CB, 2002, P NATL ACAD SCI USA, V99, P8683, DOI 10.1073/pnas.122235399; Archbold HC, 2012, ACTA PHYSIOL, V204, P74, DOI 10.1111/j.1748-1716.2011.02293.x; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; da Costa LT, 1999, ONCOGENE, V18, P5010, DOI 10.1038/sj.onc.1202872; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hergovich A, 2010, DEV CELL, V18, P508, DOI 10.1016/j.devcel.2010.04.003; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Rizvi AZ, 2005, STEM CELLS, V23, P150, DOI 10.1634/stemcells.2004-0096; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Silvis MR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001823; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104; Yochum GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018966; Yochum GS, 2010, P NATL ACAD SCI USA, V107, P145, DOI 10.1073/pnas.0912294107; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108	42	203	206	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11730	11739		10.1074/jbc.M111.327767	http://dx.doi.org/10.1074/jbc.M111.327767			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337891	Green Published, hybrid			2022-12-27	WOS:000302782200012
J	Whitham, M; Chan, MHS; Pal, M; Matthews, VB; Prelovsek, O; Lunk, S; El-Osta, A; Broenneke, H; Alber, J; Bruning, JC; Wunderlich, FT; Lancaster, GI; Febbraio, MA				Whitham, Martin; Chan, M. H. Stanley; Pal, Martin; Matthews, Vance B.; Prelovsek, Oja; Lunk, Sebastian; El-Osta, Assam; Broenneke, Hella; Alber, Jens; Bruening, Jens C.; Wunderlich, F. Thomas; Lancaster, Graeme I.; Febbraio, Mark A.			Contraction-induced Interleukin-6 Gene Transcription in Skeletal Muscle Is Regulated by c-Jun Terminal Kinase/Activator Protein-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPRESSION; HUMAN MONOCYTES; NH2-TERMINAL KINASE; EXERCISE; INDUCTION; CALCINEURIN; LIPOPOLYSACCHARIDE; ASSOCIATION; SPECIFICITY; ACTIVATION	Exercise increases the expression of the prototypical myokine IL-6, but the precise mechanism by which this occurs has yet to be identified. To mimic exercise conditions, C2C12 myotubes were mechanically stimulated via electrical pulse stimulation (EPS). We compared the responses of EPS with the pharmacological Ca2+ carrier calcimycin (A23187) because contraction induces marked increases in cytosolic Ca2+ levels or the classical I kappa B kinase/NF kappa B inflammatory response elicited by H2O2. We demonstrate that, unlike H2O2-stimulated increases in IL-6 mRNA, neither calcimycin- nor EPS-induced IL-6 mRNA expression is under the transcriptional control of NF kappa B. Rather, we show that EPS increased the phosphorylation of JNK and the reporter activity of the downstream transcription factor AP-1. Furthermore, JNK inhibition abolished the EPS-induced increase in IL-6 mRNA and protein expression. Finally, we observed an exercise-induced increase in both JNK phosphorylation and IL-6 mRNA expression in the skeletal muscles of mice after 30 min of treadmill running. Importantly, exercise did not increase IL-6 mRNA expression in skeletal muscle-specific JNK-deficient mice. These data identify a novel contraction-mediated transcriptional regulatory pathway for IL-6 in skeletal muscle.	[Febbraio, Mark A.] Baker IDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Div Obes & Metab, Melbourne, Vic 8008, Australia; [Lunk, Sebastian; El-Osta, Assam] Baker IDI Heart & Diabet Inst, Epigenet Human Hlth & Dis Lab, Melbourne, Vic 8008, Australia; [Pal, Martin; Bruening, Jens C.; Wunderlich, F. Thomas] Univ Cologne, Max Planck Inst Neurol Res, Inst Genet, D-50931 Cologne, Germany; [Pal, Martin; Bruening, Jens C.; Wunderlich, F. Thomas] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, CMMC, D-50931 Cologne, Germany; [Pal, Martin; Bruening, Jens C.; Wunderlich, F. Thomas] Univ Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, D-50931 Cologne, Germany; [Broenneke, Hella; Alber, Jens] CECAD, Phenotyping Facil, D-50674 Cologne, Germany	Baker Heart and Diabetes Institute; Baker Heart and Diabetes Institute; Max Planck Society; University of Cologne; University of Cologne; University of Cologne; University of Cologne	Febbraio, MA (corresponding author), Baker IDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Div Obes & Metab, POB 6492,St Kilda Rd Cent, Melbourne, Vic 8008, Australia.	mark.febbraio@bakeridi.edu.au	Whitham, Martin/L-1242-2019; Febbraio, Mark/AAE-9632-2019; Pal, Martin/AAL-8685-2020	Whitham, Martin/0000-0002-0254-762X; Pal, Martin/0000-0002-1563-5426; Chan, Stanley/0000-0002-4103-9441; El-Osta, Assam/0000-0003-2969-9137; Febbraio, Mark/0000-0002-9296-4418; El-Osta, Assam/0000-0001-7968-7375	National Health and Medical Research Council of Australia (NHMRC) [526606]; Victorian Government	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	This work was supported by National Health and Medical Research Council of Australia (NHMRC) Grant 526606 and the Victorian Government Operational Infrastructure Support Program.	Allen DL, 2010, AM J PHYSIOL-REG I, V298, pR198, DOI 10.1152/ajpregu.00325.2009; Aronson D, 1997, J BIOL CHEM, V272, P25636, DOI 10.1074/jbc.272.41.25636; Aronson D, 1998, BIOCHEM BIOPH RES CO, V251, P106, DOI 10.1006/bbrc.1998.9435; BALON TW, 1994, J APPL PHYSIOL, V77, P2519, DOI 10.1152/jappl.1994.77.6.2519; Banzet S, 2005, J PHYSIOL-LONDON, V566, P839, DOI 10.1113/jphysiol.2005.089193; Belgardt BF, 2010, P NATL ACAD SCI USA, V107, P6028, DOI 10.1073/pnas.1001796107; Carey AL, 2004, DIABETOLOGIA, V47, P1029, DOI 10.1007/s00125-004-1403-x; Chan MHS, 2004, FASEB J, V18, P1785, DOI 10.1096/fj.03-1039fje; DENDORFER U, 1994, MOL CELL BIOL, V14, P4443, DOI 10.1128/MCB.14.7.4443; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; Frost RA, 2003, AM J PHYSIOL-REG I, V285, pR1153, DOI 10.1152/ajpregu.00164.2003; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Holmes AG, 2004, METABOLISM, V53, P1492, DOI 10.1016/j.metabol.2004.05.015; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Keller C, 2006, CYTOKINE, V36, P141, DOI 10.1016/j.cyto.2006.10.014; Kramer HF, 2007, J APPL PHYSIOL, V103, P388, DOI 10.1152/japplphysiol.00085.2007; Kreutz M, 1997, IMMUNOLOGY, V92, P396, DOI 10.1046/j.1365-2567.1997.00365.x; MALEFYT RD, 1991, J EXP MED, V174, P1209; Matthews VB, 2009, DIABETOLOGIA, V52, P1409, DOI 10.1007/s00125-009-1364-1; McGee SL, 2006, FASEB J, V20, P348, DOI 10.1096/fj.05-4671fje; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; Nedachi T, 2009, AM J PHYSIOL-ENDOC M, V297, pE866, DOI 10.1152/ajpendo.00104.2009; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Petersen AC, 2012, ACTA PHYSIOL, V204, P382, DOI 10.1111/j.1748-1716.2011.02344.x; Rohrbach S, 2007, MOL MED, V13, P605, DOI 10.2119/2007-00071.Rohrbach; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Steensberg A, 2007, FASEB J, V21, P2683, DOI 10.1096/fj.06-7477com; Tantiwong P, 2010, AM J PHYSIOL-ENDOC M, V299, pE794, DOI 10.1152/ajpendo.00776.2009	32	74	77	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10771	10779		10.1074/jbc.M111.310581	http://dx.doi.org/10.1074/jbc.M111.310581			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22351769	Green Published, hybrid			2022-12-27	WOS:000302780100006
J	Zhang, JX; Yang, X; Wang, Z; Zhou, H; Xie, XQ; Shen, YQ; Long, JF				Zhang, Jinxiu; Yang, Xue; Wang, Zheng; Zhou, Hao; Xie, Xingqiao; Shen, Yuequan; Long, Jiafu			Structure of an L27 Domain Heterotrimer from Cell Polarity Complex Patj/Pals1/Mals2 Reveals Mutually Independent L27 Domain Assembly Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA STARDUST; PROTEIN; CRUMBS; ASSOCIATION; INTERACTS; HOMOLOGS; ADHESION; FAMILY; PHENIX	Background: Tandem L27 domains are important for multidomain proteins to assemble into supramolecular complexes for cell polarity regulation. Results: Tandem L27 domain-mediated tripartite Patj/Pals1/Mals2 and DLG1 CASK/Mals2 complexes form in a mutually independent assembly mode. Conclusion: The mutually independent assembly mode may be a novel mechanism for tandem L27 domain-mediated, tripartite complex formation. Significance: These findings reveal the distinct mechanism of tandem L27 domain-mediated assembly of obligate supramolecular complexes.	[Zhang, Jinxiu; Yang, Xue; Wang, Zheng; Zhou, Hao; Xie, Xingqiao; Shen, Yuequan; Long, Jiafu] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Zhang, Jinxiu; Yang, Xue; Wang, Zheng; Zhou, Hao; Xie, Xingqiao; Shen, Yuequan; Long, Jiafu] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Shen, YQ (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, 94 Weijin Rd, Tianjin 300071, Peoples R China.	yuequan74@yahoo.com; jflong@nankai.edu.cn	Zhou, Hao/G-9693-2019; Shen, Yuequan/C-8950-2013; Long, Jiafu/B-7420-2012	Zhou, Hao/0000-0001-6813-648X; Shen, Yuequan/0000-0002-3775-0900; Long, Jiafu/0000-0002-6625-0147	973 Program [2009CB825504]; Natural Science Foundation of China (NSFC) [31140029, 31100527, 31170684]; Fundamental Research Funds for the Central Universities [65011621, 65020241]	973 Program(National Basic Research Program of China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was funded by the 973 Program (Grant 2009CB825504), the Natural Science Foundation of China (NSFC) (Grants 31140029, 31100527, and 31170684), and the Fundamental Research Funds for the Central Universities (Grants 65011621 and 65020241).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Bohl J, 2007, J BIOL CHEM, V282, P9392, DOI 10.1074/jbc.M610002200; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Doerks T, 2000, TRENDS BIOCHEM SCI, V25, P317, DOI 10.1016/S0968-0004(00)01599-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng W, 2005, P NATL ACAD SCI USA, V102, P6861, DOI 10.1073/pnas.0409346102; Feng W, 2004, NAT STRUCT MOL BIOL, V11, P475, DOI 10.1038/nsmb751; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Harris BZ, 2002, J BIOL CHEM, V277, P34902, DOI 10.1074/jbc.M205856200; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Kamberov E, 2000, J BIOL CHEM, V275, P11425, DOI 10.1074/jbc.275.15.11425; Karnak D, 2002, J BIOL CHEM, V277, P46730, DOI 10.1074/jbc.M208781200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee S, 2002, MOL CELL BIOL, V22, P1778, DOI 10.1128/MCB.22.6.1778-1791.2002; Lemmers C, 2002, J BIOL CHEM, V277, P25408, DOI 10.1074/jbc.M202196200; Li YH, 2004, EMBO J, V23, P2723, DOI 10.1038/sj.emboj.7600294; Macara AG, 2004, CURR BIOL, V14, pR160, DOI 10.1016/j.cub.2004.01.048; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Olsen O, 2007, J CELL BIOL, V179, P151, DOI 10.1083/jcb.200702054; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Petrosky KY, 2005, J BIOL CHEM, V280, P38528, DOI 10.1074/jbc.M506536200; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Srinivasan K, 2008, DEVELOPMENT, V135, P1781, DOI 10.1242/dev.013847; Straight SW, 2006, J BIOL CHEM, V281, P37738, DOI 10.1074/jbc.M607059200; Yang X, 2010, FASEB J, V24, P4806, DOI 10.1096/fj.10-163857; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	35	12	14	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11132	11140		10.1074/jbc.M111.321216	http://dx.doi.org/10.1074/jbc.M111.321216			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22337881	Green Published, hybrid			2022-12-27	WOS:000302780100041
J	Hoy, B; Geppert, T; Boehm, M; Reisen, F; Plattner, P; Gadermaier, G; Sewald, N; Ferreira, F; Briza, P; Schneider, G; Backert, S; Wessler, S				Hoy, Benjamin; Geppert, Tim; Boehm, Manja; Reisen, Felix; Plattner, Patrick; Gadermaier, Gabriele; Sewald, Norbert; Ferreira, Fatima; Briza, Peter; Schneider, Gisbert; Backert, Steffen; Wessler, Silja			Distinct Roles of Secreted HtrA Proteases from Gram-negative Pathogens in Cleaving the Junctional Protein and Tumor Suppressor E-cadherin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICOBACTER-PYLORI; SHIGELLA-FLEXNERI; EPITHELIAL-CELLS; NATURAL SUBSTRATE; STRESS-RESPONSE; DEGP PROTEASE; EXPRESSION; MONOLAYERS; CHAPERONE; ADHESION	The periplasmic chaperone and serine protease HtrA is important for bacterial stress responses and protein quality control. Recently, we discovered that HtrA from Helicobacter pylori is secreted and cleaves E-cadherin to disrupt the epithelial barrier, but it remained unknown whether this maybe a general virulence mechanism. Here, we show that important other pathogens including enteropathogenic Escherichia coli, Shigella flexneri, and Campylobacter jejuni, but not Neisseria gonorrhoeae, cleaved E-cadherin on host cells. HtrA deletion in C. jejuni led to severe defects in E-cadherin cleavage, loss of cell adherence, paracellular transmigration, and basolateral invasion. Computational modeling of HtrAs revealed a conserved pocket in the active center exhibiting pronounced proteolytic activity. Differential E-cadherin cleavage was determined by an alanine-to-glutamine exchange in the active center of neisserial HtrA. These data suggest that HtrA-mediated E-cadherin cleavage is a prevalent pathogenic mechanism of multiple Gram-negative bacteria representing an attractive novel target for therapeutic intervention to combat bacterial infections.	[Hoy, Benjamin; Wessler, Silja] Salzburg Univ, Div Microbiol, A-5020 Salzburg, Austria; [Gadermaier, Gabriele; Ferreira, Fatima; Briza, Peter] Salzburg Univ, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria; [Geppert, Tim; Reisen, Felix; Schneider, Gisbert] ETH, Dept Chem & Appl Biosci, CH-8092 Zurich, Switzerland; [Boehm, Manja; Backert, Steffen] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 4, Ireland; [Plattner, Patrick; Sewald, Norbert] Univ Bielefeld, Dept Chem Organ & Bioorgan Chem, D-33501 Bielefeld, Germany	Salzburg University; Salzburg University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University College Dublin; University of Bielefeld	Wessler, S (corresponding author), Salzburg Univ, Div Microbiol, A-5020 Salzburg, Austria.	silja.wessler@sbg.ac.at	Briza, Peter/D-7309-2012; Wessler, Silja/C-6309-2015; Sewald, Norbert/A-2541-2012; Gadermaier, Gabriele/L-5997-2015; Ferreira, Fatima/AAB-4321-2019; Ferreira, Fatima/E-4889-2011	Briza, Peter/0000-0002-4941-6782; Wessler, Silja/0000-0001-7011-6162; Sewald, Norbert/0000-0002-0309-2655; Gadermaier, Gabriele/0000-0002-4886-417X; Ferreira, Fatima/0000-0003-0989-2335; Ferreira, Fatima/0000-0003-0989-2335; Schneider, Gisbert/0000-0001-6706-1084	Paul-Ehrlich Institute; Science Foundation Ireland [UCD 09/IN.1/B2609]; Austrian Science Fund (FWF) [P 24074] Funding Source: researchfish	Paul-Ehrlich Institute; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from the Paul-Ehrlich Institute (to B. H. trol has been also linked to bacterial pathogenicity (10), but the and S. W.) and by Science Foundation Ireland Grant UCD 09/IN.1/B2609 (to S. B.).	Anderton JM, 2007, MICROB PATHOGENESIS, V42, P225, DOI 10.1016/j.micpath.2007.02.003; Balkovetz DF, 2003, MICROBES INFECT, V5, P613, DOI 10.1016/S1286-4579(03)00089-3; Bodelon G, 2009, J BACTERIOL, V191, P5169, DOI 10.1128/JB.00458-09; Brondsted L, 2005, APPL ENVIRON MICROB, V71, P3205, DOI 10.1128/AEM.71.6.3205-3212.2005; CAVARD D, 1989, J BACTERIOL, V171, P6316, DOI 10.1128/jb.171.11.6316-6322.1989; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Hoy B, 2010, EMBO REP, V11, P798, DOI 10.1038/embor.2010.114; Ingmer H, 2009, RES MICROBIOL, V160, P704, DOI 10.1016/j.resmic.2009.08.017; Jones CH, 2002, J BACTERIOL, V184, P5762, DOI 10.1128/JB.184.20.5762-5771.2002; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Lower M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017986; Lower M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003510; Malladi V, 2004, MICROBES INFECT, V6, P38, DOI 10.1016/j.micinf.2003.09.022; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Noe V, 2001, J CELL SCI, V114, P111; Purdy GE, 2002, INFECT IMMUN, V70, P6355, DOI 10.1128/IAI.70.11.6355-6364.2002; Reisen F, 2010, J PROTEOME RES, V9, P6498, DOI 10.1021/pr100719n; SANSONETTI PJ, 1994, CELL, V76, P829, DOI 10.1016/0092-8674(94)90358-1; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; VASSELON T, 1992, INFECT IMMUN, V60, P1031, DOI 10.1128/IAI.60.3.1031-1040.1992; Vogt SL, 2010, MOL MICROBIOL, V76, P1095, DOI 10.1111/j.1365-2958.2010.07145.x; Volokhina EB, 2011, J BACTERIOL, V193, P1612, DOI 10.1128/JB.00532-10; Wang J, 1998, MOL MICROBIOL, V30, P657, DOI 10.1046/j.1365-2958.1998.01102.x; Weisel M, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-7; Wroblewski LE, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-29; Wu X, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-87	28	116	120	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2012	287	13					10115	10120		10.1074/jbc.C111.333419	http://dx.doi.org/10.1074/jbc.C111.333419			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	917IN	22337879	Green Published, hybrid			2022-12-27	WOS:000302167200043
J	Lutz, D; Wolters-Eisfeld, G; Joshi, G; Djogo, N; Jakovcevski, I; Schachner, M; Kleene, R				Lutz, David; Wolters-Eisfeld, Gerrit; Joshi, Gunjan; Djogo, Nevena; Jakovcevski, Igor; Schachner, Melitta; Kleene, Ralf			Generation and Nuclear Translocation of Sumoylated Transmembrane Fragment of Cell Adhesion Molecule L1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NON-ENDOSOMAL FUNCTIONS; IMMUNOGLOBULIN SUPERFAMILY; RECOGNITION MOLECULES; NEURITE OUTGROWTH; SPINAL-CORD; PRESENILIN/GAMMA-SECRETASE; NERVOUS-SYSTEM; NEURAL REPAIR; AXON GUIDANCE; MICE LACKING	The functions of the cell adhesion molecule L1 in the developing and adult nervous system are triggered by homophilic and heterophilic interactions that stimulate signal transductions that activate cellular responses. Here, we show that stimulation of signaling by function-triggering L1 antibodies or L1-Fc leads to serine protease-dependent cleavage of full-length L1 at the plasma membrane and generation of a sumoylated transmembrane 70-kDa fragment comprising the intracellular and transmembrane domains and part of the extracellular domain. The 70-kDa transmembrane fragment is transported from the plasma membrane to a late endosomal compartment, released from endosomal membranes into the cytoplasm, and transferred from there into the nucleus by a pathway that depends on importin and chromatin-modifying protein 1. Mutation of the sumoylation site at Lys(1172) or of the nuclear localization signal at Lys(1147) abolished L1-stimulated generation or nuclear import of the 70-kDa fragment, respectively. Nuclear import of the 70-kDa fragment may activate cellular responses in parallel or in association with phosphorylation-dependent signaling pathways. Alterations in the levels of the 70-kDa fragment during development and in the adult after spinal cord injury or in a mouse model of Alzheimer disease suggest that this fragment is functionally implicated in development, regeneration, neurode-generation, tumorigenesis, and possibly synaptic plasticity in the mature nervous system.	[Schachner, Melitta] Shantou Univ, Coll Med, Ctr Neurosci, Shantou 515041, Peoples R China; [Lutz, David; Wolters-Eisfeld, Gerrit; Joshi, Gunjan; Djogo, Nevena; Jakovcevski, Igor; Schachner, Melitta; Kleene, Ralf] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	Shantou University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Schachner, M (corresponding author), Shantou Univ, Coll Med, Ctr Neurosci, 22 Xin Ling Rd, Shantou 515041, Peoples R China.	schachner@stu.edu.cn	Lutz, David/AAX-1607-2021; Wolters-Eisfeld, Gerrit/H-8333-2019	Wolters-Eisfeld, Gerrit/0000-0002-2984-6515; Lutz, David/0000-0001-9171-4081; Jakovcevski, Igor/0000-0001-7673-9600	New Jersey Commission for Spinal Cord Research; Li Ka-Shing Foundation at Shantou University Medical College	New Jersey Commission for Spinal Cord Research; Li Ka-Shing Foundation at Shantou University Medical College	Supported by the New Jersey Commission for Spinal Cord Research and the Li Ka-Shing Foundation at Shantou University Medical College. To whom correspondence should be addressed: Center for Neuroscience, Shantou University Medical College, 22 Xin Ling Rd., Shantou 515041, China. Tel.: 86-754-88900276; Fax: 86-754-88900236; E-mail: schachner@stu.edu.cn.	APPEL F, 1995, J NEUROBIOL, V28, P297, DOI 10.1002/neu.480280304; Brummendorf T, 1998, CURR OPIN NEUROBIOL, V8, P87, DOI 10.1016/S0959-4388(98)80012-3; Cheng L, 2011, EMBO J, V30, P800, DOI 10.1038/emboj.2011.10; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; CURTIS R, 1993, J NEUROCYTOL, V22, P51, DOI 10.1007/BF01183975; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Guseva D, 2011, EXP NEUROL, V229, P339, DOI 10.1016/j.expneurol.2011.02.018; Guseva D, 2009, BRAIN, V132, P2180, DOI 10.1093/brain/awp160; Gutwein P, 2002, FASEB J, V16, P292, DOI 10.1096/fj.02-0430fje; Jakeman LB, 2006, EUR J NEUROSCI, V23, P1997, DOI 10.1111/j.1460-9568.2006.04721.x; Jakovcevski I, 2007, J NEUROSCI, V27, P7222, DOI 10.1523/JNEUROSCI.0739-07.2007; Kalus I, 2003, J BIOL CHEM, V278, P10381, DOI 10.1074/jbc.M208351200; Kamiguchi H, 1997, J NEUROSCI RES, V49, P1, DOI 10.1002/(SICI)1097-4547(19970701)49:1<1::AID-JNR1>3.0.CO;2-H; Katidou Markella, 2008, Biotechnology Journal, V3, P1564, DOI 10.1002/biot.200800281; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Kleene R, 2010, J NEUROSCI, V30, P10784, DOI 10.1523/JNEUROSCI.0297-10.2010; Kurumaji A, 2001, AM J MED GENET, V105, P99; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Law JWS, 2003, J NEUROSCI, V23, P10419; Lee TW, 2008, NEURON GLIA BIOL, V4, P223, DOI 10.1017/S1740925X09990172; Liao HJ, 2007, MOL BIOL CELL, V18, P1064, DOI 10.1091/mbc.E06-09-0802; Loers G, 2005, J NEUROCHEM, V92, P1463, DOI 10.1111/j.1471-4159.2004.02983.x; Loers G, 2007, J NEUROCHEM, V101, P865, DOI 10.1111/j.1471-4159.2006.04409.x; Makhina T, 2009, MOL CELL NEUROSCI, V41, P206, DOI 10.1016/j.mcn.2009.02.010; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Matsumoto-Miyai K, 2003, J NEUROSCI, V23, P7727; Mehanna A, 2010, MOL THER, V18, P34, DOI 10.1038/mt.2009.235; Nayeem N, 1999, J CELL SCI, V112, P4739; POLTORAK M, 1995, EXP NEUROL, V131, P266, DOI 10.1016/0014-4886(95)90048-9; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Riedle S, 2009, BIOCHEM J, V420, P391, DOI 10.1042/BJ20081625; SADOUL K, 1988, J NEUROCHEM, V50, P510, DOI 10.1111/j.1471-4159.1988.tb02941.x; Schafer MKE, 2010, CELL MOL LIFE SCI, V67, P2425, DOI 10.1007/s00018-010-0339-1; Scheschonka A, 2007, TRENDS NEUROSCI, V30, P85, DOI 10.1016/j.tins.2007.01.003; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Stauffer DR, 2001, J CELL SCI, V114, P2383; Strekalova H, 2006, NEUROBIOL AGING, V27, P1, DOI 10.1016/j.neurobiolaging.2004.11.013; Tanaka N, 2008, CANCER SCI, V99, P1293, DOI 10.1111/j.1349-7006.2008.00825.x; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; Wakabayashi Y, 2008, PROG NEURO-PSYCHOPH, V32, P1199, DOI 10.1016/j.pnpbp.2008.03.005; Zhang Y, 2008, RESTOR NEUROL NEUROS, V26, P81	50	46	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17161	17175		10.1074/jbc.M112.346759	http://dx.doi.org/10.1074/jbc.M112.346759			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22431726	Green Published, hybrid			2022-12-27	WOS:000306373000016
J	Somasekharan, S; Tanis, J; Forbush, B				Somasekharan, Suma; Tanis, Jessica; Forbush, Biff			Loop Diuretic and Ion-binding Residues Revealed by Scanning Mutagenesis of Transmembrane Helix 3 (TM3) of Na-K-Cl Cotransporter (NKCC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-3 BUMETANIDE BINDING; NA+-K+-2CL(-) COTRANSPORTER; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; TRANSPORT; MECHANISM; LEUT; PHOSPHORYLATION; INHIBITION	The Na-K-Cl cotransporter (NKCC) plays central roles in cellular chloride homeostasis and in epithelial salt transport, but to date little is known about the mechanism by which the transporter moves ions across the membrane. We examined the functional role of transmembrane helix 3 (TM3) in NKCC1 using cysteine- and tryptophan-scanning mutagenesis and analyzed our results in the context of a structural homology model based on an alignment of NKCC1 with other amino acid polyamine organocation superfamily members, AdiC and ApcT. Mutations of residues along one face of TM3 (Tyr-383, Met-382, Ala-379, Asn-376, Ala-375, Phe-372, Gly-369, and Ile-368) had large effects on translocation rate, apparent ion affinities, and loop diuretic affinity, consistent with a proposed role of TM3 in the translocation pathway. The prediction that Met-382 is part of an extracellular gate that closes to form an occluded state is strongly supported by conformational sensitivity of this residue to 2-(trimethylammonium)ethyl methanethiosulfonate, and the bumetanide insensitivity of M382W is consistent with tryptophan blocking entry of bumetanide into the cavity. Substitution effects on residues at the intracellular end of TM3 suggest that this region is also involved in ion coordination and may be part of the translocation pathway in an inward-open conformation. Mutations of predicted pore residues had large effects on binding of bumetanide and furosemide, consistent with the hypothesis that loop diuretic drugs bind within the translocation cavity. The results presented here strongly support predictions of homology models of NKCC1 and demonstrate important roles for TM3 residues in ion translocation and loop diuretic inhibition.	[Somasekharan, Suma; Tanis, Jessica; Forbush, Biff] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Somasekharan, S (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, POB 208026, New Haven, CT 06520 USA.	suma.somasekharan@yale.edu			National Institutes of Health [GM083340]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM083340 (to B. F.).	Aronica E, 2007, NEUROSCIENCE, V145, P185, DOI 10.1016/j.neuroscience.2006.11.041; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Carmosino M, 2008, MOL BIOL CELL, V19, P4341, DOI 10.1091/mbc.E08-05-0478; Castaneda-Bueno M, 2010, AM J PHYSIOL-RENAL, V299, pF1111, DOI 10.1152/ajprenal.00412.2010; Cherubino F, 2010, J MOL NEUROSCI, V41, P243, DOI 10.1007/s12031-009-9281-9; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Dehaye JP, 2003, J BIOL CHEM, V278, P11811, DOI 10.1074/jbc.M213148200; Delpire E, 2002, ANNU REV PHYSIOL, V64, P803, DOI 10.1146/annurev.physiol.64.081501.155847; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; FORBUSH B, 1983, J BIOL CHEM, V258, P1787; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gimenez I, 2002, J BIOL CHEM, V277, P8767, DOI 10.1074/jbc.C200021200; Gimenez I, 2007, J BIOL CHEM, V282, P6540, DOI 10.1074/jbc.M610780200; HAAS M, 1986, J BIOL CHEM, V261, P8434; Isenring P, 1998, J GEN PHYSIOL, V112, P549, DOI 10.1085/jgp.112.5.549; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Khafizov K, 2010, BIOCHEMISTRY-US, V49, P10702, DOI 10.1021/bi101256x; Kowalczyk L, 2011, P NATL ACAD SCI USA, V108, P3935, DOI 10.1073/pnas.1018081108; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Longpre JP, 2011, BIOPHYS J, V100, P52, DOI 10.1016/j.bpj.2010.11.012; Lytle C, 1998, AM J PHYSIOL-CELL PH, V274, pC299, DOI 10.1152/ajpcell.1998.274.2.C299; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; Melo F, 2007, PROTEIN SCI, V16, P2412, DOI 10.1110/ps.072895107; Monette Michelle Y, 2012, J Biol Chem, V287, P2210, DOI 10.1074/jbc.M111.309211; Monette MY, 2011, AM J PHYSIOL-RENAL, V300, pF840, DOI 10.1152/ajprenal.00552.2010; MOORE ML, 1995, BIOCHEM J, V309, P637, DOI 10.1042/bj3090637; Moore-Hoon ML, 2000, BIOCHEMISTRY-US, V39, P3718, DOI 10.1021/bi992301v; Pedersen M, 2008, J BIOL CHEM, V283, P2663, DOI 10.1074/jbc.M708194200; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Silberberg SD, 2005, J GEN PHYSIOL, V125, P347, DOI 10.1085/jgp.200409221; Simard CF, 2004, J BIOL CHEM, V279, P40769, DOI 10.1074/jbc.M406458200; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; TALVENHEIMO J, 1979, J BIOL CHEM, V254, P4631; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	39	49	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17308	17317		10.1074/jbc.M112.356014	http://dx.doi.org/10.1074/jbc.M112.356014			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22437837	Green Published, hybrid			2022-12-27	WOS:000306373000031
J	Spratt, DE; Wu, K; Kovacev, J; Pan, ZQ; Shaw, GS				Spratt, Donald E.; Wu, Kenneth; Kovacev, Jordan; Pan, Zhen-Qiang; Shaw, Gary S.			Selective Recruitment of an E2 similar to Ubiquitin Complex by an E3 Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-STRUCTURE DETERMINATION; TORSION ANGLE DYNAMICS; SIDE-CHAIN RESONANCES; CONJUGATING ENZYME; RING DOMAIN; HUMAN CDC34; CONFORMATIONAL CONTROL; PARKINSONS-DISEASE; PROVIDES INSIGHTS; BACKBONE AMIDE	RING E3 ligases are proteins that must selectively recruit an E2-conjugating enzyme and facilitate ubiquitin transfer to a substrate. It is not clear how a RING E3 ligase differentiates a naked E2 enzyme from the E2 similar to ubiquitin-conjugated form or how this is altered upon ubiquitin transfer. RING-box protein 1 (Rbx1/ROC1) is a key protein found in the Skp1/Cullin-1/F-box (SCF) E3 ubiquitin ligase complex that functions with the E2 ubiquitin conjugating enzyme CDC34. The solution structure of Rbx1/ROC1 revealed a globular RING domain (residues 40-108) stabilized by three structural zinc ions (root mean square deviation 0.30 +/- 0.04 angstrom) along with a disordered N terminus (residues 12-39). Titration data showed that Rbx1/ROC1 preferentially recruits CDC34 in its ubiquitin-conjugated form and favors this interaction by 50-fold compared with unconjugated CDC34. Furthermore, NMR and biochemical assays identified residues in helix alpha 2 of Rbx1/ROC1 that are essential for binding and activating CDC34 similar to ubiquitin for ubiquitylation. Taken together, this work provides the first direct structural and biochemical evidence showing that polyubiquitylation by the RING E3 ligase Rbx1/ROC1 requires the preferential recruitment of an E2 similar to ubiquitin complex and subsequent release of the unconjugated E2 protein upon ubiquitin transfer to a substrate or ubiquitin chain.	[Spratt, Donald E.; Shaw, Gary S.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON N6A 5C1, Canada; [Wu, Kenneth; Kovacev, Jordan; Pan, Zhen-Qiang] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA	Western University (University of Western Ontario); Icahn School of Medicine at Mount Sinai	Shaw, GS (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON N6A 5C1, Canada.	gshaw1@uwo.ca	Shaw, Gary S./C-7656-2009	Shaw, Gary S./0000-0002-4685-9625; Spratt, Donald/0000-0002-0699-155X	Canadian Institutes of Health Research [MOP-14606]; Canadian Cancer Society [CCS-018414]; Canada Research Chairs Program; National Institutes of Health [GM061051, CA095634]; Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Research and Technology; NATIONAL CANCER INSTITUTE [R01CA095634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061051] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Canada Research Chairs Program(Canada Research Chairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Ministry of Research and Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Steven Beasley and Pascal Mercier for helpful expertise with CYANA and Xplor-NIH. The Biomolecular NMR Facility at the University of Western Ontario was supported by a Research Resource grant from the Canadian Institutes of Health Research.; This work was supported by Canadian Cancer Society Grant CCS-018414, Canadian Institutes of Health Research Grant MOP-14606, and by the Canada Research Chairs Program (to G. S. S.). This work was also supported, in whole or in part, by National Institutes of Health Grants GM061051 and CA095634 (to Z.-Q. P.).; Recipient of a Natural Sciences and Engineering Research Council of Canada postdoctoral fellowship and an Ontario Ministry of Research and Technology postdoctoral fellowship.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; Boh BK, 2011, J MOL BIOL, V409, P136, DOI 10.1016/j.jmb.2011.03.023; Borden KLB, 1998, BIOCHEM CELL BIOL, V76, P351, DOI 10.1139/bcb-76-2-3-351; Budhidarmo R, 2012, TRENDS BIOCHEM SCI, V37, P58, DOI 10.1016/j.tibs.2011.11.001; Ceccarelli DF, 2011, CELL, V145, P1075, DOI 10.1016/j.cell.2011.05.039; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Deffenbaugh AE, 2003, CELL, V114, P611, DOI 10.1016/S0092-8674(03)00641-X; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Deshaies RJ, 2010, SUBCELL BIOCHEM, V54, P41, DOI 10.1007/978-1-4419-6676-6_4; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dominguez C, 2004, STRUCTURE, V12, P633, DOI 10.1016/j.str.2004.03.004; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Duda DM, 2011, CURR OPIN STRUC BIOL, V21, P257, DOI 10.1016/j.sbi.2011.01.003; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Gazdoiu S, 2005, P NATL ACAD SCI USA, V102, P15053, DOI 10.1073/pnas.0507646102; Gazdoiu S, 2007, MOL CELL BIOL, V27, P7041, DOI 10.1128/MCB.00812-07; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hristova VA, 2009, J BIOL CHEM, V284, P14978, DOI 10.1074/jbc.M808700200; Huang A, 2009, J MOL BIOL, V385, P507, DOI 10.1016/j.jmb.2008.10.044; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Kleiger G, 2009, J BIOL CHEM, V284, P36012, DOI 10.1074/jbc.M109.058529; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Kornhaber GJ, 2006, J BIOMOL NMR, V34, P259, DOI 10.1007/s10858-006-0027-5; Levin I, 2010, P NATL ACAD SCI USA, V107, P2848, DOI 10.1073/pnas.0914821107; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Merkley N, 2004, J BIOL CHEM, V279, P47139, DOI 10.1074/jbc.M409576200; Merkley N, 2005, J BIOL CHEM, V280, P31732, DOI 10.1074/jbc.M505205200; Petroski MD, 2006, MOL CELL, V24, P523, DOI 10.1016/j.molcel.2006.10.010; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Plafker SM, 2004, J CELL BIOL, V167, P649, DOI 10.1083/jcb.200406001; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Serniwka SA, 2009, BIOCHEMISTRY-US, V48, P12169, DOI 10.1021/bi901686j; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Spratt DE, 2011, J MOL BIOL, V407, P425, DOI 10.1016/j.jmb.2011.01.047; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zimmerman ES, 2010, CURR OPIN STRUC BIOL, V20, P714, DOI 10.1016/j.sbi.2010.08.010	65	34	34	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2012	287	21					17374	17385		10.1074/jbc.M112.353748	http://dx.doi.org/10.1074/jbc.M112.353748			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	973PU	22433864	Green Published, hybrid			2022-12-27	WOS:000306373000037
J	Fernandez-Fueyo, E; Ruiz-Duenas, FJ; Miki, Y; Martinez, MJ; Hammel, KE; Martinez, AT				Fernandez-Fueyo, Elena; Ruiz-Duenas, Francisco J.; Miki, Yuta; Jesus Martinez, Maria; Hammel, Kenneth E.; Martinez, Angel T.			Lignin-degrading Peroxidases from Genome of Selective Ligninolytic Fungus Ceriporiopsis subvermispora	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 MANGANESE PEROXIDASES; PLEUROTUS-ERYNGII; PHANEROCHAETE-CHRYSOSPORIUM; VERSATILE PEROXIDASE; MICROBIAL-DEGRADATION; ESCHERICHIA-COLI; MODEL-COMPOUND; BASIDIOMYCETE; OXIDATION; GENES	The white-rot fungus Ceriporiopsis subvermispora delignifies lignocellulose with high selectivity, but until now it has appeared to lack the specialized peroxidases, termed lignin peroxidases (LiPs) and versatile peroxidases (VPs), that are generally thought important for ligninolysis. We screened the recently sequenced C. subvermispora genome for genes that encode peroxidases with a potential ligninolytic role. A total of 26 peroxidase genes was apparent after a structural-functional classification based on homology modeling and a search for diagnostic catalytic amino acid residues. In addition to revealing the presence of nine heme-thiolate peroxidase superfamily members and the unexpected absence of the dye-decolorizing peroxidase superfamily, the search showed that the C. subvermispora genome encodes 16 class II enzymes in the plant-fungal-bacterial peroxidase superfamily, where LiPs and VPs are classified. The 16 encoded enzymes include 13 putative manganese peroxidases and one generic peroxidase but most notably two peroxidases containing the catalytic tryptophan characteristic of LiPs and VPs. We expressed these two enzymes in Escherichia coli and determined their substrate specificities on typical LiP/VP substrates, including nonphenolic lignin model monomers and dimers, as well as synthetic lignin. The results show that the two newly discovered C. subvermispora peroxidases are functionally competent LiPs and also suggest that they are phylogenetically and catalytically intermediate between classical LiPs and VPs. These results offer new insight into selective lignin degradation by C. subvermispora.	[Hammel, Kenneth E.] USDA, Forest Prod Lab, Madison, WI 53726 USA; [Fernandez-Fueyo, Elena; Ruiz-Duenas, Francisco J.; Miki, Yuta; Jesus Martinez, Maria; Martinez, Angel T.] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain	United States Department of Agriculture (USDA); United States Forest Service; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Hammel, KE (corresponding author), USDA, Forest Prod Lab, Madison, WI 53726 USA.	kehammel@wisc.edu; ATMartinez@cib.csic.es	Fernández-Fueyo, Elena/G-8372-2017; Ruiz-Dueñas, Francisco J/L-9837-2015; Hammel, Kenneth E/G-1890-2011; Martinez, Maria Jesus/F-9147-2015; Martínez, Angel T/G-7284-2017	Ruiz-Dueñas, Francisco J/0000-0002-9837-5665; Hammel, Kenneth E/0000-0002-2935-5847; Martinez, Maria Jesus/0000-0003-2166-1097; Martínez, Angel T/0000-0002-1584-2863	RAPERO from the Spanish Ministry of Economy and Competitiveness [BIO2008-01533]; HIPOP from the Spanish Ministry of Economy and Competitiveness [BIO2011-26694]; PEROXICATS [KBBE-2010-4-265397]; United States Department of Energy [DE-AI02-07ER64480]; Consejo Superior de Investigaciones Cientificas; European Social Fund; Ministry of Economy and Competitiveness (MINECO); Office of Science of the United States Department of Energy [DE-AC02-05CH11231]	RAPERO from the Spanish Ministry of Economy and Competitiveness; HIPOP from the Spanish Ministry of Economy and Competitiveness; PEROXICATS; United States Department of Energy(United States Department of Energy (DOE)); Consejo Superior de Investigaciones Cientificas; European Social Fund(European Social Fund (ESF)); Ministry of Economy and Competitiveness (MINECO); Office of Science of the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the RAPERO Grant BIO2008-01533 and HIPOP Grant BIO2011-26694 from the Spanish Ministry of Economy and Competitiveness (to A. T. M. and F.J.R.-D., respectively), by PEROXICATS European Project Grant KBBE-2010-4-265397 (to A. T. M.), and by United States Department of Energy Grant DE-AI02-07ER64480 (to K.E.H.).; Supported by a Junta para Ampliacion de Estudios fellowship of the Consejo Superior de Investigaciones Cientificas, co-funded by the European Social Fund.; Supported by a Ministry of Economy and Competitiveness (MINECO) Ramon y Cajal contract.; We thank Dr. Daniel Cullen (United States Department of Agriculture, Forest Products Laboratory, Madison, WI) and Dr. Rafael Vicuna (Pontificia Universidad Catolica de Chile, Santiago, Chile) for the invitation to participate in the C. subvermispora genome sequencing project. We thank Michael D. Mozuch for technical assistance with the DHP depolymerization reactions. Sequencing of the C. subvermispora genome by the Joint Genome Institute was supported by the Office of Science of the United States Department of Energy under Contract DE-AC02-05CH11231.	AKHTAR M, 1993, HOLZFORSCHUNG, V47, P36, DOI 10.1515/hfsg.1993.47.1.36; AKHTAR M, 1994, HOLZFORSCHUNG, V48, P199, DOI 10.1515/hfsg.1994.48.3.199; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BLANCHETTE RA, 1985, WOOD SCI TECHNOL, V19, P35, DOI 10.1007/BF00354751; Bohlin C, 2005, J MOL CATAL B-ENZYM, V35, P100, DOI 10.1016/j.molcatb.2005.06.003; Bohlin C, 2008, ENZYME MICROB TECH, V43, P199, DOI 10.1016/j.enzmictec.2008.03.002; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; CAMARERO S, 1994, APPL ENVIRON MICROB, V60, P4509, DOI 10.1128/AEM.60.12.4509-4516.1994; Canas AI, 2010, BIOTECHNOL ADV, V28, P694, DOI 10.1016/j.biotechadv.2010.05.002; Caramelo L, 1999, APPL ENVIRON MICROB, V65, P916; Cullen D, 1997, J BIOTECHNOL, V53, P273, DOI 10.1016/S0168-1656(97)01684-2; de Souza-Cruz PB, 2004, ENZYME MICROB TECH, V34, P228, DOI 10.1016/j.enzmictec.2003.10.005; Doyle WA, 1996, BIOCHEM J, V315, P15, DOI 10.1042/bj3150015; Fernandez-Fueyo E, 2012, P NATL ACAD SCI USA, V109, P5458, DOI 10.1073/pnas.1119912109; Gold MH, 2000, MET IONS BIOL SYST, V37, P559; Gutierrez A, 2011, ARCH BIOCHEM BIOPHYS, V514, P33, DOI 10.1016/j.abb.2011.08.001; HAMMEL KE, 1993, J BIOL CHEM, V268, P12274; Hammel KE, 2008, CURR OPIN PLANT BIOL, V11, P349, DOI 10.1016/j.pbi.2008.02.003; Heinfling A, 1998, FEBS LETT, V428, P141, DOI 10.1016/S0014-5793(98)00512-2; Hilden K, 2005, FUNGAL GENET BIOL, V42, P403, DOI 10.1016/j.fgb.2005.01.008; Hofrichter M, 2006, APPL MICROBIOL BIOT, V71, P276, DOI 10.1007/s00253-006-0417-3; Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0; Jensen KA, 1996, APPL ENVIRON MICROB, V62, P3679, DOI 10.1128/AEM.62.10.3679-3686.1996; Johjima T, 1999, P NATL ACAD SCI USA, V96, P1989, DOI 10.1073/pnas.96.5.1989; JONSSON L, 1990, FEBS LETT, V276, P45, DOI 10.1016/0014-5793(90)80503-B; Kersten P, 2007, FUNGAL GENET BIOL, V44, P77, DOI 10.1016/j.fgb.2006.07.007; Kinne M, 2011, HOLZFORSCHUNG, V65, P673, DOI 10.1515/HF.2011.057; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; Larrondo LF, 2001, APPL ENVIRON MICROB, V67, P2070, DOI 10.1128/AEM.67.5.2070-2075.2001; Li DM, 1999, BBA-PROTEIN STRUCT M, V1434, P356, DOI 10.1016/S0167-4838(99)00191-0; Liers C, 2010, APPL MICROBIOL BIOT, V85, P1869, DOI 10.1007/s00253-009-2173-7; Lobos S, 1998, GENE, V206, P185, DOI 10.1016/S0378-1119(97)00583-0; LOBOS S, 1994, MICROBIOL-UK, V140, P2691, DOI 10.1099/00221287-140-10-2691; Martinez AT, 2009, CURR OPIN BIOTECH, V20, P348, DOI 10.1016/j.copbio.2009.05.002; Martinez AT, 2002, ENZYME MICROB TECH, V30, P425, DOI 10.1016/S0141-0229(01)00521-X; Martinez AT, 2005, INT MICROBIOL, V8, P195; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Alvarez JM, 2009, FUNGAL GENET BIOL, V46, P104, DOI 10.1016/j.fgb.2008.10.002; Miki Y, 2011, J BIOL CHEM, V286, P15525, DOI 10.1074/jbc.M111.220996; MOEN MA, 1994, APPL ENVIRON MICROB, V60, P1956, DOI 10.1128/AEM.60.6.1956-1961.1994; Morgenstern I, 2010, APPL ENVIRON MICROB, V76, P6431, DOI 10.1128/AEM.00547-10; MORITA Y, 1988, J BIOCHEM-TOKYO, V103, P693, DOI 10.1093/oxfordjournals.jbchem.a122331; Ortiz-Bermudez P, 2003, APPL ENVIRON MICROB, V69, P5015, DOI 10.1128/AEM.69.8.5015-5018.2003; Pecyna MJ, 2009, APPL MICROBIOL BIOT, V84, P885, DOI 10.1007/s00253-009-2000-1; Perez-Boada M, 2002, ENZYME MICROB TECH, V30, P518, DOI 10.1016/S0141-0229(02)00008-X; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Rajakumar S, 1996, APPL ENVIRON MICROB, V62, P2660, DOI 10.1128/AEM.62.7.2660-2663.1996; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Ruiz-Duenas FJ, 2001, BIOCHEM SOC T, V29, P116, DOI 10.1042/BST0290116; Ruiz-Duenas FJ, 2008, BIOCHEMISTRY-US, V47, P1685, DOI 10.1021/bi7020298; Ruiz-Duenas FJ, 2011, CR BIOL, V334, P795, DOI 10.1016/j.crvi.2011.06.004; Ruiz-Duenas FJ, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P37, DOI 10.1007/978-3-642-12627-7_3; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Ruiz-Duenas FJ, 2009, J EXP BOT, V60, P441, DOI 10.1093/jxb/ern261; RUTTIMANN C, 1992, BIOTECHNOL APPL BIOC, V16, P64; SALAS C, 1995, BIOTECHNOL APPL BIOC, V21, P323; Salvachua D, 2011, BIORESOURCE TECHNOL, V102, P7500, DOI 10.1016/j.biortech.2011.05.027; Sambrook J., 2001, MOL CLONING; Scott G.M., 1998, ENV FRIENDLY TECHNOL; Shary S, 2007, APPL ENVIRON MICROB, V73, P6691, DOI 10.1128/AEM.01361-07; SREBOTNIK E, 1994, P NATL ACAD SCI USA, V91, P12794, DOI 10.1073/pnas.91.26.12794; Srebotnik E, 1997, APPL ENVIRON MICROB, V63, P4435, DOI 10.1128/AEM.63.11.4435-4440.1997; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka H, 2009, ENZYME MICROB TECH, V45, P384, DOI 10.1016/j.enzmictec.2009.06.003; Tello M, 2001, FEMS MICROBIOL LETT, V199, P91, DOI 10.1111/j.1574-6968.2001.tb10656.x; Tello M, 2000, BBA-GENE STRUCT EXPR, V1490, P137, DOI 10.1016/S0167-4781(99)00227-4; TIEN M, 1983, SCIENCE, V221, P661, DOI 10.1126/science.221.4611.661; Vicentim MP, 2009, HOLZFORSCHUNG, V63, P408, DOI 10.1515/HF.2009.067; WARIISHI H, 1994, BIOCHEMISTRY-US, V33, P5545, DOI 10.1021/bi00184a025; Cho DW, 2010, J ORG CHEM, V75, P6549, DOI 10.1021/jo1012509	71	64	65	0	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16903	16916		10.1074/jbc.M112.356378	http://dx.doi.org/10.1074/jbc.M112.356378			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22437835	Green Published, hybrid			2022-12-27	WOS:000304030900076
J	Gao, CX; Maeno, T; Ota, F; Ueno, M; Korekane, H; Takamatsu, S; Shirato, K; Matsumoto, A; Kobayashi, S; Yoshida, K; Kitazume, S; Ohtsubo, K; Betsuyaku, T; Taniguchi, N				Gao, Congxiao; Maeno, Toshitaka; Ota, Fumi; Ueno, Manabu; Korekane, Hiroaki; Takamatsu, Shinji; Shirato, Ken; Matsumoto, Akio; Kobayashi, Satoshi; Yoshida, Keiichi; Kitazume, Shinobu; Ohtsubo, Kazuaki; Betsuyaku, Tomoko; Taniguchi, Naoyuki			Sensitivity of Heterozygous alpha 1,6-Fucosyltransferase Knock-out Mice to Cigarette Smoke-induced Emphysema IMPLICATION OF ABERRANT TRANSFORMING GROWTH FACTOR-beta SIGNALING AND MATRIX METALLOPROTEINASE GENE EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; D-GLUCOSAMINIDE ALPHA; ALVEOLAR MACROPHAGES; AIRWAY INFLAMMATION; CDNA CLONING; CORE FUCOSE; RAT LUNG; COPD; ACTIVATION; RECEPTOR	We previously demonstrated that a deficiency in core fucosylation caused by the genetic disruption of alpha 1,6-fucosyltransferase (Fut8) leads to lethal abnormalities and the development of emphysematous lesions in the lung by attenuation of TGF-beta 1 receptor signaling. Herein, we investigated the physiological relevance of core fucosylation in the pathogenesis of emphysema using viable heterozygous knock-out mice (Fut8(+/-)) that were exposed to cigarette smoke (CS). The Fut8(+/-) mice exhibited a marked decrease in FUT8 activity, and matrix metalloproteinase (MMP)-9 activities were elevated in the lung at an early stage of exposure. Emphysema developed after a 3-month CS exposure, accompanied by the recruitment of large numbers of macrophages to the lung. CS exposure substantially and persistently elevated the expression level of Smad7, resulting in a significant reduction of Smad2 phosphorylation (which controls MMP-9 expression) in Fut8(+/-) mice and Fut8-deficient embryonic fibroblast cells. These in vivo and in vitro studies show that impaired core fucosylation enhances the susceptibility to CS and constitutes at least part of the disease process of emphysema, in which TGF-beta-Smad signaling is impaired and the MMP-mediated destruction of lung parenchyma is up-regulated.	[Gao, Congxiao; Ota, Fumi; Korekane, Hiroaki; Takamatsu, Shinji; Kobayashi, Satoshi; Yoshida, Keiichi; Kitazume, Shinobu; Ohtsubo, Kazuaki; Taniguchi, Naoyuki] RIKEN Adv Sci Inst, Dis Glyc Team, Max Planck Joint Ctr, Wako, Saitama 3510198, Japan; [Gao, Congxiao; Ota, Fumi; Korekane, Hiroaki; Takamatsu, Shinji; Shirato, Ken; Matsumoto, Akio; Ohtsubo, Kazuaki; Taniguchi, Naoyuki] Osaka Univ, Inst Sci & Ind Res, RIKEN Alliance Lab, Osaka 5670047, Japan; [Maeno, Toshitaka; Ueno, Manabu] Gunma Univ, Grad Sch Med, Dept Med & Biol Sci, Gunma 3718511, Japan; [Shirato, Ken] Waseda Univ, Fac Human Sci, Saitama 3591192, Japan; [Matsumoto, Akio] Chiba Univ, Grad Sch Med, Dept Pharmacol, Chiba 2608670, Japan; [Betsuyaku, Tomoko] Keio Univ, Sch Med, Dept Internal Med, Tokyo 1808582, Japan	RIKEN; Osaka University; RIKEN; Gunma University; Waseda University; Chiba University; Keio University	Taniguchi, N (corresponding author), RIKEN Adv Sci Inst, Dis Glyc Team, Max Planck Joint Ctr, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tani52@wd5.so-net.ne.jp	Taniguchi, Naoyuki/A-7086-2016; Taniguchi, Naoyuki/I-4182-2014	Taniguchi, Naoyuki/0000-0001-5889-5968; Matsumoto, Akio/0000-0002-3402-6992	National Institute of Biomedical Innovation (NIBIO); Global Center of Excellent (GCOE); Ministry of Education, Science, Sports and Culture, Japan [20249018, 23591118]; Naito Foundation, Japan; Grants-in-Aid for Scientific Research [24659111, 24790331] Funding Source: KAKEN	National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Global Center of Excellent (GCOE); Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation, Japan(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation (NIBIO), the Global Center of Excellent (GCOE) Program, and Grant-in-aid for Scientific Research (A) 20249018 from the Ministry of Education, Science, Sports and Culture, Japan.; Supported by Grant-in-aid for Scientific Research (C) 23591118 from the Ministry of Education, Science, Sports and Culture, Japan, and by the Naito Foundation, Japan.	Abboud RT, 2008, INT J TUBERC LUNG D, V12, P361; Babusyte A, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-81; Balzano G, 1999, AM J RESP CRIT CARE, V160, P1486, DOI 10.1164/ajrccm.160.5.9810105; Burgel PR, 2011, EUR RESPIR REV, V20, P7, DOI 10.1183/09059180.10010610; Devel L, 2006, J BIOL CHEM, V281, P11152, DOI 10.1074/jbc.M600222200; Domagala-Kulawik J, 2008, J PHYSIOL PHARMACOL, V59, P19; Gorska K, 2010, CURR OPIN PULM MED, V16, P89, DOI 10.1097/MCP.0b013e3283341ba0; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Hersh Craig P, 2008, Proc Am Thorac Soc, V5, P486, DOI 10.1513/pats.200706-078ET; Hong S, 2007, CANCER RES, V67, P9577, DOI 10.1158/0008-5472.CAN-07-1179; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; Ihara H, 2006, GLYCOBIOLOGY, V16, P333, DOI 10.1093/glycob/cwj068; JANOFF A, 1979, SCIENCE, V206, P1313, DOI 10.1126/science.316187; Kizuka Y, 2011, J BIOL CHEM, V286, P31875, DOI 10.1074/jbc.M111.251173; Knezevic A, 2010, GLYCOBIOLOGY, V20, P959, DOI 10.1093/glycob/cwq051; Kunz LIZ, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-34; Loukides S, 2011, CURR DRUG TARGETS, V12, P469, DOI 10.2174/138945011794751573; Matsumura K, 2007, J BIOL CHEM, V282, P15700, DOI 10.1074/jbc.M701195200; Murugan V, 2009, EXP LUNG RES, V35, P439, DOI 10.1080/01902140902759290; Okamoto T, 2009, BIOCHEM BIOPH RES CO, V383, P475, DOI 10.1016/j.bbrc.2009.04.038; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rajendrasozhan S, 2009, COPD, V6, P291, DOI 10.1080/15412550903049132; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; Shi WB, 2004, J CELL BIOL, V164, P291, DOI 10.1083/jcb.200307151; Siddiqui S, 2007, EUR RESPIR J, V30, P1043, DOI 10.1183/09031936.00162506; Stevenson CS, 2007, AM J PHYSIOL-LUNG C, V293, pL1183, DOI 10.1152/ajplung.00105.2007; Suga T, 2000, AM J RESP CELL MOL, V22, P26, DOI 10.1165/ajrcmb.22.1.3554; Takeda Y, 2008, J BIOL CHEM, V283, P26089, DOI 10.1074/jbc.M801902200; Taniguchi N, 2007, NAT CHEM BIOL, V3, P307, DOI 10.1038/nchembio0607-307; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; Uozumi N, 1996, J BIOCHEM, V120, P385; Wallace AM, 2008, COPD, V5, P13, DOI 10.1080/15412550701817789; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Wang XC, 2009, J BIOCHEM, V145, P643, DOI 10.1093/jb/mvp022; Wright JL, 2007, AM J PHYSIOL-LUNG C, V292, pL125, DOI 10.1152/ajplung.00539.2005; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008; Yamada M, 2011, J HUM GENET, V56, P857, DOI 10.1038/jhg.2011.118; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827; Yanagidani S, 1997, J BIOCHEM-TOKYO, V121, P626; Zandvoort A, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-83	41	42	45	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16699	16708		10.1074/jbc.M111.315333	http://dx.doi.org/10.1074/jbc.M111.315333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22433854	Green Published, hybrid			2022-12-27	WOS:000304030900058
J	Kohn, JA; Deshpande, K; Ortlund, EA				Kohn, Jeffrey A.; Deshpande, Kirti; Ortlund, Eric A.			Deciphering Modern Glucocorticoid Cross-pharmacology Using Ancestral Corticosteroid Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; ESTROGEN-RECEPTOR; CRYSTAL-STRUCTURE; EVOLUTION; EXPLOITATION; PROTEIN; ACTIVATION; STABILITY; MECHANISM; FUROATE	Steroid receptors (SRs) are the largest family of metazoan transcription factors and control genes involved in development, endocrine signaling, reproduction, immunity, and cancer. The entire hormone receptor system is driven by a molecular switch triggered by the binding of small lipophilic ligands. This makes the SRs ideal pharmaceutical targets, yet even the best clinically approved synthetic steroidal agonists are prone to cross-reactivity and off-target pharmacology. The mechanism underlying this promiscuity is derived from the fact that SRs share common structural features derived from their evolutionary relationship. More often than not, rational attempts to probe SR drug selectivity via mutagenesis fail even when high quality structural and functional data are available due to the fact that important mutations often result in nonfunctional receptors. This highlights the fact that SRs suffer from instability, preventing in-depth mutational analysis and hampering crystallization of key receptor-ligand complexes. We have taken a unique approach to address this problem by using a resurrected ancestral protein to determine the structure of a previously intractable complex and identified the structural mechanisms that confer activation and selectivity for a widely used glucocorticoid, mometasone furoate. Moreover, we have identified a single residue located outside of the ligand-binding pocket that controls mometasone furoate antagonism versus agonism in the human mineralocorticoid receptor.	[Ortlund, Eric A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Winship Canc Inst, Discovery & Dev Therapeut Program, Atlanta, GA 30322 USA	Emory University; Emory University	Ortlund, EA (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	eric.ortlund@emory.edu	Ortlund, Eric Anthony/P-3121-2019; Ortlund, Eric Anthony/F-4672-2014	Ortlund, Eric Anthony/0000-0001-8855-3029; Ortlund, Eric Anthony/0000-0001-8855-3029				Biggadike K, 2008, J MED CHEM, V51, P3349, DOI 10.1021/jm800279t; Bledsoe RK, 2005, J BIOL CHEM, V280, P31283, DOI 10.1074/jbc.M504098200; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Carroll SM, 2008, MOL BIOL EVOL, V25, P2643, DOI 10.1093/molbev/msn204; Carroll SM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002117; CARSONJURICA MA, 1990, ENDOCR REV, V11, P201, DOI 10.1210/edrv-11-2-201; DECALMER PBS, 1978, BRIT HEART J, V40, P184; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Gaucher EA, 2003, NATURE, V425, P285, DOI 10.1038/nature01977; Gee AC, 2001, MOL ENDOCRINOL, V15, P421, DOI 10.1210/me.15.3.421; Godoy-Ruiz R, 2006, J MOL BIOL, V362, P966, DOI 10.1016/j.jmb.2006.07.065; Hanania NA, 2008, PULM PHARMACOL THER, V21, P134, DOI 10.1016/j.pupt.2007.07.002; JERMANN TM, 1995, NATURE, V374, P57, DOI 10.1038/374057a0; Kallenberger BC, 2003, NAT STRUCT BIOL, V10, P136, DOI 10.1038/nsb892; Madauss KP, 2007, MED RES REV, V27, P374, DOI 10.1002/med.20083; Madauss KP, 2004, J MED CHEM, V47, P3381, DOI 10.1021/jm030640n; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Nettles KW, 2007, EMBO REP, V8, P563, DOI 10.1038/sj.embor.7400963; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; REMICK RA, 1988, PROG NEURO-PSYCHOPH, V12, P225, DOI 10.1016/0278-5846(88)90039-5; Roy ML, 1996, CIRCULATION, V94, P817, DOI 10.1161/01.CIR.94.4.817; Seitz T, 2010, J MOL BIOL, V403, P562, DOI 10.1016/j.jmb.2010.08.048; Stahn C, 2007, MOL CELL ENDOCRINOL, V275, P71, DOI 10.1016/j.mce.2007.05.019; Tan Ricardo A, 2008, Ther Clin Risk Manag, V4, P1201; Taverna DM, 2002, PROTEINS, V46, P105, DOI 10.1002/prot.10016; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; Wouters MA, 2003, MOL CELL, V12, P343, DOI 10.1016/S1097-2765(03)00308-3; Yamashiro K, 2010, PROTEIN ENG DES SEL, V23, P519, DOI 10.1093/protein/gzq021	30	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16267	16275		10.1074/jbc.M112.346411	http://dx.doi.org/10.1074/jbc.M112.346411			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22437833	Green Published, hybrid			2022-12-27	WOS:000304030900019
J	Qadri, YJ; Cormet-Boyaka, E; Rooj, AK; Lee, W; Parpura, V; Fuller, CM; Berdiev, BK				Qadri, Yawar J.; Cormet-Boyaka, Estelle; Rooj, Arun K.; Lee, William; Parpura, Vladimir; Fuller, Cathy M.; Berdiev, Bakhrom K.			Low Temperature and Chemical Rescue Affect Molecular Proximity of Delta F508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Epithelial Sodium Channel (ENaC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; CYSTIC-FIBROSIS; FLUORESCENT PROTEIN; CHLORIDE TRANSPORT; TRAFFICKING; 4-PHENYLBUTYRATE; EXPRESSION; RESTORATION; STIMULATION; MECHANISMS	An imbalance of chloride and sodium ion transport in several epithelia is a feature of cystic fibrosis (CF), an inherited disease that is a consequence of mutations in the cftr gene. The cftr gene codes for a Cl- channel, the cystic fibrosis transmembrane conductance regulator (CFTR). Some mutations in this gene cause the balance between Cl- secretion and Na+ absorption to be disturbed in the airways; Cl- secretion is impaired, whereas Na+ absorption is elevated. Enhanced Na+ absorption through the epithelial sodium channel (ENaC) is attributed to the failure of mutated CFTR to restrict ENaC-mediated Na+ transport. The mechanism of this regulation is controversial. Recently, we have found evidence for a close association of wild type (WT) CFTR and WT ENaC, further underscoring the role of ENaC along with CFTR in the pathophysiology of CF airway disease. In this study, we have examined the association of ENaC subunits with mutated Delta F508-CFTR, the most common mutation in CF. Deletion of phenylalanine at position 508 (Delta F508) prevents proper processing and targeting of CFTR to the plasma membrane. When Delta F508-CFTR and ENaC subunits were co-expressed in HEK293T cells, we found that individual ENaC subunits could be co-immunoprecipitated with Delta F508-CFTR, much like WT CFTR. However, when we evaluated the Delta F508-CFTR and ENaC association using fluorescence resonance energy transfer (FRET), FRET efficiencies were not significantly different from negative controls, suggesting that Delta F508-CFTR and ENaC are not in close proximity to each other under basal conditions. However, with partial correction of Delta F508-CFTR misprocessing by low temperature and chemical rescue, leading to surface expression as assessed by total internal reflection fluorescence (TIRF) microscopy, we observed a positive FRET signal. Our findings suggest that the Delta F508 mutation alters the close association of CFTR and ENaC.	[Qadri, Yawar J.] Univ N Carolina, Dept Anesthesiol, Chapel Hill, NC 27511 USA; [Cormet-Boyaka, Estelle] Ohio State Univ, Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA; [Rooj, Arun K.; Fuller, Cathy M.; Berdiev, Bakhrom K.] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Lee, William; Parpura, Vladimir] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Parpura, Vladimir; Berdiev, Bakhrom K.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Parpura, Vladimir; Berdiev, Bakhrom K.] Univ Alabama Birmingham, Ctr Biophys Sci & Engn, Birmingham, AL 35294 USA; [Berdiev, Bakhrom K.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA	University of North Carolina; University of North Carolina Chapel Hill; Ohio State University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Berdiev, BK (corresponding author), 1918 Univ Blvd,MCLM 725, Birmingham, AL 35294 USA.	berdiev@uab.edu	Cormet-Boyaka, Estelle/H-5624-2011	Qadri, Yawar/0000-0003-2138-4018	National Institutes of Health (NIH) [DK37206, P30DK072482, R474-CR11]; NHLBI [R21HL085112]; UAB Health Services Foundation; UAB Department of Physiology and Biophysics; National Science Foundation [CBET0943343]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL085112] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037206, P30DK072482, R56DK037206] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); UAB Health Services Foundation; UAB Department of Physiology and Biophysics; National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NHLBI, Grant R21HL085112 (to B. K. B.), and NIH Grants DK37206 (to C. M. F.), P30DK072482 (to the University of Alabama at Birmingham (UAB) Cystic Fibrosis (CF) Center; Director Dr. Eric J. Sorscher), and R474-CR11 (to the UAB CF Center). This work was also supported by the UAB Health Services Foundation General Endowment Fund (to B. K. B.), UAB Department of Physiology and Biophysics Funds (to B. K. B.), and National Science Foundation Grant CBET0943343 (to V. P.).	Bebok Z, 2002, J BIOL CHEM, V277, P43041, DOI 10.1074/jbc.M203154200; Berdiev BK, 2007, J BIOL CHEM, V282, P36481, DOI 10.1074/jbc.M708089200; Berdiev BK, 2000, BIOPHYS J, V78, P1881, DOI 10.1016/S0006-3495(00)76737-3; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Cormet-Boyaka E, 2002, P NATL ACAD SCI USA, V99, P12477, DOI 10.1073/pnas.192203899; Cuthbert AW, 2011, BRIT J PHARMACOL, V163, P173, DOI 10.1111/j.1476-5381.2010.01137.x; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DENNING GM, 1992, J CELL BIOL, V118, P551, DOI 10.1083/jcb.118.3.551; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Gentzsch M, 2010, J BIOL CHEM, V285, P32227, DOI 10.1074/jbc.M110.155259; Hebeisen S, 2004, J BIOL CHEM, V279, P13140, DOI 10.1074/jbc.M312649200; Helms MN, 2005, J BIOL CHEM, V280, P40885, DOI 10.1074/jbc.M509646200; Holman D, 2007, J NEUROSCI METH, V160, P302, DOI 10.1016/j.jneumeth.2006.09.018; Kapoor N, 2011, AM J PHYSIOL-CELL PH, V300, pC1246, DOI 10.1152/ajpcell.00199.2010; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Kunzelmann K., 2003, CYSTIC FIBROSIS TRAN, P55; Loo TW, 2008, BIOCHEM J, V413, P29, DOI 10.1042/BJ20071690; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Meltzer RH, 2007, J BIOL CHEM, V282, P25548, DOI 10.1074/jbc.M703825200; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Noel S, 2008, J PHARMACOL EXP THER, V325, P1016, DOI 10.1124/jpet.107.135582; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pham E, 2007, STRUCTURE, V15, P515, DOI 10.1016/j.str.2007.03.009; Robert R, 2010, MOL PHARMACOL, V77, P922, DOI 10.1124/mol.109.062679; Rogan MP, 2011, CHEST, V139, P1480, DOI 10.1378/chest.10-2077; Rowe SM, 2010, PULM PHARMACOL THER, V23, P268, DOI 10.1016/j.pupt.2010.02.001; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Rubenstein Ronald C., 1998, Current Opinion in Pediatrics, V10, P250, DOI 10.1097/00008480-199806000-00005; Rubenstein RC, 2011, AM J PHYSIOL-LUNG C, V300, pL88, DOI 10.1152/ajplung.00142.2010; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Sermet-Gaudelus I, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-5; Staruschenko A, 2004, J BIOL CHEM, V279, P27729, DOI 10.1074/jbc.M404169200; Suaud L, 2002, J BIOL CHEM, V277, P8928, DOI 10.1074/jbc.M111482200; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Zeitlin PL, 2002, MOL THER, V6, P119, DOI 10.1006/mthe.2002.0639	43	8	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16781	16790		10.1074/jbc.M111.332031	http://dx.doi.org/10.1074/jbc.M111.332031			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22442149	Green Published, hybrid			2022-12-27	WOS:000304030900065
J	Carrara, G; Saraiva, N; Gubser, C; Johnson, BF; Smith, GL				Carrara, Guia; Saraiva, Nuno; Gubser, Caroline; Johnson, Benjamin F.; Smith, Geoffrey L.			Six-transmembrane Topology for Golgi Anti-apoptotic Protein (GAAP) and Bax Inhibitor 1 (BI-1) Provides Model for the Transmembrane Bax Inhibitor-containing Motif (TMBIM) Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM; VIRUS; GENE; IDENTIFICATION; PROTECTION; HOMOLOGS; VACCINIA; VECTOR	The Golgi anti-apoptotic protein (GAAP) is a hydrophobic Golgi protein that regulates intracellular calcium fluxes and apoptosis. GAAP is highly conserved throughout eukaryotes and some strains of vaccinia virus (VACV) and camelpox virus. Based on sequence, phylogeny, and hydrophobicity, GAAPs were classified within the transmembrane Bax inhibitor-containing motif (TMBIM) family. TMBIM members are anti-apoptotic and were predicted to have seven-transmembrane domains (TMDs). However, topology prediction programs are inconsistent and predicted that GAAP and other TMBIM members have six or seven TMDs. To address this discrepancy, we mapped the transmembrane topology of viral (vGAAP) and human (hGAAP), as well as Bax inhibitor (BI-1). Data presented show a six-, not seven-, transmembrane topology for vGAAP with a putative reentrant loop at the C terminus and both termini located in the cytosol. We find that this topology is also conserved in hGAAP and BI-1. This places the charged C terminus in the cytosol, and mutation of these charged residues in hGAAP ablated its anti-apoptotic function. Given the highly conserved hydrophobicity profile within the TMBIM family and recent phylogenetic data indicating that a GAAP-like protein may have been the ancestral progenitor of a subset of the TMBIM family, we propose that this vGAAP topology may be used as a model for the remainder of the TMBIM family of proteins. The topology described provides valuable information on the structure and func-tion of an important but poorly understood family of proteins.	[Carrara, Guia; Saraiva, Nuno; Gubser, Caroline; Johnson, Benjamin F.; Smith, Geoffrey L.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Carrara, Guia; Saraiva, Nuno; Gubser, Caroline; Johnson, Benjamin F.; Smith, Geoffrey L.] Univ London Imperial Coll Sci Technol & Med, Virol Sect, Dept Med, London W2 1PG, England	University of Cambridge; Imperial College London	Smith, GL (corresponding author), Wellcome Trust Res Labs, London, England.	gls37@cam.ac.uk	Smith, Geoffrey L/G-2894-2012; Saraiva, Nuno/I-9299-2019	Saraiva, Nuno/0000-0003-1333-9137; Johnson, Benjamin/0000-0001-5991-7612; Gubser Keller, Caroline/0000-0001-9459-6076; Smith, Geoffrey L/0000-0002-3730-9955	Medical Research Council; Medical Research Council [G0900224] Funding Source: researchfish; MRC [G0900224] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the Medical Research Council.	Ahn T, 2009, FEBS J, V276, P2285, DOI 10.1111/j.1742-4658.2009.06956.x; ALCAMI A, 1995, J VIROL, V69, P4633; Bolduc N, 2003, PLANTA, V216, P377, DOI 10.1007/s00425-002-0879-1; Bultynck G, 2012, J BIOL CHEM, V287, P2544, DOI 10.1074/jbc.M111.275354; Cebulski J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020882; Chae HJ, 2003, GENE, V323, P101, DOI 10.1016/j.gene.2003.09.011; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; de Mattia F, 2009, MOL BIOL CELL, V20, P3638, DOI 10.1091/mbc.E09-05-0385; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Gubser C, 2002, J GEN VIROL, V83, P855, DOI 10.1099/0022-1317-83-4-855; Gubser C, 2007, PLOS PATHOG, V3, P246, DOI 10.1371/journal.ppat.0030017; Henke N, 2011, CELL CALCIUM, V50, P251, DOI 10.1016/j.ceca.2011.05.005; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hu L, 2009, APOPTOSIS, V14, P1255, DOI 10.1007/s10495-009-0402-2; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Kim HR, 2008, J BIOL CHEM, V283, P15946, DOI 10.1074/jbc.M800075200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee GH, 2010, MOL CELL BIOL, V30, P1800, DOI 10.1128/MCB.01357-09; Lee S, 2007, J BIOCHEM MOL BIOL, V40, P226; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Nuara AA, 2008, P NATL ACAD SCI USA, V105, P1861, DOI 10.1073/pnas.0705753105; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Somia NV, 1999, P NATL ACAD SCI USA, V96, P12667, DOI 10.1073/pnas.96.22.12667; WALTER L, 1995, GENOMICS, V28, P301, DOI 10.1006/geno.1995.1145; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Xu CY, 2008, J BIOL CHEM, V283, P11477, DOI 10.1074/jbc.M708385200; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Zhorov BS, 2004, J NEUROCHEM, V88, P782, DOI 10.1111/j.1471-4159.2004.02261.x; Zhou JH, 2008, COMPUT BIOL CHEM, V32, P159, DOI 10.1016/j.compbiolchem.2008.01.002	30	37	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15896	15905		10.1074/jbc.M111.336149	http://dx.doi.org/10.1074/jbc.M111.336149			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22418439	hybrid, Green Published			2022-12-27	WOS:000304006300068
J	Ji, YW; Sun, SY; Xu, AM; Bhargava, P; Yang, L; Lam, KSL; Gao, B; Lee, CH; Kersten, S; Qi, L				Ji, Yewei; Sun, Shengyi; Xu, Aimin; Bhargava, Prerna; Yang, Liu; Lam, Karen S. L.; Gao, Bin; Lee, Chih-Hao; Kersten, Sander; Qi, Ling			Activation of Natural Killer T Cells Promotes M2 Macrophage Polarization in Adipose Tissue and Improves Systemic Glucose Tolerance via Interleukin-4 (IL-4)/STAT6 Protein Signaling Axis in Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVARIANT NKT CELLS; ALTERNATIVE ACTIVATION; INSULIN-RESISTANCE; LIPID ANTIGEN; INFLAMMATION; RECEPTOR; MICE; FAT; RECOGNITION; MODULATION	Natural killer T (NKT) cells are important therapeutic targets in various disease models and are under clinical trials for cancer patients. However, their function in obesity and type 2 diabetes remains unclear. Our data show that adipose tissues of both mice and humans contain a population of type 1 NKT cells, whose abundance decreases with increased adiposity and insulin resistance. Although loss-of-function of NKT cells had no effect on glucose tolerance in animals with prolonged high fat diet feeding, activation of NKT cells by lipid agonist alpha-galactosylceramide enhances alternative macrophage polarization in adipose tissue and improves glucose homeostasis in animals at different stages of obesity. Furthermore, the effect of NKT cells is largely mediated by the IL-4/STAT6 signaling axis in obese adipose tissue. Thus, our data identify a novel therapeutic target for the treatment of obesity-associated inflammation and type 2 diabetes.	[Ji, Yewei; Kersten, Sander; Qi, Ling] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Sun, Shengyi; Yang, Liu; Qi, Ling] Cornell Univ, Grad Program Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Xu, Aimin; Lam, Karen S. L.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Xu, Aimin; Lam, Karen S. L.] Univ Hong Kong, Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China; [Bhargava, Prerna; Lee, Chih-Hao] Harvard Univ, Sch Publ Hlth, Dept Genet, Boston, MA 02115 USA; [Bhargava, Prerna; Lee, Chih-Hao] Harvard Univ, Sch Publ Hlth, Dept Complex Dis & Nutr, Boston, MA 02115 USA; [Gao, Bin] NIAAA, Lab Liver Dis, Rockville, MD 20852 USA; [Kersten, Sander] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, NL-6700 EV Wageningen, Netherlands	Cornell University; Cornell University; University of Hong Kong; University of Hong Kong; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Wageningen University & Research	Qi, L (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	lq35@cornell.edu	Ji, Yewei/F-5040-2014; Xu, Aimin/D-3291-2013; Kersten, Sander/A-1116-2011; /C-4315-2009	Ji, Yewei/0000-0002-4249-6812; Xu, Aimin/0000-0002-0668-033X; Kersten, Sander/0000-0003-4488-7734; Qi, Ling/0000-0001-8229-0184; Sun, Shengyi/0000-0002-1734-3902; /0000-0001-5757-541X	National Institutes of Health from NIDDK [R01DK075046]; NIDDK [R01DK082582, R01DK082582-S1]; Hong Kong Collaborative Research Fund Grant [HKU4/CRF/10]; Netherlands Nutrigenomics Centre; Cornell startup package; American Diabetes Association [7-08-JF-47, 1-12-CD-04]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075046, R01DK082582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES016645] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Hong Kong Collaborative Research Fund Grant; Netherlands Nutrigenomics Centre; Cornell startup package; American Diabetes Association(American Diabetes Association); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK075046 from NIDDK (to C. H. L.) and Grants R01DK082582 and R01DK082582-S1 from NIDDK (to L. Q.). This work was also supported by Hong Kong Collaborative Research Fund Grant HKU4/CRF/10 (to A. X. and K. S. L. L.), Netherlands Nutrigenomics Centre (to S. K.), Cornell startup package, and American Diabetes Association Grants 7-08-JF-47 and 1-12-CD-04.; Supported by the International Student Research Fellowship from Howard Hughes Medical Institute.	Bai L, 2009, P NATL ACAD SCI USA, V106, P10254, DOI 10.1073/pnas.0901228106; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2011, J EXP MED, V208, P1163, DOI 10.1084/jem.20102555; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; DELLABONA P, 1994, J EXP MED, V180, P1171, DOI 10.1084/jem.180.3.1171; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Giaccone G, 2002, CLIN CANCER RES, V8, P3702; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kis J, 2007, J LEUKOCYTE BIOL, V81, P654, DOI 10.1189/jlb.1106654; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Kotas ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025478; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lynch L, 2009, EUR J IMMUNOL, V39, P1893, DOI 10.1002/eji.200939349; Mantell BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019831; Marathe C, 2009, J LIPID RES, V50, P214, DOI 10.1194/jlr.M800189-JLR200; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ohmura K, 2010, ARTERIOSCL THROM VAS, V30, P193, DOI 10.1161/ATVBAHA.109.198614; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Schmieg J, 2005, P NATL ACAD SCI USA, V102, P1127, DOI 10.1073/pnas.0408288102; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Vijayanand P, 2007, NEW ENGL J MED, V356, P1410, DOI 10.1056/NEJMoa064691; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wilson MT, 2003, P NATL ACAD SCI USA, V100, P10913, DOI 10.1073/pnas.1833166100; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xia S, 2011, J BIOL CHEM, V286, P23591, DOI 10.1074/jbc.M111.237123; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; YOSHIMOTO T, 1995, SCIENCE, V270, P1845, DOI 10.1126/science.270.5243.1845; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	57	155	162	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13561	13571		10.1074/jbc.M112.350066	http://dx.doi.org/10.1074/jbc.M112.350066			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22396530	Green Published, hybrid			2022-12-27	WOS:000303996300013
J	Hayano, S; Kurosaka, H; Yanagita, T; Kalus, I; Milz, F; Ishihara, Y; Islam, MN; Kawanabe, N; Saito, M; Kamioka, H; Adachi, T; Dierks, T; Yamashiro, T				Hayano, Satoru; Kurosaka, Hiroshi; Yanagita, Takeshi; Kalus, Ina; Milz, Fabian; Ishihara, Yoshihito; Islam, Md. Nurul; Kawanabe, Noriaki; Saito, Masahiro; Kamioka, Hiroshi; Adachi, Taiji; Dierks, Thomas; Yamashiro, Takashi			Roles of Heparan Sulfate Sulfation in Dentinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONYCHO-DERMAL DYSPLASIA; CELL-SURFACE; TOOTH DEVELOPMENT; 6-O-ENDOSULFATASES SULF1; IN-VIVO; EXPRESSION; PROTEOGLYCANS; DSPP; MUTATION; GENE	Cell surface heparan sulfate (HS) is an essential regulator of cell signaling and development. HS traps signaling molecules, like Wnt in the glycosaminoglycan side chains of HS proteoglycans (HSPGs), and regulates their functions. Endosulfatases Sulf1 and Sulf2 are secreted at the cell surface to selectively remove 6-O-sulfate groups from HSPGs, thereby modifying the affinity of cell surface HSPGs for its ligands. This study provides molecular evidence for the functional roles of HSPG sulfation and desulfation in dentinogenesis. We show that odontogenic cells are highly sulfated on the cell surface and become desulfated during their differentiation to odontoblasts, which produce tooth dentin. Sulf1/Sulf2 double null mutant mice exhibit a thin dentin matrix and short roots combined with reduced expression of dentin sialophosphoprotein (Dspp) mRNA, encoding a dentin-specific extracellular matrix precursor protein, whereas single Sulf mutants do not show such defective phenotypes. In odontoblast cell lines, Dspp mRNA expression is potentiated by the activation of the Wnt canonical signaling pathway. In addition, pharmacological interference with HS sulfation promotes Dspp mRNA expression through activation of Wnt signaling. On the contrary, the silencing of Sulf suppresses the Wnt signaling pathway and subsequently Dspp mRNA expression. We also show that Wnt10a protein binds to cell surface HSPGs in odontoblasts, and interference with HS sulfation decreases the binding affinity of Wnt10a for HSPGs, which facilitates the binding of Wnt10a to its receptor and potentiates the Wnt signaling pathway, thereby up-regulating Dspp mRNA expression. These results demonstrate that Sulf-mediated desulfation of cellular HSPGs is an important modification that is critical for the activation of the Wnt signaling in odontoblasts and for production of the dentin matrix.	[Islam, Md. Nurul; Kawanabe, Noriaki; Kamioka, Hiroshi] Okayama Univ, Dept Orthodont, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008525, Japan; [Kalus, Ina; Milz, Fabian; Dierks, Thomas] Univ Bielefeld, Dept Chem, D-33501 Bielefeld, Germany; [Saito, Masahiro] Tokyo Univ Sci, Fac Ind Sci & Technol, Tokyo 1628601, Japan; [Adachi, Taiji] Kyoto Univ, Dept Biomechan, Res Ctr Nano Med Engn, Inst Frontier Med Sci, Kyoto 6068507, Japan	Okayama University; University of Bielefeld; Tokyo University of Science; Kyoto University		yamataka@md.okayama-u.ac.jp	ISHIHARA, Yoshihito/B-2345-2011; Yamashiro, Takashi/Y-6411-2019; Dierks, Thomas/A-3596-2012; Adachi, Taiji/P-8981-2016; Kamioka, Hiroshi/B-2476-2011; Yamashiro, Takashi/S-6010-2019	ISHIHARA, Yoshihito/0000-0002-5999-8253; Dierks, Thomas/0000-0001-6426-1339; Adachi, Taiji/0000-0001-5280-4156; Yamashiro, Takashi/0000-0002-4419-9643; Kurosaka, Hiroshi/0000-0002-8956-5467	Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22792051, 24792284] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for scientific research program from the Japan Society for the Promotion of Science (to T. Y.).	Adaimy L, 2007, AM J HUM GENET, V81, P821, DOI 10.1086/520064; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Cardigan RA, 1997, J CARDIOTHOR VASC AN, V11, P329, DOI 10.1016/S1053-0770(97)90103-8; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; Feng JQ, 1998, J BIOL CHEM, V273, P9457, DOI 10.1074/jbc.273.16.9457; Frese MA, 2009, J BIOL CHEM, V284, P28033, DOI 10.1074/jbc.M109.035808; Fritz T A, 2001, Methods Mol Biol, V171, P317; Habuchi H, 2004, GLYCOCONJUGATE J, V21, P47, DOI 10.1023/B:GLYC.0000043747.87325.5e; Holst CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000575; Ida-Yonemochi H, 2011, MATRIX BIOL, V30, P379, DOI 10.1016/j.matbio.2011.08.001; JALKANEN M, 1985, J CELL BIOL, V101, P976, DOI 10.1083/jcb.101.3.976; Kalus I, 2009, J CELL MOL MED, V13, P4505, DOI 10.1111/j.1582-4934.2008.00558.x; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Lammi L, 2004, AM J HUM GENET, V74, P1043, DOI 10.1086/386293; Langsdorf A, 2007, DEV BIOL, V311, P464, DOI 10.1016/j.ydbio.2007.08.053; Leteux C, 2001, J BIOL CHEM, V276, P12539, DOI 10.1074/jbc.M010291200; Li JS, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-14; Linde Anders, 1993, Critical Reviews in Oral Biology and Medicine, V4, P679; Lohi M, 2010, DEV DYNAM, V239, P160, DOI 10.1002/dvdy.22047; Lugemwa FN, 1996, J BIOL CHEM, V271, P19159, DOI 10.1074/jbc.271.32.19159; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nawaz S, 2009, EUR J HUM GENET, V17, P1600, DOI 10.1038/ejhg.2009.81; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Qin C, 2002, J DENT RES, V81, P392, DOI 10.1177/154405910208100607; Rajpar MH, 2002, HUM MOL GENET, V11, P2559, DOI 10.1093/hmg/11.21.2559; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Sarkar L, 1999, MECH DEVELOP, V85, P197, DOI 10.1016/S0925-4773(99)00095-7; SHIELDS ED, 1973, ARCH ORAL BIOL, V18, P543, DOI 10.1016/0003-9969(73)90075-7; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Suomalainen M, 2010, DEV DYNAM, V239, P364, DOI 10.1002/dvdy.22106; Thesleff I, 1999, BONE, V25, P123, DOI 10.1016/S8756-3282(99)00119-2; THESLEFF I, 1991, J CRAN GENET DEV BIO, V11, P229; THESLEFF I, 1989, International Journal of Developmental Biology, V33, P91; Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; van den Born J, 2005, J BIOL CHEM, V280, P20516, DOI 10.1074/jbc.M502065200; Wu N, 2010, ARCH ORAL BIOL, V55, P426, DOI 10.1016/j.archoralbio.2010.03.011; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Yamashiro T, 2001, J DENT RES, V80, P461, DOI 10.1177/00220345010800021201; Yamashiro T, 2007, DIFFERENTIATION, V75, P452, DOI 10.1111/j.1432-0436.2006.00150.x; Yanagita T, 2007, FEBS J, V274, P1655, DOI 10.1111/j.1742-4658.2007.05709.x; Yip GW, 2002, DEVELOPMENT, V129, P2109; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765	54	28	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12217	12229		10.1074/jbc.M111.332924	http://dx.doi.org/10.1074/jbc.M111.332924			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351753	Green Published, hybrid			2022-12-27	WOS:000302782200063
J	Radic, Z; Sit, RK; Kovarik, Z; Berend, S; Garcia, E; Zhang, LM; Amitai, G; Green, C; Radic, B; Fokin, VV; Sharpless, KB; Taylor, P				Radic, Zoran; Sit, Rakesh K.; Kovarik, Zrinka; Berend, Suzana; Garcia, Edzna; Zhang, Limin; Amitai, Gabriel; Green, Carol; Radic, Bozica; Fokin, Valery V.; Sharpless, K. Barry; Taylor, Palmer			Refinement of Structural Leads for Centrally Acting Oxime Reactivators of Phosphylated Cholinesterases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLICK CHEMISTRY; IN-SITU; ACETYLCHOLINESTERASE; ORGANOPHOSPHATES; RESIDUES; BINDING; BRAIN; SOMAN; BLOOD	We present a systematic structural optimization of uncharged but ionizable N-substituted 2-hydroxyiminoacetamido alkylamine reactivators of phosphylated human acetylcholinesterase (hAChE) intended to catalyze the hydrolysis of organophosphate (OP)-inhibited hAChE in the CNS. Starting with the initial lead oxime RS41A identified in our earlier study and extending to the azepine analog RS194B, reactivation rates for OP-hAChE conjugates formed by sarin, cyclosarin, VX, paraoxon, and tabun are enhanced severalfold in vitro. To analyze the mechanism of intrinsic reactivation of the OP-AChE conjugate and penetration of the blood-brain barrier, the pH dependence of the oxime and amine ionizing groups of the compounds and their nucleophilic potential were examined by UV-visible spectroscopy, H-1 NMR, and oximolysis rates for acetylthiocholine and phosphoester hydrolysis. Oximolysis rates were compared in solution and on AChE conjugates and analyzed in terms of the ionization states for reactivation of the OP-conjugated AChE. In addition, toxicity and pharmacokinetic studies in mice show significantly improved CNS penetration and retention for RS194B when compared with RS41A. The enhanced intrinsic reactivity against the OP-AChE target combined with favorable pharmacokinetic properties resulted in great improvement of antidotal properties of RS194B compared with RS41A and the standard peripherally active oxime, 2-pyridinealdoxime methiodide. Improvement was particularly noticeable when pretreatment of mice with RS194B before OP exposure was combined with RS194B reactivation therapy after the OP insult.	[Radic, Zoran; Garcia, Edzna; Zhang, Limin; Taylor, Palmer] UCSD, SSPPS, La Jolla, CA 92093 USA; [Sit, Rakesh K.; Fokin, Valery V.; Sharpless, K. Barry] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Kovarik, Zrinka; Berend, Suzana; Radic, Bozica] Inst Med Res & Occupat Hlth, HR-10001 Zagreb, Croatia; [Amitai, Gabriel] Israel Inst Biol Res, Dept Pharmacol, IL-74100 Ness Ziona, Israel; [Green, Carol] SRI Int, Menlo Pk, CA 94025 USA	University of California System; University of California San Diego; Scripps Research Institute; Institute for Medical Research & Occupational Health (IMROH); SRI International	Taylor, P (corresponding author), UCSD, SSPPS, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pwtaylor@ucsd.edu	RADIC, ZORAN/P-7924-2017		CounterACT Program; National Institutes of Health Office of the Director; National Institutes of Health from NINDS [U01 NS058046]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058046] Funding Source: NIH RePORTER	CounterACT Program; National Institutes of Health Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from NINDS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the CounterACT Program, National Institutes of Health Office of the Director, and National Institutes of Health Grant U01 NS058046 from NINDS.	Aldridge W. N., 1972, ENZYME INHIBITORS SU; Amitai G, 2007, TOXICOLOGY, V233, P187, DOI 10.1016/j.tox.2006.09.020; ASHANI Y, 1995, J BIOL CHEM, V270, P6370, DOI 10.1074/jbc.270.11.6370; Berend S, 2010, J ENZYM INHIB MED CH, V25, P531, DOI 10.3109/14756360903357593; Calic M, 2006, TOXICOLOGY, V219, P85, DOI 10.1016/j.tox.2005.11.003; Cochran R, 2011, J BIOL CHEM, V286, P29718, DOI 10.1074/jbc.M111.264739; Cook P. F., 2007, ENZYME KINETICS MECH, P225; de Koning MC, 2011, TOXICOL LETT, V206, P54, DOI 10.1016/j.toxlet.2011.04.004; Demar JC, 2010, CHEM-BIOL INTERACT, V187, P191, DOI 10.1016/j.cbi.2010.02.015; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Garcia GE, 2010, CHEM-BIOL INTERACT, V187, P199, DOI 10.1016/j.cbi.2010.02.033; HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/pnas.90.19.9031; Kalisiak J, 2011, J MED CHEM, V54, P3319, DOI 10.1021/jm200054r; Kovarik Z, 2004, BIOCHEMISTRY-US, V43, P3222, DOI 10.1021/bi036191a; Krasinski A, 2005, J AM CHEM SOC, V127, P6686, DOI 10.1021/ja043031t; Lewis WG, 2002, ANGEW CHEM INT EDIT, V41, P1053, DOI 10.1002/1521-3773(20020315)41:6<1053::AID-ANIE1053>3.0.CO;2-4; LITTLE PJ, 1988, DRUG METAB DISPOS, V16, P515; Malany S, 2000, J AM CHEM SOC, V122, P2981, DOI 10.1021/ja9933590; Mercey G, 2011, CHEM COMMUN, V47, P5295, DOI 10.1039/c1cc10787a; Radic Z, 2006, TOXICOLOGY ORGANOPHO, P161; Shih TM, 2010, CHEM-BIOL INTERACT, V187, P207, DOI 10.1016/j.cbi.2010.03.006; Silman I, 2008, CHEM-BIOL INTERACT, V175, P3, DOI 10.1016/j.cbi.2008.05.035; Sit RK, 2011, J BIOL CHEM, V286, P19422, DOI 10.1074/jbc.M111.230656; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; THOMPSON WR, 1947, BACTERIOL REV, V11, P115, DOI 10.1128/MMBR.11.2.115-145.1947; WEIL CS, 1952, BIOMETRICS, V8, P249, DOI 10.2307/3001557; Wilson I. B., 1971, DRUG DESIGN, VII, P213; WILSON IB, 1950, J BIOL CHEM, V185, P479	28	87	90	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11798	11809		10.1074/jbc.M111.333732	http://dx.doi.org/10.1074/jbc.M111.333732			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22343626	Green Published, hybrid			2022-12-27	WOS:000302782200019
J	Gubaev, A; Klostermeier, D				Gubaev, Airat; Klostermeier, Dagmar			Potassium Ions Are Required for Nucleotide-induced Closure of Gyrase N-gate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS DNA; ATP-OPERATED CLAMP; STRAND-PASSAGE; B-PROTEIN; TERMINAL FRAGMENT; 2-GATE MECHANISM; CLOSED CONFORMATION; CRYSTAL-STRUCTURE; TOPOISOMERASE-II; HYDROLYSIS	DNA gyrase catalyzes ATP-dependent negative supercoiling of DNA by a strand passage mechanism that requires coordinated opening and closing of three protein interfaces, the N-, DNA-, and C-gates. ATP binding to the GyrB subunits of gyrase causes dimerization and N-gate closure. The closure of the N-gate is a key step in the gyrase catalytic cycle, as it captures the DNA segment to be transported and poises gyrase toward strand passage. We show here that K+ ions are required for DNA supercoiling but are dispensable for ATP-independent DNA relaxation. Although DNA binding, distortion, wrapping, and DNA-induced narrowing of the N-gate occur in the absence of K+, nucleotide-induced N-gate closure depends on their presence. Our results provide evidence that K+ ions relay small conformational changes in the nucleotide-binding pocket to the formation of a tight dimer interface at the N-gate by connecting regions from both GyrB monomers and suggest an important role for K+ in synchronization of N-gate closure and DNA-gate opening.	[Gubaev, Airat; Klostermeier, Dagmar] Univ Munster, Inst Phys Chem, D-48149 Munster, Germany	University of Munster	Gubaev, A (corresponding author), Univ Munster, Inst Phys Chem, Corrensstr 30, D-48149 Munster, Germany.	airat.gubaev@uni-muenster.de			Swiss National Science Foundation (National Center of Competence in Research Nanoscale Sciences)	Swiss National Science Foundation (National Center of Competence in Research Nanoscale Sciences)	This work was supported by the Swiss National Science Foundation (National Center of Competence in Research Nanoscale Sciences).	ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; ALI JA, 1995, BIOCHEMISTRY-US, V34, P9801, DOI 10.1021/bi00030a018; BASHKIROV VI, 1991, GENETICA, V85, P3, DOI 10.1007/BF00056101; Bates AD, 2011, NUCLEIC ACIDS RES, V39, P6327, DOI 10.1093/nar/gkr258; Brino L, 2000, J BIOL CHEM, V275, P9468, DOI 10.1074/jbc.275.13.9468; Corbett KD, 2005, J MOL BIOL, V351, P545, DOI 10.1016/j.jmb.2005.06.029; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Fu GS, 2009, NUCLEIC ACIDS RES, V37, P5908, DOI 10.1093/nar/gkp586; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872; Gottler T, 2007, J MOL BIOL, V367, P1392, DOI 10.1016/j.jmb.2007.01.055; Gubaev A, 2011, P NATL ACAD SCI USA, V108, P14085, DOI 10.1073/pnas.1102100108; Gubaev A, 2009, P NATL ACAD SCI USA, V106, P13278, DOI 10.1073/pnas.0902493106; Hilbert M, 2011, NUCLEIC ACIDS RES, V39, P2260, DOI 10.1093/nar/gkq1127; Hu XJ, 2003, FEBS LETT, V544, P268, DOI 10.1016/S0014-5793(03)00519-2; Kampranis SC, 1999, P NATL ACAD SCI USA, V96, P8414, DOI 10.1073/pnas.96.15.8414; Kampranis SC, 1998, J BIOL CHEM, V273, P26305, DOI 10.1074/jbc.273.41.26305; Lanz MA, 2011, NUCLEIC ACIDS RES, V39, P9681, DOI 10.1093/nar/gkr680; LIU LF, 1978, P NATL ACAD SCI USA, V75, P2098, DOI 10.1073/pnas.75.5.2098; Machius M, 2001, P NATL ACAD SCI USA, V98, P11218, DOI 10.1073/pnas.201220098; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; Roca J, 2004, J BIOL CHEM, V279, P25783, DOI 10.1074/jbc.M402555200; ROCA J, 1994, CELL, V77, P609, DOI 10.1016/0092-8674(94)90222-4; Roca J, 2009, NUCLEIC ACIDS RES, V37, P721, DOI 10.1093/nar/gkn994; Sissi C, 2005, J MOL BIOL, V353, P1152, DOI 10.1016/j.jmb.2005.09.043; Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105; Tingey AP, 1996, NUCLEIC ACIDS RES, V24, P4868, DOI 10.1093/nar/24.24.4868; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; Williams NL, 2001, J MOL BIOL, V306, P969, DOI 10.1006/jmbi.2001.4468; Williams NL, 1999, BIOCHEMISTRY-US, V38, P14157, DOI 10.1021/bi991478m; Williams NL, 1999, BIOCHEMISTRY-US, V38, P13502, DOI 10.1021/bi9912488	30	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					10916	10921		10.1074/jbc.M111.308247	http://dx.doi.org/10.1074/jbc.M111.308247			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22343632	hybrid, Green Published			2022-12-27	WOS:000302780100020
J	Abe, R; Caaveiro, JMM; Kozuka-Hata, H; Oyama, M; Tsumoto, K				Abe, Ryota; Caaveiro, Jose M. M.; Kozuka-Hata, Hiroko; Oyama, Masaaki; Tsumoto, Kouhei			Mapping Ultra-weak Protein-Protein Interactions between Heme Transporters of Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTO-CROSS-LINKING; SURFACE PROTEIN; STRUCTURAL BASIS; UPTAKE SYSTEM; NEAT DOMAIN; IRON; ISD; DETERMINANT; RESISTANCE; RECEPTOR	Iron is an essential nutrient for the proliferation of Staphylococcus aureus during bacterial infections. The iron-regulated surface determinant (Isd) system of S. aureus transports and metabolizes iron porphyrin (heme) captured from the host organism. Transportation of heme across the thick cell wall of this bacterium requires multiple relay points. The mechanism by which heme is physically transferred between Isd transporters is largely unknown because of the transient nature of the interactions involved. Herein, we show that the IsdC transporter not only passes heme ligand to another class of Isd transporter, as previously known, but can also perform self-transfer reactions. IsdA shows a similar ability. A genetically encoded photoreactive probe was used to survey the regions of IsdC involved in self-dimerization. We propose an updated model that explicitly considers self-transfer reactions to explain heme delivery across the cell wall. An analogous photo-cross-linking strategy was employed to map transient interactions between IsdC and IsdE transporters. These experiments identified a key structural element involved in the rapid and specific transfer of heme from IsdC to IsdE. The resulting structural model was validated with a chimeric version of the homologous transporter IsdA. Overall, our results show that the ultra-weak interactions between Isd transporters are governed by bona fide protein structural motifs.	[Abe, Ryota; Caaveiro, Jose M. M.; Tsumoto, Kouhei] Univ Tokyo, Sch Frontier Sci, Dept Med Genome Sci, Minato Ku, Tokyo 1088639, Japan; [Abe, Ryota; Caaveiro, Jose M. M.; Kozuka-Hata, Hiroko; Oyama, Masaaki; Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo 1088639, Japan	University of Tokyo; University of Tokyo	Caaveiro, JMM (corresponding author), Univ Tokyo, Sch Frontier Sci, Dept Med Genome Sci, Minato Ku, Tokyo 1088639, Japan.	jmmc@ims.u-tokyo.ac.jp; tsumoto@ims.u-tokyo.ac.jp	Caaveiro, Jose/J-2790-2013	Caaveiro, Jose/0000-0001-5568-2369; Kozuka-Hata, Hiroko/0000-0002-9286-6594; Oyama, Masaaki/0000-0001-6478-3735	Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [11J06068] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by a predoctoral fellowship from the Japan Society for the Promotion of Science.	Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Beveridge TJ, 2000, GRAM-POSITIVE PATHOGENS, P3; Burkhard KA, 2007, J BIOL CHEM, V282, P15126, DOI 10.1074/jbc.M611121200; Cheng AG, 2011, TRENDS MICROBIOL, V19, P225, DOI 10.1016/j.tim.2011.01.007; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Fabian M, 2009, J BIOL CHEM, V284, P32138, DOI 10.1074/jbc.M109.040915; Farrelli IS, 2005, NAT METHODS, V2, P377, DOI 10.1038/nmeth0505-377; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Grigg JC, 2007, J BIOL CHEM, V282, P28815, DOI 10.1074/jbc.M704602200; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; Grigg JC, 2011, J MOL BIOL, V413, P684, DOI 10.1016/j.jmb.2011.08.047; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; Ho WW, 2007, J BIOL CHEM, V282, P35796, DOI 10.1074/jbc.M706761200; Kawai T, 2011, FEBS LETT, V585, P3533, DOI 10.1016/j.febslet.2011.10.015; Kim HK, 2010, VACCINE, V28, P6382, DOI 10.1016/j.vaccine.2010.02.097; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Krishnamurthy M, 2011, ACS CHEM BIOL, V6, P1321, DOI 10.1021/cb200308e; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Kusano S, 2012, PROTEIN SCI, V21, P199, DOI 10.1002/pro.2003; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Maiolica A, 2007, MOL CELL PROTEOMICS, V6, P2200, DOI 10.1074/mcp.M700274-MCP200; Majmudar CY, 2009, ANGEW CHEM INT EDIT, V48, P7021, DOI 10.1002/anie.200902669; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Moriwaki Y, 2011, BIOCHEMISTRY-US, V50, P7311, DOI 10.1021/bi200493h; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; Okuda S, 2009, P NATL ACAD SCI USA, V106, P5877, DOI 10.1073/pnas.0900896106; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ouattara M, 2010, MOL MICROBIOL, V78, P739, DOI 10.1111/j.1365-2958.2010.07367.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ran YC, 2007, J BIOL CHEM, V282, P31380, DOI 10.1074/jbc.M705967200; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Rowe AJ, 2011, METHODS, V54, P157, DOI 10.1016/j.ymeth.2011.02.006; Rybak MJ, 2001, DRUGS, V61, P1, DOI 10.2165/00003495-200161010-00001; Sato S, 2011, BIOCHEMISTRY-US, V50, P250, DOI 10.1021/bi1016183; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Shiota T, 2011, P NATL ACAD SCI USA, V108, P15179, DOI 10.1073/pnas.1105921108; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Smith TL, 1999, NEW ENGL J MED, V340, P493, DOI 10.1056/NEJM199902183400701; Springer B, 2009, WIEN KLIN WOCHENSCHR, V121, P86, DOI 10.1007/s00508-008-1126-y; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Streit JM, 2004, INT J ANTIMICROB AG, V24, P111, DOI 10.1016/j.ijantimicag.2003.12.019; Tiedemann MT, 2008, BIOCHEM SOC T, V36, P1138, DOI 10.1042/BST0361138; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; Villareal VA, 2011, J AM CHEM SOC, V133, P14176, DOI 10.1021/ja203805b; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Ye SX, 2008, J BIOL CHEM, V283, P1525, DOI 10.1074/jbc.M707355200; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200	54	42	42	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16477	16487		10.1074/jbc.M112.346700	http://dx.doi.org/10.1074/jbc.M112.346700			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22427659	Green Published, hybrid			2022-12-27	WOS:000304030900038
J	Coope, A; Milanski, M; Arruda, AP; Ignacio-Souza, LM; Saad, MJ; Anhe, GF; Velloso, LA				Coope, Andressa; Milanski, Marciane; Arruda, Ana P.; Ignacio-Souza, Leticia M.; Saad, Mario J.; Anhe, Gabriel F.; Velloso, Licio A.			Chaperone Insufficiency Links TLR4 Protein Signaling to Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; INSULIN-RESISTANCE; ER STRESS; MACROPHAGES; OBESITY; GP96; EXPRESSION; SHOCK; INTERLEUKIN-6; HOMEOSTASIS	Inflammation plays an important pathogenic role in a number of metabolic diseases such as obesity, type 2 diabetes, and atherosclerosis. The activation of inflammation in these diseases depends at least in part on the combined actions of TLR4 signaling and endoplasmic reticulum stress, which by acting in concert can boost the inflammatory response. Defining the mechanisms involved in this phenomenon may unveil potential targets for the treatment of metabolic/inflammatory diseases. Here we used LPS to induce endoplasmic reticulum stress in the human monocyte cell-line, THP-1. The unfolded protein response, produced after LPS, was dependent on CD14 activity but not on RNA-dependent protein kinase and could be inhibited by an exogenous chemical chaperone. The induction of the endoplasmic reticulum resident chaperones, GRP94 and GRP78, by LPS was of a much lower magnitude than the effect of LPS on TLR4 and MD-2 expression. In face of this apparent insufficiency of chaperone expression, we induced the expression of GRP94 and GRP78 by glucose deprivation. This approach completely reverted endoplasmic reticulum stress. The inhibition of either GRP94 or GRP78 with siRNA was sufficient to rescue the protective effect of glucose deprivation on LPS-induced endoplasmic reticulum stress. Thus, insufficient LPS-induced chaperone expression links TLR4 signaling to endoplasmic reticulum stress.	[Coope, Andressa; Milanski, Marciane; Arruda, Ana P.; Ignacio-Souza, Leticia M.; Velloso, Licio A.] Univ Estadual Campinas, Lab Cell Signaling, BR-13084761 Campinas, SP, Brazil; [Saad, Mario J.; Velloso, Licio A.] Univ Estadual Campinas, Dept Internal Med, BR-13084761 Campinas, SP, Brazil; [Anhe, Gabriel F.] Univ Estadual Campinas, Dept Pharmacol, BR-13084761 Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Velloso, LA (corresponding author), Univ Estadual Campinas, Lab Cell Signaling, BR-13084761 Campinas, SP, Brazil.	lavelloso.unicamp@gmail.com	Ignacio-Souza, Leticia/D-7510-2013; Milanski, Marciane/F-5410-2012; Saad, Mario/ABD-8262-2020; Ignácio-Souza, Letícia/AFV-9306-2022	Ignacio-Souza, Leticia/0000-0002-2040-1851; Milanski, Marciane/0000-0002-6322-5368; Ignácio-Souza, Letícia/0000-0002-2040-1851	Fundacao de Amparo a Pesquisa de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was performed with grants provided by Fundacao de Amparo a Pesquisa de Sao Paulo and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.	Abraham N, 1999, J BIOL CHEM, V274, P5953, DOI 10.1074/jbc.274.9.5953; Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; Breder I, 2010, ATHEROSCLEROSIS, V212, P30, DOI 10.1016/j.atherosclerosis.2010.04.036; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Fan W, 2007, INFECT IMMUN, V75, P3394, DOI 10.1128/IAI.01977-06; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Harding CV, 2007, IMMUNITY, V26, P141, DOI 10.1016/j.immuni.2007.02.003; Hirota M, 2006, TOXICOL IN VITRO, V20, P736, DOI 10.1016/j.tiv.2005.10.013; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kobayashi T, 2006, NAT IMMUNOL, V7, P123, DOI 10.1038/ni0206-123; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Saltoh SI, 2009, IMMUNOBIOLOGY, V214, P594, DOI 10.1016/j.imbio.2008.11.012; Seimon TA, 2006, P NATL ACAD SCI USA, V103, P19794, DOI 10.1073/pnas.0609671104; Tabas I, 2010, CIRC RES, V106, P58, DOI 10.1161/CIRCRESAHA.109.208488; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Visintin A, 2001, J IMMUNOL, V166, P249, DOI 10.4049/jimmunol.166.1.249; WAAGE A, 1989, J EXP MED, V169, P333, DOI 10.1084/jem.169.1.333; Wakabayashi Y, 2006, J IMMUNOL, V177, P1772, DOI 10.4049/jimmunol.177.3.1772; Williamson DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE304, DOI 10.1152/ajpendo.91007.2008; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Yang Y, 2005, MOL CELLS, V20, P173; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; ZIEGLERHEITBROCK HWL, 1992, IMMUNOLOGY, V75, P264	35	29	31	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15580	15589		10.1074/jbc.M111.315218	http://dx.doi.org/10.1074/jbc.M111.315218			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427667	Green Published, hybrid			2022-12-27	WOS:000304006300038
J	Creze, C; Ligabue, A; Laurent, S; Lestini, R; Laptenok, SP; Khun, J; Vos, MH; Czjzek, M; Myllykallio, H; Flament, D				Creze, Christophe; Ligabue, Alessio; Laurent, Sebastien; Lestini, Roxane; Laptenok, Sergey P.; Khun, Joelle; Vos, Marten H.; Czjzek, Mirjam; Myllykallio, Hannu; Flament, Didier			Modulation of the Pyrococcus abyssi NucS Endonuclease Activity by Replication Clamp at Functional and Structural Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; SMALL-ANGLE SCATTERING; DNA-LIGASE-I; RESONANCE ENERGY-TRANSFER; RAY SOLUTION SCATTERING; DOUBLE-STRANDED DNA; RECBCD ENZYME; X-RAY; HYPERTHERMOPHILIC ARCHAEON; CRYSTAL-STRUCTURE	Pyrococcus abyssi NucS is the founding member of a new family of structure-specific DNA endonucleases that interact with the replication clamp proliferating cell nuclear antigen (PCNA). Using a combination of small angle x-ray scattering and surface plasmon resonance analyses, we demonstrate the formation of a stable complex in solution, in which one molecule of the PabNucS homodimer binds to the outside surface of the PabPCNA homotrimer. Using fluorescent labels, PCNA is shown to increase the binding affinity of NucS toward single-strand/double-strand junctions on 5' and 3' flaps, as well as to modulate the cleavage specificity on the branched DNA structures. Our results indicate that the presence of a single major contact between the PabNucS and PabPCNA proteins, together with the complex-induced DNA bending, facilitate conformational flexibility required for specific cleavage at the single-strand/double-strand DNA junction.	[Ligabue, Alessio; Lestini, Roxane; Laptenok, Sergey P.; Khun, Joelle; Vos, Marten H.; Myllykallio, Hannu] INSERM, U696, F-91128 Palaiseau, France; [Creze, Christophe; Laurent, Sebastien; Flament, Didier] IFREMER, UMR6197, F-29280 Plouzane, France; [Creze, Christophe; Laurent, Sebastien; Flament, Didier] Univ Bretagne Occidentale, UMR6197, F-29280 Plouzane, France; [Creze, Christophe; Laurent, Sebastien; Flament, Didier] CNRS, UMR6197, Lab Microbiol Environm Extremes, F-29280 Plouzane, France; [Ligabue, Alessio; Lestini, Roxane; Laptenok, Sergey P.; Khun, Joelle; Vos, Marten H.; Myllykallio, Hannu] Ecole Polytech, CNRS, Lab Opt & Biosci, F-91128 Palaiseau, France; [Czjzek, Mirjam] Univ Paris 06, UMR 7139, Stn Biol Roscoff, Roscoff, France; [Czjzek, Mirjam] CNRS, UMR 7139, Stn Biol Roscoff, F-29680 Roscoff, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Myllykallio, H (corresponding author), INSERM, U696, F-91128 Palaiseau, France.	hannu.myllykallio@polytechnique.edu; dflament@ifremer.fr	Lestini, Roxane/R-9285-2017; LAURENT, Sébastien/ABF-4382-2020; Myllykallio, Hannu/Y-5462-2019	Lestini, Roxane/0000-0001-7377-4734; Vos, Marten/0000-0003-0493-4831; flament, didier/0000-0002-9847-2342; Myllykallio, Hannu/0000-0002-0541-1197; Laptenok, Sergey/0000-0002-6468-3010	Agence Nationale de la Recherche [ANR-07-BLAN-0371, ANR-09-PIRI-0019-03]; Brittany regional council [4852]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Brittany regional council(Region Bretagne)	This work was supported by Agence Nationale de la Recherche Grants ANR-07-BLAN-0371 (to C. C., M. C., H. M., and D. F.), ANR-09-PIRI-0019-03 (to M. V. and H. M.), and the CREAtivite & Thematiques Exploratoires program of the Brittany regional council, REPAR number 4852 (to S. L. and D. F.).	Aravind L, 2000, NUCLEIC ACIDS RES, V28, P3417, DOI 10.1093/nar/28.18.3417; Ben-Shahar TR, 2009, MOL CELL BIOL, V29, P6353, DOI 10.1128/MCB.01051-09; Castrec B, 2010, J MOL BIOL, V396, P840, DOI 10.1016/j.jmb.2010.01.006; Castrec B, 2009, J MOL BIOL, V394, P209, DOI 10.1016/j.jmb.2009.09.044; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; CLEGG RM, 1993, P NATL ACAD SCI USA, V90, P2994, DOI 10.1073/pnas.90.7.2994; Creze C, 2011, BIOCHEM SOC T, V39, P145, DOI 10.1042/BST0390145; Delarue M, 2002, J MOL BIOL, V320, P1011, DOI 10.1016/S0022-2836(02)00562-4; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Dionne I, 2003, MOL CELL, V11, P275, DOI 10.1016/S1097-2765(02)00824-9; Dore AS, 2006, NUCLEIC ACIDS RES, V34, P4515, DOI 10.1093/nar/gkl623; Ehmsen KT, 2008, NUCLEIC ACIDS RES, V36, P2182, DOI 10.1093/nar/gkm1152; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fujikane R, 2010, GENES GENET SYST, V85, P243, DOI 10.1266/ggs.85.243; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Gomes XV, 2000, EMBO J, V19, P3811, DOI 10.1093/emboj/19.14.3811; Gutteridge A, 2005, J MOL BIOL, V346, P21, DOI 10.1016/j.jmb.2004.11.013; Henneke G, 2005, J MOL BIOL, V350, P53, DOI 10.1016/j.jmb.2005.04.042; Henneke G, 2002, J MOL BIOL, V323, P795, DOI 10.1016/S0022-2836(02)01028-8; Hopkins BB, 2004, J BIOL CHEM, V279, P37049, DOI 10.1074/jbc.M404573200; Hutton RD, 2008, NUCLEIC ACIDS RES, V36, P6720, DOI 10.1093/nar/gkn745; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Kinch LN, 2005, NUCLEIC ACIDS RES, V33, P3598, DOI 10.1093/nar/gki676; Kiyonari S, 2006, J BIOL CHEM, V281, P28023, DOI 10.1074/jbc.M603403200; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2000, J APPL CRYSTALLOGR, V33, P775, DOI 10.1107/S0021889800001382; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P353; Laptenok SP, 2010, PHYS CHEM CHEM PHYS, V12, P7593, DOI 10.1039/b919700a; Lestini R, 2010, DNA REPAIR, V9, P994, DOI 10.1016/j.dnarep.2010.06.012; Levin DS, 1997, P NATL ACAD SCI USA, V94, P12863, DOI 10.1073/pnas.94.24.12863; LiCata VJ, 2008, METHOD CELL BIOL, V84, P243, DOI 10.1016/S009l-679X(07)84009-X; LOHMAN TM, 1992, METHOD ENZYMOL, V212, P400; Matsumiya S, 2003, PROTEIN SCI, V12, P823, DOI 10.1110/ps.0234503; Matsumiya S, 2001, PROTEIN SCI, V10, P17, DOI 10.1110/ps.36401; Mayanagi K, 2011, P NATL ACAD SCI USA, V108, P1845, DOI 10.1073/pnas.1010933108; Mesiet-Cladiere L, 2007, J MOL BIOL, V372, P1137, DOI 10.1016/j.jmb.2007.06.056; Miyata T, 2005, P NATL ACAD SCI USA, V102, P13795, DOI 10.1073/pnas.0506447102; Pan M, 2011, BIOCHEM SOC T, V39, P20, DOI 10.1042/BST0390020; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Pascal JM, 2006, MOL CELL, V24, P279, DOI 10.1016/j.molcel.2006.08.015; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Ren B, 2007, ACTA CRYSTALLOGR F, V63, P406, DOI 10.1107/S1744309107015278; Ren B, 2009, EMBO J, V28, P2479, DOI 10.1038/emboj.2009.192; Roberts JA, 2003, MOL MICROBIOL, V48, P361, DOI 10.1046/j.1365-2958.2003.03444.x; Rouillon C, 2007, J MOL BIOL, V369, P343, DOI 10.1016/j.jmb.2007.03.054; Rouillon C, 2011, RES MICROBIOL, V162, P19, DOI 10.1016/j.resmic.2010.09.003; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Shevelev IV, 2002, NAT REV MOL CELL BIO, V3, P364, DOI 10.1038/nrm804; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Subramanian J, 2005, GENETICS, V171, P427, DOI 10.1534/genetics.105.042861; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tainer JA, 2010, J AM CHEM SOC, V132, P7372, DOI 10.1021/ja100365x; Tsurimoto T., 1999, FRONT BIOSCI, V4, P849; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang JD, 2000, J BIOL CHEM, V275, P507, DOI 10.1074/jbc.275.1.507; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R; Xu H, 2001, BIOCHEMISTRY-US, V40, P4512, DOI 10.1021/bi010103+; Yu M, 1998, P NATL ACAD SCI USA, V95, P981, DOI 10.1073/pnas.95.3.981	65	16	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15648	15660		10.1074/jbc.M112.346361	http://dx.doi.org/10.1074/jbc.M112.346361			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22431731	Green Published, hybrid			2022-12-27	WOS:000304006300044
J	Omae, Y; Sekimizu, K; Kaito, C				Omae, Yosuke; Sekimizu, Kazuhisa; Kaito, Chikara			Inhibition of Colony-spreading Activity of Staphylococcus aureus by Secretion of delta-Hemolysin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL DNA-REPLICATION; GENE REGULATOR AGR; MYCOBACTERIUM-SMEGMATIS; VIRULENCE DETERMINANTS; BACILLUS-SUBTILIS; SLIDING MOTILITY; VIBRIO-CHOLERAE; POTASSIUM-ION; IDENTIFICATION; BACTERIA	Staphylococcus aureus spreads on the surface of soft agar, a phenomenon we termed "colony spreading." Here, we found that S. aureus culture supernatant inhibited colony spreading. We purified delta-hemolysin (Hld, delta-toxin), a major protein secreted from S. aureus, as a compound that inhibits colony spreading. The culture supernatants of hld-disrupted mutants had 30-fold lower colony-spreading inhibitory activity than those of the parent strain. Furthermore, hld-disrupted mutants had higher colony-spreading ability than the parent strain. These results suggest that S. aureus negatively regulates colony spreading by secreting delta-hemolysin.	[Omae, Yosuke; Sekimizu, Kazuhisa; Kaito, Chikara] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Kaito, C (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, 3-1,7 Chome, Tokyo 1130033, Japan.	kaito@mol.f.u-tokyo.ac.jp	Kaito, Chikara/W-1815-2019; Kaito, Chikara/G-1248-2017	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386	Naito Foundation; National Institute of Biomedical Innovation; Genome Pharmaceuticals Institute	Naito Foundation(Naito Memorial Foundation); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Genome Pharmaceuticals Institute	This work was supported by grants-in-aid for scientific research and in part by the Naito Foundation, the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, and the Genome Pharmaceuticals Institute.	Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; BIRKBECK TH, 1988, METHOD ENZYMOL, V165, P16; Brown II, 2001, J BACTERIOL, V183, P3784, DOI 10.1128/JB.183.12.3784-3790.2001; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Daum RS, 2002, J INFECT DIS, V186, P1344, DOI 10.1086/344326; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; FITTON JE, 1980, FEBS LETT, V115, P209, DOI 10.1016/0014-5793(80)81170-7; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Ichihashi N, 2003, J BIOL CHEM, V278, P28778, DOI 10.1074/jbc.M212202200; Inoue R, 2001, MOL GENET GENOMICS, V266, P564, DOI 10.1007/s004380100564; JAIN DK, 1991, J MICROBIOL METH, V13, P271, DOI 10.1016/0167-7012(91)90064-W; JANZON L, 1990, EMBO J, V9, P1391, DOI 10.1002/j.1460-2075.1990.tb08254.x; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2007, J BACTERIOL, V189, P2553, DOI 10.1128/JB.01635-06; Kaito C, 2006, MOL MICROBIOL, V62, P1601, DOI 10.1111/j.1365-2958.2006.05480.x; Kaito C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001267; Kaito C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003921; Kinsinger RF, 2005, J BACTERIOL, V187, P8462, DOI 10.1128/JB.187.24.8462-8469.2005; Kinsinger RF, 2003, J BACTERIOL, V185, P5627, DOI 10.1128/JB.185.18.5627-5631.2003; KREGER AS, 1971, INFECT IMMUN, V3, P449, DOI 10.1128/IAI.3.3.449-465.1971; Krukonis ES, 2003, CURR OPIN MICROBIOL, V6, P186, DOI 10.1016/S1369-5274(03)00032-8; LEE KH, 1987, BIOCHIM BIOPHYS ACTA, V911, P144, DOI 10.1016/0167-4838(87)90003-3; Li SL, 1997, BIOTECHNIQUES, V23, P588, DOI 10.2144/97234bm05; Matsumoto Y, 2007, INFECT IMMUN, V75, P1964, DOI 10.1128/IAI.01552-06; Nagata M, 2008, J BIOL CHEM, V283, P2176, DOI 10.1074/jbc.M705309200; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Recht J, 2000, J BACTERIOL, V182, P4348, DOI 10.1128/JB.182.15.4348-4351.2000; Recht J, 2001, J BACTERIOL, V183, P5718, DOI 10.1128/JB.183.19.5718-5724.2001; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x; Sambrook J., 2001, MOL CLONING LAB MANU; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; SMITH JM, 1956, J EXP MED, V103, P87, DOI 10.1084/jem.103.1.87; TAPPIN MJ, 1988, BIOCHEMISTRY-US, V27, P1643, DOI 10.1021/bi00405a038; Tsompanidou E, 2011, J BACTERIOL, V193, P1267, DOI 10.1128/JB.01276-10; Ueda T, 2011, MICROB PATHOGENESIS, V51, P178, DOI 10.1016/j.micpath.2011.04.003; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656	42	17	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15570	15579		10.1074/jbc.M112.357848	http://dx.doi.org/10.1074/jbc.M112.357848			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22411996	Green Published, hybrid			2022-12-27	WOS:000304006300037
J	Winkler, K; Schultz, A; Schultz, JE				Winkler, Karin; Schultz, Anita; Schultz, Joachim E.			The S-Helix Determines the Signal in a Tsr Receptor/Adenylyl Cyclase Reporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL DOMAIN; MYCOBACTERIAL ADENYLYL-CYCLASE; ESCHERICHIA-COLI ASPARTATE; RETINAL GUANYLATE-CYCLASE; LIGAND-BINDING DOMAIN; MUTATIONAL ANALYSIS; HAMP DOMAIN; TRANSMEMBRANE RECEPTORS; SERINE CHEMORECEPTOR; CYTOPLASMIC DOMAIN	A signaling or S-helix has been identified as a conserved, up to 50-residue-long segment in diverse sensory proteins (1). It is present in all major bacterial lineages and in euryarchea and eukaryotes (1). A bioinformatic analysis shows that it connects upstream receiver and downstream output domains, e. g. in histidine kinases and bacterial adenylyl cyclases. The S-helix is modeled as a two-helical parallel coiled coil. It is predicted to prevent constitutive activation of the downstream signaling domains in the absence of ligand-binding (1). We identified an S-helix of about 25 residues in the adenylyl cyclase CyaG from Arthrospira maxima. Deletion of the 25 residue segment connecting the HAMP and catalytic domains in a chimera with the Escherichia coli Tsr receptor changed the response to serine from inhibition to stimulation. Further examination showed that a deletion of one to three heptads plus a presumed stutter, i.e. 1, 2, or 3 x 7 + 4 amino acids, is required and sufficient for signal reversion. It was not necessary that the deletions be continuous, as removal of separated heptads and presumed stutters also resulted in signal reversion. Furthermore, insertion of the above segments between the HAMP and cyclase catalytic domains similarly resulted in signal reversion. This indicates that the S-helix is an independent, segmented module capable to reverse the receptor signal. Because the S-helix is present in all kingdoms of life, e.g. in human retinal guanylyl cyclase, our findings may be significant for many sensory systems.	[Winkler, Karin; Schultz, Anita; Schultz, Joachim E.] Univ Tubingen, Inst Pharmazeut, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schultz, JE (corresponding author), Univ Tubingen, Inst Pharmazeut, Morgenstelle 8, D-72076 Tubingen, Germany.	joachim.schultz@uni-tuebingen.de			Deutsche Forschungsgemeinschaft [SFB 766]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft SFB 766.	Airola MV, 2010, STRUCTURE, V18, P436, DOI 10.1016/j.str.2010.01.013; Ames P, 2008, J BACTERIOL, V190, P6676, DOI 10.1128/JB.00750-08; Anantharaman V, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-25; Appleman JA, 2003, J BACTERIOL, V185, P89, DOI 10.1128/JB.185.1.89-97.2003; Aravind L, 1999, FEMS MICROBIOL LETT, V176, P111, DOI 10.1016/S0378-1097(99)00197-4; BAUMGARTNER JW, 1994, J BACTERIOL, V176, P1157, DOI 10.1128/JB.176.4.1157-1163.1994; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Chervitz SA, 1996, P NATL ACAD SCI USA, V93, P2545, DOI 10.1073/pnas.93.6.2545; Ferris HU, 2011, STRUCTURE, V19, P378, DOI 10.1016/j.str.2011.01.006; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Galperin MY, 2005, ASM NEWS, V71, P326; Galperin MY, 2004, ENVIRON MICROBIOL, V6, P552, DOI 10.1111/j.1462-2920.2004.00633.x; Gardina PJ, 1996, SCIENCE, V274, P425, DOI 10.1126/science.274.5286.425; Gregory-Evans K, 2000, OPHTHALMOLOGY, V107, P55, DOI 10.1016/S0161-6420(99)00038-X; Gruber M, 2003, TRENDS BIOCHEM SCI, V28, P679, DOI 10.1016/j.tibs.2003.10.008; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; JIN T, 1994, J MOL BIOL, V244, P477, DOI 10.1006/jmbi.1994.1746; Kanchan K, 2010, J BIOL CHEM, V285, P2090, DOI 10.1074/jbc.M109.051698; Kelsell RE, 1998, HUM MOL GENET, V7, P1179, DOI 10.1093/hmg/7.7.1179; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; Kitanovic S, 2011, J BACTERIOL, V193, P5062, DOI 10.1128/JB.05683-11; Linder JU, 2003, CELL SIGNAL, V15, P1081, DOI 10.1016/S0898-6568(03)00130-X; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Ma XL, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-2; MESIBOV R, 1972, J BACTERIOL, V112, P315, DOI 10.1128/JB.112.1.315-326.1972; MILBURN MV, 1991, SCIENCE, V254, P1342, DOI 10.1126/science.1660187; Miller J.H., 1972, EXPT MOL GENETICS; Mondejar LG, 2012, J BIOL CHEM, V287, P1022, DOI 10.1074/jbc.M111.284067; MOWBRAY SL, 1990, J BIOL CHEM, V265, P15638; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Newell PD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000587; PARKINSON JS, 1993, CELL, V73, P857, DOI 10.1016/0092-8674(93)90267-T; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; SCOTT WG, 1993, J MOL BIOL, V232, P555, DOI 10.1006/jmbi.1993.1411; Sinha SC, 2005, EMBO J, V24, P663, DOI 10.1038/sj.emboj.7600573; Stewart V, 2010, J BACTERIOL, V192, P734, DOI 10.1128/JB.00172-09; STOCK AM, 1989, NATURE, V337, P745, DOI 10.1038/337745a0; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Tao W, 2002, MOL MICROBIOL, V43, P459, DOI 10.1046/j.1365-2958.2002.02757.x; Tews I, 2005, SCIENCE, V308, P1020, DOI 10.1126/science.1107642; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; UTSUMI R, 1989, SCIENCE, V245, P1246, DOI 10.1126/science.2476847; Ward SM, 2006, J BACTERIOL, V188, P3944, DOI 10.1128/JB.00117-06; Wright GA, 2011, J BACTERIOL, V193, P82, DOI 10.1128/JB.00953-10; Wuichet K, 2010, CURR OPIN MICROBIOL, V13, P219, DOI 10.1016/j.mib.2009.12.011; YANG Y, 1993, J MOL BIOL, V232, P493, DOI 10.1006/jmbi.1993.1405; Zhou Q, 2009, MOL MICROBIOL, V73, P801, DOI 10.1111/j.1365-2958.2009.06819.x; Zhulin IB, 2003, J BACTERIOL, V185, P285, DOI 10.1128/JB.185.1.285-294.2003	51	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15479	15488		10.1074/jbc.M112.348409	http://dx.doi.org/10.1074/jbc.M112.348409			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22427653	Green Published, hybrid			2022-12-27	WOS:000304006300029
J	Busca, A; Saxena, M; Kumar, A				Busca, Aurelia; Saxena, Mansi; Kumar, Ashok			Critical Role for Antiapoptotic Bcl-xL and Mcl-1 in Human Macrophage Survival and Cellular IAP1/2 (cIAP1/2) in Resistance to HIV-Vpr-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEMATOPOIETIC PROGENITOR CELLS; HUMAN MONOCYTIC CELLS; NF-KAPPA-B; TYPE-1 VPR; T-CELLS; IN-VITRO; UP-REGULATION; EXPRESSION; PROTEIN	Macrophages are resistant to HIV cytopathic effects, which contributes to viral persistence and reservoir formation. HIV viral protein R (Vpr) is a potent apoptosis-inducing agent for primary monocytes. Because the biologically active Vpr is found in serum and cerebrospinal fluid of HIV-infected patients, we investigated the apoptotic effect of Vpr on monocyte-derived macrophages and phorbol 12-myristate 13-acetate-activated THP1 macrophages. Our results show that primary monocytes and THP1 cells develop resistance to Vpr-induced apoptosis following differentiation into macrophages. To determine the effect of Vpr on the expression of antiapoptotic proteins, we show that in contrast to the undifferentiated cells, Vpr did not down-regulate the expression of antiapoptotic inhibitors of apoptosis (IAPs) and Bcl2 family members in macrophages, suggesting their involvement in resistance to Vpr-induced apoptosis. However, knocking down Bcl-xL and Mcl-1 proteins induced spontaneous apoptosis with no impact on susceptibility to Vpr-induced apoptosis. In contrast, down-regulation of cellular IAP1 (cIAP1) and cIAP2 by using siRNAs and SMAC (second mitochondria-derived activator of caspases) mimetic sensitized macrophages to Vpr-induced apoptosis. Overall, our results suggest that resistance to Vpr-induced apoptosis is specifically mediated by cIAP1/2 genes independent of Bcl-xL and Mcl-1, which play a key role in maintaining cell viability. Moreover, IAP modulation may be a potential strategy to eliminate HIV persistence in macrophages.	[Busca, Aurelia; Saxena, Mansi; Kumar, Ashok] Univ Ottawa, Dept Biochem Microbiol & Immunol, Res Inst, Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; [Kumar, Ashok] Univ Ottawa, Dept Pathol & Lab Med, Res Inst, Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; [Kumar, Ashok] Univ Ottawa, Infect Dis & Vaccine Res Ctr, Res Inst, Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario	Busca, A (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Res Inst, Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada.	aureliabusca@yahoo.com		Saxena, Mansi/0000-0001-5482-3158	Canadian Institutes of Health Research; Ontario HIV Treatment Network; Ontario Graduate Scholarships in Science and Technology program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network; Ontario Graduate Scholarships in Science and Technology program	This work was supported by grants from the Canadian Institutes of Health Research and the Ontario HIV Treatment Network (to A. K.).; Supported by a scholarship from the Ontario Graduate Scholarships in Science and Technology program.	Alhetheel A, 2008, AIDS, V22, P1137, DOI 10.1097/QAD.0b013e3283013d42; Aquaro S, 2002, J MED VIROL, V68, P479, DOI 10.1002/jmv.10245; Aquaro S, 2002, ANTIVIR RES, V55, P209, DOI 10.1016/S0166-3542(02)00052-9; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Ayyavoo V, 1997, J LEUKOCYTE BIOL, V62, P93, DOI 10.1002/jlb.62.1.93; Badley AD, 1996, J VIROL, V70, P199, DOI 10.1128/JVI.70.1.199-206.1996; Banga S, 2007, P NATL ACAD SCI USA, V104, P5121, DOI 10.1073/pnas.0611030104; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Busca A, 2009, CURR GENOMICS, V10, P306, DOI 10.2174/138920209788920967; Chan G, 2010, J IMMUNOL, V184, P3213, DOI 10.4049/jimmunol.0903025; Chauhan D, 2007, BLOOD, V109, P1220, DOI 10.1182/blood-2006-04-015149; Cheung HH, 2009, CANCER RES, V69, P7729, DOI 10.1158/0008-5472.CAN-09-1794; Choi HJ, 2004, J BIOL CHEM, V279, P51688, DOI 10.1074/jbc.M410068200; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Conti L, 2000, J IMMUNOL, V165, P3293, DOI 10.4049/jimmunol.165.6.3293; Fukumori T, 1998, FEBS LETT, V432, P17, DOI 10.1016/S0014-5793(98)00824-2; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gross A, 2000, INFECT IMMUN, V68, P342, DOI 10.1128/IAI.68.1.342-351.2000; Guillemard E, 2004, VIROLOGY, V329, P371, DOI 10.1016/j.virol.2004.08.030; Henklein P, 2000, J BIOL CHEM, V275, P32016, DOI 10.1074/jbc.M004044200; Hoshino S, 2007, AIDS RES HUM RETROV, V23, P391, DOI 10.1089/aid.2006.0124; Jacotot E, 2000, J EXP MED, V191, P33, DOI 10.1084/jem.191.1.33; Jones GJ, 2007, J NEUROSCI, V27, P3703, DOI 10.1523/JNEUROSCI.5522-06.2007; Josefsen D, 2000, STEM CELLS, V18, P261, DOI 10.1634/stemcells.18-4-261; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karni O, 1998, FEBS LETT, V429, P421, DOI 10.1016/S0014-5793(98)00645-0; Kiener PA, 1997, J EXP MED, V185, P1511, DOI 10.1084/jem.185.8.1511; Kitayama H, 2008, J VIROL, V82, P2528, DOI 10.1128/JVI.02094-07; Laforge M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002087; LEVY DN, 1994, P NATL ACAD SCI USA, V91, P10873, DOI 10.1073/pnas.91.23.10873; Lin H, 2001, BIOCHEM J, V353, P299, DOI 10.1042/0264-6021:3530299; Liu HT, 2001, J EXP MED, V194, P113, DOI 10.1084/jem.194.2.113; Lu M, 2010, BLOOD, V116, P4284, DOI 10.1182/blood-2010-04-279125; Lum JJ, 2003, CURR HIV RES, V1, P261, DOI 10.2174/1570162033485203; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Muthumani K, 2003, BIOCHEM BIOPH RES CO, V304, P583, DOI 10.1016/S0006-291X(03)00631-4; Muthumani K, 2002, J BIOL CHEM, V277, P37820, DOI 10.1074/jbc.M205313200; Olivetta E, 2006, EXP CELL RES, V312, P890, DOI 10.1016/j.yexcr.2005.12.003; Pagliari LJ, 2000, MOL CELL BIOL, V20, P8855, DOI 10.1128/MCB.20.23.8855-8865.2000; Patel CA, 2002, J NEUROVIROL, V8, P86, DOI 10.1080/13550280290049552; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Sabbah EN, 2005, J NEUROVIROL, V11, P489, DOI 10.1080/13550280500384941; Sanz C, 1997, BLOOD, V89, P3199, DOI 10.1182/blood.V89.9.3199; Sawaya BE, 2000, J VIROL, V74, P4877, DOI 10.1128/JVI.74.10.4877-4881.2000; Saxena M, 2011, J IMMUNOL, V187, P5865, DOI 10.4049/jimmunol.1100115; Sevilla L, 2001, J BIOL CHEM, V276, P17800, DOI 10.1074/jbc.M008270200; Sherman MP, 2002, VIROLOGY, V302, P95, DOI 10.1006/viro.2002.1576; Sly LM, 2003, J IMMUNOL, V170, P430, DOI 10.4049/jimmunol.170.1.430; Sly LM, 2002, INFECT IMMUN, V70, P5312, DOI 10.1128/IAI.70.9.5312-5315.2002; Sonza S, 1996, J VIROL, V70, P3863, DOI 10.1128/JVI.70.6.3863-3869.1996; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Stellbrink HJ, 2002, AIDS, V16, P1479, DOI 10.1097/00002030-200207260-00004; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Yao XJ, 1998, J VIROL, V72, P4686, DOI 10.1128/JVI.72.6.4686-4693.1998; Zhang Jiyan, 2003, Hematol J, V4, P277, DOI 10.1038/sj.thj.6200252; Zhang MJ, 2002, J BIOMED SCI, V9, P133; Zimmerman ES, 2006, J VIROL, V80, P10407, DOI 10.1128/JVI.01212-06	59	56	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					15118	15133		10.1074/jbc.M111.312660	http://dx.doi.org/10.1074/jbc.M111.312660			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22403404	Green Published, hybrid			2022-12-27	WOS:000304003200073
J	Banno, A; Goult, BT; Lee, H; Bate, N; Critchley, DR; Ginsberg, MH				Banno, Asoka; Goult, Benjamin T.; Lee, HoSup; Bate, Neil; Critchley, David R.; Ginsberg, Mark H.			Subcellular Localization of Talin Is Regulated by Inter-domain Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VINCULIN BINDING-SITES; INTEGRIN ACTIVATION; CYTOPLASMIC DOMAIN; STRUCTURAL BASIS; HUMAN-PLATELETS; FERM DOMAIN; GPIIB-IIIA; ADHESION; ACTIN; ROD	Talin, which is composed of head (THD) and rod domains, plays an important role in cell adhesion events in diverse species including most metazoans and Dictyostelium discoideum. Talin is abundant in the cytosol; however, it mediates adhesion by associating with integrins in the plasma membrane where it forms a primary link between integrins and the actin cytoskeleton. Cells modulate the partitioning of talin between the plasma membrane and the cytosol to control cell adhesion. Here, we combine nuclear magnetic resonance spectroscopy (NMR) with subcellular fractionation to characterize two distinct THD-rod domain interactions that control the interaction of talin with the actin cytoskeleton or its localization to the plasma membrane. Aninteraction between a discrete vinculin-binding region of the rod (VBS1/2a; Tln1(482-787)), and the THD restrains talin from interacting with the plasma membrane. Furthermore, we show that vinculin binding to VBS1/2a results in talin recruitment to the plasma membrane. Thus, we have structurally defined specific inter-domain interactions between THD and the talin rod domain that regulate the subcellular localization of talin.	[Banno, Asoka; Lee, HoSup; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Goult, Benjamin T.; Bate, Neil; Critchley, David R.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England	University of California System; University of California San Diego; University of Leicester	Ginsberg, MH (corresponding author), 9500 Gilman Dr,Mail Code 0726, La Jolla, CA 92093 USA.	mhginsberg@ucsd.edu	Goult, Benjamin T/B-3127-2009	Goult, Benjamin T/0000-0002-3438-2807	National Institutes of Health [U54 GM64346, HL078784, HL57900]; Tobacco-Related Disease Research Program Dissertation Fellowship Award; Wellcome Trust, Cancer Research UK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057900, P01HL078784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-Related Disease Research Program Dissertation Fellowship Award; Wellcome Trust, Cancer Research UK(Wellcome TrustCancer Research UK); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants U54 GM64346 (to the Cell Migration Consortium), HL078784 and HL57900, a Tobacco-Related Disease Research Program Dissertation Fellowship Award, and the Wellcome Trust, Cancer Research UK.	Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; BECKERLE MC, 1989, J CELL BIOL, V109, P3333, DOI 10.1083/jcb.109.6.3333; BERTAGNOLLI ME, 1993, J CELL SCI, V106, P1189; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Elliott PR, 2010, STRUCTURE, V18, P1289, DOI 10.1016/j.str.2010.07.011; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Goult BT, 2009, J BIOL CHEM, V284, P15097, DOI 10.1074/jbc.M900078200; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hemmings L, 1996, J CELL SCI, V109, P2715; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kalli AC, 2010, STRUCTURE, V18, P1280, DOI 10.1016/j.str.2010.07.012; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kopp PM, 2010, EUR J CELL BIOL, V89, P661, DOI 10.1016/j.ejcb.2010.05.003; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Lee HS, 2004, J MOL BIOL, V343, P771, DOI 10.1016/j.jmb.2004.08.069; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Ohmori T, 2010, BIOCHEM BIOPH RES CO, V400, P323, DOI 10.1016/j.bbrc.2010.08.056; OTOOLE TE, 1995, J BIOL CHEM, V270, P8553, DOI 10.1074/jbc.270.15.8553; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; PAINTER RG, 1985, J CELL BIOCHEM, V27, P277, DOI 10.1002/jcb.240270309; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Patel B, 2006, J BIOL CHEM, V281, P7458, DOI 10.1074/jbc.M508058200; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Petrich BG, 2007, J CLIN INVEST, V117, P2250, DOI 10.1172/JCI31024; Ratnikov B, 2005, J CELL SCI, V118, P4921, DOI 10.1242/jcs.02682; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; SHATTIL SJ, 1987, J BIOL CHEM, V262, P992; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; TAMKUN JW, 1986, CELL, V46, P271, DOI 10.1016/0092-8674(86)90744-0; Ulmer TS, 2003, BIOCHEMISTRY-US, V42, P8307, DOI 10.1021/bi034384s; Ulmer TS, 2001, BIOCHEMISTRY-US, V40, P7498, DOI 10.1021/bi010338l; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	59	37	38	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13799	13812		10.1074/jbc.M112.341214	http://dx.doi.org/10.1074/jbc.M112.341214			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22351767	hybrid, Green Published			2022-12-27	WOS:000303996300035
J	Itoh, M; Tahimic, CGT; Ide, S; Otsuki, A; Sasaoka, T; Noguchi, S; Oshimura, M; Goto, Y; Kurimasa, A				Itoh, Masayuki; Tahimic, Candice G. T.; Ide, Shuhei; Otsuki, Akihiro; Sasaoka, Toshikuni; Noguchi, Shigeru; Oshimura, Mitsuo; Goto, Yu-ichi; Kurimasa, Akihiro			Methyl CpG-binding Protein Isoform MeCP2_e2 Is Dispensable for Rett Syndrome Phenotypes but Essential for Embryo Viability and Placenta Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOME INACTIVATION PATTERNS; X-CHROMOSOME; IMPRINTED GENES; MOUSE; EXPRESSION; DEFICIENCY; MUTATION	Methyl CpG-binding protein 2 gene (MeCP2) mutations are implicated in Rett syndrome (RTT), one of the common causes of female mental retardation. Two MeCP2 isoforms have been reported: MeCP2_e2 (splicing of all four exons) and MeCP2_e1 (alternative splicing of exons 1, 3, and 4). Their relative expression levels vary among tissues, with MeCP2_e1 being more dominant in adult brain, whereas MeCP2_e2 is expressed more abundantly in placenta, liver, and skeletal muscle. In this study, we performed specific disruption of the MeCP2_e2-defining exon 2 using the Cre-loxP system and examined the consequences of selective loss of MeCP2_e2 function in vivo. We performed behavior evaluation, gene expression analysis, using RTPCR and real-time quantitative PCR, and histological analysis. We demonstrate that selective deletion of MeCP2_e2 does not result in RTT-associated neurological phenotypes but confers a survival disadvantage to embryos carrying a MeCP2_e2 null allele of maternal origin. In addition, we reveal a specific requirement for MeCP2_e2 function in extraembryonic tissue, where selective loss of MeCP2_e2 results in placenta defects and up-regulation of peg-1, as determined by the parental origin of the mutant allele. Taken together, our findings suggest a novel role for MeCP2 in normal placenta development and illustrate how paternal X chromosome inactivation in extraembryonic tissues confers a survival disadvantage for carriers of a mutant maternal MeCP2_e2 allele. Moreover, our findings provide an explanation for the absence of reports on MeCP2_e2-specific exon 2 mutations in RTT. MeCP2_e2 mutations in humans may result in a phenotype that evades a diagnosis of RTT.	[Itoh, Masayuki; Ide, Shuhei; Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Kodaira, Tokyo 1878502, Japan; [Tahimic, Candice G. T.; Otsuki, Akihiro; Oshimura, Mitsuo; Kurimasa, Akihiro] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Yonago, Tottori 6838503, Japan; [Oshimura, Mitsuo; Kurimasa, Akihiro] Tottori Univ, Res Core Chromosome Engn Technol, 21st Century Ctr Excellence Program, Yonago, Tottori 6838503, Japan; [Sasaoka, Toshikuni] Kitasato Univ, Sch Med, Dept Lab Anim Sci, Sagamihara, Kanagawa 2520374, Japan; [Noguchi, Shigeru] Kanagawa Acad Sci & Technol, Signal Transduct Project, Kawasaki, Kanagawa 2130012, Japan	National Center for Neurology & Psychiatry - Japan; Tottori University; Tottori University; Kitasato University; Kanagawa Academy Science & Technology	Itoh, M (corresponding author), 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.	itoh@ncnp.go.jp	Otsuki, Akihiro/AAI-5904-2021; Otsuki, Akihiro/C-1179-2009; Otsuki, Akihiro/AAW-8479-2020; , 笹岡俊邦/N-9152-2015	Otsuki, Akihiro/0000-0001-9173-1148; , 笹岡俊邦/0000-0002-7797-4394; Tahimic, Candice/0000-0001-5862-2652	Ministries of Health, Labor, and Welfare [15B-3, 18A-3, H21-Nanchi-Ippan-110, H22-Nanchi-Ippan-133]; Ministries of Education, Culture, Science, Sports, and Technology of Japan [18390304]	Ministries of Health, Labor, and Welfare; Ministries of Education, Culture, Science, Sports, and Technology of Japan	This work was supported by Ministries of Health, Labor, and Welfare Grants 15B-3, 18A-3, H21-Nanchi-Ippan-110, and H22-Nanchi-Ippan-133 and by Ministries of Education, Culture, Science, Sports, and Technology	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Beechey CV, 2000, CYTOGENET CELL GENET, V90, P309, DOI 10.1159/000056794; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Bourdon Violaine, 2003, Mol Diagn, V7, P3, DOI 10.2165/00066982-200307010-00002; Chaddha Vandana, 2004, Semin Fetal Neonatal Med, V9, P357, DOI 10.1016/j.siny.2004.03.006; Chang YS, 2004, ONCOGENE, V23, P6569, DOI 10.1038/sj.onc.1207882; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; Coutinho-Camillo CM, 2003, DIAGN MOL PATHOL, V12, P57, DOI 10.1097/00019606-200303000-00008; Dragich JM, 2007, J COMP NEUROL, V501, P526, DOI 10.1002/cne.21264; Fukuda T, 2005, J NEUROPATH EXP NEUR, V64, P537, DOI 10.1093/jnen/64.6.537; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; HARPER MI, 1982, J EMBRYOL EXP MORPH, V67, P127; Itoh M, 2007, J NEUROPATH EXP NEUR, V66, P117, DOI 10.1097/nen.0b013e3180302078; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kerr B, 2012, EUR J HUM GENET, V20, P69, DOI 10.1038/ejhg.2011.145; Kriaucionis S, 2004, NUCLEIC ACIDS RES, V32, P1818, DOI 10.1093/nar/gkh349; Lee KY, 2007, TRENDS ENDOCRIN MET, V18, P234, DOI 10.1016/j.tem.2007.06.002; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Looijenga LHJ, 1999, AM J HUM GENET, V64, P1445, DOI 10.1086/302382; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Mayer W, 2000, DEV DYNAM, V217, P1, DOI 10.1002/(SICI)1097-0177(200001)217:1<1::AID-DVDY1>3.0.CO;2-4; MEEHAN RR, 1992, NUCLEIC ACIDS RES, V20, P5085, DOI 10.1093/nar/20.19.5085; MIGEON BR, 1985, P NATL ACAD SCI USA, V82, P3390, DOI 10.1073/pnas.82.10.3390; Mnatzakanian GN, 2004, NAT GENET, V36, P339, DOI 10.1038/ng1327; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nikonova L, 2008, FASEB J, V22, P3925, DOI 10.1096/fj.08-108266; Obata Y, 1998, DEVELOPMENT, V125, P1553; Rett A, 1966, Wien Med Wochenschr, V116, P723; Sado T, 2005, HUM MOL GENET, V14, pR59, DOI 10.1093/hmg/ddi117; Sakatani T, 2001, BIOCHEM BIOPH RES CO, V283, P1124, DOI 10.1006/bbrc.2001.4916; Shahbazian MD, 2002, AM J MED GENET, V111, P164, DOI 10.1002/ajmg.10557; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Wu X, 2004, BIOL REPROD, V70, P1877, DOI 10.1095/biolreprod.103.024729; Young JI, 2004, AM J HUM GENET, V74, P511, DOI 10.1086/382228	40	43	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13859	13867		10.1074/jbc.M111.309864	http://dx.doi.org/10.1074/jbc.M111.309864			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22375006	Green Published, hybrid			2022-12-27	WOS:000303996300041
J	Michikawa, M; Ichinose, H; Momma, M; Biely, P; Jongkees, S; Yoshida, M; Kotake, T; Tsumuraya, Y; Withers, SG; Fujimoto, Z; Kaneko, S				Michikawa, Mari; Ichinose, Hitomi; Momma, Mitsuru; Biely, Peter; Jongkees, Seino; Yoshida, Makoto; Kotake, Toshihisa; Tsumuraya, Yoichi; Withers, Stephen G.; Fujimoto, Zui; Kaneko, Satoshi			Structural and Biochemical Characterization of Glycoside Hydrolase Family 79 beta-Glucuronidase from Acidobacterium capsulatum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE RESIDUES; ENZYMES; IDENTIFICATION; PURIFICATION; GLUCOSIDASE; HEPARANASE; MODULE; MODEL	We present the first structure of a glycoside hydrolase family 79 beta-glucuronidase from Acidobacterium capsulatum, both as a product complex with beta-D-glucuronic acid (GlcA) and as its trapped covalent 2-fluoroglucuronyl intermediate. This enzyme consists of a catalytic (beta/alpha)(8)-barrel domain and a beta-domain with irregular Greek key motifs that is of unknown function. The enzyme showed beta-glucuronidase activity and trace levels of beta-glucosidase and beta-xylosidase activities. In conjunction with mutagenesis studies, these structures identify the catalytic residues as Glu(173) (acid base) and Glu(287) (nucleophile), consistent with the retaining mechanism demonstrated by H-1 NMR analysis. Glu(45), Tyr(243), Tyr(292)-Gly(294), and Tyr(334) form the catalytic pocket and provide substrate discrimination. Consistent with this, the Y292A mutation, which affects the interaction between the main chains of Gln(293) and Gly(294) and the GlcA carboxyl group, resulted in significant loss of beta-glucuronidase activity while retaining the side activities at wild-type levels. Likewise, although the beta-glucuronidase activity of the Y334F mutant is similar to 200-fold lower (k(cat)/K-m) than that of the wild-type enzyme, the beta-glucosidase activity is actually 3 times higher and the beta-xylosidase activity is only 2.5-fold lower than the equivalent parameters for wild type, consistent with a role for Tyr(334) in recognition of the C6 position of GlcA. The involvement of Glu(45) in discriminating against binding of the O-methyl group at the C4 position of GlcA is revealed in the fact that the E45D mutant hydrolyzes PNP-beta-GlcA approximately 300-fold slower (k(cat)/K-m) than does the wild-type enzyme, whereas 4-O-methyl-GlcA-containing oligosaccharides are hydrolyzed only 7-fold slower.	[Momma, Mitsuru; Fujimoto, Zui] Natl Inst Agrobiol Sci, Biomol Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Michikawa, Mari; Ichinose, Hitomi; Kaneko, Satoshi] Natl Agr & Food Res Org NARO, Food Res Inst, Food Biotechnol Div, Tsukuba, Ibaraki 3058642, Japan; [Biely, Peter] Slovak Acad Sci, Inst Chem, SK-84538 Bratislava 45, Slovakia; [Jongkees, Seino; Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Yoshida, Makoto] Tokyo Univ Agr & Technol, Dept Environm & Nat Resource Sci, Fuchu, Tokyo 1838509, Japan; [Kotake, Toshihisa; Tsumuraya, Yoichi] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama 3388570, Japan	National Institute of Agrobiological Sciences - Japan; National Agriculture & Food Research Organization - Japan; Slovak Academy of Sciences; University of British Columbia; Tokyo University of Agriculture & Technology; Saitama University	Fujimoto, Z (corresponding author), Natl Inst Agrobiol Sci, Biomol Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	zui@affrc.go.jp; sakaneko@affrc.go.jp	Jongkees, Seino A K/I-7722-2016; Yoshida, Makoto/E-8017-2013; Biely, Peter/ABF-3465-2020; KOTAKE, TOSHIHISA/F-1117-2011	Jongkees, Seino A K/0000-0002-4796-0557; Biely, Peter/0000-0002-9915-7707; KOTAKE, TOSHIHISA/0000-0002-1110-5006; Fujimoto, Zui/0000-0002-3551-6854	Natural Sciences and Engineering Research Council, Canada	Natural Sciences and Engineering Research Council, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Supported by the Natural Sciences and Engineering Research Council, Canada.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arul L, 2008, BIOINFORMATION, V3, P194, DOI 10.6026/97320630003194; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; Dabek M, 2008, FEMS MICROBIOL ECOL, V66, P487, DOI 10.1111/j.1574-6941.2008.00520.x; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eudes A, 2008, PLANT CELL PHYSIOL, V49, P1331, DOI 10.1093/pcp/pcn108; Gandhi NS, 2012, GLYCOBIOLOGY, V22, P35, DOI 10.1093/glycob/cwr095; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hulett MD, 2000, BIOCHEMISTRY-US, V39, P15659, DOI 10.1021/bi002080p; Ichinose H, 2005, J BIOL CHEM, V280, P25820, DOI 10.1074/jbc.M501024200; Ichinose H, 2008, APPL MICROBIOL BIOT, V80, P399, DOI 10.1007/s00253-008-1551-x; Jain S, 1996, NAT STRUCT BIOL, V3, P375, DOI 10.1038/nsb0496-375; JENKINS J, 1995, FEBS LETT, V362, P281, DOI 10.1016/0014-5793(95)00252-5; Konishi T, 2008, CARBOHYD RES, V343, P1191, DOI 10.1016/j.carres.2008.03.004; Kuroyama H, 2001, CARBOHYD RES, V333, P27, DOI 10.1016/S0008-6215(01)00114-8; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McBain AJ, 1998, J MED MICROBIOL, V47, P407, DOI 10.1099/00222615-47-5-407; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura J, 2002, MICROBIOL IMMUNOL, V46, P487, DOI 10.1111/j.1348-0421.2002.tb02723.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Ritz K., 1994, BIOMASS COMPOSITIONA, P149; Sapay N, 2012, BIOPOLYMERS, V97, P21, DOI 10.1002/bip.21696; Sasaki K, 2000, J BIOL CHEM, V275, P27466; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WITHERS SG, 1995, PROTEIN SCI, V4, P361	31	32	34	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					14069	14077		10.1074/jbc.M112.346288	http://dx.doi.org/10.1074/jbc.M112.346288			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22367201	Green Published, hybrid			2022-12-27	WOS:000303996300060
J	Jacquot, A; Montigny, C; Hennrich, H; Barry, R; le Maire, M; Jaxel, C; Holthuis, J; Champeil, P; Lenoir, G				Jacquot, Aurore; Montigny, Cedric; Hennrich, Hanka; Barry, Raphaelle; le Maire, Marc; Jaxel, Christine; Holthuis, Joost; Champeil, Philippe; Lenoir, Guillaume			Phosphatidylserine Stimulation of Drs2p center dot Cdc50p Lipid Translocase Dephosphorylation Is Controlled by Phosphatidylinositol-4-phosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; P-TYPE ATPASES; TRANSPORT ADENOSINE-TRIPHOSPHATASE; YEAST PLASMA-MEMBRANE; AMINOPHOSPHOLIPID TRANSPORT; PHOSPHOLIPID TRANSLOCATION; SUBCELLULAR-LOCALIZATION; P-4-ATPASE ATP8A2; PROTEIN-TRANSPORT; DIVALENT-CATION	Here, Drs2p, a yeast lipid translocase that belongs to the family of P-4-type ATPases, was overexpressed in the yeast Saccharomyces cerevisiae together with Cdc50p, its glycosylated partner, as a result of the design of a novel co-expression vector. The resulting high yield allowed us, using crude membranes or detergent-solubilized membranes, to measure the formation from [gamma-P-32]ATP of a P-32-labeled transient phosphoenzyme at the catalytic site of Drs2p. Formation of this phosphoenzyme could be detected only if Cdc50p was co-expressed with Drs2p but was not dependent on full glycosylation of Cdc50p. It was inhibited by orthovanadate and fluoride compounds. In crude membranes, the phosphoenzyme formed at steady state at 4 degrees C displayed ADP-insensitive but temperature-sensitive decay. Solubilizing concentrations of dodecyl maltoside left this decay rate almost unaltered, whereas several other detergents accelerated it. Unexpectedly, the dephosphorylation rate for the solubilized Drs2p center dot Cdc50p complex was inhibited by the addition of phosphatidylserine. Phosphatidylserine exerted its anticipated accelerating effect on the dephosphorylation of Drs2p center dot Cdc50p complex only in the additional presence of phosphatidylinositol-4-phosphate. These results explain why phosphatidylinositol-4-phosphate tightly controls Drs2p-catalyzed lipid transport and establish the functional relevance of the Drs2p center dot Cdc50p complex overexpressed here.	[Jacquot, Aurore; Montigny, Cedric; Barry, Raphaelle; le Maire, Marc; Jaxel, Christine; Champeil, Philippe; Lenoir, Guillaume] CEA, CNRS, UMR Syst Membranaires Photobiol Stress & Detoxica, F-91191 Gif Sur Yvette, France; [Jacquot, Aurore; Montigny, Cedric; Barry, Raphaelle; le Maire, Marc; Jaxel, Christine; Champeil, Philippe; Lenoir, Guillaume] CEA, Inst Biol & Technol Saclay iBiTec S, F-91191 Gif Sur Yvette, France; [Jacquot, Aurore; le Maire, Marc; Lenoir, Guillaume] Univ Paris 11, F-91405 Orsay, France; [Hennrich, Hanka; Holthuis, Joost] Univ Utrecht, Dept Membrane Enzymol, Bijvoet Ctr & Inst Biomembranes, NL-3584 CH Utrecht, Netherlands	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Utrecht University	Lenoir, G (corresponding author), CEA Saclay, iBiTec S, F-91191 Gif Sur Yvette, France.	guillaume.lenoir@cea.fr	MONTIGNY, Cédric/AAH-4216-2021; Holthuis, Joost/AAL-9157-2020; Lenoir, Guillaume/I-4002-2019	Lenoir, Guillaume/0000-0002-8759-5179; JAXEL, CHRISTINE/0000-0002-1387-4458; Holthuis, Joost/0000-0001-8912-1586	CNRS; Commissariat a l'Energie Atomique; Ministere de l'Enseignement Superieur et de la Recherche; Agence Nationale pour la Recherche	CNRS(Centre National de la Recherche Scientifique (CNRS)); Commissariat a l'Energie Atomique(French Atomic Energy Commission); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by the CNRS and Commissariat a l'Energie Atomique, by a fellowship from the "Ministere de l'Enseignement Superieur et de la Recherche" (to A. J.), and by a grant from the Agence Nationale pour la Recherche (to C. M., C. J., and M. I. M.).	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; Cardi D, 2010, METHODS MOL BIOL, V601, P247, DOI 10.1007/978-1-60761-344-2_15; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Coleman JA, 2012, P NATL ACAD SCI USA, V109, P1449, DOI 10.1073/pnas.1108862109; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; de Meis L, 2003, J BIOL CHEM, V278, P41856, DOI 10.1074/jbc.M308280200; de Meis L, 2002, J MEMBRANE BIOL, V188, P1, DOI 10.1007/s00232-001-0171-5; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Ding JT, 2000, J BIOL CHEM, V275, P23378, DOI 10.1074/jbc.M910319199; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FUKUSHIMA Y, 1978, J BIOL CHEM, V253, P6853; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Gall WE, 2002, CURR BIOL, V12, P1623, DOI 10.1016/S0960-9822(02)01148-X; Graham TR, 2011, TRENDS CELL BIOL, V21, P113, DOI 10.1016/j.tcb.2010.10.002; Hatori Y, 2008, J BIOL CHEM, V283, P22541, DOI 10.1074/jbc.M802735200; Hauser H, 2000, BBA-BIOMEMBRANES, V1508, P164, DOI 10.1016/S0304-4157(00)00008-3; HOKIN LE, 1965, P NATL ACAD SCI USA, V54, P177, DOI 10.1073/pnas.54.1.177; Holthuis JCM, 1998, EMBO J, V17, P113, DOI 10.1093/emboj/17.1.113; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Jidenko M, 2006, PROTEIN EXPRES PURIF, V48, P32, DOI 10.1016/j.pep.2006.03.001; Lenoir G, 2002, BBA-BIOMEMBRANES, V1560, P67, DOI 10.1016/S0005-2736(01)00458-8; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; LUND S, 1989, J BIOL CHEM, V264, P4907; MACDONALD TL, 1988, TRENDS BIOCHEM SCI, V13, P15, DOI 10.1016/0968-0004(88)90012-6; MAKINOSE M, 1969, EUR J BIOCHEM, V10, P74; Mall S, 2006, J BIOL CHEM, V281, P36597, DOI 10.1074/jbc.M606869200; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Muthusamy BP, 2009, BBA-MOL CELL BIOL L, V1791, P612, DOI 10.1016/j.bbalip.2009.03.004; Natarajan P, 2009, NAT CELL BIOL, V11, P1421, DOI 10.1038/ncb1989; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Perret A, 1998, BIOCHEMISTRY-US, V37, P11412, DOI 10.1021/bi980908q; Picard M, 2006, J BIOL CHEM, V281, P3360, DOI 10.1074/jbc.M511385200; PICK U, 1982, J BIOL CHEM, V257, P6111; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; POMPON D, 1987, BIOCHEMISTRY-US, V26, P6429, DOI 10.1021/bi00394a020; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; Puts CF, 2010, J PROTEOME RES, V9, P833, DOI 10.1021/pr900743b; ROSING J, 1980, J BIOL CHEM, V255, P274; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; SHIGEKAWA M, 1983, J BIOL CHEM, V258, P8698; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vicinanza M, 2008, CELL MOL LIFE SCI, V65, P2833, DOI 10.1007/s00018-008-8353-2; Yamasaki K, 2002, J BIOL CHEM, V277, P13615, DOI 10.1074/jbc.M200625200; YU X, 1995, J BIOL CHEM, V270, P4361, DOI 10.1074/jbc.270.9.4361; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106	58	39	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13249	13261		10.1074/jbc.M111.313916	http://dx.doi.org/10.1074/jbc.M111.313916			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22351780	Green Published, hybrid			2022-12-27	WOS:000302903700062
J	Joe, MK; Kee, C; Tomarev, SI				Joe, Myung Kuk; Kee, Changwon; Tomarev, Stanislav I.			Myocilin Interacts with Syntrophins and Is Member of Dystrophin-associated Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN-ANGLE GLAUCOMA; TRABECULAR MESHWORK CELLS; SKELETAL-MUSCLE ATROPHY; GLUCOCORTICOID-INDUCED MYOPATHY; GLYCOPROTEIN COMPLEX; TRANSCRIPTION FACTORS; GENE-EXPRESSION; TRANSGENIC MICE; MUTATED MOUSE; NON-SECRETION	Genetic studies have linked myocilin to open angle glaucoma, but the functions of the protein in the eye and other tissues have remained elusive. The purpose of this investigation was to elucidate myocilin function(s). We identified alpha 1-syntrophin, a component of the dystrophin-associated protein complex (DAPC), as a myocilin-binding candidate. Myocilin interacted with alpha 1-syntrophin via its N-terminal domain and co-immunoprecipitated with alpha 1-syntrophin from C2C12 myotubes and mouse skeletal muscle. Expression of 15-fold higher levels of myocilin in the muscles of transgenic mice led to the elevated association of alpha 1-syntrophin, neuronal nitric-oxide synthase, and alpha-dystroglycan with DAPC, which increased the binding of laminin to alpha-dystroglycan and Akt signaling. Phosphorylation of Akt and Forkhead box O-class 3, key regulators of muscle size, was increased more than 3-fold, whereas the expression of muscle-specific RING finger protein-1 and atrogin-1, muscle atrophy markers, was decreased by 79 and 88%, respectively, in the muscles of transgenic mice. Consequently, the average size of muscle fibers of the transgenic mice was increased by 36% relative to controls. We suggest that intracellular myocilin plays a role as a regulator of muscle hypertrophy pathways, acting through the components of DAPC.	[Joe, Myung Kuk; Tomarev, Stanislav I.] NEI, Retinal Gangl Cell Biol Sect, Lab Retinal Cell & Mol Biol, NIH, Bethesda, MD 20892 USA; [Kee, Changwon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul 135710, South Korea	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Sungkyunkwan University (SKKU); Samsung Medical Center	Tomarev, SI (corresponding author), NEI, Retinal Gangl Cell Biol Sect, Lab Retinal Cell & Mol Biol, NIH, Bldg 6,Rm 212A,6 Ctr Dr, Bethesda, MD 20892 USA.	tomarevs@nei.nih.gov		Kee, Changwon/0000-0002-7419-0316	National Institutes of Health, NEI; NATIONAL EYE INSTITUTE [ZIAEY000318] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by the National Institutes of Health, NEI, Intramural Research Program.	Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; Ahn AH, 1996, J BIOL CHEM, V271, P2724, DOI 10.1074/jbc.271.5.2724; Alm A, 2009, EXP EYE RES, V88, P760, DOI 10.1016/j.exer.2008.12.012; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bunnell TM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002604; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; Carraro L, 2009, PHYSIOL GENOMICS, V38, P138, DOI 10.1152/physiolgenomics.00014.2009; Ehmsen J, 2002, J CELL SCI, V115, P2801; Ervasti JM, 2008, INT REV CYTOL, V265, P191, DOI 10.1016/S0074-7696(07)65005-0; Fautsch MP, 2006, EXP EYE RES, V82, P1046, DOI 10.1016/j.exer.2005.09.016; Fautsch MP, 2001, INVEST OPHTH VIS SCI, V42, P2324; Fingert JH, 1998, GENOME RES, V8, P377, DOI 10.1101/gr.8.4.377; Glass DJ, 2005, CANCER CELL, V8, P351, DOI 10.1016/j.ccr.2005.10.016; Gobeil S, 2004, INVEST OPHTH VIS SCI, V45, P3560, DOI 10.1167/iovs.04-0300; Gould DB, 2004, MOL CELL BIOL, V24, P9019, DOI 10.1128/MCB.24.20.9019-9025.2004; Gullberg G, 1999, CELL MOL LIFE SCI, V56, P442, DOI 10.1007/PL00000616; Hardy KM, 2005, J BIOL CHEM, V280, P28917, DOI 10.1074/jbc.M504803200; Hasselgren PO, 2010, CURR OPIN CLIN NUTR, V13, P423, DOI 10.1097/MCO.0b013e32833a5107; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052; Jacobson N, 2001, HUM MOL GENET, V10, P117, DOI 10.1093/hmg/10.2.117; Joe MK, 2005, BIOCHEM BIOPH RES CO, V336, P1201, DOI 10.1016/j.bbrc.2005.09.006; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Joe MK, 2010, AM J PATHOL, V176, P2880, DOI 10.2353/ajpath.2010.090853; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001; Kim MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015355; Komamura K, 2003, CARDIOVASC DRUG THER, V17, P303, DOI 10.1023/A:1027352703783; Kwon HS, 2011, J CELL PHYSIOL, V226, P3392, DOI 10.1002/jcp.22701; Kwon HS, 2009, MOL CELL BIOL, V29, P2139, DOI 10.1128/MCB.01274-08; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Lam DSC, 2000, INVEST OPHTH VIS SCI, V41, P1386; Langenbach KJ, 2002, MUSCLE NERVE, V26, P644, DOI 10.1002/mus.10258; LEUNGHAGESTEIJN CY, 1994, J CELL SCI, V107, P589; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; Malyukova I, 2006, INVEST OPHTH VIS SCI, V47, P206, DOI 10.1167/iovs.05-0220; Nakamori M, 2008, NEUROLOGY, V70, P677, DOI 10.1212/01.wnl.0000302174.08951.cf; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; Piluso G, 2000, J BIOL CHEM, V275, P15851, DOI 10.1074/jbc.M000439200; Polansky JR, 1997, OPHTHALMOLOGICA, V211, P126, DOI 10.1159/000310780; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Raffaello A, 2010, J CELL BIOL, V191, P101, DOI 10.1083/jcb.201001136; Resch ZT, 2010, EXP EYE RES, V91, P901, DOI 10.1016/j.exer.2010.09.017; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Schakman O, 2008, J ENDOCRINOL, V197, P1, DOI 10.1677/JOE-07-0606; Senatorov V, 2006, J NEUROSCI, V26, P11903, DOI 10.1523/JNEUROSCI.3020-06.2006; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Sohn S, 2002, INVEST OPHTH VIS SCI, V43, P3680; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Suzuki N, 2007, J CLIN INVEST, V117, P2468, DOI 10.1172/JCI30654; Tamm ER, 2009, EXP EYE RES, V88, P648, DOI 10.1016/j.exer.2009.02.007; Tomarev SI, 1998, BIOCHEM BIOPH RES CO, V245, P887, DOI 10.1006/bbrc.1998.8541; Tomarev SI, 2009, MOL NEUROBIOL, V40, P122, DOI 10.1007/s12035-009-8076-x; Torrado M, 2002, HUM MOL GENET, V11, P1291, DOI 10.1093/hmg/11.11.1291; Veroni C, 2007, J NEUROSCI RES, V85, P2631, DOI 10.1002/jnr.21186; Waite A, 2009, ANN MED, V41, P344, DOI 10.1080/07853890802668522; Wakayama Y, 2006, HISTOL HISTOPATHOL, V21, P23, DOI 10.14670/HH-21.23; Wentz-Hunter K, 2002, INVEST OPHTH VIS SCI, V43, P176; Wu Y, 2010, ENDOCRINOLOGY, V151, P1050, DOI 10.1210/en.2009-0530; Xiong YM, 2009, J CELL PHYSIOL, V219, P402, DOI 10.1002/jcp.21684; Yoshida M, 2000, HUM MOL GENET, V9, P1033, DOI 10.1093/hmg/9.7.1033; Zhou Y, 2008, INVEST OPHTH VIS SCI, V49, P1932, DOI 10.1167/iovs.07-1339	66	30	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13216	13227		10.1074/jbc.M111.224063	http://dx.doi.org/10.1074/jbc.M111.224063			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22371502	hybrid, Green Published			2022-12-27	WOS:000302903700059
J	Wilson, ZN; Gilroy, CA; Boitz, JM; Ullman, B; Yates, PA				Wilson, Zachary N.; Gilroy, Caslin A.; Boitz, Jan M.; Ullman, Buddy; Yates, Phillip A.			Genetic Dissection of Pyrimidine Biosynthesis and Salvage in Leishmania donovani	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOMA-BRUCEI; DIHYDROFOLATE REDUCTASE; TOXOPLASMA-GONDII; IN-VITRO; DIHYDROOROTATE DEHYDROGENASE; NUCLEOSIDE HYDROLASE; TARGETING CONSTRUCTS; THYMIDYLATE SYNTHASE; PURINE SALVAGE; MAMMALIAN HOST	Protozoan parasites of the Leishmania genus express the metabolic machinery to synthesize pyrimidine nucleotides via both de novo and salvage pathways. To evaluate the relative contributions of pyrimidine biosynthesis and salvage to pyrimidine homeostasis in both life cycle stages of Leishmania donovani, individual mutant lines deficient in either carbamoyl phosphate synthetase (CPS), the first enzyme in pyrimidine biosynthesis, uracil phosphoribosyltransferase (UPRT), a salvage enzyme, or both CPS and UPRT were constructed. The Delta cps lesion conferred pyrimidine auxotrophy and a growth requirement for medium supplementation with one of a plethora of pyrimidine nucleosides or nucleobases, although only dihydroorotate or orotate could circumvent the pyrimidine auxotrophy of the Delta cps/Delta uprt double knockout. The Delta uprt null mutant was prototrophic for pyrimidines but could not salvage uracil or any pyrimidine nucleoside. The capability of the Delta cps parasites to infect mice was somewhat diminished but still robust, indicating active pyrimidine salvage by the amastigote form of the parasite, but the Delta cps/Delta uprt mutant was completely attenuated with no persistent parasites detected after a 4-week infection. Complementation of the Delta cps/Delta uprt clone with either CPS or UPRT restored infectivity. These data establish that an intact pyrimidine biosynthesis pathway is essential for the growth of the promastigote form of L. donovani in culture, that all uracil and pyrimidine nucleoside salvage in the parasite is mediated by UPRT, and that both the biosynthetic and salvage pathways contribute to a robust infection of the mammalian host by the amastigote. These findings impact potential therapeutic design and vaccine strategies for visceral leishmaniasis.	[Wilson, Zachary N.; Gilroy, Caslin A.; Boitz, Jan M.; Ullman, Buddy; Yates, Phillip A.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Yates, PA (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol L224, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	yatesp@ohsu.edu		Wilson, Zachary/0000-0003-4269-4058	National Institutes of Health, NIAID [AI023682]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023682, R37AI023682] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grant AI023682.	Annoura T, 2005, J MOL EVOL, V60, P113, DOI 10.1007/s00239-004-0078-8; Arakaki TL, 2008, MOL MICROBIOL, V68, P37, DOI 10.1111/j.1365-2958.2008.06131.x; ARONOW B, 1987, MOL BIOCHEM PARASIT, V22, P29, DOI 10.1016/0166-6851(87)90066-1; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BEVERLEY SM, 1986, P NATL ACAD SCI USA, V83, P2584, DOI 10.1073/pnas.83.8.2584; BLATTNER J, 1992, J CELL BIOL, V119, P1129, DOI 10.1083/jcb.119.5.1129; Boitz JM, 2006, MOL BIOCHEM PARASIT, V148, P24, DOI 10.1016/j.molbiopara.2006.02.015; Boitz JM, 2006, J BIOL CHEM, V281, P16084, DOI 10.1074/jbc.M600188200; Boitz JM, 2009, INFECT IMMUN, V77, P756, DOI 10.1128/IAI.01236-08; Breton M, 2005, INFECT IMMUN, V73, P6372, DOI 10.1128/IAI.73.10.6372-6382.2005; Brodskyn C, 2000, CLIN EXP IMMUNOL, V119, P299, DOI 10.1046/j.1365-2249.2000.01122.x; BUFFET PA, 1995, ANTIMICROB AGENTS CH, V39, P2167, DOI 10.1128/AAC.39.9.2167; Carter NS, 2010, MOL MICROBIOL, V78, P92, DOI 10.1111/j.1365-2958.2010.07327.x; CARTER NS, 2003, MOL MED PARASITOLOGY, P197; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; Cui LW, 2001, GENE, V280, P153, DOI 10.1016/S0378-1119(01)00768-5; Debrabant A, 2004, INT J PARASITOL, V34, P205, DOI 10.1016/j.ijpara.2003.10.011; DWYER DM, 1972, J PARASITOL, V58, P847, DOI 10.2307/3278338; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; FAURE M, 1989, EUR J BIOCHEM, V179, P345, DOI 10.1111/j.1432-1033.1989.tb14560.x; Fox BA, 2002, NATURE, V415, P926, DOI 10.1038/415926a; FREEDMAN DJ, 1993, MOL BIOCHEM PARASIT, V62, P37, DOI 10.1016/0166-6851(93)90175-W; French JB, 2011, J BIOL CHEM, V286, P20930, DOI 10.1074/jbc.M111.228213; FREUND JN, 1987, J MOL BIOL, V193, P1, DOI 10.1016/0022-2836(87)90621-8; Fulwiler AL, 2011, MOL BIOCHEM PARASIT, V175, P209, DOI 10.1016/j.molbiopara.2010.10.008; Gao GH, 1999, J MOL BIOL, V285, P149, DOI 10.1006/jmbi.1998.2293; GARRETT CE, 1984, MOL BIOCHEM PARASIT, V11, P257, DOI 10.1016/0166-6851(84)90070-7; Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; HAMMOND DJ, 1982, BIOCHIM BIOPHYS ACTA, V718, P1, DOI 10.1016/0304-4165(82)90002-2; HAMMOND DJ, 1980, FEBS LETT, V118, P259, DOI 10.1016/0014-5793(80)80233-X; Hashimoto M, 2012, BIOCHEM BIOPH RES CO, V417, P1002, DOI 10.1016/j.bbrc.2011.12.073; HASSAN HF, 1986, COMP BIOCHEM PHYS B, V84, P217, DOI 10.1016/0305-0491(86)90209-9; HOLBROOK TW, 1975, AM J TROP MED HYG, V24, P704, DOI 10.4269/ajtmh.1975.24.704; Hwang HY, 1997, J BIOL CHEM, V272, P19488, DOI 10.1074/jbc.272.31.19488; Hwang HY, 1996, J BIOL CHEM, V271, P30840, DOI 10.1074/jbc.271.48.30840; IOVANNISCI DM, 1984, MOL CELL BIOL, V4, P1013, DOI 10.1128/MCB.4.6.1013; IOVANNISCI DM, 1984, J BIOL CHEM, V259, P4617; IOVANNISCI DM, 1983, J PARASITOL, V69, P633, DOI 10.2307/3281131; IVANETICH KM, 1990, FASEB J, V4, P1591, DOI 10.1096/fasebj.4.6.2180768; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Mikus Judith, 2000, Parasitology International, V48, P265, DOI 10.1016/S1383-5769(99)00020-3; Nara T, 1998, BBA-PROTEIN STRUCT M, V1387, P462, DOI 10.1016/S0167-4838(98)00127-7; OPPERDOES FR, 1987, ANNU REV MICROBIOL, V41, P127, DOI 10.1146/annurev.mi.41.100187.001015; OPPERDOES FR, 1988, TRENDS BIOCHEM SCI, V13, P255, DOI 10.1016/0968-0004(88)90158-2; Papageorgiou IG, 2005, PARASITOLOGY, V130, P275, DOI 10.1017/S0031182004006626; Park AY, 2000, J IMMUNOL, V165, P896, DOI 10.4049/jimmunol.165.2.896; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; PFEFFERKORN ER, 1977, J PROTOZOOL, V24, P449, DOI 10.1111/j.1550-7408.1977.tb04774.x; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; SCHNEIDE.EL, 1974, EXP CELL RES, V84, P311, DOI 10.1016/0014-4827(74)90411-X; Shi WX, 1999, J BIOL CHEM, V274, P21114, DOI 10.1074/jbc.274.30.21114; SOMMER JM, 1992, MOL BIOL CELL, V3, P749, DOI 10.1091/mbc.3.7.749; STARK GR, 1984, ANNU REV BIOCHEM, V53, P447, DOI 10.1146/annurev.bi.53.070184.002311; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Vasudevan G, 1998, P NATL ACAD SCI USA, V95, P9873, DOI 10.1073/pnas.95.17.9873; Vasudevan G, 2001, P NATL ACAD SCI USA, V98, P6092, DOI 10.1073/pnas.101537298; WAHL GM, 1979, J BIOL CHEM, V254, P8679	58	23	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12759	12770		10.1074/jbc.M112.346502	http://dx.doi.org/10.1074/jbc.M112.346502			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367196	Green Published, hybrid			2022-12-27	WOS:000302903700015
J	Carulli, S; Beck, K; Dayan, G; Boulesteix, S; Lortat-Jacob, H; Rousselle, P				Carulli, Sonia; Beck, Konrad; Dayan, Guila; Boulesteix, Sophie; Lortat-Jacob, Hugues; Rousselle, Patricia			Cell Surface Proteoglycans Syndecan-1 and-4 Bind Overlapping but Distinct Sites in Laminin alpha 3 LG45 Protein Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN ALPHA-3-BETA-1; KERATINOCYTE MIGRATION; SECONDARY STRUCTURE; BIOLOGICAL-ACTIVITY; EPITHELIAL-CELLS; HEPARAN-SULFATE; LAMA3 GENE; CHAIN; ADHESION; DYSTROGLYCAN	Keratinocyte migration during epidermal repair depends on interactions between cellular heparan sulfate proteoglycan receptors, syndecan-1 and -4, and the C-terminal globular domains (LG45) of the extracellular matrix protein laminin 332. This study investigates the molecular basis of the binding specificity of the syndecan-1 and -4 receptors expressed by human keratinocytes. We used site-directed mutagenesis to alter a recombinant LG45 protein by substituting the most critical basic residues with glutamine. All proteins were expressed in mammalian cells, purified, and characterized biochemically. We used in vitro binding assays, including surface plasmon resonance, to examine interactions between mutated LG45 and heparan sulfates, syndecan-1 and -4. We identify a major heparin binding domain on the outer edge of a beta-strand of LG45 surrounded by a track of converging low affinity residues. This domain harbors distinctive syndecan-1 and -4 binding-specific sequences. This is the first study to demonstrate a binding specificity of two proteoglycans produced by a single cell type. In addition, we found that although syndecan-1 interacts exclusively through its glycosaminoglycan chains, syndecan-4 binding relies on both its core protein and its heparan sulfate chains. These results suggest that LG45 may trigger different signals toward keratinocytes depending on its interaction with syndecan-1 or -4.	[Carulli, Sonia; Dayan, Guila; Boulesteix, Sophie; Rousselle, Patricia] Univ Lyon 1, Inst Biol & Chim Prot, FRE 3310, CNRS, F-69367 Lyon 07, France; [Beck, Konrad] Cardiff Univ, Sch Dent, Cardiff CF14 4XY, S Glam, Wales; [Lortat-Jacob, Hugues] Univ Grenoble 1, Commissariat Energie Atom, CNRS, Inst Biol Struct Jean Pierre Ebel,UMR 5075, F-38000 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Cardiff University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Rousselle, P (corresponding author), Univ Lyon 1, Inst Biol & Chim Prot, FRE 3310, CNRS, 7 Passage du Vercors, F-69367 Lyon 07, France.	patricia.rousselle@ibcp.fr	Rousselle, Patricia/CAF-3915-2022; Beck, Konrad/AAX-1351-2020; Rousselle, Patricia/J-5290-2019	Rousselle, Patricia/0000-0003-0275-4562; Beck, Konrad/0000-0001-5098-9484; Rousselle, Patricia/0000-0003-0275-4562	Agence Nationale de la Recherche [ANR-08-PCVI-0031, ANR-09-EBIO-023]; Association pour la Recherche sur le Cancer [1128]; Ligue Nationale Contre le Cancer; Rhone-Alpes region; Fondation pour la Recherche Medicale	Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Rhone-Alpes region(Region Auvergne-Rhone-Alpes); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported in part by Agence Nationale de la Recherche Grants ANR-08-PCVI-0031 and ANR-09-EBIO-023, Association pour la Recherche sur le Cancer Grant 1128, and Ligue Nationale Contre le Cancer.; Recipient of a Ph.D. studentship from the Rhone-Alpes region (Program Cible) and from the Fondation pour la Recherche Medicale.	Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Andac Z, 1999, J MOL BIOL, V287, P253, DOI 10.1006/jmbi.1999.2606; Araki E, 2009, MOL BIOL CELL, V20, P3012, DOI 10.1091/mbc.E08-09-0977; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Bachy S, 2008, J CELL PHYSIOL, V214, P238, DOI 10.1002/jcp.21184; Beck K, 1997, EUR J BIOCHEM, V247, P339, DOI 10.1111/j.1432-1033.1997.00339.x; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Decline F, 2003, CELL MOTIL CYTOSKEL, V54, P64, DOI 10.1002/cm.10086; Decline F, 2001, J CELL SCI, V114, P811; DeHauwer C, 1997, BIOCHEM BIOPH RES CO, V232, P267, DOI 10.1006/bbrc.1997.6291; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Echtermeyer F, 1999, J CELL SCI, V112, P3433; Frank DE, 2004, J CELL SCI, V117, P1351, DOI 10.1242/jcs.01003; Goldfinger LE, 1999, J CELL SCI, V112, P2615; Goldfinger LE, 1998, J CELL BIOL, V141, P255, DOI 10.1083/jcb.141.1.255; Harrison D, 2007, J BIOL CHEM, V282, P11573, DOI 10.1074/jbc.M610657200; Hintermann E, 2004, MATRIX BIOL, V23, P75, DOI 10.1016/j.matbio.2004.03.001; Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633; Hoffman MP, 2001, J BIOL CHEM, V276, P22077, DOI 10.1074/jbc.M100774200; Hozumi K, 2009, BIOCHEMISTRY-US, V48, P5375, DOI 10.1021/bi900542u; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kato K, 2002, BIOCHEMISTRY-US, V41, P10747, DOI 10.1021/bi020180k; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lampe PD, 1998, J CELL BIOL, V143, P1735, DOI 10.1083/jcb.143.6.1735; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; Mizushima H, 1997, CELL GROWTH DIFFER, V8, P979; Momota Y, 2005, J RECEPT SIG TRANSD, V25, P1, DOI 10.1081/RRS-200047870; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Nguyen BP, 2000, CURR OPIN CELL BIOL, V12, P554, DOI 10.1016/S0955-0674(00)00131-9; Okamoto O, 2003, J BIOL CHEM, V278, P44168, DOI 10.1074/jbc.M300726200; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Rapraeger AC, 1998, CURR OPIN CELL BIOL, V10, P620, DOI 10.1016/S0955-0674(98)80038-0; ROUSSELLE P, 1994, J CELL BIOL, V125, P205, DOI 10.1083/jcb.125.1.205; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; Rousselle P, 1997, J CELL BIOL, V138, P719, DOI 10.1083/jcb.138.3.719; RYAN MC, 1994, J BIOL CHEM, V269, P22779; Ryan MC, 1999, J CELL BIOL, V145, P1309, DOI 10.1083/jcb.145.6.1309; Sarrazin S, 2005, J BIOL CHEM, V280, P37558, DOI 10.1074/jbc.M507729200; Sasaki T, 2004, J CELL BIOL, V164, P959, DOI 10.1083/jcb.200401058; Sigle RO, 2004, J CELL SCI, V117, P4481, DOI 10.1242/jcs.01310; SONNENBERG A, 1993, J CELL SCI, V106, P1083; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Sulka B, 2009, J BIOL CHEM, V284, P10659, DOI 10.1074/jbc.M807643200; Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; Tran M, 2008, CANCER RES, V68, P2885, DOI 10.1158/0008-5472.CAN-07-6160; Tsubota Y, 2005, J BIOL CHEM, V280, P14370, DOI 10.1074/jbc.M413051200; Tunggal L, 2002, AM J PATHOL, V160, P459, DOI 10.1016/S0002-9440(10)64865-1; Urushibata S, 2009, BIOCHEMISTRY-US, V48, P10522, DOI 10.1021/bi901421t; Utani A, 2003, J BIOL CHEM, V278, P34483, DOI 10.1074/jbc.M304827200; Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200; Vives RR, 2004, J BIOL CHEM, V279, P54327, DOI 10.1074/jbc.M409760200; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wizemann H, 2003, J MOL BIOL, V332, P635, DOI 10.1016/S0022-2836(03)00848-9; Yamashita H, 2004, J MOL BIOL, V335, P1145, DOI 10.1016/j.jmb.2003.11.047; Zimmermann P, 1999, FASEB J, V13, pS91	62	42	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12204	12216		10.1074/jbc.M111.300061	http://dx.doi.org/10.1074/jbc.M111.300061			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351752	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000302782200062
J	Chen, G; Chen, SM; Wang, X; Ding, XF; Ding, J; Meng, LH				Chen, Guang; Chen, Si-Meng; Wang, Xiang; Ding, Xiao-Fei; Ding, Jian; Meng, Ling-Hua			Inhibition of Chemokine (CXC Motif) Ligand 12/Chemokine (CXC Motif) Receptor 4 Axis (CXCL12/CXCR4)-mediated Cell Migration by Targeting Mammalian Target of Rapamycin (mTOR) Pathway in Human Gastric Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE 3-KINASE; SIGNALING PATHWAY; GROWTH-FACTOR; CANCER CELLS; EXPRESSION; PROLIFERATION; ACTIVATION; MOTILITY; REORGANIZATION; CYTOSKELETON	CXCL12/CXCR4 plays an important role in metastasis of gastric carcinoma. Rapamycin has been reported to inhibit migration of gastric cancer cells. However, the role of mTOR pathway in CXCL12/CXCR4-mediated cell migration and the potential of drugs targeting PI3K/mTOR pathway remains unelucidated. We found that CXCL12 activated PI3K/Akt/mTOR pathway in MKN-45 cells. Stimulating CHO-K1 cells expressing pEGFP-C1-Grp1-PH fusion protein with CXCL12 resulted in generation of phosphatidylinositol ( 3,4,5)-triphosphate, which provided direct evidence of activating PI3K by CXCL12. Downregulation of p110 beta by siRNA but not p110 alpha blocked phosphorylation of Akt and S6K1 induced by CXCL12. Consistently, p110 beta-specific inhibitor blocked the CXCL12-activated PI3K/Akt/mTOR pathway. Moreover, CXCR4 immunoprecipitated by anti-p110 beta antibody increased after CXCL12 stimulation and G(i) protein inhibitor pertussis toxin abrogated CXCL12-induced activation of PI3K. Further studies demonstrated that inhibitors targeting the PI3K/mTOR pathway significantly blocked the chemotactic responses of MKN-45 cells triggered by CXCL12, which might be attributed primarily to inhibition of mTORC1 and related to prevention of F-actin reorganization as well as down-regulation of active RhoA, Rac1, and Cdc42. Furthermore, rapamycin inhibited the secretion of CXCL12 and the expression of CXCR4, which might form a positive feedback loop to further abolish upstream signaling leading to cell migration. Finally, we found cells expressing high levels of cxcl12 were sensitive to rapamycin in its activity inhibiting migration as well as proliferation. In summary, we found that the mTOR pathway played an important role in CXCL12/CXCR4-mediated cell migration and proposed that drugs targeting the mTOR pathway may be used for the therapy of metastatic gastric cancer expressing high levels of cxcl12.	[Chen, Guang; Chen, Si-Meng; Wang, Xiang; Ding, Jian; Meng, Ling-Hua] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, State Key Lab Drug Res,Div Antitumor Pharmacol, Shanghai 201203, Peoples R China; [Chen, Guang] Taizhou Coll, Sch Pharmaceut & Chem Engn, Taizhou 317000, Zhejiang, Peoples R China; [Ding, Xiao-Fei] Taizhou Coll, Sch Math & Informat Engn, Taizhou 317000, Zhejiang, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Taizhou University; Taizhou University	Ding, J (corresponding author), 555 Zu Chong Zhi Rd,Zhang Jiang Hitech Pk, Shanghai 201203, Peoples R China.	jding@mail.shcnc.ac.cn; lhmeng@mail.shcnc.ac.cn	meng, linghua/Y-8110-2019		National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" [2012ZX09301-001]; National Natural Science Foundation of China [81021062'81173079]; Chinese Academy of Sciences [KSCX2-EW-Q-3]; SA-SIBS	National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program"; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); SA-SIBS	* This work was supported in part by National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" 2012ZX09301-001, National Natural Science Foundation of China Grant 81021062'81173079, and Knowledge Innovation Program of Chinese Academy of Sciences Grant KSCX2-EW-Q-3.; <SUP>3</SUP> Supported by the SA-SIBS scholarship program. To whom correspondence may be addressed: 555 Zu Chong Zhi Rd., Zhang Jiang Hi-Tech Park, Pudong, Shanghai 201203, China. Tel. and Fax: 86-21-50806722; E-mail: lhmeng@mail.shcnc.ac.cn.	Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Barbero S, 2003, CANCER RES, V63, P1969; Baselga J, 2009, J CLIN ONCOL, V27, P2630, DOI 10.1200/JCO.2008.18.8391; Boku N, 2008, INT J CLIN ONCOL, V13, P483, DOI 10.1007/s10147-008-0847-2; Chen GA, 2010, J MOL MED, V88, P941, DOI 10.1007/s00109-010-0635-0; Chinni SR, 2006, PROSTATE, V66, P32, DOI 10.1002/pros.20318; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Ehtesham M, 2009, CANCER LETT, V274, P305, DOI 10.1016/j.canlet.2008.09.034; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Hashimoto I, 2008, EUR J CANCER, V44, P1022, DOI 10.1016/j.ejca.2008.02.043; Ishigami S, 2007, ANN SURG ONCOL, V14, P3154, DOI 10.1245/s10434-007-9521-6; Iwasa S, 2009, ANTICANCER RES, V29, P4751; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Leelawat K, 2007, WORLD J GASTROENTERO, V13, P1561, DOI 10.3748/wjg.v13.i10.1561; Li T, 2010, J PHARMACOL EXP THER, V334, P830, DOI 10.1124/jpet.110.167940; Liu L, 2008, ONCOGENE, V27, P4998, DOI 10.1038/onc.2008.137; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Liu L, 2010, J BIOL CHEM, V285, P38362, DOI 10.1074/jbc.M110.141168; Monterrubio M, 2009, BIOCHEM BIOPH RES CO, V388, P199, DOI 10.1016/j.bbrc.2009.07.153; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Song N, 2009, CANCER RES, V69, P6057, DOI 10.1158/0008-5472.CAN-08-2007; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Wald O, 2011, J THORAC CARDIOV SUR, V141, P1503, DOI 10.1016/j.jtcvs.2010.11.056; Wu YM, 2009, J NEUROCHEM, V109, P1157, DOI 10.1111/j.1471-4159.2009.06043.x; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Zhao M, 2008, BREAST CANCER RES TR, V110, P211, DOI 10.1007/s10549-007-9712-7; Zhou HY, 2010, CRIT REV EUKAR GENE, V20, P1	31	72	78	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12132	12141		10.1074/jbc.M111.302299	http://dx.doi.org/10.1074/jbc.M111.302299			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22337890	Green Published, hybrid			2022-12-27	WOS:000302782200049
J	Ghosh, D; Tsokos, GC; Kyttaris, VC				Ghosh, Debjani; Tsokos, George C.; Kyttaris, Vasileios C.			c-Jun and Ets2 Proteins Regulate Expression of Spleen Tyrosine Kinase in T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DISEASE; JNK; SYK; TRANSACTIVATION; TRANSCRIPTION; ACTIVATION; INHIBITOR; MEDIATE; GENE	Effector T cells and T cells from patients with systemic lupus erythematosus (SLE) express increased levels of the spleen tyrosine kinase (Syk). Syk binds to the T cell receptor (TCR)-CD3 complex and transduces the TCR-mediated signal in the cell more efficiently than the canonical CD3 zeta chain. The reasons for the increased expression of Syk are unclear. In the present study, we found that Syk is regulated by the transcription factor c-Jun in cooperation with Ets2. c-Jun and Ets2 bound to the SYK promoter in close proximity and increased the promoter activity in a specific manner. Disruption of c-Jun and Ets2 expression by siRNA resulted in decreased expression of Syk. Overexpression of c-Jun but not Ets2 resulted in increase in Syk protein. c-Jun and Ets2 co-immunoprecipitated and had an additive effect on Syk expression. c-Jun-driven SYK promoter activation showed a similar pattern in B cells; however, as expected, basal promoter activity was much higher in B cells as compared with T cells. Overexpression of c-Jun led to increase in intracytoplasmic calcium flux following TCR stimulation. Moreover, we found that SLE T cells had increased levels of c-Jun at baseline and phosphorylated c-Jun upon activation. Finally, disruption of c-Jun and Ets2 in SLE T cells resulted in a decrease in calcium flux upon TCR stimulation. In conclusion, c-Jun in cooperation with Ets2 increases the expression of Syk and contributes to Syk-mediated heightened calcium responses in SLE T cells.	[Ghosh, Debjani; Tsokos, George C.; Kyttaris, Vasileios C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Rheumatol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kyttaris, VC (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Rheumatol, 330 Brookline Ave,CLS 936, Boston, MA 02215 USA.	vkyttari@bidmc.harvard.edu	Kyttaris, Vasileios/AAR-4507-2020; tsokos, george C/O-3360-2013	Kyttaris, Vasileios/0000-0001-7652-3826; tsokos, george C/0000-0001-9589-2360	National Institutes of Health [RO1 AI42269, K23 AR055672]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060849, K23AR055672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AI42269 (to G. C. T.) and K23 AR055672 (to V. C. K.).	ADLER V, 1995, J BIOL CHEM, V270, P26071, DOI 10.1074/jbc.270.44.26071; Bahjat FR, 2008, ARTHRITIS RHEUM-US, V58, P1433, DOI 10.1002/art.23428; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; CROSS JC, 1993, P NATL ACAD SCI USA, V90, P8078, DOI 10.1073/pnas.90.17.8078; Deng GM, 2010, ARTHRITIS RHEUM-US, V62, P2086, DOI 10.1002/art.27452; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Ghosh D, 2012, ARTHRITIS RHEUM-US, V64, P799, DOI 10.1002/art.33375; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Krishnan S, 2003, J IMMUNOL, V170, P4189, DOI 10.4049/jimmunol.170.8.4189; Krishnan S, 2008, J IMMUNOL, V181, P8145, DOI 10.4049/jimmunol.181.11.8145; Manna PR, 2004, MOL ENDOCRINOL, V18, P558, DOI 10.1210/me.2003-0223; Manna PR, 2003, J MOL ENDOCRINOL, V30, P381, DOI 10.1677/jme.0.0300381; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; Molad Y, 2010, ANN RHEUM DIS, V69, P175, DOI 10.1136/ard.2008.102780; Nambiar MP, 2003, ARTHRITIS RHEUM, V48, P1948, DOI 10.1002/art.11072; ROZEK D, 1993, MOL CELL BIOL, V13, P5490, DOI 10.1128/MCB.13.9.5490; Weinblatt ME, 2008, ARTHRITIS RHEUM-US, V58, P3309, DOI 10.1002/art.23992; Yang BS, 1996, MOL CELL BIOL, V16, P538	19	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11833	11841		10.1074/jbc.M111.333997	http://dx.doi.org/10.1074/jbc.M111.333997			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22354960	hybrid, Green Published			2022-12-27	WOS:000302782200022
J	Kim, BK; Lee, HY; Choi, JH; Kim, JK; Yoon, JB; Yoon, SK				Kim, Bong-Kyu; Lee, Hwa-Young; Choi, Jee-Hyun; Kim, Jeong-Ki; Yoon, Jong-Bok; Yoon, Sungjoo Kim			Hairless Plays a Role in Formation of Inner Root Sheath via Regulation of Dlx3 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; NONSENSE MUTATION; FOLLICLE MORPHOGENESIS; MOLECULAR-BASIS; MOUSE; EXPRESSION; DIFFERENTIATION; FOXE1; MICE; COREPRESSOR	The Hairless (Hr), a transcription factor, is expressed in the suprabasal cell layer of the interfollicular epidermis and the lower portion of the hair follicle epithelium, where its expression is dependent on the hair cycle. Recently, we reported a new Hr mutant mouse, Hr(Hp), in which the hairless protein (HR) was overexpressed. In this study, we documented abnormal formation of inner root sheath (IRS), suppressed expression of Dlx3, and IRS keratins in the Hr(Hp)/Hr(Hp) skin. We also found that HR down-regulated Dlx3 mRNA expression through suppression of Dlx3 promoter activity. In addition, we showed that Dlx3 regulated the expression of IRS keratins. Our results demonstrate that regulation of Dlx3 by HR affects the IRS keratin expression, thus modulating the formation of IRS of hair follicle.	[Kim, Bong-Kyu; Lee, Hwa-Young; Choi, Jee-Hyun; Kim, Jeong-Ki; Yoon, Sungjoo Kim] Catholic Univ Korea, Dept Med Life Sci, Seoul 137701, South Korea; [Yoon, Jong-Bok] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; [Yoon, Jong-Bok] Yonsei Univ, Translat Res Ctr Prot Funct Control, Seoul 120749, South Korea	Catholic University of Korea; Yonsei University; Yonsei University	Yoon, SK (corresponding author), Catholic Univ Korea, Dept Med Life Sci, Seoul 137701, South Korea.	sjkyoon@catholic.ac.kr		Yoon, Jong-Bok/0000-0002-3563-0702	National Research Foundation of Korea; Ministry of Education, Science and Technology [2009-30066830]; Korea Research Foundation [KRF-32006-3005-3J04502]; Korean Government	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Research Foundation(National Research Foundation of Korea); Korean Government(Korean Government)	This work was supported by the Basic Science Research Program of the National Research Foundation of Korea; the Ministry of Education, Science and Technology Grant 2009-30066830 (to S.-3j. K. Y.); and the Korea Research Foundation Grant KRF-32006-3005-3J04502, funded by the Korean Government.	Ahmad W, 1998, GENOMICS, V53, P383, DOI 10.1006/geno.1998.5495; Baek IC, 2009, MAMM GENOME, V20, P350, DOI 10.1007/s00335-009-9191-8; Beaudoin GMJ, 2005, P NATL ACAD SCI USA, V102, P14653, DOI 10.1073/pnas.0507609102; Bikle DD, 2006, J CELL PHYSIOL, V207, P340, DOI 10.1002/jcp.20578; Billoni N, 2000, BRIT J DERMATOL, V142, P645, DOI 10.1046/j.1365-2133.2000.03408.x; Brancaccio A, 2004, HUM MOL GENET, V13, P2595, DOI 10.1093/hmg/ddh292; CACHONGONZALEZ MB, 1994, P NATL ACAD SCI USA, V91, P7717, DOI 10.1073/pnas.91.16.7717; Choi JH, 2011, BMB REP, V44, P478, DOI 10.5483/BMBRep.2011.44.7.478; COHEN SM, 1989, NATURE, V338, P432, DOI 10.1038/338432a0; Eichberger T, 2004, J INVEST DERMATOL, V122, P1180, DOI 10.1111/j.0022-202X.2004.22505.x; Feledy JA, 1999, NUCLEIC ACIDS RES, V27, P764, DOI 10.1093/nar/27.3.764; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Hsieh JC, 2003, J BIOL CHEM, V278, P38665, DOI 10.1074/jbc.M304886200; Hwang J, 2008, DEVELOPMENT, V135, P3149, DOI 10.1242/dev.022202; Kim BK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-640; Kim JK, 2010, HUM MOL GENET, V19, P445, DOI 10.1093/hmg/ddp509; Krause K, 2006, SEMIN CUTAN MED SURG, V25, P2, DOI 10.1016/j.sder.2006.01.002; Langbein L, 2005, INT REV CYTOL, V243, P1, DOI 10.1016/S0074-7696(05)43001-6; Liu Y, 2010, VET PATHOL, V47, P167, DOI 10.1177/0300985809352970; MANN SJ, 1971, ANAT RECORD, V170, P485, DOI 10.1002/ar.1091700409; Mardaryev AN, 2010, FASEB J, V24, P3869, DOI 10.1096/fj.10-160663; Moraitis AN, 2002, MOL CELL BIOL, V22, P6831, DOI 10.1128/MCB.22.19.6831-6841.2002; Morasso MI, 1996, J CELL BIOL, V135, P1879, DOI 10.1083/jcb.135.6.1879; Morasso MI, 1999, P NATL ACAD SCI USA, V96, P162, DOI 10.1073/pnas.96.1.162; Nam Y, 2006, GENOMICS, V87, P520, DOI 10.1016/j.ygeno.2005.12.005; Panteleyev AA, 2000, AM J PATHOL, V157, P1071, DOI 10.1016/S0002-9440(10)64621-4; Price JA, 1998, J MED GENET, V35, P825, DOI 10.1136/jmg.35.10.825; Price JA, 1998, HUM MOL GENET, V7, P563, DOI 10.1093/hmg/7.3.563; Runkel F, 2006, MAMM GENOME, V17, P1172, DOI 10.1007/s00335-006-0084-9; Steinmayr M, 1998, P NATL ACAD SCI USA, V95, P3960, DOI 10.1073/pnas.95.7.3960; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Tanaka S, 2007, GENOMICS, V90, P703, DOI 10.1016/j.ygeno.2007.07.013; Thompson CC, 2006, CELL CYCLE, V5, P1913, DOI 10.4161/cc.5.17.3189; Thompson CC, 1997, P NATL ACAD SCI USA, V94, P8527, DOI 10.1073/pnas.94.16.8527; Wen YR, 2009, NAT GENET, V41, P228, DOI 10.1038/ng.276; Zarach JM, 2004, DEVELOPMENT, V131, P4189, DOI 10.1242/dev.01303; Zhang JT, 2005, J INVEST DERMATOL, V124, P1200, DOI 10.1111/j.0022-202X.2005.23744.x	38	13	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16681	16688		10.1074/jbc.M111.320770	http://dx.doi.org/10.1074/jbc.M111.320770			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22442153	Green Published, hybrid			2022-12-27	WOS:000304030900056
J	Xue, ML; Dervish, S; Harrison, LC; Fulcher, G; Jackson, CJ				Xue, Meilang; Dervish, Suat; Harrison, Leonard C.; Fulcher, Gregory; Jackson, Christopher J.			Activated Protein C Inhibits Pancreatic Islet Inflammation, Stimulates T Regulatory Cells, and Prevents Diabetes in Non-obese Diabetic (NOD) Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; RECEPTOR; APOPTOSIS; TYPE-1; ANTICOAGULANT; EXPRESSION; MATRIX-METALLOPROTEINASE-9; MECHANISMS; MIGRATION; MELLITUS	Activated protein C (aPC) is a natural anticoagulant with strong cyto-protective and anti-inflammatory properties. aPC inhibits pancreatic inflammation and preserves functional islets after intraportal transplantation in mice. Whether aPC prevents the onset or development of type 1 diabetes (T1D) is unknown. In this study, when human recombinant aPC was delivered intraperitoneally, twice weekly for 10 weeks (from week 6 to 15) to non-obese diabetic (NOD) mice, a model for T1D, the incidence of diabetes was reduced from 70% (saline control) to 7.6% by 26 weeks of age. Islets of aPC-treated mice exhibited markedly increased expression of insulin, aPC/protein C, endothelial protein C receptor, and matrix metalloproteinase (MMP)-2 when examined by immunostaining. The insulitis score in aPC-treated mice was 50% less than that in control mice. T regulatory cells (Tregs) in the spleen, pancreatic islets, and pancreatic lymph nodes were increased 37, 53, and 59%, respectively, in NOD mice following aPC treatment. These Tregs had potent suppressor function and, after adoptive transfer, delayed diabetes onset in NOD. severe combined immunodeficiency mice. The culture of NOD mouse spleen cells with aPC reduced the secretion of inflammatory cytokines interleukin (IL)-1 beta and interferon-gamma but increased IL-2 and transforming growth factor-beta 1, two cytokines required for Treg differentiation. In summary, our results indicate that aPC prevents T1D in the NOD mouse. The aPC mechanism of action is complex, involving induction of Treg differentiation, inhibition of inflammation, and possibly direct cyto-protective effects on beta cells.	[Xue, Meilang; Dervish, Suat; Jackson, Christopher J.] Univ Sydney, Royal N Shore Hosp, Sutton Arthrit Res Labs, Kolling Inst Med Res, St Leonards, NSW 2065, Australia; [Fulcher, Gregory] Univ Sydney, Royal N Shore Hosp, Dept Diabet Endocrinol & Metab, Kolling Inst Med Res, St Leonards, NSW 2065, Australia; [Harrison, Leonard C.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Walter & Eliza Hall Institute	Xue, ML (corresponding author), Univ Sydney, Royal N Shore Hosp, Sutton Res Lab, Level 10,Kolling Bldg, St Leonards, NSW 2065, Australia.	meilang.xue@sydney.edu.au		Xue, Meilang/0000-0002-8563-7216; Jackson, Christopher/0000-0002-9234-9116	National Health and Medical Research Council; Juvenile Diabetes Research Foundation	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This work was supported by the National Health and Medical Research Council career development award and Juvenile Diabetes Research Foundation (innovative grant).	Adorini L, 2002, TRENDS MOL MED, V8, P31, DOI 10.1016/S1471-4914(01)02193-1; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Contreras JL, 2004, DIABETES, V53, P2804, DOI 10.2337/diabetes.53.11.2804; Eldor R, 2006, P NATL ACAD SCI USA, V103, P5072, DOI 10.1073/pnas.0508166103; Esmon CT, 2004, CRIT CARE MED, V32, pS298, DOI 10.1097/01.CCM.0000126128.64614.81; Feistritzer C, 2006, J IMMUNOL, V176, P1019, DOI 10.4049/jimmunol.176.2.1019; Galligan L, 2001, BRIT J HAEMATOL, V115, P408, DOI 10.1046/j.1365-2141.2001.03187.x; Green EA, 2003, P NATL ACAD SCI USA, V100, P10878, DOI 10.1073/pnas.1834400100; GREY ST, 1994, J IMMUNOL, V153, P3664; Griffin JH, 2006, BLOOD CELL MOL DIS, V36, P211, DOI 10.1016/j.bcmd.2005.12.023; Gruden G, 1997, DIABETES CARE, V20, P424, DOI 10.2337/diacare.20.3.424; HERRON GS, 1986, J BIOL CHEM, V261, P2814; Husari AW, 2010, SHOCK, V33, P467, DOI 10.1097/SHK.0b013e3181c69213; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Itoh T, 2002, J IMMUNOL, V169, P2643, DOI 10.4049/jimmunol.169.5.2643; Jackson C, 2008, EXPERT OPIN BIOL TH, V8, P1109, DOI 10.1517/14712598.8.8.1109 ; Jackson CJ, 2008, INT J BIOCHEM CELL B, V40, P2692, DOI 10.1016/j.biocel.2007.12.013; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Kerschen E, 2010, J CLIN INVEST, V120, P3167, DOI 10.1172/JCI42629; Knoebl Paul N, 2008, Biologics, V2, P285; Lay AJ, 2007, BLOOD, V109, P1984, DOI 10.1182/blood-2006-07-037945; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; Nguyen M, 2000, J BIOL CHEM, V275, P9095, DOI 10.1074/jbc.275.13.9095; Ochs HD, 2005, IMMUNOL REV, V203, P156, DOI 10.1111/j.0105-2896.2005.00231.x; Park L, 2008, ANN NY ACAD SCI, V1150, P177, DOI 10.1196/annals.1447.017; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; TAKEI I, 1992, J AUTOIMMUN, V5, P665, DOI 10.1016/0896-8411(92)90184-R; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; Thakur A, 1998, EXP EYE RES, V67, P9, DOI 10.1006/exer.1998.0480; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; VUKOVICH TC, 1986, DIABETES, V35, P617, DOI 10.2337/diabetes.35.5.617; Whitmont K, 2008, ARCH DERMATOL, V144, P1479, DOI 10.1001/archderm.144.11.1479; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wu J, 2000, Zhonghua Xue Ye Xue Za Zhi, V21, P472; Xue ML, 2007, ARTHRITIS RHEUM-US, V56, P2864, DOI 10.1002/art.22844; Xue ML, 2004, EXP CELL RES, V299, P119, DOI 10.1016/j.yexcr.2004.05.015; Yamenel L, 2005, CRIT CARE, V9, pR184, DOI 10.1186/cc3485; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018	42	28	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2012	287	20					16356	16364		10.1074/jbc.M111.325951	http://dx.doi.org/10.1074/jbc.M111.325951			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	942GB	22447930	Green Published, hybrid			2022-12-27	WOS:000304030900027
J	Romes, EM; Tripathy, A; Slep, KC				Romes, Erin M.; Tripathy, Ashutosh; Slep, Kevin C.			Structure of a Yeast Dyn2-Nup159 Complex and Molecular Basis for Dynein Light Chain-Nuclear Pore Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPORT; SPLICED EXON-B; INTERMEDIATE CHAIN; FUNCTIONAL INTERACTION; ESSENTIAL NUCLEOPORIN; MYOSIN VA; BINDING; ARCHITECTURE; NUP159; DBP5	The nuclear pore complex gates nucleocytoplasmic transport through a massive, eight-fold symmetric channel capped by a nucleoplasmic basket and structurally unique, cytoplasmic fibrils whose tentacles bind and regulate asymmetric traffic. The conserved Nup82 complex, composed of Nsp1, Nup82, and Nup159, forms the unique cytoplasmic fibrils that regulate mRNA nuclear export. Although the nuclear pore complex plays a fundamental, conserved role in nuclear trafficking, structural information about the cytoplasmic fibrils is limited. Here, we investigate the structural and biochemical interactions between Saccharomyces cerevisiae Nup159 and the nucleoporin, Dyn2. We find that Dyn2 is predominantly a homodimer and binds arrayed sites on Nup159, promoting the Nup159 parallel homodimerization. We present the first structure of Dyn2, determined at 1.85 angstrom resolution, complexed with a Nup159 target peptide. Dyn2 resembles homologous metazoan dynein light chains, forming homodimeric composite substrate binding sites that engage two independent 10-residue target motifs, imparting a beta-strand structure to each peptide via antiparallel extension of the Dyn2 core beta-sandwich. Dyn2 recognizes a highly conserved QT motif while allowing sequence plasticity in the flanking residues of the peptide. Isothermal titration calorimetric analysis of the comparative binding of Dyn2 to two Nup159 target sites shows similar affinities (18 and 13 mu M), but divergent thermal binding modes. Dyn2 homodimers are arrayed in the crystal lattice, likely mimicking the arrayed architecture of Dyn2 on the Nup159 multivalent binding sites. Crystallographic interdimer interactions potentially reflect a cooperative basis for Dyn2-Nup159 complex formation. Our data highlight the determinants that mediate oligomerization of the Nup82 complex and promote a directed, elongated cytoplasmic fibril architecture.	[Slep, Kevin C.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Romes, Erin M.; Tripathy, Ashutosh] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Romes, Erin M.] Univ N Carolina, Grad Program Mol Biophys & Biochem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Slep, KC (corresponding author), Univ N Carolina, Dept Biol, 402 Fordham Hall,Campus Box 3280, Chapel Hill, NC 27599 USA.	kslep@bio.unc.edu			National Institutes of Health [1R01GM094415]; March of Dimes [1-FY11-434]; University Research Council, University of North Carolina at Chapel Hill; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); University Research Council, University of North Carolina at Chapel Hill; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01GM094415 (to K. C. S.). This work was also supported by March of Dimes Grant 1-FY11-434 to K. C. S.) and a research grant from the University Research Council, University of North Carolina at Chapel Hill (to K. C. S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Allen NPC, 2002, MOL CELL PROTEOMICS, V1, P930, DOI 10.1074/mcp.T200012-MCP200; Bailer SM, 2000, J BIOL CHEM, V275, P23540, DOI 10.1074/jbc.M001963200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2008, J MOL BIOL, V384, P954, DOI 10.1016/j.jmb.2008.09.083; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Del Priore V, 1997, J CELL SCI, V110, P2987; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003; GORSCH LC, 1995, J CELL BIOL, V129, P939, DOI 10.1083/jcb.129.4.939; Hodge CA, 2011, GENE DEV, V25, P1052, DOI 10.1101/gad.2041611; Hodi Z, 2006, BIOCHEMISTRY-US, V45, P12582, DOI 10.1021/bi060991e; KRAEMER DM, 1995, J BIOL CHEM, V270, P19017, DOI 10.1074/jbc.270.32.19017; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lightcap CM, 2008, J BIOL CHEM, V283, P27314, DOI 10.1074/jbc.M800758200; MAUL GG, 1971, J CELL BIOL, V51, P558, DOI 10.1083/jcb.51.2.558; McCauley SD, 2007, LIFE SCI, V80, P959, DOI 10.1016/j.lfs.2006.11.025; Miller AL, 2004, J BIOL CHEM, V279, P51022, DOI 10.1074/jbc.M409394200; Nyarko A, 2011, BIOPHYS CHEM, V159, P41, DOI 10.1016/j.bpc.2011.05.001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Radnai L, 2010, J BIOL CHEM, V285, P38649, DOI 10.1074/jbc.M110.165894; Rapali P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018818; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003; Stelter P, 2007, NAT CELL BIOL, V9, P788, DOI 10.1038/ncb1604; Stuchell-Brereton MD, 2011, MOL BIOL CELL, V22, P2690, DOI 10.1091/mbc.E11-01-0075; Tcheperegine SE, 1999, J BIOL CHEM, V274, P5252, DOI 10.1074/jbc.274.8.5252; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Wagner W, 2006, BIOCHEMISTRY-US, V45, P11564, DOI 10.1021/bi061142u; Wang WN, 2003, J BIOL CHEM, V278, P41491, DOI 10.1074/jbc.M307118200; Weirich CS, 2004, MOL CELL, V16, P749, DOI 10.1016/j.molcel.2004.10.032; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Yoshida K, 2011, P NATL ACAD SCI USA, V108, P16571, DOI 10.1073/pnas.1112846108	42	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 4	2012	287	19					15862	15873		10.1074/jbc.M111.336172	http://dx.doi.org/10.1074/jbc.M111.336172			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941YS	22411995	hybrid, Green Published			2022-12-27	WOS:000304006300065
J	Auton, M; Sowa, KE; Behymer, M; Cruz, MA				Auton, Matthew; Sowa, Katie E.; Behymer, Molly; Cruz, Miguel A.			N-terminal Flanking Region of A1 Domain in von Willebrand Factor Stabilizes Structure of A1A2A3 Complex and Modulates Platelet Activation under Shear Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE GLYCOPROTEIN-IB; VONWILLEBRAND-FACTOR; FACTOR VWF; CONFORMATIONAL-CHANGE; ADAMTS-13 ACTIVITY; BINDING DOMAIN; A3 DOMAIN; A2 DOMAIN; COLLAGEN; RESIDUES	von Willebrand factor (vWF) mediates platelet adhesion and thrombus formation via its interaction with the platelet receptor glycoprotein (GP)Ib alpha. We have analyzed two A1A2A3 tri-domain proteins to demonstrate that the amino acid sequence, Gln(1238)-Glu(1260), in the N-terminal flanking region of the A1 domain, together with the association between the A domains, modulates vWF-GPIb alpha binding and platelet activation under shear stress. Using circular dichroism spectroscopy and differential scanning calorimetry, we have described that sequence Gln(1238)-Glu(1260) stabilizes the structural conformation of the A1A2A3 tri-domain complex. The structural stabilization imparted by this particular region inhibits the binding capacity of the tri-domain protein for GPIb alpha. Deletion of this region causes a conformational change in the A1 domain that increases binding to GPIb alpha. Only the truncated protein was capable of effectively blocking ristocetin-induced platelet agglutination. To determine the capacity of activating platelets via the interaction with GPIb alpha, whole blood was incubated with the N-terminal region truncated or intact tri-A domain protein prior to perfusion over a fibrin( ogen)-coated surface. At a high shear rate of 1,500 s(-1), platelets from blood containing the truncated protein rapidly bound, covering >90% of the fibrin(ogen) surface area, whereas the intact tri-A domain protein induced platelets to bind <10%. The results obtained in this study ascertain the relevant role of the structural association between the N-terminal flanking region of the A1 domain (amino acids Gln(1238)-Glu(1260)) and the A1A2A3 domain complex in preventing vWF to bind spontaneously to GPIb alpha in solution under high shear forces.	[Auton, Matthew; Sowa, Katie E.; Behymer, Molly; Cruz, Miguel A.] Baylor Coll Med, Cardiovasc Res Sect, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine	Cruz, MA (corresponding author), Baylor Coll Med, Cardiovasc Res Sect, Dept Med, 1 Baylor Plaza,N1319, Houston, TX 77030 USA.	miguelc@bcm.edu	Auton, Matthew/A-2960-2008	Auton, Matthew/0000-0002-4446-6932	National Institutes of Health [HL72886, HL109109]; Mary Gibson Foundation; Alkek Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072886, R01HL109109] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary Gibson Foundation; Alkek Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL72886 (to M. A. C.) and HL109109 (to M. A.). This work was also supported by the Mary Gibson Foundation and the Alkek Foundation.	Auton M, 2007, J MOL BIOL, V366, P986, DOI 10.1016/j.jmb.2006.10.067; Auton M, 2010, BIOPHYS J, V99, P1192, DOI 10.1016/j.bpj.2010.06.002; Auton M, 2010, J BIOL CHEM, V285, P22829, DOI 10.1074/jbc.M110.103358; AZUMA H, 1993, THROMB HAEMOSTASIS, V69, P192; Bonnefoy A, 2006, J THROMB HAEMOST, V4, P2151, DOI 10.1111/j.1538-7836.2006.02111.x; BONTHRON DT, 1986, NATURE, V324, P270, DOI 10.1038/324270a0; CHRISTOPHE O, 1991, BLOOD, V78, P2310; CRUZ MA, 1993, J BIOL CHEM, V268, P21238; Cruz MA, 2000, J BIOL CHEM, V275, P19098, DOI 10.1074/jbc.M002292200; Cruz MA, 2005, BLOOD, V105, P1986, DOI 10.1182/blood-2004-04-1365; Cruz MA, 2003, THROMB HAEMOSTASIS, V90, P1204, DOI 10.1160/TH03-06-0398; CRUZ MA, 1995, J BIOL CHEM, V270, P10822, DOI 10.1074/jbc.270.18.10822; DENT JA, 1990, P NATL ACAD SCI USA, V87, P6306, DOI 10.1073/pnas.87.16.6306; ENDENBURG SC, 1995, BLOOD, V86, P4158, DOI 10.1182/blood.V86.11.4158.bloodjournal86114158; Federici AB, 2009, BLOOD, V113, P526, DOI 10.1182/blood-2008-04-152280; Fu XY, 2011, BLOOD, V118, P5283, DOI 10.1182/blood-2011-01-331074; FUJIMURA Y, 1991, BLOOD, V77, P113; GIRMA JP, 1990, THROMB HAEMOSTASIS, V64, P326; Lankhof H, 1996, THROMB HAEMOSTASIS, V75, P950; Martin C, 2007, J THROMB HAEMOST, V5, P1363, DOI 10.1111/j.1538-7836.2007.02536.x; MATSUSHITA T, 1995, J BIOL CHEM, V270, P13406, DOI 10.1074/jbc.270.22.13406; MOHRI H, 1988, J BIOL CHEM, V263, P17901; Morales LD, 2006, J THROMB HAEMOST, V4, P417, DOI 10.1111/j.1538-7836.2006.01742.x; Nakayama T, 2002, J BIOL CHEM, V277, P22063, DOI 10.1074/jbc.M201327200; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; Shankaran H, 2003, BLOOD, V101, P2637, DOI 10.1182/blood-2002-05-1550; SUGIMOTO M, 1993, J BIOL CHEM, V268, P12185; Ulrichts H, 2006, J BIOL CHEM, V281, P4699, DOI 10.1074/jbc.M513314200; VERWEIJ CL, 1986, EMBO J, V5, P1839, DOI 10.1002/j.1460-2075.1986.tb04435.x; Whitelock JL, 2004, J THROMB HAEMOST, V2, P485, DOI 10.1111/j.1538-7836.2004.00601.x; Wu T, 2010, BLOOD, V115, P370, DOI 10.1182/blood-2009-03-210369; Zaidi TN, 1996, BLOOD, V88, P2967, DOI 10.1182/blood.V88.8.2967.bloodjournal8882967	33	34	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14579	14585		10.1074/jbc.M112.348573	http://dx.doi.org/10.1074/jbc.M112.348573			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22431729	hybrid, Green Published			2022-12-27	WOS:000304003200024
J	Sontag, JM; Nunbhakdi-Craig, V; White, CL; Halpain, S; Sontag, E				Sontag, Jean-Marie; Nunbhakdi-Craig, Viyada; White, Charles L., III; Halpain, Shelley; Sontag, Estelle			The Protein Phosphatase PP2A/B alpha Binds to the Microtubule-associated Proteins Tau and MAP2 at a Motif Also Recognized by the Kinase Fyn IMPLICATIONS FOR TAUOPATHIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; HYPERPHOSPHORYLATED-TAU; PHOSPHORYLATION STATE; CATALYTIC SUBUNIT; DOWN-REGULATION; 2A; BRAIN; ALPHA; EXPRESSION; ENZYME	The predominant brain microtubule-associated proteins MAP2 and tau play a critical role in microtubule cytoskeletal organization and function. We have previously reported that PP2A/B alpha, a major protein phosphatase 2A (PP2A) holoenzyme, binds to and dephosphorylates tau, and regulates microtubule stability. Here, we provide evidence that MAP2 co-purifies with and is dephosphorylated by endogenous PP2A/B alpha in bovine gray matter. It co-localizes with PP2A/B alpha in immature and mature human neuronal cell bodies. PP2A co-immunoprecipitates with and directly interacts with MAP2. Using in vitro binding assays, we show that PP2A/B alpha binds to MAP2c isoforms through a region encompassing the microtubule-binding domain and upstream proline-rich region. Tau and MAP2 compete for binding to and dephosphorylation by PP2A/B alpha. Remarkably, the protein-tyrosine kinase Fyn, which binds to the proline-rich RTPPKSP motif conserved in both MAP2 and tau, inhibits the interaction of PP2A/B alpha with either tau or MAP2c. The corresponding synthetic RTPPKSP peptide, but not the phosphorylated RpTPPKSP version, competes with Tau and MAP2c for binding to PP2A/B alpha. Significantly, down-regulation of PP2A/B alpha and deregulation of Fyn-Tau protein interactions have been linked to enhanced tau phosphorylation in Alzheimer disease. Together, our results suggest that PP2A/B alpha is part of segregated MAP2 and tau signaling scaffolds that can coordinate the action of key kinases and phosphatases involved in modulating neuronal plasticity. Deregulation of these compartmentalized multifunctional protein complexes is likely to contribute to tau deregulation, microtubule disruption, and altered signaling in tauopathies.	[Sontag, Jean-Marie; Sontag, Estelle] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Sontag, Jean-Marie; Nunbhakdi-Craig, Viyada; White, Charles L., III; Sontag, Estelle] UT SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; [Halpain, Shelley] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92037 USA	University of Newcastle; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego	Sontag, E (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia.	Estelle.Sontag@newcastle.edu.au	White, Charles L/AAJ-1858-2021; SONTAG, ESTELLE/AAE-9805-2020	White, Charles L/0000-0002-3870-2804; 	National Institutes of Health [AG18883]; French Foundation for Alzheimer research [AG12300, MH50861]; NHMRC Australia; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH050861, R01MH087823, R01MH050861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018883, P30AG012300, R56AG018883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Foundation for Alzheimer research; NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grants AG18883 (to E. S.), French Foundation for Alzheimer research (to E. S.), AG12300 (to E. S. and C. W.) and MH50861 (to S. H.), and NHMRC Australia grant (to E. S. and J. M. S.).	Alexa A, 2002, BIOCHEMISTRY-US, V41, P12427, DOI 10.1021/bi025916s; Arendt T, 2001, NEUROSCIENCE, V102, P723, DOI 10.1016/S0306-4522(00)00516-9; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; DEANCOS JG, 1993, BIOCHEM J, V296, P351, DOI 10.1042/bj2960351; Dehmelt L, 2005, GENOME BIOL, V6; Eidenmuller J, 2000, BIOCHEMISTRY-US, V39, P13166, DOI 10.1021/bi001290z; Eidenmuller J, 2001, BIOCHEM J, V357, P759, DOI 10.1042/0264-6021:3570759; Evan BJ, 2008, BIOCHEM BIOPH RES CO, V377, P1067, DOI 10.1016/j.bbrc.2008.10.108; Fan QW, 2002, J NEUROCHEM, V80, P178, DOI 10.1046/j.0022-3042.2001.00686.x; Farah CA, 2008, CELL MOTIL CYTOSKEL, V65, P515, DOI 10.1002/cm.20284; Goedert M, 2000, J NEUROCHEM, V75, P2155, DOI 10.1046/j.1471-4159.2000.0752155.x; GOEDERT M, 1995, J NEUROCHEM, V65, P2804; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Gong CX, 2000, BRAIN RES, V853, P299, DOI 10.1016/S0006-8993(99)02294-5; Gotz J, 2006, J NEUROCHEM, V98, P993, DOI 10.1111/j.1471-4159.2006.03955.x; Hiraga A, 2000, BIOCHEM J, V346, P433, DOI 10.1042/0264-6021:3460433; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Iqbal K, 2008, J ALZHEIMERS DIS, V14, P365; Ittner A, 2011, IUBMB LIFE, V63, P495, DOI 10.1002/iub.467; JOLY JC, 1989, J CELL BIOL, V109, P2289, DOI 10.1083/jcb.109.5.2289; KIM H, 1979, J CELL BIOL, V80, P266, DOI 10.1083/jcb.80.2.266; Landrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021521; Lee G, 1998, J CELL SCI, V111, P3167; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; Lim RWL, 2000, J BIOL CHEM, V275, P20578, DOI 10.1074/jbc.M001887200; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; MUMBY MC, 1987, J BIOL CHEM, V262, P6257; Nunbhakdi-Craig V, 2002, J CELL BIOL, V158, P967, DOI 10.1083/jcb.200206114; Nunbhakdi-Craig V, 2007, J NEUROCHEM, V101, P959, DOI 10.1111/j.1471-4159.2007.04503.x; Ogris E, 1997, ONCOGENE, V15, P911, DOI 10.1038/sj.onc.1201259; Reynolds CH, 2008, J BIOL CHEM, V283, P18177, DOI 10.1074/jbc.M709715200; Roger B, 2004, CURR BIOL, V14, P363, DOI 10.1016/j.cub.2004.01.058; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; Sanchez C, 1996, EUR J BIOCHEM, V241, P765, DOI 10.1111/j.1432-1033.1996.00765.x; Sanchez M. C., 1998, NEUROSCIENCE, V87, P861; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; SONTAG E, 1995, J CELL BIOL, V128, P1131, DOI 10.1083/jcb.128.6.1131; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P287, DOI 10.1093/jnen/63.4.287; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P1080, DOI 10.1093/jnen/63.10.1080; Sontag JM, 2008, J NEUROSCI, V28, P11477, DOI 10.1523/JNEUROSCI.2816-08.2008; Sontag JM, 2010, J NEUROCHEM, V115, P1455, DOI 10.1111/j.1471-4159.2010.07049.x; SURRIDGE CD, 1994, BIOCHEMISTRY-US, V33, P8051, DOI 10.1021/bi00192a009; Turowski P, 1997, EUR J BIOCHEM, V248, P200, DOI 10.1111/j.1432-1033.1997.t01-1-00200.x; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Zamora-Leon SP, 2001, J BIOL CHEM, V276, P39950, DOI 10.1074/jbc.M107807200	52	56	57	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14984	14993		10.1074/jbc.M111.338681	http://dx.doi.org/10.1074/jbc.M111.338681			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22403409	hybrid, Green Published			2022-12-27	WOS:000304003200060
J	Xie, CQ; Guo, YH; Zhu, TQ; Zhang, JF; Ma, PX; Chen, YE				Xie, Changqing; Guo, Yanhong; Zhu, Tianqing; Zhang, Jifeng; Ma, Peter X.; Chen, Y. Eugene			Yap1 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; ORGAN SIZE CONTROL; GENE-EXPRESSION; HIPPO PATHWAY; ALPHA-ACTIN; CARDIOMYOCYTE PROLIFERATION; DIFFERENTIATION; GROWTH; TRANSCRIPTION; INHIBITION	The Hippo-Yap (Yes-associated protein) signaling pathway has emerged as one of the critical pathways regulating cell proliferation, differentiation, and apoptosis in response to environmental and developmental cues. However, Yap1 roles in vascular smooth muscle cell (VSMC) biology have not been investigated. VSMCs undergo phenotypic switch, a process characterized by decreased gene expression of VSMC contractile markers and increased proliferation, migration, and matrix synthesis. The goals of the present studies were to investigate the relationship between Yap1 and VSMC phenotypic switch and to determine the molecular mechanisms by which Yap1 affects this essential process in VSMC biology. Results demonstrated that the expression of Yap1 was rapidly up-regulated by stimulation with PDGF-BB (a known inducer of phenotypic switch in VSMCs) and in the injured vessel wall. Knockdown of Yap1 impaired VSMC proliferation in vitro and enhanced the expression of VSMC contractile genes as well by increasing serum response factor binding to CArG-containing regions of VSMC-specific contractile genes within intact chromatin. Conversely, the interaction between serum response factor and its co-activator myocardin was reduced by overexpression of Yap1 in a dose-dependent manner. Taken together, these results indicate that down-regulation of Yap1 promotes VSMC contractile phenotype by both up-regulating myocardin expression and promoting the association of the serum response factor-myocardin complex with VSMC contractile gene promoters and suggest that the Yap1 signaling pathway is a central regulator of phenotypic switch of VSMCs.	[Chen, Y. Eugene] Univ Michigan, Med Ctr, Dept Internal Med, Cardiovasc Ctr, Ann Arbor, MI 48109 USA; [Ma, Peter X.] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chen, YE (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Cardiovasc Ctr, MSRB 3 7200,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	echenum@umich.edu	Guo, Yanhong/D-9764-2012; X, Peter/E-4895-2011; GUO, Yanhong/B-5325-2012		National Institutes of Health [HL105114, HL068878, HL89544]; American Heart Association [0835237N, 09SDG2260023, 0840025N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105114, R01HL068878, R01HL089544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL105114, HL068878, and HL89544 (to Y. E. C.).; Supported by American Heart Association National Career Development Grants 0835237N (to J. Z.) and 09SDG2260023 (to C. X.).; An American Heart Association Established Investigator (Grant 0840025N).	Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chang DF, 2003, DEV CELL, V4, P107, DOI 10.1016/S1534-5807(02)00396-9; Chen J, 2011, ARTERIOSCL THROM VAS, V31, P368, DOI 10.1161/ATVBAHA.110.218149; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Chen LM, 2010, PROTEIN CELL, V1, P1073, DOI 10.1007/s13238-010-0138-3; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Fan YB, 2011, J BIOL CHEM, V286, P40584, DOI 10.1074/jbc.M111.232918; Faxon DP, 1997, PROG CARDIOVASC DIS, V40, P129, DOI 10.1016/S0033-0620(97)80005-9; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Gan Q, 2007, CIRC RES, V101, P883, DOI 10.1161/CIRCRESAHA.107.154831; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hendrix JA, 2005, J CLIN INVEST, V115, P418, DOI 10.1172/JCI200522648; HOLYCROSS BJ, 1992, CIRC RES, V71, P1525, DOI 10.1161/01.RES.71.6.1525; Huang HR, 2010, J BIOL CHEM, V285, P9383, DOI [10.1074/jbc.M110.101543, 10.1074/jbc.M109.095612]; Itoh S, 2001, J MOL CELL CARDIOL, V33, P95, DOI 10.1006/jmcc.2000.1279; JAWIEN A, 1992, J CLIN INVEST, V89, P507, DOI 10.1172/JCI115613; Kawai-Kowase K, 2005, MOL CELL BIOL, V25, P8009, DOI 10.1128/MCB.25.18.8009-8023.2005; Kim S, 1997, MOL CELL BIOL, V17, P2266, DOI 10.1128/MCB.17.4.2266; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Mack CP, 2011, ARTERIOSCL THROM VAS, V31, P1495, DOI 10.1161/ATVBAHA.110.221135; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; McDonald OG, 2007, CIRC RES, V100, P1428, DOI 10.1161/01.RES.0000266448.30370.a0; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Nishida W, 2002, J BIOL CHEM, V277, P7308, DOI 10.1074/jbc.M111824200; Ono H, 2005, ARTERIOSCL THROM VAS, V25, P1871, DOI 10.1161/01.ATV.0000174588.50971.1a; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Rensen SSM, 2006, CARDIOVASC RES, V70, P136, DOI 10.1016/j.cardiores.2005.12.018; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Staley BK, 2010, CURR BIOL, V20, P1580, DOI 10.1016/j.cub.2010.07.041; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Swartz EA, 1998, AM J PHYSIOL-CELL PH, V275, pC608, DOI 10.1152/ajpcell.1998.275.2.C608; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang XB, 2010, J BIOL CHEM, V285, P23239, DOI 10.1074/jbc.M109.084673; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Xie CQ, 2009, STEM CELLS DEV, V18, P741, DOI 10.1089/scd.2008.0179; Xie CQ, 2011, ARTERIOSCL THROM VAS, V31, P1485, DOI 10.1161/ATVBAHA.110.221101; Xie CQ, 2011, STEM CELLS DEV, V20, P205, DOI 10.1089/scd.2010.0283; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yoshida T, 2004, CIRC RES, V94, P1075, DOI 10.1161/01.RES.0000125622.46280.95; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zhou JL, 2005, MOL CELL BIOL, V25, P9874, DOI 10.1128/MCB.25.22.9874-9885.2005	62	75	87	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14598	14605		10.1074/jbc.M111.329268	http://dx.doi.org/10.1074/jbc.M111.329268			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22411986	Green Published, hybrid			2022-12-27	WOS:000304003200026
J	Zanou, N; Schakman, O; Louis, P; Ruegg, UT; Dietrich, A; Birnbaumer, L; Gailly, P				Zanou, Nadege; Schakman, Olivier; Louis, Pierre; Ruegg, Urs T.; Dietrich, Alexander; Birnbaumer, Lutz; Gailly, Philippe			Trpc1 Ion Channel Modulates Phosphatidylinositol 3-Kinase/Akt Pathway during Myoblast Differentiation and Muscle Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; CELL-CYCLE ARREST; HELIX-LOOP-HELIX; SKELETAL-MUSCLE; MYOGENIN EXPRESSION; IGF-I; MYOD; ACTIVATION; HYPERTROPHY; TARGET	We previously showed in vitro that calcium entry through Trpc1 ion channels regulates myoblast migration and differentiation. In the present work, we used primary cell cultures and isolated muscles from Trpc1(-/-) and Trpc1(+/+) murine model to investigate the role of Trpc1 in myoblast differentiation and in muscle regeneration. In these models, we studied regeneration consecutive to cardiotoxin-induced muscle injury and observed a significant hypotrophy and a delayed regeneration in Trpc1(-/-) muscles consisting in smaller fiber size and increased proportion of centrally nucleated fibers. This was accompanied by a decreased expression of myogenic factors such as MyoD, Myf5, and myogenin and of one of their targets, the developmental MHC (MHCd). Consequently, muscle tension was systematically lower in muscles from Trpc1(-/-) mice. Importantly, the PI3K/Akt/mTOR/p70S6K pathway, which plays a crucial role in muscle growth and regeneration, was down-regulated in regenerating Trpc1(-/-) muscles. Indeed, phosphorylation of both Akt and p70S6K proteins was decreased as well as the activation of PI3K, the main upstream regulator of the Akt. This effect was independent of insulin-like growth factor expression. Akt phosphorylation also was reduced in Trpc1(-/-) primary myoblasts and in control myoblasts differentiated in the absence of extracellular Ca2+ or pretreated with EGTA-AM or wortmannin, suggesting that the entry of Ca2+ through Trpc1 channels enhanced the activity of PI3K. Our results emphasize the involvement of Trpc1 channels in skeletal muscle development in vitro and in vivo, and identify a Ca2+-dependent activation of the PI3K/Akt/mTOR/p70S6K pathway during myoblast differentiation and muscle regeneration.	[Zanou, Nadege; Schakman, Olivier; Louis, Pierre; Gailly, Philippe] Catholic Univ Louvain, Lab Cell Physiol, Inst Neurosci, B-1200 Brussels, Belgium; [Ruegg, Urs T.] Univ Geneva, Geneva Lausanne Sch Pharmaceut Sci, Pharmacol Lab, CH-1211 Geneva 4, Switzerland; [Dietrich, Alexander] Univ Munich, Walther Straub Inst Pharmakol & Toxikol, D-80336 Munich, Germany; [Birnbaumer, Lutz] Natl Inst Environm Hlth Sci, Neurobiol Lab, Res Triangle Pk, NC 27709 USA	Universite Catholique Louvain; University of Geneva; University of Munich; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Zanou, N (corresponding author), Catholic Univ Louvain, Lab Cell Physiol, Inst Neurosci, 55-40 Av Hippocrate, B-1200 Brussels, Belgium.	nadege.zanou@uclouvain.be; philippe.gailly@uclouvain.be	Dietrich, Alexander/G-8619-2013	Dietrich, Alexander/0000-0002-1168-8707; RUEGG, Urs/0000-0001-6078-8280	National Institutes of Health [Z01-101684]; Association francaise contre les myopathies; Association Belge contre les Maladies Neuro-musculaires; General Direction of Scientific Research of the French Community of Belgium [ARC 10/15-029]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association francaise contre les myopathies(Association Francaise contre les Myopathies); Association Belge contre les Maladies Neuro-musculaires; General Direction of Scientific Research of the French Community of Belgium; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health Z01-101684 (to L. B.). This work was also supported by the "Association francaise contre les myopathies", the "Association Belge contre les Maladies Neuro-musculaires", by Grant ARC 10/15-029 from the General Direction of Scientific Research of the French Community of Belgium.	Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Alessi DR, 1998, BBA-MOL CELL BIOL L, V1436, P151, DOI 10.1016/S0005-2760(98)00133-7; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Bergstrom DA, 2001, MOL CELL BIOL, V21, P2404, DOI 10.1128/MCB.21.7.2404-2412.2001; Beylkin DH, 2006, DEV BIOL, V294, P541, DOI 10.1016/j.ydbio.2006.02.049; Bijlenga P, 2000, P NATL ACAD SCI USA, V97, P7627, DOI 10.1073/pnas.97.13.7627; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Dietrich A, 2007, PFLUG ARCH EUR J PHY, V455, P465, DOI 10.1007/s00424-007-0314-3; Fernandez AM, 2002, J CLIN INVEST, V109, P347, DOI 10.1172/JCI200213503; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Gailly P, 1996, J PHYSIOL-LONDON, V491, P635, DOI 10.1113/jphysiol.1996.sp021245; Gavard J, 2004, J BIOL CHEM, V279, P36795, DOI 10.1074/jbc.M401705200; Gilson H, 2007, ENDOCRINOLOGY, V148, P452, DOI 10.1210/en.2006-0539; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; Glass DJ, 2010, CURR TOP MICROBIOL, V346, P267, DOI 10.1007/82_2010_78; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; LeRoith D, 2000, ENDOCRINOLOGY, V141, P1287, DOI 10.1210/en.141.4.1287; Louis M, 2004, FEBS LETT, V557, P243, DOI 10.1016/S0014-5793(03)01504-7; Louis M, 2008, J CELL SCI, V121, P3951, DOI 10.1242/jcs.037218; LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465; Ma R, 2003, J BIOL CHEM, V278, P52763, DOI 10.1074/jbc.M309610200; MARECHAL G, 1993, PFLUG ARCH EUR J PHY, V424, P478, DOI 10.1007/BF00374911; MERRITT JE, 1989, J BIOL CHEM, V264, P1522; Miyabara EH, 2010, MUSCLE NERVE, V42, P778, DOI 10.1002/mus.21754; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; OTT MO, 1991, DEVELOPMENT, V111, P1097; PRZYBYLSKI RJ, 1994, CELL CALCIUM, V15, P132, DOI 10.1016/0143-4160(94)90052-3; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; SASSOON D, 1989, NATURE, V341, P303, DOI 10.1038/341303a0; Schakman O, 2008, ENDOCRINOLOGY, V149, P3900, DOI 10.1210/en.2008-0439; SCHMID A, 1984, J BIOL CHEM, V259, P1366; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Sun LG, 2004, J CELL SCI, V117, P3021, DOI 10.1242/jcs.01142; TAPSCOTT SJ, 1990, ADV EXP MED BIOL, V280, P3; Vernon AE, 2003, DEVELOPMENT, V130, P71, DOI 10.1242/dev.00180; WEINTRAUB H, 1990, P NATL ACAD SCI USA, V87, P5623, DOI 10.1073/pnas.87.15.5623; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Whitehead JP, 2000, CURR OPIN CELL BIOL, V12, P222, DOI 10.1016/S0955-0674(99)00079-4; Wilson EM, 2007, J BIOL CHEM, V282, P5106, DOI 10.1074/jbc.C600315200; Wilson EM, 2006, J BIOL CHEM, V281, P29962, DOI 10.1074/jbc.M605445200; Wilson EM, 2004, MOL BIOL CELL, V15, P497, DOI 10.1091/mbc.E03-05-0351; Wilson EM, 2003, J BIOL CHEM, V278, P41109, DOI 10.1074/jbc.C300299200; Xu Q, 2000, J BIOL CHEM, V275, P36750, DOI 10.1074/jbc.M005030200; Zanou N, 2010, AM J PHYSIOL-CELL PH, V298, pC149, DOI 10.1152/ajpcell.00241.2009	50	48	48	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 27	2012	287	18					14524	14534		10.1074/jbc.M112.341784	http://dx.doi.org/10.1074/jbc.M112.341784			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941XU	22399301	Green Published, hybrid			2022-12-27	WOS:000304003200019
J	Wang, YF; Li, SJ; Wu, XY; Che, YZ; Li, Q				Wang, Yifan; Li, Shu Jie; Wu, Xingye; Che, Yongzhe; Li, Qiang			Clinicopathological and Biological Significance of Human Voltage-gated Proton Channel Hv1 Protein Overexpression in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALVEOLAR EPITHELIAL-CELLS; CARBOXYL-TERMINAL DOMAIN; VACUOLAR H+-ATPASE; INTRACELLULAR PH; NADPH OXIDASE; ACIDIC PH; HUMAN-NEUTROPHILS; PUMP INHIBITORS; HUMAN-MELANOMA; GROWTH	In our previous work, we showed for the first time that the voltage-gated proton channel Hv1 is specifically expressed in highly metastatic human breast tumor tissues and cell lines. However, the contribution of Hv1 to breast carcinogenesis is not well known. In this study, we showed that Hv1 expression was significantly correlated with the tumor size (p = 0.001), tumor classification (p = 0.000), lymph node status (p = 0.000), clinical stage (p = 0.000), and Her-2 status (p = 0.045). High Hv1 expression was associated significantly with shorter overall (p = 0.000) and recurrence-free survival (p = 0.000). In vitro, knockdown of Hv1 expression in the highly metastatic MDA-MB-231 cells decreased the cell proliferation and invasiveness, inhibited the cell proton secretion and intracellular pH recovery, and blocked the cell capacity of acidifying extracellular milieu. Furthermore, the gelatinase activity in MDA-MB-231 cells that suppressed Hv1 was reduced. In vivo, the breast tumor size of the implantation of the MDA-MB-231 xenografts in nude mice that were knocked down by Hv1 was dramatically smaller than that in the control groups. The results demonstrated that the inhibition of Hv1 function via knockdown of Hv1 expression can effectively retard the cancer growth and suppress the cancer metastasis by the decrease of proton extrusion and the down-regulation of gelatinase activity. Based on these results, we came to the conclusion that Hv1 is a potential biomarker for prognosis of breast cancer and a potential target for anticancer drugs in breast cancer therapy.	[Wang, Yifan; Li, Shu Jie; Li, Qiang] Nankai Univ, Sch Phys Sci, Minist Educ, Key Lab Bioact Mat, Tianjin 300071, Peoples R China; [Wu, Xingye] Tonghua Cent Hosp, Dept Pathol, Tonghua 134000, Peoples R China; [Che, Yongzhe] Nankai Univ, Sch Med, Minist Educ, Key Lab Bioact Mat, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Li, SJ (corresponding author), Nankai Univ, Sch Phys Sci, Minist Educ, Key Lab Bioact Mat, 94 Weijin Rd, Tianjin 300071, Peoples R China.	shujieli@nankai.edu.cn; cheli@nankai.edu.cn			National Natural Science Foundation of China [30970579]; National Laboratory for Oncogenes and Related Genes, WHO Collaborating Center for Research on Cancer, Shanghai Cancer Institute, Shanghai Jiao Tong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Laboratory for Oncogenes and Related Genes, WHO Collaborating Center for Research on Cancer, Shanghai Cancer Institute, Shanghai Jiao Tong University	This work was supported by National Natural Science Foundation of China Grant 30970579.; We are deeply grateful to Prof. Wenxin Qin, National Laboratory for Oncogenes and Related Genes, WHO Collaborating Center for Research on Cancer, Shanghai Cancer Institute, Shanghai Jiao Tong University, for supporting and encouraging the research and many useful discussions on the manuscript.	CHAMBARD JC, 1986, EXP CELL RES, V164, P282, DOI 10.1016/0014-4827(86)90029-7; Cherny VV, 1999, J GEN PHYSIOL, V114, P819, DOI 10.1085/jgp.114.6.819; CHERNY VV, 1995, J GEN PHYSIOL, V105, P861, DOI 10.1085/jgp.105.6.861; Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470; CLARK RA, 1987, J BIOL CHEM, V262, P4065; De Milito A, 2007, CANCER RES, V67, P5408, DOI 10.1158/0008-5472.CAN-06-4095; De Milito A, 2010, INT J CANCER, V127, P207, DOI 10.1002/ijc.25009; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DECOURSEY TE, 1994, J MEMBRANE BIOL, V141, P203; Fais S, 2010, J INTERN MED, V267, P515, DOI 10.1111/j.1365-2796.2010.02225.x; Fais S, 2007, CANCER RES, V67, P10627, DOI 10.1158/0008-5472.CAN-07-1805; Fasciglione GF, 2000, BIOPHYS J, V79, P2138, DOI 10.1016/S0006-3495(00)76461-7; Gatenby RA, 2003, CANCER RES, V63, P3847; Giannelli G, 2002, HISTOL HISTOPATHOL, V17, P339, DOI 10.14670/HH-17.339; GILLIES RJ, 1994, AM J PHYSIOL, V267, pC195, DOI 10.1152/ajpcell.1994.267.1.C195; GILLIES RJ, 1991, J BIOL CHEM, V266, P1551; GOTTLIEB RA, 1995, P NATL ACAD SCI USA, V92, P5965, DOI 10.1073/pnas.92.13.5965; GRIFFITHS JR, 1991, BRIT J CANCER, V64, P425, DOI 10.1038/bjc.1991.326; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; Henderson LM, 1997, BIOCHEM J, V325, P701, DOI 10.1042/bj3250701; Johnson LL, 2000, J BIOL CHEM, V275, P11026, DOI 10.1074/jbc.275.15.11026; Koch HP, 2008, P NATL ACAD SCI USA, V105, P9111, DOI 10.1073/pnas.0801553105; Lee SY, 2008, P NATL ACAD SCI USA, V105, P7692, DOI 10.1073/pnas.0803277105; Li SJ, 2010, J BIOL CHEM, V285, P12047, DOI 10.1074/jbc.M109.040360; Li SJ, 2009, ACTA CRYSTALLOGR F, V65, P279, DOI 10.1107/S1744309109003777; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu YD, 2005, CANCER RES, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; MartinezZaguilan R, 1996, CLIN EXP METASTAS, V14, P176, DOI 10.1007/BF00121214; MONTCOURRIER P, 1994, J CELL SCI, V107, P2381; Montcourrier P, 1997, CLIN EXP METASTAS, V15, P382, DOI 10.1023/A:1018446104071; Morgan D, 2005, J PHYSIOL-LONDON, V569, P419, DOI 10.1113/jphysiol.2005.094748; Nilsson Cathrine, 2003, Methods Cell Sci, V25, P185; PERONA R, 1988, NATURE, V334, P438, DOI 10.1038/334438a0; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; RACKER E, 1972, AM SCI, V60, P56; Raghunand N, 1999, BIOCHEM PHARMACOL, V57, P1047, DOI 10.1016/S0006-2952(99)00021-0; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; ROZHIN J, 1994, CANCER RES, V54, P6517; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; SCHLAPPACK OK, 1991, BRIT J CANCER, V64, P663, DOI 10.1038/bjc.1991.378; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Wang YF, 2011, BIOCHEM BIOPH RES CO, V412, P353, DOI 10.1016/j.bbrc.2011.07.102; Yeo M, 2004, CLIN CANCER RES, V10, P8687, DOI 10.1158/1078-0432.CCR-04-1065	45	78	79	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 20	2012	287	17					13877	13888		10.1074/jbc.M112.345280	http://dx.doi.org/10.1074/jbc.M112.345280			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	941VZ	22367212	Green Published, hybrid			2022-12-27	WOS:000303996300043
J	Liang, FC; Bageshwar, UK; Musser, SM				Liang, Fu-Cheng; Bageshwar, Umesh K.; Musser, Siegfried M.			Position-dependent Effects of Polylysine on Sec Protein Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI SECA; PROTON-MOTIVE FORCE; BACTERIAL CYTOPLASMIC MEMBRANE; PREPROTEIN TRANSLOCATION; CHARGED RESIDUES; CATALYTIC CYCLE; CHAPERONE SECB; CROSS-LINKING; ATP BINDING; IN-VITRO	The bacterial Sec protein translocation system catalyzes the transport of unfolded precursor proteins across the cytoplasmic membrane. Using a recently developed real time fluorescence-based transport assay, the effects of the number and distribution of positive charges on the transport time and transport efficiency of proOmpA were examined. As expected, an increase in the number of lysine residues generally increased transport time and decreased transport efficiency. However, the observed effects were highly dependent on the polylysine position in the mature domain. In addition, a string of consecutive positive charges generally had a more significant effect on transport time and efficiency than separating the charges into two or more charged segments. Thirty positive charges distributed throughout the mature domain resulted in effects similar to 10 consecutive charges near the N terminus of the mature domain. These data support a model in which the local effects of positive charge on the translocation kinetics dominate over total thermodynamic constraints. The rapid translocation kinetics of some highly charged proOmpA mutants suggest that the charge is partially shielded from the electric field gradient during transport, possibly by the co-migration of counter ions. The transport times of precursors with multiple positively charged sequences, or "pause sites," were fairly well predicted by a local effect model. However, the kinetic profile predicted by this local effect model was not observed. Instead, the transport kinetics observed for precursors with multiple polylysine segments support a model in which translocation through the SecYEG pore is not the rate-limiting step of transport.	[Liang, Fu-Cheng; Bageshwar, Umesh K.; Musser, Siegfried M.] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, Coll Med, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Musser, SM (corresponding author), Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, Coll Med, 1114 TAMU, College Stn, TX 77843 USA.	smusser@tamu.edu		Musser, Siegfried/0000-0002-7793-2557	National Institutes of Health [R01 GM065534]; Welch Foundation [BE-1541]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM065534 (to S. M. M.). This work was also supported by Welch Foundation Grant BE-1541 (to S. M. M.).	ANDERSSON H, 1994, EMBO J, V13, P2267, DOI 10.1002/j.1460-2075.1994.tb06508.x; AZZONE G, 1993, BIOCHIM BIOPHYS ACTA, V1183, P1, DOI 10.1016/0005-2728(93)90002-W; Bageshwar UK, 2009, MOL MICROBIOL, V74, P209, DOI 10.1111/j.1365-2958.2009.06862.x; Bauer BW, 2009, P NATL ACAD SCI USA, V106, P20800, DOI 10.1073/pnas.0910550106; Beck K, 2000, EMBO J, V19, P134, DOI 10.1093/emboj/19.1.134; Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Bonardi F, 2011, P NATL ACAD SCI USA, V108, P7775, DOI 10.1073/pnas.1101705108; CAO GQ, 1995, EMBO J, V14, P866, DOI 10.1002/j.1460-2075.1995.tb07068.x; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; Diamond DL, 1997, J BIOL CHEM, V272, P28994, DOI 10.1074/jbc.272.46.28994; Dominy Clifford N, 2003, Methods Mol Biol, V235, P209; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; DRIESSEN AJM, 1991, P NATL ACAD SCI USA, V88, P2471, DOI 10.1073/pnas.88.6.2471; DRIESSEN AJM, 1992, EMBO J, V11, P847, DOI 10.1002/j.1460-2075.1992.tb05122.x; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Duong F, 1998, EMBO J, V17, P696, DOI 10.1093/emboj/17.3.696; Duong F, 1999, EMBO J, V18, P3263, DOI 10.1093/emboj/18.12.3263; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Erlandson KJ, 2008, NATURE, V455, P984, DOI 10.1038/nature07439; Erlandson KJ, 2008, J BIOL CHEM, V283, P15709, DOI 10.1074/jbc.M710356200; GELLER B, 1993, J BIOL CHEM, V268, P9442; Gouridis G, 2009, NATURE, V462, P363, DOI 10.1038/nature08559; HARDY SJS, 1991, SCIENCE, V251, P439, DOI 10.1126/science.1989077; Harris CR, 1999, J BACTERIOL, V181, P3438, DOI 10.1128/JB.181.11.3438-3444.1999; Jilaveanu LB, 2007, J BIOL CHEM, V282, P4661, DOI 10.1074/jbc.M610828200; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; KIM YJ, 1994, CELL, V78, P845; Knoblauch NTM, 1999, J BIOL CHEM, V274, P34219, DOI 10.1074/jbc.274.48.34219; Koch HG, 1999, MOL BIOL CELL, V10, P2163, DOI 10.1091/mbc.10.7.2163; LI P, 1988, P NATL ACAD SCI USA, V85, P7685, DOI 10.1073/pnas.85.20.7685; Liang FC, 2009, MOL BIOL CELL, V20, P4256, DOI 10.1091/mbc.E09-01-0075; Musser SM, 2000, EUR J BIOCHEM, V267, P2588, DOI 10.1046/j.1432-1327.2000.01269.x; Nijeholt JALA, 2010, J BIOL CHEM, V285, P23747, DOI 10.1074/jbc.M110.124636; Nishiyama K, 1999, EMBO J, V18, P1049, DOI 10.1093/emboj/18.4.1049; Nishiyama KI, 2010, PROTEIN SCI, V19, P2402, DOI 10.1002/pro.520; Nouwen N, 1996, P NATL ACAD SCI USA, V93, P5953, DOI 10.1073/pnas.93.12.5953; Nouwen N, 2009, J MOL BIOL, V386, P1000, DOI 10.1016/j.jmb.2009.01.031; OCHMAN H, 1988, GENETICS, V120, P621; Ramamurthy V, 1997, J BIOL CHEM, V272, P23239, DOI 10.1074/jbc.272.37.23239; Randall LL, 1998, PROTEIN SCI, V7, P1195, DOI 10.1002/pro.5560070514; RANDALL LL, 1992, SCIENCE, V257, P241, DOI 10.1126/science.1631545; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Riondet C, 1999, EUR J BIOCHEM, V262, P595, DOI 10.1046/j.1432-1327.1999.00429.x; Rottenberg H, 1979, Methods Enzymol, V55, P547; Saparov SM, 2007, MOL CELL, V26, P501, DOI 10.1016/j.molcel.2007.03.022; Sardis MF, 2010, MOL MICROBIOL, V76, P1070, DOI 10.1111/j.1365-2958.2010.07176.x; Sato K, 1997, J BIOL CHEM, V272, P5880, DOI 10.1074/jbc.272.9.5880; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; SHIOZUKA K, 1990, J BIOL CHEM, V265, P18843; SIMON SM, 1992, P NATL ACAD SCI USA, V89, P3770, DOI 10.1073/pnas.89.9.3770; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; TANI K, 1990, J BIOL CHEM, V265, P17341; Tomkiewicz D, 2006, J BIOL CHEM, V281, P15709, DOI 10.1074/jbc.M600205200; van de Vossenberg JLCM, 1998, MOL MICROBIOL, V29, P1125, DOI 10.1046/j.1365-2958.1998.01001.x; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Wolk JPW, 1997, EMBO J, V16, P7297, DOI 10.1093/emboj/16.24.7297; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	62	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					12703	12714		10.1074/jbc.M111.240903	http://dx.doi.org/10.1074/jbc.M111.240903			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22367204	Green Published, hybrid			2022-12-27	WOS:000302903700010
J	Shi, K; Berghuis, AM				Shi, Kun; Berghuis, Albert M.			Structural Basis for Dual Nucleotide Selectivity of Aminoglycoside 2 ''-Phosphotransferase IVa Provides Insight on Determinants of Nucleotide Specificity of Aminoglycoside Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; STAPHYLOCOCCUS-AUREUS; CRYSTAL-STRUCTURES; RESISTANCE; BINDING; SUBSTRATE; ATP; CK2; PHOSPHOTRANSFERASE; ENTEROCOCCUS	Enzymatic phosphorylation through a family of enzymes called aminoglycoside O-phosphotransferases (APHs) is a major mechanism by which bacteria confer resistance to aminoglycoside antibiotics. Members of the APH(2 '') subfamily are of particular clinical interest because of their prevalence in pathogenic strains and their broad substrate spectra. APH(2 '') enzymes display differential preferences between ATP or GTP as the phosphate donor, with aminoglycoside 2 ''-phosphotransferase IVa (APH(2 '')-IVa) being a member that utilizes both nucleotides at comparable efficiencies. We report here four crystal structures of APH(2 '')-IVa, two of the wild type enzyme and two of single amino acid mutants, each in complex with either adenosine or guanosine. Together, these structures afford a detailed look at the nucleoside-binding site architecture for this enzyme and reveal key elements that confer dual nucleotide specificity, including a solvent network in the interior of the nucleoside-binding pocket and the conformation of an interdomain linker loop. Steady state kinetic studies, as well as sequence and structural comparisons with members of the APH(2 '') subfamily and other aminoglycoside kinases, rationalize the different substrate preferences for these enzymes. Finally, despite poor overall sequence similarity and structural homology, analysis of the nucleoside-binding pocket of APH(2 '')-IVa shows a striking resemblance to that of eukaryotic casein kinase 2 (CK2), which also exhibits dual nucleotide specificity. These results, in complement with the multitude of existing inhibitors against CK2, can serve as a structural basis for the design of nucleotide-competitive inhibitors against clinically relevant APH enzymes.	[Shi, Kun; Berghuis, Albert M.] McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada; [Berghuis, Albert M.] McGill Univ, Dept Microbiol & Immunol, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University	Berghuis, AM (corresponding author), McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, 3649 Promenade Sir William Osler,Rm 466, Montreal, PQ H3G 0B1, Canada.	albert.berghuis@mcgill.ca	Berghuis, Albert M/A-6495-2008	Berghuis, Albert/0000-0002-2663-025X	Canadian Institute of Health Research (CIHR) [MOP-13107]; CIHR Strategic Training Initiative in Chemical Biology	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Strategic Training Initiative in Chemical Biology(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institute of Health Research (CIHR) (Grant MOP-13107) (to A. M. B.).; Supported by the CIHR Strategic Training Initiative in Chemical Biology. Recipient of a CIHR Banting and Best Graduate Scholarship.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battistutta R, 2000, J BIOL CHEM, V275, P29618, DOI 10.1074/jbc.M004257200; Burk DL, 2002, PHARMACOL THERAPEUT, V93, P283, DOI 10.1016/S0163-7258(02)00197-3; Burk DL, 2001, BIOCHEMISTRY-US, V40, P8756, DOI 10.1021/bi010504p; Chandrakanth RK, 2008, CURR MICROBIOL, V56, P558, DOI 10.1007/s00284-008-9123-y; Chilin A, 2008, J MED CHEM, V51, P752, DOI 10.1021/jm070909t; Chow JW, 2000, CLIN INFECT DIS, V31, P586, DOI 10.1086/313949; Daigle DM, 1997, J BIOL CHEM, V272, P24755, DOI 10.1074/jbc.272.40.24755; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fong DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019589; Fong DH, 2010, J BIOL CHEM, V285, P9545, DOI 10.1074/jbc.M109.038364; GATICA M, 1993, FEBS LETT, V315, P173, DOI 10.1016/0014-5793(93)81157-U; GSCHWENDT M, 1995, BIOCHEM BIOPH RES CO, V206, P614, DOI 10.1006/bbrc.1995.1087; Hon WC, 1997, CELL, V89, P887, DOI 10.1016/S0092-8674(00)80274-3; MCKAY GA, 1994, BIOCHEMISTRY-US, V33, P6936, DOI 10.1021/bi00188a024; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nie Z, 2007, BIOORG MED CHEM LETT, V17, P4191, DOI 10.1016/j.bmcl.2007.05.041; Niefind K, 1999, NAT STRUCT BIOL, V6, P1100, DOI 10.1038/70033; Niefind K, 2009, CELL MOL LIFE SCI, V66, P1800, DOI 10.1007/s00018-009-9149-8; Nurizzo D, 2003, J MOL BIOL, V327, P491, DOI 10.1016/S0022-2836(03)00121-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schinkmann K, 1997, J BIOL CHEM, V272, P28695, DOI 10.1074/jbc.272.45.28695; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shakya T, 2011, CHEM BIOL, V18, P1591, DOI 10.1016/j.chembiol.2011.10.018; Shakya T, 2010, ANTIMICROB AGENTS CH, V54, P1909, DOI 10.1128/AAC.01570-09; Shi K, 2011, BIOCHEMISTRY-US, V50, P6237, DOI 10.1021/bi200747f; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith Clyde A., 2002, Current Drug Targets - Infectious Disorders, V2, P143, DOI 10.2174/1568005023342533; Toth M, 2010, PROTEIN SCI, V19, P1565, DOI 10.1002/pro.437; Toth M, 2009, J BIOL CHEM, V284, P6690, DOI 10.1074/jbc.M808148200; Yadegar A, 2009, MICROB DRUG RESIST, V15, P109, DOI 10.1089/mdr.2009.0897; Yde CW, 2005, J MOL BIOL, V347, P399, DOI 10.1016/j.jmb.2005.01.003; Young PG, 2009, J BACTERIOL, V191, P4133, DOI 10.1128/JB.00149-09; Zarrilli R, 2005, J ANTIMICROB CHEMOTH, V56, P827, DOI 10.1093/jac/dki347	34	19	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2012	287	16					13094	13102		10.1074/jbc.M112.349670	http://dx.doi.org/10.1074/jbc.M112.349670			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	927JO	22371504	Green Published, hybrid			2022-12-27	WOS:000302903700049
J	Liu, CC; Garcia, A; Mahmmoud, YA; Hamilton, EJ; Galougahi, KK; Fry, NAS; Figtree, GA; Cornelius, F; Clarke, RJ; Rasmussen, HH				Liu, Chia-Chi; Garcia, Alvaro; Mahmmoud, Yasser A.; Hamilton, Elisha J.; Galougahi, Keyvan Karimi; Fry, Natasha A. S.; Figtree, Gemma A.; Cornelius, Flemming; Clarke, Ronald J.; Rasmussen, Helge H.			Susceptibility of beta 1 Na+-K+ Pump Subunit to Glutathionylation and Oxidative Inhibition Depends on Conformational State of Pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-POTASSIUM PUMP; CRYSTAL-STRUCTURE; INTRACELLULAR NA+; ATPASE; ACTIVATION; SITES; IDENTIFICATION; PROTEINS	Glutathionylation of cysteine 46 of the beta 1 subunit of the Na+-K+ pump causes pump inhibition. However, the crystal structure, known in a state analogous to an E2.2K(+)center dot P-i configuration, indicates that the side chain of cysteine 46 is exposed to the lipid bulk phase of the membrane and not expected to be accessible to the cytosolic glutathione. We have examined whether glutathionylation depends on the conformational changes in the Na+-K+ pump cycle as described by the Albers-Post scheme. We measured beta 1 subunit glutathionylation and function of Na+-K+-ATPase in membrane fragments and in ventricular myocytes. Signals for glutathionylation in Na+-K+-ATPase-enriched membrane fragments suspended in solutions that preferentially induce E1ATP and E1Na(3) conformations were much larger than signals in solutions that induce the E2 conformation. Ouabain further reduced glutathionylation in E2 and eliminated an increase seen with exposure to the oxidant peroxynitrite (ONOO-). Inhibition of Na+-K+-ATPase activity after exposure to ONOO- was greater when the enzyme had been in the E1Na(3) than the E2 conformation. We exposed myocytes to different extracellular K+ concentrations to vary the membrane potential and hence voltage-dependent conformational poise. K+ concentrations expected to shift the poise toward E2 species reduced glutathionylation, and ouabain eliminated a ONOO--induced increase. Angiotensin II-induced NADPH oxidase-dependent Na+-K+ pump inhibition was eliminated by conditions expected to shift the poise toward the E2 species. We conclude that susceptibility of the beta 1 subunit to glutathionylation depends on the conformational poise of the Na+-K+ pump.	[Figtree, Gemma A.; Rasmussen, Helge H.] Royal N Shore Hosp, Dept Cardiol, St Leonards, NSW 2065, Australia; [Liu, Chia-Chi; Garcia, Alvaro; Hamilton, Elisha J.; Galougahi, Keyvan Karimi; Fry, Natasha A. S.; Figtree, Gemma A.; Rasmussen, Helge H.] Kolling Inst, N Shore Heart Res Grp, St Leonards, NSW 2065, Australia; [Clarke, Ronald J.] Univ Sydney, Sch Chem, Sydney, NSW 2000, Australia; [Mahmmoud, Yasser A.; Cornelius, Flemming] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; University of Sydney; Aarhus University	Rasmussen, HH (corresponding author), Royal N Shore Hosp, Dept Cardiol, St Leonards, NSW 2065, Australia.	helge.rasmussen@sydney.edu.au	Clarke, Ronald J/L-5259-2016; Hamilton, Elisha/F-8187-2010; Cornelius, Flemming/C-1912-2019; Garcia, Alvaro/E-6573-2015	Clarke, Ronald J/0000-0002-0950-8017; Hamilton, Elisha/0000-0002-1892-352X; Cornelius, Flemming/0000-0003-1566-0020; Garcia, Alvaro/0000-0002-1159-4567; Rasmussen, Helge/0000-0003-2409-4083	North Shore Heart Research Foundation; National Health & Medical Research Council (Australia) [633252]; Medical Foundation; University of Sydney; Viertel Charitable Foundation; Danish Medical Research Council; Danish Agency for Science, Technology and Innovation	North Shore Heart Research Foundation; National Health & Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Medical Foundation; University of Sydney(University of Sydney); Viertel Charitable Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Agency for Science, Technology and Innovation	The work was supported in part by a grant from the North Shore Heart Research Foundation and by Project Grant 633252 from the National Health & Medical Research Council (Australia).; Supported by the Medical Foundation, University of Sydney, and the Viertel Charitable Foundation.; Supported by the Danish Medical Research Council and the Danish Agency for Science, Technology and Innovation.	Almeida Ana G, 2004, Rev Port Cardiol, V23, P1277; BAGINSKI ES, 1967, CLIN CHIM ACTA, V15, P155, DOI 10.1016/0009-8981(67)90340-3; Bar Shimon M, 1998, J BIOL CHEM, V273, P34190, DOI 10.1074/jbc.273.51.34190; Bibert S, 2011, J BIOL CHEM, V286, P18562, DOI 10.1074/jbc.M110.184101; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Buhagiar KA, 1999, AM J PHYSIOL-CELL PH, V277, pC461, DOI 10.1152/ajpcell.1999.277.3.C461; Clavreul N, 2006, FASEB J, V20, P518, DOI 10.1096/fj.05-4875fje; Cooper AJL, 2011, EXPERT OPIN DRUG MET, V7, P891, DOI 10.1517/17425255.2011.577738; Cornelius F, 2011, J BIOL CHEM, V286, P29882, DOI 10.1074/jbc.M111.259663; Cornelius F, 2009, BIOCHEMISTRY-US, V48, P10056, DOI 10.1021/bi901212r; Dempski RE, 2009, BBA-BIOENERGETICS, V1787, P714, DOI 10.1016/j.bbabio.2009.03.021; Durr KL, 2009, J BIOL CHEM, V284, P3842, DOI 10.1074/jbc.M808101200; Dufaitre-Patouraux L, 2004, DIABETES METAB, V30, P471, DOI 10.1016/S1262-3636(07)70145-3; Figtree GA, 2009, CIRC RES, V105, P185, DOI 10.1161/CIRCRESAHA.109.199547; Gallogly MM, 2009, ANTIOXID REDOX SIGN, V11, P1059, DOI [10.1089/ars.2008.2291, 10.1089/ARS.2008.2291]; Gatto C, 2007, J MEMBRANE BIOL, V216, P49, DOI 10.1007/s00232-007-9028-x; Hansen PS, 2007, AM J PHYSIOL-CELL PH, V292, pC1070, DOI 10.1152/ajpcell.00288.2006; Hansen PS, 2002, AM J PHYSIOL-CELL PH, V283, pC1511, DOI 10.1152/ajpcell.01343.2000; Hansen RE, 2005, BIOCHEMISTRY-US, V44, P5899, DOI 10.1021/bi0500372; Harada K, 2006, J PHYSIOL SCI, V56, P113, DOI 10.2170/physiolsci.RP001905; HIRANO Y, 1988, J PHYSIOL-LONDON, V395, P455, DOI 10.1113/jphysiol.1988.sp016929; HOOL LC, 1995, AM J PHYSIOL-CELL PH, V268, pC366, DOI 10.1152/ajpcell.1995.268.2.C366; JORGENSEN PL, 1974, BIOCHIM BIOPHYS ACTA, V356, P53, DOI 10.1016/0005-2736(74)90293-4; JORGENSEN PL, 1986, BIOCHIM BIOPHYS ACTA, V860, P570, DOI 10.1016/0005-2736(86)90555-9; Klodos I, 2002, KIDNEY INT, V62, P2097, DOI 10.1046/j.1523-1755.2002.00654.x; Kong BY, 2004, BIOCHEMISTRY-US, V43, P2241, DOI 10.1021/bi0355443; LEE CO, 1975, J GEN PHYSIOL, V65, P695, DOI 10.1085/jgp.65.6.695; LUTSENKO S, 1994, J BIOL CHEM, V269, P4555; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; POST RL, 1965, J BIOL CHEM, V240, P1437; SAKMANN B, 1984, J PHYSIOL-LONDON, V347, P641, DOI 10.1113/jphysiol.1984.sp015088; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; STIMERS JR, 1990, J GEN PHYSIOL, V95, P77, DOI 10.1085/jgp.95.1.77; Sullivan DM, 2000, BIOCHEMISTRY-US, V39, P11121, DOI 10.1021/bi0007674; White CN, 2010, J BIOL CHEM, V285, P13712, DOI 10.1074/jbc.M109.090225; White CN, 2009, AM J PHYSIOL-CELL PH, V296, pC693, DOI 10.1152/ajpcell.00648.2008; William M, 2005, J PHYSIOL-LONDON, V565, P815, DOI 10.1113/jphysiol.2005.086447	40	38	39	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12353	12364		10.1074/jbc.M112.340893	http://dx.doi.org/10.1074/jbc.M112.340893			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22354969	Green Published, hybrid			2022-12-27	WOS:000302782200075
J	Liu, YC; Chen, ZJ; Burrows, SR; Purcell, AW; McCluskey, J; Rossjohn, J; Gras, S				Liu, Yu Chih; Chen, Zhenjun; Burrows, Scott R.; Purcell, Anthony W.; McCluskey, James; Rossjohn, Jamie; Gras, Stephanie			The Energetic Basis Underpinning T-cell Receptor Recognition of a Super-bulged Peptide Bound to a Major Histocompatibility Complex Class I Molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; BINDING; SPECIFICITY; IMPACT; LONG; BIAS	Although the major histocompatibility complex class I (MHC-I) molecules typically bind short peptide (p) fragments (8-10 amino acids in length), longer, "bulged" peptides are often be presented by MHC-I. Such bulged pMHC-I complexes represent challenges for T-cell receptor (TCR) ligation, although the general principles underscoring the interaction between TCRs and bulged pMHC-I complexes are unclear. To address this, we have explored the energetic basis of how an immunodominant TCR (termed SB27) binds to a 13-amino acid viral peptide (LPEPLPQGQLTAY) complexed to human leukocyte antigen (HLA) B*3508. Using the crystal structure of the SB27 TCR-HLA B*3508(LPEP) complex as a guide, we undertook a comprehensive alanine-scanning mutagenesis approach at the TCR-pMHC-I interface and examined the effect of the mutations by biophysical (affinity measurements) and cellular approaches (tetramer staining). Although the structural footprint on HLA B*3508 was small, the energetic footprint was even smaller in that only two HLA B*3508 residues were critical for the TCR interaction. Instead, the energetic basis of this TCR-pMHC-I interaction was attributed to peptide-mediated interactions in which the complementarity determining region 3 alpha and germline-encoded complementarity determining region 1 beta loops of the SB27 TCR played the principal role. Our findings highlight the peptide-centricity of TCR ligation toward a bulged pMHC-I complex.	[Liu, Yu Chih; Rossjohn, Jamie; Gras, Stephanie] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Chen, Zhenjun; McCluskey, James] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Purcell, Anthony W.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Purcell, Anthony W.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Burrows, Scott R.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Burrows, Scott R.] Australian Ctr Vaccine Dev, Brisbane, Qld 4006, Australia	Monash University; University of Melbourne; University of Melbourne; University of Melbourne; QIMR Berghofer Medical Research Institute		jamie.rossjohn@monash.edu; Stephanie.gras@monash.edu	McCluskey, James/A-1291-2007; Purcell, Anthony/AAH-1942-2019; gras, stephanie/C-8307-2013; Burrows, Scott/G-2050-2011; Rossjohn, Jamie/F-9032-2013	McCluskey, James/0000-0002-8597-815X; Purcell, Anthony/0000-0003-0532-8331; Burrows, Scott/0000-0002-1430-0472; Rossjohn, Jamie/0000-0002-2020-7522; gras, stephanie/0000-0001-7416-038X	Australian National Health and Medical Research Council (NHMRC); Australian Research Council; Monash University	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Monash University(Monash University)	This work was supported in part by the Australian National Health and Medical Research Council (NHMRC) and the Australian Research Council.; Supported by a Senior Fellowship from Monash University.	Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Bade-Doding C, 2011, HAEMATOL-HEMATOL J, V96, P110, DOI 10.3324/haematol.2010.030924; Baker BM, 2001, J EXP MED, V193, P551, DOI 10.1084/jem.193.5.551; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Bulek AM, 2012, NAT IMMUNOL, V13, P283, DOI 10.1038/ni.2206; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Burrows SR, 2006, TRENDS IMMUNOL, V27, P11, DOI 10.1016/j.it.2005.11.001; Day EB, 2011, P NATL ACAD SCI USA, V108, P9536, DOI 10.1073/pnas.1106851108; Ebert LM, 2009, CANCER RES, V69, P1046, DOI 10.1158/0008-5472.CAN-08-2926; Ely LK, 2006, P NATL ACAD SCI USA, V103, P6641, DOI 10.1073/pnas.0600743103; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; Gras S, 2008, CURR OPIN IMMUNOL, V20, P119, DOI 10.1016/j.coi.2007.12.001; Gras S, 2012, J IMMUNOL, V188, P311, DOI 10.4049/jimmunol.1102686; Gras S, 2010, J EXP MED, V207, P1555, DOI 10.1084/jem.20100603; Gras S, 2009, IMMUNITY, V30, P193, DOI 10.1016/j.immuni.2008.11.011; Hickman HD, 2004, J IMMUNOL, V172, P2944, DOI 10.4049/jimmunol.172.5.2944; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; Jones LL, 2008, BIOCHEMISTRY-US, V47, P12398, DOI 10.1021/bi801349g; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miles JJ, 2005, J IMMUNOL, V175, P3826, DOI 10.4049/jimmunol.175.6.3826; Miles JJ, 2006, J IMMUNOL, V177, P6804, DOI 10.4049/jimmunol.177.10.6804; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Speir JA, 2001, IMMUNITY, V14, P81, DOI 10.1016/S1074-7613(01)00091-7; Stadinski BD, 2011, IMMUNITY, V35, P694, DOI 10.1016/j.immuni.2011.10.012; Theodossis A, 2010, P NATL ACAD SCI USA, V107, P5534, DOI 10.1073/pnas.1000032107; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2005, J BIOL CHEM, V280, P23900, DOI 10.1074/jbc.M503060200; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920	41	24	25	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12267	12276		10.1074/jbc.M112.344689	http://dx.doi.org/10.1074/jbc.M112.344689			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22343629	Green Published, hybrid			2022-12-27	WOS:000302782200067
J	Netz, DJA; Pierik, AJ; Stumpfig, M; Bill, E; Sharma, AK; Pallesen, LJ; Walden, WE; Lill, R				Netz, Daili J. A.; Pierik, Antonio J.; Stuempfig, Martin; Bill, Eckhard; Sharma, Anil K.; Pallesen, Leif J.; Walden, William E.; Lill, Roland			A Bridging [4Fe-4S] Cluster and Nucleotide Binding Are Essential for Function of the Cfd1-Nbp35 Complex as a Scaffold in Iron-Sulfur Protein Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RES; 2-HYDROXYGLUTARYL-COA DEHYDRATASE; ACIDAMINOCOCCUS-FERMENTANS; NBP35; BIOGENESIS; COMPONENT; BIOSYNTHESIS; TRAFFICKING; MECHANISMS; EUKARYOTES	The essential P-loop NTPases Cfd1 and Nbp35 of the cytosolic iron-sulfur (Fe-S) protein assembly machinery perform a scaffold function for Fe-S cluster synthesis. Both proteins contain a nucleotide binding motif of unknown function and a C-terminal motif with four conserved cysteine residues. The latter motif defines the Mrp/Nbp35 subclass of P-loop NTPases and is suspected to be involved in transient Fe-S cluster binding. To elucidate the function of these two motifs, we first created cysteine mutant proteins of Cfd1 and Nbp35 and investigated the consequences of these mutations by genetic, cell biological, biochemical, and spectroscopic approaches. The two central cysteine residues (CPXC) of the C-terminal motif were found to be crucial for cell viability, protein function, coordination of a labile [4Fe-4S] cluster, and Cfd1-Nbp35 hetero-tetramer formation. Surprisingly, the two proximal cysteine residues were dispensable for all these functions, despite their strict evolutionary conservation. Several lines of evidence suggest that the C-terminal CPXC motifs of Cfd1-Nbp35 coordinate a bridging [4Fe-4S] cluster. Upon mutation of the nucleotide binding motifs Fe-S clusters could no longer be assembled on these proteins unless wild-type copies of Cfd1 and Nbp35 were present in trans. This result indicated that Fe-S cluster loading on these scaffold proteins is a nucleotide-dependent step. We propose that the bridging coordination of the C-terminal Fe-S cluster may be ideal for its facile assembly, labile binding, and efficient transfer to target Fe-S apoproteins, a step facilitated by the cytosolic iron-sulfur (Fe-S) protein assembly proteins Nar1 and Cia1 in vivo.	[Netz, Daili J. A.; Pierik, Antonio J.; Stuempfig, Martin; Lill, Roland] Univ Marburg, Inst Zytobiol & Zytopathol, D-35032 Marburg, Germany; [Bill, Eckhard] Max Planck Inst Bioanorgan Chem, D-45470 Mulheim An Der Ruhr, Germany; [Sharma, Anil K.; Pallesen, Leif J.; Walden, William E.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Sharma, Anil K.] MM Univ, Dept Biotechnol, Mullana Ambala 133207, India	Philipps University Marburg; Max Planck Society; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Maharishi Markandeshwar University	Lill, R (corresponding author), Univ Marburg, Inst Zytobiol & Zytopathol, Robert Koch Str 6, D-35032 Marburg, Germany.	Lill@staff.uni-marburg.de	Sharma, Anil K./AAP-1909-2020; Pierik, Antonio J/G-1108-2010	Sharma, Anil K./0000-0002-9768-1644; Pierik, Antonio J/0000-0002-1509-6370; Lill, Roland/0000-0002-8345-6518	National Institutes of Health [DK047281]; Deutsche Forschungsgemeinschaft [SFB 593, TR1, GRK 1216]; Rhon Klinikum AG; von Behring-Rontgen Stiftung; Max-Planck Gesellschaft; Fonds der chemischen Industrie; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Rhon Klinikum AG; von Behring-Rontgen Stiftung; Max-Planck Gesellschaft(Max Planck Society); Fonds der chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK047281 (to W. E. W.). This work was also supported by Deutsche Forschungsgemeinschaft (SFB 593 and TR1, Gottfried-Wilhelm Leibniz program, and GRK 1216), Rhon Klinikum AG, von Behring-Rontgen Stiftung, Max-Planck Gesellschaft, and Fonds der chemischen Industrie (to R.L.).	Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Barthelme D, 2007, J BIOL CHEM, V282, P14598, DOI 10.1074/jbc.M700825200; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Boll M, 1997, EUR J BIOCHEM, V244, P840, DOI 10.1111/j.1432-1033.1997.00840.x; Bonomi F, 2008, BIOCHEMISTRY-US, V47, P12795, DOI 10.1021/bi801565j; Boyd JM, 2008, BIOCHEMISTRY-US, V47, P8195, DOI 10.1021/bi800551y; Brazzolotto X, 2006, J BIOL CHEM, V281, P769, DOI 10.1074/jbc.M510310200; Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98; Bych K, 2008, J BIOL CHEM, V283, P35797, DOI 10.1074/jbc.M807303200; Chandramouli K, 2006, BIOCHEMISTRY-US, V45, P11087, DOI 10.1021/bi061237w; Dutkiewicz R, 2006, J BIOL CHEM, V281, P7801, DOI 10.1074/jbc.M513301200; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; HAGEN WR, 1985, FEBS LETT, V189, P250, DOI 10.1016/0014-5793(85)81033-4; HAGEN WR, 1992, ADV INORG CHEM, V38, P165, DOI 10.1016/S0898-8838(08)60064-1; Hans M, 2000, EUR J BIOCHEM, V267, P7082, DOI 10.1046/j.1432-1327.2000.01809.x; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; Heinnickel M, 2006, BIOCHEMISTRY-US, V45, P6756, DOI 10.1021/bi060031s; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jeoung JH, 2010, J MOL BIOL, V396, P1165, DOI 10.1016/j.jmb.2009.12.062; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Krauss N, 1996, NAT STRUCT BIOL, V3, P965, DOI 10.1038/nsb1196-965; Kuhnke G, 2006, MOL MEMBR BIOL, V23, P173, DOI 10.1080/09687860500473630; Lee CC, 2009, P NATL ACAD SCI USA, V106, P18474, DOI 10.1073/pnas.0909149106; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; LINDAHL PA, 1985, J BIOL CHEM, V260, P1160; Locher KP, 2001, J MOL BIOL, V307, P297, DOI 10.1006/jmbi.2000.4496; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Seemann M, 2005, J BIOL INORG CHEM, V10, P131, DOI 10.1007/s00775-004-0619-z; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Shen G, 2007, J BIOL CHEM, V282, P31909, DOI 10.1074/jbc.M705554200; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Song DS, 2008, J BIOL CHEM, V283, P9231, DOI 10.1074/jbc.M708077200; Srinivasan V, 2007, STRUCTURE, V15, P1246, DOI 10.1016/j.str.2007.08.009; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Urzica E, 2009, BIOCHEMISTRY-US, V48, P4946, DOI 10.1021/bi900312x; Vitale G, 1996, GENE, V178, P97, DOI 10.1016/0378-1119(96)00341-1; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; Zambelli B, 2009, PROTEINS, V74, P222, DOI 10.1002/prot.22205; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	57	75	77	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					12365	12378		10.1074/jbc.M111.328914	http://dx.doi.org/10.1074/jbc.M111.328914			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22362766	Green Published, hybrid			2022-12-27	WOS:000302782200076
J	Olsen, JS; DiMaio, JTM; Doran, TM; Brown, C; Nilsson, BL; Dewhurst, S				Olsen, Joanna S.; DiMaio, John T. M.; Doran, Todd M.; Brown, Caitlin; Nilsson, Bradley L.; Dewhurst, Stephen			Seminal Plasma Accelerates Semen-derived Enhancer of Viral Infection (SEVI) Fibril Formation by the Prostatic Acid Phosphatase (PAP(248-286)) Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; AMYLOID FIBRILS; HIV-INFECTION; ALZHEIMERS-DISEASE; ZINC SALTS; IN-VITRO; TRANSMISSION; MECHANISM; KINETICS; INHIBITION	Amyloid fibrils contained in semen, known as SEVI, or semen-derived enhancer of viral infection, have been shown to increase the infectivity of HIV dramatically. However, previous work with these fibrils has suggested that extensive time and nonphysiologic levels of agitation are necessary to induce amyloid formation from the precursor peptide (a proteolytic cleavage product of prostatic acid phosphatase, PAP(248-286)). Here, we show that fibril formation by PAP(248-286) is accelerated dramatically in the presence of seminal plasma (SP) and that agitation is not required for fibrillization in this setting. Analysis of the effects of specific SP components on fibril formation by PAP(248-286) revealed that this effect is primarily due to the anionic buffer components of SP (notably inorganic phosphate and sodium bicarbonate). Divalent cations present in SP had little effect on the kinetics of fibril formation, but physiologic levels of Zn2+ strongly protected SEVI fibrils from degradation by seminal proteases. Taken together, these data suggest that in the in vivo environment, PAP(248-286) is likely to form fibrils efficiently, thus providing an explanation for the presence of SEVI in human semen.	[Dewhurst, Stephen] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Sch Med & Dent, Rochester, NY 14642 USA; [DiMaio, John T. M.; Doran, Todd M.; Nilsson, Bradley L.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA	University of Rochester; University of Rochester	Dewhurst, S (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Sch Med & Dent, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	stephen_dewhurst@urmc.rochester.edu	Nilsson, Bradley/P-3718-2016	Nilsson, Bradley/0000-0003-1193-3693; Dewhurst, Stephen/0000-0001-7729-7920	National Institutes of Health [R01AI084111, T32GM007356, T32DA007232]; Creative and Novel Ideas in HIV Research award; University of Rochester Developmental Center for AIDS [P30AI078498]; DuPont young professors award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094511, P30AI078498, R01AI084111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007232] Funding Source: NIH RePORTER; Division Of Chemistry [0840410] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Creative and Novel Ideas in HIV Research award; University of Rochester Developmental Center for AIDS; DuPont young professors award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI084111 (to S. D.), T32GM007356 (to J. S. O.), and T32DA007232 (to J. S. O.). This work was also supported by a Creative and Novel Ideas in HIV Research award (to B. L. N.), by University of Rochester Developmental Center for AIDS Research Grant P30AI078498, and by a DuPont young professors award (to B. L. N.).	Alies B, 2011, J BIOL INORG CHEM, V16, P333, DOI 10.1007/s00775-010-0729-8; Arens M, 2000, J CLIN MICROBIOL, V38, P1758, DOI 10.1128/JCM.38.5.1758-1762.2000; Arnold F, 2012, J VIROL, V86, P1244, DOI 10.1128/JVI.06121-11; Balandya E, 2010, J IMMUNOL, V185, P7596, DOI 10.4049/jimmunol.1002846; Bourne N, 2005, ANTIMICROB AGENTS CH, V49, P1181, DOI 10.1128/AAC.49.3.1181-1183.2005; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Doncel GF, 2011, AM J REPROD IMMUNOL, V65, P292, DOI 10.1111/j.1600-0897.2010.00931.x; Easterhoff D, 2011, BIOPHYS J, V100, P1325, DOI 10.1016/j.bpj.2011.01.037; Fernandez-Romero JA, 2012, ANTIMICROB AGENTS CH, V56, P358, DOI 10.1128/AAC.05461-11; Goldblatt MW, 1935, BIOCHEM J, V29, P1346, DOI 10.1042/bj0291346; Haraguchi Y, 1999, ANTIVIR RES, V43, P123, DOI 10.1016/S0166-3542(99)00040-6; Harrison GA, 1933, BIOCHEM J, V27, P1152, DOI 10.1042/bj0271152; Huggins Charles, 1942, AMER JOUR PHYSIOL, V136, P467; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; KAVANAGH JP, 1985, J REPROD FERTIL, V75, P35; Kenney J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015835; Kim KA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-55; KUMEL G, 1990, J GEN VIROL, V71, P2989, DOI 10.1099/0022-1317-71-12-2989; Lee CH, 1996, J PHARM SCI, V85, P649, DOI 10.1021/js9501573; Malm J, 2000, PROSTATE, V45, P132, DOI 10.1002/1097-0045(20001001)45:2<132::AID-PROS7>3.0.CO;2-3; Martellini JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016285; MILLER CJ, 1994, J VIROL, V68, P6391, DOI 10.1128/JVI.68.10.6391-6400.1994; Morel B, 2010, BIOPHYS J, V99, P3801, DOI 10.1016/j.bpj.2010.10.039; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Neildez O, 1998, VIROLOGY, V243, P12, DOI 10.1006/viro.1997.9026; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Owen DH, 2005, J ANDROL, V26, P459, DOI 10.2164/jandrol.04104; Pfefferkorn CM, 2010, P NATL ACAD SCI USA, V107, P21447, DOI 10.1073/pnas.1006424107; Roan NR, 2011, CELL HOST MICROBE, V10, P541, DOI 10.1016/j.chom.2011.10.010; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; Sabatte J, 2007, J VIROL, V81, P13723, DOI 10.1128/JVI.01079-07; Shammas SL, 2011, BIOPHYS J, V100, P2783, DOI 10.1016/j.bpj.2011.04.039; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Straub JE, 2011, ANNU REV PHYS CHEM, V62, P437, DOI 10.1146/annurev-physchem-032210-103526; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Ye ZQ, 2009, BIOCHEMISTRY-US, V48, P11582, DOI 10.1021/bi901709j; ZHANG ZY, 1991, BIOCHEMISTRY-US, V30, P8717, DOI 10.1021/bi00100a001; Zhou Z, 2009, J BIOL CHEM, V284, P30148, DOI 10.1074/jbc.M109.002832	39	39	40	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11842	11849		10.1074/jbc.M111.314336	http://dx.doi.org/10.1074/jbc.M111.314336			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22354963	hybrid, Green Published			2022-12-27	WOS:000302782200023
J	Tanaka, K; Matsumoto, E; Higashimaki, Y; Katagiri, T; Sugimoto, T; Seino, S; Kaji, H				Tanaka, Ken-ichiro; Matsumoto, Erika; Higashimaki, Yoshiko; Katagiri, Takenobu; Sugimoto, Toshitsugu; Seino, Susumu; Kaji, Hiroshi			Role of Osteoglycin in the Linkage between Muscle and Bone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; ALKALINE-PHOSPHATASE ACTIVITY; MOLECULAR-CLONING; HIGH EXPRESSION; DIFFERENTIATION; IDENTIFICATION; GENES; SMAD3; MASS; MINERALIZATION	The interaction between muscle tissues and bone metabolism is incompletely understood. We hypothesized that there might be some humoral factors that are produced in muscle tissues and exhibit bone anabolic activity. We, therefore, performed comparative DNA microarray analysis between mouse myoblastic C2C12 cells transfected with either stable empty vector or ALK2 (R206H), the mutation that constitutively activates the bone morphogenetic protein (BMP) receptor, to search for muscle-derived bone anabolic factors. Twenty-five genes whose expression was decreased to <1/4, were identified; these included osteoglycin (OGN). Stable overexpression of OGN significantly decreased the levels of Runx2 and Osterix mRNA compared with those in cells transfected with vector alone in MC3T3-E1 cells. On the other hand, it significantly enhanced the levels of alkaline phosphatase (ALP), type I collagen (Col1), and osteocalcin (OCN) mRNA as well as beta-catenin and mineralization. A reduction in endogenous OGN level showed the opposite effects to those of OGN overexpression in MC3T3-E1 and mouse calvarial osteoblastic cells. Transient OGN overexpression significantly suppressed the levels of Runx2, Osterix, ALP, Col1, and OCN mRNA induced by BMP-2 in C2C12 cells. The conditioned medium from OGN-overexpressed and OGN-suppressed myoblastic cells enhanced and decreased, respectively, the levels of ALP, Col1, and beta-catenin in MC3T3-E1 cells. Moreover, OGNincreased Smad3/4-responsive transcriptional activity as well as Col1 mRNA levels independently of endogenous TGF-beta in these cells. In conclusion, this study suggests that OGN may be a crucial humoral bone anabolic factor that is produced by muscle tissues.	[Kaji, Hiroshi] Kinki Univ, Fac Med, Dept Physiol & Regenerat Med, Osaka 5898511, Japan; [Tanaka, Ken-ichiro; Matsumoto, Erika; Higashimaki, Yoshiko; Seino, Susumu; Kaji, Hiroshi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet & Endocrinol, Kobe, Hyogo 6500017, Japan; [Tanaka, Ken-ichiro; Sugimoto, Toshitsugu] Shimane Univ, Fac Med, Izumo, Shimane 6938501, Japan; [Katagiri, Takenobu] Saitama Med Univ, Res Ctr Genom Med, Div Pathophysiol, Hidaka, Saitama 3501241, Japan; [Seino, Susumu; Kaji, Hiroshi] Kobe Univ, Grad Sch Med, Dept Physiol & Cellular Biol, Div Cellular & Mol Med, Kobe, Hyogo 6500017, Japan	Kindai University (Kinki University); Kobe University; Shimane University; Saitama Medical University; Kobe University	Kaji, H (corresponding author), Kinki Univ, Fac Med, Dept Physiol & Regenerat Med, 377-2 Ohno Higashi, Osaka 5898511, Japan.	hkaji@med.kindai.ac.jp	Kaji, Hiroshi/AAI-5628-2020		Ministry of Education, Culture, Sports, and Science; Ministry of Science, Education, and Culture of Japan [21591179]; Grants-in-Aid for Scientific Research [21591179] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Science, Education, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant from the Global COE Program F11 from the Ministry of Education, Culture, Sports, and Science and Grant-in-aid 21591179 from the Ministry of Science, Education, and Culture of Japan (to H. K).	Balint E, 2003, J CELL BIOCHEM, V89, P401, DOI 10.1002/jcb.10515; Beecher N, 2005, INVEST OPHTH VIS SCI, V46, P4046, DOI 10.1167/iovs.05-0325; BENTZ H, 1989, J BIOL CHEM, V264, P20805; Borton AJ, 2001, J BONE MINER RES, V16, P1754, DOI 10.1359/jbmr.2001.16.10.1754; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Capozza RF, 2008, MENOPAUSE, V15, P905, DOI 10.1097/gme.0b013e318164ee85; Chan CY, 2011, MOL CELL PROTEOMICS, V10, DOI DOI 10.1074/mcp.m110.004804; Chan XCY, 2007, J PROTEOME RES, V6, P698, DOI 10.1021/pr060448k; Cui XN, 2009, WORLD J GASTROENTERO, V15, P6117, DOI 10.3748/wjg.15.6117; Cui XN, 2008, ACTA BIOCH BIOPH SIN, V40, P349, DOI 10.1111/j.1745-7270.2008.00392.x; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Febbraio MA, 2004, DIABETES, V53, P1643, DOI 10.2337/diabetes.53.7.1643; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fukuda T, 2009, J BIOL CHEM, V284, P7149, DOI 10.1074/jbc.M801681200; Ge GX, 2004, J BIOL CHEM, V279, P41626, DOI 10.1074/jbc.M406630200; Glass GE, 2011, P NATL ACAD SCI USA, V108, P1585, DOI 10.1073/pnas.1018501108; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hisa I, 2011, J BIOL CHEM, V286, P9787, DOI 10.1074/jbc.M110.179127; Inoue Y, 2009, J CELL BIOCHEM, V108, P285, DOI 10.1002/jcb.22252; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Kampmann A, 2009, MOL CELL BIOCHEM, V322, P15, DOI 10.1007/s11010-008-9935-x; Kaplan FS, 2008, BEST PRACT RES CL RH, V22, P191, DOI 10.1016/j.berh.2007.11.007; Kapur S, 2010, J BIOL CHEM, V285, P37607, DOI 10.1074/jbc.M110.169714; Karsenty G, 2010, J CLIN ENDOCR METAB, V95, P4795, DOI 10.1210/jc.2010-1030; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Khosla S, 1996, J BONE MINER RES, V11, P857; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; MADISEN L, 1990, DNA CELL BIOL, V9, P303, DOI 10.1089/dna.1990.9.303; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Nakaoka D, 2001, OSTEOPOROSIS INT, V12, P548, DOI 10.1007/s001980170075; Osawa A, 2006, GENOMICS, V88, P52, DOI 10.1016/j.ygeno.2006.02.013; Patel MJ, 2007, J CELL BIOCHEM, V101, P587, DOI 10.1002/jcb.21218; Pedersen BK, 2009, J APPL PHYSIOL, V107, P1006, DOI 10.1152/japplphysiol.00734.2009; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; RICHARDS RR, 1991, J BONE JOINT SURG AM, V73A, P1323, DOI 10.2106/00004623-199173090-00006; Shanahan CM, 1997, ARTERIOSCL THROM VAS, V17, P2437, DOI 10.1161/01.ATV.17.11.2437; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Sowa H, 2002, J BONE MINER RES, V17, P1190, DOI 10.1359/jbmr.2002.17.7.1190; Sowa H, 2004, J BIOL CHEM, V279, P40267, DOI 10.1074/jbc.M401312200; Sowa H, 2002, J BIOL CHEM, V277, P36024, DOI 10.1074/jbc.M206030200; Tasheva E, 2004, MOL VIS, V10, P758; Tasheva ES, 1999, J BIOL CHEM, V274, P18693, DOI 10.1074/jbc.274.26.18693; Tasheva ES, 2003, MOL VIS, V9, P277; Tasheva ES, 2002, BBA-GENE STRUCT EXPR, V1575, P123, DOI 10.1016/S0167-4781(02)00245-2; Tasheva ES, 2002, MOL VIS, V8, P407; Tu QS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.152405; Utvag SE, 2003, J ORTHOP TRAUMA, V17, P430, DOI 10.1097/00005131-200307000-00007; van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Williamson RE, 2008, HEARING RES, V237, P57, DOI 10.1016/j.heares.2007.12.006; Xing WR, 2005, J CELL BIOCHEM, V96, P1049, DOI 10.1002/jcb.20606	53	85	91	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2012	287	15					11616	11628		10.1074/jbc.M111.292193	http://dx.doi.org/10.1074/jbc.M111.292193			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925SR	22351757	hybrid, Green Published			2022-12-27	WOS:000302782200002
J	Karman, J; Jiang, JL; Gumlaw, N; Zhao, HM; Campos-Rivera, J; Sancho, J; Zhang, JH; Jiang, CW; Cheng, SH; Zhu, YX				Karman, Jozsef; Jiang, Ji-Lei; Gumlaw, Nathan; Zhao, Hongmei; Campos-Rivera, Juanita; Sancho, Jose; Zhang, Jinhua; Jiang, Canwen; Cheng, Seng H.; Zhu, Yunxiang			Ligation of Cytotoxic T Lymphocyte Antigen-4 to T Cell Receptor Inhibits T Cell Activation and Directs Differentiation into Foxp3(+) Regulatory T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; IMMUNOLOGICAL SYNAPSE; PERIPHERAL HOMEOSTASIS; NEGATIVE REGULATOR; CTLA-4 SUPPRESSES; CUTTING EDGE; CD28; ENGAGEMENT; INDUCTION; TOLERANCE	Background: Cross-linking of TCR to CTLA-4 attenuates TCR signaling and inhibits T activation. Results: A novel bispecific fusion protein comprising CD80 mutant (CD80w88a) and LAG-3 was designed to promote TCR and CTLA-4 cross-linking via MHCII. Conclusion: TCR and CTLA-4 cross-linking resulted in T cell inhibition and Foxp3(+) regulatory T cell differentiation. Significance: This novel bispecific protein may represent a new class of therapeutics for immune modulation.	[Karman, Jozsef; Jiang, Ji-Lei; Gumlaw, Nathan; Zhao, Hongmei; Campos-Rivera, Juanita; Sancho, Jose; Zhang, Jinhua; Jiang, Canwen; Cheng, Seng H.; Zhu, Yunxiang] Genzyme Corp, Framingham, MA 01701 USA	Sanofi-Aventis; Genzyme Corporation	Zhu, YX (corresponding author), Genzyme Corp, 49 New York Ave, Framingham, MA 01701 USA.	yunxiang.zhu@genzyme.com	Cheng, Seng H/AAC-6564-2022					BAIXERAS E, 1992, J EXP MED, V176, P327, DOI 10.1084/jem.176.2.327; Baroja ML, 2002, J IMMUNOL, V168, P5070, DOI 10.4049/jimmunol.168.10.5070; Blair PJ, 1998, J IMMUNOL, V160, P12; Bluestone JA, 2006, IMMUNITY, V24, P233, DOI 10.1016/j.immuni.2006.03.001; Bour-Jordan H, 2009, IMMUNOL REV, V229, P41, DOI 10.1111/j.1600-065X.2009.00775.x; Chen WJ, 1998, J EXP MED, V188, P1849, DOI 10.1084/jem.188.10.1849; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; Cools N, 2008, J CELL MOL MED, V12, P690, DOI 10.1111/j.1582-4934.2007.00084.x; Darlington PJ, 2002, J EXP MED, V195, P1337, DOI 10.1084/jem.20011868; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Eagar TN, 2002, EUR J IMMUNOL, V32, P972, DOI 10.1002/1521-4141(200204)32:4<972::AID-IMMU972>3.0.CO;2-M; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Fife BT, 2006, J CLIN INVEST, V116, P2252, DOI 10.1172/JCI27856; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Friedline RH, 2009, J EXP MED, V206, P421, DOI 10.1084/jem.20081811; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Griffin MD, 2000, J IMMUNOL, V164, P4433, DOI 10.4049/jimmunol.164.9.4433; Griffin MD, 2001, J IMMUNOL METHODS, V248, P77, DOI 10.1016/S0022-1759(00)00344-6; Guntermann C, 2002, J IMMUNOL, V168, P4420, DOI 10.4049/jimmunol.168.9.4420; Haribhai D, 2007, J IMMUNOL, V178, P2961, DOI 10.4049/jimmunol.178.5.2961; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Jago CB, 2004, CLIN EXP IMMUNOL, V136, P463, DOI 10.1111/j.1365-2249.2004.02478.x; Jain N, 2010, P NATL ACAD SCI USA, V107, P1524, DOI 10.1073/pnas.0910341107; Karandikar NJ, 1996, J EXP MED, V184, P783, DOI 10.1084/jem.184.2.783; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Li RB, 2007, J IMMUNOL, V179, P5191, DOI 10.4049/jimmunol.179.8.5191; Linsley PS, 2009, IMMUNOL REV, V229, P307, DOI 10.1111/j.1600-065X.2009.00780.x; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; Paterson AM, 2010, NAT IMMUNOL, V11, P109, DOI 10.1038/ni0210-109; Pentcheva-Hoang T, 2004, IMMUNITY, V21, P401, DOI 10.1016/j.immuni.2004.06.017; Rao S, 2001, CLIN IMMUNOL, V101, P136, DOI 10.1006/clim.2001.5119; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schmidt EM, 2009, J IMMUNOL, V182, P274, DOI 10.4049/jimmunol.182.1.274; Selvaraj RK, 2007, J IMMUNOL, V178, P7667, DOI 10.4049/jimmunol.178.12.7667; Tang QZ, 2004, EUR J IMMUNOL, V34, P2996, DOI 10.1002/eji.200425143; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; TRIEBEL F, 1990, J EXP MED, V171, P1393, DOI 10.1084/jem.171.5.1393; Turner MS, 2009, J IMMUNOL, V183, P4895, DOI 10.4049/jimmunol.0901459; Vasu C, 2004, J IMMUNOL, V173, P2866, DOI 10.4049/jimmunol.173.4.2866; Vasu C, 2003, INT IMMUNOL, V15, P167, DOI 10.1093/intimm/dxg017; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Walunas TL, 1998, J IMMUNOL, V160, P3855; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wu Y, 1997, J EXP MED, V185, P1327, DOI 10.1084/jem.185.7.1327	48	24	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2012	287	14					11098	11107		10.1074/jbc.M111.283705	http://dx.doi.org/10.1074/jbc.M111.283705			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	925RY	22337882	Green Published, hybrid			2022-12-27	WOS:000302780100038
